Citrus Sinensis ID: 003121
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 846 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GUH1 | 834 | U-box domain-containing p | yes | no | 0.904 | 0.917 | 0.553 | 0.0 | |
| Q94A51 | 805 | U-box domain-containing p | no | no | 0.529 | 0.556 | 0.423 | 7e-97 | |
| Q9SW11 | 835 | U-box domain-containing p | no | no | 0.853 | 0.864 | 0.304 | 4e-86 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.477 | 0.478 | 0.385 | 1e-80 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.399 | 0.424 | 0.446 | 2e-79 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.404 | 0.660 | 0.427 | 7e-79 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.420 | 0.434 | 0.419 | 2e-78 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.365 | 0.385 | 0.407 | 7e-68 | |
| O80623 | 815 | Probable receptor-like pr | no | no | 0.310 | 0.322 | 0.385 | 6e-51 | |
| C0LGQ7 | 898 | Probable LRR receptor-lik | no | no | 0.329 | 0.310 | 0.388 | 2e-50 |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 874 bits (2257), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/836 (55%), Positives = 586/836 (70%), Gaps = 71/836 (8%)
Query: 1 MALVSSVPAIAQGVDSVRCPDIQMAGITSSRRGIVEEPVASVIEDKIYVAVAKQVKESKS 60
MALVS +PA+ + S+R I G SSR GI++EPV+ +I++KI+VAV K V +SKS
Sbjct: 1 MALVSPIPAMGERAGSMRFHGIGSPGSRSSRSGIMDEPVSRLIDEKIFVAVDKHVAKSKS 60
Query: 61 VLLWALQNSGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDM 120
L+WALQN+GGK+IC+IHVH P+QMIP+MG KFP +++EE+V+ +RE ER+ +H LD
Sbjct: 61 TLIWALQNTGGKKICLIHVHQPSQMIPLMGAKFPVGAVKEEEVRVFREKEREKVHMILDD 120
Query: 121 CLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKA 180
L IC+Q GVRAEK+ E ES E GI++LIS GIRKLVMGAAAD+HY ++M DLKS+KA
Sbjct: 121 YLRICQQRGVRAEKMFIEMESIENGIVQLISELGIRKLVMGAAADRHYSRRMTDLKSRKA 180
Query: 181 ISVRQQAPASCHIWFICNGNLIYTREGSLDGIDPEISSPS--------FQASHNTENRHP 232
I VR++AP C IWF C G LI+TRE ++D + E +SP Q E+ H
Sbjct: 181 IFVRREAPTLCQIWFTCKGYLIHTREATMDDTESEYASPRPSISASDLLQTFSTPESEHQ 240
Query: 233 NCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFDRNVGNVMTSQDSIGGLSSPASRSDA 292
+ R QS T+ VQ L V N +++ S SD
Sbjct: 241 HISRVQS-----------TDSVQQL------------VSNGSSTEQS-------GRVSDG 270
Query: 293 EVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIPLIRTEGVSTLPPSKEDLQSSPPSVLDG 352
+++DE S GS G +T+ S SS P DG
Sbjct: 271 SLNTDE---EERESDGS------------------EVTGSATVMSSGHSSPSSFP---DG 306
Query: 353 SVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRK 412
VDD+ ++ +A +EA +S++EAF E LRR KAEK+A+++IRRAK SES Y+EELKRRK
Sbjct: 307 -VDDSFNVKIRKATSEAHSSKQEAFAETLRRQKAEKNALDAIRRAKQSESAYSEELKRRK 365
Query: 413 EFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVE 472
+ E A+A K +K + + +MEELQ A+ QK++LESQIA+SD T ++L QK+ AV+
Sbjct: 366 DTEIAVAKEKERFITIKNEQEVIMEELQSAMAQKAMLESQIAKSDGTMEKLNQKLDIAVK 425
Query: 473 LLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDP 532
LLQ + E++ELQ ERD+A++EAEELR + +S+ +PQ+F+DFSFSEIE AT++FD
Sbjct: 426 LLQKLRDEREELQTERDRALREAEELRSHAE--TSTLQLPQYFTDFSFSEIEEATNHFDS 483
Query: 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
+LKIGEGGYGSIY GLLRH QVAIKML+P+S QGP E+QQE+D+LSK+RHPN++TL+GAC
Sbjct: 484 TLKIGEGGYGSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNIITLIGAC 543
Query: 593 PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 652
PE W+LVYEYLP GSLEDRL+CKDNSPPLSWQ R+RIATE+C+ L+FLHS K HS+VHGD
Sbjct: 544 PEGWSLVYEYLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKAHSLVHGD 603
Query: 653 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 712
LKPANILLD+N VSKLSDFG L N S RTD GT AY+DPE +SGEL
Sbjct: 604 LKPANILLDSNLVSKLSDFGTCSLLHPNGSKS------VRTDVTGTVAYLDPEASSSGEL 657
Query: 713 TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANL 772
TPKSDVYSFGIILLRLLTGRPAL I+ EV+YALD G L +LLDPLAGDWPFVQAEQLA L
Sbjct: 658 TPKSDVYSFGIILLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAEQLARL 717
Query: 773 AMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQ 828
A+RCCE ++RP+LG +VWRVLEPMRAS GGS+S+ LG E PPYF CPIFQ
Sbjct: 718 ALRCCETVSENRPDLGTEVWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFICPIFQ 773
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 355 bits (912), Expect = 7e-97, Method: Compositional matrix adjust.
Identities = 198/468 (42%), Positives = 310/468 (66%), Gaps = 20/468 (4%)
Query: 364 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 423
+AM + S R + EA ++ + + E++ +AKA E L +E +RK EE L KL
Sbjct: 295 KAMHDIGQSDRTVYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKRLEELLEKEKL 354
Query: 424 ELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDE 483
E++ + +Q++ M+ELQ+ + LESQ+ + KE +K +A+ELL+++++++DE
Sbjct: 355 EVKMVIEQNNGFMKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQKRDE 414
Query: 484 LQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGS 543
++++ + AVKE LR+ K + S + D+SF EI AT+ FDPS K+GEG YGS
Sbjct: 415 IRIDHENAVKEVNALRRLVKGETGESSGSEML-DYSFMEINEATNEFDPSWKLGEGKYGS 473
Query: 544 IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYL 603
+YKG L+H+QVA+KML + EF++ ++ILS++RHPNLVTL+GACPE +L+Y+Y+
Sbjct: 474 VYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQYI 533
Query: 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 663
PNGSLED S ++N P LSW++RIRIA+E+CS L+FLHS P I+HG+LKP+ ILLD+N
Sbjct: 534 PNGSLEDCFSSENNVPALSWESRIRIASEICSALLFLHSNIP-CIIHGNLKPSKILLDSN 592
Query: 664 FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGI 723
V+K++D+GIS+ + + + ++DP ++DP + S E+T +SD+Y+FGI
Sbjct: 593 LVTKINDYGISQLIPIDGLD--------KSDP-----HVDPHYFVSREMTLESDIYAFGI 639
Query: 724 ILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS 783
ILL+LLT RP GI ++V+ AL+ + +LD AGDWP + ++LAN+A+RCC+ + +
Sbjct: 640 ILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCCKKNPMN 699
Query: 784 RPELGKDVWRVLEPMRA---SCGGSTSYRLGSEERCEPPPYFTCPIFQ 828
RP+L V R ++ M+A ++SY + R PP ++ CPIFQ
Sbjct: 700 RPDLAV-VLRFIDRMKAPEVPSSETSSYANQNVPR-RPPSHYLCPIFQ 745
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 320 bits (819), Expect = 4e-86, Method: Compositional matrix adjust.
Identities = 248/815 (30%), Positives = 395/815 (48%), Gaps = 93/815 (11%)
Query: 47 IYVAVAKQVKESKSVLLWALQ---NSGGKRICIIHVHTPAQMIPV-MGTKFPASSLEEEK 102
+ VA++ K SK V+ WA++ G ++H+H +P MG P S + ++
Sbjct: 22 VVVALSGSSK-SKYVVTWAIEKFATEGNVGFKLLHIHPMITSVPTPMGNAIPISEVRDDV 80
Query: 103 VQAYR-EIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMG 161
V AYR EI Q L R+ V E L ES++ I E ++ I ++V+G
Sbjct: 81 VTAYRQEILWQSEEMLKPYTKLFVRR-KVAVEVLVIESDNVAAAIAEEVTRDSIDRIVIG 139
Query: 162 AAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREGSLDG---IDPEISS 218
++ + +K D+ S + P C ++ + G L R DG I + S
Sbjct: 140 GSSRSFFSRKA-DICS----VISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIREDGSE 194
Query: 219 PSFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFDRNVG--NVMTS 276
+ +S ++ + S +RP+ L PV+ + H F G +V
Sbjct: 195 RTNSSSGSSGPTSDSSDVMSSAHDSQSRPLSL--PVRRMQH------FPAIAGQASVPME 246
Query: 277 QDSIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIPLIRTEGVSTLP 336
S+G + DAE + D + RS+ T+ S
Sbjct: 247 TSSVGSDETRCMSLDAEEARDVSSINRSS-----------------------TDTTSRWT 283
Query: 337 PSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRR 396
P + D Y++ +AM+ + +S RE R + + R
Sbjct: 284 PRRRD-----------------YEERKEAMSSS-SSNREYGNFGTRFSWSGMGVDTTHSR 325
Query: 397 AKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAES 456
A S ++ L + + + N E+E+++ + V E +A + ++ E
Sbjct: 326 ASQQASNMSDALSE-QSYTDNQVNLNFEVEKLRAELRHVQEMYAVAQTETFDASRKLGEL 384
Query: 457 DQ-------TAKELEQKIISAVELL----QNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
+Q +EL+ K A EL QN++K + + + R++A +E + R++ +++
Sbjct: 385 NQRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMRERAEREIAQRREAERKS 444
Query: 506 SSSSH----------MPQF-FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV 554
+ + PQ + F++ EI AT +F LKIG G YG++YK L H
Sbjct: 445 ARDTKEKEKLEGTLGSPQLQYQHFAWEEIMAATSSFSEELKIGMGAYGAVYKCNLHHTTA 504
Query: 555 AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSC 614
+K+L Q +FQQE++ILSKIRHP+LV L+GACPE LVYEY+ NGSLEDRL
Sbjct: 505 VVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGALVYEYMENGSLEDRLFQ 564
Query: 615 KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674
+NSPPL W R RIA E+ + L+FLH KP I+H DLKPANILLD NFVSK+ D G+S
Sbjct: 565 VNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANILLDHNFVSKVGDVGLS 624
Query: 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 734
+ + +S+ T+ +T P GT Y+DPE+ +G ++ KSD+YSFG+ILL+LLT +PA
Sbjct: 625 TMVQVDPLST-KFTIYKQTSPVGTLCYIDPEYQRTGRISSKSDIYSFGMILLQLLTAKPA 683
Query: 735 LGITKEVQYALDTG-KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 793
+ +T V+ A+D+ + +LD AG+WP + +LA LA+ C E+ K RP+L +
Sbjct: 684 IALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCTELRGKDRPDLKDQILP 743
Query: 794 VLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQ 828
LE ++ + + G +PP +F CP+ +
Sbjct: 744 ALENLKKVAEKARNSFSGVS--TQPPTHFICPLLK 776
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 301 bits (772), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 167/433 (38%), Positives = 249/433 (57%), Gaps = 29/433 (6%)
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
N E+E+++ + V E +A + ++ E +Q E +K++ E + K
Sbjct: 358 NLNFEIEKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEVAKD 417
Query: 480 EQDELQMERDKAVKEAEELR-----------------------KSRKEASSSSHMPQFFS 516
+ + ++A+KEAE+++ K + +AS S Q+
Sbjct: 418 TASKEKQRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQY-Q 476
Query: 517 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI 576
+++ EI AT +F +LKIG G YGS+YK L H A+K+LH Q +F QE++I
Sbjct: 477 HYTWEEIAAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQELEI 536
Query: 577 LSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 636
LSKIRHP+LV L+GACPE LVYEY+ NGSL+DRL +++PP+ W R RIA E+ S
Sbjct: 537 LSKIRHPHLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVASA 596
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
L+FLH KP I+H DLKP NILLD NFVSKL D G+S ++Q+++SS T+ +T P
Sbjct: 597 LVFLHKSKPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSR--TIFKQTSPV 654
Query: 697 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL-DTGKLKNLLD 755
GT Y+DPE+ +G ++PKSDVYS G+++L+L+T +PA+ IT V+ A+ D + +LD
Sbjct: 655 GTLCYIDPEYQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAILD 714
Query: 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEER 815
AG WP +LA L + C EM R+ RP+L + LE +R + + L S
Sbjct: 715 KKAGSWPISDTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADKAQN--LLSRTP 772
Query: 816 CEPPPYFTCPIFQ 828
PP +F CP+ +
Sbjct: 773 SGPPSHFICPLLK 785
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 298 bits (762), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 158/354 (44%), Positives = 220/354 (62%), Gaps = 16/354 (4%)
Query: 487 ERDKAVKEAEELRKSRKEASSSSH----MPQFFSDFSFSEIEGATHNFDPSLKIGEGGYG 542
ER +A AEE+RK ++ + Q + F + EI AT +F LKIG GGYG
Sbjct: 382 ERLEAEARAEEVRKEKQRLEDALEGGPLQRQQYMKFEWEEIVEATSSFSDELKIGVGGYG 441
Query: 543 SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEY 602
S+Y+ L H VA+K+LH +F QE++ILSKIRHP+L+ L+GACPE +LVYEY
Sbjct: 442 SVYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKIRHPHLLLLLGACPERGSLVYEY 501
Query: 603 LPNGSLEDRLSCKD------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 656
+ NGSLE+RL + PPL W R RIA E+ S L FLH+ +P IVH DLKPA
Sbjct: 502 MHNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIASALYFLHTNEPRPIVHRDLKPA 561
Query: 657 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 716
NILLD N VSK+ D G+S+ + N S+ +T+ T P GTF Y+DPE+ +G +TP+S
Sbjct: 562 NILLDRNNVSKIGDVGLSKMV--NLDPSHASTVFNETGPVGTFFYIDPEYQRTGVVTPES 619
Query: 717 DVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPLAGDWPFVQAEQLANLAM 774
D+Y+FGIILL+L+T R A+G+ ++ AL TGK +LD AGDWP +A+++ + +
Sbjct: 620 DIYAFGIILLQLVTARSAMGLAHSIEKALRDQTGKFTEILDKTAGDWPVKEAKEMVMIGL 679
Query: 775 RCCEMSRKSRPELGKDVWRVLEPMR--ASCGGSTSYRLGSEERCEPPPYFTCPI 826
RC EM ++ RP+LGK++ VLE ++ AS + + P +F CPI
Sbjct: 680 RCAEMRKRDRPDLGKEILPVLERLKEVASIARNMFADNLIDHHHNAPTHFYCPI 733
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (756), Expect = 7e-79, Method: Compositional matrix adjust.
Identities = 159/372 (42%), Positives = 225/372 (60%), Gaps = 30/372 (8%)
Query: 463 LEQKIISAVELLQNY--KKEQ-----DELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 515
LE++I++ Y +KE+ D+L+ ERD AV++ ELR S+H+
Sbjct: 94 LEEEIVTLKHQADTYLVQKEKAVTAYDQLKHERDNAVQQVNELR------DQSTHI---I 144
Query: 516 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 575
DFS ++E AT +F + ++G+ YG YKG++ +M+V IK+ L FQQE+
Sbjct: 145 LDFSRKDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVLIKLSSSQKL-----FQQEVS 199
Query: 576 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 635
IL + RHPN++T +G C EV LVYE+LPNG+LEDR+ C +NS PLSW R +I E+C
Sbjct: 200 ILRQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICTNNSAPLSWYNRTQIIGEICC 259
Query: 636 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 695
L+FLHS K ++VHGDL+P NIL+DAN+ SK+ +FG+S Q N T
Sbjct: 260 ALLFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSNLFLQLGTFPPNLT------- 312
Query: 696 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755
YMDPEF +GELT SDVYS G+I+LRLLTG P L ++++V AL + L L+D
Sbjct: 313 -ARLPYMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTLSEKVAEALGSDSLHLLID 371
Query: 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM-RASCGGSTSYRLGSEE 814
AGDWP+++A+QLA + + C M+RK RP+L +VW V+EP+ R + Y +
Sbjct: 372 KSAGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEPLTRKPPAATWPYLQSASG 431
Query: 815 RCEPPPYFTCPI 826
P F CPI
Sbjct: 432 DSSVPAAFICPI 443
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 294 bits (752), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 152/362 (41%), Positives = 222/362 (61%), Gaps = 6/362 (1%)
Query: 471 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHN 529
E + ++E+ E R+ +K E ++ K SS P+ + +F++ EI AT +
Sbjct: 400 TEKFEQKRREEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSS 459
Query: 530 FDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 589
F LKIG G YG +YK L H A+K+LH +F QE++ILSKIRHP+LV L+
Sbjct: 460 FSEDLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLL 519
Query: 590 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
GACP+ LVYEY+ NGSLEDRL ++S P+ W R+RIA E+ S L+FLH KP I+
Sbjct: 520 GACPDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPII 579
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
H DLKPANILL+ NFVSK+ D G+S + + S T+ +T P GT Y+DPE+ +
Sbjct: 580 HRDLKPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRT 639
Query: 710 GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG---KLKNLLDPLAGDWPFVQA 766
G ++PKSDVY+FG+I+L+LLTG+ A+ +T V+ A++ +L +LD AG+WP +
Sbjct: 640 GRISPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEET 699
Query: 767 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPI 826
QLA LA++C E+ K RP+L + VLE ++ + + S +PP +F CP+
Sbjct: 700 RQLAALALQCTELRSKDRPDLEDQILPVLESLKKVADKARNSL--SAAPSQPPSHFFCPL 757
Query: 827 FQ 828
+
Sbjct: 758 LK 759
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (661), Expect = 7e-68, Method: Compositional matrix adjust.
Identities = 128/314 (40%), Positives = 192/314 (61%), Gaps = 5/314 (1%)
Query: 515 FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEI 574
+ ++ EI AT F P IGEGGYG +Y+ L A+K++ + + EF +E+
Sbjct: 427 YRKYTIEEIVTATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEV 486
Query: 575 DILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 634
++LS++RHP++V L+GACPE LVYEYL NGSLE+ + + N PPL W R R+ E+
Sbjct: 487 EVLSQLRHPHVVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVA 546
Query: 635 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 694
L FLHS KP IVH DLKP NILL+ N+VSK++D G+++ ++ +++ +N T+ +
Sbjct: 547 CGLAFLHSSKPEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVT--DVAPDNVTMYRNSV 604
Query: 695 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 754
GT Y+DPE+ +G + PKSD+Y+FGII+L+LLT R GI V+ A+ G L +L
Sbjct: 605 LAGTLHYIDPEYHRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENAVKKGTLTEML 664
Query: 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEE 814
D DWP + E+LA + ++C E + RP+L +V VL+ + S + GS
Sbjct: 665 DKSVTDWPLAETEELARIGLKCAEFRCRDRPDLKSEVIPVLKRL-VETANSKVKKEGSNL 723
Query: 815 RCEPPPYFTCPIFQ 828
R P ++ CPI +
Sbjct: 724 RA--PSHYFCPILR 735
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O80623|Y2393_ARATH Probable receptor-like protein kinase At2g39360 OS=Arabidopsis thaliana GN=At2g39360 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (516), Expect = 6e-51, Method: Compositional matrix adjust.
Identities = 111/288 (38%), Positives = 176/288 (61%), Gaps = 25/288 (8%)
Query: 523 IEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR 581
I+ AT +FD SL IG GG+G +YKG+LR +VA+K P S QG +EF+ E+++L++ R
Sbjct: 480 IKEATDDFDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGLAEFKTEVEMLTQFR 539
Query: 582 HPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 639
H +LV+L+G C E +VYEY+ G+L+D L D+ P LSW+ R+ I L +
Sbjct: 540 HRHLVSLIGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRLEICVGAARGLHY 599
Query: 640 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF---LSQNEISSNNTTLCCRTDPK 696
LH+ +I+H D+K ANILLD NF++K++DFG+S+ L Q +S T K
Sbjct: 600 LHTGSTRAIIHRDVKSANILLDDNFMAKVADFGLSKTGPDLDQTHVS---------TAVK 650
Query: 697 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL--GITKE----VQYAL---DT 747
G+F Y+DPE+L +LT KSDVYSFG+++L ++ GRP + + +E +++A+
Sbjct: 651 GSFGYLDPEYLTRQQLTEKSDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEWAMKLVKK 710
Query: 748 GKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 794
GKL++++DP L G + ++ + +C + RP +G +W +
Sbjct: 711 GKLEDIIDPFLVGKVKLEEVKKYCEVTEKCLSQNGIERPAMGDLLWNL 758
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGQ7|Y4245_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g20450 OS=Arabidopsis thaliana GN=At4g20450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (511), Expect = 2e-50, Method: Compositional matrix adjust.
Identities = 119/306 (38%), Positives = 178/306 (58%), Gaps = 27/306 (8%)
Query: 499 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIK 557
RK + +S S M +++ E+ T+NF+ L GEGG+G +Y G + + QVA+K
Sbjct: 562 RKKKPSKASRSSMVANKRSYTYEEVAVITNNFERPL--GEGGFGVVYHGNVNDNEQVAVK 619
Query: 558 MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCK 615
+L S QG +F+ E+D+L ++ H NLVTLVG C E L+YEY+ NG+L+ LS +
Sbjct: 620 VLSESSAQGYKQFKAEVDLLLRVHHINLVTLVGYCDEGQHLVLIYEYMSNGNLKQHLSGE 679
Query: 616 DNSPPLSWQTRIRIATELCSVLIFLH-SCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674
++ PLSW+ R+RIA E L +LH CKP ++H D+K NILLD NF +KL DFG+S
Sbjct: 680 NSRSPLSWENRLRIAAETAQGLEYLHIGCKP-PMIHRDIKSMNILLDNNFQAKLGDFGLS 738
Query: 675 RFL---SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 731
R S+ +S+N G+ Y+DPE+ + LT KSDV+SFG++LL ++T
Sbjct: 739 RSFPVGSETHVSTN---------VAGSPGYLDPEYYRTNWLTEKSDVFSFGVVLLEIITS 789
Query: 732 RPALGITKE-------VQYALDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKS 783
+P + T+E V + L G +KN++DP + GD+ + LAM C S
Sbjct: 790 QPVIDQTREKSHIGEWVGFKLTNGDIKNIVDPSMNGDYDSSSLWKALELAMSCVSPSSSG 849
Query: 784 RPELGK 789
RP + +
Sbjct: 850 RPNMSQ 855
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 846 | ||||||
| 359489801 | 881 | PREDICTED: U-box domain-containing prote | 0.959 | 0.921 | 0.658 | 0.0 | |
| 147772798 | 881 | hypothetical protein VITISV_015820 [Viti | 0.960 | 0.922 | 0.654 | 0.0 | |
| 224064033 | 809 | predicted protein [Populus trichocarpa] | 0.882 | 0.923 | 0.683 | 0.0 | |
| 224127680 | 810 | predicted protein [Populus trichocarpa] | 0.877 | 0.916 | 0.648 | 0.0 | |
| 356568394 | 883 | PREDICTED: U-box domain-containing prote | 0.962 | 0.921 | 0.633 | 0.0 | |
| 87240964 | 884 | Protein kinase; U box [Medicago truncatu | 0.962 | 0.920 | 0.632 | 0.0 | |
| 357507363 | 896 | U-box domain-containing protein [Medicag | 0.962 | 0.908 | 0.632 | 0.0 | |
| 356531997 | 883 | PREDICTED: U-box domain-containing prote | 0.962 | 0.921 | 0.627 | 0.0 | |
| 356522608 | 879 | PREDICTED: U-box domain-containing prote | 0.953 | 0.918 | 0.614 | 0.0 | |
| 356506214 | 877 | PREDICTED: U-box domain-containing prote | 0.957 | 0.923 | 0.602 | 0.0 |
| >gi|359489801|ref|XP_002274993.2| PREDICTED: U-box domain-containing protein 33-like [Vitis vinifera] gi|297745303|emb|CBI40383.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1089 bits (2817), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 551/837 (65%), Positives = 667/837 (79%), Gaps = 25/837 (2%)
Query: 1 MALVSSVPAIAQGVDSVRCPDIQMAGITSSRRGIVEE-PVASVIEDKIYVAVAKQVKESK 59
MA+VS VPAI+Q +D VR +I ++ + SS IVEE P+A V+EDKI+VAV K+VKESK
Sbjct: 1 MAVVSPVPAISQQLDHVRLHEIGVSAVMSSTGEIVEEQPLALVVEDKIFVAVGKEVKESK 60
Query: 60 SVLLWALQNSGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLD 119
S+L+WALQNSGGKRI I+HVH PAQMIP+MG KFPAS L+E++V+AYR++ERQDMH L+
Sbjct: 61 SILVWALQNSGGKRISIVHVHQPAQMIPIMGGKFPASKLKEQEVKAYRDLERQDMHKILN 120
Query: 120 MCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKK 179
LLICR+ GVRAEKL ESE+ EKGILELIS +GI+KLV+GAAADKHY ++M++ KSKK
Sbjct: 121 DYLLICRKAGVRAEKLYIESENVEKGILELISEHGIKKLVVGAAADKHYSRRMLEPKSKK 180
Query: 180 AISVRQQAPASCHIWFICNGNLIYTREGSLDGIDPEISSP-SFQASHNTENRHPNCLRSQ 238
A VR +AP CHIWF+C G+LIYTREGSL+G D E+ +P S QAS N E N RS
Sbjct: 181 AAYVRDKAPLFCHIWFVCRGHLIYTREGSLNGADIELRTPPSQQASPNNETGQSNTFRSM 240
Query: 239 SVVLRHNRPMKLTNPVQDLFHRVRSMNFDRNVGNVMTSQDSIGGLSSPASRSDAEVSSD- 297
SV L N P KL NP QDL R+M+ + V++S D GG+S+P SR E SSD
Sbjct: 241 SVSLGQNHPSKLVNPGQDL---PRTMSVPVRI-TVLSSPDGTGGVSAPWSRMGREGSSDY 296
Query: 298 -ECTTGRSTSQGS-LSSCSSRGVIDVAMIPLIRTEGVSTL--PPSKEDLQ-SSPPSVLDG 352
+ + RS SQ S S+CSS M + +G+ + P +K+ L SSPPSVL+
Sbjct: 297 WDGISKRSPSQASGFSTCSSGD-----MAGEVNEDGLESRASPVAKQALHHSSPPSVLE- 350
Query: 353 SVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRK 412
+N+YDQL QAM EAENSRREAF+E+LRR KAEKDAIE+IRRAK +E ++EELK R+
Sbjct: 351 ---ENIYDQLEQAMVEAENSRREAFQESLRRSKAEKDAIEAIRRAKEAERSFSEELKLRR 407
Query: 413 EFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVE 472
+ EEAL ELE ++ + E+MEEL+I+L+ KSLLE+QIA+S+Q KELE+KII+AVE
Sbjct: 408 DIEEALQAQGKELESLRNKQQEIMEELKISLNHKSLLENQIADSEQVVKELEEKIIAAVE 467
Query: 473 LLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDP 532
LLQNYKKE+DELQ+ERD A+K AEEL+K + +S+SH PQ+F++FSF+EIE AT NFDP
Sbjct: 468 LLQNYKKERDELQIERDNAIKTAEELKK---KGASTSHTPQYFAEFSFAEIEKATQNFDP 524
Query: 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
S+KIGEGGYGSIYKG LRH QVAIKMLH S QGP+EFQQE+DILSK+RHPNLVTL+GAC
Sbjct: 525 SVKIGEGGYGSIYKGCLRHTQVAIKMLHSDSFQGPTEFQQEVDILSKLRHPNLVTLIGAC 584
Query: 593 PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 652
PE W L+YEYLPNGSLEDRL+C+DN+PPLSWQ RIRIA ELCSVLIFLHS P SIVHGD
Sbjct: 585 PEAWALIYEYLPNGSLEDRLNCRDNTPPLSWQARIRIAAELCSVLIFLHSNNPDSIVHGD 644
Query: 653 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 712
LKP+NILLDANF SKLSDFGI R +S + SSN+ T+CCRT PKGTFAYMDPEFL+SGEL
Sbjct: 645 LKPSNILLDANFGSKLSDFGICRVISHDGNSSNSATMCCRTGPKGTFAYMDPEFLSSGEL 704
Query: 713 TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANL 772
T KSDVYSFGIILLRLLTG+PA+GITKEVQ+ALD G L LLDPLAGDWPFVQA+QLA +
Sbjct: 705 TVKSDVYSFGIILLRLLTGKPAIGITKEVQHALDQGNLNTLLDPLAGDWPFVQAKQLALM 764
Query: 773 AMRCCEMSRKSRPELGKDVWRVLEPMRASCGG-STSYRLGSEERCEPPPYFTCPIFQ 828
A+RCCEM+RKSRP+L +VWRVLEPM+ SCG S+S+R+GSEER + PPYF CPIFQ
Sbjct: 765 ALRCCEMNRKSRPDLVSEVWRVLEPMKVSCGASSSSFRVGSEERGQIPPYFICPIFQ 821
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772798|emb|CAN67166.1| hypothetical protein VITISV_015820 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1071 bits (2769), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/836 (65%), Positives = 661/836 (79%), Gaps = 23/836 (2%)
Query: 1 MALVSSVPAIAQGVDSVRCPDIQMAGITSSRRGIVEE-PVASVIEDKIYVAVAKQVKESK 59
MA+VS VPAI+Q +D VR +I ++ + SS IVEE P+A V+EDKI+VAV K+VKESK
Sbjct: 1 MAVVSPVPAISQQLDHVRLHEIGVSAVMSSTGEIVEEQPLALVVEDKIFVAVGKEVKESK 60
Query: 60 SVLLWALQNSGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLD 119
S+L+WALQNSGGKRI I+HVH PAQMIP+MG KFPAS L+E++V+AYR++ERQDMH L+
Sbjct: 61 SILVWALQNSGGKRISIVHVHQPAQMIPIMGGKFPASKLKEQEVKAYRDLERQDMHKILN 120
Query: 120 MCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKK 179
+LICR+ GVRAEKL ESE+ EKGILELIS +GI+KLV+GAAADKHY ++M++ KSKK
Sbjct: 121 DYILICRKAGVRAEKLYIESENVEKGILELISEHGIKKLVVGAAADKHYSRRMLEPKSKK 180
Query: 180 AISVRQQAPASCHIWFICNGNLIYTREGSLDGIDPEISSP-SFQASHNTENRHPNCLRSQ 238
A VR +AP CHIWF+C G+LIYTREGS BG D E+ +P S QAS N E N RS
Sbjct: 181 AAYVRDKAPLFCHIWFVCRGHLIYTREGSXBGADIELRTPPSQQASPNNETGQSNTFRSM 240
Query: 239 SVVLRHNRPMKLTNPVQDLFHRVRSMNFDRNVGNVMTSQDSIGGLSSPASRSDAEVSSD- 297
SV L N KL NP QDL R+M+ + V++S D GG+S+P SR E SSD
Sbjct: 241 SVSLGQNHXSKLVNPGQDL---PRTMSVPVRI-TVLSSPDGTGGVSAPWSRMGREGSSDY 296
Query: 298 -ECTTGRSTSQGSLSSCSSRGVIDVAMIPLIRTEGVSTL--PPSKEDLQ-SSPPSVLDGS 353
+ + RS SQ S S S G M + +G+ + P +K+ L SSPPSVL+
Sbjct: 297 WDGISKRSPSQXSGFSXCSSG----DMAGEVNEDGLESRASPXAKQALHHSSPPSVLE-- 350
Query: 354 VDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE 413
+N+YDQL QAM EAENSRREAF+E+LRR KAEK AIE+IRRAK +E ++EELK R++
Sbjct: 351 --ENIYDQLEQAMVEAENSRREAFQESLRRSKAEKXAIEAIRRAKEAERSFSEELKLRRD 408
Query: 414 FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVEL 473
EEAL ELE ++ + E+MEEL+I+L+ KSLLE+QIA+S+Q KELE+KIISAVEL
Sbjct: 409 IEEALQAQGKELESLRNKQQEIMEELKISLNHKSLLENQIADSEQVVKELEEKIISAVEL 468
Query: 474 LQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPS 533
LQNYKKE+DELQ+ERD A+K AEEL+K + +S+SH PQ+F++FSF+EIE AT NFDPS
Sbjct: 469 LQNYKKERDELQIERDNAIKTAEELKK---KGASTSHTPQYFAEFSFAEIEKATQNFDPS 525
Query: 534 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
+KIGEGGYGSIYKG LRH QVAIKMLH S QGPSEFQQE+DILSK+RHPNLVTL+GACP
Sbjct: 526 VKIGEGGYGSIYKGCLRHTQVAIKMLHSDSFQGPSEFQQEVDILSKLRHPNLVTLIGACP 585
Query: 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 653
E W L+YEYLPNGSLEDRL+C+DN+PPLSWQ RIRIA ELCSVLIFLHS P SIVHGDL
Sbjct: 586 EAWALIYEYLPNGSLEDRLNCRDNTPPLSWQARIRIAAELCSVLIFLHSNNPDSIVHGDL 645
Query: 654 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 713
KP+NILLDANF SKLSDFGI R +S + SSN+ T+CCRT PKGTFAYMDPEFL+SGELT
Sbjct: 646 KPSNILLDANFGSKLSDFGICRVISHDGNSSNSATMCCRTGPKGTFAYMDPEFLSSGELT 705
Query: 714 PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLA 773
KSDVYSFGIILLRLLTG+PA+GITKEVQ+ALD G L LLDPLAGDWPFVQA+QLA +A
Sbjct: 706 VKSDVYSFGIILLRLLTGKPAIGITKEVQHALDQGNLNTLLDPLAGDWPFVQAKQLALMA 765
Query: 774 MRCCEMSRKSRPELGKDVWRVLEPMRASCGG-STSYRLGSEERCEPPPYFTCPIFQ 828
+RC EM+RKSRP+L +VWRVLEPM+ SCG S+S+R+GSEER + PPYF CPIFQ
Sbjct: 766 LRCXEMNRKSRPDLVSEVWRVLEPMKVSCGASSSSFRVGSEERGQIPPYFICPIFQ 821
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224064033|ref|XP_002301358.1| predicted protein [Populus trichocarpa] gi|222843084|gb|EEE80631.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1056 bits (2730), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 546/799 (68%), Positives = 620/799 (77%), Gaps = 52/799 (6%)
Query: 30 SRRGIVEEPVASVIEDKIYVAVAKQVKESKSVLLWALQNSGGKRICIIHVHTPAQMIPVM 89
S R IVEEPVA VIEDKI+VAV K VKE K +LLWALQNSGGKRICIIHV P+QMIP+M
Sbjct: 3 SGREIVEEPVARVIEDKIFVAVGKSVKECKLMLLWALQNSGGKRICIIHVLQPSQMIPLM 62
Query: 90 GTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILEL 149
GTKF AS+L+E++V+AYRE+ERQ MH LD L ICR+MGVRAEKL E ES EKGILEL
Sbjct: 63 GTKFRASALKEQEVRAYREVERQAMHKMLDEYLSICRKMGVRAEKLYVEMESIEKGILEL 122
Query: 150 ISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREGSL 209
ISH+GI+KLVMGAAADK + K MMD+KSKKAISV QAPASCHIWFIC G+LI+TREG+L
Sbjct: 123 ISHHGIKKLVMGAAADKRHSKNMMDIKSKKAISVCLQAPASCHIWFICKGHLIHTREGAL 182
Query: 210 DGIDPEISSPSFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFDRN 269
DG ++ S S Q S +TE + +RSQS+ L N +KLTNP QDL RVRSMN +
Sbjct: 183 DGTGTDVGSSSQQTSPHTEAGQLSHMRSQSIALGQNHFVKLTNPAQDLVRRVRSMNVNGR 242
Query: 270 VGNVMTSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIPLIRT 329
G LS+PAS
Sbjct: 243 GGR----------LSTPAS----------------------------------------P 252
Query: 330 EGVSTLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKD 389
+G + P S+ D S DGS +D LYDQL +AM++AENSRREAFEEA+RR KAEK
Sbjct: 253 DGGPSTPSSRSDADGSSDEYDDGSTEDPLYDQLEKAMSDAENSRREAFEEAVRRAKAEKY 312
Query: 390 AIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLL 449
A E+ R+AKASE+LY EE KRRKE EE LA K ELER+ ++ DEVMEEL+IA DQKSLL
Sbjct: 313 AFEATRKAKASENLYTEESKRRKEVEEELAKEKEELERINRECDEVMEELRIAEDQKSLL 372
Query: 450 ESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSS 509
E QI ESDQ KELEQKIISAV LLQNYKKEQDELQ ERD A+KE EELR+S+ EAS +
Sbjct: 373 EKQIKESDQMVKELEQKIISAVGLLQNYKKEQDELQKERDNALKEVEELRRSQTEASGT- 431
Query: 510 HMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE 569
HM QFFS+FS SEIE AT +FDPSLKIGEGGYGSIYKG+LR QVA+KMLH +SLQGP+E
Sbjct: 432 HMSQFFSEFSLSEIEEATQHFDPSLKIGEGGYGSIYKGVLRQTQVAVKMLHSNSLQGPAE 491
Query: 570 FQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI 629
FQQE+D+LSK+RHPNL+TL+GACPE WTL+YEYLPNGSLEDRLSC+DNSPPLSWQTRIRI
Sbjct: 492 FQQEVDVLSKMRHPNLITLIGACPEAWTLIYEYLPNGSLEDRLSCRDNSPPLSWQTRIRI 551
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
A ELCSVLIFLHS K HSIVHGDLKPANILLD NFV+KLSDFGI R L E SSNNT +
Sbjct: 552 AAELCSVLIFLHSSKQHSIVHGDLKPANILLDENFVTKLSDFGICRLLHHKEGSSNNTAI 611
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 749
CRTDPKGTF+YMDPEFL++GELTPKSDVYSFGIILLRLLT R LGITKEVQ LD G
Sbjct: 612 -CRTDPKGTFSYMDPEFLSTGELTPKSDVYSFGIILLRLLTARQPLGITKEVQCELDKGN 670
Query: 750 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYR 809
LK LLDPLAGDWPFVQAEQLA+LA+RCCEMSRK+RP+L +VWRVLEPM+ASCGGS+ ++
Sbjct: 671 LKTLLDPLAGDWPFVQAEQLAHLALRCCEMSRKNRPDLLSEVWRVLEPMKASCGGSSFFQ 730
Query: 810 LGSEERCEPPPYFTCPIFQ 828
LGSEE +PP YF CPIFQ
Sbjct: 731 LGSEEHFQPPSYFICPIFQ 749
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127680|ref|XP_002320134.1| predicted protein [Populus trichocarpa] gi|222860907|gb|EEE98449.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1016 bits (2626), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 525/810 (64%), Positives = 610/810 (75%), Gaps = 68/810 (8%)
Query: 29 SSRRGIVEEPVA---SVIEDKIYVAVAKQVKESKSVLLWALQNSGGKRICIIHVHTPAQM 85
+S R +VEE VA VIE+KI+VAV K VKE KS+L WALQ SGGKRICIIHVH PAQM
Sbjct: 2 ASGREVVEETVARVIEVIEEKIFVAVGKSVKECKSMLFWALQKSGGKRICIIHVHQPAQM 61
Query: 86 IPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKG 145
IP MGTKFPAS L+E++V+AY EIERQ+M L L +CR+MGVRAEKL E ES EKG
Sbjct: 62 IPFMGTKFPASKLKEQEVRAYWEIERQEMLKMLGEYLFLCRKMGVRAEKLYVEMESIEKG 121
Query: 146 ILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTR 205
ILELIS +GIRKLVMGAAADK Y K MMD+KSKKA+SV QAPASCHIWFIC G+LI TR
Sbjct: 122 ILELISQHGIRKLVMGAAADKRYSKNMMDIKSKKAVSVCLQAPASCHIWFICKGHLIQTR 181
Query: 206 EGSLDGIDPEISSPSFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMN 265
+G+LDG D ++ S Q S NTE N +RSQS++ + +KLTNP QDLF ++ +
Sbjct: 182 KGALDGTDTDVRPSSQQKSPNTEAGQSNIMRSQSILFGQHHHVKLTNPAQDLFRKMEGLQ 241
Query: 266 FDRNVGNVMTSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIP 325
R G + T +I
Sbjct: 242 LHR--GQMQTG---------------------------------------------VLIN 254
Query: 326 LIRTEGVSTLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGK 385
++R +GV LP +Q S DGS++D LYDQL QAMAEAENSR EA EEA+R K
Sbjct: 255 MMRYQGV--LP----KIQFSHH---DGSIEDPLYDQLEQAMAEAENSRFEASEEAVRCAK 305
Query: 386 AEKDAIESIRRAKASESLYAEELKRR-------KEFEEALANGKLELERMKKQHDEVMEE 438
E+D +E+IR+AKASESLY EE KRR + +E L ELE++ K+ DEVM E
Sbjct: 306 EERDVVEAIRKAKASESLYTEESKRRTVVEEELAKEKEELEKINKELEKINKEQDEVMGE 365
Query: 439 LQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 498
L IA D KSLLE QI ESD+ KELEQKIISAV LLQNYKKE+D L RD A+KEAEEL
Sbjct: 366 LCIAQDHKSLLEKQIEESDEMVKELEQKIISAVGLLQNYKKERDHLHKGRDYALKEAEEL 425
Query: 499 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKM 558
R+++ EASS+ HMP+FFSDFSFSEIE ATH+FDPS KIGEGGYG+IYKG+LR QVA+KM
Sbjct: 426 RRNQTEASST-HMPRFFSDFSFSEIEEATHHFDPSRKIGEGGYGNIYKGVLRQTQVAVKM 484
Query: 559 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNS 618
L +S+QGP+EFQQE+++LSK+RHPNL+TLVGACPE WTL+YEYLPNGSLEDRLSCKDNS
Sbjct: 485 LDSNSMQGPAEFQQEVNVLSKMRHPNLITLVGACPEAWTLIYEYLPNGSLEDRLSCKDNS 544
Query: 619 PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678
PPLSWQTRIRIATELCSVLIFLHS KPHSIVHGDLKPANILLD NFV+KLSDFGI R L
Sbjct: 545 PPLSWQTRIRIATELCSVLIFLHSSKPHSIVHGDLKPANILLDENFVTKLSDFGICRLLD 604
Query: 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT 738
E SSNNTT+ CRTDPKGTF YMDPEF+++GEL+PKSDVYSFGIILLRLLT R ALGIT
Sbjct: 605 HKEGSSNNTTI-CRTDPKGTFVYMDPEFVSTGELSPKSDVYSFGIILLRLLTARQALGIT 663
Query: 739 KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
KEV+YALD G LK LLDPLAGDWPFVQAE LA++A+RCCEM+RK+RP+L +VWRVLEPM
Sbjct: 664 KEVRYALDKGTLKTLLDPLAGDWPFVQAEMLAHMALRCCEMNRKNRPDLASEVWRVLEPM 723
Query: 799 RASCGGSTSYRLGSEERCEPPPYFTCPIFQ 828
+ASCG S+ +LGSEE +PP YFTCPIFQ
Sbjct: 724 KASCGTSSFSQLGSEEHFQPPSYFTCPIFQ 753
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568394|ref|XP_003552396.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1011 bits (2613), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 530/837 (63%), Positives = 636/837 (75%), Gaps = 23/837 (2%)
Query: 1 MALVSSVPAIAQGVDSVRCPDIQMAGITSSRRGIVEEPVASVIEDKIYVAVAKQVKESKS 60
MA+VS +PA Q + SVR ++ + +EEP SV++ IYVAV K+VKES+
Sbjct: 1 MAVVSPMPATTQRMGSVR-------SLSDAGGKFLEEPNPSVVDQPIYVAVTKEVKESRL 53
Query: 61 VLLWALQNSGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDM 120
L+WA+QNSGGKRICI++VH A M+P++G KFPAS+L+EE+VQAY E ERQ MH LD
Sbjct: 54 NLIWAIQNSGGKRICILYVHVRATMVPLLGGKFPASALKEEQVQAYWEEERQGMHRILDD 113
Query: 121 CLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKA 180
L IC++MGVRAEKL E +S EKGILELIS +GI+KLVMGAA+DK+Y ++MMDLKSKKA
Sbjct: 114 YLRICQRMGVRAEKLHIEMDSIEKGILELISQHGIQKLVMGAASDKYYNRRMMDLKSKKA 173
Query: 181 ISVRQQAPASCHIWFICNGNLIYTREGSLDGIDPEISSPSFQASHNTENRHPNCLRSQSV 240
ISV +QAPASCHI F+C G LI+TR+ S + + +++SP Q N+ LRSQSV
Sbjct: 174 ISVCKQAPASCHIQFVCKGRLIHTRDRSSNEGNADVTSPLVQQVPNS----VRSLRSQSV 229
Query: 241 VLRHNRPMKLTNPVQDLFHRVRSMNFDRNVGNVMT--SQDSIGGLSSPASRSDAEVSSDE 298
L +R LTNP +LF RVRS N D + + MT S + G S+P R EVSSDE
Sbjct: 230 TLGQDRRANLTNPALELFRRVRSAN-DGHGASFMTVSSPEDTEGFSTPHDRMGTEVSSDE 288
Query: 299 CTTGRSTSQGSLSSCSSRGVIDVAMIPLI---RTEGVSTLPPSK---EDLQ-SSPPSVLD 351
S LS+CS V ++A P + +E L S+ EDL SSPPS LD
Sbjct: 289 SDRLSRMSPSGLSTCSDSAV-ELAFTPSLINESSENALELTLSRRIIEDLHYSSPPSTLD 347
Query: 352 GSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR 411
G +DD +Y+QL QA AEAEN+ A++E +RR KAEKDA E+IR+ KASESLY EEL R
Sbjct: 348 GGMDDTIYEQLEQARAEAENATLNAYQETVRRRKAEKDAFEAIRKVKASESLYTEELNLR 407
Query: 412 KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAV 471
K EE L K ELE MK D+V EEL +ALDQK LESQIA S+ KELEQKI+SAV
Sbjct: 408 KMTEEKLRKEKEELESMKSLRDKVKEELCLALDQKESLESQIASSELMVKELEQKILSAV 467
Query: 472 ELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFD 531
+LLQ+YK E+DELQM+RD A++EAEELRK + EAS + ++PQ FS+FSFSEI+ AT NF+
Sbjct: 468 DLLQSYKNERDELQMQRDNALREAEELRKKQGEASGT-NVPQLFSEFSFSEIKEATSNFN 526
Query: 532 PSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 591
PS KIGEGGYGSI+KG+LRH +VAIKML+ S+QGP EFQQE+D+LSK+RHPNL+TL+GA
Sbjct: 527 PSSKIGEGGYGSIFKGVLRHTEVAIKMLNSDSMQGPLEFQQEVDVLSKLRHPNLITLIGA 586
Query: 592 CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
CP+ W LVYEYLPNGSLEDRL+CK+N+PPLSWQ RIRIA ELCS LIFLHS KPHS+VHG
Sbjct: 587 CPDSWALVYEYLPNGSLEDRLACKNNTPPLSWQARIRIAAELCSALIFLHSSKPHSVVHG 646
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DLKP+NILLDAN +SKLSDFGI R LS E SS+NTT RTDPKGTF YMDPEFLASGE
Sbjct: 647 DLKPSNILLDANLISKLSDFGICRILSNCESSSSNTTEFWRTDPKGTFVYMDPEFLASGE 706
Query: 712 LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLAN 771
LTPKSDVYSFGIILLRLLTGRPALGITKEV+YALDTGKLK+LLDPLAGDWPFVQAEQLA
Sbjct: 707 LTPKSDVYSFGIILLRLLTGRPALGITKEVKYALDTGKLKSLLDPLAGDWPFVQAEQLAR 766
Query: 772 LAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQ 828
LA+RCC+M+RKSRP+L DVWRVL+ MR S GG+ S+ L SE +PP YF CPIFQ
Sbjct: 767 LALRCCDMNRKSRPDLYSDVWRVLDAMRVSSGGANSFGLSSEGLLQPPSYFICPIFQ 823
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|87240964|gb|ABD32822.1| Protein kinase; U box [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2594), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 530/838 (63%), Positives = 639/838 (76%), Gaps = 24/838 (2%)
Query: 1 MALVSSVPAIAQGVDSVRCPDIQMAGITSSRRGIVEEPVASVIEDKIYVAVAKQVKESKS 60
MA+VSS+PA Q SV + + R I EEP V+++ I VAV+K VKESK
Sbjct: 1 MAVVSSMPATIQRTGSV-------SSVRDVRGEIEEEPNQIVVDEVICVAVSKDVKESKL 53
Query: 61 VLLWALQNSGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDM 120
L+WA+QNSGGK+ICI+ VH PA MIP+MG KFPASSL++++V+AYRE+ERQ++H LD
Sbjct: 54 NLIWAIQNSGGKKICILFVHVPATMIPLMGAKFPASSLKDQEVRAYREMERQNVHKTLDE 113
Query: 121 CLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKA 180
L IC++MGVRAEKL E E+ EKGI+ELIS +GIRKL+MGAA+DK+Y ++MMDL+S+KA
Sbjct: 114 YLRICQRMGVRAEKLHIEMENIEKGIIELISQHGIRKLIMGAASDKNYSRRMMDLRSRKA 173
Query: 181 ISVRQQAPASCHIWFICNGNLIYTREGSLDGIDPEISSPSFQASHNTENRHPNCLRSQSV 240
I V +QAP+SCHI FIC G+LI+TR+ SLD + E++SP Q N+ P+ RSQS+
Sbjct: 174 IYVCEQAPSSCHIQFICKGHLIHTRDRSLDERNVEVASPLLQQGPNSV--RPS--RSQSI 229
Query: 241 VLRHNRPMKLTNPVQDLFHRVRSMNFDRNVGNVMTSQDSIG--GLSSPASRSDAEVSSDE 298
L N + Q+LF RVRS N D ++ T+ + G S+P +R EVSSDE
Sbjct: 230 TLGQNHRTNSISSSQELFRRVRSAN-DGMTASITTNSSPVDNEGFSTPRNRRGTEVSSDE 288
Query: 299 CTTGRSTSQGSLSSCSSRGVIDVAMIPLI---RTEGVSTLPPS----KEDLQS-SPPSVL 350
TS LS+ S ID + P E S L S EDL+ SPPSVL
Sbjct: 289 SDRLSRTSPSGLSTFSD-STIDPTLTPYSVAESCENASDLTLSHLIKDEDLRHLSPPSVL 347
Query: 351 DGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKR 410
DG V+D LYDQL QAM+EA N+ R A++E RRGKAEKDAIE+IRRAKASESLY +EL
Sbjct: 348 DGGVNDTLYDQLEQAMSEANNATRHAYQETFRRGKAEKDAIEAIRRAKASESLYTDELNL 407
Query: 411 RKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISA 470
RK EE L K ELE + Q D+V EEL++A+D KS LESQ+A S+ +ELEQKIISA
Sbjct: 408 RKMAEEELRKEKEELESVTSQRDKVNEELRLAVDLKSSLESQLASSEVMIQELEQKIISA 467
Query: 471 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF 530
VELLQ+YK E+DELQ++RD A++EAE+LRK + E SS+ H+PQ FS+FSFSEIE AT NF
Sbjct: 468 VELLQSYKNERDELQIQRDNALREAEDLRKKQGEGSST-HVPQLFSEFSFSEIEEATSNF 526
Query: 531 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 590
+PSLKIGEGGYG+IYKGLLRH +VAIK+LH +S+QGP EFQQE+D+LSK+RHPNL+TL+G
Sbjct: 527 NPSLKIGEGGYGNIYKGLLRHTEVAIKILHANSMQGPLEFQQEVDVLSKLRHPNLITLIG 586
Query: 591 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
ACPE W+LVYEYLPNGSLEDRL+CKDN+ PLSWQTRIRIA ELCS LIFLHS KPHSIVH
Sbjct: 587 ACPESWSLVYEYLPNGSLEDRLACKDNTHPLSWQTRIRIAAELCSALIFLHSSKPHSIVH 646
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 710
GDLKP+NI+LD N VSKLSDFGI R LS E SSNN T +TDPKGTF YMDPEFLASG
Sbjct: 647 GDLKPSNIILDGNLVSKLSDFGICRVLSNYENSSNNNTQFWKTDPKGTFVYMDPEFLASG 706
Query: 711 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 770
ELTPKSDVYSFGIILLRLLTGRPALGITKEV+YA+DTGKL +LLDPLAGDWPFVQAEQLA
Sbjct: 707 ELTPKSDVYSFGIILLRLLTGRPALGITKEVKYAVDTGKLTSLLDPLAGDWPFVQAEQLA 766
Query: 771 NLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQ 828
LA+RCCEM+RKSRP+L DVWR+L+ MRAS GG+ S+ L SE +PP YF CPIFQ
Sbjct: 767 RLALRCCEMNRKSRPDLHSDVWRILDAMRASSGGTNSFGLSSEGPHQPPSYFICPIFQ 824
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357507363|ref|XP_003623970.1| U-box domain-containing protein [Medicago truncatula] gi|355498985|gb|AES80188.1| U-box domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2594), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 530/838 (63%), Positives = 639/838 (76%), Gaps = 24/838 (2%)
Query: 1 MALVSSVPAIAQGVDSVRCPDIQMAGITSSRRGIVEEPVASVIEDKIYVAVAKQVKESKS 60
MA+VSS+PA Q SV + + R I EEP V+++ I VAV+K VKESK
Sbjct: 13 MAVVSSMPATIQRTGSV-------SSVRDVRGEIEEEPNQIVVDEVICVAVSKDVKESKL 65
Query: 61 VLLWALQNSGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDM 120
L+WA+QNSGGK+ICI+ VH PA MIP+MG KFPASSL++++V+AYRE+ERQ++H LD
Sbjct: 66 NLIWAIQNSGGKKICILFVHVPATMIPLMGAKFPASSLKDQEVRAYREMERQNVHKTLDE 125
Query: 121 CLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKA 180
L IC++MGVRAEKL E E+ EKGI+ELIS +GIRKL+MGAA+DK+Y ++MMDL+S+KA
Sbjct: 126 YLRICQRMGVRAEKLHIEMENIEKGIIELISQHGIRKLIMGAASDKNYSRRMMDLRSRKA 185
Query: 181 ISVRQQAPASCHIWFICNGNLIYTREGSLDGIDPEISSPSFQASHNTENRHPNCLRSQSV 240
I V +QAP+SCHI FIC G+LI+TR+ SLD + E++SP Q N+ P+ RSQS+
Sbjct: 186 IYVCEQAPSSCHIQFICKGHLIHTRDRSLDERNVEVASPLLQQGPNSV--RPS--RSQSI 241
Query: 241 VLRHNRPMKLTNPVQDLFHRVRSMNFDRNVGNVMTSQDSIG--GLSSPASRSDAEVSSDE 298
L N + Q+LF RVRS N D ++ T+ + G S+P +R EVSSDE
Sbjct: 242 TLGQNHRTNSISSSQELFRRVRSAN-DGMTASITTNSSPVDNEGFSTPRNRRGTEVSSDE 300
Query: 299 CTTGRSTSQGSLSSCSSRGVIDVAMIPLI---RTEGVSTLPPS----KEDLQS-SPPSVL 350
TS LS+ S ID + P E S L S EDL+ SPPSVL
Sbjct: 301 SDRLSRTSPSGLSTFSD-STIDPTLTPYSVAESCENASDLTLSHLIKDEDLRHLSPPSVL 359
Query: 351 DGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKR 410
DG V+D LYDQL QAM+EA N+ R A++E RRGKAEKDAIE+IRRAKASESLY +EL
Sbjct: 360 DGGVNDTLYDQLEQAMSEANNATRHAYQETFRRGKAEKDAIEAIRRAKASESLYTDELNL 419
Query: 411 RKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISA 470
RK EE L K ELE + Q D+V EEL++A+D KS LESQ+A S+ +ELEQKIISA
Sbjct: 420 RKMAEEELRKEKEELESVTSQRDKVNEELRLAVDLKSSLESQLASSEVMIQELEQKIISA 479
Query: 471 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF 530
VELLQ+YK E+DELQ++RD A++EAE+LRK + E SS+ H+PQ FS+FSFSEIE AT NF
Sbjct: 480 VELLQSYKNERDELQIQRDNALREAEDLRKKQGEGSST-HVPQLFSEFSFSEIEEATSNF 538
Query: 531 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 590
+PSLKIGEGGYG+IYKGLLRH +VAIK+LH +S+QGP EFQQE+D+LSK+RHPNL+TL+G
Sbjct: 539 NPSLKIGEGGYGNIYKGLLRHTEVAIKILHANSMQGPLEFQQEVDVLSKLRHPNLITLIG 598
Query: 591 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
ACPE W+LVYEYLPNGSLEDRL+CKDN+ PLSWQTRIRIA ELCS LIFLHS KPHSIVH
Sbjct: 599 ACPESWSLVYEYLPNGSLEDRLACKDNTHPLSWQTRIRIAAELCSALIFLHSSKPHSIVH 658
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 710
GDLKP+NI+LD N VSKLSDFGI R LS E SSNN T +TDPKGTF YMDPEFLASG
Sbjct: 659 GDLKPSNIILDGNLVSKLSDFGICRVLSNYENSSNNNTQFWKTDPKGTFVYMDPEFLASG 718
Query: 711 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 770
ELTPKSDVYSFGIILLRLLTGRPALGITKEV+YA+DTGKL +LLDPLAGDWPFVQAEQLA
Sbjct: 719 ELTPKSDVYSFGIILLRLLTGRPALGITKEVKYAVDTGKLTSLLDPLAGDWPFVQAEQLA 778
Query: 771 NLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQ 828
LA+RCCEM+RKSRP+L DVWR+L+ MRAS GG+ S+ L SE +PP YF CPIFQ
Sbjct: 779 RLALRCCEMNRKSRPDLHSDVWRILDAMRASSGGTNSFGLSSEGPHQPPSYFICPIFQ 836
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531997|ref|XP_003534561.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 996 bits (2574), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 525/837 (62%), Positives = 631/837 (75%), Gaps = 23/837 (2%)
Query: 1 MALVSSVPAIAQGVDSVRCPDIQMAGITSSRRGIVEEPVASVIEDKIYVAVAKQVKESKS 60
MA+VS VPA Q + SVR ++ + I+EEP V++ IYVAV K+VKESK
Sbjct: 1 MAVVSPVPATTQRMGSVRL-------LSDAGGEILEEPNPRVVDQPIYVAVTKEVKESKL 53
Query: 61 VLLWALQNSGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDM 120
L+WA+Q SGGKRICI++VH A MIP++G KFPAS+L+EE+V+AY E ERQ MH LD
Sbjct: 54 NLIWAIQTSGGKRICILYVHVRATMIPLLGGKFPASTLKEEQVEAYWEEERQGMHGILDE 113
Query: 121 CLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKA 180
L IC++MGVRAEKL E +S EKGILELIS +GIRKLVMGAA+DK+Y ++MMDLKSKKA
Sbjct: 114 YLCICQRMGVRAEKLHIEMDSIEKGILELISQHGIRKLVMGAASDKYYNRRMMDLKSKKA 173
Query: 181 ISVRQQAPASCHIWFICNGNLIYTREGSLDGIDPEISSPSFQASHNTENRHPNCLRSQSV 240
+SV +QAPASCHI F+C G+LI+TR+ S D + E++SP Q N+ LRS S+
Sbjct: 174 VSVCKQAPASCHIQFVCKGHLIHTRDRSSDEGNAEVASPLVQQVPNS----LKSLRSLSI 229
Query: 241 VLRHNRPMKLTNPVQDLFHRVRSMNFDRNVGNVM--TSQDSIGGLSSPASRSDAEVSSDE 298
L + +TNP +LF RVRS N D + + M +S + GLS+P R EVSSDE
Sbjct: 230 TLGQDCQANITNPALELFRRVRSAN-DGHGASFMAVSSPEDTEGLSTPRDRMGTEVSSDE 288
Query: 299 CTTGRSTSQGSLSSCSSRGVIDVAMIPLI---RTEGVSTLPPSK---EDLQ-SSPPSVLD 351
S LS+CS V ++A+ P + +E L S EDL SSPPS LD
Sbjct: 289 SDRLSRMSPSGLSTCSDSAV-ELALTPSLINESSENALELTLSHLIIEDLHHSSPPSTLD 347
Query: 352 GSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR 411
G +DD +YDQL QA AEAEN+ A++E +RR KAEKDA E+IR+ KASESLYAEEL +R
Sbjct: 348 GGMDDTIYDQLEQARAEAENATLNAYQETVRRMKAEKDAFEAIRKIKASESLYAEELNQR 407
Query: 412 KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAV 471
K EE L K ELE MK D V EEL++ALDQK+ LESQIA ++ KELEQKI+SAV
Sbjct: 408 KMAEEKLRKEKEELENMKSLRDTVKEELRLALDQKASLESQIASTELMIKELEQKILSAV 467
Query: 472 ELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFD 531
LLQ+YK E+DELQM+ D A++EAEELRK + EAS + H+PQ S+FSFSEI+ AT NF+
Sbjct: 468 GLLQSYKNERDELQMQCDNALREAEELRKKQGEASGT-HVPQLCSEFSFSEIKEATSNFN 526
Query: 532 PSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 591
PS KIGEGGYGSI+KG+L H +VAIKML+ S+QGP EFQQE+D+LSK+RHPNL+TL+GA
Sbjct: 527 PSSKIGEGGYGSIFKGVLHHTEVAIKMLNSDSMQGPLEFQQEVDVLSKLRHPNLITLIGA 586
Query: 592 CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
CP+ W LVYEYLPNGSLEDRL+CKDN+PPLSWQ RIRIA ELCS LIFLHS KPHS+VHG
Sbjct: 587 CPDSWALVYEYLPNGSLEDRLACKDNTPPLSWQARIRIAAELCSALIFLHSSKPHSVVHG 646
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DLKP+NILLDAN +SKLSDFGI R LS E S +NTT RTDPKGTF YMDPEFLASGE
Sbjct: 647 DLKPSNILLDANLISKLSDFGICRILSNCESSGSNTTEFWRTDPKGTFVYMDPEFLASGE 706
Query: 712 LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLAN 771
LTPKSDVYSFGIILLRLLTGRPALGIT EV+YALDTGKLK+LLDPLAGDWPFVQAEQLA
Sbjct: 707 LTPKSDVYSFGIILLRLLTGRPALGITMEVKYALDTGKLKSLLDPLAGDWPFVQAEQLAR 766
Query: 772 LAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQ 828
LA+RCC+M+RKSRP+L DVWR+L+ MR S GG+ S+ L SE + P YF CPIFQ
Sbjct: 767 LALRCCDMNRKSRPDLYSDVWRILDAMRVSSGGANSFGLSSEGLLQSPSYFICPIFQ 823
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522608|ref|XP_003529938.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 996 bits (2574), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/838 (61%), Positives = 621/838 (74%), Gaps = 31/838 (3%)
Query: 1 MALVSSVPAIAQGVDSVRC-PDIQMAGITSSRRGIVEEPVASVIEDKIYVAVAKQVKESK 59
MA+VSS+PA V+ V DI + GI +SRR IV +P S++ D IYVAV K VK SK
Sbjct: 1 MAMVSSMPATPPQVNPVNSLRDIGVPGIMTSRRKIVNKPSPSMVNDTIYVAVGKNVKSSK 60
Query: 60 SVLLWALQNSGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLD 119
S L+WA+QNSGG+RICI+HVH PA MIP+MG KFPAS+L EE+VQ Y E ER M+ LD
Sbjct: 61 SNLIWAIQNSGGRRICILHVHVPAPMIPLMGAKFPASALREEEVQDYHETERLKMYKTLD 120
Query: 120 MCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKK 179
L IC+ MGVRA KL E + EKGI+ELIS YGI+KLVMGAA+DK++ ++M +SKK
Sbjct: 121 AYLSICQGMGVRAGKLQIEMDCIEKGIVELISQYGIQKLVMGAASDKYHSRRMTAPRSKK 180
Query: 180 AISVRQQAPASCHIWFICNGNLIYTREGSLDGIDPEISSPSFQASHNTENRHPNCLRSQS 239
AI V +QAPASCHI FICNG LI+TR+ SLD + E++ P Q N+E LRSQS
Sbjct: 181 AIYVCEQAPASCHIQFICNGYLIHTRDCSLDIGNVEVAFPMAQQMANSEVGGSPKLRSQS 240
Query: 240 VVLRHNRPMKLTNPVQDLFHRVRSMNFDRNVGNVMTSQDSIGGLSSPASRSDAEVSSDEC 299
+V N +KLTNP Q+LF RVRS+N G S AS SD
Sbjct: 241 IVQGQNHGIKLTNPAQELFRRVRSVN--------------DGHRRSLASVSDESYGQ--- 283
Query: 300 TTGRSTSQGSLSSCSSRGVIDVAMIPLIRTEGVST---------LPPSKEDLQSSPPSVL 350
+GRS S S CS ++ + P + ++G +K S+ PS +
Sbjct: 284 -SGRSPS--VFSMCSHSISVEPGLTPNLISDGSENELDLTLNGPFLINKNLHHSASPSEM 340
Query: 351 DGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKR 410
DG +DD LYDQL QAMAEA NS+R+A++E +RRG AEK+AI++IRRAK +E+LY EELK
Sbjct: 341 DGGMDDALYDQLEQAMAEAVNSKRDAYQETVRRGNAEKNAIDAIRRAKTTENLYKEELKL 400
Query: 411 RKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISA 470
RKE EEA+ +L MK Q D+V EEL++AL Q S LE+QIA ++ KELEQKIISA
Sbjct: 401 RKEQEEAVEKANEKLNNMKSQTDKVNEELRLALFQNSSLENQIASTELMIKELEQKIISA 460
Query: 471 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF 530
LLQNYK E D+LQ++RD AV EAEE R+ + EASSS+H Q FS+FSF EI+ AT NF
Sbjct: 461 ENLLQNYKDELDDLQIQRDIAVGEAEEFRRKQWEASSSAHKLQCFSEFSFQEIKEATSNF 520
Query: 531 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 590
+PS KIGEGGYGSI+KG+LRH +VAIKML+ S QGP EFQQE+++LSK+RHPN++TL+G
Sbjct: 521 NPSQKIGEGGYGSIFKGILRHAEVAIKMLNRDSTQGPEEFQQEVEVLSKLRHPNIITLIG 580
Query: 591 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
ACPE WTLVYEYLPNGSLEDRL+CKDNSPPLSWQTRIRIATELCS LIFLHS KPHSI H
Sbjct: 581 ACPESWTLVYEYLPNGSLEDRLNCKDNSPPLSWQTRIRIATELCSALIFLHSNKPHSIAH 640
Query: 651 GDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
GDLKPANILLDAN VSKLSDFGI R LS + SSN+TT RTDPKGTF Y+DPEFLAS
Sbjct: 641 GDLKPANILLDANLVSKLSDFGICRILLSCQDSSSNSTTQFWRTDPKGTFVYLDPEFLAS 700
Query: 710 GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 769
GELTPKSDVYSFGIILLRL+TG+PALGI KEVQYALD GKLK++LDP AGDWPF+ AE+L
Sbjct: 701 GELTPKSDVYSFGIILLRLMTGKPALGIIKEVQYALDAGKLKSILDPFAGDWPFMLAEEL 760
Query: 770 ANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIF 827
LA+RCCEM+RKSRP+L DVWR+LEPMRAS G + +++LGS+ C+PPPYF CPIF
Sbjct: 761 VRLALRCCEMNRKSRPDLYPDVWRILEPMRASSGVTNTFQLGSQGLCQPPPYFICPIF 818
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356506214|ref|XP_003521882.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 964 bits (2493), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/833 (60%), Positives = 614/833 (73%), Gaps = 23/833 (2%)
Query: 1 MALVSSVPAIAQGVDSVRC-PDIQMAGITSSRRGIVEEPVASVIEDKIYVAVAKQVKESK 59
MA+VS +PA V+ V + + GI +SRR IV EP S++ + IYVAVAK VK+SK
Sbjct: 1 MAVVSPMPATPPQVNPVNLLRNTGVPGIMTSRREIVNEPSPSMVNETIYVAVAKDVKDSK 60
Query: 60 SVLLWALQNSGGKRICIIHVHTPAQMIPV--MGTKFPASSLEEEKVQAYREIERQDMHNH 117
L+WA+QNSGG+RICI+HVH PA MIP+ MG KFPAS+L EE VQ Y E ER MH
Sbjct: 61 LNLIWAIQNSGGRRICILHVHVPAPMIPLALMGAKFPASALREEGVQDYHERERLKMHKT 120
Query: 118 LDMCLLICRQMGVRAEKL-DTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLK 176
LD L IC++MGVRA KL E + EKGI+ELIS YGI+KLVMGAA+DK++ ++M L+
Sbjct: 121 LDAYLFICQRMGVRARKLLHIEMDCIEKGIVELISRYGIQKLVMGAASDKYHSRRMTSLR 180
Query: 177 SKKAISVRQQAPASCHIWFICNGNLIYTREGSLDGIDPEISSPSFQASHNTENRHPNCLR 236
SKKAI V +QAPASCHI FICNG LI+TR+ SL+ + E+ P Q N+E H L
Sbjct: 181 SKKAIYVCEQAPASCHIQFICNGYLIHTRDCSLNRGNVEVEFPLLQQMANSEVGHSPNLS 240
Query: 237 SQSVVLRHNRPMKLTNPVQDLFHRVRSMNFDRNVGNVMTSQDSIGGLSSPASRSDAEVSS 296
QS++ N +KLTNP Q+LF RVRS+N D ++ ++ + S G L+ P+ S S
Sbjct: 241 FQSILQGQNHGIKLTNPAQELFRRVRSVN-DGHMRSLESVSSSEGFLTPPSKFSKNISSI 299
Query: 297 DECTTGRSTSQGSLSSCSSRGVIDVAMIPLIRTEGVSTLPP--SKEDLQSSPPSVLDGSV 354
+ T + GS +D+ + P +K+ SS PSVLD +
Sbjct: 300 EPGLTPNLINDGS------ENALDLIL----------NYPSLINKDLHHSSSPSVLDEGM 343
Query: 355 DDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF 414
DD LY QL Q MAEA N+RR+A++E +RR KAEKDAI++I RAKA+E+LY EELK RKE
Sbjct: 344 DDALYYQLEQVMAEASNARRDAYQETVRRSKAEKDAIDAIHRAKATENLYKEELKLRKEQ 403
Query: 415 EEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 474
EEA+ +L MK Q D+V EEL++ALDQ S LE+QIA ++ KEL+QKIISA++LL
Sbjct: 404 EEAVEKANEKLNNMKSQTDKVNEELRLALDQNSSLENQIASTELMVKELKQKIISALDLL 463
Query: 475 QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSL 534
QNYK E D+LQ++RD AV EAEE R + EASSS+ FSDFSF EI+ AT NF+PS
Sbjct: 464 QNYKDELDDLQIQRDNAVGEAEEFRSKQGEASSSAQELHCFSDFSFQEIKEATSNFNPSK 523
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 594
KIGEGGYGSI+KG+LRH +VAIKML+P S QGP EFQQE+++LSK+RHPNL+TL+GAC E
Sbjct: 524 KIGEGGYGSIFKGVLRHTEVAIKMLNPDSTQGPLEFQQEVEVLSKLRHPNLITLIGACAE 583
Query: 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 654
WTLVYEYLPNGSLEDRL+ KDN+PPLSWQTRI IA ELCS L FLHS KPHSI HGDLK
Sbjct: 584 SWTLVYEYLPNGSLEDRLNRKDNTPPLSWQTRICIAAELCSALNFLHSNKPHSIAHGDLK 643
Query: 655 PANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTP 714
PANILLDAN VSKLSDFGI R LS + SSN+TT RT PKGTF Y+DPEFLASGELTP
Sbjct: 644 PANILLDANLVSKLSDFGICRILSCQDSSSNSTTQFWRTVPKGTFVYVDPEFLASGELTP 703
Query: 715 KSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAM 774
KSDVYSFGIILLRL+TG+PALGI KEVQYALD GKLK++LDPLAG+WPF+ AE+L LA+
Sbjct: 704 KSDVYSFGIILLRLMTGKPALGIIKEVQYALDAGKLKSILDPLAGEWPFMLAEELIRLAL 763
Query: 775 RCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIF 827
RCCEM+RK+RPEL DVWR+LEPMRAS + + +LGS+ C+PPPYF CPIF
Sbjct: 764 RCCEMNRKNRPELYSDVWRILEPMRASSVVTNTSQLGSQRLCQPPPYFICPIF 816
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 846 | ||||||
| TAIR|locus:2050669 | 834 | AT2G45910 [Arabidopsis thalian | 0.562 | 0.570 | 0.655 | 3e-165 | |
| TAIR|locus:2101353 | 805 | AT3G49060 [Arabidopsis thalian | 0.529 | 0.556 | 0.423 | 1e-124 | |
| TAIR|locus:2128131 | 764 | AT4G31230 [Arabidopsis thalian | 0.535 | 0.592 | 0.404 | 3.1e-87 | |
| TAIR|locus:2117343 | 835 | AT4G25160 [Arabidopsis thalian | 0.592 | 0.6 | 0.349 | 2.1e-86 | |
| TAIR|locus:2143094 | 701 | AT5G12000 [Arabidopsis thalian | 0.508 | 0.613 | 0.387 | 1.9e-85 | |
| TAIR|locus:2015656 | 758 | AT1G16760 [Arabidopsis thalian | 0.453 | 0.506 | 0.419 | 1.9e-85 | |
| TAIR|locus:2030245 | 697 | AT1G72760 [Arabidopsis thalian | 0.436 | 0.529 | 0.395 | 2.3e-84 | |
| TAIR|locus:2176177 | 819 | AT5G51270 [Arabidopsis thalian | 0.544 | 0.562 | 0.371 | 6.5e-83 | |
| TAIR|locus:2180677 | 703 | AT5G26150 [Arabidopsis thalian | 0.497 | 0.598 | 0.401 | 1.1e-82 | |
| TAIR|locus:2151641 | 796 | AT5G61560 [Arabidopsis thalian | 0.477 | 0.507 | 0.401 | 1.1e-82 |
| TAIR|locus:2050669 AT2G45910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1608 (571.1 bits), Expect = 3.0e-165, P = 3.0e-165
Identities = 318/485 (65%), Positives = 388/485 (80%)
Query: 344 SSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESL 403
SSP S DG VDD+ ++ +A +EA +S++EAF E LRR KAEK+A+++IRRAK SES
Sbjct: 298 SSPSSFPDG-VDDSFNVKIRKATSEAHSSKQEAFAETLRRQKAEKNALDAIRRAKQSESA 356
Query: 404 YAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKEL 463
Y+EELKRRK+ E A+A K +K + + +MEELQ A+ QK++LESQIA+SD T ++L
Sbjct: 357 YSEELKRRKDTEIAVAKEKERFITIKNEQEVIMEELQSAMAQKAMLESQIAKSDGTMEKL 416
Query: 464 EQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEI 523
QK+ AV+LLQ + E++ELQ ERD+A++EAEELR S E +S+ +PQ+F+DFSFSEI
Sbjct: 417 NQKLDIAVKLLQKLRDEREELQTERDRALREAEELR-SHAE-TSTLQLPQYFTDFSFSEI 474
Query: 524 EGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP 583
E AT++FD +LKIGEGGYGSIY GLLRH QVAIKML+P+S QGP E+QQE+D+LSK+RHP
Sbjct: 475 EEATNHFDSTLKIGEGGYGSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHP 534
Query: 584 NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
N++TL+GACPE W+LVYEYLP GSLEDRL+CKDNSPPLSWQ R+RIATE+C+ L+FLHS
Sbjct: 535 NIITLIGACPEGWSLVYEYLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSN 594
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
K HS+VHGDLKPANILLD+N VSKLSDFG L N S RTD GT AY+D
Sbjct: 595 KAHSLVHGDLKPANILLDSNLVSKLSDFGTCSLLHPNGSKS------VRTDVTGTVAYLD 648
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763
PE +SGELTPKSDVYSFGIILLRLLTGRPAL I+ EV+YALD G L +LLDPLAGDWPF
Sbjct: 649 PEASSSGELTPKSDVYSFGIILLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPF 708
Query: 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFT 823
VQAEQLA LA+RCCE ++RP+LG +VWRVLEPMRAS GGS+S+ LG E PPYF
Sbjct: 709 VQAEQLARLALRCCETVSENRPDLGTEVWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFI 768
Query: 824 CPIFQ 828
CPIFQ
Sbjct: 769 CPIFQ 773
|
|
| TAIR|locus:2101353 AT3G49060 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 954 (340.9 bits), Expect = 1.0e-124, Sum P(2) = 1.0e-124
Identities = 198/468 (42%), Positives = 310/468 (66%)
Query: 364 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 423
+AM + S R + EA ++ + + E++ +AKA E L +E +RK EE L KL
Sbjct: 295 KAMHDIGQSDRTVYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKRLEELLEKEKL 354
Query: 424 ELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDE 483
E++ + +Q++ M+ELQ+ + LESQ+ + KE +K +A+ELL+++++++DE
Sbjct: 355 EVKMVIEQNNGFMKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQKRDE 414
Query: 484 LQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGS 543
++++ + AVKE LR+ K + S + D+SF EI AT+ FDPS K+GEG YGS
Sbjct: 415 IRIDHENAVKEVNALRRLVKGETGESSGSEML-DYSFMEINEATNEFDPSWKLGEGKYGS 473
Query: 544 IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYL 603
+YKG L+H+QVA+KML + EF++ ++ILS++RHPNLVTL+GACPE +L+Y+Y+
Sbjct: 474 VYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQYI 533
Query: 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 663
PNGSLED S ++N P LSW++RIRIA+E+CS L+FLHS P I+HG+LKP+ ILLD+N
Sbjct: 534 PNGSLEDCFSSENNVPALSWESRIRIASEICSALLFLHSNIP-CIIHGNLKPSKILLDSN 592
Query: 664 FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGI 723
V+K++D+GIS+ + + + ++DP ++DP + S E+T +SD+Y+FGI
Sbjct: 593 LVTKINDYGISQLIPIDGLD--------KSDP-----HVDPHYFVSREMTLESDIYAFGI 639
Query: 724 ILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS 783
ILL+LLT RP GI ++V+ AL+ + +LD AGDWP + ++LAN+A+RCC+ + +
Sbjct: 640 ILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCCKKNPMN 699
Query: 784 RPELGKDVWRVLEPMRAS---CGGSTSYRLGSEERCEPPPYFTCPIFQ 828
RP+L V R ++ M+A ++SY + R PP ++ CPIFQ
Sbjct: 700 RPDLAV-VLRFIDRMKAPEVPSSETSSYANQNVPR-RPPSHYLCPIFQ 745
|
|
| TAIR|locus:2128131 AT4G31230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 3.1e-87, Sum P(2) = 3.1e-87
Identities = 192/475 (40%), Positives = 272/475 (57%)
Query: 341 DLQSSPPSVLDGS-VDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKA 399
D +PP + + S VD ++ + + S AF + A + +A
Sbjct: 280 DPNRTPPRLSNFSDVDYCSFESMTFGRRSMDLSSPTAFSTGSFENERFSSASQGGDDVEA 339
Query: 400 SESLYAEELKRRKEF-----EEAL-ANGKL-ELERMKKQHDEVMEELQIALDQKSLLESQ 452
ELK+ E +EAL A K EL+R K + EE ++A ++ +L
Sbjct: 340 EMRRLKLELKQTMEMYSTACKEALTAKHKATELQRWKLAEERKFEEAKLA-EEAALA--- 395
Query: 453 IAESDQTAKELEQKIISAVELLQNYKKEQDELQMERD-KAVKEAEELRKSRKEASSSSHM 511
IAE ++ AK + + A E Q + +++ + KA+KE+E +R +A ++
Sbjct: 396 IAEKEK-AKS--KAAMEAAEAAQRIADIESRKRVDAETKALKESE----ARTKAVNALAK 448
Query: 512 PQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQ 571
+ +S EIE AT FD KIGEG YG +YK L H VA+K L P + QG S+FQ
Sbjct: 449 DVRYRKYSIEEIEDATEFFDDKYKIGEGSYGPVYKCYLDHTPVAVKALRPDAAQGRSQFQ 508
Query: 572 QEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 631
+E+++L IRHPN+V L+GACPE LVYE++ NGSLEDRL + +SP LSWQTR RIA
Sbjct: 509 KEVEVLCSIRHPNMVLLLGACPECGCLVYEFMANGSLEDRLFRQGDSPALSWQTRFRIAA 568
Query: 632 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 691
E+ +VL+FLH KP +VH DLKPANILLD NFVSKL+D G++R + + +N T
Sbjct: 569 EIGTVLLFLHQTKPEPLVHRDLKPANILLDRNFVSKLADVGLARLVPPSV--ANTVTQYH 626
Query: 692 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 751
T GTF Y+DPE+ +G L KSD+YS GI+ L+L+TG+P +G+T V+ AL+ G LK
Sbjct: 627 MTSTAGTFCYIDPEYQQTGMLGVKSDIYSLGIMFLQLITGKPPMGLTHYVERALEKGNLK 686
Query: 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGST 806
+LLDP DWP + A LA++C E+ RK RP+L K + L +R ST
Sbjct: 687 DLLDPAVSDWPVEDTTEFAKLALKCAEIRRKDRPDLSKVILPELNRLRVLAEEST 741
|
|
| TAIR|locus:2117343 AT4G25160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 759 (272.2 bits), Expect = 2.1e-86, Sum P(2) = 2.1e-86
Identities = 181/518 (34%), Positives = 281/518 (54%)
Query: 320 DVAMIPLIRTEGVSTLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEE 379
DV+ I T+ S P + D + + + S + Y + +
Sbjct: 267 DVSSINRSSTDTTSRWTPRRRDYEERKEA-MSSSSSNREYGNFGTRFSWSGMGVDTTHSR 325
Query: 380 ALRRGKAEKDAI--ESIRRAKASESLYAEELKRR-KEFEEALANGKLELERMKKQHDEVM 436
A ++ DA+ +S + + + E+L+ + +E A + E ++ E+
Sbjct: 326 ASQQASNMSDALSEQSYTDNQVNLNFEVEKLRAELRHVQEMYAVAQTETFDASRKLGELN 385
Query: 437 E---ELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVK 493
+ E I L++ L E + E + K+ +K E ++ ++ + E+ R+ K
Sbjct: 386 QRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMR--ERAEREIAQRREAERK 443
Query: 494 EAEELRKSRK-EASSSSHMPQF-FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH 551
A + ++ K E + S PQ + F++ EI AT +F LKIG G YG++YK L H
Sbjct: 444 SARDTKEKEKLEGTLGS--PQLQYQHFAWEEIMAATSSFSEELKIGMGAYGAVYKCNLHH 501
Query: 552 MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDR 611
+K+L Q +FQQE++ILSKIRHP+LV L+GACPE LVYEY+ NGSLEDR
Sbjct: 502 TTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGALVYEYMENGSLEDR 561
Query: 612 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671
L +NSPPL W R RIA E+ + L+FLH KP I+H DLKPANILLD NFVSK+ D
Sbjct: 562 LFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANILLDHNFVSKVGDV 621
Query: 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 731
G+S + + +S+ T+ +T P GT Y+DPE+ +G ++ KSD+YSFG+ILL+LLT
Sbjct: 622 GLSTMVQVDPLSTK-FTIYKQTSPVGTLCYIDPEYQRTGRISSKSDIYSFGMILLQLLTA 680
Query: 732 RPALGITKEVQYALDTG-KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 790
+PA+ +T V+ A+D+ + +LD AG+WP + +LA LA+ C E+ K RP+L
Sbjct: 681 KPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCTELRGKDRPDLKDQ 740
Query: 791 VWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQ 828
+ LE ++ + + G +PP +F CP+ +
Sbjct: 741 ILPALENLKKVAEKARNSFSGVST--QPPTHFICPLLK 776
|
|
| TAIR|locus:2143094 AT5G12000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 788 (282.4 bits), Expect = 1.9e-85, Sum P(2) = 1.9e-85
Identities = 172/444 (38%), Positives = 265/444 (59%)
Query: 353 SVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRK 412
S D D + M + + E F+ G +++ A +S R +A ELK+
Sbjct: 247 SFSDESSDVGSMMMMGSIDLSAENFDMVGGSGSSDESASQSTRDIEAEMKRLKIELKQTM 306
Query: 413 EFEEALANGKLELERMKKQHDE-VMEELQIALDQKSLLESQIAESDQTAKELEQ-KIISA 470
+ + L ++ + ++ MEE + + ++ E+ +A + E+E+ K +A
Sbjct: 307 DMYSSACKEALNAKKKANELNQWKMEEARRFEEARNAEEAALAVA-----EMEKAKCRAA 361
Query: 471 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF---FSDFSFSEIEGAT 527
+E + ++ EL+ +R K E + R+S+++ + S + Q + +S EIE AT
Sbjct: 362 LEAAEKAQR-MAELEGQRRKQA-EMKARRESQEKDRALSALVQNDVRYRKYSIDEIEVAT 419
Query: 528 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 587
F + KIGEGGYG +Y G L H VAIK+L P + QG +FQQE+++LS IRHP++V
Sbjct: 420 ERFANNRKIGEGGYGPVYHGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLSSIRHPHMVL 479
Query: 588 LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
L+GACPE LVYE++ NGSLEDRL + NSPPLSW+ R +IA E+ + L FLH KP
Sbjct: 480 LLGACPEYGCLVYEFMDNGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALSFLHQAKPEP 539
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
+VH DLKPANILLD N+VSK+SD G++R + + +N T T GTF Y+DPE+
Sbjct: 540 LVHRDLKPANILLDKNYVSKISDVGLARLVPASV--ANTVTQYHMTSAAGTFCYIDPEYQ 597
Query: 708 ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 767
+G+LT KSD++S GI+LL+++T + +G+ V A+D G K++LDP+ DWP +A
Sbjct: 598 QTGKLTTKSDIFSLGIMLLQIITAKSPMGLAHHVSRAIDKGTFKDMLDPVVPDWPVEEAL 657
Query: 768 QLANLAMRCCEMSRKSRPELGKDV 791
A L +RC E+ ++ RP+LGK++
Sbjct: 658 NFAKLCLRCAELRKRDRPDLGKEI 681
|
|
| TAIR|locus:2015656 AT1G16760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 782 (280.3 bits), Expect = 1.9e-85, Sum P(2) = 1.9e-85
Identities = 166/396 (41%), Positives = 242/396 (61%)
Query: 413 EFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVE 472
+ E + +LEL++ + E A ++ + L+ E ++ +EL+ +A+
Sbjct: 324 DVEAQMKRLRLELKQTMDMYSSACREALTARNEATELQKLRTEEERRLEELKMTEETAMS 383
Query: 473 LLQNYK-KEQDELQM-ERDKAVKEAEELR------KSRKEASS-SSHMPQFFSDFSFSEI 523
+++N + K + L+ E + E E R K KE+ S S H + +S EI
Sbjct: 384 IVENERAKAKTALEAAEAANRLAEVEAKRRVHAEMKVLKESDSFSRHSIVRYRKYSVQEI 443
Query: 524 EGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP 583
E T NF S K+GEGGYG +++G L H VA+K+L P + QG S+F +E+++LS IRHP
Sbjct: 444 EEGTANFAESRKVGEGGYGPVFRGHLDHTSVAVKVLRPDAAQGRSQFHKEVEVLSCIRHP 503
Query: 584 NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
N+V L+GACPE LVYEY+ GSL+DRL + N+PP+SWQ R RIA E+ + L+FLH
Sbjct: 504 NMVLLLGACPEYGILVYEYMARGSLDDRLFRRGNTPPISWQLRFRIAAEIATGLLFLHQT 563
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
KP IVH DLKP N+LLD N+VSK+SD G++R + + N T T GTF Y+D
Sbjct: 564 KPEPIVHRDLKPGNVLLDHNYVSKISDVGLARLVPA---VAENVTQYRVTSAAGTFCYID 620
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763
PE+ +G L KSDVYS GI+LL+LLT + +G+ V+ A++ G LK++LDP DWP
Sbjct: 621 PEYQQTGMLGVKSDVYSLGIMLLQLLTAKQPMGLAYYVEQAIEEGTLKDMLDPAVPDWPL 680
Query: 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799
+A LA L+++C E+ RK RP+LGK+V L +R
Sbjct: 681 EEALSLAKLSLQCAELRRKDRPDLGKEVMPELSRLR 716
|
|
| TAIR|locus:2030245 AT1G72760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 740 (265.6 bits), Expect = 2.3e-84, Sum P(4) = 2.3e-84
Identities = 153/387 (39%), Positives = 235/387 (60%)
Query: 404 YAEELKRRKEFEEALANGKLELERMKKQHDEV--MEELQIALDQKSLLESQIAESDQTAK 461
Y E+ + E E + +LEL++ K D E Q +E A SD+ +
Sbjct: 266 YVEQQNQNLEAE--VRRLRLELKQFNKDKDTTNQKENSQETPWSDEKIELPRALSDRETQ 323
Query: 462 ELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFS 521
+ + A E+ + K ++ ++ + ++ L K + S + +S
Sbjct: 324 KTQSAAFQAAEIAKRIAK----MESQKRRLLEMQANLDKQMMFTTVS------YRRYSIK 373
Query: 522 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR 581
++E AT+ F +LKIGEGGYG +YK +L + VAIK+L +G +FQQEI++LS +R
Sbjct: 374 DVEDATYGFSDALKIGEGGYGPVYKAVLDYTSVAIKILKSGITEGLKQFQQEIEVLSSMR 433
Query: 582 HPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
HPN+V L+GACPE LVYEY+ NG+LEDRL CK+N+PPLSW+ R RIA+E+ + L+FLH
Sbjct: 434 HPNMVILLGACPEYGCLVYEYMENGTLEDRLFCKNNTPPLSWRARFRIASEIATGLLFLH 493
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS-NNTTLCCRTDPKGTFA 700
KP +VH DLKPANILLD + K+SD G++R + + +N + T GTF
Sbjct: 494 QAKPEPLVHRDLKPANILLDKHLTCKISDVGLARLVPPAVADTYSNYHM---TSAAGTFC 550
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760
Y+DPE+ +G L KSD+YSFG++LL+++T +PA+G+ +V+ A++ L+ +LDP +
Sbjct: 551 YIDPEYQQTGMLGVKSDLYSFGVVLLQIITAQPAMGLGHKVEMAVENNNLREILDPTVSE 610
Query: 761 WPFVQAEQLANLAMRCCEMSRKSRPEL 787
WP + +LA LA++CCE+ +K RP+L
Sbjct: 611 WPEEETLELAKLALQCCELRKKDRPDL 637
|
|
| TAIR|locus:2176177 AT5G51270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 759 (272.2 bits), Expect = 6.5e-83, Sum P(2) = 6.5e-83
Identities = 176/474 (37%), Positives = 265/474 (55%)
Query: 363 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN-G 421
A + E SR ++ R KDA+ S+ ++ + ++ L
Sbjct: 291 ASKRSSPETSRSVSWNPQFRDFDERKDAMSSMSSNFEYGNVVTPLGHYFTDNQDTLNEIS 350
Query: 422 KLELERMKKQHDEVMEELQI-ALDQKSLLESQIAESDQTAKELEQKIISA--VELLQNYK 478
KL E ++ H E+ Q+ LD L +++ + T E E K I+ E + +
Sbjct: 351 KLRAE-LRHAH-EMYAVAQVETLDASRKL-NELKFEELTLLEHETKGIAKKETEKFEQKR 407
Query: 479 KEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHNFDPSLKIG 537
+E+ E R+ +K E ++ K SS P+ + +F++ EI AT +F LKIG
Sbjct: 408 REEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSFSEDLKIG 467
Query: 538 EGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWT 597
G YG +YK L H A+K+LH +F QE++ILSKIRHP+LV L+GACP+
Sbjct: 468 MGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLGACPDHGA 527
Query: 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 657
LVYEY+ NGSLEDRL ++S P+ W R+RIA E+ S L+FLH KP I+H DLKPAN
Sbjct: 528 LVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIHRDLKPAN 587
Query: 658 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 717
ILL+ NFVSK+ D G+S + + S T+ +T P GT Y+DPE+ +G ++PKSD
Sbjct: 588 ILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTGRISPKSD 647
Query: 718 VYSFGIILLRLLTGRPALGITKEVQYALDTG---KLKNLLDPLAGDWPFVQAEQLANLAM 774
VY+FG+I+L+LLTG+ A+ +T V+ A++ +L +LD AG+WP + QLA LA+
Sbjct: 648 VYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETRQLAALAL 707
Query: 775 RCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQ 828
+C E+ K RP+L + VLE ++ + + S +PP +F CP+ +
Sbjct: 708 QCTELRSKDRPDLEDQILPVLESLKKVADKARNSL--SAAPSQPPSHFFCPLLK 759
|
|
| TAIR|locus:2180677 AT5G26150 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 796 (285.3 bits), Expect = 1.1e-82, Sum P(2) = 1.1e-82
Identities = 177/441 (40%), Positives = 265/441 (60%)
Query: 352 GSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR 411
GSVD + + + A +S E+ ++ + +AE ++ K + +Y+ K
Sbjct: 260 GSVDLSSQNSM-DFYHGASSSSEESIPQSTKDIEAEMRRLKL--ELKQTMDMYSSACKEA 316
Query: 412 KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESD-QTAKELEQKIISA 470
+ AN EL + K + E+ +++ ++ +L ++I ++ +TA E +K
Sbjct: 317 LTAKRK-AN---ELNQWKIEEARKFEKARLS-EEAALAVAEIEKAKCRTAVEAAEKAQRM 371
Query: 471 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF 530
EL + +++Q E+ KAV E ++ K R S+ +H + +S EIE AT F
Sbjct: 372 AEL-EGQRRKQAEM-----KAVSEEKD--KDRA-VSALAHNDVRYRKYSIEEIEEATERF 422
Query: 531 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 590
KIGEGGYG +Y G L H VAIK+L P + QG +FQQE+++L IRHP++V L+G
Sbjct: 423 ANHRKIGEGGYGPVYNGELDHTPVAIKVLRPDAAQGKKQFQQEVEVLCSIRHPHMVLLLG 482
Query: 591 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
ACPE LVYE++ NGSLEDRL NSPPLSW+ R IA E+ + L FLH KP +VH
Sbjct: 483 ACPEYGCLVYEFMENGSLEDRLFRTGNSPPLSWRKRFEIAAEIATALSFLHQAKPEPLVH 542
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 710
DLKPANILLD N+VSK+SD G++R + + +++ T T GTF Y+DPE+ +G
Sbjct: 543 RDLKPANILLDKNYVSKISDVGLARLVPAS--IADSVTQFHMTSAAGTFCYIDPEYQQTG 600
Query: 711 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 770
LT KSDVYS GI+LL+++TGRP +G+ +V A+ G K +LDP+ DWP +A+ A
Sbjct: 601 MLTTKSDVYSLGILLLQIITGRPPMGLAHQVSRAISKGTFKEMLDPVVPDWPVQEAQSFA 660
Query: 771 NLAMRCCEMSRKSRPELGKDV 791
LA++C E+ ++ RP+LGK+V
Sbjct: 661 TLALKCAELRKRDRPDLGKEV 681
|
|
| TAIR|locus:2151641 AT5G61560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 1.1e-82, Sum P(2) = 1.1e-82
Identities = 171/426 (40%), Positives = 252/426 (59%)
Query: 417 ALANGKLELERMKKQHDEVMEELQIALDQKSLL--ESQIAESDQTAKELEQKIISAVELL 474
A+A ++ ++ KK D + A K+L E + E + +E ++ + EL+
Sbjct: 314 AVAQSEV-IDASKKMQDLNQRRSEEATRLKNLTIREEEADEVVEMERERQEDAENEAELV 372
Query: 475 QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH----MPQFFSDFSFSEIEGATHNF 530
+ + + E ER +A AEE+RK ++ + Q + F + EI AT +F
Sbjct: 373 RECIERETE---ERLEAEARAEEVRKEKQRLEDALEGGPLQRQQYMKFEWEEIVEATSSF 429
Query: 531 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 590
LKIG GGYGS+Y+ L H VA+K+LH +F QE++ILSKIRHP+L+ L+G
Sbjct: 430 SDELKIGVGGYGSVYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKIRHPHLLLLLG 489
Query: 591 ACPEVWTLVYEYLPNGSLEDRLSCK------DNSPPLSWQTRIRIATELCSVLIFLHSCK 644
ACPE +LVYEY+ NGSLE+RL + PPL W R RIA E+ S L FLH+ +
Sbjct: 490 ACPERGSLVYEYMHNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIASALYFLHTNE 549
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
P IVH DLKPANILLD N VSK+ D G+S+ ++ + S+ +T+ T P GTF Y+DP
Sbjct: 550 PRPIVHRDLKPANILLDRNNVSKIGDVGLSKMVNLDP--SHASTVFNETGPVGTFFYIDP 607
Query: 705 EFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPLAGDWP 762
E+ +G +TP+SD+Y+FGIILL+L+T R A+G+ ++ AL TGK +LD AGDWP
Sbjct: 608 EYQRTGVVTPESDIYAFGIILLQLVTARSAMGLAHSIEKALRDQTGKFTEILDKTAGDWP 667
Query: 763 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR--ASCGGSTSYRLGSEERCEPPP 820
+A+++ + +RC EM ++ RP+LGK++ VLE ++ AS + + P
Sbjct: 668 VKEAKEMVMIGLRCAEMRKRDRPDLGKEILPVLERLKEVASIARNMFADNLIDHHHNAPT 727
Query: 821 YFTCPI 826
+F CPI
Sbjct: 728 HFYCPI 733
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q8GUH1 | PUB33_ARATH | 2, ., 7, ., 1, 1, ., - | 0.5538 | 0.9042 | 0.9172 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00026876001 | SubName- Full=Chromosome chr15 scaffold_40, whole genome shotgun sequence; (849 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 846 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 7e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-09 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 8e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-08 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-08 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 5e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 5e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-07 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 7e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-07 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 9e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-07 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 3e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 3e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 5e-06 | |
| COG1579 | 239 | COG1579, COG1579, Zn-ribbon protein, possibly nucl | 5e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-06 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 9e-06 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 9e-06 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 9e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-05 | |
| COG1340 | 294 | COG1340, COG1340, Uncharacterized archaeal coiled- | 1e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 1e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 1e-05 | |
| PRK03918 | 880 | PRK03918, PRK03918, chromosome segregation protein | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-05 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 3e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 3e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-05 | |
| COG1842 | 225 | COG1842, PspA, Phage shock protein A (IM30), suppr | 3e-05 | |
| pfam04012 | 220 | pfam04012, PspA_IM30, PspA/IM30 family | 3e-05 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 3e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 4e-05 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 4e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 4e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 4e-05 | |
| pfam13868 | 349 | pfam13868, Trichoplein, Tumour suppressor, Mitosta | 4e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 6e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 6e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 6e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 7e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 7e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-05 | |
| pfam12128 | 1198 | pfam12128, DUF3584, Protein of unknown function (D | 9e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 1e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 1e-04 | |
| PRK12704 | 520 | PRK12704, PRK12704, phosphodiesterase; Provisional | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| pfam09731 | 493 | pfam09731, Mitofilin, Mitochondrial inner membrane | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 2e-04 | |
| pfam02463 | 1162 | pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 3e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 3e-04 | |
| COG4487 | 438 | COG4487, COG4487, Uncharacterized protein conserve | 3e-04 | |
| pfam13863 | 126 | pfam13863, DUF4200, Domain of unknown function (DU | 3e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 4e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 4e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 4e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 4e-04 | |
| PRK03918 | 880 | PRK03918, PRK03918, chromosome segregation protein | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| pfam00769 | 244 | pfam00769, ERM, Ezrin/radixin/moesin family | 4e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| pfam01576 | 859 | pfam01576, Myosin_tail_1, Myosin tail | 4e-04 | |
| PRK03918 | 880 | PRK03918, PRK03918, chromosome segregation protein | 5e-04 | |
| pfam13949 | 292 | pfam13949, ALIX_LYPXL_bnd, ALIX V-shaped domain bi | 5e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-04 | |
| pfam13514 | 1118 | pfam13514, AAA_27, AAA domain | 5e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| TIGR03319 | 514 | TIGR03319, RNase_Y, ribonuclease Y | 5e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 6e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 7e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 7e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 8e-04 | |
| pfam00430 | 132 | pfam00430, ATP-synt_B, ATP synthase B/B' CF(0) | 9e-04 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 0.001 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 0.001 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.001 | |
| pfam01576 | 859 | pfam01576, Myosin_tail_1, Myosin tail | 0.001 | |
| COG4477 | 570 | COG4477, EzrA, Negative regulator of septation rin | 0.001 | |
| PRK02224 | 880 | PRK02224, PRK02224, chromosome segregation protein | 0.001 | |
| PRK14139 | 185 | PRK14139, PRK14139, heat shock protein GrpE; Provi | 0.001 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 0.002 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.002 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 0.002 | |
| pfam02463 | 1162 | pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| PRK12705 | 508 | PRK12705, PRK12705, hypothetical protein; Provisio | 0.002 | |
| pfam12037 | 276 | pfam12037, DUF3523, Domain of unknown function (DU | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| PRK00409 | 782 | PRK00409, PRK00409, recombination and DNA strand e | 0.002 | |
| COG4372 | 499 | COG4372, COG4372, Uncharacterized protein conserve | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 0.003 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 0.003 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.003 | |
| COG4026 | 290 | COG4026, COG4026, Uncharacterized protein containi | 0.003 | |
| COG3096 | 1480 | COG3096, MukB, Uncharacterized protein involved in | 0.003 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.003 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.003 | |
| COG0711 | 161 | COG0711, AtpF, F0F1-type ATP synthase, subunit b [ | 0.003 | |
| pfam10368 | 205 | pfam10368, YkyA, Putative cell-wall binding lipopr | 0.003 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 0.004 | |
| pfam07111 | 739 | pfam07111, HCR, Alpha helical coiled-coil rod prot | 0.004 | |
| COG4717 | 984 | COG4717, COG4717, Uncharacterized conserved protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 3e-50
Identities = 79/200 (39%), Positives = 110/200 (55%), Gaps = 20/200 (10%)
Query: 536 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGAC 592
+GEGG+G++Y + +VAIK++ E +EI+IL K+ HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
LV EY GSL+D L K+N LS +RI ++ L +LHS + I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 651 GDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 708
DLKP NILLD+ N KL+DFG+S+ L+ + S T+ GT AYM PE L
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIV------GTPAYMAPEVLLG 167
Query: 709 SGELTPKSDVYSFGIILLRL 728
G + KSD++S G+IL L
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-47
Identities = 83/268 (30%), Positives = 117/268 (43%), Gaps = 30/268 (11%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 591
K+GEG +G +Y + VAIK++ + +EI IL K++HPN+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 592 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
+++ LV EY G L D L LS ++ S L +LHS I
Sbjct: 66 FEDEDKLY-LVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS---KGI 118
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
VH DLKP NILLD + KL+DFG++R L E TT GT YM PE L
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFV------GTPEYMAPEVLL 169
Query: 709 SGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 767
D++S G+IL LLTG+ P G + ++ GK K P D
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS----P 225
Query: 768 QLANLAMRCCEMSRKSRP---ELGKDVW 792
+ +L + + R E + +
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEALQHPF 253
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 7e-46
Identities = 54/156 (34%), Positives = 81/156 (51%), Gaps = 12/156 (7%)
Query: 46 KIYVAVAKQVKESKSVLLWALQN--SGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKV 103
+ VAV K K+SK+ L WAL N + G+ I ++HVH P IP K E
Sbjct: 1 SVAVAVDK-DKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKL-------EVA 52
Query: 104 QAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAA 163
AY++ E ++ L C + GV+ E + E + K I+E ++ +GI KLVMGA+
Sbjct: 53 SAYKQEEDKEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGAS 112
Query: 164 ADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNG 199
+D H+ K KS A SV ++AP C ++ + G
Sbjct: 113 SDNHFSMK--FKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 8e-46
Identities = 98/273 (35%), Positives = 137/273 (50%), Gaps = 34/273 (12%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLV 589
K+G G +G++YK + VA+K+L S + + Q EI IL ++ HPN+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 590 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
A ++ LV EY G L D LS PLS +IA ++ L +LHS +
Sbjct: 65 DAFEDKDHLY-LVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHS---N 117
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
I+H DLKP NILLD N V K++DFG+++ L ++ SS+ TT GT YM PE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFV------GTPWYMAPEV 169
Query: 707 LASGEL-TPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFV 764
L G PK DV+S G+IL LLTG+P G Q L + L PL D P
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI---RRILGPPLEFDEPKW 226
Query: 765 --QAEQLANLAMRCCEMSRKSRP---ELGKDVW 792
+E+ +L +C RP E+ + W
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPW 259
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 85/263 (32%), Positives = 127/263 (48%), Gaps = 32/263 (12%)
Query: 535 KIGEGGYGSIYKGLLR------HMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 587
K+GEG +G +YKG L+ ++VA+K L S Q EF +E I+ K+ HPN+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 588 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
L+G C E +V EY+ G L L + N P LS + A ++ + +L S
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESKN- 122
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+H DL N L+ N V K+SDFG+SR L ++ + K +M PE
Sbjct: 123 --FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-------YRKRGGKLPIRWMAPE 173
Query: 706 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWP 762
L G+ T KSDV+SFG++L + T +P G++ +EV L G L P
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG---YRLPQ-----P 225
Query: 763 FVQAEQLANLAMRCCEMSRKSRP 785
+L +L ++C + RP
Sbjct: 226 PNCPPELYDLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 6e-43
Identities = 87/264 (32%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 535 KIGEGGYGSIYKGLLR------HMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 587
K+GEG +G +YKG L+ ++VA+K L S Q EF +E I+ K+ HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 588 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPP-LSWQTRIRIATELCSVLIFLHSCK 644
L+G C E +V EY+P G L D L + N P LS + A ++ + +L S
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLESKN 123
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
+H DL N L+ N V K+SDFG+SR L ++ K +M P
Sbjct: 124 ---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK-------VKGGKLPIRWMAP 173
Query: 705 EFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDW 761
E L G+ T KSDV+SFG++L + T P G++ EV L G L
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG---YRLPK----- 225
Query: 762 PFVQAEQLANLAMRCCEMSRKSRP 785
P +L L ++C + RP
Sbjct: 226 PPNCPPELYKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 83/265 (31%), Positives = 131/265 (49%), Gaps = 35/265 (13%)
Query: 535 KIGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 587
K+GEG +G +YKG L+ +VA+K L S + EF +E I+ K+ HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 588 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
L+G C E +V EY+P G L D L + + L+ + +++A ++ + +L S
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES--- 120
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMD 703
+ VH DL N L+ N V K+SDFG+SR + +++ R G +M
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY--------RKRGGGKLPIKWMA 172
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGD 760
PE L G+ T KSDV+SFG++L + T +P G++ +EV L+ G L
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG---YRLPRPENC 229
Query: 761 WPFVQAEQLANLAMRCCEMSRKSRP 785
+L L ++C + RP
Sbjct: 230 PD-----ELYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 535 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 588
K+GEG +G +YKG L+ +VA+K L S + +F +E ++ K+ HPN+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 589 VGACPEV--WTLVYEYLPNGSLEDRL------SCKDNSPPLSWQTRIRIATELCSVLIFL 640
+G C E LV EY+ G L D L LS + + A ++ + +L
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
S K VH DL N L+ + V K+SDFG+SR + ++ P
Sbjct: 122 ASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD---YYRKKTGGKLP---IR 172
Query: 701 YMDPEFLASGELTPKSDVYSFGIIL 725
+M PE L G T KSDV+SFG++L
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLL 197
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 73/209 (34%), Positives = 109/209 (52%), Gaps = 20/209 (9%)
Query: 530 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 587
F+ KIG+GG+G +YK + VAIK++ S + + EI IL K +HPN+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 588 LVGA--CP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
G+ E+W +V E+ GSL+D L K + L+ + EL L +LHS
Sbjct: 62 YYGSYLKKDELW-IVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS-- 116
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
+ I+H D+K ANILL ++ KL DFG+S LS + + NT + GT +M P
Sbjct: 117 -NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK--ARNTMV-------GTPYWMAP 166
Query: 705 EFLASGELTPKSDVYSFGIILLRLLTGRP 733
E + K+D++S GI + L G+P
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 535 KIGEGGYGSIYKGLLRHM--QVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 590
+G G +GS+Y L + +A+K L S + ++EI ILS ++HPN+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 591 AC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+ + EY+ GSL L L + ++ L +LHS +
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYTRQILEGLAYLHS---N 120
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
IVH D+K ANIL+D++ V KL+DFG ++ L E ++ +GT +M PE
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV------RGTPYWMAPEV 174
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRP 733
+ E +D++S G ++ + TG+P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 133 bits (334), Expect = 1e-33
Identities = 88/269 (32%), Positives = 123/269 (45%), Gaps = 22/269 (8%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHP-NLVTL-- 588
K+GEG +G +Y VA+K+L E F +EI IL+ + HP N+V L
Sbjct: 7 KLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 589 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
LV EY+ GSLED L PLS + I ++ S L +LHS I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122
Query: 649 VHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
+H D+KP NILLD + V KL DFG+++ L +S+ L + GT YM PE L
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP--STSVGTPGYMAPEVL 180
Query: 708 ASGEL---TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------LKNLLDPLA 758
L + SD++S GI L LLTG P K T K +L PL+
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 759 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 787
P + ++ ++L + K+R
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 535 KIGEGGYGSIYKGLLRH----MQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 588
+IG+G +G +Y L+R +K L S + + E+ IL K+ HPN++
Sbjct: 7 QIGKGSFGKVY--LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 589 VGACPEVWT------LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLH 641
E + +V EY G L ++ K P + + +LC L +LH
Sbjct: 65 Y----ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
S K I+H D+KP NI L +N + KL DFGIS+ LS + T+ GT Y
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK--TVV------GTPYY 169
Query: 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 734
+ PE + KSD++S G +L L T +
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVG 590
IG G +G +YKGL VAIK + ++ + QEID+L ++HPN+V +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 591 ACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
+ +L + EY NGSL + P ++ L +LH +
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHE---QGV 120
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
+H D+K ANIL + V KL+DFG++ L+ GT +M PE +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--------DASVVGTPYWMAPEVIE 172
Query: 709 SGELTPKSDVYSFGIILLRLLTGRP 733
+ SD++S G ++ LLTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 591
+G+G G +YK + A+K +H + + +E+ L P +V GA
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 592 C--PEVWTLVYEYLPNGSLEDRL--SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
++V EY+ GSL D L K P L+ IA ++ L +LH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLH--TKRH 120
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
I+H D+KP+N+L+++ K++DFGIS+ L NT C T GT YM PE +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLE-------NTLDQCNTF-VGTVTYMSPERI 172
Query: 708 ASGELTPKSDVYSFGIILLRLLTGR 732
+ +D++S G+ LL G+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 73/220 (33%), Positives = 108/220 (49%), Gaps = 18/220 (8%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 592
K+G G +G ++ G +VA+K L P ++ P F QE I+ K+RH LV L C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 593 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
E +V EY+ GSL D L L + +A ++ + +L S + +H
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL NIL+ N V K++DFG++R + +E R K + PE G
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDE-------YTAREGAKFPIKWTAPEAANYGR 180
Query: 712 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 748
T KSDV+SFGI+L ++T GR P G+T EV ++ G
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 46/236 (19%)
Query: 528 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML---HPHSLQGPSEFQQEIDILSKI-R 581
+F IGEG + ++ + + AIK+L + + E ++L+++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 582 HPNLVTLVGACPEVWT--------LVYEYLPNGSLED---RLSCKDNSPPLSWQTRIR-I 629
HP ++ L +T V EY PNG L + D + R
Sbjct: 61 HPGIIKLY------YTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-------EKCTRFY 107
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
A E+ L +LHS I+H DLKP NILLD + K++DFG ++ L N +N
Sbjct: 108 AAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 690 CCRTDPK------------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
D + GT Y+ PE L SD+++ G I+ ++LTG+P
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 73/208 (35%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 536 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 588
+G+G +G + L+R A+K+L + E + E +ILS+I HP +V L
Sbjct: 1 LGKGSFGKVL--LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 589 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHSCKP 645
A E LV EY P G L LS S + R R A E+ L +LHS
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFS-EERARFYAAEIVLALEYLHS--- 111
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
I++ DLKP NILLDA+ KL+DFG+++ LS S T C GT Y+ PE
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC------GTPEYLAPE 163
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
L D +S G++L +LTG+P
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 18/220 (8%)
Query: 535 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
K+G G +G +++GL + VA+K L P ++ P +F E I+ K+RHP L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 594 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
E +V E + GSL + L L I +A ++ S + +L + + +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQ-GGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHR 127
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL N+L+ N + K++DFG++R + ++ + R K + PE
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEA-------REGAKFPIKWTAPEAALYNR 180
Query: 712 LTPKSDVYSFGIILLRLLT-GR-PALGIT-KEVQYALDTG 748
+ KSDV+SFGI+L ++T GR P G+T EV +D G
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 18/192 (9%)
Query: 536 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEV 595
IG+G +G + G R +VA+K L S + F E +++ +RHPNLV L+G +
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 596 WTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 653
L V EY+ GSL D L + + ++ ++ A ++C + +L VH DL
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHRDL 128
Query: 654 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 713
N+L+ + V+K+SDFG+++ SQ + S K + PE L + +
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQDSG-----------KLPVKWTAPEALREKKFS 177
Query: 714 PKSDVYSFGIIL 725
KSDV+SFGI+L
Sbjct: 178 TKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 50/222 (22%)
Query: 536 IGEGGYGSIYKGLL------RHMQ-VAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 587
+GEG +G +YKG L VAIK L + EF+QE +++S ++HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 588 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSP---------------PLSWQTRIRIA 630
L+G C + +++EYL +G L + L NSP L + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLV--RNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 631 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS------ 684
++ + + +L S H VH DL N L+ K+SDFG+SR +I S
Sbjct: 131 IQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSR-----DIYSADYYRV 182
Query: 685 -NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 725
+ + L R +M PE + G+ T +SD++SFG++L
Sbjct: 183 QSKSLLPVR--------WMPPEAILYGKFTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 70/213 (32%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVG 590
KIG G +G +Y L +A+K + + E E+ +L ++HPNLV G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 591 ACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHSCKP 645
EV + EY G+LE+ L + IR+ T +L L +LHS
Sbjct: 67 V--EVHREKVYIFMEYCSGGTLEELLEHGRILD----EHVIRVYTLQLLEGLAYLHSHG- 119
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT--DPKGTFAYMD 703
IVH D+KPANI LD N V KL DFG + NNTT GT AYM
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAV------KLKNNTTTMGEEVQSLAGTPAYMA 171
Query: 704 PEFLASGELTPK---SDVYSFGIILLRLLTGRP 733
PE + G+ +D++S G ++L + TG+
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 588
I +G YG ++ L + AIK++ + ++ Q E DILS+ + P +V L
Sbjct: 1 ISKGAYGRVF--LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 589 VGACPEVWTL--VYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
+ L V EYLP G SL + + D RI IA E+ L +LHS
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIA-EIVLALEYLHS- 111
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLCCRTDPKGTFAY 701
+ I+H DLKP NIL+D+N KL+DFG+S+ +++ R GT Y
Sbjct: 112 --NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI--VGTPDY 167
Query: 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
+ PE + + D +S G IL L G P
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGA 591
++G G G + K L R + + + +Q E+DIL K P +V GA
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 592 C---PEVWTLVYEYLPNGSLEDRL-SCKDNSP--PLSWQTRIRIATELCSVLIFLHSCKP 645
++ + EY+ GSL+ L + P L +IA + L +LH
Sbjct: 68 FYNNGDIS-ICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE--K 119
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
H I+H D+KP+NIL+++ KL DFG+S L N ++ GT +YM PE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV-NSLAKTFV---------GTSSYMAPE 169
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGR 732
+ + + KSD++S G+ L+ L TGR
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 30/215 (13%)
Query: 535 KIGEGGYGSIYKGLLRH--------MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNL 585
++GEG +G + R+ QVA+K L+ Q S+F++EI+IL + H N+
Sbjct: 11 QLGEGHFGKVELC--RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 586 VTLVGACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
V G C + L+ EYLP+GSL D L + + ++ + + ++++C + +L
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTLCCRTDPKGTF 699
S + +H DL NIL+++ + K+SDFG+++ L +++ P F
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP----GESP--IF 177
Query: 700 AYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRP 733
Y PE L + + + SDV+SFG+ L L T G P
Sbjct: 178 WYA-PECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 535 KIGEGGYGSIYKG-----LLRHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 588
K+G+G +G + +G + + VA+K L L +F +E I+ + H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 589 VGACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
G V T +V E P GSL DRL KD T A ++ + + +L S
Sbjct: 62 YGV---VLTHPLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQIANGMRYLES-- 115
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE---ISSNNTTLCCRTDPKGTFAY 701
+H DL NILL ++ K+ DFG+ R L QNE + + K FA+
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL--------KVPFAW 166
Query: 702 MDPEFLASGELTPKSDVYSFGIILLRLLT 730
PE L + + SDV+ FG+ L + T
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 67/249 (26%), Positives = 117/249 (46%), Gaps = 51/249 (20%)
Query: 536 IGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVT 587
+GEG +G ++ G H VA+K L + + F++E ++L+ +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 588 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSP-------------PLSWQTRIRIATE 632
G C E +V+EY+ +G L L + + P L+ ++IA +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFL--RSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 633 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN------ 686
+ S +++L S VH DL N L+ + V K+ DFG+SR ++ + +
Sbjct: 131 IASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYTTDYYRVGG 182
Query: 687 -TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GR-PALGIT-KEVQ 742
T L R +M PE + + T +SDV+SFG++L + T G+ P G++ +EV
Sbjct: 183 HTMLPIR--------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234
Query: 743 YALDTGKLK 751
+ G+L
Sbjct: 235 ECITQGRLL 243
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 70/208 (33%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNLVTL 588
K+GEG YG +YK R + VA+K + + +G PS +EI +L +++HPN+V L
Sbjct: 6 KLGEGTYGVVYKA--RDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 589 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
V LV+EY L+ L PLS I +L L + HS H
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYCHS---H 117
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE- 705
I+H DLKP NIL++ + V KL+DFG++R T T T Y PE
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARA-----FGIPLRTY---THEVVTLWYRAPEI 169
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
L S + D++S G I ++TG+P
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 80/256 (31%), Positives = 125/256 (48%), Gaps = 25/256 (9%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
K+G G +G ++ G H +VAIK L S+ P F E +++ +++HP LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 594 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 652
E ++ EY+ NGSL D L + L+ I +A ++ + F+ + +H D
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIER---KNYIHRD 127
Query: 653 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 712
L+ ANIL+ K++DFG++R + NE ++ R K + PE + G
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGTF 180
Query: 713 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTGKLKNLLDPLAGDWPFVQAEQL 769
T KSDV+SFGI+L ++T GR P G+T EV L+ G P + P E+L
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----PRPDNCP----EEL 232
Query: 770 ANLAMRCCEMSRKSRP 785
L C + + RP
Sbjct: 233 YELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 536 IGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 594
+G G +G ++ G R + VAIKM+ ++ +F +E ++ K+ HPNLV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 595 VWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 652
+ V EY+ NG L + L ++ L + + + +++C + +L S + +H D
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRD 125
Query: 653 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 712
L N L+ + V K+SDFG++R++ ++ +S+ T K + PE
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT-------KFPVKWAPPEVFDYSRF 178
Query: 713 TPKSDVYSFGIILLRLLTG 731
+ KSDV+SFG+++ + +
Sbjct: 179 SSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 82/257 (31%), Positives = 125/257 (48%), Gaps = 25/257 (9%)
Query: 534 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
+K+G+G +G ++ G +VAIK L P ++ P F QE ++ K+RH LV L
Sbjct: 12 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 593 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
E +V EY+ GSL D L + L + +A ++ S + ++ + VH
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 126
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 179
Query: 712 LTPKSDVYSFGIILLRLLT-GR-PALG-ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 768
T KSDV+SFGI+L L T GR P G + +EV ++ G P + P E
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----PCPPECP----ES 231
Query: 769 LANLAMRCCEMSRKSRP 785
L +L +C + RP
Sbjct: 232 LHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 21/224 (9%)
Query: 536 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 589
+G G +GS+ KG+ ++VA+K L H G EF +E +++++ HP +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 590 GAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
G C E LV E P G L L K + +A ++ + +L S
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYL--KKR-REIPVSDLKELAHQVAMGMAYLESKH---F 116
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
VH DL N+LL +K+SDFG+SR L + + T + + PE +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRAL-----GAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 709 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 749
G+ + KSDV+S+G+ L + +P + EV L++G+
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 72/265 (27%), Positives = 115/265 (43%), Gaps = 31/265 (11%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVT 587
IG+G +G++ K +R + K + ++ E QQ E++IL +++HPN+V
Sbjct: 7 TIGKGSFGTVRK--VRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVR 63
Query: 588 ----LVGACPEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLH- 641
++ + +V EY G L + CK + + RI T+L L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 642 -SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
S ++++H DLKPANI LDAN KL DFG+++ L S+ GT
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---GHDSSFAKTYV-----GTPY 175
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760
YM PE L KSD++S G ++ L P ++Q A K+K
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA---SKIKEGKFR---R 229
Query: 761 WPFVQAEQLANLAMRCCEMSRKSRP 785
P+ + +L + + RP
Sbjct: 230 IPYRYSSELNEVIKSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 58/204 (28%), Positives = 105/204 (51%), Gaps = 25/204 (12%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
K+G G +G +++GL + ++VAIK+L L +FQ+E+ L ++RH +L++L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 594 E---VWTLVYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
V+ ++ E + GSL L + L I +A ++ + +L
Sbjct: 73 VGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLEE---Q 123
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
+ +H DL NIL+ + V K++DFG++R + ++ S++ K + + PE
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK--------KIPYKWTAPEA 175
Query: 707 LASGELTPKSDVYSFGIILLRLLT 730
+ G + KSDV+SFGI+L + T
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-22
Identities = 92/314 (29%), Positives = 137/314 (43%), Gaps = 43/314 (13%)
Query: 513 QFF-SDFSFS-EIEGATHNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS 568
QFF S S S I + I G G+ YKG + MQ +K ++ + S
Sbjct: 673 QFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS 732
Query: 569 EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 626
E + K++HPN+V L+G C + L++EY+ +L + L LSW+ R
Sbjct: 733 EIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERR 782
Query: 627 IRIATELCSVLIFLH-SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685
+IA + L FLH C P ++V G+L P I++D L S
Sbjct: 783 RKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHL-------------RLSL 828
Query: 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR----PALG----I 737
LC T + AY+ PE + ++T KSD+Y FG+IL+ LLTG+ G I
Sbjct: 829 PGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI 888
Query: 738 TKEVQYALDTGKLKNLLDP-LAGDWPFVQAE--QLANLAMRCCEMSRKSRPELGKDVWRV 794
+ +Y L +DP + GD Q E ++ NLA+ C +RP DV +
Sbjct: 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP-CANDVLKT 947
Query: 795 LEPMRASCGGSTSY 808
LE S +
Sbjct: 948 LESASRSSSSCVTG 961
|
Length = 968 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 588
+IGEG +G ++K + + VA+K + L+G P++ +EI L +HP +V L
Sbjct: 7 RIGEGAHGIVFKA--KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 589 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+ + LV EY+P L + L +D PL L + ++H+ +
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVL--RDEERPLPEAQVKSYMRMLLKGVAYMHA---N 118
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
I+H DLKPAN+L+ A+ V K++DFG++R S+ E + T Y PE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL-------YSHQVATRWYRAPEL 171
Query: 707 L-ASGELTPKSDVYSFGIILLRLLTGRP 733
L + + P D+++ G I LL G P
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-22
Identities = 73/220 (33%), Positives = 113/220 (51%), Gaps = 17/220 (7%)
Query: 534 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
+K+G+G +G ++ G +VAIK L P ++ P F QE I+ K+RH LV L
Sbjct: 12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 593 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
E +V E++ GSL D L D L + +A ++ + ++ + +H
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERM---NYIHR 126
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 179
Query: 712 LTPKSDVYSFGIILLRLLT-GR-PALG-ITKEVQYALDTG 748
T KSDV+SFGI+L L+T GR P G + +EV ++ G
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 26/207 (12%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 590
KIGEG G +YK R +VAIK + L+ ++ EI I+ +HPN+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKHPNIVDYYD 82
Query: 591 AC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI-RIATELCSVLIFLHSCKPH 646
+ E+W +V EY+ GSL D ++ N ++ + +I + E+ L +LHS
Sbjct: 83 SYLVGDELW-VVMEYMDGGSLTDIITQ--NFVRMN-EPQIAYVCREVLQGLEYLHS---Q 135
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
+++H D+K NILL + KL+DFG + L++ E S N+ + GT +M PE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK-EKSKRNSVV-------GTPYWMAPEV 187
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRP 733
+ + PK D++S GI+ + + G P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 74/271 (27%), Positives = 124/271 (45%), Gaps = 50/271 (18%)
Query: 536 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 589
IG G +G + +G L+ + VAIK L S + +F E I+ + HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 590 GACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
G + + + EY+ NGSL+ L ++N + + + + S + +L +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYLSE---MN 126
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD---- 703
VH DL NIL+++N V K+SDFG+SR L D + T+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLE---------------DSEATYTTKGGKIP 171
Query: 704 -----PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG-KLKNLL 754
PE +A + T SDV+SFGI++ +++ RP ++ ++V A++ G +L
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL---- 227
Query: 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
P D P + L + C + R RP
Sbjct: 228 -PPPMDCPSALYQ----LMLDCWQKDRNERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 27/229 (11%)
Query: 536 IGEGGYGSIYKG-------LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 588
+G G +GS+Y+G +V++ + + +QEI +LSK++HPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 589 VGACPEVWTL-VY-EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE-LCSVLIFLHSCKP 645
+G E L ++ E +P GSL L + P + IR+ T + L +LH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFP----EPVIRLYTRQILLGLEYLHD--- 120
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+ VH D+K ANIL+D N V KL+DFG+++ ++ + KG+ +M PE
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSF----KGSPYWMAPE 171
Query: 706 FLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753
+A G +D++S G +L + TG+P + V G+ K L
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL 220
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 64/211 (30%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIK-MLHPHSLQGPSEF-QQEIDILSKIRHPNLVTLVG 590
+GEG YG + K + VAIK + + +E+ +L ++RH N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 591 ACPEV--WTLVYEYLPNGSLEDRLSCKDNSPP-----LSWQTRIRIATELCSVLIFLHSC 643
A LV+EY+ LE + PP WQ L + + HS
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHS- 118
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
H+I+H D+KP NIL+ + V KL DFG +R L + L TD T Y
Sbjct: 119 --HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR----PASPL---TDYVATRWYRA 169
Query: 704 PEFL-ASGELTPKSDVYSFGIILLRLLTGRP 733
PE L DV++ G I+ LL G P
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 35/216 (16%)
Query: 530 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL 585
FD K+GEG YGS+YK + H + VAIK++ E +EI IL + P +
Sbjct: 5 FDILEKLGEGSYGSVYKAI--HKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYI 60
Query: 586 VTLVGAC---PEVWTLVYEYLPNGSLED--RLSCKDNSPPLSWQTRIRIATELCSV---L 637
V G+ ++W +V EY GS+ D +++ K L+ + IA L L
Sbjct: 61 VKYYGSYFKNTDLW-IVMEYCGAGSVSDIMKITNK----TLTEE---EIAAILYQTLKGL 112
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+LHS + +H D+K NILL+ +KL+DFG+S L + ++ NT + G
Sbjct: 113 EYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNTVI-------G 161
Query: 698 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
T +M PE + K+D++S GI + + G+P
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 16/196 (8%)
Query: 533 SLKIGEGGYGSIYKGL-LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 591
+IG G +G ++ G L +VAIK + ++ +F +E ++ K+ HP LV L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 592 CPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
C E LV+E++ +G L D L + S +T + + ++C + +L S +++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLES---SNVI 122
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
H DL N L+ N V K+SDFG++RF+ ++ +S+ T K + PE +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWSSPEVFSF 175
Query: 710 GELTPKSDVYSFGIIL 725
+ + KSDV+SFG+++
Sbjct: 176 SKYSSKSDVWSFGVLM 191
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 73/224 (32%), Positives = 99/224 (44%), Gaps = 41/224 (18%)
Query: 536 IGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 592
IGEG YG +YK + VAIK++ E ++E +IL K HPN+ T GA
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 593 ---------PEVWTLVYEYLPNGSLED---RLSCKDNSPPLSWQTRIRIA---TELCSVL 637
++W LV E GS+ D L K W IA E L
Sbjct: 73 IKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGL 126
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+LH + ++H D+K NILL N KL DFG+S L + + NT + G
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-DSTLGRRNTFI-------G 175
Query: 698 TFAYMDPEFLASGE-----LTPKSDVYSFGIILLRLLTGRPALG 736
T +M PE +A E +SDV+S GI + L G+P L
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 78/256 (30%), Positives = 124/256 (48%), Gaps = 25/256 (9%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
K+G G +G ++ G + +VA+K L P ++ P F +E I+ K+RH LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 594 E-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 652
E +V EY+ GSL D L + L + +A ++ + + ++ + +H D
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERM---NYIHRD 127
Query: 653 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 712
L+ ANIL+ V K++DFG++R + NE ++ R K + PE G
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRF 180
Query: 713 TPKSDVYSFGIILLRLLT-GR-PALGI-TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 769
T KSDV+SFGI+L L+T GR P G+ +EV ++ G P D P L
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM----PCPQDCPI----SL 232
Query: 770 ANLAMRCCEMSRKSRP 785
L ++C + + RP
Sbjct: 233 HELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLH----PHSLQGPSEFQQEIDILSKIRHPNLVT- 587
IG G +Y L + +VAIK + S+ E ++E+ +S+ HPN+V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD---ELRKEVQAMSQCNHPNVVKY 64
Query: 588 ----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL---IFL 640
+VG E+W LV YL GSL D + +S P IAT L VL +L
Sbjct: 65 YTSFVVGD--ELW-LVMPYLSGGSLLDIMK---SSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
HS + +H D+K NILL + K++DFG+S L+ + R GT
Sbjct: 119 HS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV----RKTFVGTPC 171
Query: 701 YMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRP 733
+M PE + K+D++SFGI + L TG
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 4e-21
Identities = 59/203 (29%), Positives = 107/203 (52%), Gaps = 22/203 (10%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
K+G G YG +Y+G+ + + VA+K L +++ EF +E ++ +I+HPNLV L+G C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 593 ---PEVWTLVYEYLPNGSLEDRLSCKDNS--PPLSWQTRIRIATELCSVLIFLHSCKPHS 647
P + ++ E++ G+L D L + + + +AT++ S + +L +
Sbjct: 72 TREPPFY-IITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KN 124
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
+H DL N L+ N + K++DFG+SR ++ + T K + PE L
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESL 177
Query: 708 ASGELTPKSDVYSFGIILLRLLT 730
A + + KSDV++FG++L + T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 34/216 (15%)
Query: 535 KIGEGGYGSIYKGL-LRHMQ-VAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVG 590
+IGEG YG +YK + + VA+K + + + P +EI +L K+RHPN+V L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK- 64
Query: 591 ACPEVWT--------LVYEYLPNGSLEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFL 640
E+ T +V+EY+ + L L + + Q + +L L +L
Sbjct: 65 ---EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES---QIK-CYMKQLLEGLQYL 116
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
HS I+H D+K +NIL++ + V KL+DFG++R + S++ T T
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVI------TLW 166
Query: 701 YMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL 735
Y PE L + P+ D++S G IL L G+P
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIK-MLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVG 590
KIGEG YG +YK L VAIK + +G P +EI +L ++ HPN++ L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL- 64
Query: 591 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHSC 643
+V+ LV+E++ + L + KD L ++ I+ +L L F HS
Sbjct: 65 ---DVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLP-ESLIKSYLYQLLQGLAFCHS- 116
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
H I+H DLKP N+L++ V KL+DFG++R S T T Y
Sbjct: 117 --HGILHRDLKPENLLINTEGVLKLADFGLAR-----SFGSPVRPY---THYVVTRWYRA 166
Query: 704 PE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
PE L + D++S G I LL+ RP
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 536 IGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 592
+G+G +G +YK + + A K++ S + +F EIDILS+ +HPN+V L A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
++W L+ E+ G+L D + + Q R + ++ L FLHS H ++H
Sbjct: 73 YENKLWILI-EFCDGGAL-DSIMLELERGLTEPQIRY-VCRQMLEALNFLHS---HKVIH 126
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-- 708
DLK NILL + KL+DFG+S + N +TL R GT +M PE +A
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVS--------AKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 709 ---SGELTPKSDVYSFGIILLRLLTGRP 733
K+D++S GI L+ L P
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIK---MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 590
KIG+G +G +YKG+L+ + +VA+K P L+ +F QE +IL + HPN+V L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIG 59
Query: 591 ACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
C + + V E +P GSL L K N + ++ + + + + +L S +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL--DAAAGMEYLES---KNC 114
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
+H DL N L+ N V K+SDFG+SR + ++ + P + PE L
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL---KQIP---IKWTAPEALN 168
Query: 709 SGELTPKSDVYSFGIILLRLLTG 731
G T +SDV+S+GI+L +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 591
IG+G +G +YK + + VAIK++ + + QQEI LS+ R P + G+
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 592 CPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
+ L + EY GS D L L I E+ L +LH +
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGK---I 120
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
H D+K ANILL KL+DFG+S L+ +S NT + GT +M PE +
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTST-MSKRNTFV-------GTPFWMAPEVIKQ 172
Query: 710 GELTPKSDVYSFGIILLRLLTGRPAL 735
K+D++S GI + L G P L
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ------EIDILSKIRHPNL 585
+G G +G + L+RH A+K+L + + +Q E IL IRHP L
Sbjct: 9 LGTGSFGRVM--LVRHKGSGKYYALKILSKAKI---VKLKQVEHVLNEKRILQSIRHPFL 63
Query: 586 VTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
V L G+ + L V EY+P G L L K P R A ++ L +LHS
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEP-VARFYAA-QVVLALEYLHSL 120
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-TLCCRTDPKGTFAYM 702
IV+ DLKP N+LLD++ K++DFG ++ + T TLC GT Y+
Sbjct: 121 D---IVYRDLKPENLLLDSDGYIKITDFGFAKRV------KGRTYTLC------GTPEYL 165
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
PE + S D ++ GI++ +L G P
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 47/275 (17%)
Query: 536 IGEGGYGSIYKGLLRH-------MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 587
+G+G +G +Y+GL + +VAIK ++ + S++ EF E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 588 LVGAC----PEVWTLVYEYLPNGSLEDRL-SCK------DNSPPLSWQTRIRIATELCSV 636
L+G P + +V E + G L+ L S + P + Q I++A E+
Sbjct: 74 LLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
+ +L + K VH DL N ++ + K+ DFG++R + + + R K
Sbjct: 132 MAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY--------RKGGK 180
Query: 697 GTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKE--VQYALDTGKL 750
G +M PE L G T KSDV+SFG++L + T +P G++ E +++ +D G L
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240
Query: 751 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
D P ++L L C + + K RP
Sbjct: 241 ---------DLPENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 7e-20
Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 56/299 (18%)
Query: 536 IGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNL 585
+GEG +G + K ++ VA+KML ++ SE + E ++L ++ HP++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHV 65
Query: 586 VTLVGACP--EVWTLVYEYLPNGSLE------------------DRLSCKDNSP---PLS 622
+ L GAC L+ EY GSL +R S ++P L+
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 623 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682
I A ++ + +L K +VH DL N+L+ K+SDFG+SR + + +
Sbjct: 126 MGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED- 181
Query: 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKE 740
+ R+ + +M E L T +SDV+SFG++L ++T G P GI E
Sbjct: 182 -----SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 741 VQYALDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
+L NLL + P +E++ NL + C + RP D+ + LE M
Sbjct: 237 --------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF-ADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 66/266 (24%), Positives = 110/266 (41%), Gaps = 29/266 (10%)
Query: 536 IGEGGYGSIYKGLL----RHMQVAIKMLHPHSLQGPSEFQQ--------EIDILSKIRHP 583
IG+G YG +Y L M V L Q+ EI+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 584 NLVTLVG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
N+V +G E ++ EY+P GS+ SC Q ++ L +LH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIG---SCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
S I+H DLK N+L+DA+ + K+SDFGIS+ + N ++ +G+ +
Sbjct: 126 S---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM------QGSVFW 176
Query: 702 MDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759
M PE + S + K D++S G ++L + GR + + G ++ P+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-APPIPP 235
Query: 760 DWPFVQAEQLANLAMRCCEMSRKSRP 785
D + + C ++ +RP
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 74/269 (27%), Positives = 132/269 (49%), Gaps = 31/269 (11%)
Query: 536 IGEGGYGSIYKGLLRH-----MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 589
IG G +G + +G L+ + VAIK L ++ + +F E I+ + HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 590 G----ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
G + P + ++ E++ NG+L+ L D T I++ L + +
Sbjct: 72 GVVTKSRPVM--IITEFMENGALDSFLRQNDGQ-----FTVIQLVGMLRGIAAGMKYLSE 124
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+ VH DL NIL+++N V K+SDFG+SRFL + +++ T K + PE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD---TSDPTYTSSLGGKIPIRWTAPE 181
Query: 706 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWP 762
+A + T SDV+S+GI++ +++ RP ++ ++V A++ ++ P D P
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----QDYRLPPPMDCP 237
Query: 763 FVQAEQLANLAMRCCEMSRKSRPELGKDV 791
L L + C + R +RP+ G+ V
Sbjct: 238 TA----LHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 30/194 (15%)
Query: 553 QVAIKMLHP----HSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG 606
VA+K+L P ++ + +F +E+ ILS++ PN+ L+G C ++ EY+ NG
Sbjct: 48 LVAVKVLRPDASDNARE---DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104
Query: 607 SLEDRLS--------CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 658
L L NS LS+ T + +AT++ S + +L S + VH DL N
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161
Query: 659 LLDANFVSKLSDFGISRFLSQNEIS--SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 716
L+ N+ K++DFG+SR L ++ L R +M E + G+ T KS
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR--------WMAWESVLLGKFTTKS 213
Query: 717 DVYSFGIILLRLLT 730
DV++FG+ L +LT
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-19
Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 16/192 (8%)
Query: 553 QVAIKML---HPHSLQGPSEFQQEIDILSKIRHPNLVTLV--GACPEVWTL-VYEYLPNG 606
+VAIK+L P + F++E + +++ HPN+V L+ G P V+EY+P
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV- 665
+L + L+ L R+ ++ L H+ IVH DLKP NI++ V
Sbjct: 65 TLREVLA---ADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVR 118
Query: 666 --SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGI 723
+K+ DFGI L ++ TL T+ GT Y PE L +TP SD+Y++G+
Sbjct: 119 PHAKVLDFGIGTLLPGVR-DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 724 ILLRLLTGRPAL 735
I L LTG+ +
Sbjct: 178 IFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 81/297 (27%), Positives = 137/297 (46%), Gaps = 58/297 (19%)
Query: 536 IGEGGYGSIYK----GLLRH---MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 587
IG+G +G +++ GLL + VA+KML S ++FQ+E ++++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 588 LVGACP--EVWTLVYEYLPNGSLEDRL-------------------SCKDNSPPLSWQTR 626
L+G C + L++EY+ G L + L C N PLS +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 627 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR--FLSQNEISS 684
+ IA ++ + + +L K VH DL N L+ N V K++DFG+SR + + +S
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEV 741
N + R +M PE + T +SDV+++G++L + + +P G+ +EV
Sbjct: 190 ENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
Query: 742 QYALDTGKLKNLLD--PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796
Y + G + + D PL +L NL C RP + R+L+
Sbjct: 242 IYYVRDGNVLSCPDNCPL----------ELYNLMRLCWSKLPSDRPSFA-SINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQE--ID---ILSKIRHP 583
+F+ KIG+G +G ++K ++R + + L + ++E ID +L+K+
Sbjct: 1 DFEILNKIGKGSFGVVFK-VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSS 59
Query: 584 NLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSP---PLSWQTRIRIATELCSVLI 638
++ + + L V EY NG L L + P W+ I+I L
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA---- 115
Query: 639 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 698
LHS K I+H D+K N+ LDA K+ D G+++ LS N +N GT
Sbjct: 116 HLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV--------GT 164
Query: 699 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758
Y+ PE KSDV++ G++L TG+ Q AL ++ + P++
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA--NNQGALILKIIRGVFPPVS 222
Query: 759 GDWPFVQAEQLANLAMRCCEMSRKSRPE 786
+ Q QLA L +C + RP+
Sbjct: 223 Q--MYSQ--QLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 27/257 (10%)
Query: 535 KIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
K+G G +G ++ +H +VA+K + P S+ F E +++ ++H LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 594 -EVWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
E ++ E++ GSL D L + + PL I + ++ + F+ + +H
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHR 126
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL+ ANIL+ A+ V K++DFG++R + NE ++ R K + PE + G
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGS 179
Query: 712 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTGKLKNLLDPLAGDWPFVQAEQ 768
T KSDV+SFGI+L+ ++T GR P G++ EV AL+ G + E+
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC--------PEE 231
Query: 769 LANLAMRCCEMSRKSRP 785
L N+ MRC + + RP
Sbjct: 232 LYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 75/284 (26%), Positives = 131/284 (46%), Gaps = 50/284 (17%)
Query: 536 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 589
IG G +G +++G+L+ + VAIK L P ++ + +F E I+ + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 590 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
G + ++ EY+ NG+L+ L D + ++ L + + +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGE-----FSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA------- 700
VH DL NIL+++N K+SDFG+SR L DP+GT+
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLED--------------DPEGTYTTSGGKIP 173
Query: 701 --YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG-KLKNLL 754
+ PE +A + T SDV+SFGI++ +++ RP ++ EV A++ G +L
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL---- 229
Query: 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
P D P + L ++C + R RP D+ +L+ +
Sbjct: 230 -PAPMDCP----SAVYQLMLQCWQQDRARRPRFV-DIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 80/278 (28%), Positives = 122/278 (43%), Gaps = 26/278 (9%)
Query: 527 THNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIR 581
NF KIG+G + +YK LL VA+K + + Q +EID+L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 582 HPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLI 638
HPN++ + + E L V E G L + K + +T + +LCS L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 639 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 698
+HS I+H D+KPAN+ + A V KL D G+ RF S ++++ GT
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GT 169
Query: 699 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758
YM PE + KSD++S G +L + + K Y+L K PL
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP 229
Query: 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796
D +E+L +L RC + RP D+ VL+
Sbjct: 230 AD---HYSEELRDLVSRCINPDPEKRP----DISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 36/213 (16%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGP----SEFQQEIDILSKIRH---PN 584
IG G YG++Y+G H+ VA+K++ +L P S+ Q+E+ +LS++R PN
Sbjct: 9 IGRGAYGAVYRGK--HVPTGRVVALKII---NLDTPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 585 LVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
+ G+ P +W ++ EY GS+ + + P++ + I E+ L ++H
Sbjct: 64 ITKYYGSYLKGPRLW-IIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH 118
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
++H D+K ANIL+ KL DFG++ L+QN SS +T GT +
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFV------GTPYW 167
Query: 702 MDPEFLASG-ELTPKSDVYSFGIILLRLLTGRP 733
M PE + G K+D++S GI + + TG P
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 78/299 (26%), Positives = 132/299 (44%), Gaps = 66/299 (22%)
Query: 535 KIGEGGYGSIY----KGLLRHMQ------------VAIKMLHPHSLQGP-SEFQQEIDIL 577
K+GEG +G ++ +GL + VA+KML + ++F +EI I+
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 578 SKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSL---------EDRLSCKDNSPPLSWQTR 626
S++++PN++ L+G C + ++ EY+ NG L E + +N P +S
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 627 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS--S 684
+ +A ++ S + +L S + VH DL N L+ ++ K++DFG+SR L +
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA 744
L R +M E + G+ T SDV++FG+ L + T + KE Y+
Sbjct: 189 GRAVLPIR--------WMAWESILLGKFTTASDVWAFGVTLWEMFT------LCKEQPYS 234
Query: 745 L--DTGKLKNLLDPLAGDWPFVQAEQ------------LANLAMRCCEMSRKSRPELGK 789
L D ++N G++ Q Q + L MRC K RP K
Sbjct: 235 LLSDEQVIEN-----TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 536 IGEGGYGSIYKGL-------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 588
+G+G +G +Y L QV P + + + + EI +L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 589 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
G E ++ EY+P GS++D+L L+ + ++ + +LHS +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS---N 123
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK----GTFAYM 702
IVH D+K ANIL D+ KL DFG S+ L T+C GT +M
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ---------TICSSGTGMKSVTGTPYWM 174
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
PE ++ K+DV+S G ++ +LT +P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 65/231 (28%), Positives = 93/231 (40%), Gaps = 54/231 (23%)
Query: 536 IGEGGYGSIYKGLLRHMQV-----AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 590
+G GG+G + ++ +K H E +IL + HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 591 -------------ACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 635
C E+WT++ + G ++ + R IA C
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD---RGLFDE------------YTARFYIA---CV 102
Query: 636 VLIF--LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-TLCCR 692
VL F LH+ I++ DLKP N+LLD+N KL DFG ++ L S T T C
Sbjct: 103 VLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK----SGQKTWTFC-- 153
Query: 693 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 743
GT Y+ PE + + D +S GI+L LLTGRP G E
Sbjct: 154 ----GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 28/210 (13%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEF---QQEIDILSKIRHPNLVTLV 589
+IG G YG +YK VAIK++ L+ +F QQEI +L + RHPN+V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 590 GA---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
G+ ++W +V EY GSL+D + PLS + E L +LH
Sbjct: 67 GSYLRRDKLW-IVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHETG-- 121
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
+H D+K ANILL + KL+DFG+S L+ I+ + + GT +M PE
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFI-------GTPYWMAPEV 172
Query: 707 LA---SGELTPKSDVYSFGIILLRLLTGRP 733
A G K D+++ GI + L +P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 18/200 (9%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
++G G +G + G R VAIKM+ S+ EF +E ++ K+ H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 594 EVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
+ + V EY+ NG L + L +++ + + ++C + +L S +H
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHR 124
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLASG 710
DL N L+D K+SDFG+SR++ +E SS + R P PE L
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP--------PEVLLYS 176
Query: 711 ELTPKSDVYSFGIILLRLLT 730
+ + KSDV++FG+++ + +
Sbjct: 177 KFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 536 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSE---------FQQEIDILSKIRHPN 584
IG G +GS+Y G+ +A+K + S+ S+ +EI +L +++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 585 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
+V +G+ + + EY+P GS+ L+ + +R ++ L +LH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYLHN 124
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
I+H D+K ANIL+D K+SDFGIS+ L N +S+ R +G+ +M
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG--ARPSLQGSVFWM 179
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLTGR 732
PE + T K+D++S G +++ +LTG+
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 536 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF--QQEIDILSKIRHPNLVTLVGA 591
+G G +G ++ + V IK + + Q E +L + HPN++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 592 CPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
E L V EY P G+L + + + NS L T + + +L+ LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQ---ILLALHHVHTKLIL 123
Query: 650 HGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
H DLK NILLD + V K+ DFGIS+ LS S T + GT Y+ PE
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSK--SKAYTVV-------GTPCYISPELCE 174
Query: 709 SGELTPKSDVYSFGIILLRLLT 730
KSD+++ G +L L +
Sbjct: 175 GKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 67/259 (25%), Positives = 119/259 (45%), Gaps = 21/259 (8%)
Query: 536 IGEGGYGSIYKGLLRHMQ-VAIKM--LHPHS-LQGPSEF---QQEIDILSKIRHPNLVTL 588
+G+G YG++Y GL Q +A+K L + L E+ Q+E+D+L ++H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 589 VGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+G C + T+ E++P GS+ L + PL + ++ + +LH+ +
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHN---N 121
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
+VH D+K N++L N + KL DFG +R L+ + ++ + GT +M PE
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHGTPYWMAPEV 179
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766
+ KSD++S G + + TG+P L + G + L+ L P +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL----PDSFS 235
Query: 767 EQLANLAMRCCEMSRKSRP 785
+ C + RP
Sbjct: 236 AAAIDFVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 31/268 (11%)
Query: 536 IGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 589
IG G +G + G L R + VAIK L ++ + +F E I+ + HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 590 GA---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
G V +V EY+ NGSL+ L D T I++ L + +
Sbjct: 72 GVVTKSKPV-MIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYLSDM 125
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
VH DL NIL+++N V K+SDFG+SR L + ++ T K + PE
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTAPEA 180
Query: 707 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 763
+A + T SDV+S+GI++ +++ RP ++ ++V A++ G L P+ D P
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG--YRLPAPM--DCPA 236
Query: 764 VQAEQLANLAMRCCEMSRKSRPELGKDV 791
L L + C + R RP+ + V
Sbjct: 237 A----LHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 8e-18
Identities = 72/206 (34%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 535 KIGEGGYGSIYK-GLLRHMQV-AIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 590
K+G+G YGS+YK L Q A+K + S+ + + EI IL+ + HPN+++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 591 ACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
A + L V EY P G L +S K + Q RI +L L LH K
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--- 123
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
I+H DLK ANILL AN + K+ D GIS+ L +N T + GT YM PE
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQI-------GTPHYMAPEVW 173
Query: 708 ASGELTPKSDVYSFGIILLRLLTGRP 733
+ KSD++S G +L + T P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNL 585
NF K+GEG Y ++YKG R VA+K +H + +G PS +EI ++ +++H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 586 VTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
V L V LV+EY+ + L+ + L T +L + F C
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF---C 116
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRF--LSQNEISSNNTTLCCRTDPKGTFAY 701
+ ++H DLKP N+L++ KL+DFG++R + N S+ TL Y
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW----------Y 166
Query: 702 MDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
P+ L S + D++S G I+ ++TGRP
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 83/284 (29%), Positives = 132/284 (46%), Gaps = 46/284 (16%)
Query: 535 KIGEGGYGSIYKGLL-----RHMQ-VAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVT 587
++GE +G IYKG L H Q VAIK L + Q EFQQE +++++ HPN+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 588 LVGACPEVW--TLVYEYLPNGSLEDRL---------SCKDNS-----PPLSWQTRIRIAT 631
L+G + +++EYL G L + L C + L + IA
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 632 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 691
++ + + +L S H VH DL NIL+ K+SD G+SR EI S +
Sbjct: 132 QIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSR-----EIYSADYY--- 180
Query: 692 RTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGITKEVQYALDT 747
R PK +M PE + G+ + SD++SFG++L + + +P G + Q ++
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEM 238
Query: 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791
+ + LL P + D P ++ +L C + RP KD+
Sbjct: 239 VRKRQLL-PCSEDCP----PRMYSLMTECWQEGPSRRPRF-KDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 35/220 (15%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 587
++GEG +G ++ + M VA+K L +L +FQ+E ++L+ ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 588 LVGAC--PEVWTLVYEYLPNGSLE--------DRLSCKDNSP-----PLSWQTRIRIATE 632
G C + +V+EY+ +G L D + D P L + IA++
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 633 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLC 690
+ S +++L S VH DL N L+ AN + K+ DFG+SR + + +T L
Sbjct: 132 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 691 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730
R +M PE + + T +SDV+SFG+IL + T
Sbjct: 189 IR--------WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 535 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 591
KIG+G G++Y + +VAIK ++ EI ++ + +HPN+V + +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 592 --CPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
E+W +V EYL GSL D ++ C D + + E L FLHS +
Sbjct: 86 LVGDELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS---NQ 135
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
++H D+K NILL + KL+DFG ++ + S +T+ GT +M PE +
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPEVV 187
Query: 708 ASGELTPKSDVYSFGIILLRLLTGRP 733
PK D++S GI+ + ++ G P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 36/217 (16%)
Query: 535 KIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSE---FQ--QEIDILSKIRHPNLVT 587
K+GEG Y +YK + VAIK + + + F +EI +L +++HPN++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 588 LVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFL 640
L+ +V+ LV+E++ LE + KD S L+ I+ L +L
Sbjct: 67 LL----DVFGHKSNINLVFEFME-TDLEKVI--KDKSIVLT-PADIKSYMLMTLRGLEYL 118
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTDPKGTF 699
HS + I+H DLKP N+L+ ++ V KL+DFG++R F S N ++ T
Sbjct: 119 HS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV---------TR 166
Query: 700 AYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 735
Y PE + D++S G I LL P L
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 535 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL 588
IGEG +G +Y+G+ + VA+K + E F QE I+ + HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 589 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+G E VW +V E P G L L S L+ + I + +L + L +L S +
Sbjct: 73 IGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLA--SLILYSYQLSTALAYLESKR-- 127
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
VH D+ N+L+ + KL DFG+SR+L + K +M PE
Sbjct: 128 -FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-------KLPIKWMAPES 179
Query: 707 LASGELTPKSDVYSFGIILLRLL 729
+ T SDV+ FG+ + +L
Sbjct: 180 INFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 56/224 (25%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 536 IGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPS-EFQQEIDILSKIRHPNLVTL 588
+G G +G++YKG+ + VAIK+L + + E E +++ + HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 589 VGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+G C L+ + +P G L D + +++ + Q + ++ + +L
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLEE---KR 129
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
+VH DL N+L+ K++DFG+++ L +E + K +M E +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH------AEGGKVPIKWMALESI 183
Query: 708 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTG 748
T KSDV+S+G+ + L+T +P GI E+ L+ G
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 536 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLV 589
IGEG +G + + +++ M AIKML + + +F E+++L K+ HPN++ L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 590 GACPEVWTL--VYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELC 634
GAC L EY P G+L D L + L+ Q ++ A+++
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 635 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 694
+ + +L +H DL N+L+ N SK++DFG+SR +T
Sbjct: 130 TGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---------GEEVYVKKTM 177
Query: 695 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 738
+ +M E L T KSDV+SFG++L + L G P G+T
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 591
+IG+G +G +YKG+ + VAIK++ + E QQEI +LS+ P + G+
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 592 ---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
++W ++ EYL GS D L PL I E+ L +LHS +
Sbjct: 71 YLKGTKLW-IIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 122
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
+H D+K AN+LL KL+DFG++ L+ +I N GT +M PE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPEVIK 174
Query: 709 SGELTPKSDVYSFGIILLRLLTGRP 733
K+D++S GI + L G P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 591
KIG+G +G ++KG+ Q VAIK++ + E QQEI +LS+ P + G+
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 592 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
++W ++ EYL GS D L PL I E+ L +LHS K
Sbjct: 71 YLKDTKLW-IIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKK--- 122
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
+H D+K AN+LL + KL+DFG++ L+ +I N GT +M PE +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPEVIK 174
Query: 709 SGELTPKSDVYSFGIILLRLLTGRP 733
K+D++S GI + L G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 42/227 (18%)
Query: 535 KIGEGGYGSIY----KGLLRHMQ--------------VAIKMLHPHSLQGP-SEFQQEID 575
K+GEG +G ++ +G+ + M VA+KML + + ++F +EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 576 ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS--------CKDNSPPLSWQT 625
I+S+++ PN++ L+ C L + EY+ NG L LS K + +S+ T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 626 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS-- 683
I +AT++ S + +L S + VH DL N L+ N+ K++DFG+SR L +
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730
L R +M E + G+ T SDV++FG+ L +LT
Sbjct: 189 QGRAVLPIR--------WMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 72/267 (26%), Positives = 115/267 (43%), Gaps = 22/267 (8%)
Query: 529 NFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHP 583
NF KIG G + +Y+ LL + VA+K + L +EID+L ++ HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 584 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFL 640
N++ + E +V E G L + K + +T + +LCS L +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
HS ++H D+KPAN+ + A V KL D G+ RF S ++++ GT
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GTPY 171
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760
YM PE + KSD++S G +L + + K Y+L + PL D
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 231
Query: 761 WPFVQAEQLANLAMRCCEMSRKSRPEL 787
+E+L L C + RP++
Sbjct: 232 H---YSEELRQLVNMCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 18/220 (8%)
Query: 535 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--VGA 591
K+G G +G ++ G + +VA+K L P ++ + F +E +++ ++H LV L V
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 592 CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
E ++ EY+ GSL D L D + I + ++ + ++ + +H
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL+ AN+L+ + + K++DFG++R + NE ++ R K + PE + G
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGS 180
Query: 712 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 748
T KSDV+SFGI+L ++T G+ P G++ +V AL G
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 61/194 (31%), Positives = 101/194 (52%), Gaps = 22/194 (11%)
Query: 536 IGEGGYGSIYKGLLRHMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 594
IG+G +G + G R +VA+K + + + Q F E +++++RH NLV L+G E
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 595 ---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
+V EY+ GSL D L + S L ++ + ++C + +L + ++ VH
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEA---NNFVHR 126
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL N+L+ + V+K+SDFG+++ E SS T K + PE L +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT------GKLPVKWTAPEALREKK 175
Query: 712 LTPKSDVYSFGIIL 725
+ KSDV+SFGI+L
Sbjct: 176 FSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 30/237 (12%)
Query: 522 EIEGATHNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 579
E E + +G+G YG +Y L +++AIK + + +EI + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 580 IRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCK-----DNSPPLSWQTRIRIATE 632
++H N+V +G+ E + + E +P GSL L K DN + + T+ +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----Q 116
Query: 633 LCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQ-NEISSNNTTLC 690
+ L +LH + IVH D+K N+L++ + V K+SDFG S+ L+ N + T
Sbjct: 117 ILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT--- 170
Query: 691 CRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 745
GT YM PE + G +D++S G ++ + TG+P E Q A+
Sbjct: 171 ------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 84/248 (33%), Positives = 116/248 (46%), Gaps = 44/248 (17%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLH-PHSLQG-PSEFQQEIDILSKIR---HPNLV 586
IGEG YG++YK R + VA+K + P S +G P +EI +L ++ HPN+V
Sbjct: 7 IGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 587 TLVGAC--PEVW-----TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 639
L+ C P TLV+E++ + L LS K P L +T + +L + F
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLS-KCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 640 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
LHS H IVH DLKP NIL+ ++ K++DFG++R I S L T T
Sbjct: 123 LHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMAL---TSVVVTL 170
Query: 700 AYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD--- 755
Y PE L S TP D++S G I L RP T E +L + D
Sbjct: 171 WYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEAD------QLDKIFDVIG 223
Query: 756 -PLAGDWP 762
P +WP
Sbjct: 224 LPSEEEWP 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 42/279 (15%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGP-SEFQQEIDILSKI 580
N +G G +G ++ + ++ V +K L + SEF++E+D+ K+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 581 RHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRL------SCKDNSPPLSWQTRIRIATE 632
H N+V L+G C E ++ EY G L+ L K PPLS + ++ + T+
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 633 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCC 691
+ + L + VH DL N L+ + K+S +S+ + N +
Sbjct: 126 IALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 692 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTG 748
R ++ PE + + + KSDV+SFG+++ + T P G++ +EV L G
Sbjct: 183 R--------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234
Query: 749 KLKNLLDPLAGDWPFVQA--EQLANLAMRCCEMSRKSRP 785
KL+ P + +L L RC ++ K RP
Sbjct: 235 KLE---------LPVPEGCPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 536 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLV 589
IGEG +G + K ++ M AIK + ++ + +F E+++L K+ HPN++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 590 GACPEVWTL--VYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELC 634
GAC L EY P+G+L D L + LS Q + A ++
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 635 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 694
+ +L +H DL NIL+ N+V+K++DFG+SR +T
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 170
Query: 695 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 738
+ +M E L T SDV+S+G++L + L G P G+T
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ------QEIDILSKIRHPN 584
+GEG YG + K +H + VAIK L+ + +EI +L ++RH N
Sbjct: 8 LVGEGSYGMVMK--CKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 585 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
LV L+ + LV+E++ + L+D L N L + ++ + F HS
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNG--LDESRVRKYLFQILRGIEFCHS 118
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL-SQNEISSNNTTLCCRTDPKGTFAY 701
H+I+H D+KP NIL+ + V KL DFG +R L + E+ TD T Y
Sbjct: 119 ---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY---------TDYVATRWY 166
Query: 702 MDPEFLASGELTPKS-DVYSFGIILLRLLTGRP 733
PE L ++ D+++ G ++ +LTG P
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 536 IGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 589
IG+G +G +Y G L + + A+K L+ L+ +F +E I+ HPN+++L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 590 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
G C P V V Y+ +G L + + + ++P + + I ++ + +L S
Sbjct: 63 GICLPSEGSPLV---VLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASK 117
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
K VH DL N +LD +F K++DFG++R + E S + T K +M
Sbjct: 118 K---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN----HTGAKLPVKWMA 170
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLT 730
E L + + T KSDV+SFG++L L+T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 39/264 (14%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-P 593
IGEG +G++ +G +VA+K + F +E +++K+ H NLV L+G
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 594 EVWTLVYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
+V E + G+L + L + + L ++ + ++ + +L S K +V
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLESKK---LV 122
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
H DL NIL+ + V+K+SDFG++R + +N+ L + + PE L
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVK--------WTAPEALKH 171
Query: 710 GELTPKSDVYSFGIILLRLLT-GR---PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765
+ + KSDV+S+G++L + + GR P + + KEV+ ++ G ++P G V
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-KEVKECVEKGY---RMEPPEGCPADVY 227
Query: 766 AEQLANLAMRCCEMSRKSRPELGK 789
L C E K RP K
Sbjct: 228 V-----LMTSCWETEPKKRPSFHK 246
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 74/270 (27%), Positives = 121/270 (44%), Gaps = 46/270 (17%)
Query: 535 KIGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTL 588
KIGEG +G L++ Q IK ++ + E ++E+ +LS ++HPN+V
Sbjct: 7 KIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 589 VGACPEVWTL--VYEYLPNGSLEDRLSCKDNSP-----PLSWQTRIRIATELCSVLIFLH 641
+ E L V +Y G L +++ + L W ++C L +H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVH 118
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
K I+H D+K NI L + KL DFGI+R L N+T RT GT Y
Sbjct: 119 DRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL-------NSTVELART-CIGTPYY 167
Query: 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL-LDPLAGD 760
+ PE + KSD+++ G +L + T +++A + G +KNL L + G
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT----------LKHAFEAGNMKNLVLKIIRGS 217
Query: 761 WPFVQAE---QLANLAMRCCEMSRKSRPEL 787
+P V + L NL + + + + RP +
Sbjct: 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSV 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 42/274 (15%)
Query: 536 IGEGGYGSIYKGLLRHM--------QVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLV 586
+G G +G +Y+G + +VA+K L + Q EF +E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 587 TLVGAC--PEVWTLVYEYLPNGSL----EDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
L+G C E ++ E + G L D + P L+ + + I ++ ++L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 641 HSCKPHSIVHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 695
+ H +H DL N L+ DA+ V K+ DFG++R + +++ +
Sbjct: 123 E--QMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK------EGEG 173
Query: 696 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GR---PALGITKEVQYALDTGKLK 751
+M PE L G+ T +SDV+SFG+++ +LT G+ PAL + +Q+ G+L+
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ 233
Query: 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
P +++ L C RP
Sbjct: 234 K---------PENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 536 IGEGGYGSIYKGLLRH--------MQVAIKMLHPHSLQGPS-EFQQEIDILSKIRHPNLV 586
+GEG +G + L R+ QVA+K L P S + ++EI+IL + H N+V
Sbjct: 12 LGEGHFGKVE--LCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 587 TLVGACPEVW----TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
G C E L+ E+LP+GSL++ L N ++ + +++ A ++C + +L S
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP--RNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
VH DL N+L+++ K+ DFG+++ I ++ + D +
Sbjct: 128 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEYYTVKDDLDSPVFWY 179
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLT 730
PE L + SDV+SFG+ L LLT
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 34/219 (15%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 587
++GEG +G ++ + M VA+K L S +FQ+E ++L+ ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 588 LVGACPE--VWTLVYEYLPNGSLEDRLSC-----------KDNSP-PLSWQTRIRIATEL 633
G C E +V+EY+ +G L L +D +P L+ + IA+++
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 634 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLCC 691
S +++L S VH DL N L+ V K+ DFG+SR + + T L
Sbjct: 132 ASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 692 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730
R +M PE + + T +SD++SFG++L + T
Sbjct: 189 R--------WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 37/218 (16%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 586
D +KIGEG G + + QVA+K + Q E+ I+ +HPN+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 587 T-----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVL- 637
LVG E+W +V E+L G+L D ++ TR+ +IAT +VL
Sbjct: 80 EMYSSYLVG--DELW-VVMEFLEGGALTDIVT----------HTRMNEEQIATVCLAVLK 126
Query: 638 --IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 695
FLH+ ++H D+K +ILL ++ KLSDFG F +Q +S + R
Sbjct: 127 ALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFG---FCAQ--VSKE---VPRRKSL 175
Query: 696 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT +M PE ++ + D++S GI+++ ++ G P
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 529 NFDPSLKIGEGGYGS--IYKGLLRHMQVAIKMLHPHSLQGPSEF--QQEIDILSKIRHPN 584
++ P +G+G +G +Y+ V K ++ L EI ILS ++HPN
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 585 LVTLVGACPEVWTLV--YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
++ + TL+ EY G+L D++ + + + ++ S + ++H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIHK 119
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
I+H D+K NI L + KL DFGIS+ L +E S T + GT YM
Sbjct: 120 ---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVV-------GTPYYM 168
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLT 730
PE + KSD+++ G +L LLT
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 536 IGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 589
+G+G +GS+ +Q VA+K L + + +F++EI+IL ++H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 590 GACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
G C LV EYLP GSL D L + L + + A+++C + +L S +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQ--KHRERLDHRKLLLYASQICKGMEYLGSKR- 128
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
VH DL NIL+++ K+ DFG+++ L Q++ R + + PE
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-----EYYKVREPGESPIFWYAPE 181
Query: 706 FLASGELTPKSDVYSFGIILLRLLT 730
L + + SDV+SFG++L L T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPN 584
F ++G+GGYG ++ + VA+K + L +E + E DIL+ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 585 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSW-QTRIRIATELCSVLIFLH 641
LV L+ A E L EY+P G L+ N LS R +A +V
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAV----D 115
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
+ +H DLKP N L+DA+ KL+DFG LS+ ++ N+ + G+ Y
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFG----LSKGIVTYANSVV-------GSPDY 164
Query: 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
M PE L D +S G +L L G P
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 65/236 (27%), Positives = 110/236 (46%), Gaps = 54/236 (22%)
Query: 535 KIGEGGYGSIY--------------------KGLLRHMQVAIKMLHPHSLQGP-SEFQQE 573
K+GEG +G ++ KG R + VA+K+L P + + ++F +E
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG--RPLLVAVKILRPDANKNARNDFLKE 69
Query: 574 IDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK----------DNSPP- 620
+ ILS+++ PN++ L+G C + ++ EY+ NG L LS D PP
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 621 -----LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675
+S+ + + +A ++ S + +L S + VH DL N L+ N K++DFG+SR
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSR 186
Query: 676 FLSQNEIS--SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 729
L + L R +M E + G+ T SDV++FG+ L +L
Sbjct: 187 NLYAGDYYRIQGRAVLPIR--------WMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 49/164 (29%), Positives = 72/164 (43%), Gaps = 19/164 (11%)
Query: 572 QEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI 629
E IL ++ HP LV L + E LV + L G L LS K S + +++
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFS-EEQVKF 104
Query: 630 -ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688
E+ L +LHS I+H D+KP NILLD ++DF I+ ++ + T+
Sbjct: 105 WICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTS 158
Query: 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
GT YM PE L + D +S G+ L G+
Sbjct: 159 TS------GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 529 NFDPSLKIGEGGYGSIY--KGLLRHMQVAIKM--LHPHSLQGPSEFQQEIDILSKIRHPN 584
++ KIGEG +G IY K IK L ++ ++E+ +L+K++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 585 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCK-----DNSPPLSWQTRIRIATELCSVL 637
+VT + E L V EY G L R++ + LSW +I + L
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLG------L 114
Query: 638 IFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
+H K I+H D+K NI L N V+KL DFGI+R L N++ T
Sbjct: 115 KHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-------NDSMELAYT-CV 163
Query: 697 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730
GT Y+ PE + K+D++S G +L L T
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-16
Identities = 52/224 (23%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 569 EFQQEIDILSKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 626
++EI +++++ HP+++ ++GA E + L E++ GS+ LS
Sbjct: 49 ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS---KYGAFKEAVI 105
Query: 627 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSN 685
I +L L +LH + I+H D+K AN+L+D+ +++DFG + L
Sbjct: 106 INYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL-------- 154
Query: 686 NTTLCCRTDPKG----TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV 741
+ +G T A+M PE L + DV+S G +++ + T +P K
Sbjct: 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS 214
Query: 742 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
+ K+ + P + L ++ +RC E+ + RP
Sbjct: 215 NHLALIFKIASATTA--PSIPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 6e-16
Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 32/224 (14%)
Query: 528 HNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQGPSEFQQEIDILSKI 580
HN ++GEG +G ++ ++ VA+K L S +F +E ++L+ +
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 581 RHPNLVTLVGACPE--VWTLVYEYLPNGSLE--------DRLSCKDNSPP--LSWQTRIR 628
+H ++V G C E +V+EY+ +G L D + + + P L+ +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 629 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNN 686
IA ++ + +++L S VH DL N L+ N + K+ DFG+SR + + +
Sbjct: 125 IAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730
T L R +M PE + + T +SDV+S G++L + T
Sbjct: 182 TMLPIR--------WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
++G G +G ++ G R ++VAIK ++ ++ +F +E ++ K+ HP LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 594 EVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
+ L V E++ NG L + L + LS + + ++C + +L +S +H
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHR 124
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL N L+ + V K+SDFG++R++ +E +S+ + K + PE +
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS-------SGAKFPVKWSPPEVFNFSK 177
Query: 712 LTPKSDVYSFGIILLRLLT 730
+ KSDV+SFG+++ + T
Sbjct: 178 YSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 55/164 (33%), Positives = 87/164 (53%), Gaps = 19/164 (11%)
Query: 572 QEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 628
+E+ I+ + R P +V+ GA + + E++ GSL DR+ K P+ + +
Sbjct: 52 RELQIMHECRSPYIVSFYGAFLNENNI-CMCMEFMDCGSL-DRIYKKGG--PIPVEILGK 107
Query: 629 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688
IA + L +L++ H I+H D+KP+NIL+++ KL DFG+S L I+S T
Sbjct: 108 IAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL----INSIADT 161
Query: 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
GT YM PE + G+ T KSDV+S GI ++ L G+
Sbjct: 162 FV------GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 7e-16
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 591
+IG+G +G ++KG+ Q VAIK++ + E QQEI +LS+ P + G+
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 592 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSCKP 645
++W ++ EYL GS D L + P +IAT E+ L +LHS K
Sbjct: 71 YLKGTKLW-IIMEYLGGGSALDLL----RAGPFD---EFQIATMLKEILKGLDYLHSEKK 122
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+H D+K AN+LL KL+DFG++ L+ +I N GT +M PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPE 171
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
+ K+D++S GI + L G P
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 8e-16
Identities = 69/229 (30%), Positives = 118/229 (51%), Gaps = 30/229 (13%)
Query: 536 IGEGGYGSIYKGL------LRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLV 586
+G G +G++YKG+ + VAIK+L+ + GP EF E I++ + HP+LV
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLV 72
Query: 587 TLVGAC--PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
L+G C P + LV + +P+G L D + KDN + Q + ++ +++L
Sbjct: 73 RLLGVCLSPTI-QLVTQLMPHGCLLDYVHEHKDN---IGSQLLLNWCVQIAKGMMYLEE- 127
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
+VH DL N+L+ + K++DFG++R L +E N K +M
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN------ADGGKMPIKWMA 179
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 749
E + + T +SDV+S+G+ + L+T G+P GI T+E+ L+ G+
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPH---SLQGPSEFQQEIDILSKIR 581
+ + +G G +G ++ L+R A+K++ L+ E +L ++
Sbjct: 2 DLERIKTVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 582 HPNLVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 633
HP ++ L WT ++ EY+P G L L NS S T + A+E+
Sbjct: 60 HPFIIRLF------WTEHDQRFLYMLMEYVPGGELFSYLR---NSGRFSNSTGLFYASEI 110
Query: 634 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 693
L +LHS IV+ DLKP NILLD KL+DFG ++ ++ TLC
Sbjct: 111 VCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLC--- 159
Query: 694 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT Y+ PE + S D ++ GI++ +L G P
Sbjct: 160 ---GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 47/242 (19%)
Query: 536 IGEGGYGSIYKGLLR-------HMQVAIKML----HPHSLQGPSEFQQEIDILSKI-RHP 583
+GEG +G + K VA+KML L S+ E++++ I +H
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL---SDLVSEMEMMKMIGKHK 76
Query: 584 NLVTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPP---------------LSWQT 625
N++ L+G C + ++ +V EY +G+L D L + PP L+ +
Sbjct: 77 NIINLLGVCTQEGPLYVVV-EYAAHGNLRDFL--RARRPPGEYASPDDPRPPEETLTQKD 133
Query: 626 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685
+ A ++ + FL S K +H DL N+L+ + V K++DFG++R + +
Sbjct: 134 LVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQY 743
T+ + +M PE L T +SDV+SFG++L + T G P GI E +
Sbjct: 191 ------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244
Query: 744 AL 745
L
Sbjct: 245 KL 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 71/260 (27%), Positives = 123/260 (47%), Gaps = 47/260 (18%)
Query: 501 SRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV----AI 556
S +SSS+ + S SE+E +IG G G++YK + H A+
Sbjct: 54 SSSSSSSSASGSAPSAAKSLSELERVN-------RIGSGAGGTVYK--VIHRPTGRLYAL 104
Query: 557 KMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVW------TLVYEYLPNGSLE 609
K+++ H + +EI+IL + HPN+V C +++ ++ E++ GSLE
Sbjct: 105 KVIYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLE 160
Query: 610 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 669
+ L+ +A ++ S + +LH IVH D+KP+N+L+++ K++
Sbjct: 161 GTHIADE--QFLA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIA 210
Query: 670 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF----LASGELTPKS-DVYSFGII 724
DFG+SR L+Q N++ GT AYM PE L G + D++S G+
Sbjct: 211 DFGVSRILAQTMDPCNSSV--------GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262
Query: 725 LLRLLTGRPALGITKEVQYA 744
+L GR G+ ++ +A
Sbjct: 263 ILEFYLGRFPFGVGRQGDWA 282
|
Length = 353 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL-- 588
KIGEG YG +YKG + VA+K + S + PS +EI +L +++HPN+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 589 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
V L++E+L + L+ L D+ P + + + L +L + C +
Sbjct: 67 VLMQESRLYLIFEFL-SMDLKKYL---DSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FL 707
+H DLKP N+L+D V KL+DFG++R + + T T Y PE L
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLAR--------AFGIPVRVYTHEVVTLWYRAPEVLL 174
Query: 708 ASGELTPKSDVYSFGIILLRLLTGRP 733
S + D++S G I + T +P
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 43/274 (15%)
Query: 535 KIGEGGYGSIYKGLLRHM-------QVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLV 586
++G+G +G +Y+G R + +VA+K ++ SL+ EF E ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 587 TLVGACP--EVWTLVYEYLPNGSLEDRLSC-------KDNSPPLSWQTRIRIATELCSVL 637
L+G + +V E + +G L+ L PP + Q I++A E+ +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+L++ K VH DL N ++ +F K+ DFG++R + + + R KG
Sbjct: 133 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY--------RKGGKG 181
Query: 698 TF--AYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 751
+M PE L G T SD++SFG++L + L +P G++ E +++ +D G L
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 240
Query: 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
D P E++ +L C + + K RP
Sbjct: 241 --------DQPDNCPERVTDLMRMCWQFNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 529 NFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHP 583
NF KIG G + +Y+ LL VA+K + + Q +EID+L ++ HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 584 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFL 640
N++ + + E +V E G L + K + +T + +LCS + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
HS ++H D+KPAN+ + A V KL D G+ RF S ++++ GT
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GTPY 171
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRL 728
YM PE + KSD++S G +L +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGA 591
++GEG GS+ K L++ + + + P +Q E++I + P +V GA
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 592 CPEVWT----LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+ + + EY GSL+ K + + +IA + L +LHS K
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK-- 125
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
I+H D+KP+NILL KL DFG+S L ++S T GT YM PE
Sbjct: 126 -IIHRDIKPSNILLTRKGQVKLCDFGVSGEL----VNSLAGTFT------GTSFYMAPER 174
Query: 707 LASGELTPKSDVYSFGIILLRLLTGR 732
+ + SDV+S G+ LL + R
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 57/182 (31%), Positives = 87/182 (47%), Gaps = 17/182 (9%)
Query: 554 VAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVYEYLPNGSL 608
VA+K L Q S +++EI+IL + H N+V G C E L+ EY+P GSL
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 668
D L K L+ + A ++C + +LHS +H DL N+LLD + + K+
Sbjct: 96 RDYLP-KHK---LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKI 148
Query: 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL 728
DFG+++ + + R D + E L + + SDV+SFG+ L L
Sbjct: 149 GDFGLAKAVPEGHEYYR-----VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
Query: 729 LT 730
LT
Sbjct: 204 LT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 536 IGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLV 589
IGEG +G + K ++ M AIK + ++ + +F E+++L K+ HPN++ L+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 590 GACPE--VWTLVYEYLPNGSLEDRLS-------------CKDNSPPLSWQTRIRIATELC 634
GAC L EY P+G+L D L + LS Q + A ++
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 635 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 694
+ +L +H DL NIL+ N+V+K++DFG+SR +T
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 182
Query: 695 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 738
+ +M E L T SDV+S+G++L + L G P G+T
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 535 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 589
K+GEG Y +++KG L VA+K + H P +E+ +L ++H N+VTL +
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 590 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
TLV+EYL + L+ L DN L ++I + +L L C I+
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIF--MFQLLRGLSYCHKRKIL 125
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 708
H DLKP N+L++ KL+DFG++R S + +N + T Y P+ L
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--------TLWYRPPDVLLG 177
Query: 709 SGELTPKSDVYSFGIILLRLLTGRP 733
S E + D++ G IL + TGRP
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 69/231 (29%), Positives = 98/231 (42%), Gaps = 71/231 (30%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIK---------MLHPHSLQGPSEFQQEIDILSKIR 581
KIGEG YG ++K R+ + VAIK ++ +L+ EI +L +++
Sbjct: 8 KIGEGSYGVVFK--CRNRETGQIVAIKKFVESEDDPVIKKIALR-------EIRMLKQLK 58
Query: 582 HPNLVTLVGACPEVWT------LVYEYL-----------PNGSLEDRLSCKDNSPPLSWQ 624
HPNLV L+ EV+ LV+EY P G K + WQ
Sbjct: 59 HPNLVNLI----EVFRRKRKLHLVFEYCDHTVLNELEKNPRGV--PEHLIKK----IIWQ 108
Query: 625 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684
T L ++ C H+ +H D+KP NIL+ KL DFG +R L+
Sbjct: 109 T-----------LQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD- 156
Query: 685 NNTTLCCRTDPKGTFAYMDPEFLASGELT--PKSDVYSFGIILLRLLTGRP 733
TD T Y PE L G+ P DV++ G + LLTG+P
Sbjct: 157 -------YTDYVATRWYRAPELLV-GDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 536 IGEGGYGSIYKGLLRH-------MQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 587
+G G +G +Y+GL R +QVA+K L S Q S+F E I+SK H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 588 LVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSP------PLSWQTRIRIATELCSVLIF 639
L+G E ++ E + G L+ L ++N P L+ + + A V
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFL--RENRPRPERPSSLTMKDLLFCA---RDVAKG 128
Query: 640 LHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD-- 694
+ + +H D+ N LL V+K++DFG++R +I R
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIY--------RASYY 175
Query: 695 PKGTFA-----YMDPEFLASGELTPKSDVYSFGIIL 725
KG A +M PE G T K+DV+SFG++L
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 47/225 (20%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKM-LHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 588
KIG+G +G ++K RH + VA+K L + +G P +EI IL ++H N+V L
Sbjct: 19 KIGQGTFGEVFKA--RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 76
Query: 589 VGACPEVWT----------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--------RIA 630
+ C T LV+E+ C+ + L + ++
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEF-----------CEHDLAGLLSNKNVKFTLSEIKKVM 125
Query: 631 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 690
L + L ++H K I+H D+K ANIL+ + + KL+DFG++R S ++ S N
Sbjct: 126 KMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN---- 178
Query: 691 CRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRP 733
T+ T Y PE L GE P D++ G I+ + T P
Sbjct: 179 RYTNRVVTLWYRPPELLL-GERDYGPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 20/196 (10%)
Query: 536 IGEGGYGSIYKGLLR-HMQVAIKMLH---PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 591
+G+G +G ++KG L+ VA+K P L+ +F E IL + HPN+V L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKLIGV 60
Query: 592 CPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
C + +V E +P G L K + L + ++ A + + + +L S + +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLES---KNCI 115
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
H DL N L+ N V K+SDFG+SR SS+ + + PE L
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK-------QIPIKWTAPEALNY 168
Query: 710 GELTPKSDVYSFGIIL 725
G + +SDV+S+GI+L
Sbjct: 169 GRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKM--LHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 588
KIGEG YG +YK R +A+K L PS +EI +L +++H N+V L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 589 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
V + LV+EYL + L+ + D+SP + R+ I T L +L + C H +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM---DSSPDFAKNPRL-IKTYLYQILRGIAYCHSHRV 123
Query: 649 VHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-F 706
+H DLKP N+L+D KL+DFG++R + T T Y PE
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFG--------IPVRTFTHEVVTLWYRAPEIL 175
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRP 733
L S + D++S G I ++ +P
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-15
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 535 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 587
KIG+G G++Y + +VAIK ++ EI ++ + ++PN+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 588 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
LVG E+W +V EYL GSL D ++ C D + + E L FLHS
Sbjct: 86 LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALDFLHS--- 133
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+ ++H D+K NILL + KL+DFG ++ + S +T+ GT +M PE
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPE 185
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
+ PK D++S GI+ + ++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 71/221 (32%), Positives = 106/221 (47%), Gaps = 39/221 (17%)
Query: 536 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVG 590
+G G YG +YKG RH++ AIK++ + E + EI++L K H N+ T G
Sbjct: 24 VGNGTYGQVYKG--RHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 591 A----CP-----EVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFL 640
A P ++W LV E+ GS+ D + + K N+ W I E+ L L
Sbjct: 81 AFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYI--CREILRGLAHL 137
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
H+ H ++H D+K N+LL N KL DFG+S L + + NT + GT
Sbjct: 138 HA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFI-------GTPY 186
Query: 701 YMDPEFLASGELTP------KSDVYSFGIILLRLLTGRPAL 735
+M PE +A E P +SD++S GI + + G P L
Sbjct: 187 WMAPEVIACDE-NPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 33/265 (12%)
Query: 536 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 586
+G G +G + + GL + M+VA+KML P + E E+ I+S + H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 587 TLVGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
L+GAC P + ++ EY G L + L K S L+ + + + ++ + FL S
Sbjct: 103 NLLGACTIGGPIL--VITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFLAS 159
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL--SQNEISSNNTTLCCRTDPKGTFA 700
+ +H DL N+LL + K+ DFG++R + N + N L +
Sbjct: 160 ---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-------- 208
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760
+M PE + + T +SDV+S+GI+L + + LG +D+ K + +
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSNPYPGMPVDSKFYKLIKEGYRMA 264
Query: 761 WPFVQAEQLANLAMRCCEMSRKSRP 785
P ++ ++ C + RP
Sbjct: 265 QPEHAPAEIYDIMKTCWDADPLKRP 289
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 70/235 (29%), Positives = 109/235 (46%), Gaps = 24/235 (10%)
Query: 535 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 589
K+GEG Y ++YKG L VA+K + H P +E+ +L ++H N+VTL +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 590 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
+ TLV+EYL + L+ L NS + + L +L L+ C ++
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-----NVKLFLFQLLRGLNYCHRRKVL 126
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 708
H DLKP N+L++ KL+DFG++R S + +N + T Y P+ L
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--------TLWYRPPDILLG 178
Query: 709 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWP 762
S + + + D++ G I + TGRP G T E Q + L P WP
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNLVTL 588
KIGEG YG +YK R VA+K + +G PS +EI +L ++ HPN+V L
Sbjct: 6 KIGEGTYGVVYKA--RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 589 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSCK 644
V LV+E+L + L+ + D+SP + +L + + HS
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYM---DSSPLTGLDPPLIKSYLYQLLQGIAYCHS-- 117
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
H ++H DLKP N+L+D KL+DFG++R + + T T Y P
Sbjct: 118 -HRVLHRDLKPQNLLIDREGALKLADFGLAR--------AFGVPVRTYTHEVVTLWYRAP 168
Query: 705 EFLASGEL--TPKSDVYSFGIILLRLLTGRP 733
E L TP D++S G I ++ RP
Sbjct: 169 EILLGSRQYSTP-VDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 72/221 (32%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 536 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVG 590
+G G YG +YKG RH++ AIK++ + E +QEI++L K H N+ T G
Sbjct: 14 VGNGTYGQVYKG--RHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYG 70
Query: 591 AC---------PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFL 640
A ++W LV E+ GS+ D + + K N+ W I E+ L L
Sbjct: 71 AFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLSHL 127
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
H H ++H D+K N+LL N KL DFG+S L + + NT + GT
Sbjct: 128 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFI-------GTPY 176
Query: 701 YMDPEFLASGELTP------KSDVYSFGIILLRLLTGRPAL 735
+M PE +A E P KSD++S GI + + G P L
Sbjct: 177 WMAPEVIACDE-NPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 2e-14
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 535 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 587
KIG+G G++Y + +VAI+ ++ EI ++ + ++PN+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 588 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
LVG E+W +V EYL GSL D ++ C D + + E L FLHS
Sbjct: 87 LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS--- 134
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+ ++H D+K NILL + KL+DFG F +Q I+ + R+ GT +M PE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQ--ITPEQSK---RSTMVGTPYWMAPE 186
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
+ PK D++S GI+ + ++ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 68/228 (29%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQG--PSEFQQEIDILSKIRH 582
F+ +IGEG YG +Y+ R VA+K + + + P +EI +L +RH
Sbjct: 8 EFEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 583 PNLVTL----VGACPEVWTLVYEYLPNGSLEDRLSCKDNSP-PLSWQTRIRIATELCSVL 637
PN+V L VG + LV EY +D S DN P P S + +L L
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCE----QDLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDP 695
+LH + I+H DLK +N+LL K++DFG++R ++ TL
Sbjct: 122 QYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW----- 173
Query: 696 KGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 742
Y PE L T D+++ G IL LL +P L E++
Sbjct: 174 -----YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 68/216 (31%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKM--LHPHSLQGPSEFQQEIDILSKIRH 582
NF KIGEG YG +YK R+ VA+K L + PS +EI +L ++ H
Sbjct: 1 NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 58
Query: 583 PNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
PN+V L V LV+E+L +D D SP + I + L +L L
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASPLSGIPLPL-IKSYLFQLLQGL 113
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
C H ++H DLKP N+L++ KL+DFG++R + T T
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--------VPVRTYTHEVVTLW 165
Query: 701 YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 735
Y PE L + D++S G I ++T R AL
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 37/91 (40%), Positives = 51/91 (56%), Gaps = 13/91 (14%)
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
H ++H D+KP+NILLDA+ KL DFGIS L ++ +T G AYM PE
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---------AKTRSAGCAAYMAPE 184
Query: 706 FLASGELTPK----SDVYSFGIILLRLLTGR 732
+ + PK +DV+S GI L+ L TG+
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 73/264 (27%), Positives = 117/264 (44%), Gaps = 31/264 (11%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLH---PHSLQGPSEFQQEIDILSKIRHPNLVTLV 589
+IG G +G ++ G LR + VA+K P L+ ++F QE IL + HPN+V L+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLI 59
Query: 590 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
G C + +V E + G L + P L + I++ + + +L S
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLES---KH 114
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
+H DL N L+ V K+SDFG+SR + E +T + P + PE L
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIP---VKWTAPEAL 168
Query: 708 ASGELTPKSDVYSFGIILLRL--LTGRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 764
G + +SDV+SFGI+L L P ++ ++ + A++ G L P +
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---VRLPC-----PEL 220
Query: 765 QAEQLANLAMRCCEMSRKSRPELG 788
+ + L RC E RP
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 39/218 (17%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIR-HPNLVTL 588
K+G+G YG ++K + R VA+K + + + ++ Q+ EI L ++ HPN+V L
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 589 VGACPEV----WTLVYEYLPN--------GSLEDRLSCKDNSPPLSWQTRIRIATELCSV 636
+ LV+EY+ LED + I +L
Sbjct: 73 LNVIKAENDKDIYLVFEYMETDLHAVIRANILED-------------VHKRYIMYQLLKA 119
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
L ++HS +++H DLKP+NILL+++ KL+DFG++R LS+ E + N L TD
Sbjct: 120 LKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL---TDYV 173
Query: 697 GTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 733
T Y PE L S T D++S G IL +L G+P
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 52/278 (18%)
Query: 536 IGEGGYGSIYKGLLRH-----MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTL 588
+GEG +GS+ +G L ++VA+K + H+ EF E + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 589 VGACPEVWTL--------VYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 637
+G C E +L + ++ +G L L L QT ++ ++ +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR------FLSQNEISSNNTTLCC 691
+L + + +H DL N +L + ++DFG+S+ + Q I+
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA-------- 175
Query: 692 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGI----ILLRLLTGRPALGITKEVQYALDT 747
K ++ E LA T KSDV++FG+ I R T P + + Y
Sbjct: 176 ----KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG 231
Query: 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
+LK D L ++L +L C K RP
Sbjct: 232 NRLKQPEDCL---------DELYDLMYSCWRADPKDRP 260
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 68/239 (28%), Positives = 111/239 (46%), Gaps = 24/239 (10%)
Query: 535 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 589
K+GEG Y +++KG L VA+K + H P +E+ +L ++H N+VTL +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 590 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
+ TLV+EYL +D D+ + ++I L +L L C ++
Sbjct: 73 VHTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHRRKVL 126
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 708
H DLKP N+L++ KL+DFG++R S + +N + T Y P+ L
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--------TLWYRPPDVLLG 178
Query: 709 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766
S E + + D++ G I + +GRP G T E + L + L P WP + +
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISS 234
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 69/260 (26%), Positives = 114/260 (43%), Gaps = 38/260 (14%)
Query: 536 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQ-GPSEFQQ-------------EIDILSK 579
+GEG YG + K L VAIK + + ++ +Q E+ I+++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 580 IRHPNLVTLVGA-CPEVW-TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 637
I+H N++ LV + LV + + L+ + D L+ I ++ + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV---DRKIRLTESQVKCILLQILNGL 132
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS---SNNTTLCCR-- 692
LH +H DL PANI +++ + K++DFG++R S S + T+ R
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 693 -TDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 750
T T Y PE L + + D++S G I LLTG+P E+ G++
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---QLGRI 246
Query: 751 KNLL-DPLAGDWPFVQAEQL 769
LL P +WP QA++L
Sbjct: 247 FELLGTPNEDNWP--QAKKL 264
|
Length = 335 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKML--HPHSLQGPSEFQQEIDILSKIRHPNLVTL 588
+I EG YG +Y+ R + VA+K L P +EI+IL K++HPN+VT+
Sbjct: 12 RIEEGTYGVVYRA--RDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 589 ----VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
VG+ + +V EY+ + L+ + + P + +L S + LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCLMLQLLSGVAHLHD-- 124
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
+ I+H DLK +N+LL+ + K+ DFG++R E S T T Y P
Sbjct: 125 -NWILHRDLKTSNLLLNNRGILKICDFGLAR-----EYGSPLKPY---TQLVVTLWYRAP 175
Query: 705 E-FLASGELTPKSDVYSFGIILLRLLTGRP 733
E L + E + D++S G I LLT +P
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-14
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 26/210 (12%)
Query: 535 KIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
++G+G +G +YK + A K++ S + ++ EI+IL+ HP +V L+GA
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 593 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHSCKPHSI 648
++W ++ E+ P G+++ + D + +I+ I ++ L +LHS K I
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHSMK---I 131
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
+H DLK N+LL + KL+DFG+S + N TL R GT +M PE +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS--------AKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 709 SGEL--TP---KSDVYSFGIILLRLLTGRP 733
+ TP K+D++S GI L+ + P
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 9e-14
Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGA 591
++G+G YGS+YK L R V + M S+F Q E+DIL K P +V GA
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 592 CPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
+ VY EY+ GSL+ + + + RI + L FL + H+I
Sbjct: 68 F-FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNI 124
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
+H D+KP N+L++ N KL DFG+S S T + C++ YM PE +
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQS-------YMAPERIK 174
Query: 709 SGEL------TPKSDVYSFGIILLRLLTGR 732
SG T +SDV+S G+ +L + GR
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 52/198 (26%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 534 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 588
+++G G +G + KG+ + + VAIK+L + + E +E +I+ ++ +P +V +
Sbjct: 1 VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 589 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+G C E LV E G L LS K + +S + + V + + + +
Sbjct: 61 IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVS-----NVVELMHQVSMGMKYLEGKN 115
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
VH DL N+LL +K+SDFG+S+ L ++++ R+ K + PE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKAL-----GADDSYYKARSAGKWPLKWYAPECI 170
Query: 708 ASGELTPKSDVYSFGIIL 725
+ + +SDV+S+GI +
Sbjct: 171 NFRKFSSRSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 75/248 (30%), Positives = 111/248 (44%), Gaps = 32/248 (12%)
Query: 530 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQG-PSEFQQEIDILSKIR---H 582
++P +IG G YG++YK H VA+K + + G P +E+ +L ++ H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 583 PNLVTLVGACPEVWT-------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 635
PN+V L+ C T LV+E++ + L L K P L +T + +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLD-KVPPPGLPAETIKDLMRQFLR 119
Query: 636 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 695
L FLH+ + IVH DLKP NIL+ + KL+DFG++R I S L T
Sbjct: 120 GLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMAL---TPV 167
Query: 696 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755
T Y PE L D++S G I + +P E A GK+ +L+
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLIG 224
Query: 756 -PLAGDWP 762
P DWP
Sbjct: 225 LPPEDDWP 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 38/232 (16%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPN 584
+++ K+GEG +G +YK VA+K + H+ + P +EI IL K++HPN
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68
Query: 585 LVTLVGACPEVWTLVYEYLPNGSLEDRLS--------CKDNSPPLSWQTRIR-------- 628
+V L+ + E P+ S R S D S L ++
Sbjct: 69 VVPLI-------DMAVER-PDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKC 119
Query: 629 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688
+L + +LH I+H D+K ANIL+D + K++DFG++R +
Sbjct: 120 YMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 689 LCCRTDPKG---TFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPAL 735
T Y PE L GE T D++ G + + T RP L
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTRRPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 40/285 (14%)
Query: 528 HNFDPSLKIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSLQG--PSEFQQEIDILSKI 580
++ +IGEG YG ++K R ++ VA+K + + + P +E+ +L +
Sbjct: 1 QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 581 R---HPNLVTLVGACP-------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 630
HPN+V L C TLV+E++ + L L K P + +T +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLD-KVPEPGVPTETIKDMM 116
Query: 631 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 690
+L L FLHS H +VH DLKP NIL+ ++ KL+DFG++R S ++
Sbjct: 117 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-- 171
Query: 691 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 750
T Y PE L D++S G I + +P + +V GK+
Sbjct: 172 -------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKI 221
Query: 751 KNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRP---ELGKDV 791
+++ P DWP A + + K ELGKD+
Sbjct: 222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 266
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 530 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 587
+ +KIGEG G + +H QVA+KM+ Q E+ I+ +H N+V
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 588 -----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 639
LVG E+W L+ E+L G+L D +S QTR+ +IAT SVL
Sbjct: 83 MYKSYLVGE--ELWVLM-EFLQGGALTDIVS----------QTRLNEEQIATVCESVLQA 129
Query: 640 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
L ++H D+K +ILL + KLSDFG +S++ + R GT
Sbjct: 130 LCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--------VPKRKSLVGTP 181
Query: 700 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
+M PE ++ + D++S GI+++ ++ G P
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 535 KIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
++G+G +G +YK + V A K++ S + ++ EIDIL+ HPN+V L+ A
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 593 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
+W L+ E+ G++ D + + P Q R+ + + L +LH K I+
Sbjct: 72 YYENNLWILI-EFCAGGAV-DAVMLELERPLTEPQIRV-VCKQTLEALNYLHENK---II 125
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL-- 707
H DLK NIL + KL+DFG+S + N T+ R GT +M PE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 708 ASGELTP---KSDVYSFGIILLRLLTGRP 733
+ + P K+DV+S GI L+ + P
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQ--EIDILSKI-RHPNLVTLV 589
++G+G +GS+Y + VAIK + E E+ L K+ HPN+V L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 590 GACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHS 642
EV+ V+EY+ G+L L P S ++ IR I ++ L +H
Sbjct: 65 ----EVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFS-ESVIRSIIYQILQGLAHIHK 117
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
H H DLKP N+L+ V K++DFG++R EI S TD T Y
Sbjct: 118 ---HGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPY----TDYVSTRWYR 165
Query: 703 DPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
PE L S + D+++ G I+ L T RP
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 536 IGEGGYGSIYKGL-------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 588
+G+G +G +Y L QV P + + S + EI +L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 589 VGACPE----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
G + T+ EY+P GS++D+L L+ + ++ + +LHS
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHS-- 124
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
+ IVH D+K ANIL D+ KL DFG S+ L I + T + T GT +M P
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT--ICMSGTGIRSVT---GTPYWMSP 178
Query: 705 EFLASGELTPKSDVYSFGIILLRLLTGRP 733
E ++ K+DV+S G ++ +LT +P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 73/276 (26%), Positives = 130/276 (47%), Gaps = 43/276 (15%)
Query: 535 KIGEGGYGSIYKGLLR-------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLV 586
++G+G +G +Y+G+ + +VAIK ++ S++ EF E ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 587 TLVGACPEVW-TLV-YEYLPNGSLEDRL----SCKDNSP---PLSWQTRIRIATELCSVL 637
L+G + TLV E + G L+ L +N+P P S + I++A E+ +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+L++ K VH DL N ++ +F K+ DFG++R + + + R KG
Sbjct: 133 AYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY--------RKGGKG 181
Query: 698 TFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 751
+M PE L G T SDV+SFG++L + L +P G++ E +++ ++ G L
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL- 240
Query: 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787
D P + L L C + + K RP
Sbjct: 241 --------DKPDNCPDMLFELMRMCWQYNPKMRPSF 268
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKIRHPN 584
+F+ +IG G YG +YK R++ AIK++ + + QQEI ++ +H N
Sbjct: 10 DFELIQRIGSGTYGDVYKA--RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 585 LVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
+V G+ ++W + E+ GSL+D + PLS ++ E L +LH
Sbjct: 68 IVAYFGSYLRRDKLW-ICMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLH 123
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
S +H D+K ANILL N KL+DFG+S ++ T+ R GT +
Sbjct: 124 S---KGKMHRDIKGANILLTDNGHVKLADFGVSAQIT--------ATIAKRKSFIGTPYW 172
Query: 702 MDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPAL 735
M PE A G D+++ GI + L +P +
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 75/262 (28%), Positives = 117/262 (44%), Gaps = 37/262 (14%)
Query: 536 IGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVTLV 589
+G G G++YK LL +A+K++ L E Q+ E++IL K P ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI---PLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 590 GA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
GA ++ E++ GSL D + RIA + L +L S K
Sbjct: 66 GAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLGRIAVAVVKGLTYLWSLK--- 115
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
I+H D+KP+N+L++ KL DFG+S L ++S T GT AYM PE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYV------GTNAYMAPERI 165
Query: 708 ASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLD---PLAGDWPF 763
+ + SDV+S GI + L GR P I K + L+ ++D P+ F
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225
Query: 764 VQAEQLANLAMRCCEMSRKSRP 785
+E+ + +C K RP
Sbjct: 226 --SEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 51/289 (17%)
Query: 535 KIGEGGYGSIYKG----LLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVT 587
+IG G +G + G + +V +K L + P E F QE+ ++ HPN++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 588 LVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSC 643
+G C E + LV E+ P G L++ L Q + R+A E+ S L++LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGI--SRFLSQNEISSNNTTLCCRTDPKGTFAY 701
+H DL N L A+ K+ D+G+ ++ I+ + + R +
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR--------W 168
Query: 702 MDPEFLAS-------GELTPKSDVYSFGIILLRLLTGR----PALGITKEVQYALDTGKL 750
+ PE + + T KS+++S G+ + L T P L + ++ + +
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228
Query: 751 K----NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795
K L + W V M+ C + ++RP ++V +L
Sbjct: 229 KLPKPQLDLKYSDRWYEV---------MQFCWLDPETRPTA-EEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 25/217 (11%)
Query: 528 HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKIRHP 583
H+++ ++G G YG +YK R++ A+K++ S QQEI ++ + +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKA--RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC 66
Query: 584 NLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
N+V G+ E + EY GSL+D + PLS + E L +LH
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLH 123
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
S +H D+K ANILL N KL+DFG++ ++ T+ R GT +
Sbjct: 124 S---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT--------ATIAKRKSFIGTPYW 172
Query: 702 MDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPAL 735
M PE A +G D+++ GI + L +P +
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 1e-12
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 591
KIG+G G+++ + +VAIK ++ EI ++ ++++PN+V + +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 592 -CPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
+ +V EYL GSL D ++ C D + + + E L FLH+ + +
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA------VCRECLQALEFLHA---NQV 136
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
+H D+K N+LL + KL+DFG ++ + S +T+ GT +M PE +
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPEVVT 188
Query: 709 SGELTPKSDVYSFGIILLRLLTGRP 733
PK D++S GI+ + ++ G P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 59/227 (25%), Positives = 109/227 (48%), Gaps = 25/227 (11%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 587
++G G +G++ KG+ + + VA+K+L + P+ E +E +++ ++ +P +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVR 60
Query: 588 LVGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC-SVLIFLHSCKP 645
++G C E W LV E G L L + + TEL V + + +
Sbjct: 61 MIGICEAESWMLVMELAELGPLNKFLQKNKH-------VTEKNITELVHQVSMGMKYLEE 113
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+ VH DL N+LL +K+SDFG+S+ L +E +T K + PE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE-----NYYKAKTHGKWPVKWYAPE 168
Query: 706 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 749
+ + + KSDV+SFG+++ + +P G+ EV +++G+
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 39/245 (15%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL--V 589
K+GEG Y ++YKG + VA+K + +G P +E +L ++H N+VTL +
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 590 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS------- 642
+ TLV+EYL D + + +V +FL
Sbjct: 72 IHTKKTLTLVFEYLD----------TDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLAY 118
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDPKGTFA 700
C ++H DLKP N+L+ KL+DFG++R S S+ TL
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW---------- 168
Query: 701 YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759
Y P+ L S E + D++ G I + TGRP + +V+ L + L P
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK-IFRVLGTPTEE 227
Query: 760 DWPFV 764
WP V
Sbjct: 228 TWPGV 232
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVT 587
+GEG YG + K RH + VAIK + E ++ E+ +L ++ N+V
Sbjct: 9 VGEGAYGVVLK--CRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVE 64
Query: 588 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
L A LV+EY+ LE + PP ++ + + ++ +H C
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP------EKVRSYIYQLIKAIHWCHK 118
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+ IVH D+KP N+L+ N V KL DFG +R LS+ ++ T+ T Y PE
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN-------YTEYVATRWYRSPE 171
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
L D++S G IL L G+P
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 26/206 (12%)
Query: 536 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ----QEIDILSKIRHPNLVTLV 589
I +G +GS+Y K AIK+L + ++ + ++ + P + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 590 GA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+ + LV EYL G S L + E+ + LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCA---SLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RG 117
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
I+H D+KP N+L+D KL+DFG+SR +N+ GT Y+ PE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------------KFVGTPDYLAPETI 165
Query: 708 ASGELTPKSDVYSFGIILLRLLTGRP 733
SD +S G ++ L G P
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 536 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 588
+G+G +G +Y R + V P S + E + EI +L + H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 589 VGAC---PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
G E ++ E++P GS++D+L + L+ + ++ + +LHS
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHS-- 124
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
+ IVH D+K ANIL D+ KL DFG S+ L I + T + T GT +M P
Sbjct: 125 -NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT--ICLSGTGMKSVT---GTPYWMSP 178
Query: 705 EFLASGELTPKSDVYSFGIILLRLLTGRP 733
E ++ K+D++S G ++ +LT +P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 44/225 (19%)
Query: 535 KIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNL 585
++GE +G +YKG L + VAIK L + +GP EF+ E + S+++HPN+
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 586 VTLVGACP--EVWTLVYEYLPN----------------GSLEDRLSCKDNSPPLSWQTRI 627
V L+G + ++++ Y + GS +D + K P + +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF---V 127
Query: 628 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS--N 685
I T++ + + FL S H +VH DL N+L+ K+SD G+ R + +
Sbjct: 128 HIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730
N+ L R +M PE + G+ + SD++S+G++L + +
Sbjct: 185 NSLLPIR--------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 535 KIGEGGYGSIY--KGLLRHMQVAIKMLH--PHSLQGPSEF---QQEIDILSKIRHPNLVT 587
++G+G +G++Y K + +K+L P P+E QE +LSK+ HP +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 588 LVGACPE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
+ E + ++ EY L+ +L K LS ++ +L+ +H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLS---ENQVCEWFIQLLLGVHYMH 123
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
I+H DLK NI L N + K+ DFG+SR L + TT GT YM P
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS--CDLATTF------TGTPYYMSP 174
Query: 705 EFLASGELTPKSDVYSFGIIL 725
E L KSD++S G IL
Sbjct: 175 EALKHQGYDSKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSL-QG-PSEFQQEIDILSKIRHPN 584
++ KIGEG YG+++K R VA+K + +G PS +EI +L +++H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 585 LVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
+V L V + TLV+EY + SC + P ++ +L L F HS
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS---FMFQLLKGLAFCHS 117
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
H+++H DLKP N+L++ N KL+DFG++R + + C + T Y
Sbjct: 118 ---HNVLHRDLKPQNLLINKNGELKLADFGLAR--------AFGIPVRCYSAEVVTLWYR 166
Query: 703 DPEFLASGELTPKS-DVYSFGIILLRLLT-GRP 733
P+ L +L S D++S G I L GRP
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 35/90 (38%), Positives = 46/90 (51%), Gaps = 12/90 (13%)
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
I+H D+KP+NILLD N KL DFGIS L + I+ +T G YM PE
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIA--------KTRDAGCRPYMAPE 177
Query: 706 FLASGELTP---KSDVYSFGIILLRLLTGR 732
+ +SDV+S GI L + TG+
Sbjct: 178 RIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 536 IGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLV 586
+G G +G+++KG+ + VAIK + S G FQ+ D + + H +V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIV 72
Query: 587 TLVGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
L+G CP LV + P GSL D + + + L Q + ++ + +L
Sbjct: 73 RLLGICPGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEE--- 127
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
H +VH +L NILL ++ + +++DFG++ L ++ ++ K +M E
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY------FYSEHKTPIKWMALE 181
Query: 706 FLASGELTPKSDVYSFGIILLRLLT 730
+ G T +SDV+S+G+ + +++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSK-IRHPNLVT 587
IG+G +G + L +H A+K+L ++ E + E ++L K ++HP LV
Sbjct: 3 IGKGSFGKVL--LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 588 LVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCK 644
L + + V +Y+ G L L + + P + R R A E+ S L +LHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSLN 116
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
I++ DLKP NILLD+ L+DFG+ + E S +T C GT Y+ P
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFC------GTPEYLAP 165
Query: 705 EFLASGELTPKSDVYSFGIILLRLLTGRP 733
E L D + G +L +L G P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 70/238 (29%), Positives = 105/238 (44%), Gaps = 48/238 (20%)
Query: 530 FDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNL 585
FD +IGEG YG +YK + VA+K + + +G P +EI IL ++ H N+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 586 VTLVGACPEVWT----------------LVYEYLPN---GSLEDRLS--CKDNSPPLSWQ 624
V L E+ T LV+EY+ + G LE L +D+
Sbjct: 69 VNLK----EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH------- 117
Query: 625 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684
I + + +L L+ C + +H D+K +NILL+ KL+DFG++R + E
Sbjct: 118 ----IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 685 NNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEV 741
T+ T Y PE L E P DV+S G IL L T +P +E+
Sbjct: 174 -------YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 29/214 (13%)
Query: 531 DPSLKIGEGGYGSIYKGLLRHMQVAIKML-HPH--SLQGPSEFQQEIDILSKIRHPNLVT 587
S+ I E SIYKG+ + +V I+ H + EI L +I N++
Sbjct: 23 YTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK 82
Query: 588 LVG-------ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
+ G P + +L+ EY G L + L D LS++T++ +A + C L L
Sbjct: 83 IYGFIIDIVDDLPRL-SLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNL 138
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
+ K + + +L + L+ N+ K+ G+ + LS + N
Sbjct: 139 Y--KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF-----------MV 185
Query: 701 YMDPEFLAS--GELTPKSDVYSFGIILLRLLTGR 732
Y + L E T K D+YS G++L + TG+
Sbjct: 186 YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 45/218 (20%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKML--HPHSLQGPSEFQQEIDILSKIR-HPNLVT 587
KIGEG + + K + + AIK + H SL+ + + EI L ++ HPN++
Sbjct: 6 KIGEGTFSEVLKA--QSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILR 62
Query: 588 LVGACPEV--------WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 639
L+ EV LV+E L + +L + + K PL + +L L
Sbjct: 63 LI----EVLFDRKTGRLALVFE-LMDMNLYELI--KGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 640 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR---TDPK 696
+H + I H D+KP NIL+ + + KL+DFG R + + T+
Sbjct: 116 MHR---NGIFHRDIKPENILIKDDIL-KLADFGSCR------------GIYSKPPYTEYI 159
Query: 697 GTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
T Y PE L G PK D+++ G + +L+ P
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 52/231 (22%)
Query: 528 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQ----EIDILSK 579
+ IGEG YG + + ++VAIK + P H F Q EI IL +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-----FCQRTLREIKILRR 59
Query: 580 IRHPNLVTL--------VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLS--------W 623
+H N++ + + +V+ +V E + L + + LS +
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVY-IVQELMET-DLYKLIK----TQHLSNDHIQYFLY 113
Query: 624 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683
Q +R L ++HS +++H DLKP+N+LL+ N K+ DFG++R
Sbjct: 114 QI-LR-------GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 684 SNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
+ T+ T Y PE L S T D++S G IL +L+ RP
Sbjct: 163 TGFL-----TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 68/249 (27%), Positives = 113/249 (45%), Gaps = 23/249 (9%)
Query: 525 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIR 581
G +++ K+GEG Y ++YKG + VA+K++ +G P +E +L ++
Sbjct: 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK 61
Query: 582 HPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLI 638
H N+V L + E TLV+EY+ D D P +++ +L L
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 639 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 698
++H I+H DLKP N+L+ KL+DFG++R S + +N + T
Sbjct: 118 YIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--------T 166
Query: 699 FAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757
Y P+ L S E + D++ G I + ++ G A K++Q L+ L L P
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV-LGTPN 225
Query: 758 AGDWPFVQA 766
WP V +
Sbjct: 226 EDTWPGVHS 234
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 554 VAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLVGACPEVWTL--VYEYLPNGSLE 609
VA+KML + + S+ E++++ I +H N++ L+GAC + L + EY G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 610 DRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 656
+ L + ++++ + ++ + +L S K +H DL
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166
Query: 657 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 716
N+L+ N V K++DFG++R + N I T T+ + +M PE L T +S
Sbjct: 167 NVLVTENNVMKIADFGLARDV--NNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQS 220
Query: 717 DVYSFGIILLRLLT--GRPALGITKEVQYAL 745
DV+SFG+++ + T G P GI E + L
Sbjct: 221 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 530 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 587
D +KIGEG G + ++ VA+K + Q E+ I+ +H N+V
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 588 -----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 639
LVG E+W +V E+L G+L D ++ TR+ +IA +VL
Sbjct: 82 MYNSYLVG--DELW-VVMEFLEGGALTDIVT----------HTRMNEEQIAAVCLAVLKA 128
Query: 640 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
L ++H D+K +ILL + KLSDFG +S+ E+ + + GT
Sbjct: 129 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLV-------GTP 180
Query: 700 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
+M PE ++ P+ D++S GI+++ ++ G P
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 530 FDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 587
D +KIGEG G + +H QVA+K + Q E+ I+ H N+V
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 588 -----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 639
LVG E+W +V E+L G+L D ++ TR+ +IAT SVL
Sbjct: 84 MYNSYLVG--DELW-VVMEFLEGGALTDIVT----------HTRMNEEQIATVCLSVLRA 130
Query: 640 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
L ++H D+K +ILL ++ KLSDFG +S+ E+ + + GT
Sbjct: 131 LSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLV-------GTP 182
Query: 700 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
+M PE ++ + D++S GI+++ ++ G P
Sbjct: 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 63/217 (29%), Positives = 89/217 (41%), Gaps = 41/217 (18%)
Query: 536 IGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 586
+G+GGYG ++ G + M+V K + + + + E +IL ++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 587 TLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE------LCSVLI 638
L+ A L+ EYL G L L R I E L + +
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLE------------REGIFMEDTACFYLSEISL 111
Query: 639 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPK 696
L I++ DLKP NILLDA KL+DFG L + I T C
Sbjct: 112 ALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFG----LCKESIHEGTVTHTFC------ 161
Query: 697 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT YM PE L D +S G ++ +LTG P
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 59/276 (21%)
Query: 536 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-----FQQEIDILSKIRHPNLV 586
+G+G YG + L+RH Q IK L +L+ S +QE +LS+++HPN+V
Sbjct: 8 VGKGSYGEV--SLVRHRTDGKQYVIKKL---NLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 587 TLVGACPEVWT-------LVYEYLPNGSLEDRLSCKD-----NSPPLSWQTRIRIATELC 634
E W +V + G L +L + + + W +I +A
Sbjct: 63 AY----RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA---- 114
Query: 635 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL-SQNEISSNNTTLCCRT 693
L +LH I+H DLK N+ L + K+ D GI+R L +Q +++S TL
Sbjct: 115 --LQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS---TLI--- 163
Query: 694 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI--TKEVQYALDTGKLK 751
GT YM PE ++ KSDV++ G + + T + A + Y + GKL
Sbjct: 164 ---GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP 220
Query: 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787
P+ D+ + +L L + RP +
Sbjct: 221 ----PMPKDY----SPELGELIATMLSKRPEKRPSV 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 535 KIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL-- 588
K+GEG Y ++YKG+ R + VA+K++ + +G P +E +L ++H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQL-VALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 589 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHSCKPHS 647
+ E T V+EY+ D P +R+ +L L ++H
Sbjct: 71 IIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QH 123
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDPKGTFAYMDPE 705
I+H DLKP N+L+ KL+DFG++R S SS TL Y P+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLW----------YRPPD 173
Query: 706 -FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD-PLAGDWPF 763
L + + + D++ G I + +L G+PA +V L+ K+ +L P WP
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE--KIWTVLGVPTEDTWP- 230
Query: 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795
++ L E +P+ + VW+ L
Sbjct: 231 ----GVSKLPNYKPEWFLPCKPQQLRVVWKRL 258
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 536 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 588
+G G +G +Y R + V P S + E + EI +L +RH +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 589 VGAC--PE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
G PE ++ EY+P GS++D+L L+ R ++ + +LHS
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHS-- 124
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
+ IVH D+K ANIL D+ KL DFG S+ + I + T + T GT +M P
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT--ICMSGTGIKSVT---GTPYWMSP 178
Query: 705 EFLASGELTPKSDVYSFGIILLRLLTGRP 733
E ++ K+DV+S ++ +LT +P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 538 EGGYGSIYKGLLRHM------QVAIKMLHPHSLQGPSEFQ-----QEIDILSKIRHPNLV 586
EG +G I+ G+L +V +K + H+ SE Q QE +L + H N++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA----SEIQVTLLLQESCLLYGLSHQNIL 71
Query: 587 TLVGACPEVWT---LVYEYLPNGSLED-----RLSCKDNSPPLSWQTRIRIATELCSVLI 638
++ C E ++Y Y+ G+L+ RL +N LS Q + +A ++ +
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 639 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 698
+LH ++H D+ N ++D K++D +SR L + C +
Sbjct: 132 YLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH------CLGDNENRP 182
Query: 699 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730
+M E L + E + SDV+SFG++L L+T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 29/208 (13%)
Query: 536 IGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGPSEFQ--QEIDILSKIRHPNLV 586
+G+G +G ++ L+R + A+K+L +L+ + E DIL+++ HP +V
Sbjct: 4 LGQGSFGKVF--LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 587 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSC 643
L A L+ ++L G L RLS + + ++ EL L LHS
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
I++ DLKP NILLD KL+DFG+S+ +E + C GT YM
Sbjct: 118 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFC------GTVEYMA 166
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLTG 731
PE + T +D +SFG+++ +LTG
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 4e-11
Identities = 64/238 (26%), Positives = 94/238 (39%), Gaps = 58/238 (24%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKML-------HPHSLQGPSEFQQEIDILSKIRHPN 584
IG G +G ++ L+R A+K+L + + E DIL+ P
Sbjct: 9 IGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQI----AHVRAERDILADADSPW 62
Query: 585 LVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 636
+V L ++ LV EY+P G L + L KD P R IA EL
Sbjct: 63 IVKLY------YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ET-ARFYIA-ELVLA 113
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS----------RFLSQNEISSNN 686
L +H +H D+KP NIL+DA+ KL+DFG+ +L+ +
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 687 TTLCCRTDPK-----------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
+ R GT Y+ PE L + D +S G+IL +L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 528 HNFDPSLKIGEGGYGSIYKGLLRH---MQV-AIKMLHPHSLQGPSE---FQQEIDILSKI 580
+FD IG G +G + L+RH QV A+K+L + S+ F +E DI++
Sbjct: 43 EDFDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 581 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 638
+V L A + +V EY+P G L + +S D P W R A E+ L
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKW-ARFYTA-EVVLALD 156
Query: 639 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 698
+HS +H D+KP N+LLD + KL+DFG + N + +T + GT
Sbjct: 157 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-------GT 206
Query: 699 FAYMDPEFLAS----GELTPKSDVYSFGIILLRLLTGRP 733
Y+ PE L S G + D +S G+ L +L G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 536 IGEGGYGSIYKGLLRHM--QVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLV----T 587
IG+G YG + + H +VAIK ++ + + +EI +L +RHP++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 588 LVGACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
++ + +V+E L L + D+ P Q + +L L ++H+
Sbjct: 68 MLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFL---YQLLRALKYIHTA- 122
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-TLCCRTDPKGTFAYMD 703
++ H DLKP NIL +A+ K+ DFG++R ++ N+T T TD T Y
Sbjct: 123 --NVFHRDLKPKNILANADCKLKICDFGLAR------VAFNDTPTAIFWTDYVATRWYRA 174
Query: 704 PEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 746
PE S + TP D++S G I +LTG+P L K V + LD
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP-LFPGKNVVHQLD 218
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 51/277 (18%)
Query: 536 IGEGGYGSIYKGLLRH----MQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLV 589
+GEG +GS+ +G L ++VA+K + + +F E + + HPN++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 590 GACPEVW--------TLVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVLI 638
G C + ++ ++ +G L L D L Q ++ T++ S +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 639 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR------FLSQNEISSNNTTLCCR 692
+L S S +H DL N +L+ N ++DFG+S+ + Q I+
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA--------- 174
Query: 693 TDPKGTFAYMDPEFLASGELTPKSDVYSFGI----ILLRLLTGRPALGITKEVQYALDTG 748
K ++ E LA T KSDV+SFG+ I R T P + ++ Y
Sbjct: 175 ---KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
Query: 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
+LK D L G L +L C ++ K RP
Sbjct: 232 RLKQPPDCLDG---------LYSLMSSCWLLNPKDRP 259
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 28/206 (13%)
Query: 536 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQ---EIDILSKIRHPNLVTLV 589
+G G G + K L R + +A K++H L+ P+ Q E+ +L + P +V
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIH---LEIKPAIRNQIIRELKVLHECNSPYIVGFY 65
Query: 590 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
GA E+ ++ E++ GSL D++ K P + +I IA + L +L + H
Sbjct: 66 GAFYSDGEI-SICMEHMDGGSL-DQVLKKAGRIPENILGKISIA--VLRGLTYLR--EKH 119
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
I+H D+KP+NIL+++ KL DFG+S L I S + GT +YM PE
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSYMSPER 169
Query: 707 LASGELTPKSDVYSFGIILLRLLTGR 732
L T +SD++S G+ L+ + GR
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 535 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 589
+IG G +G++Y + + VAIK + Q ++Q +E+ L K+RHPN +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 590 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
G T LV EY GS D L + PL + L +LHS H+
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
++H D+K NILL + KL DFG S + ++ N + GT +M PE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFG-----SASIMAPANXFV-------GTPYWMAPEVI 183
Query: 708 AS---GELTPKSDVYSFGIILLRLLTGRPAL 735
+ G+ K DV+S GI + L +P L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 63/270 (23%), Positives = 113/270 (41%), Gaps = 35/270 (12%)
Query: 536 IGEGGYGSIYK-------GLLRHMQVAIKMLHPHSLQGPSEFQQEID--------ILSKI 580
+G G +G +YK L ++ I + +P + E + I I ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALK-EINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 581 RHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVL 637
RHPN+V E L V + + L + S K+ + + I ++ L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+LH K IVH DL P NI+L + ++DFG+++ T G
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---------LTSVVG 175
Query: 698 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757
T Y PE + + K+DV++FG IL ++ T +P T + A T ++ + +PL
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA--TKIVEAVYEPL 233
Query: 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787
+ +E + ++ C ++RP++
Sbjct: 234 PEG---MYSEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 67/211 (31%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 589
+IG G +G++Y VAIK + Q ++Q +E+ L ++RHPN +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 590 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
G T LV EY GS D L + PL I L +LHS H
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHS---HE 135
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-F 706
+H D+K NILL KL+DFG S + +S N+ + GT +M PE
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFG-----SASLVSPANSFV-------GTPYWMAPEVI 183
Query: 707 LA--SGELTPKSDVYSFGIILLRLLTGRPAL 735
LA G+ K DV+S GI + L +P L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 589
+IG G +G++Y H VA+K + Q ++Q +E+ L +++HPN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 590 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
G + T LV EY GS D L + PL I L +LHS H+
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HN 141
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
++H D+K NILL KL+DFG S ++ S N+ + GT +M PE +
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFV-------GTPYWMAPEVI 189
Query: 708 AS---GELTPKSDVYSFGIILLRLLTGRPAL 735
+ G+ K DV+S GI + L +P L
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 8e-11
Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 49/228 (21%)
Query: 535 KIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVT 587
IG G YG +YK ++ + AIK Q Q +EI +L +++H N+V+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 588 LVGACPE-----VWTLVYEYLPNGSLE----DRLSCKDNSPP-----LSWQTRIRIATEL 633
LV E V+ L+++Y + + R + + + PP L WQ +
Sbjct: 67 LVEVFLEHADKSVY-LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------I 117
Query: 634 CSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGISRFL---SQNEISSNN 686
+ + +LHS + ++H DLKPANIL+ V K+ D G++R + +
Sbjct: 118 LNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 687 TTLCCRTDPKGTFAYMDPEF-LASGELTPKSDVYSFGIILLRLLTGRP 733
+ T Y PE L + T D+++ G I LLT P
Sbjct: 175 VVV--------TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 34/228 (14%)
Query: 527 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHP 583
T ++ IG+G YG +YK + A+K+L P S E + E +IL + HP
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHP 79
Query: 584 NLVTLVG--------ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR---IATE 632
N+V G ++W LV E GS+ + + L R+ I+
Sbjct: 80 NVVKFYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGL-----LICGQRLDEAMISYI 133
Query: 633 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 692
L L+ L + I+H D+K NILL KL DFG+S L+ + N +
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---- 189
Query: 693 TDPKGTFAYMDPEFLASGE-----LTPKSDVYSFGIILLRLLTGRPAL 735
GT +M PE +A + + DV+S GI + L G P L
Sbjct: 190 ----GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 1e-10
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 46/221 (20%)
Query: 536 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ---------QEIDILSKIRHPN 584
IG G YG + + +VAIK + F +EI +L +RH N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 585 LVTLVGACP--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCS 635
++ L+ +V+ +V E + L + PL+ I+ ++
Sbjct: 61 IIGLLDILRPPSPEDFNDVY-IVTELMET-DLHKVIKSPQ---PLTDD-HIQYFLYQILR 114
Query: 636 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT--LCCRT 693
L +LHS ++H DLKP+NIL+++N K+ DFG++R + +E T + R
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 694 DPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
Y PE L+S T D++S G I LLT +P
Sbjct: 172 -------YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 11/104 (10%)
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
A E+ L FLH I++ DLK N+LLD+ K++DFG+ + + + T+
Sbjct: 102 AAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTST 155
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
C GT Y+ PE L+ P D ++ G++L +L G+
Sbjct: 156 FC-----GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 49/273 (17%)
Query: 536 IGEGGYGSIYKGLLRH------------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP 583
+G+G + +IYKG+LR + V +K+L + F + ++S++ H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61
Query: 584 NLVTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
+LV L G C + +V EY+ G L+ L + N+ L W ++ +A +L S L +L
Sbjct: 62 HLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 643 CKPHSIVHGDLKPANILL---DAN-----FVSKLSDFGISRFLSQNEISSNNTTLCCRTD 694
K +VHG++ NIL+ N F+ KLSD GI T+ R +
Sbjct: 120 KK---LVHGNVCGKNILVARYGLNEGYVPFI-KLSDPGIPI------------TVLSREE 163
Query: 695 PKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 752
++ PE + +G+ LT +D +SFG LL + + T + ++
Sbjct: 164 RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223
Query: 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
L D +LANL +C RP
Sbjct: 224 RLPMP--DCA-----ELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 35/214 (16%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ--QEIDILSKIRH-PNLVTL 588
+G G YG + K +RH+ +A+K + ++ + + ++DI + P VT
Sbjct: 9 LGRGAYGVVDK--MRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 589 VGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSC 643
GA +VW + + + SL D+ K L+ I +IA + L +LHS
Sbjct: 66 YGALFREGDVW--ICMEVMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS- 121
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
S++H D+KP+N+L++ N KL DFGIS +L + ++ +T G YM
Sbjct: 122 -KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVA--------KTIDAGCKPYMA 171
Query: 704 PEFLASGELTP-----KSDVYSFGIILLRLLTGR 732
PE + + EL KSDV+S GI ++ L TGR
Sbjct: 172 PERI-NPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 41/240 (17%)
Query: 536 IGEGGYGSIYKGLL---------RHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 584
+GEG +G + R +VA+KML + + S+ E++++ I +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 585 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 627
++ L+GAC + L + EY G+L + L + PP LS++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 628 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 687
A ++ + +L S K +H DL N+L+ + V K++DFG++R + + I
Sbjct: 144 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKK 198
Query: 688 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 745
T T+ + +M PE L T +SDV+SFG++L + T G P G+ E + L
Sbjct: 199 T----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 30/214 (14%)
Query: 552 MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACPE---VWTLVYEYLPNG 606
+ VA+KML + + S+ E++++ I +H N++ L+GAC + ++ LV EY G
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLV-EYASKG 103
Query: 607 SLEDRL-------------SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 653
+L + L +CK L+++ + A ++ + +L S K +H DL
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDL 160
Query: 654 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 713
N+L+ + V K++DFG++R + I T T+ + +M PE L T
Sbjct: 161 AARNVLVTEDNVMKIADFGLAR--DVHNIDYYKKT----TNGRLPVKWMAPEALFDRVYT 214
Query: 714 PKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 745
+SDV+SFG++L + T G P GI E + L
Sbjct: 215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 37/238 (15%)
Query: 536 IGEGGYGSIYK----GLLRHMQ-----VAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPN 584
+GEG +G + + G+ + VA+KML ++ + ++ E++++ I +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 585 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCK-----DNSP--------PLSWQTRIRI 629
++ L+G C + L + EY G+L + L + D + LS++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
A ++ + +L S + +H DL N+L+ + V K++DFG++R + I T
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHD--IDYYKKTS 194
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 745
R K +M PE L T +SDV+SFGI++ + T G P GI E + L
Sbjct: 195 NGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIR 581
++D IG G +G + L+RH A+K+L + S+ F +E DI++
Sbjct: 44 DYDVVKVIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 582 HPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 639
P +V L A + +V EY+P G L + +S D P W + T V++
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWA---KFYT--AEVVLA 154
Query: 640 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
L + ++H D+KP N+LLD + KL+DFG + + + +T + GT
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-------GTP 207
Query: 700 AYMDPEFLAS----GELTPKSDVYSFGIILLRLLTG 731
Y+ PE L S G + D +S G+ L +L G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 535 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 589
+IG G +G++Y + + + VAIK + Q ++Q +E+ L +I+HPN +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 590 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
G T LV EY GS D L + PL I L +LHS H+
Sbjct: 92 GCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HN 145
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
++H D+K NILL KL+DFG S + S N+ + GT +M PE +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFG-----SASIASPANSFV-------GTPYWMAPEVI 193
Query: 708 AS---GELTPKSDVYSFGIILLRLLTGRPAL 735
+ G+ K DV+S GI + L +P L
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 11/104 (10%)
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
A E+ L+FLH H +++ DLK NILLDA KL+DFG+ + + ++ TT
Sbjct: 102 AAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTT 155
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
C GT Y+ PE L E P D ++ G+++ ++ G+P
Sbjct: 156 FC-----GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 536 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 588
IG G +G + L+RH A+K+L + S+ F +E DI++ P +V L
Sbjct: 51 IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 589 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
A + +V EY+P G L + +S D P W R T V++ L +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWA---RFYT--AEVVLALDAIHSM 161
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
+H D+KP N+LLD + KL+DFG +++ + +T + GT Y+ PE
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-------GTPDYISPEV 214
Query: 707 LAS----GELTPKSDVYSFGIILLRLLTG 731
L S G + D +S G+ L +L G
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 52/205 (25%), Positives = 80/205 (39%), Gaps = 22/205 (10%)
Query: 536 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVG 590
+G+GG+G + ++ A K L L +G E IL K+ +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 591 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
A + LV + G L+ + P I A ++ L LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHLHQ---RRI 116
Query: 649 VHGDLKPANILLDANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
V+ DLKP N+LLD + ++SD G++ +I GT YM PE L
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR----------AGTPGYMAPEVL 166
Query: 708 ASGELTPKSDVYSFGIILLRLLTGR 732
D ++ G L ++ GR
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 536 IGEGGYGS--IYKGLLRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
+GEG +G + + + + A+K + P S + ++E +L+K++HPN+V +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 593 PEVWTL--VYEYLPNGSLEDRLSCKDNSPPL-SWQTRIRIATELCSVLIFLHSCKPHSIV 649
L V EY G L ++ K L T ++ ++C + +H + ++
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VL 122
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
H D+K NI L N KL DFG +R L ++ C GT Y+ PE +
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLL------TSPGAYACTY--VGTPYYVPPEIWEN 174
Query: 710 GELTPKSDVYSFGIILLRLLT 730
KSD++S G IL L T
Sbjct: 175 MPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 64/223 (28%), Positives = 96/223 (43%), Gaps = 40/223 (17%)
Query: 536 IGEGGYGSIYKGLLRH--MQVAIKMLHP-HSLQGPSEFQQEIDILSKIR-HPNLVTLVG- 590
IG+G YG ++K L + + A+K+L P H + E + E +IL + HPN+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID--EEIEAEYNILKALSDHPNVVKFYGM 83
Query: 591 -------ACPEVWTLVYEYLPNGSLEDRLSC-----KDNSPPLSWQTRIRIATELCSVLI 638
++W LV E GS+ D + + P+ IA L L+
Sbjct: 84 YYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPI-------IAYILHEALM 135
Query: 639 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 698
L + +H D+K NILL KL DFG+S L+ + N + GT
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--------GT 187
Query: 699 FAYMDPEFLASGE-----LTPKSDVYSFGIILLRLLTGRPALG 736
+M PE +A + + DV+S GI + L G P L
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 57/225 (25%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 536 IGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTL 588
+G G +G++YKG+ + VAIK+L + S + E E +++ + P + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 589 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+G C LV + +P G L D + ++N + Q + ++ + +L +
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNWCVQIAKGMSYLEEVR--- 129
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
+VH DL N+L+ + K++DFG++R L +E + K +M E +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH------ADGGKVPIKWMALESI 183
Query: 708 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 749
T +SDV+S+G+ + L+T +P GI +E+ L+ G+
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 70/239 (29%), Positives = 106/239 (44%), Gaps = 45/239 (18%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIR 581
+F+ I G YG++Y L+RH + A+K ++ +L ++ QQ E DIL+
Sbjct: 2 DFETIKLISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE 59
Query: 582 HPNLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 634
+P +V++ + C +V EY+ G D + N L E
Sbjct: 60 NPFVVSMFCSFETKRHLC-----MVMEYVEGG---DCATLLKNIGALPVDMARMYFAETV 111
Query: 635 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 694
L +LH+ + IVH DLKP N+L+ + KL+DFG LS+ + S T L
Sbjct: 112 LALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFG----LSKIGLMSLTTNLYEGHI 164
Query: 695 PKGTFAYMD------PEFLA------SGELTPKSDVYSFGIILLRLLTG-RPALGITKE 740
K T ++D PE++A G P D ++ GIIL L G P G T E
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPE 222
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 66/275 (24%), Positives = 114/275 (41%), Gaps = 40/275 (14%)
Query: 536 IGEGGYGSIYKGLLRH-----MQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTL 588
+G+G +GS+ + L+ +VA+KML S EF +E + + HPN++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 589 VGACPE--------VWTLVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 637
+G + ++ ++ +G L L + L QT +R ++ S +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+L S + +H DL N +L+ N ++DFG+S+ + + C P
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG---CASKLPVK 180
Query: 698 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEV-QYALDTGKLKNL 753
A E LA T SDV++FG+ + ++T P G+ E+ Y + +LK
Sbjct: 181 WLAL---ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237
Query: 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 788
D L E + L +C K RP
Sbjct: 238 PDCL---------EDVYELMCQCWSPEPKCRPSFQ 263
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 583
+F+ ++G G G + K ++H + +A K++H ++ +E+ +L + P
Sbjct: 6 DFERISELGAGNGGVVTK--VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 584 NLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
+V GA E+ ++ E++ GSL+ L P + +++ + L +L
Sbjct: 64 YIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKEAKRIPE---EILGKVSIAVLRGLAYL 119
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
+ H I+H D+KP+NIL+++ KL DFG+S L I S + GT +
Sbjct: 120 R--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRS 167
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
YM PE L + +SD++S G+ L+ L GR
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 536 IGEGGYGSIYKGLLR------HMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVTL 588
+G G +G++YKGL + VAIK L S + E E +++ + +P++ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 589 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+G C L+ + +P G L D + +++ + Q + ++ + +L
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEE---RR 129
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
+VH DL N+L+ K++DFG+++ L +E + K +M E +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH------AEGGKVPIKWMALESI 183
Query: 708 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 749
T +SDV+S+G+ + L+T +P GI E+ L+ G+
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 38/220 (17%)
Query: 528 HNFDPSLKIGEGGYGSI----YKGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKI 580
+F+ +G G +G + +KG + AIK L + + Q QE IL ++
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYY--AIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 581 RHPNLVTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 637
HP +V ++ + + V+ + E++ G L L P +A + L
Sbjct: 76 SHPFIVNMMCSFQDENRVY-FLLEFVVGGELFTHLRKAGRFPN-------DVAKFYHAEL 127
Query: 638 I----FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 693
+ +LHS I++ DLKP N+LLD K++DFG ++ ++ TLC
Sbjct: 128 VLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLC--- 176
Query: 694 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT Y+ PE + S D ++ G++L + G P
Sbjct: 177 ---GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSK-IRHPNLVT 587
IG+G +G + L RH A+K+L ++ E E ++L K ++HP LV
Sbjct: 3 IGKGSFGKVL--LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 588 LVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCK 644
L + L V +Y+ G L L + R R A E+ S L +LHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL- 115
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
+IV+ DLKP NILLD+ L+DFG+ + E + +T C GT Y+ P
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFC------GTPEYLAP 165
Query: 705 EFLASGELTPKSDVYSFGIILLRLLTGRP 733
E L D + G +L +L G P
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 536 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQQEID-----ILSKIRHPNLVTL 588
IG+G +G + K L A+K+L + E Q+ I +L ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVGL 61
Query: 589 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 645
+ E V +++ G L L ++ S P + R R A E+ S L +LHS
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFP---EPRARFYAAEIASALGYLHSIN- 116
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
IV+ DLKP NILLD+ L+DFG+ + S TT C GT Y+ PE
Sbjct: 117 --IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFC------GTPEYLAPE 166
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
+ D + G +L +L G P
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 535 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLV 586
IG+GG G +Y L + +VA+K + + P F +E I + + HP +V
Sbjct: 9 LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 587 TLVGACPEVWTLVYE--YLPNGSLEDRL----SCKDNSPPLSWQTRI----RIATELCSV 636
+ C + + Y Y+ +L+ L + S L+ +T + I ++C+
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE-----ISSNNTTLCC 691
+ ++HS ++H DLKP NILL + D+G + F E I + +C
Sbjct: 126 IEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 692 R--TDPK---GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730
T P GT YM PE L + +D+Y+ G+IL ++LT
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 66/250 (26%), Positives = 101/250 (40%), Gaps = 57/250 (22%)
Query: 528 HNFDPSLKIGEGGYGSIYKGLLRH--------MQVAIK--MLHPHSLQGPSEFQQEIDIL 577
+F+ IG G +G + L++ M+ K ML + + + E DIL
Sbjct: 1 DDFESIKVIGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQV---AHVRAERDIL 55
Query: 578 SKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSW-QTRIRIATELC 634
++ +P +V L + L+ EYLP G + L KD + +TR IA
Sbjct: 56 AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT---FTEEETRFYIA---- 108
Query: 635 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS------------RFLSQNEI 682
++ + S +H D+KP N+LLDA KLSDFG+ R LS
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 683 SSNNTTLCCRTDPK------------------GTFAYMDPE-FLASGELTPKSDVYSFGI 723
S+ + K GT Y+ PE FL +G + D +S G+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGV 227
Query: 724 ILLRLLTGRP 733
I+ +L G P
Sbjct: 228 IMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 36/234 (15%)
Query: 536 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVG 590
IG+G +G + + R Q A+K + + SE E +L+++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 591 A--CPEVWTLVYEYLPNGSLEDRLS---CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
+ PE LV ++ G L L D S + R A LC+ L LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-----RARFYTAELLCA-LENLHK--- 111
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
++++ DLKP NILLD L DFG+ + +++ +N T C GT Y+ PE
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN--TFC------GTPEYLAPE 163
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL--KNLLDPL 757
L T D ++ G++L +LTG P Y + ++ K L +PL
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPPF-------YDENVNEMYRKILQEPL 210
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 535 KIGEGGYGSIYKGL----LRHMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLV 589
+IG G +G + G QV +K L S+Q +F +E ++H NL+ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 590 GACPEV--WTLVYEYLPNGSLEDRL-SCK--DNSPPLSWQTRIRIATELCSVLIFLHSCK 644
G C EV + LV E+ P G L+ L SC+ + P T R+A E+ L+ LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLHK-- 118
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGIS 674
++ +H DL N LL A+ K+ D+G+S
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGP---SEFQQEIDILSKIR 581
+FD +G G +G + ++R A+K++ L S F++E DILS
Sbjct: 2 DFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 582 HPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 639
P + L A + LV EY P G L L+ ++ + + L +++
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFD-EDMAQFY--LAELVLA 114
Query: 640 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
+HS VH D+KP N+L+D KL+DFG S +++N P GT
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG-----SAARLTANKMVNS--KLPVGTP 167
Query: 700 AYMDPEFLASGELTPKS------DVYSFGIILLRLLTGR 732
Y+ PE L + K D +S G+I ++ GR
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 529 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 579
NF+ +G G YG ++ G L M+V K + + E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 580 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 636
+R P LVTL A L+ +Y+ G L L +++ + R+ IA E+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT--ESEVRVYIA-EIVLA 117
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTDP 695
L LH I++ D+K NILLD+ L+DFG+S+ FL++ E + + C
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFC----- 167
Query: 696 KGTFAYMDPEFLASGELTPKS--DVYSFGIILLRLLTG 731
GT YM PE + G D +S G++ LLTG
Sbjct: 168 -GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 52/274 (18%)
Query: 536 IGEGGYGSIYKGL---------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 586
+G+G + I+KG+ L +V +K+L F + ++S++ H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 587 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
G C + +V EY+ GSL+ L N +SW ++ +A +L L FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLED-- 118
Query: 645 PHSIVHGDLKPANILL----DANFVS----KLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
+ HG++ N+LL D + KLSD GIS + EI L R
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLER---- 167
Query: 697 GTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTG--RP--ALGITKEVQYALDTGKLK 751
++ PE + L+ +D +SFG L + +G +P AL K++Q+ D +L
Sbjct: 168 --IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLP 225
Query: 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
A W +LANL +C + RP
Sbjct: 226 ------APKW-----TELANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 8e-09
Identities = 32/165 (19%), Positives = 68/165 (41%), Gaps = 19/165 (11%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIES--------IRRAKASESLYAEELK-- 409
+L + + E E E ++ G+ E+ ++ I + S + EL+
Sbjct: 261 SELEKRLEEIEQLLEELNKKIKDLGEEEQLRVKEKIGELEAEIASLERSIAEKERELEDA 320
Query: 410 --RRKEFEEALANGKLE-------LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA 460
R + E + E +E +K+ D++ EE ++ L +++ E D+
Sbjct: 321 EERLAKLEAEIDKLLAEIEELEREIEEERKRRDKLTEEYAELKEELEDLRAELEEVDKEF 380
Query: 461 KELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
E ++ E L+ K+E +EL+ E D+ +E + L + +
Sbjct: 381 AETRDELKDYREKLEKLKREINELKRELDRLQEELQRLSEELADL 425
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 636 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 695
VL+ +H ++H D+K ANILL +N + KL DFG S+ + T C
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC----- 206
Query: 696 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRP 733
GT Y+ PE + K+D++S G++L LLT RP
Sbjct: 207 -GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 42/216 (19%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID-----ILSKIRHPNLV 586
IG+G +G + L + A+K+L ++ E Q I +L ++HP LV
Sbjct: 3 IGKGSFGKVL--LAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLV 59
Query: 587 TLVGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELCSVL 637
L + E V +Y+ G L E + R R A E+ S +
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL----------EPRARFYAAEVASAI 109
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+LHS +I++ DLKP NILLD+ L+DFG+ + E +T C G
Sbjct: 110 GYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFC------G 158
Query: 698 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
T Y+ PE L D + G +L +L G P
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNL 585
+F+ ++G G G ++K + + +A K++H ++ +E+ +L + P +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 586 VTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
V GA E+ ++ E++ GSL+ L P Q +++ + L +L
Sbjct: 66 VGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLR- 120
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
+ H I+H D+KP+NIL+++ KL DFG+S L I S + GT +YM
Sbjct: 121 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSYM 169
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLTGR 732
PE L + +SD++S G+ L+ + GR
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-08
Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 419
+L +A E E EE +A ++ + + A EELKR E E
Sbjct: 354 AELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEE-- 411
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
LER+ ++ +++ EEL+ + L++++ E ++ +ELE+++ + L+ ++
Sbjct: 412 ----RLERLSERLEDLKEELKELEAELEELQTELEELNEELEELEEQLEELRDRLKELER 467
Query: 480 EQDELQMERDKAVKEAEELRK 500
E ELQ E + KE L
Sbjct: 468 ELAELQEELQRLEKELSSLEA 488
|
Length = 1163 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 67/247 (27%), Positives = 100/247 (40%), Gaps = 32/247 (12%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIK--MLHPHSLQGPSEFQQEIDILSKIRH-PNLVTLV 589
KIGEG YG +YK ++ VA+K L P +EI +L + +V L+
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 590 --------GACPEVWTLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 639
P ++ LV+EYL + D + + PL +T +L +
Sbjct: 68 DVEHVEEKNGKPSLY-LVFEYLDSDLKKFMDS-NGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 640 LHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 698
H H ++H DLKP N+L+D + K++D G+ R S + T T
Sbjct: 126 CHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS--------IPVKSYTHEIVT 174
Query: 699 FAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757
Y PE L S + D++S G I + +P E+Q L KL L P
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL--LGTPT 232
Query: 758 AGDWPFV 764
WP V
Sbjct: 233 EQVWPGV 239
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 529 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 579
NF+ +G G YG ++ G L M+V K + + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 580 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 636
IR P LVTL A L+ +Y+ G L LS ++ Q E+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS---GEIVLA 117
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
L LH I++ D+K NILLD+N L+DFG+S+ ++E+ + C
Sbjct: 118 LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFC------ 167
Query: 697 GTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTG 731
GT YM P+ + G+ D +S G+++ LLTG
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 529 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 579
NF+ +G G YG ++ G L M+V K + + E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 580 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCS 635
+R P LVTL A L+ +Y+ G + L +DN + +R + E+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEIIL 116
Query: 636 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTD 694
L LH IV+ D+K NILLD+ L+DFG+S+ FLS+ + + C
Sbjct: 117 ALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK--ERTYSFC---- 167
Query: 695 PKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 731
GT YM PE + K+ D +S GI++ LLTG
Sbjct: 168 --GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 62/246 (25%), Positives = 104/246 (42%), Gaps = 32/246 (13%)
Query: 496 EELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ-- 553
+ L+ +K+ S S+ P+ + + + NF +L G G +G + ++
Sbjct: 5 KNLQLHKKKDSDSTKEPKRKNKMKYEDF-----NFIRTL--GTGSFGRVILATYKNEDFP 57
Query: 554 -VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGS 607
VAIK + + E IL+ I HP V L G+ + LV E++ G
Sbjct: 58 PVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGE 117
Query: 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 667
L P A ++ + +L S +IV+ DLKP N+LLD + K
Sbjct: 118 FFTFLRRNKRFPN---DVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIK 171
Query: 668 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 727
++DFG ++ + + TLC GT Y+ PE L + +D ++ GI +
Sbjct: 172 MTDFGFAKV-----VDTRTYTLC------GTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220
Query: 728 LLTGRP 733
+L G P
Sbjct: 221 ILVGCP 226
|
Length = 340 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 45/165 (27%), Positives = 65/165 (39%), Gaps = 31/165 (18%)
Query: 578 SKIRHPNLVTLVGACPEVWTLVY---EYLPNGSL-----EDRLSCKDNSPPLSWQTRIRI 629
+ RHP LV L AC + V EY G L D S + R
Sbjct: 57 NSERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----------EPRAVF 105
Query: 630 -ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688
A + L +LH + IV+ DLK N+LLD K++DFG+ + +T
Sbjct: 106 YAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTST 160
Query: 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
C GT ++ PE L T D + G+++ +L G
Sbjct: 161 FC------GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 49/145 (33%), Positives = 68/145 (46%), Gaps = 17/145 (11%)
Query: 598 LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 656
V EYL G L + SC P + A E+ L FLHS IV+ DLK
Sbjct: 73 FVMEYLNGGDLMFHIQSCHKFDLPRA----TFYAAEIICGLQFLHS---KGIVYRDLKLD 125
Query: 657 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 716
NILLD + K++DFG+ + +N + T C GT Y+ PE L +
Sbjct: 126 NILLDTDGHIKIADFGMCK---ENMLGDAKTCTFC-----GTPDYIAPEILLGQKYNTSV 177
Query: 717 DVYSFGIILLRLLTGR-PALGITKE 740
D +SFG++L +L G+ P G +E
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEE 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 536 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGPSEFQQ-----EIDILSKIRHPNL 585
+G G +G + +G L R + VAI L G S+ Q+ E L + H N+
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLR----AGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 586 VTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
V L G T+ V EY+ NG+L+ L + + L + + L S + +L
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
VH L +L++++ V K+S F R L +++ + TT+ K +
Sbjct: 127 ---GYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTM----SGKSPVLWAA 176
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLT 730
PE + + SDV+SFGI++ +++
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-08
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 356 DNLYDQLAQAMAEAE--NSRREAFEEALRRGKAEKD-----------AIESIRRAKAS-E 401
+ L +LA E E SR E EE L + E + +ES+ A A +
Sbjct: 719 EELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEALAKLK 778
Query: 402 SLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAK 461
E ++R+ +E L + ELE +++ D + EL+ ++ LE +I E ++ +
Sbjct: 779 EEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELEEEIE 838
Query: 462 ELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
ELE+K+ E L+ +KE +EL+ E ++ E EEL KE
Sbjct: 839 ELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDELKEL 882
|
Length = 1163 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 52/165 (31%), Positives = 74/165 (44%), Gaps = 22/165 (13%)
Query: 573 EIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRI 629
E +L RHP L L + L V EY G L LS + S + R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYG 101
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-- 687
A E+ S L +LHSC +V+ DLK N++LD + K++DFG L + IS T
Sbjct: 102 A-EIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFG----LCKEGISDGATMK 153
Query: 688 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
T C GT Y+ PE L + D + G+++ ++ GR
Sbjct: 154 TFC------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 40/111 (36%), Positives = 54/111 (48%), Gaps = 17/111 (15%)
Query: 624 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683
+ + IA EL L LH + IV+ DLKP NILLDA L DFG LS+ ++
Sbjct: 97 RAKFYIA-ELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFG----LSKANLT 148
Query: 684 SNNT--TLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTG 731
N T T C GT Y+ PE L + T D +S G+++ + G
Sbjct: 149 DNKTTNTFC------GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 536 IGEGGYGSI--YKGLLRHMQVAIK-MLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--V 589
+G G +G + + L VAIK ++ P S ++ +E+ +L +RH N+++L +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 590 GACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
P E V E L G+ RL S PL Q ++ L ++HS +
Sbjct: 78 FISPLEDIYFVTELL--GTDLHRLL---TSRPLEKQFIQYFLYQILRGLKYVHSA---GV 129
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK-----GTFAYMD 703
VH DLKP+NIL++ N K+ DFG++R DP+ T Y
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARI----------------QDPQMTGYVSTRYYRA 173
Query: 704 PE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
PE L + + D++S G I +L G+P
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 536 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL----V 589
IG G +G +Y+ + +VAIK + LQ P +E+ I+ + H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 590 GACPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
C + +V E++P + N+ L + +LC L ++HS
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS- 188
Query: 644 KPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
I H DLKP N+L+D N KL DFG ++ L + S + +C R Y
Sbjct: 189 --KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV--SYICSRF-------YR 237
Query: 703 DPEF-LASGELTPKSDVYSFGIILLRLLTGRP 733
PE L + T D++S G I+ ++ G P
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 11/103 (10%)
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
A E+ L FLH I++ DLK N+LLD + K++DFG+ + +N +
Sbjct: 102 AAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKAST 155
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
C GT Y+ PE L + D +SFG++L +L G+
Sbjct: 156 FC-----GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 32/226 (14%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 588
K+G G YG +YK + + A+K + + + +EI +L +++HPN+++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 65
Query: 589 ---VGACPEVWTLVYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
A +VW L+++Y + ++ + K N P+ R + + L +L +H
Sbjct: 66 VFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQL-PRGMVKSLLYQILDGIHY 123
Query: 643 CKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTL--CCRTDP- 695
+ ++H DLKPANIL+ K++D G +R N+ L DP
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--------NSPLKPLADLDPV 175
Query: 696 KGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRPALGITKE 740
TF Y PE L K+ D+++ G I LLT P +E
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 535 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 588
K+G G YG +YK + + A+K + + + +EI +L +++HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQK 65
Query: 589 ---VGACPEVWTLVYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
+ +VW L+++Y + ++ + K N P+ R + + L +L +H
Sbjct: 66 VFLSHSDRKVW-LLFDYAEHDLWHIIKFHRASKANKKPMQL-PRSMVKSLLYQILDGIHY 123
Query: 643 CKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTL--CCRTDP- 695
+ ++H DLKPANIL+ K++D G +R N+ L DP
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--------NSPLKPLADLDPV 175
Query: 696 KGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRPALGITKE 740
TF Y PE L K+ D+++ G I LLT P +E
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
L ++HS +++H DLKP+N+LL+AN K+ DFG++R + + T+
Sbjct: 121 LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFMTEYV 169
Query: 697 GTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
T Y PE L E T DV+S G I LL +P
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 38/232 (16%)
Query: 536 IGEGGYGSIY------KGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKIRH--- 582
IG GG+G +Y G + M+ IKM QG + E +LS +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----QGETLALNERIMLSLVSTGDC 56
Query: 583 PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
P +V + A P+ + + + + G L LS S A E+ L +
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHM 113
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
H+ +V+ DLKPANILLD + ++SD G++ S+ + ++ GT
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----------VGTHG 160
Query: 701 YMDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKL 750
YM PE L G S D +S G +L +LL G P + ++ +D L
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 11/102 (10%)
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
A E+ S L+FLH I++ DLK N+LLD KL+DFG+ + N ++ +T
Sbjct: 102 AAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STF 156
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 731
C GT Y+ PE L P D ++ G++L +L G
Sbjct: 157 C------GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
A E+ L FLHS I++ DLK N++LD + K++DFG+ + +N N +
Sbjct: 102 AAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRAST 155
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
C GT Y+ PE L + T D +SFG++L +L G+
Sbjct: 156 FC-----GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 535 KIGEGGYG-----SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 589
+IG G +G IY V ++ S + +EF Q+ D ++HPN++ +
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 590 GACPEV--WTLVYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSC 643
G C E + LV+EY G L+ LS + NS L Q R+A E+ + + +H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHK- 117
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGI--SRFLSQNEISSNNTTLCCR-TDPKGTFA 700
H+ +H DL N L ++ K+ D+GI SR+ + ++ + R P+
Sbjct: 118 --HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLL 729
+ L + E T S+V++ G+ L L
Sbjct: 176 FHGG--LITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 57/239 (23%), Positives = 95/239 (39%), Gaps = 75/239 (31%)
Query: 536 IGEGGYGSIYKGLLRH--MQVAIK---MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 590
+G G G ++ + +VA+K + P S++ +EI I+ ++ H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDHDNIVK--- 66
Query: 591 ACPEVWTLVYEYL-PNGSLEDRLSCKDNSPPLSWQTRIRIA--------TELCSV----- 636
VYE L P+GS D + + T + T+L +V
Sbjct: 67 --------VYEVLGPSGS--------DLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP 110
Query: 637 ----------------LIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFL-- 677
L ++HS +++H DLKPAN+ ++ + V K+ DFG++R +
Sbjct: 111 LSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167
Query: 678 --SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRP 733
S S T Y P L S T D+++ G I +LTG+P
Sbjct: 168 HYSHKGYLSEGLV---------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 536 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 588
+G+G +G + L+R A+K+L + E E +L RHP L L
Sbjct: 3 LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 589 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 645
A + V EY G L LS + + R R E+ S L +LHS
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS--- 113
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMD 703
+V+ D+K N++LD + K++DFG L + IS T T C GT Y+
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFC------GTPEYLA 163
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLTGR 732
PE L + D + G+++ ++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 49/225 (21%)
Query: 535 KIGEGGYGSI----YKGLLRHMQVAIK---------MLHPHSLQGPSEFQQEIDILSKIR 581
++G+G YG + VAIK +L +L+ E+ +L R
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-------ELKLLRHFR 59
Query: 582 -HPNLVTLV-------GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLS---WQTRI-RI 629
H N+ L G E++ +YE L L + + PL+ +Q+ I +I
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELY--LYEELMEADLHQIIR---SGQPLTDAHFQSFIYQI 114
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
LC L ++HS +++H DLKP N+L++A+ K+ DFG++R S+N +
Sbjct: 115 ---LCG-LKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM- 166
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRP 733
T+ T Y PE + S + K+ DV+S G IL LL +P
Sbjct: 167 ---TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
A E+ L FLHS I++ DLK N++LDA K++DFG+ + +N T
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRT 160
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
C GT Y+ PE +A D ++FG++L +L G+P
Sbjct: 161 FC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-07
Identities = 33/148 (22%), Positives = 69/148 (46%), Gaps = 5/148 (3%)
Query: 363 AQAMAEAENSRREAFEEALRRGKAEKDAIE-SIRRAK----ASESLYAEELKRRKEFEEA 417
+ E EE + + E + +E + A+ A E +RR+ E+
Sbjct: 770 LEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQE 829
Query: 418 LANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNY 477
+ + E+E ++++ DE+ EEL+ + L+ ++ E + +ELE ++ E +
Sbjct: 830 IEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDELKELEEEKEEL 889
Query: 478 KKEQDELQMERDKAVKEAEELRKSRKEA 505
++E EL+ E + +E E+LR+ +E
Sbjct: 890 EEELRELESELAELKEEIEKLRERLEEL 917
|
Length = 1163 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 588
+G+G +G + L+R A+K+L + E E +L RHP L +L
Sbjct: 3 LGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 589 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 645
+ + V EY+ G L LS + + R R E+ S L +LHS K
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSGK- 115
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMD 703
IV+ DLK N++LD + K++DFG L + I+ T T C GT Y+
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFG----LCKEGITDAATMKTFC------GTPEYLA 163
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLTGR 732
PE L + D + G+++ ++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 536 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVG 590
IG G +G + ++H + A+K+L+ + +E F++E ++L + TL
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 591 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
A + LV +Y G L LS ++ P R IA +++ +HS
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYIA----EMVLAIHSIHQLHY 123
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
VH D+KP N+LLD N +L+DFG ++Q+ ++ + GT Y+ PE L
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-------GTPDYISPEILQ 176
Query: 709 S-----GELTPKSDVYSFGIILLRLLTG 731
+ G+ P+ D +S G+ + +L G
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 50/174 (28%), Positives = 70/174 (40%), Gaps = 33/174 (18%)
Query: 573 EIDILSKIRHPNLVTLVGACPEVW-TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 631
EIDIL I H ++ L+ A W + V +P D + D S PL + I I
Sbjct: 136 EIDILKTISHRAIINLIHAYR--WKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQR 192
Query: 632 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 691
L L +LH I+H D+K NI LD + L DFG + C
Sbjct: 193 RLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA----------------C 233
Query: 692 RTD-----PK-----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 735
+ D P+ GT PE LA K+D++S G++L + L
Sbjct: 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-07
Identities = 35/155 (22%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 419
++L + + E E E + K E + +E R+A E EE E E L
Sbjct: 754 EELQERLEELEEELESLEEALAKL-KEEIEELEEKRQALQEELEELEEELE--EAERRLD 810
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
+ ELE ++++ + + +E++ ++ LE ++ E ++ +ELE+++ E L+ +
Sbjct: 811 ALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEA 870
Query: 480 EQDEL-------QMERDKAVKEAEELRKSRKEASS 507
E++EL + E+++ +E EL E
Sbjct: 871 EKEELEDELKELEEEKEELEEELRELESELAELKE 905
|
Length = 1163 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 45/140 (32%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 636 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 695
+++ L ++H DLK ANI L + KL DFG S+ S + ++ C
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC----- 232
Query: 696 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG-----ITKEVQYA-LD-- 746
GT Y+ PE + K+D++S G+IL LLT RP G I ++V Y D
Sbjct: 233 -GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291
Query: 747 ----TGKLKNLLDPLAGDWP 762
+ +K LLDPL P
Sbjct: 292 PCPVSSGMKALLDPLLSKNP 311
|
Length = 478 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 9e-07
Identities = 33/148 (22%), Positives = 68/148 (45%)
Query: 358 LYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEA 417
L ++L E + E + + E+ E R A E + R +E EE
Sbjct: 686 LEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELAALEEELEQLQSRLEELEEE 745
Query: 418 LANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNY 477
L + ELE ++++ +E+ EEL+ + + L+ +I E ++ + L++++ E L+
Sbjct: 746 LEELEEELEELQERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEA 805
Query: 478 KKEQDELQMERDKAVKEAEELRKSRKEA 505
++ D L+ E + + E L + +E
Sbjct: 806 ERRLDALERELESLEQRRERLEQEIEEL 833
|
Length = 1163 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 9e-07
Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 38/236 (16%)
Query: 528 HNFDPSLKIGEGGYGSIYKGLLRHMQV-----AIKMLHPHSLQGPSEFQQ---EIDILSK 579
+F +G+G G ++ L ++ A+K+L + ++ ++ E +IL+
Sbjct: 1 KHFKKIKLLGKGDVGRVF---LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILAT 57
Query: 580 IRHPNLVTLVG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 637
+ HP L TL LV +Y P G L L + LS + A E+ L
Sbjct: 58 LDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLLAL 116
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS----------------QNE 681
+LH IV+ DLKP NILL + LSDF +S+ +
Sbjct: 117 EYLH-LL--GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 682 ISSNNTTLCCRTDPK-----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
S + T + GT Y+ PE ++ D ++ GI+L +L G
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 16/141 (11%)
Query: 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKPHSIVHGDLKPA 656
LV EY+ G L + + P + R A E+C L FLH I++ DLK
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLP----EEHARFYAAEICIALNFLHE---RGIIYRDLKLD 125
Query: 657 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 716
N+LLDA+ KL+D+G+ + + + T+ C GT Y+ PE L E
Sbjct: 126 NVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFC-----GTPNYIAPEILRGEEYGFSV 177
Query: 717 DVYSFGIILLRLLTGRPALGI 737
D ++ G+++ ++ GR I
Sbjct: 178 DWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-06
Identities = 35/139 (25%), Positives = 69/139 (49%), Gaps = 7/139 (5%)
Query: 371 NSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELK-RRKEFEEALANGKLELERMK 429
E EE L R + E + ++ +A + + EELK +E E L + EL +K
Sbjct: 238 RKELEELEEELSRLEEELEELQE-ELEEAEKEI--EELKSELEELREELEELQEELLELK 294
Query: 430 KQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERD 489
++ +E+ E+ + ++ LE+++ E ++ +EL++KI + E L+ + +EL+
Sbjct: 295 EEIEELEGEISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLA 354
Query: 490 ---KAVKEAEELRKSRKEA 505
+A +E EE + E
Sbjct: 355 ELEEAKEELEEKLSALLEE 373
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-06
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 8/167 (4%)
Query: 339 KEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAK 398
+E+L+S ++ + ++ QA+ E E EEA RR A + +ES+ + +
Sbjct: 764 EEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRR 823
Query: 399 ASESLYAEELK-RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESD 457
EEL+ +E EE L + ELE ++K+ +E+ EEL+ +K LE ++
Sbjct: 824 ERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDEL---- 879
Query: 458 QTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 504
KELE++ E L+ + E EL+ E +K + EEL +
Sbjct: 880 ---KELEEEKEELEEELRELESELAELKEEIEKLRERLEELEAKLER 923
|
Length = 1163 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 20/212 (9%)
Query: 536 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVG 590
+G+GG+G + +R A K L ++ G S E IL K+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 591 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
A + LV + G L+ + N P + + A E+ L LH +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR---ENT 123
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
V+ DLKP NILLD ++SD G++ + + E GT YM PE L
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---------GTVGYMAPEVLN 174
Query: 709 SGELTPKSDVYSFGIILLRLLTGRPALGITKE 740
+ T D + G ++ ++ G+ KE
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
L +LHS I+H D+KP N+L+++N V K+ DFG++R +E T
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-------SKHMTQEV 165
Query: 697 GTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGR 732
T Y PE L S T D++S G I LL R
Sbjct: 166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-06
Identities = 30/142 (21%), Positives = 53/142 (37%), Gaps = 4/142 (2%)
Query: 363 AQAMAEAENSRRE--AFEEAL--RRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 418
Q E+ A EE L + E + + E L +E +E L
Sbjct: 192 GQLSELLEDIEDLLEALEEELKELKKLEEIQEEQEEEELEQEIEALEERLAELEEEKERL 251
Query: 419 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 478
K L ++ E ++ + L + L ++ E + +ELE++I E L+ +
Sbjct: 252 EELKARLLEIESLELEALKIREEELRELERLLEELEEKIERLEELEREIEELEEELEGLR 311
Query: 479 KEQDELQMERDKAVKEAEELRK 500
+EL+ +K E L K
Sbjct: 312 ALLEELEELLEKLKSLEERLEK 333
|
Length = 908 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 11/104 (10%)
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
A E+ L FLHS I++ DLK N++LD+ K++DFG+ + +N T
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKT 160
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
C GT Y+ PE +A D ++FG++L +L G+
Sbjct: 161 FC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 57/225 (25%), Positives = 87/225 (38%), Gaps = 60/225 (26%)
Query: 536 IGEGGYGSIYKGLLRH--MQVAIK-MLHPHSLQGPSEFQQEID---------ILSKIRHP 583
+G G YG + +VAIK + P FQ I +L + H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRP--------FQSAIHAKRTYRELRLLKHMDHE 74
Query: 584 NLVTLVGACPEVWTLVYEYLPNGSLED-------------RLSCKDNSPPLSWQTRIR-I 629
N++ L+ +V+T P SLED L+ LS I+ +
Sbjct: 75 NVIGLL----DVFT------PASSLEDFQDVYLVTHLMGADLNNIVKCQKLS-DDHIQFL 123
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
++ L ++HS I+H DLKP+NI ++ + K+ DFG++R
Sbjct: 124 VYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--------- 171
Query: 690 CCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
T T Y PE L D++S G I+ LLTG+
Sbjct: 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-06
Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF-EEALA 419
+L + E + E+ K+ K+ + S+ EEL+R+ E + LA
Sbjct: 668 ELKELEEELAELEAQ-LEKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELA 726
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
+ ELE+++ + +E+ EEL+ ++ L+ ++ ELE+++ S E L K+
Sbjct: 727 ALEEELEQLQSRLEELEEELEELEEELEELQERLE-------ELEEELESLEEALAKLKE 779
Query: 480 EQDELQMERDKAVKEAEELRKSRKEA 505
E +EL+ +R +E EEL + +EA
Sbjct: 780 EIEELEEKRQALQEELEELEEELEEA 805
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-06
Identities = 39/173 (22%), Positives = 70/173 (40%), Gaps = 25/173 (14%)
Query: 361 QLAQAMAEAENSRR------EAFEEALRRGKAEKDAIESIRR--AKASESLYAEELK--- 409
+L + E E EEA + + K +E +R + E L + +
Sbjct: 240 ELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELREELEELQEELLELKEEIEE 299
Query: 410 ----------RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQT 459
R +E E L + LE +K++ + + EEL+ LE +AE ++
Sbjct: 300 LEGEISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLAELEEA 359
Query: 460 AKELEQK----IISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 508
+ELE+K + EL + ++E EL+ E + E EEL++ +
Sbjct: 360 KEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEER 412
|
Length = 1163 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 536 IGEGGYGSIY---KGLLRHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRH---PNLV 586
IG GG+G +Y K M A+K L + QG + E +LS + P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 587 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
+ A P+ + + + G L LS S + ATE+ L +H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHN-- 115
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
+V+ DLKPANILLD + ++SD G++ S+ + ++ GT YM P
Sbjct: 116 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----------VGTHGYMAP 164
Query: 705 EFLASGELTPKS-DVYSFGIILLRLLTG 731
E L G S D +S G +L +LL G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 536 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVG 590
+G+GG+G + +R A K L ++ G + E IL K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 591 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
A + LV + G L+ + N P Q I A ELC L L I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQR---ERI 123
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
V+ DLKP NILLD ++SD G++ + + E T+ R GT YM PE +
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGE------TVRGRV---GTVGYMAPEVIN 174
Query: 709 SGELTPKSDVYSFGIILLRLLTGRPALGITKE 740
+ + T D + G ++ ++ G+ KE
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 529 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP 583
+ P IG G YG + + +VAIK + PH+ P+ ++ E+ IL +H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 584 NLVTL-------VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 636
N++ + +V+ +V + L L + PL+ + +L
Sbjct: 65 NIIAIRDILRPPGADFKDVY-VVMD-LMESDLHHIIHSDQ---PLTEEHIRYFLYQLLRG 119
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
L ++HS ++H DLKP+N+L++ + ++ DFG++R LS + T+
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM----TEYV 172
Query: 697 GTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPAL 735
T Y PE L S E T D++S G I +L GR L
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 24/112 (21%), Positives = 49/112 (43%), Gaps = 16/112 (14%)
Query: 570 FQQEIDILSKIRH-----PNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQ 624
++E+ IL + P ++ + + L+ E++ +L+ +S +
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWSY-LLMEWIEGETLD----------EVSEE 86
Query: 625 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676
+ IA +L +L LH + HGDL P NIL+D + + D+ + +
Sbjct: 87 EKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 536 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVG 590
IG G +G + L++ A+K+L+ + +E F++E D+L + + TL
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 591 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
A + LV +Y G L LS ++ P R +A ++I + S
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA----EMVIAIDSVHQLHY 123
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
VH D+KP NIL+D N +L+DFG L ++ ++ + GT Y+ PE L
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-------GTPDYISPEILQ 176
Query: 709 S-----GELTPKSDVYSFGIILLRLLTG 731
+ G+ P+ D +S G+ + +L G
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 5e-06
Identities = 28/155 (18%), Positives = 61/155 (39%), Gaps = 11/155 (7%)
Query: 361 QLAQAMAEAEN--SRREAFEEALRRGKAEKDAIESIRRAKASE-----SLYAEELKRRKE 413
+LA+ AE + + E E + + +D + E + E K E
Sbjct: 323 RLAKLEAEIDKLLAEIEELEREIEEERKRRDKLTEEYAELKEELEDLRAELEEVDKEFAE 382
Query: 414 FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKI---ISA 470
+ L + + +LE++K++ +E+ EL ++ L ++A+ + +E KI
Sbjct: 383 TRDELKDYREKLEKLKREINELKRELDRLQEELQRLSEELADLNAAIAGIEAKINELEEE 442
Query: 471 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
E + ++ E ++E+ A E +
Sbjct: 443 KEDKA-LEIKKQEWKLEQLAADLSKYEQELYDLKE 476
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|224495 COG1579, COG1579, Zn-ribbon protein, possibly nucleic acid-binding [General function prediction only] | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 373 RREAFEEALRRGKAEKDAI----ESIRRAKAS--------ESLYAEELKRRKEFEEALAN 420
R + +AL++ KAE +A+ E++ ES E +R K EE L+
Sbjct: 25 RIKEIRKALKKAKAELEALNKALEALEIELEDLENQVSQLESEIQEIRERIKRAEEKLSA 84
Query: 421 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 480
K E E E+QIA ++ + LE ++AE + ++LE++I E L+ +K
Sbjct: 85 VKDERELRALNI-----EIQIAKERINSLEDELAELMEEIEKLEKEIEDLKERLERLEKN 139
Query: 481 QDELQMERDKAVKEAEELRK--SRKEASSSSHMPQ 513
E + ++ V E E + S K +
Sbjct: 140 LAEAEARLEEEVAEIREEGQELSSKREELKEKLDP 174
|
Length = 239 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 582 HPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 637
HP LV L +C V E++ G L + + P + R + E+ L
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLP----EEHARFYSAEISLAL 109
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
FLH I++ DLK N+LLDA KL+D+G+ + + + T+ C G
Sbjct: 110 NFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFC-----G 158
Query: 698 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 737
T Y+ PE L + D ++ G+++ ++ GR I
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 20/212 (9%)
Query: 536 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVG 590
+G+GG+G + +R A K L ++ G + E IL K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 591 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
A + LV + G L+ + N P + + A E+ L LH I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR---ERI 123
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
V+ DLKP NILLD ++SD G++ + + E GT YM PE +
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---------GTVGYMAPEVVK 174
Query: 709 SGELTPKSDVYSFGIILLRLLTGRPALGITKE 740
+ T D + G ++ ++ G+ KE
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-06
Identities = 34/156 (21%), Positives = 72/156 (46%), Gaps = 8/156 (5%)
Query: 357 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEE 416
+L + + E EE + + ++ I + L+ +E E
Sbjct: 263 SLELEALKIREEELRELERLLEELEEKIERLEELEREIEELEEELEGLRALLEELEELLE 322
Query: 417 ALANGKLELERMKKQHDEVMEELQIALDQK----SLLESQIAESDQTAKELEQKIISAVE 472
L + + LE+++++ +++ EL+ ++K LLE ++ E ++ +ELE+++ A+E
Sbjct: 323 KLKSLEERLEKLEEKLEKLESELEELAEEKNELAKLLEERLKELEERLEELEKELEKALE 382
Query: 473 LLQNYKKEQDEL---QMERDKAVKEA-EELRKSRKE 504
L+ ++ EL E A++E EEL + KE
Sbjct: 383 RLKQLEEAIQELKEELAELSAALEEIQEELEELEKE 418
|
Length = 908 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-06
Identities = 43/205 (20%), Positives = 84/205 (40%), Gaps = 27/205 (13%)
Query: 340 EDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESI----- 394
ED +L+ + + + E ++ +E R ++ ++S+
Sbjct: 565 EDRLQELKELLEELRLLRTRKEELEELRERLKELKKKLKELEERLSQLEELLQSLELSEA 624
Query: 395 -RRAKASESLYAEELKRRKE---FEEALANGKLELERMKKQ-HDEVMEELQIALDQKSLL 449
+ +E EL++ EE L ELE ++ E+ ELQ +++ L
Sbjct: 625 ENELEEAEEELESELEKLNLQAELEELLQAALEELEEKVEELEAEIRRELQRIENEEQLE 684
Query: 450 ESQIAESDQTAKELEQ-------------KIISAVELLQNYKKEQDELQMERD---KAVK 493
E ++ E +Q +ELEQ +I +E L++ K E +EL+ E + KA++
Sbjct: 685 E-KLEELEQLEEELEQLREELEELLKKLGEIEQLIEELESRKAELEELKKELEKLEKALE 743
Query: 494 EAEELRKSRKEASSSSHMPQFFSDF 518
EELR+ +A + + +
Sbjct: 744 LLEELREKLGKAGLRADILRNLLAQ 768
|
Length = 908 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (117), Expect = 9e-06
Identities = 35/135 (25%), Positives = 70/135 (51%), Gaps = 12/135 (8%)
Query: 363 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 422
A+ +AE ++A EAL++ E E +++ +A E AEELK+ +E K
Sbjct: 1677 AEEAKKAEEDEKKA-AEALKKEAEEAKKAEELKKKEAEEKKKAEELKKAEEEN------K 1729
Query: 423 LELERMKKQHDE---VMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
++ E KK+ +E EE + ++K + E ++ A+E+ ++ + +E + +
Sbjct: 1730 IKAEEAKKEAEEDKKKAEEAKKDEEEKKKIAHLKKEEEKKAEEIRKEKEAVIE--EELDE 1787
Query: 480 EQDELQMERDKAVKE 494
E ++ +ME DK +K+
Sbjct: 1788 EDEKRRMEVDKKIKD 1802
|
Length = 2084 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-05
Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 16/153 (10%)
Query: 368 EAENSRREAFEEALRRGKAEKDAI---ESIRRAKASESLYAEELKRRKEF---EEALANG 421
+ E RE E L + AE + + + E L R+E E LA
Sbjct: 336 KEELEERETLLEELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEI 395
Query: 422 KLELERMKKQHDEV-------MEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 474
+ ELE +K++ + + E L+ ++ LE+++ E +EL +++ E L
Sbjct: 396 RNELEELKREIESLEERLERLSERLEDLKEELKELEAELEELQTELEELNEELEELEEQL 455
Query: 475 QNYKKEQDELQMERDKAVKEAEELRKSRKEASS 507
+ + EL+ E + EEL++ KE SS
Sbjct: 456 EELRDRLKELERELAEL---QEELQRLEKELSS 485
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-05
Identities = 32/149 (21%), Positives = 59/149 (39%), Gaps = 8/149 (5%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 420
+L + + E E E ++ E + K EEL+ R+ E
Sbjct: 292 ELKEEIEELEGEISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLE---- 347
Query: 421 GKLELERMKKQHDEVMEELQIALD-QKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
ELE++ + +E EEL+ L LE + ELE ++ L+ K+
Sbjct: 348 ---ELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKR 404
Query: 480 EQDELQMERDKAVKEAEELRKSRKEASSS 508
E + L+ ++ + E+L++ KE +
Sbjct: 405 EIESLEERLERLSERLEDLKEELKELEAE 433
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-05
Identities = 36/151 (23%), Positives = 73/151 (48%), Gaps = 8/151 (5%)
Query: 357 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRR----AKASESLYAEELKRRK 412
L ++LA+ A+ E E + ++ +D +E +RR + EL +
Sbjct: 671 ELEEELAELEAQLE-KLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELAALE 729
Query: 413 EFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVE 472
E E L + ELE ++ +E +EELQ L++ LE ++ ++ +L+++I E
Sbjct: 730 EELEQLQSRLEELEEELEELEEELEELQERLEE---LEEELESLEEALAKLKEEIEELEE 786
Query: 473 LLQNYKKEQDELQMERDKAVKEAEELRKSRK 503
Q ++E +EL+ E ++A + + L + +
Sbjct: 787 KRQALQEELEELEEELEEAERRLDALERELE 817
|
Length = 1163 |
| >gnl|CDD|224259 COG1340, COG1340, Uncharacterized archaeal coiled-coil protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 29/158 (18%), Positives = 65/158 (41%), Gaps = 5/158 (3%)
Query: 356 DNLYDQLAQAMAEAENSRREAFEEALRRG--KAEKDAIESIRRAKASESLYAEELKRRKE 413
D + +L + E + + E L K+ + IE + + + + L EE + +
Sbjct: 79 DEINAKLQELRKEYRELKEKRNEFNLGGRSIKSLEREIERLEKKQQTSVLTPEEERELVQ 138
Query: 414 FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLES---QIAESDQTAKELEQKIISA 470
+ L + ++ ++++++ E + K +I E A+E +++I
Sbjct: 139 KIKELRKELEDAKKALEENEKLKELKAEIDELKKKAREIHEKIQELANEAQEYHEEMIKL 198
Query: 471 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 508
E +KE DEL E + K+ +EL + + +
Sbjct: 199 FEEADELRKEADELHEEFVELSKKIDELHEEFRNLQNE 236
|
Length = 294 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-05
Identities = 38/158 (24%), Positives = 63/158 (39%), Gaps = 9/158 (5%)
Query: 356 DNLYDQLAQAMAEAEN-SRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF 414
L LA+ AE E R A + R +A E L AE +E
Sbjct: 729 SALRKDLARLEAEVEQLEERIAQLSKELTELEAEIEELEERLEEAEEEL-AEAEAEIEEL 787
Query: 415 EEALANGKLELERMKKQHDEVMEE---LQIALDQKSL----LESQIAESDQTAKELEQKI 467
E + K EL+ +++ DE+ E L LE +IA +++ ++LE++I
Sbjct: 788 EAQIEQLKEELKALREALDELRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQI 847
Query: 468 ISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
E +++ E +EL+ ++ E E L R
Sbjct: 848 EELSEDIESLAAEIEELEELIEELESELEALLNERASL 885
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 22/136 (16%), Positives = 49/136 (36%), Gaps = 7/136 (5%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 420
L + AE EA R E+ + RR + E E + + +
Sbjct: 804 ALDELRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQIEELSEDIESLAAEIEE 863
Query: 421 GKLELERMKKQHDEVMEE-------LQIALDQKSLLESQIAESDQTAKELEQKIISAVEL 473
+ +E ++ + + ++ E L + + L ++ E + EL +++ E
Sbjct: 864 LEELIEELESELEALLNERASLEEALALLRSELEELSEELRELESKRSELRRELEELREK 923
Query: 474 LQNYKKEQDELQMERD 489
L + + L++ D
Sbjct: 924 LAQLELRLEGLEVRID 939
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 368 EAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR-KEFEEA------LAN 420
E + E+ L + E + ES+ EEL+ R KE E L +
Sbjct: 552 EELKKKLAELEKKLDELEEELAELLKELEELGFESV--EELEERLKELEPFYNEYLELKD 609
Query: 421 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 480
+ ELER +K+ ++ EEL A ++ + E ++ E + +ELE+K + E + ++E
Sbjct: 610 AEKELEREEKELKKLEEELDKAFEELAETEKRLEELRKELEELEKKY--SEEEYEELREE 667
Query: 481 QDELQMERDKAVKEAEELRKSRKEASSS 508
EL E E EEL K R+E +
Sbjct: 668 YLELSRELAGLRAELEELEKRREEIKKT 695
|
Length = 880 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 13/123 (10%)
Query: 610 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 669
R + + SP LS+ + + ++ + + FL S + VH DL N+L+ + K+
Sbjct: 225 RRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKIC 281
Query: 670 DFGISRFL--SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 727
DFG++R + N IS +T L +M PE + + T SDV+SFGI+L
Sbjct: 282 DFGLARDIMRDSNYISKGSTFL--------PLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 728 LLT 730
+ T
Sbjct: 334 IFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-05
Identities = 36/179 (20%), Positives = 75/179 (41%), Gaps = 34/179 (18%)
Query: 360 DQLAQAMAEAENSRREAFEE------ALRRGKAEKDA----IESIRRAKAS-ESLYAEEL 408
++L Q + E E E E+ L + E + +E + K E E
Sbjct: 824 ERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDELKELE 883
Query: 409 KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA-------- 460
+ ++E EE L + EL +K++ +++ E L+ + LE ++ E ++
Sbjct: 884 EEKEELEEELRELESELAELKEEIEKLRERLEELEAKLERLEVELPELEEELEEEYEDTL 943
Query: 461 -KELEQKI--------------ISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 504
ELE++I + A+E + ++ +EL+ +R+ + E+L + +E
Sbjct: 944 ETELEREIERLEEEIEALGPVNLRAIEEYEEVEERYEELKSQREDLEEAKEKLLEVIEE 1002
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-05
Identities = 38/181 (20%), Positives = 72/181 (39%), Gaps = 28/181 (15%)
Query: 356 DNLYDQLAQAMAEAENSRRE------AFEEALRRGKAEKDAIESIRRAKASESLYAEEL- 408
+L D L + + E R+ + + +E + EEL
Sbjct: 698 RSLEDLLEELRRQLEELERQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQ 757
Query: 409 KRRKEFEEAL-------ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE------ 455
+R +E EE L A K E+E ++++ + EEL+ ++ E ++
Sbjct: 758 ERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELE 817
Query: 456 --------SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 507
+Q +ELE++I E L ++E +EL+ E ++ +E EEL ++E
Sbjct: 818 SLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELED 877
Query: 508 S 508
Sbjct: 878 E 878
|
Length = 1163 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
A E+ L FLH I++ DLK N++LD+ K++DFG+ + ++ + T
Sbjct: 107 AAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRT 160
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
C GT Y+ PE +A D +++G++L +L G+P
Sbjct: 161 FC-----GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 17/132 (12%)
Query: 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 658
+Y ++ + + + KD PL QTR I +L + ++H K ++H D+K NI
Sbjct: 249 LYSFMYDEAFD----WKDR--PLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENI 298
Query: 659 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDV 718
L+ + L DFG + + + + + GT A PE LA +D+
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-------GTVATNSPEILAGDGYCEITDI 351
Query: 719 YSFGIILLRLLT 730
+S G+ILL +L+
Sbjct: 352 WSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 12/114 (10%)
Query: 627 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686
I + ++ ++ LHS IV+ D+KP N+LLD +LSD G++ E+
Sbjct: 98 IHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAV-----ELKDGK 149
Query: 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 740
T T GT YM PE L + D ++ G + ++ GR KE
Sbjct: 150 TI----TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-05
Identities = 33/166 (19%), Positives = 73/166 (43%), Gaps = 17/166 (10%)
Query: 356 DNLYDQLAQAMAEAENS------RREAFEEALRRGKAE----KDAIESIRRAKASESLYA 405
+N D+L+Q +++A E E+ + K ++ + S+ + +
Sbjct: 701 ENRLDELSQELSDASRKIGEIEKEIEQLEQEEEKLKERLEELEEDLSSLEQEIENVKSEL 760
Query: 406 EEL-KRRKEFEEALANGKLEL---ERMKKQH--DEVMEELQIALDQKSLLESQIAESDQT 459
+EL R +E EE L + L E E+ EL ++ S +E+++ E +Q
Sbjct: 761 KELEARIEELEEDLHKLEEALNDLEARLSHSRIPEIQAELSKLEEEVSRIEARLREIEQK 820
Query: 460 AKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
L + + +Q ++++ +L+ E+ K++++ E +KE
Sbjct: 821 LNRLTLEKEYLEKEIQELQEQRIDLK-EQIKSIEKEIENLNGKKEE 865
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-05
Identities = 34/154 (22%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 360 DQLAQAMAE-----AENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF 414
++L + E AE EA E L E + + L + E
Sbjct: 344 EKLEELKEELESLEAELEELEAELEELESRLEELEE-QLETLRSKVAQLELQIASLNNEI 402
Query: 415 EEALANGKLE-LERMKKQHDEVMEELQIALD--QKSLLESQIAESDQTAKELEQKIISAV 471
E A +LE LE +++ + +EEL L+ + L++++ E ++ +EL++++
Sbjct: 403 ERLEA--RLERLEDRRERLQQEIEELLKKLEEAELKELQAELEELEEELEELQEELERLE 460
Query: 472 ELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
E L+ ++E +E + D A +E +L+ +R ++
Sbjct: 461 EALEELREELEEAEQALDAAERELAQLQ-ARLDS 493
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
A E+C L LH IV+ DLKP NILLD + ++SD G++ + + + T+
Sbjct: 108 AAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ------TI 158
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
R GT YM PE + + T D ++ G +L ++ G+
Sbjct: 159 KGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|224755 COG1842, PspA, Phage shock protein A (IM30), suppresses sigma54-dependent transcription [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 38/155 (24%), Positives = 74/155 (47%), Gaps = 24/155 (15%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 419
+LA+A R+A +A+ R K + +E + AE+L+ + E AL
Sbjct: 38 SELAKA--------RQALAQAIARQKQLERKLEEAQA-------RAEKLEEKA--ELALQ 80
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
G +L R E +EE Q D LE+++ ++++ ++L++++ + + + +
Sbjct: 81 AGNEDLAR------EALEEKQSLEDLAKALEAELQQAEEQVEKLKKQLAALEQKIAELRA 134
Query: 480 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF 514
+++ L R A K E++ +S SSSS M F
Sbjct: 135 KKEAL-KARKAAAKAQEKVNRSLGGGSSSSAMAAF 168
|
Length = 225 |
| >gnl|CDD|217843 pfam04012, PspA_IM30, PspA/IM30 family | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 37/155 (23%), Positives = 58/155 (37%), Gaps = 31/155 (20%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 419
LAQ +A + R+ E+ + K E A ++ K +E L E L E+
Sbjct: 44 QALAQVIARQKQLERKLEEQKEQAKKLENKARAALT--KGNEELAREALAEIATLEKQAE 101
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
+ + + + A++Q L Q+A LE KI Q K
Sbjct: 102 -----------ALETQLTQQRSAVEQ---LRKQLA-------ALETKI-------QQLKA 133
Query: 480 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF 514
++ L+ R KA K E + S AS+ S F
Sbjct: 134 KKTALKA-RLKAAKAQEAVNTSLGSASTESATDSF 167
|
This family includes PspA a protein that suppresses sigma54-dependent transcription. The PspA protein, a negative regulator of the Escherichia coli phage shock psp operon, is produced when virulence factors are exported through secretins in many Gram-negative pathogenic bacteria and its homologue in plants, VIPP1, plays a critical role in thylakoid biogenesis, essential for photosynthesis. Activation of transcription by the enhancer-dependent bacterial sigma(54) containing RNA polymerase occurs through ATP hydrolysis-driven protein conformational changes enabled by activator proteins that belong to the large AAA(+) mechanochemical protein family. It has been shown that PspA directly and specifically acts upon and binds to the AAA(+) domain of the PspF transcription activator. Length = 220 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 25/119 (21%), Positives = 41/119 (34%), Gaps = 20/119 (16%)
Query: 46 KIYVAVAKQVKESKSVLLWALQN--SGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKV 103
+I VAV +ES+ L WA + G + ++HV P
Sbjct: 1 RILVAVDGS-EESERALRWAARLARRLGAELVLLHVVDPPPSSAA--------------- 44
Query: 104 QAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGA 162
E+ ++ L+ + GV+ E + ILE G +VMG+
Sbjct: 45 -ELAELLEEEARALLEALREALAEAGVKVE-TVVLEGDPAEAILEAAEELGADLIVMGS 101
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-05
Identities = 43/186 (23%), Positives = 73/186 (39%), Gaps = 49/186 (26%)
Query: 360 DQLAQAMAEAENSRREAFEEAL-------RRGKAEK--------------------DAIE 392
+++ A E RR+ EEA R+ +AE+ +E
Sbjct: 147 EEIINAKPEE---RRKLIEEAAGVSKYKERKEEAERKLERTEENLERLEDLLEELEKQLE 203
Query: 393 SIRRAKASESLYAEELKRRKEFEEALANGKL------------ELERMKKQHDEVMEELQ 440
+ R Y E +E E AL KL EL R++++ +E+ EEL+
Sbjct: 204 KLERQAEKAERYQELKAELRELELALLLAKLKELRKELEELEEELSRLEEELEELQEELE 263
Query: 441 IALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 500
A + L+S++ +EL +++ E L K+E +EL+ E + EEL
Sbjct: 264 EAEKEIEELKSEL-------EELREELEELQEELLELKEEIEELEGEISLLRERLEELEN 316
Query: 501 SRKEAS 506
+E
Sbjct: 317 ELEELE 322
|
Length = 1163 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-05
Identities = 31/145 (21%), Positives = 64/145 (44%), Gaps = 11/145 (7%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 419
+ L + +AE E + E R + E +E+++ + L+ +E
Sbjct: 235 EALEERLAELEEEKERLEELKARLLEIESLELEALKIREEELRELERLLEELEE------ 288
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
++ER+++ E+ E + ++LLE ++ K LE+++ E L+ +
Sbjct: 289 ----KIERLEELEREIEELEEELEGLRALLEELEELLEKL-KSLEERLEKLEEKLEKLES 343
Query: 480 EQDELQMERDKAVKEAEELRKSRKE 504
E +EL E+++ K EE K +E
Sbjct: 344 ELEELAEEKNELAKLLEERLKELEE 368
|
Length = 908 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-05
Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 17/172 (9%)
Query: 350 LDGSVDDNLYDQLAQAMA-EAENSRREAFEEALR----RGKAEKDAIESIRRA----KAS 400
L S D +D A EA EEA + + + + A E+ ++A KA
Sbjct: 1072 LKPSYKDFDFDAKEDNRADEATEEAFGKAEEAKKTETGKAEEARKAEEAKKKAEDARKAE 1131
Query: 401 ESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA 460
E+ AE+ ++ +E +A ++E+ R K + EE + A D K ++ AE + A
Sbjct: 1132 EARKAEDARKAEEARKAEDAKRVEIAR-KAEDARKAEEARKAEDAKKAEAARKAEEVRKA 1190
Query: 461 KEL----EQKIISAVELLQNYKKEQDELQMERDK---AVKEAEELRKSRKEA 505
+EL + + A + +K ++ + E K AVK+AEE +K +EA
Sbjct: 1191 EELRKAEDARKAEAARKAEEERKAEEARKAEDAKKAEAVKKAEEAKKDAEEA 1242
|
Length = 2084 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-05
Identities = 30/134 (22%), Positives = 57/134 (42%), Gaps = 9/134 (6%)
Query: 373 RREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQH 432
R E E L + E E +E +E EE L +LE+ ++++
Sbjct: 233 RLEELREELEELQEELKEAEEELEELTAEL---------QELEEKLEELRLEVSELEEEI 283
Query: 433 DEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAV 492
+E+ +EL ++ S LE Q + LE+++ L+ + + DEL E +
Sbjct: 284 EELQKELYALANEISRLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELE 343
Query: 493 KEAEELRKSRKEAS 506
++ EEL++ +
Sbjct: 344 EKLEELKEELESLE 357
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|206039 pfam13868, Trichoplein, Tumour suppressor, Mitostatin | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 4e-05
Identities = 38/161 (23%), Positives = 78/161 (48%), Gaps = 20/161 (12%)
Query: 358 LYDQLAQAMAEAENSRREAFEEALRRGKAEKDAI-ESIRRAKASESLYAEELKRRK---- 412
L + + E E R+E +EE L+ E++ + E I R + + A+E + ++
Sbjct: 72 GRAVLQEQIEEREKRRQEEYEERLQ----EREQMDEIIERIQEEDEAEAQEKREKQKKLR 127
Query: 413 -EFEEALANGKLELERMKKQHDEVMEELQIA------LDQKSLLESQIAESDQTAKELEQ 465
E +E ++E + +K+ + EEL+I +++ E++ E + KE E
Sbjct: 128 EEIDEFNEE-RIERKEEEKERER-EEELKILEYQREKAEREEEREAERRERKE-EKEREV 184
Query: 466 KIISA-VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
+ A E ++ ++E DEL+ + + E +E +K ++EA
Sbjct: 185 ARLRAQQEEAEDEREELDELRADLYQEEYERKERQKEKEEA 225
|
Trichoplein or mitostatin, was first defined as a meiosis-specific nuclear structural protein. It has since been linked with mitochondrial movement. It is associated with the mitochondrial outer membrane, and over-expression leads to reduction in mitochondrial motility whereas lack of it enhances mitochondrial movement. The activity appears to be mediated through binding the mitochondria to the actin intermediate filaments (IFs). Length = 349 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 33/136 (24%), Positives = 55/136 (40%), Gaps = 19/136 (13%)
Query: 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 661
+ R+ CK N + I ++ + L ++H H I HGD+KP NI++D
Sbjct: 110 VENTKEIFKRIKCK-NKKLIK-----NIMKDMLTTLEYIHE---HGISHGDIKPENIMVD 160
Query: 662 ANFVSKLSDFGISRFLSQN----EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 717
N + D+GI+ + E S L +GT Y + +T + D
Sbjct: 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDL-----HRGTLYYAGLDAHNGACVTRRGD 215
Query: 718 VYSFGIILLRLLTGRP 733
+ S G +L+ G
Sbjct: 216 LESLGYCMLK-WAGIK 230
|
Length = 294 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 536 IGEGGYGSIYKGLLRHM-QV-AIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVG 590
IG G +G + +++ QV A+K+L+ + +E F++E D+L + L
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68
Query: 591 ACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
A LV +Y G L LS ++ P R +A +++ + S
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA----EMVLAIDSVHQLGY 123
Query: 649 VHGDLKPANILLDANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
VH D+KP N+LLD N +L+DFG R L+ + SN GT Y+ PE L
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV--------GTPDYISPEIL 175
Query: 708 -----ASGELTPKSDVYSFGIILLRLLTG 731
G P+ D +S G+ + +L G
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 536 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVG 590
+G+GG+G + +R A K L+ L+ ++ E IL+K+ +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 591 ACPEVWT---LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
A + T LV + G L + + + +P ++ S L LH
Sbjct: 61 AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---R 116
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
I++ DLKP N+LLD + ++SD G++ L + + GT +M PE
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--------GTPGFMAPEL 168
Query: 707 LASGELTPKSDVYSFGIILLRLLTGR 732
L E D ++ G+ L ++ R
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-05
Identities = 31/149 (20%), Positives = 67/149 (44%), Gaps = 4/149 (2%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 420
+++ E E E R + ++ + E+L E + E EEA
Sbjct: 303 EISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLAELEEAKEE 362
Query: 421 GKLELERMKKQHDEVMEELQIALD----QKSLLESQIAESDQTAKELEQKIISAVELLQN 476
+ +L + ++ +E+ E L+ L + + + +++ E + + LE+++ E L++
Sbjct: 363 LEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEERLERLSERLED 422
Query: 477 YKKEQDELQMERDKAVKEAEELRKSRKEA 505
K+E EL+ E ++ E EEL + +E
Sbjct: 423 LKEELKELEAELEELQTELEELNEELEEL 451
|
Length = 1163 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (110), Expect = 6e-05
Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 21/152 (13%)
Query: 363 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRA-----KASESLYAEELKRRKE---F 414
A+A +AE R+ EEA + A+K E++++A A E+ AEE + +E F
Sbjct: 1202 AEAARKAEEERK--AEEARKAEDAKK--AEAVKKAEEAKKDAEEAKKAEEERNNEEIRKF 1257
Query: 415 EEA-LANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVEL 473
EEA +A+ +K + +EL+ A ++K E++ AE + A E ++K A E
Sbjct: 1258 EEARMAHFARRQAAIKAEEARKADELKKAEEKKKADEAKKAEEKKKADEAKKK---AEE- 1313
Query: 474 LQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
K+ DE + + ++A K+A+ +K +EA
Sbjct: 1314 ----AKKADEAKKKAEEAKKKADAAKKKAEEA 1341
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (110), Expect = 6e-05
Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 7/148 (4%)
Query: 364 QAMAEAENSRR-EAFEEALRRGKAEK-DAIESIRRA-----KASESLYAEELKRRKEFEE 416
QA +AE +R+ + ++A + KA++ E ++A KA E+ A+E K++ E +
Sbjct: 1269 QAAIKAEEARKADELKKAEEKKKADEAKKAEEKKKADEAKKKAEEAKKADEAKKKAEEAK 1328
Query: 417 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 476
A+ + K+ E + A ++ + AE+ + KE +K A +
Sbjct: 1329 KKADAAKKKAEEAKKAAEAAKAEAEAAADEAEAAEEKAEAAEKKKEEAKKKADAAKKKAE 1388
Query: 477 YKKEQDELQMERDKAVKEAEELRKSRKE 504
KK+ DE + + ++ K+A+EL+K+
Sbjct: 1389 EKKKADEAKKKAEEDKKKADELKKAAAA 1416
|
Length = 2084 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 21/165 (12%)
Query: 573 EIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI- 629
E +L RHP L L + + V EY G L LS ++ + + R R
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RER---VFSEDRARFY 100
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-- 687
E+ S L +LHS K ++V+ DLK N++LD + K++DFG L + I T
Sbjct: 101 GAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGATMK 154
Query: 688 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
T C GT Y+ PE L + D + G+++ ++ GR
Sbjct: 155 TFC------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 7e-05
Identities = 37/155 (23%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 363 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 422
A+ + +AE +++ E+ ++ EK E +++A+ + A E ++ E ++ A
Sbjct: 1622 AEELKKAEEEKKKV-EQLKKKEAEEKKKAEELKKAEEENKIKAAEEAKKAEEDKKKAEEA 1680
Query: 423 LELERMKKQHDEVM----EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 478
+ E +K+ E + EE + A + K + ++++ K E+ I A E K
Sbjct: 1681 KKAEEDEKKAAEALKKEAEEAKKAEELKKKEAEEKKKAEELKKAEEENKIKAEEA----K 1736
Query: 479 KEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQ 513
KE +E DK K+AEE +K +E +H+ +
Sbjct: 1737 KEAEE-----DK--KKAEEAKKDEEEKKKIAHLKK 1764
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 7e-05
Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 355 DDNLYDQLAQAMAEAENSRRE---AFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR 411
D N+ + A+ +AE +R E E ++ KAE+ + KA E AEE K++
Sbjct: 1575 DKNMALRKAEEAKKAEEARIEEVMKLYEEEKKMKAEEAKKAEEAKIKAEELKKAEEEKKK 1634
Query: 412 KE-FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISA 470
E ++ A K + E +KK +E + +K+ + + AE + A+E E+K A
Sbjct: 1635 VEQLKKKEAEEKKKAEELKKAEEENKIKAA-EEAKKAEEDKKKAEEAKKAEEDEKKAAEA 1693
Query: 471 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 504
++ K+ +EL+ + + K+AEEL+K+ +E
Sbjct: 1694 LKKEAEEAKKAEELKKKEAEEKKKAEELKKAEEE 1727
|
Length = 2084 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 32/173 (18%)
Query: 573 EIDILSKIRHPNLVTLVGA-------C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLS 622
E IL I HP+++ L G C P T +Y YL + + ++ D
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYL---AAKRNIAICD------ 183
Query: 623 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682
+ I + + +LH + I+H D+K NI ++ L DFG + F +I
Sbjct: 184 ---ILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACF--PVDI 235
Query: 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 735
++N GT A PE LA P D++S GI+L + T +L
Sbjct: 236 NANKYY-----GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 9/92 (9%)
Query: 639 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 698
FL S K +H DL NILL N V K+ DFG++R + ++ D +
Sbjct: 188 FLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK------GDARLP 238
Query: 699 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730
+M PE + T +SDV+SFG++L + +
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|221432 pfam12128, DUF3584, Protein of unknown function (DUF3584) | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 9e-05
Identities = 39/184 (21%), Positives = 76/184 (41%), Gaps = 43/184 (23%)
Query: 341 DLQSSPPSVLDGSVDDNLYD-QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKA 399
DL P +++GS D LY L + + A E LR R +A
Sbjct: 569 DLD---PQLVEGSDSDTLYGVSLDLQRLDVPDY--AANETELRE-----------RLQQA 612
Query: 400 SESLYAEELKRRKEFEEALA---------------------NGKLELERMKKQHDEVMEE 438
E+L + ++K+ EE L +L+L+R++ + + ++
Sbjct: 613 EEALQSAV-AKQKQAEEQLVQANAELEEQKRAEAEARTALKQARLDLQRLQNEQQSLKDK 671
Query: 439 LQIAL-DQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEE 497
L++A+ ++K E+Q+ + D K+L ++ + L+ K + EL+ ER + E
Sbjct: 672 LELAIAERKQQAETQLRQLDAQLKQLLEQQQAF---LEALKDDFRELRTERLAKWQVVEG 728
Query: 498 LRKS 501
+
Sbjct: 729 ELDN 732
|
This protein is found in bacteria and eukaryotes. Proteins in this family are typically between 943 to 1234 amino acids in length. This family contains a P-loop motif suggesting it is a nucleotide binding protein. It may be involved in replication. Length = 1198 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-04
Identities = 30/138 (21%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 373 RREAFEEALRRGKAE--KDAIESIRRAKAS-ESLYAEELKRRKEFEEALANGKLELERMK 429
E AL K + + +E + + E E + +E E+ + K ELE ++
Sbjct: 221 ELRELELALLLAKLKELRKELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELR 280
Query: 430 KQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERD 489
++ +E+ EEL ++ LE +I+ + +ELE + L+ ++ +EL+ + +
Sbjct: 281 EELEELQEELLELKEEIEELEGEISLLRERLEELENE-------LEELEERLEELKEKIE 333
Query: 490 KAVKEAEELRKSRKEASS 507
+E EE +E
Sbjct: 334 ALKEELEERETLLEELEQ 351
|
Length = 1163 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-04
Identities = 33/143 (23%), Positives = 60/143 (41%), Gaps = 2/143 (1%)
Query: 368 EAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELER 427
E E +E L+ + E + + + E E E EE + + EL
Sbjct: 235 EELREELEELQEELKEAEEELEELT--AELQELEEKLEELRLEVSELEEEIEELQKELYA 292
Query: 428 MKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQME 487
+ + + ++ QI ++ + LE Q+ E + +ELE K+ E L +++ +EL+ E
Sbjct: 293 LANEISRLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEE 352
Query: 488 RDKAVKEAEELRKSRKEASSSSH 510
+ E EEL +E S
Sbjct: 353 LESLEAELEELEAELEELESRLE 375
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 33/165 (20%), Positives = 69/165 (41%), Gaps = 14/165 (8%)
Query: 357 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEE 416
L +++AQ E E E R +AE++ E+ + E+ + + K E
Sbjct: 744 QLEERIAQLSKELTELEAEIEELEERLEEAEEELAEAEAEIEELEAQIEQLKEELKALRE 803
Query: 417 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 476
AL + EL + ++ + E L+ + + E ++ + ++ +EL + I S ++
Sbjct: 804 ALDELRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQIEELSEDIESLAAEIEE 863
Query: 477 YKKEQDELQMERDKAVKE--------------AEELRKSRKEASS 507
++ +EL+ E + + E EEL + +E S
Sbjct: 864 LEELIEELESELEALLNERASLEEALALLRSELEELSEELRELES 908
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|237177 PRK12704, PRK12704, phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (109), Expect = 1e-04
Identities = 27/117 (23%), Positives = 60/117 (51%), Gaps = 7/117 (5%)
Query: 385 KAEKDAIESIRRAKASESLYAEELKRRKEFE--EALANGKLELERMKKQHDEVMEELQIA 442
+AE++A + AK AE +K+ E E + + E E+ ++ +++L+
Sbjct: 35 EAEEEAKRILEEAKKE----AEAIKKEALLEAKEEIHKLRNEFEKELRERRNELQKLEKR 90
Query: 443 LDQK-SLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 498
L QK L+ ++ ++ +ELE+K + Q +K+++EL+ ++ ++E E +
Sbjct: 91 LLQKEENLDRKLELLEKREEELEKKEKELEQKQQELEKKEEELEELIEEQLQELERI 147
|
Length = 520 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 44/163 (26%), Positives = 63/163 (38%), Gaps = 33/163 (20%)
Query: 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 657
L+ E+LP G + L KD +T+ IA + ++ S +H D+KP N
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLT--EEETQFYIAETVLAI----DSIHQLGFIHRDIKPDN 131
Query: 658 ILLDANFVSKLSDFGI---------------------SRFLSQNEISSNNTTLCCRTDPK 696
+LLD+ KLSDFG+ S F QN S R +
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 697 ------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT Y+ PE D +S G+I+ +L G P
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 33/164 (20%)
Query: 576 ILSKIRHPNLV----TLVG---AC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQT 625
+L + HP+++ TLV C P + +Y YL S PL
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTK-----------RSRPLPIDQ 158
Query: 626 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685
+ I ++ L +LH+ I+H D+K NI ++ + D G ++F ++
Sbjct: 159 ALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPA 212
Query: 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 729
L GT PE LA + K+D++S GI+L +L
Sbjct: 213 FLGLA------GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 40/142 (28%), Positives = 67/142 (47%), Gaps = 16/142 (11%)
Query: 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 659
Y+ + +++ LS D S L+ + ++ + FL S + VH DL N+L
Sbjct: 214 YKGSNDSEVKNLLS-DDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVL 269
Query: 660 LDANFVSKLSDFGISRFL--SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 717
L + K+ DFG++R + N +S +T L + +M PE + T SD
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK--------WMAPESIFDNLYTTLSD 321
Query: 718 VYSFGIILLRL--LTGRPALGI 737
V+S+GI+L + L G P G+
Sbjct: 322 VWSYGILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 48/221 (21%)
Query: 534 LKIGEGGYGSIYKGLLRHM--QVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLV 589
++G G YG++ L R +VAIK L+ S +E+ +L ++H N++ L+
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 590 GACPEVWT------------LVYEYLPN--GSL--EDRLSCKDNSPPLSWQTRIR-IATE 632
+V+T LV ++ G L ++LS + RI+ + +
Sbjct: 81 ----DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS----------EDRIQFLVYQ 126
Query: 633 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 692
+ L ++H+ I+H DLKP N+ ++ + K+ DFG++R + +E++ T R
Sbjct: 127 MLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEMTGYVVTRWYR 182
Query: 693 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
P+ +M T D++S G I+ +LTG+P
Sbjct: 183 A-PEVILNWM--------HYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|220369 pfam09731, Mitofilin, Mitochondrial inner membrane protein | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 45/192 (23%), Positives = 82/192 (42%), Gaps = 28/192 (14%)
Query: 337 PSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRR 396
P ++L S ++D +DNL D L +A A+ + ++ E++ +E +
Sbjct: 136 PVVQELVSIFNDLIDSIKEDNLKDDLESLIASAKEELDQLSKKLAELKAEEEEELERALK 195
Query: 397 AKASESL--YAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIA 454
K E L EEL R E +EA ++++ + + EEL+ ++K L ++
Sbjct: 196 EKREELLSKLEEELLARLESKEAA-----LEKQLRLEFEREKEELRKKYEEK--LRQELE 248
Query: 455 E-----SDQTAKELEQKIISAVELLQNYKKEQDE-LQMERD----------KAVKEAEEL 498
+ EL + A+EL + + KE E ++ ER+ +K E+
Sbjct: 249 RQAEAHEQKLKNELALQ---AIELQREFNKEIKEKVEEERNGRLAKLAELNSRLKGLEKA 305
Query: 499 RKSRKEASSSSH 510
SR EA +H
Sbjct: 306 LDSRSEAEDENH 317
|
Mitofilin controls mitochondrial cristae morphology. Mitofilin is enriched in the narrow space between the inner boundary and the outer membranes, where it forms a homotypic interaction and assembles into a large multimeric protein complex. The first 78 amino acids contain a typical amino-terminal-cleavable mitochondrial presequence rich in positive-charged and hydroxylated residues and a membrane anchor domain. In addition, it has three centrally located coiled coil domains. Length = 493 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 39/211 (18%)
Query: 532 PSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HP 583
LK+ +G +G + +L+H +Q IK + +++ E + ++ +P
Sbjct: 20 KKLKLIDGKFGKVS--VLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNP 69
Query: 584 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
N + L + + L+ +Y+ +G L D L LS +I +L L LH
Sbjct: 70 NFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 642 SCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
H+I+H D+K N+L D A L D+G L + T C GT
Sbjct: 127 K---HNIIHNDIKLENVLYDRAKDRIYLCDYG----LCKII----GTPSCYD----GTLD 171
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTG 731
Y PE + D ++ G++ LLTG
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 24/130 (18%), Positives = 58/130 (44%), Gaps = 8/130 (6%)
Query: 382 RRGKAEKDAIESIRRAKASESLYAEELKRR-KEFEEALANGKLELERMKKQHDEVMEELQ 440
R K ++ + + + LK + E+ L + +LE +++Q +E+ EL
Sbjct: 667 RELKELEEELAELEAQLEKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELA 726
Query: 441 IALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 500
++ L+S++ +ELE+++ E L+ ++ +EL+ E + + +L++
Sbjct: 727 ALEEELEQLQSRL-------EELEEELEELEEELEELQERLEELEEELESLEEALAKLKE 779
Query: 501 SRKEASSSSH 510
+E
Sbjct: 780 EIEELEEKRQ 789
|
Length = 1163 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 37/166 (22%), Positives = 69/166 (41%), Gaps = 32/166 (19%)
Query: 373 RREAFEEA-------LRRGKAEK-------------DAIESIRRAKASESLYAEELKRRK 412
RR FEEA RR + E+ D + + R S AE+ +R K
Sbjct: 157 RRAIFEEAAGISKYKERRKETERKLERTRENLDRLEDILNELERQLKSLERQAEKAERYK 216
Query: 413 EFEEALANGKL-----ELERMKKQHDEVMEELQIALDQKSLLESQIAESD---QTAK--- 461
E + L +L LE ++++ +E+ EEL+ A ++ L +++ E + + +
Sbjct: 217 ELKAELRELELALLVLRLEELREELEELQEELKEAEEELEELTAELQELEEKLEELRLEV 276
Query: 462 -ELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 506
ELE++I + L E L+ ++ + L + +E
Sbjct: 277 SELEEEIEELQKELYALANEISRLEQQKQILRERLANLERQLEELE 322
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|217051 pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 37/140 (26%), Positives = 69/140 (49%), Gaps = 1/140 (0%)
Query: 368 EAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELER 427
N R + L R + E+ K E L A+ LK KE E+ + EL+
Sbjct: 233 LKLNEERIDLLQELLRDEQEEIESSKQELEKEEEIL-AQVLKENKEEEKEKKLQEEELKL 291
Query: 428 MKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQME 487
+ K+ +E+ EL +K E ++ ES++ K+LE+++ E ++ +KE EL+++
Sbjct: 292 LAKEEEELKSELLKLERRKVDDEEKLKESEKELKKLEKELKKEKEEIEELEKELKELEIK 351
Query: 488 RDKAVKEAEELRKSRKEASS 507
R+ +E E+L K +++
Sbjct: 352 REAEEEEEEQLEKLQEKLEQ 371
|
This domain is found at the N terminus of SMC proteins. The SMC (structural maintenance of chromosomes) superfamily proteins have ATP-binding domains at the N- and C-termini, and two extended coiled-coil domains separated by a hinge in the middle. The eukaryotic SMC proteins form two kind of heterodimers: the SMC1/SMC3 and the SMC2/SMC4 types. These heterodimers constitute an essential part of higher order complexes, which are involved in chromatin and DNA dynamics. This family also includes the RecF and RecN proteins that are involved in DNA metabolism and recombination. Length = 1162 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 522 EIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKML-HP-HSLQGPSEFQQEIDIL 577
E+ N P +G G YGS+ ++VA+K L P S+ +E+ +L
Sbjct: 14 EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 578 SKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTR 626
++H N++ L+ +L VY +L L + + C+ D+ L +Q
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-- 128
Query: 627 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686
+ L ++HS I+H DLKP+N+ ++ + K+ DFG++R
Sbjct: 129 ------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------ 173
Query: 687 TTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGR 732
T T Y PE + + D++S G I+ LLTGR
Sbjct: 174 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 31/118 (26%), Positives = 58/118 (49%), Gaps = 11/118 (9%)
Query: 610 DRLSCKDNSP--PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 667
D +D PL +R ++++ + FL S + +H D+ N+LL V+K
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAK 252
Query: 668 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 725
+ DFG++R + N++ + + + +M PE + T +SDV+S+GI+L
Sbjct: 253 ICDFGLARDI------MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 304
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 12/117 (10%)
Query: 614 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673
K L+ + I + ++ + FL S K +H DL NILL N V K+ DFG+
Sbjct: 172 YKK---VLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGL 225
Query: 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730
+R + + + + D + +M PE + T +SDV+SFG++L + +
Sbjct: 226 ARDIYK------DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 23/167 (13%)
Query: 568 SEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLS--CKDNSPPLS 622
QQEI +++HPN++ V + E++ +V + GS ED L + P
Sbjct: 44 KLLQQEIITSRQLQHPNILPYVTSFIVDSELY-VVSPLMAYGSCEDLLKTHFPEGLP--- 99
Query: 623 WQTRIR-IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681
+ I I ++ + L ++HS +H +K ++ILL + LS S +
Sbjct: 100 -ELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM---- 151
Query: 682 ISSNNTTLCCRTDPKGT---FAYMDPEFLASGEL--TPKSDVYSFGI 723
I PK + ++ PE L KSD+YS GI
Sbjct: 152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 13/113 (11%)
Query: 620 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR--FL 677
PL+ + I + ++ + FL S K +H DL NILL N V K+ DFG++R +
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730
+ + + L +M PE + T +SDV+SFG++L + +
Sbjct: 227 DPDYVRKGSARL--------PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-04
Identities = 33/153 (21%), Positives = 68/153 (44%), Gaps = 7/153 (4%)
Query: 359 YDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 418
+++ + + E E E E L + E +E S+ L EL E + +
Sbjct: 405 LEEIQEELEELEKELEEL-ERELEELEEEIKKLEEQINQLESKELMIAELAGAGE-KCPV 462
Query: 419 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISA----VELL 474
+L E K+ + EL+ L+++ E + AE + +ELE+++ +ELL
Sbjct: 463 CGQELPEEHEKELLELYELELE-ELEEELSREKEEAELREEIEELEKELRELEEELIELL 521
Query: 475 QNYKKEQDELQMERDKAVKEAEELRKSRKEASS 507
+ + ++EL+ + +K EEL + +++
Sbjct: 522 ELEEALKEELEEKLEKLENLLEELEELKEKLQL 554
|
Length = 908 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-04
Identities = 25/97 (25%), Positives = 47/97 (48%)
Query: 409 KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 468
++ +E EE +A + L ++K+ +E+ EEL+ + L QI+ + LE ++
Sbjct: 684 EKIEELEEKIAELEKALAELRKELEELEEELEQLRKELEELSRQISALRKDLARLEAEVE 743
Query: 469 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
E + KE EL+ E ++ + EE + EA
Sbjct: 744 QLEERIAQLSKELTELEAEIEELEERLEEAEEELAEA 780
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|226889 COG4487, COG4487, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 32/158 (20%), Positives = 68/158 (43%), Gaps = 16/158 (10%)
Query: 356 DNLYDQLAQAMAEAENSR---REAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRK 412
+ + L + EA R R A ++ L + + + + ++ +E + EL +
Sbjct: 38 SRILNTLEEFEKEANEKRAQYRSAKKKELSQLEEQLINQKKEQKNLFNEQIKQFELALQD 97
Query: 413 EFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQ-TAKELEQKIISAV 471
E LE + + D+ +E L+ LD+ S ++ + Q TA+ +E+K +
Sbjct: 98 E-----IAKLEALELLNLEKDKELELLEKELDELSK---ELQKQLQNTAEIIEKKRENNK 149
Query: 472 EL----LQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
+N KK ++ L++ER+K ++ E +
Sbjct: 150 NEERLKFENEKKLEESLELEREKFEEQLHEANLDLEFK 187
|
Length = 438 |
| >gnl|CDD|206034 pfam13863, DUF4200, Domain of unknown function (DUF4200) | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 25/100 (25%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 409 KRRKEFEEALANGKLELERMKKQHDEVMEELQ---IALDQK-SLLESQIAESDQTAKELE 464
KRR+ E +L L+ +++ + E L+ L++K L+ + + D+ KE E
Sbjct: 5 KRREMEEV-----QLALDAKREEFERREELLKQREEELEKKEEELQESLIKFDKFLKENE 59
Query: 465 QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 504
K A + + KK + E + E + E EEL+ ++
Sbjct: 60 AKRRRAEKKAEEEKKLRKEKEEEIKELKAELEELKAEIEK 99
|
This family is found in eukaryotes. It is a coiled-coil domain of unknwon function. Length = 126 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 4e-04
Identities = 41/166 (24%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 363 AQAMAEAENSRREAFEEALRRGKAEKDAIESIR----RAKASESLYAEELKRRKEFEEAL 418
A+ +A+ ++++A EEA + +A+K A E+ + + KA E+ A+E K++ E +
Sbjct: 1427 AEEKKKADEAKKKA-EEAKKADEAKKKAEEAKKAEEAKKKAEEAKKADEAKKKAEEAKKA 1485
Query: 419 ANGKLELERMKKQHDEV---------MEELQIALDQKSLLESQIAESDQTAKEL----EQ 465
K + E KK+ DE +E + A + K E++ AE + A E E+
Sbjct: 1486 DEAKKKAEEAKKKADEAKKAAEAKKKADEAKKAEEAKKADEAKKAEEAKKADEAKKAEEK 1545
Query: 466 KIISAVELLQNYKKEQDELQME--------RDKAVKEAEELRKSRK 503
K ++ + KK +++ + E ++ A+++AEE +K+ +
Sbjct: 1546 KKADELKKAEELKKAEEKKKAEEAKKAEEDKNMALRKAEEAKKAEE 1591
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 4e-04
Identities = 35/146 (23%), Positives = 66/146 (45%), Gaps = 7/146 (4%)
Query: 363 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 422
A+ +AE +++ ++ + KAE+ R + LY EE K + E + K
Sbjct: 1560 AEEKKKAEEAKKAEEDKNMALRKAEEAKKAEEARIEEVMKLYEEEKKMKAEEAKKAEEAK 1619
Query: 423 LELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL---QNYKK 479
++ E +KK +E + Q+ K + ++++ K E+ I A E + KK
Sbjct: 1620 IKAEELKKAEEEKKKVEQL----KKKEAEEKKKAEELKKAEEENKIKAAEEAKKAEEDKK 1675
Query: 480 EQDELQMERDKAVKEAEELRKSRKEA 505
+ +E + + K AE L+K +EA
Sbjct: 1676 KAEEAKKAEEDEKKAAEALKKEAEEA 1701
|
Length = 2084 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-04
Identities = 28/145 (19%), Positives = 57/145 (39%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 420
Q N R+ E + + E E E E + + E L
Sbjct: 303 QKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEELESLEAELEE 362
Query: 421 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 480
+ ELE ++ + +E+ E+L+ + + LE QIA + + LE ++ + + ++E
Sbjct: 363 LEAELEELESRLEELEEQLETLRSKVAQLELQIASLNNEIERLEARLERLEDRRERLQQE 422
Query: 481 QDELQMERDKAVKEAEELRKSRKEA 505
+EL + ++A + + E
Sbjct: 423 IEELLKKLEEAELKELQAELEELEE 447
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-04
Identities = 30/152 (19%), Positives = 63/152 (41%), Gaps = 9/152 (5%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 420
+ Q A + E+ + + +E + + L E + E E LA
Sbjct: 284 EELQKELYALANEISRLEQQKQILRERLANLER-QLEELEAQL-EELESKLDELAEELAE 341
Query: 421 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVE-------L 473
+ +LE +K++ + + EL+ + LES++ E ++ + L K+
Sbjct: 342 LEEKLEELKEELESLEAELEELEAELEELESRLEELEEQLETLRSKVAQLELQIASLNNE 401
Query: 474 LQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
++ + + L+ R++ +E EEL K +EA
Sbjct: 402 IERLEARLERLEDRRERLQQEIEELLKKLEEA 433
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-04
Identities = 31/123 (25%), Positives = 60/123 (48%), Gaps = 3/123 (2%)
Query: 385 KAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALD 444
A K+ E I+ K + +KR + EE + + ELE + ++ +E+ EL +
Sbjct: 162 NAYKNLGEVIKEIKRRIERLEKFIKRTENIEELIKEKEKELEEVLREINEISSELPELRE 221
Query: 445 QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD---ELQMERDKAVKEAEELRKS 501
+ LE ++ E ++ +E+E+ L + +K ++ EL+ ++ KE EEL +
Sbjct: 222 ELEKLEKEVKELEELKEEIEELEKELESLEGSKRKLEEKIRELEERIEELKKEIEELEEK 281
Query: 502 RKE 504
KE
Sbjct: 282 VKE 284
|
Length = 880 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 24/82 (29%), Positives = 45/82 (54%), Gaps = 6/82 (7%)
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
+H DL NILL ++K+ DFG++R + N++ + + + +M PE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDI------RNDSNYVVKGNARLPVKWMAPESIF 289
Query: 709 SGELTPKSDVYSFGIILLRLLT 730
+ T +SDV+S+GI+L + +
Sbjct: 290 NCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|216108 pfam00769, ERM, Ezrin/radixin/moesin family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 37/154 (24%), Positives = 69/154 (44%), Gaps = 26/154 (16%)
Query: 368 EAENSRREA------FEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANG 421
EAE ++E EE +RR A+K+ E A E+LK+ +E + L
Sbjct: 2 EAEREQQELEERMEQMEEDMRR--AQKELEEYEETAL----ELEEKLKQEEEEAQLLEKK 55
Query: 422 KLELERMKKQHDEVMEELQIALD-QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 480
ELE ++ +EE A + ++ LE+++ E+ +LE+ E + ++
Sbjct: 56 ADELEEENRR----LEEEAAASEEERERLEAEVDEATAEVAKLEE----EREKKEAETRQ 107
Query: 481 -QDELQMERDKAVKEAEELRKSRKEASSSSHMPQ 513
Q EL+ ++ + +EL EA+++ P
Sbjct: 108 LQQELREAQEAHERARQEL----LEAAAAPTAPP 137
|
This family of proteins contain a band 4.1 domain (pfam00373), at their amino terminus. This family represents the rest of these proteins. Length = 244 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 44/163 (26%), Positives = 64/163 (39%), Gaps = 33/163 (20%)
Query: 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 657
L+ E+LP G + L KD + Q I ++ + + +H D+KP N
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYI------AETVLAIDAIHQLGFIHRDIKPDN 131
Query: 658 ILLDANFVSKLSDFGIS------------RFLSQNEIS-----SNNTTLCCRTDPK---- 696
+LLDA KLSDFG+ R L+ N S + N+ T K
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 697 ------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT Y+ PE D +S G+I+ +L G P
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|144972 pfam01576, Myosin_tail_1, Myosin tail | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-04
Identities = 47/174 (27%), Positives = 70/174 (40%), Gaps = 33/174 (18%)
Query: 356 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKR----- 410
+L DQL + E+A RR +AEKD +++ +A +L EE K
Sbjct: 443 HDLTDQLGEG-----GRNVHELEKARRRLEAEKDELQAALE-EAEAALELEESKVLRAQV 496
Query: 411 -----RKEFEEALANGKLELERMKKQHDEVMEELQIALDQ-----------KSLLESQIA 454
R E E LA + E E +K H +E LQ L+ K LE I
Sbjct: 497 ELSQIRSEIERRLAEKEEEFENTRKNHQRAIESLQATLEAEAKGKAEASRLKKKLEGDIN 556
Query: 455 ESDQTAKELEQKIISAVELLQNYKKEQD---ELQMERDKAVKEAEELRKSRKEA 505
E + L+ + E +N KK Q ELQ + ++ + E+ R+ A
Sbjct: 557 ELEIA---LDHANKANAEAQKNVKKYQQQVKELQTQVEEEQRAREDAREQLAVA 607
|
The myosin molecule is a multi-subunit complex made up of two heavy chains and four light chains it is a fundamental contractile protein found in all eukaryote cell types. This family consists of the coiled-coil myosin heavy chain tail region. The coiled-coil is composed of the tail from two molecules of myosin. These can then assemble into the macromolecular thick filament. The coiled-coil region provides the structural backbone the thick filament. Length = 859 |
| >gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-04
Identities = 29/141 (20%), Positives = 63/141 (44%), Gaps = 11/141 (7%)
Query: 373 RREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQH 432
E EE + + ++ ++ ++ K Y + + +E+ + L + L R++++
Sbjct: 264 LEERIEELKKEIEELEEKVKELKELKEKAEEYIKLSEFYEEYLDELREIEKRLSRLEEEI 323
Query: 433 DEVMEELQIALDQKSLLESQIAESDQTAKELE---------QKIISAVELLQNYKKEQDE 483
+ + E ++ +++ LE + + K LE ++ + E L+ KK
Sbjct: 324 NGIEERIKELEEKEERLEELKKKLKELEKRLEELEERHELYEEAKAKKEELERLKKRLTG 383
Query: 484 LQMERDKAVKEAEELRKSRKE 504
L E K KE EEL K+++E
Sbjct: 384 LTPE--KLEKELEELEKAKEE 402
|
Length = 880 |
| >gnl|CDD|222469 pfam13949, ALIX_LYPXL_bnd, ALIX V-shaped domain binding to HIV | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 37/185 (20%), Positives = 72/185 (38%), Gaps = 24/185 (12%)
Query: 329 TEGVSTLPPS-----KEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRR 383
EG LPPS +E L+ S+DD +L+Q E +E
Sbjct: 1 LEGPLGLPPSLLEKAEEIRSEGGIERLERSLDD--LPELSQRN-------EEILDEIKEL 51
Query: 384 GKAEKDAIESIRRA-------KASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVM 436
E+ E +R S L AE + +++ L +++ + +E
Sbjct: 52 LDEEESEDEQLRAKYGERWTRPPSSELTAELREELRKYRGYLEQASESDAQLRSKLEEHE 111
Query: 437 EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAE 496
E L++ + LE+ + S + ++ + L+ + +EL+ ER+K ++E +
Sbjct: 112 ENLELLSGPEEELEALLPSSSPS---KTPEVSEQISRLRELLNKLNELKAEREKLLEELK 168
Query: 497 ELRKS 501
E +
Sbjct: 169 EKAQD 173
|
The binding of the LYPxL motif of late HIV p6Gag and EIAV p9Gag to this domain is necessary for viral budding.This domain is generally central between an N-terminal Bro1 domain, pfam03097 and a C-terminal proline-rich domain. The retroviruses thus used this domain to hijack the ESCRT system of the cell. Length = 292 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 20/160 (12%)
Query: 582 HPNLVTLVGACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 637
HP LV L +C + + V EY+ G L + + P + R + E+ L
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----EEHARFYSAEISLAL 109
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+LH I++ DLK N+LLD+ KL+D+G+ + + + T+ C G
Sbjct: 110 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFC-----G 158
Query: 698 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 737
T Y+ PE L + D ++ G+++ ++ GR I
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|205692 pfam13514, AAA_27, AAA domain | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-04
Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 13/156 (8%)
Query: 352 GSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR 411
GSV D L + + R+ AL K K+ IR + + + +K
Sbjct: 129 GSVRDELEKEADELWKP--RGRKPEINVAL---KELKELEAEIREVQLKTRTWKDLVKAL 183
Query: 412 KEFEEALANGKLELERMKKQHDEVMEELQIALDQ---KSLLESQIAESDQTAKELEQKII 468
E EE LAN + EL +++K+ +E L+ L + LE Q+A E+
Sbjct: 184 DEAEEELANLRKELRQLEKEKQR-LERLRRLLPLLAERKALEQQLAA----LGEVIDLPP 238
Query: 469 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 504
AVE + + E + + + E L+ E
Sbjct: 239 DAVERYEEARAELRAARRNLELLTERLEALQAELDE 274
|
This domain is found in a number of double-strand DNA break proteins. This domain contains a P-loop motif. Length = 1118 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 43/215 (20%)
Query: 536 IGEGGYGSIYKGLL--------------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR 581
+G G IY G+L + ++V +K+L P F + ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 582 HPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 639
H ++V L G C +V E++ G L+ L S L+ + ++A +L S L +
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120
Query: 640 LHSCKPHSIVHGDLKPANILL-------DANFVSKLSDFGIS-RFLSQNEISSNNTTLCC 691
L +VHG++ NILL + KLSD GI LS+ E C
Sbjct: 121 LEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQE--------CV 169
Query: 692 RTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIIL 725
P ++ PE + S L+ +D +SFG L
Sbjct: 170 ERIP-----WIAPECVEDSKNLSIAADKWSFGTTL 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|188306 TIGR03319, RNase_Y, ribonuclease Y | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 5e-04
Identities = 32/142 (22%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 362 LAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANG 421
+ +A EAE ++EA EA + +E + + +E L E +R + EE L
Sbjct: 38 IEEAKKEAETLKKEALLEAKEEVHKLRAELERELKERRNE-LQRLE-RRLLQREETLDR- 94
Query: 422 KLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE- 480
++E + K+ + + ++ + +++ L+ + E ++ E +++ L Q KE
Sbjct: 95 --KMESLDKKEENLEKKEKELSNKEKNLDEKEEELEELIAEQREELERISGLTQEEAKEI 152
Query: 481 -----QDELQMERDKAVKEAEE 497
++E + E K +KE EE
Sbjct: 153 LLEEVEEEARHEAAKLIKEIEE 174
|
Members of this family are RNase Y, an endoribonuclease. The member from Bacillus subtilis, YmdA, has been shown to be involved in turnover of yitJ riboswitch [Transcription, Degradation of RNA]. Length = 514 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-04
Identities = 32/149 (21%), Positives = 65/149 (43%), Gaps = 5/149 (3%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR-KEFEEAL 418
++L + + E E E E+AL + E + +E E EEL R+ + L
Sbjct: 680 EELEEKIEELEEKIAEL-EKALAELRKELEELEEELEQLRKE---LEELSRQISALRKDL 735
Query: 419 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 478
A + E+E+++++ ++ +EL + LE ++ E+++ E E +I ++ K
Sbjct: 736 ARLEAEVEQLEERIAQLSKELTELEAEIEELEERLEEAEEELAEAEAEIEELEAQIEQLK 795
Query: 479 KEQDELQMERDKAVKEAEELRKSRKEASS 507
+E L+ D+ E L +
Sbjct: 796 EELKALREALDELRAELTLLNEEAANLRE 824
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 7e-04
Identities = 37/145 (25%), Positives = 73/145 (50%), Gaps = 9/145 (6%)
Query: 363 AQAMAEAENSRR-EAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANG 421
A + +AE ++ E ++A KAE+D ++R+A+ E+ AEE + + +
Sbjct: 1548 ADELKKAEELKKAEEKKKAEEAKKAEEDKNMALRKAE--EAKKAEEARIEEVMKLYEEEK 1605
Query: 422 KLELERMKKQHDEVM--EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
K++ E KK + + EEL+ A ++K +E + + K+ E+ + E K
Sbjct: 1606 KMKAEEAKKAEEAKIKAEELKKAEEEKKKVEQLKKKEAEEKKKAEE--LKKAEEENKIKA 1663
Query: 480 EQDELQMERDKAVKEAEELRKSRKE 504
++ + E DK K+AEE +K+ ++
Sbjct: 1664 AEEAKKAEEDK--KKAEEAKKAEED 1686
|
Length = 2084 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 7e-04
Identities = 35/151 (23%), Positives = 66/151 (43%), Gaps = 6/151 (3%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASE-----SLYAEELKRRKEF 414
++ + +AEAE + E E + + K E A+ +E A +R +
Sbjct: 771 EEAEEELAEAE-AEIEELEAQIEQLKEELKALREALDELRAELTLLNEEAANLRERLESL 829
Query: 415 EEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 474
E +A + LE +++Q +E+ E+++ + LE I E + + L + S E L
Sbjct: 830 ERRIAATERRLEDLEEQIEELSEDIESLAAEIEELEELIEELESELEALLNERASLEEAL 889
Query: 475 QNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
+ E +EL E + + ELR+ +E
Sbjct: 890 ALLRSELEELSEELRELESKRSELRRELEEL 920
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 42/170 (24%), Positives = 62/170 (36%), Gaps = 41/170 (24%)
Query: 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 658
V +Y+P G + L R IA C++ S +H D+KP NI
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFE--EDLARFYIAELTCAI----ESVHKMGFIHRDIKPDNI 132
Query: 659 LLDANFVSKLSDFGI---------SRFLSQN------------EISSNNT---------- 687
L+D + KL+DFG+ S++ + E S +
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192
Query: 688 ----TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
C GT Y+ PE L T D +S G+IL +L G+P
Sbjct: 193 KRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 8e-04
Identities = 36/154 (23%), Positives = 77/154 (50%), Gaps = 11/154 (7%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 419
D+ A +AE + ++ EEA ++ A K E ++A ++ AEE K++ + + A
Sbjct: 1357 DEAEAAEEKAEAAEKKK-EEAKKKADAAKKKAEEKKKADEAKK-KAEEDKKKADELKKAA 1414
Query: 420 NGKLELERMKKQHDEV--MEELQIALDQKSLLES--QIAESDQTAKELEQKIISAVELLQ 475
K + + KK+ +E +E + ++ + + AE + A+E ++K A + +
Sbjct: 1415 AAKKKADEAKKKAEEKKKADEAKKKAEEAKKADEAKKKAEEAKKAEEAKKKAEEAKKADE 1474
Query: 476 NYKKEQ-----DELQMERDKAVKEAEELRKSRKE 504
KK + DE + + ++A K+A+E +K+ +
Sbjct: 1475 AKKKAEEAKKADEAKKKAEEAKKKADEAKKAAEA 1508
|
Length = 2084 |
| >gnl|CDD|109486 pfam00430, ATP-synt_B, ATP synthase B/B' CF(0) | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 9e-04
Identities = 32/112 (28%), Positives = 55/112 (49%), Gaps = 22/112 (19%)
Query: 360 DQLAQAMAEAENSRREA------FEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE 413
+++A + EAE ++A E+ L +A +A E I AK A++LK
Sbjct: 33 EKIANNIKEAEERLKQAAALLAEAEQQLA--QARAEASEIINNAKKE----AQKLK---- 82
Query: 414 FEEALANGKLELERMKKQ-HDEVMEELQIALDQKSLLESQIAE-SDQTAKEL 463
EE LA + + ER+ + E+ +E + AL + L Q+A + Q A++L
Sbjct: 83 -EEILAEAQKDAERLLESARAEIEQEKEQALAE---LRQQVAALAVQIAEKL 130
|
Part of the CF(0) (base unit) of the ATP synthase. The base unit is thought to translocate protons through membrane (inner membrane in mitochondria, thylakoid membrane in plants, cytoplasmic membrane in bacteria). The B subunits are thought to interact with the stalk of the CF(1) subunits. This domain should not be confused with the ab CF(1) proteins (in the head of the ATP synthase) which are found in pfam00006. Length = 132 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 0.001
Identities = 32/162 (19%), Positives = 67/162 (41%), Gaps = 12/162 (7%)
Query: 356 DNLYDQLAQAMAEAENSRREAFE--EALRRGKAEKDAIES-IRRAKASESLYAEELKRRK 412
+ L +L+ +E E + L + IE I + + E E L+ +
Sbjct: 684 EGLKRELSSLQSELRRIENRLDELSQELSDASRKIGEIEKEIEQLEQEEEKLKERLEELE 743
Query: 413 EFEEALANGKLELERMKKQHDEVMEELQIALDQ---------KSLLESQIAESDQTAKEL 463
E +L ++ K+ + +EEL+ L + L S+I E +L
Sbjct: 744 EDLSSLEQEIENVKSELKELEARIEELEEDLHKLEEALNDLEARLSHSRIPEIQAELSKL 803
Query: 464 EQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
E+++ L+ +++ + L +E++ KE +EL++ R +
Sbjct: 804 EEEVSRIEARLREIEQKLNRLTLEKEYLEKEIQELQEQRIDL 845
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 0.001
Identities = 27/126 (21%), Positives = 61/126 (48%), Gaps = 1/126 (0%)
Query: 380 ALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF-EEALANGKLELERMKKQHDEVMEE 438
++ G K + + +R EL+ + E EE L + K EL ++ +E+ +
Sbjct: 651 SITGGSRNKRSSLAQKRELKELEEELAELEAQLEKLEEELKSLKNELRSLEDLLEELRRQ 710
Query: 439 LQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 498
L+ Q L+ ++A ++ ++L+ ++ E L+ ++E +ELQ ++ +E E L
Sbjct: 711 LEELERQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESL 770
Query: 499 RKSRKE 504
++ +
Sbjct: 771 EEALAK 776
|
Length = 1163 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 0.001
Identities = 49/156 (31%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 363 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF---EEALA 419
A+ +A+ ++++A EEA ++ K A E+ + KA E+ AEE K+ E EEA
Sbjct: 1479 AEEAKKADEAKKKA-EEAKKKADEAKKAAEA--KKKADEAKKAEEAKKADEAKKAEEAKK 1535
Query: 420 NGKLELERMKKQHDEV--MEELQIALDQKSLLESQIAESDQT--------AKELEQKIIS 469
+ + KK+ DE+ EEL+ A ++K E++ AE D+ AK+ E+ I
Sbjct: 1536 ADEAKKAEEKKKADELKKAEELKKAEEKKKAEEAKKAEEDKNMALRKAEEAKKAEEARIE 1595
Query: 470 AV-ELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 504
V +L + KK + E + ++A +AEEL+K+ +E
Sbjct: 1596 EVMKLYEEEKKMKAEEAKKAEEAKIKAEELKKAEEE 1631
|
Length = 2084 |
| >gnl|CDD|144972 pfam01576, Myosin_tail_1, Myosin tail | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.001
Identities = 48/152 (31%), Positives = 72/152 (47%), Gaps = 26/152 (17%)
Query: 359 YDQLAQAMAEAENSRREAFEEALRRGKAEKDAI----ESIRRAKASESLYAEELKRRK-- 412
D L + + E ++ E E L + AE ES +A E EELK++
Sbjct: 273 LDSLREQLEEESEAKAEL-ERQLSKANAEIQQWRSKFESEGALRAEE---LEELKKKLNQ 328
Query: 413 ---EFEEAL--ANGKL-ELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQK 466
E EEA AN K LE+ K + +E+LQI L++ ++ A ELE+K
Sbjct: 329 KISELEEAAEAANAKCDSLEKTKSRLQSELEDLQIELER----------ANAAASELEKK 378
Query: 467 IISAVELLQNYKKEQDELQMERDKAVKEAEEL 498
+ ++L +K++ DELQ E D A +EA L
Sbjct: 379 QKNFDKILAEWKRKVDELQAELDTAQREARNL 410
|
The myosin molecule is a multi-subunit complex made up of two heavy chains and four light chains it is a fundamental contractile protein found in all eukaryote cell types. This family consists of the coiled-coil myosin heavy chain tail region. The coiled-coil is composed of the tail from two molecules of myosin. These can then assemble into the macromolecular thick filament. The coiled-coil region provides the structural backbone the thick filament. Length = 859 |
| >gnl|CDD|226883 COG4477, EzrA, Negative regulator of septation ring formation [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 38/164 (23%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 356 DNLYDQLAQAMAEAEN---SRREAFEEALRRGKAEKDAI-ESIRRAKASESLYAEELKRR 411
++LYD L + EA+N + L + K + + E I R K S L EL
Sbjct: 291 ESLYDLLERE-VEAKNVVEENLPILPDYLEKAKENNEHLKEEIERVKESYRLAETELGSV 349
Query: 412 KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAV 471
++FE+ EL+ ++ DE++E ++ S L+ + E ++ ++E +
Sbjct: 350 RKFEK-------ELKELESVLDEILENIEAQEVAYSELQDNLEEIEKALTDIEDEQEKVQ 402
Query: 472 ELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 515
E L + +K++ E + ++ + E+ K E S+ +P+ F
Sbjct: 403 EHLTSLRKDELEARENLERLKSKLHEI-KRYMEKSNLPGLPETF 445
|
Length = 570 |
| >gnl|CDD|179385 PRK02224, PRK02224, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDA---IESIR-RAKASESLYAEELKRRKEFE 415
++L + + E E EE L R + +A IE + R + E L AE + +E
Sbjct: 478 EELEAELEDLE-EEVEEVEERLERAEDLVEAEDRIERLEERREDLEELIAERRETIEEKR 536
Query: 416 EALAN-----GKLELERMKKQHD--EVMEELQIALDQKSLLESQIAESDQTAKELEQKII 468
E +LE E +K+ E EE + A ++ + L S++AE + + LE +I
Sbjct: 537 ERAEELRERAAELEAEAEEKREAAAEAEEEAEEAREEVAELNSKLAELKERIESLE-RIR 595
Query: 469 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSR 502
+ + + + + E + L+ E+ +A+ E + R+ R
Sbjct: 596 TLLAAIADAEDEIERLR-EKREALAELNDERRER 628
|
Length = 880 |
| >gnl|CDD|237621 PRK14139, PRK14139, heat shock protein GrpE; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.001
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 14/94 (14%)
Query: 358 LYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE-FEE 416
L D +A AE EN RR A E+ KA K AIES +AE L K+ E
Sbjct: 51 LQDSFLRAKAETENVRRRAQEDV---AKAHKFAIES----------FAESLLPVKDSLEA 97
Query: 417 ALANGKLELERMKKQHDEVMEELQIALDQKSLLE 450
ALA+ +LE++++ + +++L A ++ ++E
Sbjct: 98 ALADESGDLEKLREGVELTLKQLTSAFEKGRVVE 131
|
Length = 185 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 32/163 (19%), Positives = 64/163 (39%), Gaps = 26/163 (15%)
Query: 357 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELK------- 409
+L +L+ + + EE + R +A IE E Y E+
Sbjct: 783 DLEARLSHSRIPEIQAELSKLEEEVSRIEARLREIEQKLNRLTLEKEYLEKEIQELQEQR 842
Query: 410 -----RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELE 464
+ K E+ + N + E + +E +EEL+ AL LES++ +L+
Sbjct: 843 IDLKEQIKSIEKEIENLNGKKEEL----EEELEELEAALRD---LESRL-------GDLK 888
Query: 465 QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 507
++ L+ +++ +EL+ + +K K EL+ +
Sbjct: 889 KERDELEAQLRELERKIEELEAQIEKKRKRLSELKAKLEALEE 931
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (97), Expect = 0.002
Identities = 33/142 (23%), Positives = 67/142 (47%), Gaps = 4/142 (2%)
Query: 363 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 422
A +AE ++ +EA ++ + K A E+ ++A+ ++ A+ K++ E + A
Sbjct: 1292 ADEAKKAEEKKK--ADEAKKKAEEAKKADEAKKKAEEAKK-KADAAKKKAEEAKKAAEAA 1348
Query: 423 LELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 482
E EE A ++K + A++ + E ++K A + + KK+ D
Sbjct: 1349 KAEAEAAADEAEAAEEKAEAAEKKKEEAKKKADAAKKKAEEKKKADEAKKKAEEDKKKAD 1408
Query: 483 ELQMERDKAVKEAEELRKSRKE 504
EL+ + A K+A+E +K +E
Sbjct: 1409 ELK-KAAAAKKKADEAKKKAEE 1429
|
Length = 2084 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.002
Identities = 32/167 (19%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 359 YDQLAQAMAEAENSRREAFEE--ALRRGKAEKDA-IESIRRAKAS------------ESL 403
++L + + E + +EA EE L E + +E +R + +L
Sbjct: 234 LEELREELEELQEELKEAEEELEELTAELQELEEKLEELRLEVSELEEEIEELQKELYAL 293
Query: 404 YAE--ELKRRKEF-EEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA 460
E L+++K+ E LAN + +LE ++ Q +E+ +L ++ + LE ++ E +
Sbjct: 294 ANEISRLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEEL 353
Query: 461 KELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 507
+ LE ++ L+ + +EL+ + + + +L ++
Sbjct: 354 ESLEAELEELEAELEELESRLEELEEQLETLRSKVAQLELQIASLNN 400
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|217051 pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 30/139 (21%), Positives = 57/139 (41%), Gaps = 3/139 (2%)
Query: 367 AEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELE 426
E E L+ + + D E ++ ++ +ELK+ KE E L ELE
Sbjct: 290 KLLAKEEEELKSELLKLERRKVDDEEKLKESEKELKKLEKELKKEKEEIEELEKELKELE 349
Query: 427 RMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQM 486
++ +E E+L + LE E K +++ SA +L + + ++E +
Sbjct: 350 IKREAEEEEEEQL---EKLQEKLEQLEEELLAKKKLESERLSSAAKLKEEELELKNEEEK 406
Query: 487 ERDKAVKEAEELRKSRKEA 505
E ++ +E+ KE
Sbjct: 407 EAKLLLELSEQEEDLLKEE 425
|
This domain is found at the N terminus of SMC proteins. The SMC (structural maintenance of chromosomes) superfamily proteins have ATP-binding domains at the N- and C-termini, and two extended coiled-coil domains separated by a hinge in the middle. The eukaryotic SMC proteins form two kind of heterodimers: the SMC1/SMC3 and the SMC2/SMC4 types. These heterodimers constitute an essential part of higher order complexes, which are involved in chromatin and DNA dynamics. This family also includes the RecF and RecN proteins that are involved in DNA metabolism and recombination. Length = 1162 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 41/135 (30%), Positives = 54/135 (40%), Gaps = 17/135 (12%)
Query: 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 657
LV ++ G L +S N P + R A E+ L LH IV DL P N
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVK---RWAAEMVVALDALHR---EGIVCRDLNPNN 115
Query: 658 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 717
ILLD +L+ F +E+ + C + Y PE E T D
Sbjct: 116 ILLDDRGHIQLTYFS-----RWSEVEDS----CDGEAVENM--YCAPEVGGISEETEACD 164
Query: 718 VYSFGIILLRLLTGR 732
+S G IL LLTG+
Sbjct: 165 WWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|237178 PRK12705, PRK12705, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 32/134 (23%), Positives = 55/134 (41%), Gaps = 5/134 (3%)
Query: 362 LAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEE-LKRRKEFEEALAN 420
L +A EAE A EA E++ R + E EE L +++E +A A
Sbjct: 39 LQEAQKEAEEKLEAALLEAKELLLRERNQQRQEARREREELQREEERLVQKEEQLDARAE 98
Query: 421 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 480
+L+ ++ Q +E + L + LE Q+ L + LL+ E
Sbjct: 99 ---KLDNLENQLEEREKALSARELELEELEKQLDNELYRVAGLTPEQARK-LLLKLLDAE 154
Query: 481 QDELQMERDKAVKE 494
+E + +R K ++E
Sbjct: 155 LEEEKAQRVKKIEE 168
|
Length = 508 |
| >gnl|CDD|221389 pfam12037, DUF3523, Domain of unknown function (DUF3523) | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 34/131 (25%), Positives = 65/131 (49%), Gaps = 13/131 (9%)
Query: 379 EALRRG-KAEKDAIESIRRA-KASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVM 436
AL RG KA ++ +ES A KA E +E R+ E E + + + + K + V
Sbjct: 32 TALERGAKALRE-LESSPHAKKAFELSKMQEKTRQAELEAKIKEYEAQQAQAKLERARVE 90
Query: 437 EELQIALDQKSLLESQIAESDQTAK---ELEQKIISAVELLQNYKKEQDELQMERDKAVK 493
E +++ L+ Q + Q A+ EL +K EL Q ++ ++ L+M+ + ++
Sbjct: 91 AE-----ERRKTLQEQTQQEQQRAQYQDELARKRYQK-ELEQQRRQNEELLKMQEESVLR 144
Query: 494 EAEELRKSRKE 504
+ E +R++ +E
Sbjct: 145 Q-EAMRRATEE 154
|
This presumed domain is functionally uncharacterized. This domain is found in eukaryotes. This domain is typically between 257 to 277 amino acids in length. This domain is found associated with pfam00004. This domain has a conserved LER sequence motif. Length = 276 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 657
LV EYL G ++ L + ++ +E+ L +LH H I+H DLKP N
Sbjct: 81 LVMEYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDN 134
Query: 658 ILLDANFVSKLSDFGISRFLSQNEI 682
+L+ KL+DFG+S+ E+
Sbjct: 135 MLISNEGHIKLTDFGLSKVTLNREL 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|234750 PRK00409, PRK00409, recombination and DNA strand exchange inhibitor protein; Reviewed | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.002
Identities = 38/131 (29%), Positives = 58/131 (44%), Gaps = 39/131 (29%)
Query: 376 AFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEV 435
AFE A R G E I AK L E+ K +L +
Sbjct: 490 AFEIAKRLGLPE----NIIEEAKK---LIGED--------------KEKLNEL------- 521
Query: 436 MEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEA 495
IA SL E + E +Q A+E E + A +L + ++++++LQ E DK ++EA
Sbjct: 522 -----IA----SLEELER-ELEQKAEEAEALLKEAEKLKEELEEKKEKLQEEEDKLLEEA 571
Query: 496 E-ELRKSRKEA 505
E E +++ KEA
Sbjct: 572 EKEAQQAIKEA 582
|
Length = 782 |
| >gnl|CDD|226809 COG4372, COG4372, Uncharacterized protein conserved in bacteria with the myosin-like domain [Function unknown] | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 29/133 (21%), Positives = 57/133 (42%), Gaps = 2/133 (1%)
Query: 377 FEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVM 436
LR G + D I RA +E A+ KR E E A +L+ R +++ V
Sbjct: 65 LNRNLRSGVFQLDDIRPQLRALRTELGTAQGEKRAAETEREAARSELQKARQERE--AVR 122
Query: 437 EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAE 496
+EL A + + ++A + A++L+ ++ + E + + + LQ + + A
Sbjct: 123 QELAAARQNLAKAQQELARLTKQAQDLQTRLKTLAEQRRQLEAQAQSLQASQKQLQASAT 182
Query: 497 ELRKSRKEASSSS 509
+L+ + S
Sbjct: 183 QLKSQVLDLKLRS 195
|
Length = 499 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.002
Identities = 69/310 (22%), Positives = 129/310 (41%), Gaps = 59/310 (19%)
Query: 535 KIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 588
KIG G +G ++ L++H + K + L+ S+ E++++ +++H N+V
Sbjct: 20 KIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 589 VG-----ACPEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHS 642
+ A +++ L+ E+ G L + C + + I +L L + H+
Sbjct: 78 IDRFLNKANQKLYILM-EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136
Query: 643 CKP----HSIVHGDLKPANILLDANF-----------------VSKLSDFGISRFLSQNE 681
K ++H DLKP NI L ++K+ DFG+S+ +
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196
Query: 682 ISSNNTTLCCRTDPKGTFAYMDPEFL--ASGELTPKSDVYSFGIILLRLLTGRPALGITK 739
++ + C GT Y PE L + KSD+++ G I+ L +G+ K
Sbjct: 197 MAHS----CV-----GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF--HK 245
Query: 740 EVQYALDTGKLKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPE----LGKDVWRV 794
++ +LK D P+ G ++++L L +S K RP LG + +
Sbjct: 246 ANNFSQLISELKRGPDLPIKG-----KSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
Query: 795 LEPMRASCGG 804
+ P + GG
Sbjct: 301 VGPPVGAAGG 310
|
Length = 1021 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.003
Identities = 27/143 (18%), Positives = 54/143 (37%), Gaps = 3/143 (2%)
Query: 359 YDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 418
+ L + E + E +E + + I K EEL+R E L
Sbjct: 366 LEDLRAELEEVDKEFAETRDELKDYREKLEKLKREINELKRELDRLQEELQRL---SEEL 422
Query: 419 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 478
A+ + ++ + +E+ EE + + E ++ + + EQ++ E +
Sbjct: 423 ADLNAAIAGIEAKINELEEEKEDKALEIKKQEWKLEQLAADLSKYEQELYDLKEEYDRVE 482
Query: 479 KEQDELQMERDKAVKEAEELRKS 501
KE +LQ E +A +A +
Sbjct: 483 KELSKLQRELAEAEAQARASEER 505
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.003
Identities = 30/157 (19%), Positives = 66/157 (42%), Gaps = 9/157 (5%)
Query: 357 NLYDQLAQAMAEAEN---SRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE 413
L + + E S E E+ + + + +E + K L +R KE
Sbjct: 308 EGLRALLEELEELLEKLKSLEERLEKLEEKLEKLESELEELAEEK--NELAKLLEERLKE 365
Query: 414 FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVEL 473
EE L + ELE+ ++ ++ E +Q ++ + L + + E + +ELE++ +E
Sbjct: 366 LEERLEELEKELEKALERLKQLEEAIQELKEELAELSAALEEIQEELEELEKE----LEE 421
Query: 474 LQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH 510
L+ +E +E + ++ + + E E + +
Sbjct: 422 LERELEELEEEIKKLEEQINQLESKELMIAELAGAGE 458
|
Length = 908 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.003
Identities = 35/136 (25%), Positives = 64/136 (47%), Gaps = 4/136 (2%)
Query: 368 EAENSRREAFEEALRRGKAEKDAIESIRRA--KASESLYAEELKRRKEFEEALANGKLEL 425
EA+ + E E +R+ + + A + R+A KA E+ A+ELK+ +E ++A K E
Sbjct: 1241 EAKKAEEERNNEEIRKFEEARMAHFARRQAAIKAEEARKADELKKAEEKKKADEAKKAEE 1300
Query: 426 ERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQ 485
++ + + EE + A + K E ++D K+ E+ +A + DE +
Sbjct: 1301 KKKADEAKKKAEEAKKADEAKKKAEEAKKKADAAKKKAEEAKKAAEAAKAEAEAAADEAE 1360
Query: 486 MERDKAVKEAEELRKS 501
+K EA E +K
Sbjct: 1361 AAEEK--AEAAEKKKE 1374
|
Length = 2084 |
| >gnl|CDD|226513 COG4026, COG4026, Uncharacterized protein containing TOPRIM domain, potential nuclease [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 31/132 (23%), Positives = 55/132 (41%), Gaps = 9/132 (6%)
Query: 411 RKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQ---KI 467
RKE + AL L+ + ++ ++ E+ + K LE E ++ KELE+ +
Sbjct: 109 RKELKNALVRAGLKTLQRVPEYMDLKEDY---EELKEKLEELQKEKEELLKELEELEAEY 165
Query: 468 ISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGAT 527
E L+ + E L+ K E +L+K E +P+ + S++ T
Sbjct: 166 EEVQERLKRLEVENSRLEEMLKKLPGEVYDLKKRWDELEPGVELPE---EELISDLVKET 222
Query: 528 HNFDPSLKIGEG 539
N P G+G
Sbjct: 223 LNLAPKDIEGQG 234
|
Length = 290 |
| >gnl|CDD|225638 COG3096, MukB, Uncharacterized protein involved in chromosome partitioning [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 42/176 (23%), Positives = 78/176 (44%), Gaps = 28/176 (15%)
Query: 327 IRTEGV--STLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRG 384
I+ G S L P LQS P ++QL + A+A+ +R+A ++A
Sbjct: 912 IQQHGNTLSKLEPIASVLQSDPEQ----------FEQLKEDYAQAQQMQRQARQQAF--- 958
Query: 385 KAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALD 444
A + ++ RRA S S AE L + E L + LE+ + + E+L+
Sbjct: 959 -ALTEVVQ--RRAHFSYSDSAEMLSENSDLNEKL---RQRLEQAEAERTRAREQLR---- 1008
Query: 445 QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 500
Q ++Q+++ +Q L+ + ELL ++E ++ + D +E +R+
Sbjct: 1009 QH---QAQLSQYNQVLASLKSSYDTKKELLNELQQELQDIGVRADSGAEERARIRR 1061
|
Length = 1480 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 12/92 (13%)
Query: 640 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
LHS I+H DLKP+NI++ ++ K+ DFG++R N + + T
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV---------TR 186
Query: 700 AYMDPEFLASGELTPKSDVYSFGIILLRLLTG 731
Y PE + D++S G I+ L+ G
Sbjct: 187 YYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 536 IGEGGYGSI---YKGLLRHMQVAIKML-HP-HSLQGPSEFQQEIDILSKIRHPNLVTLV- 589
+G G YGS+ Y LR +VA+K L P SL +E+ +L ++H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ-KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 590 ----GACPEVWTLVY--EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
E + VY L L + + C+ LS + + +L L ++HS
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIVKCQK----LSDEHVQFLIYQLLRGLKYIHSA 137
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
I+H DLKP+N+ ++ + ++ DFG++R + +E+ T T Y
Sbjct: 138 ---GIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEM----------TGYVATRWYRA 183
Query: 704 PEFLASG-ELTPKSDVYSFGIILLRLLTGR 732
PE + + D++S G I+ LL G+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223783 COG0711, AtpF, F0F1-type ATP synthase, subunit b [Energy production and conversion] | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.003
Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 13/130 (10%)
Query: 385 KAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALD 444
K A++ R+AK ++ L E + ++E + LA + ELE ++Q E++E+
Sbjct: 29 KPILKALDE-RQAKIADDLAEAE-RLKEEAQALLAEYEQELEEAREQASEIIEQA----- 81
Query: 445 QKSLLESQIAE-SDQTAKELEQKIISAVELLQNYKKE-QDELQME-RDKAVKEAEELRKS 501
K E E + +ELE+ +A ++ K+ +EL+ E + AV AE+L
Sbjct: 82 -KKEAEQIAEEIKAEAEEELERIKEAAEAEIEAEKERALEELRAEVAELAVAIAEKL--L 138
Query: 502 RKEASSSSHM 511
K+ ++
Sbjct: 139 GKKVDEAAQK 148
|
Length = 161 |
| >gnl|CDD|220719 pfam10368, YkyA, Putative cell-wall binding lipoprotein | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 39/134 (29%), Positives = 69/134 (51%), Gaps = 11/134 (8%)
Query: 357 NLYDQLAQAMAEAENSRREAFEEAL----RRGK---AEKDAIESIRRAKASESLYAEELK 409
LYDQ+ Q + + ++ ++AL +R K EK++IE S Y E+++
Sbjct: 51 ELYDQIIQLGKDDNEAIKKLSDQALANVDKREKLLKKEKESIEKSEEEFKSAKKYIEKIE 110
Query: 410 RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIIS 469
+K ++A K+ ER K +D++ + + AL+ + L + + D T KEL++K I
Sbjct: 111 DKKLKKKAKQLVKVMKERYK-SYDKLYKAYKKALNLEKELYEYLKDKDLTLKELDEK-IK 168
Query: 470 AVELLQNYKKEQDE 483
AV Q+Y+K Q
Sbjct: 169 AVN--QSYEKIQKA 180
|
YkyA is a family of proteins containing a lipoprotein signal and a hydrolase domain. It is similar to cell wall binding proteins and might also be recognisable by a host immune defence system. It is thus likely to belong to pathways important for pathogenicity. Length = 205 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.004
Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 18/157 (11%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 419
++L + N R EEAL ++E + + R S+ +E E LA
Sbjct: 869 EELESELEALLNERASL-EEALALLRSELEELSEELRELESKRSELRRE--LEELREKLA 925
Query: 420 NGKLELERMKKQHDEVME--------ELQIALDQKSLLESQIAESDQTAKELEQKI---- 467
+L LE ++ + D + E L+ A ++ +E E+ + K LE KI
Sbjct: 926 QLELRLEGLEVRIDNLQERLSEEYSLTLEEAEALENKIEDDEEEARRRLKRLENKIKELG 985
Query: 468 ---ISAVELLQNYKKEQDELQMERDKAVKEAEELRKS 501
++A+E + K+ D L +++ + E L ++
Sbjct: 986 PVNLAAIEEYEELKERYDFLTAQKEDLTEAKETLEEA 1022
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|148617 pfam07111, HCR, Alpha helical coiled-coil rod protein (HCR) | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.004
Identities = 39/130 (30%), Positives = 60/130 (46%), Gaps = 13/130 (10%)
Query: 368 EAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELER 427
EA+ EA A + G+AE E +R A A AEE+ RK EE G+ ELE
Sbjct: 97 EAQAEELEALAVAEKAGRAE---AEGLRAALAG----AEEV--RKNLEEG---GQQELEE 144
Query: 428 MKKQHDEVMEELQIALDQK-SLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQM 486
++ H E + L A + S L S+ +++ + LE + + L + E D L+
Sbjct: 145 AQRLHQEQLSSLTQAHLEALSSLRSKAEGLEKSLQSLETRRAGEAKALAAAQAEADTLRE 204
Query: 487 ERDKAVKEAE 496
+ K +E E
Sbjct: 205 QLSKTQEELE 214
|
This family consists of several mammalian alpha helical coiled-coil rod HCR proteins. The function of HCR is unknown but it has been implicated in psoriasis in humans and is thought to affect keratinocyte proliferation. Length = 739 |
| >gnl|CDD|227061 COG4717, COG4717, Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 33/146 (22%), Positives = 61/146 (41%), Gaps = 5/146 (3%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKAS-ESLYAEELKRRKEFEEALA 419
++ +AF EA R + + +A E + AE + ++
Sbjct: 712 EILDLFDCGTADTEDAFREAAREEQQLTQRESRLESLEAQLEGVAAEAYELSASLDQR-E 770
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIA--ESDQTAKELEQKIISAVELLQNY 477
+ EL +++ D + EE++ Q + L QIA E T EL Q+ S E L+
Sbjct: 771 LKEEELALLEEAIDALDEEVEELHAQVAALSRQIAQLEGGGTVAELRQRRESLKEDLEEK 830
Query: 478 KKEQDELQMERDKAVKEAEELRKSRK 503
++ L++ + ++EA L K R+
Sbjct: 831 ARKWASLRLAV-QVLEEALRLFKERR 855
|
Length = 984 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 846 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.5 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.42 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.4 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.38 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.23 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.21 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.03 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.97 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 98.92 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.72 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 98.66 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.43 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.17 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.13 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.06 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.98 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.98 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.96 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 97.95 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.88 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.87 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.8 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.69 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.61 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.58 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 97.51 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.47 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.46 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.4 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.31 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.19 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.12 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.11 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.05 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.75 | |
| PLN02236 | 344 | choline kinase | 96.71 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.67 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.6 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.51 | |
| KOG1029 | 1118 | consensus Endocytic adaptor protein intersectin [S | 96.22 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=419.56 Aligned_cols=276 Identities=45% Similarity=0.793 Sum_probs=234.7
Q ss_pred cCCCCChhhhhhhcCCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc
Q 003121 514 FFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592 (846)
Q Consensus 514 ~~~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~ 592 (846)
....|++.++..+|++|.....||+||||.||+|...+ ..||||++.........+|.+|+.+|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999987 78999988776543134599999999999999999999999
Q ss_pred c--C-ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeee
Q 003121 593 P--E-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 669 (846)
Q Consensus 593 ~--~-~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~ 669 (846)
. + ..+|||||+++|+|.++|...... +++|..+++|+.++|+||.|||...+.+||||||||+|||||.++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 4 3 389999999999999999766544 89999999999999999999999765689999999999999999999999
Q ss_pred cccccccccc-ccccCCCccccccCCC-CCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCc---------
Q 003121 670 DFGISRFLSQ-NEISSNNTTLCCRTDP-KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT--------- 738 (846)
Q Consensus 670 DFGla~~~~~-~~~~~~~~~~~~~~~~-~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~--------- 738 (846)
|||+|+.... .... ... .||.+|+|||++..+..+.++|||||||+|+||+||+++.+..
T Consensus 220 DFGLa~~~~~~~~~~---------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV---------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred CccCcccCCccccce---------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999976543 1110 011 5999999999999999999999999999999999999888643
Q ss_pred hHHHHHHhhhhhccccCCCC--CCCCh-hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 739 KEVQYALDTGKLKNLLDPLA--GDWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 739 ~~~~~~~~~~~~~~~ld~~~--~~~p~-~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.+....+..+++.+++|+.. ..++. .....+..++.+|++.+|.+||+| .+|.++|+.+..
T Consensus 291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m-~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTM-SQVVKELEGILS 354 (361)
T ss_pred HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCH-HHHHHHHHhhcc
Confidence 22234556678899999875 45554 567789999999999999999999 667777765543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=402.09 Aligned_cols=257 Identities=35% Similarity=0.551 Sum_probs=214.2
Q ss_pred CcccceeeeeCceEEEEEEECCeE-EEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccccC---ceEEEEEec
Q 003121 530 FDPSLKIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE---VWTLVYEYL 603 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~~~-VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~~---~~~lVmEy~ 603 (846)
+.....||.|+||+||+|.++|+. ||||++....... ...|.+|+.+|.+++|||||+++|+|.+ ..++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344556999999999999999988 9999998764433 3489999999999999999999999954 378999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-eEecccCCCceEecCCC-ceeeecccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-IVHGDLKPANILLDANF-VSKLSDFGISRFLSQNE 681 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g-iiHrDLkp~NILl~~~~-~vKL~DFGla~~~~~~~ 681 (846)
++|+|..+|... ....+++..++.|+.||++|+.|||+ ++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999754 35689999999999999999999999 56 99999999999999998 99999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLA--SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~--~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
. ..+...||+.|||||++. ...|+.|+|||||||+||||+||+.||........+.... . ...++
T Consensus 199 ~--------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~-~----~~~Rp 265 (362)
T KOG0192|consen 199 T--------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV-V----GGLRP 265 (362)
T ss_pred c--------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-h----cCCCC
Confidence 1 113356999999999999 5689999999999999999999999998776533221111 1 12233
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCC
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGG 804 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~ 804 (846)
..|..++..+..|+.+||..+|..||++ .++...|+.+......
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f-~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSF-LEIVSRLESIMSHISS 309 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCH-HHHHHHHHHHHHhhcc
Confidence 4455577899999999999999999999 8899999988776543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=381.38 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=201.6
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
.++|+.++.||+|+||.||.++-+ |..+|+|++++..+.. ..+++.|-+||...++|+||+||.+|. +++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 458999999999999999999765 6789999999875543 456889999999999999999999995 579999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||++||++..+|.. ...|++..+..++.+++.|+..||+ .|+|||||||+|+|||..|++||+|||||..+..
T Consensus 220 MEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999954 4569999999999999999999999 9999999999999999999999999999964432
Q ss_pred ccccC---------------CCccc------------------------cccCCCCCCcccCChhhhccCCCCchhhHHH
Q 003121 680 NEISS---------------NNTTL------------------------CCRTDPKGTFAYMDPEFLASGELTPKSDVYS 720 (846)
Q Consensus 680 ~~~~~---------------~~~~~------------------------~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwS 720 (846)
..... ..... ......+|||.|||||++.+.+|+..||+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 11000 00000 0012347999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCC
Q 003121 721 FGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 721 lGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
||||+||||.|.|||.........-..-++...+.... ....+.+..+||.+||. +|.+|-.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999987766543333333333222111 11234789999999999 9999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=379.91 Aligned_cols=244 Identities=32% Similarity=0.495 Sum_probs=201.9
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
..+|.....||.|.||+||+|+++ +..||||.+..... ...+.+..|+.+|+.++|||||.|++++ ++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888899999999999999987 57899999987643 2345678999999999999999999998 56799999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC------Cceeeeccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN------FVSKLSDFGIS 674 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~------~~vKL~DFGla 674 (846)
|||.||+|.+++..+ +.+++.++..++.||+.||++||. ++||||||||+||||+.+ -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999644 469999999999999999999999 999999999999999764 46899999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 754 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~l 754 (846)
+.+..... .. +.+|+|.|||||++..++|+.|+|+||+|+|||+|++|++||......+......+-.+.
T Consensus 163 R~L~~~~~---a~------tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~- 232 (429)
T KOG0595|consen 163 RFLQPGSM---AE------TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI- 232 (429)
T ss_pred hhCCchhH---HH------HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc-
Confidence 99875432 22 345999999999999999999999999999999999999999866655443322222222
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 755 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
.+..+...+..+.+|+...+..+|.+|-++..
T Consensus 233 ---~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 233 ---VPVLPAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred ---cCchhhhccCchhhhhhHHHhcCccccCchHH
Confidence 22333444556778999999999999988843
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=390.72 Aligned_cols=242 Identities=26% Similarity=0.416 Sum_probs=207.0
Q ss_pred CCCcccceeeeeCceEEEEEEE--CCeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEeccccC--ceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lVm 600 (846)
..|...+.||+|||+.||.++. .|..||+|++.+.... ..+.+.+||+|.+.|+|||||+++++|++ +.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999987 3788999999875433 35679999999999999999999999964 699999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
|+|..++|..++. ...++++.+++.++.||+.||.|||+ ++|||||||..|+||+++.+|||+|||||..+...
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999994 45789999999999999999999999 89999999999999999999999999999988654
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
+ .... +.+|||.|+|||++....++..+||||+|||||.||+|+|||.... +......-+..+..
T Consensus 172 ~--Erk~------TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-vkety~~Ik~~~Y~------ 236 (592)
T KOG0575|consen 172 G--ERKK------TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-VKETYNKIKLNEYS------ 236 (592)
T ss_pred c--cccc------eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-HHHHHHHHHhcCcc------
Confidence 2 2223 3459999999999999999999999999999999999999997553 33333333333332
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.|...+....+||.++|+.+|.+||++ ++|
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl-~~v 266 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSL-DEV 266 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCH-HHH
Confidence 344667889999999999999999999 444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=372.45 Aligned_cols=237 Identities=29% Similarity=0.379 Sum_probs=200.8
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
..+|++.++||+|+||+||.++.+ ++.+|+|++++.... ...+...|..||..++||+||+|+..|+ +.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 458999999999999999998766 567999999886443 3467889999999999999999999995 579999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
+||+.||.|..+|. ....+++..+..++.+|+.||.|||+ +|||||||||+|||||.+|+++|+|||||+..-.
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999994 44569999999999999999999999 9999999999999999999999999999995443
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHhhhhhccccCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPL 757 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~--~~~~~~~~~~~ld~~ 757 (846)
.... . .+.+||+.|||||++.+.+|+..+|||||||++|||+||.|||...+... ..+..++
T Consensus 178 ~~~~--t------~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-------- 241 (357)
T KOG0598|consen 178 DGDA--T------RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-------- 241 (357)
T ss_pred CCCc--c------ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--------
Confidence 3211 1 23579999999999999999999999999999999999999997665433 2222222
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCC
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
....|...+....+|+.++|..+|++|-
T Consensus 242 ~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 2233455678899999999999999995
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=387.00 Aligned_cols=252 Identities=31% Similarity=0.529 Sum_probs=214.2
Q ss_pred CCcccceeeeeCceEEEEEEECCe-EEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 605 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~~-~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~g 605 (846)
.+...+.||+|-||+||.|.+++. .||+|.++.... ..+.|.+|++||++|+|+|||+|+|+|. +..|||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 455677899999999999999986 899999987643 4678999999999999999999999994 358999999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|.++|.. .....+...+.+.++.|||+|++||++ +++|||||...||||+++..+||+|||||+...++.+...
T Consensus 286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 999999965 345678999999999999999999999 8999999999999999999999999999996665544322
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCCCCCCCC
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 762 (846)
.+..-...|.|||.+..+.++.+||||||||+||||+| |+.|++.....+ ..++.| .+-..|
T Consensus 362 -------~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G--------yRlp~P 426 (468)
T KOG0197|consen 362 -------EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG--------YRLPRP 426 (468)
T ss_pred -------CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc--------CcCCCC
Confidence 23345778999999999999999999999999999999 999987765543 223332 223346
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
..+|+.+.+|+..||+.+|++|||| +.+...|+++...
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF-~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTF-ETLREVLEDFFTS 464 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCH-HHHHHHHHHhhhc
Confidence 6778999999999999999999999 7788888877543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=373.99 Aligned_cols=241 Identities=28% Similarity=0.447 Sum_probs=195.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC-------chhHHHHHHHHHhcCCCceeeEeccc--cCce
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-------PSEFQQEIDILSKIRHPNLVTLVGAC--PEVW 596 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~-------~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~ 596 (846)
+.|.+.+.||+|+||.|-+|..+ ++.||||++++..... ...+.+|++||++|+|||||+++++| ++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 35777889999999999999876 6889999998763322 12357999999999999999999999 4578
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC---Cceeeecccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGI 673 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~---~~vKL~DFGl 673 (846)
|+||||+.||+|.+.+..+ +.+.+.....++.|++.||.|||+ +||+||||||+|||+..+ ..+||+|||+
T Consensus 252 YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence 9999999999999999533 457778889999999999999999 999999999999999766 7899999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHhh
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALDT 747 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~~~ksDVwSlGviL~elltG~~pf~~~~~---~~~~~~~ 747 (846)
|+..+... .. .+.+|||.|.|||++.++. +..++|+||+||+||-+|+|.|||..... ....+..
T Consensus 326 AK~~g~~s---fm------~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 326 AKVSGEGS---FM------KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred hhccccce---eh------hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 99886432 22 3346999999999998765 34488999999999999999999964432 2233333
Q ss_pred hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
+++.. ....| ...+++..+||.+||..||++||++.
T Consensus 397 G~y~f----~p~~w-~~Iseea~dlI~~mL~VdP~~R~s~~ 432 (475)
T KOG0615|consen 397 GRYAF----GPLQW-DRISEEALDLINWMLVVDPENRPSAD 432 (475)
T ss_pred Ccccc----cChhh-hhhhHHHHHHHHHhhEeCcccCcCHH
Confidence 33321 12223 34678899999999999999999993
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.67 Aligned_cols=253 Identities=28% Similarity=0.418 Sum_probs=205.9
Q ss_pred CCCcccceeeeeCceEEEEEEE--CCeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEec-ccc---CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVG-ACP---EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g-~~~---~~~~lV 599 (846)
.+|.+.++||+|.||+||++.. .+..||.|.++-.... ..+....|+.+|++|+|||||++++ .|. +.++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3688889999999999999875 4788999998844332 2346789999999999999999999 452 237899
Q ss_pred EEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecccCCCceEecCCCceeeecccccccc
Q 003121 600 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
||||.+|+|...+... .....+++..+++++.|++.||..+|+.-++ -|+||||||.||+|+.+|.|||+||||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999988654 3456799999999999999999999984333 3899999999999999999999999999988
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HhhhhhccccC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLD 755 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~--~~~~~~~~~ld 755 (846)
....... ...+|||.||+||.+...+|+.+|||||+||++|||+.-++||.+.+..... +..+.
T Consensus 179 ~s~~tfA--------~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd------ 244 (375)
T KOG0591|consen 179 SSKTTFA--------HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD------ 244 (375)
T ss_pred cchhHHH--------HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC------
Confidence 7654322 3456999999999999999999999999999999999999999888654432 22221
Q ss_pred CCCCCCC-hhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 756 PLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 756 ~~~~~~p-~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.+..| ...+..+..||..|+..||+.||+....+.++..
T Consensus 245 --~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 245 --YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11223 5678999999999999999999985344444444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=367.52 Aligned_cols=240 Identities=26% Similarity=0.383 Sum_probs=198.4
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cC-ceEEEEEec
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PE-VWTLVYEYL 603 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~-~~~lVmEy~ 603 (846)
.+....||+|..|+||++.++ +..+|+|++..... ....++.+|++|++.++|||||.+||+| .. ..+++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344567999999999999988 57799999965432 2346789999999999999999999998 33 388999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++|||++++.. .+.+++....+|+.++++||.|||.. ++||||||||+||||+..|.|||||||.++.+....
T Consensus 161 DgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~-- 233 (364)
T KOG0581|consen 161 DGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI-- 233 (364)
T ss_pred CCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhhh--
Confidence 99999999943 35699999999999999999999953 679999999999999999999999999998775541
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----hHHHHHHhhhhhccccCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT-----KEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~-----~~~~~~~~~~~~~~~ld~~~ 758 (846)
..+.+||..|||||.+.+..|+.++||||||++++|+.+|+-||... ..+.. +..+++...
T Consensus 234 --------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L------l~~Iv~~pp 299 (364)
T KOG0581|consen 234 --------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL------LCAIVDEPP 299 (364)
T ss_pred --------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH------HHHHhcCCC
Confidence 13467999999999999999999999999999999999999998654 22221 122233223
Q ss_pred CCCChh-hHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFV-QAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~-~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+..|.. .+++|+.|+..||+++|.+||++ +++
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~-~qL 332 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSA-KQL 332 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCH-HHH
Confidence 334443 67889999999999999999999 444
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=344.19 Aligned_cols=234 Identities=26% Similarity=0.389 Sum_probs=199.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
.+|+..+.||.|+||+|...+.+ +..+|+|++.+.... ..++..+|..+|+.+.||++++|++.|. ...|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 36888899999999999998876 567999999876443 3456789999999999999999999985 4689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||++||.|..+|+ ...++++..++.++.+|+.||.|||+ ++|++|||||+|||||.+|++||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999995 34569999999999999999999999 89999999999999999999999999999987543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
..+ .+|||.|+|||++...+|+.++|+|||||++|||+.|++||...+.... .+ .++ ...-.
T Consensus 198 -----T~T------lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i-Y~-----KI~-~~~v~ 259 (355)
T KOG0616|consen 198 -----TWT------LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI-YE-----KIL-EGKVK 259 (355)
T ss_pred -----EEE------ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-HH-----HHH-hCccc
Confidence 233 3599999999999999999999999999999999999999987776331 11 111 11224
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCC
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
+|..-+..+.+|+...|++|-.+|-
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhhh
Confidence 5677778899999999999999994
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=364.35 Aligned_cols=250 Identities=28% Similarity=0.417 Sum_probs=206.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhc-CCCceeeEeccccC--ceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~--~~~lV 599 (846)
.+|..++.||.|+|++||+|+.. ++.+|||++.+.-. ....-+..|-++|.+| .||.|++||..|.+ .+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 36777788999999999999876 57899999876522 2234577899999999 89999999999954 69999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
+||+++|+|.++|.+. +.|++...+.++.+|+.||.|||+ +|||||||||+|||||.+|++||+|||.|+.+..
T Consensus 153 Le~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 9999999999999544 569999999999999999999999 9999999999999999999999999999999876
Q ss_pred cccc-----CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcccc
Q 003121 680 NEIS-----SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 754 (846)
Q Consensus 680 ~~~~-----~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~l 754 (846)
.... ...........++||..|.+||+|..+..++.+|+|+||||||+|+.|.|||...++.........+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l---- 302 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL---- 302 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh----
Confidence 5443 1111212235689999999999999999999999999999999999999999887764432222211
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 755 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.-.||..-++.+.+|+.+.|-.+|.+|++. ++|
T Consensus 303 ---~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~-~qI 335 (604)
T KOG0592|consen 303 ---DYEFPEGFPEDARDLIKKLLVRDPSDRLTS-QQI 335 (604)
T ss_pred ---cccCCCCCCHHHHHHHHHHHccCccccccH-HHH
Confidence 123445555889999999999999999998 444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=353.57 Aligned_cols=248 Identities=30% Similarity=0.501 Sum_probs=201.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cC--ceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PE--VWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~--~~~lVmE 601 (846)
.++...+.||+|.||.||.+... +...|||.+........+.+.+|+.+|++|+|||||+++|.. .+ .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35677788999999999999887 478999988765333355689999999999999999999963 34 5889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-CCceeeeccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-~~~vKL~DFGla~~~~~~ 680 (846)
|+++|+|.+++...+. .|++..+..++.||+.||.|||+ +|||||||||+||||+. +|.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999964432 69999999999999999999999 99999999999999999 799999999999876541
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCc-hHHHHHHhhhhhccccCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGIT-KEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~ksDVwSlGviL~elltG~~pf~~~-~~~~~~~~~~~~~~~ld~~~ 758 (846)
.... .......||+.|||||++..+. ...++|||||||++.||+||.+||... ......+..+.- ...
T Consensus 172 ~~~~-----~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~-----~~~ 241 (313)
T KOG0198|consen 172 GTKS-----DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE-----DSL 241 (313)
T ss_pred cccc-----cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc-----CCC
Confidence 1111 1113457999999999998643 345999999999999999999999762 333333333322 123
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+.+|...+....+++.+|+..+|..|||+ +++
T Consensus 242 P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta-~eL 273 (313)
T KOG0198|consen 242 PEIPDSLSDEAKDFLRKCFKRDPEKRPTA-EEL 273 (313)
T ss_pred CCCCcccCHHHHHHHHHHhhcCcccCcCH-HHH
Confidence 46777788999999999999999999999 444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=335.42 Aligned_cols=245 Identities=27% Similarity=0.390 Sum_probs=196.3
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
.|+.+.++|+|+||.||+++.+ |+.||||++....... .+...+|+.+|++|+|||+|.|+.+| ...++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 5777889999999999999887 5789999997654321 24567999999999999999999999 4579999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
|+..-|.++- .....++...+..|++|++.|+.|+|. +++|||||||+||||+.+|.+||||||+|+.+....
T Consensus 83 ~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg- 155 (396)
T KOG0593|consen 83 CDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG- 155 (396)
T ss_pred cchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence 9886666543 234568899999999999999999999 899999999999999999999999999999886421
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhh-------------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG------------- 748 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~------------- 748 (846)
.. .+.-+.|.||.|||.+.+ .+|++.+||||+||++.||+||.|.|.+.+.+.......
T Consensus 156 -d~------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 156 -DN------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred -ch------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 11 134457999999999988 689999999999999999999999998887765543211
Q ss_pred -----hhccccCC-------CCCCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 749 -----KLKNLLDP-------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 749 -----~~~~~ld~-------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
.+..+.-| +...+| ..+.-+.+|+..||..||.+|++-.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~ 279 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCE 279 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHH
Confidence 11111111 112222 2244789999999999999999873
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.38 Aligned_cols=245 Identities=22% Similarity=0.336 Sum_probs=200.1
Q ss_pred cceeeeeCceEEEEEEECCeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccccC------ceEEEEEec
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE------VWTLVYEYL 603 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~~------~~~lVmEy~ 603 (846)
...||+|++|.||+|.+++..||||.+....... .+.|.+|+.+|++++||||++++|+|.+ ..++||||+
T Consensus 25 ~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred CeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3579999999999999999999999998654333 3567899999999999999999998743 578999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++|+|.+++.. ...+++...+.++.+++.||.|||.. .+++||||||+|||++.++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999953 34688999999999999999999973 378899999999999999999999999988654321
Q ss_pred CCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
....|+..|+|||++.+ ..++.++|||||||++|||+||+.||............ .... .....
T Consensus 178 ---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i--~~~~---~~~~~ 243 (283)
T PHA02988 178 ---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI--INKN---NSLKL 243 (283)
T ss_pred ---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhcC---CCCCC
Confidence 12358999999999976 68999999999999999999999999765432211110 0000 11123
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
|...+..+.+|+.+||+.+|.+||++ ++++..|+.+.
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~-~ell~~l~~~~ 280 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNI-KEILYNLSLYK 280 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCH-HHHHHHHHHHH
Confidence 33456889999999999999999999 88888888765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=357.43 Aligned_cols=258 Identities=25% Similarity=0.393 Sum_probs=201.9
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccc---C
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP---E 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~---~ 594 (846)
.++|.+.++||+|+||.||+|.+. +..||||++...... ....+.+|+.+|..+ +||||++++|+|. .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 457888999999999999999752 246999998754322 235688999999999 8999999999884 3
Q ss_pred ceEEEEEecCCCchhhhhccCCC---------------------------------------------------------
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDN--------------------------------------------------------- 617 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~--------------------------------------------------------- 617 (846)
.+++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 47899999999999998864311
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCccccccCCC
Q 003121 618 --SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 695 (846)
Q Consensus 618 --~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~ 695 (846)
..++++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......... .....
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~------~~~~~ 236 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------RKGSA 236 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchh------cccCC
Confidence 2358889999999999999999999 899999999999999999999999999998654321111 01223
Q ss_pred CCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHH
Q 003121 696 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAM 774 (846)
Q Consensus 696 ~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~ 774 (846)
.+++.|+|||++.+..++.++|||||||+||||++ |.+||............ +. +......+...+..+.+|+.
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~l~~li~ 311 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR--LK---DGTRMRAPENATPEIYRIML 311 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH--Hh---cCCCCCCCCCCCHHHHHHHH
Confidence 46789999999998899999999999999999997 99999754322111111 00 11111223345678999999
Q ss_pred HHhccCcCCCCChHHHHHHHHHHHH
Q 003121 775 RCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 775 ~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
+||+.+|.+||++ .++++.|+.+.
T Consensus 312 ~cl~~dp~~RPs~-~el~~~l~~~~ 335 (338)
T cd05102 312 ACWQGDPKERPTF-SALVEILGDLL 335 (338)
T ss_pred HHccCChhhCcCH-HHHHHHHHHHH
Confidence 9999999999999 88888888764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=345.46 Aligned_cols=255 Identities=25% Similarity=0.323 Sum_probs=208.3
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
...+|++...||.|..+.||+|++. +..||||+++.....+ .+.+++|+..|+.++||||++++.+| ...+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 4557999999999999999999886 6789999999876554 47899999999999999999999988 56799999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
.||.+||+.+++...-. ..+++..+..|+.++++||.|||+ +|.||||||+.||||+.+|.|||+|||.+-.+...
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999965532 349999999999999999999999 99999999999999999999999999998876654
Q ss_pred cccCCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC---
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD--- 755 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld--- 755 (846)
+ . ... .......||++|||||+++. .+|+.|+|||||||+..||.+|..||.....++..+.. +.+...
T Consensus 180 G-~--R~~-~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~pp~~~ 253 (516)
T KOG0582|consen 180 G-D--RQV-TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDPPTLL 253 (516)
T ss_pred C-c--eee-EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCCCCcc
Confidence 3 1 111 11166789999999999754 47999999999999999999999999888876654432 222111
Q ss_pred --CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHH
Q 003121 756 --PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 790 (846)
Q Consensus 756 --~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 790 (846)
....+.....+..+.+++..||.+||.+||++.+.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskL 290 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKL 290 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHH
Confidence 00111112224689999999999999999999443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=358.42 Aligned_cols=243 Identities=26% Similarity=0.409 Sum_probs=205.1
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
.|....+||+|..|.||.+... +..||||.+........+-+.+|+.+|+.++|+|||+++..| .+..++|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 4556678999999999999765 567999999988777777899999999999999999999987 577999999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
||+|.|.+. ...+++.++..|+.+++.||.|||. +||+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 354 ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 354 GGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 999999984 3348999999999999999999999 9999999999999999999999999999998766542
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.++..+|||.|||||+.....|++++||||||++++||+-|.|||-..+.......... ...| .-..+..
T Consensus 425 ------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~---ng~P-~lk~~~k 494 (550)
T KOG0578|consen 425 ------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTP-KLKNPEK 494 (550)
T ss_pred ------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh---cCCC-CcCCccc
Confidence 23456799999999999999999999999999999999999999965554443222111 0111 1123456
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+..|.+|+.+||+.|+.+||++ .++
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA-~eL 520 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASA-KEL 520 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCH-HHH
Confidence 67899999999999999999999 444
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=361.57 Aligned_cols=241 Identities=24% Similarity=0.313 Sum_probs=202.0
Q ss_pred hhcCCCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCCC---chhHHHHHHHHHhc-CCCceeeEeccc--cCce
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG---PSEFQQEIDILSKI-RHPNLVTLVGAC--PEVW 596 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~ 596 (846)
....+|..+++||+|.||+|+.+..++ ..+|||++++..... .+....|..|+... +||.++.|+.+| .+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345689999999999999999998875 579999999875543 45567899998888 599999999999 5689
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
|+||||+.||++..+. ....|++..+..|+++++.||.|||. +||||||||.+|||||.+|++||+|||+|+-
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999954433 34569999999999999999999999 9999999999999999999999999999985
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCC
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
.-..+ +. .++.+|||.|||||++.+..|+.++|||||||+|||||+|.+||.+.++.+.. +.+..
T Consensus 518 ~m~~g---~~-----TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F-------dsI~~ 582 (694)
T KOG0694|consen 518 GMGQG---DR-----TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF-------DSIVN 582 (694)
T ss_pred cCCCC---Cc-----cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHhc
Confidence 32111 11 14567999999999999999999999999999999999999999877664421 11112
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
....+|...+.+...++.++|.++|++|-..
T Consensus 583 d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2345778889999999999999999999866
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=349.22 Aligned_cols=249 Identities=29% Similarity=0.402 Sum_probs=201.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc----cCceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC----PEVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~----~~~~~lV 599 (846)
..|+.+.+||+|.||.||+|+.. +..||+|++..... ..+....+||.||++|+||||++|.+.. ...+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 35777889999999999999875 57799999987653 3355678999999999999999999976 2368999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
+|||+. +|.-++. .....|++.++..|+.|++.||.|+|. +||+|||||.+|||||.+|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999976 7888774 234579999999999999999999999 9999999999999999999999999999998876
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..... .++.+-|.||.|||.|.+. .|+.++|+||.||||.||++|+|.|.+..++.+.-..-++.. .|..
T Consensus 271 ~~~~~-------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcG--SP~e 341 (560)
T KOG0600|consen 271 SGSAP-------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCG--SPTE 341 (560)
T ss_pred CCCcc-------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhC--CCCh
Confidence 54322 2455679999999999885 799999999999999999999999998888765543322211 1111
Q ss_pred CCCC------------------------hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWP------------------------FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p------------------------~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..|+ ...+....+|+..+|..||.+|.|+.+.+
T Consensus 342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 1121 11245678999999999999999995443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=353.78 Aligned_cols=241 Identities=30% Similarity=0.413 Sum_probs=202.9
Q ss_pred CCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|-+...||+|.||+||||+.++ +.||||.+.+.... ....+.+|++|++.|+|||||.++++|+ .++++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 56677789999999999998775 67999999875432 2345899999999999999999999995 468999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+.| +|+.+|. ....++++.+..|+.++..||.|||+ ++|+|||+||.||||+.+|++|++|||+|+.+.....
T Consensus 83 a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 83 AVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred hhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence 976 9999995 33569999999999999999999999 8999999999999999999999999999998765321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
..+...|||.|||||...++.|+..+|.||+|||+|||.+|+|||....-.. +...+......||
T Consensus 156 --------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~-------Lv~~I~~d~v~~p 220 (808)
T KOG0597|consen 156 --------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ-------LVKSILKDPVKPP 220 (808)
T ss_pred --------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH-------HHHHHhcCCCCCc
Confidence 1245679999999999999999999999999999999999999995444322 1222222334577
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+..+..|+.-.|.+||..|.+....+
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 78889999999999999999999985443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=352.88 Aligned_cols=244 Identities=28% Similarity=0.401 Sum_probs=201.2
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC----CC-CCchhHHHHHHHHHhcC-CCceeeEeccc--cCc
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH----SL-QGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEV 595 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~----~~-~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~--~~~ 595 (846)
..+.|...+.||+|+||+|+.|... +..||||++... .. ...+.+.+|+.+++.++ ||||++++.++ ...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999775 688999977664 11 22446778999999998 99999999987 456
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC-Cceeeeccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGIS 674 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~-~~vKL~DFGla 674 (846)
.++||||+.||+|.+++.. ..++.+..+..++.|++.|+.|+|+ +||+||||||+|||++.+ +.+||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999954 4678899999999999999999999 899999999999999999 99999999999
Q ss_pred cccc-cccccCCCccccccCCCCCCcccCChhhhccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc
Q 003121 675 RFLS-QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 751 (846)
Q Consensus 675 ~~~~-~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~-~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~ 751 (846)
.... .... ..+.+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||...+.......
T Consensus 169 ~~~~~~~~~---------l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k----- 234 (370)
T KOG0583|consen 169 AISPGEDGL---------LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK----- 234 (370)
T ss_pred cccCCCCCc---------ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-----
Confidence 9773 2211 13456999999999999877 85 789999999999999999999987544332111
Q ss_pred cccCCCCCCCChhh-HHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 752 NLLDPLAGDWPFVQ-AEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 752 ~~ld~~~~~~p~~~-~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
+....-.+|... +..+..|+.+||..+|..|+++ .++.
T Consensus 235 --i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~-~~i~ 273 (370)
T KOG0583|consen 235 --IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITL-LEIL 273 (370)
T ss_pred --HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCH-HHHh
Confidence 111112234444 7889999999999999999999 5554
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=357.30 Aligned_cols=265 Identities=26% Similarity=0.470 Sum_probs=207.5
Q ss_pred hhhhhhcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc-cCceE
Q 003121 521 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC-PEVWT 597 (846)
Q Consensus 521 ~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~-~~~~~ 597 (846)
.+++...+.+.+...||+|.||+||+|.|.| .||||+++...... .+.|++|+.+|++-+|-||+-++|+| .+.+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~A 463 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLA 463 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCcee
Confidence 3344444456677889999999999999976 59999998775543 35699999999999999999999999 44568
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
||.-+|.|-+|..+|+-.+ ..|...+.+.|+.||++|+.|||. ++|||||||..||||.++++|||+||||+..-
T Consensus 464 IiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence 9999999999999996443 568889999999999999999999 99999999999999999999999999998754
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcccc
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 754 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~l 754 (846)
........ .....|...|||||++.. .+|+..+|||||||++|||+||..||......+-.+..++-...
T Consensus 539 ~~w~g~~q------~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~- 611 (678)
T KOG0193|consen 539 TRWSGEQQ------LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM- 611 (678)
T ss_pred eeeccccc------cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC-
Confidence 32211110 123458999999999964 46999999999999999999999999844333322233322222
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 755 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
+........+++.+.+|+..||..++++||.+ ..|+..|+.+..
T Consensus 612 -pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F-~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 -PDLSKIRSNCPKAMKRLLSDCWKFDREERPLF-PQLLSKLEELLP 655 (678)
T ss_pred -ccchhhhccCHHHHHHHHHHHHhcCcccCccH-HHHHHHHHHhhh
Confidence 22222234567899999999999999999999 556565555444
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.30 Aligned_cols=245 Identities=27% Similarity=0.418 Sum_probs=199.8
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|...++||+|.||.||+|... |+.||||+++.....+ .....+|++.|+.++||||+.|+++|+ +.+.||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 5777788999999999999875 6889999998764432 345789999999999999999999995 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
++ .+|+..+. +....|+...+..++.++++||+|||. +.|+||||||+|+|++.+|.+||+|||+++.+.....
T Consensus 83 m~-tdLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 96 59999884 556789999999999999999999999 8999999999999999999999999999998875542
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. +..+-|.+|.|||.+.+. .|+..+|+||.|||+.||+-|.|.|.+....++.... +..+-.|....|
T Consensus 157 ~~--------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I--f~~LGTP~~~~W 226 (318)
T KOG0659|consen 157 IQ--------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI--FRALGTPTPDQW 226 (318)
T ss_pred cc--------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH--HHHcCCCCcccC
Confidence 22 122469999999999874 7999999999999999999999999887766543221 111112222222
Q ss_pred C-----------------------hhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 762 P-----------------------FVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 762 p-----------------------~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
| ...+..+.+|+..+|..||.+|+++.+
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q 277 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ 277 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence 2 223456799999999999999999943
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=372.82 Aligned_cols=259 Identities=28% Similarity=0.517 Sum_probs=216.7
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCc
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEV 595 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~ 595 (846)
...+....+.||+|.||+||+|...+ +.||||.++..... ...+|++|+++|..|+|||||+|+|.| .+.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 34466677889999999999998753 45999999977654 567899999999999999999999999 467
Q ss_pred eEEEEEecCCCchhhhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC
Q 003121 596 WTLVYEYLPNGSLEDRLSCKD-----------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 664 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~ 664 (846)
+++|+|||..|||.++|.... ..++|+..+.+.|+.|||.|+.||-+ +.+|||||-..|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceeccce
Confidence 999999999999999995431 13459999999999999999999999 7899999999999999999
Q ss_pred ceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--H
Q 003121 665 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--V 741 (846)
Q Consensus 665 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~--~ 741 (846)
.|||+||||++.+...++.... ....-..+|||||.+..++|+++||||||||+|||+++ |+.|+..... +
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~------~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVR------GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred EEEecccccchhhhhhhhhccc------CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 9999999999977665544322 12234789999999999999999999999999999999 8888765433 4
Q ss_pred HHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 742 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 742 ~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
...+..+++ -..|..+|..++.|+..||+.+|.+||+| ++|...|+.+....
T Consensus 715 Ie~i~~g~l--------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF-~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 IECIRAGQL--------LSCPENCPTEVYSLMLECWNENPKRRPSF-KEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHcCCc--------ccCCCCCCHHHHHHHHHHhhcCcccCCCH-HHHHHHHHHHHhcC
Confidence 444555443 23567778999999999999999999999 89999998776543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.68 Aligned_cols=259 Identities=27% Similarity=0.462 Sum_probs=198.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC------------------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR------------------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTL 588 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~------------------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l 588 (846)
++|...++||+|+||.||++.+. +..||+|.+...... ....|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46888899999999999999753 236999998764322 23468899999999999999999
Q ss_pred ecccc--CceEEEEEecCCCchhhhhccCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEe
Q 003121 589 VGACP--EVWTLVYEYLPNGSLEDRLSCKD----------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650 (846)
Q Consensus 589 ~g~~~--~~~~lVmEy~~ggsL~~~L~~~~----------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiH 650 (846)
+++|. +..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+ ++|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 99884 56899999999999999885321 12357888999999999999999999 89999
Q ss_pred cccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh
Q 003121 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730 (846)
Q Consensus 651 rDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt 730 (846)
|||||+|||++.++.+||+|||+++.+....... ......++..|+|||++.++.++.++||||||+++|+|++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR------IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeE------ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 9999999999999999999999998654332111 1123346889999999988899999999999999999987
Q ss_pred --CCCCCCCchHHHHHHhhhh-hccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 731 --GRPALGITKEVQYALDTGK-LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 731 --G~~pf~~~~~~~~~~~~~~-~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
|..||.............. +...........+...+..+.+|+.+||..+|.+||++ .++.+.|+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~-~~i~~~l~ 303 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF-SDIHAFLT 303 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH-HHHHHHHh
Confidence 5567765433221111100 11111111112233456789999999999999999999 77777664
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=351.92 Aligned_cols=239 Identities=26% Similarity=0.406 Sum_probs=202.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
+-|.+++.||.|+-|.|..|++. |+.+|||++.+.... .+..+.+|+-||+.+.||||++||+.+. ..+|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 35777888999999999999875 788999999876322 2456899999999999999999999985 4699999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||++||.|+++|.. .++|++.+++++++||+.|+.|+|. .+|+||||||+|+|||.++.+||+|||+|.+...+
T Consensus 92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999954 4679999999999999999999999 88999999999999999999999999999876554
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HhhhhhccccCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPL 757 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~--~~~~~~~~~ld~~ 757 (846)
... .+.+|+|.|.+||++.+.+| +.++||||+|||||.||||+.||+..+-.... +..|.+
T Consensus 166 klL---------eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f------- 229 (786)
T KOG0588|consen 166 KLL---------ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF------- 229 (786)
T ss_pred ccc---------cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-------
Confidence 321 33469999999999999988 57899999999999999999999865543322 222222
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+.|...+.+.++|+.+|+.+||..|.|+ ++|
T Consensus 230 --~MPs~Is~eaQdLLr~ml~VDp~~RiT~-~eI 260 (786)
T KOG0588|consen 230 --EMPSNISSEAQDLLRRMLDVDPSTRITT-EEI 260 (786)
T ss_pred --cCCCcCCHHHHHHHHHHhccCccccccH-HHH
Confidence 2356677899999999999999999999 554
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=341.09 Aligned_cols=234 Identities=26% Similarity=0.349 Sum_probs=193.9
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
+|...+.||+|+||.||+|... +..||+|++..... .....+.+|+.+|+.++||||+++++++. ...++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6888899999999999999886 67899999875422 23456889999999999999999999874 46889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 82 YVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999999853 3468999999999999999999999 899999999999999999999999999988653221
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
....||+.|+|||++.+..++.++|||||||++|+|+||+.||............ . .....+
T Consensus 156 -----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i--~-----~~~~~~ 217 (291)
T cd05612 156 -----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--L-----AGKLEF 217 (291)
T ss_pred -----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H-----hCCcCC
Confidence 1235899999999999888999999999999999999999999765443211111 0 011234
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCC
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
|...+..+.+|+.+||+.+|.+||+
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccC
Confidence 4445678999999999999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.44 Aligned_cols=247 Identities=28% Similarity=0.380 Sum_probs=194.4
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--------------CchhHHHHHHHHHhcCCCceeeEec
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------------GPSEFQQEIDILSKIRHPNLVTLVG 590 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--------------~~~~f~~Ei~iL~~l~HpnIv~l~g 590 (846)
.+.|.+...||+|.||.|-+|+.. ++.||||++.+.... ..+.+.+||.||++|+|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 457889999999999999999875 578999999765221 1257899999999999999999999
Q ss_pred cc----cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 591 AC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 591 ~~----~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
+. .+.+|||+|||..|.+...= .....|++.+++.|+.++..||.|||+ +|||||||||+|+||+.+|++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcE
Confidence 87 35799999999998876532 223339999999999999999999999 999999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 003121 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE----LTPKSDVYSFGIILLRLLTGRPALGITKEVQ 742 (846)
Q Consensus 667 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~~~ksDVwSlGviL~elltG~~pf~~~~~~~ 742 (846)
||+|||.+..+......... .+....+|||.|+|||...++. .+.+.||||+||+||.|+.|+-||-......
T Consensus 250 KIsDFGVs~~~~~~~~~~~d---~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSD---DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred EeeccceeeecccCCccccH---HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999876443211111 1223467999999999997743 3567899999999999999999996655443
Q ss_pred HHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 743 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 743 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.. ...... |+.-.......+.+.+||+++|++||..|.++
T Consensus 327 l~--~KIvn~---pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l 366 (576)
T KOG0585|consen 327 LF--DKIVND---PLEFPENPEINEDLKDLIKRLLEKDPEQRITL 366 (576)
T ss_pred HH--HHHhcC---cccCCCcccccHHHHHHHHHHhhcChhheeeh
Confidence 21 111111 22111122456889999999999999999998
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=350.09 Aligned_cols=240 Identities=28% Similarity=0.473 Sum_probs=198.2
Q ss_pred cceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCchhh
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLED 610 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggsL~~ 610 (846)
+.-||.|+.|-||.|.+.+..||||+++.-. ..+|+-|++|+||||+.+.|+|. ..+|||||||..|-|..
T Consensus 129 LeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 3459999999999999999999999876322 35788899999999999999994 46889999999999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCcccc
Q 003121 611 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 690 (846)
Q Consensus 611 ~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 690 (846)
+|. ...+++......|..+||.|+.|||. +.|||||||+-||||+.+..|||+|||.++-.....+
T Consensus 202 VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST-------- 267 (904)
T KOG4721|consen 202 VLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST-------- 267 (904)
T ss_pred HHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhh--------
Confidence 994 34568888899999999999999999 8899999999999999999999999999886654321
Q ss_pred ccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHH
Q 003121 691 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 770 (846)
Q Consensus 691 ~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~ 770 (846)
+..++||..|||||++.+.+.+.|+|||||||+|||||||..||...+... +-.+--.+. +....|..+++.|.
T Consensus 268 -kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--IIwGVGsNs---L~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 268 -KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--IIWGVGSNS---LHLPVPSTCPDGFK 341 (904)
T ss_pred -hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--eEEeccCCc---ccccCcccCchHHH
Confidence 134679999999999999999999999999999999999999996554422 111111111 22234566779999
Q ss_pred HHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 771 NLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 771 ~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
-|+++||+..|.+||+| ..++..|+-...
T Consensus 342 lL~Kqcw~sKpRNRPSF-rqil~HldIa~p 370 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSF-RQILLHLDIASP 370 (904)
T ss_pred HHHHHHHhcCCCCCccH-HHHHHHHhhcCH
Confidence 99999999999999999 666666664443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=336.30 Aligned_cols=240 Identities=25% Similarity=0.343 Sum_probs=193.1
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
|...+.||+|+||.||++... +..||+|.+...... ....+.+|+.+|++++||||++++++| .+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999875 678999998754322 234578899999999999999999987 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999988875332 3468999999999999999999999 8999999999999999999999999999986533211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHhhhhhccccCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 760 (846)
.....||+.|+|||++.+..++.++|||||||++|+|++|++||....... ..+.. .+......
T Consensus 158 ---------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~ 223 (285)
T cd05631 158 ---------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR-----RVKEDQEE 223 (285)
T ss_pred ---------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH-----Hhhccccc
Confidence 123458999999999999999999999999999999999999997643311 11111 01111122
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
++...+..+.+|+.+||+.+|.+||+.
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 344456789999999999999999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=371.86 Aligned_cols=262 Identities=29% Similarity=0.455 Sum_probs=213.7
Q ss_pred CCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
+....+.||+|.||.||.|.+.+ ..||||.+.... .+...+|.+|..+|++++|||||+++|+|- ...+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 45567789999999999998863 239999988753 344678999999999999999999999994 46889
Q ss_pred EEEecCCCchhhhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 599 VYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
++|||.||+|..+|+... ....|+....+.++.|||+|..||+. +++|||||...|+||+....|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999996542 14578999999999999999999999 88999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
+-+....+.... ....-...|||||.+..+.++.|+|||||||+|||++| |..||+..+..+-.....
T Consensus 850 rDiy~~~yyr~~------~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~----- 918 (1025)
T KOG1095|consen 850 RDIYDKDYYRKH------GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL----- 918 (1025)
T ss_pred Hhhhhchheecc------CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH-----
Confidence 955444332211 11234578999999999999999999999999999999 999998877655332111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCCC
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGST 806 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~~ 806 (846)
...+-+.|..+++.+.+|+..||+.+|++||+| ..+++.+..+.....+..
T Consensus 919 -~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F-~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 919 -EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSF-RTIVEQDPAISNAALGTI 969 (1025)
T ss_pred -hCCccCCCCCCChHHHHHHHHHccCChhhCccH-HHHHhhhhhhhhhhccCc
Confidence 111334577889999999999999999999999 677777777766544433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=342.78 Aligned_cols=247 Identities=25% Similarity=0.348 Sum_probs=198.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchh--HHHHHHHHHhcC-CCceeeEecccc--C-ceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIR-HPNLVTLVGACP--E-VWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~--f~~Ei~iL~~l~-HpnIv~l~g~~~--~-~~~lV 599 (846)
++|...++||.|.||.||+|+.. +..||||.++..-.. .++ -.+|+.-|++|+ |||||+|...+- + .+|+|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 46888899999999999999875 577999998865433 333 458999999998 999999999883 3 68999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
||||+ .+|..++..+ +.+|++..+..|+.||+.||+|+|. +|+.||||||+|||+..+..+||+|||+||.+..
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence 99996 5999998644 6789999999999999999999999 9999999999999999899999999999997754
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh---------
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK--------- 749 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~--------- 749 (846)
... .+.-+.|.||.|||+|.. +-|+.++|+|++|||++|+.+-+|.|.+.++.......-.
T Consensus 163 kpP---------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 163 KPP---------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred CCC---------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence 432 134457999999999864 6799999999999999999999999988877655432110
Q ss_pred ------hccccCCCCCCC--------ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 750 ------LKNLLDPLAGDW--------PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 750 ------~~~~ld~~~~~~--------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+...+....+.. -...+.++.+|+.+||..||.+|||+ ++.
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA-~~a 288 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA-SQA 288 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH-HHH
Confidence 111111111000 01245789999999999999999999 444
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=343.85 Aligned_cols=240 Identities=26% Similarity=0.364 Sum_probs=200.3
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
.|.....||+|.||.||+|.+. ++.||||++...... ..+++++|+.+|.++++|||.++||++ ...++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4666678999999999999987 467999999876544 357899999999999999999999987 56788999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
.||++.+.|. ....+.+..+..++.+++.||.|||. ++.+|||||+.||||..+|.+||+|||.+..+......
T Consensus 94 ~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 94 GGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred cCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999994 34456888889999999999999999 89999999999999999999999999999877654322
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
+.+.+|||.|||||++....|+.++||||||++.+||++|.||+.....+...+... ....+....
T Consensus 168 --------r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp------k~~PP~L~~ 233 (467)
T KOG0201|consen 168 --------RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP------KSAPPRLDG 233 (467)
T ss_pred --------cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc------CCCCCcccc
Confidence 245679999999999998899999999999999999999999997766543221111 111122222
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
..++.|.+|+..||.++|+.||++.
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~ 258 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAK 258 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHH
Confidence 4467899999999999999999983
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=345.79 Aligned_cols=235 Identities=22% Similarity=0.318 Sum_probs=194.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
.+|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+|++++||||+++++++ .+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 47888999999999999999886 57899999875422 2345688999999999999999999988 45689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999853 3468899999999999999999999 89999999999999999999999999999865432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
. ....||+.|+|||++.+..++.++|||||||++|+|+||++||............ .. ....
T Consensus 172 ~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i--~~-----~~~~ 233 (329)
T PTZ00263 172 T-----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--LA-----GRLK 233 (329)
T ss_pred c-----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH--hc-----CCcC
Confidence 1 1235899999999999999999999999999999999999999765443211110 00 1122
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCC
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
+|...+..+.+|+.+||+.+|.+||+
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCC
Confidence 34445678999999999999999997
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.73 Aligned_cols=231 Identities=23% Similarity=0.281 Sum_probs=188.0
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCCCc
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGS 607 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ggs 607 (846)
.||+|+||.||++... +..||||++...... ....+.+|+.+|+.++||||++++++| .+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 6999999999999875 578999998754322 234577899999999999999999988 456889999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCc
Q 003121 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 687 (846)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 687 (846)
|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++........
T Consensus 82 L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~---- 151 (323)
T cd05571 82 LFFHLSR---ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT---- 151 (323)
T ss_pred HHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc----
Confidence 9998853 3568999999999999999999999 89999999999999999999999999998753221110
Q ss_pred cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHH
Q 003121 688 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 767 (846)
Q Consensus 688 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 767 (846)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||......... ... . .....+|...+.
T Consensus 152 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~~-~-----~~~~~~p~~~~~ 220 (323)
T cd05571 152 ----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELI-L-----MEEIRFPRTLSP 220 (323)
T ss_pred ----ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-HHH-H-----cCCCCCCCCCCH
Confidence 12345999999999999999999999999999999999999999665432211 111 0 111234455678
Q ss_pred HHHHHHHHHhccCcCCCCC
Q 003121 768 QLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 768 ~l~~Li~~Cl~~~P~~RPt 786 (846)
.+.+|+.+||..+|.+||+
T Consensus 221 ~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHHccCCHHHcCC
Confidence 8999999999999999993
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=346.63 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=199.6
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccc--Cc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EV 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~ 595 (846)
.++|...++||+|+||.||+|.+. +..||||+++.... ...+.+.+|+.+|..+ +||||++++++|. +.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 447889999999999999999742 34799999975432 2345688999999999 8999999999984 56
Q ss_pred eEEEEEecCCCchhhhhccCCC----------------------------------------------------------
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDN---------------------------------------------------------- 617 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~---------------------------------------------------------- 617 (846)
.++|||||++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 8899999999999998853211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 618 --------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 618 --------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
...+++..++.++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1257889999999999999999999 89999999999999999999999999999865432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. ......++..|+|||++.+..++.++|||||||++|+|++ |.+||............ +.. ......|
T Consensus 271 ~------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~--~~~---~~~~~~~ 339 (375)
T cd05104 271 V------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM--IKE---GYRMLSP 339 (375)
T ss_pred c------ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH--HHh---CccCCCC
Confidence 0 0122345678999999999999999999999999999998 89999654322111111 000 0111122
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
...+..+.+|+.+||+.+|.+||++ .++++.|+.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~-~eil~~l~~ 373 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTF-KQIVQLIEQ 373 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCH-HHHHHHHHh
Confidence 3345789999999999999999999 778777764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=328.09 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=199.3
Q ss_pred CCCcccceeeeeCceEEEEEEEC-----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
.+|.+.+.||+|+||.||+|.+. +..||+|.++..... ....|.+|+.+|++++||||++++|++ .+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788889999999999999764 357999998865322 234688999999999999999999987 4568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++... ...+++..++.++.+|+.||.|||+ ++++||||||+|||++.++.+||+|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999998533 3468999999999999999999999 8999999999999999999999999998765322
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |.+||............. ....
T Consensus 160 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~--~~~~---- 226 (266)
T cd05064 160 EAIY-------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE--DGFR---- 226 (266)
T ss_pred cchh-------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH--CCCC----
Confidence 1110 0112345778999999999999999999999999999875 999997554332111111 0111
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
...+...+..+.+++.+||+.+|.+||++ +++.+.|..+
T Consensus 227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~-~~i~~~l~~~ 265 (266)
T cd05064 227 LPAPRNCPNLLHQLMLDCWQKERGERPRF-SQIHSILSKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCCCH-HHHHHHHHhh
Confidence 11233456789999999999999999999 7887777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=335.86 Aligned_cols=256 Identities=22% Similarity=0.369 Sum_probs=201.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--Ce----EEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc-CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV 599 (846)
.+|...+.||+|+||.||+|.+. +. .||+|.+..... .....+.+|+.+++.++||||++++|+|. +..++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 36888999999999999999863 22 489999875432 23457889999999999999999999984 467899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
+||+++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 87 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 9999999999998533 3458899999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..... ......++..|+|||++.+..++.++|||||||++|||+| |++||............ .. ...
T Consensus 162 ~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~---~~---~~~ 229 (316)
T cd05108 162 DEKEY------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EK---GER 229 (316)
T ss_pred CCcce------eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---hC---CCC
Confidence 32110 0112335778999999999999999999999999999998 99999765432211000 00 011
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
...+...+..+.+++.+||..+|.+||++ .+++..+..+...
T Consensus 230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~-~~l~~~l~~~~~~ 271 (316)
T cd05108 230 LPQPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKMARD 271 (316)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHcC
Confidence 11233445789999999999999999999 6777777766543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=341.99 Aligned_cols=247 Identities=27% Similarity=0.352 Sum_probs=198.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|.+.+.||+|+||.||+|... +..||||++..... .....+.+|+.+|..++||||+++++++ .+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999886 57899999875422 2235688999999999999999999988 45689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY 154 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence 99999999999843 3468899999999999999999999 89999999999999999999999999998765331
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcccc-CCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL-DPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~l-d~~~~ 759 (846)
.....||+.|+|||++.+..++.++|||||||++|+|++|++||..................+ .+...
T Consensus 155 -----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 223 (333)
T cd05600 155 -----------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD 223 (333)
T ss_pred -----------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Confidence 123459999999999998899999999999999999999999997654433211111111111 11111
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
......+..+.+|+.+||..+|.+||++ ++++
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~-~~ll 255 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSL-EDIK 255 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCH-HHHH
Confidence 1112346789999999999999999998 5543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=329.96 Aligned_cols=249 Identities=26% Similarity=0.322 Sum_probs=194.3
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|.+.+.||+|+||.||++..+ +..||+|++..... .....+.+|+.+++.++||||++++++|. +..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 6888999999999999999986 46799999876432 22456889999999999999999999884 568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|..+.. ....+++..+..++.||+.||.|||. ++|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 82 VEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99887766542 23468999999999999999999999 8999999999999999999999999999987643221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc-----------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK----------- 751 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~----------- 751 (846)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|++||................
T Consensus 156 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07848 156 AN-------YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF 228 (287)
T ss_pred cc-------ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhh
Confidence 11 123458999999999998889999999999999999999999997654432211111000
Q ss_pred -------cccCCCC-------CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 752 -------NLLDPLA-------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 752 -------~~ld~~~-------~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+.. ..+....+..+.+|+.+||+.+|.+||++ +++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~-~~~ 281 (287)
T cd07848 229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT-EQC 281 (287)
T ss_pred hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH-HHH
Confidence 0000000 01111245679999999999999999999 544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=345.40 Aligned_cols=257 Identities=24% Similarity=0.404 Sum_probs=200.9
Q ss_pred cCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccc--Cc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--EV 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~ 595 (846)
.++|...+.||+|+||.||+|...+ ..||||++...... ....+.+|+.+|+.+ +||||++++++|. ..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 4478899999999999999987532 46999999764322 234688999999999 8999999999984 46
Q ss_pred eEEEEEecCCCchhhhhccCC-----------------------------------------------------------
Q 003121 596 WTLVYEYLPNGSLEDRLSCKD----------------------------------------------------------- 616 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~----------------------------------------------------------- 616 (846)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 889999999999999885321
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCcc
Q 003121 617 --------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688 (846)
Q Consensus 617 --------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 688 (846)
...++++..++.|+.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~---- 269 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---- 269 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee----
Confidence 12357889999999999999999999 899999999999999999999999999998654321110
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHH
Q 003121 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 767 (846)
Q Consensus 689 ~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 767 (846)
......++..|+|||++.+..++.++|||||||++|+|++ |++||............ .... .....+...+.
T Consensus 270 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~--~~~~---~~~~~~~~~~~ 342 (374)
T cd05106 270 --VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM--VKRG---YQMSRPDFAPP 342 (374)
T ss_pred --eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH--HHcc---cCccCCCCCCH
Confidence 0122345678999999988899999999999999999997 99999654322111111 0011 11122333467
Q ss_pred HHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 768 QLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 768 ~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
.+.+++.+||+.+|.+||++ .++++.|+.+
T Consensus 343 ~l~~li~~cl~~dp~~RPs~-~~l~~~l~~~ 372 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTF-SQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHcCCChhhCcCH-HHHHHHHHHH
Confidence 89999999999999999999 8888888765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.37 Aligned_cols=231 Identities=23% Similarity=0.301 Sum_probs=188.1
Q ss_pred eeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCch
Q 003121 536 IGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 608 (846)
Q Consensus 536 LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggsL 608 (846)
||+|+||.||++... +..||+|++.... ......+.+|+.+|.+++||||++++++|. +..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999886 5679999987532 223456788999999999999999999884 568999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCcc
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 688 (846)
.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~----- 149 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK----- 149 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc-----
Confidence 999853 3468999999999999999999999 89999999999999999999999999998854322110
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHH
Q 003121 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 768 (846)
Q Consensus 689 ~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 768 (846)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||......... .. ... ....+|...+..
T Consensus 150 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-~~-~~~-----~~~~~~~~~~~~ 219 (312)
T cd05585 150 ---TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY-RK-ILQ-----EPLRFPDGFDRD 219 (312)
T ss_pred ---cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH-HH-HHc-----CCCCCCCcCCHH
Confidence 12345999999999999999999999999999999999999999755432211 11 011 112334455678
Q ss_pred HHHHHHHHhccCcCCCCCh
Q 003121 769 LANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 769 l~~Li~~Cl~~~P~~RPt~ 787 (846)
+.+|+.+||..+|.+||++
T Consensus 220 ~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred HHHHHHHHcCCCHHHcCCC
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=312.65 Aligned_cols=243 Identities=25% Similarity=0.411 Sum_probs=202.3
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
+.++|++.+.||+|.||.||.|+.+. ..||+|++.+... ....++.+|++|-+.|+||||+++||+|- ...||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34578999999999999999999874 5699999987643 23457899999999999999999999994 46899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
++||.++|+|...|... ....+++.....+..|+|.||.|+|. +++|||||||+|+|++..+.+||+|||.+....
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999533 34568889999999999999999999 899999999999999999999999999987543
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
. ... ...+||..|.+||...+..++..+|+|++|++.||++.|.|||....... ....- ....
T Consensus 176 ~----~kR------~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tYkrI------~k~~ 238 (281)
T KOG0580|consen 176 S----NKR------KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TYKRI------RKVD 238 (281)
T ss_pred C----CCc------eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HHHHH------HHcc
Confidence 2 122 33459999999999999999999999999999999999999997555222 22111 1122
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
-.+|...+....+||.+|+.++|.+|....+
T Consensus 239 ~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~ 269 (281)
T KOG0580|consen 239 LKFPSTISGGAADLISRLLVKNPIERLALTE 269 (281)
T ss_pred ccCCcccChhHHHHHHHHhccCccccccHHH
Confidence 2345667889999999999999999999843
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=327.77 Aligned_cols=247 Identities=39% Similarity=0.619 Sum_probs=190.2
Q ss_pred ccceeeeeCceEEEEEEEC------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 532 PSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
..+.||.|.||.||+|.+. +..|+||.++..... ..+.|.+|+++|++++||||++++|+|. +..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3467999999999999998 477999999653322 2567999999999999999999999984 458899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.++|... ....+++..+..|+.||+.||.|||+ ++++|+||+|.|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999655 24568999999999999999999999 8899999999999999999999999999987632211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
. .......+...|+|||.+....++.++||||||+++|||+| |+.||............. +......
T Consensus 159 ~------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~------~~~~~~~ 226 (259)
T PF07714_consen 159 Y------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK------QGQRLPI 226 (259)
T ss_dssp E------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH------TTEETTS
T ss_pred c------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccee
Confidence 1 11122346789999999999889999999999999999999 789986654332111111 1111223
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
+...+..+.+++.+||..+|.+||++ .++++.|
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~-~~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSF-QEILQEL 259 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--H-HHHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCH-HHHHhcC
Confidence 33456789999999999999999999 6776654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=343.24 Aligned_cols=235 Identities=23% Similarity=0.316 Sum_probs=193.0
Q ss_pred cCCCcccceeeeeCceEEEEEEECC---eEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~---~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
..+|...+.||+|+||.||+|.+.+ ..||+|.+.... ......+.+|+.+|+.++||||++++++|. ...++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468889999999999999998653 479999986532 223456889999999999999999999984 46889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999853 3468999999999999999999999 899999999999999999999999999998653
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
... ....||+.|+|||++.+..++.++|||||||++|+|+||.+||............ .. ..
T Consensus 183 ~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i---~~----~~ 244 (340)
T PTZ00426 183 TRT-----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI---LE----GI 244 (340)
T ss_pred CCc-----------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH---hc----CC
Confidence 211 1235899999999999888999999999999999999999999766543211111 00 11
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCC
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
..+|...+..+.+++.+||+.+|.+|+
T Consensus 245 ~~~p~~~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 245 IYFPKFLDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHcC
Confidence 123444567899999999999999996
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=354.07 Aligned_cols=248 Identities=20% Similarity=0.243 Sum_probs=198.8
Q ss_pred CCcccceeeeeCceEEEEEEEC---CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~---~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
.|...+.||+|+||.||++... +..||+|.+..........+.+|+.+|+.++||||++++++| .+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999764 456888877554433345678899999999999999999998 45789999999
Q ss_pred CCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 604 PNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 604 ~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
++|+|.++|... ....++++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887532 334578999999999999999999999 8999999999999999999999999999987643221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||++||......... .. ..... ...+|
T Consensus 225 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~-~~-~~~~~----~~~~~ 292 (478)
T PTZ00267 225 LD------VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM-QQ-VLYGK----YDPFP 292 (478)
T ss_pred cc------cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH-HHhCC----CCCCC
Confidence 10 113346999999999999999999999999999999999999999765442211 11 01111 11233
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+..+.+|+.+||..+|.+||++.+.+
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 44567899999999999999999985443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.20 Aligned_cols=238 Identities=24% Similarity=0.413 Sum_probs=201.8
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCc---hhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~---~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
..+|++.+.||+|.||+|-++... |+.||||.+++....+. -++.+|++||+.|+||||+.+|.+|. +...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 457889999999999999999764 78999999988755543 45889999999999999999999995 568899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||..+|.|.|++..+ ..|++.+++.++.||..|+.|+|. ++++|||||.+|||||.|+++||+||||+.++..
T Consensus 132 MEYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999544 569999999999999999999999 9999999999999999999999999999998876
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..+. .+++|+|.|.+||+..+.+| ++.+|.|||||+||.|+.|.-||++.+......... ......|
T Consensus 206 ~kfL---------qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs-~GaYrEP-- 273 (668)
T KOG0611|consen 206 KKFL---------QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS-RGAYREP-- 273 (668)
T ss_pred ccHH---------HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh-cccccCC--
Confidence 5432 34569999999999999888 689999999999999999999998877644322221 1222222
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
. .+....-||++||.+||++|-|+
T Consensus 274 -~----~PSdA~gLIRwmLmVNP~RRATi 297 (668)
T KOG0611|consen 274 -E----TPSDASGLIRWMLMVNPERRATI 297 (668)
T ss_pred -C----CCchHHHHHHHHHhcCcccchhH
Confidence 2 23467889999999999999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=318.83 Aligned_cols=245 Identities=28% Similarity=0.346 Sum_probs=196.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEe----ccccCceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLV----GACPEVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~----g~~~~~~~lV 599 (846)
++|+..+.|++|.||.||+|+.+ +..||+|+++...... +-.-.+||.+|.+++|||||.+- |..-+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 36888899999999999999887 4679999998764321 33468999999999999999974 4446779999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
||||+. +|..++... ..+|...+...++.|+++||+|||. +.|+||||||+|+|++..|.+||+|||+|+.++.
T Consensus 156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999975 888888533 3689999999999999999999999 8999999999999999999999999999998765
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCC--
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP-- 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~-- 756 (846)
... ..+..+-|.+|.|||.+.+. .|+++.|+||+|||+.||++++|.|.+..+.......- ..+-.|
T Consensus 230 p~k--------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If--~llGtPte 299 (419)
T KOG0663|consen 230 PLK--------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIF--KLLGTPSE 299 (419)
T ss_pred Ccc--------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHH--HHhCCCcc
Confidence 421 12445579999999999875 69999999999999999999999998876655432211 111111
Q ss_pred ------------------------CCCCCChh-hHHHHHHHHHHHhccCcCCCCChH
Q 003121 757 ------------------------LAGDWPFV-QAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 757 ------------------------~~~~~p~~-~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
+...|+.. .++.-.+|+..+|.+||.+|-|+.
T Consensus 300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~ 356 (419)
T KOG0663|consen 300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAE 356 (419)
T ss_pred ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHH
Confidence 11222222 346778999999999999999993
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=338.68 Aligned_cols=230 Identities=23% Similarity=0.293 Sum_probs=186.7
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCCCc
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGS 607 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ggs 607 (846)
.||+|+||.||++... +..||+|++..... .....+.+|+.+++.++||||++++++| .+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 6999999999999875 57899999876422 2234577899999999999999999987 456899999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCc
Q 003121 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 687 (846)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 687 (846)
|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++........
T Consensus 82 L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---- 151 (323)
T cd05595 82 LFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---- 151 (323)
T ss_pred HHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc----
Confidence 9988843 3468999999999999999999999 89999999999999999999999999998753221110
Q ss_pred cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHH
Q 003121 688 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 767 (846)
Q Consensus 688 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 767 (846)
.....||+.|+|||++.++.++.++|||||||++|+|++|+.||......... ... . .....+|...+.
T Consensus 152 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-~~~-~-----~~~~~~p~~~~~ 220 (323)
T cd05595 152 ----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-ELI-L-----MEEIRFPRTLSP 220 (323)
T ss_pred ----cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHH-h-----cCCCCCCCCCCH
Confidence 12345899999999999889999999999999999999999999655432211 110 0 011123445568
Q ss_pred HHHHHHHHHhccCcCCCC
Q 003121 768 QLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 768 ~l~~Li~~Cl~~~P~~RP 785 (846)
.+.+|+.+||+.+|.+||
T Consensus 221 ~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred HHHHHHHHHccCCHHHhC
Confidence 899999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.00 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=200.7
Q ss_pred CCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
+|...+.||+|+||.||+|...+ ..||+|.+...... ....|.+|+.++..++||||+++++++. ...++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57788899999999999998653 45999998754322 2346889999999999999999999884 46889
Q ss_pred EEEecCCCchhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc
Q 003121 599 VYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 665 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~ 665 (846)
+|||+++|+|.+++..... ...+++..++.++.+++.||.|||. ++++||||||+|||++.++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 9999999999999854311 1468899999999999999999999 89999999999999999999
Q ss_pred eeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 003121 666 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA 744 (846)
Q Consensus 666 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~ 744 (846)
+||+|||+++......... ......+++.|+|||.+.++.++.++|||||||++|||++ |..||.........
T Consensus 163 ~~L~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 163 VKISDFGLSRDIYSADYYR------VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred EEECCCcceeecccccccc------ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999998654322111 1123457889999999988899999999999999999998 99998654432211
Q ss_pred HhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 745 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 745 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
.. + ........+...+..+.+|+.+||+.+|.+||++ .++...|+.
T Consensus 237 -~~--i---~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~-~~i~~~l~~ 282 (283)
T cd05048 237 -EM--I---RSRQLLPCPEDCPARVYALMIECWNEIPARRPRF-KDIHTRLRS 282 (283)
T ss_pred -HH--H---HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHhc
Confidence 10 0 0111122344556899999999999999999999 788777764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=338.26 Aligned_cols=230 Identities=23% Similarity=0.269 Sum_probs=187.5
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCCCc
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGS 607 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ggs 607 (846)
.||+|+||.||++... +..||+|++..... .....+.+|+.+|+.++||||+++++++ .+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 5999999999999875 57899999976432 2234678899999999999999999887 456899999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCc
Q 003121 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 687 (846)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 687 (846)
|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 82 L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~---- 151 (328)
T cd05593 82 LFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT---- 151 (328)
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc----
Confidence 9988843 3468999999999999999999999 89999999999999999999999999998753221110
Q ss_pred cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHH
Q 003121 688 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 767 (846)
Q Consensus 688 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 767 (846)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||............ ......+|...+.
T Consensus 152 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~-------~~~~~~~p~~~~~ 220 (328)
T cd05593 152 ----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LMEDIKFPRTLSA 220 (328)
T ss_pred ----cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh-------ccCCccCCCCCCH
Confidence 12345999999999999889999999999999999999999999765443211111 1111234445668
Q ss_pred HHHHHHHHHhccCcCCCC
Q 003121 768 QLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 768 ~l~~Li~~Cl~~~P~~RP 785 (846)
.+.+|+.+||..+|.+||
T Consensus 221 ~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred HHHHHHHHHcCCCHHHcC
Confidence 899999999999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.69 Aligned_cols=247 Identities=25% Similarity=0.456 Sum_probs=197.6
Q ss_pred CCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 605 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~g 605 (846)
+|...+.||+|+||.||++.+.. ..+|+|.+.... .....|.+|+.+|++++||||++++++|. +..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 57778899999999999998875 579999876443 33567899999999999999999999884 468899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|.+++... ...+++..++.++.+++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~- 157 (256)
T cd05114 84 GCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS- 157 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec-
Confidence 9999988533 2358899999999999999999999 899999999999999999999999999988654322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....++..|+|||++.+..++.++||||||+++|+|++ |++||................ ....|..
T Consensus 158 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~------~~~~~~~ 225 (256)
T cd05114 158 ------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF------RLYRPKL 225 (256)
T ss_pred ------cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC------CCCCCCC
Confidence 112235678999999988889999999999999999999 999997655433221111111 1112333
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
.+..+.+|+.+||..+|.+||++ +++...|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~-~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTF-AELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCH-HHHHHhh
Confidence 45789999999999999999999 6665554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=338.52 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=207.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCc--hhHHHHHHHHHhcCCCceeeEecccc--Cc-eEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTLVGACP--EV-WTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~--~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~-~~lVm 600 (846)
++|...+++|+|+||.++..+.+ ++.+++|.+.......+ ....+|+.++++++|||||.+.++|. +. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 47888999999999999876655 57899999987755443 45789999999999999999999993 34 78999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
+||+||+|.+.+.+.+ ...+++..+..|+.||+.||.|||. +.|+|||||+.|||++.++.|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999996554 5679999999999999999999998 88999999999999999999999999999988765
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
.... ....||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+........ ......|+..
T Consensus 160 ~~~a--------~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki--~~~~~~Plp~- 228 (426)
T KOG0589|consen 160 DSLA--------STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI--NRGLYSPLPS- 228 (426)
T ss_pred hhhh--------heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH--hhccCCCCCc-
Confidence 4111 2346999999999999999999999999999999999999999887765543333 2233445444
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..+..|+..|+..+|..||++.+.+
T Consensus 229 ---~ys~el~~lv~~~l~~~P~~RPsa~~LL 256 (426)
T KOG0589|consen 229 ---MYSSELRSLVKSMLRKNPEHRPSALELL 256 (426)
T ss_pred ---cccHHHHHHHHHHhhcCCccCCCHHHHh
Confidence 4458899999999999999999994443
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.67 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=199.0
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--Cc
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EV 595 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~ 595 (846)
..++|+..+.||+|+||.||+|.+.+ ..||||.+..... .....|.+|+.+++.++||||++++++|. ..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35578999999999999999998653 4699999865322 22346889999999999999999999984 46
Q ss_pred eEEEEEecCCCchhhhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceee
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDN-------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 668 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL 668 (846)
.++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+ .+++||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 8899999999999999854221 2356788999999999999999999 89999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhh
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDT 747 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~ 747 (846)
+|||+++.......... .....+++.|+|||++.++.++.++|||||||++|+|++ |.+||......... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~-~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRK------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL-RF 233 (277)
T ss_pred CCCCCccccCCcceeec------CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HH
Confidence 99999886543322111 112346788999999998899999999999999999999 78898655432211 10
Q ss_pred hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.........+...+..+.+++.+||+.+|.+||++ .+++..|+
T Consensus 234 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~e~l~~l~ 276 (277)
T cd05062 234 -----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIK 276 (277)
T ss_pred -----HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHhh
Confidence 00111112233456789999999999999999999 66666654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=327.50 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=190.5
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
.++|...++||.|+||.||+|... +..||||++...... ....+.+|+.+++.++||||+++++++ .+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999885 578999998754322 234678899999999999999999988 456889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+. ++|.+++.. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 577777643 23468889999999999999999999 899999999999999999999999999987543221
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh--c-------
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL--K------- 751 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~--~------- 751 (846)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|+||.+||.........+..... .
T Consensus 158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 158 HT--------YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229 (303)
T ss_pred cc--------CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhc
Confidence 10 123458999999999875 45889999999999999999999999765433221111000 0
Q ss_pred ----c--ccCCC------CCC----CC-hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 752 ----N--LLDPL------AGD----WP-FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 752 ----~--~ld~~------~~~----~p-~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. ...+. ... |. ...+..+.+|+.+||+.+|.+||++ +++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~-~~~ 285 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA-QAA 285 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH-HHH
Confidence 0 00000 000 00 0113568899999999999999999 444
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=325.48 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=190.1
Q ss_pred CCcccceeeeeCceEEEEEEEC---CeEEEEEEecCCCCC--CchhHHHHHHHHHhc---CCCceeeEecccc-------
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKI---RHPNLVTLVGACP------- 593 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~---~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~------- 593 (846)
+|.....||+|+||.||+|... +..||+|.+...... ....+.+|+.+++.+ +||||++++++|.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888899999999999999873 467999998754322 234567788888776 6999999999872
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
...++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 34789999996 68888885432 3458999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc-
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN- 752 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~- 752 (846)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|++||.................
T Consensus 157 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~ 227 (290)
T cd07862 157 ARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227 (290)
T ss_pred eEeccCCc---------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 98654321 01234589999999999888999999999999999999999999976554322111100000
Q ss_pred ---------------ccCCCCC----CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 ---------------LLDPLAG----DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ---------------~ld~~~~----~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+.+... .+....+..+.+|+.+||+.+|++||++ .++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-~~~ 284 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-YSA 284 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH-HHH
Confidence 0000000 0111235678999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=333.90 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=189.7
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccc-------CceE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP-------EVWT 597 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-------~~~~ 597 (846)
+|.+.++||+|+||.||+|... +..||||.+.... ......+.+|+.+|+.++||||+++++++. ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778889999999999999875 5789999987532 223346889999999999999999999862 1378
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688888842 3468999999999999999999999 89999999999999999999999999999865
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH----------
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL---------- 745 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~---------- 745 (846)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||..........
T Consensus 154 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 154 FNDTPTAI-----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred ccccCccc-----cccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 33221110 1133569999999999876 578999999999999999999999996544321100
Q ss_pred -------hhhhh----ccccCC----CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 746 -------DTGKL----KNLLDP----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 746 -------~~~~~----~~~ld~----~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..... ..+... ....++ ..+..+.+|+.+||..+|.+||++ +++
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~-~e~ 287 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTA-EEA 287 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCH-HHH
Confidence 00000 000000 000111 234568999999999999999999 444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=320.80 Aligned_cols=251 Identities=25% Similarity=0.454 Sum_probs=201.4
Q ss_pred CCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
++|...++||+|+||.||+|...+ ..||+|.+.... ...+.+.+|+.+++.++||||+++++++ .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 468888999999999999998764 679999887543 2356789999999999999999999887 356889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+|+|.+++... ....+++..++.++.+++.||.|||+ ++++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999988543 23468899999999999999999999 899999999999999999999999999998764322111
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.....++..|+|||++..+.++.++|||||||++|+|+| |+.||............. .....+. +.
T Consensus 161 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~--~~~~~~~----~~ 227 (261)
T cd05072 161 -------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ--RGYRMPR----ME 227 (261)
T ss_pred -------cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH--cCCCCCC----CC
Confidence 122346778999999988889999999999999999998 999996543322111110 1111111 22
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
..+..+.+++.+||..+|++||++ +++.++|+.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~ 260 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTF-DYLQSVLDD 260 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCH-HHHHHHHhc
Confidence 345789999999999999999999 888888875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=345.09 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=206.9
Q ss_pred cCCCcccceeeeeCceEEEEEEECC-----eE-EEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEeccc--cCc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH-----MQ-VAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEV 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~-VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~ 595 (846)
.++....++||+|+||+||+|.+.- .. ||||..+... ......|.+|..+|++++|||||++||++ ...
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455666899999999999998752 13 8999988633 22345799999999999999999999987 567
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
+++|||+|+||+|.++|.... ..++..+++.++.+++.||+|||+ +++|||||-..|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999996443 369999999999999999999999 899999999999999999999999999988
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhcccc
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLL 754 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~l 754 (846)
.-....... . ...-...|+|||.+..+-|+.++|||||||++||+++ |..||............ ..
T Consensus 311 ~~~~~~~~~--~------~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI-----~~ 377 (474)
T KOG0194|consen 311 AGSQYVMKK--F------LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI-----VK 377 (474)
T ss_pred CCcceeecc--c------cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH-----Hh
Confidence 654211111 0 1124678999999999999999999999999999999 88899766543211111 01
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCC
Q 003121 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 803 (846)
Q Consensus 755 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~ 803 (846)
...+...|...+..+..++.+||..+|.+||+| ..+.+.++.+.....
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm-~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTM-STIKKKLEALEKKKE 425 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCH-HHHHHHHHHHHhccc
Confidence 122233455677899999999999999999999 888888888776543
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=334.42 Aligned_cols=236 Identities=25% Similarity=0.309 Sum_probs=189.0
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
.||+|+||.||+|... +..||||+++.... .....+..|..++..+ +||||+++++++ .+..++||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999886 46799999875421 2234456677777654 899999999987 45688999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---- 151 (316)
T cd05592 82 DLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---- 151 (316)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC----
Confidence 99998843 3468999999999999999999999 8999999999999999999999999999975432211
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ . .....+|...+
T Consensus 152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i---~----~~~~~~~~~~~ 220 (316)
T cd05592 152 ----KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI---L----NDRPHFPRWIS 220 (316)
T ss_pred ----ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH---H----cCCCCCCCCCC
Confidence 112345999999999999889999999999999999999999999765543221111 1 11223444566
Q ss_pred HHHHHHHHHHhccCcCCCCChHHHH
Q 003121 767 EQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+.+|+.+||..+|.+||++..++
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHH
Confidence 7899999999999999999985444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=342.49 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=202.6
Q ss_pred hhcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhcC-CCceeeEecccc--
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGACP-- 593 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~-- 593 (846)
...+.|.+.++||+|+||.||+|.+.+ ..||||++...... ..+.|.+|+.+|+++. ||||++++++|.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 345678899999999999999998642 35999999754322 2457899999999996 999999999994
Q ss_pred CceEEEEEecCCCchhhhhccCC---------------------------------------------------------
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKD--------------------------------------------------------- 616 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~--------------------------------------------------------- 616 (846)
...+||||||++|+|.++|....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 46899999999999998875321
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe
Q 003121 617 ------------------------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 660 (846)
Q Consensus 617 ------------------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl 660 (846)
....+++..++.++.||+.||.|||. ++|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEE
Confidence 01357888999999999999999999 899999999999999
Q ss_pred cCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 003121 661 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK 739 (846)
Q Consensus 661 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~ 739 (846)
+.++.+||+|||+++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYV------SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred eCCCEEEEEeCCcceecccccccc------ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 999999999999998654322110 1122347788999999988899999999999999999997 999986542
Q ss_pred HHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 740 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 740 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
........ ... ......+...+..+.+|+.+||+.+|.+||++ .++.++|+.+
T Consensus 345 ~~~~~~~~--~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~~l~~~l~~l 397 (400)
T cd05105 345 VDSTFYNK--IKS---GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSF-LHLSDIVESL 397 (400)
T ss_pred hhHHHHHH--Hhc---CCCCCCCccCCHHHHHHHHHHCccCHhHCcCH-HHHHHHHHHH
Confidence 21111111 000 11112334456789999999999999999999 7888888765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=341.66 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=193.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|...+.||+|+||.||++... ++.||||++..... .....+.+|+.+|..++||||++++++| .+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999885 57899999975422 2234578899999999999999999988 45688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++.. ...+++..+..++.||+.||.|||. ++|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999853 3468999999999999999999999 89999999999999999999999999998765322
Q ss_pred cccCCCcc------------------------------ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh
Q 003121 681 EISSNNTT------------------------------LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730 (846)
Q Consensus 681 ~~~~~~~~------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt 730 (846)
........ ........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 11000000 000112469999999999999999999999999999999999
Q ss_pred CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCC
Q 003121 731 GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 731 G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
|++||..................+ ........+..+.+|+.+|+. +|.+|++
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETL---QFPDEVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCcc---CCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 999997665433221111111111 001111245789999999996 9999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=318.30 Aligned_cols=258 Identities=25% Similarity=0.396 Sum_probs=206.1
Q ss_pred hhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC-------chhHHHHHHHHHhcCCCceeeEeccc--
Q 003121 524 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-------PSEFQQEIDILSKIRHPNLVTLVGAC-- 592 (846)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~-------~~~f~~Ei~iL~~l~HpnIv~l~g~~-- 592 (846)
.....+|-.+.+||+|||++||++..- .+.||||+-....... ..+..+|..|.+.|+||.||++|++|
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 334457888999999999999999764 5789999876543211 13467899999999999999999998
Q ss_pred -cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec---CCCceee
Q 003121 593 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKL 668 (846)
Q Consensus 593 -~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~---~~~~vKL 668 (846)
.+.+|-|+|||+|-+|+.+|.. ...+++.+++.|+.||+.||.||...+| +|||.||||.||||- ..|.+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccEEEecCcccceeEe
Confidence 4679999999999999999943 3568999999999999999999998774 899999999999995 4588999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA 744 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~ 744 (846)
+||||++.+....+..... ....+...||.||++||.+.-+ .++.++||||+|||||.++.|+.||+........
T Consensus 615 TDFGLSKIMdddSy~~vdG-meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDG-MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred eecchhhhccCCccCcccc-eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 9999999987665432221 1223567899999999998644 4788999999999999999999999987766666
Q ss_pred HhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 745 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 745 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
+....+...-....+..| ..+.....+|++||.+.-++|.+.
T Consensus 694 LqeNTIlkAtEVqFP~KP-vVsseAkaFIRRCLaYRKeDR~DV 735 (775)
T KOG1151|consen 694 LQENTILKATEVQFPPKP-VVSSEAKAFIRRCLAYRKEDRIDV 735 (775)
T ss_pred HhhhchhcceeccCCCCC-ccCHHHHHHHHHHHHhhhhhhhhH
Confidence 655544333333233333 345678999999999999999876
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.93 Aligned_cols=249 Identities=26% Similarity=0.337 Sum_probs=191.2
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
.+|...++||.|+||.||+|... +..||+|.+..... .....+.+|+.++++++||||+++++++. ...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999876 57899999875432 23456789999999999999999999874 458899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++ +|.+++... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 888887432 3457899999999999999999999 8999999999999999999999999999876432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhh-------------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG------------- 748 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~------------- 748 (846)
. .....|++.|+|||++.+ ..++.++|||||||++|+|+||++||.............
T Consensus 159 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 159 T--------YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred c--------ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 1 123458999999999875 468999999999999999999999996554322111000
Q ss_pred -----hhccccCCCCC-----CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 749 -----KLKNLLDPLAG-----DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 749 -----~~~~~ld~~~~-----~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+...+.+... ......+..+.+|+.+||..+|.+|||+ +++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~-~~~ 282 (288)
T cd07871 231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA-EAA 282 (288)
T ss_pred cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH-HHH
Confidence 00000000000 0011234678999999999999999999 444
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=333.30 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=195.1
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
.++|+..+.||+|+||.||++... +..||+|.+..... .....+.+|+++|++++||||+++++++ .+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357899999999999999999886 56799999875422 1235689999999999999999999987 456899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++|+|.+++.. ...+++..+..++.+++.||.|||+. ++|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999853 34588999999999999999999982 369999999999999999999999999987653321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh------------
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------ 749 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~------------ 749 (846)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||............+.
T Consensus 159 ----------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 159 ----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred ----------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence 1224589999999999988999999999999999999999999965433221100000
Q ss_pred ----------------------------hccccCCCCCCCC-hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 750 ----------------------------LKNLLDPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 750 ----------------------------~~~~ld~~~~~~p-~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+..+.....+..+ ...+..+.+|+.+||+.+|++||++ +++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~-~el 298 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL-KML 298 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCH-HHH
Confidence 0000000001111 1245689999999999999999999 554
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=324.05 Aligned_cols=253 Identities=24% Similarity=0.430 Sum_probs=200.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~ 597 (846)
.+|.+.+.||+|+||.||+|... +..||||.+...... ....|.+|+++|+.++||||+++++++ ....+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777889999999999999764 257999998765433 346799999999999999999999988 35689
Q ss_pred EEEEecCCCchhhhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 598 LVYEYLPNGSLEDRLSCKD-----------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
+||||+++|+|.+++.... ....+++..+..++.+|+.||.|||. ++++||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999986432 13458899999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHH
Q 003121 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 745 (846)
Q Consensus 667 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~ 745 (846)
||+|||+++.......... .....+++.|+|||++.++.++.++|||||||++|+|++ |..||.........
T Consensus 162 kl~d~g~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~- 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRV------GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI- 234 (280)
T ss_pred EECCcccceecccCcceec------CCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-
Confidence 9999999876533221110 122346789999999999999999999999999999999 99998654432211
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.... ... ....+...+..+.+|+.+||..+|.+||++ .++++.|+
T Consensus 235 ~~~~-~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~eil~~l~ 279 (280)
T cd05049 235 ECIT-QGR----LLQRPRTCPSEVYDIMLGCWKRDPQQRINI-KDIHERLQ 279 (280)
T ss_pred HHHH-cCC----cCCCCCCCCHHHHHHHHHHcCCCcccCCCH-HHHHHHhh
Confidence 1111 111 111223455789999999999999999999 77777664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=319.22 Aligned_cols=243 Identities=25% Similarity=0.440 Sum_probs=194.8
Q ss_pred eeeeeCceEEEEEEEC----CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEecCCCc
Q 003121 535 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGS 607 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~----~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy~~ggs 607 (846)
.||+|+||.||+|.+. +..+|+|++...... ..+.+.+|+.+++.++||||++++|++. +.+++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 5899999999999763 467999998754322 2356889999999999999999999984 56789999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCc
Q 003121 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 687 (846)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 687 (846)
|.+++.. ...+++..+..++.|++.||.|||. ++|+||||||.|||++.++.+||+|||+++...........
T Consensus 82 L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~- 154 (257)
T cd05116 82 LNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA- 154 (257)
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee-
Confidence 9999843 3468999999999999999999999 89999999999999999999999999999876433211100
Q ss_pred cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCCCCCCCChh
Q 003121 688 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 688 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....++..|+|||.+....++.++|||||||++|||+| |++||....... ..+..+ .....|..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~--------~~~~~~~~ 222 (257)
T cd05116 155 ----KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG--------ERMECPQR 222 (257)
T ss_pred ----cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC--------CCCCCCCC
Confidence 122335689999999988889999999999999999998 999997543322 111111 11233445
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
.+..+.+|+.+||+.+|.+||++ ..|.+.|+.
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~-~~i~~~l~~ 254 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGF-AVVELRLRN 254 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCH-HHHHHHHhc
Confidence 66889999999999999999999 777777653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=319.97 Aligned_cols=251 Identities=27% Similarity=0.495 Sum_probs=202.0
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
+|...+.||.|+||.||+|.+. +..||+|.+.... .....+.+|+.+++.++||||++++++| .+..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 5777889999999999999886 5789999987532 3356789999999999999999999988 456889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+++|.+++.... ...+++..++.++.|++.||.|||. ++++||||||+|||++.++.+||+|||++..........
T Consensus 86 ~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 86 YGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999985432 3468999999999999999999999 899999999999999999999999999998764432111
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
. ....++..|+|||.+.+..++.++|||||||++|+|+| |.+||......... .. +.. ......+.
T Consensus 162 ~-------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~--~~~---~~~~~~~~ 228 (263)
T cd05052 162 H-------AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-EL--LEK---GYRMERPE 228 (263)
T ss_pred c-------CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HH--HHC---CCCCCCCC
Confidence 1 11234678999999988899999999999999999998 99999654432211 11 111 11223344
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
..+..+.+|+.+||..+|.+||++ .++.+.|+.+
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~-~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSF-AEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCH-HHHHHHHHhh
Confidence 556889999999999999999999 7888887754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=325.40 Aligned_cols=256 Identities=24% Similarity=0.468 Sum_probs=204.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
++|.+.+.||+|+||.||++... +..+|+|.+..........+.+|+.+|++++||||++++++|. +..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888889999999999999752 2458999887654334557899999999999999999999884 56889
Q ss_pred EEEecCCCchhhhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceee
Q 003121 599 VYEYLPNGSLEDRLSCKD----------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 668 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL 668 (846)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+ +|++||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999885321 22358999999999999999999999 89999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHH
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YAL 745 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~ 745 (846)
+|||+++......... ......++..|+|||++.+..++.++|||||||++|+|+| |.+||....... ..+
T Consensus 162 ~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred ccCCccccccCCceee------cCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999998654322111 1122346788999999988889999999999999999999 999996554322 111
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
..+. . ...+...+..+.+|+.+||+.+|.+||++ .++...|+.+...
T Consensus 236 ~~~~----~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~v~~~l~~~~~~ 282 (288)
T cd05093 236 TQGR----V----LQRPRTCPKEVYDLMLGCWQREPHMRLNI-KEIHSLLQNLAKA 282 (288)
T ss_pred HcCC----c----CCCCCCCCHHHHHHHHHHccCChhhCCCH-HHHHHHHHHHHHh
Confidence 1111 1 11222345679999999999999999999 8888889888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.10 Aligned_cols=253 Identities=25% Similarity=0.324 Sum_probs=199.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|.+.+.||+|+||.||+|... +..||||++..... .....+..|+.+|..++||||+++++++. +..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999987 68899999975422 23456889999999999999999999884 5688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++... ..+++..+..++.||+.||.|||. +||+||||||+||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 568999999999999999999999 89999999999999999999999999999866543
Q ss_pred cccC---------------------CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 003121 681 EISS---------------------NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK 739 (846)
Q Consensus 681 ~~~~---------------------~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~ 739 (846)
.... ............||+.|+|||++.+..++.++|||||||+||+|++|++||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2000 0000011234569999999999999999999999999999999999999997665
Q ss_pred HHHHHHhhhhhcc-ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCC-hHHHHH
Q 003121 740 EVQYALDTGKLKN-LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE-LGKDVW 792 (846)
Q Consensus 740 ~~~~~~~~~~~~~-~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt-~~~~v~ 792 (846)
............. ...+.. ...+..+.+|+.+|+. +|.+||+ + ++++
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~----~~~~~~~~~li~~ll~-dp~~R~~s~-~~ll 283 (350)
T cd05573 235 LQETYNKIINWKESLRFPPD----PPVSPEAIDLICRLLC-DPEDRLGSF-EEIK 283 (350)
T ss_pred HHHHHHHHhccCCcccCCCC----CCCCHHHHHHHHHHcc-ChhhcCCCH-HHHh
Confidence 4332211111111 111111 1146789999999997 9999999 6 5553
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.26 Aligned_cols=253 Identities=26% Similarity=0.491 Sum_probs=206.1
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
...+|...++||.|+||.||+|...+ ..+++|.+..........+..|+.+++.++||||+++++++ .+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34468888999999999999998874 77999998876655567899999999999999999999988 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++.... ...+++..+..++.+|+.||.|||+ ++++||||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996432 3568999999999999999999999 8999999999999999999999999999986643221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
. .....++..|+|||.+....++.++||||||+++|+|++ |+.||............. .......
T Consensus 160 ~--------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~------~~~~~~~ 225 (261)
T cd05148 160 L--------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT------AGYRMPC 225 (261)
T ss_pred c--------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH------hCCcCCC
Confidence 1 112346788999999988889999999999999999998 899996554322111110 1111223
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
+...+..+.+++.+||+.+|.+||++ .++.+.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~-~~l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSF-KALREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHhc
Confidence 34556889999999999999999999 788888764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.70 Aligned_cols=238 Identities=22% Similarity=0.283 Sum_probs=191.5
Q ss_pred CCcccceeeeeCceEEEEEEECC--eEEEEEEecCCC---CCCchhHHHHHHHHHhcCCC-ceeeEeccc--cCceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHP-NLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~Hp-nIv~l~g~~--~~~~~lVm 600 (846)
+|...+.||+|+||.||+|...+ ..||||++.... ......+..|+.++..+.|+ +|+.+++++ .+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999998874 579999987542 22345678899999999765 577888877 45689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++.. ...+++..+..++.||+.||.|||. ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999998843 3458899999999999999999999 89999999999999999999999999998743211
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... .....||+.|+|||++.+..++.++|||||||++|+|+||++||............. .....
T Consensus 155 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~-------~~~~~ 219 (324)
T cd05587 155 GKT--------TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM-------EHNVS 219 (324)
T ss_pred CCc--------eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCCCC
Confidence 100 122458999999999999999999999999999999999999997655432211111 11223
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
+|...+..+.+|+.+||..+|.+||+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 444566789999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.32 Aligned_cols=232 Identities=27% Similarity=0.354 Sum_probs=187.1
Q ss_pred ceeeeeCceEEEEEEE-----CCeEEEEEEecCCCC----CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 534 LKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL----QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~-----~~~~VAIK~l~~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
++||+|+||.||++.. .+..||||++..... .....+.+|+.+|+.++||||++++++|. +..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999875 357799999875321 22345778999999999999999999883 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999998843 3467888999999999999999999 8999999999999999999999999999875432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. .....||+.|+|||++.+..++.++|||||||++|+|++|++||............. . .....|
T Consensus 156 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~------~-~~~~~~ 220 (323)
T cd05584 156 V--------THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL------K-GKLNLP 220 (323)
T ss_pred c--------ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH------c-CCCCCC
Confidence 1 122458999999999998889999999999999999999999997655432211110 0 112234
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCC
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
...+..+.+|+.+||+.+|.+||+
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~ 244 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLG 244 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCC
Confidence 455678999999999999999993
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.76 Aligned_cols=257 Identities=25% Similarity=0.479 Sum_probs=204.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
.+|.....||+|+||.||+|... +..+++|.+..........+.+|+.++++++||||+++++++. +..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999753 2458999887655444567999999999999999999999984 46889
Q ss_pred EEEecCCCchhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc
Q 003121 599 VYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 665 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~ 665 (846)
||||+++++|.+++.... ....+++..++.++.+|+.||.|||. ++|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999985432 12348999999999999999999999 89999999999999999999
Q ss_pred eeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 003121 666 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA 744 (846)
Q Consensus 666 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~ 744 (846)
+||+|||++.......... ......|+..|+|||++.+..++.++|||||||++|+|+| |++||........
T Consensus 162 ~~l~dfg~a~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV- 234 (291)
T ss_pred EEECCCCcccccCCCceee------cCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 9999999997654322111 0123347889999999998899999999999999999999 9999865443221
Q ss_pred HhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 745 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 745 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
+... ........+...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 235 ~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECI-----TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNI-KEIYKILHALGK 284 (291)
T ss_pred HHHH-----hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCH-HHHHHHHHHHHh
Confidence 1111 1111112233446789999999999999999999 889899988855
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=351.41 Aligned_cols=254 Identities=21% Similarity=0.291 Sum_probs=202.4
Q ss_pred hhhhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccccC--
Q 003121 521 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-- 594 (846)
Q Consensus 521 ~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-- 594 (846)
.++.....+|.+.+.||+|+||.||++... +..||||++...... ....+.+|+.+|..++|+||+++++.+..
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 344455679999999999999999999874 688999998765332 23457889999999999999998876521
Q ss_pred --------ceEEEEEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc
Q 003121 595 --------VWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 665 (846)
Q Consensus 595 --------~~~lVmEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~ 665 (846)
..++||||+++|+|.+++... ....++++..+..++.|++.||.|||+ ++|+||||||+||||+.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCC
Confidence 257999999999999988543 234579999999999999999999999 89999999999999999999
Q ss_pred eeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 003121 666 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 745 (846)
Q Consensus 666 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~ 745 (846)
+||+|||+++.+........ .....||+.|+|||++.+..++.++|||||||+||||++|++||.........
T Consensus 182 vkL~DFGls~~~~~~~~~~~------~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~- 254 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDV------GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM- 254 (496)
T ss_pred EEEEecccCeeccccccccc------cccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-
Confidence 99999999987643221111 12346999999999999999999999999999999999999999765442211
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
. ........+ .|...+..+.+|+.+||+.+|.+||++.+
T Consensus 255 ~-~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~RPs~~e 293 (496)
T PTZ00283 255 H-KTLAGRYDP----LPPSISPEMQEIVTALLSSDPKRRPSSSK 293 (496)
T ss_pred H-HHhcCCCCC----CCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 1 111111222 33445678999999999999999999943
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=318.14 Aligned_cols=252 Identities=27% Similarity=0.466 Sum_probs=201.9
Q ss_pred cCCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
..+|...+.||+|+||.||+|.+.+ ..||+|.+.... .....+.+|+.++++++||||+++++++. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 3468888999999999999998754 679999987644 23567899999999999999999999884 4688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++.... ...+++..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985433 3468999999999999999999999 89999999999999999999999999999876532111
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
.. ....++..|+|||++.+..++.++||||||+++|+|+| |+.||............. .... ...+
T Consensus 160 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~--~~~~----~~~~ 226 (261)
T cd05068 160 AR-------EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD--QGYR----MPCP 226 (261)
T ss_pred cc-------CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCC----CCCC
Confidence 00 11223568999999988899999999999999999999 999997654322111111 1111 1123
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
...+..+.+++.+||+.+|.+||++ +++...|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~-~~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTF-ETLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCH-HHHHHHHhc
Confidence 3445789999999999999999999 788887765
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=323.36 Aligned_cols=250 Identities=27% Similarity=0.433 Sum_probs=197.1
Q ss_pred CCcccceeeeeCceEEEEEEE------CCeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~------~~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
+|+..+.||+|+||.||+|.+ .+..|++|.+...... ....|.+|+.+++.++||||+++++++ ....++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 577788999999999999985 2367999998754322 235688999999999999999999987 3568999
Q ss_pred EEecCCCchhhhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc
Q 003121 600 YEYLPNGSLEDRLSCKD--------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 665 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~--------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~ 665 (846)
|||+++|+|.+++.... ....+++...+.++.+++.||.|||+ ++++||||||+|||++.++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence 99999999999884321 12357889999999999999999999 89999999999999999999
Q ss_pred eeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--
Q 003121 666 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ-- 742 (846)
Q Consensus 666 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~-- 742 (846)
+||+|||+++.......... .....++..|+|||++.++.++.++|||||||++|+|++ |.+||.......
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 163 VKISDLGLSREIYSADYYRV------QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred EEeccccccccccCCcceec------ccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999986643321111 122346788999999988889999999999999999999 999996544321
Q ss_pred HHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 743 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 743 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
..+... . . ...+...+..+.+++.+||+.+|.+||++ .++.+.|.
T Consensus 237 ~~~~~~---~-~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-~~i~~~l~ 281 (283)
T cd05090 237 EMVRKR---Q-L----LPCSEDCPPRMYSLMTECWQEGPSRRPRF-KDIHTRLR 281 (283)
T ss_pred HHHHcC---C-c----CCCCCCCCHHHHHHHHHHcccCcccCcCH-HHHHHHhh
Confidence 111111 1 1 11233456789999999999999999999 66776665
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=318.40 Aligned_cols=247 Identities=26% Similarity=0.460 Sum_probs=197.1
Q ss_pred CCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 605 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~g 605 (846)
+|.....||+|+||.||.|.+.+ ..+|||.+.... ...+.|.+|+.++++++||||++++++|. +..++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 57778899999999999998876 459999887543 33567999999999999999999999984 457899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|.+++... ...+++..++.++.+|+.||.|||+ ++++|+||||.|||++.++.+||+|||+++.........
T Consensus 84 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~- 157 (256)
T cd05113 84 GCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS- 157 (256)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee-
Confidence 9999998543 2368999999999999999999999 899999999999999999999999999988654322110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....++..|+|||.+.+..++.++|||||||++|+|+| |..||............ ... .....+..
T Consensus 158 ------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~--~~~----~~~~~~~~ 225 (256)
T cd05113 158 ------SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV--SQG----LRLYRPHL 225 (256)
T ss_pred ------cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH--hcC----CCCCCCCC
Confidence 112346778999999988889999999999999999999 99999755432211111 111 11112233
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
.+..+.+++.+||..+|.+||++ .+++..|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~-~~ll~~~ 255 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTF-QQLLSSI 255 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCH-HHHHHhh
Confidence 45789999999999999999999 6665544
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=333.26 Aligned_cols=238 Identities=21% Similarity=0.295 Sum_probs=191.9
Q ss_pred CCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCC---CCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lVm 600 (846)
+|...+.||+|+||.||+|...+ ..||||++..... .....+..|..++..+ +||+|+++++++. +..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788899999999999998864 6899999876432 1233567788888887 5899999998873 5688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+.+.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988843 3458899999999999999999999 89999999999999999999999999998754321
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... .....||+.|+|||++.+..++.++|||||||++|+|+||++||............. .....
T Consensus 155 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~-------~~~~~ 219 (323)
T cd05616 155 GVT--------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-------EHNVA 219 (323)
T ss_pred CCc--------cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCCC
Confidence 111 123459999999999999999999999999999999999999997665432211111 11123
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
+|...+..+.+|+.+||+.+|.+|++.
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 445567889999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.58 Aligned_cols=236 Identities=22% Similarity=0.275 Sum_probs=188.5
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHH---HhcCCCceeeEeccc--cCceEEE
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDIL---SKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL---~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
|.+.+.||+|+||.||+|... +..||||++..... ...+.+.+|+.++ +.++||||+++++++ .+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999876 57899999975422 2234566777665 466899999999988 4568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|..++. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999998873 2468999999999999999999999 8999999999999999999999999999875322
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
... ......||+.|+|||++.+..++.++|||||||++|+|++|++||............. . ...
T Consensus 154 ~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~--~-----~~~ 218 (324)
T cd05589 154 FGD--------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV--N-----DEV 218 (324)
T ss_pred CCC--------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h-----CCC
Confidence 111 0123469999999999998899999999999999999999999997654432211110 0 111
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.+|...+..+.+|+.+||..+|.+||+.
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 2344456889999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.88 Aligned_cols=244 Identities=25% Similarity=0.460 Sum_probs=194.9
Q ss_pred eeeeeCceEEEEEEEC----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEecCCCch
Q 003121 535 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGSL 608 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~----~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy~~ggsL 608 (846)
.||+|+||.||+|.+. +..||+|++...... ..+.|.+|+.++++++||||++++++|. +..++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999875 346999998765322 2356889999999999999999999984 467899999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCcc
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 688 (846)
.+++... ...+++..+..++.+|+.||.|||. ++++||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--- 153 (257)
T cd05115 82 NKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--- 153 (257)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee---
Confidence 9988532 3468999999999999999999999 8999999999999999999999999999986543321111
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH--HHhhhhhccccCCCCCCCChhh
Q 003121 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDWPFVQ 765 (846)
Q Consensus 689 ~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~ 765 (846)
......+++.|+|||++.+..++.++|||||||++|+|++ |.+||........ .+..+ .....+...
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~ 223 (257)
T cd05115 154 --ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG--------KRLDCPAEC 223 (257)
T ss_pred --ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--------CCCCCCCCC
Confidence 0122335678999999988889999999999999999996 9999965543221 11111 112334455
Q ss_pred HHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 766 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 766 ~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
+..+.+++.+||..+|++||++ ..|.+.|+.
T Consensus 224 ~~~l~~li~~c~~~~~~~Rp~~-~~i~~~l~~ 254 (257)
T cd05115 224 PPEMYALMKDCWIYKWEDRPNF-AKVEERMRT 254 (257)
T ss_pred CHHHHHHHHHHcCCChhhCcCH-HHHHHHHhh
Confidence 6889999999999999999999 777777664
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=319.15 Aligned_cols=253 Identities=27% Similarity=0.439 Sum_probs=201.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC-----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
++|...+.||+|+||.||+|.+. ...||||.+...... ....|.+|+.++++++||||+++++++ .+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 46888899999999999999875 246999998754322 235688999999999999999999987 3468899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++++|.+++... ...+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998543 2468999999999999999999999 8999999999999999999999999999997752
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||............. .. ..
T Consensus 159 ~~~~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~--~~----~~ 226 (266)
T cd05033 159 SEATYT------TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE--DG----YR 226 (266)
T ss_pred ccccee------ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH--cC----CC
Confidence 111100 012335778999999998899999999999999999998 999996543322111110 11 11
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
...+...+..+.+|+.+||+.+|.+||++ .++.+.|+.+
T Consensus 227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~-~ei~~~l~~~ 265 (266)
T cd05033 227 LPPPMDCPSALYQLMLDCWQKDRNERPTF-SQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHhh
Confidence 12233456789999999999999999999 8888888754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.46 Aligned_cols=236 Identities=25% Similarity=0.343 Sum_probs=188.4
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
.||+|+||+||+|... +..||||++.... ......+..|..++..+ +||||+++++++ .+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999886 4679999987642 12234567788888764 999999999988 45688999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--- 152 (316)
T cd05619 82 DLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--- 152 (316)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc---
Confidence 99999843 3468899999999999999999999 89999999999999999999999999998753221100
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...... ....+|...+
T Consensus 153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~~i~~------~~~~~~~~~~ 220 (316)
T cd05619 153 -----TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-FQSIRM------DNPCYPRWLT 220 (316)
T ss_pred -----eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh------CCCCCCccCC
Confidence 1234589999999999988999999999999999999999999976543221 111111 1112333456
Q ss_pred HHHHHHHHHHhccCcCCCCChHHHH
Q 003121 767 EQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+.+|+.+||+.+|.+||++..++
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChHHH
Confidence 7899999999999999999995444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.72 Aligned_cols=250 Identities=27% Similarity=0.307 Sum_probs=199.7
Q ss_pred CCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCCCc---hhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~~~---~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
+|+..+.||.|.-|+||.+..++ ..+|+|++.+...... .+.+.|-+||+.++||.++.||+.|. +..|||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 56777889999999999999987 6799999988755443 35677999999999999999999994 56889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
||+||+|..++. ++....|++..++.++.+++.||+|||- .|||+|||||+||||-++|++.|+||.|+.......
T Consensus 158 yCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999998775 4456779999999999999999999999 899999999999999999999999999975331100
Q ss_pred c-----------------------------cCCC-------------------ccccccCCCCCCcccCChhhhccCCCC
Q 003121 682 I-----------------------------SSNN-------------------TTLCCRTDPKGTFAYMDPEFLASGELT 713 (846)
Q Consensus 682 ~-----------------------------~~~~-------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~~ 713 (846)
+ .... .+.......+||-.|+|||++.+.+.+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0000 011223456899999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 714 PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 714 ~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.++|||+|||+||||+.|..||.+.+......+. +.. +...++.| ..+..+.+||++.|.+||.+|-..
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI--v~~--~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI--VGQ--PLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH--hcC--CCcCCCCC-cchhHHHHHHHHHhccChhhhhcc
Confidence 9999999999999999999999776654322111 111 11112222 456789999999999999999873
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=339.15 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=191.8
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
.|...+.||+|+||+||+|... +..||||++...... ....+.+|+.+|..++||||++++++|. +..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999875 468999999764322 2346889999999999999999999984 56889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|++||+|.+++.. ...+++..+..++.||+.||.|||. +||+||||||+||||+.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999853 3458899999999999999999999 899999999999999999999999999986442110
Q ss_pred ccCC---------------------------------------CccccccCCCCCCcccCChhhhccCCCCchhhHHHHH
Q 003121 682 ISSN---------------------------------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG 722 (846)
Q Consensus 682 ~~~~---------------------------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlG 722 (846)
.... ....+......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0000 0000001234699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHh--ccCcCCCCChHHHH
Q 003121 723 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCC--EMSRKSRPELGKDV 791 (846)
Q Consensus 723 viL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl--~~~P~~RPt~~~~v 791 (846)
|++|||+||++||..................+ ........+..+.+|+.+|+ ..+|..||++ .++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~-~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTL---HIPPQVKLSPEAVDLITKLCCSAEERLGRNGA-DDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---CCCCCCCCCHHHHHHHHHHccCcccccCCCCH-HHH
Confidence 99999999999997655433222111111111 00111124567889998854 4556669998 444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=319.08 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=195.2
Q ss_pred cccceeeeeCceEEEEEEECC----eEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--------Cce
Q 003121 531 DPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------EVW 596 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~~----~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~~~ 596 (846)
.+.++||+|+||.||+|.+.. ..||+|.+..... .....+.+|+.+|+.++||||++++++|. ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999998764 2589998875432 22456889999999999999999999762 136
Q ss_pred EEEEEecCCCchhhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 597 TLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
++||||+++|+|.+++... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 7999999999999887422 223458999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH--HHhhhhh
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKL 750 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~--~~~~~~~ 750 (846)
++.+........ .....+++.|++||++.+..++.++|||||||++|+|++ |++||........ .+..+.
T Consensus 159 ~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 231 (272)
T cd05075 159 SKKIYNGDYYRQ------GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN- 231 (272)
T ss_pred ccccCcccceec------CCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence 987643321110 012236778999999998899999999999999999999 8999965433221 111111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 751 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 751 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
....+...+..+.+++.+||..+|.+||++ .++++.|+.+
T Consensus 232 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~l~~~l~~~ 271 (272)
T cd05075 232 -------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSF-ETLRCELEKA 271 (272)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHhh
Confidence 111223445789999999999999999999 7787777653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.51 Aligned_cols=252 Identities=23% Similarity=0.401 Sum_probs=198.1
Q ss_pred CCcccceeeeeCceEEEEEEEC--Ce----EEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc-CceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~----~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVm 600 (846)
+|...+.||+|+||.||+|.+. +. .|++|.+...... ....+..|+.+++.++||||++++|++. ...++++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~ 87 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT 87 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEE
Confidence 5777889999999999999874 33 4788887543221 2245778888999999999999999984 4577999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++.+...
T Consensus 88 e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 88 QLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 999999999998533 3468999999999999999999999 89999999999999999999999999999876433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPL 757 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~~ 757 (846)
..... .....++..|+|||++.++.++.++|||||||++|||+| |..||....... ..+..+.
T Consensus 163 ~~~~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------- 228 (279)
T cd05111 163 DKKYF------YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE-------- 228 (279)
T ss_pred Ccccc------cCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------
Confidence 21111 123447789999999998899999999999999999998 999996654322 1122111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
....+...+..+..++.+||..+|.+||++ .++...|..+..
T Consensus 229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~-~el~~~l~~~~~ 270 (279)
T cd05111 229 RLAQPQICTIDVYMVMVKCWMIDENVRPTF-KELANEFTRMAR 270 (279)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHHh
Confidence 111122345678999999999999999999 777777776553
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.29 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=201.2
Q ss_pred CCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEecCC
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPN 605 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy~~g 605 (846)
++|.+.++||+|+||.||+|...+ ..||+|.+..... ....|.+|+.++++++||||+++++++. ...++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 468888999999999999998764 6799999876443 4567999999999999999999999874 457899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
++|.+++.... ...+++..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||++..+.......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~- 159 (260)
T cd05070 85 GSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA- 159 (260)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc-
Confidence 99999985432 3458999999999999999999999 899999999999999999999999999998764322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....++..|+|||++.+..++.++||||||+++|+|++ |.+||............ . .......+..
T Consensus 160 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~---~---~~~~~~~~~~ 227 (260)
T cd05070 160 ------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV---E---RGYRMPCPQD 227 (260)
T ss_pred ------ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---H---cCCCCCCCCc
Confidence 012235678999999988889999999999999999999 99999654432211111 0 1111223344
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
.+..+.+|+.+||..+|.+||++ ..+.+.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~-~~l~~~l~~ 259 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTF-EYLQSFLED 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCH-HHHHHHHhc
Confidence 56789999999999999999999 677777653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.83 Aligned_cols=232 Identities=25% Similarity=0.313 Sum_probs=187.7
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
.||+|+||.||+|... +..||||++.... ......+..|..++..+ +||||+++++++ .+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999876 5789999987542 22345677899999877 699999999988 45689999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~--- 152 (320)
T cd05590 82 DLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--- 152 (320)
T ss_pred hHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc---
Confidence 99998843 3468999999999999999999999 89999999999999999999999999998753221110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
.....||+.|+|||++.+..++.++|||||||++|+|++|++||............ .. ....+|...+
T Consensus 153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i--~~-----~~~~~~~~~~ 220 (320)
T cd05590 153 -----TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--LN-----DEVVYPTWLS 220 (320)
T ss_pred -----ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH--hc-----CCCCCCCCCC
Confidence 12345999999999999889999999999999999999999999766543221111 11 1112334456
Q ss_pred HHHHHHHHHHhccCcCCCCCh
Q 003121 767 EQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
..+.+|+.+||+.+|.+||++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCC
Confidence 789999999999999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=334.58 Aligned_cols=241 Identities=25% Similarity=0.396 Sum_probs=185.8
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
+|...++||+|+||.||+|.+. ++.||||++...... ....+.+|+.+|+.++||||+++++++. ..+++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3455678999999999999886 578999998654322 2356889999999999999999999984 4688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++|+|.+.. .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+......
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 999986543 24567888999999999999999 89999999999999999999999999999876432110
Q ss_pred CCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
.....||..|+|||++.. ...+.++|||||||++|+|++|+.||.......+........ ....
T Consensus 225 --------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~---~~~~ 293 (353)
T PLN00034 225 --------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC---MSQP 293 (353)
T ss_pred --------ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---ccCC
Confidence 123459999999998743 234568999999999999999999997433211111110000 0111
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+...+..+.+|+.+||..+|.+||++ .++
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-~el 325 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSA-MQL 325 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 22233456789999999999999999999 544
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=331.61 Aligned_cols=237 Identities=23% Similarity=0.288 Sum_probs=189.2
Q ss_pred ceeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEEEEecCC
Q 003121 534 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPN 605 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lVmEy~~g 605 (846)
+.||+|+||.||+|... +..||+|++.... ......+..|..++..+ +||||+++++++. +..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999886 5689999987642 12334567788888765 8999999999884 568899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 151 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--- 151 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---
Confidence 999998843 3468899999999999999999999 8999999999999999999999999999874321110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 765 (846)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..... .....+|...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-~~~~~------~~~~~~~~~~ 219 (316)
T cd05620 152 -----RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-FESIR------VDTPHYPRWI 219 (316)
T ss_pred -----ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHH------hCCCCCCCCC
Confidence 01234589999999999999999999999999999999999999976544321 11111 1112234445
Q ss_pred HHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 766 AEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 766 ~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+..+.+|+.+||+.+|.+||++.+++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHH
Confidence 67899999999999999999985444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=324.18 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=193.7
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
+|+..++||+|+||.||++... +..||+|.+...... ....+.+|+.+++.++||||+++++.+. +..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777889999999999999875 578999998754322 2245778999999999999999999874 56899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++|+|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888543 23568999999999999999999999 899999999999999999999999999988653221
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+...+......+
T Consensus 157 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~ 224 (285)
T cd05605 157 T---------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKEDQEEY 224 (285)
T ss_pred c---------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhccccc
Confidence 1 012358999999999998889999999999999999999999997643321110 0111111122233
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCC
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
+...+..+.+|+.+||..||.+||+
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLG 249 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcC
Confidence 4455678999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=323.69 Aligned_cols=236 Identities=23% Similarity=0.321 Sum_probs=188.5
Q ss_pred eeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCch
Q 003121 536 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 608 (846)
Q Consensus 536 LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggsL 608 (846)
||+|+||+||++... +..||+|.+...... ..+.+..|+.+|+.++||||+++++++. ...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 578999998754322 2345778999999999999999998873 468899999999999
Q ss_pred hhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCc
Q 003121 609 EDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 687 (846)
Q Consensus 609 ~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 687 (846)
.+.+... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---- 153 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK---- 153 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc----
Confidence 9877432 234579999999999999999999999 89999999999999999999999999998765432211
Q ss_pred cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHhhhhhccccCCCCCCCChhh
Q 003121 688 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFVQ 765 (846)
Q Consensus 688 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 765 (846)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+... .+. ....++...
T Consensus 154 ----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~----~~~-~~~~~~~~~ 224 (280)
T cd05608 154 ----TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR----ILN-DSVTYPDKF 224 (280)
T ss_pred ----ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh----hcc-cCCCCcccC
Confidence 123458999999999999999999999999999999999999996543211 111111 111 112334455
Q ss_pred HHHHHHHHHHHhccCcCCCCCh
Q 003121 766 AEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 766 ~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
+..+.+|+.+||+.+|.+||++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCC
Confidence 6889999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.88 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=203.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|...+.||+|+||.||+|... +..||+|.++..... ....+.+|+.++++++|+||+++++++ .+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 47888899999999999999886 688999988753322 245788999999999999999999988 34688999
Q ss_pred EecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 601 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
||+++|+|.+++... .....+++..+..++.+++.||.|||+ .|++||||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988543 234568999999999999999999999 8999999999999999999999999999886543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.........+......... .
T Consensus 159 ~~~~--------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~ 226 (267)
T cd08224 159 KTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY----P 226 (267)
T ss_pred CCcc--------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC----C
Confidence 2211 112358899999999988889999999999999999999999995433211111110001111 1
Q ss_pred CCCh-hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 760 DWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 760 ~~p~-~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
..|. ..+..+.+++.+||..+|.+||++ .++++.|..+.
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~-~~il~~~~~~~ 266 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDI-SYVLQVAKEMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCH-HHHHHHHHHhc
Confidence 1122 345689999999999999999999 78888887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=321.47 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=200.0
Q ss_pred CCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
+|.+.+.||+|+||.||+|.... ..+++|.+..... .....+.+|+.+++.++||||+++++.|. +..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46677889999999999998642 4589998875432 12356889999999999999999999884 56889
Q ss_pred EEEecCCCchhhhhccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCc
Q 003121 599 VYEYLPNGSLEDRLSCKD---------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 657 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~N 657 (846)
||||+.+|+|.+++.... ...++++..++.++.+++.||.|||+ ++++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 999999999999875321 12468899999999999999999999 899999999999
Q ss_pred eEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 003121 658 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG 736 (846)
Q Consensus 658 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~ 736 (846)
||++.++.+||+|||+++.......... .....++..|+|||++.+..++.++||||||+++|+|+| |..||.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVK------RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhc------ccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999986543221110 122346778999999988889999999999999999999 999996
Q ss_pred CchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 737 ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 737 ~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
........ .. .. .......+...+..+.+++.+||+.+|.+||++ .++.+.|+.+-
T Consensus 232 ~~~~~~~~-~~--~~---~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~-~~i~~~l~~~~ 287 (290)
T cd05045 232 GIAPERLF-NL--LK---TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF-ADISKELEKMM 287 (290)
T ss_pred CCCHHHHH-HH--Hh---CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCH-HHHHHHHHHHH
Confidence 55432211 10 00 011112233456789999999999999999999 88888888764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.04 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=199.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc----CceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~ 597 (846)
.+|.+.+.||+|+||.||++.+. +..||+|.+..........|.+|+.+|++++||||+++++++. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788889999999999999753 5679999987654444567899999999999999999999762 3578
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+++|+|.+++... ...+++..+..++.+++.||.|||. +|++||||||+|||++.++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998532 3458999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHhhh--------
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDTG-------- 748 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~-~~~~~~-------- 748 (846)
........ ......++..|+|||++.+..++.++|||||||++|||++|..++....... ..+...
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 159 PQDKEYYK-----VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233 (284)
T ss_pred cCCCccee-----ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence 43321100 0112234567999999988889999999999999999999887764332110 000000
Q ss_pred hhccccC-CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 749 KLKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 749 ~~~~~ld-~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
.+...+. ......+...+..+.+|+.+||..+|.+||++ .++.+.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSF-SELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCH-HHHHHHHHhc
Confidence 0000000 01111223345789999999999999999999 8888888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=334.25 Aligned_cols=241 Identities=26% Similarity=0.334 Sum_probs=189.7
Q ss_pred CCcccceeeeeCceEEEEEEE-----CCeEEEEEEecCCCC----CCchhHHHHHHHHHhc-CCCceeeEecccc--Cce
Q 003121 529 NFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL----QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVW 596 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-----~~~~VAIK~l~~~~~----~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~ 596 (846)
+|.+.+.||+|+||.||++.. .+..||+|++..... ...+.+..|+.+|..+ +||||+++++++. ...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999875 357899999875321 2235678899999999 5999999998874 468
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 899999999999999853 3458999999999999999999999 8999999999999999999999999999986
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHhhhhhccc
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNL 753 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~--~~~~~~~~~~~~ 753 (846)
+....... .....||+.|+|||++.+. .++.++|||||||++|+|+||+.||...... ...+... ..
T Consensus 155 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~-- 224 (332)
T cd05614 155 FLSEEKER-------TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR-IL-- 224 (332)
T ss_pred ccccCCCc-------cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH-Hh--
Confidence 53322111 1234599999999999765 4788999999999999999999999643211 1111111 11
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.....++...+..+.+|+.+||..+|.+||++
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 256 (332)
T cd05614 225 --KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGA 256 (332)
T ss_pred --cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence 11123344456789999999999999999953
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.70 Aligned_cols=231 Identities=23% Similarity=0.266 Sum_probs=185.8
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCCCc
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGS 607 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ggs 607 (846)
.||+|+||.||++... +..||+|++..... .....+..|+.++..++||||+++++++ .+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 5999999999999875 57899999976422 2234577899999999999999999887 456899999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCc
Q 003121 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 687 (846)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 687 (846)
|.+++.. ...+++..+..++.||+.||.|||+. +||+||||||+|||++.++.+||+|||+++........
T Consensus 82 L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---- 152 (325)
T cd05594 82 LFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---- 152 (325)
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc----
Confidence 9988843 34689999999999999999999962 58999999999999999999999999998753221111
Q ss_pred cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHH
Q 003121 688 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 767 (846)
Q Consensus 688 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 767 (846)
.....||+.|+|||++.+..++.++|||||||+||+|+||+.||............ ......+|...+.
T Consensus 153 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-------~~~~~~~p~~~~~ 221 (325)
T cd05594 153 ----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LMEEIRFPRTLSP 221 (325)
T ss_pred ----cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-------hcCCCCCCCCCCH
Confidence 12245999999999999899999999999999999999999999655432211110 0111123444567
Q ss_pred HHHHHHHHHhccCcCCCC
Q 003121 768 QLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 768 ~l~~Li~~Cl~~~P~~RP 785 (846)
.+.+|+.+||+.+|.+|+
T Consensus 222 ~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred HHHHHHHHHhhcCHHHhC
Confidence 899999999999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=324.36 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=203.4
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccc--C
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E 594 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~ 594 (846)
..++|...+.||+|+||.||++...+ ..+|+|.+..... .....+.+|+.++.++ +||||++++++|. .
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 44578888999999999999998642 5699999875422 2234588999999999 8999999999884 4
Q ss_pred ceEEEEEecCCCchhhhhccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec
Q 003121 595 VWTLVYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 661 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~ 661 (846)
..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 588999999999999998532 224568999999999999999999999 8999999999999999
Q ss_pred CCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 003121 662 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 740 (846)
Q Consensus 662 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~ 740 (846)
.++.+||+|||+++.+......... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKT------TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred CCCeEEeCccccccccccccceecc------CCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 9999999999999876543211111 22345678999999988899999999999999999998 9999975543
Q ss_pred HHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 741 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 741 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
.... ... ........+...+..+.+|+.+||..+|.+||++ .++++.|+.+
T Consensus 241 ~~~~-~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~eil~~l~~~ 291 (293)
T cd05053 241 EELF-KLL-----KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTF-KQLVEDLDRM 291 (293)
T ss_pred HHHH-HHH-----HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH-HHHHHHHHHh
Confidence 2211 110 0111122344556789999999999999999999 7888887765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=331.45 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=191.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|+..+.||+|+||+||++... +..||||++..... .....+.+|+.++.+++||||+++++.+. ...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888999999999999999875 57899999975422 22346788999999999999999999884 4688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999853 3568999999999999999999999 89999999999999999999999999999865322
Q ss_pred cccCCC---------------------------ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 003121 681 EISSNN---------------------------TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733 (846)
Q Consensus 681 ~~~~~~---------------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~ 733 (846)
...... ..........||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 110000 00000123469999999999999999999999999999999999999
Q ss_pred CCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhc--cCcCCCCChHHHHH
Q 003121 734 ALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 792 (846)
Q Consensus 734 pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~--~~P~~RPt~~~~v~ 792 (846)
||..................+. .+.. ...+..+.+|+.+++. .++..||++ +++.
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~--~p~~-~~~s~~~~~li~~l~~~~~~r~~r~~~-~ei~ 291 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETLI--FPPE-VPISEKAKDLILRFCCEWEHRIGAPGV-EEIK 291 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCccc--CCCc-CCCCHHHHHHHHHHcCChhhcCCCCCH-HHHh
Confidence 9976544332111111111110 1111 1235678888888654 233356887 5553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=334.34 Aligned_cols=238 Identities=22% Similarity=0.281 Sum_probs=186.3
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lVmEy~~gg 606 (846)
.||+|+||.||++... +..||||+++.... .....+..|..++..+ +||||++++++|. ...++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6999999999999886 57899999986432 2234578999999998 7999999999884 4689999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---- 151 (329)
T cd05588 82 DLMFHMQR---QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---- 151 (329)
T ss_pred CHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC----
Confidence 99988843 3469999999999999999999999 8999999999999999999999999999874321110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH---HHHhhhhhccccCCCCCCCCh
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ---YALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~---~~~~~~~~~~~ld~~~~~~p~ 763 (846)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... ..... .....+.......|.
T Consensus 152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~p~ 226 (329)
T cd05588 152 ----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED-YLFQVILEKQIRIPR 226 (329)
T ss_pred ----ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchH-HHHHHHHcCCCCCCC
Confidence 0123458999999999999999999999999999999999999996321100 00000 000000111122344
Q ss_pred hhHHHHHHHHHHHhccCcCCCCCh
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
..+..+.+|+.+||+.+|.+||+.
T Consensus 227 ~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 227 SLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCC
Confidence 456789999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.81 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=202.3
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|.+.+.||+|+||.||+|... +..||||.+....... ...+.+|+.+++.++||||+++++++ .+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888899999999999999874 6889999886543322 24578899999999999999999987 45688999
Q ss_pred EecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 601 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
||+++|+|.+++... .....+++..+..++.+|+.||.|||+ ++++|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999888532 223468899999999999999999999 8999999999999999999999999999887643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.... .....|++.|+|||.+.+..++.++|+||||+++|+|+||+.||.........+.. .+.....+ +
T Consensus 159 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~--~ 227 (267)
T cd08228 159 KTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ-KIEQCDYP--P 227 (267)
T ss_pred hhHH--------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH-HHhcCCCC--C
Confidence 3211 12235889999999998888999999999999999999999998543221111111 11111111 1
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
..+...+..+.+++.+||..+|.+||++ .++++.++.++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~-~~vl~~~~~~~ 266 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDI-GYVHQIAKQMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCH-HHHHHHHHHhc
Confidence 1122345789999999999999999999 88888887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.47 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=198.4
Q ss_pred CcccceeeeeCceEEEEEEECC-----eEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--C------
Q 003121 530 FDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--E------ 594 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~------ 594 (846)
|.+.+.||+|+||.||+|.... ..||+|.++..... ....+.+|+.+|+.++||||+++++++. +
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4566789999999999998742 56999998754322 2356889999999999999999999762 1
Q ss_pred ceEEEEEecCCCchhhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DF 671 (846)
..++||||+++|+|..++... .....+++..++.++.|++.||.|||. ++++||||||+||+++.++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 268999999999999888443 123468999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhh
Q 003121 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL 750 (846)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~ 750 (846)
|+++.+........ .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...........
T Consensus 158 g~~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~---- 227 (273)
T cd05035 158 GLSKKIYSGDYYRQ------GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY---- 227 (273)
T ss_pred cceeeccccccccc------cccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Confidence 99987644321110 011235678999999988889999999999999999999 9999965543221111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 751 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 751 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
.........+...+..+.+++.+||+.+|.+||++ .++.+.|+.+
T Consensus 228 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~e~~~~l~~~ 272 (273)
T cd05035 228 --LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTF-TKLREVLENI 272 (273)
T ss_pred --HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHhh
Confidence 11111122334456789999999999999999999 7888887764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=332.81 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=200.1
Q ss_pred cCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccc---C
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP---E 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~---~ 594 (846)
.++|.+.+.||.|+||.||+|...+ +.||+|++...... ....+.+|+.++.++ +||||++++++|. .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 3478889999999999999996532 57999998754322 124577899999999 8999999999873 3
Q ss_pred ceEEEEEecCCCchhhhhccCCC---------------------------------------------------------
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDN--------------------------------------------------------- 617 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~--------------------------------------------------------- 617 (846)
.++++|||+++|+|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 57899999999999998853211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCC
Q 003121 618 -SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696 (846)
Q Consensus 618 -~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~ 696 (846)
..++++..+..++.||+.||.|||. +||+||||||.|||++.++.+||+|||+++.+....... ......
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~------~~~~~~ 236 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------RKGDAR 236 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh------hccCCC
Confidence 1368999999999999999999999 899999999999999999999999999998764322111 112234
Q ss_pred CCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHH
Q 003121 697 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMR 775 (846)
Q Consensus 697 Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~ 775 (846)
++..|+|||++.+..++.++|||||||+||+|++ |.+||............ +... .....+...+..+.+++.+
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~--~~~~---~~~~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR--LKEG---TRMRAPEYATPEIYSIMLD 311 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH--Hhcc---CCCCCCccCCHHHHHHHHH
Confidence 6788999999999999999999999999999998 99999653221111110 1110 0111223345789999999
Q ss_pred HhccCcCCCCChHHHHHHHHHHHH
Q 003121 776 CCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 776 Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
||+.+|.+||++ .++++.|+.+.
T Consensus 312 cl~~~p~~RPs~-~ell~~l~~~~ 334 (337)
T cd05054 312 CWHNNPEDRPTF-SELVEILGDLL 334 (337)
T ss_pred HccCChhhCcCH-HHHHHHHHHHH
Confidence 999999999999 78888888654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.18 Aligned_cols=252 Identities=32% Similarity=0.495 Sum_probs=201.8
Q ss_pred CCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc-cCceEEEEEecCC
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTLVYEYLPN 605 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~-~~~~~lVmEy~~g 605 (846)
++|.+.++||+|+||.||+|.+.+ ..||+|.+.... ...+.|.+|+.+++.++||||+++++.+ .+..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 468899999999999999998765 479999987533 2356789999999999999999999977 4567899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|.+++... ....+++..+..++.+++.||.|||+ ++++||||||.||+++.++.+||+|||+++.+.......
T Consensus 85 ~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~- 159 (262)
T cd05071 85 GSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA- 159 (262)
T ss_pred CcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccccc-
Confidence 9999998543 23457899999999999999999999 899999999999999999999999999998664332111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....++..|+|||++.+..++.++|||||||++|+|+| |.+||........ .... .... ....+..
T Consensus 160 ------~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~~-~~~~----~~~~~~~ 227 (262)
T cd05071 160 ------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQV-ERGY----RMPCPPE 227 (262)
T ss_pred ------ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHHH-hcCC----CCCCccc
Confidence 012346788999999988899999999999999999999 8899965533221 1110 0111 1112234
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
.+..+.+|+.+||+.+|.+||++ .++.+.|+..
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~-~~~~~~l~~~ 260 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTF-EYLQAFLEDY 260 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCH-HHHHHHHHHh
Confidence 56789999999999999999999 7888887753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=339.18 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=189.6
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
+|...++||.|+||.||++... +..||||++..... .....+.+|+.+|++++||||++++++|. ...|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 6888899999999999999875 57899999865322 12356788999999999999999999984 46899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 82 FLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999853 3468899999999999999999999 899999999999999999999999999997432211
Q ss_pred ccC----------CCcc-----------------------------ccccCCCCCCcccCChhhhccCCCCchhhHHHHH
Q 003121 682 ISS----------NNTT-----------------------------LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG 722 (846)
Q Consensus 682 ~~~----------~~~~-----------------------------~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlG 722 (846)
... .... ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 0000 0000124699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCC---CCh
Q 003121 723 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR---PEL 787 (846)
Q Consensus 723 viL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~R---Pt~ 787 (846)
|++|||+||++||..................+. .+. ....+..+.+|+.+|+. +|.+| |++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRETLY--FPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC--CCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 999999999999976544322111111111110 011 11245789999999997 77776 477
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.26 Aligned_cols=243 Identities=27% Similarity=0.464 Sum_probs=198.7
Q ss_pred CCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc---cCceEEEEEecCC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPN 605 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~---~~~~~lVmEy~~g 605 (846)
+|...+.||+|+||.||++...+..||+|.+.... ..+.|.+|+.++++++||||+++++++ ....++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 67788899999999999999999999999986432 245789999999999999999999875 2458899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|.+++.... ...+++..++.++.+++.||.|||+ +|++||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 85 GSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 99999985432 2458899999999999999999999 899999999999999999999999999987543221
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH--HHhhhhhccccCCCCCCCC
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p 762 (846)
....++..|+|||++.+..++.++|||||||++|+|++ |++||........ .+..+ .....+
T Consensus 157 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~ 221 (256)
T cd05082 157 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMDAP 221 (256)
T ss_pred -------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--------CCCCCC
Confidence 11235678999999988889999999999999999998 9999965433221 11111 111233
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
...+..+.+++.+||+.+|.+||++ .++.+.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~-~~l~~~l~~ 255 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSF-LQLREQLEH 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCH-HHHHHHHhc
Confidence 4456789999999999999999999 777777764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.79 Aligned_cols=247 Identities=25% Similarity=0.472 Sum_probs=196.8
Q ss_pred CCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 605 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~g 605 (846)
+|...+.||+|+||.||+|.+.+ ..+|+|.+..... ....|.+|+.++++++||||+++++++. ...++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 46778889999999999998864 4799999865432 3457889999999999999999999874 468899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 99999985332 368999999999999999999999 899999999999999999999999999988654322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....++..|+|||.+.+..++.++||||||+++|+|+| |.+||............ ... .....+..
T Consensus 158 ------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~~---~~~~~~~~ 225 (256)
T cd05059 158 ------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV---SAG---YRLYRPKL 225 (256)
T ss_pred ------cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH---HcC---CcCCCCCC
Confidence 112234568999999998899999999999999999999 89999755433221111 111 11123334
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
.+..+.+|+.+||..+|.+||++ .++++.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~-~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAF-KKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCH-HHHHHHh
Confidence 56789999999999999999999 6665544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.93 Aligned_cols=258 Identities=27% Similarity=0.479 Sum_probs=215.4
Q ss_pred hhhhhhcCCCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCce
Q 003121 521 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVW 596 (846)
Q Consensus 521 ~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~ 596 (846)
++++-...+.....+||.|.||.||.|.|+. -.||||.++.+.+ ..++|.+|..+|+.++|||+|+|+|+| +..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3444445566777899999999999999985 5799999987654 478999999999999999999999999 4579
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
|||+|||..|+|.++|+..+. ..++.-..+.++.||..|+.||.. +++|||||...|+|+.++..|||+||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999976643 456777888999999999999999 8999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHhhhhhccc
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNL 753 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~--~~~~~~~~~~~~ 753 (846)
+..+.+...... .-.+.|.|||-|....++.|+|||+|||+|||+.| |-.|+.+.+.- -..++.+
T Consensus 415 MtgDTYTAHAGA-------KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg----- 482 (1157)
T KOG4278|consen 415 MTGDTYTAHAGA-------KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG----- 482 (1157)
T ss_pred hcCCceecccCc-------cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-----
Confidence 987765543322 23678999999999999999999999999999998 88888654432 2222222
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
.+-+.|..+++.+++|++.||+.+|.+||+| .++.+.++.+-
T Consensus 483 ---yRM~~PeGCPpkVYeLMraCW~WsPsDRPsF-aeiHqafEtmf 524 (1157)
T KOG4278|consen 483 ---YRMDGPEGCPPKVYELMRACWNWSPSDRPSF-AEIHQAFETMF 524 (1157)
T ss_pred ---ccccCCCCCCHHHHHHHHHHhcCCcccCccH-HHHHHHHHHHh
Confidence 2334567788999999999999999999999 78888887664
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.82 Aligned_cols=249 Identities=27% Similarity=0.342 Sum_probs=195.4
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
..+|...+.||+|+||.||+|... +..||+|++..........+.+|+.++++++||||+++++++ .+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 347899999999999999999874 578999999765444456788999999999999999999987 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++.. ..++++..+..++.|++.||.|||+ ++|+||||+|+||+++.++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998843 3468999999999999999999999 8999999999999999999999999999986643211
Q ss_pred cCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
. .....|++.|+|||.+. ...++.++|||||||++|+|++|++||.............. ....+...
T Consensus 162 ~--------~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~ 231 (267)
T cd06646 162 K--------RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK--SNFQPPKL 231 (267)
T ss_pred c--------cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec--CCCCCCCC
Confidence 0 12235889999999984 34578899999999999999999999854433221111100 01111111
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
..+...+..+.+|+.+||..+|.+||++ ++++
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~-~~il 263 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTA-ERLL 263 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCH-HHHh
Confidence 1112235789999999999999999999 5554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=331.61 Aligned_cols=231 Identities=26% Similarity=0.364 Sum_probs=186.3
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lVmEy~~gg 606 (846)
.||+|+||.||+|... +..||||++..... .....+..|..++..+ +||||+++++++. +..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5999999999999886 46899999876422 2234577899999876 7999999999884 5689999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+.+.. ...+++..+..++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--- 152 (321)
T cd05591 82 DLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--- 152 (321)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc---
Confidence 99988843 3468899999999999999999999 89999999999999999999999999998754322111
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||............ .. ....+|...+
T Consensus 153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i--~~-----~~~~~p~~~~ 220 (321)
T cd05591 153 -----TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI--LH-----DDVLYPVWLS 220 (321)
T ss_pred -----ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH--Hc-----CCCCCCCCCC
Confidence 12345899999999999889999999999999999999999999766543321111 00 0112233456
Q ss_pred HHHHHHHHHHhccCcCCCCC
Q 003121 767 EQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt 786 (846)
..+.+|+.+||..+|.+||+
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred HHHHHHHHHHhccCHHHcCC
Confidence 78999999999999999993
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.71 Aligned_cols=244 Identities=28% Similarity=0.432 Sum_probs=191.7
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCCCchh
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLE 609 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ggsL~ 609 (846)
.||+|+||.||+|... ++.||+|.+..... .....|.+|+.++++++||||++++++| ....++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5999999999999874 67899998764322 2235689999999999999999999988 34688999999999999
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCccc
Q 003121 610 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689 (846)
Q Consensus 610 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 689 (846)
+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~---- 152 (252)
T cd05084 82 TFLRTE--GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST---- 152 (252)
T ss_pred HHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc----
Confidence 998532 3468999999999999999999999 8999999999999999999999999999876442211100
Q ss_pred cccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHH
Q 003121 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 768 (846)
Q Consensus 690 ~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 768 (846)
.....++..|+|||.+.++.++.++||||||+++|+|++ |.+||............. . ......+...+..
T Consensus 153 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~ 224 (252)
T cd05084 153 --GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---Q---GVRLPCPELCPDA 224 (252)
T ss_pred --CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---c---CCCCCCcccCCHH
Confidence 011224567999999998899999999999999999998 999996543322111110 0 1112233445678
Q ss_pred HHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 769 LANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 769 l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
+.+|+.+||..+|.+||++ .++.+.|.
T Consensus 225 ~~~li~~~l~~~p~~Rps~-~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSF-STVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCH-HHHHHHHh
Confidence 9999999999999999999 77776664
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=339.06 Aligned_cols=248 Identities=22% Similarity=0.296 Sum_probs=190.5
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
+|...++||+|+||.||+|... +..||+|++...... ....+.+|+.+|++++||||++++++|. +..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888899999999999999875 577999998754321 2346889999999999999999999984 56899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
||++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998533 458899999999999999999999 899999999999999999999999999986432110
Q ss_pred ccCC---------------------------------------CccccccCCCCCCcccCChhhhccCCCCchhhHHHHH
Q 003121 682 ISSN---------------------------------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG 722 (846)
Q Consensus 682 ~~~~---------------------------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlG 722 (846)
.... ...........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0000 0000001234699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCC
Q 003121 723 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 723 viL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
|+||||+||++||..................+ ........+..+.+|+.+|+ .+|.+|++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSL---HIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---CCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 99999999999997665443222221111111 11111234567888888876 49999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=321.11 Aligned_cols=253 Identities=24% Similarity=0.418 Sum_probs=198.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
.+|....+||+|+||.||++... +..+|+|.+..........|.+|+++++.++||||+++++++. +..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35777889999999999999642 3568999887654444567999999999999999999999884 56889
Q ss_pred EEEecCCCchhhhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 599 VYEYLPNGSLEDRLSCKDN------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999854321 1358899999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHH
Q 003121 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 745 (846)
Q Consensus 667 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~ 745 (846)
||+|||+++.......... .....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||..........
T Consensus 162 kL~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRV------GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred EECCCCceeEcCCCceeec------CCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 9999999876543221110 122335788999999998899999999999999999998 999996543322111
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.. ........+...+..+.+|+.+||..+|.+||++ .++...|+
T Consensus 236 ~~------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~-~~l~~~l~ 279 (280)
T cd05092 236 CI------TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVI-KDIHSRLQ 279 (280)
T ss_pred HH------HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCH-HHHHHHHh
Confidence 11 0111112233456789999999999999999999 77776664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.28 Aligned_cols=237 Identities=30% Similarity=0.481 Sum_probs=198.5
Q ss_pred eeeeeCceEEEEEEECCe--EEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccccCc--eEEEEEecCCCchhh
Q 003121 535 KIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLED 610 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~~--~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lVmEy~~ggsL~~ 610 (846)
+||+|.||+||.|+...+ .+|||-+.........-+..||.+.+.|+|.|||+++|+|.+. +-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 699999999999998764 5799998877666666789999999999999999999999553 558999999999999
Q ss_pred hhccCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec-CCCceeeeccccccccccccccCCCc
Q 003121 611 RLSCKDNSPPL--SWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNT 687 (846)
Q Consensus 611 ~L~~~~~~~~l--~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~ 687 (846)
+|+.+ -+|+ ++.+.-.+..||++||.|||. +.|||||||-+||||+ -.|.+||+|||.++.+..-.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin------ 730 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN------ 730 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC------
Confidence 99654 3456 788999999999999999999 8899999999999996 67999999999998765432
Q ss_pred cccccCCCCCCcccCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHhhhhhccccCCCCCCCChh
Q 003121 688 TLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 688 ~~~~~~~~~Gt~~Y~APE~l~~~--~~~~ksDVwSlGviL~elltG~~pf~~~~~~~-~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.+..++.||..|||||++..+ +|+.++|||||||++.||.||+|||......+ ..+..|-+. ..++.|..
T Consensus 731 --P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK-----vHP~iPee 803 (1226)
T KOG4279|consen 731 --PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK-----VHPPIPEE 803 (1226)
T ss_pred --ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-----cCCCCcHH
Confidence 122446699999999999876 59999999999999999999999995443333 223333222 34567888
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
.+.+...+|++|+..+|.+||++..
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~ 828 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKD 828 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHH
Confidence 8999999999999999999999943
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.85 Aligned_cols=240 Identities=24% Similarity=0.302 Sum_probs=187.3
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHH-HHHhcCCCceeeEeccc--cCceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~-iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
.||+|+||+||+|... +..||||++...... ....+..|.. +++.++||||+++++++ .+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 6999999999999885 678999998754221 2234455555 56789999999999987 45689999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 151 (323)
T cd05575 82 ELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---- 151 (323)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC----
Confidence 99998853 3468899999999999999999999 8999999999999999999999999999875322111
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
......||+.|+|||++.+..++.++|||||||++|+|++|++||............ .... ...+...+
T Consensus 152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i--~~~~-----~~~~~~~~ 220 (323)
T cd05575 152 ----TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--LNKP-----LRLKPNIS 220 (323)
T ss_pred ----ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH--HcCC-----CCCCCCCC
Confidence 112345999999999999989999999999999999999999999765432211111 1111 11223346
Q ss_pred HHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 767 EQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
..+.+|+.+||+.+|.+||++...+.+++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~il 249 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIK 249 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCCCCHHHHH
Confidence 78999999999999999999843333333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=321.76 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=197.7
Q ss_pred CCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
+|.+.+.||+|+||.||+|... +..||||++....... ...|.+|+.++..++||||+++++++. ...++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667778999999999999864 2569999987543221 356889999999999999999999884 56889
Q ss_pred EEEecCCCchhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc
Q 003121 599 VYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 665 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~ 665 (846)
++||+.+++|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||.|||++.++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 999999999999884221 12458889999999999999999999 89999999999999999999
Q ss_pred eeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 003121 666 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA 744 (846)
Q Consensus 666 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~ 744 (846)
+||+|||+++......... ......+++.|+|||.+.++.++.++|||||||++|||+| |.+||........
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYK------LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV- 235 (283)
T ss_pred eEecccccccccccchhee------eccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 9999999988654322111 0123346789999999988889999999999999999998 8889865433221
Q ss_pred HhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 745 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 745 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
... +........+...+..+.+|+.+||+.+|.+||++ .+++..|+
T Consensus 236 ~~~-----i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~-~~i~~~l~ 281 (283)
T cd05091 236 IEM-----IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRF-KDIHSRLR 281 (283)
T ss_pred HHH-----HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCH-HHHHHHhh
Confidence 111 11111122344456789999999999999999999 77777665
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=335.37 Aligned_cols=233 Identities=27% Similarity=0.329 Sum_probs=189.2
Q ss_pred ceeeeeCceEEEEEEE-----CCeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 534 LKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~-----~~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
+.||+|+||.||++.. .+..||+|++...... ....+.+|+.+|++++||||+++++++ ....|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999998864 3578999999764322 234577899999999999999999988 456889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~- 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK- 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-
Confidence 9999998843 3468999999999999999999999 89999999999999999999999999998765332110
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||............. . .....|..
T Consensus 155 -------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~-----~~~~~p~~ 220 (318)
T cd05582 155 -------AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--K-----AKLGMPQF 220 (318)
T ss_pred -------eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--c-----CCCCCCCC
Confidence 123458999999999998889999999999999999999999997654432211110 0 11123444
Q ss_pred hHHHHHHHHHHHhccCcCCCCCh
Q 003121 765 QAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.+..+.+|+.+||+.+|.+||++
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a 243 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGA 243 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCC
Confidence 56789999999999999999996
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=337.99 Aligned_cols=250 Identities=23% Similarity=0.303 Sum_probs=191.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|.+.++||+|+||.||++... +..||||++..... .....+.+|+.+|+.++||||+++++.| .+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 57899999865321 2245688999999999999999999988 45689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999853 3458889999999999999999999 89999999999999999999999999998533210
Q ss_pred cccC-----------------------------------CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHH
Q 003121 681 EISS-----------------------------------NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 725 (846)
Q Consensus 681 ~~~~-----------------------------------~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL 725 (846)
.... .....+......||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0000 00000111234699999999999998999999999999999
Q ss_pred HHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCC---Ch
Q 003121 726 LRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP---EL 787 (846)
Q Consensus 726 ~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RP---t~ 787 (846)
|+|+||++||..................+ ........+..+.+|+.+|+ .+|.+|+ ++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~ 295 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTL---HIPSQAKLSREASDLILRLC-CGAEDRLGKNGA 295 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCccc---cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence 99999999997665433222211111111 11111234567889999977 4999999 66
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=342.66 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=187.1
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--------C--
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--------E-- 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~-- 594 (846)
..+|...++||+|+||.||+|... +..||||.+... .....+|+.+|+.++||||+++++++. .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999875 578999988542 234568999999999999999988651 1
Q ss_pred ceEEEEEecCCCchhhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC-Cceeeeccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSC-KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFG 672 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~-~~vKL~DFG 672 (846)
.+++||||+++ +|.+++.. ......+++..+..++.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999975 66665532 2334578999999999999999999999 899999999999999865 479999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh--
Q 003121 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-- 749 (846)
Q Consensus 673 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~-- 749 (846)
+++.+...... ....||+.|+|||++.+. .|+.++|||||||+||||+||++||..............
T Consensus 217 la~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 287 (440)
T PTZ00036 217 SAKNLLAGQRS---------VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287 (440)
T ss_pred cchhccCCCCc---------ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99865432211 123589999999998764 699999999999999999999999976544322111100
Q ss_pred --------------hccccCC------CCCCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 750 --------------LKNLLDP------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 750 --------------~~~~ld~------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
+....-+ +...+|...+..+.+|+.+||..+|.+||++.+
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e 347 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE 347 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 0000000 011123334578999999999999999999944
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.32 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=200.0
Q ss_pred CCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~ 597 (846)
++|.+...||+|+||.||+|...+ ..||+|.+..... .....+.+|+.+|+.++||||+++++++ ....+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 478888999999999999998753 5699999865432 2234688999999999999999999987 45688
Q ss_pred EEEEecCCCchhhhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeec
Q 003121 598 LVYEYLPNGSLEDRLSCKD-------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 670 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~D 670 (846)
+||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence 9999999999999985432 12357889999999999999999999 8999999999999999999999999
Q ss_pred cccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhh
Q 003121 671 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGK 749 (846)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~ 749 (846)
||+++.+........ .....++..|+|||.+.++.++.++|||||||++|+|+| |.+||......... ....
T Consensus 163 fg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-~~~~ 235 (277)
T cd05032 163 FGMTRDIYETDYYRK------GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL-KFVI 235 (277)
T ss_pred cccchhhccCccccc------CCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH-HHHh
Confidence 999986644322111 122346889999999988889999999999999999998 99999654432211 1110
Q ss_pred hccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 750 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 750 ~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.......|...+..+.+|+.+||+.+|.+||++ .++...|+
T Consensus 236 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~l~~~l~ 276 (277)
T cd05032 236 -----DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTF-LEIVSSLK 276 (277)
T ss_pred -----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCH-HHHHHHhc
Confidence 111112233446789999999999999999999 77766654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.74 Aligned_cols=247 Identities=26% Similarity=0.439 Sum_probs=196.6
Q ss_pred ceeeeeCceEEEEEEECC-----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEecCCC
Q 003121 534 LKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNG 606 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy~~gg 606 (846)
++||+|+||.||+|.+.. ..+|+|.+...... ....+.+|+.+++.++||||+++++++. +..++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 369999999999997642 56999998865442 3456889999999999999999999884 4678999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+++... ..+++..+..++.|++.||.|||. .+++||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~-- 152 (257)
T cd05060 81 PLLKYLKKR---REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-- 152 (257)
T ss_pred cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc--
Confidence 999999533 368999999999999999999999 889999999999999999999999999998764332111
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhh
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 765 (846)
.......++..|+|||.+.+..++.++|||||||++|+|++ |.+||............... .....+...
T Consensus 153 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~ 223 (257)
T cd05060 153 ---RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG------ERLPRPEEC 223 (257)
T ss_pred ---ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC------CcCCCCCCC
Confidence 01112235678999999988899999999999999999998 99999755432211111100 011233445
Q ss_pred HHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 766 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 766 ~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
+..+.+++.+||..+|.+||++ .++.+.|+.+
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~-~~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTF-SELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCH-HHHHHHHHhc
Confidence 6789999999999999999999 7888888754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.41 Aligned_cols=246 Identities=28% Similarity=0.404 Sum_probs=196.0
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCc-eeeEecccc--C------c
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPN-LVTLVGACP--E------V 595 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~Hpn-Iv~l~g~~~--~------~ 595 (846)
.|....+||+|.||+||+|+.. |..||+|++...... .+....+|+.+|+.|+|+| |++|++++. + .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 4666778999999999999876 678999999876542 4567789999999999999 999999883 2 6
Q ss_pred eEEEEEecCCCchhhhhccCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
+++|+||+. .+|..++...... ..++...+..++.||+.||+|||+ ++|+||||||+||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 789999995 5899988644321 357778999999999999999999 99999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
+...-... ..+..++|.+|.|||++.+. .|++.+||||+|||++||+++++.|.+..+............
T Consensus 168 ra~~ip~~--------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG- 238 (323)
T KOG0594|consen 168 RAFSIPMR--------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG- 238 (323)
T ss_pred HHhcCCcc--------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC-
Confidence 95542211 12456789999999999886 799999999999999999999999988877655433221111
Q ss_pred cCCCCCCCCh------------------hh-------HHHHHHHHHHHhccCcCCCCChH
Q 003121 754 LDPLAGDWPF------------------VQ-------AEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 754 ld~~~~~~p~------------------~~-------~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
.|....||. .. .....+|+.+|++.+|.+|.++.
T Consensus 239 -tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~ 297 (323)
T KOG0594|consen 239 -TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAK 297 (323)
T ss_pred -CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHH
Confidence 111111211 11 13789999999999999999983
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.97 Aligned_cols=251 Identities=30% Similarity=0.496 Sum_probs=202.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc-cCceEEEEEecCC
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTLVYEYLPN 605 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~-~~~~~lVmEy~~g 605 (846)
++|.+.++||+|+||.||+|... +..||+|.+.... .....|.+|+.++++++||||+++++++ .+..++||||+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence 46888899999999999999875 4789999987544 3456899999999999999999999987 4568899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|.+++.... ...+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~- 159 (260)
T cd05067 85 GSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA- 159 (260)
T ss_pred CCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc-
Confidence 99999885433 3568999999999999999999999 899999999999999999999999999997664322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....++..|+|||++.+..++.++||||||+++|+|++ |++||............ .... ....+..
T Consensus 160 ------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~---~~~~~~~ 227 (260)
T cd05067 160 ------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL---ERGY---RMPRPDN 227 (260)
T ss_pred ------ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---HcCC---CCCCCCC
Confidence 122346788999999988889999999999999999999 99999655432211111 1110 1112233
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
.+..+.+++.+||..+|.+||++ +.+...|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~-~~l~~~l~~ 259 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTF-EYLRSVLED 259 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCH-HHHHHHhhc
Confidence 45789999999999999999999 788777764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=330.77 Aligned_cols=239 Identities=21% Similarity=0.319 Sum_probs=191.1
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcC-CCceeeEeccc--cCceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~lVm 600 (846)
+|+..+.||+|+||.||++... +..||+|++..... .....+..|..++..+. ||+|+++++++ .+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999876 57899999875422 22345778999998886 57777888877 35689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999998843 3468999999999999999999999 89999999999999999999999999998754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... .....||+.|+|||++.+..++.++|||||||++|+|+||++||............ . .....
T Consensus 155 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i--~-----~~~~~ 219 (323)
T cd05615 155 GVT--------TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI--M-----EHNVS 219 (323)
T ss_pred Ccc--------ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--H-----hCCCC
Confidence 110 12245899999999999889999999999999999999999999766543211111 0 01123
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
+|...+..+.+|+.+||..+|.+|++..
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 3445567899999999999999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=333.16 Aligned_cols=239 Identities=22% Similarity=0.277 Sum_probs=185.9
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
.||+|+||.||++... +..||+|++...... ....+..|+.++.++ +||||+++++++ ....++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 6999999999999876 467999999864322 234577899998877 899999999987 45689999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|..++.. ...+++..+..++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~--- 152 (329)
T cd05618 82 DLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--- 152 (329)
T ss_pred CHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc---
Confidence 99988843 3468999999999999999999999 89999999999999999999999999998753221110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHhhhhhccccCCCCCCCChh
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||....... .......+...+.......|..
T Consensus 153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 227 (329)
T cd05618 153 -----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 227 (329)
T ss_pred -----cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCC
Confidence 123458999999999999999999999999999999999999995211000 0000000000011111234445
Q ss_pred hHHHHHHHHHHHhccCcCCCCCh
Q 003121 765 QAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.+..+.+|+.+||..+|.+||+.
T Consensus 228 ~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 228 LSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCHHHHHHHHHHhcCCHHHcCCC
Confidence 56789999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.72 Aligned_cols=257 Identities=27% Similarity=0.410 Sum_probs=202.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|...+.||+|+||.||+|... +..+|||.+....... ...+.+|+.+++.++||||++++++| .+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 35777888999999999999864 6789999887543322 34688999999999999999999987 45688999
Q ss_pred EecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 601 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
||+++++|.+++... .....+++..++.++.+|+.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988542 234568999999999999999999999 8999999999999999999999999999886543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.... .....|+..|+|||++.+..++.++||||||+++|+|++|..||............. +.....+ .
T Consensus 159 ~~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~--~ 227 (267)
T cd08229 159 KTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-IEQCDYP--P 227 (267)
T ss_pred CCcc--------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh-hhcCCCC--C
Confidence 2211 112358999999999988889999999999999999999999996433211111111 1111111 0
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
..+...+..+.+|+.+||..+|.+||++ .+|+++++++.
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~i~~~~~~~~ 266 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDI-TYVYDVAKRMH 266 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCH-HHHHHHHhhhc
Confidence 1112356789999999999999999999 88888888763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=323.28 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=204.4
Q ss_pred cCCCcccceeeeeCceEEEEEEECC---------eEEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEecccc--
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP-- 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~---------~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~-- 593 (846)
.++|.+.+.||+|+||.||++...+ ..+|+|.+.... ......+..|+.+++.+ +||||++++++|.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578899999999999999997632 359999987642 22345688899999999 7999999999884
Q ss_pred CceEEEEEecCCCchhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 660 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl 660 (846)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ +|++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 468899999999999999964321 2358899999999999999999999 899999999999999
Q ss_pred cCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 003121 661 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK 739 (846)
Q Consensus 661 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~ 739 (846)
+.++.+||+|||+++.......... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhc------cccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999999999999876543221110 012235678999999988889999999999999999998 889986554
Q ss_pred HHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 740 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 740 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
.... ...... ....+.+...+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 248 ~~~~-~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~evl~~l~~~~~~~ 303 (307)
T cd05098 248 VEEL-FKLLKE-----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRILALT 303 (307)
T ss_pred HHHH-HHHHHc-----CCCCCCCCcCCHHHHHHHHHHcccChhhCcCH-HHHHHHHHHHHHHh
Confidence 3221 111000 11122344456789999999999999999999 88888988877653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.31 Aligned_cols=198 Identities=26% Similarity=0.409 Sum_probs=169.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
.++|+..++||.|+||.||++... +..+|+|.+..... .....+.+|+.+|+.++||||++++++| .+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 357899999999999999999886 56799998875422 1235688999999999999999999998 456899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++|+|.+++.. ...+++..+..++.+++.||.|||+. ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999999853 34588999999999999999999972 369999999999999999999999999987653321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK 739 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~ 739 (846)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 159 ----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 159 ----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred ----------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 122358999999999998889999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.39 Aligned_cols=239 Identities=24% Similarity=0.327 Sum_probs=187.5
Q ss_pred eeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCch
Q 003121 536 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 608 (846)
Q Consensus 536 LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggsL 608 (846)
||+|+||.||++... +..||+|.+...... ....+..|+++|++++||||+++++++. ...++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999876 678999998653222 2234567999999999999999999884 468899999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCcc
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 688 (846)
.+++.... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce------
Confidence 98875332 3458899999999999999999999 8999999999999999999999999999876543211
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHhhhhhccccCCCCCCCChhhH
Q 003121 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 689 ~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
.....|++.|+|||++.+..++.++|||||||++|+|++|++||...... ...+........+... ....+
T Consensus 151 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 223 (277)
T cd05607 151 ---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE----HQNFT 223 (277)
T ss_pred ---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc----cccCC
Confidence 02235899999999999888999999999999999999999999654321 1111111111111111 11345
Q ss_pred HHHHHHHHHHhccCcCCCCChHHHH
Q 003121 767 EQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+.+|+.+||+.+|.+||++.+.+
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccch
Confidence 7899999999999999999994433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.23 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=200.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--Ce----EEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc-CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV 599 (846)
.+|...++||+|+||.||+|.+. +. .||+|++...... ....+.+|+.++..++||||++++++|. ...+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 46788899999999999999864 32 4899998754322 2356889999999999999999999884 457899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|+|+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 9999999999998532 3468999999999999999999999 8999999999999999999999999999987643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~ 756 (846)
..... ......+++.|+|||.+.+..++.++|||||||++|||+| |.+||....... ..+..+.
T Consensus 162 ~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------- 228 (279)
T cd05109 162 DETEY------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE------- 228 (279)
T ss_pred cccee------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------
Confidence 22110 0112335788999999988899999999999999999998 999996543322 1111110
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
....+...+..+.+++.+||..+|.+||++ .+++..|..+..
T Consensus 229 -~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~-~~l~~~l~~~~~ 270 (279)
T cd05109 229 -RLPQPPICTIDVYMIMVKCWMIDSECRPRF-RELVDEFSRMAR 270 (279)
T ss_pred -cCCCCccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHhhc
Confidence 111123345789999999999999999999 677777776644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.97 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=204.3
Q ss_pred cCCCcccceeeeeCceEEEEEEECC------eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc---Cce
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP---EVW 596 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~------~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~---~~~ 596 (846)
.++|.....||+|+||.||+|.+.. ..|++|.+..... .....+.+|+.+|+.++||||+++++++. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999998754 6799998864322 22356889999999999999999999863 468
Q ss_pred EEEEEecCCCchhhhhccCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNS-----PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~-----~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DF 671 (846)
+++++|+++|+|.+++...... ..+++..++.++.+++.||.|||+ ++++||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998543222 568999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhh
Q 003121 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL 750 (846)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~ 750 (846)
|+++.+........ .....++..|+|||++.+..++.++|||||||++|++++ |++||.............
T Consensus 162 g~~~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-- 233 (280)
T cd05043 162 ALSRDLFPMDYHCL------GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-- 233 (280)
T ss_pred CCcccccCCceEEe------CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH--
Confidence 99986543321110 112346778999999988889999999999999999999 999997654433211110
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 751 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 751 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
. ......+...+..+.+++.+||..+|.+||++ .++...|..+..
T Consensus 234 -~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~~~~~l~~~~~ 278 (280)
T cd05043 234 -D---GYRLAQPINCPDELFAVMACCWALDPEERPSF-SQLVQCLTDFHA 278 (280)
T ss_pred -c---CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHHh
Confidence 0 01111223345789999999999999999999 888888887653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=328.01 Aligned_cols=232 Identities=22% Similarity=0.292 Sum_probs=188.0
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
.||+|+||.||++... +..||||++.... ......+..|..++..+ +||||+++++++ .+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999886 4689999997542 22344577899999888 799999999987 45689999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 152 (318)
T cd05570 82 DLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--- 152 (318)
T ss_pred CHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc---
Confidence 99988843 3468999999999999999999999 89999999999999999999999999998743221110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||............. .....+|...+
T Consensus 153 -----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~-------~~~~~~~~~~~ 220 (318)
T cd05570 153 -----TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL-------EDEVRYPRWLS 220 (318)
T ss_pred -----ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH-------cCCCCCCCcCC
Confidence 122358999999999999999999999999999999999999997654432211110 01112344556
Q ss_pred HHHHHHHHHHhccCcCCCCCh
Q 003121 767 EQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
..+.+|+.+||..+|.+||++
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCC
Confidence 889999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=312.01 Aligned_cols=247 Identities=28% Similarity=0.470 Sum_probs=202.3
Q ss_pred CCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCC
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 605 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~g 605 (846)
.+|...+.||.|+||.||+|...++.||+|.+..... ....+.+|+.+++.++||||+++++++ .+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4678888999999999999999999999999976543 456789999999999999999999987 4568899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
++|.+++.... ...+++..+..++.|++.||.|||. ++++||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 85 GSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 99999985433 2368999999999999999999999 8999999999999999999999999999986632211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
...++..|+|||++.++.++.++||||||+++|+|++ |+.||............. .. .....+..
T Consensus 158 --------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--~~----~~~~~~~~ 223 (256)
T cd05039 158 --------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE--KG----YRMEAPEG 223 (256)
T ss_pred --------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh--cC----CCCCCccC
Confidence 1235678999999988889999999999999999997 999996654322111110 00 01122333
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
.+..+.+++.+||..+|.+||++ .++.+.|+.
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~-~~l~~~l~~ 255 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTF-KQLREQLAL 255 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCH-HHHHHHHhc
Confidence 46789999999999999999999 777777754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.97 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=197.5
Q ss_pred cccceeeeeCceEEEEEEEC------CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc----CceEEE
Q 003121 531 DPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLV 599 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~------~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lV 599 (846)
...+.||+|+||+||.+.+. +..||+|.+..... .....|.+|+.+|+.++||||++++++|. ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 77788999999999887542 46799999876432 23456889999999999999999999873 247899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++.. ..+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999842 348999999999999999999999 8999999999999999999999999999987653
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHhh-------hhhc
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDT-------GKLK 751 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~-~~~~~~-------~~~~ 751 (846)
....... .....++..|+|||++.+..++.++||||||+++|+|+||..||...... ...... ..+.
T Consensus 160 ~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 160 GHEYYRV-----REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cchhhcc-----CCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 2211000 11234567899999998888999999999999999999999998643321 111100 0011
Q ss_pred cccC-CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 752 NLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 752 ~~ld-~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
..++ ......+...+..+.+++.+||+.+|.+||++ ++++..|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF-RSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCH-HHHHHHHHHhh
Confidence 1111 01112234456789999999999999999999 78888887663
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=332.17 Aligned_cols=233 Identities=24% Similarity=0.318 Sum_probs=186.5
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
.||+|+||.||++... +..||+|++...... ....+.+|+.++.++ +||||+.+++++ ....++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999876 478999999864322 234578999999888 699999999987 35689999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--- 152 (327)
T cd05617 82 DLMFHMQR---QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--- 152 (327)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc---
Confidence 99988843 3469999999999999999999999 89999999999999999999999999998753221100
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHhhhhhccccCCCCCC
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~------~~~~~~~~~~~~~ld~~~~~ 760 (846)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||..... ........ ......
T Consensus 153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~------~~~~~~ 221 (327)
T cd05617 153 -----TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI------LEKPIR 221 (327)
T ss_pred -----eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH------HhCCCC
Confidence 1234599999999999999999999999999999999999999953211 11111110 011122
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.|...+..+.+++.+||..+|.+||++
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 444556789999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=344.75 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=210.6
Q ss_pred CCcccceeeeeCceEEEEEEEC--C---eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--H---MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~---~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
...+.++||.|.||+||+|.++ + ..||||.++.... ....+|..|..||.+++||||++|.|... ....||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4456778999999999999886 3 4699999987533 33567999999999999999999999873 4678999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
|||++|+|+.+|+.++ +.|++.++.-++..|+.|+.||-. +++|||||...||||+.+..+|++||||++.+.++
T Consensus 710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999997665 459999999999999999999999 89999999999999999999999999999987654
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHhhhhhccccCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDPL 757 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~--~~~~~~~~~~~~~ld~~ 757 (846)
.. ...++ .+..-...|.|||.+...+++.+||||||||++||.++ |..|+....+ +..+++.+ .
T Consensus 785 ~~-~~ytt----~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g--------y 851 (996)
T KOG0196|consen 785 PE-AAYTT----LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG--------Y 851 (996)
T ss_pred CC-ccccc----cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc--------c
Confidence 31 11111 23344689999999999999999999999999999876 8888765443 22333332 2
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
+-.-|..++..|.+|++.||+++..+||.| ..|+..|+++-..
T Consensus 852 RLPpPmDCP~aL~qLMldCWqkdR~~RP~F-~qiV~~lDklIrn 894 (996)
T KOG0196|consen 852 RLPPPMDCPAALYQLMLDCWQKDRNRRPKF-AQIVSTLDKLIRN 894 (996)
T ss_pred CCCCCCCCcHHHHHHHHHHHHHHhhcCCCH-HHHHHHHHHHhcC
Confidence 333467788999999999999999999999 7888999887654
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=330.45 Aligned_cols=240 Identities=25% Similarity=0.327 Sum_probs=187.2
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHH-HHHhcCCCceeeEeccc--cCceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~-iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
.||+|+||.||+|... +..||+|++..... .....+..|.. +++.++||||++++++| .+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999885 57899999875422 12234555554 67889999999999987 45689999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|...+.. ...+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 82 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--- 152 (321)
T cd05603 82 ELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--- 152 (321)
T ss_pred CHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc---
Confidence 99988843 3458889999999999999999999 89999999999999999999999999998753221110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
.....||+.|+|||++.+..++.++|||||||++|+|++|++||...+.... .... ... ....|...+
T Consensus 153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i-~~~-----~~~~~~~~~ 220 (321)
T cd05603 153 -----TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-YDNI-LHK-----PLQLPGGKT 220 (321)
T ss_pred -----cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-HHHH-hcC-----CCCCCCCCC
Confidence 1234589999999999988999999999999999999999999976543221 1110 111 112334456
Q ss_pred HHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 767 EQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
..+.+++.+||+.+|.+||+....+.+++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~ 249 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAKADFLEIK 249 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCCCCHHHHh
Confidence 78999999999999999998744444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.55 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=198.2
Q ss_pred CCCcccceeeeeCceEEEEEEECC----eEEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~----~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lV 599 (846)
++|.+...||+|+||.||+|.... ..+++|.++... ......|.+|+.++.++ +||||+++++++. ...++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888899999999999998753 247888877432 22235688999999999 7999999999884 458899
Q ss_pred EEecCCCchhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 600 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999985432 12358899999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHH
Q 003121 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 745 (846)
Q Consensus 667 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~ 745 (846)
||+|||++....... . ......+..|+|||++.+..++.++|||||||++|+|+| |.+||........ .
T Consensus 159 kl~dfg~~~~~~~~~--~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-~ 228 (297)
T cd05089 159 KIADFGLSRGEEVYV--K-------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-Y 228 (297)
T ss_pred EECCcCCCcccccee--c-------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-H
Confidence 999999986432110 0 011123567999999988889999999999999999997 9999965543221 1
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
.. .........+...+..+.+|+.+||+.+|.+||++ .++.+.|+.+...
T Consensus 229 ~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~~~~~ 278 (297)
T cd05089 229 EK-----LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPF-AQISVQLSRMLEA 278 (297)
T ss_pred HH-----HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHh
Confidence 11 11111122233456789999999999999999999 7777777776644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=347.46 Aligned_cols=263 Identities=22% Similarity=0.331 Sum_probs=204.3
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEeccc-----c-
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC-----P- 593 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~-----~- 593 (846)
+.....++.+.+.|.+|||+.||.+...+ ..||+|++-..+......+.+||++|++|. |||||.+++++ .
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 33455678888999999999999998863 789999988777777788999999999996 99999999954 1
Q ss_pred ---CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeec
Q 003121 594 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 670 (846)
Q Consensus 594 ---~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~D 670 (846)
-.++|.||||.||.|-|++..+... .|++.++++|+.++++|+.+||++.| +|||||||-+||||+.+|..||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEcCCCCEEeCc
Confidence 1367899999999999999655433 39999999999999999999999875 899999999999999999999999
Q ss_pred cccccccccccccCCCcc-ccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHh
Q 003121 671 FGISRFLSQNEISSNNTT-LCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 746 (846)
Q Consensus 671 FGla~~~~~~~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~ 746 (846)
||.+.............. +...-..--|+.|.|||++. +.+++.|+|||+|||+||-|+....||+.... .++.
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--laIl 267 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--LAIL 267 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--eeEE
Confidence 999874432221110000 00000112489999999874 56799999999999999999999999976633 2233
Q ss_pred hhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 747 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 747 ~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.+++. .+.+ ...+..|.+||..||+.+|.+||++.+.+..+.+
T Consensus 268 ng~Y~------~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 268 NGNYS------FPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ecccc------CCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 33322 1222 3567899999999999999999999544444433
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.58 Aligned_cols=244 Identities=25% Similarity=0.402 Sum_probs=197.7
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|...+.||+|+||.||+|... +..|++|.+..... .....+.+|+.+++.++||||+++++++. ...++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677788999999999999885 57899999875432 23456889999999999999999999884 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|.+++... ....+++..++.++.+++.||.|||. ++++|+||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998643 23568999999999999999999999 8999999999999999999999999999886654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. .....|++.|+|||++.+..++.++|+|||||++|+|+||+.||........... ..... ....+
T Consensus 157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~----~~~~~ 222 (256)
T cd08529 157 F--------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK--IIRGV----FPPVS 222 (256)
T ss_pred h--------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHcCC----CCCCc
Confidence 1 1223588999999999998999999999999999999999999976654322111 11111 12223
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+..+.+++.+||+.+|.+||++ .++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~-~~l 250 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDT-FQL 250 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCH-HHH
Confidence 3455789999999999999999999 444
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=352.46 Aligned_cols=267 Identities=23% Similarity=0.322 Sum_probs=205.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|...++||+|+||.||+|... +..||||++....... ...|.+|+.++++++||||+++++++. +..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999999999999875 5789999997543222 346889999999999999999999884 4688999
Q ss_pred EecCCCchhhhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccc
Q 003121 601 EYLPNGSLEDRLSCKD--------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 672 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFG 672 (846)
||++||+|.+++.... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 12346677889999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCC----------CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 003121 673 ISRFLSQNEISSN----------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 742 (846)
Q Consensus 673 la~~~~~~~~~~~----------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~ 742 (846)
+++.......... ...........||+.|+|||++.+..++.++|||||||++|||+||++||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987622110000 000011123569999999999999999999999999999999999999996543322
Q ss_pred HHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 743 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 743 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
.... . ....+.........+..+.+++.+||..+|.+||+..+++...|+.+...
T Consensus 239 i~~~-~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISYR-D---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhh-h---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111 1 11111111111234577999999999999999998888888888876543
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=311.40 Aligned_cols=251 Identities=31% Similarity=0.485 Sum_probs=200.5
Q ss_pred CCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEecCC
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPN 605 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy~~g 605 (846)
.+|....+||+|+||.||+|.+.+ ..+|+|.+.... ...+.+.+|+.+++.++||||+++++++. +..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 357888899999999999998865 479999886543 23467889999999999999999999874 457899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|.+++.... ...+++..+..++.+++.||.|||+ .|++|+||||+|||++.++.+||+|||++..........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~- 159 (260)
T cd05069 85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA- 159 (260)
T ss_pred CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc-
Confidence 99999985432 3458899999999999999999999 899999999999999999999999999998764322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....++..|+|||.+.+..++.++||||||+++|+|+| |++||......... .. .... .....+..
T Consensus 160 ------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~--~~~~---~~~~~~~~ 227 (260)
T cd05069 160 ------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-EQ--VERG---YRMPCPQG 227 (260)
T ss_pred ------cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH--HHcC---CCCCCCcc
Confidence 012346788999999988889999999999999999999 99999654432211 11 1111 11122334
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
.+..+.+++.+||..+|.+||++ +.+.+.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTF-EYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCH-HHHHHHHhc
Confidence 56789999999999999999999 778777764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.95 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=197.7
Q ss_pred cCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--Cce
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 596 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~ 596 (846)
+++|.+.+.||+|+||.||+|.+.+ ..||+|.+...... ....|.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4578888999999999999998854 56899987654322 2346899999999999999999999873 468
Q ss_pred EEEEEecCCCchhhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC---ceeee
Q 003121 597 TLVYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLS 669 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~---~vKL~ 669 (846)
++||||+++|+|.+++..... ...+++..++.++.+|+.||.|||. ++++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 899999999999999854421 2358999999999999999999999 8999999999999998654 68999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhh
Q 003121 670 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTG 748 (846)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~ 748 (846)
|||+++.+........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 162 dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~- 234 (277)
T cd05036 162 DFGMARDIYRASYYRK------GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV- 234 (277)
T ss_pred cCccccccCCccceec------CCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-
Confidence 9999987633221110 112234678999999998899999999999999999997 99999754432211110
Q ss_pred hhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 749 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.......+|...+..+.+++.+||+.+|.+||++ .++++.|.
T Consensus 235 -----~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~-~~vl~~l~ 276 (277)
T cd05036 235 -----TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNF-ATILERIQ 276 (277)
T ss_pred -----HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHhh
Confidence 0111223345556889999999999999999999 66666553
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=334.20 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=203.1
Q ss_pred hhhcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCCC-chhHHHHHHHHHhcC-CCceeeEecccc-
Q 003121 524 EGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKIR-HPNLVTLVGACP- 593 (846)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~~-~~~f~~Ei~iL~~l~-HpnIv~l~g~~~- 593 (846)
.....+|.+.++||+|+||.||+|.+.+ ..||+|+++...... ...+.+|+.+|.++. ||||++++|+|.
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3445578888999999999999998643 479999997643222 346889999999997 999999999984
Q ss_pred -CceEEEEEecCCCchhhhhccCC--------------------------------------------------------
Q 003121 594 -EVWTLVYEYLPNGSLEDRLSCKD-------------------------------------------------------- 616 (846)
Q Consensus 594 -~~~~lVmEy~~ggsL~~~L~~~~-------------------------------------------------------- 616 (846)
...++||||+++|+|.+++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 46899999999999999885431
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCc
Q 003121 617 ---------------------------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 657 (846)
Q Consensus 617 ---------------------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~N 657 (846)
....+++..++.|+.+|+.||.|||+ ++++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 11347788899999999999999998 899999999999
Q ss_pred eEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 003121 658 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG 736 (846)
Q Consensus 658 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~ 736 (846)
||++.++.+||+|||+++.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYIS------KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccccc------CCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999986533221100 122347889999999988889999999999999999998 899996
Q ss_pred CchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 737 ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 737 ~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
........... +.. ......|...+..+.+|+.+||..+|.+||++ ++++..|+.+
T Consensus 344 ~~~~~~~~~~~--~~~---~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-~ell~~L~~~ 399 (401)
T cd05107 344 ELPMNEQFYNA--IKR---GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDF-SQLVHLVGDL 399 (401)
T ss_pred CCCchHHHHHH--HHc---CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHH
Confidence 54332221111 000 01112234456789999999999999999999 7888888765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.62 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=199.9
Q ss_pred CCCcccceeeeeCceEEEEEEECC------------------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH------------------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTL 588 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~------------------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l 588 (846)
.+|.+.+.||+|+||.||++...+ ..||+|.+...... ....+.+|+.+|++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 478889999999999999987643 35899998765322 34578899999999999999999
Q ss_pred ecccc--CceEEEEEecCCCchhhhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCce
Q 003121 589 VGACP--EVWTLVYEYLPNGSLEDRLSCKD--------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 658 (846)
Q Consensus 589 ~g~~~--~~~~lVmEy~~ggsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NI 658 (846)
+++|. +..++||||+++++|.+++.... ....+++..++.++.+++.||.|||+ ++++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 99884 56889999999999999985432 12368999999999999999999999 8999999999999
Q ss_pred EecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 003121 659 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALG 736 (846)
Q Consensus 659 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt--G~~pf~ 736 (846)
|++.++.++|+|||+++......... ......+++.|+|||++.++.++.++|||||||++|+|++ |..||.
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYR------VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eecCCCceEEccccceeecccCccee------ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999999999999988654332111 1123446789999999988889999999999999999998 778886
Q ss_pred CchHHHHHHhhhhh-ccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 737 ITKEVQYALDTGKL-KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 737 ~~~~~~~~~~~~~~-~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.............. ...-.......+...+..+.+|+.+||+.+|.+||++ .++++.|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~-~el~~~L~ 295 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF-REIHLFLQ 295 (296)
T ss_pred CcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH-HHHHHHhc
Confidence 54332211111111 0000111112233455789999999999999999999 77777664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.47 Aligned_cols=259 Identities=27% Similarity=0.461 Sum_probs=197.1
Q ss_pred CCCcccceeeeeCceEEEEEEECC----------------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH----------------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVG 590 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~----------------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g 590 (846)
++|.+.++||+|+||.||++...+ ..||+|.++..... ....|.+|+++|++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478888999999999999987642 24899998764222 2346889999999999999999999
Q ss_pred cc--cCceEEEEEecCCCchhhhhccCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceE
Q 003121 591 AC--PEVWTLVYEYLPNGSLEDRLSCKD---------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 659 (846)
Q Consensus 591 ~~--~~~~~lVmEy~~ggsL~~~L~~~~---------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NIL 659 (846)
++ ....++||||+++++|.+++.... ....+++..++.++.+++.||.|||+ ++++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 88 456889999999999999885322 12347889999999999999999999 89999999999999
Q ss_pred ecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 003121 660 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI 737 (846)
Q Consensus 660 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt--G~~pf~~ 737 (846)
++.++.+||+|||++..+...... ...+...++..|+|||++.++.++.++|||||||++|+|++ |..||..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EcCCCcEEecccccccccccCcce------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999865432111 01123346789999999998899999999999999999998 6678865
Q ss_pred chHHHHHHhhhh-hccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 738 TKEVQYALDTGK-LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 738 ~~~~~~~~~~~~-~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
............ +...........+...+..+.+|+.+||..+|.+||++ .++.+.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~-~~i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF-NKIHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHh
Confidence 433221111111 00000111111223345789999999999999999999 77777665
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=335.18 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=193.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
..+|...++||+|+||.||++... +..||+|++..... .....+.+|+.+|+.++||||+++++++. ...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457888999999999999999876 57899999865321 22345788999999999999999999884 458899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||++||+|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999998842 347888899999999999999999 8999999999999999999999999999986543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|++||................ .
T Consensus 195 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~ 264 (370)
T cd05596 195 NGMVR-------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK---N 264 (370)
T ss_pred CCccc-------CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC---C
Confidence 22111 1234699999999998653 47899999999999999999999997665432211110000 0
Q ss_pred CCCCCCCh--hhHHHHHHHHHHHhccCcCC--CCChHHHH
Q 003121 756 PLAGDWPF--VQAEQLANLAMRCCEMSRKS--RPELGKDV 791 (846)
Q Consensus 756 ~~~~~~p~--~~~~~l~~Li~~Cl~~~P~~--RPt~~~~v 791 (846)
. ..+|. ..+..+.+|+.+||..+|.+ ||++ +++
T Consensus 265 ~--~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~-~el 301 (370)
T cd05596 265 S--LTFPDDIEISKQAKDLICAFLTDREVRLGRNGV-DEI 301 (370)
T ss_pred c--CCCCCcCCCCHHHHHHHHHHccChhhccCCCCH-HHH
Confidence 0 11221 34678999999999999987 9998 554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.79 Aligned_cols=257 Identities=24% Similarity=0.411 Sum_probs=199.3
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCc
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEV 595 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~ 595 (846)
...+|.+.++||+|+||.||+|..+ +..||+|.+...... ....+.+|+.+++.++||||+++++++ ...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3457889999999999999999754 246999987644321 223578899999999999999999987 346
Q ss_pred eEEEEEecCCCchhhhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceee
Q 003121 596 WTLVYEYLPNGSLEDRLSCKD-------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 668 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL 668 (846)
.++||||+++|+|.+++.... ....+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 899999999999999996432 13456778899999999999999999 89999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhh
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDT 747 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~ 747 (846)
+|||+++.......... .....++..|+|||.+.++.++.++|||||||++|||++ |.+||........ ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~-~~- 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRK------GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-LK- 232 (288)
T ss_pred CcCCccccccccccccc------cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HH-
Confidence 99999986543221111 122345778999999998899999999999999999998 7889965443221 11
Q ss_pred hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
...+......+...+..+.+++.+||+.+|.+||++ .++.+.|+..
T Consensus 233 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~ll~~l~~~ 278 (288)
T cd05061 233 ----FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTF-LEIVNLLKDD 278 (288)
T ss_pred ----HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHhh
Confidence 011111112233445789999999999999999999 6676666643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=331.62 Aligned_cols=244 Identities=25% Similarity=0.325 Sum_probs=193.6
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
+|.....||+|+||.||++... +..||||+++.... .....+.+|+.+++.++||||+++++++. +..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 6888899999999999999875 57899999986432 22356889999999999999999999874 46889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 82 YQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 99999999998543 2468999999999999999999999 899999999999999999999999999998764332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLA------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
.. ......||+.|+|||++. ...++.++|||||||++|+|++|+.||..................+.
T Consensus 157 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 229 (330)
T cd05601 157 MV-------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229 (330)
T ss_pred ce-------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC
Confidence 11 012245899999999986 45678999999999999999999999976544332111111111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
.+. ....+..+.+|+..||. +|.+||++.
T Consensus 230 --~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~ 258 (330)
T cd05601 230 --FPE-DPKVSSDFLDLIQSLLC-GQKERLGYE 258 (330)
T ss_pred --CCC-CCCCCHHHHHHHHHHcc-ChhhCCCHH
Confidence 011 12345789999999998 999999993
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=331.48 Aligned_cols=240 Identities=25% Similarity=0.295 Sum_probs=187.0
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHH-HHHhcCCCceeeEeccc--cCceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~-iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
.||+|+||+||++... +..||+|++..... .....+..|.. +++.++||||+++++++ .+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 5999999999999875 67899999875422 12234555655 46778999999999987 45689999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|..++. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---- 151 (325)
T cd05604 82 ELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---- 151 (325)
T ss_pred CHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC----
Confidence 9998884 33568999999999999999999999 8999999999999999999999999999875322111
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
......||+.|+|||++.+..++.++|||||||++|+|++|++||......... ... .... ...+...+
T Consensus 152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-~~~-~~~~-----~~~~~~~~ 220 (325)
T cd05604 152 ----TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY-DNI-LHKP-----LVLRPGAS 220 (325)
T ss_pred ----CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH-HHH-HcCC-----ccCCCCCC
Confidence 012345999999999999999999999999999999999999999765433211 110 1110 11122345
Q ss_pred HHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 767 EQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
..+.+++.+||..+|.+||++...+.+++
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 77999999999999999998843343333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=320.67 Aligned_cols=260 Identities=23% Similarity=0.397 Sum_probs=203.9
Q ss_pred cCCCcccceeeeeCceEEEEEEEC---------CeEEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEecccc--
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP-- 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~---------~~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~-- 593 (846)
..+|.+...||+|+||.||++... +..||+|.+.... ......+.+|+.+++.+ +||||++++++|.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 446888899999999999999752 2369999887542 22345688999999999 8999999999884
Q ss_pred CceEEEEEecCCCchhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 660 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl 660 (846)
...++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ +|++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 458899999999999999864321 2357889999999999999999999 899999999999999
Q ss_pred cCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 003121 661 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK 739 (846)
Q Consensus 661 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~ 739 (846)
+.++.+||+|||+++.......... .....+++.|+|||++.+..++.++||||||+++|+|+| |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cCCCcEEECCCccceeccccccccc------ccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999987643321110 122346788999999988889999999999999999998 888886544
Q ss_pred HHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 740 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 740 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
.... ..... .......+...+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 245 ~~~~-~~~~~-----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-~e~l~~l~~~~~~~ 300 (304)
T cd05101 245 VEEL-FKLLK-----EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF-KQLVEDLDRILTLT 300 (304)
T ss_pred HHHH-HHHHH-----cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCH-HHHHHHHHHHHHhh
Confidence 3221 11100 011112233456789999999999999999999 88888888876653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=330.15 Aligned_cols=240 Identities=24% Similarity=0.313 Sum_probs=186.5
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHH-HHHhcCCCceeeEeccc--cCceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~-iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
.||+|+||.||++... +..||+|++..... .....+..|.. +++.++||||+++++++ .+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6999999999999886 46799999875321 11223444444 56788999999999987 45689999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~--- 152 (325)
T cd05602 82 ELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--- 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC---
Confidence 99998853 3457888899999999999999999 89999999999999999999999999998754221110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
.....||+.|+|||++.+..++.++|||||||++|+|++|++||............ ... ....+...+
T Consensus 153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~-----~~~~~~~~~ 220 (325)
T cd05602 153 -----TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNK-----PLQLKPNIT 220 (325)
T ss_pred -----cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH--HhC-----CcCCCCCCC
Confidence 12345999999999999999999999999999999999999999765543321111 011 111223456
Q ss_pred HHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 767 EQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
..+.+|+.+||+.+|.+||++.+.+.+++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 78999999999999999999854443333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=310.84 Aligned_cols=247 Identities=28% Similarity=0.409 Sum_probs=196.2
Q ss_pred eeeeeCceEEEEEEECC-----eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEecCCCc
Q 003121 535 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGS 607 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy~~ggs 607 (846)
+||+|+||.||+|.+.. ..||||.+..... ...+.+.+|+.++++++||||+++++.+. ...++||||+++|+
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~ 81 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGS 81 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCc
Confidence 58999999999998742 3599999987655 34567899999999999999999999874 46789999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCc
Q 003121 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 687 (846)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 687 (846)
|.+++..... ..+++..++.++.|++.||.|||. ++++|+||+|+|||++.++.+||+|||+++.+.........
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~- 156 (257)
T cd05040 82 LLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM- 156 (257)
T ss_pred HHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec-
Confidence 9999865432 568999999999999999999999 89999999999999999999999999999876543211100
Q ss_pred cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 688 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 688 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
.....++..|+|||++.+..++.++|||||||++|+|+| |.+||.............. .......+...+
T Consensus 157 ----~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 227 (257)
T cd05040 157 ----EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK-----EGERLERPEACP 227 (257)
T ss_pred ----ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----cCCcCCCCccCC
Confidence 112457889999999998899999999999999999999 9999965443321111111 011111233445
Q ss_pred HHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 767 EQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
..+.+++.+||+.+|.+||++ .+++..|.
T Consensus 228 ~~~~~li~~~l~~~p~~Rps~-~~~~~~l~ 256 (257)
T cd05040 228 QDIYNVMLQCWAHNPADRPTF-AALREFLP 256 (257)
T ss_pred HHHHHHHHHHCCCCcccCCCH-HHHHHHhc
Confidence 789999999999999999999 66666553
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=330.86 Aligned_cols=252 Identities=27% Similarity=0.467 Sum_probs=209.0
Q ss_pred CcccceeeeeCceEEEEEEECC------eEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEeccccC-ceEEEEE
Q 003121 530 FDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVYE 601 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~------~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-~~~lVmE 601 (846)
..+.++||.|-||.||+|++.. -.||||.-+.+. ..+.+.|..|..+|++++|||||+|+|+|.+ ..+||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmE 470 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVME 470 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEe
Confidence 3445689999999999998853 249999887753 3446789999999999999999999999954 6889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
.++.|.|..+|..+ ...|+......++.||+.||.|||+ +.+|||||...|||+...-.|||+|||+++.+....
T Consensus 471 L~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 471 LAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred cccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999999644 3468889999999999999999999 889999999999999999999999999999987765
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
+... +...-...|||||-+.-..++.++|||-|||.+||++. |..||.+.....- +..+-...+..
T Consensus 546 yYka-------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV------I~~iEnGeRlP 612 (974)
T KOG4257|consen 546 YYKA-------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV------IGHIENGERLP 612 (974)
T ss_pred hhhc-------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce------EEEecCCCCCC
Confidence 4322 22345778999999999999999999999999999987 9999965433210 11112234456
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.|..++..|..|+.+||..+|.+||.+ .++...|..+..
T Consensus 613 ~P~nCPp~LYslmskcWayeP~kRPrf-tei~~~lsdv~q 651 (974)
T KOG4257|consen 613 CPPNCPPALYSLMSKCWAYEPSKRPRF-TEIKAILSDVLQ 651 (974)
T ss_pred CCCCCChHHHHHHHHHhccCcccCCcH-HHHHHHHHHHHH
Confidence 678888999999999999999999999 778777777654
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=315.97 Aligned_cols=241 Identities=25% Similarity=0.379 Sum_probs=191.9
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCC
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 605 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~g 605 (846)
|++.+.||.|+||.||+|... +..+++|.+..........+.+|+.+++.++||||++++++| ....++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566778999999999999886 467899988765444456788999999999999999999987 4568899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|..++... ..++++..+..++.+++.||.|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc---
Confidence 9999887532 3568999999999999999999999 8999999999999999999999999999876532211
Q ss_pred CccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
......|++.|+|||++. +..++.++|||||||++|+|++|++||................ .+ ...
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---~~-~~~ 229 (282)
T cd06643 159 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PP-TLA 229 (282)
T ss_pred -----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC---CC-CCC
Confidence 112345899999999984 3457889999999999999999999997655433322221111 01 111
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.+...+..+.+|+.+||..+|.+||++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~ 256 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTT 256 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCH
Confidence 223345789999999999999999999
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=313.16 Aligned_cols=248 Identities=28% Similarity=0.388 Sum_probs=195.5
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccc--------
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP-------- 593 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~-------- 593 (846)
.+++.|+..+.||+|+||.||+|... +..||+|.+.... .....+..|+.++.++ +||||++++++|.
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45667888899999999999999875 5789999987543 3346788999999998 7999999999873
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
...++||||+++|+|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 3478999999999999998543 23468899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 748 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~ 748 (846)
+........ ......|++.|+|||++. ...++.++|||||||++|+|++|.+||.............
T Consensus 158 ~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~ 229 (272)
T cd06637 158 SAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 229 (272)
T ss_pred ceecccccc--------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh
Confidence 886543211 112345899999999986 3358889999999999999999999996544332221111
Q ss_pred hhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 749 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. .+.....+...+..+.+|+.+||..+|.+||++ .++
T Consensus 230 ~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~i 266 (272)
T cd06637 230 R-----NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTT-EQL 266 (272)
T ss_pred c-----CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCH-HHH
Confidence 0 011111112345689999999999999999999 444
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=313.07 Aligned_cols=255 Identities=25% Similarity=0.453 Sum_probs=199.8
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--C---eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--H---MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~---~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
.++|+..+.||+|+||.||+|... + ..+|+|.+..... .....+..|+.++++++||||+++++++. +..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346788899999999999999875 2 3699998865422 22456889999999999999999999984 46889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+++++|.+++... ...+++..+..++.+++.||.|||. .+++||||||+|||++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998532 3568999999999999999999999 899999999999999999999999999988664
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
........ ......++.|+|||++.+..++.++|||||||++|+|+| |+.||............. ...
T Consensus 159 ~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~------~~~ 227 (268)
T cd05063 159 DDPEGTYT-----TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN------DGF 227 (268)
T ss_pred ccccccee-----ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh------cCC
Confidence 32211100 111224567999999988889999999999999999998 999996544322111111 011
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
....+...+..+.+|+.+||..+|.+||++ .++...|+.+
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~-~~i~~~l~~~ 267 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRF-VDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHhh
Confidence 112233446789999999999999999999 7888887754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=314.04 Aligned_cols=254 Identities=25% Similarity=0.390 Sum_probs=202.8
Q ss_pred CCCcccceeeeeCceEEEEEEECC-----eEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVm 600 (846)
.+|.+.++||+|+||.||+|.+.. ..|+||...... ....+.+.+|+.++++++||||++++++|. +..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 457788899999999999998643 368999887554 223457899999999999999999999884 4578999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++... ...+++..+..++.+++.||.|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 86 ELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999543 2358999999999999999999999 89999999999999999999999999999866443
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.... .+...++..|+|||.+....++.++||||||+++|+|++ |.+||.............+.. ..
T Consensus 161 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------~~ 227 (270)
T cd05056 161 SYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE------RL 227 (270)
T ss_pred ccee-------cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC------cC
Confidence 2111 112235678999999988889999999999999999996 999997655433221111111 11
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
..+...+..+.+++.+||..+|.+||++ .++...|+.+..
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~~~~~l~~~~~ 267 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRF-TELKAQLSDILQ 267 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHh
Confidence 1233456789999999999999999999 788888887754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=317.94 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=197.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
.+|...+.||.|+||.||+|... +..|++|.+..........+.+|+.+++.++||||+++++.| ....++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888899999999999999864 578999999876655567789999999999999999999987 45789999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++. ...+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 9999999884 2357899999999999999999999 89999999999999999999999999998765432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.....|++.|+|||.+.+..++.++|||||||++|+|++|++||.............. .. .+ ....+.
T Consensus 173 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~--~~-~~-~~~~~~ 240 (296)
T cd06654 173 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--NG-TP-ELQNPE 240 (296)
T ss_pred --------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc--CC-CC-CCCCcc
Confidence 1223589999999999888899999999999999999999999976544222111110 00 01 111233
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..+.+|+.+||..+|.+||++ .++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~-~ei 267 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSA-KEL 267 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCH-HHH
Confidence 455779999999999999999999 444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=308.40 Aligned_cols=245 Identities=31% Similarity=0.513 Sum_probs=199.1
Q ss_pred eeeeeCceEEEEEEEC-----CeEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~gg 606 (846)
.||+|+||.||+|... +..|++|.+....... ...+.+|+.++..++||||+++++++. ...++||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 6999999999999886 5679999998764433 567899999999999999999999884 4688999999999
Q ss_pred chhhhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 607 SLEDRLSCKDN------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 607 sL~~~L~~~~~------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
+|.+++..... ...+++..++.++.+++.||.|||+ ++++||||+|+||+++.++.+||+|||++......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999965421 3679999999999999999999999 89999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.... ......+++.|+|||.+....++.++||||||+++|+|++ |.+||............. .....
T Consensus 159 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~~~~~ 226 (262)
T cd00192 159 DYYR------KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR------KGYRL 226 (262)
T ss_pred cccc------cccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH------cCCCC
Confidence 2110 1123457899999999988889999999999999999999 699997664332211111 11222
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
..+...+..+.+++.+||+.+|.+||++ .+++..|
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~l~~~l 261 (262)
T cd00192 227 PKPEYCPDELYELMLSCWQLDPEDRPTF-SELVERL 261 (262)
T ss_pred CCCccCChHHHHHHHHHccCCcccCcCH-HHHHHhh
Confidence 3344556889999999999999999999 6666554
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=313.60 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=199.3
Q ss_pred CCCcccceeeeeCceEEEEEEEC-----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
.+|...+.||+|+||.||+|... +..+|+|.+...... ....|.+|+.++++++||||+++++++ .+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788889999999999999863 236999998754321 235688999999999999999999987 4568899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++++|.+++... ...+++..+..++.+++.||.|||+ ++++||||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998543 2468999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~ 756 (846)
...... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||....... ..+..+
T Consensus 159 ~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-------- 225 (267)
T cd05066 159 DPEAAY-----TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-------- 225 (267)
T ss_pred ccceee-----ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC--------
Confidence 321110 0112334678999999998899999999999999999887 999996543321 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
.....+...+..+.+++.+||+.+|.+||++ .++.+.|+.+
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~~ 266 (267)
T cd05066 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKF-EQIVSILDKL 266 (267)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCchhCCCH-HHHHHHHHhh
Confidence 1112233446789999999999999999999 7887877753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=311.05 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=197.0
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEE
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 598 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 598 (846)
++.++.++.....||+|+||.||+|... +..|++|.+..........+.+|+.+++.++||||++++++| .+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4455667777789999999999999876 467999998766544556789999999999999999999988 456889
Q ss_pred EEEecCCCchhhhhccCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-CCceeeecccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPL--SWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISR 675 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l--~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-~~~vKL~DFGla~ 675 (846)
||||+++++|.+++.... .++ ++..+..++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999986432 234 788889999999999999999 89999999999999976 6799999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
........ .....|++.|+|||++.+.. ++.++||||||+++|+|++|++||...............
T Consensus 158 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--- 226 (268)
T cd06624 158 RLAGINPC--------TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--- 226 (268)
T ss_pred ecccCCCc--------cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh---
Confidence 65432111 11234889999999986643 789999999999999999999999644322111111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+.+|...+..+.+|+.+||..+|.+||++ .++
T Consensus 227 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~l 262 (268)
T cd06624 227 -FKIHPEIPESLSAEAKNFILRCFEPDPDKRASA-HDL 262 (268)
T ss_pred -hccCCCCCcccCHHHHHHHHHHcCCCchhCCCH-HHH
Confidence 111223444566789999999999999999999 444
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=311.13 Aligned_cols=249 Identities=27% Similarity=0.441 Sum_probs=191.4
Q ss_pred eeeeeCceEEEEEEEC-----CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEeccc---cCceEEEEEecCC
Q 003121 535 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPN 605 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~---~~~~~lVmEy~~g 605 (846)
.||+|+||.||+|.+. ...||||.+.... ......+.+|+.+++.++||||++++++| ....++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5899999999999863 2469999886432 22345788999999999999999999976 2347899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|.+++... ...+++..+..++.+++.||.|||+ .+++||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 82 GDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999998533 2346778889999999999999999 8999999999999999999999999999986543221110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
. ......++..|+|||.+.+..++.++|||||||++|||++ |.+||............ ........+..
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 226 (262)
T cd05058 157 H----NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL------LQGRRLLQPEY 226 (262)
T ss_pred c----ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------hcCCCCCCCCc
Confidence 0 0122346788999999988899999999999999999999 56777654432211111 11111122333
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
.+..+.+++.+||..+|.+||++ .+++..|+.+.
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~-~~il~~l~~~~ 260 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTF-SELVSRIEQIF 260 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHh
Confidence 45789999999999999999999 78888877654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=352.34 Aligned_cols=242 Identities=27% Similarity=0.329 Sum_probs=198.5
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEeccccC--ceEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTL 598 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~l 598 (846)
...+|.+.++||+|+||.|...+.++ +.+|.|++++..+. ...-|..|-+||..-+.++|+.|+.+|.+ ++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 34579999999999999999998874 66999999874332 23468899999999999999999999954 6899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||++||+|-.+|...+ ++++..++.|+.+|..||.-||+ .|+|||||||+|||||..|++||+|||.|-.+.
T Consensus 153 VMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 999999999999996443 69999999999999999999999 899999999999999999999999999998877
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
.++.... ...+|||.|++||+|.. +.|++.|||||+||++|||+.|..||....-+..--......+.
T Consensus 227 ~dG~V~s-------~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 227 ADGTVRS-------SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred CCCcEEe-------ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 5543322 34579999999999953 56999999999999999999999999766655432222222222
Q ss_pred cCCCCCCCC--hhhHHHHHHHHHHHhccCcCCCCC
Q 003121 754 LDPLAGDWP--FVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 754 ld~~~~~~p--~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
+. || ...++...+||.+.+. +|..|-.
T Consensus 300 l~-----FP~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 300 LS-----FPDETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred cC-----CCcccccCHHHHHHHHHHhc-Chhhhcc
Confidence 22 23 3467899999999886 6777776
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.12 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=195.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--Ce--EEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HM--QVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~--~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lV 599 (846)
++|.+.+.||+|+||.||+|.+. +. .+++|.+..... .....+.+|+.++.++ +||||++++++|. ...++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788889999999999999875 33 468887764322 2234688999999999 8999999999984 468899
Q ss_pred EEecCCCchhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 600 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+ +|++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999985432 12468999999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHH
Q 003121 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 745 (846)
Q Consensus 667 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~ 745 (846)
||+|||+++...... . .....++..|+|||++.+..++.++|||||||++|+|+| |.+||........ .
T Consensus 164 kl~dfg~~~~~~~~~--~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~ 233 (303)
T cd05088 164 KIADFGLSRGQEVYV--K-------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-Y 233 (303)
T ss_pred EeCccccCcccchhh--h-------cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-H
Confidence 999999986432110 0 011235678999999988889999999999999999998 9999965443221 1
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
... ........+...+..+.+|+.+||..+|.+||++ ++++..|..+.
T Consensus 234 ~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~il~~l~~~~ 281 (303)
T cd05088 234 EKL-----PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQILVSLNRML 281 (303)
T ss_pred HHH-----hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHH
Confidence 111 1111112233345789999999999999999999 66666666554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=319.11 Aligned_cols=280 Identities=25% Similarity=0.418 Sum_probs=210.3
Q ss_pred CCCcccceeeeeCceEEEEEEEC--Ce----EEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccc-CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~VAIK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV 599 (846)
.+|...+.||+|+||.||+|.+. +. .||+|.+....... ...+.+|+.+++.++||||++++|+|. ...+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 36777889999999999999874 32 57999887543221 236889999999999999999999884 457799
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
+||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999998533 3458899999999999999999999 8999999999999999999999999999986643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHhhhhhccccCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDP 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~--~~~~~~~~~~~~ld~ 756 (846)
...... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... ...+..+ .. .+
T Consensus 162 ~~~~~~------~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~-~~ 231 (303)
T cd05110 162 DEKEYN------ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG---ER-LP 231 (303)
T ss_pred cccccc------cCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC---CC-CC
Confidence 221100 112346788999999988899999999999999999998 88999654321 1111111 00 11
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCCCCCcCCCCCCCCCCCCCCCCcccc
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQV 829 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~~~~~~~~~~~~~~p~~~~~pi~q~ 829 (846)
.+...+..+.+++.+||..+|.+||++ .++...|..+....... .-...+....-|.+...|+|++
T Consensus 232 ----~~~~~~~~~~~li~~c~~~~p~~Rp~~-~~l~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 297 (303)
T cd05110 232 ----QPPICTIDVYMVMVKCWMIDADSRPKF-KELAAEFSRMARDPQRY--LVIQGDDRMKLPSPNDSKFFQN 297 (303)
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHhchhhh--eeeccCCcCCCCCCchhhHHhc
Confidence 122345679999999999999999999 77878887765442221 1122333334466666676665
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.60 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=191.6
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
+|+..+.||+|+||.||++... +..||||++..... .....+..|+.++..++||||+++++.+. +.+++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 6888899999999999999875 57899999975322 22456788999999999999999999884 46899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 82 FLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999853 3468999999999999999999999 899999999999999999999999999987553221
Q ss_pred ccCCC---------------------------ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003121 682 ISSNN---------------------------TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 734 (846)
Q Consensus 682 ~~~~~---------------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~p 734 (846)
..... ..........||+.|+|||++.+..++.++|||||||++|||+||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00000 000001234699999999999999999999999999999999999999
Q ss_pred CCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 735 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 735 f~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
|..................+. . +. ....+..+.+|+.+|+. +|.+|++.
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~-~-p~-~~~~s~~~~~li~~l~~-~p~~R~~~ 284 (360)
T cd05627 236 FCSETPQETYRKVMNWKETLV-F-PP-EVPISEKAKDLILRFCT-DSENRIGS 284 (360)
T ss_pred CCCCCHHHHHHHHHcCCCcee-c-CC-CCCCCHHHHHHHHHhcc-ChhhcCCC
Confidence 976554332111111111111 0 00 11245678999999874 99999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=313.71 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=192.6
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
+|...+.||.|+||.||+|... +..||||.+...... ....+.+|+.+++.++||||+++++++ ....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999875 578999998754322 235688999999999999999999998 4568999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+. ++|.+++........+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 6888887554444678999999999999999999999 8999999999999999999999999999875532211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh------------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------ 749 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~------------ 749 (846)
......+++.|+|||++.+. .++.++|||||||++|+|+||++||..............
T Consensus 157 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 157 --------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred --------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 11233578999999998754 578999999999999999999999976544322211100
Q ss_pred ------hcccc----CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 750 ------LKNLL----DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 750 ------~~~~l----d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..... ...........+..+.+|+.+||..+|.+||++ .++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-~~l 279 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA-KKA 279 (285)
T ss_pred chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH-HHH
Confidence 00000 000000111235678899999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=335.18 Aligned_cols=243 Identities=22% Similarity=0.308 Sum_probs=186.3
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
.+|...++||+|+||.||++... +..||||... ...+.+|+.+|++|+||||++++++| ....++||||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 46889999999999999999876 5789999743 23578999999999999999999987 45688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
. ++|..++.. ...+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 5 688887743 3458899999999999999999999 89999999999999999999999999999754322110
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH----------HHHHHhh-h----
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE----------VQYALDT-G---- 748 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~----------~~~~~~~-~---- 748 (846)
......||+.|+|||++.+..++.++|||||||++|+|+||++||..... ....+.. +
T Consensus 239 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~ 311 (391)
T PHA03212 239 -------KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311 (391)
T ss_pred -------ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence 11234699999999999988999999999999999999999977632110 0000000 0
Q ss_pred --------hhc-------c--ccCC-CCCCCC--hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 749 --------KLK-------N--LLDP-LAGDWP--FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 749 --------~~~-------~--~ld~-~~~~~p--~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+. . ...+ ..+.|. ...+..+.+|+.+||..+|.+||++ +++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta-~el 373 (391)
T PHA03212 312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA-EAL 373 (391)
T ss_pred hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH-HHH
Confidence 000 0 0000 011111 1235679999999999999999999 444
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=327.08 Aligned_cols=246 Identities=29% Similarity=0.448 Sum_probs=206.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcC-CCceeeEecccc--CceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~-HpnIv~l~g~~~--~~~~l 598 (846)
...|.+.+.||.|.||.||+++.. |..+|+|++.+....+ ...+.+|+.||+++. |||||.++++|. ...++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 446888899999999999999876 5789999998876544 358999999999998 999999999995 46799
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC----CCceeeeccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA----NFVSKLSDFGIS 674 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~----~~~vKL~DFGla 674 (846)
|||+|.||.|.+.+... .+++..+..++.+|+.++.|||+ .||+||||||+|+|+.. ++.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999655 29999999999999999999999 89999999999999963 357999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 754 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~l 754 (846)
....... .....+||+.|+|||++....|+..+||||+||++|.|++|.+||............ ...-.
T Consensus 187 ~~~~~~~---------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i--~~~~~ 255 (382)
T KOG0032|consen 187 KFIKPGE---------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI--LRGDF 255 (382)
T ss_pred eEccCCc---------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH--HcCCC
Confidence 9876521 113457999999999999999999999999999999999999999877654433321 11222
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 755 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
+...+.|+. .+..+.+++.+|+..+|..|+++ .+++
T Consensus 256 ~f~~~~w~~-is~~akd~i~~ll~~dp~~R~ta-~~~L 291 (382)
T KOG0032|consen 256 DFTSEPWDD-ISESAKDFIRKLLEFDPRKRLTA-AQAL 291 (382)
T ss_pred CCCCCCccc-cCHHHHHHHHHhcccCcccCCCH-HHHh
Confidence 445556654 47889999999999999999999 4443
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=327.24 Aligned_cols=246 Identities=21% Similarity=0.290 Sum_probs=188.8
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccc--------C
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--------E 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~ 594 (846)
..+|...+.||+|+||.||++... +..||||++.... ......+.+|+.+++.++||||+++++++. .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468999999999999999999875 5789999987542 223456789999999999999999999873 2
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
..|+||||+.+ +|...+. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 36899999975 5655552 247888999999999999999999 89999999999999999999999999998
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh-------
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT------- 747 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~------- 747 (846)
+....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+........
T Consensus 171 ~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 241 (359)
T cd07876 171 RTACTNFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241 (359)
T ss_pred cccccCcc---------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 75432211 12345899999999999989999999999999999999999999755432110000
Q ss_pred ---------hhhccc-------------------cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 748 ---------GKLKNL-------------------LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 748 ---------~~~~~~-------------------ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...... ..+.........+..+.+|+.+||..+|.+||++ .++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-~e~ 312 (359)
T cd07876 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV-DEA 312 (359)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH-HHH
Confidence 000000 0000001111234678999999999999999999 444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=331.48 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=190.6
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
.++|...+.||+|+||.||++... +..||+|++..... .....+.+|+.+++.++||||+++++++. ...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 357888999999999999999886 56899999865321 22345789999999999999999999884 468999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++..+..
T Consensus 122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999998842 347889999999999999999999 8999999999999999999999999999987643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
.... ......||+.|+|||++.+. .++.++|||||||+||+|+||++||.................
T Consensus 195 ~~~~-------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~--- 264 (370)
T cd05621 195 TGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN--- 264 (370)
T ss_pred CCce-------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---
Confidence 2211 01234699999999999754 378899999999999999999999976554322111100000
Q ss_pred CCCCCCCh--hhHHHHHHHHHHHhccCcCC--CCChHHHH
Q 003121 756 PLAGDWPF--VQAEQLANLAMRCCEMSRKS--RPELGKDV 791 (846)
Q Consensus 756 ~~~~~~p~--~~~~~l~~Li~~Cl~~~P~~--RPt~~~~v 791 (846)
...+|. ..+..+.+|+..|+..++.+ ||++ .++
T Consensus 265 --~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~-~e~ 301 (370)
T cd05621 265 --SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGV-EEI 301 (370)
T ss_pred --ccCCCCcccCCHHHHHHHHHHccCchhccCCCCH-HHH
Confidence 111222 34678999999999855543 7888 444
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=320.30 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=202.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC---------CeEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccc--C
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E 594 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~---------~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~ 594 (846)
.+|.+.++||+|+||.||++... ...+|+|.+..... .....+.+|+.+++.+ +||||++++++|. .
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46888899999999999999752 24699999875432 2235688999999999 6999999999884 4
Q ss_pred ceEEEEEecCCCchhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 661 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~ 661 (846)
..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+ +|++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 5889999999999999985432 12458999999999999999999999 8999999999999999
Q ss_pred CCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 003121 662 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 740 (846)
Q Consensus 662 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~ 740 (846)
.++.+||+|||+++.......... .....++..|+|||++.++.++.++|||||||++|+|++ |..||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKK------TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred CCCcEEEccccccccccccccccc------cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999986643221110 011235578999999988889999999999999999999 8999965443
Q ss_pred HHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 741 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 741 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
.. ...... .......+...+..+.+|+.+||..+|.+||++ .++++.|..+....
T Consensus 243 ~~-~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-~~ll~~l~~~~~~~ 297 (314)
T cd05099 243 EE-LFKLLR-----EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTF-KQLVEALDKVLAAV 297 (314)
T ss_pred HH-HHHHHH-----cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHHHHh
Confidence 21 111100 111112234456789999999999999999999 88888888876643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.23 Aligned_cols=247 Identities=26% Similarity=0.460 Sum_probs=197.1
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCc---------hhHHHHHHHHHhcCCCceeeEeccc--cCce
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---------SEFQQEIDILSKIRHPNLVTLVGAC--PEVW 596 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~---------~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~ 596 (846)
|.....||.|+||.||+|... +..+|+|.+........ +.+.+|+.++++++||||+++++++ .+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566778999999999999875 57899998876543322 4578899999999999999999987 4568
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+++++|.+++.. ...+++..+..++.+++.||.|||. ++++||||+|+|||++.++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 899999999999999943 3468899999999999999999999 8999999999999999999999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCC
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
........... .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.............. .
T Consensus 156 ~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~ 227 (267)
T cd06628 156 LEANSLSTKTN--GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------N 227 (267)
T ss_pred cccccccCCcc--ccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc------c
Confidence 65322111111 111234588999999999988899999999999999999999999976544332221111 1
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..+...+..+.+++.+||+.+|.+||++ .++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i 261 (267)
T cd06628 228 ASPEIPSNISSEAIDFLEKTFEIDHNKRPTA-AEL 261 (267)
T ss_pred CCCcCCcccCHHHHHHHHHHccCCchhCcCH-HHH
Confidence 2223344456889999999999999999999 544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=309.34 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=197.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHHhcCCCceeeEeccc--cCceEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 598 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-----~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 598 (846)
.+|...+.||.|+||.||.+... +..||+|.+...... ....+.+|+.++++++||||+++++++ .+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999864 578999998754322 124688899999999999999999998 456889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+++++|.+++.. ...+++..+..++.+++.||.|||. .+++||||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998853 3458899999999999999999999 899999999999999999999999999987654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
....... ......|+..|+|||++.+..++.++||||||+++|+|++|++||............. .....
T Consensus 156 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~~ 225 (263)
T cd06625 156 TICSSGT-----GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-----TQPTN 225 (263)
T ss_pred ccccccc-----cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh-----ccCCC
Confidence 3211100 0022357899999999998889999999999999999999999996554332221111 11112
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
...+...+..+.+++.+||..+|.+||++ .+++
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~ll 258 (263)
T cd06625 226 PQLPSHVSPDARNFLRRTFVENAKKRPSA-EELL 258 (263)
T ss_pred CCCCccCCHHHHHHHHHHhhcCcccCCCH-HHHh
Confidence 23344556789999999999999999999 5543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=315.33 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=196.8
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecC--CCCCCchhHHHHHHHHHhcCCCceeeEecccc-------C
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-------E 594 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~--~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-------~ 594 (846)
....|...+.||+|+||.|..+... +..||||++.. .......+..+|+.+|+.++|+||+.+++.+. .
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456776788999999999999876 57899999873 23334567889999999999999999999873 2
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
..|+|+|+| +.+|...+. .+..|+...+..++.||++||.|+|+ .+++||||||.|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccce
Confidence 489999999 579999884 33459999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH--------
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL-------- 745 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~-------- 745 (846)
+..... ......+.-+-|.+|.|||++.. ..|+.+.||||.||||.||++|+|.|.+.+.+....
T Consensus 173 R~~~~~------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 173 RYLDKF------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred eecccc------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 987643 11112355668999999998865 579999999999999999999999997766544321
Q ss_pred ---------hhhhhccccC--CCC------CCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 746 ---------DTGKLKNLLD--PLA------GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 746 ---------~~~~~~~~ld--~~~------~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
...+....+. |.. .-+| .......+|+.+||..||.+|+|+.+
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHH
Confidence 1011111111 111 1122 33467899999999999999999943
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=317.70 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=196.4
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc----cC---ceEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC----PE---VWTLV 599 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~----~~---~~~lV 599 (846)
.|...+++|.|.||.||+|... +..||||..-.+. .--.+|+.+|+.++|||||+|+.+| +. ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5777889999999999999887 4689999875432 2235899999999999999998877 22 34589
Q ss_pred EEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC-Cceeeecccccccc
Q 003121 600 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFL 677 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~-~~vKL~DFGla~~~ 677 (846)
|||+|. +|...+... ..+..++.-.+.-+.+||++||.|||. .||+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999975 888888532 234567778889999999999999999 899999999999999976 99999999999988
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh------
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL------ 750 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~------ 750 (846)
...... .... .|..|.|||.+.+. .|+.+.||||.||++.||+-|+|.|.+.+......+.-+.
T Consensus 177 ~~~epn--iSYi-------cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 177 VKGEPN--ISYI-------CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred ccCCCc--eeEE-------EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 765432 2222 48899999999874 7999999999999999999999999876665444321110
Q ss_pred ---------------ccccCCCCCC-CChhhHHHHHHHHHHHhccCcCCCCChHHHHH-HHHHHHHhh
Q 003121 751 ---------------KNLLDPLAGD-WPFVQAEQLANLAMRCCEMSRKSRPELGKDVW-RVLEPMRAS 801 (846)
Q Consensus 751 ---------------~~~ld~~~~~-~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~-~~L~~l~~~ 801 (846)
..+....... +....+.+..+|+.++|..+|.+|.++.+.+. ...+.++..
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1111111111 33455788999999999999999999855442 334555544
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.74 Aligned_cols=245 Identities=24% Similarity=0.390 Sum_probs=199.1
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
..+|...+.||.|+||.||+|... +..|++|.+........+.+.+|+.+++.++||||++++++| .+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 346888999999999999999864 678999998766555566789999999999999999999988 4568999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|..++. ...+++..+..++.+++.||.|||+ +|++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999884 2358999999999999999999999 8999999999999999999999999999886543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. .....|++.|+|||.+.+..++.++|||||||++|+|++|++||............... .. + ....+
T Consensus 171 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~--~~-~-~~~~~ 238 (296)
T cd06655 171 K--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--GT-P-ELQNP 238 (296)
T ss_pred c--------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CC-c-ccCCc
Confidence 1 12235889999999998888999999999999999999999999776554332211110 00 0 11123
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKD 790 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 790 (846)
...+..+.+|+.+||..+|.+||++.+.
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~i 266 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKEL 266 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 3345789999999999999999999443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=316.33 Aligned_cols=252 Identities=27% Similarity=0.496 Sum_probs=197.7
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--Cce
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 596 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~ 596 (846)
.++|.....||+|+||.||++... +..||+|.+..... .....|.+|+.+++.++||||++++++|. +..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888999999999999999863 36799999875432 22356889999999999999999999884 468
Q ss_pred EEEEEecCCCchhhhhccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCc
Q 003121 597 TLVYEYLPNGSLEDRLSCKD-------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 657 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~-------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~N 657 (846)
++||||+++|+|.+++.... ....+++..++.++.+++.||.|||. ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999985321 12357889999999999999999999 899999999999
Q ss_pred eEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 003121 658 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG 736 (846)
Q Consensus 658 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~ 736 (846)
||++.++.+||+|||++..+......... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKAS------ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred eEecCCCceEECccccceecccCcccccc------CCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999998765432211100 12235678999999988899999999999999999998 888885
Q ss_pred CchHHH--HHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 737 ITKEVQ--YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 737 ~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
...... ..+..+. ....+...+..+.+|+.+||+.+|.+||++ .++...|+
T Consensus 235 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-~el~~~l~ 287 (288)
T cd05050 235 GMAHEEVIYYVRDGN--------VLSCPDNCPLELYNLMRLCWSKLPSDRPSF-ASINRILQ 287 (288)
T ss_pred CCCHHHHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHcccCcccCCCH-HHHHHHhh
Confidence 433222 1111111 111233445789999999999999999999 77777665
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=313.90 Aligned_cols=248 Identities=27% Similarity=0.373 Sum_probs=189.0
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhc---CCCceeeEecccc-------C
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKI---RHPNLVTLVGACP-------E 594 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~-------~ 594 (846)
+|.+.+.||+|+||.||+|... ++.||+|.+...... ....+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778889999999999999876 578999998764322 223567788888776 6999999999873 2
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 36899999974 8888775432 3458999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc---
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK--- 751 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~--- 751 (846)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|++||................
T Consensus 156 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07863 156 RIYSCQMA---------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 226 (288)
T ss_pred ccccCccc---------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC
Confidence 86643211 122358999999999998899999999999999999999999996554322111100000
Q ss_pred ------c-------ccCCCC----CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 752 ------N-------LLDPLA----GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 752 ------~-------~ld~~~----~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. ...+.. .......+..+.+|+.+||+.||.+||++ .++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~~~ 282 (288)
T cd07863 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA-FRA 282 (288)
T ss_pred ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH-HHH
Confidence 0 000000 00111335678999999999999999998 444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.64 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=187.1
Q ss_pred eeeeeCceEEEEEEECC----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCc
Q 003121 535 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS 607 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~----~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggs 607 (846)
.||+|+||.||+|.+.+ ..+|+|.+...... ....+.+|+.++++++||||++++++|. ...++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998653 46899988765322 2346889999999999999999999884 45789999999999
Q ss_pred hhhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 608 LEDRLSCKD--NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 608 L~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|.+++.... ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~- 157 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV- 157 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee-
Confidence 999986432 22356777888999999999999999 899999999999999999999999999987543322111
Q ss_pred CccccccCCCCCCcccCChhhhccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASG-------ELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~-------~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
......|+..|+|||++.+. .++.++||||||+++|+|++ |++||............ .........
T Consensus 158 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~ 231 (269)
T cd05087 158 -----TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VREQQLKLP 231 (269)
T ss_pred -----cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-hhcccCCCC
Confidence 11234578899999998642 35789999999999999996 99999654433211110 001111111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
.+......++.+.+++.+|| .+|.+||++ ++|+..|
T Consensus 232 ~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~-~~l~~~l 267 (269)
T cd05087 232 KPRLKLPLSDRWYEVMQFCW-LQPEQRPSA-EEVHLLL 267 (269)
T ss_pred CCccCCCCChHHHHHHHHHh-cCcccCCCH-HHHHHHh
Confidence 12222234567899999999 689999999 7776665
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=317.91 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=200.5
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccc--C
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--E 594 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~ 594 (846)
..++|...+.||+|+||.||++... +..||+|.+...... ..+.+.+|+.+++++ +||||++++++|. +
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457888999999999999999752 246999998754322 235688999999999 7999999999883 5
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
..++||||+++|+|.+++.... ...+++.++..++.+++.||.|||+ ++|+|+||||+|||++.++.+||+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence 6899999999999999985432 2348999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
+........ .......++..|+|||.+.+..++.++|||||||++|+|+| |.+||............ ...
T Consensus 189 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~--~~~- 259 (302)
T cd05055 189 RDIMNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL--IKE- 259 (302)
T ss_pred ccccCCCce------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH--HHc-
Confidence 865432110 01122346788999999998899999999999999999998 99998654332211110 000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
......+...+..+.+|+.+||..+|.+||++ .++++.|+.+
T Consensus 260 --~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-~ell~~l~~~ 301 (302)
T cd05055 260 --GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTF-KQIVQLIGKQ 301 (302)
T ss_pred --CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHHhh
Confidence 01111223345789999999999999999999 7787777653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=312.76 Aligned_cols=247 Identities=27% Similarity=0.357 Sum_probs=194.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
++|...++||+|+||.||+|... +..||+|.++.........+.+|+.+++.++||||+++++++ .+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46788889999999999999875 578999998766544455688999999999999999999987 45788999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++.. ...+++..+..++.+++.||.|||. +|++|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 99999998843 3468999999999999999999999 8999999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
......|++.|+|||++. .+.++.++|||||||++|+|++|.+||.............. .....+.. .
T Consensus 162 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~-~ 232 (267)
T cd06645 162 -------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-SNFQPPKL-K 232 (267)
T ss_pred -------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-cCCCCCcc-c
Confidence 112345899999999984 45688999999999999999999999854433221111110 11111111 1
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+..+.+++.+||..+|.+||++ +++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~-~~l 262 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTA-EKL 262 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCH-HHH
Confidence 111234679999999999999999999 544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.26 Aligned_cols=252 Identities=31% Similarity=0.523 Sum_probs=202.0
Q ss_pred cCCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
.++|.+.+.||.|+||.||+|...+ ..||||.+.... .....+.+|+.++++++||||+++++++. ...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4578889999999999999998764 679999987543 34567999999999999999999999884 4689999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++.... ...+++..+..++.+++.||.|||. ++++|+||||+||+++.++.+||+|||++..+......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999985432 3468999999999999999999999 89999999999999999999999999998866432111
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. .....++..|+|||.+.+..++.++||||||+++|+|+| |+.||........ +... ... .....+
T Consensus 160 ~-------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-~~~~-~~~----~~~~~~ 226 (261)
T cd05034 160 A-------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV-LEQV-ERG----YRMPRP 226 (261)
T ss_pred h-------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHH-HcC----CCCCCC
Confidence 1 112235678999999998889999999999999999999 9999965443221 1111 011 111122
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
...+..+.+++.+||..+|.+||++ +++...|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~-~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTF-EYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCH-HHHHHHHhc
Confidence 3345789999999999999999999 788777764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.03 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=204.2
Q ss_pred CCcccceeeeeCceEEEEEEECC-----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmE 601 (846)
.....++||+|.||.|++|.|.. -.||||.++..... ..+.|.+|+.+|.+|+|||+++|||..- ....+|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~E 190 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFE 190 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhh
Confidence 34556789999999999999973 35999999987654 4678999999999999999999999985 56779999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
++++|+|.+.|.. .....|.......|+.|||.|+.||.. +++|||||-..|+||-....|||+||||.+.+....
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999976 556778899999999999999999999 899999999999999999999999999999876543
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
..-.. .....-.+.|+|||.+....++.++|||+|||++|||+| |..||.+..-..-..... +..+-.
T Consensus 267 d~Yvm-----~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD------~~erLp 335 (1039)
T KOG0199|consen 267 DMYVM-----APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID------AGERLP 335 (1039)
T ss_pred cceEe-----cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc------ccccCC
Confidence 21110 112234788999999999999999999999999999999 788997655433211111 122334
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKD 790 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 790 (846)
.|..+++.+++++..||..+|.+||+|...
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHH
Confidence 577889999999999999999999999443
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.55 Aligned_cols=243 Identities=27% Similarity=0.432 Sum_probs=191.7
Q ss_pred eeeeeCceEEEEEEEC-CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCchhh
Q 003121 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLED 610 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggsL~~ 610 (846)
+||+|+||.||+|... +..||+|.+...... ....|.+|+.+++.++||||++++++|. ...++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 5899999999999875 467999988754322 1236889999999999999999999884 46889999999999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCcccc
Q 003121 611 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 690 (846)
Q Consensus 611 ~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 690 (846)
++... ...+++..++.++.+++.||.|||. ++++||||||+||+++.++.+||+|||++...........
T Consensus 82 ~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~----- 151 (250)
T cd05085 82 FLRKK--KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS----- 151 (250)
T ss_pred HHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccC-----
Confidence 88533 3458899999999999999999999 8999999999999999999999999999875433221110
Q ss_pred ccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHH
Q 003121 691 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 769 (846)
Q Consensus 691 ~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l 769 (846)
....+++.|+|||++.++.++.++||||||+++|+|++ |..||............. . ......+...+..+
T Consensus 152 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~~ 223 (250)
T cd05085 152 --GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE---K---GYRMSCPQKCPDDV 223 (250)
T ss_pred --CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH---c---CCCCCCCCCCCHHH
Confidence 11234678999999988899999999999999999998 999996554332111111 1 11112233456789
Q ss_pred HHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 770 ANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 770 ~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.+|+.+||..+|.+||++ .++.+.|.
T Consensus 224 ~~li~~~l~~~p~~Rp~~-~~l~~~l~ 249 (250)
T cd05085 224 YKVMQRCWDYKPENRPKF-SELQKELA 249 (250)
T ss_pred HHHHHHHcccCcccCCCH-HHHHHHhc
Confidence 999999999999999999 67766553
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.36 Aligned_cols=261 Identities=23% Similarity=0.383 Sum_probs=204.1
Q ss_pred CCCcccceeeeeCceEEEEEEECC---------eEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccc--C
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E 594 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~---------~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~ 594 (846)
.+|.+.+.||+|+||.||++...+ ..||+|.+..... .....+.+|+.+++++ +||||++++++|. .
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468889999999999999997531 3689998875322 2245788999999999 8999999999984 4
Q ss_pred ceEEEEEecCCCchhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 661 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~ 661 (846)
..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||. +|++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 5889999999999999986432 12358889999999999999999999 8999999999999999
Q ss_pred CCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 003121 662 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 740 (846)
Q Consensus 662 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~ 740 (846)
.++.+||+|||+++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |.+||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred CCCcEEECCcccceeccccccccc------ccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999986543221100 122335678999999998899999999999999999998 8899865543
Q ss_pred HHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCC
Q 003121 741 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGG 804 (846)
Q Consensus 741 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~ 804 (846)
.... ... ........+...+..+.+|+.+||+.+|.+||++ .+++..|+.+......
T Consensus 243 ~~~~-~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-~ell~~l~~~~~~~~~ 299 (334)
T cd05100 243 EELF-KLL-----KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTF-KQLVEDLDRVLTVTST 299 (334)
T ss_pred HHHH-HHH-----HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH-HHHHHHHHHHhhhcCC
Confidence 2211 110 0111112233445789999999999999999999 8888888888766543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=324.73 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=198.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccc---Cc
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP---EV 595 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~---~~ 595 (846)
++|.+.+.||+|+||.||+|.+. ++.||||+++..... ....+.+|+.+|.++ +||||++++++|. ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 47889999999999999999742 467999999754322 234688999999999 6899999999873 35
Q ss_pred eEEEEEecCCCchhhhhccCCC----------------------------------------------------------
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDN---------------------------------------------------------- 617 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~---------------------------------------------------------- 617 (846)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999998854210
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCccccc
Q 003121 618 ------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 691 (846)
Q Consensus 618 ------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~ 691 (846)
...+++..+..++.||+.||.|||+ ++|+||||||.|||++.++.+||+|||++.......... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~------~ 237 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------R 237 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh------h
Confidence 1247888899999999999999999 899999999999999999999999999998653321110 1
Q ss_pred cCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHH
Q 003121 692 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 770 (846)
Q Consensus 692 ~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~ 770 (846)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||............ +.. ......|...+..+.
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~ 312 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKE---GTRMRAPDYTTPEMY 312 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH--Hhc---cCCCCCCCCCCHHHH
Confidence 122346778999999988899999999999999999997 99998654321111110 000 011112223456799
Q ss_pred HHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 771 NLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 771 ~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
+++.+||+.+|.+||++ .++++.|+.+.
T Consensus 313 ~~~~~cl~~~p~~Rps~-~eil~~l~~~~ 340 (343)
T cd05103 313 QTMLDCWHGEPSQRPTF-SELVEHLGNLL 340 (343)
T ss_pred HHHHHHccCChhhCcCH-HHHHHHHHHHH
Confidence 99999999999999999 77888887664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=308.78 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=196.4
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
+|...+.||.|+||.||++... +..+|+|.+.... ....+.+.+|+.+++.++||||+++++++ ....++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4777889999999999999875 5789999986432 23346788999999999999999999988 45689999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++|+|.+++... ....+++..+..++.+++.||.|||+ ++|+|+||||+|||++.++.++|+|||++.........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999988532 23468899999999999999999999 89999999999999999999999999998765432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.....|++.|+|||++.+..++.++|+||||+++|+|++|.+||............ ......+ .+.
T Consensus 157 --------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~----~~~ 222 (255)
T cd08219 157 --------ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV--CQGSYKP----LPS 222 (255)
T ss_pred --------cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH--hcCCCCC----CCc
Confidence 12245899999999998888999999999999999999999999765543321111 1111111 223
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..+.+|+.+||+.+|.+||++ .++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~-~~i 249 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSA-TTI 249 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCH-HHH
Confidence 345679999999999999999999 444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=309.18 Aligned_cols=244 Identities=26% Similarity=0.406 Sum_probs=197.4
Q ss_pred CCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc-cCceEEEEEecCCCc
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTLVYEYLPNGS 607 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~-~~~~~lVmEy~~ggs 607 (846)
+|.+.+.||+|+||.||+|...+..||+|.+.... ....+.+|+.+++.++||||+++++++ .+..++||||+++|+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~ 84 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGN 84 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCC
Confidence 57788899999999999999889999999986532 345789999999999999999999987 456889999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCc
Q 003121 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 687 (846)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 687 (846)
|.+++.... ...+++..++.++.|++.||.|||. +|++||||||+|||++.++.+||+|||++.......
T Consensus 85 L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~------ 154 (254)
T cd05083 85 LVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV------ 154 (254)
T ss_pred HHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC------
Confidence 999986442 3458899999999999999999999 899999999999999999999999999987543211
Q ss_pred cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 688 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 688 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
.....+..|+|||++.++.++.++|+|||||++|+|++ |++||............. .. .....+...+
T Consensus 155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~--~~----~~~~~~~~~~ 223 (254)
T cd05083 155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE--KG----YRMEPPEGCP 223 (254)
T ss_pred -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh--CC----CCCCCCCcCC
Confidence 11234678999999988899999999999999999998 999996554322111110 01 1111223445
Q ss_pred HHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 767 EQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
..+.+++.+||+.+|.+||++ +++...|+
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~-~~l~~~l~ 252 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSF-HKLREKLE 252 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCH-HHHHHHHc
Confidence 789999999999999999999 66766654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.76 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=200.0
Q ss_pred hhhhhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccc---
Q 003121 520 FSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--- 593 (846)
Q Consensus 520 ~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--- 593 (846)
++.+....++|.....||+|+||.||++... +..+|+|++.... .....+.+|+.+++.+ +||||++++++|.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 4556667889999999999999999999875 5789999876532 2235688999999999 7999999999861
Q ss_pred ----CceEEEEEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceee
Q 003121 594 ----EVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 668 (846)
Q Consensus 594 ----~~~~lVmEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL 668 (846)
+..++||||+++++|.+++... .....+++..+..++.+++.||.|||+ ++++||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEE
Confidence 3578999999999999887532 234568899999999999999999999 89999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 743 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~ 743 (846)
+|||+++........ .....|++.|+|||++.. ..++.++|||||||++|+|++|++||........
T Consensus 166 ~dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 166 VDFGVSAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred ccCCceeecccCCCc--------cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 999998866432211 123358999999999853 4578899999999999999999999976554332
Q ss_pred HHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 744 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 744 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
....... ..+ ....+...+..+.+|+.+||+.+|.+||++ .+++
T Consensus 238 ~~~~~~~---~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~ell 281 (286)
T cd06638 238 LFKIPRN---PPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTV-SDLL 281 (286)
T ss_pred Hhhcccc---CCC-cccCCCCcCHHHHHHHHHHccCCcccCCCH-HHHh
Confidence 2211111 001 011122335679999999999999999999 5543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=312.23 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=197.9
Q ss_pred CCcccceeeeeCceEEEEEEECC-----eEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
+|...+.||+|+||.||+|.... ..||||.+.... ......|..|+.++++++||||+++++++. ...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 56778899999999999998752 359999987542 222457899999999999999999999883 4578999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++... ...+++..++.++.|++.||.|||+ +|++||||||+|||++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998543 3468999999999999999999999 89999999999999999999999999998866432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
....... ......++..|+|||++.+..++.++|||||||++|||++ |.+||............. .. ...
T Consensus 160 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~--~~----~~~ 230 (269)
T cd05065 160 TSDPTYT---SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE--QD----YRL 230 (269)
T ss_pred ccccccc---cccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH--cC----CcC
Confidence 2111000 0011123567999999998899999999999999999987 999996554322111110 11 111
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
..+...+..+.+++.+||..+|.+||++ .++...|+.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~~ 268 (269)
T cd05065 231 PPPMDCPTALHQLMLDCWQKDRNARPKF-GQIVSTLDKM 268 (269)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHhh
Confidence 2233445789999999999999999999 7777777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.02 Aligned_cols=258 Identities=28% Similarity=0.476 Sum_probs=206.1
Q ss_pred CCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCc-hhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~-~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
...+.++||+|-||+|..+...+ ..||||.++....... ..|.+|+++|.+|+|||||+|+|+| ++.+++|+||++
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 45567789999999999999887 8899999998766554 7899999999999999999999999 678999999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+|+|..+|..... +.+......+|+.||+.|++||.+ -++|||||.+.|+|++.++++||+|||+++-+....+..
T Consensus 619 nGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 619 NGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred cCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 9999999965532 224556778899999999999999 689999999999999999999999999999665443321
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCchHHHHHHhhhhhccc-cCCCCCCC
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYALDTGKLKNL-LDPLAGDW 761 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt--G~~pf~~~~~~~~~~~~~~~~~~-ld~~~~~~ 761 (846)
. .+..+-...|||||.+..+++++++|||+||+++||+++ ...||......+-.-+.+.+... -.......
T Consensus 695 v------qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 695 V------QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred e------ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence 1 123446789999999999999999999999999999876 67888654332221111111110 01122345
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
|..++..+.+|+++||+.+-.+||++ +.+...|..
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsF-e~lh~~lq~ 803 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSF-EQLHLFLQE 803 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCH-HHHHHHHHH
Confidence 66778999999999999999999999 667666654
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.86 Aligned_cols=244 Identities=27% Similarity=0.400 Sum_probs=198.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
++|...+.||.|+||.||+|... +..+++|.+..... .+.+.+|++++++++||||+++++++ ....+++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888899999999999999986 47899999875432 56899999999999999999999988 45688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++... ...+++..+..++.+++.||.|||+ .+++||||+|.||+++.++.+||+|||++.........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999999998532 3568999999999999999999999 89999999999999999999999999998876433211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.....|+..|+|||++.+..++.++||||||+++|+|+||++||............... .......+.
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~ 223 (256)
T cd06612 156 --------RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK----PPPTLSDPE 223 (256)
T ss_pred --------cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC----CCCCCCchh
Confidence 12234789999999998889999999999999999999999999765443322221110 011111223
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..+.+++.+||+.+|.+||++ +++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~-~~i 250 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSA-IQL 250 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCH-HHH
Confidence 345789999999999999999999 554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=316.08 Aligned_cols=259 Identities=27% Similarity=0.455 Sum_probs=196.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC------------------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR------------------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTL 588 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~------------------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l 588 (846)
++|.+.++||+|+||.||++... ...||+|.+...... ....|.+|+.+|+.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999987542 235899998754322 24578999999999999999999
Q ss_pred eccc--cCceEEEEEecCCCchhhhhccCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCce
Q 003121 589 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDN--------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 658 (846)
Q Consensus 589 ~g~~--~~~~~lVmEy~~ggsL~~~L~~~~~--------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NI 658 (846)
++++ .+..++||||+++|+|.+++..... ...+++..+..++.+++.||.|||+ ++++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 9987 4568999999999999998854321 1347788999999999999999999 8999999999999
Q ss_pred EecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 003121 659 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALG 736 (846)
Q Consensus 659 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt--G~~pf~ 736 (846)
|++.++.+||+|||+++.+....... ..+...+++.|++||...++.++.++|||||||++|||+| |..||.
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYR------IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred EEcCCCCEEeccCcccccccCCccee------ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999998654322110 0122335678999999888899999999999999999998 778886
Q ss_pred CchHHHHHHhhhhh-ccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 737 ITKEVQYALDTGKL-KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 737 ~~~~~~~~~~~~~~-~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.............. ...........+...+..+.+|+.+||+.+|.+||++ .++.+.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-~~i~~~l~ 295 (296)
T cd05095 236 QLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF-QEIHATLL 295 (296)
T ss_pred ccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH-HHHHHHHh
Confidence 54332211111110 0000011111123345789999999999999999999 77777664
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.47 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=194.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
+.|.+.++||.|+||.||+|... +..|++|.+..........+.+|+.+++.++||||++++++| ....++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46888999999999999999876 478999998765444456788999999999999999999987 45689999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|..++... ...+++..+..++.|++.||.|||. ++++||||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 999998877432 3468999999999999999999999 89999999999999999999999999998754322111
Q ss_pred CCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
.....|++.|+|||++. ...++.++|||||||++|+|++|.+||............. ....+.
T Consensus 167 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~- 234 (292)
T cd06644 167 --------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPT- 234 (292)
T ss_pred --------cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh---cCCCcc-
Confidence 12235889999999985 3457889999999999999999999997654432221111 111110
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+...+..+.+|+.+||..+|.+||++ +++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i 266 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSA-AQL 266 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCH-HHH
Confidence 11122345679999999999999999999 444
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.20 Aligned_cols=250 Identities=24% Similarity=0.449 Sum_probs=196.2
Q ss_pred CCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCC------chhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG------PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~------~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
+|...+.||.|+||.||+|... +..+|+|.+....... ...+.+|+++|+.++||||++++++|. ...++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3667788999999999999874 5779999887543211 245889999999999999999999984 468899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++++|.+++... .++++..+..++.|++.||.|||. .+|+|+||+|.||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998532 458899999999999999999999 8999999999999999999999999999886532
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
........ .......|+..|+|||++.+..++.++|||||||++|+|++|+.||................... +
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~ 228 (265)
T cd06631 155 VGLHGTHS--NMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM----P 228 (265)
T ss_pred cccccccc--ccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC----C
Confidence 21111000 01123458999999999998889999999999999999999999997655443222221111111 1
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+...+..+.+++.+||..+|.+||++ .++
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~-~~~ 259 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSA-LQL 259 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCH-HHH
Confidence 2233456789999999999999999999 444
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=303.78 Aligned_cols=243 Identities=25% Similarity=0.408 Sum_probs=196.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC--CCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
+.|++...||+|.|+.||+.... |+.+|+|+++.. ...+.+++.+|+.|-+.|+||||++|..... ...|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 36777788999999999998765 577888887654 2235578899999999999999999999874 45889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec---CCCceeeeccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLS 678 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~---~~~~vKL~DFGla~~~~ 678 (846)
++.|++|..-+..+ ..+++..+-.++.||+.+|.|+|. ++|||||+||.|+||. ..--+||+|||+|..+.
T Consensus 91 ~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred cccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999997666433 457788888999999999999999 9999999999999995 34578999999999876
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
.... ..+..|||.|||||++...+|+..+|||+.|||||-|+.|++||....... +-.+......+.-.
T Consensus 165 ~g~~---------~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 165 DGEA---------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYEQIKAGAYDYPS 233 (355)
T ss_pred Cccc---------cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHHHHhccccCCCC
Confidence 3211 135679999999999999999999999999999999999999997743322 11222333344444
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
+.|+ ..++...+|+++||..||.+|.|+.
T Consensus 234 ~~w~-~is~~Ak~LvrrML~~dP~kRIta~ 262 (355)
T KOG0033|consen 234 PEWD-TVTPEAKSLIRRMLTVNPKKRITAD 262 (355)
T ss_pred cccC-cCCHHHHHHHHHHhccChhhhccHH
Confidence 5665 4567799999999999999999984
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=328.25 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=189.7
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccccC-------ceE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VWT 597 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-------~~~ 597 (846)
+|++.++||+|+||.||++... +..||||.+..... .....+.+|+.+|+.++||||+++++++.. ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778889999999999999864 68899999865321 223568899999999999999999998732 578
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+. ++|.+.+. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777773 33568999999999999999999999 89999999999999999999999999999865
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh-------
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------- 749 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~------- 749 (846)
...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|++||..............
T Consensus 154 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 154 EPDESK-------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred ccCccc-------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 432211 11234589999999999774 589999999999999999999999976543221110000
Q ss_pred ----------hcccc-CCCCC-------CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 750 ----------LKNLL-DPLAG-------DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 750 ----------~~~~l-d~~~~-------~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+. .+... ......++.+.+|+.+||+.||.+||++ .++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-~e~ 285 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA-ADA 285 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH-HHH
Confidence 00000 00000 1112235678999999999999999999 444
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=315.92 Aligned_cols=241 Identities=24% Similarity=0.331 Sum_probs=190.9
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
|+..+.||+|+||.||++... +..||+|.+....... ...+.+|+.++++++|+||+.+++.+ .+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 666788999999999999886 5689999987643322 23577899999999999999999987 3568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999885432 2458999999999999999999999 8999999999999999999999999999876532211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. ....|++.|+|||++.+..++.++|||||||++|+|++|++||......... ......+......++
T Consensus 158 ~---------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~ 225 (285)
T cd05630 158 I---------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVQEEYS 225 (285)
T ss_pred c---------cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhhhhhcC
Confidence 0 1235899999999999889999999999999999999999999754321000 000111111111223
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCC
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
...+..+.+|+.+||+.+|.+||+
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccC
Confidence 344577999999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.93 Aligned_cols=249 Identities=22% Similarity=0.373 Sum_probs=185.5
Q ss_pred eeeeeCceEEEEEEECC----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCc
Q 003121 535 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS 607 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~----~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggs 607 (846)
.||+|+||.||+|...+ ..+++|.+...... ....|.+|+.+++.++||||++++++|. ...++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999997532 46888887644322 2346789999999999999999999884 46899999999999
Q ss_pred hhhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 608 LEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 608 L~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|.+++..... ...+++.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865422 2335678889999999999999999 8999999999999999999999999999875432211110
Q ss_pred CccccccCCCCCCcccCChhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~-------~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
.....+++.|+|||++.. ..++.++|||||||++|+|++ |.+||........ +............
T Consensus 159 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~ 231 (269)
T cd05042 159 ------KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVREQDIKLP 231 (269)
T ss_pred ------cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHhhccCccCC
Confidence 022346788999999743 356789999999999999999 7888865543221 1111111111111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
.+.++...+..+.+++..|| .+|.+||++ ++|.+.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~-~~v~~~l 267 (269)
T cd05042 232 KPQLDLKYSDRWYEVMQFCW-LDPETRPTA-EEVHELL 267 (269)
T ss_pred CCcccccCCHHHHHHHHHHh-cCcccccCH-HHHHHHh
Confidence 22233345677888999998 599999999 7776665
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.51 Aligned_cols=246 Identities=20% Similarity=0.271 Sum_probs=190.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--------C
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------E 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~ 594 (846)
.++|...+.||+|+||.||++... +..||||++..... .....+.+|+.+++.++||||+++++++. .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999875 57899999875422 22356789999999999999999998763 2
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 36899999975 6666662 247888999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh-----
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----- 749 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~----- 749 (846)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+........-.
T Consensus 174 ~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (364)
T cd07875 174 RTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244 (364)
T ss_pred cccCCCCc---------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 86543211 1234589999999999999999999999999999999999999976543221100000
Q ss_pred ------------------------------hccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 750 ------------------------------LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 750 ------------------------------~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+...+.+............+.+|+.+||+.||.+|||+ .++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~-~e~ 315 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV-DEA 315 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH-HHH
Confidence 00000000111111224578999999999999999999 444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.39 Aligned_cols=245 Identities=27% Similarity=0.462 Sum_probs=190.2
Q ss_pred eeeeeCceEEEEEEECC----eEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEEEEecCCC
Q 003121 535 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~----~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lVmEy~~gg 606 (846)
.||+|+||.||+|...+ ..+++|.+..... .....+.+|+.++.++ +||||++++++|. ...++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999998753 2478888874322 2345788999999999 8999999999984 4588999999999
Q ss_pred chhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 607 SLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 607 sL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
+|.+++.... ....+++..++.++.+++.||.|||+ ++++||||||+|||++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999985432 12358899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhcc
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKN 752 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~ 752 (846)
+....... . ......+..|+|||++....++.++|||||||++|+|++ |.+||........ ....
T Consensus 159 ~~~~~~~~--~-------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~---- 224 (270)
T cd05047 159 SRGQEVYV--K-------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKL---- 224 (270)
T ss_pred ccccchhh--h-------ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-HHHH----
Confidence 86322110 0 011234677999999988889999999999999999997 9999965433221 1110
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 753 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
........+...+..+.+|+.+||..+|.+||++ .+++..|+.+
T Consensus 225 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~~l~~~ 268 (270)
T cd05047 225 -PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQILVSLNRM 268 (270)
T ss_pred -hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCH-HHHHHHHHHh
Confidence 0111112233345789999999999999999999 7777777655
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=329.87 Aligned_cols=249 Identities=24% Similarity=0.295 Sum_probs=191.4
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceE
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 597 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~ 597 (846)
...++|...+.||+|+||.||++... +..||+|++..... .....+.+|+.+++.++||||+++++++. ...+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34468999999999999999999886 46899999864321 22345788999999999999999999884 4688
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+++|+|.+++.. ..++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 120 lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 99999999999998842 347888999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
....... .....||+.|+|||++... .++.++|||||||++|+|++|++||...+..............
T Consensus 193 ~~~~~~~-------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 193 NKEGMVR-------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred CcCCccc-------ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 4322111 1234699999999999753 3789999999999999999999999766543221111100010
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCC---CCChHHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKS---RPELGKDVW 792 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~---RPt~~~~v~ 792 (846)
+ ....+...+..+.+|+.+|+. +|.. ||++ +++.
T Consensus 266 ~---~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~-~ei~ 302 (371)
T cd05622 266 L---TFPDDNDISKEAKNLICAFLT-DREVRLGRNGV-EEIK 302 (371)
T ss_pred c---cCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCH-HHHh
Confidence 1 101112356789999999998 4444 6676 4443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=325.70 Aligned_cols=247 Identities=20% Similarity=0.262 Sum_probs=190.2
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--------
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-------- 593 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-------- 593 (846)
..++|...+.||+|+||.||++... +..||||.+...... ....+.+|+.+++.++||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468999999999999999999865 578999998754222 2356778999999999999999999872
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 236899999975 5666552 247888999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh------
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT------ 747 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~------ 747 (846)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 166 ~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (355)
T cd07874 166 ARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_pred cccCCCccc---------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 986533211 12345899999999999889999999999999999999999999765432211000
Q ss_pred ----------hhhcccc-------------------CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 748 ----------GKLKNLL-------------------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 748 ----------~~~~~~l-------------------d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
......+ -+....++...+..+.+|+.+||..+|.+||++ .++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~-~el 308 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-DEA 308 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH-HHH
Confidence 0000000 000111222235678999999999999999999 444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.64 Aligned_cols=248 Identities=29% Similarity=0.380 Sum_probs=199.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
++|...+.||.|+||.||+|... +..+++|.+..........+.+|+.++++++||||+++++++ ....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 47888899999999999999875 477999999876555567899999999999999999999987 45688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++... ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999988532 2568999999999999999999999 89999999999999999999999999998765432110
Q ss_pred CCCccccccCCCCCCcccCChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
.....|+..|+|||.+.+. .++.++||||||+++|+|+||++||.............. .. +.+....
T Consensus 158 --------~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-~~-~~~~~~~ 227 (262)
T cd06613 158 --------RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-SN-FPPPKLK 227 (262)
T ss_pred --------cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cc-CCCcccc
Confidence 1223588999999999776 789999999999999999999999976544332221111 11 1111111
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+...+..+.+|+.+||..+|.+||++ +++
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~i 257 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTA-TKL 257 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCH-HHH
Confidence 233446789999999999999999999 544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.14 Aligned_cols=234 Identities=26% Similarity=0.390 Sum_probs=182.6
Q ss_pred eeeeeCceEEEEEEECC--------------eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 535 KIGEGGYGSIYKGLLRH--------------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~--------------~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
.||+|+||.||+|.+.. ..|++|.+..........|.+|+.+++.++||||++++++|. ...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998531 358999887654444457889999999999999999999984 46889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc-------eeeecc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-------SKLSDF 671 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~-------vKL~DF 671 (846)
||||+++|+|..++... ..++++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +|++||
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999998887432 3468999999999999999999999 89999999999999987654 899999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCchHHHHHHhhhh
Q 003121 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLL-TGRPALGITKEVQYALDTGK 749 (846)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~~~ksDVwSlGviL~ell-tG~~pf~~~~~~~~~~~~~~ 749 (846)
|++...... ....|+..|+|||++. +..++.++|||||||++|+|+ +|..||..........
T Consensus 157 g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---- 220 (262)
T cd05077 157 GIPITVLSR------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER---- 220 (262)
T ss_pred CCCccccCc------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH----
Confidence 998654321 1234788999999987 456899999999999999998 5888886543222110
Q ss_pred hccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHH
Q 003121 750 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 794 (846)
Q Consensus 750 ~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~ 794 (846)
+....... ....+..+.+|+.+||+.+|.+||++ .+++..
T Consensus 221 ~~~~~~~~----~~~~~~~~~~li~~cl~~dp~~Rp~~-~~il~~ 260 (262)
T cd05077 221 FYEGQCML----VTPSCKELADLMTHCMNYDPNQRPFF-RAIMRD 260 (262)
T ss_pred HHhcCccC----CCCChHHHHHHHHHHcCCChhhCcCH-HHHHHh
Confidence 10000011 11224679999999999999999999 666544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.34 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=190.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
.+|...++||+|+||.||+|... +..||+|.+...... ....+.+|+.++++++||||+++++++ .+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888999999999999999875 567999998754332 234678999999999999999999988 4568999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++ +|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 777777432 3458889999999999999999999 8999999999999999999999999999876433211
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh---------h--
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------L-- 750 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~---------~-- 750 (846)
. .....+|+.|+|||++.+ ..++.++|||||||++|+|+||++||.............. +
T Consensus 160 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 160 T--------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred c--------cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 1 123357999999999865 4689999999999999999999999965443221110000 0
Q ss_pred -------ccccCCCC-C----CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 -------KNLLDPLA-G----DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 -------~~~ld~~~-~----~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...-.+.. . ......+..+.+|+.+||+.+|.+|||+ .++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-~e~ 283 (309)
T cd07872 232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA-EEA 283 (309)
T ss_pred hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH-HHH
Confidence 00000000 0 0011235678999999999999999999 444
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.84 Aligned_cols=241 Identities=24% Similarity=0.315 Sum_probs=192.2
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
|...+.||+|+||+||+|... ++.||+|.+...... ....+.+|+.+|+.++|+||+.+++++ .+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566778999999999999886 578999998764322 224577899999999999999998877 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++.... ..++++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998885332 3469999999999999999999999 8999999999999999999999999999876432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHh-hhhhccccCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-TGKLKNLLDPLAGDW 761 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~-~~~~~~~ld~~~~~~ 761 (846)
.....|++.|+|||++.+..++.++|+|||||++|+|+||.+||........... ...... ....+
T Consensus 158 ---------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05632 158 ---------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE----TEEVY 224 (285)
T ss_pred ---------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc----ccccc
Confidence 0223589999999999888999999999999999999999999976543221111 111111 11123
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
+...+..+.+|+.+||+.+|.+||+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCC
Confidence 33445779999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.70 Aligned_cols=248 Identities=26% Similarity=0.493 Sum_probs=196.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecC
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 604 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ 604 (846)
.+|...+.||.|+||.||+|.+. +..+|+|.+..... ....|.+|++++++++||||+++++++. ...++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35777889999999999999876 67899998875432 3467999999999999999999999884 46889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+++|.+++... ..++++..+..++.+++.||.|||+ ++++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999988533 2468899999999999999999999 899999999999999999999999999987654321110
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.....++..|+|||.+.++.++.++||||||+++|+|++ |++||.........-... ..... ..+.
T Consensus 158 -------~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~---~~~~ 224 (256)
T cd05112 158 -------STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN---AGFRL---YKPR 224 (256)
T ss_pred -------cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh---CCCCC---CCCC
Confidence 112235678999999988899999999999999999998 999997554322111110 00011 1122
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
..+..+.+|+.+||..+|.+||++ .++++.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~-~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSF-SLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCH-HHHHHhh
Confidence 345789999999999999999999 6666554
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.50 Aligned_cols=244 Identities=25% Similarity=0.391 Sum_probs=197.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
.+|...+.||.|+||.||+|... +..||+|.+........+.+.+|+.+++.++||||++++++| .+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57888899999999999999864 688999999866555566788999999999999999999988 45689999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++. ...+++..+..++.+++.||.|||+ .+++||||||+|||++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999884 2357889999999999999999999 89999999999999999999999999998765432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|++||............... .......+.
T Consensus 172 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~----~~~~~~~~~ 239 (297)
T cd06656 172 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN----GTPELQNPE 239 (297)
T ss_pred --------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC----CCCCCCCcc
Confidence 12235889999999999888999999999999999999999999655432211111100 000111233
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..+.+|+.+||..+|.+||++ .++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~-~~i 266 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSA-KEL 266 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 455778999999999999999999 444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.46 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=196.7
Q ss_pred CCcccceeeeeCceEEEEEEEC------CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc----CceE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWT 597 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~------~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~ 597 (846)
.|...+.||+|+||.||.+.+. +..||+|.+..... .....+.+|+.+|+.++||||++++++|. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4677889999999999998753 46799999875532 22457899999999999999999999884 3478
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||++|++|.+++... ...+++..+..++.+++.||.|||+ +|++||||||+|||++.++.+||+|||+++.+
T Consensus 85 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 999999999999998533 2358999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHh--------hh
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALD--------TG 748 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~-~~~~--------~~ 748 (846)
....... .......|+..|+|||++.+..++.++|||||||++|+|+|++.|+....... .... ..
T Consensus 160 ~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 160 ETDKEYY-----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR 234 (284)
T ss_pred ccCccce-----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence 4332110 01123447788999999988889999999999999999999877653211100 0000 00
Q ss_pred hhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 749 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
.............+...+..+.+|+.+||+.+|.+||++ ++++..|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTF-QNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCH-HHHHHHHHhh
Confidence 000000011111223356789999999999999999999 7787777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.35 Aligned_cols=250 Identities=30% Similarity=0.525 Sum_probs=200.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEecC
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLP 604 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy~~ 604 (846)
..+|...++||+|+||.||++... +..+|+|.+.... .....+.+|+.+++.++|+||+++++.+. ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 347888999999999999999865 4679999887543 23467899999999999999999998874 45789999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+|+|.+++.... ...+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.+||+|||++..+.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 84 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999986432 3467889999999999999999999 899999999999999999999999999997654322111
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCCCCCCC
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~~~~~~ 761 (846)
.....++..|+|||++..+.++.++|+|||||++|+|+| |++||....... ..+..+ ...+ .
T Consensus 160 -------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----~~~~----~ 224 (260)
T cd05073 160 -------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG----YRMP----R 224 (260)
T ss_pred -------ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC----CCCC----C
Confidence 122346778999999988889999999999999999999 999997544322 111111 1111 1
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
+...+..+.+++.+||+.+|.+||++ .++...|+.
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~-~~l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTF-EYIQSVLDD 259 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCH-HHHHHHHhc
Confidence 22345789999999999999999999 788787764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.54 Aligned_cols=194 Identities=25% Similarity=0.408 Sum_probs=157.2
Q ss_pred cceeeeeCceEEEEEEEC----CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc----CceEEEEEecC
Q 003121 533 SLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYEYLP 604 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~----~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lVmEy~~ 604 (846)
..+||+|+||.||+|... +..||+|.+..... ...+.+|+.+|++++||||+++++++. ...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999864 36799999875432 346789999999999999999999872 35789999985
Q ss_pred CCchhhhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe----cCCCceeeeccccc
Q 003121 605 NGSLEDRLSCK------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGIS 674 (846)
Q Consensus 605 ggsL~~~L~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl----~~~~~vKL~DFGla 674 (846)
++|.+++... .....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5777776422 122358999999999999999999999 899999999999999 45689999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI 737 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~ 737 (846)
+.+....... .......||+.|+|||++.+. .++.++|||||||++|+|+||++||..
T Consensus 160 ~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPL-----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccc-----cccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 8764332111 111335689999999999774 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=346.56 Aligned_cols=252 Identities=21% Similarity=0.347 Sum_probs=195.6
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc----Cce
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP----EVW 596 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~ 596 (846)
....+|.+..+||.|+||+||++... +..||+|.+...... ....|..|+.+|++|+|||||+++++|. ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999886 467999998754332 2356889999999999999999999872 358
Q ss_pred EEEEEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CceEecccCCCceEecC---------
Q 003121 597 TLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKP----HSIVHGDLKPANILLDA--------- 662 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~----~giiHrDLkp~NILl~~--------- 662 (846)
||||||+++|+|.++|... .....+++..++.|+.||+.||.|||...+ ++||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 8999999999999988543 223579999999999999999999998431 45999999999999964
Q ss_pred --------CCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCC
Q 003121 663 --------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGR 732 (846)
Q Consensus 663 --------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~~~ksDVwSlGviL~elltG~ 732 (846)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||+|+||.
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 24589999999986543211 122358999999999864 45899999999999999999999
Q ss_pred CCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 733 PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 733 ~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+||.........+.... ...... ....+..+.+||..||..+|.+||++.+.+
T Consensus 241 ~PF~~~~~~~qli~~lk--~~p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 241 TPFHKANNFSQLISELK--RGPDLP----IKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CCCCcCCcHHHHHHHHh--cCCCCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 99976554433222211 111110 112357899999999999999999994433
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.61 Aligned_cols=246 Identities=28% Similarity=0.390 Sum_probs=196.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
++|.+.+.||.|+||.||+|... +..||+|.+........+.|.+|+.++++++||||+++++++ ....++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46888899999999999999885 578999998765444456788999999999999999999988 45688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++... ..++++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 999999988533 3468999999999999999999999 8999999999999999999999999999876533211
Q ss_pred CCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
......|++.|+|||.+. ...++.++||||||+++|+|++|++||.............. ...+ .
T Consensus 159 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-~ 227 (280)
T cd06611 159 -------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK---SEPP-T 227 (280)
T ss_pred -------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc---CCCC-C
Confidence 112345899999999985 33577899999999999999999999976654332222111 1001 1
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+...+..+.+++.+||+.+|.+||++ .++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~i 259 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTA-AEL 259 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCH-HHH
Confidence 11122345789999999999999999999 444
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.04 Aligned_cols=244 Identities=28% Similarity=0.452 Sum_probs=199.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC----Cc----hhHHHHHHHHHhc-CCCceeeEeccccC-
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ----GP----SEFQQEIDILSKI-RHPNLVTLVGACPE- 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~----~~----~~f~~Ei~iL~~l-~HpnIv~l~g~~~~- 594 (846)
...|.+.+.||.|..+.|.++..+ +..+|+|++...... .. +.-.+|+.||+++ -||||+.|.+++..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 346777788999999999988765 577999988754322 12 2345799999998 69999999999854
Q ss_pred -ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 595 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 595 -~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
.+++|+|.|+.|.|.|+|. ..-.+++...++|+.++..|+.|||. ++||||||||+|||++++..+||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence 5779999999999999994 34569999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HH
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--AL 745 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~--~~ 745 (846)
++.+...... ...+|||+|+|||.+.. .+|+..+|+|++|||+|.|+.|.|||....++-. .+
T Consensus 170 a~~l~~GekL---------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I 240 (411)
T KOG0599|consen 170 ACQLEPGEKL---------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI 240 (411)
T ss_pred eeccCCchhH---------HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH
Confidence 9988765422 23459999999998853 3688999999999999999999999987666432 23
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..|+ .....++|. +.+....+||.+||+.||.+|.|. ++.
T Consensus 241 meGk----yqF~speWa-dis~~~KdLIsrlLqVdp~~Rita-ke~ 280 (411)
T KOG0599|consen 241 MEGK----YQFRSPEWA-DISATVKDLISRLLQVDPTKRITA-KEA 280 (411)
T ss_pred Hhcc----cccCCcchh-hccccHHHHHHHHHeeCchhcccH-HHH
Confidence 3333 334455664 456779999999999999999999 443
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=336.71 Aligned_cols=250 Identities=21% Similarity=0.272 Sum_probs=186.2
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCC------ceeeEecccc-
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP------NLVTLVGACP- 593 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hp------nIv~l~g~~~- 593 (846)
+...+++|.+.++||+|+||+||+|... +..||||+++.... ....+..|+.++..++|. +|++++++|.
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345678999999999999999999875 57799999864321 234567788888887654 5888888873
Q ss_pred --CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC-------
Q 003121 594 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF------- 664 (846)
Q Consensus 594 --~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~------- 664 (846)
...++||+++ +++|.+++.. ...+++..+..|+.||+.||.|||.. .|||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccc
Confidence 3578999988 7788888743 24689999999999999999999971 3899999999999998765
Q ss_pred ---------ceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003121 665 ---------VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 735 (846)
Q Consensus 665 ---------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf 735 (846)
.+||+|||++...... .....||+.|+|||++.+..|+.++|||||||+||||+||++||
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~~-----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERHS-----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccCCCCceEEECCCCccccCccc-----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4999999987543211 12346999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHhhhhhc-----------------cccC---CCCCCC---------------ChhhHHHHHHHHHHHhccC
Q 003121 736 GITKEVQYALDTGKLK-----------------NLLD---PLAGDW---------------PFVQAEQLANLAMRCCEMS 780 (846)
Q Consensus 736 ~~~~~~~~~~~~~~~~-----------------~~ld---~~~~~~---------------p~~~~~~l~~Li~~Cl~~~ 780 (846)
................ .+.. ...... .......+.+||.+||+.|
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 7655432111100000 0000 000000 0012356789999999999
Q ss_pred cCCCCChHHHH
Q 003121 781 RKSRPELGKDV 791 (846)
Q Consensus 781 P~~RPt~~~~v 791 (846)
|.+||++ +++
T Consensus 426 P~~R~ta-~e~ 435 (467)
T PTZ00284 426 RQKRLNA-RQM 435 (467)
T ss_pred hhhCCCH-HHH
Confidence 9999999 444
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.59 Aligned_cols=246 Identities=25% Similarity=0.456 Sum_probs=193.9
Q ss_pred eeeeeCceEEEEEEECC--------eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 535 KIGEGGYGSIYKGLLRH--------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~--------~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
.||+|+||.||+|.... ..+|||.+..... .....+.+|+.+++.++||||++++++| .+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998753 4699998765432 2345788999999999999999999988 35689999999
Q ss_pred CCCchhhhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC-----ceeeeccccc
Q 003121 604 PNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-----VSKLSDFGIS 674 (846)
Q Consensus 604 ~ggsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~-----~vKL~DFGla 674 (846)
++|+|.+++.... ....+++..++.++.+++.||.|||+ ++++|+||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999985431 23458899999999999999999998 8899999999999999877 8999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
+.......... .....++..|+|||++.++.++.++|||||||++|+|+| |+.||.............
T Consensus 159 ~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~----- 227 (269)
T cd05044 159 RDIYKSDYYRK------EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT----- 227 (269)
T ss_pred ccccccccccc------CcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-----
Confidence 86543321111 122346789999999999999999999999999999998 999996554332211110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.......+...+..+.+|+.+||..+|.+||++ +++.+.|.
T Consensus 228 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~ 268 (269)
T cd05044 228 -AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTF-DRIQEILQ 268 (269)
T ss_pred -cCCccCCcccchHHHHHHHHHHcCCCcccCCCH-HHHHHHHh
Confidence 011112334456889999999999999999999 77776664
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=320.06 Aligned_cols=246 Identities=24% Similarity=0.294 Sum_probs=187.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|.+.+.||+|+||.||++... +..||+|++..... .....+.+|+.++..++||||++++++|. +..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888999999999999999876 57899999875321 22345889999999999999999999884 4689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998532 3468899999999999999999999 89999999999999999999999999998765432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
.... .....||+.|+|||++.. +.++.++|||||||++|+|++|+.||..................+.
T Consensus 156 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 228 (331)
T cd05597 156 GTVQ-------SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ 228 (331)
T ss_pred CCcc-------ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc
Confidence 2111 112358999999999863 4578899999999999999999999976543322111110011111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCc--CCCCCh
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSR--KSRPEL 787 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P--~~RPt~ 787 (846)
.... ....+..+.+|+.+|+...+ ..||++
T Consensus 229 -~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~ 260 (331)
T cd05597 229 -FPPD-VTDVSEEAKDLIRRLICSPETRLGRNGL 260 (331)
T ss_pred -CCCc-cCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 1111 12246789999999886533 336777
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.92 Aligned_cols=244 Identities=22% Similarity=0.299 Sum_probs=187.8
Q ss_pred CCCcccceeeeeCceEEEEEEECC----eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~----~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
.+|.+..+||.|+||.||++...+ ..||+|.+... ..+.+|+.+|++++||||+++++++. ...++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 468999999999999999987643 56999987642 24578999999999999999999884 56889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+. ++|.+++. ....+++..++.|+.||+.||.|||. +||+||||||+||||+.++.+||+|||+++.+....
T Consensus 167 ~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 167 KYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 995 68888873 34569999999999999999999999 899999999999999999999999999998654432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHhhh-------
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALDTG------- 748 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~------~~~~~~~~------- 748 (846)
.... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||..... ....+..-
T Consensus 240 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 240 DTPQ------CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred cccc------ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 1111 1234699999999999989999999999999999999999999854321 11100000
Q ss_pred ----------hhccccCCCCCCCC-------hhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 749 ----------KLKNLLDPLAGDWP-------FVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 749 ----------~~~~~ld~~~~~~p-------~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
.+..........++ ...+..+.+||.+||..+|.+||++.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e 371 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQD 371 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHH
Confidence 00000000111111 112457889999999999999999943
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=303.55 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=195.7
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--C-ceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--E-VWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~-~~~lVmE 601 (846)
+|.+.+.||+|+||.||++... +..||+|.+..... .....+.+|+.++++++|||++++++.+. + ..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999875 46799999875432 22356889999999999999999998863 2 4689999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++++|.+++... ...++++.+++.++.+++.||.+||+ ++++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988543 23468999999999999999999999 899999999999999999999999999998664321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||............ ....+ +..
T Consensus 157 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~--~~~~~----~~~ 222 (257)
T cd08223 157 D--------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI--IEGKL----PPM 222 (257)
T ss_pred C--------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HhcCC----CCC
Confidence 1 112345899999999999989999999999999999999999999765432211111 11111 122
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+...+..+.+|+.+||+.+|.+||++ .++
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~-~~~ 251 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSV-KSI 251 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCH-HHH
Confidence 33455789999999999999999998 444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=316.27 Aligned_cols=242 Identities=23% Similarity=0.369 Sum_probs=201.7
Q ss_pred CCCcccceeeeeCceEEEEEE--ECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~--~~~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
+-|++.+.||+|.|..|-.++ +.|..||||++.+..... ..++.+|+.-|+.++|||||+||.+. ...+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 358888899999999998874 568999999998875543 45789999999999999999999987 457999999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec-CCCceeeeccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~-~~~~vKL~DFGla~~~~~~ 680 (846)
+-.+|+|+|++.+.. ..+.+..+.+++.||+.|+.|+|+ ..+|||||||+||.+- .-|-|||.|||++..+.+.
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999997543 568999999999999999999999 5699999999998875 5589999999999877654
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~-~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
... +..+|+..|.|||++.+..|+ +++||||||||||.|++|++||...+.-+.. ..++|- .-
T Consensus 173 ~kL---------~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL------TmImDC-KY 236 (864)
T KOG4717|consen 173 KKL---------TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL------TMIMDC-KY 236 (864)
T ss_pred chh---------hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh------hhhhcc-cc
Confidence 321 345699999999999999986 6889999999999999999999765543321 111111 11
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..|.+.+.++.+||..||..+|++|.+. ++|
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAsl-EeI 267 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASL-EEI 267 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccH-HHH
Confidence 2467889999999999999999999998 443
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=308.64 Aligned_cols=245 Identities=35% Similarity=0.533 Sum_probs=192.3
Q ss_pred CcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCCCch--hHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 530 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~~~~--~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
|+..+.||+|+||+||++...+ ..||+|++......... ...+|+.+++.++||||+++++++ ....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5667899999999999999874 57999999876433222 234599999999999999999988 45688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++. ....+++..+..++.+|+.||.+||+ ++|+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~- 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE- 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS-
T ss_pred cccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc-
Confidence 9999999995 34568999999999999999999999 8999999999999999999999999999876411110
Q ss_pred CCCccccccCCCCCCcccCChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHhhhhhccccCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTGRPALGITK--EVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~~~ksDVwSlGviL~elltG~~pf~~~~--~~~~~~~~~~~~~~ld~~~~~ 760 (846)
......++..|+|||++. +..++.++||||||+++|+|++|..||.... .....+.............
T Consensus 154 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 224 (260)
T PF00069_consen 154 -------NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-- 224 (260)
T ss_dssp -------EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT--
T ss_pred -------ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc--
Confidence 113345899999999998 7789999999999999999999999998762 1111121111111111100
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
........+.+|+.+||+.+|.+||++ .++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~-~~l 254 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSA-EEL 254 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTH-HHH
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCH-HHH
Confidence 011123789999999999999999999 444
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.37 Aligned_cols=259 Identities=26% Similarity=0.444 Sum_probs=200.2
Q ss_pred CCcccceeeeeCceEEEEEEEC------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccccC----ceE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE----VWT 597 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----~~~ 597 (846)
+|...+.||+|+||.||+|.+. +..||||.+...... ....|.+|+++++.++||||+++++++.. ..+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 5667788999999999999864 467999999865442 35679999999999999999999998743 588
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+++++|.+++... ...+++..+..++.+++.||.|||. ++++||||||.|||++.++.+||+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999533 2358999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--------Hhhhh
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--------LDTGK 749 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~--------~~~~~ 749 (846)
........ ......++..|++||.+.+..++.++||||||+++|+|+||..||......... .....
T Consensus 160 ~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 160 PEDKDYYY-----VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred ccCCccee-----ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 53221110 011233567799999998888999999999999999999999988543211100 00000
Q ss_pred hcccc-CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 750 LKNLL-DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 750 ~~~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
+...+ .......+...+..+.+|+.+||+.+|.+||++ .+++++|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSF-ADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCH-HHHHHHHhhc
Confidence 00000 001111123345789999999999999999999 8888888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.40 Aligned_cols=242 Identities=26% Similarity=0.362 Sum_probs=188.5
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
+|...++||+|+||.||+|... +..||+|.+..... .....+.+|+.++++++||||++++++| .+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5777889999999999999874 57899999865422 2234688999999999999999999987 45688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++|+|..+. .+++..+..++.+++.||.|||+ ++|+|+||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999986542 36788899999999999999999 899999999999999999999999999987653321
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-HhhhhhccccCCCCCCC-
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-LDTGKLKNLLDPLAGDW- 761 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~-~~~~~~~~~ld~~~~~~- 761 (846)
.....||..|+|||++.+..++.++||||||+++|+|+||+.||......... ..........+......
T Consensus 150 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (279)
T cd06619 150 --------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP 221 (279)
T ss_pred --------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC
Confidence 12345899999999999889999999999999999999999999542211000 00000111111111111
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+..+.+++.+||+.+|.+||++ +++
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~-~ei 250 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAP-ENL 250 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCH-HHH
Confidence 11234679999999999999999999 554
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.62 Aligned_cols=257 Identities=27% Similarity=0.364 Sum_probs=200.8
Q ss_pred CChhhhhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccc-
Q 003121 518 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP- 593 (846)
Q Consensus 518 ~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~- 593 (846)
+.+.++..+.++|.....||+|+||.||++... +..+|+|++.... .....+.+|+.++.++ +||||++++++|.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445667778889999999999999999999875 5789999986542 2245678999999999 8999999999873
Q ss_pred ------CceEEEEEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 594 ------EVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 594 ------~~~~lVmEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
...++||||+++|+|.+++... .....+++..++.++.+++.||.|||. .+++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 2478999999999999988532 234568999999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 003121 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITKEV 741 (846)
Q Consensus 667 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~~~ksDVwSlGviL~elltG~~pf~~~~~~ 741 (846)
||+|||++......... .....|+..|+|||.+... .++.++|||||||++|+|++|++||......
T Consensus 168 kl~dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred EEeecccchhccccccc--------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 99999998865432211 1223589999999998653 3688999999999999999999999765443
Q ss_pred HHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 742 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 742 ~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
......... ..+.. ..+......+.+|+.+||+.+|.+||++ .++
T Consensus 240 ~~~~~~~~~---~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~i 284 (291)
T cd06639 240 KTLFKIPRN---PPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSV-THL 284 (291)
T ss_pred HHHHHHhcC---CCCCC-CcccccCHHHHHHHHHHhhcChhhCcCH-HHH
Confidence 322221110 00000 1122234579999999999999999999 444
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=317.53 Aligned_cols=248 Identities=24% Similarity=0.271 Sum_probs=189.4
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
+|...++||+|+||.||++... +..||+|++.... ......+..|+.++..++||||+++++++ .+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 6888899999999999999886 4679999986422 11234588899999999999999999988 456899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 y~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 82 YYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred ccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999532 3468999999999999999999999 899999999999999999999999999987553322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
.. ......||+.|+|||++. ...++.++|||||||++|||++|++||................. ..
T Consensus 157 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~ 227 (332)
T cd05623 157 TV-------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RF 227 (332)
T ss_pred cc-------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc--cc
Confidence 11 012245999999999986 34688999999999999999999999976554332111110000 00
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCC--CCChHHHH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKS--RPELGKDV 791 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~--RPt~~~~v 791 (846)
..+......+..+.+|+.+|+..++.+ ||++ +++
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~-~~~ 263 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGI-EDF 263 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCH-HHH
Confidence 011112234678999999998654443 5677 444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.98 Aligned_cols=235 Identities=26% Similarity=0.412 Sum_probs=181.2
Q ss_pred eeeeeCceEEEEEEEC--------------------------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeE
Q 003121 535 KIGEGGYGSIYKGLLR--------------------------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 588 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--------------------------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l 588 (846)
+||+|+||.||+|.+. ...|++|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999999742 13489998875433334568889999999999999999
Q ss_pred ecccc--CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC--
Q 003121 589 VGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-- 664 (846)
Q Consensus 589 ~g~~~--~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~-- 664 (846)
+++|. ...++||||+++|+|..++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 99983 4688999999999999988532 3468899999999999999999999 8999999999999997643
Q ss_pred -----ceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHH-hCCCCCCC
Q 003121 665 -----VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLL-TGRPALGI 737 (846)
Q Consensus 665 -----~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~ell-tG~~pf~~ 737 (846)
.+||+|||++...... ....+++.|+|||.+.+ ..++.++|||||||++|||+ +|++||..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred cCccceeeecCCccccccccc------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 4799999987643221 11247888999998875 56899999999999999994 79999965
Q ss_pred chHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 738 TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 738 ~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
......... +... ...+......+.+|+.+||+.+|.+||++ .++++.|
T Consensus 225 ~~~~~~~~~---~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rps~-~~il~~L 273 (274)
T cd05076 225 RTPSEKERF---YEKK-----HRLPEPSCKELATLISQCLTYEPTQRPSF-RTILRDL 273 (274)
T ss_pred cChHHHHHH---HHhc-----cCCCCCCChHHHHHHHHHcccChhhCcCH-HHHHHhh
Confidence 433221100 0000 01112223579999999999999999999 6665543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=302.72 Aligned_cols=244 Identities=29% Similarity=0.465 Sum_probs=193.4
Q ss_pred eeeeeCceEEEEEEEC-CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCchhh
Q 003121 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLED 610 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggsL~~ 610 (846)
+||.|+||.||++... ++.||+|.+...... ....+.+|++++++++||||+++++++. ...++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 6999999999999876 688999988765433 3457899999999999999999999884 46889999999999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCcccc
Q 003121 611 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 690 (846)
Q Consensus 611 ~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 690 (846)
++... ...+++..+..++.+++.||.|||+ ++++||||||+|||++.++.+||+|||++...........
T Consensus 82 ~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~----- 151 (251)
T cd05041 82 FLRKK--KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS----- 151 (251)
T ss_pred HHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec-----
Confidence 98543 2468899999999999999999999 8999999999999999999999999999886542211111
Q ss_pred ccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHH
Q 003121 691 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 769 (846)
Q Consensus 691 ~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l 769 (846)
.....++..|+|||.+.++.++.++|||||||++|+|+| |..||............. . ......+...+..+
T Consensus 152 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~~ 224 (251)
T cd05041 152 -DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE---S---GYRMPAPQLCPEEI 224 (251)
T ss_pred -cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh---c---CCCCCCCccCCHHH
Confidence 011234677999999988899999999999999999999 889986554322111110 0 00111233456789
Q ss_pred HHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 770 ANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 770 ~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.+++.+||..+|.+||++ .++++.|+
T Consensus 225 ~~li~~~l~~~p~~Rp~~-~ell~~l~ 250 (251)
T cd05041 225 YRLMLQCWAYDPENRPSF-SEIYNELQ 250 (251)
T ss_pred HHHHHHHhccChhhCcCH-HHHHHHhh
Confidence 999999999999999999 77776664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.34 Aligned_cols=241 Identities=28% Similarity=0.380 Sum_probs=195.5
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
+|...+.||.|+||.||+|... +..||+|.+.... ......+.+|+.+++.++||||+++++++ ....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5778889999999999999875 5789999987543 22345688999999999999999999987 34688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++.. .++++..+..++.|++.||.|||. ++++||||+|+||+++.++.++|+|||+++........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 99999999842 278999999999999999999999 89999999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.....|++.|+|||++.+..++.++||||||+++|+|+||++||............. ....+ ..+.
T Consensus 155 --------~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~~~---~~~~ 220 (274)
T cd06609 155 --------RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP---KNNPP---SLEG 220 (274)
T ss_pred --------cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh---hcCCC---CCcc
Confidence 123458899999999998889999999999999999999999997654332211111 11111 1111
Q ss_pred h-hHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 764 V-QAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 764 ~-~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. .+..+.+++.+||..+|.+||++ +++
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt~-~~i 248 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPSA-KEL 248 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCH-HHH
Confidence 2 45679999999999999999999 444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=327.69 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=201.5
Q ss_pred CcccceeeeeCceEEEEEEECCeE--EEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCC
Q 003121 530 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 605 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~~~--VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~g 605 (846)
|+++..||.|+||.||++..+... .|.|++........++|.-||+||..++||+||+|++.| ...+++..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 455667999999999999988644 577888777766778899999999999999999999864 7789999999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|-.+.++... ..+|++.++..++.+++.||.|||+ ++|||||||..|||++-+|.++|+|||.+-...
T Consensus 114 GAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------- 181 (1187)
T KOG0579|consen 114 GAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------- 181 (1187)
T ss_pred chHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch-------
Confidence 9988877533 4679999999999999999999999 899999999999999999999999999875322
Q ss_pred CccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
.+.-.+..+.|||.|||||+.. ..+|+.++|||||||+|.||..+.||....+.+.-.+...+.. |...-
T Consensus 182 -~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe----PPTLl 256 (1187)
T KOG0579|consen 182 -STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE----PPTLL 256 (1187)
T ss_pred -hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC----CCccc
Confidence 2222345678999999999875 4579999999999999999999999998777766555443322 11112
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKD 790 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 790 (846)
.|...+..|.+++.+||.+||..||++++.
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaql 286 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQL 286 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHH
Confidence 244556789999999999999999998543
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=307.88 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=201.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--C----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc-cCceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~----~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~-~~~~~lV 599 (846)
.+|...+.||+|+||.||+|.+. + ..||+|.+...... ....+.+|+.+|+.++||||++++++| ....++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 46778889999999999999864 2 25899988765432 235688999999999999999999988 4568899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999998533 3458999999999999999999999 8999999999999999999999999999987653
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..... ......++..|+|||.+....++.++||||||+++|||+| |++||.............. ...
T Consensus 162 ~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------~~~ 229 (279)
T cd05057 162 DEKEY------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK------GER 229 (279)
T ss_pred cccce------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC------CCC
Confidence 22110 0112234678999999988889999999999999999999 9999976543221111110 011
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
...|...+..+.+++.+||..+|.+||++ .++...|+.+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~-~~l~~~l~~~~~ 270 (279)
T cd05057 230 LPQPPICTIDVYMVLVKCWMIDAESRPTF-KELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHHh
Confidence 12233345679999999999999999999 778888877644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=318.17 Aligned_cols=246 Identities=23% Similarity=0.293 Sum_probs=188.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|.+.+.||+|+||.||++... +..||+|++..... .....+.+|+.++..++||||+++++++ .+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 46799999865321 1234578899999999999999999988 45688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||++||+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999542 2468899999999999999999999 89999999999999999999999999999865433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
.... .....||+.|+|||++.+ +.++.++|||||||+||+|++|+.||..................+
T Consensus 156 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~- 227 (331)
T cd05624 156 GTVQ-------SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF- 227 (331)
T ss_pred Ccee-------eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc-
Confidence 2111 122459999999999875 468889999999999999999999997654432211110000000
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCC--CCCh
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKS--RPEL 787 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~--RPt~ 787 (846)
+. +......++.+.+|+.+|+...+.+ |+++
T Consensus 228 ~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~ 260 (331)
T cd05624 228 QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGI 260 (331)
T ss_pred cC-CCccccCCHHHHHHHHHHccCchhhcCCCCH
Confidence 01 1111224578999999999865543 3455
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.71 Aligned_cols=234 Identities=29% Similarity=0.468 Sum_probs=185.2
Q ss_pred eeeeeCceEEEEEEECCe------------EEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEE
Q 003121 535 KIGEGGYGSIYKGLLRHM------------QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYE 601 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~~------------~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmE 601 (846)
.||+|+||.||+|.+.+. .|++|.+...... ...|.+|+.+|+.++||||++++++|. ...++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 599999999999988643 3788887654433 568999999999999999999999874 56789999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC-------ceeeeccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-------VSKLSDFGIS 674 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~-------~vKL~DFGla 674 (846)
|+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 81 YVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred cCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999985432 268999999999999999999999 8999999999999999887 7999999998
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLK 751 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~ 751 (846)
...... ....++..|+|||++... .++.++||||||+++|+|++ |..||.............
T Consensus 156 ~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~--- 220 (259)
T cd05037 156 ITVLSR------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ--- 220 (259)
T ss_pred cccccc------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---
Confidence 865431 122367789999999876 78999999999999999999 577885543221111000
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 752 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
. ....+......+.+++.+||..+|.+||++ .++++.|
T Consensus 221 ---~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~il~~l 258 (259)
T cd05037 221 ---D--QHRLPMPDCAELANLINQCWTYDPTKRPSF-RAILRDL 258 (259)
T ss_pred ---c--CCCCCCCCchHHHHHHHHHhccChhhCCCH-HHHHHhc
Confidence 0 011111223789999999999999999999 5665544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=313.69 Aligned_cols=193 Identities=25% Similarity=0.417 Sum_probs=156.6
Q ss_pred ceeeeeCceEEEEEEECC----eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc----cCceEEEEEecCC
Q 003121 534 LKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC----PEVWTLVYEYLPN 605 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~----~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~----~~~~~lVmEy~~g 605 (846)
.+||+|+||.||+|...+ ..||+|.+..... ...+.+|+.+|++++||||++++++| ....++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999998642 5799998875432 34678999999999999999999987 2457899999865
Q ss_pred CchhhhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe----cCCCceeeecccccc
Q 003121 606 GSLEDRLSCK------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGISR 675 (846)
Q Consensus 606 gsL~~~L~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl----~~~~~vKL~DFGla~ 675 (846)
+|.+++... .....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 676665321 123358899999999999999999999 899999999999999 566899999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI 737 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~ 737 (846)
.......... ......||+.|+|||++.+. .++.++|||||||++|+|+||++||..
T Consensus 161 ~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLA-----DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCccccc-----ccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 7654321111 11234689999999998764 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.05 Aligned_cols=247 Identities=28% Similarity=0.406 Sum_probs=194.3
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
+|+..+.||+|+||.||++... +..||+|.+..... .....+.+|+.++++++||||+++++++ ....++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778889999999999999886 67899998865321 2235688999999999999999999987 45688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|..++........+++..+..++.+|+.||.|||.. .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA- 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence 9999998885433344789999999999999999999962 4899999999999999999999999999876532211
Q ss_pred CCCccccccCCCCCCcccCChhhhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~------~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
....|++.|+|||.+.+. .++.++|||||||++|+|+||+.||.......... .+.......
T Consensus 159 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~ 226 (286)
T cd06622 159 ---------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA---QLSAIVDGD 226 (286)
T ss_pred ---------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH---HHHHHhhcC
Confidence 223488899999998544 35889999999999999999999996543221110 111111222
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+...+..+.+|+.+||..+|.+||++ .++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~l 259 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTY-AQL 259 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCH-HHH
Confidence 223344466889999999999999999999 444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=297.23 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=206.4
Q ss_pred hhcCCCcccceeeeeCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc-------cCc
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-------PEV 595 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~-------~~~ 595 (846)
....+|.+.++||+|||+.||.+.. .+..+|+|++......+.+...+|++..++++||||+++++++ ...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3456899999999999999998764 4677999999888777788899999999999999999999987 234
Q ss_pred eEEEEEecCCCchhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
.||+++|...|+|.+.+.... .+..+++.+++.|+.+|++||.+||...| ++.||||||.|||++..+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999886553 34479999999999999999999999664 6999999999999999999999999998
Q ss_pred cccccccccCC-CccccccCCCCCCcccCChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHHh
Q 003121 675 RFLSQNEISSN-NTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKE----VQYALD 746 (846)
Q Consensus 675 ~~~~~~~~~~~-~~~~~~~~~~~Gt~~Y~APE~l~~~---~~~~ksDVwSlGviL~elltG~~pf~~~~~----~~~~~~ 746 (846)
....-...... ............|..|.|||.+.-. ..+.++|||||||+||+|+.|..||+..-. +..++.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 76542211110 1111112334579999999998643 578899999999999999999999952211 111111
Q ss_pred hhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 747 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 747 ~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
.+.+. -|..+ ..++.+.+|+..|++.+|.+||++ .+++..++.+
T Consensus 257 n~q~s---~P~~~----~yse~l~~lik~mlqvdP~qRP~i-~~ll~~~d~L 300 (302)
T KOG2345|consen 257 NAQIS---IPNSS----RYSEALHQLIKSMLQVDPNQRPTI-PELLSKLDDL 300 (302)
T ss_pred ccccc---cCCCC----CccHHHHHHHHHHhcCCcccCCCH-HHHHHHHHhh
Confidence 21111 11111 156899999999999999999999 6776666654
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=304.06 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=194.2
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHHhcCCCceeeEecccc----Cce
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP----EVW 596 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-----~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~ 596 (846)
.+|...+.||+|+||.||+|... +..|++|.+...... ....+.+|+.+++.++||||+++++++. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999874 578999988754322 1245788999999999999999999873 347
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
+++|||+++++|.+++.. ...+++.....++.|++.||.|||. .+|+||||+|+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999853 2458899999999999999999998 8999999999999999999999999999886
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCC
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
+......... .....|+..|+|||++.+..++.++|||||||++|+|++|++||............ ...+
T Consensus 156 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~-----~~~~ 225 (266)
T cd06651 156 LQTICMSGTG-----IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-----ATQP 225 (266)
T ss_pred cccccccCCc-----cccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH-----hcCC
Confidence 5432111110 12234889999999998888999999999999999999999999755433322111 1112
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..|...+..+..++ +||..+|.+||++ +++
T Consensus 226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~-~ei 258 (266)
T cd06651 226 TNPQLPSHISEHARDFL-GCIFVEARHRPSA-EEL 258 (266)
T ss_pred CCCCCchhcCHHHHHHH-HHhcCChhhCcCH-HHH
Confidence 23344555567788888 6888999999999 444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.75 Aligned_cols=242 Identities=26% Similarity=0.375 Sum_probs=202.2
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
-|++..+||+|+||.||++.++ |..||||.+... .+..++.+|+.||+++++|++|++||.+ ...+++|||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4788889999999999999887 678999988754 3467899999999999999999999976 456899999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
.|+..|+++. .+.+|+++++..++...+.||.|||. ..-||||||..||||+.+|++||+|||.+..+.....
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-- 184 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-- 184 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence 9999999953 45789999999999999999999999 6689999999999999999999999999987755432
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.++...|||.|||||++..-.|+.++||||||++..||..|+||+..-..+...+.. ..-.|-.-..|..
T Consensus 185 ------KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----PT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 185 ------KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----PTKPPPTFKKPEE 254 (502)
T ss_pred ------hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----cCCCCCCCCChHh
Confidence 234567999999999999999999999999999999999999999765554321110 1111111223555
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
.+..|.++++.||-++|++|-++..
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~ 279 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALR 279 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHH
Confidence 6789999999999999999998744
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.93 Aligned_cols=245 Identities=25% Similarity=0.329 Sum_probs=201.1
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
.+.|..-++||+||||+||-+..+ |+.+|.|.+.+... .+.....+|..||.+++.|.||.|-.+| .+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 345788889999999999988765 67789988866533 2334578899999999999999998887 5789999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|..|+||+|.-+|...++ +.+++..++.++.+|+.||.+||. .+||+|||||+|||||+.|+++|+|+|||.-+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999976554 789999999999999999999999 8999999999999999999999999999998765
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.... ...+||.+|||||++.++.|+...|||||||+||||+.|+.||.....-. ....+...+.....
T Consensus 340 g~~~---------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---k~eEvdrr~~~~~~ 407 (591)
T KOG0986|consen 340 GKPI---------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---KREEVDRRTLEDPE 407 (591)
T ss_pred CCcc---------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---hHHHHHHHHhcchh
Confidence 5421 33479999999999999999999999999999999999999996543311 11112222222233
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.++..-++++..|....|.++|.+|-.-
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccC
Confidence 4555556889999999999999999754
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=312.12 Aligned_cols=243 Identities=25% Similarity=0.363 Sum_probs=193.6
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCC
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 605 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~g 605 (846)
|+....||.|+||.||++... +..||+|.+..........+.+|+.++..++||||++++++| .+..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334457999999999999874 688999998765555556788999999999999999999987 4578999999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
++|..++. ...+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++.........
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-- 173 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-- 173 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--
Confidence 99998773 2458899999999999999999999 89999999999999999999999999998755432111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 765 (846)
.....|+..|+|||++.+..++.++|||||||++|+|++|++||............. ....+.. ..+...
T Consensus 174 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~-~~~~~~ 243 (297)
T cd06659 174 ------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR---DSPPPKL-KNAHKI 243 (297)
T ss_pred ------ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---ccCCCCc-cccCCC
Confidence 122358999999999988889999999999999999999999997554433221111 1111111 111233
Q ss_pred HHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 766 AEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 766 ~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
+..+.+++.+||+.+|.+||++ ++++
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~-~~ll 269 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATA-QELL 269 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCH-HHHh
Confidence 5679999999999999999999 4543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.85 Aligned_cols=248 Identities=23% Similarity=0.291 Sum_probs=190.2
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
..|..++.||-|+||+|.++.-. +..+|.|.|.+.+... ..++..|.+||...+.++||+||..|. +.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 35777888999999999988654 3568999988765432 346788999999999999999999995 5799999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
+|++||++..+|.+. +-|.+..++.++.++.+|+.+.|. .|+|||||||+|||||.+|++||+|||||.-+.-.
T Consensus 709 dYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceec
Confidence 999999999999644 458899999999999999999999 89999999999999999999999999999644211
Q ss_pred ---cccCC-------------------------------CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHH
Q 003121 681 ---EISSN-------------------------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 726 (846)
Q Consensus 681 ---~~~~~-------------------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ 726 (846)
.+... ....+..-..+||+.|+|||++...+|+..|||||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 11000 00001112347999999999999999999999999999999
Q ss_pred HHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCC
Q 003121 727 RLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 727 elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
||+.|++||-.......-....++...++. .+-...+.+..+||.++|. .++.|.
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~---~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHI---PYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhcccc---ccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999999665544333333334444432 2223345667777776654 455554
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=312.01 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=190.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
++|...++||.|+||.||+|... +..||+|.+...... ....+.+|+.+++.++||||+++++++ ....++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999876 578999998754322 234678999999999999999999998 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+. ++|.+++... ...+++..+..++.||+.||.|||+ ++|+|+||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888877533 3468899999999999999999999 8999999999999999999999999999875432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh---------hcc
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------LKN 752 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~---------~~~ 752 (846)
. .....+++.|+|||++.+. .++.++|||||||++|+|+||++||.............. +..
T Consensus 160 ~--------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 160 T--------YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred c--------ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 1 1223578999999998754 578899999999999999999999976543221110000 000
Q ss_pred ccC------CCCCC--------CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 LLD------PLAGD--------WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ~ld------~~~~~--------~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+. ...+. +....+..+.+|+.+||+.+|.+||++ +++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~-~ei 283 (301)
T cd07873 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA-EEA 283 (301)
T ss_pred hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCH-HHH
Confidence 000 00000 112235678999999999999999999 444
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=309.56 Aligned_cols=235 Identities=26% Similarity=0.399 Sum_probs=184.1
Q ss_pred eeeeeCceEEEEEEECC---------eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 535 KIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~---------~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
.||.|+||.||+|.... ..|++|.+........+.+..|+.+++.++||||+++++++ .+..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 59999999999997642 34888887654433446788999999999999999999988 35788999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc--------eeeecccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--------SKLSDFGISR 675 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~--------vKL~DFGla~ 675 (846)
++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +|++|||++.
T Consensus 82 ~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999998543 2368899999999999999999999 89999999999999987765 5899999876
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhC-CCCCCCchHHHHHHhhhhhccc
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG-~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
..... ....+++.|+|||++.+. .++.++|||||||++|+|++| .+||............. .
T Consensus 157 ~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~---~- 220 (258)
T cd05078 157 TVLPK------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE---D- 220 (258)
T ss_pred ccCCc------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH---c-
Confidence 54321 123478899999999764 589999999999999999998 46665443322111110 0
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
....|......+.+|+.+||+.+|.+||++ +++++.|
T Consensus 221 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~~l 257 (258)
T cd05078 221 ----RHQLPAPKWTELANLINQCMDYEPDFRPSF-RAIIRDL 257 (258)
T ss_pred ----cccCCCCCcHHHHHHHHHHhccChhhCCCH-HHHHHhc
Confidence 112233334679999999999999999999 6666554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=319.79 Aligned_cols=244 Identities=20% Similarity=0.300 Sum_probs=188.1
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--------C
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------E 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~ 594 (846)
.++|...+.||.|+||.||+|... +..||||.+..... .....+.+|+.+|+.++||||+++++++. .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 357888899999999999999875 46899999875422 22345778999999999999999998773 2
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
..+++|+++ +++|.+++. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence 368999988 789988773 2458999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh----
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---- 749 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~---- 749 (846)
+...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|++||..............
T Consensus 166 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07878 166 RQADDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT 234 (343)
T ss_pred eecCCCc-----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 8653321 23358999999999977 4689999999999999999999999975443221110000
Q ss_pred -------------hccccCCCCCCCC--------hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 750 -------------LKNLLDPLAGDWP--------FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 750 -------------~~~~ld~~~~~~p--------~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+.. .+..+ ......+.+|+.+||..+|.+||++ .++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~-~el 295 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA-SEA 295 (343)
T ss_pred CCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH-HHH
Confidence 0000000 00011 0123457899999999999999999 444
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=309.23 Aligned_cols=241 Identities=28% Similarity=0.412 Sum_probs=193.2
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
|...+.||+|+||.||+|... +..||+|.+..... .....+.+|+.+++.++||||++++++| ....++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 556677999999999999875 57899999875432 2235688999999999999999999988 346899999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+++|.+++. ..++++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 86 ~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 86 GGSALDLLK----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 999999884 2468899999999999999999999 8999999999999999999999999999876543211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
......|+..|+|||++.+..++.++|||||||++|+|+||++||........... .........+..
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~ 224 (277)
T cd06642 157 ------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL------IPKNSPPTLEGQ 224 (277)
T ss_pred ------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh------hhcCCCCCCCcc
Confidence 11223588999999999988899999999999999999999999964433221111 011111222334
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
.+..+.+++.+||..+|.+||++ .+++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~-~~il 251 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTA-KELL 251 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCH-HHHH
Confidence 56789999999999999999999 4443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.71 Aligned_cols=254 Identities=27% Similarity=0.373 Sum_probs=197.9
Q ss_pred ChhhhhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccc--
Q 003121 519 SFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP-- 593 (846)
Q Consensus 519 ~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~-- 593 (846)
++.++....+.|+....||.|+||.||+|... +..||+|++.... .....+..|+.++.++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34455566778999999999999999999885 5789999986543 2345688999999998 7999999999872
Q ss_pred ------CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCcee
Q 003121 594 ------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 667 (846)
Q Consensus 594 ------~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vK 667 (846)
...++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+ ++|+|+||+|+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 35789999999999999885432 3458888899999999999999999 8999999999999999999999
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 003121 668 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 742 (846)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~ 742 (846)
|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|+|+||.+||.......
T Consensus 162 l~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 162 LVDFGVSAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred EeeCcchhhhhcccc--------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 999999876532211 012345899999999986 3468889999999999999999999996544332
Q ss_pred HHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 743 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 743 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....... ...+ ...+...+..+.+|+.+||..+|.+||++ .++
T Consensus 234 ~~~~~~~---~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-~el 276 (282)
T cd06636 234 ALFLIPR---NPPP--KLKSKKWSKKFIDFIEGCLVKNYLSRPST-EQL 276 (282)
T ss_pred hhhhHhh---CCCC--CCcccccCHHHHHHHHHHhCCChhhCcCH-HHH
Confidence 2211111 1111 00112245789999999999999999999 444
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=305.58 Aligned_cols=248 Identities=28% Similarity=0.370 Sum_probs=192.2
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|+....||+|+||.||+|... +..||+|++..... .....+.+|+.++++++||||+++++++. ...++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 6888889999999999999886 57899998865432 22346789999999999999999999883 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|..++. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 82 CDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred cCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99998888763 23458999999999999999999999 8999999999999999999999999999987644321
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh-hccc-------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-LKNL------- 753 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~-~~~~------- 753 (846)
. .....++..|+|||++.+ ..++.++||||||+++|+|+||++||.............. +...
T Consensus 156 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 156 D--------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred c--------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 1 012347889999999876 4588999999999999999999999976544322211100 0000
Q ss_pred ----------cCCCCC-C-----CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 ----------LDPLAG-D-----WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 ----------ld~~~~-~-----~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+... . +....+..+.+|+.+||+.+|.+||++ .++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~ei 280 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC-EEL 280 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCH-HHH
Confidence 000000 0 001235678999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=304.60 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=197.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~ 597 (846)
.+|.....||.|+||.||+|... ...|++|.+...... ....+.+|+.+|++++||||++++++|. +..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888889999999999999864 256999988754432 2357899999999999999999999985 4688
Q ss_pred EEEEecCCCchhhhhccCCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNS------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~------~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DF 671 (846)
+||||+++|+|.+++...... ..+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998644321 268999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhh
Q 003121 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL 750 (846)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~ 750 (846)
|++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||........ +.....
T Consensus 162 ~~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~-~~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEYYK-------LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV-LNRLQA 233 (275)
T ss_pred ccccccCcccccc-------cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH-HHHHHc
Confidence 9987543221111 122346788999999988889999999999999999999 8889864433221 111111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 751 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 751 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.....+ .+...+..+.+++.+||..+|.+||++ .+++..|.
T Consensus 234 ~~~~~~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~-~~~l~~l~ 274 (275)
T cd05046 234 GKLELP----VPEGCPSRLYKLMTRCWAVNPKDRPSF-SELVSALG 274 (275)
T ss_pred CCcCCC----CCCCCCHHHHHHHHHHcCCCcccCCCH-HHHHHHhc
Confidence 111111 122345789999999999999999999 66666553
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=303.46 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=194.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHHhcCCCceeeEeccccC----ce
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACPE----VW 596 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-----~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----~~ 596 (846)
.+|...+.||+|+||.||+|... +..||||.+...... ....+.+|+.++++++||||+++++++.+ .+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999875 578999988643211 12467889999999999999999998743 47
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+++++|.+++... ..+++..+..++.+++.||.|||+ .+++|+||||+|||++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 7999999999999988532 357888999999999999999999 8999999999999999999999999999886
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCC
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
.......... .....|+..|+|||++.+..++.++|||||||++|+|++|++||.......... .. ...+
T Consensus 156 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~----~~~~ 225 (265)
T cd06652 156 LQTICLSGTG-----MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-KI----ATQP 225 (265)
T ss_pred cccccccccc-----cccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-HH----hcCC
Confidence 5432111110 122358999999999988889999999999999999999999997554332211 11 1122
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..|...+..+.+++.+||. +|.+||++ +++
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~-~~i 258 (265)
T cd06652 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSA-DEL 258 (265)
T ss_pred CCCCCchhhCHHHHHHHHHHhc-ChhhCCCH-HHH
Confidence 2334455667789999999995 99999998 444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=312.40 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=191.4
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
+|...+.||+|+||.||++... +..+|+|.+...... ....+.+|++++.+++||||++++++| .+..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 6888899999999999999876 467899988754221 234588999999999999999999988 45789999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++... ..+++..+..++.+++.||.|||+. .+++||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (308)
T cd06615 82 DGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 155 (308)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccccc-
Confidence 999999998533 5688999999999999999999972 4799999999999999999999999999875532211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh-hccc---------
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-LKNL--------- 753 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~-~~~~--------- 753 (846)
....|+..|+|||++.+..++.++|||||||++|+|+||+.||.............. ....
T Consensus 156 ---------~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 156 ---------NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ---------ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 223589999999999888899999999999999999999999864432111100000 0000
Q ss_pred --------------------cCCCCCCCC-hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 --------------------LDPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 --------------------ld~~~~~~p-~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+..| ...+..+.+|+.+||..+|.+||++ .++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~l 284 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL-KEL 284 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 000000001 1135679999999999999999999 444
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=301.50 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=196.4
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|+..+.||.|+||.||.+... +..+++|.+..... .....+.+|+.+|++++||||+++++++. +..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788899999999988877654 57899998875432 23456889999999999999999999984 467899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++.... ...+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986432 3568999999999999999999999 8999999999999999999999999999986644321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||............. ..... ..+
T Consensus 157 --------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~--~~~~~----~~~ 222 (256)
T cd08221 157 --------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV--QGNYT----PVV 222 (256)
T ss_pred --------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCC----CCc
Confidence 1123458999999999988889999999999999999999999997654432211111 11111 122
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
...+..+.+++.+||+.+|.+||++ ++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~-~~ll 251 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTA-DEVL 251 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCH-HHHh
Confidence 3345789999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=305.65 Aligned_cols=241 Identities=27% Similarity=0.399 Sum_probs=195.4
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
.|...++||.|+||.||+|... +..||||.+..... .....+.+|+.+++.++||||++++++|. ...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4677788999999999999875 57899999875432 22456889999999999999999999884 5689999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++|+|.+++.. .++++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 99999998842 358889999999999999999999 89999999999999999999999999999765432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.....++..|+|||++.+..++.++|+|||||++|+|+||.+||............ ........+.
T Consensus 158 --------~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~~~ 223 (277)
T cd06640 158 --------RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------PKNNPPTLTG 223 (277)
T ss_pred --------cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh------hcCCCCCCch
Confidence 12235788999999998888999999999999999999999999755432211111 0011223344
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..+.+++.+||+.+|.+||++ .++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~-~~i 250 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTA-KEL 250 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCH-HHH
Confidence 567889999999999999999999 554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=324.57 Aligned_cols=231 Identities=25% Similarity=0.313 Sum_probs=180.5
Q ss_pred eeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhc---CCCceeeEecccc--CceEEEEEecCC
Q 003121 536 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKI---RHPNLVTLVGACP--EVWTLVYEYLPN 605 (846)
Q Consensus 536 LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~--~~~~lVmEy~~g 605 (846)
||+|+||+||+|... +..||||++...... ....+..|..++..+ +||||+.+++++. +..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999876 578999998653221 123455677777765 6999999999874 568999999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-- 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence 999988853 3468999999999999999999999 89999999999999999999999999998754322111
Q ss_pred CccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC-h
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP-F 763 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p-~ 763 (846)
.....||+.|+|||++.+. .++.++|||||||++|+|+||+.||........ ......... .++ .
T Consensus 153 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~------~~~~~ 219 (330)
T cd05586 153 ------TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-YRNIAFGKV------RFPKN 219 (330)
T ss_pred ------ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-HHHHHcCCC------CCCCc
Confidence 1234599999999999765 589999999999999999999999976543321 111111110 111 1
Q ss_pred hhHHHHHHHHHHHhccCcCCCCCh
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
..+..+.+|+.+||..+|.+||+.
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCC
Confidence 245789999999999999999964
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=301.73 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=197.6
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc----CceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lVm 600 (846)
+|+..+.||.|+||.||++... +..||+|.+...... ..+.+..|+.+++.++||||+++++++. ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999875 578999998754332 2346888999999999999999998762 3478999
Q ss_pred EecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecccCCCceEecCCCceeeecccccccc
Q 003121 601 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCK--PHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
||+++++|.+++... ....++++..++.++.+|+.||.|||... ..+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998543 23467899999999999999999999321 278999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
...... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||......... .. .....
T Consensus 161 ~~~~~~--------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~----~~~~~ 226 (265)
T cd08217 161 GHDSSF--------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA--SK----IKEGK 226 (265)
T ss_pred cCCccc--------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH--HH----HhcCC
Confidence 543210 12235899999999999888999999999999999999999999766532211 11 11111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
....+...+..+.+|+.+||..+|.+||++ .+++
T Consensus 227 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~-~~il 260 (265)
T cd08217 227 FRRIPYRYSSELNEVIKSMLNVDPDKRPST-EELL 260 (265)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCH-HHHh
Confidence 223344556889999999999999999999 5543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=300.44 Aligned_cols=246 Identities=31% Similarity=0.502 Sum_probs=195.8
Q ss_pred cccceeeeeCceEEEEEEECC------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 531 DPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~~------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
.+.+.||.|+||.||++...+ ..||+|.+...... ....+..|+.++..++||||+++++++. ...+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999998875 67999999765443 4567899999999999999999999884 46889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++++|.+++..... ..+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999853321 128999999999999999999999 899999999999999999999999999998765442
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
.... ....+++.|+|||.+.+..++.++||||||+++|+|++ |++||............... . ...
T Consensus 158 ~~~~-------~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~-----~~~ 224 (258)
T smart00219 158 YYKK-------KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-Y-----RLP 224 (258)
T ss_pred cccc-------ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-C-----CCC
Confidence 2111 12237889999999988889999999999999999998 88999754332221111110 0 111
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 794 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~ 794 (846)
.+...+..+.+++.+||..+|.+||++ .++++.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~-~~ll~~ 257 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTF-SELVEI 257 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCH-HHHHhh
Confidence 223356789999999999999999999 555543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=311.63 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=193.3
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
.|.....||.|+||.||++... +..||||.+........+.+.+|+.+++.++||||+++++.+ .+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999874 578999998765444456788999999999999999999987 457899999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+++|.+++. ...+++..+..++.+|+.||.|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 103 ~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~- 174 (292)
T cd06658 103 GGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK- 174 (292)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-
Confidence 999999873 2358899999999999999999999 89999999999999999999999999998755332111
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........... +...+.+... ....
T Consensus 175 -------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~-~~~~ 243 (292)
T cd06658 175 -------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRDNLPPRVK-DSHK 243 (292)
T ss_pred -------CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCccc-cccc
Confidence 1123489999999999888899999999999999999999999976544322111 1111111111 1123
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+..+.+++.+||..+|.+||++ +++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~-~~i 269 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATA-QEL 269 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 45679999999999999999999 444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.75 Aligned_cols=237 Identities=28% Similarity=0.385 Sum_probs=194.1
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
.|..++.||.|+||-||.+.+. ...||||.+.-...+. ..++.+|+..|.+|+|||+|.+-|+| ....+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4777888999999999999875 4679999987655444 35688999999999999999999998 445789999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
||- |+-.|+|.- ...|+.+-.+..|+.+.+.||+|||+ ++.||||||..||||++.|.|||+|||.|....+.
T Consensus 107 YCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 995 677777742 34679999999999999999999999 89999999999999999999999999998766543
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..++|||.|||||++. .|.|+-++|||||||+..||...+||+-..+.+........- -.|..
T Consensus 180 -----------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN---esPtL 245 (948)
T KOG0577|consen 180 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---ESPTL 245 (948)
T ss_pred -----------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc---CCCCC
Confidence 3457999999999985 478999999999999999999999998666655433222110 11111
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
. ....++.|..|+..||++-|.+|||..
T Consensus 246 q--s~eWS~~F~~Fvd~CLqKipqeRptse 273 (948)
T KOG0577|consen 246 Q--SNEWSDYFRNFVDSCLQKIPQERPTSE 273 (948)
T ss_pred C--CchhHHHHHHHHHHHHhhCcccCCcHH
Confidence 1 233468899999999999999999983
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=303.77 Aligned_cols=250 Identities=30% Similarity=0.394 Sum_probs=196.3
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccc--------
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP-------- 593 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~-------- 593 (846)
..+++|...+.||.|+||.||+|... +..+++|++..... ..+.+.+|+.+++++ +||||++++++|.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45678999999999999999999985 46799999876543 346789999999999 7999999999883
Q ss_pred CceEEEEEecCCCchhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccc
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 672 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFG 672 (846)
...++||||+++++|.+++.... ....+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence 23689999999999999885422 24578999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003121 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 747 (846)
Q Consensus 673 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~ 747 (846)
++........ ......|++.|+|||++.. ..++.++|||||||+||+|+||++||............
T Consensus 159 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 230 (275)
T cd06608 159 VSAQLDSTLG--------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230 (275)
T ss_pred cceecccchh--------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence 9876543211 1123458999999999854 34678999999999999999999999654332221111
Q ss_pred hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. ....+ ....+...+..+.+|+.+||..+|.+||++ .++
T Consensus 231 ~---~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~-~~l 269 (275)
T cd06608 231 P---RNPPP-TLKSPENWSKKFNDFISECLIKNYEQRPFM-EEL 269 (275)
T ss_pred h---ccCCC-CCCchhhcCHHHHHHHHHHhhcChhhCcCH-HHH
Confidence 1 10011 111122245689999999999999999999 444
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.89 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=195.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
++|...++||+|+||.||++... +..||+|++..... .....+.+|+++++.++||||+++++++ ...+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46778889999999999999886 67899998875432 2346788999999999999999999998 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++.. ..++++..+..++.+++.||.|||+. ++++||||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 999999998843 34689999999999999999999963 4799999999999999999999999999865432110
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH------HHHhhhhhccccCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ------YALDTGKLKNLLDP 756 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~------~~~~~~~~~~~ld~ 756 (846)
....|+..|+|||++.+..++.++|||||||++|+|+||+.||....... ..+. ..+...+..
T Consensus 160 ----------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 228 (284)
T cd06620 160 ----------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-DLLQQIVQE 228 (284)
T ss_pred ----------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH-HHHHHHhhc
Confidence 12358999999999988899999999999999999999999997543210 0000 001111111
Q ss_pred CCCCCCh-hhHHHHHHHHHHHhccCcCCCCChHHHHHHH
Q 003121 757 LAGDWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVWRV 794 (846)
Q Consensus 757 ~~~~~p~-~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~ 794 (846)
.....+. ..+..+.+|+.+||..+|.+||++ +++...
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~-~e~~~~ 266 (284)
T cd06620 229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTP-QQLCAM 266 (284)
T ss_pred cCCCCCchhcCHHHHHHHHHHhcCCcccCcCH-HHHhcC
Confidence 1111111 245679999999999999999999 666543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=304.08 Aligned_cols=253 Identities=24% Similarity=0.395 Sum_probs=195.6
Q ss_pred CcccceeeeeCceEEEEEEEC-----CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccccC--------
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-------- 594 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-------- 594 (846)
|...+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999864 467999998764322 24568899999999999999999997621
Q ss_pred ceEEEEEecCCCchhhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DF 671 (846)
..+++++|+++|+|.+++... .....+++.....++.+|+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 246899999999998877432 122357899999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhh
Q 003121 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL 750 (846)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~ 750 (846)
|+++.......... .....+++.|++||.+....++.++|||||||++|+|++ |++||...............
T Consensus 158 g~~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQ------GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231 (273)
T ss_pred cccccccCCcceec------CCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 99986543221111 112235678999999988889999999999999999999 89999755442211111000
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 751 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 751 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
. ....+...+..+.+++.+||..+|.+||++ .+++..|+.+
T Consensus 232 ~------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~-~~~~~~l~~~ 272 (273)
T cd05074 232 N------RLKQPPDCLEDVYELMCQCWSPEPKCRPSF-QHLRDQLELI 272 (273)
T ss_pred C------cCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHhh
Confidence 0 111223345789999999999999999999 8888888754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.12 Aligned_cols=257 Identities=23% Similarity=0.277 Sum_probs=199.5
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
+|...+.||+|+||.||++... +..||+|.+...... ....+..|+++|+.++||||+++++.+. ...++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6788889999999999999886 478999999865433 2356889999999999999999999873 46889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+.+++|.+++... ....+++..+..++.|++.||.|||. .+++|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999988533 23568999999999999999999999 899999999999999999999999999987653321
Q ss_pred ccCCCc---------------------cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH
Q 003121 682 ISSNNT---------------------TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 740 (846)
Q Consensus 682 ~~~~~~---------------------~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~ 740 (846)
...... .........||..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 110000 00011234689999999999988899999999999999999999999976554
Q ss_pred HHHHHhhhhhccccCCCCCCCCh--hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 741 VQYALDTGKLKNLLDPLAGDWPF--VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 741 ~~~~~~~~~~~~~ld~~~~~~p~--~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
........ .. ...++. ..+..+.+++.+||..+|.+||+....+.++|.
T Consensus 238 ~~~~~~~~--~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFSNIL--KK-----EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHHh--cC-----CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 32211111 00 011111 146889999999999999999996444444443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.36 Aligned_cols=247 Identities=23% Similarity=0.385 Sum_probs=183.8
Q ss_pred eeeeeCceEEEEEEECC----eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCc
Q 003121 535 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS 607 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~----~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggs 607 (846)
.||+|+||.||+|...+ ..+++|.+..... .....|.+|+.+++.++||||+++++.|. ...++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 59999999999997542 2466777665432 23467999999999999999999999984 46789999999999
Q ss_pred hhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 608 LEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 608 L~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
|.+++.... ....+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-- 156 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE-- 156 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh--
Confidence 999986432 23456777888999999999999999 899999999999999999999999999976432211100
Q ss_pred ccccccCCCCCCcccCChhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHH--hhhhhccccCC
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL--DTGKLKNLLDP 756 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~-------~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~--~~~~~~~~ld~ 756 (846)
......|+..|+|||++.. ..++.++|||||||++|||++ |.+||.......... ..+......
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-- 230 (268)
T cd05086 157 ----TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF-- 230 (268)
T ss_pred ----cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccC--
Confidence 0123457899999998743 245789999999999999997 577886544322111 111111111
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
.+.++...++.+.+++..|| .+|.+||++ +++.+.|
T Consensus 231 -~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~-~~i~~~l 266 (268)
T cd05086 231 -KPQLELPYSERWYEVLQFCW-LSPEKRATA-EEVHRLL 266 (268)
T ss_pred -CCccCCCCcHHHHHHHHHHh-hCcccCCCH-HHHHHHh
Confidence 22233334578899999999 689999999 6676655
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=312.68 Aligned_cols=253 Identities=18% Similarity=0.244 Sum_probs=187.0
Q ss_pred cceeeee--CceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 533 SLKIGEG--GYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 533 ~~~LG~G--~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
..+||+| +||+||++... +..||+|.+....... ...+.+|+.+++.++||||++++++| .+..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4579999 78999999876 5789999987653322 24577899999999999999999988 456889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++++|||.+..........
T Consensus 83 ~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999985432 2458999999999999999999999 899999999999999999999999998765432211100
Q ss_pred CCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh--hhhccccCC----
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--GKLKNLLDP---- 756 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~--~~~~~~ld~---- 756 (846)
...........++..|+|||++.+ ..++.++|||||||++|+|++|++||............ +.....++.
T Consensus 159 -~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 159 -RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred -cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 000001122347788999999976 46899999999999999999999999654332211111 100000000
Q ss_pred ---------------------------------CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 757 ---------------------------------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 757 ---------------------------------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+....+..+.+|+.+||+.+|.+||++ +++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-~el 304 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA-STL 304 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH-HHH
Confidence 0001112234679999999999999999999 555
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=299.88 Aligned_cols=241 Identities=27% Similarity=0.431 Sum_probs=195.6
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-----~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
|...+.||+|+||.||+|... +..|++|.+...... ....+.+|+.+++.++||||+++++++. ...++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566678999999999999885 678999988754321 2356889999999999999999999884 4688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++++|.+++.. ..++++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999853 3458899999999999999999999 89999999999999999999999999998865432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.. .....|++.|++||.+.... ++.++|+||||+++|+|++|++||................. ..
T Consensus 156 ~~---------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~ 221 (258)
T cd06632 156 SF---------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-----LP 221 (258)
T ss_pred cc---------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----CC
Confidence 20 12345899999999997766 89999999999999999999999976654443333222111 12
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+...+..+.+++.+||..+|.+||++ .++
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~~ 252 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTA-AEL 252 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCH-HHH
Confidence 2333456789999999999999999999 444
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.09 Aligned_cols=238 Identities=25% Similarity=0.305 Sum_probs=199.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCch---hHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~---~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
-++|+.+++||+|.||+|..++-+ ++.+|||++++......+ +-..|-.+|+..+||.+..|-.+| .+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 357899999999999999988765 678999999987554443 445789999999999999998887 4679999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||.+||.|..+|.+ ...+++...+.+..+|..||.|||+ ++||+||||.+|+|||.+|++||+|||+|+---.
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999999953 4568999999999999999999999 8999999999999999999999999999984322
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.. .. ....+|||.|+|||++....|+.++|||.+||++|||++|+.||...+.. ++-+++..-.-
T Consensus 321 ~g--~t------~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-------kLFeLIl~ed~ 385 (516)
T KOG0690|consen 321 YG--DT------TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-------KLFELILMEDL 385 (516)
T ss_pred cc--ce------eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-------HHHHHHHhhhc
Confidence 11 11 24467999999999999999999999999999999999999999654432 22333333334
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCC
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
.+|...+++...|+.-.|.++|++|.
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 56777888999999999999999995
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.08 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=192.9
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC----------chhHHHHHHHHHhcCCCceeeEeccc--cC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG----------PSEFQQEIDILSKIRHPNLVTLVGAC--PE 594 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~----------~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~ 594 (846)
+|...+.||.|+||.||+|... +..||+|.+....... .+.+.+|+.+++.++||||+++++++ .+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4666788999999999999764 6789999886432110 13578899999999999999999988 45
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
..++||||+++++|.+++... .++++..+..++.+|+.||.|||+ ++++||||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 688999999999999998533 568999999999999999999999 89999999999999999999999999998
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 752 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~ 752 (846)
+......... ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||................
T Consensus 156 ~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~- 228 (272)
T cd06629 156 KKSDDIYDND------QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR- 228 (272)
T ss_pred cccccccccc------ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc-
Confidence 7653221110 112345899999999987654 8899999999999999999999997554433222211110
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.............+..+.+++.+||..+|.+||++ .++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~i 266 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTA-REL 266 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCH-HHH
Confidence 01111111222346789999999999999999998 444
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.90 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=199.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
++|...+.||.|+||+||+|... +..+++|++..... .....+.+|+.+|+.++||||+++++.+ .+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36888999999999999999874 56899999875432 2456789999999999999999999987 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|.+++........+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999998654333568999999999999999999999 8999999999999999999999999999987654322
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
... .......|+..|+|||++... .++.++|+|||||++|+|++|+.||............. .. ..+.....
T Consensus 158 ~~~----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~--~~-~~~~~~~~ 230 (267)
T cd06610 158 RTR----KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL--QN-DPPSLETG 230 (267)
T ss_pred ccc----cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh--cC-CCCCcCCc
Confidence 110 011233589999999999877 78999999999999999999999997654432211111 11 01111111
Q ss_pred --ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 --PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 --p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+..+.+++.+||..+|.+||++ .++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~l 261 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTA-EEL 261 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCH-HHH
Confidence 12345789999999999999999998 444
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.15 Aligned_cols=258 Identities=22% Similarity=0.272 Sum_probs=196.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|...+.||+|+||.||++... +..|++|.+...... ....+.+|+.+++.++||||+++++++. +..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999886 467999998765322 2346789999999999999999999884 4578999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||++|++|.+++.. ...+++..+..++.+++.||.|||+ ++++||||||.|||++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 3468999999999999999999999 89999999999999999999999999998742111
Q ss_pred cccC-------CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 681 EISS-------NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 681 ~~~~-------~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
.... ............|+..|+|||.+.+..++.++|+|||||++|+|++|..||........ .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~-~~~~~~~~~ 233 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDI 233 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccc
Confidence 0000 00000111234578899999999888899999999999999999999999965443221 111111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
..+. .+...+..+.+++.+||+.+|.+||+. ..+.++|+
T Consensus 234 ~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~-~~~~~ll~ 272 (305)
T cd05609 234 EWPE---GDEALPADAQDLISRLLRQNPLERLGT-GGAFEVKQ 272 (305)
T ss_pred CCCC---ccccCCHHHHHHHHHHhccChhhccCc-cCHHHHHh
Confidence 1111 111345779999999999999999997 33444444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=306.80 Aligned_cols=248 Identities=26% Similarity=0.359 Sum_probs=192.0
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|...++||+|+||.||+|... +..||+|.+...... ..+.+.+|+++|+.++||||++++++|. ...++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 6788899999999999999985 578999988654322 2456889999999999999999999984 468999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|..+... ...+++..+..++.+|+.||.|||+ .+++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 82 VDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999887632 2348999999999999999999999 8999999999999999999999999999886543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh-----------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL----------- 750 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~----------- 750 (846)
. .....|+..|+|||++.+ ..++.++||||||+++|+|++|++||...............
T Consensus 156 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 156 V--------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred c--------cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 1 122357899999999875 35788999999999999999999999655432211110000
Q ss_pred -------ccccCCCCC------CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 -------KNLLDPLAG------DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 -------~~~ld~~~~------~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+... ......+..+.+|+.+||..+|.+||++ .++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~-~~i 280 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS-SQL 280 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH-HHH
Confidence 000000000 0011235779999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=326.93 Aligned_cols=191 Identities=23% Similarity=0.339 Sum_probs=161.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
...|.+...||+|+||.||++... +..||||... ...+.+|+.+|++|+|||||++++++ ....++||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346888999999999999999987 4679999632 23567899999999999999999987 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+. ++|.+++... ...+++..++.|+.||+.||.|||. +||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 6888877432 3469999999999999999999999 8999999999999999999999999999986543211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 735 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf 735 (846)
.. ......||+.|+|||++.+..++.++|||||||+||||++|..++
T Consensus 316 ~~------~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TP------FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cc------cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 10 112346999999999999999999999999999999999987654
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=302.22 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=195.3
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
+|.....||+|+||.||+|... +..||+|.+...... ....+.+|+.+|++++||||+++++++. +..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777889999999999999864 578999998754321 1346889999999999999999999984 46889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC-ceeeecccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFL 677 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~-~vKL~DFGla~~~ 677 (846)
||||+++++|.+++.. ..++++..+..++.|++.||.|||+ ++++|+||+|.||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999853 3468899999999999999999999 8999999999999998775 6999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
......... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||................ ....
T Consensus 155 ~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~ 228 (268)
T cd06630 155 AAKGTGAGE----FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--SATT 228 (268)
T ss_pred ccccccCCc----cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh--ccCC
Confidence 543211111 1123458999999999988889999999999999999999999996433211110000000 0111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+...+..+.+++.+||..+|.+||++ .++
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~-~~l 261 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPS-REL 261 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCH-HHH
Confidence 233455566889999999999999999999 444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.97 Aligned_cols=244 Identities=23% Similarity=0.364 Sum_probs=195.6
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|...++||+|+||.||++... +..||+|.+..... .....+.+|+.++++++||||+++++++. ...++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778889999999999998874 57899999875432 22357899999999999999999999884 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|.+++.... ...+++..++.++.+++.||.|||+ ++++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999885332 2457899999999999999999999 8999999999999999999999999999986543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. .....|++.|+|||++.++.++.++|+|||||++|+|+||+.||............ ... .....+
T Consensus 157 ~--------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--~~~----~~~~~~ 222 (256)
T cd08218 157 L--------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI--IRG----SYPPVS 222 (256)
T ss_pred h--------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH--hcC----CCCCCc
Confidence 1 01234888999999998888999999999999999999999999755433221111 111 111223
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+..+.+++.+||+.+|.+||++ .++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~-~~v 250 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSV-NSI 250 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCH-HHH
Confidence 3446789999999999999999999 444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=303.30 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=200.1
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
..+..|.....||.|+||.||+|.+. +..|++|++..... ....+.+|+++++.++||||++++++| ....++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34557888889999999999999987 67899999976543 456788999999999999999999987 46788999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++++|.+++.... ..+++..+..++.+++.||.|||. .|++|+||+|.||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999996432 379999999999999999999999 89999999999999999999999999998755432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... .....++..|++||++.+..++.++|+||||+++|+|++|+.||.............. ..... ..
T Consensus 170 ~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~--~~ 237 (286)
T cd06614 170 KSK--------RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT--KGIPP--LK 237 (286)
T ss_pred hhh--------hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCC--Cc
Confidence 110 1223478899999999888899999999999999999999999976654432221111 11111 11
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+...+..+.+++.+||+.+|.+||++ .++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~i 267 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSA-EEL 267 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCH-HHH
Confidence 122245789999999999999999999 444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.12 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=195.3
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
+|+..++||+|+||.||+|... +..||+|.++.... .....+.+|+++++.++||||++++++| .+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6888899999999999999886 57899998875422 2346789999999999999999999998 3568999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
++++.|..++. ....+++..+..++.+|+.||.|||. ++++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99887776653 23458999999999999999999999 8999999999999999999999999999887654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc----------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK---------- 751 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~---------- 751 (846)
.. .....|+..|+|||++.+. .++.++||||||+++|+|++|++||................
T Consensus 156 ~~-------~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 156 SP-------LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred cc-------ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh
Confidence 00 1234578999999999887 78999999999999999999999997654432221111000
Q ss_pred ----------cccCCC-----CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 752 ----------NLLDPL-----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 752 ----------~~ld~~-----~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...... ...++...+..+.+|+.+||..+|.+||++ +++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~i 282 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC-DEL 282 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH-HHH
Confidence 000000 001233346789999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.91 Aligned_cols=251 Identities=23% Similarity=0.410 Sum_probs=195.5
Q ss_pred CCcccceeeeeCceEEEEEEECC---eEEEEEEecCCCCC----------CchhHHHHHHHHHh-cCCCceeeEeccc--
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLHPHSLQ----------GPSEFQQEIDILSK-IRHPNLVTLVGAC-- 592 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~---~~VAIK~l~~~~~~----------~~~~f~~Ei~iL~~-l~HpnIv~l~g~~-- 592 (846)
+|...+.||+|+||.||+|...+ ..+|+|.+...... ....+..|+.++.+ ++||||++++++|
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36777889999999999999864 67999988643211 12346778888875 7999999999988
Q ss_pred cCceEEEEEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecc
Q 003121 593 PEVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671 (846)
Q Consensus 593 ~~~~~lVmEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DF 671 (846)
.+..++||||+++++|.+++... .....+++..++.++.+++.||.|||.. .+++|+||+|.|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 45688999999999999887432 2345689999999999999999999952 57999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc
Q 003121 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 751 (846)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~ 751 (846)
|++....... ......|+..|++||.+.++.++.++||||||+++|+|++|++||............. .
T Consensus 159 g~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~--~ 227 (269)
T cd08528 159 GLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV--E 227 (269)
T ss_pred cceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh--h
Confidence 9998654332 0123458999999999998889999999999999999999999997654433211111 1
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 752 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
....+... ...+..+.+++.+||+.+|.+||++ .++..++.
T Consensus 228 ~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rp~~-~e~~~~~~ 268 (269)
T cd08528 228 AVYEPLPE---GMYSEDVTDVITSCLTPDAEARPDI-IQVSAMIS 268 (269)
T ss_pred ccCCcCCc---ccCCHHHHHHHHHHCCCCCccCCCH-HHHHHHhc
Confidence 11111111 1235789999999999999999999 67766654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.15 Aligned_cols=245 Identities=26% Similarity=0.403 Sum_probs=196.7
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
.++|...+.||.|+||.||+|... +..||+|.+........+.+.+|+.+++.++||||++++++| .+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 357888899999999999999864 578999998765544556789999999999999999999988 4568999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|.+++.. ..+++..+..++.+++.||.|||+ +|++||||+|+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998842 347889999999999999999999 8999999999999999999999999999876543321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. .....|++.|++||.+..+.++.++||||||+++|+|++|++||................ .+. ...+
T Consensus 171 ~--------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~---~~~-~~~~ 238 (293)
T cd06647 171 K--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG---TPE-LQNP 238 (293)
T ss_pred c--------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC---CCC-CCCc
Confidence 1 122358899999999988889999999999999999999999997654432211111000 000 0112
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+..+.+++.+||..+|.+||++ .++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~-~~i 266 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSA-KEL 266 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 2345679999999999999999999 444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=304.86 Aligned_cols=248 Identities=25% Similarity=0.310 Sum_probs=191.0
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-----~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
+|...+.||.|+||.||+|... +..||||.+...... ....+..|+.++++++||||+++++++. +..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677788999999999999875 578999999765432 1235678999999999999999999984 468899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+ +|+|.+++.... ..+++..++.++.||+.||.|||. ++++|+||+|+|||++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999985332 369999999999999999999999 8999999999999999999999999999987644
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh--------
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-------- 750 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~-------- 750 (846)
.... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...............
T Consensus 155 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 155 PNRK--------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226 (298)
T ss_pred CCcc--------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence 3211 122347889999999865 46789999999999999999999988654432211100000
Q ss_pred ----ccccCC---------CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 ----KNLLDP---------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 ----~~~ld~---------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...... .........+..+.+|+.+||..+|.+||++ .++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-~e~ 279 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA-RQA 279 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCH-HHH
Confidence 000000 0000112335789999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=302.12 Aligned_cols=247 Identities=28% Similarity=0.369 Sum_probs=193.2
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc----CceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lVmE 601 (846)
+|+..+.||.|+||.||++... ++.+|+|.+..... .....+.+|++++++++||||++++++|. ..+++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 6788889999999999999985 57899999875433 22456899999999999999999999873 25789999
Q ss_pred ecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 602 YLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 602 y~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
|+++++|.+++... .....+++..+..++.+|+.||.|||. .+++|+||+|.||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999999887432 234568899999999999999999999 89999999999999999999999999998755322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHHhhhhhccccCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE----VQYALDTGKLKNLLDP 756 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~----~~~~~~~~~~~~~ld~ 756 (846)
.. ....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ...... .+.....+
T Consensus 159 ~~----------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~ 226 (287)
T cd06621 159 LA----------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS--YIVNMPNP 226 (287)
T ss_pred cc----------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH--HHhcCCch
Confidence 11 123478899999999988999999999999999999999999975521 011000 01110001
Q ss_pred CCCCCC---hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 757 LAGDWP---FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 757 ~~~~~p---~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+ ...++.+.+|+.+||..+|.+||++ .++
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~ei 263 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTP-WDM 263 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCH-HHH
Confidence 111111 1235789999999999999999999 444
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=302.11 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=188.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
++|.....||.|+||.||+|... +..||||.+...... ....+.+|+.++++++||||+++++++. +..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999875 578999998754322 2345778999999999999999999884 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+.+ +|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 975 898887533 2468899999999999999999999 8999999999999999999999999999875432111
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHh-hhhh----------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-TGKL---------- 750 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~-~~~~---------- 750 (846)
. .....++..|+|||++.+ ..++.++||||||+++|+|++|++||.........+. ....
T Consensus 159 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 159 T--------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred c--------ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 0 112346889999999875 4588999999999999999999999965442111110 0000
Q ss_pred --------ccccCCC------CCCCC-hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 --------KNLLDPL------AGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 --------~~~ld~~------~~~~p-~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+. ...++ ......+.+++.+||+.+|.+||++ .++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~-~e~ 285 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA-AEA 285 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH-HHH
Confidence 0000000 00000 0012678899999999999999999 444
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.22 Aligned_cols=248 Identities=26% Similarity=0.305 Sum_probs=186.9
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|...+.||+|+||.||+|... +..||+|.+...... ....+.+|+.++++++||||+++++++. ...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999885 678999998754222 2346788999999999999999999984 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+. ++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 4777766432 3468999999999999999999999 8999999999999999999999999999986543211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhh-------------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG------------- 748 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~------------- 748 (846)
. .....+++.|+|||++.+. .++.++|||||||++|+|+||..||.........+...
T Consensus 155 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 155 C--------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred C--------cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 0 1234578999999998765 47899999999999999999887753322211111100
Q ss_pred hhccccCC-CCCC---------CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 749 KLKNLLDP-LAGD---------WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 749 ~~~~~ld~-~~~~---------~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
......+. .... .....+..+.+|+.+||+.+|.+|||+ +++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-~~i 278 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA-EEA 278 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH-HHH
Confidence 00000000 0000 011235688999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.29 Aligned_cols=243 Identities=24% Similarity=0.391 Sum_probs=194.7
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
+|...+.||+|+||.||++... +..+|+|.+...... ....+.+|+.+|++++||||+++++.+ .+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778889999999999998875 578999998765322 245688999999999999999999987 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC-Cceeeecccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~-~~vKL~DFGla~~~~~~~ 681 (846)
+++++|.+++.... ...+++..+..++.+++.||.|||+ ++++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999985432 3458999999999999999999999 899999999999999854 568999999998764332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||............. .... ...
T Consensus 157 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~--~~~~----~~~ 221 (256)
T cd08220 157 KA---------YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM--SGTF----API 221 (256)
T ss_pred cc---------cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH--hcCC----CCC
Confidence 11 12358899999999988889999999999999999999999997655433222111 1111 112
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+...+..+.+++.+||..+|.+||++ .++
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~-~~l 250 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQL-SQI 250 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCH-HHH
Confidence 23345789999999999999999999 444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=301.84 Aligned_cols=238 Identities=25% Similarity=0.314 Sum_probs=195.9
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
+|...+.||.|+||.||++... +..||+|.+...... ..+.+.+|+.++++++||||+++++++ ....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778889999999999999886 678999999764332 346788999999999999999999988 456899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+.+++|.+++... .++++..+..++.+|+.||.|||. ++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998432 578999999999999999999999 899999999999999999999999999988654332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHhhhhhccccCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--VQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~--~~~~~~~~~~~~~ld~~~~ 759 (846)
. .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||..... ....... ... ...
T Consensus 155 ~---------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~----~~~ 219 (258)
T cd05578 155 L---------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK--QET----ADV 219 (258)
T ss_pred c---------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH--hcc----ccc
Confidence 1 1224588999999999888899999999999999999999999976543 1111111 110 122
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
..|...+..+.+++.+||+.+|.+||++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCc
Confidence 2344456889999999999999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.16 Aligned_cols=235 Identities=26% Similarity=0.352 Sum_probs=192.8
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
+|...+.||+|+||.||++... +..||+|++..... ...+.+.+|+++|++++||||+++++++ ....++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 6788899999999999999885 57899999875432 2245688999999999999999999987 456889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++++|.+++... ..+++..+..++.||+.||.|||+ ++++||||+|.|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 82 YVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred cCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence 99999999998533 568999999999999999999999 899999999999999999999999999988654321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
....|++.|+|||.+.+..++.++||||||+++|+|++|+.||............. . .....
T Consensus 156 -----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~-----~~~~~ 217 (290)
T cd05580 156 -----------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--E-----GKVRF 217 (290)
T ss_pred -----------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--c-----CCccC
Confidence 12348999999999988889999999999999999999999997655322111110 0 01122
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
|...+..+.+++.+||..+|.+||+.
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~ 243 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGN 243 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCc
Confidence 33446789999999999999999943
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=316.98 Aligned_cols=188 Identities=21% Similarity=0.322 Sum_probs=158.0
Q ss_pred CCCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
.+|.+.+.||+|+||.||+|...+ ..||+|+... .....|+.+|++++||||++++++| ....++||||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 368889999999999999999864 5799997432 2346799999999999999999988 45688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
. ++|.+++.. ...++++..+..|+.||+.||.|||. ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 140 ~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 212 (357)
T PHA03209 140 S-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA- 212 (357)
T ss_pred C-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc-
Confidence 5 688887743 33568999999999999999999999 8999999999999999999999999999875322110
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCC-CCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALG 736 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~-~pf~ 736 (846)
.....||+.|+|||++.+..++.++|||||||++|||+++. ++|.
T Consensus 213 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 213 --------FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred --------cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 12345899999999999989999999999999999999854 4443
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=300.41 Aligned_cols=241 Identities=26% Similarity=0.420 Sum_probs=192.7
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcC---CCceeeEecccc--CceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIR---HPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~--~~~~lVm 600 (846)
.|...+.||.|+||.||+|... +..||+|.+..... .....+.+|+.++++++ |||+++++++|. ...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677788999999999999974 57899999875432 33457889999999997 999999999883 4588999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++++|.+++.. .++++..++.++.+++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998842 368999999999999999999999 89999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
... .....|+..|+|||.+.++ .++.++|+|||||++|+|++|++||............. ... .+
T Consensus 155 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---~~~---~~ 220 (277)
T cd06917 155 SSK--------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP---KSK---PP 220 (277)
T ss_pred ccc--------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---cCC---CC
Confidence 211 1234589999999998754 47899999999999999999999997655433211111 111 11
Q ss_pred CCCh-hhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 760 DWPF-VQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 760 ~~p~-~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.++. ..+..+.+++.+||+.+|.+||++ .++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~-~~i 252 (277)
T cd06917 221 RLEDNGYSKLLREFVAACLDEEPKERLSA-EEL 252 (277)
T ss_pred CCCcccCCHHHHHHHHHHcCCCcccCcCH-HHH
Confidence 1111 145789999999999999999999 444
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=302.26 Aligned_cols=249 Identities=26% Similarity=0.346 Sum_probs=190.3
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|+..+.||.|+||.||+|... +..||||.+...... ....+.+|++++++++||||+++++++. +..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778889999999999999875 578999988754322 2356889999999999999999999983 568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+. ++|..++.... ...+++..+..++.+++.||.|||. ++++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68888875432 3568999999999999999999999 8999999999999999999999999999876543211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc---------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN--------- 752 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~--------- 752 (846)
. .....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||.................
T Consensus 156 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07860 156 T--------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 227 (284)
T ss_pred c--------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 1 12234788999999887644 68899999999999999999999976544322211100000
Q ss_pred -------------ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 -------------LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 -------------~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.............+..+.+++.+||+.+|.+||++ +++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~~ 278 (284)
T cd07860 228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA-KAA 278 (284)
T ss_pred hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH-HHH
Confidence 00000000111234678899999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=302.54 Aligned_cols=242 Identities=24% Similarity=0.362 Sum_probs=193.4
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCC
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 605 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~g 605 (846)
|...++||+|+||.||++... +..+++|.+........+.+.+|+.+++.++||||+++++++ .+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999865 578999998755444456688999999999999999999987 4678999999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
++|.+++.. ..+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-- 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-- 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--
Confidence 999999853 458899999999999999999999 89999999999999999999999999988755332111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 765 (846)
.....|++.|+|||.+.+..++.++||||||+++|+|++|++||........... +.....+ ....+...
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~---~~~~~~~-~~~~~~~~ 241 (285)
T cd06648 172 ------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR---IRDNLPP-KLKNLHKV 241 (285)
T ss_pred ------cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH---HHhcCCC-CCcccccC
Confidence 1224589999999999888899999999999999999999999965543322111 1111111 11112224
Q ss_pred HHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 766 AEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 766 ~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+..+.+++.+||..+|.+||++ .++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~-~~i 266 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATA-AEL 266 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCH-HHH
Confidence 5789999999999999999999 444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.25 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=192.9
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|.+.+.||.|+||.||+|... +..||+|++..... .....+.+|+.++++++||||+++++++. ...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999875 57899999876542 22457899999999999999999999874 568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+ +++|.+++... ..++++..++.++.+|+.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999988533 2569999999999999999999999 8999999999999999999999999999987644321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh-hhh----------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-GKL---------- 750 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~-~~~---------- 750 (846)
. ......|+..|+|||++.+. .++.++||||||+++|+|+||.+||............ ..+
T Consensus 155 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 155 R-------LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred C-------ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 0 01234589999999998654 4689999999999999999999998655432211000 000
Q ss_pred -------ccccCCCCC-----CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 -------KNLLDPLAG-----DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 -------~~~ld~~~~-----~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+... ......+..+.+|+.+||..+|.+||++ +++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~-~~~ 279 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA-AEA 279 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH-HHH
Confidence 000000000 0111235789999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=300.12 Aligned_cols=242 Identities=28% Similarity=0.420 Sum_probs=194.1
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
|...++||.|+||.||+|... +..||||.+..... .....+.+|+.++++++||||+++++++ .+..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667788999999999999874 57899998865432 2235688999999999999999999988 356889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+++|.+++. ...+++..+..++.+++.||.|||+ ++++|+||+|.||+++.++.++|+|||++..+.....
T Consensus 86 ~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 86 GGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 999999884 2458899999999999999999999 8999999999999999999999999999876543211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
......|+..|+|||.+.+..++.++|+|||||++|+|++|.+||............. .......+..
T Consensus 157 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~ 224 (277)
T cd06641 157 ------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------KNNPPTLEGN 224 (277)
T ss_pred ------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh------cCCCCCCCcc
Confidence 1123458899999999988889999999999999999999999997544322111110 0111122334
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDVWR 793 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~ 793 (846)
.+..+.+++.+||+.+|.+||++ .+++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~-~~~l~ 252 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTA-KELLK 252 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCH-HHHHh
Confidence 45789999999999999999999 55543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=296.59 Aligned_cols=246 Identities=31% Similarity=0.451 Sum_probs=194.3
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
+|...+.||+|+||.||+|... +..|++|.+...... ....+..|+.+++.++||||+++++.+ .+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999874 578999998866543 356789999999999999999999987 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|.+++.. ...+++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999853 3457889999999999999999999 8999999999999999999999999999887654322
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCch-HHHHHHhhhhhccccCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTGRPALGITK-EVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~~~ksDVwSlGviL~elltG~~pf~~~~-~~~~~~~~~~~~~~ld~~~ 758 (846)
..... .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||.... .......... ...+..
T Consensus 155 ~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~ 227 (264)
T cd06626 155 TMGEE----VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GHKPPI 227 (264)
T ss_pred ccccc----ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CCCCCC
Confidence 11110 11245889999999998766 8899999999999999999999996542 2221111111 111111
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
+.+ ...+..+.+++.+||+.+|.+||++.
T Consensus 228 ~~~-~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (264)
T cd06626 228 PDS-LQLSPEGKDFLDRCLESDPKKRPTAS 256 (264)
T ss_pred Ccc-cccCHHHHHHHHHHccCCcccCCCHH
Confidence 111 12367789999999999999999993
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=315.46 Aligned_cols=247 Identities=27% Similarity=0.374 Sum_probs=194.4
Q ss_pred hhcCCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCC--CCCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEE
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHS--LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTL 598 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~l 598 (846)
.....|++.++||+||.+.||++...+ +.+|+|.+.... .+..+-|.+|+..|.+| .|.+||+||+|- +..+|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 344579999999999999999998875 568888765432 23346799999999999 599999999985 567999
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||-+ .+|..+|..+... ...| .+..+..|++.|+.++|. +||||-||||.|+|+-. |.+||+|||+|..+.
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeeccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 999974 5899999655432 2334 788999999999999999 99999999999999964 589999999999887
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE-----------LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 747 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-----------~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~ 747 (846)
.+.+... +...+||+.||+||.+.... .+.++||||||||||+|+.|++||+......
T Consensus 511 ~DTTsI~------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~----- 579 (677)
T KOG0596|consen 511 PDTTSIV------KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI----- 579 (677)
T ss_pred cccccee------eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-----
Confidence 6654433 34567999999999995422 5678999999999999999999997655433
Q ss_pred hhhccccCC-CCCCCChhhHH-HHHHHHHHHhccCcCCCCChHH
Q 003121 748 GKLKNLLDP-LAGDWPFVQAE-QLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 748 ~~~~~~ld~-~~~~~p~~~~~-~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
.++..+.+| ..-+||..... .+.++++.||..||++||+..+
T Consensus 580 aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~e 623 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPE 623 (677)
T ss_pred HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHH
Confidence 234455555 22344433333 3999999999999999999943
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=301.13 Aligned_cols=245 Identities=27% Similarity=0.391 Sum_probs=186.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHH-HHhcCCCceeeEeccc--cCceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDI-LSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~i-L~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
++|.....||+|+||.||++... +..||||.+..... .....+..|+.+ ++.++||||+++++++ ....++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999886 67899999876432 223355667665 5667899999999988 456899999
Q ss_pred ecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecccCCCceEecCCCceeeecccccccccc
Q 003121 602 YLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 602 y~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|++ |+|.+++... .....+++..++.++.||+.||.|||+ + +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6787777432 234579999999999999999999998 6 899999999999999999999999999886533
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~----~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
... .+...|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.........+.. .+.
T Consensus 157 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~ 222 (283)
T cd06617 157 SVA---------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ-----VVE 222 (283)
T ss_pred ccc---------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH-----HHh
Confidence 211 122358899999998864 45788999999999999999999999643211111111 011
Q ss_pred CCCCCCC-hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 756 PLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 756 ~~~~~~p-~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
......+ ...+..+.+++.+||..+|.+||++ .++
T Consensus 223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~-~~i 258 (283)
T cd06617 223 EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNY-PEL 258 (283)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 1111111 1235789999999999999999999 444
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=300.26 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=189.2
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++.+|...+.||+|+||.||+|... +..||+|.+....... ...+.+|+.+|+.++||||+++++++. +..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4568999999999999999999875 6789999987553322 346789999999999999999999874 4688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+. ++|.+.+... ...+++..+..++.|++.||.|||. ++|+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 5666665322 3457888899999999999999999 89999999999999999999999999998754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh----------
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------- 749 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~---------- 749 (846)
... .....+++.|+|||++.+. .++.++|||||||++|+|+||++||.........+....
T Consensus 157 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 157 SQT--------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred CCC--------CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 111 1223478999999998764 588899999999999999999999975543222111100
Q ss_pred ------hccccCCCCCC---------C-ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 750 ------LKNLLDPLAGD---------W-PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 750 ------~~~~ld~~~~~---------~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+.......... + ....+..+.+++.+|+..+|.+||++ +++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~-~~~ 285 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA-QDA 285 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH-HHH
Confidence 00000000000 0 00124578999999999999999999 443
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=290.21 Aligned_cols=244 Identities=30% Similarity=0.478 Sum_probs=198.6
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
+|...+.||+|+||.||++... +..+++|++..........+.+|+.++++++||||+++++++ ....++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677789999999999999986 678999999876554556899999999999999999999987 456889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+++|.+++.... ..+++..+..++.+++.||.|||. ++++||||+|.||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999985432 568999999999999999999999 8999999999999999999999999999887654321
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....|+..|++||.+.+..++.++||||||+++|+|++|++||.............. ........+..
T Consensus 154 -------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~ 222 (253)
T cd05122 154 -------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT----NGPPGLRNPEK 222 (253)
T ss_pred -------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cCCCCcCcccc
Confidence 1223588999999999888899999999999999999999999976643332222211 11111111222
Q ss_pred hHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 765 QAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+..+.+++.+||..+|.+||++ .++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~-~~~ 248 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTA-EQL 248 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCH-HHH
Confidence 25789999999999999999999 444
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.40 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=192.7
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
+|+..++||.|+||.||+|... +..||||.+...... ....+.+|+.++++++||||++++++|. +..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778889999999999999985 678999998765332 3456788999999999999999999984 5689999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++ +|.+++........+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 888887654444579999999999999999999999 8999999999999999999999999999976543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh---------cc-
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL---------KN- 752 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~---------~~- 752 (846)
......+++.|++||++.+. .++.++|||||||++|+|++|++||............... ..
T Consensus 156 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07836 156 -------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI 228 (284)
T ss_pred -------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence 01223478999999998664 5789999999999999999999999755432211110000 00
Q ss_pred -ccCCCCCC-----------CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 -LLDPLAGD-----------WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 -~ld~~~~~-----------~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
........ +....+..+.+++.+||+.+|.+||++ .++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~-~~~ 278 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA-HDA 278 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH-HHH
Confidence 00000001 111235678999999999999999999 444
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=295.91 Aligned_cols=244 Identities=26% Similarity=0.407 Sum_probs=194.7
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|...+.||.|+||.||+|... +..||+|.+..... ...+.+.+|+.+++.++||||+++++.+. ...++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999886 57899999876422 23456889999999999999999999884 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC-ceeeecccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNE 681 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~-~vKL~DFGla~~~~~~~ 681 (846)
+++++|.+++.... ...+++..+..++.+++.||.|||+ .+++|+||||.||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999885432 3458999999999999999999999 8999999999999999875 56999999988664322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. .....|++.|+|||++.+..++.++|+||||+++|+|++|..||............ ....+.+.
T Consensus 157 ~~--------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~---- 222 (257)
T cd08225 157 EL--------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI--CQGYFAPI---- 222 (257)
T ss_pred cc--------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--hcccCCCC----
Confidence 11 01234899999999998888999999999999999999999999765443322111 11112222
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+...+..+.+++.+||..+|.+||++ .++
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~-~~l 251 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSI-TSI 251 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCH-HHH
Confidence 22335689999999999999999999 554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=295.40 Aligned_cols=244 Identities=24% Similarity=0.357 Sum_probs=198.6
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
+|+..+.||.|+||.||++... +..|++|.+..... .....+.+|+.++..++||||+++++++. ...++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 6788899999999999999886 57899999876544 33567999999999999999999999884 4688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++... .++++..+..++.+++.||.|||.. .+++||||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999999533 5689999999999999999999973 57999999999999999999999999998876443211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHhhhhhccccCCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--EVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~--~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
. ....++..|+|||.+.+..++.++|+||||+++|+|+||++||.... ......... ........
T Consensus 157 ~--------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 223 (264)
T cd06623 157 C--------NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-----CDGPPPSL 223 (264)
T ss_pred c--------cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH-----hcCCCCCC
Confidence 1 12347899999999998889999999999999999999999997664 221111111 11112223
Q ss_pred Chh-hHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFV-QAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~-~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+.. .+..+.+++.+||..+|.+||++ .++
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~-~~l 253 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSA-AEL 253 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCH-HHH
Confidence 333 56789999999999999999999 444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=299.22 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=190.0
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
|+..+.||.|++|.||+|... +..||+|++...... ....+.+|+++++.++||||+++++++. +..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999875 688999998765322 2356889999999999999999999884 5688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
+ ++|.+++.... ...+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68988885332 1368999999999999999999999 89999999999999999999999999998765322110
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh-------------
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------- 749 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~------------- 749 (846)
.....+++.|+|||++.+. .++.++||||||+++|+|+||++||..............
T Consensus 156 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07835 156 --------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227 (283)
T ss_pred --------cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh
Confidence 1223468899999988664 578999999999999999999999976544322111100
Q ss_pred ---------hccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 750 ---------LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 750 ---------~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+...............+..+.+++.+||+.+|.+||++ +++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~i 277 (283)
T cd07835 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA-KAA 277 (283)
T ss_pred hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH-HHH
Confidence 00000000111122334678999999999999999999 544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=300.20 Aligned_cols=249 Identities=26% Similarity=0.317 Sum_probs=189.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcC-CCceeeEecccc--Cc-----
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR-HPNLVTLVGACP--EV----- 595 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~--~~----- 595 (846)
++|...+.||+|+||.||+|... +..||||.+...... ....+.+|+.+++.+. ||||+++++++. +.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999875 578999988754322 2356888999999995 699999999873 22
Q ss_pred eEEEEEecCCCchhhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-CCceeeeccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFG 672 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-~~~vKL~DFG 672 (846)
.++||||+++ +|.+++..... ..++++..+..++.||+.||.|||. ++|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 6899999985 78887754321 3568999999999999999999999 89999999999999998 8999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc
Q 003121 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 751 (846)
Q Consensus 673 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~ 751 (846)
+++.+...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|.+||................
T Consensus 157 ~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~ 228 (295)
T cd07837 157 LGRAFSIPVKS--------YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228 (295)
T ss_pred cceecCCCccc--------cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 98865332111 012347889999998865 457899999999999999999999997655443222111000
Q ss_pred cccCCCC---------------C--------CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 752 NLLDPLA---------------G--------DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 752 ~~ld~~~---------------~--------~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+.. . ......+..+.+||.+||..+|.+||++ .++
T Consensus 229 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~-~ei 288 (295)
T cd07837 229 --GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA-KAA 288 (295)
T ss_pred --CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH-HHH
Confidence 00000 0 0011245679999999999999999999 444
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=301.05 Aligned_cols=236 Identities=25% Similarity=0.328 Sum_probs=187.6
Q ss_pred eeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCCCch
Q 003121 536 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSL 608 (846)
Q Consensus 536 LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ggsL 608 (846)
||+|+||+||++... +..||+|.+..... .....+..|+.+|+.++||||+++++++ .+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999765 67899999875432 2234567899999999999999999987 4568999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCcc
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 688 (846)
.+++..... ..+++..+..++.|++.||.|||. ++++||||+|+|||++.++.+||+|||++........
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~------ 150 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK------ 150 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc------
Confidence 999864432 468999999999999999999999 8999999999999999999999999999876543111
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHhhhhhccccCCCCCCCChhhH
Q 003121 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 689 ~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
.....++..|+|||++.++.++.++|||||||++|+|++|+.||...... ...+.... .......+...+
T Consensus 151 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 222 (277)
T cd05577 151 ---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-----LEMAVEYPDKFS 222 (277)
T ss_pred ---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-----ccccccCCccCC
Confidence 01234788999999998888999999999999999999999999654331 11111111 111222333446
Q ss_pred HHHHHHHHHHhccCcCCCCChHH
Q 003121 767 EQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
..+.+++.+||+.+|.+||++.+
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCc
Confidence 78999999999999999996533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=300.98 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=191.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--c--CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--P--EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~--~~~~lV 599 (846)
++|...+.||.|+||.||+|... +..+++|.+....... ...+.+|+.++++++||||+++++++ . ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 36888889999999999999986 5789999987543221 23567899999999999999999987 3 578999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+. ++|.+++.... ..+++..+..++.||+.||.|||+ ++++|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 58988885432 368999999999999999999999 8999999999999999999999999999886654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh---------
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK--------- 749 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~--------- 749 (846)
.... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||..............
T Consensus 159 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (293)
T cd07843 159 PLKP--------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230 (293)
T ss_pred Cccc--------cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence 3211 1223478899999998764 468999999999999999999999975543221100000
Q ss_pred --------------hcc-ccCCCCCCCChh-hHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 750 --------------LKN-LLDPLAGDWPFV-QAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 750 --------------~~~-~ld~~~~~~p~~-~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+.. ........++.. .++.+.+|+.+||+.+|++||++ .++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-~el 287 (293)
T cd07843 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA-EDA 287 (293)
T ss_pred HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH-HHH
Confidence 000 000011222222 46779999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.52 Aligned_cols=243 Identities=27% Similarity=0.391 Sum_probs=194.2
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
+|+..+.||.|+||.||++... +..||+|.+..... .....+.+|++++++++||||+++++.| ....++||||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777788999999999999887 67899999876533 2335688999999999999999999987 45688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++++|.+++.... .++++..+..++.+++.||.|||+. .+++|+||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999999985332 5788999999999999999999982 57999999999999999999999999998765432111
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHHhhhhhccccCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK----EVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~----~~~~~~~~~~~~~~ld~~~~ 759 (846)
...|+..|+|||++.+..++.++||||||+++|+|++|..||.... .....+. ........
T Consensus 158 ----------~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 222 (265)
T cd06605 158 ----------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ-----YIVNEPPP 222 (265)
T ss_pred ----------cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH-----HHhcCCCC
Confidence 1348899999999988899999999999999999999999996542 1111111 11111111
Q ss_pred CCChh-hHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 760 DWPFV-QAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 760 ~~p~~-~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+.. .+..+.++|.+||..+|.+||++ .++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~l 254 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSY-KEL 254 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCH-HHH
Confidence 12222 45779999999999999999999 444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=302.45 Aligned_cols=201 Identities=25% Similarity=0.359 Sum_probs=163.7
Q ss_pred CCcccceeeeeCceEEEEEEEC----CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccc----CceE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWT 597 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~----~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~ 597 (846)
.|....+||+|+||.||+|... +..||+|.+.... ......+.+|+.+++.++||||++++++|. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999884 4789999998743 222356788999999999999999999983 4588
Q ss_pred EEEEecCCCchhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC----CCceeeecc
Q 003121 598 LVYEYLPNGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA----NFVSKLSDF 671 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~----~~~vKL~DF 671 (846)
+||||+++ +|.+++... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 566655322 222478999999999999999999999 89999999999999999 899999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 003121 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGIT 738 (846)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~ 738 (846)
|++.......... .......+++.|+|||++.+. .++.++|||||||++|+|++|++||...
T Consensus 157 g~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 157 GLARLFNAPLKPL-----ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccccccCCCcccc-----cccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9998764432110 111234589999999988764 5889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=300.72 Aligned_cols=249 Identities=25% Similarity=0.317 Sum_probs=187.4
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcC-CCceeeEeccc--cCceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~lVmEy 602 (846)
+|....+||+|+||.||++... +..||+|.+...... ....+.+|+.++.++. ||||+++++++ +...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999886 578999998754322 2346889999999996 99999999987 4467899999
Q ss_pred cCCCchhhhhcc--CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 603 LPNGSLEDRLSC--KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 603 ~~ggsL~~~L~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
+.. +|.++... ......+++..+..++.+++.||.|||+. .+++||||||+|||++.++.+||+|||+++.+...
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55543321 11235689999999999999999999972 38999999999999999999999999999765432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
... ....|++.|+|||++.+. .++.++|||||||++|+|++|++||.........+... ........
T Consensus 162 ~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 231 (288)
T cd06616 162 IAK---------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV-VKGDPPIL 231 (288)
T ss_pred Ccc---------ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhh-cCCCCCcC
Confidence 111 123488999999999776 68999999999999999999999996554221111111 00000011
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+...+..+.+|+.+||..+|.+||++ +++
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~i 264 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKY-KEL 264 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 112223356789999999999999999999 444
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=288.70 Aligned_cols=245 Identities=27% Similarity=0.419 Sum_probs=198.2
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc----CceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lVm 600 (846)
+|...+.||+|+||.||+|... +..|++|++..... ...+.+.+|+.++++++||||+++++.+. ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667788999999999999987 67899999876543 23567899999999999999999999874 4588999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++++|.+++... ..+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998533 379999999999999999999999 89999999999999999999999999999876554
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... .......++..|+|||.+.+..++.++||||||+++|+|++|..||............ ... ......
T Consensus 155 ~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~--~~~~~~ 224 (260)
T cd06606 155 ETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK--IGS--SGEPPE 224 (260)
T ss_pred ccc------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHh--ccc--cCCCcC
Confidence 321 0012345899999999998888999999999999999999999999765521111111 110 011223
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
.+...+..+.+++.+|+..+|.+||++.+
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ 253 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADE 253 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHH
Confidence 34445688999999999999999999933
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=302.03 Aligned_cols=257 Identities=16% Similarity=0.192 Sum_probs=180.9
Q ss_pred CCCcccceeeeeCceEEEEEEECCe-----EEEEEEecCCCCCCc-h----------hHHHHHHHHHhcCCCceeeEecc
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRHM-----QVAIKMLHPHSLQGP-S----------EFQQEIDILSKIRHPNLVTLVGA 591 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~~-----~VAIK~l~~~~~~~~-~----------~f~~Ei~iL~~l~HpnIv~l~g~ 591 (846)
..|.+.++||+|+||.||+|.+.+. .+|+|+......... + ....+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5789999999999999999987643 466775433221110 0 11223344566789999999987
Q ss_pred ccC------ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc
Q 003121 592 CPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 665 (846)
Q Consensus 592 ~~~------~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~ 665 (846)
+.. ..+++|+++. .++.+.+.. ....++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence 532 2467888774 356665532 2335778889999999999999999 89999999999999999999
Q ss_pred eeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 003121 666 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 745 (846)
Q Consensus 666 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~ 745 (846)
+||+|||+++.+........ ..........||+.|+|||++.+..++.++|||||||++|||++|++||.........+
T Consensus 165 ~~l~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIE-YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccc-cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999987643221110 00011123469999999999999999999999999999999999999996552211111
Q ss_pred ---hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHH
Q 003121 746 ---DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 795 (846)
Q Consensus 746 ---~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 795 (846)
.......+.... . .....++.+.+++..|+..+|.+||++ +++.+.+
T Consensus 244 ~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~rp~~-~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEGK-I-KIKNANKFIYDFIECVTKLSYEEKPDY-DALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhhh-h-ccCCCCHHHHHHHHHHHhCCCCCCCCH-HHHHHhh
Confidence 111111111110 0 112335789999999999999999999 6776654
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.97 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=194.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-----CCchhHHHHHHHHHhcCCCceeeEeccccC----ce
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-----QGPSEFQQEIDILSKIRHPNLVTLVGACPE----VW 596 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----~~ 596 (846)
.+|.+.+.||+|+||.||+|... +..||+|.+..... .....+.+|+.++++++||||+++++++.+ .+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999875 57899998754321 122468899999999999999999998732 47
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+++++|.+++.. ..++++.....++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998853 2458899999999999999999999 8999999999999999999999999999986
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCC
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
......... ......|+..|+|||++.+..++.++|||||||++|+|++|++||............. ..+
T Consensus 156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~ 225 (264)
T cd06653 156 IQTICMSGT-----GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA-----TQP 225 (264)
T ss_pred cccccccCc-----cccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH-----cCC
Confidence 532111100 0122458999999999988889999999999999999999999997654433222111 112
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
..+..|...++.+.+++.+||. +|..||+..
T Consensus 226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~ 256 (264)
T cd06653 226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAE 256 (264)
T ss_pred CCCCCCcccCHHHHHHHHHHhc-CcccCccHH
Confidence 2234455667889999999999 579999993
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=295.55 Aligned_cols=232 Identities=26% Similarity=0.348 Sum_probs=189.7
Q ss_pred eeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCCCch
Q 003121 536 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSL 608 (846)
Q Consensus 536 LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ggsL 608 (846)
||.|+||.||++... +..||+|++...... ....+.+|+.+++.++||||+++++.+ ....++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999987 688999998765332 235689999999999999999999987 3468899999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCcc
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 688 (846)
.+++... ..+++..+..++.+|+.||.|||+ ++++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~------ 148 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK------ 148 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc------
Confidence 9998533 458899999999999999999999 8999999999999999999999999999987644310
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--EVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 689 ~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~--~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
.....|++.|++||.+.+..++.++|+||||+++|+|++|.+||.... ........ .. ......+|...+
T Consensus 149 ---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~---~~~~~~~~~~~~ 220 (262)
T cd05572 149 ---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI--LK---GNGKLEFPNYID 220 (262)
T ss_pred ---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH--hc---cCCCCCCCcccC
Confidence 012358899999999988889999999999999999999999997665 22111110 00 012233444456
Q ss_pred HHHHHHHHHHhccCcCCCCCh
Q 003121 767 EQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
..+.+++.+||..+|.+||++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred HHHHHHHHHHccCChhhCcCC
Confidence 889999999999999999994
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=293.92 Aligned_cols=247 Identities=27% Similarity=0.344 Sum_probs=192.7
Q ss_pred eeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCch
Q 003121 536 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 608 (846)
Q Consensus 536 LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggsL 608 (846)
||.|+||.||++... +..+++|.+..... .....+.+|+.++++++||||+++++.+. ...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 67899999876543 23456889999999999999999998873 468899999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCcc
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 688 (846)
.+++... ..+++..+..++.|++.||.|||. ++++|+||+|+||+++.++.+||+|||++..............
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9998533 368999999999999999999999 8999999999999999999999999999875433211000000
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhh--H
Q 003121 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ--A 766 (846)
Q Consensus 689 ~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~--~ 766 (846)
........++..|++||.+....++.++||||||+++|+|++|..||.............. ....++... +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 227 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-------GKIEWPEDVEVS 227 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------CCcCCCccccCC
Confidence 0011234578899999999888899999999999999999999999976554332111110 011223232 6
Q ss_pred HHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 767 EQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
..+.+++.+||+.+|.+||++ ..+.++|+
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~-~~~~~~l~ 256 (265)
T cd05579 228 DEAIDLISKLLVPDPEKRLGA-KSIEEIKN 256 (265)
T ss_pred HHHHHHHHHHhcCCHhhcCCC-ccHHHHhc
Confidence 789999999999999999998 44544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=301.90 Aligned_cols=235 Identities=23% Similarity=0.320 Sum_probs=194.1
Q ss_pred CCCcccceeeeeCceEEEEEEECCe--EEEEEEecCCCCC---CchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~~--~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV 599 (846)
.+|..+.+||+|+||+|..+..+|+ .+|||++++.... +.+--..|-.+|... +-|.+++|..+| .+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4789999999999999999988874 5999999886432 223334677788766 578888888877 4789999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+.||+|.-++... +.+.+..+..++.+|+-||-|||+ +|||+||||.+|||||.+|++||+|||+++----
T Consensus 429 MEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999988533 457788999999999999999999 9999999999999999999999999999983211
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHhhhhhccccCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPL 757 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~--~~~~~~~~~~ld~~ 757 (846)
.. ..+ .+.+|||.|+|||++...+|+.++|||||||+||||+.|++||++.++... ++...
T Consensus 503 ~~---~TT-----kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh--------- 565 (683)
T KOG0696|consen 503 DG---VTT-----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH--------- 565 (683)
T ss_pred CC---cce-----eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc---------
Confidence 11 111 245699999999999999999999999999999999999999988766442 22222
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCC
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
.-.+|...+.+...+....+.+.|.+|.
T Consensus 566 nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 2346788889999999999999999995
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.31 Aligned_cols=241 Identities=23% Similarity=0.349 Sum_probs=190.7
Q ss_pred cccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCCC
Q 003121 531 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
....+||+|+||.||++... +..||||.+..........+.+|+.+++.++||||+++++.+ .+..++||||++++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 33467999999999999885 578999988654444455688999999999999999999987 56789999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+++. ...+++..+..++.+++.||.|||+ +|++||||+|+||+++.++.++|+|||++.........
T Consensus 103 ~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--- 172 (292)
T cd06657 103 ALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--- 172 (292)
T ss_pred cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc---
Confidence 9999873 2358899999999999999999999 89999999999999999999999999998765432110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
.....|++.|++||++.+..++.++|+||||+++|+|++|.+||............ ...+.+.... ....+
T Consensus 173 -----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~ 243 (292)
T cd06657 173 -----RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKN-LHKVS 243 (292)
T ss_pred -----ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhhCCcccCC-cccCC
Confidence 12234889999999998888999999999999999999999999765433211110 1111111111 12235
Q ss_pred HHHHHHHHHHhccCcCCCCChHHHH
Q 003121 767 EQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+.+++.+||..+|.+||++ .++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~-~~l 267 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATA-AEL 267 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCH-HHH
Confidence 678999999999999999999 444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=300.05 Aligned_cols=240 Identities=28% Similarity=0.396 Sum_probs=189.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
..|...+.||+|+||.||+|... +..||+|.+....... ...+.+|+.+++.++||||++++++| .+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999875 6789999986543322 24588999999999999999999998 45688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||++ |+|.+++... ..++++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 5666666422 3468999999999999999999999 89999999999999999999999999998765322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
....|++.|+|||++. .+.++.++||||||+++|+|+||++||.............. .. .+.
T Consensus 169 ------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-~~--~~~ 233 (307)
T cd06607 169 ------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-ND--SPT 233 (307)
T ss_pred ------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-CC--CCC
Confidence 1234788999999874 35688999999999999999999999976544332211110 00 011
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. .+...+..+.+++.+||..+|.+||++ .++
T Consensus 234 ~--~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i 264 (307)
T cd06607 234 L--SSNDWSDYFRNFVDSCLQKIPQDRPSS-EEL 264 (307)
T ss_pred C--CchhhCHHHHHHHHHHhcCChhhCcCH-HHH
Confidence 0 112245689999999999999999999 444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=301.44 Aligned_cols=254 Identities=21% Similarity=0.246 Sum_probs=190.8
Q ss_pred ccceeeeeCceEEEEEEECCeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCCCc
Q 003121 532 PSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGS 607 (846)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ggs 607 (846)
+.+.+|.|+++.||++...+..||||++.... ......+.+|+.+++.++||||+++++++ .+..+++|||+++|+
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34456777888888888888999999987652 23346799999999999999999999987 356889999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCc
Q 003121 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 687 (846)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 687 (846)
|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||.+.......... ..
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~-~~ 160 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ-RV 160 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccc-cc
Confidence 999986432 2458899999999999999999999 899999999999999999999999999987654322111 11
Q ss_pred cccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh--hccccC--------
Q 003121 688 TLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK--LKNLLD-------- 755 (846)
Q Consensus 688 ~~~~~~~~~Gt~~Y~APE~l~~--~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~--~~~~ld-------- 755 (846)
.........++..|+|||++.. ..++.++|||||||++|+|++|+.||.........+.... ....++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 1111233457889999999876 3588999999999999999999999976544332221110 000000
Q ss_pred -----------------CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 756 -----------------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 756 -----------------~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
......+...+..+.+|+.+||..+|.+||++ +++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~l 292 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA-SQL 292 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH-HHH
Confidence 00011122334678999999999999999999 444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=288.61 Aligned_cols=242 Identities=28% Similarity=0.440 Sum_probs=198.0
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
+|...+.||+|+||.||++... +..|++|.+..... .....+.+|++++++++|||++++++++. ...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999875 57899999987654 23457899999999999999999999873 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|.+++... .++++..+..++.+++.||.|||. +||+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998533 568999999999999999999999 8999999999999999999999999999987654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|++||............. .......+
T Consensus 155 ~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~ 220 (254)
T cd06627 155 D--------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------QDDHPPLP 220 (254)
T ss_pred c--------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------ccCCCCCC
Confidence 1 122358999999999988888999999999999999999999997654433222211 01112234
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+..+.+++.+||..+|++||++ .++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~-~~~ 248 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTA-KQL 248 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCH-HHH
Confidence 4456889999999999999999999 444
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=289.88 Aligned_cols=245 Identities=27% Similarity=0.450 Sum_probs=199.3
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
+|...+.||.|+||.||++... +..|++|++..... .....+.+|+++++.++|||++++++.+ .+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999987 68899999876543 3445688999999999999999999887 4568899999
Q ss_pred cCCCchhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 603 LPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 603 ~~ggsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
+++++|.+++.... ....+++..+..++.+++.||.|||. +|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886432 23679999999999999999999999 899999999999999999999999999998764432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||........... .......+ .
T Consensus 158 ~~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~----~ 223 (258)
T cd08215 158 DL--------AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK--ILKGQYPP----I 223 (258)
T ss_pred ce--------ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH--HhcCCCCC----C
Confidence 11 1223589999999999888899999999999999999999999976553322111 11111222 2
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+...+..+.+++.+||..+|.+||++ .++
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~-~~l 252 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSI-AQI 252 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCH-HHH
Confidence 33455789999999999999999999 444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=298.90 Aligned_cols=250 Identities=27% Similarity=0.326 Sum_probs=190.6
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccc----CceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP----EVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~l 598 (846)
..+|...+.||.|+||.||+|... +..||+|.+....... ...+.+|+.++++++||||+++++++. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357889999999999999999885 5789999987543221 234678999999999999999999873 35789
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+. ++|.+++... ...+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 4788877532 2568999999999999999999999 899999999999999999999999999998764
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc-----
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN----- 752 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~----- 752 (846)
..... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||.................
T Consensus 160 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 160 LPAKP--------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES 231 (309)
T ss_pred CccCC--------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 32211 122346888999999865 4588999999999999999999999976554332111100000
Q ss_pred c---c-------CCCCCCCC--------hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 L---L-------DPLAGDWP--------FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ~---l-------d~~~~~~p--------~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. + .......+ ...+..+.+|+.+||+.||.+||++ +++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~-~~i 287 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA-EEA 287 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH-HHH
Confidence 0 0 00000000 1135678999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=305.64 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=191.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc------CceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP------EVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~------~~~~ 597 (846)
.+|...+.||.|+||.||+|... +..||+|++..... .....+.+|+.+|+.++||||++++++|. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57888899999999999999875 67899999876432 23456788999999999999999998763 3578
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+. |+|.+++.. ...+++..+..++.||+.||.|||. ++|+||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 689888843 3458999999999999999999999 89999999999999999999999999999865
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---h-------
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL---D------- 746 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~---~------- 746 (846)
........ .......|+..|+|||++.+ ..++.++|||||||++|+|++|++||.......... .
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 158 SSSPTEHK----YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred cccCcCCC----cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 43321110 11123468999999999866 468999999999999999999999996543321100 0
Q ss_pred -------hhhhccccC--CCCCCC-----ChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 747 -------TGKLKNLLD--PLAGDW-----PFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 747 -------~~~~~~~ld--~~~~~~-----p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
......... +..... ....+..+.+++.+||+.+|.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 290 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 000000000 000011 1223578999999999999999999943
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=296.15 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=188.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
++|.....||+|+||.||+|... ++.||+|.+..... .....+.+|+.+++.++||||+++++++. ...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999875 57899999865432 22356889999999999999999999984 56889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-CCceeeeccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-~~~vKL~DFGla~~~~~~ 680 (846)
|++ ++|.+++.... ...+++..+..++.+|+.||.|||. ++++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 57777774332 2346788889999999999999999 89999999999999985 567999999999765332
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh-ccccC---
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-KNLLD--- 755 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~-~~~ld--- 755 (846)
... .....|++.|+|||++.+. .++.++|||||||++|+|+||++||............... .....
T Consensus 157 ~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 157 VRT--------FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred ccc--------cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 110 1223478999999998664 5789999999999999999999999765443221111000 00000
Q ss_pred ----------CCCCCC--------ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 756 ----------PLAGDW--------PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 756 ----------~~~~~~--------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....| ....+..+.+++.+|+..+|.+||++ .++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~-~~~ 281 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA-RAA 281 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH-HHH
Confidence 000000 11235678999999999999999999 444
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=297.24 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=188.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc----------
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP---------- 593 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~---------- 593 (846)
++|....+||+|+||.||+|... +..||||.+...... ....+.+|+.++++++||||++++++|.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47899999999999999999875 578999988654322 1235678999999999999999999872
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
...++||||+. ++|.+.+... ...+++..+..++.||+.||.|||+ ++++|+||||+|||++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 23589999996 4787777432 2468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 752 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~ 752 (846)
+............ ......++..|+|||++.+. .++.++||||||+++|+|+||++||..............+..
T Consensus 166 ~~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 166 ARAFSLSKNSKPN----RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cccccCCcccCCC----CccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9866443211100 11234578999999998764 478899999999999999999999965543221111000000
Q ss_pred ccC------------------CCC-------CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 LLD------------------PLA-------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ~ld------------------~~~-------~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+. +.. .-++......+.+|+.+||..+|.+||++ +++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~-~e~ 304 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA-DTA 304 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH-HHH
Confidence 000 000 00011124567899999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=305.12 Aligned_cols=246 Identities=21% Similarity=0.281 Sum_probs=189.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccc--------C
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--------E 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~ 594 (846)
..+|...+.||+|+||.||+|... +..||||.+.... ......+.+|+.+++.++||||++++++|. .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 357999999999999999999875 6789999986432 222346778999999999999999999873 2
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
..++||||+. ++|.+.+.. .++...+..++.|++.||.|||. +||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 3689999996 578877732 28888999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhh------
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG------ 748 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~------ 748 (846)
+....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.........
T Consensus 166 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (353)
T cd07850 166 RTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236 (353)
T ss_pred eeCCCCCC---------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 86543211 122358899999999999999999999999999999999999996544321100000
Q ss_pred ----------h---------------hccccC----C-CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 749 ----------K---------------LKNLLD----P-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 749 ----------~---------------~~~~ld----~-~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. +..... + .....+...+..+.+|+.+||+.+|.+||++ .++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~ei 308 (353)
T cd07850 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV-DDA 308 (353)
T ss_pred CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH-HHH
Confidence 0 000000 0 0000012345678999999999999999999 444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=304.88 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=189.1
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc-------Cce
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-------EVW 596 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-------~~~ 596 (846)
.++|...++||+|+||.||+|... +..||||.+..... .....+.+|+.++++++||||+++++++. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 357999999999999999999875 57899999865322 22356788999999999999999998762 236
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+. ++|.+++. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 89999996 47777763 2468999999999999999999999 8999999999999999999999999999986
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh--------
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-------- 747 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~-------- 747 (846)
......... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|++||...+........
T Consensus 156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 156 ADPEHDHTG-----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred ccccccccC-----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 543221111 1123468999999998755 46899999999999999999999999654332111000
Q ss_pred -hhhccccC----------CCCCC--C---ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 748 -GKLKNLLD----------PLAGD--W---PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 748 -~~~~~~ld----------~~~~~--~---p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..+.. +.... + ....+..+.+|+.+||+.+|.+||++ .++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-~e~ 289 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV-EEA 289 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH-HHH
Confidence 00000000 00000 0 01224678999999999999999999 444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=293.12 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=190.1
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccc----CceEEEEE
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYE 601 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lVmE 601 (846)
|...++||.|+||.||+|... +..+|+|.+.... ......+.+|+.++++++|||++++++++. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999886 4789999998763 222356889999999999999999999884 45899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++ +|.+++... ...+++..++.++.+|+.||.|||. ++++|+||+|+|||++.++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 888887433 2478999999999999999999999 899999999999999999999999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC-----
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD----- 755 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld----- 755 (846)
... .....++..|+|||.+.+ ..++.++||||||+++|+|+||++||....................
T Consensus 155 ~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 155 SAD-------YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred ccc-------ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 100 122347889999998765 4578999999999999999999999976543222111100000000
Q ss_pred ------------CC-------CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 756 ------------PL-------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 756 ------------~~-------~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+. ...+....+..+.+++.+||..+|.+||++ .++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-~~~ 281 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA-DQA 281 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH-HHH
Confidence 00 000011125688999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=294.54 Aligned_cols=231 Identities=27% Similarity=0.338 Sum_probs=177.6
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHh---cCCCceeeEeccc--cCceEEEEEecC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSK---IRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~---l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
.||+|+||.||++... +..+|+|.+....... ...+.+|..++.. .+||||+.+++++ .+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999875 5789999987643221 1234455544443 4799999999887 456889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999988853 3469999999999999999999999 8999999999999999999999999999875432210
Q ss_pred CCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHhhhhhccccCCCCCCCC
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~-~~~~~~~~~~~~ld~~~~~~p 762 (846)
....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ...+..... ......+
T Consensus 153 --------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~ 219 (279)
T cd05633 153 --------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TVNVELP 219 (279)
T ss_pred --------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-----cCCcCCc
Confidence 12358999999999864 46899999999999999999999999643221 111111111 1111233
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCC
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
...+..+.+++.+||..+|.+||+
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcC
Confidence 345678999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=291.91 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=184.7
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcC-CCceeeEecccc----CceEEEEE
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGACP----EVWTLVYE 601 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~----~~~~lVmE 601 (846)
|...++||+|+||.||+|... +..||+|.++..... ......+|+.++.++. ||||++++++|. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556778999999999999875 578999998764221 2234457999999985 999999999873 56899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|++ |+|.+.+... ...+++..++.++.+++.||.|||. ++++||||+|+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5777777432 2468999999999999999999999 89999999999999999 999999999998664322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc--------c
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK--------N 752 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~--------~ 752 (846)
.. ....++..|+|||++.. +.++.++|||||||++|+|++|.+||...+............ .
T Consensus 154 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07831 154 PY---------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK 224 (282)
T ss_pred Cc---------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 11 12347899999997754 557889999999999999999999997654322111000000 0
Q ss_pred ccC---CCCCCC-----------ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 LLD---PLAGDW-----------PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ~ld---~~~~~~-----------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+. .....+ ....+..+.+|+.+||..+|.+||++ +++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~-~~~ 276 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA-KQA 276 (282)
T ss_pred hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH-HHH
Confidence 000 000001 12346889999999999999999999 444
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=292.14 Aligned_cols=238 Identities=20% Similarity=0.286 Sum_probs=182.1
Q ss_pred CCCccccee--eeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKI--GEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~L--G~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|.+.+.+ |.|+||.||++... +..+|+|.+....... .|+.+...+ +||||++++++| .+..++||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 345555555 99999999999875 5679999987543221 133333323 799999999987 45789999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC-ceeeecccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQ 679 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~-~vKL~DFGla~~~~~ 679 (846)
||+++|+|.+++... .++++..+..++.||+.||.|||+ .+++||||||+||+++.++ .++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 89 DYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 999999999998533 379999999999999999999999 8999999999999999988 999999999876542
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.. ...|+..|+|||++.+..++.++||||||+++|+|++|+.||........... .+.... ....
T Consensus 163 ~~------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~-~~~~ 227 (267)
T PHA03390 163 PS------------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE--SLLKRQ-QKKL 227 (267)
T ss_pred Cc------------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH--HHHHhh-cccC
Confidence 21 22489999999999988999999999999999999999999974432111000 011111 1111
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+...+..+.+|+.+||+.+|.+||+..+++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 259 (267)
T PHA03390 228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEI 259 (267)
T ss_pred CcccccCHHHHHHHHHHhccChhhCCchHHHH
Confidence 22334567899999999999999999642444
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=311.20 Aligned_cols=242 Identities=26% Similarity=0.383 Sum_probs=201.0
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEE
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 598 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 598 (846)
...+.|.+...||+|.|++|..|+.. +..||||.+.+..... ...+.+|+++|+.|+|||||+|+.+. +..+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34568999999999999999999875 6889999998875543 34688999999999999999999986 567999
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+.+|.++++|.... .+.+..+..++.|+..|++|||+ ++|+|||||.+||||+.+..+||+|||++.++.
T Consensus 133 V~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999996443 45568899999999999999999 999999999999999999999999999999886
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
..... .+.+|++.|.|||++.+..| ++.+|+||+|++||.|+.|..||++..... +....+. .
T Consensus 207 ~~~~l---------qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--Lr~rvl~-----g 270 (596)
T KOG0586|consen 207 YGLML---------QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--LRPRVLR-----G 270 (596)
T ss_pred ccccc---------cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc--ccchhee-----e
Confidence 43321 34569999999999998876 689999999999999999999997654322 1111110 0
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
.-..|...+-++.+|++++|-++|.+|+++.
T Consensus 271 k~rIp~~ms~dce~lLrk~lvl~Pskr~~~d 301 (596)
T KOG0586|consen 271 KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCD 301 (596)
T ss_pred eecccceeechhHHHHHHhhccCccccCCHH
Confidence 1123455667899999999999999999983
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=328.11 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=190.1
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEeccc-----------
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGAC----------- 592 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~----------- 592 (846)
..+|+....||+||||.||+++.+ |..+|||++.... ......+.+|+.+|++|+|||||++|.++
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 347888999999999999999765 8999999998664 22235688999999999999999986322
Q ss_pred -------------------------------------------------c------------------------------
Q 003121 593 -------------------------------------------------P------------------------------ 593 (846)
Q Consensus 593 -------------------------------------------------~------------------------------ 593 (846)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 003121 594 -------------------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642 (846)
Q Consensus 594 -------------------------------~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~ 642 (846)
-.+||-||||+..+|.+++..+.... .....++++.+|++||.|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence 01356788998888888875332111 356789999999999999999
Q ss_pred cCCCceEecccCCCceEecCCCceeeeccccccccc----c--cc----ccCCCccccccCCCCCCcccCChhhhccC--
Q 003121 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS----Q--NE----ISSNNTTLCCRTDPKGTFAYMDPEFLASG-- 710 (846)
Q Consensus 643 ~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~----~--~~----~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-- 710 (846)
+|||||||||.||||+.++.|||+|||+|.... . .. ...........++.+||.-|+|||++.+.
T Consensus 716 ---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 ---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred ---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 899999999999999999999999999998722 0 00 00111111134677899999999999764
Q ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 711 -ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 711 -~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
.|+.|+|+|||||||+||+. ||+..-+....+.. +....-|...++.......-+.+|.++++.||.+|||+.+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~--LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTN--LRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHh--cccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 49999999999999999985 48655443333222 2222222224444455567799999999999999999954
Q ss_pred HH
Q 003121 790 DV 791 (846)
Q Consensus 790 ~v 791 (846)
.+
T Consensus 868 LL 869 (1351)
T KOG1035|consen 868 LL 869 (1351)
T ss_pred Hh
Confidence 43
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=316.83 Aligned_cols=196 Identities=34% Similarity=0.536 Sum_probs=169.8
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccc--------CceE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP--------EVWT 597 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~~~~ 597 (846)
.+.....||+||||.||+|+.+ |..||||.++... ....+...+|+++|++|+|||||+++++=. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455667999999999999876 6789999998754 344577889999999999999999998753 2356
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC--C--ceeeecccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN--F--VSKLSDFGI 673 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~--~--~vKL~DFGl 673 (846)
+|||||.||||+..|..-.+...|++.+.+.++.+++.||.|||. +||+||||||.||++-.+ | ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999999888888899999999999999999999998 899999999999999432 3 469999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALG 736 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~ 736 (846)
|+-+.++.. .+...||..|.+||.+.. +.|+..+|.|||||++|+++||..||-
T Consensus 171 Arel~d~s~---------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 171 ARELDDNSL---------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccCCCCCe---------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 998766531 145679999999999984 789999999999999999999999983
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=292.19 Aligned_cols=247 Identities=27% Similarity=0.402 Sum_probs=198.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcC-CCceeeEecccc--CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~--~~~~lV 599 (846)
++|...+.||.|+||.||+|... +..||+|++..... .....+.+|+.++++++ ||||+++++++. +..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999885 68899999876432 22356889999999998 999999999884 468899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++++|.+++.. ...+++..+..++.+++.||.|||. ++++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999853 3469999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCC------------ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003121 680 NEISSNN------------TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 747 (846)
Q Consensus 680 ~~~~~~~------------~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~ 747 (846)
....... ..........|+..|+|||.+....++.++|+||||+++|++++|+.||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 3211000 0011123346889999999998888999999999999999999999999766543321111
Q ss_pred hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
. .....++...+..+.+|+.+||+.+|.+||++
T Consensus 235 ~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 235 L-------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred H-------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 1 11122334446789999999999999999999
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=309.37 Aligned_cols=237 Identities=22% Similarity=0.331 Sum_probs=200.8
Q ss_pred CCcccceeeeeCceEEEEEEECCeE--EEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccccC--ceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~~~--VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lVmE 601 (846)
++.....||-||||.|-....++.. +|+|++++... ...+++..|-.||..+++|+||+||-.|.+ +.|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3445567999999999998888755 78888877533 335678899999999999999999999954 6889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
-|-||.|...|+ ..+.|+..+...++..+.+|+.|||. +|||+|||||+|+||+.+|.+||.|||+|+.+....
T Consensus 501 aClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999995 34568889999999999999999999 999999999999999999999999999999886543
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HhhhhhccccCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLAG 759 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~--~~~~~~~~~ld~~~~ 759 (846)
.. .+++|||.|.|||++.+...+.++|.||||+++|||+||.|||...+++..- +..+ ++ .-
T Consensus 575 ---KT------wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-----id--~i 638 (732)
T KOG0614|consen 575 ---KT------WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-----ID--KI 638 (732)
T ss_pred ---ce------eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-----hh--hh
Confidence 22 2356999999999999999999999999999999999999999888775421 1111 11 23
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.||...++...+|+++.|..+|.+|...
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~ 666 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLGY 666 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhcc
Confidence 5788889999999999999999999863
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=302.58 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=194.1
Q ss_pred cCCCCChhhhhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEe
Q 003121 514 FFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLV 589 (846)
Q Consensus 514 ~~~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~ 589 (846)
+++.....++...+++|...+.||+|+||.||+|... +..||+|++..... .....+.+|+.++++++||||++++
T Consensus 3 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~ 82 (345)
T cd07877 3 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82 (345)
T ss_pred cchhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccccee
Confidence 3444455666677789999999999999999999864 57899999875321 2235678899999999999999999
Q ss_pred cccc--------CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec
Q 003121 590 GACP--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 661 (846)
Q Consensus 590 g~~~--------~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~ 661 (846)
+++. ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+||+++
T Consensus 83 ~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~ 154 (345)
T cd07877 83 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVN 154 (345)
T ss_pred eeeeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEc
Confidence 8773 2367788876 7899887742 358999999999999999999999 8999999999999999
Q ss_pred CCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchH
Q 003121 662 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKE 740 (846)
Q Consensus 662 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~ 740 (846)
.++.+||+|||+++...... ....|+..|+|||.+.+ ..++.++|||||||++|+|++|++||.....
T Consensus 155 ~~~~~kl~dfg~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 223 (345)
T cd07877 155 EDCELKILDFGLARHTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223 (345)
T ss_pred CCCCEEEecccccccccccc-----------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999987543211 12357899999999866 5688999999999999999999999965433
Q ss_pred HHHHHhhh--------------------hhccccCC----CCCCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 741 VQYALDTG--------------------KLKNLLDP----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 741 ~~~~~~~~--------------------~~~~~ld~----~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
........ .....+.. ...+.....+..+.+|+.+||+.+|.+||++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 295 (345)
T cd07877 224 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 295 (345)
T ss_pred HHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHH
Confidence 22110000 00000000 00000112346789999999999999999983
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=290.77 Aligned_cols=247 Identities=26% Similarity=0.335 Sum_probs=191.4
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
|...+.||.|++|.||+|... +..+++|.+...... ....+.+|+.+|++++||||+++++++ ....++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999875 678999998765332 345788999999999999999999987 45688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++ +|.+++... ..++++..+..++.+++.||.|||. ++|+|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 75 888877533 2578999999999999999999999 89999999999999999999999999999876543210
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh---------ccc
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL---------KNL 753 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~---------~~~ 753 (846)
.....++..|+|||.+.+. .++.++|+||||+++|+|+||++||...+........... ...
T Consensus 155 --------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 155 --------YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred --------ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 1223478899999999876 7899999999999999999999999765543321111000 000
Q ss_pred cC--------------CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 LD--------------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 ld--------------~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.. ..........+..+.+++.+||..+|.+||++ .++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-~~l 277 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA-EQA 277 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH-HHH
Confidence 00 00000111245789999999999999999999 444
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=296.60 Aligned_cols=243 Identities=26% Similarity=0.354 Sum_probs=189.0
Q ss_pred CCcccceeeeeCceEEEEEEE-----CCeEEEEEEecCCCC----CCchhHHHHHHHHHhc-CCCceeeEecccc--Cce
Q 003121 529 NFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL----QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVW 596 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~-----~~~~VAIK~l~~~~~----~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~ 596 (846)
+|...+.||.|+||.||++.. .+..||+|++..... ...+.+.+|+.+|.++ +||||+.+++++. ...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999876 467899999875432 2235688899999999 5999999998874 457
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+++++|.+++.. ..++++..+..++.|++.||.|||+ ++++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 899999999999999853 3468899999999999999999999 8999999999999999999999999999886
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcccc
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 754 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~l 754 (846)
........ .....|+..|+|||.+... .++.++||||||+++|+|+||..||........... +...+
T Consensus 155 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~~ 224 (290)
T cd05613 155 FHEDEVER-------AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE---ISRRI 224 (290)
T ss_pred cccccccc-------cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH---HHHHh
Confidence 54322111 1224589999999998753 478899999999999999999999964322110000 00011
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 755 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
......++...+..+.+|+.+||..+|.+||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~ 257 (290)
T cd05613 225 LKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGC 257 (290)
T ss_pred hccCCCCCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 111223444556789999999999999999843
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=296.50 Aligned_cols=241 Identities=28% Similarity=0.379 Sum_probs=188.3
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
.|...+.||+|+||.||+|... +..||+|.+....... ...+.+|+.+++.++|||+++++++|. +..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777889999999999999874 5789999987543322 246888999999999999999999883 46889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|++| +|.+.+... ..++++..+..++.+++.||.|||+ ++++||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9975 777766422 3568999999999999999999999 89999999999999999999999999998754321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
....|++.|+|||++. .+.++.++|||||||++|+|++|++||............. .... +
T Consensus 179 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~--~~~~-~-- 242 (317)
T cd06635 179 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--QNES-P-- 242 (317)
T ss_pred -----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--hccC-C--
Confidence 1234889999999974 4568899999999999999999999986543322111110 0000 0
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 793 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~ 793 (846)
...+...+..+.+|+.+||+.+|.+||++ .+++.
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~il~ 276 (317)
T cd06635 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTS-EELLK 276 (317)
T ss_pred CCCCccccHHHHHHHHHHccCCcccCcCH-HHHHh
Confidence 01112335679999999999999999999 55543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=302.75 Aligned_cols=249 Identities=25% Similarity=0.315 Sum_probs=190.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEeccccC-------ce
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VW 596 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-------~~ 596 (846)
.+|...+.||+|+||.||+|... +..||||.+.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 46888999999999999999875 5789999987542 2233467789999999999999999998732 37
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+. ++|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 85 YIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 89999995 68888874 23569999999999999999999999 8999999999999999999999999999986
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH----------
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL---------- 745 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~---------- 745 (846)
....... .....|+..|+|||.+.. ..++.++|||||||++|+|++|++||...+......
T Consensus 158 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (337)
T cd07858 158 TSEKGDF--------MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS 229 (337)
T ss_pred cCCCccc--------ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 6432110 122357899999998865 468899999999999999999999996543221100
Q ss_pred -------hhhhhcccc-------CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 746 -------DTGKLKNLL-------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 746 -------~~~~~~~~l-------d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
........+ .+.........+..+.+|+.+||+.+|.+||++ ++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~-~ell 289 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV-EEAL 289 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCH-HHHH
Confidence 000000000 000001112345778999999999999999999 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=289.55 Aligned_cols=233 Identities=24% Similarity=0.282 Sum_probs=181.5
Q ss_pred ceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCc---hhHHHHHHHH-HhcCCCceeeEecccc--CceEEEEEecCC
Q 003121 534 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---SEFQQEIDIL-SKIRHPNLVTLVGACP--EVWTLVYEYLPN 605 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~---~~f~~Ei~iL-~~l~HpnIv~l~g~~~--~~~~lVmEy~~g 605 (846)
+.||.|+||.||+|... ++.||+|.+........ ..+..|..++ ..++||||+++++++. +..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999874 57899999875432221 2344555544 4458999999999984 468999999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
++|.+++.. ..++++..+..++.|++.||.|||+ .+++||||+|.|||++.++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 999999843 3468899999999999999999999 89999999999999999999999999998754321
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 765 (846)
....|++.|++||.+.+..++.++||||||+++|+|+||.+||............. ..... .....+...
T Consensus 151 -------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~ 220 (260)
T cd05611 151 -------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL--SRRIN-WPEEVKEFC 220 (260)
T ss_pred -------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hcccC-CCCcccccC
Confidence 12348899999999988889999999999999999999999997654322111110 00111 011112234
Q ss_pred HHHHHHHHHHHhccCcCCCCCh
Q 003121 766 AEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 766 ~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
+..+.+++.+||..+|.+||++
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~ 242 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGA 242 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCC
Confidence 6789999999999999999977
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=336.50 Aligned_cols=246 Identities=26% Similarity=0.332 Sum_probs=196.3
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
.+-++.....||.|.||.||.|... |...|+|-++.... .....+.+|+.+|..++|||+|++||+= .+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3446777788999999999999875 55689997765433 2345688999999999999999999974 5678999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
||||.+|+|.+++. .+.-+++.....+..|++.||.|||+ +|||||||||+||||+.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999994 33446777888999999999999999 9999999999999999999999999999998765
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHHhhhhhccccC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKE-VQYALDTGKLKNLLD 755 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~~~ksDVwSlGviL~elltG~~pf~~~~~-~~~~~~~~~~~~~ld 755 (846)
...... ......+||+.|||||++.+. +...+.||||+||+++||+||+.||...+. ..-....+ .
T Consensus 1387 ~~~~~~----~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~------~ 1456 (1509)
T KOG4645|consen 1387 NAQTMP----GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA------A 1456 (1509)
T ss_pred chhcCC----HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh------c
Confidence 421111 112346799999999999753 467799999999999999999999964432 22111111 1
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.-.+..|...+..-.+++.+||..||+.|-++
T Consensus 1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~ 1488 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTA 1488 (1509)
T ss_pred cCCCCCchhhhHhHHHHHHHHHhcCchhhhHH
Confidence 12345566678889999999999999999665
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=294.29 Aligned_cols=251 Identities=27% Similarity=0.365 Sum_probs=191.5
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccccC-------
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE------- 594 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~------- 594 (846)
..++|.+.+.||.|+||.||+|... +..||||.++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3457888999999999999999985 57899999875432 223467889999999999999999998732
Q ss_pred -----ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeee
Q 003121 595 -----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 669 (846)
Q Consensus 595 -----~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~ 669 (846)
..++||||+++ +|.+.+... ...+++..+..++.||+.||.|||+ ++|+||||||.||+++.++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence 57899999976 666666432 3468999999999999999999999 899999999999999999999999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003121 670 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 748 (846)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~ 748 (846)
|||++.......... .....++..|+|||.+.+. .++.++|||||||++|+|++|++||.............
T Consensus 159 dfg~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 159 DFGLARLYNSEESRP-------YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred cccccccccCCcccc-------cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999998764432111 0123468889999988654 57899999999999999999999997655433221111
Q ss_pred hhcccc-----------------CC-------CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 749 KLKNLL-----------------DP-------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 749 ~~~~~l-----------------d~-------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...... ++ ....+ ...+..+.+|+.+||..+|.+||++ .++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~-~~i 296 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTA-EEA 296 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCH-HHH
Confidence 100000 00 00011 1235789999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=294.92 Aligned_cols=256 Identities=25% Similarity=0.309 Sum_probs=189.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccc---------
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--------- 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------- 593 (846)
.++|...++||.|+||.||+|... +..||||.+......+ ...+.+|+++++.++||||+++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999886 5789999886543322 346788999999999999999998762
Q ss_pred -CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccc
Q 003121 594 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 672 (846)
Q Consensus 594 -~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFG 672 (846)
...++||||+.+ +|...+.. ....+++..+..++.|++.||.|||. ++|+|+||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCc
Confidence 236899999965 66666632 23469999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCc---cccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003121 673 ISRFLSQNEISSNNT---TLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 748 (846)
Q Consensus 673 la~~~~~~~~~~~~~---~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~ 748 (846)
+++............ .....+...|++.|+|||.+.+. .++.++|||||||++|+|++|++||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 998664332211100 00011234578999999988654 58899999999999999999999997654432111100
Q ss_pred hhc---------------cccC-CCCCCCC-------hhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 749 KLK---------------NLLD-PLAGDWP-------FVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 749 ~~~---------------~~ld-~~~~~~p-------~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
... ...+ ......+ ......+.+++.+||..+|.+||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ 303 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTAS 303 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHH
Confidence 000 0000 0000011 11225788999999999999999983
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=287.18 Aligned_cols=243 Identities=30% Similarity=0.421 Sum_probs=196.3
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
+|....+||.|+||.||++... +..+++|.+...... ....+.+|+.+++.++||||+++++++ ....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999775 568999998764322 234678899999999999999999887 3568899999
Q ss_pred cCCCchhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 603 LPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 603 ~~ggsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
+++++|.+++.... ....+++..+..++.+++.||.|||+ +|++|+||+|.||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999885432 23568999999999999999999999 899999999999999999999999999998765431
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
. ....|++.|++||.+.+..++.++|+||||+++|+|++|++||............ ..... +..
T Consensus 158 -~---------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~~~~----~~~ 221 (256)
T cd08530 158 -A---------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV--QRGKY----PPI 221 (256)
T ss_pred -c---------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hcCCC----CCC
Confidence 1 1234789999999999888999999999999999999999999766543221111 11111 122
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+...+..+.+++.+||..+|.+||++ .++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~-~~~ 250 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNC-DKI 250 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCH-HHH
Confidence 33456789999999999999999999 444
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=288.51 Aligned_cols=244 Identities=24% Similarity=0.352 Sum_probs=190.8
Q ss_pred CCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCC-----CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL-----QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~-----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
+|.+.++||+|+||.||++.... ..+++|+++.... .....+..|+.+++.++||||+++++++. ...++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46777899999999999998764 3466666654322 12235778999999999999999999883 468899
Q ss_pred EEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 600 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
|||+++++|.+++... .....+++..+..++.+++.||.|||+ +|++|+||+|+||+++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 234579999999999999999999999 89999999999999985 569999999988664
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||............ .....
T Consensus 157 ~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~~~~~ 222 (260)
T cd08222 157 GSCDL--------ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI------VEGPT 222 (260)
T ss_pred CCccc--------ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------HcCCC
Confidence 32211 12235889999999998888999999999999999999999999755443322111 11112
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+...+..+.+++.+||..+|.+||++ .++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i 254 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSA-AEI 254 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCH-HHH
Confidence 22344556789999999999999999999 444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=293.90 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=187.7
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcC-CCceeeEecccc--CceEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~--~~~~lVm 600 (846)
.++|.....||+|+||.||+|.+. +..||||.+...... ....+..|+.++.++. ||||++++++|. ...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 356888899999999999999987 788999999764322 2345677888777775 999999999983 4688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+. ++|.+++... ..++++..+..++.+|+.||.|||+. ++|+||||+|+||+++.++.+||+|||++..+...
T Consensus 94 e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 5777766432 24789999999999999999999972 48999999999999999999999999998765432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGE----LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.........+... +... .+
T Consensus 169 ~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~-~~ 237 (296)
T cd06618 169 KAK---------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI-LQEE-PP 237 (296)
T ss_pred Ccc---------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH-hcCC-CC
Confidence 211 1234788999999987543 7889999999999999999999996533221111110 1110 01
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.. ......+..+.+|+.+||..+|.+||++ +++
T Consensus 238 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~-~~i 270 (296)
T cd06618 238 SL-PPNEGFSPDFCSFVDLCLTKDHRKRPKY-REL 270 (296)
T ss_pred CC-CCCCCCCHHHHHHHHHHccCChhhCCCH-HHH
Confidence 11 1111245789999999999999999999 444
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=309.08 Aligned_cols=199 Identities=30% Similarity=0.394 Sum_probs=168.6
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-C-----CceeeEeccc--cCce
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-H-----PNLVTLVGAC--PEVW 596 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-H-----pnIv~l~g~~--~~~~ 596 (846)
..+|.+.+.||+|.||.|.++... +..||||+++..... ..+-..|+.||..|+ | -|+|+++++| ..+.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 337888999999999999999887 467999999865322 345567999999997 3 4899999987 6789
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC--CCceeeeccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA--NFVSKLSDFGIS 674 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~--~~~vKL~DFGla 674 (846)
|||+|.+ ..+|.++|..+. -.+|+...++.|+.||+.||.+||. .+|||+||||+||||.. ...+||+|||.|
T Consensus 264 ciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999 569999996554 3569999999999999999999999 89999999999999964 348999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 742 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~ 742 (846)
.+...... .-.-+..|.|||++.+.+|+.+.||||||||+.||+||.|.|.+.++..
T Consensus 339 c~~~q~vy-----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 339 CFESQRVY-----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred cccCCcce-----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 98765432 1124778999999999999999999999999999999999997766643
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=295.31 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=193.0
Q ss_pred CCcccceeeeeCceEEEEEEEC-----CeEEEEEEecCCCC----CCchhHHHHHHHHHhc-CCCceeeEecccc--Cce
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSL----QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVW 596 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~~----~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~ 596 (846)
+|...+.||+|+||.||++... +..||||.+..... .....+.+|+.++.++ +||||+++++.+. ...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677889999999999998753 46799999875322 2235688999999999 6999999998874 468
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||. .+++||||+|.||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 899999999999998853 2468899999999999999999999 8999999999999999999999999999876
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHhhhhhcc
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKN 752 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~~~ksDVwSlGviL~elltG~~pf~~~~~~--~~~~~~~~~~~ 752 (846)
+...... ......|+..|+|||.+.+.. ++.++||||||+++|+|+||..||...... ...+... ...
T Consensus 155 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~ 226 (288)
T cd05583 155 FLAEEEE-------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR-ILK 226 (288)
T ss_pred ccccccc-------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH-HHc
Confidence 5433211 112235899999999987654 788999999999999999999999643221 1111111 111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 753 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
.....+...+..+.+++.+||+.+|.+||++ ..+.+.|+
T Consensus 227 ----~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~-~~~~~~l~ 265 (288)
T cd05583 227 ----SKPPFPKTMSAEARDFIQKLLEKDPKKRLGA-NGADEIKN 265 (288)
T ss_pred ----cCCCCCcccCHHHHHHHHHHhcCCHhhccCc-chHHHHhc
Confidence 1122333445789999999999999999998 55555554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=291.29 Aligned_cols=230 Identities=26% Similarity=0.327 Sum_probs=178.3
Q ss_pred eeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHH---HHhcCCCceeeEecccc--CceEEEEEecC
Q 003121 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDI---LSKIRHPNLVTLVGACP--EVWTLVYEYLP 604 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~i---L~~l~HpnIv~l~g~~~--~~~~lVmEy~~ 604 (846)
.||+|+||.||++... ++.||+|.+....... ...+..|..+ ++...||||+.+++++. +..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999775 5789999987643221 1224444443 44457999999999873 56889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
||+|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++..+.....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 9999998842 3569999999999999999999999 8999999999999999999999999999875532210
Q ss_pred CCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHhhhhhccccCCCCCCCC
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~-~~~~~~~~~~~ld~~~~~~p 762 (846)
....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||....... ...... .......++
T Consensus 153 --------~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~ 219 (278)
T cd05606 153 --------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----TLTMAVELP 219 (278)
T ss_pred --------cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-----hhccCCCCC
Confidence 123589999999999755 68999999999999999999999996542211 111111 111122334
Q ss_pred hhhHHHHHHHHHHHhccCcCCCC
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
...+..+.+++.+||..+|.+||
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhcc
Confidence 44568899999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=297.23 Aligned_cols=251 Identities=21% Similarity=0.240 Sum_probs=184.5
Q ss_pred eeeee--CceEEEEEEE--CCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCCC
Q 003121 535 KIGEG--GYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 535 ~LG~G--~fG~Vy~g~~--~~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
.||+| +||+||++.. .++.||+|++....... .+.+.+|+.+++.++||||++++++| .+..++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999987 46899999987643322 35688999999999999999999998 45688999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+|++|||.+.......... .
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~-~ 159 (328)
T cd08226 85 SANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA-K 159 (328)
T ss_pred CHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc-c
Confidence 9999886442 2358899999999999999999999 899999999999999999999999998654332211110 0
Q ss_pred ccccccCCCCCCcccCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc-------------
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK------------- 751 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~--~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~------------- 751 (846)
..........++..|+|||++.+. .++.++|||||||++|+|++|++||................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 000000112356789999999764 57899999999999999999999997544322211110000
Q ss_pred --------------------------ccc-CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHH
Q 003121 752 --------------------------NLL-DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 790 (846)
Q Consensus 752 --------------------------~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 790 (846)
... .......+...+..+.+|+.+||+.+|.+|||+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~ 305 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL 305 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHH
Confidence 000 000111122346789999999999999999999443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=300.84 Aligned_cols=254 Identities=27% Similarity=0.384 Sum_probs=190.6
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC--CCCCchhHHHHHHHHHhc-CCCceeeEeccccC----ceE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE----VWT 597 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~--~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~----~~~ 597 (846)
.++|...+.||+|+||.||+|... +..+|+|.+... .......+.+|+.+++++ +||||++++++|.. ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 356888889999999999999875 578999988643 222334677899999999 99999999998732 478
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||++ ++|..++.. ..+++..+..++.+|+.||.|||+ +||+||||||+|||++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 589888742 268899999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh---------
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--------- 747 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~--------- 747 (846)
.......... ......||+.|+|||.+.+ ..++.++||||||+++|+|+||++||............
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 158 SELEENPENP---VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred ccccccccCc---chhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 5432111000 1123458999999998765 45788999999999999999999999654332211000
Q ss_pred --------hhhccccC----C---CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 748 --------GKLKNLLD----P---LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 748 --------~~~~~~ld----~---~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
.....+++ . .........+..+.+|+.+||+.+|.+||++ .+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~-~~il 293 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA-EEAL 293 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH-HHHh
Confidence 00000000 0 0001111245789999999999999999999 4443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=320.33 Aligned_cols=252 Identities=19% Similarity=0.242 Sum_probs=176.3
Q ss_pred CCCcccceeeeeCceEEEEEEECCe---EEEEEEec--------------CC---CCCCchhHHHHHHHHHhcCCCceee
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRHM---QVAIKMLH--------------PH---SLQGPSEFQQEIDILSKIRHPNLVT 587 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~VAIK~l~--------------~~---~~~~~~~f~~Ei~iL~~l~HpnIv~ 587 (846)
.+|.+..+||+|+||+||++.++.. .+++|.+. .. .......+.+|+.+|+.++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 5799999999999999999876421 12222110 00 0111245789999999999999999
Q ss_pred Eeccc--cCceEEEEEecCCCchhhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC
Q 003121 588 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKD--NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 663 (846)
Q Consensus 588 l~g~~--~~~~~lVmEy~~ggsL~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~ 663 (846)
+++++ .+..|+|++++. ++|.+++.... .........+..|+.||+.||.|||+ ++||||||||+||||+.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCC
Confidence 99998 456889999985 56666653321 11223456778899999999999999 899999999999999999
Q ss_pred CceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCC-CCCCch--H
Q 003121 664 FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP-ALGITK--E 740 (846)
Q Consensus 664 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~-pf~~~~--~ 740 (846)
+.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+||||++|.. |+.... .
T Consensus 304 ~~vkL~DFGla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREA-------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred CCEEEEeCCCceecCccccc-------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 99999999999876432211 1123469999999999999999999999999999999999874 443221 1
Q ss_pred HHHHHhhhh---------------hccccCC-----CCCCCC-----hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 741 VQYALDTGK---------------LKNLLDP-----LAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 741 ~~~~~~~~~---------------~~~~ld~-----~~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
......... +...++. .....+ ...+..+.+++.+||..||.+||++ .++
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa-~el 451 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA-AEL 451 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH-HHH
Confidence 111111000 0000000 000000 0123467888999999999999999 444
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=299.88 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=186.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccccC--------c
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE--------V 595 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--------~ 595 (846)
.+|.....||+|+||.||+|... +..||||.+..... .....+.+|+.+++.++||||++++++|.. .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 57888899999999999999864 67899999875322 123457899999999999999999998732 3
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
+++||||+. ++|..++ ...+++..+..++.|++.||.|||. ++++||||||+|||++.++.+||+|||+++
T Consensus 95 ~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred EEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 589999996 4776655 2358899999999999999999999 899999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh-----
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----- 749 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~----- 749 (846)
...... ....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..............
T Consensus 166 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (342)
T cd07879 166 HADAEM-----------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 234 (342)
T ss_pred CCCCCC-----------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 543211 12347889999999876 4689999999999999999999999976543221111000
Q ss_pred ------------hccccC--CC--CCCC---ChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 750 ------------LKNLLD--PL--AGDW---PFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 750 ------------~~~~ld--~~--~~~~---p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
...... +. ...+ ....+..+.+|+.+||+.+|.+||++ ++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~-~e~l 295 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA-TEAL 295 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH-HHHh
Confidence 000000 00 0000 01234568999999999999999999 5553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=298.38 Aligned_cols=251 Identities=25% Similarity=0.328 Sum_probs=193.2
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEeccccC-------ceE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VWT 597 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-------~~~ 597 (846)
+|.+.+.||.|+||.||+|... +..||||.+.... ......+.+|+.+++.++||||+++++++.. ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778889999999999999876 5789999987643 2334678999999999999999999998732 478
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||++ ++|.+++.. ..++++..+..++.+|+.||.|||+ +||+||||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 588888843 3379999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh-------
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------- 749 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~------- 749 (846)
....... .......+++.|+|||++.+. .++.++|+||||+++|+|++|++||..............
T Consensus 154 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 228 (330)
T cd07834 154 DPDEDEK-----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228 (330)
T ss_pred ccccccc-----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence 5432100 011234589999999999887 789999999999999999999999976543221110000
Q ss_pred ----------hccccCCCC-------CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 750 ----------LKNLLDPLA-------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 750 ----------~~~~ld~~~-------~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
....+.... .......+..+.+|+.+||+.+|.+||++ ++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~ll 287 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA-DEAL 287 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH-HHHH
Confidence 000000000 00011235678999999999999999999 4443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=300.96 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=189.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccccC-----------
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----------- 594 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----------- 594 (846)
.+|...+.||.|+||.||+|... +..||+|.+..........+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57899999999999999999875 57899999877655556678899999999999999999987632
Q ss_pred -----ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec-CCCceee
Q 003121 595 -----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKL 668 (846)
Q Consensus 595 -----~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~-~~~~vKL 668 (846)
..++||||+. ++|.+++. ...+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence 3689999997 58888773 2358899999999999999999999 8999999999999997 4567899
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 747 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~ 747 (846)
+|||+++.+........ ......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||............
T Consensus 157 ~dfg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 157 GDFGLARIVDPHYSHKG-----YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred CCcccceecCCcccccc-----ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999986543211110 0122357889999998755 46888999999999999999999999655432221110
Q ss_pred hh------------hc-----ccc-CCCCCC-----CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 748 GK------------LK-----NLL-DPLAGD-----WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 748 ~~------------~~-----~~l-d~~~~~-----~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.. +. ... ...... .....+..+.+|+.+||..+|.+||++ .++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~el 297 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA-EEA 297 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH-HHH
Confidence 00 00 000 000000 011234678999999999999999999 444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=339.15 Aligned_cols=249 Identities=30% Similarity=0.477 Sum_probs=194.4
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
.|.....||+|+||.||+|... +..||||.+..... ....|+.++++++|||||+++|+| .+..++||||++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 4666778999999999999864 67899999864332 224578999999999999999998 346889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+|+|.+++. .++|..+..|+.+|+.||.|||.....+|+||||||+||+++.++..++. ||........
T Consensus 767 ~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 767 GKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 999999983 38899999999999999999996444799999999999999999888875 6654432111
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHhhhhhccccCC
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--------EVQYALDTGKLKNLLDP 756 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~--------~~~~~~~~~~~~~~ld~ 756 (846)
....||+.|+|||++.+..++.++|||||||++|||+||++||.... +............++++
T Consensus 836 --------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 836 --------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred --------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 12258999999999999999999999999999999999999985321 11111112222333343
Q ss_pred CCC---CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 757 LAG---DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 757 ~~~---~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
... ..+......+.+++.+||+.+|.+||++ .++++.|+.+...
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~-~evl~~L~~~~~~ 954 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA-NDVLKTLESASRS 954 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH-HHHHHHHHHhhcc
Confidence 321 2233455678899999999999999999 7888888877554
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=287.05 Aligned_cols=247 Identities=29% Similarity=0.384 Sum_probs=187.8
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhc---CCCceeeEecccc--Cc-----
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI---RHPNLVTLVGACP--EV----- 595 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l---~HpnIv~l~g~~~--~~----- 595 (846)
|...+.||.|+||.||+|... +..||+|.+....... ...+.+|+.++.++ +||||++++++|. +.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566788999999999999986 5789999997543221 24567788888766 5999999999983 33
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.+++|||+.+ +|.+++.... ...+++..+..++.+++.||.|||+ ++++|+||+|+|||++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 7899999974 7888875432 2358999999999999999999999 899999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc----
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK---- 751 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~---- 751 (846)
........ ....++..|+|||++.+..++.++|||||||++|+|++|.+||................
T Consensus 156 ~~~~~~~~---------~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07838 156 IYSFEMAL---------TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPS 226 (287)
T ss_pred eccCCccc---------ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCC
Confidence 76433211 12247889999999998889999999999999999999999997654432211100000
Q ss_pred ------------cccCCCC----CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 752 ------------NLLDPLA----GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 752 ------------~~ld~~~----~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....... .......+..+.+++.+||+.+|.+||++ .++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~-~~i 281 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA-FEA 281 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH-HHH
Confidence 0000000 00011235678999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=290.12 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=188.5
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcC-CCceeeEeccc--cCceEEEEEec
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
|.+.+.||.|+||.||+|... +..|+||.+...... ......+|+..+++++ ||||+++++++ .+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 556778999999999999985 577999998754322 2234567999999999 99999999988 45689999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
+|+|.+.+.... ...+++..+..++.+++.+|.|||+ ++++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 789988885433 3468999999999999999999999 89999999999999999999999999998865432211
Q ss_pred CCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh-------------
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------- 749 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~------------- 749 (846)
....|+..|+|||++.. ..++.++|+||||+++|+|++|++||..............
T Consensus 156 ---------~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07830 156 ---------TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226 (283)
T ss_pred ---------CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence 22347899999998854 4578999999999999999999999965543322111000
Q ss_pred --hccccC----CC----CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 750 --LKNLLD----PL----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 750 --~~~~ld----~~----~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+..... .. ........+..+.+|+.+||..+|.+||++ +++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-~ei 277 (283)
T cd07830 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA-SQA 277 (283)
T ss_pred hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH-HHH
Confidence 000000 00 001111124679999999999999999999 544
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=298.49 Aligned_cols=245 Identities=23% Similarity=0.331 Sum_probs=189.1
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccccC-------
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE------- 594 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~------- 594 (846)
..++|...+.||+|+||.||++... +..||||.+...... ....+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4567999999999999999999875 578999998653221 23467899999999999999999998732
Q ss_pred -ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 595 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 595 -~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
.+++||||+ +++|.+++. ...+++..+..++.||+.||.|||. +||+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999 779988873 2468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh--
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-- 750 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~-- 750 (846)
+....... ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|++||...............
T Consensus 165 ~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 165 ARQTDSEM-----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233 (343)
T ss_pred ccccccCc-----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 87653211 12347899999999876 45889999999999999999999999765432211110000
Q ss_pred ---------------ccccCCC-------CCCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 751 ---------------KNLLDPL-------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 751 ---------------~~~ld~~-------~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
...+... ...+....+..+.+++.+|++.+|.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~ 294 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAE 294 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHH
Confidence 0000000 00011123456899999999999999999943
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=295.47 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=188.2
Q ss_pred CCcc-cceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--------------chhHHHHHHHHHhcCCCceeeEecc
Q 003121 529 NFDP-SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--------------PSEFQQEIDILSKIRHPNLVTLVGA 591 (846)
Q Consensus 529 ~f~~-~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--------------~~~f~~Ei~iL~~l~HpnIv~l~g~ 591 (846)
+|.. .+.||.|+||.||+|... +..||||.+....... ...+.+|+.+++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 4543 456999999999999865 5789999986543221 1247789999999999999999998
Q ss_pred c--cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeee
Q 003121 592 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 669 (846)
Q Consensus 592 ~--~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~ 669 (846)
+ .+..++||||+. |+|.+++.. ...+++.....++.|++.||.|||. ++++||||+|+|||++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence 7 456889999996 688888842 3458999999999999999999999 899999999999999999999999
Q ss_pred ccccccccccccccCC-----C-ccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 003121 670 DFGISRFLSQNEISSN-----N-TTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 742 (846)
Q Consensus 670 DFGla~~~~~~~~~~~-----~-~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~ 742 (846)
|||++........... . ..........+++.|+|||.+.+. .++.++|||||||++|+|+||.+||.......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999987652211100 0 000011234578899999998764 47899999999999999999999997665432
Q ss_pred HHHhhhhhccccCCCCCCC-----------------------ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 743 YALDTGKLKNLLDPLAGDW-----------------------PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 743 ~~~~~~~~~~~ld~~~~~~-----------------------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
........ ...+....| ....+..+.+++.+||..+|.+||++ +++
T Consensus 242 ~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-~~~ 310 (335)
T PTZ00024 242 QLGRIFEL--LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA-KEA 310 (335)
T ss_pred HHHHHHHH--hCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH-HHH
Confidence 21110000 000000000 11235678999999999999999999 444
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=296.26 Aligned_cols=246 Identities=24% Similarity=0.302 Sum_probs=189.2
Q ss_pred hhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc---Cce
Q 003121 524 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP---EVW 596 (846)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~---~~~ 596 (846)
-..+++|...+.||.|+||.||++... +..||||.+..... .....+.+|+.+++.++||||++++++|. ...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345678999999999999999999865 57899998865322 22456889999999999999999999872 458
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+ +++|.+++. ..++++..+..++.|++.||.|||+ ++|+||||+|.|||++.++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 568888873 2357888899999999999999999 8999999999999999999999999999875
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh--------
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-------- 747 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~-------- 747 (846)
..... ....++..|+|||.+.+ ..++.++|||||||++|+|+||++||............
T Consensus 158 ~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 158 QDPQM-----------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred cCCCc-----------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 43211 12347889999998866 56899999999999999999999999655432111000
Q ss_pred ---------hhhccccCCC--CCCCC-----hhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 748 ---------GKLKNLLDPL--AGDWP-----FVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 748 ---------~~~~~~ld~~--~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
......+... ....| ...+..+.+++.+||+.+|.+||++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ 283 (328)
T cd07856 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA 283 (328)
T ss_pred HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 0000000000 00011 12357899999999999999999993
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=292.15 Aligned_cols=240 Identities=28% Similarity=0.385 Sum_probs=186.7
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
.|...+.||.|+||.||+|... +..||+|.+...... ....+.+|+.+++.++|||++++++++ ....++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4667778999999999999875 577999988643222 234577899999999999999999987 456889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+. |+|.+.+... ..++++..+..++.+++.||.|||+ ++++||||+|+|||++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 5777766422 3468899999999999999999999 89999999999999999999999999998765321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
....|++.|+|||.+. .+.++.++|||||||++|+|++|..||............. ... .+.
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~-~~~- 233 (308)
T cd06634 169 -----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--QNE-SPA- 233 (308)
T ss_pred -----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh--hcC-CCC-
Confidence 1234789999999985 3568889999999999999999999986544322111110 000 010
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
..+...+..+.+|+.+||..+|.+||++ ++++
T Consensus 234 -~~~~~~~~~~~~li~~cl~~~P~~Rp~~-~~ll 265 (308)
T cd06634 234 -LQSGHWSEYFRNFVDSCLQKIPQDRPTS-EVLL 265 (308)
T ss_pred -cCcccccHHHHHHHHHHhhCCcccCCCH-HHHh
Confidence 0112345779999999999999999999 5553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=294.82 Aligned_cols=251 Identities=23% Similarity=0.275 Sum_probs=186.7
Q ss_pred CCcccceeeeeCceEEEEEEECC----eEEEEEEecCCCCC--CchhHHHHHHHHHhc-CCCceeeEecccc------Cc
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQ--GPSEFQQEIDILSKI-RHPNLVTLVGACP------EV 595 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~----~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~------~~ 595 (846)
+|...+.||+|+||.||++...+ ..||||.+...... ....+.+|+.+++++ +||||+++++.+. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999998864 47999998643211 234678899999999 5999999998641 34
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.+++++|+. ++|.+++. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678899885 68888884 33568999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---h-----
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL---D----- 746 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~---~----- 746 (846)
.+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+...... .
T Consensus 154 ~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd07857 154 GFSENPGENA----GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229 (332)
T ss_pred eccccccccc----ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence 6643321111 01123468999999998765 468999999999999999999999997544211100 0
Q ss_pred ---------hhhh-------ccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 747 ---------TGKL-------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 747 ---------~~~~-------~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.... ...............+..+.+|+.+||+.+|.+||++ .++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-~~l 289 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV-EEA 289 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH-HHH
Confidence 0000 0000000000011135679999999999999999999 444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=286.36 Aligned_cols=247 Identities=29% Similarity=0.425 Sum_probs=191.2
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
|.....||+|+||.||+|... +..||+|.+.... ......+..|+.+++.++||||+++++++. +..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999886 5789999998753 223456889999999999999999999874 4688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
+ ++|.+++.... ..+++..+..++.+++.||.|||. ++|+||||+|+||+++.++.+||+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58999885332 468999999999999999999999 89999999999999999999999999999876432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh------------
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL------------ 750 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~------------ 750 (846)
.....++..|+|||.+.+. .++.++|||||||++|+|++|++||...............
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 155 --------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred --------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 1123467889999999776 7899999999999999999999999765543221111000
Q ss_pred ccc--cCCCCCCCC--------hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 KNL--LDPLAGDWP--------FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 ~~~--ld~~~~~~p--------~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
... .+.....++ ...+..+.+++.+||..+|.+||++ .++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-~~~ 276 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA-KEA 276 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCH-HHH
Confidence 000 000001110 1125679999999999999999999 444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=307.84 Aligned_cols=239 Identities=21% Similarity=0.377 Sum_probs=182.4
Q ss_pred cceeeeeCceEEEEEEECCeE--EE---EEEecCC-CCCCchhHHHHHHHHHhcCCCceeeEeccccC----ceEEEEEe
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQ--VA---IKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVYEY 602 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~--VA---IK~l~~~-~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----~~~lVmEy 602 (846)
..+||+|.|-+||+|.+.... || ||.-... .....+.|..|+.+|+.|+|||||++|+++.+ ...+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 346999999999999987543 33 2221111 11224679999999999999999999999832 36799999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-CCceeeecccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-~~~vKL~DFGla~~~~~~~ 681 (846)
+..|+|+.++.+. ..++...+..|+.||++||.|||+..| +|||||||.+||||+. -|.|||+|+|||.......
T Consensus 125 ~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999544 447788999999999999999999776 8999999999999975 5899999999999876543
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
. ....|||.|||||++. ..|+..+||||||++++||+|+..|+.--......... ...-+.|.. +
T Consensus 201 a----------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK--V~SGiKP~s--l 265 (632)
T KOG0584|consen 201 A----------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK--VTSGIKPAA--L 265 (632)
T ss_pred c----------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH--HHcCCCHHH--h
Confidence 2 1246999999999996 78999999999999999999999998532221111111 111111110 1
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.......+.++|.+|+.. ..+||++.+.+
T Consensus 266 ~kV~dPevr~fIekCl~~-~~~R~sa~eLL 294 (632)
T KOG0584|consen 266 SKVKDPEVREFIEKCLAT-KSERLSAKELL 294 (632)
T ss_pred hccCCHHHHHHHHHHhcC-chhccCHHHHh
Confidence 112245799999999999 99999994443
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=289.44 Aligned_cols=238 Identities=27% Similarity=0.380 Sum_probs=185.4
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
|....+||+|+||.||+|... +..|++|.+....... ...+.+|+.+++.++|||++++++++. +..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555677999999999999874 5789999987543322 245788999999999999999999884 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+. |+|.+++... ..++++..+..++.+|+.||.|||+ +|++||||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 96 5777776432 3468999999999999999999999 89999999999999999999999999987643211
Q ss_pred cCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
....|+..|+|||++. .+.++.++|||||||++|+|++|.+||.............. ... +..
T Consensus 175 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~--~~~- 240 (313)
T cd06633 175 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDS--PTL- 240 (313)
T ss_pred ----------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-cCC--CCC-
Confidence 2235889999999984 35688999999999999999999999966544332221111 010 100
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+..+.+|+.+||+.+|.+||++ .++
T Consensus 241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~-~~~ 270 (313)
T cd06633 241 -QSNEWTDSFRGFVDYCLQKIPQERPAS-AEL 270 (313)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 011223579999999999999999999 444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=280.81 Aligned_cols=232 Identities=30% Similarity=0.398 Sum_probs=189.8
Q ss_pred eeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCch
Q 003121 536 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 608 (846)
Q Consensus 536 LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggsL 608 (846)
||.|+||.||++... +..+++|.+...... ....+..|+.++++++||||+++++.+. ...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999886 578999998765433 2357889999999999999999999874 467899999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCcc
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 688 (846)
.+++... ..+++..+..++.|++.||.|||. .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------ 148 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------ 148 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC------
Confidence 9998533 368999999999999999999999 8999999999999999999999999999886543210
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHH
Q 003121 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 768 (846)
Q Consensus 689 ~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 768 (846)
......|+..|++||.+.+..++.++|+||||+++|+|++|+.||........ ... . .. ....++...+..
T Consensus 149 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~~--~---~~-~~~~~~~~~~~~ 219 (250)
T cd05123 149 --RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-YEK--I---LK-DPLRFPEFLSPE 219 (250)
T ss_pred --cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHH--H---hc-CCCCCCCCCCHH
Confidence 01234588999999999888889999999999999999999999976553221 111 0 00 122344445688
Q ss_pred HHHHHHHHhccCcCCCCChH
Q 003121 769 LANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 769 l~~Li~~Cl~~~P~~RPt~~ 788 (846)
+.+++.+||..+|.+||++.
T Consensus 220 l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHHHHHHHhcCCHhhCCCcc
Confidence 99999999999999999984
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=280.82 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=193.0
Q ss_pred hcCCCccc-ceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccccC------c
Q 003121 526 ATHNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE------V 595 (846)
Q Consensus 526 ~~~~f~~~-~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~------~ 595 (846)
.+++|.+. .+||-|-.|.|-.+..+ +..+|+|++.. ....++|+++.-.. .|||||.++++|.+ .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34456543 47999999999988776 56799999863 34678999987666 69999999998843 4
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC---CCceeeeccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFG 672 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~---~~~vKL~DFG 672 (846)
+.+|||+|+||.|+..+..++ ...+++.++..|+.||+.|+.|||+ .+|.||||||+|+|... |-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 668999999999999996553 4679999999999999999999999 89999999999999964 5679999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHhhhhh
Q 003121 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKL 750 (846)
Q Consensus 673 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~--~~~~~~~~~ 750 (846)
+|+....... ..+.+-||.|.|||++...+|+..+|+||+||++|-||.|+|||....-. .........
T Consensus 210 FAK~t~~~~~---------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~ 280 (400)
T KOG0604|consen 210 FAKETQEPGD---------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR 280 (400)
T ss_pred cccccCCCcc---------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh
Confidence 9986543211 13345799999999999899999999999999999999999999543221 111111111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
......-.++|. ..++...++|+.+|..+|.+|-|+ +++
T Consensus 281 ~gqy~FP~pEWs-~VSe~aKdlIR~LLkt~PteRlTI-~~~ 319 (400)
T KOG0604|consen 281 TGQYEFPEPEWS-CVSEAAKDLIRKLLKTEPTERLTI-EEV 319 (400)
T ss_pred ccCccCCChhHh-HHHHHHHHHHHHHhcCCchhheeH-HHh
Confidence 222333445564 457889999999999999999999 444
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=280.17 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=188.7
Q ss_pred CCcccceeeeeCceEEEEEEECC------eEEEEEEecCCCCC-C-chhHHHHHHHHHhcCCCceeeEeccc---cCceE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTLVGAC---PEVWT 597 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~------~~VAIK~l~~~~~~-~-~~~f~~Ei~iL~~l~HpnIv~l~g~~---~~~~~ 597 (846)
.|+.+..||+|.||.||++...+ ..+|||.++..... + .....+|+.+++.++||||+.|..+| ....+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 57888899999999999996542 35899999865332 2 23578999999999999999998887 34688
Q ss_pred EEEEecCCCchhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC----Cceeeecc
Q 003121 598 LVYEYLPNGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN----FVSKLSDF 671 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~----~~vKL~DF 671 (846)
+++||.+. +|..++... .....++......|++||+.|+.|||+ +-|+||||||.||||..+ |.|||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999976 777766432 233568889999999999999999999 899999999999999877 99999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchH-------HHH
Q 003121 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKE-------VQY 743 (846)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~-------~~~ 743 (846)
|+++.+...-... ......+-|++|.|||.+.+. .||++.|||+.|||+.||+|-.|.|.+... +..
T Consensus 181 GlaR~~~~plkpl-----~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 181 GLARLFNNPLKPL-----ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred cHHHHhhcccccc-----ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 9999886543221 112334569999999999875 699999999999999999999998854322 111
Q ss_pred HHhhhhhccccCCCCCCCChh--------------------------------hHHHHHHHHHHHhccCcCCCCChH
Q 003121 744 ALDTGKLKNLLDPLAGDWPFV--------------------------------QAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 744 ~~~~~~~~~~ld~~~~~~p~~--------------------------------~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
......+.-+--|...+||.. -++...+|+.++|..||.+|.|+.
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~ 332 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAE 332 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHH
Confidence 111111111112333333210 123478899999999999999983
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=296.56 Aligned_cols=246 Identities=22% Similarity=0.317 Sum_probs=189.5
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccc--C-----
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--E----- 594 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~----- 594 (846)
..++|.....||.|+||.||+|... +..||||++.... ......+.+|+.++++++||||+++++++. +
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567999999999999999999886 5789999986532 122345778999999999999999988763 2
Q ss_pred -ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 595 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 595 -~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
..++|+||+ +++|.+++.. .++++..+..++.+++.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 278999998 6799998842 468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 752 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~ 752 (846)
+....... ....++..|+|||.+.+. .++.++|||||||++|+|+||++||.................
T Consensus 165 ~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 233 (343)
T cd07851 165 ARHTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233 (343)
T ss_pred cccccccc-----------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Confidence 88653321 123478899999998653 678999999999999999999999965543321111000000
Q ss_pred -----------------ccCCC----CCCC---ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 -----------------LLDPL----AGDW---PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 -----------------~ld~~----~~~~---p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+... ...+ ....+..+.+|+.+||..+|.+||++ .++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~-~el 295 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA-AEA 295 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCH-HHH
Confidence 00000 0000 01135689999999999999999999 444
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=275.56 Aligned_cols=239 Identities=25% Similarity=0.364 Sum_probs=184.0
Q ss_pred cceeeeeCceEEEEEEECC--eEEEEEEecCCCC-CCchhHHHHHHHHHhcC-CCceeeEeccc--cCceEEEEEecCCC
Q 003121 533 SLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL-QGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
+..||.|..|.|++..++. ...|||.+..... ....++...++++...+ +|+||+.+|+| ....++.||.| +.
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 3459999999999999885 7899999887543 23456778888877764 89999999998 44577889987 44
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
.++.+|... ..++++..+-++...+..||.||... ++|||||+||+|||+|..|.+||||||++..+......
T Consensus 176 C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--- 248 (391)
T KOG0983|consen 176 CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--- 248 (391)
T ss_pred HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc---
Confidence 566666433 35699999999999999999999874 68999999999999999999999999999877654321
Q ss_pred ccccccCCCCCCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~---~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
+...|-+.|||||.+.. ..|+..+|||||||.|+||.||+.||..-+..-..+-. +.+-..|..+.- .
T Consensus 249 ------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk--vln~ePP~L~~~-~ 319 (391)
T KOG0983|consen 249 ------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK--VLNEEPPLLPGH-M 319 (391)
T ss_pred ------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH--HHhcCCCCCCcc-c
Confidence 34569999999999964 36899999999999999999999999764322111111 111111222111 1
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
.-+..|.+++..||.+|+.+||...
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~ 344 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYN 344 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchH
Confidence 1357899999999999999999983
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=315.21 Aligned_cols=143 Identities=29% Similarity=0.435 Sum_probs=126.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
.+|.+.++||+|+||.||+|.+. +..||||++....... ...+..|+.++..++||||+++++++ ....|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 47888999999999999999987 6889999997654332 25688999999999999999999887 45789999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
||+.+++|.+++.. ...+++..++.|+.||+.||.|||. ++||||||||+||||+.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 99999999999843 2458889999999999999999999 8999999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=304.77 Aligned_cols=253 Identities=28% Similarity=0.393 Sum_probs=207.7
Q ss_pred hhhhhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc----
Q 003121 520 FSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC---- 592 (846)
Q Consensus 520 ~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~---- 592 (846)
+..+...+..|++...||.|.+|.||+++.. ++.+|+|++..... ..+++..|.+||+.+ +|||++.++|++
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3344456677899999999999999988664 67899999887653 346788999999988 799999999987
Q ss_pred ---cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeee
Q 003121 593 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 669 (846)
Q Consensus 593 ---~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~ 669 (846)
++.++||||||.|||.-|++.... ...+.|..+..|+..++.||.+||. +.+||||||-.||||+.++.|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence 567999999999999999986555 6779999999999999999999999 789999999999999999999999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 003121 670 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA 744 (846)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~ 744 (846)
|||++..+.... ..+.+..|||.|||||++... .|+..+|+||||++..||.-|.||+.....+...
T Consensus 166 DFGvSaQldsT~--------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL 237 (953)
T KOG0587|consen 166 DFGVSAQLDSTV--------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL 237 (953)
T ss_pred eeeeeeeeeccc--------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh
Confidence 999988765432 233556799999999999653 4788999999999999999999999877776654
Q ss_pred HhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 745 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 745 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
+...+- .|.....|..-++.|.++|..||.++..+||++.+
T Consensus 238 F~IpRN----PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ 278 (953)
T KOG0587|consen 238 FLIPRN----PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEE 278 (953)
T ss_pred ccCCCC----CCccccchhhHHHHHHHHHHHHHhhccccCcchhh
Confidence 333211 11111224455789999999999999999999844
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=276.91 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=191.5
Q ss_pred ceeeeeCceEEEEEE--ECCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEEEEecCCCch
Q 003121 534 LKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNGSL 608 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~--~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lVmEy~~ggsL 608 (846)
..||+|+|+.|-.++ ..+..+|||++.+........+.+|++++.+. .|+||++|+.+|+ +.+|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 359999999998765 45788999999988777788899999999999 5999999999995 479999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC---ceeeeccccccccccccccCC
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~---~vKL~DFGla~~~~~~~~~~~ 685 (846)
..++... ..+++.++.++..+|+.||.|||. +||.||||||+|||..... -+||+||.|..-+.....-+
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s- 236 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS- 236 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC-
Confidence 9988543 569999999999999999999999 9999999999999996543 57999999876543222111
Q ss_pred CccccccCCCCCCcccCChhhhc---c--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-------------Hhh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLA---S--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-------------LDT 747 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~---~--~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~-------------~~~ 747 (846)
........+++|+..|||||+.. + ..|+.++|.||||||||-||.|++||.+.--.... +-.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 11122335678999999999763 2 35899999999999999999999999542111111 111
Q ss_pred hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
.........-..+|. ..+....+|+...+-.++.+|-++.+
T Consensus 317 sIQEGkYeFPdkdWa-hIS~eakdlisnLlvrda~~rlsa~~ 357 (463)
T KOG0607|consen 317 SIQEGKYEFPDKDWA-HISSEAKDLISNLLVRDAKQRLSAAQ 357 (463)
T ss_pred HHhccCCcCChhhhH-HhhHHHHHHHHHHHhccHHhhhhhhh
Confidence 111111222333453 45677899999999999999988843
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=284.87 Aligned_cols=259 Identities=22% Similarity=0.337 Sum_probs=192.7
Q ss_pred CCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHh--cCCCceeeEecccc------CceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK--IRHPNLVTLVGACP------EVWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~--l~HpnIv~l~g~~~------~~~~lVm 600 (846)
...+.+.||+|.||+||+|.|+|..||||+|...+ ...+.+|.+|.+. |+|+||+.++++-. ..++||.
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred eeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 45677789999999999999999999999997643 3468899999877 49999999998751 2478999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEecccCCCceEecCCCceeeecccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-----KPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-----~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
+|.+.|||.|+|. ...++....++++..+|.||++||.. ..-.|.|||||+.||||..+|.+-|+|+|||-
T Consensus 289 dYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 289 DYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred ecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999994 35689999999999999999999951 11259999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC----CC--CchhhHHHHHHHHHHHHhC----------CCCCCC--
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----EL--TPKSDVYSFGIILLRLLTG----------RPALGI-- 737 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~--~~ksDVwSlGviL~elltG----------~~pf~~-- 737 (846)
........ .....+..+||..|||||++... .+ -..+||||||.++||++-. ++||..
T Consensus 365 ~h~~~t~~----idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 365 RHDSDTDT----IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred EecccCCc----ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 66544211 11122456899999999999643 12 2358999999999999852 367632
Q ss_pred --chHHHHHHhhhhhccccCCCCCCCCh-hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 738 --TKEVQYALDTGKLKNLLDPLAGDWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 738 --~~~~~~~~~~~~~~~~ld~~~~~~p~-~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
+..++...+.--...+.......|.. .....+.+|++.||..+|.-|-|+ =.+-+-|.++.
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA-LriKKtl~~l~ 504 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA-LRIKKTLAKLS 504 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH-HHHHHHHHHHh
Confidence 22222222211112222222223322 235678999999999999999998 34555555554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=285.75 Aligned_cols=257 Identities=27% Similarity=0.422 Sum_probs=195.9
Q ss_pred CCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc--CCCceeeEecccc------CceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI--RHPNLVTLVGACP------EVWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l--~HpnIv~l~g~~~------~~~~lVm 600 (846)
.......||+|+||.||+|.+.++.||||++... ....|..|-+|.+.. .|+||++++++-. ..+.||+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 3455667999999999999999999999999754 345788999988764 8999999999752 2578999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC------CceEecccCCCceEecCCCceeeeccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP------HSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~------~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
+|.+.|+|.++|. ...++|....+|+..+++||+|||.-.| .+|+|||||+.||||.+|+++-|+|||||
T Consensus 288 ~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999994 3458999999999999999999997443 46999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCC-----chhhHHHHHHHHHHHHhCCCCC--CCch-------
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELT-----PKSDVYSFGIILLRLLTGRPAL--GITK------- 739 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~-----~ksDVwSlGviL~elltG~~pf--~~~~------- 739 (846)
..+......... -+.+||..|||||+|.+. .+. .+.||||+|.+||||++.-..+ +...
T Consensus 364 l~~~p~~~~~d~------~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 364 LRLEPGKPQGDT------HGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred EEecCCCCCcch------hhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 988754322211 236799999999999764 232 3689999999999999865433 1111
Q ss_pred ----------HHHHHHhhhhhccccCCCCCCCChh-hHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 740 ----------EVQYALDTGKLKNLLDPLAGDWPFV-QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 740 ----------~~~~~~~~~~~~~~ld~~~~~~p~~-~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
.++..+...+.... +...|..+ ....+.+.+..||..||+-|-|+ .-+.+.+..+....
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~---~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA-~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPK---IPDAWRKHAGMAVLCETIEECWDHDAEARLTA-GCVEERMAELMMLW 507 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCC---ChhhhhcCccHHHHHHHHHHHcCCchhhhhhh-HHHHHHHHHHhccC
Confidence 11111111111111 11122222 25679999999999999999999 66777777666554
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=300.61 Aligned_cols=249 Identities=25% Similarity=0.432 Sum_probs=204.1
Q ss_pred cccceeeeeCceEEEEEEEC--C----eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEe
Q 003121 531 DPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEY 602 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~--~----~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy 602 (846)
...++||.|+||+||+|.|- + -+||||++..... .....|..|+-+|..|+|||+++|+|+|. ....||++|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~ 778 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL 778 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence 44568999999999999874 2 4699999876543 33567999999999999999999999995 457799999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.|+++. ++.++..+..+.|..||++|+.|||. +.++||||-..||||..-.++||.|||+++.+..+..
T Consensus 779 mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999964 45678889999999999999999998 8999999999999999999999999999998876543
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHhhhhhccccCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK--EVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~--~~~~~~~~~~~~~~ld~~~~ 759 (846)
.-.. ....-.+.|||=|.+....|+.++|||||||++||++| |..|+.... +....++.+ .+-
T Consensus 854 ey~~------~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g--------eRL 919 (1177)
T KOG1025|consen 854 EYSA------PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG--------ERL 919 (1177)
T ss_pred cccc------cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc--------ccC
Confidence 2211 22334678999999999999999999999999999999 777775443 223333332 234
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
..|+.++.+++.++.+||..|+..||+| +++...+..+.
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~f-kel~~~fs~~a 958 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTF-KELAEEFSRMA 958 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccH-HHHHHHHHHHh
Confidence 4677889999999999999999999999 66666665543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=276.50 Aligned_cols=217 Identities=24% Similarity=0.214 Sum_probs=175.3
Q ss_pred eCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCchhhhhcc
Q 003121 539 GGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSC 614 (846)
Q Consensus 539 G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggsL~~~L~~ 614 (846)
|.||.||++... ++.||+|.+.... .+.+|...+....||||+++++++. +..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 5789999987643 3445666666778999999999873 568899999999999998853
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCccccccCC
Q 003121 615 KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 694 (846)
Q Consensus 615 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 694 (846)
. .++++..+..++.+++.||.|||. ++|+||||||+||+++.++.++|+|||++....... ..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----------~~ 141 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----------DG 141 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----------cc
Confidence 3 358999999999999999999999 899999999999999999999999999876553321 12
Q ss_pred CCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHH
Q 003121 695 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAM 774 (846)
Q Consensus 695 ~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~ 774 (846)
..++..|+|||++.+..++.++||||+|+++|+|++|++||....... . . ......|...+..+.+|+.
T Consensus 142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---~-----~---~~~~~~~~~~~~~~~~li~ 210 (237)
T cd05576 142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---N-----T---HTTLNIPEWVSEEARSLLQ 210 (237)
T ss_pred CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---c-----c---ccccCCcccCCHHHHHHHH
Confidence 236778999999988889999999999999999999998875432110 0 0 0011233445678999999
Q ss_pred HHhccCcCCCCChH
Q 003121 775 RCCEMSRKSRPELG 788 (846)
Q Consensus 775 ~Cl~~~P~~RPt~~ 788 (846)
+||+.+|.+||++.
T Consensus 211 ~~l~~dp~~R~~~~ 224 (237)
T cd05576 211 QLLQFNPTERLGAG 224 (237)
T ss_pred HHccCCHHHhcCCC
Confidence 99999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=310.57 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=202.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC---------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccc--C
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--E 594 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~---------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~ 594 (846)
.+..+.+.||.|.||.|++|... ...||||.++..... ..+.+..|+++|+.+ .||||+.|+|+|. .
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455568999999999999754 246999999875443 456799999999999 6999999999995 4
Q ss_pred ceEEEEEecCCCchhhhhccCC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKD-----NS--------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 661 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~-----~~--------~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~ 661 (846)
..++|+||+..|+|..+|+... .. ..++....+.++.|||.|+.||++ .++|||||-..|||++
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence 6889999999999999996554 00 248999999999999999999999 8899999999999999
Q ss_pred CCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 003121 662 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 740 (846)
Q Consensus 662 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~ 740 (846)
.+..+||+|||+|+............ +...-...|||||.+....|+.++|||||||+||||+| |..|+.....
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~-----~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKS-----SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecC-----CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 99999999999999665443221111 00012445999999999999999999999999999999 8889976321
Q ss_pred HHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 741 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 741 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
....+. .+.+..+...|..++.++.++++.||+.+|.+||++ .++.+.++.+
T Consensus 528 ~~~l~~-----~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F-~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 TEELLE-----FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTF-SECVEFFEKH 579 (609)
T ss_pred HHHHHH-----HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCH-HHHHHHHHHH
Confidence 111111 111223334577788999999999999999999999 6777777664
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=290.42 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=203.7
Q ss_pred cceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCCC
Q 003121 533 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 606 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~gg 606 (846)
.+.||.|.||+||-|+++ |+.||||++.+... ...+.+++|+.||.+++||.||.|---| ++..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 457999999999999887 68899999987543 2346789999999999999999998877 57899999999776
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC---Cceeeecccccccccccccc
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~---~~vKL~DFGla~~~~~~~~~ 683 (846)
-|+-+|.. ..+.|++.....+..||+.||.|||. ++|+|.||||+||||... ..+||||||+|+.++...+.
T Consensus 649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 66666642 34579999999999999999999999 899999999999999643 57999999999999876432
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
...+|||.|+|||++.++.|+..-|+||.|||+|--+.|.-||.........+....+.. . ...|.
T Consensus 724 ---------rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMy--P--p~PW~- 789 (888)
T KOG4236|consen 724 ---------RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMY--P--PNPWS- 789 (888)
T ss_pred ---------hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccccc--C--CCchh-
Confidence 234699999999999999999999999999999999999999987777665554433322 1 22343
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHH----------HHHHHHHHHhhCC
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKD----------VWRVLEPMRASCG 803 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~----------v~~~L~~l~~~~~ 803 (846)
..+....+||...|++.-++|-+..+. .|.-|+.+....+
T Consensus 790 eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~ig 839 (888)
T KOG4236|consen 790 EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIG 839 (888)
T ss_pred hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhC
Confidence 446678999999999999999887432 3555666655444
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=274.59 Aligned_cols=242 Identities=26% Similarity=0.303 Sum_probs=185.4
Q ss_pred cccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEEEecC
Q 003121 531 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
..+..||.|.||+|++-.++ |+..|||.++.... ....++..|.++..+- +.||||++||++ +...++.||+|.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 33456999999999998876 57899999987654 3456788898877665 789999999986 445779999984
Q ss_pred CCchhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 605 NGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 605 ggsL~~~L~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
.||..+...- .....+++...-.|......||.||... ..||||||||+||||+..|.+||||||++..+..+..
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA 223 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA 223 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence 5766544211 1234688888889999999999999874 5699999999999999999999999999987654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
. +.-.|-..|||||.+.. .+|+.+|||||||++|||+.||.-|+...+.+-..+..- ..-+|-.-.
T Consensus 224 k---------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V---v~gdpp~l~ 291 (361)
T KOG1006|consen 224 K---------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV---VIGDPPILL 291 (361)
T ss_pred h---------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH---HcCCCCeec
Confidence 1 23358889999999964 359999999999999999999999997655533222211 111221111
Q ss_pred CC---hhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 761 WP---FVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 761 ~p---~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.+ .+.+..+..+|..|+.++..+||.+
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky 321 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKY 321 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcch
Confidence 12 2356789999999999999999998
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=273.27 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=192.9
Q ss_pred CCCcccceeeeeCceEEEEEEECC--eEEEEEEecCC---CCCCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPH---SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lV 599 (846)
++|+++++||+|+|.+|..+.+.. +.+|+|++++. ...+.+.++.|-.+..+. +||.+|-|..+|. ..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 478899999999999999888764 66999998875 334456678899888877 7999999998884 568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
.||++||+|..++. ....|++..++.+..+|+.||.|||+ +|||+||||.+|+|||..|++||+|+|+++---.
T Consensus 330 ieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999988874 44569999999999999999999999 9999999999999999999999999999984322
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHhhhhhccccCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--VQYALDTGKLKNLLDPL 757 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~--~~~~~~~~~~~~~ld~~ 757 (846)
.. .. .++.+|||.|+|||++.+..|+..+|||+|||+++||+.|+.||+.... .....+..-+.-++ ..
T Consensus 404 ~g----d~----tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-ek 474 (593)
T KOG0695|consen 404 PG----DT----TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-EK 474 (593)
T ss_pred CC----cc----cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-hh
Confidence 21 11 1346799999999999999999999999999999999999999964321 00001111111111 11
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCC
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
.-..|...+-....+++..|++||++|.
T Consensus 475 qiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 475 QIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccccceeehhhHHHHHHhhcCCcHHhc
Confidence 1234555566788899999999999984
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=249.24 Aligned_cols=243 Identities=28% Similarity=0.393 Sum_probs=188.4
Q ss_pred CCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
+|+..++||+|.||+||+|+.++ ..||+|.++.... .-+....+|+.+|+.|.|.|||+|++.. .....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667789999999999998874 5799999886543 2356789999999999999999999986 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
|. .+|..+.... ++.++.+....++.|+++||.|.|+ ++++||||||.|+||+.+|.+||+|||+++.++-..
T Consensus 83 cd-qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hh-HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 95 4787776433 4568899999999999999999999 899999999999999999999999999999765332
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCC-CCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
.|.+..+-|.+|.+|.++.+.+ |++..|+||-|||+.|+.. |+|.|.+.+-.......-+. +-.|....
T Consensus 156 -------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~--lg~p~ed~ 226 (292)
T KOG0662|consen 156 -------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL--LGTPTEDQ 226 (292)
T ss_pred -------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH--hCCCcccc
Confidence 2334455799999999998764 8999999999999999986 88888765543333222111 11111222
Q ss_pred CCh---------------------hh---HHHHHHHHHHHhccCcCCCCCh
Q 003121 761 WPF---------------------VQ---AEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 761 ~p~---------------------~~---~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
||. .. ...-.+|+...+..+|..|.++
T Consensus 227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisa 277 (292)
T KOG0662|consen 227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISA 277 (292)
T ss_pred CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCH
Confidence 221 11 1234788888888899999888
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=267.59 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=191.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC--CCCCchhHHHHHHHHHhcCCCceeeEecccc----------
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACP---------- 593 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~---------- 593 (846)
+.|.-..+||+|.||+||++..+ ++.||+|++-.. ...-+....+|+++|..|.|+|++.|+..|.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45677788999999999999876 466888765432 2223456789999999999999999999882
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
..+|+||.+|+. +|..+|. +....++..++..++.++..||.|+|. +.|+|||+||+|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 138999999975 8888884 333568999999999999999999999 7899999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 752 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~ 752 (846)
++.+....... ....++.+-|.+|.+||.+.+. .|+++.|||.-|||+.||+||.|-|....+.........+..
T Consensus 171 ar~fs~~~n~~----kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 171 ARAFSTSKNVV----KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccceecccccC----CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 98776543222 1223566679999999999875 799999999999999999999999976655433221111111
Q ss_pred cc-------------------CCCCCCC---------ChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 753 LL-------------------DPLAGDW---------PFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 753 ~l-------------------d~~~~~~---------p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.+ .|+.... |..-.+...+|+..++..||.+|+++
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a 309 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA 309 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch
Confidence 11 1111000 11113467899999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=290.89 Aligned_cols=232 Identities=26% Similarity=0.360 Sum_probs=187.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccccC--ceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~--~~~lVmE 601 (846)
+..|.....+|.|+|+.|-.+... ++..++|++... ..+..+|+.++... +||||+++.+.|.+ ..|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 556888888999999999988775 567999998765 22446788777666 79999999999854 6889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe-cCCCceeeeccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL-DANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl-~~~~~vKL~DFGla~~~~~~ 680 (846)
++.|+-|.+.+.... .....+..|+.+|+.|+.|||. +|+|||||||+|||+ +..++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999998888774332 2236777899999999999999 899999999999999 68999999999999876554
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
. ...+-|..|.|||++...+|+.+|||||||++||+||+|+.||.....-..... .+ ..+.
T Consensus 470 ~-----------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~-----~i---~~~~ 530 (612)
T KOG0603|consen 470 C-----------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT-----RI---QMPK 530 (612)
T ss_pred h-----------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH-----hh---cCCc
Confidence 1 223468999999999989999999999999999999999999976544311111 11 1122
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
+....++..++|+.+||+.+|.+||++.
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~ 558 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGAD 558 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChh
Confidence 2345678999999999999999999993
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=257.82 Aligned_cols=233 Identities=31% Similarity=0.424 Sum_probs=186.6
Q ss_pred CceEEEEEEECC--eEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCchhhhhcc
Q 003121 540 GYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSC 614 (846)
Q Consensus 540 ~fG~Vy~g~~~~--~~VAIK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggsL~~~L~~ 614 (846)
+||.||+|...+ ..+++|++....... ...+.+|+.++++++|+||+++++++. ...+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 689999999864 789999998765544 578999999999999999999999984 568899999999999999853
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCccccccCC
Q 003121 615 KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 694 (846)
Q Consensus 615 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 694 (846)
. ..+++..+..++.+++.+|.+||. .+++|+||+|.||+++.++.++|+|||++........ ...
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---------~~~ 145 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---------LTT 145 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeeccccc---------ccc
Confidence 2 238899999999999999999999 8999999999999999999999999999987654320 123
Q ss_pred CCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHH
Q 003121 695 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAM 774 (846)
Q Consensus 695 ~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~ 774 (846)
..++..|++||.+....++.++||||||+++|+|++|.+||.............. ...... ... ....+..+.+++.
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~-~~~~~~-~~~-~~~~~~~~~~~i~ 222 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG-KPKPPF-PPP-EWKISPEAKDLIR 222 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh-ccCCCC-ccc-cccCCHHHHHHHH
Confidence 4588999999999888899999999999999999999999976322222211111 000000 000 0004578999999
Q ss_pred HHhccCcCCCCChHHHH
Q 003121 775 RCCEMSRKSRPELGKDV 791 (846)
Q Consensus 775 ~Cl~~~P~~RPt~~~~v 791 (846)
+||..+|.+||++ .++
T Consensus 223 ~~l~~~p~~Rp~~-~~~ 238 (244)
T smart00220 223 KLLVKDPEKRLTA-EEA 238 (244)
T ss_pred HHccCCchhccCH-HHH
Confidence 9999999999999 444
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=252.19 Aligned_cols=260 Identities=22% Similarity=0.391 Sum_probs=198.9
Q ss_pred CCCCCCcCCCCChhhhh-hhcCCCcccceeeeeCceEEEEEE--ECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CC
Q 003121 508 SSHMPQFFSDFSFSEIE-GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HP 583 (846)
Q Consensus 508 ~~~~~~~~~~~~~~ei~-~~~~~f~~~~~LG~G~fG~Vy~g~--~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-Hp 583 (846)
....|..+++|..-.+. +..++|++.+++|+|.|++||.|. .++..++||++++.. ...+.+|+.||..|. ||
T Consensus 17 n~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~ 93 (338)
T KOG0668|consen 17 NEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGP 93 (338)
T ss_pred cccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCC
Confidence 34456667777654443 456789999999999999999998 456889999998754 457999999999997 99
Q ss_pred ceeeEeccccC----ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceE
Q 003121 584 NLVTLVGACPE----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 659 (846)
Q Consensus 584 nIv~l~g~~~~----~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NIL 659 (846)
||++|++...+ ...||+||+++.+...+. +.|+...+..++.+++.||.|+|+ +||+|||+||.|++
T Consensus 94 NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvm 164 (338)
T KOG0668|consen 94 NIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVM 164 (338)
T ss_pred CeeehhhhhcCccccCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceee
Confidence 99999998844 467999999998887765 457778899999999999999999 99999999999999
Q ss_pred ecC-CCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-
Q 003121 660 LDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALG- 736 (846)
Q Consensus 660 l~~-~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~- 736 (846)
||. ...++|+|+|+|.+..+..... . .+.+..|.-||.+.. ..|+.+-|+|||||+|..|+..+.||-
T Consensus 165 Idh~~rkLrlIDWGLAEFYHp~~eYn--V-------RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 165 IDHELRKLRLIDWGLAEFYHPGKEYN--V-------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred echhhceeeeeecchHhhcCCCceee--e-------eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 985 4679999999999987754322 1 235778899999976 468999999999999999999998873
Q ss_pred CchHHHHHHhh-------------hhhccccCC---------CCCCCCh--------hhHHHHHHHHHHHhccCcCCCCC
Q 003121 737 ITKEVQYALDT-------------GKLKNLLDP---------LAGDWPF--------VQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 737 ~~~~~~~~~~~-------------~~~~~~ld~---------~~~~~p~--------~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
+.+.....+.. .+..-.++| ....|.. ...++..+|+.+.|..|-.+|||
T Consensus 236 G~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT 315 (338)
T KOG0668|consen 236 GHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT 315 (338)
T ss_pred CCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc
Confidence 22221111110 011111221 1112211 11367899999999999999999
Q ss_pred hH
Q 003121 787 LG 788 (846)
Q Consensus 787 ~~ 788 (846)
+.
T Consensus 316 ak 317 (338)
T KOG0668|consen 316 AK 317 (338)
T ss_pred hH
Confidence 93
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=291.03 Aligned_cols=245 Identities=28% Similarity=0.374 Sum_probs=190.6
Q ss_pred CCcccceeeeeCceE-EEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEEEEecC
Q 003121 529 NFDPSLKIGEGGYGS-IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLP 604 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~-Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lVmEy~~ 604 (846)
-|...+.+|.|.-|+ ||+|.+.++.||||++-... .+-.++|+..|+.- +|||||++|+.-. ...||..|.|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 356667799999885 79999999999999886533 33568999999998 6999999998753 45889999995
Q ss_pred CCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC---C--Cceeeeccccccccc
Q 003121 605 NGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---N--FVSKLSDFGISRFLS 678 (846)
Q Consensus 605 ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~---~--~~vKL~DFGla~~~~ 678 (846)
.+|.+++... .......-...+.+..|++.||++||+ -+||||||||.||||+. + ..++|+|||+|+.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5999999653 110111113457889999999999999 68999999999999975 2 578999999999887
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCchHHHHHHhhhhhccccCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG-~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
........ ..+..||-+|+|||++.....+.++|||||||++|+.++| .+||+..-..+..+..++..-.....
T Consensus 663 ~~~sS~~r-----~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~ 737 (903)
T KOG1027|consen 663 GGKSSFSR-----LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEP 737 (903)
T ss_pred CCcchhhc-----ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeecc
Confidence 66533222 3567799999999999998888899999999999999996 89998776665555554433222111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..++ ...+||.+|+..+|..||++.+.+
T Consensus 738 ~~d~------eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 738 LPDC------EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred CchH------HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1111 789999999999999999995443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=289.45 Aligned_cols=251 Identities=21% Similarity=0.221 Sum_probs=162.3
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecc--------
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA-------- 591 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~-------- 591 (846)
..++|...++||+|+||.||+|.+. +..||||.+..... .+.+..+ .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568999999999999999999875 45799998764321 1111111 1222223333333222
Q ss_pred ccCceEEEEEecCCCchhhhhccCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccC
Q 003121 592 CPEVWTLVYEYLPNGSLEDRLSCKDNS-----------------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 654 (846)
Q Consensus 592 ~~~~~~lVmEy~~ggsL~~~L~~~~~~-----------------~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLk 654 (846)
.....++||||+.+++|.+++...... .......+..|+.||+.||.|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 134688999999999999988533210 011233456799999999999999 899999999
Q ss_pred CCceEecC-CCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC----------------------C
Q 003121 655 PANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----------------------E 711 (846)
Q Consensus 655 p~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----------------------~ 711 (846)
|+||||+. ++.+||+|||+++.+...... ......||+.|+|||.+... .
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-------CCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 99999985 689999999999865432211 11234689999999976422 2
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHHhhh-----hhccccCCCC-CC------CChhhHHHHHHHHHHHhc
Q 003121 712 LTPKSDVYSFGIILLRLLTGRPALGITKE-VQYALDTG-----KLKNLLDPLA-GD------WPFVQAEQLANLAMRCCE 778 (846)
Q Consensus 712 ~~~ksDVwSlGviL~elltG~~pf~~~~~-~~~~~~~~-----~~~~~ld~~~-~~------~p~~~~~~l~~Li~~Cl~ 778 (846)
++.++|||||||+||||+++..+++.... ....+... .+...+.+.. .+ ..........+|+.+||+
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 34567999999999999997665532211 11111100 0111111110 00 000112345689999999
Q ss_pred cCcCCCCChHHHH
Q 003121 779 MSRKSRPELGKDV 791 (846)
Q Consensus 779 ~~P~~RPt~~~~v 791 (846)
.||.+||++ +++
T Consensus 436 ~dP~kR~ta-~e~ 447 (566)
T PLN03225 436 FKGRQRISA-KAA 447 (566)
T ss_pred CCcccCCCH-HHH
Confidence 999999999 444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=279.66 Aligned_cols=253 Identities=20% Similarity=0.237 Sum_probs=175.8
Q ss_pred hcCCCcccceeeeeCceEEEEEEE------------------CCeEEEEEEecCCCCCCchh--------------HHHH
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLL------------------RHMQVAIKMLHPHSLQGPSE--------------FQQE 573 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~------------------~~~~VAIK~l~~~~~~~~~~--------------f~~E 573 (846)
..++|.+.++||+|+||.||+|.+ .+..||||.+........+. +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 466899999999999999999964 23569999987543322222 3347
Q ss_pred HHHHHhcCCCce-----eeEecccc----------CceEEEEEecCCCchhhhhccCCC---------------------
Q 003121 574 IDILSKIRHPNL-----VTLVGACP----------EVWTLVYEYLPNGSLEDRLSCKDN--------------------- 617 (846)
Q Consensus 574 i~iL~~l~HpnI-----v~l~g~~~----------~~~~lVmEy~~ggsL~~~L~~~~~--------------------- 617 (846)
+.++.+++|.++ ++++++|. ...+|||||+++|+|.++|.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777876654 56777762 347899999999999998853211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCC
Q 003121 618 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697 (846)
Q Consensus 618 ~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~G 697 (846)
...+++..+..++.+++.||.|||. ++|+||||||+|||++.++.+||+|||++......... . .....+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~---~----~~~g~~ 372 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF---N----PLYGML 372 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc---C----ccccCC
Confidence 1235677889999999999999999 89999999999999999999999999999755332111 0 012335
Q ss_pred CcccCChhhhccCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCchHHHHHHhh--hhhcc
Q 003121 698 TFAYMDPEFLASGE--------------------L--TPKSDVYSFGIILLRLLTGRP-ALGITKEVQYALDT--GKLKN 752 (846)
Q Consensus 698 t~~Y~APE~l~~~~--------------------~--~~ksDVwSlGviL~elltG~~-pf~~~~~~~~~~~~--~~~~~ 752 (846)
|+.|+|||.+.... | ..+.||||+||++|+|++|.. ||.....+...+.. .....
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~ 452 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR 452 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence 89999999885432 1 124799999999999999874 77533222211110 00000
Q ss_pred c--cCCCCCCCC--hhhHHHHHHHHHHHhccCc---CCCCChH
Q 003121 753 L--LDPLAGDWP--FVQAEQLANLAMRCCEMSR---KSRPELG 788 (846)
Q Consensus 753 ~--ld~~~~~~p--~~~~~~l~~Li~~Cl~~~P---~~RPt~~ 788 (846)
+ ......+++ ...+....+|+.+||..+| .+|+++.
T Consensus 453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ 495 (507)
T PLN03224 453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVG 495 (507)
T ss_pred HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHH
Confidence 0 000011111 2245789999999999866 6899993
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=260.97 Aligned_cols=263 Identities=24% Similarity=0.385 Sum_probs=210.0
Q ss_pred hhhhhcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc
Q 003121 522 EIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP 593 (846)
Q Consensus 522 ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~ 593 (846)
++.....++....++-+|.||+||+|.|+. +.|.+|.++....+ ....+..|.-.|..+.|||++.+.|.+-
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 333444566777789999999999998763 34677877655322 3456889999999999999999999883
Q ss_pred ---CceEEEEEecCCCchhhhhc-----cCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc
Q 003121 594 ---EVWTLVYEYLPNGSLEDRLS-----CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 665 (846)
Q Consensus 594 ---~~~~lVmEy~~ggsL~~~L~-----~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~ 665 (846)
+..+.+|.++.-|+|..+|. .......++..+...++.|++.|+.|||. +++||.||...|++||+...
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhee
Confidence 45678899999999999996 22334567788899999999999999999 99999999999999999999
Q ss_pred eeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 003121 666 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA 744 (846)
Q Consensus 666 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~ 744 (846)
+||+|=.+++-+.+.++. |...+.-....||+||.+.+..|+.++|||||||+||||+| |+.|+..-+.++..
T Consensus 435 VkltDsaLSRDLFP~DYh------cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYH------CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred EEeccchhccccCccccc------ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 999999999977655432 22333446788999999999999999999999999999999 88998766655432
Q ss_pred HhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 745 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 745 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.-+.|..+-..|..++++|..++..||...|++||++ +.+..-|.++-+
T Consensus 509 ------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf-~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 509 ------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSF-SQLVICLSEFHT 557 (563)
T ss_pred ------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCH-HHHHHHHHHHHH
Confidence 1122333444577889999999999999999999999 677777776644
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=279.95 Aligned_cols=250 Identities=28% Similarity=0.365 Sum_probs=207.7
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
...+|+....+|.|.||.||+++.. +...|+|+++.....+..-+++|+-+++..+|||||.++|.+ .+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3458999999999999999999876 577999999988777778889999999999999999999998 567999999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
||.||+|.+.. ....++++.++...+.+.+.||+|||+ +|-+|||||-.|||++..|.+|++|||.+-.+..
T Consensus 93 ycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred ecCCCccccee---eecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhh--
Confidence 99999999987 355789999999999999999999999 8999999999999999999999999998765543
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
++..+....||+.|||||+.. .+.|...||||++|+...|+---+||......++......+ ...+|..
T Consensus 165 ------ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk--S~~qpp~ 236 (829)
T KOG0576|consen 165 ------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK--SGFQPPT 236 (829)
T ss_pred ------hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc--cCCCCCc
Confidence 233445678999999999873 56899999999999999999999998765555544333221 2223322
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..-+..-++.|.+|++.|+.++|++||++.+.+
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 222334467899999999999999999985544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-29 Score=263.16 Aligned_cols=248 Identities=26% Similarity=0.361 Sum_probs=188.6
Q ss_pred cCCCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcC--CCc----eeeEeccc--cCce
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIR--HPN----LVTLVGAC--PEVW 596 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~--Hpn----Iv~l~g~~--~~~~ 596 (846)
+.+|.+..+||+|.||.|-.+..+. ..||||+++..... .+...-|+++|.++. .|+ +|.+.++| ..+.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 5689999999999999999988764 57999998754322 345667999999993 233 67787887 4678
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC--------------
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-------------- 662 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-------------- 662 (846)
|||+|.+ |-|+.++|..+ +-.+++...++.|+.|++.+++|||+ .+++|-||||+|||+-.
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 8999998 66999999543 45689999999999999999999999 88999999999999932
Q ss_pred ------CCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003121 663 ------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 736 (846)
Q Consensus 663 ------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~ 736 (846)
+..+||+|||.|.+..... +..+.|..|.|||++.+-+++..|||||+||||+|+.||...|.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 2358999999998766543 22347999999999999999999999999999999999999996
Q ss_pred CchHHHHH-H-------------hhhhhccccCCCCCCCC-------------------------hhhHHHHHHHHHHHh
Q 003121 737 ITKEVQYA-L-------------DTGKLKNLLDPLAGDWP-------------------------FVQAEQLANLAMRCC 777 (846)
Q Consensus 737 ~~~~~~~~-~-------------~~~~~~~~ld~~~~~~p-------------------------~~~~~~l~~Li~~Cl 777 (846)
..+..+.. + .............-+|| ......|.+|+.+||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 65532211 0 00000000000011111 122357999999999
Q ss_pred ccCcCCCCChHHHH
Q 003121 778 EMSRKSRPELGKDV 791 (846)
Q Consensus 778 ~~~P~~RPt~~~~v 791 (846)
..||.+|+|+.+.+
T Consensus 391 ~fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 391 EFDPARRITLREAL 404 (415)
T ss_pred ccCccccccHHHHh
Confidence 99999999995443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=238.94 Aligned_cols=199 Identities=26% Similarity=0.365 Sum_probs=159.0
Q ss_pred cCCCcccceeeeeCceEEE--EEEECCeEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy--~g~~~~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVm 600 (846)
.++......||+|+||.|- +-...|+..|+|.+...-. +...+..+|+++..+. .+|.+|.+||.. ....++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 3445556679999999874 4455688899999876532 2345677888887665 799999999976 34688999
Q ss_pred EecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 601 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|.|. .||..+...- +.+..+++..+-+|+..+..||.|||+. ..+||||+||+||||+.+|.+|+||||++..+.+
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9995 5787655332 4556789999999999999999999985 6799999999999999999999999999987765
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS----GELTPKSDVYSFGIILLRLLTGRPALGI 737 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~----~~~~~ksDVwSlGviL~elltG~~pf~~ 737 (846)
+... +-..|-..|||||.+.. ..|+-++||||||+++.||.+++.|+..
T Consensus 202 SiAk---------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 202 SIAK---------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhHH---------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 4311 11247788999999854 3699999999999999999999999853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=230.76 Aligned_cols=205 Identities=39% Similarity=0.601 Sum_probs=176.6
Q ss_pred eeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccccC--ceEEEEEecCCCchhh
Q 003121 536 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLED 610 (846)
Q Consensus 536 LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lVmEy~~ggsL~~ 610 (846)
||.|++|.||++... +..+++|++...... ....+.+|+.+++.+.|++|+++++++.. ..+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999998 788999999865432 23579999999999999999999999854 7889999999999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-CCceeeeccccccccccccccCCCccc
Q 003121 611 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTL 689 (846)
Q Consensus 611 ~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~ 689 (846)
++.... ..+++..++.++.+++.+|.+||. .+++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------- 148 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------- 148 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------
Confidence 985332 468899999999999999999999 89999999999999999 89999999999986654321
Q ss_pred cccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHH
Q 003121 690 CCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 768 (846)
Q Consensus 690 ~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 768 (846)
......+...|++||.+... .++.+.|+|++|+++++| ..
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~ 189 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PE 189 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HH
Confidence 01223478899999999877 788999999999999999 56
Q ss_pred HHHHHHHHhccCcCCCCChHHHHH
Q 003121 769 LANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 769 l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
+.+++..|+..+|.+||++ .+++
T Consensus 190 ~~~~l~~~l~~~p~~R~~~-~~l~ 212 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSA-KEIL 212 (215)
T ss_pred HHHHHHHHhhCCcccCcCH-HHHh
Confidence 9999999999999999999 5554
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=231.51 Aligned_cols=196 Identities=37% Similarity=0.553 Sum_probs=167.0
Q ss_pred CcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecC
Q 003121 530 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 604 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ 604 (846)
|.....||.|+||.||++...+ ..+++|.+...... ....+.+|++.+..++|+|++++++++. ...++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566789999999999999864 78999999876544 5678899999999999999999999874 57889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+++|.+++..... .+++.....++.+++.+|.+||. ++++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999999853321 18899999999999999999999 79999999999999999999999999999876543200
Q ss_pred CCccccccCCCCCCcccCChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPALGI 737 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l-~~~~~~~ksDVwSlGviL~elltG~~pf~~ 737 (846)
......++..|++||.+ ....++.++|||+||+++++|++|++||..
T Consensus 155 ------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 01223578899999998 666788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-28 Score=245.45 Aligned_cols=198 Identities=25% Similarity=0.397 Sum_probs=162.8
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC--CCCCchhHHHHHHHHHhcCCCceeeEecccc-------CceE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACP-------EVWT 597 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-------~~~~ 597 (846)
+.++.+.||-|+||.||..++. ++.||+|++... ....-..+.+|+.+|.-++|.|++..+++.. ...|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 5667788999999999988775 678999987643 2223457899999999999999999988762 2356
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+++|.|. .+|..++. ...+|+.+.+.-++.||++||.|||+ .+|+||||||.|+|++.|..+||+|||+++..
T Consensus 134 V~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEeccccccccc
Confidence 7888885 58888773 45678889999999999999999999 89999999999999999999999999999987
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchH
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKE 740 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~ 740 (846)
....... ++..+-|..|.|||++++. .|+.+.||||.|||+.||+..+..|.....
T Consensus 207 e~d~~~h-------MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 207 DQRDRLN-------MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred chhhhhh-------hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 6544221 1223458899999999985 699999999999999999998888854443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-27 Score=257.44 Aligned_cols=194 Identities=24% Similarity=0.393 Sum_probs=165.2
Q ss_pred cCCCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCC--------CchhHHHHHHHHHhcC---CCceeeEecccc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ--------GPSEFQQEIDILSKIR---HPNLVTLVGACP 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~--------~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~ 593 (846)
..+|...+.||.|+||.|+.++++. ..|+||.+.+.... ....+-.|+.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468899999999999999999874 67999998775332 1234667999999997 999999999995
Q ss_pred --CceEEEEEec-CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeec
Q 003121 594 --EVWTLVYEYL-PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 670 (846)
Q Consensus 594 --~~~~lVmEy~-~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~D 670 (846)
+++||+||-- +|.+|++++. ..+.+++..+..|+.|++.|+++||. .||||||||-+|+.++.+|.+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEee
Confidence 4688999864 5668999984 45679999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccccccCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 003121 671 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALG 736 (846)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~ 736 (846)
||.+.+.....+ ...+||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksgpf----------d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGPF----------DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCCc----------ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876654321 23569999999999998877 667899999999999999888874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=250.11 Aligned_cols=199 Identities=25% Similarity=0.330 Sum_probs=167.9
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC------CCceeeEeccc--cCc
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR------HPNLVTLVGAC--PEV 595 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~------HpnIv~l~g~~--~~~ 595 (846)
...+|.+....|+|-|++|.+|... +..||||++...... ...=++|++||++|+ --|+++|+-.| ..+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 3457888888999999999999875 578999999865432 234568999999995 34788988877 567
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC-Cceeeeccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGIS 674 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~-~~vKL~DFGla 674 (846)
+|||+|-+ ..+|.++|...+....|....+..|+.|++.||..|.. -||+|.||||+|||++++ ..+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCccc
Confidence 99999988 46999999888888889999999999999999999999 589999999999999865 57899999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK 739 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~ 739 (846)
..........+. -+-.|.|||++.+-+|+...|+||.||+||||.||+..|.+..
T Consensus 585 ~~~~eneitPYL----------VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 585 SFASENEITPYL----------VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cccccccccHHH----------HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 887765543322 2567999999999999999999999999999999999996543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=232.08 Aligned_cols=241 Identities=21% Similarity=0.264 Sum_probs=182.9
Q ss_pred CCCcccceeeeeCceEEEEEEE--CCeEEEEEEecCC--CCCCchhHHHHHHHHHhcCCCceeeEeccccC--------c
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--------V 595 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~VAIK~l~~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--------~ 595 (846)
.+|.....+|.|.- .|..+.+ .+.+||+|.+... .........+|..++..++|+||++++.+|.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777778888888 5555543 4788999987654 12234567899999999999999999999832 4
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
+|+||||+. ++|...+. -.++-.++..|+.|+++|+.|||+ .||+||||||+||++..++.+||.|||+++
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence 789999995 58877764 346677889999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHh---------
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--------- 746 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~--------- 746 (846)
..... ...+..+.|..|.|||++.+..|...+||||+||++.||++|.-.|.+......-..
T Consensus 167 ~e~~~---------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 167 TEDTD---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred ccCcc---------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence 65433 122445689999999999998899999999999999999999988865433211100
Q ss_pred ---------h-------------hhhccccC----CCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 747 ---------T-------------GKLKNLLD----PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 747 ---------~-------------~~~~~~ld----~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
. -.+...+. +...+.+...+..+.+|+.+||-.+|++|-+.
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv 304 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV 304 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH
Confidence 0 00111110 01111122335678999999999999999998
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-25 Score=236.15 Aligned_cols=198 Identities=29% Similarity=0.433 Sum_probs=161.5
Q ss_pred CCCcccceeeeeCceEEEEEEECC-----eEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV 599 (846)
..|....+||.|.|+.||++++.. ..||+|.+...+ .+..+..|++.|..+ -+.||+++.+++ .+...+|
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 457788899999999999997643 579999987653 467899999999999 599999999998 5779999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-CCceeeeccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLS 678 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-~~~vKL~DFGla~~~~ 678 (846)
|||++.....+++. .++...+..+++.++.||.++|. +|||||||||.|+|.+. .+.-.|.|||+|....
T Consensus 114 lp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred ecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHH
Confidence 99999999998883 36688999999999999999999 99999999999999984 4677899999997221
Q ss_pred ccc------------ccC------------------------CCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHH
Q 003121 679 QNE------------ISS------------------------NNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSF 721 (846)
Q Consensus 679 ~~~------------~~~------------------------~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSl 721 (846)
... ... +...........||++|.|||++.. +..++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 100 000 0000111244579999999999875 567899999999
Q ss_pred HHHHHHHHhCCCCCC
Q 003121 722 GIILLRLLTGRPALG 736 (846)
Q Consensus 722 GviL~elltG~~pf~ 736 (846)
|||++-+++++.||-
T Consensus 265 GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFF 279 (418)
T ss_pred cceeehhhccccccc
Confidence 999999999999984
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=231.48 Aligned_cols=130 Identities=23% Similarity=0.339 Sum_probs=108.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-----C---CceeeEeccc----
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----H---PNLVTLVGAC---- 592 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-----H---pnIv~l~g~~---- 592 (846)
.++|-+.++||.|.|++||++... .+.||+|+.+..... .+....||.+|++++ | .+||+|++.|
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 357999999999999999999876 467999998754322 355678999999984 3 3699999998
Q ss_pred --cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec
Q 003121 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 661 (846)
Q Consensus 593 --~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~ 661 (846)
..++|+|+|++ |.+|..++.... -..++...+..|+.||+.||.|||.. -||||-||||+||||.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence 24689999999 778888886443 45689999999999999999999984 5899999999999993
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=268.31 Aligned_cols=198 Identities=16% Similarity=0.184 Sum_probs=137.5
Q ss_pred hcCC-CceeeEeccc---------cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCce
Q 003121 579 KIRH-PNLVTLVGAC---------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648 (846)
Q Consensus 579 ~l~H-pnIv~l~g~~---------~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gi 648 (846)
.++| +||++++++| .+.++++|||+ +++|.++|.. ...++++..+..|+.||+.||.|||+ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 4556 5888888877 12466788887 6699999953 23569999999999999999999999 899
Q ss_pred EecccCCCceEecCC-------------------Cceeeecccccccccccccc---C-----CCccccccCCCCCCccc
Q 003121 649 VHGDLKPANILLDAN-------------------FVSKLSDFGISRFLSQNEIS---S-----NNTTLCCRTDPKGTFAY 701 (846)
Q Consensus 649 iHrDLkp~NILl~~~-------------------~~vKL~DFGla~~~~~~~~~---~-----~~~~~~~~~~~~Gt~~Y 701 (846)
+||||||+||||+.. +.+||+|||+++........ . ............||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 44556666665532110000 0 00000001224689999
Q ss_pred CChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCc
Q 003121 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 781 (846)
Q Consensus 702 ~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P 781 (846)
+|||++.+..|+.++|||||||+||||++|.+|+.........+... .+.+ .+ .........++.+||+.+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~----~~~~---~~-~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR----VLPP---QI-LLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh----hcCh---hh-hhcCHHHHHHHHHhCCCCh
Confidence 99999999999999999999999999999999885432221111111 1111 11 1112346788999999999
Q ss_pred CCCCChHHH
Q 003121 782 KSRPELGKD 790 (846)
Q Consensus 782 ~~RPt~~~~ 790 (846)
.+||++.+.
T Consensus 254 ~~Rps~~ei 262 (793)
T PLN00181 254 SCRPSMSEL 262 (793)
T ss_pred hhCcChHHH
Confidence 999999443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=220.13 Aligned_cols=239 Identities=21% Similarity=0.325 Sum_probs=176.2
Q ss_pred CCCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecc-c--cCceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA-C--PEVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~-~--~~~~~lVmE 601 (846)
+.|.+.+.||+|.||.+-.+.+++ +.+++|.++... ....+|.+|..---.| .|.||+.-|+. | .+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 468889999999999999999985 679999887643 3467899998776666 58999987764 4 456778999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec--CCCceeeecccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~--~~~~vKL~DFGla~~~~~ 679 (846)
|++.|+|..-+. ...+.+.....++.|++.|+.|+|+ +++||||||.+||||- +...+||||||+.+..+.
T Consensus 103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999988773 3457788899999999999999999 8999999999999993 446899999999876543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH-HHhhhhhccc
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-ALDTGKLKNL 753 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~-~~~~~~~~~~ 753 (846)
... ....+..|.+||.+... ...+.+|+|.|||++|.++||.+||........ -.+-..+...
T Consensus 176 tV~-----------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 176 TVK-----------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred eeh-----------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence 221 11246679999987532 246789999999999999999999953211100 0011111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCC
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
..+..+.--..-++.+..+.++-|..++++|=
T Consensus 245 k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 245 KNPALPKKFNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred cCccCchhhcccCHHHHHHHHHhcCCcccccc
Confidence 22222222222346688888899999998883
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=209.26 Aligned_cols=166 Identities=22% Similarity=0.228 Sum_probs=124.6
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|.+++... ..++++..++.|+.||+.||.|||+ ++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899988532 3569999999999999999999999 55 999999999999999 99988654321
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh-hccccCCCCCCCChh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-LKNLLDPLAGDWPFV 764 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~-~~~~ld~~~~~~p~~ 764 (846)
..||+.|+|||++.+..++.++|||||||++|||+||++||.........+.... ......+.....+..
T Consensus 64 ---------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (176)
T smart00750 64 ---------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLES 134 (176)
T ss_pred ---------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHH
Confidence 1489999999999999999999999999999999999999965443222111100 000011111111222
Q ss_pred hHH--HHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 765 QAE--QLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 765 ~~~--~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
... .+.+++.+||..+|.+||++ .++++.+..+
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~-~~ll~~~~~~ 169 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAA-NHYLAHCRAL 169 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCH-HHHHHHHHHH
Confidence 333 69999999999999999999 6666666544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-24 Score=216.88 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=200.9
Q ss_pred CCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
......+|.+...|+.|+|++.+..+++|+++...... ..+|..|.-.|+-+.||||+.++|+| +.+..++..||+
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 34556789999999999999999999999988764432 35799999999999999999999999 457889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
-|+|...|... ..-..+..++.+++.+|++|++|||+.+| -|.-.-|++..++||++.+++|+- +-+++...
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kfsfq----- 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ----- 342 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-ccceeeee-----
Confidence 99999999644 23456778999999999999999999865 244557899999999999888742 21111111
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCC---chhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELT---PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~---~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
..+..-.|.||+||.+...+-+ .++|+|||+++||||.|...||.....++.... -.++.++...
T Consensus 343 -------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-----ialeglrv~i 410 (448)
T KOG0195|consen 343 -------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-----IALEGLRVHI 410 (448)
T ss_pred -------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----hhhccccccC
Confidence 1233468999999999876543 478999999999999999999987777665433 2345566677
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
|+..+..+.+|+.-|++.||.+||.+ +.++.+|+.+.
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkf-dmivpilekm~ 447 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKF-DMIVPILEKMI 447 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCc-ceehhhHHHhc
Confidence 88888999999999999999999999 88889988764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-22 Score=221.35 Aligned_cols=274 Identities=23% Similarity=0.277 Sum_probs=202.1
Q ss_pred CCcccceeeeeCceEEEEEEECC---eEEEEEEecCCCCCCchhHHHHHHHHHhcCC----CceeeEeccc---cCceEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLHPHSLQGPSEFQQEIDILSKIRH----PNLVTLVGAC---PEVWTL 598 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~---~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~H----pnIv~l~g~~---~~~~~l 598 (846)
+|.+.++||+|+||.||.+.... ..+|+|............+..|+.+|..+.. +++..+++.. ....++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999998765 3689998776544433478899999999973 5788887766 345789
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC-----Cceeeecccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-----FVSKLSDFGI 673 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~-----~~vKL~DFGl 673 (846)
||+.+ |.+|.++..... ...++..+.+.|+.|++.+|.+||+ .|++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999775443 5679999999999999999999999 899999999999999865 4689999999
Q ss_pred cc--ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHhhhh
Q 003121 674 SR--FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGK 749 (846)
Q Consensus 674 a~--~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~--~~~~~~~~ 749 (846)
++ .+..................+||..|+++....+...+.+.|+||++.++.+++.|..||...... ...+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 332222111001101123456999999999999999999999999999999999999998544321 11111111
Q ss_pred hccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCCCCCcCCC
Q 003121 750 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGS 812 (846)
Q Consensus 750 ~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~~~~~~~~ 812 (846)
....... .....+..+..+...+-..+...+|.. ..+...+.......+......+++
T Consensus 254 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy-~~~~~~l~~~~~~~~~~~~~~~dw 311 (322)
T KOG1164|consen 254 RKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDY-EKLAELLKDVFDSEGSKEDSPFDW 311 (322)
T ss_pred hhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCH-HHHHHHHHHHHHhcCCCCCCCCcc
Confidence 1111111 222345678888888888999999999 777777777666654444444443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=227.74 Aligned_cols=171 Identities=16% Similarity=0.122 Sum_probs=129.4
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC---CeEEEEEEecCCCC-----CCchhHHHHHHHHHhcCCCceee-EeccccCc
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL-----QGPSEFQQEIDILSKIRHPNLVT-LVGACPEV 595 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~---~~~VAIK~l~~~~~-----~~~~~f~~Ei~iL~~l~HpnIv~-l~g~~~~~ 595 (846)
...++|.....||+|+||+||+|.+. +..||||++..... .....|.+|+.+|++++|+||+. +++. ..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--~~ 92 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--GK 92 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--CC
Confidence 44567999999999999999999874 46689998764311 11345899999999999999985 5443 45
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccc-CCCceEecCCCceeeeccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL-KPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDL-kp~NILl~~~~~vKL~DFGla 674 (846)
.|+||||++|++|.... . .. ...++.+++.||.|||+ +||+|||| ||+|||++.++.+||+|||+|
T Consensus 93 ~~LVmE~~~G~~L~~~~---~----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 93 DGLVRGWTEGVPLHLAR---P----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cEEEEEccCCCCHHHhC---c----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 79999999999996321 1 11 14678899999999999 89999999 999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 710 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~ 710 (846)
+.+..............-.+..|++.|+|||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 987654321111000111345689999999998643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-21 Score=203.77 Aligned_cols=258 Identities=33% Similarity=0.467 Sum_probs=193.3
Q ss_pred CcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCC-ceeeEeccccC--ceEEEEEec
Q 003121 530 FDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHP-NLVTLVGACPE--VWTLVYEYL 603 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~Hp-nIv~l~g~~~~--~~~lVmEy~ 603 (846)
|.....||.|+||.||++... ..+++|.+....... ...|.+|+.++..+.|+ +|+++++.+.. ..+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 566778999999999999888 788999988764433 56799999999999988 79999988743 358999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC-ceeeeccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~-~vKL~DFGla~~~~~~~~ 682 (846)
.+++|.+++........++......++.+++.+|.|+|. .+++|||+||+||+++..+ .++++|||+++.+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999999766322111368899999999999999999999 8899999999999999988 799999999986544332
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHhhhhhcc---c
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALDTGKLKN---L 753 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~~~ksDVwSlGviL~elltG~~pf~~~~~---~~~~~~~~~~~~---~ 753 (846)
..... .......||..|++||.+.+ ..++...|+||+|++++++++|..||..... ............ .
T Consensus 158 ~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 158 TSSIP--ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred ccccc--ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 11100 01244579999999999987 5788999999999999999999999866553 111111111100 0
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 793 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~ 793 (846)
........+......+.+++..|+..+|..|.+.......
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0011111111123578999999999999999998554443
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=179.98 Aligned_cols=144 Identities=37% Similarity=0.602 Sum_probs=121.8
Q ss_pred EEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 46 KIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLL 123 (846)
Q Consensus 46 ~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~ 123 (846)
+|+||||+| ++|.+||+||++.. .+..|+++||.+|+.......+ ..+....+.+..++.++++|+++..
T Consensus 1 ~ILVavD~S-~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~~~~ 72 (146)
T cd01989 1 SVAVAVDKD-KKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSG-------KLEVASAYKQEEDKEAKELLLPYRC 72 (146)
T ss_pred CEEEEecCc-cccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCcc-------chHHHHHHHHHHHHHHHHHHHHHHH
Confidence 589999999 99999999999985 4789999999987533221110 1123455666777888999999999
Q ss_pred HHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEecC
Q 003121 124 ICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNG 199 (846)
Q Consensus 124 ~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~~g 199 (846)
.|...++++++.++++++|+++|+++++++++|+||||+|+++.+.|.+. .|.++..|++.+|++|.|++|++|
T Consensus 73 ~~~~~~~~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~--gssva~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 73 FCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFK--KSDVASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred HHhhcCCeEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeeccc--CCchhHHHHhcCCCCceEEEEeCc
Confidence 99999999999998888999999999999999999999999999887764 347999999999999999999998
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-21 Score=226.73 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=181.1
Q ss_pred CCcccceeeeeCceEEEEEEECCeEEEEEEecCCC-CCCchhHHHHHHH--HHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHS-LQGPSEFQQEIDI--LSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~-~~~~~~f~~Ei~i--L~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
+|...+.||.+.|=+|.+|+.+...|+||++-+.. ..+...|.+.+.- ...++|||.+++.-.- ....|||-+|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 56677889999999999999998889999997765 3344555544433 3445899999886654 34577888898
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
.. +|.|+| ..++.|..-+...|+.|++.||.-+|. .||+|||||.+||||+.-..+.|+||.--+...-....
T Consensus 104 kh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 KH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred hh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 54 899999 455778888999999999999999999 89999999999999999889999999876633221111
Q ss_pred CCCccccccCCCCCCcccCChhhhccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhc
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASG----------E-LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLK 751 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~----------~-~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~ 751 (846)
......+. .+...-.+|+|||.+... . .++++||||+||++.||++ |+|+|....-+.+.-. . .
T Consensus 177 Padf~fFF-DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~--~-~ 252 (1431)
T KOG1240|consen 177 PADFTFFF-DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG--N-A 252 (1431)
T ss_pred cccceEEE-ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc--C-c
Confidence 11112222 233345689999988542 2 6789999999999999988 8999976655443211 1 0
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHH
Q 003121 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 793 (846)
Q Consensus 752 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~ 793 (846)
......... .....+++|++.|++.+|.+|-++ ++.++
T Consensus 253 ~~~e~~Le~---Ied~~~Rnlil~Mi~rdPs~RlSA-edyL~ 290 (1431)
T KOG1240|consen 253 DDPEQLLEK---IEDVSLRNLILSMIQRDPSKRLSA-EDYLQ 290 (1431)
T ss_pred cCHHHHHHh---CcCccHHHHHHHHHccCchhccCH-HHHHH
Confidence 000000111 112469999999999999999998 44433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-19 Score=188.03 Aligned_cols=272 Identities=18% Similarity=0.257 Sum_probs=199.0
Q ss_pred cCCCcccceeeeeCceEEEEEE--ECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEec--cccCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVG--ACPEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~--~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g--~~~~~~~lVmE 601 (846)
.-+|.+.++||+|.||+.+.|. +++.+||||.-...+ ..-++..|....+.|. .++|...|. -|.-+..||||
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4489999999999999999996 468999999755433 2346888999988885 578776654 45556779999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC-----Cceeeeccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-----FVSKLSDFGISRF 676 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~-----~~vKL~DFGla~~ 676 (846)
++ |-||+|+..-.+ ..|+..++.-++.|++.-+.|+|. +.+|+|||||+|+||... ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 98 779998885443 458999999999999999999999 899999999999999743 3678999999998
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HH---HHhhhhhc
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QY---ALDTGKLK 751 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~--~~---~~~~~~~~ 751 (846)
+.+..+...-. ........||..||+-....+.+.+..-|+=|||-++.+.|-|..||.+.... .. .+-..+..
T Consensus 179 YrDp~TkqHIP-YrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 179 YRDPKTKQHIP-YREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hcCccccccCc-cccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 76655432211 12334567999999998888889999999999999999999999999543221 11 11111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCCCCCcCCC
Q 003121 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGS 812 (846)
Q Consensus 752 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~~~~~~~~ 812 (846)
..+..+...+ +.++..-+.-.-.++-.+-|+. +-+...+..+....+-+....++|
T Consensus 258 T~i~~Lc~g~----P~efa~Yl~yvR~L~F~E~PDY-dylr~Lf~dvldr~g~t~Dg~yDW 313 (449)
T KOG1165|consen 258 TPIEVLCEGF----PEEFATYLRYVRRLDFFETPDY-DYLRKLFDDVLDRLGETDDGEYDW 313 (449)
T ss_pred CCHHHHHhcC----HHHHHHHHHHHHhcCcccCCCH-HHHHHHHHHHHHhcCCcccccccc
Confidence 1122222333 4677777777777888888998 666666666655544433333333
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=181.77 Aligned_cols=260 Identities=20% Similarity=0.285 Sum_probs=192.1
Q ss_pred cCCCcccceeeeeCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHHhcCC-CceeeEeccc--cCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH-PNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~H-pnIv~l~g~~--~~~~~lVmE 601 (846)
.+.|...++||.|+||.+|.|.. .|..||||+-..... ..++..|..+...|++ ..|..+..+. .+...+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 45799999999999999999976 478999998654432 2367889999999975 5555555444 345779999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC---Cceeeeccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLS 678 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~---~~vKL~DFGla~~~~ 678 (846)
.+ |-||++++.-. ...++..+.+-++-|++.-++|+|. +++|||||||+|+|..-+ ..+.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 77999988433 2358888999999999999999999 899999999999999644 467899999999876
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH-----HHhhhhhccc
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-----ALDTGKLKNL 753 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~-----~~~~~~~~~~ 753 (846)
+..+...- ......+..||..|.+--...+...+...|+=|+|.+|.++.-|..||.+...... .+.+.++...
T Consensus 166 d~~t~~HI-pyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 166 DIRTRQHI-PYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred cccccccC-ccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 54432211 11223456799999998888777888899999999999999999999965433221 2233334444
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
+..+...+| .++.-.+.-|-..--.+-|+. .-+.+.+.-+..
T Consensus 245 ie~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy-~ylrqlFriLfr 286 (341)
T KOG1163|consen 245 IEVLCKGFP----AEFAMYLNYCRGLGFEEKPDY-MYLRQLFRILFR 286 (341)
T ss_pred HHHHhCCCc----HHHHHHHHHHhhcCCCCCCcH-HHHHHHHHHHHh
Confidence 444444554 567888888888888888877 334444444333
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-20 Score=194.05 Aligned_cols=169 Identities=16% Similarity=0.175 Sum_probs=132.8
Q ss_pred hcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchh---------HHHHHHHHHhcCCCceeeEecccc---
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE---------FQQEIDILSKIRHPNLVTLVGACP--- 593 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~---------f~~Ei~iL~~l~HpnIv~l~g~~~--- 593 (846)
..++|...+.||.|+||.||.....+..+|||++++........ +.+|+..+.+++||+|..+.+++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 35689999999999999999987777789999998764433322 678999999999999998877642
Q ss_pred -------CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 594 -------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 594 -------~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
...+|||||++|.+|.++.. ++. ....+++.+|..||. +|++|||++|+||+++.+| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence 24789999999999988741 222 345689999999999 8999999999999999988 9
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHH
Q 003121 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 729 (846)
Q Consensus 667 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ell 729 (846)
+|+|||.......... ..-+.....|+.++|+||||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a--------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA--------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhh--------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 9999998764422110 011344556778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.3e-20 Score=186.28 Aligned_cols=137 Identities=18% Similarity=0.184 Sum_probs=106.0
Q ss_pred ceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCC---------chhH-----------------HHHHHHHHhcCCCcee
Q 003121 534 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG---------PSEF-----------------QQEIDILSKIRHPNLV 586 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~---------~~~f-----------------~~Ei~iL~~l~HpnIv 586 (846)
..||+|+||.||+|... |..||||+++...... ...| ..|+.+|.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 46999999999999875 7899999997653211 1122 3499999999877663
Q ss_pred eEeccccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceEecccCCCceEecCCCc
Q 003121 587 TLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL-HSCKPHSIVHGDLKPANILLDANFV 665 (846)
Q Consensus 587 ~l~g~~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~giiHrDLkp~NILl~~~~~ 665 (846)
..........+|||||++|++|...+. ...+++......++.|++.+|.+| |. .||+||||||+|||++ ++.
T Consensus 83 ~p~~~~~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILLKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCc
Confidence 322222233489999999887765432 224688999999999999999999 67 7999999999999998 478
Q ss_pred eeeecccccccc
Q 003121 666 SKLSDFGISRFL 677 (846)
Q Consensus 666 vKL~DFGla~~~ 677 (846)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=183.80 Aligned_cols=192 Identities=15% Similarity=0.063 Sum_probs=141.9
Q ss_pred cccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCc----hhHHHHHHHHHhcC-CCceeeEeccccCceEEEEEecCC
Q 003121 531 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP----SEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYLPN 605 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~----~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~lVmEy~~g 605 (846)
.....|++|+||+||.+...+.+++.+.+........ ..|.+|+++|++|. |++|++++++ ...+++|+|+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence 3456799999999998877788888888775543211 24789999999995 5889999886 457899999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccc-CCCceEecCCCceeeecccccccccccccc-
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL-KPANILLDANFVSKLSDFGISRFLSQNEIS- 683 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDL-kp~NILl~~~~~vKL~DFGla~~~~~~~~~- 683 (846)
.+|...+. . ....++.+++.+|.++|. +||+|||| ||+|||++.++.++|+|||++.........
T Consensus 83 ~~L~~~~~---~-------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPP---R-------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhh---h-------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99875431 0 123577899999999999 89999999 799999999999999999999865432210
Q ss_pred ---C-CCccccccCCCCCCcccCChhhhccC-CCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 003121 684 ---S-NNTTLCCRTDPKGTFAYMDPEFLASG-ELT-PKSDVYSFGIILLRLLTGRPALGI 737 (846)
Q Consensus 684 ---~-~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~-~ksDVwSlGviL~elltG~~pf~~ 737 (846)
. .............++.|++|+...-- ..+ ...++++.|+-+|.++||+.++..
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 00000001112378889999754322 233 567999999999999999887743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-20 Score=210.20 Aligned_cols=221 Identities=27% Similarity=0.319 Sum_probs=178.8
Q ss_pred eeeeCceEEEEE-----EECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcC-CCceeeEeccc--cCceEEEEEecCC
Q 003121 536 IGEGGYGSIYKG-----LLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPN 605 (846)
Q Consensus 536 LG~G~fG~Vy~g-----~~~~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~lVmEy~~g 605 (846)
+|+|.||.|+.. ...+..+|.|++++..... ......|..++..++ ||.+|++...+ +...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 799999999863 3345678999887754332 225567899999997 99999999887 4568999999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|.|...+.. ...+.+.....+...++-++.++|. .+|+|||+|++||+++.+|++|+.|||+++..-....
T Consensus 82 g~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 82 GDLFTRLSK---EVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred chhhhcccc---CCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999998843 3457777888889999999999999 8999999999999999999999999999986544321
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 765 (846)
.+||..|||||++. .+...+|+||||++.++|+||..||.. ... ..+.-.....|...
T Consensus 153 ---------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-~~~----------~~Il~~~~~~p~~l 210 (612)
T KOG0603|consen 153 ---------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-DTM----------KRILKAELEMPREL 210 (612)
T ss_pred ---------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-HHH----------HHHhhhccCCchhh
Confidence 15999999999997 677899999999999999999999976 111 11111233457778
Q ss_pred HHHHHHHHHHHhccCcCCCCCh
Q 003121 766 AEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 766 ~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
...+..++..++..+|.+|-..
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhcc
Confidence 8899999999999999999755
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-20 Score=219.01 Aligned_cols=247 Identities=22% Similarity=0.304 Sum_probs=175.7
Q ss_pred cccceeeeeCceEEEEEEEC--CeEEEEEEecCC--CCCCc----hhHHHHHHHHHhcCCCceeeEeccccC--ceEEEE
Q 003121 531 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGP----SEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY 600 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~--~~~~~----~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lVm 600 (846)
.....+|.|.||.|+..... ...++.|.+... ..... ..+..|+.+-..|.|||++..+..+.+ ..+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34567999999977766543 233444433211 11111 125568888888999999887776532 333449
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
|||++ +|..++... ..+....+-.++.|++.||.|||. .||.||||||+|++++.+|.+||+|||.+..+.-.
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999998533 457888999999999999999999 89999999999999999999999999998866433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTP-KSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~-ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.. .......+.+|+..|+|||++.+..|++ ..||||.|+++..|++|+.||.......................+
T Consensus 474 ~e----~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 474 WE----KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG 549 (601)
T ss_pred cc----hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence 21 1123346678999999999999999986 479999999999999999999544332111000000000001111
Q ss_pred C--CChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 760 D--WPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 760 ~--~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
. .-...+.....++.++|+.+|.+|-++.
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~ 580 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIE 580 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHH
Confidence 1 1123456789999999999999999993
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=177.08 Aligned_cols=141 Identities=17% Similarity=0.152 Sum_probs=109.3
Q ss_pred cceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCC--------------------------chhHHHHHHHHHhcCCCce
Q 003121 533 SLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG--------------------------PSEFQQEIDILSKIRHPNL 585 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~--------------------------~~~f~~Ei~iL~~l~HpnI 585 (846)
...||+|+||.||+|... |..||||+++...... ...+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 357999999999999875 7899999998753210 0123578999999999987
Q ss_pred eeEeccccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc
Q 003121 586 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 665 (846)
Q Consensus 586 v~l~g~~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~ 665 (846)
.....+.....+|||||++|+++..... ...+++......++.+++.+|.+||+. +||+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CCC
Confidence 4433322234589999999886543321 124577889999999999999999983 5899999999999999 889
Q ss_pred eeeecccccccccc
Q 003121 666 SKLSDFGISRFLSQ 679 (846)
Q Consensus 666 vKL~DFGla~~~~~ 679 (846)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=177.12 Aligned_cols=229 Identities=21% Similarity=0.298 Sum_probs=148.4
Q ss_pred CcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCC---CchhHHHHHHHHHhcCC---C-------c------eeeE
Q 003121 530 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRH---P-------N------LVTL 588 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~H---p-------n------Iv~l 588 (846)
+.....||.|+|+.||.+++.. ..+|+|++...... ..+.+.+|.-....+.+ | . ++++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4455679999999999999975 88999988765422 23456666654444322 1 1 2222
Q ss_pred ecc---c---c-------CceEEEEEecCCCchhhhhcc---CC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEec
Q 003121 589 VGA---C---P-------EVWTLVYEYLPNGSLEDRLSC---KD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651 (846)
Q Consensus 589 ~g~---~---~-------~~~~lVmEy~~ggsL~~~L~~---~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHr 651 (846)
-+- + . -+.+++|+-+ .++|.+++.. .. ....+....++.+..|+.+.+++||. .|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 110 0 0 1345777777 4688877532 11 12234455667788999999999999 999999
Q ss_pred ccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC--------CCCchhhHHHHHH
Q 003121 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--------ELTPKSDVYSFGI 723 (846)
Q Consensus 652 DLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--------~~~~ksDVwSlGv 723 (846)
||+|+|+|++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-----------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 99999999999999999999987655433211 1245779999977442 4788999999999
Q ss_pred HHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCC
Q 003121 724 ILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR 784 (846)
Q Consensus 724 iL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~R 784 (846)
++|.|++|+.||+........ . .....+. ..++.+..||..+|+.+|.+|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~--~--------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADP--E--------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTS--G--------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCccccc--c--------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999999866432110 0 0223344 678999999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=172.50 Aligned_cols=134 Identities=18% Similarity=0.213 Sum_probs=103.7
Q ss_pred cccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc-----CCCceeeEeccccCc-----eE-EE
Q 003121 531 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-----RHPNLVTLVGACPEV-----WT-LV 599 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-----~HpnIv~l~g~~~~~-----~~-lV 599 (846)
....+||+|+||.||.... ....+||++........+.+.+|+.+++.+ +||||++++|++.+. .+ +|
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~-~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPE-DAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CCcceecCCCceEEEECCC-CcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 3456899999999996222 223479988775544567899999999999 579999999998543 23 78
Q ss_pred EEe--cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCceEecccCCCceEecC----CCceeeeccc
Q 003121 600 YEY--LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL-IFLHSCKPHSIVHGDLKPANILLDA----NFVSKLSDFG 672 (846)
Q Consensus 600 mEy--~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~~~giiHrDLkp~NILl~~----~~~vKL~DFG 672 (846)
||| +++|+|.+++.. ..+++. ..++.+++.++ .|||+ ++|+||||||+|||++. ++.++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 667999999943 235554 35678888888 89999 89999999999999974 3489999955
Q ss_pred cc
Q 003121 673 IS 674 (846)
Q Consensus 673 la 674 (846)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.6e-18 Score=200.26 Aligned_cols=216 Identities=24% Similarity=0.307 Sum_probs=148.5
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccccCceEEEEEec
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYL 603 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~lVmEy~ 603 (846)
...+|+.+++|..|+||-||...++ .+++|+|+ ++... +.+- ||.....|. .|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npf-------------vv---- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPF-------------VV---- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCcc-------------ee----
Confidence 4568999999999999999999877 57789854 32211 1111 222233333 33
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
|+-.+++. +.++++... +.+++|||+ .||+|||+||+|+||+.-|++|++|||+++........
T Consensus 136 --gDc~tllk---~~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLK---NIGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhcc---cCCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 55555552 334444433 778999999 89999999999999999999999999998753221111
Q ss_pred C-------CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHhhhhhccccC
Q 003121 684 S-------NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDTGKLKNLLD 755 (846)
Q Consensus 684 ~-------~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~-~~~~~~~~~~~ld 755 (846)
. ...........+||+.|+|||++...+|+..+|||++|+|+||.+.|..||.+....+ ...-.+....+.+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 0 0111122344579999999999999999999999999999999999999987663322 1111111111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
. ....+.+.++++.++|+.+|..|--.
T Consensus 280 ---~--dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 280 ---E--DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred ---c--CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 1 22245789999999999999999644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=172.95 Aligned_cols=198 Identities=22% Similarity=0.252 Sum_probs=140.0
Q ss_pred CCCceeeEecccc-----------------------------CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHH
Q 003121 581 RHPNLVTLVGACP-----------------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 631 (846)
Q Consensus 581 ~HpnIv~l~g~~~-----------------------------~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~ 631 (846)
.|||||+++++|- ...|+||...+ .+|..+|..+ ..+....+-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 5999999988761 12578888775 4888888433 356678888999
Q ss_pred HHHHHHHHHhhcCCCceEecccCCCceEe--cCCC--ceeeeccccccccccccccCCCccccccCCCCCCcccCChhhh
Q 003121 632 ELCSVLIFLHSCKPHSIVHGDLKPANILL--DANF--VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707 (846)
Q Consensus 632 qia~aL~~LH~~~~~giiHrDLkp~NILl--~~~~--~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l 707 (846)
|+++|+.|||. +||.|||+|++|||| |+|+ .+.|+|||+|---......... .....+.-|...-||||+.
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy--~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPY--ESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeecccccccccc--ccccccCCCcceecchhhh
Confidence 99999999999 999999999999999 3443 5689999987533221111111 1112344588899999998
Q ss_pred ccCC-----C-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCc
Q 003121 708 ASGE-----L-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 781 (846)
Q Consensus 708 ~~~~-----~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P 781 (846)
...+ . -.++|.|+.|.+.||+++...||.....+. ++.....+ ...+..|..++..+.+|+...|+.+|
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~--L~~r~Yqe---~qLPalp~~vpp~~rqlV~~lL~r~p 498 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML--LDTRTYQE---SQLPALPSRVPPVARQLVFDLLKRDP 498 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe--echhhhhh---hhCCCCcccCChHHHHHHHHHhcCCc
Confidence 6532 1 247999999999999999999997644322 11111221 12233345566789999999999999
Q ss_pred CCCCChHHHHHHH
Q 003121 782 KSRPELGKDVWRV 794 (846)
Q Consensus 782 ~~RPt~~~~v~~~ 794 (846)
.+||+. .....+
T Consensus 499 skRvsp-~iAANv 510 (598)
T KOG4158|consen 499 SKRVSP-NIAANV 510 (598)
T ss_pred cccCCc-cHHHhH
Confidence 999987 443333
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.1e-17 Score=185.69 Aligned_cols=211 Identities=27% Similarity=0.446 Sum_probs=154.5
Q ss_pred HHhcCCCceeeEeccc--cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccC
Q 003121 577 LSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 654 (846)
Q Consensus 577 L~~l~HpnIv~l~g~~--~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLk 654 (846)
|+.+.|.|+.+++|.| ....+.|.+||..|+|.|.+.. ....+++.....+..+|+.||.|||... ...|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999998 4568899999999999999964 3467889999999999999999999942 23999999
Q ss_pred CCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC---C----CCchhhHHHHHHHHHH
Q 003121 655 PANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG---E----LTPKSDVYSFGIILLR 727 (846)
Q Consensus 655 p~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~----~~~ksDVwSlGviL~e 727 (846)
+.|+++|..+.+||+|||+............. ....-...|.|||.+... . .+.+.||||||++++|
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~------~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAH------HPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred cccceeeeeEEEEechhhhccccccccccccc------chhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 99999999999999999998876431000000 111235679999999763 1 4667999999999999
Q ss_pred HHhCCCCCCCchHHHH---HHhhhhhcc-ccCCCCCCCC-h-hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 728 LLTGRPALGITKEVQY---ALDTGKLKN-LLDPLAGDWP-F-VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 728 lltG~~pf~~~~~~~~---~~~~~~~~~-~ld~~~~~~p-~-~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
+++...||+....... .+.. +.. ...+.++... . ...+.+..++.+||..+|.+||++ +.+...++.+..
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~--~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~-~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILR--VKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI-EQIRSKLLTINK 226 (484)
T ss_pred HHhccCccccccccCChHHHHHH--HHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH-HHHHhhhhhhcc
Confidence 9999999975322111 1111 111 1112222211 1 233479999999999999999999 666666655543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.8e-17 Score=164.69 Aligned_cols=129 Identities=27% Similarity=0.406 Sum_probs=106.0
Q ss_pred eeeeeCceEEEEEEECCeEEEEEEecCCCCCC--------chhHHHHHHHHHhcCCCce--eeEeccccCceEEEEEecC
Q 003121 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPNL--VTLVGACPEVWTLVYEYLP 604 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~--------~~~f~~Ei~iL~~l~HpnI--v~l~g~~~~~~~lVmEy~~ 604 (846)
.||+|+||.||+|.+.+..|++|......... ...+.+|+.++..+.|+++ ..+++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 38999999999999999999999876543211 1456789999999988754 4555555667899999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
|++|.+++.... ..++.+++.+|.+||. .|++|||++|.|||++ ++.++++|||+++..
T Consensus 81 g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGN----------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcH----------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998873211 0789999999999999 8999999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.7e-17 Score=166.19 Aligned_cols=132 Identities=27% Similarity=0.438 Sum_probs=110.1
Q ss_pred ceeeeeCceEEEEEEECCeEEEEEEecCCCCCCc--------hhHHHHHHHHHhcCCCceeeEecc--ccCceEEEEEec
Q 003121 534 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP--------SEFQQEIDILSKIRHPNLVTLVGA--CPEVWTLVYEYL 603 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~--------~~f~~Ei~iL~~l~HpnIv~l~g~--~~~~~~lVmEy~ 603 (846)
+.||+|++|.||+|.+.+..|++|+......... ..+.+|+.++..+.|+||.....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 4699999999999999999999998765433221 347789999999999887654444 456788999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
+|++|.+++... .. .+..++.+++.+|.+||. .+++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988422 12 788999999999999999 8999999999999999 78999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.9e-17 Score=170.01 Aligned_cols=140 Identities=18% Similarity=0.158 Sum_probs=109.8
Q ss_pred CCcccceeeeeCceEEEEEE---ECCeEEEEEEecCCCCC-------------------C-----chhHHHHHHHHHhcC
Q 003121 529 NFDPSLKIGEGGYGSIYKGL---LRHMQVAIKMLHPHSLQ-------------------G-----PSEFQQEIDILSKIR 581 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~---~~~~~VAIK~l~~~~~~-------------------~-----~~~f~~Ei~iL~~l~ 581 (846)
.|.+...||+|+||.||+|. ..+..||||+++..... . ...+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46777889999999999998 24789999998764311 0 012568999999997
Q ss_pred CC--ceeeEeccccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-eEecccCCCce
Q 003121 582 HP--NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-IVHGDLKPANI 658 (846)
Q Consensus 582 Hp--nIv~l~g~~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g-iiHrDLkp~NI 658 (846)
+. .+.++++. ...++||||++|++|...+. ...++.......++.+|+.+|.+||. +| ++||||||+||
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhE
Confidence 53 34455543 24589999999988876542 22345666778999999999999999 88 99999999999
Q ss_pred EecCCCceeeecccccccc
Q 003121 659 LLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 659 Ll~~~~~vKL~DFGla~~~ 677 (846)
|++ ++.++|+|||++...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 889999999988754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3e-17 Score=182.41 Aligned_cols=173 Identities=24% Similarity=0.364 Sum_probs=133.2
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
++|+.|++|...+|.++|.++......++.....++.|++.|+.| ++.+|+|+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999877766778888999999999999999 57999999999999999999999999998
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
.......+... .....+...||.+||+||.+.+..|+.++||||||+||+|+++ =..+|. . .+.+..+
T Consensus 404 ts~~~~~~~~~--~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r-----~~t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAP--AAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----R-----IATLTDI 472 (516)
T ss_pred eecccCCcccc--hhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----H-----HHhhhhh
Confidence 76654431111 1123466789999999999999999999999999999999998 222221 1 1111121
Q ss_pred cCCCCCCCCh---hhHHHHHHHHHHHhccCcCCCCCh
Q 003121 754 LDPLAGDWPF---VQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 754 ld~~~~~~p~---~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
-+ +.||+ ...+.-..|+.+++...|.+||++
T Consensus 473 r~---g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 473 RD---GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hc---CCCChHHhhcCcHHHHHHHHhcCCCcccCchH
Confidence 11 22221 112345789999999999999965
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.8e-16 Score=185.86 Aligned_cols=196 Identities=26% Similarity=0.347 Sum_probs=153.4
Q ss_pred hhhhhhcCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceee----Eecc--cc
Q 003121 521 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----LVGA--CP 593 (846)
Q Consensus 521 ~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~----l~g~--~~ 593 (846)
.+++.....|.+.+.||+|+||.||+|... ++.||+|+=++.... +|.--.+++.+|+ |-+.. +..+ |.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk-~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLK-PQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhc-hhhhcchHHHHHHHccC
Confidence 344455567889999999999999999876 678999997765543 4444556666666 43333 2222 36
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-------CCce
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-------NFVS 666 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-------~~~v 666 (846)
+..+||+||.+.|+|.+++. ....++|.....++.+++..+..||. .+|||+||||+|+||.. ...+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccce
Confidence 77889999999999999994 66779999999999999999999999 78999999999999942 3468
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCC
Q 003121 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732 (846)
Q Consensus 667 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~ 732 (846)
+|+|||.+--+.--. ... .....++|-.+-.+|+..+..++...|.|.|+.+++-||.|+
T Consensus 841 ~lIDfG~siDm~lfp---~~~---~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFP---DGT---KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred EEEecccceeeeEcC---CCc---EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 999999886432111 111 113345788899999999999999999999999999999995
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.5e-16 Score=184.57 Aligned_cols=137 Identities=28% Similarity=0.370 Sum_probs=111.6
Q ss_pred hcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCC--------CchhHHHHHHHHHhcCCCceeeEeccc--cCc
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ--------GPSEFQQEIDILSKIRHPNLVTLVGAC--PEV 595 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~--------~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~ 595 (846)
....|...+.||+|+||.||+|.+.+..+++|+....... ..+.+.+|+.++..++|++|+..+.++ ...
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3445667889999999999999998877766654332111 124578999999999999988765544 457
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.++||||++|++|.+++. ....++.+++.+|.+||+ ++++||||||+|||+ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 889999999999999873 457889999999999999 899999999999999 57799999999987
Q ss_pred cc
Q 003121 676 FL 677 (846)
Q Consensus 676 ~~ 677 (846)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.7e-16 Score=157.64 Aligned_cols=136 Identities=20% Similarity=0.179 Sum_probs=107.7
Q ss_pred CCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCC----------------------CchhHHHHHHHHHhcCCC--
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ----------------------GPSEFQQEIDILSKIRHP-- 583 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~----------------------~~~~f~~Ei~iL~~l~Hp-- 583 (846)
.|...+.||.|+||.||++... +..||||++...... ....+..|..++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3667788999999999999885 789999987653210 011356799999999887
Q ss_pred ceeeEeccccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC
Q 003121 584 NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 663 (846)
Q Consensus 584 nIv~l~g~~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~ 663 (846)
++...++. ...++||||++|++|...... .....++.+++.++.++|. .||+||||||.||+++.+
T Consensus 96 ~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 96 PVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCC
Confidence 44555543 345899999999998775420 2456788999999999999 899999999999999999
Q ss_pred Cceeeeccccccccc
Q 003121 664 FVSKLSDFGISRFLS 678 (846)
Q Consensus 664 ~~vKL~DFGla~~~~ 678 (846)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=140.36 Aligned_cols=132 Identities=20% Similarity=0.276 Sum_probs=112.3
Q ss_pred cceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCC--CceeeEecccc--CceEEEEEecCCCch
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH--PNLVTLVGACP--EVWTLVYEYLPNGSL 608 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~H--pnIv~l~g~~~--~~~~lVmEy~~ggsL 608 (846)
.+.||.|.++.||++...+..+++|....... ...+.+|+.++..++| ++++++++++. +..+++|||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 45799999999999999888999999865433 4578999999999976 58888888774 368999999998877
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
..+ +......++.+++.+|.+||.....+++|+|++|.|||++.++.++++|||++..
T Consensus 81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 4557778899999999999996656899999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.9e-13 Score=132.65 Aligned_cols=138 Identities=14% Similarity=0.190 Sum_probs=99.3
Q ss_pred CCEEEEEecCCccc--cHHHHHHHhhc--CCCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHH
Q 003121 44 EDKIYVAVAKQVKE--SKSVLLWALQN--SGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLD 119 (846)
Q Consensus 44 ~~~V~VAVD~s~~~--S~~AL~Wal~n--~~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 119 (846)
-++|+||||+| ++ |.+||+||++- ..+.+|+|+||.++.......+ +... ..... .+...+.+++.|+
T Consensus 2 ~~~ILv~~D~s-~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~~~--~~~~-~~~~~----~~~~~~~~~~~l~ 73 (144)
T PRK15005 2 NRTILVPIDIS-DSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYASLG--LAYS-AELPA----MDDLKAEAKSQLE 73 (144)
T ss_pred CccEEEecCCC-chhHHHHHHHHHHHHHhccCCeEEEEEEEccCccccccc--cccc-ccchH----HHHHHHHHHHHHH
Confidence 37899999999 77 57999999986 3578999999998643211111 1000 00011 1223444556667
Q ss_pred HHHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 120 MCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 120 ~~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
++...+...+++++..+.. |+|.+.|+++++++++|+||||+|+ +.+.|.+. |.++..|++.++ |.|++|
T Consensus 74 ~~~~~~~~~~~~~~~~v~~-G~p~~~I~~~a~~~~~DLIV~Gs~~-~~~~~~ll---GS~a~~vl~~a~--cpVlvV 143 (144)
T PRK15005 74 EIIKKFKLPTDRVHVHVEE-GSPKDRILELAKKIPADMIIIASHR-PDITTYLL---GSNAAAVVRHAE--CSVLVV 143 (144)
T ss_pred HHHHHhCCCCCceEEEEeC-CCHHHHHHHHHHHcCCCEEEEeCCC-CCchheee---cchHHHHHHhCC--CCEEEe
Confidence 7776676777788777654 7999999999999999999999984 45665554 778999999987 999987
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.4e-14 Score=143.10 Aligned_cols=137 Identities=18% Similarity=0.189 Sum_probs=96.9
Q ss_pred cceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCC--chh----------------------HHHHHHHHHhcCCCc--e
Q 003121 533 SLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG--PSE----------------------FQQEIDILSKIRHPN--L 585 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~--~~~----------------------f~~Ei~iL~~l~Hpn--I 585 (846)
.+.||+|+||.||+|... +..||||++....... ... ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999887 7889999987643211 111 135666666664432 3
Q ss_pred eeEeccccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc
Q 003121 586 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 665 (846)
Q Consensus 586 v~l~g~~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~ 665 (846)
.+.++. ...++||||++++++........ ... .....++.+++.++.++|.. .+|+||||||+||+++ ++.
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CCc
Confidence 444443 34689999999965432111000 011 56788999999999999973 5799999999999999 889
Q ss_pred eeeeccccccccc
Q 003121 666 SKLSDFGISRFLS 678 (846)
Q Consensus 666 vKL~DFGla~~~~ 678 (846)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=7e-14 Score=147.90 Aligned_cols=132 Identities=20% Similarity=0.218 Sum_probs=103.6
Q ss_pred ceee-eeCceEEEEEEECCeEEEEEEecCCCC-------------CCchhHHHHHHHHHhcCCCce--eeEeccccC---
Q 003121 534 LKIG-EGGYGSIYKGLLRHMQVAIKMLHPHSL-------------QGPSEFQQEIDILSKIRHPNL--VTLVGACPE--- 594 (846)
Q Consensus 534 ~~LG-~G~fG~Vy~g~~~~~~VAIK~l~~~~~-------------~~~~~f~~Ei~iL~~l~HpnI--v~l~g~~~~--- 594 (846)
..|| .||.|+||.....+..++||.+..... .....+.+|+.++..|+|++| +..++++..
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4588 899999999988889999998853211 123457889999999998775 566665311
Q ss_pred ---ceEEEEEecCC-CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeec
Q 003121 595 ---VWTLVYEYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 670 (846)
Q Consensus 595 ---~~~lVmEy~~g-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~D 670 (846)
..++||||++| .+|.+++.. .+++.. .+.+|+.+|.+||. +||+||||||.|||++.++.++|+|
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence 23599999997 689888742 234443 35689999999999 8999999999999999999999999
Q ss_pred cccccc
Q 003121 671 FGISRF 676 (846)
Q Consensus 671 FGla~~ 676 (846)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998764
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.8e-13 Score=129.33 Aligned_cols=121 Identities=12% Similarity=0.242 Sum_probs=100.4
Q ss_pred EEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 46 KIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLL 123 (846)
Q Consensus 46 ~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~ 123 (846)
+|+||||++ +.|++||+||++.. .+..|++|||.++... . ..+..++.++.++.
T Consensus 1 ~Ilv~vd~s-~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~------~-----------------~~~~~~~~l~~~~~ 56 (124)
T cd01987 1 RILVCISGG-PNAERLIRRAARLADRLKAPWYVVYVETPRLN------R-----------------LSEAERRRLAEALR 56 (124)
T ss_pred CEEEEECCC-cchHHHHHHHHHHHHHhCCCEEEEEEecCccc------c-----------------CCHHHHHHHHHHHH
Confidence 589999999 99999999999873 4779999999875321 0 01234567888888
Q ss_pred HHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 124 ICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 124 ~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
.+++.++.+ .++.+++++++|+++++++++|+||||+|+++.++|.+. |.++..++..+ .-|.||++
T Consensus 57 ~~~~~~~~~--~~~~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~---Gs~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 57 LAEELGAEV--VTLPGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFR---GSLVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred HHHHcCCEE--EEEeCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhc---ccHHHHHHHhC-CCCeEEEe
Confidence 888877754 455678999999999999999999999999999998876 78889999998 88999987
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.4e-13 Score=131.85 Aligned_cols=138 Identities=16% Similarity=0.171 Sum_probs=102.7
Q ss_pred CCEEEEEecCCc-cccHHHHHHHhhcC-CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHH
Q 003121 44 EDKIYVAVAKQV-KESKSVLLWALQNS-GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMC 121 (846)
Q Consensus 44 ~~~V~VAVD~s~-~~S~~AL~Wal~n~-~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 121 (846)
-++|+||||+|. +.|.+||+||+.-. ....|+|+||.++...... . .+. ...+.+.+..++.+++.|+++
T Consensus 2 ~~~ILv~vD~S~~~~s~~al~~A~~la~~~~~l~llhv~~~~~~~~~-~-~~~------~~~~~~~~~~~~~~~~~l~~~ 73 (142)
T PRK15456 2 YKTIIMPVDVFEMELSDKAVRHAEFLAQDDGVIHLLHVLPGSASLSL-H-RFA------ADVRRFEEHLQHEAEERLQTM 73 (142)
T ss_pred CccEEEeccCCchhHHHHHHHHHHHHHhcCCeEEEEEEecCcccccc-c-ccc------cchhhHHHHHHHHHHHHHHHH
Confidence 378999999982 38999999999752 2458999999987532111 0 000 112334455666677778888
Q ss_pred HHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 122 LLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 122 ~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
.......+++++..+.+ |+|.+.|+++++++++|+||||+||++ +.+.+. |.++..|++.++ |.|.+|
T Consensus 74 ~~~~~~~~~~v~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~-~~~~ll---GS~a~~v~~~a~--~pVLvV 141 (142)
T PRK15456 74 VSHFTIDPSRIKQHVRF-GSVRDEVNELAEELGADVVVIGSRNPS-ISTHLL---GSNASSVIRHAN--LPVLVV 141 (142)
T ss_pred HHHhCCCCcceEEEEcC-CChHHHHHHHHhhcCCCEEEEcCCCCC-ccceec---CccHHHHHHcCC--CCEEEe
Confidence 87776667888876655 799999999999999999999999976 665543 788999999976 888876
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.2e-14 Score=171.87 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=180.8
Q ss_pred cCCCcccceeeeeCceEEEEEEEC---CeEEEEEEecCCC--CCCchhHHHHHHHHHhcC-CCceeeEeccc--cCceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~---~~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~l 598 (846)
...|...+.||+|.|+.|-..... ...+|.|.+.... .........|..+-..+. |+|++.+++.. ++..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345777788999999999776553 2456777665543 222344556888888887 99999999987 456789
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCceEecccCCCceEecCCC-ceeeeccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH-SCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRF 676 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~giiHrDLkp~NILl~~~~-~vKL~DFGla~~ 676 (846)
+++|..||++.+.+... .....+....-.++.|+..+|.|+| . .++.||||||+|.+++..+ ..|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999999887311 1124555677889999999999999 6 7899999999999999999 999999999987
Q ss_pred ccc-ccccCCCccccccCCCCC-CcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 677 LSQ-NEISSNNTTLCCRTDPKG-TFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 677 ~~~-~~~~~~~~~~~~~~~~~G-t~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
+.. ..... ......| ++.|+|||.+.+. ...+..|+||.|+++.-+++|..|+........ ....+
T Consensus 175 ~~~~~g~~~------~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-----~~~~~ 243 (601)
T KOG0590|consen 175 YRNKNGAER------SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-----RYSSW 243 (601)
T ss_pred ccccCCcce------eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-----cceee
Confidence 765 22111 1134457 9999999999885 456789999999999999999999865443221 11111
Q ss_pred cCC----CCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 754 LDP----LAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 754 ld~----~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
... ....| ........+++.+++..+|..|.+.
T Consensus 244 ~~~~~~~~~~~~-~~~~~~~~~~l~k~l~~~~~~r~s~ 280 (601)
T KOG0590|consen 244 KSNKGRFTQLPW-NSISDQAHDLLHKILKENPSNRLSI 280 (601)
T ss_pred cccccccccCcc-ccCChhhhhcccccccCCchhcccc
Confidence 111 11112 2334668889999999999999988
|
|
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.6e-12 Score=124.84 Aligned_cols=133 Identities=16% Similarity=0.182 Sum_probs=95.8
Q ss_pred CEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCL 122 (846)
Q Consensus 45 ~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~ 122 (846)
++|+||||+| +.|.+||+||++-. .+.+|+|+||.++.... ..+..++ . .+...+..++.+++.++++.
T Consensus 4 k~ILvavD~S-~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~-~~~~~~~----~---~~~~~~~~~~~~~~~l~~~~ 74 (142)
T PRK09982 4 KHIGVAISGN-EEDALLVNKALELARHNDAHLTLIHIDDGLSEL-YPGIYFP----A---TEDILQLLKNKSDNKLYKLT 74 (142)
T ss_pred eEEEEEecCC-cchHHHHHHHHHHHHHhCCeEEEEEEccCcchh-chhhhcc----c---hHHHHHHHHHHHHHHHHHHH
Confidence 7899999999 99999999999873 57899999998765321 1111111 1 12234445556667777777
Q ss_pred HHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEe
Q 003121 123 LICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFIC 197 (846)
Q Consensus 123 ~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~ 197 (846)
..+.. ..++..+ ..|+|++.|++++++.++|+||||+| ++.++|.+ + ++..|++. .-|.|.+|-
T Consensus 75 ~~~~~--~~~~~~v-~~G~p~~~I~~~A~~~~aDLIVmG~~-~~~~~~~~----~-va~~V~~~--s~~pVLvv~ 138 (142)
T PRK09982 75 KNIQW--PKTKLRI-ERGEMPETLLEIMQKEQCDLLVCGHH-HSFINRLM----P-AYRGMINK--MSADLLIVP 138 (142)
T ss_pred HhcCC--CcceEEE-EecCHHHHHHHHHHHcCCCEEEEeCC-hhHHHHHH----H-HHHHHHhc--CCCCEEEec
Confidence 66543 2344444 55899999999999999999999986 67777666 3 77888887 458888873
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.3e-12 Score=124.06 Aligned_cols=133 Identities=16% Similarity=0.217 Sum_probs=92.1
Q ss_pred CEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCL 122 (846)
Q Consensus 45 ~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~ 122 (846)
++|+||||+| +.|..||.||++.. .+..|+|+||.++.... ..+ ... .....+.+...+...+.+ .
T Consensus 4 ~~ILvavD~S-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~-~~~-~~~------~~~~~~~~~~~~~~~~~l---~ 71 (144)
T PRK15118 4 KHILIAVDLS-PESKVLVEKAVSMARPYNAKVSLIHVDVNYSDL-YTG-LID------VNLGDMQKRISEETHHAL---T 71 (144)
T ss_pred eEEEEEccCC-hhHHHHHHHHHHHHHhhCCEEEEEEEccChhhh-hhh-hhh------cchHHHHHHHHHHHHHHH---H
Confidence 6899999999 99999999999874 47799999995443111 111 000 011222222233333333 3
Q ss_pred HHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEe
Q 003121 123 LICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFIC 197 (846)
Q Consensus 123 ~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~ 197 (846)
.++...++.+...++..|+|.+.|+++|+++++|+||||+|+ +.+. .+ +.++..|++.++ |.|.+|-
T Consensus 72 ~~~~~~~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~-~~~~-~l----gSva~~v~~~a~--~pVLvv~ 138 (144)
T PRK15118 72 ELSTNAGYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQ-DFWS-KL----MSSARQLINTVH--VDMLIVP 138 (144)
T ss_pred HHHHhCCCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCcc-cHHH-HH----HHHHHHHHhhCC--CCEEEec
Confidence 344567888766666678999999999999999999999996 3333 23 368899999977 9999984
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.5e-12 Score=119.90 Aligned_cols=129 Identities=19% Similarity=0.236 Sum_probs=104.4
Q ss_pred EEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 46 KIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLL 123 (846)
Q Consensus 46 ~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~ 123 (846)
+|+||||++ +.+.+||+||..-. .+..|+++||.+++..... . ......+..+++++.+..
T Consensus 1 ~ILv~vd~s-~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~-------~---------~~~~~~~~~~~~~~~~~~ 63 (132)
T cd01988 1 RILVPVANP-NTARDLLELAAALARAQNGEIIPLNVIEVPNHSSP-------S---------QLEVNVQRARKLLRQAER 63 (132)
T ss_pred CEEEecCCc-hhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCc-------c---------hhHHHHHHHHHHHHHHHH
Confidence 589999999 99999999998864 5679999999986532110 0 011234567788999999
Q ss_pred HHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 124 ICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 124 ~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
.+.+.|++++..+..++++.+.||++++++++|+||||+++.+.+.+.+. |.++..|++.++ |.|.+|
T Consensus 64 ~~~~~g~~~~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~l---Gs~~~~v~~~~~--~pvlvv 131 (132)
T cd01988 64 IAASLGVPVHTIIRIDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLF---GGVIDQVLESAP--CDVAVV 131 (132)
T ss_pred HhhhcCCceEEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceec---CchHHHHHhcCC--CCEEEe
Confidence 99999999998887778999999999999999999999999888765543 678889998877 888876
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.8e-12 Score=117.91 Aligned_cols=137 Identities=20% Similarity=0.281 Sum_probs=98.8
Q ss_pred cCCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDM 120 (846)
Q Consensus 43 ~~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 120 (846)
|-++|+||||++ +.+.+|++||+... .+..|+++||.++....... ....................
T Consensus 1 M~~~Ilv~~d~~-~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 68 (140)
T PF00582_consen 1 MYKRILVAIDGS-EESRRALRFALELAKRSGAEITLLHVIPPPPQYSFS-----------AAEDEESEEEAEEEEQARQA 68 (140)
T ss_dssp -TSEEEEEESSS-HHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHH-----------HHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEEEECCC-HHHHHHHHHHHHHHHhhCCeEEEEEeeccccccccc-----------cccccccccccchhhhhhhH
Confidence 457999999999 99999999999974 58899999999876331110 00111111111111111111
Q ss_pred HHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 121 CLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 121 ~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
....+...+.......+..+++.++|+++++++++|+||||+++++.+.+.+. +.++..++..+| |.|++|
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~---gs~~~~l~~~~~--~pVlvv 139 (140)
T PF00582_consen 69 EAEEAEAEGGIVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLF---GSVAEKLLRHAP--CPVLVV 139 (140)
T ss_dssp HHHHHHHHTTSEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSS---HHHHHHHHHHTS--SEEEEE
T ss_pred HHHHHhhhccceeEEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCc---CCHHHHHHHcCC--CCEEEe
Confidence 11556666666677777889999999999999999999999999888888664 888899999988 898886
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.8e-12 Score=125.24 Aligned_cols=129 Identities=18% Similarity=0.144 Sum_probs=99.6
Q ss_pred ceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEeccccCceEEEEEecCCCchhhhh
Q 003121 534 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGSLEDRL 612 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lVmEy~~ggsL~~~L 612 (846)
+.|+.|.++.||++...+..|++|....... ....+.+|+.++..+.+.++ .++++......++||||++|.++....
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~ 82 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTED 82 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccccc
Confidence 4688999999999999999999999765432 22357899999999865444 456666665678999999998876431
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecccCCCceEecCCCceeeecccccc
Q 003121 613 SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK--PHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 613 ~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
. ....++.+++.+|..||... +.+++|+|++|.||+++ ++.++++|||.+.
T Consensus 83 --------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 83 --------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred --------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 0 12345678999999999843 33479999999999999 6689999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.5e-12 Score=146.42 Aligned_cols=138 Identities=22% Similarity=0.286 Sum_probs=98.1
Q ss_pred ceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCC--------------------------c--------------hhHHH
Q 003121 534 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG--------------------------P--------------SEFQQ 572 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~--------------------------~--------------~~f~~ 572 (846)
+.||.|++|.||+|++. |+.||||+.++..... . -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999885 7899999987652110 0 02445
Q ss_pred HHHHHHhcC-----CCce--eeEeccccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHH-HHHHHhhcC
Q 003121 573 EIDILSKIR-----HPNL--VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS-VLIFLHSCK 644 (846)
Q Consensus 573 Ei~iL~~l~-----HpnI--v~l~g~~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~-aL~~LH~~~ 644 (846)
|...+.++. +|+| .+++..+....+|||||++|++|.+++..... .+ ....++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHh--
Confidence 666666652 3433 23343334567899999999999887642211 12 23445555555 4677787
Q ss_pred CCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 645 ~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
.|++|+|++|.||+++.++.++|+|||++..+..
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8999999999999999999999999999887653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.5e-12 Score=137.01 Aligned_cols=208 Identities=23% Similarity=0.305 Sum_probs=143.9
Q ss_pred hHHHHHHHHHhcCCCceeeEeccccC-------ceEEEEEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 003121 569 EFQQEIDILSKIRHPNLVTLVGACPE-------VWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFL 640 (846)
Q Consensus 569 ~f~~Ei~iL~~l~HpnIv~l~g~~~~-------~~~lVmEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~L 640 (846)
....=..-|-++.|-|||++..|+.+ ...++.||+..|+|..+|.+. .....+......+|+.||+.||.||
T Consensus 113 k~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yL 192 (458)
T KOG1266|consen 113 KRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYL 192 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhh
Confidence 34444556677889999999988843 356899999999999999654 3445677888889999999999999
Q ss_pred hhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHH
Q 003121 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYS 720 (846)
Q Consensus 641 H~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwS 720 (846)
|++.| +|+|+++..+-|++..+|-+|++--.... .. ...+...........|.++|.+||.-.....+.++|||+
T Consensus 193 hs~~P-piihgnlTc~tifiq~ngLIkig~~ap~s-~h---~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~ 267 (458)
T KOG1266|consen 193 HSCDP-PIIHGNLTCDTIFIQHNGLIKIGSVAPDS-TH---PSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYK 267 (458)
T ss_pred hccCC-ccccCCcchhheeecCCceEEecccCccc-cc---hhhhhhhHhhhhccccCCccccCCcCcccccccchhhhh
Confidence 99986 89999999999999999998875322111 11 111111112223345789999999877777888999999
Q ss_pred HHHHHHHHHhCCCCCC-CchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 721 FGIILLRLLTGRPALG-ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 721 lGviL~elltG~~pf~-~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
||+..++|..|...-. ....+. ........+-.+.. ..-+.++..|++-.|..||++..++
T Consensus 268 fgmcAlemailEiq~tnseS~~~---~ee~ia~~i~~len-------~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 268 FGMCALEMAILEIQSTNSESKVE---VEENIANVIIGLEN-------GLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred hhHHHHHHHHheeccCCCcceee---hhhhhhhheeeccC-------ccccCcCcccccCCCCCCcchhhhh
Confidence 9999999988764321 111111 01111111111110 1235678899999999999995544
|
|
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=2e-10 Score=111.15 Aligned_cols=132 Identities=18% Similarity=0.252 Sum_probs=97.7
Q ss_pred CEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCL 122 (846)
Q Consensus 45 ~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~ 122 (846)
++|+||+|.| +.|..||++|++-. .+..|+++||.+++.... .+ .....+.+++...+..++.++++
T Consensus 4 ~~ILv~~D~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~l~~~- 72 (142)
T PRK10116 4 SNILVAVAVT-PESQQLLAKAVSIARPVNGKISLITLASDPEMYN----QF-----AAPMLEDLRSVMQEETQSFLDKL- 72 (142)
T ss_pred ceEEEEccCC-cchHHHHHHHHHHHHHhCCEEEEEEEccCcccch----hh-----hHHHHHHHHHHHHHHHHHHHHHH-
Confidence 6999999999 99999999998853 467999999987643211 11 11223444555555555555544
Q ss_pred HHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 123 LICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 123 ~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
+.+.++..+...+..|++.++|++++++.++|+||||+|+++.+.|-+ + ++..|+..+ -|.|.+|
T Consensus 73 --~~~~~~~~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~~----s-~a~~v~~~~--~~pVLvv 137 (142)
T PRK10116 73 --IQDADYPIEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRAS----C-SAKRVIASS--EVDVLLV 137 (142)
T ss_pred --HHhcCCCeEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHHH----H-HHHHHHhcC--CCCEEEE
Confidence 456677766666678999999999999999999999999988887754 2 577888874 5888887
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.9e-10 Score=126.06 Aligned_cols=142 Identities=11% Similarity=0.104 Sum_probs=109.1
Q ss_pred CCEEEEEecCCccccHHHHHHHhhc--CCCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHH
Q 003121 44 EDKIYVAVAKQVKESKSVLLWALQN--SGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMC 121 (846)
Q Consensus 44 ~~~V~VAVD~s~~~S~~AL~Wal~n--~~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 121 (846)
-++|+||+|+| +.|..||.||+.- ..+..|+++||.+++.. +.++ . ...+.....++...+..++.|+.+
T Consensus 3 ~~~ILv~~D~s-~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~-~~~~-~-----~~~~~~~~~~~~~~~~~~~~l~~~ 74 (305)
T PRK11175 3 YQNILVVIDPN-QDDQPALRRAVYLAQRNGGKITAFLPIYDFSY-EMTT-L-----LSPDEREAMRQGVISQRTAWIREQ 74 (305)
T ss_pred cceEEEEcCCC-ccccHHHHHHHHHHHhcCCCEEEEEeccCchh-hhhc-c-----cchhHHHHHHHHHHHHHHHHHHHH
Confidence 36899999999 9999999999985 34678999999865422 1111 1 111222333344445566778888
Q ss_pred HHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEec
Q 003121 122 LLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICN 198 (846)
Q Consensus 122 ~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~~ 198 (846)
...+...+++++..++..|++.++|+++++++++|+||||+++.+.+.+.+. +..+..+++.++ |-|++|-.
T Consensus 75 ~~~~~~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~---gs~~~~l~~~~~--~pvlvv~~ 146 (305)
T PRK11175 75 AKPYLDAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIF---TPTDWHLLRKCP--CPVLMVKD 146 (305)
T ss_pred HHHHhhcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhcc---ChhHHHHHhcCC--CCEEEecc
Confidence 8888888999998777678999999999999999999999999887777665 677888888876 99999954
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.1e-11 Score=147.13 Aligned_cols=249 Identities=24% Similarity=0.244 Sum_probs=174.8
Q ss_pred cCCCcccceeeeeCceEEEEEEECC--eEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecc--ccCceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGA--CPEVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~--~~~~~~lV 599 (846)
.+.|.+.+-+-.|.|+.++-+.-.+ ...++|+..... ....+....+-.++-..+||-++..... |....+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 3456666778899999998765442 234444433221 1122334445555544567878777666 46789999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
++|+.+++|...|+ +.+..+..-...+...+..++++||. ..+.|+|++|.|+|+..+++.+++|||+......
T Consensus 883 ~~~~~~~~~~Skl~---~~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLH---NSGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hHHhccCCchhhhh---cCCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999999884 33456666677778889999999999 5689999999999999999999999985432211
Q ss_pred cc----c--cC------------CCcc-----ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003121 680 NE----I--SS------------NNTT-----LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 736 (846)
Q Consensus 680 ~~----~--~~------------~~~~-----~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~ 736 (846)
.. . .. .... ........||+.|.+||.+.+...+..+|+|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 10 0 00 0000 012345679999999999999999999999999999999999999997
Q ss_pred CchHHHHHHhhhhhcccc--CCCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 737 ITKEVQYALDTGKLKNLL--DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 737 ~~~~~~~~~~~~~~~~~l--d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.....+-. .+++ +...+.-+...+....+++.+.+..+|.+|-.+
T Consensus 1037 a~tpq~~f------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1037 AETPQQIF------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred Ccchhhhh------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCc
Confidence 65543321 1222 122233344557789999999999999999887
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.9e-11 Score=136.27 Aligned_cols=141 Identities=19% Similarity=0.262 Sum_probs=91.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--------------------------Cc--------h---
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------------------------GP--------S--- 568 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--------------------------~~--------~--- 568 (846)
..|+. +.||.|++|.||+|++. |+.||||+.++.... +. .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 67999999999999985 689999999865210 00 0
Q ss_pred ---hHHHHHHHHHhcC----CCcee---eEeccccCceEEEEEecCCCchhhhhccCCCC---CCCCHHHHHHHHHHHHH
Q 003121 569 ---EFQQEIDILSKIR----HPNLV---TLVGACPEVWTLVYEYLPNGSLEDRLSCKDNS---PPLSWQTRIRIATELCS 635 (846)
Q Consensus 569 ---~f~~Ei~iL~~l~----HpnIv---~l~g~~~~~~~lVmEy~~ggsL~~~L~~~~~~---~~l~~~~~~~i~~qia~ 635 (846)
+|.+|+..+.+++ +.+.+ ++|.-+....+|||||+.|+.|.++..-...+ ..+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 2445555555552 33222 33333344577999999999997742111111 112222222233333
Q ss_pred HHHHHhhcCCCceEecccCCCceEecCCC----ceeeecccccccccc
Q 003121 636 VLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGISRFLSQ 679 (846)
Q Consensus 636 aL~~LH~~~~~giiHrDLkp~NILl~~~~----~vKL~DFGla~~~~~ 679 (846)
.. .|++|+|++|.||+++.+| .++++|||++..+..
T Consensus 277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 23 7899999999999999888 999999999987754
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.2e-10 Score=103.51 Aligned_cols=128 Identities=23% Similarity=0.378 Sum_probs=101.6
Q ss_pred EEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 46 KIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLL 123 (846)
Q Consensus 46 ~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~ 123 (846)
+|+||+|.+ ..+..+|+||++.. .+..|+++||.++....+. .+.+......++.|+.+..
T Consensus 1 ~ilv~i~~~-~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~----------------~~~~~~~~~~~~~l~~~~~ 63 (130)
T cd00293 1 RILVAVDGS-EESERALRWAARLARRLGAELVLLHVVDPPPSSAA----------------ELAELLEEEARALLEALRE 63 (130)
T ss_pred CEEEEeCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcch----------------hHHHHHHHHHHHHHHHHHH
Confidence 589999999 99999999999974 4779999999876432110 2334455667789999999
Q ss_pred HHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 124 ICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 124 ~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
.|...++.+...+.. +++.++|+++++++++|+||||+++++.+.+.+. +.++..+++. .-|.|+++
T Consensus 64 ~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~---~~~~~~ll~~--~~~pvliv 130 (130)
T cd00293 64 ALAEAGVKVETVVLE-GDPAEAILEAAEELGADLIVMGSRGRSGLRRLLL---GSVAERVLRH--APCPVLVV 130 (130)
T ss_pred HHhcCCCceEEEEec-CCCHHHHHHHHHHcCCCEEEEcCCCCCccceeee---ccHHHHHHhC--CCCCEEeC
Confidence 998889998877655 5669999999999999999999998888766554 7788888887 33766653
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.6e-11 Score=133.77 Aligned_cols=243 Identities=24% Similarity=0.260 Sum_probs=169.7
Q ss_pred CCcccceeee--eCceEEEEEEE--C--CeEEEEEEecCC--CCCCchhHHHHHHHHHhc-CCCceeeEecccc--CceE
Q 003121 529 NFDPSLKIGE--GGYGSIYKGLL--R--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWT 597 (846)
Q Consensus 529 ~f~~~~~LG~--G~fG~Vy~g~~--~--~~~VAIK~l~~~--~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~ 597 (846)
.|.....+|. |.+|.||.+.. . +..+|+|.-+.. .......=.+|+.-..++ .|+|.++.+..+. +..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3555667899 99999999887 3 466888873322 222222334677777777 4999999777774 4567
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCceEecccCCCceEecCC-Cceeeeccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS----VLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFG 672 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~----aL~~LH~~~~~giiHrDLkp~NILl~~~-~~vKL~DFG 672 (846)
+-+|+| +.+|..+.... ...++....+.++.+... ||..+|. .+++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence 777887 56777766422 234666777888888888 9999999 889999999999999998 889999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc
Q 003121 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 752 (846)
Q Consensus 673 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~ 752 (846)
+...+........... ..+..|...|++||.+ .+-++...|+|++|.++.+-.+|..++.......+.... .
T Consensus 269 ~v~~i~~~~~~~~~~~---~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r----~ 340 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKV---SKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR----Q 340 (524)
T ss_pred eeEEccCCccccceee---eecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc----c
Confidence 9998877654332221 1334688899999987 456888999999999999999987665332111111001 1
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 753 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
... ..++-...+..+..++..+++.+|..|++.
T Consensus 341 ~~i--p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~ 373 (524)
T KOG0601|consen 341 GYI--PLEFCEGGSSSLRSVTSQMLDEDPRLRLTA 373 (524)
T ss_pred ccC--chhhhcCcchhhhhHHHHhcCcchhhhhHH
Confidence 111 111111223456669999999999999987
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.6e-10 Score=114.21 Aligned_cols=139 Identities=22% Similarity=0.324 Sum_probs=109.5
Q ss_pred ceeeeeCceEEEEEEECC-eEEEEEEecCCCC-CCchhHHHHHHHHHhcCC--CceeeEeccccC-----ceEEEEEecC
Q 003121 534 LKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRH--PNLVTLVGACPE-----VWTLVYEYLP 604 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~H--pnIv~l~g~~~~-----~~~lVmEy~~ 604 (846)
+.|+.|.++.||++...+ ..+++|....... .....+.+|+.++..+.+ .++.++++++.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998876 7899999765432 235578999999999975 345667776644 5689999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK---------------------------------------- 644 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------------- 644 (846)
|.+|.+.+.. ..++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988876521 35777788888999999999998531
Q ss_pred -------------CCceEecccCCCceEecC--CCceeeeccccccc
Q 003121 645 -------------PHSIVHGDLKPANILLDA--NFVSKLSDFGISRF 676 (846)
Q Consensus 645 -------------~~giiHrDLkp~NILl~~--~~~vKL~DFGla~~ 676 (846)
+..++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999997653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.7e-09 Score=113.14 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=167.2
Q ss_pred cccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceee--------EeccccC-ceEEEE
Q 003121 531 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVT--------LVGACPE-VWTLVY 600 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~--------l~g~~~~-~~~lVm 600 (846)
.+...||+||-+.+|.----+. .+.|+++....- .-.+-+..|... .||-+-. |+|--.. ...+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d-~VAKIYh~Pppa---~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD-QVAKIYHAPPPA---AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchhhc-hhheeecCCCch---HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4456799999999995322122 344776654322 222334444444 5664432 2332222 255778
Q ss_pred EecCCC-chhhhhc---cCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 601 EYLPNG-SLEDRLS---CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 601 Ey~~gg-sL~~~L~---~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
..+.|. -..+++. ++...+...|+..++.+..++.+.+.||. .|.+-+|++++|+|+.+++.|.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence 777664 2333332 23455678999999999999999999999 8999999999999999999999987332111
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCc-------hHHHH
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTG-RPALGIT-------KEVQY 743 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG-~~pf~~~-------~~~~~ 743 (846)
- .+... .-..+|...|.+||... +..-+...|.|.||+++++++.| ++||.+- ...+.
T Consensus 167 ~------~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 167 N------ANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred c------cCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 1 11111 12357999999999875 23456789999999999999886 9999532 22232
Q ss_pred HHhhhhhc------cccCCCCCCCChhh-HHHHHHHHHHHhcc--CcCCCCChHHHHHHHHHHHHhhC
Q 003121 744 ALDTGKLK------NLLDPLAGDWPFVQ-AEQLANLAMRCCEM--SRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 744 ~~~~~~~~------~~ld~~~~~~p~~~-~~~l~~Li~~Cl~~--~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
.+..+.+. .-+.+....||... +..+..|..+|+.. ++.-||+. +.....|..+++..
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a-~aW~aAl~al~~~L 304 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA-KAWVAALDALRQQL 304 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH-HHHHHHHHHHHHhh
Confidence 33333332 22233445566543 67899999999975 46789999 77778888887664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=8e-10 Score=112.69 Aligned_cols=134 Identities=16% Similarity=0.141 Sum_probs=96.7
Q ss_pred ceeeeeCceEEEEEEEC--------CeEEEEEEecCCCCC----------C------------chhHH----HHHHHHHh
Q 003121 534 LKIGEGGYGSIYKGLLR--------HMQVAIKMLHPHSLQ----------G------------PSEFQ----QEIDILSK 579 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~--------~~~VAIK~l~~~~~~----------~------------~~~f~----~Ei~iL~~ 579 (846)
..||.|.-+.||.|... +..+|||+.+..... + ...+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 35899999999999765 268999988643110 0 01233 79999999
Q ss_pred cCC--CceeeEeccccCceEEEEEecCCCchhh-hhccCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceEecccCC
Q 003121 580 IRH--PNLVTLVGACPEVWTLVYEYLPNGSLED-RLSCKDNSPPLSWQTRIRIATELCSVLIFL-HSCKPHSIVHGDLKP 655 (846)
Q Consensus 580 l~H--pnIv~l~g~~~~~~~lVmEy~~ggsL~~-~L~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~giiHrDLkp 655 (846)
+.. -++..++++ ...+|||||+.++.+.. .|. ...++......+..+++.+|..| |. .|+||+||++
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 853 455555654 56789999997654422 221 12345556778889999999998 77 7999999999
Q ss_pred CceEecCCCceeeecccccccc
Q 003121 656 ANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 656 ~NILl~~~~~vKL~DFGla~~~ 677 (846)
.|||++ ++.+.|+|||.+-..
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeC
Confidence 999997 467999999977644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1e-09 Score=108.60 Aligned_cols=128 Identities=28% Similarity=0.397 Sum_probs=101.6
Q ss_pred eeeeeCceEEEEEEECCeEEEEEEecCCCCCCc--------hhHHHHHHHHHhcCC--CceeeEeccccCceEEEEEecC
Q 003121 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP--------SEFQQEIDILSKIRH--PNLVTLVGACPEVWTLVYEYLP 604 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~--------~~f~~Ei~iL~~l~H--pnIv~l~g~~~~~~~lVmEy~~ 604 (846)
.+++|+-+.+|.+.+.+.++++|.-.+.....+ ..-.+|..+|.+++- -+...++++.++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 578999999999988888888886555443322 235679999998853 3445567777888889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
|..|.+.+... ...++..+-.-+.-||. .||+|+||.++||++..++ +.++||||+.+
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999888422 25677778888889999 8999999999999998775 89999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.9e-10 Score=130.94 Aligned_cols=248 Identities=24% Similarity=0.249 Sum_probs=171.4
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC---CeEEEEEEecCCCCCCchhH--HHHHHHHHhc-CCCceeeEeccc--cCceE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEF--QQEIDILSKI-RHPNLVTLVGAC--PEVWT 597 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~---~~~VAIK~l~~~~~~~~~~f--~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~ 597 (846)
...+|.....||.|.|+.||....+ +..+++|.+........+++ ..|+-+...+ .|.|++.++..+ .+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888999999999999987654 46788887766544433332 3566666666 588888877665 35677
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC-Cceeeeccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRF 676 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~-~~vKL~DFGla~~ 676 (846)
+=.|||.++++...+. ...-+....++++..+++.++.++|+ +.++|+|+||.||++..+ +..+++|||+...
T Consensus 343 ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccc
Confidence 8899999998877662 22346677889999999999999998 899999999999999886 7889999998764
Q ss_pred cccccccCCCccccccCCCCCCccc-CChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAY-MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y-~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
+.-.... + .-++..| .+|..+....+..+.|+||||.-+.+.++|.+.-....... .+..
T Consensus 417 ~~~~~~~------~----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---------~i~~ 477 (524)
T KOG0601|consen 417 LAFSSGV------F----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---------TIRS 477 (524)
T ss_pred cceeccc------c----cccccccccchhhccccccccccccccccccccccccCcccCcccccce---------eeec
Confidence 3211110 0 1123334 35555556678899999999999999999975432221111 1111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
......+..- ..+..+...+...++..||.+ .++....+..++
T Consensus 478 ~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~-~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 478 GDTPNLPGLK-LQLQVLLKVMINPDRKRRPSA-VELSLHSEFYRD 520 (524)
T ss_pred ccccCCCchH-HhhhhhhhhhcCCccccchhh-hhhcccchhhhh
Confidence 1111222222 778889999999999999988 444444443333
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-09 Score=117.54 Aligned_cols=137 Identities=16% Similarity=0.261 Sum_probs=95.1
Q ss_pred CEEEEEecCCcccc-------HHHHHHHhhc---CCCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVKES-------KSVLLWALQN---SGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDM 114 (846)
Q Consensus 45 ~~V~VAVD~s~~~S-------~~AL~Wal~n---~~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (846)
++|+||+|.| +.+ ..||++|++- +++..|+|+||.++.... .. ...+. ..+ ..+.+..++..
T Consensus 153 ~~Ilva~D~s-~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~-~~-~~~~~--~~~---~~~~~~~~~~~ 224 (305)
T PRK11175 153 GKILVAVNVA-SEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPIN-IA-IELPE--FDP---SVYNDAIRGQH 224 (305)
T ss_pred CeEEEEeCCC-CCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchh-cc-ccccc--cch---hhHHHHHHHHH
Confidence 7999999998 543 6799999874 337799999998754221 00 01110 111 12222222233
Q ss_pred HHHHHHHHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEE
Q 003121 115 HNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIW 194 (846)
Q Consensus 115 ~~ll~~~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~ 194 (846)
.+.+.++ +...++..+...+..|++.++|+++++++++|+||||+++++.+.+.+. |.++..|+..++ |.|.
T Consensus 225 ~~~l~~~---~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~ll---GS~a~~v~~~~~--~pVL 296 (305)
T PRK11175 225 LLAMKAL---RQKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFL---GNTAEHVIDHLN--CDLL 296 (305)
T ss_pred HHHHHHH---HHHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceee---cchHHHHHhcCC--CCEE
Confidence 3334443 3344676654555668999999999999999999999999999988776 788999999988 9999
Q ss_pred EEe
Q 003121 195 FIC 197 (846)
Q Consensus 195 ~i~ 197 (846)
+|.
T Consensus 297 vv~ 299 (305)
T PRK11175 297 AIK 299 (305)
T ss_pred EEc
Confidence 993
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.1e-09 Score=120.48 Aligned_cols=161 Identities=19% Similarity=0.222 Sum_probs=116.9
Q ss_pred CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHH
Q 003121 551 HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 628 (846)
Q Consensus 551 ~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~ 628 (846)
+.+|.|...........+...+-++.|+.++||||++++..+. ...|||+|-+. .|..++.. +.......
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v~~ 108 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEVCL 108 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHHHH
Confidence 5677777776554433456788899999999999999999884 46799999985 46666632 22345566
Q ss_pred HHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhc
Q 003121 629 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708 (846)
Q Consensus 629 i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 708 (846)
.+.||+.||.|||.- .+++|++|.-.-|+|+..|..||++|.++......... .. ...--..|..|+.+.
T Consensus 109 Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~------~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 109 GLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AK------SLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cc------cchhhhcccChhhcC
Confidence 789999999999863 57999999999999999999999999987654322110 00 001122356666543
Q ss_pred cCCCCchhhHHHHHHHHHHHHhC
Q 003121 709 SGELTPKSDVYSFGIILLRLLTG 731 (846)
Q Consensus 709 ~~~~~~ksDVwSlGviL~elltG 731 (846)
... -..|.|-|||++++++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 222 457999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.3e-09 Score=101.35 Aligned_cols=141 Identities=21% Similarity=0.255 Sum_probs=102.1
Q ss_pred ccceeeeeCceEEEEEEECCeEEEEEEecCCCCCC--------chhHHHHHHHHHhcCCCce--eeEeccccCceEEEEE
Q 003121 532 PSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPNL--VTLVGACPEVWTLVYE 601 (846)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~--------~~~f~~Ei~iL~~l~HpnI--v~l~g~~~~~~~lVmE 601 (846)
....|-+|+-+.|+++.+.|+.+.||.-......- .....+|+.+|.+++--.| .+++-+-.....|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 45678999999999999999998888644332221 2346789999998853222 2333333456789999
Q ss_pred ecCC-CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC---ceeeeccccccc
Q 003121 602 YLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRF 676 (846)
Q Consensus 602 y~~g-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~---~vKL~DFGla~~ 676 (846)
|++| .++.+++....... ........++..|-..+.-||. ++|||+||..+||+|..++ .+.|+|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 37777775443322 2223347888999999999999 8999999999999996554 457999998753
|
|
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.7e-09 Score=115.10 Aligned_cols=101 Identities=12% Similarity=0.200 Sum_probs=77.7
Q ss_pred cCCEEEEEecCCccccHHHHHHHhhcC--C--CCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVAKQVKESKSVLLWALQNS--G--GKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHL 118 (846)
Q Consensus 43 ~~~~V~VAVD~s~~~S~~AL~Wal~n~--~--~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 118 (846)
|-+||+||||+| +.|.+|+++|++-. . +.+|++|||.++..... . . ....+..++++
T Consensus 4 ~ykkILVavDGS-e~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~--~-----~-----------~~~~~~~eell 64 (357)
T PRK12652 4 AANRLLVPVADS-VTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDP--E-----G-----------QDELAAAEELL 64 (357)
T ss_pred ccCeEEEEeCCC-HHHHHHHHHHHHHHHhcCCCCEEEEEEEecCccccc--c-----h-----------hHHHHHHHHHH
Confidence 447999999999 99999999999973 2 47999999987542210 0 0 11223445666
Q ss_pred HHHHHHHhh------cCCeeeEEEeec-------CchhhHHHHHHHHcCCCEEEEcc
Q 003121 119 DMCLLICRQ------MGVRAEKLDTES-------ESTEKGILELISHYGIRKLVMGA 162 (846)
Q Consensus 119 ~~~~~~C~~------~~V~~e~~~~e~-------~d~~~~I~~~v~~~~i~~LVmGs 162 (846)
+++...+.+ .||++++.++++ |+|++.|+++|+++++|+||||-
T Consensus 65 e~~~~~~~~~l~~~~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~ 121 (357)
T PRK12652 65 ERVEVWATEDLGDDASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDP 121 (357)
T ss_pred HHHHHHHHHhhhcccCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECC
Confidence 677666654 699999888764 89999999999999999999994
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.1e-07 Score=106.33 Aligned_cols=166 Identities=22% Similarity=0.310 Sum_probs=129.2
Q ss_pred ceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc------CceEEEEEecCC-Cchhhh
Q 003121 541 YGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------EVWTLVYEYLPN-GSLEDR 611 (846)
Q Consensus 541 fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~------~~~~lVmEy~~g-gsL~~~ 611 (846)
-.+.|++... |..|++|+++............-++.++++.|+|||++..+|. ...+|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3577888754 7789999998776666666778899999999999999987763 247899999886 477776
Q ss_pred hccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 612 LSCK------------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 612 L~~~------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
.... ..+...++..+|.++.|+..||.++|+ .|+.-+-|.|.+||++.+..++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5322 123457789999999999999999999 8999999999999999998999998888766544
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 734 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~p 734 (846)
+.. +| +. --.+-|.=-||.+++.|.||..-
T Consensus 446 d~~--------------------~~--le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT--------------------EP--LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC--------------------cc--hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 320 00 11 11356888999999999999643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.2e-08 Score=98.44 Aligned_cols=124 Identities=23% Similarity=0.245 Sum_probs=79.8
Q ss_pred EEEEEEEC-CeEEEEEEecCCCCCC---------------------c-----hhHHHHHHHHHhcCCC--ceeeEecccc
Q 003121 543 SIYKGLLR-HMQVAIKMLHPHSLQG---------------------P-----SEFQQEIDILSKIRHP--NLVTLVGACP 593 (846)
Q Consensus 543 ~Vy~g~~~-~~~VAIK~l~~~~~~~---------------------~-----~~f~~Ei~iL~~l~Hp--nIv~l~g~~~ 593 (846)
.||.|... +..+|||+.+.....- . ....+|...|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999874 6789999986532110 0 1356899999999755 45566644
Q ss_pred CceEEEEEecC--CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCceEecccCCCceEecCCCceeeec
Q 003121 594 EVWTLVYEYLP--NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF-LHSCKPHSIVHGDLKPANILLDANFVSKLSD 670 (846)
Q Consensus 594 ~~~~lVmEy~~--ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~-LH~~~~~giiHrDLkp~NILl~~~~~vKL~D 670 (846)
...+|||||+. |..+..+.... ++......++.+++..+.. +|. .||+|+||.+.|||++.+ .+.|+|
T Consensus 79 ~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence 35679999998 65555443211 1123456677788885555 567 799999999999999988 899999
Q ss_pred ccccccc
Q 003121 671 FGISRFL 677 (846)
Q Consensus 671 FGla~~~ 677 (846)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.6e-07 Score=99.24 Aligned_cols=137 Identities=15% Similarity=0.077 Sum_probs=97.8
Q ss_pred eeeeCceEEEEEEECCeEEEEEEecCCCCC-----------CchhHHHHHHHHHhcCCCce--eeEeccc-------cCc
Q 003121 536 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ-----------GPSEFQQEIDILSKIRHPNL--VTLVGAC-------PEV 595 (846)
Q Consensus 536 LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~-----------~~~~f~~Ei~iL~~l~HpnI--v~l~g~~-------~~~ 595 (846)
+-......|++..+.|..+.||........ ....+.+|...+.+|..-+| ..++++. ...
T Consensus 30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 444444557788888899999977543311 11247899999988842222 2232222 124
Q ss_pred eEEEEEecCCC-chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-------CCcee
Q 003121 596 WTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-------NFVSK 667 (846)
Q Consensus 596 ~~lVmEy~~gg-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-------~~~vK 667 (846)
.+||||++++. +|.+++.... ..+.+......++.+++..+.-||. +||+|+|+++.|||++. ++.+.
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEE
Confidence 67999999886 8988874221 2345566778999999999999999 99999999999999975 46889
Q ss_pred eeccccccc
Q 003121 668 LSDFGISRF 676 (846)
Q Consensus 668 L~DFGla~~ 676 (846)
|+||+.+..
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998753
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.6e-07 Score=87.23 Aligned_cols=143 Identities=19% Similarity=0.228 Sum_probs=104.6
Q ss_pred cCCEEEEEec-CCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVA-KQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLD 119 (846)
Q Consensus 43 ~~~~V~VAVD-~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 119 (846)
+-++|++++| ++ +.+..|+.||++.. .+..+.++||.++.............. ..............+.+.
T Consensus 4 ~~~~il~~~d~~s-~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 77 (154)
T COG0589 4 MYKKILVAVDVGS-EAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADA-----PIPLSEEELEEEAEELLA 77 (154)
T ss_pred ccceEEEEeCCCC-HHHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccccc-----hhhhhHHHHHHHHHHHHH
Confidence 3479999999 99 99999999999973 566888999987653322111110000 022233444566778888
Q ss_pred HHHHHHhhcCCee-eEEEeecCch-hhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEe
Q 003121 120 MCLLICRQMGVRA-EKLDTESEST-EKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFIC 197 (846)
Q Consensus 120 ~~~~~C~~~~V~~-e~~~~e~~d~-~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~ 197 (846)
.+.....+.++.. +..+.+ |++ .+.|++++.+.++|+||||+++.+.+.+.+ -|.++++|+..+ -|.|.++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~-g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~l---lGsvs~~v~~~~--~~pVlvv~ 151 (154)
T COG0589 78 EAKALAEAAGVPVVETEVVE-GSPSAEEILELAEEEDADLIVVGSRGRSGLSRLL---LGSVAEKVLRHA--PCPVLVVR 151 (154)
T ss_pred HHHHHHHHcCCCeeEEEEec-CCCcHHHHHHHHHHhCCCEEEECCCCCcccccee---eehhHHHHHhcC--CCCEEEEc
Confidence 8888888889885 666555 555 799999999999999999999988888844 478889999885 47777763
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.5e-07 Score=96.99 Aligned_cols=133 Identities=20% Similarity=0.186 Sum_probs=94.1
Q ss_pred CcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCC----------------------CchhHHHHHHHHHhcCCC--c
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ----------------------GPSEFQQEIDILSKIRHP--N 584 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~----------------------~~~~f~~Ei~iL~~l~Hp--n 584 (846)
..+..+||-|.-+.||.|... +.++|||.-+..... .....++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345678999999999999987 789999976542111 012356899999999655 5
Q ss_pred eeeEeccccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC
Q 003121 585 LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 664 (846)
Q Consensus 585 Iv~l~g~~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~ 664 (846)
+.+.+++ +...+||||++|-.|...- ++....-.++..|++-+.-+-. .||||+|+++-|||++.+|
T Consensus 173 VP~P~~~--nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW--NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc--ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCC
Confidence 6665554 5678999999986665432 1222333444444444443334 6899999999999999999
Q ss_pred ceeeecccccc
Q 003121 665 VSKLSDFGISR 675 (846)
Q Consensus 665 ~vKL~DFGla~ 675 (846)
.+.++||--+.
T Consensus 240 ~~~vIDwPQ~v 250 (304)
T COG0478 240 DIVVIDWPQAV 250 (304)
T ss_pred CEEEEeCcccc
Confidence 99999998554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=7.2e-08 Score=111.60 Aligned_cols=150 Identities=23% Similarity=0.355 Sum_probs=102.9
Q ss_pred HHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc-cccCCCccccccCCCCCCcccCChhhhccC
Q 003121 632 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN-EISSNNTTLCCRTDPKGTFAYMDPEFLASG 710 (846)
Q Consensus 632 qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~-~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~ 710 (846)
+++.||.|+|.. .++||++|.|++|.++.++.+||++|+++-..... .+...........-..-...|.|||++...
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 344899999985 57999999999999999999999999987654331 111000000000011246789999999988
Q ss_pred CCCchhhHHHHHHHHHHHH-hCCCCCCCchHHH-HHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 711 ELTPKSDVYSFGIILLRLL-TGRPALGITKEVQ-YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 711 ~~~~ksDVwSlGviL~ell-tG~~pf~~~~~~~-~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
..+.++|+||+|+++|.+. .|++-+....... +..... ..+.....+....+.++.+-+.+++..++.-||++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~----~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN----LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc----ccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 8889999999999999998 5666554332211 111111 11112223345567889999999999999999976
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.8e-06 Score=87.24 Aligned_cols=136 Identities=16% Similarity=0.124 Sum_probs=103.1
Q ss_pred eeeeCceEEEEEEECCeEEEEEEecCCC------CCCchhHHHHHHHHHhcCCC--ceeeEecccc-------CceEEEE
Q 003121 536 IGEGGYGSIYKGLLRHMQVAIKMLHPHS------LQGPSEFQQEIDILSKIRHP--NLVTLVGACP-------EVWTLVY 600 (846)
Q Consensus 536 LG~G~fG~Vy~g~~~~~~VAIK~l~~~~------~~~~~~f~~Ei~iL~~l~Hp--nIv~l~g~~~-------~~~~lVm 600 (846)
-|+||.+-|++-.+.|..+-+|.-...- ..+...|.+|+..|.+|..- .+.+++ ++. -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 4779999999988888888888765321 22456799999999999532 244444 221 1356999
Q ss_pred EecCC-CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc--eeeeccccccc
Q 003121 601 EYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--SKLSDFGISRF 676 (846)
Q Consensus 601 Ey~~g-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~--vKL~DFGla~~ 676 (846)
|-+.| -+|.+++... ...+.+...+..++.+++..+.-||. .|+.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 4888887432 22356777888999999999999999 89999999999999986666 99999986653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.3e-06 Score=90.48 Aligned_cols=105 Identities=30% Similarity=0.332 Sum_probs=80.1
Q ss_pred chhHHHHHHHHHhcCCCc--eeeEecccc------CceEEEEEecCCC-chhhhhccCCCCCCCCHHHHHHHHHHHHHHH
Q 003121 567 PSEFQQEIDILSKIRHPN--LVTLVGACP------EVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVL 637 (846)
Q Consensus 567 ~~~f~~Ei~iL~~l~Hpn--Iv~l~g~~~------~~~~lVmEy~~gg-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL 637 (846)
.....+|...+..|..-. +.+.+++.. ...+||+|++++. +|.+++.... .++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 456888999888874322 233333331 2357999999885 7999885322 155667889999999999
Q ss_pred HHHhhcCCCceEecccCCCceEecCCC---ceeeecccccccc
Q 003121 638 IFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRFL 677 (846)
Q Consensus 638 ~~LH~~~~~giiHrDLkp~NILl~~~~---~vKL~DFGla~~~ 677 (846)
.-||. +||+|+|+++.|||++.++ .+.|+||+-++..
T Consensus 132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 9999999999999999876 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=9e-06 Score=85.42 Aligned_cols=131 Identities=18% Similarity=0.238 Sum_probs=81.1
Q ss_pred cceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc--eeeEeccc--cCceEEEEEecCCCc-
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVGAC--PEVWTLVYEYLPNGS- 607 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn--Iv~l~g~~--~~~~~lVmEy~~ggs- 607 (846)
...||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.++++ .+...+|||+++|.+
T Consensus 6 ~~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 6 WTQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred heeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 357999999999984 35567888876532 3456789999999885333 34455553 345678999999863
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHhhc-CCCc
Q 003121 608 LEDRLSCKDNSPPLSWQTRIRIATELCSV---------------------------------------LIFLHSC-KPHS 647 (846)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~qia~a---------------------------------------L~~LH~~-~~~g 647 (846)
+...+. .+......++..++.. ..+|... .+..
T Consensus 82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 221110 0001111111111111 1222211 1235
Q ss_pred eEecccCCCceEecCCCceeeecccccc
Q 003121 648 IVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 648 iiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.1e-05 Score=83.71 Aligned_cols=140 Identities=21% Similarity=0.302 Sum_probs=84.1
Q ss_pred ceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCC--ceeeEeccc-----cCceEEEEEecCCC
Q 003121 534 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGAC-----PEVWTLVYEYLPNG 606 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~l~g~~-----~~~~~lVmEy~~gg 606 (846)
+.|+.|..+.||+....+..+++|..... .....+.+|..++..|... .+.+++..+ ....+++|+|++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 56899999999999998889999997654 2345788999999888532 345555533 22368999999998
Q ss_pred chhh----------------hhc---cC-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHhh--
Q 003121 607 SLED----------------RLS---CK-DNSPPLSWQTR---------IRI------------ATELCS-VLIFLHS-- 642 (846)
Q Consensus 607 sL~~----------------~L~---~~-~~~~~l~~~~~---------~~i------------~~qia~-aL~~LH~-- 642 (846)
.+.. .+. .. ....++..... ... ...+.. .+..++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7776 111 11 01111111110 000 011222 3333332
Q ss_pred --cCCCceEecccCCCceEec-CCCceeeecccccc
Q 003121 643 --CKPHSIVHGDLKPANILLD-ANFVSKLSDFGISR 675 (846)
Q Consensus 643 --~~~~giiHrDLkp~NILl~-~~~~vKL~DFGla~ 675 (846)
..+..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1346799999999999999 66666899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.17 E-value=7.4e-06 Score=84.45 Aligned_cols=135 Identities=19% Similarity=0.209 Sum_probs=91.8
Q ss_pred hcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchh---------HHHHHHHHHhcCCC---ceeeEecc--
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE---------FQQEIDILSKIRHP---NLVTLVGA-- 591 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~---------f~~Ei~iL~~l~Hp---nIv~l~g~-- 591 (846)
...+|...+.+-......|.+-..++..+.+|..+......... ..+.+..+..++.. ....++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 34567777788888888888888889999999987654322221 22444444444322 12222211
Q ss_pred -----ccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 592 -----CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 592 -----~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
+....+|||||++|..|.+... ++. .+...+..++.-||. .|++|+|..|.|++++.++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-E
Confidence 1344668999999988876541 222 244567788999999 8999999999999999665 8
Q ss_pred eeecccccc
Q 003121 667 KLSDFGISR 675 (846)
Q Consensus 667 KL~DFGla~ 675 (846)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=5.7e-06 Score=96.21 Aligned_cols=138 Identities=21% Similarity=0.296 Sum_probs=91.6
Q ss_pred ceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCc------------------------------h----------hHHH
Q 003121 534 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGP------------------------------S----------EFQQ 572 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~------------------------------~----------~f~~ 572 (846)
..|+.++-|.||+|++. |+.||||+.++.-.... + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 46999999999999998 79999999987532110 0 1344
Q ss_pred HHHHHHhcC-----CCce--eeEeccccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHH-HHHHhhcC
Q 003121 573 EIDILSKIR-----HPNL--VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV-LIFLHSCK 644 (846)
Q Consensus 573 Ei~iL~~l~-----HpnI--v~l~g~~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~a-L~~LH~~~ 644 (846)
|...+.+++ .|++ .+++--+.....|+|||++|..+.+...... ..++... ++..++.+ +.-+=.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~-- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLR-- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHh--
Confidence 555555542 3433 2333333456679999999998888753222 2344332 33333322 111112
Q ss_pred CCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 645 ~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
.|++|.|..|.||+++.+|.+-+.|||+...+..
T Consensus 284 -dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 -DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 6899999999999999999999999999876654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.06 E-value=8.9e-05 Score=75.60 Aligned_cols=106 Identities=23% Similarity=0.228 Sum_probs=84.8
Q ss_pred HHHHHHHHhcCC-CceeeEeccccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceE
Q 003121 571 QQEIDILSKIRH-PNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649 (846)
Q Consensus 571 ~~Ei~iL~~l~H-pnIv~l~g~~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gii 649 (846)
..|.-+|+.+.+ +++.+++|+|.. ++|.||...+++...-.....-...+|..+.+|+.++++.+.+|++.....+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 468889999976 699999999975 56999998776643210001112468999999999999999999987666788
Q ss_pred ecccCCCceEecCCCceeeeccccccccc
Q 003121 650 HGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 650 HrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
-.|++|+|+-++++|.+|++|...+-...
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchhH
Confidence 89999999999999999999998766543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.98 E-value=5.2e-05 Score=79.09 Aligned_cols=134 Identities=19% Similarity=0.210 Sum_probs=85.8
Q ss_pred eeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCch------------------------hHHHHHHHHHhcC--CCceee
Q 003121 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPS------------------------EFQQEIDILSKIR--HPNLVT 587 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~------------------------~f~~Ei~iL~~l~--HpnIv~ 587 (846)
.|+.|.-+.||+|... +..+|+|+++........ ...+|+..|+++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 4667777889998765 688999999765332110 1245777777663 222233
Q ss_pred EeccccCceEEEEEecCCCch-hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 588 LVGACPEVWTLVYEYLPNGSL-EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 588 l~g~~~~~~~lVmEy~~ggsL-~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
-+++ ....|||||+....+ .-.| ...++.......+..++++.+.-|-.. .++||+||+.-|||+. ++.+
T Consensus 135 Pi~~--~~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 135 PIAF--RNNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred ceee--cCCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeE
Confidence 3332 235699999854311 0111 112233335666777777777766542 5799999999999999 7899
Q ss_pred eeecccccccc
Q 003121 667 KLSDFGISRFL 677 (846)
Q Consensus 667 KL~DFGla~~~ 677 (846)
.|+|||-|...
T Consensus 206 ~iID~~QaV~~ 216 (268)
T COG1718 206 YIIDVSQAVTI 216 (268)
T ss_pred EEEECcccccc
Confidence 99999977644
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.5e-05 Score=80.81 Aligned_cols=137 Identities=16% Similarity=0.166 Sum_probs=82.7
Q ss_pred eeeeCc-eEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEeccccC--ceEEEEEecCCCchhhh
Q 003121 536 IGEGGY-GSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE--VWTLVYEYLPNGSLEDR 611 (846)
Q Consensus 536 LG~G~f-G~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~--~~~lVmEy~~ggsL~~~ 611 (846)
|-.|.+ ..||+....+..+.+|+..... ...+.+|+.++..+. +--+.++++++.. ..++||||++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 445555 7889987777778888876543 346788999998884 3335566666543 57899999999877643
Q ss_pred h-------------------ccCCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHHhh----cCC
Q 003121 612 L-------------------SCKDN-SPPLSWQ--TRIRIAT--------------------ELCSVLIFLHS----CKP 645 (846)
Q Consensus 612 L-------------------~~~~~-~~~l~~~--~~~~i~~--------------------qia~aL~~LH~----~~~ 645 (846)
. +.... ..++... ....... .+...+..|-. ..+
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 10000 1111100 0000000 01111222211 112
Q ss_pred CceEecccCCCceEecCCCceeeecccccc
Q 003121 646 HSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 646 ~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 458999999999999998888899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=2.8e-05 Score=76.95 Aligned_cols=129 Identities=19% Similarity=0.192 Sum_probs=91.7
Q ss_pred cccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceee-EeccccCceEEEEEecCCCchh
Q 003121 531 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT-LVGACPEVWTLVYEYLPNGSLE 609 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~-l~g~~~~~~~lVmEy~~ggsL~ 609 (846)
...+.||+|.+|.||.|.+.+..+|+|+-..++ ....+..|+++|..+.--++.+ +|.+ .. -++.|||+.|-.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y-g~-~~i~me~i~G~~L~ 100 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY-GE-DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe-ch-hhhhhhhhcCcchh
Confidence 445679999999999999999999999876543 3467999999999998766654 3333 22 23459999998887
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccC-CCceEecCCCceeeeccccccc
Q 003121 610 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK-PANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 610 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLk-p~NILl~~~~~vKL~DFGla~~ 676 (846)
+.-... + .+-...+++.-.-|.. .||-|+.|. |...+|..++.+.|+||.-|..
T Consensus 101 ~~~~~~------~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIGG------D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcc------c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 765211 1 2223345555455666 789999997 5555555555999999998763
|
|
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=6.2e-05 Score=94.43 Aligned_cols=126 Identities=15% Similarity=0.256 Sum_probs=95.5
Q ss_pred ccccCCEEEEEecCCccccHHHHHHHhhc--CCCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHH
Q 003121 40 ASVIEDKIYVAVAKQVKESKSVLLWALQN--SGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNH 117 (846)
Q Consensus 40 ~~~~~~~V~VAVD~s~~~S~~AL~Wal~n--~~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 117 (846)
.+...++|+|+|+++ .+|.+.+++|.+- -.+..+++|||.+|... ..+ .+ ...-
T Consensus 246 ~~~~~eriLV~v~~~-~~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~~------~~~----------------~~-~~~~ 301 (895)
T PRK10490 246 VWHTRDAILLCIGHN-TGSEKLVRTAARLAARLGSVWHAVYVETPRLH------RLP----------------EK-KRRA 301 (895)
T ss_pred CCCcCCeEEEEECCC-cchHHHHHHHHHHHHhcCCCEEEEEEecCCcC------cCC----------------HH-HHHH
Confidence 345668999999999 9999999998876 35779999999976311 000 11 2233
Q ss_pred HHHHHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEe
Q 003121 118 LDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFIC 197 (846)
Q Consensus 118 l~~~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~ 197 (846)
+.++..+|++.|-++ +.+.++|+.++|+++|..+||+.||||.+.++.+ + ++++++..+++.++ ...|++|.
T Consensus 302 l~~~~~lA~~lGa~~--~~~~~~dva~~i~~~A~~~~vt~IViG~s~~~~~---~--~~~s~~~~l~r~~~-~idi~iv~ 373 (895)
T PRK10490 302 ILSALRLAQELGAET--ATLSDPAEEKAVLRYAREHNLGKIIIGRRASRRW---W--RRESFADRLARLGP-DLDLVIVA 373 (895)
T ss_pred HHHHHHHHHHcCCEE--EEEeCCCHHHHHHHHHHHhCCCEEEECCCCCCCC---c--cCCCHHHHHHHhCC-CCCEEEEe
Confidence 455667999988874 4557899999999999999999999998876654 2 25678888888886 46999995
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00011 Score=91.56 Aligned_cols=76 Identities=16% Similarity=0.303 Sum_probs=55.5
Q ss_pred cceeeeeCceEEEEEEECC----eEEEEEEecCCCC-CCchhHHHHHHHHHhcC-CCce--eeEeccccC-----ceEEE
Q 003121 533 SLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIR-HPNL--VTLVGACPE-----VWTLV 599 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~----~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~-HpnI--v~l~g~~~~-----~~~lV 599 (846)
...|+.|.+..+|+....+ ..+++|+...... .....+.+|+.+|+.|. |++| .+++++|.+ ..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4568899999999877654 3677777654322 23356889999999995 6665 777887743 47899
Q ss_pred EEecCCCch
Q 003121 600 YEYLPNGSL 608 (846)
Q Consensus 600 mEy~~ggsL 608 (846)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=2.7e-06 Score=97.62 Aligned_cols=187 Identities=19% Similarity=0.149 Sum_probs=131.1
Q ss_pred cCCCcccceeeeeCceEEEEEEECCeE-EEEEEecCCCCCCchhHHHHHHHHHhcCCCc-eeeEeccc--cCceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~-VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn-Iv~l~g~~--~~~~~lVmEy 602 (846)
+.-+....-+++|+++++||.+...+. ...+++.. .....-++++|.+++||| .+..++.+ ++...++|+|
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 334455556899999999987655322 22444332 245667999999999999 66667666 3457789999
Q ss_pred cCCC-chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 603 LPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 603 ~~gg-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
+.++ +-.... ......+...+...+...-+++|++||+ -.-+|+| |||..+ +..|.+||+....+....
T Consensus 316 ~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc
Confidence 9877 222111 0111123333445566777888999998 3348888 887766 578999999887665542
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 737 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~ 737 (846)
......+|+.++|||+...+.+....|+|++|+--.+|.-|-+|-..
T Consensus 386 ---------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 386 ---------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ---------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 11345699999999999999999999999999988888888877644
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.87 E-value=7e-05 Score=79.00 Aligned_cols=71 Identities=11% Similarity=0.165 Sum_probs=45.4
Q ss_pred ceeeeeCce-EEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCC---ceeeEeccccC-----ceEEEEEecC
Q 003121 534 LKIGEGGYG-SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP---NLVTLVGACPE-----VWTLVYEYLP 604 (846)
Q Consensus 534 ~~LG~G~fG-~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hp---nIv~l~g~~~~-----~~~lVmEy~~ 604 (846)
..|+.||.. .||+. +..+++|..+.. .....+.+|..+|..|... .+.++++.... ..+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457777776 48864 345777875542 2345789999999887531 23344444321 3478999999
Q ss_pred CCchh
Q 003121 605 NGSLE 609 (846)
Q Consensus 605 ggsL~ 609 (846)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.80 E-value=7e-05 Score=87.00 Aligned_cols=138 Identities=20% Similarity=0.255 Sum_probs=92.7
Q ss_pred eeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCc---------------------------h----------hHHHHHHH
Q 003121 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGP---------------------------S----------EFQQEIDI 576 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~---------------------------~----------~f~~Ei~i 576 (846)
.||.-+.|.||+|+.+ |..||||+-++.-.... + +|.+|.+.
T Consensus 168 piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~N 247 (538)
T KOG1235|consen 168 PIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKN 247 (538)
T ss_pred hhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHh
Confidence 5899999999999987 57799999876522110 0 24556555
Q ss_pred HHhc----CCCc------eeeEeccccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 003121 577 LSKI----RHPN------LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646 (846)
Q Consensus 577 L~~l----~Hpn------Iv~l~g~~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 646 (846)
..++ .|-+ |.++|-.+.....|+||||+|.-+.|+..-.. ..++.. .++..+.++ |++..-..
T Consensus 248 ae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~---~i~~~l~~~--~~~qIf~~ 320 (538)
T KOG1235|consen 248 AERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPH---DILNKLVEA--YLEQIFKT 320 (538)
T ss_pred HHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHH---HHHHHHHHH--HHHHHHhc
Confidence 4443 3555 55666666777889999999987776543222 224444 333333332 33332226
Q ss_pred ceEecccCCCceEecC----CCceeeecccccccccc
Q 003121 647 SIVHGDLKPANILLDA----NFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 647 giiHrDLkp~NILl~~----~~~vKL~DFGla~~~~~ 679 (846)
|++|.|-.|.||++.. ++.+.+-|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999983 67899999999876644
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00015 Score=77.60 Aligned_cols=138 Identities=17% Similarity=0.135 Sum_probs=80.9
Q ss_pred eeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEeccccCceEEEEEecCCCchhhh---
Q 003121 536 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGSLEDR--- 611 (846)
Q Consensus 536 LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lVmEy~~ggsL~~~--- 611 (846)
+..|-.+.+|+....+..+++|........-.-...+|..+++.+..-.+ .++++.+. .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~--~~~v~e~i~G~~~~~~~~~ 81 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE--HWLLVEWLEGEVITLDQFV 81 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC--CEEEEEeccCccccccccc
Confidence 45677789998887788889987654322211246789999999854322 33444433 4689999998765421
Q ss_pred --------------hccCC-CCCCCCHHHH-HHHHHHH---------HHHHHHHhhc-----CCCceEecccCCCceEec
Q 003121 612 --------------LSCKD-NSPPLSWQTR-IRIATEL---------CSVLIFLHSC-----KPHSIVHGDLKPANILLD 661 (846)
Q Consensus 612 --------------L~~~~-~~~~l~~~~~-~~i~~qi---------a~aL~~LH~~-----~~~giiHrDLkp~NILl~ 661 (846)
|+... ...+++.... ..+..++ ...+..+-.. .+..++|+|+.|.|||++
T Consensus 82 ~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~ 161 (256)
T TIGR02721 82 ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT 161 (256)
T ss_pred CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe
Confidence 11111 1122222211 1221111 1112222111 124689999999999999
Q ss_pred CCCceeeeccccccc
Q 003121 662 ANFVSKLSDFGISRF 676 (846)
Q Consensus 662 ~~~~vKL~DFGla~~ 676 (846)
.++ +.|+||+.+..
T Consensus 162 ~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 162 PQG-LKLIDWEYASD 175 (256)
T ss_pred CCC-CEEEeccccCc
Confidence 877 78999997653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00064 Score=74.50 Aligned_cols=73 Identities=22% Similarity=0.132 Sum_probs=54.9
Q ss_pred ceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCC---CceeeEecccc-----CceEEEEEecCC
Q 003121 534 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH---PNLVTLVGACP-----EVWTLVYEYLPN 605 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~H---pnIv~l~g~~~-----~~~~lVmEy~~g 605 (846)
..||.|..+.||+-...+..+.+|..+. ......|..|...|+.|.- ..+.++++.|. +..+||||+++|
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 3599999999999876656677787543 1234689999999998843 35777887663 448999999998
Q ss_pred Cch
Q 003121 606 GSL 608 (846)
Q Consensus 606 gsL 608 (846)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00053 Score=72.08 Aligned_cols=139 Identities=19% Similarity=0.275 Sum_probs=81.1
Q ss_pred ceeeeeCceEEEEEEEC---CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc-eeeEeccccCceEEEEEecCCCchh
Q 003121 534 LKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGACPEVWTLVYEYLPNGSLE 609 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~---~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~lVmEy~~ggsL~ 609 (846)
+.|..|-...+|+.... +..|++|+....... .-...+|+.++..+...+ ..++++.+. ..+||||++|.++.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l~ 80 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTLE 80 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcCC
Confidence 45777778899998766 467889977643221 123457999999885333 344555443 34799999987663
Q ss_pred hh--------------h---ccCCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHHH-
Q 003121 610 DR--------------L---SCKDNS--------PPLS-WQTRIRIAT----------------------ELCSVLIFL- 640 (846)
Q Consensus 610 ~~--------------L---~~~~~~--------~~l~-~~~~~~i~~----------------------qia~aL~~L- 640 (846)
.. | +..... .... +..+..+.. .+...+..|
T Consensus 81 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 160 (235)
T cd05157 81 PEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLK 160 (235)
T ss_pred HHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHH
Confidence 21 0 111100 1111 222222211 111111111
Q ss_pred ---hhc-CCCceEecccCCCceEecC-CCceeeecccccc
Q 003121 641 ---HSC-KPHSIVHGDLKPANILLDA-NFVSKLSDFGISR 675 (846)
Q Consensus 641 ---H~~-~~~giiHrDLkp~NILl~~-~~~vKL~DFGla~ 675 (846)
... .+..++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 161 ~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 161 ELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 111 2357999999999999997 5789999999765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0015 Score=77.63 Aligned_cols=132 Identities=14% Similarity=0.177 Sum_probs=101.2
Q ss_pred cccCCEEEEEecCCccccHHHHHHHhhc--CCCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHH
Q 003121 41 SVIEDKIYVAVAKQVKESKSVLLWALQN--SGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHL 118 (846)
Q Consensus 41 ~~~~~~V~VAVD~s~~~S~~AL~Wal~n--~~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 118 (846)
+...++|+|+|+++ ..|..-++||-.- .-+..+..|||-.|-.... .+....-|
T Consensus 245 ~~~~e~ilvcI~~~-~~~e~liR~a~RlA~~~~a~~~av~v~~~~~~~~-----------------------~~~~~~~l 300 (890)
T COG2205 245 WAARERILVCISGS-PGSEKLIRRAARLASRLHAKWTAVYVETPELHRL-----------------------SEKEARRL 300 (890)
T ss_pred ccccceEEEEECCC-CchHHHHHHHHHHHHHhCCCeEEEEEeccccccc-----------------------cHHHHHHH
Confidence 55568999999999 8999999999765 3577999999997753310 23345567
Q ss_pred HHHHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEec
Q 003121 119 DMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICN 198 (846)
Q Consensus 119 ~~~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~~ 198 (846)
.....+|.+-|-+ ++.+.++|++++|.+++..+++++||||-+.++-+.|.|. ++++...+...+ ...|++|..
T Consensus 301 ~~~~~Lae~lGae--~~~l~~~dv~~~i~~ya~~~~~TkiViG~~~~~rw~~~~~---~~l~~~L~~~~~-~idv~ii~~ 374 (890)
T COG2205 301 HENLRLAEELGAE--IVTLYGGDVAKAIARYAREHNATKIVIGRSRRSRWRRLFK---GSLADRLAREAP-GIDVHIVAL 374 (890)
T ss_pred HHHHHHHHHhCCe--EEEEeCCcHHHHHHHHHHHcCCeeEEeCCCcchHHHHHhc---ccHHHHHHhcCC-CceEEEeeC
Confidence 7888888887654 5555689999999999999999999999887777776665 566666666655 458888876
Q ss_pred Ceee
Q 003121 199 GNLI 202 (846)
Q Consensus 199 gk~~ 202 (846)
+...
T Consensus 375 ~~~~ 378 (890)
T COG2205 375 DAPP 378 (890)
T ss_pred CCCc
Confidence 5444
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.001 Score=73.51 Aligned_cols=139 Identities=19% Similarity=0.260 Sum_probs=78.3
Q ss_pred ceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-----CCceeeE-----eccccCceEEEEEec
Q 003121 534 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----HPNLVTL-----VGACPEVWTLVYEYL 603 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-----HpnIv~l-----~g~~~~~~~lVmEy~ 603 (846)
+.|+.|....+|+....+..+++|++.. ...+.+..|+.++..|. -|.++.- +....+..+++++|+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 3466777789999877777899998762 22345556667666663 3333321 111234578999999
Q ss_pred CCCchhh-----------hh---ccCCC--------CCCCCH-HHHHH------------HH-HHHHHHHHHHhh----c
Q 003121 604 PNGSLED-----------RL---SCKDN--------SPPLSW-QTRIR------------IA-TELCSVLIFLHS----C 643 (846)
Q Consensus 604 ~ggsL~~-----------~L---~~~~~--------~~~l~~-~~~~~------------i~-~qia~aL~~LH~----~ 643 (846)
+|..+.. .| +.... ...+.| ..... .. ..+...+..+.. .
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 9875421 11 10000 001111 11111 01 111122233321 1
Q ss_pred CCCceEecccCCCceEecCCCceeeecccccc
Q 003121 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 644 ~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
-|.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 35689999999999999977666899999765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.001 Score=75.39 Aligned_cols=74 Identities=16% Similarity=0.087 Sum_probs=56.2
Q ss_pred ceeeeeCceEEEEEEECCe--EEEEEEecCCC-------CCCchhHHHHHHHHHhcC---CCceeeEeccccCceEEEEE
Q 003121 534 LKIGEGGYGSIYKGLLRHM--QVAIKMLHPHS-------LQGPSEFQQEIDILSKIR---HPNLVTLVGACPEVWTLVYE 601 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~~--~VAIK~l~~~~-------~~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~~~~lVmE 601 (846)
+.||.|.+..||+....+. .|+||.-.+.. ....+.+..|.+.|..+. ..++.+++.+..+..++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 4689999999999988753 79999854321 124567788999998873 35677888887888899999
Q ss_pred ecCCCc
Q 003121 602 YLPNGS 607 (846)
Q Consensus 602 y~~ggs 607 (846)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00067 Score=74.01 Aligned_cols=140 Identities=16% Similarity=0.183 Sum_probs=86.3
Q ss_pred cceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCC--ceeeEeccc--------cCceEEEEEe
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGAC--------PEVWTLVYEY 602 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~l~g~~--------~~~~~lVmEy 602 (846)
...|..|....+|+....+..+++|+... .....+..|+.++..|.+- .+.+++... .+..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 34577777789999877777899998764 2345677889888888432 244544432 3346789999
Q ss_pred cCCCchhh-----------hh---cc----CCCC----CCCCHHHHH----------HHHHHHHHHHHHHhh----cCCC
Q 003121 603 LPNGSLED-----------RL---SC----KDNS----PPLSWQTRI----------RIATELCSVLIFLHS----CKPH 646 (846)
Q Consensus 603 ~~ggsL~~-----------~L---~~----~~~~----~~l~~~~~~----------~i~~qia~aL~~LH~----~~~~ 646 (846)
++|..+.. .| +. .... ....|.... .....+..++.++.. ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876532 00 00 0000 011221111 011123334444443 2346
Q ss_pred ceEecccCCCceEecCCCceeeecccccc
Q 003121 647 SIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 647 giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 79999999999999998777899999765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0024 Score=65.62 Aligned_cols=128 Identities=23% Similarity=0.283 Sum_probs=85.6
Q ss_pred cceeeeeCceEEEEEEEC-CeEEEEEEecCCC----------------CCCchhHHHHHHHHHhcC------CCceeeEe
Q 003121 533 SLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHS----------------LQGPSEFQQEIDILSKIR------HPNLVTLV 589 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~----------------~~~~~~f~~Ei~iL~~l~------HpnIv~l~ 589 (846)
...||+|+.=.||. +. +....||+..+.. .....++.+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999994 33 3457889888765 112356777887777666 78899999
Q ss_pred ccccC--ceEEEEEecCC------CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec
Q 003121 590 GACPE--VWTLVYEYLPN------GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 661 (846)
Q Consensus 590 g~~~~--~~~lVmEy~~g------gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~ 661 (846)
|+... ...+|+|.+.+ -+|.+++.. ..++. .....+. .-..||-. +.|+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEEE
Confidence 99854 46688887543 257777732 23444 3333333 33445555 6799999999999995
Q ss_pred CC---C-ceeeec-ccc
Q 003121 662 AN---F-VSKLSD-FGI 673 (846)
Q Consensus 662 ~~---~-~vKL~D-FGl 673 (846)
.. . .+.|+| ||-
T Consensus 153 ~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ecCCCceEEEEEeCCCC
Confidence 32 2 567777 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.20 E-value=7.4e-05 Score=92.89 Aligned_cols=174 Identities=14% Similarity=0.021 Sum_probs=123.7
Q ss_pred EEEEEecCCCCCCch-----hHHHHHHHHHhcCCCceeeEeccc----cCceEEEEEecCCCchhhhhccC-CCCCCCCH
Q 003121 554 VAIKMLHPHSLQGPS-----EFQQEIDILSKIRHPNLVTLVGAC----PEVWTLVYEYLPNGSLEDRLSCK-DNSPPLSW 623 (846)
Q Consensus 554 VAIK~l~~~~~~~~~-----~f~~Ei~iL~~l~HpnIv~l~g~~----~~~~~lVmEy~~ggsL~~~L~~~-~~~~~l~~ 623 (846)
+.+|+.+....+... ....|.+-++...|+++...+.-. ...-+.+++|+.+|.+.+.+.+. ...+++..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 556666544333322 234455566667899988765544 23467899999999999988654 34455555
Q ss_pred HHHHHHHHHHHHHHHHHhhcCC--CceEecccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCccc
Q 003121 624 QTRIRIATELCSVLIFLHSCKP--HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701 (846)
Q Consensus 624 ~~~~~i~~qia~aL~~LH~~~~--~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y 701 (846)
.-+.....+......-+|.... +--+|++||+.|.+|..+..+|++++|+.+...+.. ...+...+++.|
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--------sf~Gl~l~sp~~ 1406 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--------SFFGLELCSPIY 1406 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH--------hhhhhhhCCHHH
Confidence 4444444444555566665432 336899999999999999999999999998332221 112345688899
Q ss_pred CChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003121 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 735 (846)
Q Consensus 702 ~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf 735 (846)
+.|++...-.++.++|+|..|+.+|...-|.++|
T Consensus 1407 v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1407 VLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9999998888999999999999999999998888
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0029 Score=64.74 Aligned_cols=123 Identities=25% Similarity=0.375 Sum_probs=88.4
Q ss_pred CCCcccceeeeeCc-eEEEEEEECCeEEEEEEecCCCCC---------------------CchhHHHHHHHHHhcC---C
Q 003121 528 HNFDPSLKIGEGGY-GSIYKGLLRHMQVAIKMLHPHSLQ---------------------GPSEFQQEIDILSKIR---H 582 (846)
Q Consensus 528 ~~f~~~~~LG~G~f-G~Vy~g~~~~~~VAIK~l~~~~~~---------------------~~~~f~~Ei~iL~~l~---H 582 (846)
.+++..+.||.|.- |.||+....|..+|+|++..-... -.+-|..|.....+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888999999999 999999999999999994321100 0124778888877774 4
Q ss_pred Cce--eeEeccc--c------------------CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 003121 583 PNL--VTLVGAC--P------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640 (846)
Q Consensus 583 pnI--v~l~g~~--~------------------~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~L 640 (846)
.++ |+.+|+. . ..+.||.||++... .+. .+-+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHHH
Confidence 455 8888875 1 12457888876532 122 22344566667788
Q ss_pred hhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 641 H~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
|. .||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---CCeeeccCcccccc-----CCEEEecccC
Confidence 88 89999999999997 4489999964
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0046 Score=67.97 Aligned_cols=141 Identities=18% Similarity=0.208 Sum_probs=83.6
Q ss_pred cceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCC--ceeeEeccc--------cCceEEEEEe
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGAC--------PEVWTLVYEY 602 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~l~g~~--------~~~~~lVmEy 602 (846)
...++.|-...+|+....+..+++|+.+... ..+.+..|+.++..|... .+.+++... .+..+++|+|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 3456767678999887666678889876522 245667788888887422 244444432 2346799999
Q ss_pred cCCCchhh-----------h---hccCCCC--CC-------CCHHHHHH------------HHHHHHHHHHHHhh----c
Q 003121 603 LPNGSLED-----------R---LSCKDNS--PP-------LSWQTRIR------------IATELCSVLIFLHS----C 643 (846)
Q Consensus 603 ~~ggsL~~-----------~---L~~~~~~--~~-------l~~~~~~~------------i~~qia~aL~~LH~----~ 643 (846)
++|..+.. . ++..... .+ -.|..... ....+...+.+|.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99865421 0 1100000 00 11111100 01123334555532 2
Q ss_pred CCCceEecccCCCceEecCCCceeeecccccc
Q 003121 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 644 ~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 35789999999999999988877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0028 Score=69.44 Aligned_cols=138 Identities=23% Similarity=0.317 Sum_probs=81.4
Q ss_pred eeeeeCceEEEEEEECC--------eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEeccccCceEEEEEecCC
Q 003121 535 KIGEGGYGSIYKGLLRH--------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPN 605 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~--------~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lVmEy~~g 605 (846)
.|..|-...||+....+ ..+++|+..... .......+|..++..+....+ .++++++.+ .+|++|++|
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--~~v~e~i~G 81 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN--GRIEEFIPS 81 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC--CchhheeCC
Confidence 45556666888877653 678999876543 223456789999988853322 345555543 468999998
Q ss_pred Cchhhh-----------------hccCCCCC------CCC--HHHHHH--------------------------HHHHHH
Q 003121 606 GSLEDR-----------------LSCKDNSP------PLS--WQTRIR--------------------------IATELC 634 (846)
Q Consensus 606 gsL~~~-----------------L~~~~~~~------~l~--~~~~~~--------------------------i~~qia 634 (846)
..+... |+...... ..+ +..... +...+.
T Consensus 82 ~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (302)
T cd05156 82 RTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDEA 161 (302)
T ss_pred CcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHHH
Confidence 766431 01111000 111 111111 111222
Q ss_pred HHHHHHhh------cCCCceEecccCCCceEecCC----Cceeeecccccc
Q 003121 635 SVLIFLHS------CKPHSIVHGDLKPANILLDAN----FVSKLSDFGISR 675 (846)
Q Consensus 635 ~aL~~LH~------~~~~giiHrDLkp~NILl~~~----~~vKL~DFGla~ 675 (846)
..+.+|-. ..+..++|+|+.|.|||++.+ +.++|+||..|.
T Consensus 162 ~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 162 KYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22333432 134679999999999999974 789999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0024 Score=78.75 Aligned_cols=187 Identities=24% Similarity=0.235 Sum_probs=127.3
Q ss_pred HHHHHHHHhcCCCceeeEeccccCc------eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 003121 571 QQEIDILSKIRHPNLVTLVGACPEV------WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644 (846)
Q Consensus 571 ~~Ei~iL~~l~HpnIv~l~g~~~~~------~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~ 644 (846)
..|...+.++.|+|++.++++.-+. ..+..+||..-++...+. .-..++..+.+.+..++.+||.|+|.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~-- 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHS-- 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHH--
Confidence 4567778888999999998875321 224557888888888884 34568888999999999999999999
Q ss_pred CCceEecccCCC---ceEecCCCceeee--ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCch--hh
Q 003121 645 PHSIVHGDLKPA---NILLDANFVSKLS--DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK--SD 717 (846)
Q Consensus 645 ~~giiHrDLkp~---NILl~~~~~vKL~--DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~k--sD 717 (846)
....|.-|.-. +-..+..+.+.++ ||+.++.+........ ..-+..|.+||.+....++.+ .|
T Consensus 305 -~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---------~~~~~~~~~~e~~~~~~~~~~r~~d 374 (1351)
T KOG1035|consen 305 -LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---------DLLAEIRNADEDLKENTAKKSRLTD 374 (1351)
T ss_pred -hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---------hcCccccccccccccccchhhhhhH
Confidence 33444444433 4444556677766 8888776655432221 123566788888766655544 79
Q ss_pred HHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 718 VYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 718 VwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
+|.+|..+..+..|..+-........ +++. .....+.++..+|+..++++|+...
T Consensus 375 L~~lgll~~~~~~~~~i~~~~~~~~~---------~l~~-------~~~~~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 375 LWCLGLLLLQLSQGEDISEKSAVPVS---------LLDV-------LSTSELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHHHHHHhhhhhcCcccccccchhh---------hhcc-------ccchhhhhhhhhhcchhhhhccchh
Confidence 99999999999998765432222111 1110 0112578888999999999999983
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.012 Score=64.79 Aligned_cols=132 Identities=20% Similarity=0.351 Sum_probs=81.7
Q ss_pred eeCce-EEEEEEECCeEEEEEEecC--CCCCCchhHHHHHHHHHhcCC--CceeeEeccccCce----EEEEEecCCCch
Q 003121 538 EGGYG-SIYKGLLRHMQVAIKMLHP--HSLQGPSEFQQEIDILSKIRH--PNLVTLVGACPEVW----TLVYEYLPNGSL 608 (846)
Q Consensus 538 ~G~fG-~Vy~g~~~~~~VAIK~l~~--~~~~~~~~f~~Ei~iL~~l~H--pnIv~l~g~~~~~~----~lVmEy~~ggsL 608 (846)
+||+. .+|.....++++++. ... ..........+|..+|+.+.- .-+...++.|.+.. +.||+|+.|..+
T Consensus 34 ~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~ 112 (321)
T COG3173 34 SGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV 112 (321)
T ss_pred cCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence 34443 445544447777777 321 122233457789999988853 23455678886655 899999998544
Q ss_pred hhhhccCCCCCCCCHHHHHHHH-HHHHHHHHHHhhcC-------------------------------------------
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIA-TELCSVLIFLHSCK------------------------------------------- 644 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~-~qia~aL~~LH~~~------------------------------------------- 644 (846)
.+.+.. .+.. ..++ ..++..|+-||+..
T Consensus 113 ~~~~~~------~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 113 WSALPP------ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred cCcCCc------ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 433311 1111 1112 24444455555321
Q ss_pred ------------CCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 645 ------------PHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 645 ------------~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
+..++|+|+.+.||+++.++-+=|.||+++.+-.
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 2368999999999999998889999999987543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.012 Score=65.83 Aligned_cols=139 Identities=15% Similarity=0.177 Sum_probs=81.1
Q ss_pred eeeeeCceEEEEEEEC------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCcee-eEeccccCceEEEEEecCCCc
Q 003121 535 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV-TLVGACPEVWTLVYEYLPNGS 607 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv-~l~g~~~~~~~lVmEy~~ggs 607 (846)
.|-.|-.-.+|+..+. +..|++|+.........+ -.+|..++..+..-++. ++++.+... .|++|+++.+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g~~ 119 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHART 119 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCCCC
Confidence 4545667789987653 257899987664332222 36799999988543333 455666443 6899998876
Q ss_pred hhhh-----------------hccCCC---CCCCCHHHHHHHHHHH-----------------HHHHHHH----hh-cCC
Q 003121 608 LEDR-----------------LSCKDN---SPPLSWQTRIRIATEL-----------------CSVLIFL----HS-CKP 645 (846)
Q Consensus 608 L~~~-----------------L~~~~~---~~~l~~~~~~~i~~qi-----------------a~aL~~L----H~-~~~ 645 (846)
|... ++.... ..+..+..+..+..++ ...+..| .. ..+
T Consensus 120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~ 199 (344)
T PLN02236 120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE 199 (344)
T ss_pred CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence 6421 111110 0112233333332111 1112222 21 223
Q ss_pred CceEecccCCCceEecC-CCceeeeccccccc
Q 003121 646 HSIVHGDLKPANILLDA-NFVSKLSDFGISRF 676 (846)
Q Consensus 646 ~giiHrDLkp~NILl~~-~~~vKL~DFGla~~ 676 (846)
..++|+|+++.|||++. ++.+.|+||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 57899999999999986 47899999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.01 Score=67.35 Aligned_cols=73 Identities=14% Similarity=0.068 Sum_probs=54.8
Q ss_pred cceeeeeCceEEEEEEECCeEEEEEEecCCCC-------CCchhHHHHHHHHHhcC---CCceeeEeccccCceEEEEEe
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL-------QGPSEFQQEIDILSKIR---HPNLVTLVGACPEVWTLVYEY 602 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~-------~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~~~~lVmEy 602 (846)
.+.||.|....||+....+..++||.-.+... .+...-..|...|+.+. ..++.+++.+|++..+++|||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 44689999999999887777799997653211 13445566777777664 347888999999999999999
Q ss_pred cCC
Q 003121 603 LPN 605 (846)
Q Consensus 603 ~~g 605 (846)
+++
T Consensus 117 L~~ 119 (418)
T PLN02756 117 LEP 119 (418)
T ss_pred cCC
Confidence 977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.015 Score=64.75 Aligned_cols=78 Identities=15% Similarity=0.114 Sum_probs=54.0
Q ss_pred eeeeeCceEEEEEEECC--eEEEEEEecCC-------CCCCchhHHHHHHHHHhcC--CC-ceeeEeccccCceEEEEEe
Q 003121 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPH-------SLQGPSEFQQEIDILSKIR--HP-NLVTLVGACPEVWTLVYEY 602 (846)
Q Consensus 535 ~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~-------~~~~~~~f~~Ei~iL~~l~--Hp-nIv~l~g~~~~~~~lVmEy 602 (846)
.||.|....||++...+ +.|+||.-.+. -..+.++..-|...|+... -| ++.++|.+-++...+|||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 47889999999998775 47999964321 1233466778888887763 34 5666777777778899999
Q ss_pred cCCC-chhhhh
Q 003121 603 LPNG-SLEDRL 612 (846)
Q Consensus 603 ~~gg-sL~~~L 612 (846)
++.. .|++.|
T Consensus 82 L~~~~ilR~~L 92 (370)
T TIGR01767 82 LSHHKIARKGL 92 (370)
T ss_pred CccchHHHHHH
Confidence 9653 343433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0018 Score=69.94 Aligned_cols=147 Identities=14% Similarity=0.191 Sum_probs=94.6
Q ss_pred CCCCChhhhhhhcC---CCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCC-----C-----------------ch
Q 003121 515 FSDFSFSEIEGATH---NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-----G-----------------PS 568 (846)
Q Consensus 515 ~~~~~~~ei~~~~~---~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~-----~-----------------~~ 568 (846)
+.-|.+--++...+ -+...+.||-|.-+.||.+-.. |++.++|.-+..... . .-
T Consensus 76 y~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRl 155 (465)
T KOG2268|consen 76 YAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRL 155 (465)
T ss_pred eccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHH
Confidence 34444444443322 3577889999999999999877 788888864332110 0 01
Q ss_pred hHHHHHHHHHhcCC-C-ceeeEeccccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 003121 569 EFQQEIDILSKIRH-P-NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646 (846)
Q Consensus 569 ~f~~Ei~iL~~l~H-p-nIv~l~g~~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 646 (846)
...+|...|+.|.. - -+.+.+++ ...++|||++.|-.|...-.- .+..+ +...+..-+.-|-. +
T Consensus 156 aa~kEfafmkaL~e~gfpVPkpiD~--~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~---~ 221 (465)
T KOG2268|consen 156 AATKEFAFMKALYERGFPVPKPIDH--NRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLAN---H 221 (465)
T ss_pred HHHHHHHHHHHHHHcCCCCCCcccc--cceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHH---c
Confidence 24568888888742 1 23334443 457889999998777654311 11122 33333334444555 8
Q ss_pred ceEecccCCCceEecCCCceeeecccccc
Q 003121 647 SIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 647 giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
|+||+|.+--||+++.++.++++||--+-
T Consensus 222 GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred CceecccchheeEEecCCCEEEeechHhh
Confidence 99999999999999999999999998654
|
|
| >KOG1029 consensus Endocytic adaptor protein intersectin [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.2 Score=59.12 Aligned_cols=9 Identities=33% Similarity=0.593 Sum_probs=4.2
Q ss_pred chHHHHHHH
Q 003121 421 GKLELERMK 429 (846)
Q Consensus 421 ~k~ele~~~ 429 (846)
.|+|+|+++
T Consensus 401 ar~ElEkqR 409 (1118)
T KOG1029|consen 401 AREELEKQR 409 (1118)
T ss_pred HHHHHHHHH
Confidence 344555444
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 846 | ||||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-49 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-49 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-48 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-45 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-43 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-37 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-05 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 9e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-04 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 1e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 |
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 846 | |||
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-99 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 6e-99 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-86 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-67 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-66 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 5e-63 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-61 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 6e-61 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 7e-60 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 8e-60 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 6e-59 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-58 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-57 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-54 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-51 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 6e-50 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-49 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 9e-48 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-39 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-37 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-37 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-37 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-36 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-36 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 9e-36 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-35 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-35 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-35 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-35 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-35 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-35 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-35 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-35 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 5e-35 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-35 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-35 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 9e-35 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-34 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-34 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-34 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-34 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-34 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-34 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-34 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-34 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 6e-34 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 6e-34 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 6e-34 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-34 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-34 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 9e-34 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-33 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-33 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-33 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-33 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-33 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-33 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-33 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-33 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-33 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 5e-33 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 7e-33 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 7e-33 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-33 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 8e-33 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 8e-33 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-32 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-32 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-32 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-32 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-32 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 7e-32 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 8e-32 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-31 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-31 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-31 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-31 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-31 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-31 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-31 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-31 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 5e-31 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-31 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 9e-31 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-30 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-30 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-30 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-30 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 6e-30 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 9e-30 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-29 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-29 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 3e-29 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-29 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-29 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 5e-29 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-29 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-29 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 7e-29 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-29 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-28 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-28 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-28 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-28 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-28 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-28 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-28 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-28 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-28 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-28 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-28 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-28 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-28 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-28 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-28 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-28 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 8e-28 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 8e-28 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-27 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-27 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-27 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-27 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-27 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-27 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-27 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-27 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-27 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-26 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-26 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-26 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-26 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-26 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-26 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-26 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-26 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 9e-26 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 9e-26 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-25 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-25 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-25 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-25 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-25 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-25 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-25 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-25 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-25 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-25 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-24 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-24 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-24 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-24 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-24 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-24 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-24 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 6e-24 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-24 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 8e-24 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 9e-24 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-23 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-23 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-23 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-23 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-23 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-22 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-21 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-21 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-21 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-21 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-21 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-21 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-20 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 6e-20 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-19 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-19 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-19 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-19 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-19 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 5e-19 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 5e-19 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 8e-19 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 8e-19 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-18 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-18 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-18 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-18 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-08 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 7e-18 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 9e-18 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-17 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-17 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-17 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-17 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-17 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-17 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-17 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-17 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 4e-17 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-16 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-15 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-15 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-15 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-15 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-15 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 6e-15 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 7e-15 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 8e-15 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 8e-15 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-14 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-14 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-14 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-14 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-14 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-14 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-14 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-13 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-13 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-13 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 6e-13 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-12 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-12 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-11 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-10 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-11 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-11 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-11 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-10 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-10 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 8e-10 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 4e-09 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 1e-07 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 1e-07 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 4e-07 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 2e-06 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 4e-06 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-09 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-09 | |
| 1c1g_A | 284 | Tropomyosin; contractIle protein; 7.00A {Sus scrof | 2e-09 | |
| 1c1g_A | 284 | Tropomyosin; contractIle protein; 7.00A {Sus scrof | 4e-08 | |
| 1c1g_A | 284 | Tropomyosin; contractIle protein; 7.00A {Sus scrof | 4e-08 | |
| 1c1g_A | 284 | Tropomyosin; contractIle protein; 7.00A {Sus scrof | 3e-07 | |
| 1c1g_A | 284 | Tropomyosin; contractIle protein; 7.00A {Sus scrof | 4e-07 | |
| 1c1g_A | 284 | Tropomyosin; contractIle protein; 7.00A {Sus scrof | 7e-07 | |
| 1c1g_A | 284 | Tropomyosin; contractIle protein; 7.00A {Sus scrof | 3e-06 | |
| 1c1g_A | 284 | Tropomyosin; contractIle protein; 7.00A {Sus scrof | 5e-06 | |
| 1c1g_A | 284 | Tropomyosin; contractIle protein; 7.00A {Sus scrof | 9e-06 | |
| 1c1g_A | 284 | Tropomyosin; contractIle protein; 7.00A {Sus scrof | 6e-05 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 7e-09 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 1e-07 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 4e-07 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 7e-07 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 4e-06 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 2e-05 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 7e-08 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 7e-08 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-07 | |
| 3lvg_D | 190 | LCB, clathrin light chain B; SELF assembly, coated | 4e-07 | |
| 3lvg_D | 190 | LCB, clathrin light chain B; SELF assembly, coated | 1e-06 | |
| 2zuo_A | 861 | MVP, major vault protein; repeat domains, protein- | 2e-06 | |
| 2efr_A | 155 | General control protein GCN4 and tropomyosin 1 Al; | 3e-06 | |
| 1w1w_A | 430 | Structural maintenance of chromosome 1; cohesin, c | 1e-05 | |
| 1cii_A | 602 | Colicin IA; bacteriocin, ION channel formation, tr | 2e-05 | |
| 2v71_A | 189 | Nuclear distribution protein NUDE-like 1; developm | 2e-05 | |
| 1f5n_A | 592 | Interferon-induced guanylate-binding protein 1; GB | 8e-05 | |
| 2xs1_A | 704 | Programmed cell death 6-interacting protein; prote | 1e-04 | |
| 3haj_A | 486 | Human pacsin2 F-BAR; pacsin,syndapin,FAP52,F-BAR, | 1e-04 | |
| 2fxo_A | 129 | Myosin heavy chain, cardiac muscle beta isoform; c | 2e-04 | |
| 4f61_I | 240 | Stathmin-like domain R4; alpha-tubulin, beta-tubul | 2e-04 | |
| 3qwe_A | 279 | GMIP, GEM-interacting protein; structural genomics | 2e-04 | |
| 3na7_A | 256 | HP0958; flagellar biogenesis, flagellum export, C4 | 3e-04 | |
| 2v0o_A | 276 | FCHO2, FCH domain only protein 2; lipid-binding pr | 4e-04 | |
| 3auy_A | 371 | DNA double-strand break repair RAD50 ATPase; DNA r | 5e-04 | |
| 2dgj_A | 257 | Hypothetical protein EBHA; helix-bundle, ROD-like | 7e-04 | |
| 3o0z_A | 168 | RHO-associated protein kinase 1; coiled-coil, tran | 7e-04 |
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = 1e-99
Identities = 118/314 (37%), Positives = 176/314 (56%), Gaps = 31/314 (9%)
Query: 501 SRKEASSSSHMPQFFS-DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKM 558
S +A SSS++ F S ++E AT+NFD IG G +G +YKG+LR +VA+K
Sbjct: 11 SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 559 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKD 616
P S QG EF+ EI+ LS RHP+LV+L+G C E L+Y+Y+ NG+L+ L D
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 617 N-SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675
+ +SW+ R+ I L +LH+ +I+H D+K NILLD NFV K++DFGIS+
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187
Query: 676 FLSQNE---ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
++ + +S T KGT Y+DPE+ G LT KSDVYSFG++L +L R
Sbjct: 188 KGTELDQTHLS---------TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 733 PALGITKE------VQYA---LDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRK 782
A+ + ++A + G+L+ ++DP LA + + A++C +S +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 783 SRPELGKDVWRVLE 796
RP +G DV LE
Sbjct: 299 DRPSMG-DVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = 6e-99
Identities = 114/304 (37%), Positives = 171/304 (56%), Gaps = 31/304 (10%)
Query: 518 FSFSEIEGATHNFDPSL------KIGEGGYGSIYKGLLRHMQVAIKMLHPH----SLQGP 567
FSF E++ T+NFD K+GEGG+G +YKG + + VA+K L + +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 568 SEFQQEIDILSKIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQT 625
+F QEI +++K +H NLV L+G + LVY Y+PNGSL DRLSC D +PPLSW
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 626 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685
R +IA + + FLH + +H D+K ANILLD F +K+SDFG++R + +
Sbjct: 135 RCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 745
+ + GT AYM PE L GE+TPKSD+YSFG++LL ++TG PA+ +E Q L
Sbjct: 192 TSRI------VGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 746 --------DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797
+ +++ +D D E + ++A +C + RP++ V ++L+
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK-KVQQLLQE 303
Query: 798 MRAS 801
M AS
Sbjct: 304 MTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-86
Identities = 101/299 (33%), Positives = 161/299 (53%), Gaps = 31/299 (10%)
Query: 518 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGP-SEFQQEID 575
FS E++ A+ NF +G GG+G +YKG L VA+K L QG +FQ E++
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 576 ILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATE 632
++S H NL+ L G C LVY Y+ NGS+ L ++ PPL W R RIA
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 633 LCSVLIFLH-SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTL 689
L +LH C P I+H D+K ANILLD F + + DFG+++ + + ++
Sbjct: 140 SARGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT------ 192
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--------V 741
T +GT ++ PE+L++G+ + K+DV+ +G++LL L+TG+ A + + +
Sbjct: 193 ---TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 742 QYA---LDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796
+ L KL+ L+D L G++ + EQL +A+ C + S RP++ +V R+LE
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS-EVVRMLE 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 2e-67
Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 21/273 (7%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 594
+G G +G + K R VAIK + S + F E+ LS++ HPN+V L GAC
Sbjct: 15 VVGRGAFGVVCKAKWRAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 654
LV EY GSL + L + P + + + + +LHS +P +++H DLK
Sbjct: 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 655 PANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 713
P N+LL A V K+ DFG + + + T+ KG+ A+M PE +
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQTH-----------MTNNKGSAAWMAPEVFEGSNYS 181
Query: 714 PKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANL 772
K DV+S+GIIL ++T R P I + PL + P + + +L
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLP----KPIESL 236
Query: 773 AMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 805
RC RP + +++ +++ + G+
Sbjct: 237 MTRCWSKDPSQRPSM-EEIVKIMTHLMRYFPGA 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 2e-66
Identities = 83/315 (26%), Positives = 134/315 (42%), Gaps = 21/315 (6%)
Query: 492 VKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH 551
+K ++ F +++ + + KIG G +G++++
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 552 MQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGS 607
VA+K+L EF +E+ I+ ++RHPN+V +GA P ++V EYL GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 667
L L L + R+ +A ++ + +LH+ P IVH +LK N+L+D + K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVK 179
Query: 668 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 727
+ DFG+SR + +SS GT +M PE L KSDVYSFG+IL
Sbjct: 180 VCDFGLSRLKASTFLSS--------KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWE 231
Query: 728 LLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 786
L T + P + Q G K + + Q+A + C RP
Sbjct: 232 LATLQQPWGNLN-PAQVVAAVGF-KCKRLEIPRNLN----PQVAAIIEGCWTNEPWKRPS 285
Query: 787 LGKDVWRVLEPMRAS 801
+ +L P+ S
Sbjct: 286 F-ATIMDLLRPLIKS 299
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 5e-63
Identities = 67/319 (21%), Positives = 115/319 (36%), Gaps = 53/319 (16%)
Query: 501 SRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLH 560
SS D + + G +G ++K L + VA+K+
Sbjct: 3 HHHHHHSSG------VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFP 56
Query: 561 PHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWT---LVYEYLPNGSLEDRLSC 614
Q + + E+ L ++H N++ +GA V L+ + GSL D L
Sbjct: 57 IQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-- 113
Query: 615 KDNSPPLSWQTRIRIATELCSVLIFLHS--------CKPHSIVHGDLKPANILLDANFVS 666
+ +SW IA + L +LH KP I H D+K N+LL N +
Sbjct: 114 --KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-ISHRDIKSKNVLLKNNLTA 170
Query: 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSF 721
++DFG++ + + + GT YM PE L + + D+Y+
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQV------GTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 722 GIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 781
G++L L + A + +Y L + + M+ + +
Sbjct: 225 GLVLWELASRCTAADGPVD-EYML------PFEEEIGQHPSLED--------MQEVVVHK 269
Query: 782 KSRPELGKDVWRVLEPMRA 800
K RP L +D W+ M
Sbjct: 270 KKRPVL-RDYWQKHAGMAM 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-61
Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 36/279 (12%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS----EFQQEIDILSKIRHPNLVTLVG 590
IG GG+G +Y+ +VA+K + S +QE + + ++HPN++ L G
Sbjct: 14 IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 591 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
C LV E+ G L LS K + + A ++ + +LH I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 649 VHGDLKPANILLD--------ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
+H DLK +NIL+ +N + K++DFG++R + S G +A
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----------AGAYA 179
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 759
+M PE + + + SDV+S+G++L LLTG P GI + A L P+
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGVAM-NKLALPIPS 237
Query: 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
P E A L C SRP ++ L +
Sbjct: 238 TCP----EPFAKLMEDCWNPDPHSRPSF-TNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 6e-61
Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 26/273 (9%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC 592
+IG G +G++YKG H VA+KML+ + F+ E+ +L K RH N++ +G
Sbjct: 31 RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 593 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
+V ++ SL L + + I IA + + +LH+ I+H
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DLK NI L + K+ DFG++ S+ S G+ +M PE + +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ------LSGSILWMAPEVIRMQD 198
Query: 712 LTP---KSDVYSFGIILLRLLTGR-PALGIT--KEVQYALDTGKLKNLLDPLAGDWPFVQ 765
P +SDVY+FGI+L L+TG+ P I ++ + G L L + + P
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP--- 255
Query: 766 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
+++ L C + R RP + +E +
Sbjct: 256 -KRMKRLMAECLKKKRDERPSF-PRILAEIEEL 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 7e-60
Identities = 80/282 (28%), Positives = 135/282 (47%), Gaps = 38/282 (13%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS-------EFQQEIDILSKIRHPNL 585
+IG+GG+G ++KG + VAIK L +G + EFQ+E+ I+S + HPN+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 586 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
V L G +V E++P G L RL D + P+ W ++R+ ++ + ++ + P
Sbjct: 86 VKLYGLMHNPPRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 646 HSIVHGDLKPANILLD-----ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
IVH DL+ NI L A +K++DFG+S+ S ++ + G F
Sbjct: 144 -PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSV----SGLLGNFQ 191
Query: 701 YMDPEFLASGEL--TPKSDVYSFGIILLRLLTGR-PALGIT-KEVQYALDTGKLKNLLDP 756
+M PE + + E T K+D YSF +IL +LTG P + ++++ + + L
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGLRPT 250
Query: 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
+ D P +L N+ C K RP + + L +
Sbjct: 251 IPEDCP----PRLRNVIELCWSGDPKKRPHF-SYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 8e-60
Identities = 62/281 (22%), Positives = 109/281 (38%), Gaps = 20/281 (7%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
+G+G +G K R + +K L + F +E+ ++ + HPN++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
+ + EY+ G+L + K W R+ A ++ S + +LHS I+H
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIH 131
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK------GTFAYMDP 704
DL N L+ N ++DFG++R + + + D K G +M P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 705 EFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764
E + K DV+SFGI+L ++ A L + P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCP-- 249
Query: 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 805
+ +RCC++ + RP + LE +R G
Sbjct: 250 --PSFFPITVRCCDLDPEKRPSF-VKLEHWLETLRMHLAGH 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 3e-58
Identities = 58/279 (20%), Positives = 109/279 (39%), Gaps = 33/279 (11%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC 592
IG+G +G +Y G H +VAI+++ F++E+ + RH N+V +GAC
Sbjct: 40 LIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
P ++ +L + +D L +IA E+ + +LH+ I+H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILH 153
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 710
DLK N+ D V ++DFG+ + L G ++ PE +
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKL---RIQNGWLCHLAPEIIRQL 209
Query: 711 EL---------TPKSDVYSFGIILLRLLTGR-PALGITKE-VQYALDTGKLKNLLDPLAG 759
+ SDV++ G I L P E + + + TG +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM---KPNLSQI 266
Query: 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
++++++ + C ++ RP + +LE +
Sbjct: 267 GMG----KEISDILLFCWAFEQEERPTF-TKLMDMLEKL 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-57
Identities = 51/275 (18%), Positives = 108/275 (39%), Gaps = 32/275 (11%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC 592
K+ E G ++KG + + +K+L +F +E L HPN++ ++GAC
Sbjct: 17 KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 593 --PEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
P + ++P GSL + L + + + ++ A ++ + FLH+ +P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LI 134
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL- 707
L ++++D + +++S + A++ PE L
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQS-------------PGRMYAPAWVAPEALQ 181
Query: 708 --ASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764
+D++SF ++L L+T P ++ ++ + L+ L +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVA-LEGLRPTIPPGIS-- 237
Query: 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799
++ L C RP+ + +LE M+
Sbjct: 238 --PHVSKLMKICMNEDPAKRPKF-DMIVPILEKMQ 269
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 190 bits (483), Expect = 4e-54
Identities = 65/248 (26%), Positives = 96/248 (38%), Gaps = 31/248 (12%)
Query: 517 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI 576
+ + SE N IG G YG++YKG L VA+K+ + Q F E +I
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ---NFINEKNI 58
Query: 577 --LSKIRHPNLVTLVGAC--------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 626
+ + H N+ + E LV EY PNGSL L + W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYL-LVMEYYPNGSLXKYL----SLHTSDWVSS 113
Query: 627 IRIATELCSVLIFLHSCKPHS------IVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680
R+A + L +LH+ P I H DL N+L+ + +SDFG+S L+ N
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 681 EISSNNTTLCCRTDPKGTFAYMDPEFL-------ASGELTPKSDVYSFGIILLRLLTGRP 733
+ GT YM PE L + D+Y+ G+I +
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 734 ALGITKEV 741
L + V
Sbjct: 234 DLFPGESV 241
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-51
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGAC 592
+G+G YG +++G + VA+K+ + + +E ++ +RH N++ + +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIASD 71
Query: 593 -------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS--- 642
++W L+ Y GSL D L L + +RI + S L LH
Sbjct: 72 MTSRHSSTQLW-LITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 643 ---CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
KP +I H DLK NIL+ N ++D G++ SQ+ N GT
Sbjct: 127 GTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST----NQLDVGNNPRVGTK 181
Query: 700 AYMDPEFL------ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 742
YM PE L + + D+++FG++L + + GI ++ +
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-49
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGAC 592
+IG+G YG ++ G R +VA+K+ + +E +I +RH N++ + A
Sbjct: 44 QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAAD 100
Query: 593 -------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS--- 642
+++ L+ +Y NGSL D L S L ++ +++A S L LH+
Sbjct: 101 IKGTGSWTQLY-LITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 643 ---CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
KP +I H DLK NIL+ N ++D G++ + N GT
Sbjct: 156 STQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT----NEVDIPPNTRVGTK 210
Query: 700 AYMDPEFLA------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 742
YM PE L + +D+YSFG+IL + + GI +E Q
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 9e-48
Identities = 66/284 (23%), Positives = 111/284 (39%), Gaps = 41/284 (14%)
Query: 480 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEG 539
E L ++L + S S +P I IG+G
Sbjct: 1 EDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQE-------SIGKG 53
Query: 540 GYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGAC----- 592
+G +++G R +VA+K+ + + +E +I +RH N++ + A
Sbjct: 54 RFGEVWRGKWRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNG 110
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS------CK 644
++W LV +Y +GSL D L N ++ + I++A S L LH K
Sbjct: 111 TWTQLW-LVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
P +I H DLK NIL+ N ++D G++ +T GT YM P
Sbjct: 166 P-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA----TDTIDIAPNHRVGTKRYMAP 220
Query: 705 EFL------ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 742
E L E ++D+Y+ G++ + GI ++ Q
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 535 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 589
+G+G ++++G RH AIK+ + S P + +E ++L K+ H N+V L
Sbjct: 16 ILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 590 GACPEVWT-----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
A E T L+ E+ P GSL L N+ L + + ++ + L
Sbjct: 74 -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 645 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
+ IVH ++KP NI+ D V KL+DFG +R L +E +L GT
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLY------GTEE 180
Query: 701 YMDPEFLASGEL--------TPKSDVYSFGIILLRLLTGRP 733
Y+ P+ L D++S G+ TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-37
Identities = 78/285 (27%), Positives = 134/285 (47%), Gaps = 40/285 (14%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL- 588
K+G GG ++Y + +++VAIK + + F++E+ S++ H N+V++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 589 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
V + + LV EY+ +L + + ++ PLS T I ++ + H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD---MR 131
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
IVH D+KP NIL+D+N K+ DFGI++ LS+ ++ N L GT Y PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-------GTVQYFSPEQA 184
Query: 708 ASGELTPKSDVYSFGIILLRLLTGRP------ALGI-TKEVQYALDTGKLKNLLDPLAGD 760
+D+YS GI+L +L G P A+ I K +Q ++ + + D
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN-----VTTDVRKD 239
Query: 761 WPFVQAEQLANLAMRCCEMSRKSRP----ELGKDVWRVLEPMRAS 801
P + L+N+ +R E + +R E+ D+ VL RA+
Sbjct: 240 IP----QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 535 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 589
+G+G ++++G RH AIK+ + S P + +E ++L K+ H N+V L
Sbjct: 16 ILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 590 GACPEVWT-----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
A E T L+ E+ P GSL L N+ L + + ++ + L
Sbjct: 74 -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 645 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
+ IVH ++KP NI+ D V KL+DFG +R L +E +L GT
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLY------GTEE 180
Query: 701 YMDPEFLASGEL--------TPKSDVYSFGIILLRLLTGRP 733
Y+ P+ L D++S G+ TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 33/262 (12%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGA 591
+IG G +G ++ G LR + VA+K ++F QE IL + HPN+V L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 592 CPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
C + ++ +V E + G L + L +T +++ + + + +L S
Sbjct: 181 CTQKQPIY-IVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KCC 234
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEF 706
+H DL N L+ V K+SDFG+SR + + + PE
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA--------ASGGLRQVPVKWTAPEA 286
Query: 707 LASGELTPKSDVYSFGIILLRLLT-GR-PALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 763
L G + +SDV+SFGI+L + G P ++ ++ + ++ G L P
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG---GRLPC-----PE 338
Query: 764 VQAEQLANLAMRCCEMSRKSRP 785
+ + + L +C RP
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQRP 360
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL- 588
+G GG G +Y+ +R VA+K++ P Q+E +++ P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 589 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
G + + L L PL+ + I ++ S L H+
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHA---AG 154
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
H D+KP NIL+ A+ + L DFGI+ + +++ T+ GT YM PE
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-------GTLYYMAPERF 207
Query: 708 ASGELTPKSDVYSFGIILLRLLTGRP 733
+ T ++D+Y+ +L LTG P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSP 233
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 535 KIGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 587
+G G +G++YKGL + VAIK L S + E E +++ + +P++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 588 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
L+G C V L+ + +P G L D + +++ + Q + ++ + +L
Sbjct: 82 LLGICLTSTVQ-LITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLED--- 135
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMD 703
+VH DL N+L+ K++DFG+++ L E G +M
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMA 187
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
E + T +SDV+S+G+ + L+T +P GI E+ L+ G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 535 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNL--VTLV 589
+IG GG +++ L Q AIK ++ + ++ EI L+K++ + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 590 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+ +V E N L L K + R + + +H H
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HG 147
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
IVH DLKPAN L+ + KL DFGI+ + + S + GT YM PE +
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV------GTVNYMPPEAI 200
Query: 708 -----------ASGELTPKSDVYSFGIILLRLLTGRP 733
+ +++PKSDV+S G IL + G+
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLV 589
KIG G + +Y+ + VA+K + L +EID+L ++ HPN++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 590 GACPEVWTL--VYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+ E L V E G L + K + +T + +LCS L +HS
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---R 155
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
++H D+KPAN+ + A V KL D G+ RF ++ GT YM PE
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFF--------SSKTTAAHSLVGTPYYMSPER 207
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRPA 734
+ KSD++S G +L + +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 535 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVT 587
IG G YG K R + K L S+ +E Q E+++L +++HPN+V
Sbjct: 13 TIGTGSYGRCQKI--RRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVR 69
Query: 588 LVGACPEVWT----LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
+ +V EY G L + L + +R+ T+L L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 643 CK--PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
H+++H DLKPAN+ LD KL DFG++R L+ + +S T GT
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFV------GTPY 181
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 734
YM PE + KSD++S G +L L P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 59/252 (23%), Positives = 97/252 (38%), Gaps = 22/252 (8%)
Query: 498 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVA 555
+ S SS + F + ++ K+GEGG+ + +GL A
Sbjct: 1 MGSSHHHHHHSS--GRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYA 58
Query: 556 IKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-------PEVWTLVYEYLPNGSL 608
+K + H Q E Q+E D+ HPN++ LV C E W L+ + G+L
Sbjct: 59 LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW-LLLPFFKRGTL 117
Query: 609 EDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 667
+ + KD L+ + + +C L +H+ H DLKP NILL
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPV 174
Query: 668 LSDFGISRFLSQNEISSNNTTLCCRTDPK--GTFAYMDPEFLAS---GELTPKSDVYSFG 722
L D G + + L + T +Y PE + + ++DV+S G
Sbjct: 175 LMDLGSMNQAC-IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233
Query: 723 IILLRLLTGRPA 734
+L ++ G
Sbjct: 234 CVLYAMMFGEGP 245
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 535 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNL--VTLV 589
+IG GG +++ L Q AIK ++ + ++ EI L+K++ + + L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 590 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+ +V E N L L K + R + + +H H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HG 128
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
IVH DLKPAN L+ + KL DFGI+ + + S + GT YM PE +
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV------GTVNYMPPEAI 181
Query: 708 -----------ASGELTPKSDVYSFGIILLRLLTGRP 733
+ +++PKSDV+S G IL + G+
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 535 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVT 587
+GEG +G + QVA+K L P S ++ ++EI+IL + H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 588 LVGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
G C L+ E+LP+GSL++ L N ++ + +++ A ++C + +L S
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS- 144
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
VH DL N+L+++ K+ DFG+++ + ++ + D +
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-----EYYTVKDDRDSPVFWYA 197
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLT 730
PE L + SDV+SFG+ L LLT
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 535 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 588
++G+G +GS+ VA+K L + + +F++EI+IL ++H N+V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 589 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
G C L+ EYLP GSL D L + + + ++ +++C + +L +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
+H DL NIL++ K+ DFG+++ L Q++ + + + P
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EFFKVKEPGESPIFWYAP 186
Query: 705 EFLASGELTPKSDVYSFGIILLRLLT 730
E L + + SDV+SFG++L L T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 24/223 (10%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNL 585
+F+P +G GG+G +++ + AIK + P+ + +E+ L+K+ HP +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 586 VTLVGACPEVWT--------------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 631
V A E T + + +L+D ++ + + I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 632 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE----ISSNNT 687
++ + FLHS ++H DLKP+NI + V K+ DFG+ + Q+E + +
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 688 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730
T GT YM PE + + K D++S G+IL LL
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 535 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 588
++G+G +GS+ VA+K L + + +F++EI+IL ++H N+V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 589 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
G C L+ EYLP GSL D L + + + ++ +++C + +L +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 163
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
+H DL NIL++ K+ DFG+++ L Q++ + + + P
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EYYKVKEPGESPIFWYAP 217
Query: 705 EFLASGELTPKSDVYSFGIILLRLLT 730
E L + + SDV+SFG++L L T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 535 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 588
++G+G +GS+ VA+K L +FQ+EI IL + +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 589 VGACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
G LV EYLP+G L D L + + L + ++++C + +L S
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS-- 145
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
VH DL NIL+++ K++DFG+++ L ++ R + + P
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-----DYYVVREPGQSPIFWYAP 199
Query: 705 EFLASGELTPKSDVYSFGIILLRLLT 730
E L+ + +SDV+SFG++L L T
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 24/235 (10%)
Query: 507 SSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL 564
SS + + F +E + KIGEG +G Q IK + S
Sbjct: 7 HSSGVDLGTENLYFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI-NISR 61
Query: 565 QGPSEFQ---QEIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSP 619
E + +E+ +L+ ++HPN+V + E +L V +Y G L R++
Sbjct: 62 MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN-AQKGV 120
Query: 620 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679
+ ++C L +H K I+H D+K NI L + +L DFGI+R L+
Sbjct: 121 LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177
Query: 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 734
GT Y+ PE + KSD+++ G +L L T + A
Sbjct: 178 T--VELARACI------GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-35
Identities = 65/286 (22%), Positives = 99/286 (34%), Gaps = 52/286 (18%)
Query: 535 KIGEGGYGSIYKGL---LRHMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL-- 588
I GG G IY L + V +K L E L+++ HP++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 589 VGACPEVWT-----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
+ +V EY+ SL+ L I E+ L +LHS
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHS- 200
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
+V+ DLKP NI+L + KL D G I+S GT +
Sbjct: 201 --IGLVYNDLKPENIMLTEEQL-KLIDLGAVS-----RINSFGYLY-------GTPGFQA 245
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763
PE + T +D+Y+ G L L P G+ +D L D P
Sbjct: 246 PE-IVRTGPTVATDIYTVGRTLAALTLDLPT-----------RNGR---YVDGLPEDDPV 290
Query: 764 VQA-EQLANLAMRCCEMSRKSRP----ELGKDVWRVLEPMRASCGG 804
++ + L R + + R E+ + VL + A G
Sbjct: 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTG 336
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 9e-35
Identities = 64/281 (22%), Positives = 103/281 (36%), Gaps = 41/281 (14%)
Query: 477 YKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHN---FDPS 533
+ + R +KE + R+ S S S E + +
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61
Query: 534 LKIGEGGYGSIYKGLLRHMQ-VAIKM-----LHPHSLQGPSEFQQEIDILSKIRHPNL-- 585
+IG GG +++ L Q AIK +L ++ EI L+K++ +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYLNKLQQHSDKI 118
Query: 586 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
+ L + +V E N L L K + R + + +H
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ- 173
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
H IVH DLKPAN L+ + KL DFGI+ + + S + G YM
Sbjct: 174 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV------GAVNYMP 224
Query: 704 PEFL-----------ASGELTPKSDVYSFGIILLRLLTGRP 733
PE + + +++PKSDV+S G IL + G+
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 61/222 (27%), Positives = 109/222 (49%), Gaps = 23/222 (10%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
+IG G +G ++ G +VAIK + ++ +F +E +++ K+ HP LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 594 E---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
E + LV E++ +G L D L + + +T + + ++C + +L ++H
Sbjct: 74 EQAPIC-LVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIH 127
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
DL N L+ N V K+SDFG++RF+ ++ SS T + + PE +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--------WASPEVFSF 179
Query: 710 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
+ KSDV+SFG+++ + + P + EV + TG
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-34
Identities = 72/220 (32%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
K+G+G +G ++ G +VAIK L P ++ P F QE ++ K+RH LV L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 594 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
E ++ +V EY+ GSL D L + L + +A ++ S + ++ + VH
Sbjct: 250 EEPIY-IVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 357
Query: 712 LTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
T KSDV+SFGI+L L T P G+ +EV ++ G
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-34
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 535 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 589
++G GG+G + + H QVAIK E + EI I+ K+ HPN+V+
Sbjct: 21 RLGTGGFGYVLRW--IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 590 GACPEVWT---------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
P+ L EY G L L+ +N L + +++ S L +L
Sbjct: 79 -EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 641 HSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
H + I+H DLKP NI+L + K+ D G ++ L Q E+ T G
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFV------G 185
Query: 698 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
T Y+ PE L + T D +SFG + +TG
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 63/222 (28%), Positives = 116/222 (52%), Gaps = 21/222 (9%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
K+G G YG +Y+G+ + + VA+K L +++ EF +E ++ +I+HPNLV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 593 PE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
+ ++ E++ G+L D L + N +S + +AT++ S + +L + +
Sbjct: 286 TREPPFY-IITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 340
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
H +L N L+ N + K++DFG+SR ++ + ++ K + PE LA
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-------HAGAKFPIKWTAPESLAY 393
Query: 710 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
+ + KSDV++FG++L + T P GI +V L+
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 435
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 23/222 (10%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
++G G +G + G + VA+KM+ S+ EF QE + K+ HP LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 594 E---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
+ ++ +V EY+ NG L + L + + L + + ++C + FL S H +H
Sbjct: 74 KEYPIY-IVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIH 127
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
DL N L+D + K+SDFG++R++ ++ +SS T + + PE
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK--------WSAPEVFHY 179
Query: 710 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
+ + KSDV++FGI++ + + P T EV + G
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 26/210 (12%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 590
+IG G + ++YKGL ++VA + F++E ++L ++HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 591 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
+ LV E + +G+L+ L + + ++ L FLH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 645 PHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
P I+H DLK NI + K+ D G++ + + GT +M
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV----------IGTPEFMA 198
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLTGRP 733
PE DVY+FG+ +L + T
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEY 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-34
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 592
IG+G +G + G R +VA+K + + F E +++++RH NLV L+G
Sbjct: 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
++ +V EY+ GSL D L L ++ + ++C + +L ++ VH
Sbjct: 258 EKGGLY-IVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 312
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEFLA 708
DL N+L+ + V+K+SDFG+++ S T G PE L
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEAS-------------STQDTGKLPVKWTAPEALR 359
Query: 709 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
+ + KSDV+SFGI+L + + P I K+V ++ G
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
++G G +G ++ G H +VA+K L S+ P F E +++ +++H LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 594 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
+ ++ ++ EY+ NGSL D L + L+ + +A ++ + F+ + +H
Sbjct: 79 QEPIY-IITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL+ ANIL+ K++DFG++R + NE ++ R K + PE + G
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGT 186
Query: 712 LTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
T KSDV+SFGI+L ++T P G+T EV L+ G
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 535 KIGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 587
+G G +G++YKGL + VAIK L S + E E +++ + +P++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 588 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
L+G C V L+ + +P G L D + +++ + Q + ++ + +L
Sbjct: 82 LLGICLTSTVQ-LITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLED--- 135
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMD 703
+VH DL N+L+ K++DFG+++ L E G +M
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMA 187
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
E + T +SDV+S+G+ + L+T +P GI E+ L+ G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 53/227 (23%), Positives = 99/227 (43%), Gaps = 25/227 (11%)
Query: 534 LKIGEGGYGSIYKGLLRH----MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 588
+++G G +GS+ +G+ R + VAIK+L E +E I+ ++ +P +V L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 589 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+G C + LV E G L L + + ++ + +L
Sbjct: 76 IGVCQAEALM-LVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE---K 129
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMDP 704
+ VH DL N+LL +K+SDFG+S+ L ++ G + + P
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-------SYYTARSAGKWPLKWYAP 182
Query: 705 EFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
E + + + +SDV+S+G+ + L+ +P + EV ++ G
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 34/231 (14%)
Query: 527 THNFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQEIDILSKIRH 582
+F+ +G+G +G + K R+ AIK + H+ + S E+ +L+ + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA--RNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNH 61
Query: 583 PNLVTLVGA------------CPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRI 627
+V A + + ++ EY NG+L D + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYW 119
Query: 628 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 687
R+ ++ L ++HS I+H DLKP NI +D + K+ DFG+++ + ++
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 688 TLCCRTDPK------GTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTG 731
+ GT Y+ E L +G K D+YS GII ++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-34
Identities = 72/220 (32%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
K+G+G +G ++ G +VAIK L P ++ P F QE ++ K+RH LV L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 594 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
E ++ +V EY+ GSL D L + L + +A ++ S + ++ + VH
Sbjct: 333 EEPIY-IVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 440
Query: 712 LTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
T KSDV+SFGI+L L T P G+ +EV ++ G
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-34
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
K+G G +G ++ H +VA+K + P S+ F E +++ ++H LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 594 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
+ ++ ++ E++ GSL D L D I + ++ + F+ + +H
Sbjct: 254 KEPIY-IITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 308
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLASG 710
DL+ ANIL+ A+ V K++DFG++R + NE + + + PE + G
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--------WTAPEAINFG 360
Query: 711 ELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
T KSDV+SFGI+L+ ++T P G++ EV AL+ G
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 592
IG+G +G + G R +VA+K + + F E +++++RH NLV L+G
Sbjct: 28 TIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
++ +V EY+ GSL D L L ++ + ++C + +L ++ VH
Sbjct: 86 EKGGLY-IVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 140
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEFLA 708
DL N+L+ + V+K+SDFG+++ S T G PE L
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEAS-------------STQDTGKLPVKWTAPEALR 187
Query: 709 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
+ + KSDV+SFGI+L + + P I K+V ++ G
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 41/227 (18%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN 584
+F IG GG+G ++K +H IK + ++ + + ++E+ L+K+ H N
Sbjct: 12 DFKEIELIGSGGFGQVFKA--KHRIDGKTYVIKRV-KYNNE---KAEREVKALAKLDHVN 65
Query: 585 LVTLVGA---------------CPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTR 626
+V G ++ E+ G+LE + K L
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDKVLA 124
Query: 627 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686
+ + ++ + ++HS K +++ DLKP+NI L K+ DFG+ L +
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKR 178
Query: 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
T GT YM PE ++S + + D+Y+ G+IL LL
Sbjct: 179 TRSK------GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 23/222 (10%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
++G G +G + G R VAIKM+ S+ EF +E ++ + H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 594 E---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
+ ++ ++ EY+ NG L + L ++ Q + + ++C + +L S +H
Sbjct: 90 KQRPIF-IITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
DL N L++ V K+SDFG+SR++ +E SS + R + PE L
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR--------WSPPEVLMY 195
Query: 710 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
+ + KSD+++FG+++ + + P T E + G
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 64/224 (28%), Positives = 116/224 (51%), Gaps = 25/224 (11%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
K+G G YG +Y+G+ + + VA+K L +++ EF +E ++ +I+HPNLV L+G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 593 PE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
+ ++ E++ G+L D L + N +S + +AT++ S + +L + +
Sbjct: 79 TREPPFY-IITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 133
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEFL 707
H DL N L+ N + K++DFG+SR ++ + +++ F PE L
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA---------GAKFPIKWTAPESL 184
Query: 708 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
A + + KSDV++FG++L + T P GI +V L+
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 535 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLV 586
K+G+G +G + +G + VA+K L P L P +F +E++ + + H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 587 TLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
L G + +V E P GSL DRL + + T R A ++ + +L S
Sbjct: 85 RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLES-- 139
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
+H DL N+LL + K+ DFG+ R L QN+ + K FA+ P
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHYVMQEHRKVPFAWCAP 193
Query: 705 EFLASGELTPKSDVYSFGIIL 725
E L + + SD + FG+ L
Sbjct: 194 ESLKTRTFSHASDTWMFGVTL 214
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 50/229 (21%), Positives = 90/229 (39%), Gaps = 46/229 (20%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEF-----------------QQEIDIL 577
+ +G + I + A+K L+ +F + E+ I+
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 578 SKIRHPNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSC-----KDNSPPLSWQTR 626
+ I++ +T + T ++YEY+ N S+ K+ + + Q
Sbjct: 98 TDIKNEYCLTCE----GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 627 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686
I + + ++H+ K +I H D+KP+NIL+D N KLSDFG S+ +
Sbjct: 154 KCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFG----ESEYMVDKKI 207
Query: 687 TTLCCRTDPKGTFAYMDPEFLASGELT--PKSDVYSFGIILLRLLTGRP 733
GT+ +M PEF ++ K D++S GI L +
Sbjct: 208 KGSR------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 27/229 (11%)
Query: 535 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 588
IG+G +G +Y G +Q AIK L +Q F +E ++ + HPN++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 589 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
+G ++ Y+ +G L + + + + I ++ + +L
Sbjct: 88 IGIMLPPEGLPH-VLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAE-- 142
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYM 702
VH DL N +LD +F K++DFG++R + E S + +
Sbjct: 143 -QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS------VQQHRHARLPVKWT 195
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
E L + T KSDV+SFG++L LLT P I ++ + L G
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 70/308 (22%), Positives = 125/308 (40%), Gaps = 32/308 (10%)
Query: 506 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLH 560
S+ P+ I ++ + IG G +G +Y G L + A+K L+
Sbjct: 3 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 62
Query: 561 P-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLEDRLSCKD 616
+ S+F E I+ HPN+++L+G C Y+ +G L + + ++
Sbjct: 63 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RN 120
Query: 617 NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676
+ + + I ++ + +L S VH DL N +LD F K++DFG++R
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 177
Query: 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPA 734
+ E S + + K +M E L + + T KSDV+SFG++L L+T P
Sbjct: 178 MYDKEYYSVHNKTGAKLPVK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
Query: 735 LGIT-KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP---ELGKD 790
+ ++ L G L P + L + ++C + RP EL
Sbjct: 234 PDVNTFDITVYLLQG---RRLLQ-----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285
Query: 791 VWRVLEPM 798
+ +
Sbjct: 286 ISAIFSTF 293
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 588
+G+G +G++Y L R Q +A+K+L L+ Q E++I S +RHPN++ L
Sbjct: 17 LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 589 VG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
G L+ EY P G++ L Q TEL + L + HS
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHS---K 128
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
++H D+KP N+LL + K++DFG S + SS T LC GT Y+ PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLC------GTLDYLPPEM 178
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRP 733
+ K D++S G++ L G+P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 535 KIGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 587
+GEG +G + VA+K L Q S ++QEIDIL + H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 588 LVGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
G C LV EY+P GSL D L +S L+ + A ++C + +LH+
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQL--LLFAQQICEGMAYLHAQ 153
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
+H DL N+LLD + + K+ DFG+++ + + R D +
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-----EYYRVREDGDSPVFWYA 205
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLT 730
PE L + SDV+SFG+ L LLT
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 24/226 (10%)
Query: 535 KIGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 587
+G G +G+++KG+ + V IK++ Q + + + H ++V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 588 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
L+G CP + LV +YLP GSL D + + + L Q + ++ + +L
Sbjct: 80 LLGLCPGSSLQ-LVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEE--- 133
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
H +VH +L N+LL + +++DFG++ L ++ ++ K +M E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL------YSEAKTPIKWMALE 187
Query: 706 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
+ G+ T +SDV+S+G+ + L+T P G+ EV L+ G
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 535 KIGEGGYGSIYKGLLRH-----MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 588
+GEG +G +Y+G+ + + VA+K +L +F E I+ + HP++V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 589 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+G E W ++ E P G L L + N L T + + ++C + +L S
Sbjct: 79 IGIIEEEPTW-IIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---I 132
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
+ VH D+ NIL+ + KL DFG+SR++ + + T + +M PE
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT-------RLPIKWMSPES 185
Query: 707 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
+ T SDV+ F + + +L+ +P + K+V L+ G
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 535 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 588
IGEG +G +++G+ + VAIK S +F QE + + HP++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 589 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+G E VW ++ E G L L + L + I A +L + L +L S
Sbjct: 82 IGVITENPVW-IIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES---K 135
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
VH D+ N+L+ +N KL DFG+SR++ + + K +M PE
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLPIKWMAPES 188
Query: 707 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
+ T SDV+ FG+ + +L +P G+ +V ++ G
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 233
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 7e-33
Identities = 46/262 (17%), Positives = 87/262 (33%), Gaps = 35/262 (13%)
Query: 498 LRKSRKEASSSSHMPQFFSDFS----FSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-- 551
L K SS + ++ +E + + +GEG + +Y+
Sbjct: 31 LSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90
Query: 552 -----MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604
+ +K+ P + Q ++ L + A LV E
Sbjct: 91 DAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150
Query: 605 NGSLEDRLSCKDNSP--PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 662
G+L + ++ N+P + I A + ++ +H C+ I+HGD+KP N +L
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGN 207
Query: 663 NFVS-----------KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
F+ L D G S + + T C T + E L++
Sbjct: 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC------ETSGFQCVEMLSNKP 261
Query: 712 LTPKSDVYSFGIILLRLLTGRP 733
+ D + + +L G
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTY 283
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 42/238 (17%)
Query: 535 KIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL 585
+G+G + I+KG+ R +V +K+L F + ++SK+ H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 586 VTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
V G C E LV E++ GSL+ L K N ++ ++ +A +L + + FL
Sbjct: 75 VLNYGVCVCGDENI-LVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 643 CKPHSIVHGDLKPANILLDA--------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 694
++++HG++ NILL KLSD GIS + +I
Sbjct: 132 ---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL----------- 177
Query: 695 PKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTG 748
+ ++ PE L +D +SFG L + +G +P + + +
Sbjct: 178 -QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-33
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 535 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTL 588
IG G G + G LR + VAIK L + + +F E I+ + HPN++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 589 VGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
G +V EY+ NGSL+ L + + + + + + + + +L
Sbjct: 116 EGVVTRGRLAM-IVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSD--- 169
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MD 703
VH DL N+L+D+N V K+SDFG+SR L + ++ TT G
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-------GGKIPIRWTA 222
Query: 704 PEFLASGELTPKSDVYSFGIIL 725
PE +A + SDV+SFG+++
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVM 244
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 535 KIGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 588
+G G +G + G L + + VAIK L ++ + +F E I+ + HPN++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 589 VGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
G + V +V EY+ NGSL+ L + + + + + + S + +L
Sbjct: 112 EGVVTKSKPVM-IVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSD--- 165
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MD 703
VH DL NIL+++N V K+SDFG+ R L + ++ T G
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR-------GGKIPIRWTS 218
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
PE +A + T SDV+S+GI+L +++ RP ++ ++V A+D G
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 535 KIGEGGYGSIYKG----LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 587
+G GG ++ R VA+K+L + PS F++E + + HP +V
Sbjct: 19 ILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 588 L------VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
+ + +V EY+ +L D + P++ + I + + C L F H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTLCCRTDPKGTF 699
+ I+H D+KPANI++ A K+ DFGI+R ++ + ++ + GT
Sbjct: 134 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-------GTA 183
Query: 700 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
Y+ PE + +SDVYS G +L +LTG P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 68/301 (22%), Positives = 119/301 (39%), Gaps = 33/301 (10%)
Query: 499 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-----MQ 553
+ S+ P+ I ++ + IG G +G +Y G L +
Sbjct: 60 GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 554 VAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLE 609
A+K L+ + S+F E I+ HPN+++L+G C Y+ +G L
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 610 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 669
+ + ++ + + + I ++ + FL S VH DL N +LD F K++
Sbjct: 180 NFI--RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA 234
Query: 670 DFGISRFLSQNEISSNNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLR 727
DFG++R + E S +M E L + + T KSDV+SFG++L
Sbjct: 235 DFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288
Query: 728 LLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR 784
L+T P + ++ L G L P + L + ++C + R
Sbjct: 289 LMTRGAPPYPDVNTFDITVYLLQG---RRLLQ-----PEYCPDPLYEVMLKCWHPKAEMR 340
Query: 785 P 785
P
Sbjct: 341 P 341
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 25/203 (12%)
Query: 535 KIGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 587
IG G +G +YKG+L+ + VAIK L + + +F E I+ + H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 588 LVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
L G + + ++ EY+ NG+L+ L ++ S + + + + + +L +
Sbjct: 111 LEGVISKYKPMM-IITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLAN-- 165
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--M 702
+ VH DL NIL+++N V K+SDFG+SR L + ++ T+ G
Sbjct: 166 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-------GGKIPIRWT 217
Query: 703 DPEFLASGELTPKSDVYSFGIIL 725
PE ++ + T SDV+SFGI++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVM 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 20/219 (9%)
Query: 535 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGA 591
+ EGG+ +Y + + + A+K L + + QE+ + K+ HPN+V A
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 592 CPEVWT---------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
L+ L G L + L ++ PLS T ++I + C + +H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK----GT 698
KP I+H DLK N+LL KL DFG + +S S + + + T
Sbjct: 155 QKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 699 FAYMDPE---FLASGELTPKSDVYSFGIILLRLLTGRPA 734
Y PE ++ + K D+++ G IL L +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 536 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 593
+G+G YG +Y G Q +AIK + + +EI + ++H N+V +G+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 594 EVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
E + E +P GSL L K + QT ++ L +LH + IVH
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHR 146
Query: 652 DLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 710
D+K N+L++ + V K+SDFG S+ L+ I+ T GT YM PE + G
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETF------TGTLQYMAPEIIDKG 198
Query: 711 EL--TPKSDVYSFGIILLRLLTGRP 733
+D++S G ++ + TG+P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-32
Identities = 69/262 (26%), Positives = 109/262 (41%), Gaps = 32/262 (12%)
Query: 535 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 588
IGEG +G +++G+ M VAIK S +F QE + + HP++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 589 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+G E VW ++ E G L L + L + I A +L + L +L S
Sbjct: 457 IGVITENPVW-IIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES---K 510
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
VH D+ N+L+ +N KL DFG+SR++ + + K +M PE
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLPIKWMAPES 563
Query: 707 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 763
+ T SDV+ FG+ + +L +P G+ +V ++ G L P
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPM-----PP 615
Query: 764 VQAEQLANLAMRCCEMSRKSRP 785
L +L +C RP
Sbjct: 616 NCPPTLYSLMTKCWAYDPSRRP 637
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 19/224 (8%)
Query: 535 KIGEGGYGSIYKGLLR----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 589
++G G +GS+ +G+ R + VAIK+L E +E I+ ++ +P +V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 590 GAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
G C E LV E G L L + + ++ + +L +
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 457
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
VH +L N+LL +K+SDFG+S+ L ++ + R+ K + PE +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYAPECIN 512
Query: 709 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 749
+ + +SDV+S+G+ + L+ +P + EV ++ GK
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 588
+G+G + +Y + VAIKM+ ++ Q+ E+ I +++HP+++ L
Sbjct: 19 LGKGSFAGVY--RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 589 VGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
+ LV E NG + L K+ P S ++ + +++LHS
Sbjct: 77 Y----NYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
H I+H DL +N+LL N K++DFG++ L + TLC GT Y+
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--HEKHYTLC------GTPNYI 179
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
PE +SDV+S G + LL GRP
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 535 KIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 587
++GEG +G ++ M VA+K L +L +FQ+E ++L+ ++H ++V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 588 LVGACPEV--WTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRIATE 632
G C + +V+EY+ +G L L + L + IA++
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 633 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 692
+ S +++L S VH DL N L+ AN + K+ DFG+SR + + R
Sbjct: 142 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY--------YR 190
Query: 693 TDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 725
+M PE + + T +SDV+SFG+IL
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 588
+G+G +G++Y L R Q +A+K+L L+ Q EI+I S +RHPN++ +
Sbjct: 22 LGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 589 VG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+ L+ E+ P G L L Q EL L + H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCHE---R 133
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
++H D+KP N+L+ K++DFG S + S T+C GT Y+ PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRTMC------GTLDYLPPEM 183
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRP 733
+ K D++ G++ L G P
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-31
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 529 NFDPSLKIGEGGYGSI-YKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLV 586
+F P +G G G+I Y+G+ + VA+K + P +E+ +L + HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81
Query: 587 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
+ + E +L++ + KD + I + + S L LHS
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHS-- 136
Query: 645 PHSIVHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
+IVH DLKP NIL+ + +SDFG+ + L+ S + + GT
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-----GTE 190
Query: 700 AYMDPEFL---ASGELTPKSDVYSFGIILLRLLT-GRP 733
++ PE L T D++S G + +++ G
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 64/277 (23%), Positives = 117/277 (42%), Gaps = 45/277 (16%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 587
++GEG +G ++ + M VA+K L S +FQ+E ++L+ ++H ++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 588 LVGACPEV--WTLVYEYLPNGSLEDRL------------SCKDNSPPLSWQTRIRIATEL 633
G C E +V+EY+ +G L L PL + +A+++
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 634 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 693
+ +++L VH DL N L+ V K+ DFG+SR +I S + R
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYY---RV 216
Query: 694 DPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
+ +M PE + + T +SDV+SFG++L + T +P ++ E + G
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276
Query: 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
L+ P ++ + C + + R
Sbjct: 277 ---RELER-----PRACPPEVYAIMRGCWQREPQQRH 305
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 51/236 (21%), Positives = 96/236 (40%), Gaps = 33/236 (13%)
Query: 535 KIGEGGYGSIYKGLLRH-----MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVT 587
+GEG +GS+ +G L+ ++VA+K + S + EF E + HPN++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 588 LVGAC----PEVWTLVY---EYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 637
L+G C + ++ G L L + + QT ++ ++ +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+L + + +H DL N +L + ++DFG+S+ + +
Sbjct: 161 EYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR--------IA 209
Query: 698 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
++ E LA T KSDV++FG+ + + T P G+ E+ L G
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 52/252 (20%), Positives = 95/252 (37%), Gaps = 24/252 (9%)
Query: 488 RDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKG 547
+ K ++ D+ + E H ++G G +G +++
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRM 77
Query: 548 LLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEY 602
+ Q A+K + + +E+ + + P +V L GA P V + E
Sbjct: 78 KDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVN-IFMEL 131
Query: 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 662
L GSL + L + + L +LH+ + I+HGD+K N+LL +
Sbjct: 132 LEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSS 185
Query: 663 NFVS-KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 721
+ L DFG + L + + +L GT +M PE + K D++S
Sbjct: 186 DGSRAALCDFGHALCLQPDGLG---KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242
Query: 722 GIILLRLLTGRP 733
++L +L G
Sbjct: 243 CCMMLHMLNGCH 254
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 25/226 (11%)
Query: 535 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTL 588
++G G +G++ KG + VA+K+L + E E +++ ++ +P +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 589 VGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+G C E W LV E G L L + + + I + ++ + +L +
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---SN 137
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMDPE 705
VH DL N+LL +K+SDFG+S+ L +E + G + + PE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-------NYYKAQTHGKWPVKWYAPE 190
Query: 706 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
+ + + KSDV+SFG+++ + +P G+ EV L+ G
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 59/264 (22%), Positives = 89/264 (33%), Gaps = 43/264 (16%)
Query: 482 DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGY 541
+ + + V E ++ + P+ F SF + ++G G Y
Sbjct: 21 QSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLS----------RLGHGSY 70
Query: 542 GSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQ---QEIDILSKI-RHPNLVTLVGACPEV 595
G ++K + A+K +GP + E+ K+ +HP V L A
Sbjct: 71 GEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA---- 125
Query: 596 WT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
W L E SL+ C+ L + L LHS +V
Sbjct: 126 WEEGGILYLQTELC-GPSLQQH--CEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLV 179
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
H D+KPANI L KL DFG+ L G YM PE L
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GAGEVQE------GDPRYMAPELLQG 230
Query: 710 GELTPKSDVYSFGIILLRLLTGRP 733
+DV+S G+ +L +
Sbjct: 231 S-YGTAADVFSLGLTILEVACNME 253
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 70/310 (22%), Positives = 133/310 (42%), Gaps = 42/310 (13%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 586
++G+G +G +Y+G+ + +VAIK ++ S++ EF E ++ + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 587 TLVGACPEV--WTLVYEYLPNGSLED-------RLSCKDNSPPLSWQTRIRIATELCSVL 637
L+G + ++ E + G L+ ++ P S I++A E+ +
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+L++ + VH DL N ++ +F K+ DFG++R + + + R KG
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--------YRKGGKG 200
Query: 698 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKN 752
+M PE L G T SDV+SFG++L + T +P G++ ++V + G
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG---G 257
Query: 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGS 812
LLD P + L L C + + K RP ++ ++ S+
Sbjct: 258 LLDK-----PDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIKEEMEPGFREVSFYYSE 311
Query: 813 EERCEPPPYF 822
E + P
Sbjct: 312 ENKLPEPEEL 321
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 34/237 (14%)
Query: 535 KIGEGGYGSIYKGLLRH-----MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVT 587
+G+G +GS+ + L+ ++VA+KML + EF +E + + HP++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 588 LVGAC----PEVWT----LVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSV 636
LVG + ++ ++ +G L L +N L QT +R ++
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
+ +L S + +H DL N +L + ++DFG+SR + + R
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY--------YRQGCA 198
Query: 697 GTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
++ E LA T SDV++FG+ + ++T P GI E+ L G
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 43/345 (12%), Positives = 87/345 (25%), Gaps = 60/345 (17%)
Query: 484 LQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGS 543
+ +EA + + EA +++ PQ S + + G
Sbjct: 18 EEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSV 77
Query: 544 IYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVGACPEVWT- 597
++ A+K+ + SE + +++ + +
Sbjct: 78 VFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137
Query: 598 ---------------------------LVYEYLPNGSLEDRLSCKDNSP----PLSWQTR 626
L+ + LE S D
Sbjct: 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFRGDEGILAL 196
Query: 627 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686
+ +L + L S +VHG P N+ + + L D ++ +
Sbjct: 197 HILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRG 248
Query: 687 TTLCCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRPALGITKEVQYA 744
Y EFL + T + + G+ + R+ G+
Sbjct: 249 PASS------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-- 300
Query: 745 LDTGKLKNLLDPLAGDWPFVQA----EQLANLAMRCCEMSRKSRP 785
+ K +L P F + + L R R+ R
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 60/273 (21%), Positives = 108/273 (39%), Gaps = 41/273 (15%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 586
+G G +G +Y+G + +QVA+K L S Q +F E I+SK H N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 587 TLVGACPEV--WTLVYEYLPNGSLED----RLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
+G + ++ E + G L+ L+ + +A ++ +L
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 641 HSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+ +H D+ N LL V+K+ DFG++R + + R
Sbjct: 157 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------YYRKGGCA 205
Query: 698 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKN 752
+M PE G T K+D +SFG++L + + P + +EV + +G
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG---G 262
Query: 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
+DP P + + +C + + RP
Sbjct: 263 RMDP-----PKNCPGPVYRIMTQCWQHQPEDRP 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 27/208 (12%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 588
+G+GG+ + + A K++ L P + EI I + H ++V
Sbjct: 23 LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 589 VGACPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
G E V+ E SL + + L+ ++ +LH
Sbjct: 81 HG-FFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR--- 133
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+ ++H DLK N+ L+ + K+ DFG++ + + LC GT Y+ PE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLC------GTPNYIAPE 185
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
L+ + + DV+S G I+ LL G+P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 52/246 (21%), Positives = 95/246 (38%), Gaps = 35/246 (14%)
Query: 499 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----V 554
+ A + +P+ D + + +G+GG+ + +
Sbjct: 18 PGAPAAAPPAKEIPEVLVD------PRSRRRYVRGRFLGKGGFAKCF--EISDADTKEVF 69
Query: 555 AIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSL 608
A K++ L P + EI I + H ++V G E V+ E SL
Sbjct: 70 AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSL 128
Query: 609 EDRLSCKDNSPPLS-WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 667
+ + L+ + R ++ +LH + ++H DLK N+ L+ + K
Sbjct: 129 LELHKRRK---ALTEPEAR-YYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVK 181
Query: 668 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 727
+ DFG++ + + LC GT Y+ PE L+ + + DV+S G I+
Sbjct: 182 IGDFGLATKVEYD--GERKKVLC------GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233
Query: 728 LLTGRP 733
LL G+P
Sbjct: 234 LLVGKP 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 39/219 (17%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 585
+G G +G + + M VA+KML P L E+ +LS + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 586 VTLVGAC--PEVWTLVYEYLPNGSLEDRL---------------SCKDNSPPLSWQTRIR 628
V L+GAC ++ EY G L + L +D+ L + +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 629 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688
+ ++ + FL S +H DL NILL ++K+ DFG++R + +
Sbjct: 150 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG- 205
Query: 689 LCCRTDPKGTFAY--MDPEFLASGELTPKSDVYSFGIIL 725
M PE + + T +SDV+S+GI L
Sbjct: 206 -------NARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 41/273 (15%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 586
+G G +G +Y+G + +QVA+K L S Q +F E I+SK H N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 587 TLVGACPEV--WTLVYEYLPNGSLEDRL----SCKDNSPPLSWQTRIRIATELCSVLIFL 640
+G + ++ E + G L+ L L+ + +A ++ +L
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 641 HSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+ +H D+ N LL V+K+ DFG++R + + R
Sbjct: 198 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------YYRKGGCA 246
Query: 698 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKN 752
+M PE G T K+D +SFG++L + + P + +EV + +G
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG---G 303
Query: 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
+DP P + + +C + + RP
Sbjct: 304 RMDP-----PKNCPGPVYRIMTQCWQHQPEDRP 331
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 71/321 (22%), Positives = 125/321 (38%), Gaps = 43/321 (13%)
Query: 490 KAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL 549
K ++E E + RK + Q + + E + ++G G G ++K
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKIS-------ELGAGNGGVVFKVSH 54
Query: 550 RHMQ--VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGAC---PEVWTLVYE 601
+ +A K++H P+ Q E+ +L + P +V GA E+ + E
Sbjct: 55 KPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-ICME 111
Query: 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 661
++ GSL+ L + + Q +++ + L +L H I+H D+KP+NIL++
Sbjct: 112 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 166
Query: 662 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 721
+ KL DFG+S L S N+ + GT +YM PE L + +SD++S
Sbjct: 167 SRGEIKLCDFGVSGQLID---SMANSFV-------GTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 722 GIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMS- 780
G+ L+ + GR + + L G P L M
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276
Query: 781 ---------RKSRPELGKDVW 792
+ P+L V+
Sbjct: 277 IFELLDYIVNEPPPKLPSGVF 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 3e-29
Identities = 32/295 (10%), Positives = 78/295 (26%), Gaps = 53/295 (17%)
Query: 482 DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSF-SEIEGATHNFDPSLKIGEGG 540
+ V+ E +S ++ S+ + F SE+ +G+
Sbjct: 31 ELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQED 90
Query: 541 YGSIYKG--LLRHMQVAIKML----------------------------HPHSLQGPSEF 570
+ + + + + + F
Sbjct: 91 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150
Query: 571 QQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLEDRL----SCKDNSPPLSW 623
D++ + ++ + ++W L +L+ S L
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210
Query: 624 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683
R+++ ++ +L LH + +VH L+P +I+LD L+ F
Sbjct: 211 HARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-------R 260
Query: 684 SNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRP 733
+ + L +T D ++ G+ + +
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 535 KIGEGGYGSIYKGLLRH---------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHP 583
+GEG +G + + VA+KML + + S+ E++++ I +H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 584 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIR 628
N++ L+GAC ++ EY G+L + L + ++++ +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 629 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688
+L + +L S K +H DL N+L+ N V K++DFG++R ++ + T
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT- 217
Query: 689 LCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 725
G +M PE L T +SDV+SFG+++
Sbjct: 218 -------NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 40/218 (18%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 586
++GE +G +YKG L VAIK L EF+ E + ++++HPN+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 587 TLVGAC----PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRI 629
L+G P ++++ Y +G L + L + L + +
Sbjct: 76 CLLGVVTKDQP--LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
++ + + +L S H +VH DL N+L+ K+SD G+ R + +
Sbjct: 134 VAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY------- 183
Query: 690 CCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 725
+ +M PE + G+ + SD++S+G++L
Sbjct: 184 -YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
KIG+G G++Y + +VAI+ ++ EI ++ + ++PN+V + +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 593 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
E+W +V EYL GSL D ++ + + E L FLHS + ++
Sbjct: 87 LVGDELW-VVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 138
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
H D+K NILL + KL+DFG ++ E S +T + GT +M PE +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMV-------GTPYWMAPEVVTR 190
Query: 710 GELTPKSDVYSFGIILLRLLTGRP 733
PK D++S GI+ + ++ G P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 68/238 (28%), Positives = 108/238 (45%), Gaps = 36/238 (15%)
Query: 535 KIGEGGYGSIYKGLLR----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNLVTL 588
IGEG +G + K ++ M AIK + S +F E+++L K+ HPN++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 589 VGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRIATEL 633
+GAC L EY P+G+L D L + LS Q + A ++
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 634 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 693
+ +L +H DL NIL+ N+V+K++DFG+SR + + L R
Sbjct: 152 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMGRLPVR- 206
Query: 694 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 748
+M E L T SDV+S+G++L +++ G P G+T E+ L G
Sbjct: 207 -------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 59/245 (24%), Positives = 96/245 (39%), Gaps = 42/245 (17%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 585
+G G +G + + VA+KML + E+ IL I H N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 586 VTLVGACPEV---WTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRI 629
V L+GAC + ++ E+ G+L L L+ + I
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
+ ++ + FL S K +H DL NILL V K+ DFG++R + ++
Sbjct: 154 SFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-- 208
Query: 690 CCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT-GR---PALGITKEVQY 743
+M PE + T +SDV+SFG++L + + G P + I +E
Sbjct: 209 ------DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 744 ALDTG 748
L G
Sbjct: 263 RLKEG 267
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
KIGEG G + +H QVA+KM+ Q E+ I+ +H N+V + +
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 593 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
E+W ++ E+L G+L D +S L+ + + + L +LH+ ++
Sbjct: 112 LVGEELW-VLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHA---QGVI 163
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
H D+K +ILL + KLSDFG +S ++ + + GT +M PE ++
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLV-------GTPYWMAPEVISR 215
Query: 710 GELTPKSDVYSFGIILLRLLTGRP 733
+ D++S GI+++ ++ G P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEP 239
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-29
Identities = 58/262 (22%), Positives = 98/262 (37%), Gaps = 41/262 (15%)
Query: 535 KIGEGGYGSI-YKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 592
+G G G++ ++G + VA+K + EI +L++ HPN++ +
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCSE 78
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL----CSVLIFLHSCKPH 646
+ E N +L+D + K+ S + L S + LHS
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 647 SIVHGDLKPANILLD-------------ANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 693
I+H DLKP NIL+ N +SDFG+ + L + S
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL----N 190
Query: 694 DPKGTFAYMDPEFLASGE-------LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 745
+P GT + PE L LT D++S G + +L+ G+ G + +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 746 DTGKLKNLLDPLAGDWPFVQAE 767
G +L + + AE
Sbjct: 251 IRGIF-SLDEMKCLHDRSLIAE 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 33/288 (11%), Positives = 79/288 (27%), Gaps = 63/288 (21%)
Query: 494 EAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-- 551
+E ++ + S+S SE+ +G+ + + +
Sbjct: 39 TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 98
Query: 552 MQVAIKML----------------------------HPHSLQGPSEFQQEIDILSKIRHP 583
+ + + + F D++ +
Sbjct: 99 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158
Query: 584 NLVTLVGACPEVWTLVY---EYLPNGSLEDRL----SCKDNSPPLSWQTRIRIATELCSV 636
++ + ++W L +L+ S L R+++ ++ +
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
L LH + +VH L+P +I+LD L+ F R
Sbjct: 219 LASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------------RVVSS 263
Query: 697 GTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRP 733
+ + PE A +T D ++ G+++ +
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 535 KIGEGGYGSIYKGLLR---------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHP 583
+GEG +G + +VA+KML + + S+ E++++ I +H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 584 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIR 628
N++ L+GAC ++ EY G+L + L + LS + +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 629 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688
A ++ + +L S K +H DL N+L+ + V K++DFG++R + +
Sbjct: 196 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY------ 246
Query: 689 LCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 725
+ G +M PE L T +SDV+SFG++L
Sbjct: 247 --YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 57/230 (24%), Positives = 109/230 (47%), Gaps = 32/230 (13%)
Query: 521 SEIEGATHNFDPSL------KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ 572
E E + DP+ ++G+G +G +YK + A K++ S + ++
Sbjct: 6 REYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV 65
Query: 573 EIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR- 628
EI+IL+ HP +V L+GA ++W ++ E+ P G+++ + + L+ + +I+
Sbjct: 66 EIEILATCDHPYIVKLLGAYYHDGKLW-IMIEFCPGGAVDAIM--LELDRGLT-EPQIQV 121
Query: 629 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688
+ ++ L FLHS I+H DLK N+L+ +L+DFG+S + ++
Sbjct: 122 VCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQKRDSF 177
Query: 689 LCCRTDPKGTFAYMDPEFLASGELT-----PKSDVYSFGIILLRLLTGRP 733
+ GT +M PE + + K+D++S GI L+ + P
Sbjct: 178 I-------GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 35/215 (16%)
Query: 535 KIGEGGYGSIYKGLLR-------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 585
+G G +G + + ++VA+KML E+ I+S + +H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 586 VTLVGAC--PEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATE 632
V L+GAC ++ EY G L E + + S + + +++
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 633 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTLC 690
+ + FL S + +H D+ N+LL V+K+ DFG++R + + I N L
Sbjct: 173 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 691 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 725
+ +M PE + T +SDV+S+GI+L
Sbjct: 230 VK--------WMAPESIFDCVYTVQSDVWSYGILL 256
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 591
K+G G +G ++ R ++ IK ++ Q P E + EI++L + HPN++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 592 C--PEVWTLVYEYLPNGSLEDRLSCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHSI 648
+V E G L +R+ LS + ++ + L + HS +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145
Query: 649 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
VH DLKP NIL + K+ DFG++ +E S T GT YM PE
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAA------GTALYMAPE 196
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
++T K D++S G+++ LLTG
Sbjct: 197 VF-KRDVTFKCDIWSAGVVMYFLLTGCL 223
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLV 589
+G+G +G + + + A+K++ ++ ++ +E+ +L ++ HPN++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 590 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+ LV E G L D + + S RI ++ S + ++H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHK---NK 146
Query: 648 IVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
IVH DLKP N+LL + ++ DFG+S ++ D GT Y+ P
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---------MKDKIGTAYYIAP 197
Query: 705 EFLASGELTPKSDVYSFGIILLRLLTGRP 733
E L G K DV+S G+IL LL+G P
Sbjct: 198 EVL-HGTYDEKCDVWSTGVILYILLSGCP 225
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 56/262 (21%), Positives = 104/262 (39%), Gaps = 32/262 (12%)
Query: 478 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 537
K + + K E++ K + + E ++G
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILE------------ELG 60
Query: 538 EGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--P 593
G +G +++ + + K ++ + EI I++++ HP L+ L A
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 653
L+ E+L G L DR++ +D +S I + C L +H HSIVH D+
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHE---HSIVHLDI 175
Query: 654 KPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
KP NI+ + S K+ DFG++ L+ +EI T + PE +
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTT------ATAEFAAPEIVDREP 226
Query: 712 LTPKSDVYSFGIILLRLLTGRP 733
+ +D+++ G++ LL+G
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLS 248
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 591
+G G + ++ R A+K + S + EI +L KI+H N+VTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 592 -CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
+ LV + + G L DR+ + + + + ++ S + +LH + IVH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLHE---NGIVH 129
Query: 651 GDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
DLKP N+L + N ++DFG+S+ + +T C GT Y+ PE L
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STAC------GTPGYVAPEVL 179
Query: 708 ASGELTPKSDVYSFGIILLRLLTGRP 733
A + D +S G+I LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYP 205
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 44/224 (19%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 586
+GEG +G + K H VA+KML S + E ++L ++ HP+++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 587 TLVGAC--PEVWTLVYEYLPNGSLEDRL---------------------SCKDNSPPLSW 623
L GAC L+ EY GSL L + L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 624 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683
I A ++ + +L K +VH DL NIL+ K+SDFG+SR + + +
Sbjct: 150 GDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 684 SNNTTLCCRTDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 725
+ +G +M E L T +SDV+SFG++L
Sbjct: 207 VKRS--------QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
K+GEG YGS+YK + + VAIK + E +EI I+ + P++V G+
Sbjct: 36 KLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 593 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSCKPH 646
++W +V EY GS+ D + + + L T IAT L +LH
Sbjct: 94 FKNTDLW-IVMEYCGAGSVSDII--RLRNKTL---TEDEIATILQSTLKGLEYLHF---M 144
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
+H D+K NILL+ +KL+DFG++ L+ + ++ NT + GT +M PE
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT-DTMAKRNTVI-------GTPFWMAPEV 196
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRP 733
+ +D++S GI + + G+P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGA 591
IG G + + +VAIK ++ Q E +EI +S+ HPN+V+ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 592 ---CPEVWTLVYEYLPNGSLED--RLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSC 643
E+W LV + L GS+ D + IAT E+ L +LH
Sbjct: 82 FVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
+ +H D+K NILL + +++DFG+S FL+ + T R GT +M
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT---GGDITRNKVRKTFVGTPCWMA 194
Query: 704 PEFLASGEL-TPKSDVYSFGIILLRLLTGRP 733
PE + K+D++SFGI + L TG
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 59/271 (21%), Positives = 113/271 (41%), Gaps = 26/271 (9%)
Query: 475 QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF---- 530
Q+ + +E + A KS++ ++ + +P + F +
Sbjct: 30 QDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFY 89
Query: 531 --DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 586
+ +G G +G ++K +++A K++ ++ E + EI +++++ H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 587 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
L A LV EY+ G L DR+ + + L+ I ++C + +H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ-- 205
Query: 645 PHSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
I+H DLKP NIL K+ DFG++R E GT ++
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNF------GTPEFL 255
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
PE + ++ +D++S G+I LL+G
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 590
K+G G YG + + H++ AIK++ S+ S +E+ +L + HPN++ L
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 591 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
+ LV E G L D + + + I ++ S + +LH H+I
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHK---HNI 157
Query: 649 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
VH DLKP N+LL + + + K+ DFG+S + + GT Y+ PE
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---------MKERLGTAYYIAPE 208
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
L + K DV+S G+IL LL G P
Sbjct: 209 VL-RKKYDEKCDVWSIGVILFILLAGYP 235
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGA 591
KIG+G +G ++KG+ Q VAIK++ + + QQEI +LS+ P + G+
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 592 ---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSCKP 645
++W ++ EYL GS D L PL +IAT E+ L +LHS
Sbjct: 89 YLKDTKLW-IIMEYLGGGSALDLLEPG----PL---DETQIATILREILKGLDYLHS--- 137
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+H D+K AN+LL + KL+DFG++ L+ NT + GT +M PE
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNTFV-------GTPFWMAPE 189
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
+ K+D++S GI + L G P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEP 217
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 44/224 (19%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 585
+G G +G + +QVA+KML E+ +++++ H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 586 VTLVGAC--PEVWTLVYEYLPNGSL--------------------EDRLSCKDNSPPLSW 623
V L+GAC L++EY G L + RL +++ L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 624 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683
+ + A ++ + FL VH DL N+L+ V K+ DFG++R + +
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 684 SNNTTLCCRTDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 725
+M PE L G T KSDV+S+GI+L
Sbjct: 229 VVRG--------NARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 46/243 (18%), Positives = 80/243 (32%), Gaps = 23/243 (9%)
Query: 505 ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEG--GYGSIYKGLLRHMQ--VAIKM-- 558
A H + S ++ IG+G ++ + V ++
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
Query: 559 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA---CPEVWTLVYEYLPNGSLEDRLSCK 615
L S + + Q E+ + HPN+V E+W +V ++ GS +D +
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW-VVTSFMAYGSAKDLICTH 120
Query: 616 DNSPPLSWQTRIRIATELCSVLI---FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 672
+ IA L VL ++H VH +K ++IL+ + LS
Sbjct: 121 FMDG----MNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLR 173
Query: 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLT 730
+ + + ++ PE L KSD+YS GI L
Sbjct: 174 SNLSMI-SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232
Query: 731 GRP 733
G
Sbjct: 233 GHV 235
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-28
Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 535 KIGEGGYGSIYKGLLRH---------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHP 583
+GEG +G + + VA+KML + + S+ E++++ I +H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 584 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIR 628
N++ L+GAC ++ EY G+L + L + ++++ +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 629 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688
+L + +L S K +H DL N+L+ N V K++DFG++R ++ +
Sbjct: 208 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY------ 258
Query: 689 LCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 725
+ G +M PE L T +SDV+SFG+++
Sbjct: 259 --YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-28
Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 38/241 (15%)
Query: 515 FSDFSFSEIEGATHNF----DPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS 568
F D + + S +G G G + R +VAI+++ S
Sbjct: 118 FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS 177
Query: 569 E--------FQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNS 618
+ EI+IL K+ HP ++ + + + +V E + G L D++
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR- 235
Query: 619 PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISR 675
L T ++ + +LH + I+H DLKP N+LL + + + K++DFG S+
Sbjct: 236 --LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290
Query: 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL---TPKSDVYSFGIILLRLLTGR 732
L + + TLC GT Y+ PE L S D +S G+IL L+G
Sbjct: 291 ILGETSLM---RTLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341
Query: 733 P 733
P
Sbjct: 342 P 342
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 53/262 (20%), Positives = 106/262 (40%), Gaps = 20/262 (7%)
Query: 478 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 537
+K + ++ + + S + Q++ + + ++D ++G
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166
Query: 538 EGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--P 593
G +G +++ R A K + ++EI +S +RHP LV L A
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226
Query: 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 653
++YE++ G L ++++ + N +S + ++C L +H ++ VH DL
Sbjct: 227 NEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE---NNYVHLDL 281
Query: 654 KPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
KP NI+ + KL DFG++ L + GT + PE
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTT------GTAEFAAPEVAEGKP 332
Query: 712 LTPKSDVYSFGIILLRLLTGRP 733
+ +D++S G++ LL+G
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLS 354
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 536 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTL- 588
IG+G + + RH+ +VAIK++ L S +E+ I+ + HPN+V L
Sbjct: 23 IGKGNFAKVKLA--RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 589 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
V + L+ EY G + D L + + ++ S + + H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ---KR 134
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
IVH DLK N+LLDA+ K++DFG S + C G Y PE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD---AFC------GAPPYAAPELF 185
Query: 708 ASGEL--TPKSDVYSFGIILLRLLTGR 732
G+ P+ DV+S G+IL L++G
Sbjct: 186 -QGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
IG G +G + + + ++ A K + + ++ F+QEI+I+ + HPN++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
LV E G L +R+ K RI ++ S + + H ++ H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHK---LNVAH 129
Query: 651 GDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
DLKP N L + KL DFG++ ++ T GT Y+ P+ L
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKV------GTPYYVSPQVL 180
Query: 708 ASGELTPKSDVYSFGIILLRLLTGRP 733
G P+ D +S G+++ LL G P
Sbjct: 181 -EGLYGPECDEWSAGVMMYVLLCGYP 205
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTLVG 590
+G+G +G + K R + A+K+++ S + S +E+++L K+ HPN++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 591 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
+ +V E G L D + + S RI ++ S + ++H H+I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHK---HNI 142
Query: 649 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
VH DLKP NILL + + K+ DFG+S QN GT Y+ PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI------GTAYYIAPE 193
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
L G K DV+S G+IL LL+G P
Sbjct: 194 VL-RGTYDEKCDVWSAGVILYILLSGTP 220
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 61/240 (25%), Positives = 96/240 (40%), Gaps = 66/240 (27%)
Query: 536 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEF--------------------- 570
IG+G YG + + A+K+L L + F
Sbjct: 21 IGKGSYGVVKLA--YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 571 -----QQEIDILSKIRHPNLVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCKDN 617
QEI IL K+ HPN+V LV EV +V+E + G + + + K
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLK-- 132
Query: 618 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677
PLS +L + +LH I+H D+KP+N+L+ + K++DFG+S
Sbjct: 133 --PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS--- 184
Query: 678 SQNEISSNNTTL--CCRTDPKGTFAYMDPEFLASGELT---PKSDVYSFGIILLRLLTGR 732
NE ++ L GT A+M PE L+ DV++ G+ L + G+
Sbjct: 185 --NEFKGSDALLSNTV-----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-27
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 36/219 (16%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS-------------EFQQEIDILSK 579
K+G G YG + + H + AIK++ E EI +L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 580 IRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 637
+ HPN++ L + + LV E+ G L +++ + I ++ S +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGI 159
Query: 638 IFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 694
+LH H+IVH D+KP NILL ++ K+ DFG+S F S++
Sbjct: 160 CYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRL---- 209
Query: 695 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT Y+ PE L + K DV+S G+I+ LL G P
Sbjct: 210 --GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 41/218 (18%)
Query: 536 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVT 587
+GEG YG + + + A+K+L L+ + EI +L ++RH N++
Sbjct: 13 LGEGSYGKVKEV--LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 588 LVGACPEVWT--------LVYEYLPNGSLE--DRLSCKDNSPPLS-WQTRIRIATELCSV 636
LV +V +V EY G E D + K Q +L
Sbjct: 71 LV----DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----RFPVCQAH-GYFCQLIDG 121
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
L +LHS IVH D+KP N+LL K+S G++ L T
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ------ 172
Query: 697 GTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGR 732
G+ A+ PE + K D++S G+ L + TG
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 44/224 (19%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 586
IGEG +G +++ VA+KML S ++FQ+E ++++ +PN+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 587 TLVGACPEV--WTLVYEYLPNGSLEDRL---------------------SCKDNSPPLSW 623
L+G C L++EY+ G L + L PPLS
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 624 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683
++ IA ++ + + +L VH DL N L+ N V K++DFG+SR + +
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY- 229
Query: 684 SNNTTLCCRTDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 725
+ D +M PE + T +SDV+++G++L
Sbjct: 230 -------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 34/217 (15%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--------FQQEIDILSKIRHPN 584
+G G G + R +VAIK++ S + EI+IL K+ HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 585 LVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
++ + + + +V E + G L D++ L T ++ + +LH
Sbjct: 77 IIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHE 132
Query: 643 CKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
+ I+H DLKP N+LL + + + K++DFG S+ L + + TLC GT
Sbjct: 133 ---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLC------GTP 180
Query: 700 AYMDPEFLASGEL---TPKSDVYSFGIILLRLLTGRP 733
Y+ PE L S D +S G+IL L+G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 507 SSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPH 562
+S + + S + F+ +G G YG +YKG RH++ AIK++
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG--RHVKTGQLAAIKVMDVT 60
Query: 563 SLQGPSEFQQEIDILSKI-RHPNLVTLVGA---------CPEVWTLVYEYLPNGSLEDRL 612
E +QEI++L K H N+ T GA ++W LV E+ GS+ D +
Sbjct: 61 G-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLI 118
Query: 613 SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 672
+ I E+ L LH H ++H D+K N+LL N KL DFG
Sbjct: 119 KNTKGNTLKEEWIAY-ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-----PKSDVYSFGIILLR 727
+S L + NT + GT +M PE +A E KSD++S GI +
Sbjct: 175 VSAQLD-RTVGRRNTFI-------GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
Query: 728 LLTGRP 733
+ G P
Sbjct: 227 MAEGAP 232
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 536 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 588
+G G +G + G H +VA+K+L+ ++ + EI L RHP+++ L
Sbjct: 19 LGVGTFGKVKIG--EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 589 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
V + P + +V EY+ G L D + + R+ ++ S + + H H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHR---H 130
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
+VH DLKP N+LLDA+ +K++DFG+S +S E T C G+ Y PE
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSC------GSPNYAAPEV 181
Query: 707 LASGEL--TPKSDVYSFGIILLRLLTGR 732
+ SG L P+ D++S G+IL LL G
Sbjct: 182 I-SGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 590
+G+G +G + K R + A+K+++ S + +E+++L K+ HPN++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 591 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
+ +V E G L D + + S RI ++ S + ++H H+I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHK---HNI 142
Query: 649 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
VH DLKP NILL + + K+ DFG+S QN GT Y+ PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI------GTAYYIAPE 193
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
L G K DV+S G+IL LL+G P
Sbjct: 194 VL-RGTYDEKCDVWSAGVILYILLSGTP 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 586
++G G + + K + ++ A K + + E ++E+ IL ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 587 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
TL L+ E + G L D L+ K++ LS + ++ + +LH+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHT-- 133
Query: 645 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
I H DLKP NI+L KL DFG++ + + GT
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF------GTPE 183
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
++ PE + L ++D++S G+I LL+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 586
++G G + + K + + A K + L E ++E++IL +IRHPN++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 587 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
TL L+ E + G L D L+ K++ L+ + ++ + +LHS
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHS-- 126
Query: 645 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
I H DLKP NI+L N KL DFGI+ + + GT
Sbjct: 127 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF------GTPE 176
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
++ PE + L ++D++S G+I LL+G
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 536 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVG 590
+GEG YG + L + VA+K++ E ++EI I + H N+V
Sbjct: 15 LGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY- 71
Query: 591 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
L EY G L DR+ + R +L + +++LH
Sbjct: 72 ---GHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
I H D+KP N+LLD K+SDFG++ N +C GT Y+ P
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVAP 176
Query: 705 EFLASGEL--TPKSDVYSFGIILLRLLTGR 732
E L DV+S GI+L +L G
Sbjct: 177 ELL-KRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 57/214 (26%), Positives = 85/214 (39%), Gaps = 30/214 (14%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHP-HSLQGPSEFQQEIDI-LSKIRHPNLVTL 588
+IG G YGS+ K H +A+K + + + ++D+ + P +V
Sbjct: 29 EIGRGAYGSVNKM--VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 589 VGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSC 643
GA + W + E + + S + + I +I L L
Sbjct: 87 YGALFREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE- 143
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
I+H D+KP+NILLD + KL DFGIS L + I+ G YM
Sbjct: 144 -NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDA--------GCRPYMA 193
Query: 704 PEFLASGELTP----KSDVYSFGIILLRLLTGRP 733
PE + +SDV+S GI L L TGR
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 9/175 (5%)
Query: 563 SLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP 620
S +I + N V + L + +L+D ++ + +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 621 LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680
+ I ++ + FLHS ++H DLKP+NI + V K+ DFG+ + Q+
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 681 E----ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 731
E + + T GT YM PE + + K D++S G+IL LL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 590
++G+G + + + + + ++ A K+++ L ++E I K++HPN+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 591 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
+ LV++ + G L + + ++ S ++ + + HS + I
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHS---NGI 126
Query: 649 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
VH +LKP N+LL KL+DFG++ ++ +E GT Y+ PE
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFA------GTPGYLSPE 177
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
L + D+++ G+IL LL G P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYP 205
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHP-HSLQGPSEFQQEIDI-LSKIRHPNLVTL 588
++G G YG + K RH+ +A+K + + Q ++DI + + P VT
Sbjct: 14 ELGRGAYGVVEKM--RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 589 VGAC---PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
GA +VW + E + + SL+ D + +IA + L LHS
Sbjct: 72 YGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-- 127
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
S++H D+KP+N+L++A K+ DFGIS +L + D G YM P
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--------DDVAKDID-AGCKPYMAP 178
Query: 705 EFLASGELTP----KSDVYSFGIILLRLLTGRP 733
E + KSD++S GI ++ L R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 586
++G G + + K + +Q A K + + + ++E+ IL +I+HPN++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 587 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
TL L+ E + G L D L+ K++ L+ + ++ + + +LHS
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHS-- 132
Query: 645 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
I H DLKP NI+L K+ DFG++ + + GT
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF------GTPE 182
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
++ PE + L ++D++S G+I LL+G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 61/283 (21%), Positives = 101/283 (35%), Gaps = 64/283 (22%)
Query: 503 KEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLH 560
SS +F S E+ + IG+G YG + + AIK+++
Sbjct: 4 HHHHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 561 PHSLQGPSE-----FQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLS 613
+ ++ + + E+ ++ K+ HPN+ L + LV E G L D+L+
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 614 CKDNSPPLSWQTRI-------------------------------------RIATELCSV 636
+ + I ++ S
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 637 LIFLHSCKPHSIVHGDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNN--TTLCCR 692
L +LH+ I H D+KP N L + +F KL DFG+S+ + TT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-- 235
Query: 693 TDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRP 733
GT ++ PE L + PK D +S G++L LL G
Sbjct: 236 ----GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 536 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVG 590
+GEG YG + L + VA+K++ E ++EI I + H N+V
Sbjct: 15 LGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY- 71
Query: 591 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
L EY G L DR+ + R +L + +++LH
Sbjct: 72 ---GHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
I H D+KP N+LLD K+SDFG++ N +C GT Y+ P
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVAP 176
Query: 705 EFLASGEL--TPKSDVYSFGIILLRLLTGR 732
E L DV+S GI+L +L G
Sbjct: 177 ELL-KRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 586
++G G + + K + ++ A K + + E ++E+ IL ++ HPN++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 587 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
TL L+ E + G L D L+ K++ LS + ++ + +LH+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHT-- 133
Query: 645 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
I H DLKP NI+L KL DFG++ + + GT
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF------GTPE 183
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
++ PE + L ++D++S G+I LL+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHP-HSLQGPSEFQQEIDILSK-IRHPNLVTLVG 590
++G G G ++K R +A+K + + + ++D++ K P +V G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 591 AC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+V+ + E + E K P+ + ++ + L +L H
Sbjct: 92 TFITNTDVF-IAMELM-GTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLKE--KHG 145
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
++H D+KP+NILLD KL DFGIS L ++ + + + G AYM PE +
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSA--------GCAAYMAPERI 196
Query: 708 ASGEL-----TPKSDVYSFGIILLRLLTGRP 733
+ ++DV+S GI L+ L TG+
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 44/207 (21%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
+G G +G +++ + K + ++EI IL+ RH N++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
E +++E++ + +R++ L+ + + ++C L FLHS H+I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 651 GDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
D++P NI+ + K+ +FG +R L + L Y PE
Sbjct: 126 FDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNF---RLLF------TAPEYYAPEV 174
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRP 733
++ +D++S G ++ LL+G
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 49/229 (21%), Positives = 85/229 (37%), Gaps = 45/229 (19%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQ---QEIDILSKI-RHPNLVTL 588
KIG G +GS++K + R AIK L G + Q +E+ + + +H ++V
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 589 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
A E + EY GSL D +S + ++ L ++HS
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS- 135
Query: 646 HSIVHGDLKPANILLDAN-------------------FVSKLSDFGISRFLSQNEISSNN 686
+VH D+KP+NI + + K+ D G ISS
Sbjct: 136 --LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-----RISSPQ 188
Query: 687 TTLCCRTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTGRPA 734
+G ++ E L + PK+D+++ + ++ P
Sbjct: 189 VE-------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 590
++G+G + + + + + ++ A K+++ L ++E I K++HPN+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 591 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
+ LV++ + G L + + ++ S ++ + + HS + I
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHS---NGI 149
Query: 649 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
VH +LKP N+LL KL+DFG++ ++ +E GT Y+ PE
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFA------GTPGYLSPE 200
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
L + D+++ G+IL LL G P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYP 228
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---------FQQEIDILSKI-RH 582
+G G + + + + + A+K++ S +E+DIL K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 583 PNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
PN++ L + LV++ + G L D L+ K LS + +I L V+ L
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICAL 140
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
H +IVH DLKP NILLD + KL+DFG S L E +C GT +
Sbjct: 141 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVC------GTPS 188
Query: 701 YMDPEFLASGEL------TPKSDVYSFGIILLRLLTGRP 733
Y+ PE + + D++S G+I+ LL G P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 525 GATHNFDPSLK---------IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQE 573
G+T +F + +GEG + + + + A+K++ S +E
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 574 IDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 630
+++L + + H N++ L+ + + LV+E + GS+ + + + + +
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH---FNELEASVVV 117
Query: 631 TELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNT 687
++ S L FLH+ I H DLKP NIL + K+ DF + + N S +
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 688 TLCCRTDPKGTFAYMDPEFLASGELTPKS-----DVYSFGIILLRLLTGRP 733
T T P G+ YM PE + + D++S G+IL LL+G P
Sbjct: 175 TPELLT-PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 71/309 (22%), Positives = 119/309 (38%), Gaps = 34/309 (11%)
Query: 444 DQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRK 503
+ + + + + L ++ K+ + +
Sbjct: 10 GVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGT 69
Query: 504 EASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP 561
E M ++ + +DP IG G + + + R + A+K++
Sbjct: 70 ENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV 129
Query: 562 HSLQGPSE--------FQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPNGSLED 610
+ + E ++E IL ++ HP+++TL+ + LV++ + G L D
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD 189
Query: 611 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 670
L+ K LS + I L + FLH+ ++IVH DLKP NILLD N +LSD
Sbjct: 190 YLTEKVA---LSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSD 243
Query: 671 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL------TPKSDVYSFGII 724
FG S L E LC GT Y+ PE L + D+++ G+I
Sbjct: 244 FGFSCHLEPGEKL---RELC------GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
Query: 725 LLRLLTGRP 733
L LL G P
Sbjct: 295 LFTLLAGSP 303
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRH-PNLVTLV 589
++G G + + + + + + A K L +E EI +L + P ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 590 GA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
L+ EY G + + + +S IR+ ++ + +LH ++
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQ---NN 151
Query: 648 IVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
IVH DLKP NILL K+ DFG+SR + + GT Y+ P
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL---REIM------GTPEYLAP 202
Query: 705 EFLASGELTPKSDVYSFGIILLRLLTGRP 733
E L +T +D+++ GII LLT
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTS 231
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 43/208 (20%), Positives = 85/208 (40%), Gaps = 23/208 (11%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 590
++G+G + + + + + A +++ L ++E I ++HPN+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 591 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
+ L+++ + G L + + ++ S ++ ++ H +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQ---MGV 131
Query: 649 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
VH +LKP N+LL KL+DFG++ + + GT Y+ PE
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFA------GTPGYLSPE 183
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
L D+++ G+IL LL G P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYP 211
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 46/247 (18%), Positives = 94/247 (38%), Gaps = 30/247 (12%)
Query: 500 KSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIK 557
+ D F ++ ++ IG+G + + + + R Q A+K
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDV------YELCEVIGKGPFSVVRRCINRETGQQFAVK 55
Query: 558 M-----LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLED 610
+ + ++E I ++HP++V L+ + +V+E++ L
Sbjct: 56 IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 115
Query: 611 RLSCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVS 666
+ + ++ S ++ L + H ++I+H D+KP +LL + +
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPV 172
Query: 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 726
KL FG++ L ++ GT +M PE + DV+ G+IL
Sbjct: 173 KLGGFGVAIQLGES--GLVAGGRV------GTPHFMAPEVVKREPYGKPVDVWGCGVILF 224
Query: 727 RLLTGRP 733
LL+G
Sbjct: 225 ILLSGCL 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 35/214 (16%)
Query: 536 IGEGGYGSIYKGLLRHM----QVAIKML------HPHSLQGPSEFQQEIDILSKIRH--P 583
+G GG+GS+Y G + VAIK + L + E+ +L K+
Sbjct: 51 LGSGGFGSVYSG--IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 584 NLVTL--VGACPEVWTLVYEY-LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
++ L P+ + L+ E P L D ++ + L + ++ +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHC 165
Query: 641 HSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
H+ ++H D+K NIL+D N KL DFG L T GT
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFD------GTR 212
Query: 700 AYMDPEFLASGELT-PKSDVYSFGIILLRLLTGR 732
Y PE++ + V+S GI+L ++ G
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 61/267 (22%), Positives = 112/267 (41%), Gaps = 26/267 (9%)
Query: 474 LQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPS 533
+ ++ + + + ++ + ++S +P ++ D S + + F+
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGS--NRDALSDFFEVE 58
Query: 534 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 591
++G G +Y+ + A+K+L + EI +L ++ HPN++ L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 592 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
P +LV E + G L DR+ K S + ++ + +LH + IV
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHE---NGIV 170
Query: 650 HGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
H DLKP N+L + K++DFG+S+ + + T+C GT Y PE
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVC------GTPGYCAPEI 221
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRP 733
L P+ D++S GII LL G
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFE 248
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 588
+GEG + ++ L R + AIK+L + ++ E D++S++ HP V L
Sbjct: 38 LGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 589 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
E Y NG L + K S + TR A E+ S L +LH
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDET-CTRFYTA-EIVSALEYLHG---K 149
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
I+H DLKP NILL+ + +++DFG ++ LS + + GT Y+ PE
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV------GTAQYVSPEL 203
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRP 733
L SD+++ G I+ +L+ G P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKML---HPHSLQGPSEFQQEIDILSKIRHPNLVTLV 589
+IG G +G++Y VAIK + S + + +E+ L K+RHPN +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 590 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSC 643
G W LV EY GS D L + + PL + IA L +LHS
Sbjct: 121 GCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPL---QEVEIAAVTHGALQGLAYLHS- 172
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
H+++H D+K NILL + KL DFG + + ++ N+ + GT +M
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFV-------GTPYWMA 218
Query: 704 PEFLAS---GELTPKSDVYSFGIILLRLLTGRP 733
PE + + G+ K DV+S GI + L +P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 37/212 (17%)
Query: 536 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 588
+G G +G + G +H +VA+K+L+ ++ + EI L RHP+++ L
Sbjct: 24 LGVGTFGKVKVG--KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 589 VGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
+V + +V EY+ G L D + L + R+ ++ S + + H
Sbjct: 82 Y----QVISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHR 134
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
H +VH DLKP N+LLDA+ +K++DFG+S +S E T C G+ Y
Sbjct: 135 ---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSC------GSPNYA 182
Query: 703 DPEFLASGEL--TPKSDVYSFGIILLRLLTGR 732
PE + SG L P+ D++S G+IL LL G
Sbjct: 183 APEVI-SGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 31/211 (14%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA 591
+G G G + + R + A+K+L+ +QE+D + P++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQASGGPHIVCILDV 90
Query: 592 CPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
+ ++ E + G L R+ + + + + I ++ + + FLHS
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHS--- 146
Query: 646 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
H+I H D+KP N+L + + V KL+DFG ++ +QN + T C T Y+
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPC------YTPYYV 196
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
PE L + D++S G+I+ LL G P
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 30/208 (14%)
Query: 536 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 588
+GEG +G + H +VA+K + L+ + EI L +RHP+++ L
Sbjct: 17 LGEGSFGKVKLA--THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 589 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
V P +V EY G L D + K ++ R ++ + + H H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHR---H 127
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
IVH DLKP N+LLD N K++DFG+S ++ T C G+ Y PE
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK---TSC------GSPNYAAPEV 178
Query: 707 LASGEL--TPKSDVYSFGIILLRLLTGR 732
+ +G+L P+ DV+S GI+L +L GR
Sbjct: 179 I-NGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 35/214 (16%)
Query: 536 IGEGGYGSIYKGLLRHM----QVAIKM-----LHPHSLQGPSEFQQ---EIDILSKIRHP 583
+G G +G ++ +V +K + + + EI ILS++ H
Sbjct: 32 LGSGAFGFVWTA--VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 584 NLVTL--VGACPEVWTLVYEYLPNGS-LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
N++ + + + LV E +G L + L I +L S + +L
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYL 146
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
I+H D+K NI++ +F KL DFG + +L + ++ T C GT
Sbjct: 147 RL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY---TFC------GTIE 194
Query: 701 YMDPEFLASGEL--TPKSDVYSFGIILLRLLTGR 732
Y PE L G P+ +++S G+ L L+
Sbjct: 195 YCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 37/216 (17%)
Query: 536 IGEGGYGSIYKGLLRHM----QVAIKML------HPHSLQGPSEFQQEIDILSKIR---- 581
+G+GG+G+++ G + QVAIK++ L E+ +L K+
Sbjct: 39 LGKGGFGTVFAG--HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 582 HPNLVTL--VGACPEVWTLVYEY-LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 638
HP ++ L E + LV E LP L D ++ K L ++ + +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQ 153
Query: 639 FLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
HS +VH D+K NIL+D +KL DFG L T G
Sbjct: 154 HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFD------G 200
Query: 698 TFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGR 732
T Y PE+++ + + V+S GI+L ++ G
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 34/208 (16%), Positives = 56/208 (26%), Gaps = 54/208 (25%)
Query: 535 KIGEGGYGSIYKG----LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 587
G ++ L R QVA+ + P + E LS+I P +
Sbjct: 38 FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 588 L--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
+ V +V E++ GSL++ + P IR L + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGA-IRAMQSLAAAADAAHR--- 147
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+ P+ + + + L A M
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVL----------------------------AYPATMPDA 179
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
P+ D+ G L LL R
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRW 200
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 25/207 (12%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGA 591
+GEG + K + + + A+K++ Q+EI L HPN+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEV 74
Query: 592 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
LV E L G L +R+ K + S I +L S + +H +V
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSAVSHMHD---VGVV 128
Query: 650 HGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
H DLKP N+L + N K+ DFG +R +N L P T Y PE
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARL-----KPPDNQPL---KTPCFTLHYAAPEL 180
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRP 733
L D++S G+IL +L+G+
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSK-IRHPNLVTLVGA 591
IG G Y + + + +M+ A+K++ +EI+IL + +HPN++TL
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDV 84
Query: 592 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
+ +V E + G L D++ + S + + + + +LH+ +V
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHA---QGVV 138
Query: 650 HGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
H DLKP+NIL + + ++ DFG ++ L T C T ++ P
Sbjct: 139 HRDLKPSNILYVDESGNPESI-RICDFGFAKQLRAEN--GLLMTPC------YTANFVAP 189
Query: 705 EFLASGELTPKSDVYSFGIILLRLLTGRP 733
E L D++S G++L +LTG
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 63/280 (22%), Positives = 103/280 (36%), Gaps = 46/280 (16%)
Query: 471 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF 530
++LL +E ++ +DK V A+ L+ + + DF
Sbjct: 18 LDLLLGVHQELGASELAQDKYV--ADFLQWAEPIVVRLKEVRLQRDDFEI---------- 65
Query: 531 DPSLK-IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIRH 582
LK IG G + + +++ Q A+K+++ + E F++E D+L
Sbjct: 66 ---LKVIGRGAFSEVA--VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 583 PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
+ L A LV EY G L LS P R +A E+ + +
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSV 178
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
H VH D+KP NILLD +L+DFG L + + GT
Sbjct: 179 HR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL-VAV------GTPD 228
Query: 701 YMDPEFLASGELTPKSDVY-------SFGIILLRLLTGRP 733
Y+ PE L + P + Y + G+ + G+
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 30/211 (14%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA 591
+G G G + + + + A+KML ++E+++ + + P++V +V
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 123
Query: 592 CPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
++ +V E L G L R+ + + + + I + + +LHS
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS--- 179
Query: 646 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
+I H D+KP N+L N + KL+DFG ++ + + TT C T Y+
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPC------YTPYYV 230
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
PE L + D++S G+I+ LL G P
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 69/303 (22%), Positives = 116/303 (38%), Gaps = 46/303 (15%)
Query: 447 SLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 506
LE I + + + +++L E + + R+K + E L ++ S
Sbjct: 7 RQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNI--LEYLEWAKPFTS 64
Query: 507 SSSHMPQFFSDFSFSEIEGATHNFDPSLK-IGEGGYGSIYKGLLRHMQ----VAIKMLHP 561
M DF LK IG G +G + +++ A+K+L+
Sbjct: 65 KVKQMRLHREDFEI-------------LKVIGRGAFGEVA--VVKLKNADKVFAMKILNK 109
Query: 562 HSLQGPSE---FQQEIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKD 616
+ +E F++E D+L + TL A LV +Y G L LS +
Sbjct: 110 WEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE 169
Query: 617 NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS-R 675
+ P R +A E+ + +H VH D+KP NIL+D N +L+DFG +
Sbjct: 170 DRLPEEM-ARFYLA-EMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS-----DVYSFGIILLRLLT 730
+ + S+ GT Y+ PE L + E D +S G+ + +L
Sbjct: 225 LMEDGTVQSS--VAV------GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 731 GRP 733
G
Sbjct: 277 GET 279
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 588
+GEG YG + K R+ VAIK +EI +L ++RH NLV L
Sbjct: 32 LVGEGSYGMVMKC--RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 589 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+ C + W LV+E++ + ++ D L + L +Q + ++ + + F HS H
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHS---H 143
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
+I+H D+KP NIL+ + V KL DFG +R +++ D T Y PE
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVY---DDEVATRWYRAPEL 195
Query: 707 L-ASGELTPKSDVYSFGIILLRLLTGRP 733
L + DV++ G ++ + G P
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEP 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 57/207 (27%), Positives = 83/207 (40%), Gaps = 29/207 (14%)
Query: 536 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--V 589
IG G +G L+R VA+K + + Q+EI +RHPN+V V
Sbjct: 28 IGSGNFGVAR--LMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEV 84
Query: 590 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
P ++ EY G L +R+ S +L S + + HS I
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHS---MQIC 138
Query: 650 HGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
H DLK N LLD + K+ DFG S+ + + GT AY+ PE L
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STV------GTPAYIAPEVL 189
Query: 708 ASGEL--TPKSDVYSFGIILLRLLTGR 732
+ +DV+S G+ L +L G
Sbjct: 190 -LRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL- 588
K+G G Y ++YKG + VA+K + S +G PS +EI ++ +++H N+V L
Sbjct: 12 KLGNGTYATVYKG--LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLY 69
Query: 589 -VGACPEVWTLVYEYLPN--GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
V TLV+E++ N D + + L +L L F H
Sbjct: 70 DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--- 126
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA----- 700
+ I+H DLKP N+L++ KL DFG++R P TF+
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG---------------IPVNTFSSEVVT 171
Query: 701 --YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
Y P+ + S + D++S G IL ++TG+P
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 50/229 (21%)
Query: 534 LKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 589
K+G G YG +YK + + A+K + + +EI +L +++HPN+++L
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQ 84
Query: 590 GACPE-----VWTLVYEYLPN---GSLEDRLSCKDNSP--PLSWQTRIRIATELCSVLIF 639
VW L+++Y + ++ + K N L + ++ + +
Sbjct: 85 KVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 640 LHSCKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTLCCRTDP 695
LH+ + ++H DLKPANIL+ K++D G +R + P
Sbjct: 144 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN---------------SP 185
Query: 696 KGTFAYMDPE-----------FLASGELTPKSDVYSFGIILLRLLTGRP 733
A +DP L + T D+++ G I LLT P
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 6e-20
Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 588
KIGEG YG ++K R+ VAIK +EI +L +++HPNLV L
Sbjct: 10 KIGEGSYGVVFKC--RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 589 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
+ LV+EY + ++ L + I + + F H H
Sbjct: 68 LEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHK---H 121
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
+ +H D+KP NIL+ + V KL DFG +R ++ + D T Y PE
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFAR-----LLTGPSDYY---DDEVATRWYRSPEL 173
Query: 707 LASGEL-TPKSDVYSFGIILLRLLTGRP 733
L P DV++ G + LL+G P
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVP 201
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNL 585
+ K+GEG Y ++YKG + VA+K + +G P +E+ +L ++H N+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 586 VTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
VTL + + TLV+EYL L+ L D ++ +L L + H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHR- 118
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA--- 700
++H DLKP N+L++ KL+DFG++R S P T+
Sbjct: 119 --QKVLHRDLKPQNLLINERGELKLADFGLARAKS---------------IPTKTYDNEV 161
Query: 701 ----YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
Y P+ L S + + + D++ G I + TGRP
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 535 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL--V 589
KIGEG YG +YK + + A+K + G PS +EI IL +++H N+V L V
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 590 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
+ LV+E+L L+ L L T +L + + + H ++
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA-------YM 702
H DLKP N+L++ K++DFG++R P + Y
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFG---------------IPVRKYTHEIVTLWYR 167
Query: 703 DPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
P+ + S + + D++S G I ++ G P
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 66/268 (24%), Positives = 109/268 (40%), Gaps = 45/268 (16%)
Query: 480 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLK-IGE 538
+ D + ++K + L + + + + D+ +K IG
Sbjct: 35 DLDFPALRKNKNI--DNFLSRYKDTINKIRDLRMKAEDYEV-------------VKVIGR 79
Query: 539 GGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVGA 591
G +G + L+RH A+K+L + S+ F +E DI++ P +V L A
Sbjct: 80 GAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137
Query: 592 --CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
+V EY+P G L + +S D R A E+ L +HS +
Sbjct: 138 FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA-EVVLALDAIHS---MGFI 190
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
H D+KP N+LLD + KL+DFG +++ + + T GT Y+ PE L S
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD-TAV------GTPDYISPEVLKS 243
Query: 710 ----GELTPKSDVYSFGIILLRLLTGRP 733
G + D +S G+ L +L G
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 535 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL--V 589
K+GEG YG +YK + VA+K + + G PS +EI +L ++ HPN+V+L V
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 590 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
TLV+E++ L+ L +N L +L + H H I+
Sbjct: 88 IHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRIL 141
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA-------YM 702
H DLKP N+L++++ KL+DFG++R P ++ Y
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFG---------------IPVRSYTHEVVTLWYR 186
Query: 703 DPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
P+ + S + + D++S G I ++TG+P
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 51/221 (23%)
Query: 536 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTL 588
IG+G +G + +++ A+K ++ +E + +E+ I+ + HP LV L
Sbjct: 23 IGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 589 VGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATELCS 635
+ E +V + L G L E+ ++ I EL
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-------------VKLFIC-ELVM 126
Query: 636 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 695
L +L + I+H D+KP NILLD + ++DF I+ L + TT+
Sbjct: 127 ALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMA----- 175
Query: 696 KGTFAYMDPEFLASGELTPKS---DVYSFGIILLRLLTGRP 733
GT YM PE +S + S D +S G+ LL GR
Sbjct: 176 -GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 5e-19
Identities = 78/344 (22%), Positives = 131/344 (38%), Gaps = 47/344 (13%)
Query: 406 EELKRRKEFEEALAN-GKLEL-ERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKEL 463
EE K EF E + KLE E E+ + + + + L
Sbjct: 77 EEAKPLVEFYEEIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHL 136
Query: 464 EQKIISAVELLQNYKKEQ-DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSE 522
+K + +L Q Y +E L+ + + E+++ + + + ++ +DFS
Sbjct: 137 VKKQVPP-DLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSV-- 193
Query: 523 IEGATHNFDPSLK-IGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQ---QEIDI 576
+ IG GG+G +Y A+K L ++ E +
Sbjct: 194 -----------HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 577 LSKI---RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-A 630
LS + P +V + A P+ + + + + G L LS + +R A
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYA 298
Query: 631 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 690
E+ L +H+ +V+ DLKPANILLD + ++SD G++ + S
Sbjct: 299 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHAS 350
Query: 691 CRTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRP 733
GT YM PE L G S D +S G +L +LL G
Sbjct: 351 V-----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 45/220 (20%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL 588
K+GEG YG +YK VAIK + + G P +E+ +L +++H N++ L
Sbjct: 41 KLGEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 589 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
V L++EY N D D +P +S + +L + + F HS
Sbjct: 99 KSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---R 151
Query: 647 SIVHGDLKPANILLDANFVS-----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA- 700
+H DLKP N+LL + S K+ DFG++R P F
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG---------------IPIRQFTH 196
Query: 701 ------YMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 733
Y PE L S + D++S I +L P
Sbjct: 197 EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 8e-19
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 39/217 (17%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL 588
KIGEG YG+++K ++ + VA+K + G PS +EI +L +++H N+V L
Sbjct: 9 KIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 589 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
V + TLV+E+ L+ + L + +L L F HS
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHS---R 120
Query: 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA------ 700
+++H DLKP N+L++ N KL++FG++R P ++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFG---------------IPVRCYSAEVVTL 165
Query: 701 -YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 735
Y P+ + + D++S G I L L
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-19
Identities = 65/289 (22%), Positives = 117/289 (40%), Gaps = 45/289 (15%)
Query: 458 QTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSD 517
+T +E ++ +A++ + + K+Q +M+ + + + + ++
Sbjct: 91 ETPEE-REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 518 FSFSEIEGATHNFDPSLK-IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQ 572
F + LK +G+G +G + L++ A+K+L + E
Sbjct: 150 FEY-------------LKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAH 194
Query: 573 ---EIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI 627
E +L RHP L L + + V EY G L LS + + R
Sbjct: 195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS----EDRA 250
Query: 628 RI-ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686
R E+ S L +LHS ++V+ DLK N++LD + K++DFG L + I
Sbjct: 251 RFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGA 304
Query: 687 T--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
T T C GT Y+ PE L + D + G+++ ++ GR
Sbjct: 305 TMKTFC------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 48/221 (21%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ--------EIDILSKIRH 582
+GEG + ++YK R VAIK + L SE + EI +L ++ H
Sbjct: 17 FLGEGQFATVYKA--RDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLLQELSH 71
Query: 583 PNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
PN++ L+ A +LV++++ LE + KDNS L+ L +L
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
H H I+H DLKP N+LLD N V KL+DFG+++ P +
Sbjct: 129 HQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG---------------SPNRAYT 170
Query: 701 -------YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
Y PE + D+++ G IL LL P
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-18
Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 55/230 (23%)
Query: 529 NFDPSLK-IGEGGYGSIYKGLLRHMQV-------AIKMLHPHSLQGPSEFQ--QEIDILS 578
F+ LK +G+G +G ++ L++ + A+K+L +L+ + E DIL
Sbjct: 25 QFEL-LKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 579 KIRHPNLVTLVGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQT 625
++ HP +V L A L+ ++L G L E+
Sbjct: 82 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-------------V 128
Query: 626 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685
+ +A EL L LHS I++ DLKP NILLD KL+DFG LS+ I
Sbjct: 129 KFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG----LSKESIDHE 180
Query: 686 NT--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
+ C GT YM PE + T +D +SFG+++ +LTG
Sbjct: 181 KKAYSFC------GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 43/218 (19%)
Query: 535 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL----- 588
IG G +G +++ L +VAIK + LQ +E+ I+ ++HPN+V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 589 --VGACPEVW-TLVYEYLP---NGSLEDRLSCKDNSPPL-----SWQTRIRIATELCSVL 637
EV+ LV EY+P + K P L +Q L L
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ--------LLRSL 154
Query: 638 IFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
++HS I H D+KP N+LLD V KL DFG ++ L E N + C
Sbjct: 155 AYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYIC----- 203
Query: 697 GTFAYMDPEF-LASGELTPKSDVYSFGIILLRLLTGRP 733
+ Y PE + T D++S G ++ L+ G+P
Sbjct: 204 -SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 88.0 bits (217), Expect = 6e-18
Identities = 112/721 (15%), Positives = 214/721 (29%), Gaps = 246/721 (34%)
Query: 7 VPAIAQGVDSVRCPDIQ--MAGITSSR--RGIVEEPVASVIEDKIYVAVAKQVKESKSVL 62
A D C D+Q I S I+ A L
Sbjct: 26 EDAFVDNFD---CKDVQDMPKSILSKEEIDHIIMSKDA---VSGTLR------------L 67
Query: 63 LWALQNSGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQ------AYREIERQDMHN 116
W L + + + V ++ KF S ++ E+ Q Y E +R ++N
Sbjct: 68 FWTLLSKQ-EEMVQKFVEEVLRI----NYKFLMSPIKTEQRQPSMMTRMYIE-QRDRLYN 121
Query: 117 HLDMCLLICRQMGV-RAEKLDTESESTEKGILELISH-----YGIR---K--LVMGAAAD 165
+ + V R + + +LEL G+ K + +
Sbjct: 122 DNQ----VFAKYNVSRLQPY----LKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS 173
Query: 166 KHYKKKM------MDL---KSKKAISVRQQAPASCHIWFICNGNLIYTREGSLDGIDPEI 216
+ KM ++L S + + Q L+Y + + +
Sbjct: 174 YKVQCKMDFKIFWLNLKNCNSPETVLEMLQ-------------KLLYQIDPNWT-SRSDH 219
Query: 217 SSPSFQASHNTENR---------HPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFD 267
SS H+ + + NCL +VL + VQ+ + N
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCL----LVLLN---------VQNAKA-WNAFNLS 265
Query: 268 RNVGNVMTSQD-SIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIPL 326
+ ++T++ + S A+ + +S D + + + S +D
Sbjct: 266 CKI--LLTTRFKQVTDFLSAATTT--HISLDHHSMTLTPDE-VKSLLLK--YLDCR---- 314
Query: 327 IRTEGVSTLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKA 386
LP E L ++P ++ E++R G A
Sbjct: 315 -----PQDLPR--EVLTTNP---------------RRLSI----------IAESIRDGLA 342
Query: 387 --------EKDAIESIRRAKAS-ESLYAEELKRRKEFEEALA----NGKLE---LERM-- 428
D + +I ++S L E ++ F+ L+ + + L +
Sbjct: 343 TWDNWKHVNCDKLTTII--ESSLNVLEPAEYRKM--FDR-LSVFPPSAHIPTILLSLIWF 397
Query: 429 KKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMER 488
+VM + L + SL+E Q ES IS + K + +
Sbjct: 398 DVIKSDVMVVVN-KLHKYSLVEKQPKES----------TISIPSIYLELKVKLENEYALH 446
Query: 489 DKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL 548
V + + ++ Q+F +S I G+
Sbjct: 447 RSIVDHYNIPKTFDSDDLIPPYLDQYF----YSHI----------------GH------- 479
Query: 549 LRHMQVAIKMLHPHSLQGPSEFQQE-ID---ILSKIRHPNLVTLVGACPEVWTLV----- 599
H++ + HP + + F+ +D + KIRH + T A + +
Sbjct: 480 --HLK---NIEHPERM---TLFRMVFLDFRFLEQKIRHDS--TAWNASGSILNTLQQLKF 529
Query: 600 YE-YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 658
Y+ Y+ DN P R+ + ++L FL + + I K ++
Sbjct: 530 YKPYI-----------CDNDPKYE---RL-----VNAILDFLPKIEENLICS---KYTDL 567
Query: 659 L 659
L
Sbjct: 568 L 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 6e-08
Identities = 72/501 (14%), Positives = 145/501 (28%), Gaps = 137/501 (27%)
Query: 366 MAEAENSRR---EAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 422
E + + FE+A KD + + + E + + + K+
Sbjct: 11 TGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEI--DHIIMSKDAVSGT---L 65
Query: 423 LELERMKKQHDEVMEELQIALDQK--SLLESQIAESDQTAKELEQKIISAVELLQNYKKE 480
+ + +E++++ + + L S I + + + I + L N +
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125
Query: 481 QDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGG 540
+ + R + +LR++ E + ++ G G
Sbjct: 126 FAKYNVSRLQPYL---KLRQALLELRPAKNV--------------LID--------GVLG 160
Query: 541 YGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI----LSKIRHPNLVTLVGACPEVW 596
G K + A+ + + +Q +F+ I L P V + +
Sbjct: 161 SG---KTWV-----ALDVCLSYKVQCKMDFK----IFWLNLKNCNSPETVLEM-----LQ 203
Query: 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-IVHGDLKP 655
L+Y+ PN + S S Q +R + + +V +++
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR--------LLKSKPYENCLLVLLNVQN 255
Query: 656 ANILLDANFVSKLSDFG-----ISRFLS-QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
A +A F + +RF + +S+ TT T E
Sbjct: 256 AKA-WNA-F-----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT--PDEVK-- 304
Query: 710 GELTPKSDVYSFGIILLRL----LTGRP-ALG-ITKEVQYALDTGKLKNLLDPLAGDWPF 763
L K L LT P L I + ++ L T N W
Sbjct: 305 -SLLLK----YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT--WDN--------WKH 349
Query: 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFT 823
V ++L + VLEP +E R +
Sbjct: 350 VNCDKLTTIIESSLN---------------VLEP--------------AEYR---KMFDR 377
Query: 824 CPIFQVSSYV--AVAHVWWPN 842
+F S+++ + + W +
Sbjct: 378 LSVFPPSAHIPTILLSLIWFD 398
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 7e-18
Identities = 72/337 (21%), Positives = 119/337 (35%), Gaps = 31/337 (9%)
Query: 411 RKEFEEALANGKLELERMKKQHDEVME-ELQIALDQKSLLESQIAESDQTAKELEQKIIS 469
R F E A + EL R D V E E+ +K+ + +
Sbjct: 64 RLLFREFCAT-RPELSRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVP 122
Query: 470 --AVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGAT 527
V ++ + ++ E L + S F + + E + T
Sbjct: 123 RQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVT 182
Query: 528 -HNFDPSLKIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQ---EIDILSKIR 581
+ F +G+GG+G + +R A K L ++ E IL K+
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 582 HPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLI 638
+V+L A + LV + G L+ + + R A E+C L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFP-EARAVFYAAEICCGLE 300
Query: 639 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPK 696
LH IV+ DLKP NILLD + ++SD G++ + T
Sbjct: 301 DLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV-----HVPEGQTIKGRV------ 346
Query: 697 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT YM PE + + T D ++ G +L ++ G+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 9e-18
Identities = 64/340 (18%), Positives = 120/340 (35%), Gaps = 42/340 (12%)
Query: 405 AEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELE 464
E+ + + + + +D + L+ Q ++ L+
Sbjct: 79 HEQHGPALQLWKDIED-----------YDTADDALRPQKAQALRAAYLEPQAQLFCSFLD 127
Query: 465 QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIE 524
+ ++ D L +AV L ++ + S F + + E +
Sbjct: 128 AETVARAR-----AGAGDGLFQPLLRAVLA--HLGQAPFQEFLDSLYFLRFLQWKWLEAQ 180
Query: 525 GAT-HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ---QEIDI 576
F +G GG+G ++ + A K L+ L+ +Q E I
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVF--ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 577 LSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATEL 633
L+K+ +V+L A LV + G + + D P + R ++
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 634 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 693
S L LH +I++ DLKP N+LLD + ++SD G++ L + +
Sbjct: 299 VSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYA--- 350
Query: 694 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT +M PE L E D ++ G+ L ++ R
Sbjct: 351 ---GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 48/249 (19%)
Query: 511 MPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQ- 565
M + + + + ++ KIG+G +G ++K RH + VA+K + + +
Sbjct: 1 MAKQYDSVECPFCDEVS-KYEKLAKIGQGTFGEVFKA--RHRKTGQKVALKKVLMENEKE 57
Query: 566 G-PSEFQQEIDILSKIRHPNLVTLVGACPEVWT----------LVYEYLPN---GSLEDR 611
G P +EI IL ++H N+V L+ C + LV+++ + G L +
Sbjct: 58 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 117
Query: 612 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671
+ R+ L + L ++H + I+H D+K AN+L+ + V KL+DF
Sbjct: 118 ------LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168
Query: 672 GISRFLSQNEISSNNT------TLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGII 724
G++R S + S N TL Y PE L + P D++ G I
Sbjct: 169 GLARAFSLAKNSQPNRYTNRVVTLW----------YRPPELLLGERDYGPPIDLWGAGCI 218
Query: 725 LLRLLTGRP 733
+ + T P
Sbjct: 219 MAEMWTRSP 227
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 43/222 (19%)
Query: 535 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG-----PSEFQQEIDIL---SKIRH 582
+IG G YG++YK R VA+K + + G P +E+ +L H
Sbjct: 16 EIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 583 PNLVTLV-------GACPEVWTLVYEYLPN---GSLEDRLSCKDNSPPLSWQTRIRIATE 632
PN+V L+ TLV+E++ L+ P L +T + +
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-----PPPGLPAETIKDLMRQ 128
Query: 633 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCC 691
L FLH+ + IVH DLKP NIL+ + KL+DFG++R + Q ++ TL
Sbjct: 129 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW- 184
Query: 692 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
Y PE L D++S G I + +P
Sbjct: 185 ---------YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 53/268 (19%), Positives = 104/268 (38%), Gaps = 50/268 (18%)
Query: 478 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 537
KK ++ ++ A + + L+K + +++ + F + +G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKT------------LG 50
Query: 538 EGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLVG 590
G +G + L++H + A+K+L + + + E IL + P LV L
Sbjct: 51 TGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 591 AC--PEVWTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
+ +V EY+ G + L R A ++ +LHS
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-----HARFYAA-QIVLTFEYLHS--- 159
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+++ DLKP N+L+D +++DFG ++ + TLC GT + PE
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLC------GTPEALAPE 208
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRP 733
+ S D ++ G+++ + G P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 66/265 (24%), Positives = 103/265 (38%), Gaps = 54/265 (20%)
Query: 489 DKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL 548
V ++ K ++ P + S+++ + IG G +G +Y+
Sbjct: 25 SMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAK 74
Query: 549 LRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWT--------L 598
L VAIK + LQ +E+ I+ K+ H N+V L L
Sbjct: 75 LCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130
Query: 599 VYEYLP---NGSLEDRLSCKDNSPPL-----SWQTRIRIATELCSVLIFLHSCKPHSIVH 650
V +Y+P K P + +Q L L ++HS I H
Sbjct: 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--------LFRSLAYIHS---FGICH 179
Query: 651 GDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 708
D+KP N+LLD + V KL DFG ++ L + E N + C + Y PE
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYIC------SRYYRAPELIFG 230
Query: 709 SGELTPKSDVYSFGIILLRLLTGRP 733
+ + T DV+S G +L LL G+P
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 57/232 (24%)
Query: 529 NFDPSLK-IGEGGYGSIYKGLLRHMQV-------AIKMLH-PHSLQGPSEFQQ---EIDI 576
F+ L+ +G+GGYG ++ +R + A+K+L ++ + E +I
Sbjct: 18 CFEL-LRVLGKGGYGKVF--QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74
Query: 577 LSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSW 623
L +++HP +V L+ A L+ EYL G L ED
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT------------ 122
Query: 624 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683
+A E+ L LH I++ DLKP NI+L+ KL+DFG L + I
Sbjct: 123 -ACFYLA-EISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFG----LCKESIH 173
Query: 684 SNNT--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
T C GT YM PE L D +S G ++ +LTG P
Sbjct: 174 DGTVTHTFC------GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 83.0 bits (204), Expect = 3e-17
Identities = 50/265 (18%), Positives = 79/265 (29%), Gaps = 59/265 (22%)
Query: 508 SSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--- 564
S P FS T KIGEG +G +++ + H VAIK++
Sbjct: 6 SQKGPVPFSHCL------PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLV 59
Query: 565 -----QGPSEFQQEIDILSKI---------RHPNLVTLV------GACPEVWTLVYEYLP 604
+ E EI I ++ R + L G+ P + +++
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 605 --NGSLEDRLS--------------------CKDNSPPLSWQTRIRIATELCSVLIFLHS 642
GS DR + + S T I +L + L
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE- 178
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISR---FLSQNEISSNNTTLCCRTDPKGTF 699
H DL N+LL + KL + S S R + G
Sbjct: 179 -ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIV 237
Query: 700 AYMDPEF---LASGELTPKSDVYSF 721
+ D L +G+ + D+Y
Sbjct: 238 VFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 53/247 (21%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 500 KSRKEASSSSHMPQFFSDFSFSEIE-GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAI 556
++R ++H P+ + D+ +E G ++ K+G G Y +++ + + +V +
Sbjct: 7 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 66
Query: 557 KMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTL--VGACPEVWTLVY--EYLPNGSLEDR 611
K+L P + + ++EI IL +R PN++TL + P T E++ N
Sbjct: 67 KILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF--- 120
Query: 612 LSCKDNSPPLSWQTRIR-IATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLS 669
K L+ IR E+ L + HS I+H D+KP N+++D + +L
Sbjct: 121 ---KQLYQTLT-DYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLI 173
Query: 670 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRL 728
D+G++ F + + + PE L ++ D++S G +L +
Sbjct: 174 DWGLAEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 224
Query: 729 LTGRPAL 735
+ +
Sbjct: 225 IFRKEPF 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 42/214 (19%)
Query: 536 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTL 588
+G G +G ++ L+R A+K+L + + + E +LS + HP ++ +
Sbjct: 14 LGTGSFGRVH--LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 589 VGAC--PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELCSVLIF 639
G + ++ +Y+ G L R + A E+C L +
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP----------NPVAKFYAAEVCLALEY 121
Query: 640 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 699
LHS I++ DLKP NILLD N K++DFG ++ + TLC GT
Sbjct: 122 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLC------GTP 167
Query: 700 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
Y+ PE +++ D +SFGI++ +L G
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 535 KIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSLQG--PSEFQQEIDIL---SKIRHPN 584
+IGEG YG ++K R ++ VA+K + + + P +E+ +L HPN
Sbjct: 18 EIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 585 LVTLVGACPEVW-------TLVYEYLPN---GSLEDRLSCKDNSPPLSWQTRIRIATELC 634
+V L C TLV+E++ L+ P + +T + +L
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-----PEPGVPTETIKDMMFQLL 130
Query: 635 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRT 693
L FLHS H +VH DLKP NIL+ ++ KL+DFG++R + Q ++S TL
Sbjct: 131 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW--- 184
Query: 694 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
Y PE L D++S G I + +P
Sbjct: 185 -------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 56/221 (25%), Positives = 87/221 (39%), Gaps = 53/221 (23%)
Query: 536 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKIRHP 583
+G+G +G + + V A+K+L + E E +L RHP
Sbjct: 13 LGKGTFGKV-------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 584 NLVTLVGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELC 634
L L A + V EY G L E + + R R E+
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT----------EERARFYGAEIV 115
Query: 635 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCR 692
S L +LHS +V+ D+K N++LD + K++DFG L + IS T T C
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFC-- 166
Query: 693 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT Y+ PE L + D + G+++ ++ GR
Sbjct: 167 ----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 43/211 (20%), Positives = 80/211 (37%), Gaps = 51/211 (24%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA 591
+G G G + + + + A+KML ++E+++ + + P++V +V
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 79
Query: 592 CPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
++ +V E L G L R+ + + + + I + + +LHS
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS--- 135
Query: 646 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
+I H D+KP N+L N + KL+DFG +
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------------------------- 167
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
E D++S G+I+ LL G P
Sbjct: 168 -KETTGEK-YDKSCDMWSLGVIMYILLCGYP 196
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 52/246 (21%), Positives = 91/246 (36%), Gaps = 40/246 (16%)
Query: 505 ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPH 562
S S F+S + IG G G + VAIK L
Sbjct: 2 GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-SR 60
Query: 563 SLQGPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLP---NGS 607
Q + ++ E+ ++ + H N++ L + +V+ +V E +
Sbjct: 61 PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY-IVMELMDANLCQV 119
Query: 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 667
++ L + L +Q LC + LHS I+H DLKP+NI++ ++ K
Sbjct: 120 IQMELD-HERMSYLLYQM-------LCG-IKHLHSA---GIIHRDLKPSNIVVKSDCTLK 167
Query: 668 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 727
+ DFG++R + + T T Y PE + D++S G I+
Sbjct: 168 ILDFGLARTAGTSFMM---------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
Query: 728 LLTGRP 733
++ G
Sbjct: 219 MIKGGV 224
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 74/286 (25%)
Query: 480 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHNFDPSLK-IG 537
+ ++ ++ + A+ + H + +F LK +G
Sbjct: 17 GAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFEL-------------LKVLG 63
Query: 538 EGGYGSIYKGLLRHMQV-------AIKMLHPHSLQGPSEFQQ----EIDILSKIRH-PNL 585
G YG ++ L+R + A+K+L ++ ++ + E +L IR P L
Sbjct: 64 TGAYGKVF--LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 586 VTLVGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATE 632
VTL A L+ +Y+ G L E +I + E
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-------------VQIYVG-E 167
Query: 633 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT---TL 689
+ L LH I++ D+K NILLD+N L+DFG LS+ ++
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFG----LSKEFVADETERAYDF 220
Query: 690 CCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRP 733
C GT YM P+ + G+ D +S G+++ LLTG
Sbjct: 221 C------GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 49/242 (20%), Positives = 81/242 (33%), Gaps = 39/242 (16%)
Query: 516 SDFSFSEIEGATHN----FDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSE- 569
+ + ++ H + I G YG++ G+ + VAIK + G +
Sbjct: 6 GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN 65
Query: 570 -FQQ---------EIDILSKIRHPNLVTLVGA-CPEVWT------LVYEYLPNGSLEDRL 612
EI +L+ HPN++ L LV E + L +
Sbjct: 66 ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI 124
Query: 613 SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 672
D +S Q + L LH +VH DL P NILL N + DF
Sbjct: 125 --HDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFN 179
Query: 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTG 731
++R + + T Y PE + T D++S G ++ +
Sbjct: 180 LAREDTADANK---------THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 732 RP 733
+
Sbjct: 231 KA 232
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 59/281 (20%), Positives = 103/281 (36%), Gaps = 61/281 (21%)
Query: 475 QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHNFDPS 533
+Y E + EE +++ S DF
Sbjct: 10 HDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDL------------- 56
Query: 534 LK-IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEF---QQEIDILSKI-RHPN 584
L+ IG G Y + L+R + A++++ + + Q E + + HP
Sbjct: 57 LRVIGRGSYAKVL--LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 585 LVTLVGAC---PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELC 634
LV L +C V EY+ G L + +L + R + E+
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----------EEHARFYSAEIS 163
Query: 635 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCR 692
L +LH I++ DLK N+LLD+ KL+D+G + + + +T T C
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFC-- 214
Query: 693 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT Y+ PE L + D ++ G+++ ++ GR
Sbjct: 215 ----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 61/255 (23%), Positives = 104/255 (40%), Gaps = 46/255 (18%)
Query: 499 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAI 556
A++++ P+ F ++ + IGEG YG + L ++VAI
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVF-DV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAI 57
Query: 557 KMLHPHSLQGPSEFQQ---------EIDILSKIRHPNLVTLVGACP--------EVWTLV 599
K + P F+ EI IL + RH N++ + +V+ +V
Sbjct: 58 KKISP--------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY-IV 108
Query: 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 659
+ + E L + LS ++ L ++HS +++H DLKP+N+L
Sbjct: 109 QDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLL 160
Query: 660 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDV 718
L+ K+ DFG++R + + T+ T Y PE L S T D+
Sbjct: 161 LNTTCDLKICDFGLARVADPDHDHTGFL-----TEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 719 YSFGIILLRLLTGRP 733
+S G IL +L+ RP
Sbjct: 216 WSVGCILAEMLSNRP 230
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 40/220 (18%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS----EFQQEIDILSKIRHPNLVTL 588
G+G +G++ G + M VAIK + +Q P E Q + L+ + HPN+V L
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQ-IMQDLAVLHHPNIVQL 84
Query: 589 --------VGACPEVW-TLVYEYLPNGSLED--RL--SCKDNSPPLSWQTRIRIATELCS 635
+++ +V EY+P + R + +L
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 636 VLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 694
+ LH ++ H D+KP N+L++ A+ KL DFG ++ LS +E N C
Sbjct: 141 SIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYIC--- 193
Query: 695 PKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
+ Y PE + T D++S G I ++ G P
Sbjct: 194 ---SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 8e-15
Identities = 60/320 (18%), Positives = 108/320 (33%), Gaps = 78/320 (24%)
Query: 478 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 537
++ + ++ + RK + ++ MP+ SD+ + ++ IG
Sbjct: 9 AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD------RYEIRHLIG 62
Query: 538 EGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---------EIDILSKIRHPNLV 586
G YG + + + VAIK + F+ EI IL+++ H ++V
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDHVV 115
Query: 587 TLVGACP--------EVWTLVYEYLP---------NGSLEDRLSCKDNSPPLSWQTRIRI 629
++ E++ +V E L + L +
Sbjct: 116 KVLDIVIPKDVEKFDELY-VVLEIADSDFKKLFRTPVYLTELHIKT-----LLYNL---- 165
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
L + ++HS I+H DLKPAN L++ + K+ DFG++R + E ++ +
Sbjct: 166 ---LVG-VKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 690 CCRTDPKGTFAYMD-------------------PE-FLASGELTPKSDVYSFGIILLRLL 729
R D + PE L T DV+S G I LL
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 730 TGRPALGITKEVQYALDTGK 749
+ L G
Sbjct: 279 NMIKENVAYHADRGPLFPGS 298
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 8e-15
Identities = 78/280 (27%), Positives = 112/280 (40%), Gaps = 69/280 (24%)
Query: 478 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLK-I 536
+ Q+ M + A A + + +S+ P SDF F LK I
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKP---SDFHF-------------LKVI 46
Query: 537 GEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEF---QQEIDILSK-IRHPNLVTL 588
G+G +G + L RH A+K+L ++ E E ++L K ++HP LV L
Sbjct: 47 GKGSFGKVL--LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 589 VGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATELCS 635
+ + V +Y+ G L E R R A E+ S
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-------------ARFYAA-EIAS 150
Query: 636 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRT 693
L +LHS +IV+ DLKP NILLD+ L+DFG L + I N+T T C
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFG----LCKENIEHNSTTSTFC--- 200
Query: 694 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT Y+ PE L D + G +L +L G P
Sbjct: 201 ---GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 57/217 (26%), Positives = 84/217 (38%), Gaps = 44/217 (20%)
Query: 536 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSK-IRH 582
+G+G +G + AIK L + + E +LS H
Sbjct: 25 LGKGSFGKV-------FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 583 PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIF 639
P L + E V EYL G L + +R A E+ L F
Sbjct: 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD----LSRATFYAAEIILGLQF 133
Query: 640 LHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPK 696
LHS IV+ DLK NILLD + + K++DFG + + + + T C
Sbjct: 134 LHS---KGIVYRDLKLDNILLDKDGHI-KIADFG----MCKENMLGDAKTNTFC------ 179
Query: 697 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT Y+ PE L + D +SFG++L +L G+
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 49/243 (20%), Positives = 84/243 (34%), Gaps = 60/243 (24%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL---- 588
+G G +G + + + A+K + P +E+DI+ + H N++ L
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYF 69
Query: 589 -----VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE----------- 632
P + L + K S + + E
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129
Query: 633 --------------------LCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDF 671
L + F+HS I H D+KP N+L+++ KL DF
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLT 730
G ++ L +E + C + Y PE L + E TP D++S G + L+
Sbjct: 187 GSAKKLIPSE---PSVAYIC------SRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 731 GRP 733
G+P
Sbjct: 238 GKP 240
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 56/223 (25%)
Query: 536 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKI-RH 582
IG G Y + + V A+K++ + + Q E + + H
Sbjct: 17 IGRGSYAKV-------LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 583 PNLVTLVGAC---PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATE 632
P LV L +C V EY+ G L + +L + R + E
Sbjct: 70 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----------EEHARFYSAE 118
Query: 633 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLC 690
+ L +LH I++ DLK N+LLD+ KL+D+G + + + +T T C
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFC 171
Query: 691 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT Y+ PE L + D ++ G+++ ++ GR
Sbjct: 172 ------GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 51/222 (22%), Positives = 83/222 (37%), Gaps = 54/222 (24%)
Query: 536 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKI-RH 582
+G+G +G + M A+K+L + + E +L+ +
Sbjct: 28 LGKGSFGKV-------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 583 PNLVTLVGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATEL 633
P L L + V EY+ G L R + A E+
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----------EPHAVFYAAEI 130
Query: 634 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCC 691
L FL S I++ DLK N++LD+ K++DFG + + I T T C
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIWDGVTTKTFC- 182
Query: 692 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT Y+ PE +A D ++FG++L +L G+
Sbjct: 183 -----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 49/236 (20%), Positives = 86/236 (36%), Gaps = 22/236 (9%)
Query: 506 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS 563
S S QF+S + IG G G + VAIK L
Sbjct: 40 SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRP 98
Query: 564 LQGPSEFQQ---EIDILSKIRHPNLVTL---VGACPEVWTLVYEYLPNGSLEDRLSCKDN 617
Q + ++ E+ ++ + H N+++L + YL ++ L
Sbjct: 99 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 158
Query: 618 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677
+ + LC + LHS I+H DLKP+NI++ ++ K+ DFG++R
Sbjct: 159 MELDHERMSYLLYQMLCG-IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214
Query: 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
+ + T T Y PE + D++S G I+ ++ +
Sbjct: 215 GTSFMM---------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 59/222 (26%), Positives = 86/222 (38%), Gaps = 54/222 (24%)
Query: 536 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKI-RH 582
+G+G +G + M A+K+L + + E ILS H
Sbjct: 31 LGKGSFGKV-------MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 583 PNLVTLVGAC--PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATEL 633
P L L P+ V E++ G L R + R R A E+
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----------EARARFYAAEI 133
Query: 634 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCC 691
S L+FLH I++ DLK N+LLD KL+DFG + + I + T T C
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFG----MCKEGICNGVTTATFC- 185
Query: 692 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
GT Y+ PE L P D ++ G++L +L G
Sbjct: 186 -----GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 55/234 (23%)
Query: 530 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---------EIDILS 578
F +GEG YG + + VAIK + P F + EI IL
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILK 64
Query: 579 KIRHPNLVTLVGACP--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLS-------- 622
+H N++T+ EV+ ++ E + L +S + LS
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVY-IIQELMQT-DLHRVIS----TQMLSDDHIQYFI 118
Query: 623 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682
+QT L + + LH +++H DLKP+N+L+++N K+ DFG++R + ++
Sbjct: 119 YQT-------LRA-VKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 683 SSNNTTLCCR--TDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
++ T + T Y PE L S + + DV+S G IL L RP
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 53/290 (18%), Positives = 97/290 (33%), Gaps = 73/290 (25%)
Query: 499 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM--QVAI 556
+ + Q + + N+ IG G YG +Y ++ VAI
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPD------NYIIKHLIGRGSYGYVYLAYDKNTEKNVAI 56
Query: 557 KMLHPHSLQGPSEFQQ---------EIDILSKIRHPNLVTLVGACP--------EVWTLV 599
K ++ F+ EI IL++++ ++ L E++ +V
Sbjct: 57 KKVN-------RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY-IV 108
Query: 600 YEYLP---------NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
E L + ++ + + L F+H I+H
Sbjct: 109 LEIADSDLKKLFKTPIFLTE-----EHIKTILYNL-------LLG-ENFIHES---GIIH 152
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD------- 703
DLKPAN LL+ + K+ DFG++R ++ + ++ L +P +
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212
Query: 704 -------PE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 745
PE L T D++S G I LL + ++ L
Sbjct: 213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 1e-13
Identities = 57/284 (20%), Positives = 105/284 (36%), Gaps = 56/284 (19%)
Query: 469 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATH 528
E + +++ + ++ + E + K ++ + +DF+F
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNF-------- 345
Query: 529 NFDPSLK-IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEFQQ---EID 575
L +G+G +G + M A+K+L + + + E
Sbjct: 346 -----LMVLGKGSFGKV-------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 576 ILSKI-RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-AT 631
+L+ + P L L + V EY+ G L + + A
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----EPHAVFYAA 449
Query: 632 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TL 689
E+ L FL S I++ DLK N++LD+ K++DFG + + I T T
Sbjct: 450 EIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIWDGVTTKTF 502
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
C GT Y+ PE +A D ++FG++L +L G+
Sbjct: 503 C------GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 527 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIR 581
+ +G GG G ++ + +VAIK + L P + EI I+ ++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---VLTDPQSVKHALREIKIIRRLD 66
Query: 582 HPNLVTLVGA-CPEVWTLVYEYLPNGSLED-----RLSCKD-----NSPPLSWQTRIRIA 630
H N+V + P L + L D PL +
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126
Query: 631 TELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTL 689
+L L ++HS +++H DLKPAN+ ++ + V K+ DFG++R + + S+ L
Sbjct: 127 YQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY--SHKGHL 181
Query: 690 CCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
++ T Y P L+ T D+++ G I +LTG+
Sbjct: 182 ---SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 52/247 (21%), Positives = 96/247 (38%), Gaps = 43/247 (17%)
Query: 505 ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPH 562
+ S F+ + +G G YGS+ + + +VAIK L
Sbjct: 1 SLSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SR 59
Query: 563 SLQGPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLP---NGS 607
Q ++ E+ +L ++H N++ L + + + LV ++
Sbjct: 60 PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY-LVMPFMQTDLQKI 118
Query: 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 667
+ + S ++ L +Q L L ++HS +VH DLKP N+ ++ + K
Sbjct: 119 MGLKFS-EEKIQYLVYQM-------LKG-LKYIHSA---GVVHRDLKPGNLAVNEDCELK 166
Query: 668 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILL 726
+ DFG++R + + T T Y PE L+ D++S G I+
Sbjct: 167 ILDFGLAR--------HADAEM---TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 727 RLLTGRP 733
+LTG+
Sbjct: 216 EMLTGKT 222
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 62/221 (28%), Positives = 88/221 (39%), Gaps = 51/221 (23%)
Query: 536 IGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRH------PN 584
IG+G +G + K H VA+KM+ +Q EI IL +R N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 585 LVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 637
++ ++ C + +E L + +L + L K+ S + A + L
Sbjct: 161 VIHMLENFTFRNHIC-----MTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQN---EISSNNTTLCCR 692
LH + I+H DLKP NILL S K+ DFG S + Q I S R
Sbjct: 214 DALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS-------R 263
Query: 693 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
F Y PE + D++S G IL LLTG P
Sbjct: 264 ------F-YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 51/241 (21%), Positives = 90/241 (37%), Gaps = 40/241 (16%)
Query: 512 PQFFSDFSFSEIEGA----THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ 565
P S F E+ + +G G YG++ + +VAIK L Q
Sbjct: 5 PPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQ 63
Query: 566 GPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLPNGSLEDRLS 613
++ E+ +L +RH N++ L + + + LV ++ L
Sbjct: 64 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY-LVMPFM-----GTDLG 117
Query: 614 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673
L + ++ L ++H+ I+H DLKP N+ ++ + K+ DFG+
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGR 732
+R T T Y PE L T D++S G I+ ++TG+
Sbjct: 175 ARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
Query: 733 P 733
Sbjct: 224 T 224
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 55/243 (22%), Positives = 96/243 (39%), Gaps = 36/243 (14%)
Query: 506 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS 563
S P F+ I + +G G YGS+ ++VA+K L
Sbjct: 7 HHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRP 65
Query: 564 LQGPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLPNGSLEDR 611
Q ++ E+ +L ++H N++ L + +V+ LV + L +
Sbjct: 66 FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-LVTHLMGA-DLNNI 123
Query: 612 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671
+ C+ L+ + ++ L ++HS I+H DLKP+N+ ++ + K+ DF
Sbjct: 124 VKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176
Query: 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLT 730
G++R + T T Y PE L D++S G I+ LLT
Sbjct: 177 GLARHTADE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 731 GRP 733
GR
Sbjct: 226 GRT 228
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 62/246 (25%), Positives = 102/246 (41%), Gaps = 63/246 (25%)
Query: 527 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---------EID 575
++ K+G+G YG ++K + R VA+K + FQ EI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 576 ILSKIR-HPNLVTLVGACP-----EVWTLVYEYLPNGSLEDRLSCKDNSPPLS------- 622
IL+++ H N+V L+ +V+ LV++Y+ E L + L
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVY-LVFDYM-----ETDLHAVIRANILEPVHKQYV 114
Query: 623 -WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681
+Q + + +LHS ++H D+KP+NILL+A K++DFG+SR
Sbjct: 115 VYQL-------IKV-IKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 682 ISSNNTTLCCRTDPKGTFAYMD-------------PE-FLASGELTPKSDVYSFGIILLR 727
+NN L + + PE L S + T D++S G IL
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223
Query: 728 LLTGRP 733
+L G+P
Sbjct: 224 ILCGKP 229
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 56/268 (20%), Positives = 101/268 (37%), Gaps = 32/268 (11%)
Query: 500 KSRKEASSSSHMPQFFSDFSF----------SEIEGA-THNFDPSLKIGE-GGYGSIYKG 547
K KE ++ S S+ + GA T P + I E +G++
Sbjct: 58 KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 117
Query: 548 LLRHMQVAIK-MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNG 606
L + + ++ I + K R ++ + + V E +
Sbjct: 118 LRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS--GFVEEKSLSD 175
Query: 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666
E+ L+ + I + ++ + FL S K +H DL NILL V
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVV 232
Query: 667 KLSDFGISRFLSQNE--ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGII 724
K+ DFG++R + ++ + + L + +M PE + T +SDV+SFG++
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLK--------WMAPETIFDRVYTIQSDVWSFGVL 284
Query: 725 LLRLLT-GR---PALGITKEVQYALDTG 748
L + + G P + I +E L G
Sbjct: 285 LWEIFSLGASPYPGVKIDEEFCRRLKEG 312
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 43/195 (22%), Positives = 65/195 (33%), Gaps = 32/195 (16%)
Query: 535 KIGEGGYGSIYKGLLRHM-------QVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 585
+G G +G + + + VA+KML + E+ IL I H N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 586 VTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
V L+GAC ++ E+ G+L L K N R V
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV------ 142
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG---TF 699
+ DLK + ++ S S F + LS E L +
Sbjct: 143 ----GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198
Query: 700 AY-----MDPEFLAS 709
++ M EFLAS
Sbjct: 199 SFQVAKGM--EFLAS 211
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 41/239 (17%), Positives = 91/239 (38%), Gaps = 71/239 (29%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKML------HPHSLQGPSEFQQEIDILSKIR----- 581
K+G G + +++ ++ + VA+K++ + + EI +L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA-------EDEIKLLQRVNDADNT 78
Query: 582 ------HPNLVTLVGA-----------CPEVWTLVYEYLPNGSLEDRLSCKDNSP-PLSW 623
+++ L+ +V+E L +L + ++ PL
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVV-----MVFEVL-GENLLALIKKYEHRGIPLI- 131
Query: 624 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS------KLSDFGISRFL 677
+ +I+ +L L ++H + I+H D+KP N+L++ K++D G + +
Sbjct: 132 YVK-QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 678 SQ---NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
+ N I + Y PE L +D++S ++ L+TG
Sbjct: 189 DEHYTNSIQTR--------------EYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 45/220 (20%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP------ 583
IG+G +G + K + VAIK++ + Q E+ +L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 584 NLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIRIATELCS 635
+V L C LV+E L + +L D L ++ + +S + A ++C+
Sbjct: 117 YIVHLKRHFMFRNHLC-----LVFEML-SYNLYDLL--RNTNFRGVSLNLTRKFAQQMCT 168
Query: 636 VLIFLHSCKPHSIVHGDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 693
L+FL + + I+H DLKP NILL K+ DFG S L Q + R
Sbjct: 169 ALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSR- 222
Query: 694 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
F Y PE L D++S G IL+ + TG P
Sbjct: 223 -----F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV--- 589
KIG G +G IY G + +VAIK+ + + E I ++ + +
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 590 GACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
GA + +V E L G SLED + S +T + +A ++ S + ++HS +
Sbjct: 74 GAEGDYNVMVMELL--GPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS---KNF 126
Query: 649 VHGDLKPANILL----DANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTFAY 701
+H D+KP N L+ N V + DFG++ ++ + + + R + GT Y
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVY-IIDFGLAKKYRD----ARTHQHIPYRENKNLTGTARY 181
Query: 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
E + + D+ S G +L+ G
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 43/245 (17%), Positives = 90/245 (36%), Gaps = 47/245 (19%)
Query: 535 KIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQ-----QEIDILSKIRH 582
IG+GG+G IY + +K+ + +E + + + + K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 583 PNLVTLVGACPEVWT------------LVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRI 629
+ +G + ++ + G L+ + N+ S +T +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY--EANAKRFSRKTVLQL 157
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK--LSDFGISRFLSQNEISSNNT 687
+ + +L ++H H VHGD+K +N+LL+ + L D+G++
Sbjct: 158 SLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY-----RYCPEGV 209
Query: 688 TLCCRTDPK----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGI---TK 739
DPK GT + + + + D+ G +++ LTG P K
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269
Query: 740 EVQYA 744
V+ +
Sbjct: 270 YVRDS 274
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 40/244 (16%), Positives = 78/244 (31%), Gaps = 45/244 (18%)
Query: 535 KIGEGGYGSIYKG----------LLRHMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHP 583
G +Y+ + + ++K+ L F Q ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 584 NLVTLVGAC--PEVWT----------LVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIA 630
+ P LV L G SL+ LS ++ +++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQVA 165
Query: 631 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK--LSDFGISRFLSQNEISSNNTT 688
L L FLH + VHG++ NI +D S+ L+ +G + +
Sbjct: 166 CRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF-----RYCPSGKH 217
Query: 689 LCCRTDPK----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGI---TKE 740
+ + G ++ + + +SD+ S G +L+ L G P T++
Sbjct: 218 VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED 277
Query: 741 VQYA 744
+
Sbjct: 278 IMKQ 281
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 47/228 (20%), Positives = 84/228 (36%), Gaps = 44/228 (19%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
KIG GG+G IY + + A ++ + F E+ ++ + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWIER 102
Query: 593 --------PEVW-------------TLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIA 630
P + +V E L G L+ + T +++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQ---NGTFKKSTVLQLG 157
Query: 631 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK--LSDFGISRFLSQNEISSNNTT 688
+ VL ++H + VHGD+K AN+LL + L+D+G+S N
Sbjct: 158 IRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY-----RYCPNGNH 209
Query: 689 LCCRTDPK----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
+ +P+ GT + + L+ +SDV G +LR L G+
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 31/156 (19%), Positives = 69/156 (44%), Gaps = 14/156 (8%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 419
+++ +A + E E R + E++ + ++ K +L+ + E EE A
Sbjct: 912 EEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLE-EEEAA 970
Query: 420 NGKLELERMKKQHDEVMEELQIALD-----------QKSLLESQIAESDQTAKELEQKII 468
KL+LE K D +++++ + ++ LLE ++++ E E+K
Sbjct: 971 RQKLQLE--KVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAK 1028
Query: 469 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 504
+ +L ++ EL++ K K +EL K +++
Sbjct: 1029 NLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRK 1064
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 25/148 (16%), Positives = 57/148 (38%), Gaps = 4/148 (2%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKAS----ESLYAEELKRRKEFEE 416
+ + E+ ++ + K K E + + E K + + E
Sbjct: 980 TADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLKNKHES 1039
Query: 417 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 476
++ ++ L++ +K E+ + + + S L QIAE EL+ ++ E LQ
Sbjct: 1040 MISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEELQA 1099
Query: 477 YKKEQDELQMERDKAVKEAEELRKSRKE 504
++ +++ A+K+ EL +
Sbjct: 1100 ALARLEDETSQKNNALKKIRELESHISD 1127
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 29/154 (18%), Positives = 62/154 (40%), Gaps = 11/154 (7%)
Query: 356 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 415
++ ++L + E E + E++ +++ + K EL+ R + E
Sbjct: 996 EDQNNKLTKERKLLE----ERVSDLTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKE 1051
Query: 416 EA----LANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAV 471
E L K +LE E + ELQ Q + L++Q+A+ ++ + ++
Sbjct: 1052 EKSRQELEKIKRKLEGESSDLHEQIAELQ---AQIAELKAQLAKKEEELQAALARLEDET 1108
Query: 472 ELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
N K+ EL+ ++ E + +R +A
Sbjct: 1109 SQKNNALKKIRELESHISDLQEDLESEKAARNKA 1142
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 26/144 (18%), Positives = 56/144 (38%)
Query: 363 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 422
Q E + + E +AE+ + + + E + E R +E EE +
Sbjct: 888 TQLCEEKNLLQEKLQAETELYAEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQ 947
Query: 423 LELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 482
E ++M++Q ++ E+L+ + L+ + +D K++E I+ + KE+
Sbjct: 948 AEKKKMQQQMLDLEEQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERK 1007
Query: 483 ELQMERDKAVKEAEELRKSRKEAS 506
L+ E + K +
Sbjct: 1008 LLEERVSDLTTNLAEEEEKAKNLT 1031
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 24/161 (14%), Positives = 63/161 (39%), Gaps = 7/161 (4%)
Query: 356 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 415
L ++++ +A + K E E R K E E K +++ E
Sbjct: 1007 KLLEERVSDLTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLE 1066
Query: 416 EALANGKLELERMKKQHDEVMEELQIALDQKSLLESQI-------AESDQTAKELEQKII 468
++ ++ ++ Q E+ +L ++ +++ + + +ELE I
Sbjct: 1067 GESSDLHEQIAELQAQIAELKAQLAKKEEELQAALARLEDETSQKNNALKKIRELESHIS 1126
Query: 469 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSS 509
E L++ K +++ + ++ +E E L+ ++ ++
Sbjct: 1127 DLQEDLESEKAARNKAEKQKRDLSEELEALKTELEDTLDTT 1167
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 27/140 (19%), Positives = 54/140 (38%), Gaps = 18/140 (12%)
Query: 368 EAENSRREAFEEALRRGKAE-KDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELE 426
+ E R+ E+ R+ + E D E I +A + +L + KE E A +LE E
Sbjct: 1049 KKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAK-KEEELQAALARLEDE 1107
Query: 427 R------------MKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 474
++ ++ E+L+ ++ E Q + + + L+ ++ E
Sbjct: 1108 TSQKNNALKKIRELESHISDLQEDLESEKAARNKAEKQKRDLSEELEALKTEL----EDT 1163
Query: 475 QNYKKEQDELQMERDKAVKE 494
+ Q EL+ K +
Sbjct: 1164 LDTTATQQELRGSDYKDDDD 1183
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 20/127 (15%), Positives = 51/127 (40%)
Query: 379 EALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEE 438
L+ + E++ + ++ + KE E+ E ++++ E
Sbjct: 848 PLLKVTRQEEEMQAKDEELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQEKLQAETEL 907
Query: 439 LQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 498
A + + L ++ E ++ E+E +I E Q + E+ ++Q + ++ EE
Sbjct: 908 YAEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEEE 967
Query: 499 RKSRKEA 505
+R++
Sbjct: 968 EAARQKL 974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 29/213 (13%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV--- 589
+IGEG +G I++G LL + QVAIK S + + E + + V
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 590 GACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
G LV + L G SLED L S +T A ++ + + +H S+
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE---KSL 127
Query: 649 VHGDLKPANILL------DANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTF 699
V+ D+KP N L+ +AN + + DFG+ + + R GT
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFYRD----PVTKQHIPYREKKNLSGTA 182
Query: 700 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
YM E + + D+ + G + + L G
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV--- 589
KIG G +G IY G + + +VAIK+ + + + E I ++ + V
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 590 GACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
G + LV + L G SLED S LS +T + +A ++ + + F+HS S
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHS---KSF 124
Query: 649 VHGDLKPANILL----DANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTFAY 701
+H D+KP N L+ AN V + DFG++ ++ + + + R + GT Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTS----THQHIPYRENKNLTGTARY 179
Query: 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
E + + D+ S G +L+ L G
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 29/213 (13%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH----PNLVTL 588
KIG G +G + G L + VAIK+ S + E ++ P +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 589 VGACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
G C + +V E L G SLED D + S +T + IA +L S + ++HS +
Sbjct: 74 -GPCGKYNAMVLELL--GPSLEDLFDLCDRT--FSLKTVLMIAIQLISRMEYVHS---KN 125
Query: 648 IVHGDLKPANILLDANFVSK-----LSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTF 699
+++ D+KP N L+ + DF ++ ++ + R GT
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE----TKKHIPYREHKSLTGTA 181
Query: 700 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 732
YM E + + D+ + G + + L G
Sbjct: 182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 25/145 (17%), Positives = 55/145 (37%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 419
++LA A+ + E + + A E E A + + + E E ++ +
Sbjct: 104 ERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYE 163
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
+L ++ + E +++ + + LE +I K LE + + Y++
Sbjct: 164 EVARKLVIIESDLERAEERAELSEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEE 223
Query: 480 EQDELQMERDKAVKEAEELRKSRKE 504
E L + +A AE +S +
Sbjct: 224 EIKVLSDKLKEAETRAEFAERSVTK 248
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 23/154 (14%), Positives = 66/154 (42%), Gaps = 4/154 (2%)
Query: 356 DNLYDQLAQAMAEAE--NSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE 413
+N D+ +A A+ + R + E+ L + + A E + ++ +
Sbjct: 16 ENALDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATED--ELDKYSEALKDAQEKLEL 73
Query: 414 FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVEL 473
E+ + + ++ + ++ EEL A ++ + ++ E+++ A E E+ +
Sbjct: 74 AEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERGMKVIESR 133
Query: 474 LQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 507
Q +++ + +++ +A AE+ + +E +
Sbjct: 134 AQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVAR 167
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 32/143 (22%), Positives = 66/143 (46%)
Query: 356 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 415
+ QL +A AE++ R+ E A + E D + RA+ SE AE + K
Sbjct: 142 EIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEEIKTVT 201
Query: 416 EALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQ 475
L + + + E+ ++ D+ EE+++ D+ E++ ++++ +LE+ I + L
Sbjct: 202 NNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTKLEKSIDDLEDELY 261
Query: 476 NYKKEQDELQMERDKAVKEAEEL 498
K + + E D A+ + +
Sbjct: 262 AQKLKYKAISEELDHALNDMTSI 284
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 22/146 (15%), Positives = 50/146 (34%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 419
+ + + E + E A++ E R+ ES +R + E A
Sbjct: 132 SRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCA 191
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
+ E++ + + + + ++ E +I KE E + A + +K
Sbjct: 192 ELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTKLEK 251
Query: 480 EQDELQMERDKAVKEAEELRKSRKEA 505
D+L+ E + + + + A
Sbjct: 252 SIDDLEDELYAQKLKYKAISEELDHA 277
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 22/148 (14%), Positives = 54/148 (36%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 420
++ + EN+ A E + AE + + + + ++ EAL +
Sbjct: 7 KMQMLKLDKENALDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDELDKYSEALKD 66
Query: 421 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 480
+ +LE +K+ + ++ + L E ++ + + QK+ A + ++
Sbjct: 67 AQEKLELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERG 126
Query: 481 QDELQMERDKAVKEAEELRKSRKEASSS 508
++ K ++ E KEA
Sbjct: 127 MKVIESRAQKDEEKMEIQEIQLKEAKHI 154
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 20/151 (13%), Positives = 55/151 (36%)
Query: 357 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEE 416
D+L + ++++ + + AE D RR + E +R +
Sbjct: 52 ATEDELDKYSEALKDAQEKLELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQ 111
Query: 417 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 476
L + + ++ + Q ++ + E Q+ E+ A++ ++K L
Sbjct: 112 KLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVI 171
Query: 477 YKKEQDELQMERDKAVKEAEELRKSRKEASS 507
+ + + + + + + EL + K ++
Sbjct: 172 IESDLERAEERAELSEGKCAELEEEIKTVTN 202
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 20/146 (13%), Positives = 51/146 (34%), Gaps = 2/146 (1%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 420
++ ++ A+ + + E E L+ K + + R+ + + EE
Sbjct: 128 KVIESRAQKDEEKMEIQEIQLKEAKHIAEDAD--RKYEEVARKLVIIESDLERAEERAEL 185
Query: 421 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 480
+ + ++++ V L+ Q + + ++ K L K+ A + ++
Sbjct: 186 SEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERS 245
Query: 481 QDELQMERDKAVKEAEELRKSRKEAS 506
+L+ D E + K S
Sbjct: 246 VTKLEKSIDDLEDELYAQKLKYKAIS 271
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 22/148 (14%), Positives = 63/148 (42%), Gaps = 3/148 (2%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 419
L + + E+ + EAL+ + + + E ++A +E+ A +R + FEE L
Sbjct: 44 VSLQKKLKATEDELDKY-SEALKDAQEKLELAE--KKATDAEADVASLNRRIQLFEEELD 100
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
+ L ++ +E + + ++ES+ + ++ + E ++ A + ++ +
Sbjct: 101 RAQERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADR 160
Query: 480 EQDELQMERDKAVKEAEELRKSRKEASS 507
+ +E+ + + E + + +
Sbjct: 161 KYEEVARKLVIIESDLERAEERAELSEG 188
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 17/83 (20%), Positives = 41/83 (49%)
Query: 425 LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDEL 484
++ +KK+ + + + ALD+ E+ ++ +K+LE +++S + L+ + E D+
Sbjct: 1 MDAIKKKMQMLKLDKENALDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDELDKY 60
Query: 485 QMERDKAVKEAEELRKSRKEASS 507
A ++ E K +A +
Sbjct: 61 SEALKDAQEKLELAEKKATDAEA 83
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 22/159 (13%), Positives = 60/159 (37%), Gaps = 7/159 (4%)
Query: 356 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 415
+ + A A+ + R +A++ ++++ + +E E + K E
Sbjct: 72 ELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERGMKVIE 131
Query: 416 EALANGKLELERMKKQHDEV---MEELQIALD----QKSLLESQIAESDQTAKELEQKII 468
+ ++E + Q E E+ + + ++ES + +++ A+ E K
Sbjct: 132 SRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCA 191
Query: 469 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 507
E ++ L+ + +K ++ ++ + K S
Sbjct: 192 ELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSD 230
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 7e-09
Identities = 24/149 (16%), Positives = 61/149 (40%), Gaps = 1/149 (0%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR-KEFEEALA 419
L + RR + L++ K E ++E ++ +L+R+ E +
Sbjct: 886 TLKAIVYLQCCYRRMMAKRELKKLKIEARSVERYKKLHIGLENKIMQLQRKIDEQNKEYK 945
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
+ ++ ++ + E+L+ +++ + E + + L+++I + L +
Sbjct: 946 SLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQT 1005
Query: 480 EQDELQMERDKAVKEAEELRKSRKEASSS 508
E+ ++ DK E E+L KE ++
Sbjct: 1006 EKKTIEEWADKYKHETEQLVSELKEQNTL 1034
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 26/158 (16%), Positives = 57/158 (36%), Gaps = 14/158 (8%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 420
+ + E E +++ E ++ R+ Y L++ E +
Sbjct: 903 KRELKKLKIEARSVERYKKL--HIGLENKIMQLQRKIDEQNKEYKSLLEKMNNLEITYST 960
Query: 421 GKLEL----ERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 476
+L ER++ EE + A ++ L+ +IA+ + + + + + E
Sbjct: 961 ETEKLRSDVERLRMS----EEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKTIEEWADK 1016
Query: 477 YKKEQDELQMERDKAV----KEAEELRKSRKEASSSSH 510
YK E ++L E + E EEL + + +
Sbjct: 1017 YKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEIT 1054
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 24/147 (16%), Positives = 58/147 (39%), Gaps = 3/147 (2%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIES-IRRAKASESLYAEELKRRKEFEEALA 419
+ +++ ++ R R ++ RR A L +++ R
Sbjct: 863 REHKSIIIQKHVRGWLARVHYHRTLKAIVYLQCCYRRMMAKRELKKLKIEARSVERYKKL 922
Query: 420 NGKLE--LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNY 477
+ LE + +++++ DE +E + L++ + LE + + + +++ + E +N
Sbjct: 923 HIGLENKIMQLQRKIDEQNKEYKSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNA 982
Query: 478 KKEQDELQMERDKAVKEAEELRKSRKE 504
LQ E K KE + + +K
Sbjct: 983 TNRVLSLQEEIAKLRKELHQTQTEKKT 1009
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 29/173 (16%), Positives = 59/173 (34%), Gaps = 14/173 (8%)
Query: 342 LQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASE 401
+Q + + D A + + R I+ R +
Sbjct: 822 IQKFQRMYVVRKRYQCMRDATIALQALLRGYLVRNKYQMMLREHKSI-IIQKHVRGWLAR 880
Query: 402 SLYAEELKRR----KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESD 457
Y LK + +A K EL+++K + V ++ LE++I +
Sbjct: 881 VHYHRTLKAIVYLQCCYRRMMA--KRELKKLKIEARSVERYKKL----HIGLENKIMQLQ 934
Query: 458 QTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH 510
+ E ++ LL+ + E +K + E LR S +EA ++++
Sbjct: 935 RKIDEQNKEY---KSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNATN 984
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 14/145 (9%), Positives = 50/145 (34%), Gaps = 7/145 (4%)
Query: 364 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 423
+ + ++ +R A +++ + Y + +R+ + + +
Sbjct: 857 KYQMMLREHKSIIIQKHVRGWLARVHYHRTLKAIVYLQCCYRRMMAKRELKKLKIEARSV 916
Query: 424 E-LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 482
E +++ + + +LQ +D+ + + LE + + + +
Sbjct: 917 ERYKKLHIGLENKIMQLQRKIDE---QNKEYKSLLEKMNNLEITY---STETEKLRSDVE 970
Query: 483 ELQMERDKAVKEAEELRKSRKEASS 507
L+M ++A + ++E +
Sbjct: 971 RLRMSEEEAKNATNRVLSLQEEIAK 995
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 20/134 (14%), Positives = 52/134 (38%), Gaps = 9/134 (6%)
Query: 364 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 423
+ E + + E LR + E + + EE+ + ++ K
Sbjct: 955 EITYSTETEKLRSDVERLRMSEEEAKNATNRVLSLQ------EEIAKLRKELHQTQTEKK 1008
Query: 424 ELERMKKQHDEVMEELQIALD-QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 482
+E ++ E+L L Q +LL+++ E ++ + ++I +E + +E
Sbjct: 1009 TIEEWADKYKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEITETME--KKLVEETK 1066
Query: 483 ELQMERDKAVKEAE 496
+L+++ + +
Sbjct: 1067 QLELDLNDERLRYQ 1080
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 51/271 (18%), Positives = 86/271 (31%), Gaps = 95/271 (35%)
Query: 535 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF-QQEIDILSKIR-----HPN-- 584
K+G G + +++ + VA+K++ S + +E EI +L +R PN
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVK--SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 585 -LVTLVGA-----------CPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIAT 631
+V L+ C +V+E L G L K N L +I
Sbjct: 102 MVVQLLDDFKISGVNGTHIC-----MVFEVL--GHHLLK-WIIKSNYQGLPLPCVKKIIQ 153
Query: 632 ELCSVLIFLHSCKPHSIVHGDLKPANILL------------------------------- 660
++ L +LH+ I+H D+KP NILL
Sbjct: 154 QVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 661 ------------------DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
K++D G + ++ + T+ T Y
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----------HFTEDIQTRQYR 260
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
E L +D++S + L TG
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDY 291
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 57/246 (23%), Positives = 90/246 (36%), Gaps = 77/246 (31%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKML---HPHSLQGPSEFQQEIDILSKIRH-----PN 584
K+G+G +G + + A+K++ ++ + E DIL KI++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 585 LVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIR-IATELCS 635
+V G C L++E L SL + + N+ + I+ E+
Sbjct: 98 IVKYHGKFMYYDHMC-----LIFEPL-GPSLYEII--TRNNYNGFHIE-DIKLYCIEILK 148
Query: 636 VLIFLHSCKPHSIVHGDLKPANILLDANFVS-------------------------KLSD 670
L +L + H DLKP NILLD + KL D
Sbjct: 149 ALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 671 FGISRFLSQNE---ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 727
FG + F S I++ R Y PE + + SD++SFG +L
Sbjct: 206 FGCATFKSDYHGSIINT-------RQ-------YRAPEVILNLGWDVSSDMWSFGCVLAE 251
Query: 728 LLTGRP 733
L TG
Sbjct: 252 LYTGSL 257
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 57/240 (23%), Positives = 89/240 (37%), Gaps = 69/240 (28%)
Query: 535 KIGEGGYGSIYKGLLRHMQ---VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP----- 583
+GEG +G + + + VA+K++ + EI +L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNST 76
Query: 584 -NLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIR-IATEL 633
V ++ C +V+E L S D + K+N P IR +A ++
Sbjct: 77 FRCVQMLEWFEHHGHIC-----IVFELL-GLSTYDFI--KENGFLPFRLD-HIRKMAYQI 127
Query: 634 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-------------------KLSDFGIS 674
C + FLHS K + H DLKP NIL + + K+ DFG +
Sbjct: 128 CKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 733
+ ++ T + R Y PE LA G P DV+S G IL+ G
Sbjct: 185 TYDDEHHS----TLVSTR------H-YRAPEVILALGWSQP-CDVWSIGCILIEYYLGFT 232
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 50/240 (20%), Positives = 84/240 (35%), Gaps = 69/240 (28%)
Query: 535 KIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP----- 583
+GEG +G + + L QVA+K++ + EI++L KI+
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENK 81
Query: 584 -NLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 635
V + C + +E L + + ++N P +A +LC
Sbjct: 82 FLCVLMSDWFNFHGHMC-----IAFELL-GKNTFE-FLKENNFQPYPLPHVRHMAYQLCH 134
Query: 636 VLIFLHSCKPHSIVHGDLKPANILLDANFVS-------------------KLSDFGISRF 676
L FLH + + H DLKP NIL + +++DFG + F
Sbjct: 135 ALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 677 LSQNE---ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
++ +++ R Y PE + DV+S G IL G
Sbjct: 192 DHEHHTTIVAT-------R------H-YRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 4e-07
Identities = 15/77 (19%), Positives = 33/77 (42%), Gaps = 4/77 (5%)
Query: 431 QHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIIS-AVELLQNYKKEQDELQMERD 489
Q D + +E + + ++ E D +K +EQ+ A + L+ + + Q E Q+E++
Sbjct: 76 QADRLTQEPESIRKWREEQRKRLQELDAASKVMEQEWREKAKKDLEEWNQRQSE-QVEKN 134
Query: 490 KAV--KEAEELRKSRKE 504
K + +
Sbjct: 135 KINNRIADKAFYQQPDA 151
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 1e-06
Identities = 23/110 (20%), Positives = 42/110 (38%), Gaps = 33/110 (30%)
Query: 361 QLAQAMAEAENSR--REAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 418
Q + E E+ R RE + L E DA + +E + E+A
Sbjct: 76 QADRLTQEPESIRKWREEQRKRL----QELDAASKVME---------QEWR-----EKA- 116
Query: 419 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 468
K +LE ++ E +E K+ + ++IA+ ++ + II
Sbjct: 117 ---KKDLEEWNQRQSEQVE--------KNKINNRIAD-KAFYQQPDADII 154
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 2e-06
Identities = 26/140 (18%), Positives = 54/140 (38%), Gaps = 8/140 (5%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 420
Q +EAE +R+E E +A A+ES AKA AE R E E ++
Sbjct: 691 QKILDQSEAEKARKELLEL-----EAMSMAVESTGNAKAEAESRAEA--ARIEGEGSVLQ 743
Query: 421 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQT-AKELEQKIISAVELLQNYKK 479
KL+ + + + + +E ++ + + + E + + A++L + +
Sbjct: 744 AKLKAQALAIETEAELERVKKVREMELIYARAQLELEVSKAQQLANVEAKKFKEMTEALG 803
Query: 480 EQDELQMERDKAVKEAEELR 499
+ + + L+
Sbjct: 804 PGTIRDLAVAGPEMQVKLLQ 823
|
| >2efr_A General control protein GCN4 and tropomyosin 1 Al; destabilizing cluster, hydrophobic core, contractIle protein; 1.80A {Saccharomyces cerevisiae} PDB: 2efs_A 2d3e_A Length = 155 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 26/145 (17%), Positives = 60/145 (41%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 420
++ Q + E + + + +K + RA+ SE AE + K L +
Sbjct: 1 RMKQLEDKVEELLSKNYHLENEVARLKKLLERAEERAELSEGKSAELEEELKTVTNNLKS 60
Query: 421 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 480
+ + E+ ++ D+ EE+++ D+ E++ ++++ +LE+ I + L K +
Sbjct: 61 LEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTKLEKSIDDLEDELYAQKLK 120
Query: 481 QDELQMERDKAVKEAEELRKSRKEA 505
+ E + + EEL
Sbjct: 121 YKAISEEMKQLEDKVEELLSKNYHL 145
|
| >1w1w_A Structural maintenance of chromosome 1; cohesin, chromosome segregation, cell adhesion, kleisin, MIT cell cycle; HET: ATG; 2.90A {Saccharomyces cerevisiae} SCOP: c.37.1.12 Length = 430 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 18/144 (12%), Positives = 50/144 (34%), Gaps = 9/144 (6%)
Query: 370 ENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANG---KLELE 426
+ + + L A + E + A+ E ++ K E E
Sbjct: 124 KTVSYKDYSIFLENENILIKAKNFLVFQGDVEQIAAQSPVELSRMFEEVSGSIQYKKEYE 183
Query: 427 RMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVEL------LQNYKKE 480
+K++ +++ + ++ + + ++ E+ + + E
Sbjct: 184 ELKEKIEKLSKSATESIKNRRRIHGELKTYKSPGLEVLFQGPRGSRYDEAEGRFEVINNE 243
Query: 481 QDELQMERDKAVKEAEELRKSRKE 504
++L+ E K + + +++K RKE
Sbjct: 244 TEQLKAEEKKILNQFLKIKKKRKE 267
|
| >1cii_A Colicin IA; bacteriocin, ION channel formation, transmembrane protein; 3.00A {Escherichia coli} SCOP: f.1.1.1 h.4.3.1 Length = 602 | Back alignment and structure |
|---|
Score = 47.4 bits (111), Expect = 2e-05
Identities = 22/151 (14%), Positives = 48/151 (31%), Gaps = 1/151 (0%)
Query: 356 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKR-RKEF 414
+ L+ E EN R EA + A + +++ +A + A+ ++ +
Sbjct: 56 TAYKNTLSAQQKENENKRTEAGKRLSAAIAAREKDENTLKTLRAGNADAADITRQEFRLL 115
Query: 415 EEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 474
+ L E + E ++ L E+ ++ E++ A
Sbjct: 116 QAELREYGFRTEIAGYDALRLHTESRMLFADADSLRISPREARSLIEQAEKRQKDAQNAD 175
Query: 475 QNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
+ E + + EL K+ A
Sbjct: 176 KKAADMLAEYERRKGILDTRLSELEKNGGAA 206
|
| >2v71_A Nuclear distribution protein NUDE-like 1; developmental protein, nuclear protein, neurogenesis, cytosk LIS1 binding, differentiation; 2.24A {Rattus norvegicus} Length = 189 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 24/155 (15%), Positives = 62/155 (40%), Gaps = 7/155 (4%)
Query: 359 YDQLAQAMAEAENSRREAFEEAL-----RRGKAEKDAIESIRRAKA-SESLYAEELKRRK 412
+ + + E + RE E L + + +D +R K E+L + +
Sbjct: 26 FQEARDELVEFQEGSRE-LEAELEAQLVQAEQRNRDLQADNQRLKYEVEALKEKLEHQYA 84
Query: 413 EFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVE 472
+ + ++ + +L + + +++ + ++ LE + + ++ EQ++ A+E
Sbjct: 85 QSYKQVSVLEDDLSQTRAIKEQLHKYVRELEQANDDLERAKRATIMSLEDFEQRLNQAIE 144
Query: 473 LLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 507
+ E DE + + +E R R+E +
Sbjct: 145 RNAFLESELDEKESLLVSVQRLKDEARDLRQELAV 179
|
| >1f5n_A Interferon-induced guanylate-binding protein 1; GBP, GTP hydrolysis, GDP, GMP, dynamin related, large GTPase family. GMPPNP, GPPNHP.; HET: GNP; 1.70A {Homo sapiens} SCOP: a.114.1.1 c.37.1.8 PDB: 1dg3_A* 2b8w_A* 2b92_A* 2bc9_A* 2d4h_A* Length = 592 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 8e-05
Identities = 21/164 (12%), Positives = 60/164 (36%), Gaps = 13/164 (7%)
Query: 356 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 415
Y Q + + + + +EE + +AE+ ++ ++ + + E E
Sbjct: 430 PGGYRLFVQKLQDLKK---KYYEEPRKGIQAEEILQTYLKSKESMTDAILQTDQTLTEKE 486
Query: 416 EALANGKLELERMKKQHDEVMEELQ-----IALDQKSLLESQIAESDQTAKELEQKIISA 470
+ + +++ E + + E + + ++S E +++ + Q +
Sbjct: 487 KEIEVERVKAESAQASAKMLHEMQRKNEQMMEQKERSYQEHLKQLTEKMENDRVQLLKEQ 546
Query: 471 VELLQNYKKEQDEL-----QMERDKAVKEAEELRKSRKEASSSS 509
L +EQ++L Q E E ++L+ + + +
Sbjct: 547 ERTLALKLQEQEQLLKEGFQKESRIMKNEIQDLQTKMRRRKACT 590
|
| >2xs1_A Programmed cell death 6-interacting protein; protein transport-viral protein complex, cell cycle; 2.30A {Homo sapiens} PDB: 2xs8_A 2oev_A 2r05_A 2r02_A 2r03_A 2oex_A 2ojq_A Length = 704 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 1e-04
Identities = 28/157 (17%), Positives = 55/157 (35%), Gaps = 12/157 (7%)
Query: 360 DQLAQAMAEAENSRREAFE---------EALRRGKAE-KDAIESIRRAKASESLYAEELK 409
+ +A + + E L + + E AI S AK + +E +
Sbjct: 499 TNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQG--SEVVN 556
Query: 410 RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIIS 469
K L K E E ++ V ++ + I E + EL++
Sbjct: 557 VLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGG 616
Query: 470 AVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 506
+Q K+Q+ L + +E ++++S EA+
Sbjct: 617 LTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEAN 653
|
| >3haj_A Human pacsin2 F-BAR; pacsin,syndapin,FAP52,F-BAR, alternative splicing, coiled coil, cytoplasmic vesicle, endocytosis, phosphoprotein, polymorphism; 2.78A {Homo sapiens} Length = 486 | Back alignment and structure |
|---|
Score = 44.4 bits (103), Expect = 1e-04
Identities = 28/166 (16%), Positives = 51/166 (30%), Gaps = 8/166 (4%)
Query: 355 DDNLYDQLAQAMAEAENSRREAFEEALR-RGKAEKDAIESIRRAKASESLYAEELKRRKE 413
+ Y + + + + + L R + EK + + E+ +
Sbjct: 20 EVGNYKRTVKRIDDGHRLCSD-LMNCLHERARIEKAYAQQLTEWARRWRQLVEKGPQYGT 78
Query: 414 FEEALANGKLELERMKKQHDEVMEELQ------IALDQKSLLESQIAESDQTAKELEQKI 467
E+A E ER+ + H EV L I QK Q+ + KE E
Sbjct: 79 VEKAWMAFMSEAERVSELHLEVKASLMNDDFEKIKNWQKEAFHKQMMGGFKETKEAEDGF 138
Query: 468 ISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQ 513
A + KE + + A KE + + + +
Sbjct: 139 RKAQKPWAKKLKEVEAAKKAHHAACKEEKLAISREANSKADPSLNP 184
|
| >2fxo_A Myosin heavy chain, cardiac muscle beta isoform; coiled coil (dimeric, parallel), familial hypertrophic cardiomyopathy, FHC-associated mutant E924K; 2.50A {Homo sapiens} SCOP: h.1.26.1 PDB: 2fxm_A Length = 129 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 22/121 (18%), Positives = 52/121 (42%), Gaps = 7/121 (5%)
Query: 381 LRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQ 440
L+ + EK+ + + RRKE EE ++ + ++ +++ ++Q
Sbjct: 6 LKSAEREKEMASMKEEFTRLKEALEKSEARRKELEE-------KMVSLLQEKNDLQLQVQ 58
Query: 441 IALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 500
D + E + + + +LE K+ + L++ ++ EL ++ K E EL++
Sbjct: 59 AEQDNLADAEERCDQLIKNKIQLEAKVKEMNKRLEDEEEMNAELTAKKRKLEDECSELKR 118
Query: 501 S 501
Sbjct: 119 D 119
|
| >4f61_I Stathmin-like domain R4; alpha-tubulin, beta-tubulin, GTPase, microtubule, RB3, stath tubulin, cell cycle; HET: GTP GDP; 4.17A {Artificial gene} Length = 240 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 2e-04
Identities = 30/146 (20%), Positives = 64/146 (43%), Gaps = 6/146 (4%)
Query: 361 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 420
+LAQ M + +R F L R + + E +R+ E + E+
Sbjct: 97 KLAQKMESNKENREAHFAAMLERLQEKDKHAEEVRQRAIEE----NNNWIKMAKEKLAQK 152
Query: 421 GKLELERMKKQHDEVMEELQIALD-QKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
+ E K Q E+++ L + ++ +++ I E++ K ++K+ +E + ++
Sbjct: 153 MESNKENRKYQEAELLKHLAEKREHEREVIQRAIEENNNWIKMAKEKLAQKMESNKENRE 212
Query: 480 EQDELQMER-DKAVKEAEELRKSRKE 504
+ER + K AEE+RK+++
Sbjct: 213 AHFAAMLERLQEKDKHAEEVRKNKEL 238
|
| >3qwe_A GMIP, GEM-interacting protein; structural genomics consortium, SGC, protein binding; 2.40A {Homo sapiens} Length = 279 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 2e-04
Identities = 27/144 (18%), Positives = 61/144 (42%), Gaps = 16/144 (11%)
Query: 358 LYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEA 417
Y LA E E R+E E+ ++ K +A++++RRA+ +E+L+ R +
Sbjct: 99 YYQPLAAKRTEIEKWRKEFKEQWMKEQKRMNEAVQALRRAQLQYVQRSEDLRARSQGSPE 158
Query: 418 LANGKLE------LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAV 471
+ + ER ++ +E + Q A ++ + E++ ++LE V
Sbjct: 159 DSAPQASPGPSKQQERRRRSREEAQAKAQEAEAL---YQACVREANARQQDLEIAKQRIV 215
Query: 472 ELLQNYKKEQDELQMERDKAVKEA 495
++ +L + D+ ++
Sbjct: 216 SHVR-------KLVFQGDEVLRRV 232
|
| >3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori} Length = 256 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 15/97 (15%), Positives = 35/97 (36%), Gaps = 5/97 (5%)
Query: 409 KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 468
+E + L + E K + EE Q S E + +++ +++K+
Sbjct: 25 PLIREKRKDLDKALNDKEAKNKAILNLEEEKLALKLQVSKNEQTLQDTNAKIASIQKKMS 84
Query: 469 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 505
++E L +E D A + + + + +
Sbjct: 85 EIKS-----ERELRSLNIEEDIAKERSNQANREIENL 116
|
| >2v0o_A FCHO2, FCH domain only protein 2; lipid-binding protein, EFC domain, vesicle trafficking, membrane curvature, endocytosis, exocytosis, F-BAR domain; 2.30A {Homo sapiens} Length = 276 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 29/229 (12%), Positives = 77/229 (33%), Gaps = 28/229 (12%)
Query: 375 EAFEEALRRGKAEKDAIESIR-----RAKASESLYAEELKR----------RKEFEEALA 419
F+ K + + + + RA E Y+ + + F
Sbjct: 18 SGFDVLYHNMKHGQISTKELADFVRERATI-EEAYSRSMTKLAKSASNYSQLGTFAPVWD 76
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
K E++ H +++ +LQ + + ++ E ++ K+ ++++ +E +Q +
Sbjct: 77 VFKTSTEKLANCHLDLVRKLQELIKE---VQKYGEEQVKSHKKTKEEVAGTLEAVQTIQS 133
Query: 480 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSE---------IEGATHNF 530
LQ ++ + E + +KE ++ + + + A +F
Sbjct: 134 ITQALQKSKENYNAKCVEQERLKKEGATQREIEKAAVKSKKATDTYKLYVEKYALAKADF 193
Query: 531 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 579
+ + + I + L H++ I L + + Q +
Sbjct: 194 EQKMTETAQKFQDIEETHLIHIKEIIGSLSNAIKEIHLQIGQVHEEFIN 242
|
| >3auy_A DNA double-strand break repair RAD50 ATPase; DNA repair, ABC transporter ATPase domain-like; HET: DNA ADP; 2.70A {Methanocaldococcus jannaschii} PDB: 3aux_A* 3av0_B* Length = 371 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 21/143 (14%), Positives = 48/143 (33%), Gaps = 12/143 (8%)
Query: 366 MAEAENSRREAFEEAL----------RRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 415
++ + + E + L + G+ K+ + + R + + E LK R +
Sbjct: 141 LSLKPSEKLETVAKLLGIDEFEKCYQKMGEIVKEYEKRLERIEGELNYKEESLKARLKEM 200
Query: 416 EALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQ 475
L K +L + + D+V Q L E + + E + ++
Sbjct: 201 SNLEKEKEKLTKFVEYLDKVRRIFGRNGFQAYLREKYVPLIQKYLNEAFSEFDLPYSFVE 260
Query: 476 NYKKEQDELQMERDKAVKEAEEL 498
+ E+++ V + L
Sbjct: 261 --LTKDFEVRVHAPNGVLTIDNL 281
|
| >2dgj_A Hypothetical protein EBHA; helix-bundle, ROD-like structure, adhesin, cell adhesion; 2.35A {Staphylococcus aureus} Length = 257 | Back alignment and structure |
|---|
Score = 41.5 bits (96), Expect = 7e-04
Identities = 30/174 (17%), Positives = 63/174 (36%), Gaps = 15/174 (8%)
Query: 350 LDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGK-------AEKDAIESIRRAKASES 402
L +DD + Q +AE S++ A+++A+ K ++ RA +
Sbjct: 6 LQHGIDDENATKQTQKYRDAEQSKKTAYDQAVAAAKAILNKQTGSNSDKAAVDRALQQVT 65
Query: 403 LYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLE------SQIAES 456
+ L + EA A + L + + L+ ++Q + ++ +
Sbjct: 66 STKDALNGDAKLAEAKAAARQNLGTLNHITNAQRTALEGQINQATTVDGVNTVKTNANTL 125
Query: 457 DQTAKELEQKIISAVELLQ--NYKKEQDELQMERDKAVKEAEELRKSRKEASSS 508
D L+ I L+ NY + + +AV AE + + ++S
Sbjct: 126 DGAMNSLQGAINDKDATLRNQNYLDADESKRNAYTQAVTAAEGILNKQTGGNTS 179
|
| >3o0z_A RHO-associated protein kinase 1; coiled-coil, transferase; HET: MSE; 2.33A {Homo sapiens} Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (94), Expect = 7e-04
Identities = 27/128 (21%), Positives = 50/128 (39%), Gaps = 8/128 (6%)
Query: 378 EEALRRGKAEKDAIESIRRAKASESLYAEEL-KRRKEFEEALANGKLELERMKKQHDEVM 436
EEA + E D +R++ S +L +E +E LE K Q D+
Sbjct: 16 EEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNR----ILENSKSQTDKDY 71
Query: 437 EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAE 496
+LQ L+ + +L+ +I S E +++ K ++++ ER +A
Sbjct: 72 YQLQAILEA---ERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLN 128
Query: 497 ELRKSRKE 504
K +
Sbjct: 129 HSEKEKNN 136
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 846 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.59 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.59 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 99.55 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.53 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 99.5 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 99.5 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.48 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 99.45 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 99.45 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 99.44 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 99.42 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 99.34 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 99.3 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.25 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.23 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.17 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.15 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.12 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.1 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.04 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.01 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 98.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.12 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.0 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.54 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.47 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.44 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.4 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.31 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.1 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.8 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.69 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.44 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.18 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.16 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.44 | |
| 2fxo_A | 129 | Myosin heavy chain, cardiac muscle beta isoform; c | 93.78 | |
| 3vkg_A | 3245 | Dynein heavy chain, cytoplasmic; AAA+ protein, mol | 93.52 | |
| 3vkg_A | 3245 | Dynein heavy chain, cytoplasmic; AAA+ protein, mol | 92.57 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 92.46 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.4 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 91.16 | |
| 3na7_A | 256 | HP0958; flagellar biogenesis, flagellum export, C4 | 90.97 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 89.91 | |
| 3qwe_A | 279 | GMIP, GEM-interacting protein; structural genomics | 88.56 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 88.27 | |
| 3ol1_A | 119 | Vimentin; structural genomics, PSI-2, protein stru | 88.23 | |
| 2b9c_A | 147 | Striated-muscle alpha tropomyosin; alpha-helix, co | 87.02 | |
| 2ocy_A | 154 | RAB guanine nucleotide exchange factor SEC2; RAB, | 86.54 | |
| 3tnu_B | 129 | Keratin, type II cytoskeletal 5; coiled-coil, stru | 85.42 | |
| 3bas_A | 89 | Myosin heavy chain, striated muscle/general contro | 84.17 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 84.04 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.69 | |
| 2efr_A | 155 | General control protein GCN4 and tropomyosin 1 Al; | 80.39 | |
| 2i1j_A | 575 | Moesin; FERM, coiled-coil, C-ermad, ERM, radixin, | 80.18 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=449.26 Aligned_cols=263 Identities=25% Similarity=0.414 Sum_probs=209.9
Q ss_pred hcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccc-cCceEEEEEe
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTLVYEY 602 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~-~~~~~lVmEy 602 (846)
..++|.+.++||+|+||+||+|.+++ .||||+++..... ..+.|.+|+.+|++++|||||+++|+| .+.++|||||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy 112 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQW 112 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEc
Confidence 34577888999999999999998876 5999998754332 235699999999999999999999998 4568999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
|+||+|.++|... ..++++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999533 3569999999999999999999999 8999999999999999999999999999987654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
... .....||+.|||||++.+ +.|+.++|||||||+||||+||++||............ .......|...
T Consensus 188 ~~~------~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~-~~~~~~~p~~~ 260 (307)
T 3omv_A 188 SQQ------VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM-VGRGYASPDLS 260 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH-HHTTCCCCCST
T ss_pred cee------ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH-HhcCCCCCCcc
Confidence 111 134569999999999964 46899999999999999999999999764432221111 11122333344
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
..+..++..+.+|+.+||+.+|.+||++ .+|+..|+.|+...
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-~ei~~~Le~l~~~l 302 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLF-PQILSSIELLQHSL 302 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCH-HHHHHHHHHHHTTC
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHhccC
Confidence 4555667899999999999999999999 88889999887653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=451.46 Aligned_cols=256 Identities=24% Similarity=0.457 Sum_probs=212.2
Q ss_pred CCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
++|.+.++||+|+||+||+|.+. +..||||+++.......+.|.+|+.+|++|+|||||+++|+|. +..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46888899999999999999874 4679999998655444567999999999999999999999994 56899
Q ss_pred EEEecCCCchhhhhccC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceee
Q 003121 599 VYEYLPNGSLEDRLSCK----------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 668 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~----------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL 668 (846)
|||||++|+|.++|... .....++|..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999643 234579999999999999999999999 89999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH--HH
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--AL 745 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~--~~ 745 (846)
+|||+|+.......... .....||+.|||||++.++.|+.++|||||||+||||+| |++||........ .+
T Consensus 170 ~DFGla~~~~~~~~~~~------~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRV------GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEE------TTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcccceecCCCCceee------cCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999987654332111 122358999999999999999999999999999999999 9999976554332 12
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
..+ .....|..+++.+.+|+.+||+.+|.+||++ ++|.+.|+.+...
T Consensus 244 ~~~--------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 TQG--------RVLQRPRTCPQEVYELMLGCWQREPHMRKNI-KGIHTLLQNLAKA 290 (299)
T ss_dssp HHT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred HcC--------CCCCCCccchHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHhc
Confidence 221 1223455667899999999999999999999 7888999988764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=452.37 Aligned_cols=256 Identities=24% Similarity=0.449 Sum_probs=206.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
.+|.+.++||+|+||+||+|.++ +..||||+++.......+.|.+|+.+|++|+|||||+++|+|. +..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46778889999999999999875 4679999998655444567999999999999999999999994 46899
Q ss_pred EEEecCCCchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 599 VYEYLPNGSLEDRLSCKD------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
|||||++|+|.++|.... ...+++|..++.|+.||+.||.|||+ ++||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999996532 23579999999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH-
Q 003121 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA- 744 (846)
Q Consensus 667 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~- 744 (846)
||+|||+++.+........ .+...||+.|||||++.+..|+.++|||||||+||||+| |++||.........
T Consensus 198 Ki~DFGla~~~~~~~~~~~------~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRV------GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp EECCCC----------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred EEcccccceeccCCCccee------cCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999997654322111 134569999999999999999999999999999999999 89999765543321
Q ss_pred -HhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 745 -LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 745 -~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
+..+ .....|..+++.+.+|+.+||+.+|.+||++ ++|.+.|+.+...
T Consensus 272 ~i~~g--------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 CITQG--------RELERPRACPPEVYAIMRGCWQREPQQRHSI-KDVHARLQALAQA 320 (329)
T ss_dssp HHHHT--------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCH-HHHHHHHHHHHHS
T ss_pred HHHcC--------CCCCCcccccHHHHHHHHHHcCcChhHCcCH-HHHHHHHHHHhhC
Confidence 1111 1233455667899999999999999999999 8888999988653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=445.57 Aligned_cols=254 Identities=23% Similarity=0.372 Sum_probs=208.0
Q ss_pred CCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
++.+.++||+|+||+||+|.+. ++.||||+++..... ..+.|.+|+.+|++|+|||||+++|+|. +..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566789999999999999874 367999999765332 3467999999999999999999999994 56899
Q ss_pred EEEecCCCchhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc
Q 003121 599 VYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 665 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~ 665 (846)
|||||++|+|.++|..... ...+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence 9999999999999964321 2469999999999999999999999 89999999999999999999
Q ss_pred eeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 003121 666 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA 744 (846)
Q Consensus 666 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~ 744 (846)
+||+|||+++.+........ .+...||+.|||||++.++.|+.++|||||||+||||+| |++||.........
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~------~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKL------LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCS------SSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred EEECCcccceeccCCCceeE------ecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999997654332211 134569999999999999999999999999999999999 89999766543321
Q ss_pred HhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 745 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 745 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
... ........|..++..+.+|+.+||+.+|.+||+| .+|.+.|+.+
T Consensus 258 ~~i------~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~-~ei~~~L~a~ 304 (308)
T 4gt4_A 258 EMI------RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRF-KDIHSRLRAW 304 (308)
T ss_dssp HHH------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTS
T ss_pred HHH------HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCH-HHHHHHHHhc
Confidence 111 1111223455667889999999999999999999 7787777754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=438.97 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=205.3
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
..|+..++||+|+||+||+|.+. ++.||||++........+.+.+|+.+|++++|||||+++++| .+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 36888899999999999999986 678999999876666677899999999999999999999998 45799999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
+||+|.+++.. ..+++..+..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999853 359999999999999999999999 89999999999999999999999999999976543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.+..+||+.|||||++.+..|+.++|||||||+||||+||++||............ .....+.. ..+.
T Consensus 227 --------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~~~~~~-~~~~ 294 (346)
T 4fih_A 227 --------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRL-KNLH 294 (346)
T ss_dssp --------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSSCCCC-SCGG
T ss_pred --------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcCCCCCC-Cccc
Confidence 13457999999999999999999999999999999999999999776554322111 11111211 2233
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..+.+||.+||..||.+||++ +++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta-~e~ 321 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATA-AEL 321 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCH-HHH
Confidence 456889999999999999999999 444
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=437.32 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=203.8
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
.+.|...++||+|+||+||+|.+. +..||||+++.... +.+|+.+|+.|+|||||+++++| .+.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888889999999999999986 67899999986432 25799999999999999999998 4568999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC-ceeeecccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNE 681 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~-~vKL~DFGla~~~~~~~ 681 (846)
|+||+|.++|... .++++..+..|+.||+.||.|||+ ++||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999543 469999999999999999999999 8999999999999999887 69999999999876543
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHhhhhhccccCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLAG 759 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~--~~~~~~~~~~~ld~~~~ 759 (846)
..... ......+||+.|||||++.+..|+.++|||||||+||||+||++||....... ..+... .+...
T Consensus 206 ~~~~~---~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~~~~~ 276 (336)
T 4g3f_A 206 LGKSL---LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE------PPPIR 276 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS------CCGGG
T ss_pred cccce---ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC------CCCch
Confidence 22111 11234579999999999999999999999999999999999999996543321 111111 11112
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
..|...+..+.+||.+||..||.+||++ .++++.|.......
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa-~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRASA-MELRRKVGKALQEV 318 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHT
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcCH-HHHHHHHHHHHhhh
Confidence 2344567889999999999999999999 77777776655443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=442.01 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=198.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
++|.+.++||+|+||+||+|... ++.||||++....... .+.|.+|+.+|++|+|||||+++++| .+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999986 6889999998654332 35689999999999999999999998 456899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
||+||+|.++|... ....+++..++.|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999643 23568999999999999999999999 899999999999999999999999999999765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. .+..+||+.|||||++.+..|+.++|||||||+||||+||++||...+........ ...... ..
T Consensus 180 ~~--------~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--~~~~~~----~~ 245 (350)
T 4b9d_A 180 EL--------ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI--ISGSFP----PV 245 (350)
T ss_dssp HH--------HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHTCCC----CC
T ss_pred cc--------ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--HcCCCC----CC
Confidence 11 11235999999999999999999999999999999999999999876554322211 111111 23
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
+...+..+.+||.+||..||.+||++ ++++
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~-~e~l 275 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSV-NSIL 275 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCH-HHHH
T ss_pred CccCCHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 34456889999999999999999999 5543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=440.06 Aligned_cols=265 Identities=25% Similarity=0.354 Sum_probs=216.0
Q ss_pred CChhhhhhhcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCC-CceeeE
Q 003121 518 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRH-PNLVTL 588 (846)
Q Consensus 518 ~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~H-pnIv~l 588 (846)
|...+++...++|.+.++||+|+||+||+|.+.+ +.||||++...... ....|.+|+.+|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4455666667889999999999999999998764 46999999765432 23568999999999965 999999
Q ss_pred ecccc---CceEEEEEecCCCchhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecc
Q 003121 589 VGACP---EVWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 652 (846)
Q Consensus 589 ~g~~~---~~~~lVmEy~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrD 652 (846)
+|+|. ..++||||||++|+|.++|.... ....+++..++.|+.||+.||.|||+ ++|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCc
Confidence 99983 35899999999999999996432 13468999999999999999999999 8999999
Q ss_pred cCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-C
Q 003121 653 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-G 731 (846)
Q Consensus 653 Lkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G 731 (846)
|||+||||+.++.+||+|||+|+.+....... ..+...||+.|||||++.++.|+.++|||||||+||||+| |
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~------~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYV------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCce------eeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence 99999999999999999999999765432111 1133458999999999999999999999999999999998 9
Q ss_pred CCCCCCchHH---HHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 732 RPALGITKEV---QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 732 ~~pf~~~~~~---~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
++||...... ...+..+ .....|...++.+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 285 ~~Pf~~~~~~~~~~~~i~~g--------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~-~eil~~L~~llq 347 (353)
T 4ase_A 285 ASPYPGVKIDEEFCRRLKEG--------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNLLQ 347 (353)
T ss_dssp CCSSTTCCCSHHHHHHHHHT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcC--------CCCCCCccCCHHHHHHHHHHcCcChhHCcCH-HHHHHHHHHHHH
Confidence 9999764322 2222221 1233455567889999999999999999999 788888887654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=432.32 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=203.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|++.+.||+|+||+||+|... ++.||||++.+. .......+.+|+++|++|+|||||+++++|. +.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999986 678999999753 2234567999999999999999999999984 5689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
|||+||+|.+++... ..+++..+..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999543 469999999999999999999999 89999999999999999999999999999987543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
..... ....+||+.|||||++.+..|+.++|||||||+||+|+||++||...+......... .. ...
T Consensus 186 ~~~~~------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--~~-----~~~ 252 (311)
T 4aw0_A 186 SKQAR------ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII--KL-----EYD 252 (311)
T ss_dssp TTCCC------BCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HT-----CCC
T ss_pred CCccc------ccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cC-----CCC
Confidence 22111 134579999999999999999999999999999999999999997665433211111 11 123
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
+|...+..+.+||.+||..||.+||++
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~ 279 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGC 279 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTS
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcCh
Confidence 455567889999999999999999998
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=440.93 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=205.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
..|+..++||+|+||.||+|.+. +..||||++........+.+.+|+.+|+.|+|||||+++++| .+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46889999999999999999986 678999999877766778899999999999999999999998 46799999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
+||+|.+++.. ..+++..+..|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999999853 359999999999999999999999 89999999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
....+||+.|||||++.+..|+.++|||||||+||||++|++||............ .....+... .+.
T Consensus 304 --------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~~~~~~~-~~~ 371 (423)
T 4fie_A 304 --------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLK-NLH 371 (423)
T ss_dssp --------BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCS-CTT
T ss_pred --------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcCCCCCCc-ccc
Confidence 13456999999999999999999999999999999999999999766554322111 111112111 223
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..+.+||.+||..||.+||++ .++
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta-~el 398 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATA-AEL 398 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCH-HHH
Confidence 456789999999999999999999 444
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=421.47 Aligned_cols=239 Identities=23% Similarity=0.391 Sum_probs=191.6
Q ss_pred cccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc------CceEEEE
Q 003121 531 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP------EVWTLVY 600 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~------~~~~lVm 600 (846)
...++||+|+||+||+|.+. +..||||++...... ..+.|.+|+.+|++|+|||||+++++|. ..+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55668999999999999987 568999999765332 2356899999999999999999999873 2478999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecccCCCceEecC-CCceeeecccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLDA-NFVSKLSDFGISRFL 677 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g--iiHrDLkp~NILl~~-~~~vKL~DFGla~~~ 677 (846)
|||+||+|.++|... .++++..+..|+.||+.||.|||+ ++ ||||||||+||||+. +|.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999543 569999999999999999999999 66 999999999999984 799999999999864
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
.... ....+||+.|||||++. +.|+.++|||||||+||||+||++||............- .....
T Consensus 183 ~~~~----------~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i--~~~~~-- 247 (290)
T 3fpq_A 183 RASF----------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV--TSGVK-- 247 (290)
T ss_dssp CTTS----------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH--TTTCC--
T ss_pred CCCc----------cCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH--HcCCC--
Confidence 3221 12346999999999986 469999999999999999999999996544333222111 11111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...++...++.+.+|+.+||..||.+|||+ +++
T Consensus 248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~-~e~ 280 (290)
T 3fpq_A 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSI-KDL 280 (290)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 112233345689999999999999999999 444
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=428.25 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=197.0
Q ss_pred CCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHH--HHHHHHHhcCCCceeeEeccccC------ceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQ--QEIDILSKIRHPNLVTLVGACPE------VWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~--~Ei~iL~~l~HpnIv~l~g~~~~------~~~lVm 600 (846)
+|.+.++||+|+||+||+|.++|+.||||++.... ...+. .|+.++.+++|||||+++|+|.+ .++|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 46777899999999999999999999999997532 23344 45555678899999999999842 468999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEecccCCCceEecCCCceeeecccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-----KPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-----~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
|||++|+|.++|.. .++++..+++|+.|++.||.|||+. +..+||||||||+||||+.++.+||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 3589999999999999999999972 12389999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCchHH--------
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEV-------- 741 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~------~~~~ksDVwSlGviL~elltG~~pf~~~~~~-------- 741 (846)
........... ......||+.|||||++.+. .|+.++|||||||+||||+||.+||+.....
T Consensus 157 ~~~~~~~~~~~----~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 157 RHDSATDTIDI----APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp EEETTTTEESC----C-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred cccCCCCceee----ecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 76543211111 11345699999999999754 3678999999999999999998877432110
Q ss_pred -----HHHHhhhhhccccCCCCCC-C-ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 742 -----QYALDTGKLKNLLDPLAGD-W-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 742 -----~~~~~~~~~~~~ld~~~~~-~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
...+........+.|..+. + +...+..+.+|+.+||+.||.+|||+ .+|.+.|+.|...
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCH-HHHHHHHHHHHHC
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCH-HHHHHHHHHHHHH
Confidence 0011111111112221111 1 12345789999999999999999999 8888999988654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=416.15 Aligned_cols=240 Identities=26% Similarity=0.403 Sum_probs=187.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|.+.+.||+|+||+||+|... ++.||||+++..... ....+.+|+.+|++++|||||++++++ .+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 688999999765332 245689999999999999999999998 45689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||| +|+|.+++... .++++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 78999998543 469999999999999999999999 89999999999999999999999999999876443
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.. .....||+.|+|||++.+..| +.++|||||||+||+|+||++||...+......... . ...
T Consensus 166 ~~---------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~---~----~~~ 229 (275)
T 3hyh_A 166 NF---------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS---N----GVY 229 (275)
T ss_dssp ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H----TCC
T ss_pred Cc---------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---c----CCC
Confidence 21 123569999999999998876 579999999999999999999997665432211111 1 112
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+|...+..+.+|+.+||+.||.+|||+ +++
T Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~R~s~-~ei 260 (275)
T 3hyh_A 230 TLPKFLSPGAAGLIKRMLIVNPLNRISI-HEI 260 (275)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 2445567889999999999999999999 444
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=424.71 Aligned_cols=239 Identities=27% Similarity=0.327 Sum_probs=193.2
Q ss_pred CCCcccceeeeeCceEEEEEEEC-----CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 598 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 598 (846)
++|++.+.||+|+||+||+|... ++.||||+++.... .....+.+|+.+|++++|||||+++++| .+.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999862 46799999976432 1234688999999999999999999998 457899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
|||||+||+|.++|... ..+++..+..|+.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999543 469999999999999999999999 899999999999999999999999999998654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..... ....+||+.|||||++.+..|+.++|||||||+||||+||++||...+......... .. .
T Consensus 178 ~~~~~--------~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~-----~ 242 (304)
T 3ubd_A 178 DHEKK--------AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL--KA-----K 242 (304)
T ss_dssp ---CC--------CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HC-----C
T ss_pred CCCcc--------ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH--cC-----C
Confidence 33211 133569999999999999999999999999999999999999998765543221111 11 1
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
..+|...+..+.+|+.+||+.||.+||++
T Consensus 243 ~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 23455567889999999999999999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=411.48 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=185.4
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccccC-----------
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE----------- 594 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----------- 594 (846)
+|++.+.||+|+||+||+|... +..||||+++..... ..+.+.+|+.+|++|+|||||+++++|.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5888999999999999999986 688999999754322 23568899999999999999999998731
Q ss_pred ---ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecc
Q 003121 595 ---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671 (846)
Q Consensus 595 ---~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DF 671 (846)
.+|+|||||+||+|.+++.........++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 268999999999999999765544556778899999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCC----ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003121 672 GISRFLSQNEISSNN----TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 747 (846)
Q Consensus 672 Gla~~~~~~~~~~~~----~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~ 747 (846)
|+|+.+......... ......+..+||+.|||||++.+..|+.++|||||||+||||++ ||.........+..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 999987654321110 01112244579999999999999999999999999999999997 77544332221111
Q ss_pred hhhccccCCCCCCCCh---hhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 748 GKLKNLLDPLAGDWPF---VQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~---~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. .. ..+|. ..++.+.+|+.+||+.||.+||++ .++
T Consensus 240 ~--~~------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~-~ei 277 (299)
T 4g31_A 240 V--RN------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-INI 277 (299)
T ss_dssp H--HT------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred H--hc------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCH-HHH
Confidence 1 11 11222 233567889999999999999999 444
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=409.14 Aligned_cols=253 Identities=24% Similarity=0.300 Sum_probs=196.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--------C
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--------E 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~ 594 (846)
.++|.+.+.||+|+||+||+|... ++.||||++...... ....+.+|+.+|+.|+|||||++++++. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999986 688999999765332 2346889999999999999999999863 3
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
..|||||||. |+|.+++. ...++++..+..|+.||+.||.|||+ +|||||||||+|||++.+|.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeeccee
Confidence 5799999995 68999884 34579999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
+.+........ ......+||+.|+|||++.+. .|+.++||||+||++|||+||++||...+..............
T Consensus 206 ~~~~~~~~~~~----~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~ 281 (398)
T 4b99_A 206 RGLCTSPAEHQ----YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281 (398)
T ss_dssp BCC-------C----CCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eecccCccccc----cccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 87654321111 112446799999999998875 5799999999999999999999999876554332211100000
Q ss_pred -----------------cC--CCCCCCC-----hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 -----------------LD--PLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 -----------------ld--~~~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+. +.....+ ...+..+.+||.+||..||.+|||+ +++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-~e~ 342 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA-AAA 342 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH-HHH
Confidence 00 0000001 1235678999999999999999999 443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=393.35 Aligned_cols=202 Identities=28% Similarity=0.374 Sum_probs=167.0
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC-----CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc--cCce
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVW 596 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~ 596 (846)
...+.|.+.++||+|+||+||+|..+ +..||||.+.... ....+.+|+++|+.+ +|||||+++++| .+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34567999999999999999999863 4679999986543 345788999999998 699999999988 4678
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC-Cceeeecccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISR 675 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~-~~vKL~DFGla~ 675 (846)
|+|||||+||+|.+++ ..+++..+..++.||+.||.|||+ +|||||||||+||||+.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999998 248999999999999999999999 899999999999999876 899999999998
Q ss_pred ccccccccCCC--------------------ccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCC
Q 003121 676 FLSQNEISSNN--------------------TTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPA 734 (846)
Q Consensus 676 ~~~~~~~~~~~--------------------~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~p 734 (846)
........... ......+..+||+.|+|||++.+. .|+.++||||+||++|||+||++|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65433211000 000112345799999999999875 589999999999999999999999
Q ss_pred CCC
Q 003121 735 LGI 737 (846)
Q Consensus 735 f~~ 737 (846)
|..
T Consensus 247 f~~ 249 (361)
T 4f9c_A 247 FYK 249 (361)
T ss_dssp SSC
T ss_pred CCC
Confidence 943
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=414.96 Aligned_cols=247 Identities=21% Similarity=0.333 Sum_probs=203.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
++|.+.+.||+|+||.||+|..+ +..||||++........+.+.+|+.+|+.|+|||||+|+++|. ..+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57999999999999999999986 6789999998765445567899999999999999999999984 5689999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC--Cceeeecccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN--FVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~--~~vKL~DFGla~~~~~~~ 681 (846)
+||+|.++|.. ....+++..+..|+.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999853 23569999999999999999999999 899999999999999854 899999999999875432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. ...+||+.|+|||++.+..|+.++|||||||+||+|++|++||................. .. ....
T Consensus 312 ~~---------~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~--~~-~~~~ 379 (573)
T 3uto_A 312 SV---------KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW--NM-DDSA 379 (573)
T ss_dssp EE---------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC--CC-CSGG
T ss_pred ce---------eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC--CC-Cccc
Confidence 11 123599999999999999999999999999999999999999987665433222111111 11 1111
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
+...+..+.+||.+||..||.+||++ .+++
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~-~e~l 409 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTI-HQAL 409 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCH-HHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 22346789999999999999999999 5543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=414.48 Aligned_cols=239 Identities=27% Similarity=0.357 Sum_probs=193.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHH---HHHHHhcCCCceeeEeccc--cCceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQE---IDILSKIRHPNLVTLVGAC--PEVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~E---i~iL~~l~HpnIv~l~g~~--~~~~~ 597 (846)
++|++.++||+|+||+||+|... +..||||++.+.. ......+.+| +.+++.++|||||+|+++| .+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 47899999999999999999986 5789999997532 1223334444 5666778999999999998 45799
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
||||||+||+|.++|... ..+++..+..|+.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999643 469999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHhhhhhccccC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLD 755 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~-~~~~~~~~~~~~ld 755 (846)
..... ...+||+.|||||++.. ..|+.++|||||||+||||+||++||...... ...+......
T Consensus 343 ~~~~~----------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~---- 408 (689)
T 3v5w_A 343 SKKKP----------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---- 408 (689)
T ss_dssp SSCCC----------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----
T ss_pred CCCCC----------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----
Confidence 54321 23469999999999975 57999999999999999999999999653221 1111111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
....+|...+..+.+||.+||..||.+|++.
T Consensus 409 -~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 409 -MAVELPDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred -CCCCCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence 1123455667889999999999999999983
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=371.30 Aligned_cols=276 Identities=39% Similarity=0.663 Sum_probs=224.2
Q ss_pred CCCChhhhhhhcCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc-
Q 003121 516 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP- 593 (846)
Q Consensus 516 ~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~- 593 (846)
..+.+.++...+++|...+.||+|+||.||+|.+. +..||||++........+.+.+|+.+|+.++||||++++++|.
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34556677788899999999999999999999976 6889999988766555678999999999999999999999984
Q ss_pred -CceEEEEEecCCCchhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecc
Q 003121 594 -EVWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671 (846)
Q Consensus 594 -~~~~lVmEy~~ggsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DF 671 (846)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 46899999999999999996443 23469999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH------HH---
Q 003121 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQ--- 742 (846)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~------~~--- 742 (846)
|+++.......... .....||+.|+|||++.+..++.++|||||||++|+|+||++||..... ..
T Consensus 184 g~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 257 (321)
T 2qkw_B 184 GISKKGTELDQTHL------STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257 (321)
T ss_dssp TTCEECSSSSCCCC------BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred cccccccccccccc------ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence 99986543221111 1234589999999999999999999999999999999999999964321 11
Q ss_pred HHHhhhhhccccCC-CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 743 YALDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 743 ~~~~~~~~~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
.....+.+...+++ .....+...+..+.+|+.+||..+|.+||++ .++++.|+.+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~~l~~ 316 (321)
T 2qkw_B 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM-GDVLWKLEYALRL 316 (321)
T ss_dssp HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHS
T ss_pred hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHhhc
Confidence 11222233333333 2334566778899999999999999999999 7888888877654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=374.47 Aligned_cols=264 Identities=30% Similarity=0.475 Sum_probs=207.4
Q ss_pred hhhhhhcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccc--Cce
Q 003121 521 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVW 596 (846)
Q Consensus 521 ~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~ 596 (846)
.++.....+|.+.+.||+|+||.||+|.+.+..||||++....... ...|.+|+.+|++++||||++++++|. ...
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3444556689999999999999999999999999999997654322 246889999999999999999999984 468
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecccCCCceEecCCCceeeeccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g--iiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
++||||+++|+|.+++........+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 9999999999999999654333458999999999999999999999 77 999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 754 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~l 754 (846)
+........ .....||+.|+|||++.+..++.++|||||||++|+|+||+.||..............
T Consensus 187 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~----- 253 (309)
T 3p86_A 187 RLKASTFLS--------SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF----- 253 (309)
T ss_dssp -----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH-----
T ss_pred ccccccccc--------cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----
Confidence 865432211 1234599999999999999999999999999999999999999987654432221111
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 755 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
.......|...+..+.+|+.+||..+|.+||++ .++++.|+.+...
T Consensus 254 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~~ll~~L~~~~~~ 299 (309)
T 3p86_A 254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSF-ATIMDLLRPLIKS 299 (309)
T ss_dssp SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHC-
T ss_pred cCCCCCCCccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHh
Confidence 111223445566889999999999999999999 8888898887654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=367.18 Aligned_cols=276 Identities=41% Similarity=0.697 Sum_probs=227.6
Q ss_pred cCCCCChhhhhhhcCCCccc------ceeeeeCceEEEEEEECCeEEEEEEecCCCC----CCchhHHHHHHHHHhcCCC
Q 003121 514 FFSDFSFSEIEGATHNFDPS------LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL----QGPSEFQQEIDILSKIRHP 583 (846)
Q Consensus 514 ~~~~~~~~ei~~~~~~f~~~------~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~----~~~~~f~~Ei~iL~~l~Hp 583 (846)
.+..|++.++...+.+|+.. ++||+|+||.||+|...+..||||++..... .....+.+|+.++++++||
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 34678899999999999887 8999999999999999999999999876432 1235688999999999999
Q ss_pred ceeeEecccc--CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec
Q 003121 584 NLVTLVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 661 (846)
Q Consensus 584 nIv~l~g~~~--~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~ 661 (846)
||+++++++. +..++||||+++|+|.+++.......++++..++.++.+|+.||.|||+ +||+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEc
Confidence 9999999984 5689999999999999999765556779999999999999999999999 8999999999999999
Q ss_pred CCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 003121 662 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV 741 (846)
Q Consensus 662 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~ 741 (846)
.++.+||+|||+++........ .......||+.|+|||++.+ .++.++||||||+++|+|+||++||......
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQT------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSC------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred CCCcEEEeeccccccccccccc------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 9999999999999865432211 11123469999999998864 5899999999999999999999999754321
Q ss_pred ------HHHH--hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 742 ------QYAL--DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 742 ------~~~~--~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
...+ ....+...++......+...+..+.+|+.+||+.+|.+||++ .++++.|+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-~~l~~~L~~l~~ 306 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI-KKVQQLLQEMTA 306 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHC-
T ss_pred HHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHhc
Confidence 1111 111233444555566777888999999999999999999999 889999988765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=369.21 Aligned_cols=258 Identities=27% Similarity=0.437 Sum_probs=207.8
Q ss_pred CCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccccCceEEEEEecCCCc
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGS 607 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~lVmEy~~ggs 607 (846)
++|...+.||+|+||.||+|.+.+..||||.+... .....|.+|+.+|++++||||++++++|.+..++||||+++|+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGS 85 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCB
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCC
Confidence 46888899999999999999999999999998643 2346789999999999999999999999888999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc-eeeeccccccccccccccCCC
Q 003121 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-SKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~-vKL~DFGla~~~~~~~~~~~~ 686 (846)
|.+++........+++..++.++.||+.||.|||+.+++||+||||||+|||++.++. +||+|||++.......
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~----- 160 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----- 160 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----
Confidence 9999976554456889999999999999999999977678999999999999998876 7999999987553221
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhH
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 766 (846)
....||+.|+|||++.+..++.++||||||+++|+|+||+.||.........+....... .....+...+
T Consensus 161 ------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 230 (307)
T 2eva_A 161 ------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG----TRPPLIKNLP 230 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT----CCCCCBTTCC
T ss_pred ------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC----CCCCcccccC
Confidence 123589999999999998999999999999999999999999964322111111110111 1122233455
Q ss_pred HHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCC
Q 003121 767 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 803 (846)
Q Consensus 767 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~ 803 (846)
..+.+|+.+||..+|.+||++ .++++.|+.+.....
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSM-EEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHGGGCC
T ss_pred HHHHHHHHHHhcCChhhCcCH-HHHHHHHHHHHHhcc
Confidence 789999999999999999999 889999998877654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=363.81 Aligned_cols=245 Identities=25% Similarity=0.387 Sum_probs=204.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
..+|...+.||+|+||.||+|... +..||||++........+.+.+|+.+++.++||||++++++| .+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 357999999999999999999864 678999999876666677899999999999999999999987 4678999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++.. ..+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999853 258999999999999999999999 8999999999999999999999999999987654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. .....||+.|+|||++.+..++.++|||||||++|+|+||++||................ ......+
T Consensus 172 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~ 239 (297)
T 3fxz_A 172 K--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG----TPELQNP 239 (297)
T ss_dssp C--------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC----SCCCSCG
T ss_pred c--------cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----CCCCCCc
Confidence 1 133469999999999999999999999999999999999999997665543322211111 0111224
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+..+.+|+.+||..+|.+||++ .++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~-~el 267 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSA-KEL 267 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred cccCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 4556889999999999999999999 444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=370.53 Aligned_cols=276 Identities=36% Similarity=0.643 Sum_probs=221.9
Q ss_pred cCCCCChhhhhhhcCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecc
Q 003121 514 FFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGA 591 (846)
Q Consensus 514 ~~~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~ 591 (846)
....|++.++....++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3567889999999999999999999999999999875 678999999865432 33479999999999999999999999
Q ss_pred c--cCceEEEEEecCCCchhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceee
Q 003121 592 C--PEVWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 668 (846)
Q Consensus 592 ~--~~~~~lVmEy~~ggsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL 668 (846)
| ....++||||+++|+|.+++.... ...++++..+..++.+++.||.|||+....||+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 8 456889999999999999996543 3456999999999999999999999932229999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-------H
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-------V 741 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~-------~ 741 (846)
+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|+||++||..... .
T Consensus 176 ~Dfg~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 248 (326)
T 3uim_A 176 GDFGLAKLMDYKDTH-------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248 (326)
T ss_dssp CCCSSCEECCSSSSC-------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBH
T ss_pred ccCccccccCccccc-------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhH
Confidence 999999876433211 11334599999999999988999999999999999999999999952211 0
Q ss_pred HHH----HhhhhhccccCC-CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 742 QYA----LDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 742 ~~~----~~~~~~~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
... ..........+. ....++...+..+.+|+.+||+.+|.+||++ .++++.|+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~ell~~L~~ 308 (326)
T 3uim_A 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM-SEVVRMLEG 308 (326)
T ss_dssp HHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH-HHHHHHHHT
T ss_pred HHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH-HHHHHHhcC
Confidence 000 111112222222 2345667778899999999999999999999 788888874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=369.00 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=208.8
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
.++|.+.+.||+|+||.||+|.+. +..||||++...... ....|.+|+.+|++++||||++++++|. ...++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457889999999999999999984 346999999764322 2356899999999999999999999984 46889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+++|+|.+++... ...+++..++.|+.+|+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999533 3569999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||............. ...
T Consensus 203 ~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~------~~~ 271 (325)
T 3kul_A 203 DDPDAA-----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE------EGY 271 (325)
T ss_dssp ----CC-----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH------TTC
T ss_pred cCccce-----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH------cCC
Confidence 432111 11133457889999999998999999999999999999999 999997655433221111 111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
....+...+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 272 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~eil~~L~~l~~~~ 315 (325)
T 3kul_A 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRF-SQIVSVLDALIRSP 315 (325)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHSC
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHhCc
Confidence 222344556889999999999999999999 88999999887654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=363.63 Aligned_cols=265 Identities=23% Similarity=0.389 Sum_probs=207.6
Q ss_pred cCCCcccceeeeeCceEEEEEEE------CCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc----Cce
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVW 596 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~------~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~ 596 (846)
.++|.+.++||+|+||.||+|.+ .+..||||++..........|.+|+.+|++++||||++++++|. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35788999999999999999985 35789999998654444467899999999999999999999872 458
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999543 2358999999999999999999999 8999999999999999999999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-Hhh--------
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-LDT-------- 747 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~-~~~-------- 747 (846)
......... ......||+.|+|||++.+..++.++||||||+++|+|+||..||......... ...
T Consensus 164 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 164 LPQDKEFFK-----VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp -----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred ccCCcceee-----eccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 654321111 112345788899999999999999999999999999999999998654322110 000
Q ss_pred -hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 748 -GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 748 -~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
..............+...+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~el~~~L~~l~~~l 293 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF-RDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHHC-
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHHHhc
Confidence 0001111122233445567889999999999999999999 88999999987754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=361.68 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=199.5
Q ss_pred cCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHh--cCCCceeeEecccc------CceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK--IRHPNLVTLVGACP------EVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~--l~HpnIv~l~g~~~------~~~~l 598 (846)
.++|.+.+.||+|+||.||+|.+.+..||||++... ....+..|.+++.. ++||||+++++++. ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 457899999999999999999999999999998653 34567778888777 79999999999862 34789
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCceEecccCCCceEecCCCceeeec
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH--------SCKPHSIVHGDLKPANILLDANFVSKLSD 670 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~giiHrDLkp~NILl~~~~~vKL~D 670 (846)
||||+++|+|.+++. ...+++..++.++.||+.||.||| + ++|+||||||+||||+.++.+||+|
T Consensus 84 v~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred ehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence 999999999999993 346999999999999999999999 6 8999999999999999999999999
Q ss_pred cccccccccccccCCCccccccCCCCCCcccCChhhhccC------CCCchhhHHHHHHHHHHHHhC----------CCC
Q 003121 671 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTG----------RPA 734 (846)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~------~~~~ksDVwSlGviL~elltG----------~~p 734 (846)
||+++.......... .......||+.|+|||++.+. .++.++|||||||++|+|+|| .+|
T Consensus 157 fg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLD----VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp CTTCEEEETTTTEEE----CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred CCCeeeccccccccc----ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999986654322111 111334699999999999876 455799999999999999999 888
Q ss_pred CCCchH----HHHHHhhhhhccccCCCCCCC-----ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 735 LGITKE----VQYALDTGKLKNLLDPLAGDW-----PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 735 f~~~~~----~~~~~~~~~~~~~ld~~~~~~-----p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
|..... ... +...... ....... +...+..+.+|+.+||+.+|.+||++ .++++.|+.+
T Consensus 233 f~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDPSFED-MRKVVCV---DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA-LRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSCCHHH-HHHHHTT---SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH-HHHHHHHHHH
T ss_pred ccccCCCCcchhh-hhHHHhc---cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH-HHHHHHHhcc
Confidence 843211 111 1110001 1111122 23457889999999999999999999 8888888765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=365.40 Aligned_cols=267 Identities=22% Similarity=0.409 Sum_probs=209.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
.++|...++||+|+||.||+|.+. +..||+|++..........|.+|+.+|++++||||++++++| ....++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357888999999999999999986 678999998765444456799999999999999999999998 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999643 3569999999999999999999999 8999999999999999999999999999987654332
Q ss_pred cCCCc------cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCC
Q 003121 683 SSNNT------TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 683 ~~~~~------~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
..... .........||+.|+|||++.+..++.++||||||+++|+|++|.+||............ .....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-~~~~~~~- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-NVRGFLD- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-CHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-hhhcccc-
Confidence 21100 000112456999999999999999999999999999999999999998543211000000 0000000
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCC
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 803 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~ 803 (846)
...+...+..+.+|+.+||+.+|.+||++ .++.+.|+.++....
T Consensus 242 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 242 --RYCPPNCPPSFFPITVRCCDLDPEKRPSF-VKLEHWLETLRMHLA 285 (310)
T ss_dssp --HTCCTTCCTTHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHHH
T ss_pred --ccCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHhcc
Confidence 01123344679999999999999999999 889999999887653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=373.71 Aligned_cols=260 Identities=23% Similarity=0.396 Sum_probs=210.1
Q ss_pred cCCCcccceeeeeCceEEEEEEEC---------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccc--
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP-- 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~---------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~-- 593 (846)
.++|.+.+.||+|+||.||+|.+. +..||||+++..... ....+.+|+.+|+.+ +||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 457889999999999999999863 246999999764321 235688999999999 8999999999984
Q ss_pred CceEEEEEecCCCchhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 660 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl 660 (846)
+..|+||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 468999999999999999965431 2458999999999999999999999 899999999999999
Q ss_pred cCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 003121 661 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK 739 (846)
Q Consensus 661 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~ 739 (846)
+.++.+||+|||+++.......... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCT------TTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCCEEEccccCCcccCcccceec------ccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999987654322111 123457899999999999999999999999999999999 999997654
Q ss_pred HHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 740 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 740 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
....... +........|...+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 311 ~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-~ell~~L~~il~~~ 366 (370)
T 2psq_A 311 VEELFKL------LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRILTLT 366 (370)
T ss_dssp GGGHHHH------HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHH
T ss_pred HHHHHHH------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHHh
Confidence 3221110 11111223445566889999999999999999999 88889998876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=352.89 Aligned_cols=255 Identities=25% Similarity=0.463 Sum_probs=211.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
.++|...+.||+|+||.||+|.+. +..||+|++.... ...+.+.+|+.+|++++||||++++++|. ...++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 357888999999999999999985 5789999998654 34567999999999999999999999984 4689999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 999999999533 3568999999999999999999999 89999999999999999999999999999876543221
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. .....||+.|+|||++.+..++.++||||||+++|+|+| |++||............. .......+
T Consensus 163 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~------~~~~~~~~ 229 (269)
T 4hcu_A 163 S-------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------TGFRLYKP 229 (269)
T ss_dssp S-------TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TTCCCCCC
T ss_pred c-------ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh------cCccCCCC
Confidence 1 123457889999999999999999999999999999999 999997665433221111 11122233
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
...+..+.+|+.+||+.+|.+||++ .++++.|+.+...
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~-~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAF-SRLLRQLAEIAES 267 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCCcccCcCH-HHHHHHHHHHHHc
Confidence 4456789999999999999999999 8898999888754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=370.62 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=205.2
Q ss_pred hhcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccccC------ceEE
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE------VWTL 598 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~------~~~l 598 (846)
-..++|.+.++||+|+||.||+|.+.+..||||++..... ....+..|+.+|++++||||++++++|.. .+++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cchhhchhhheecccCceEEEEEEECCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3456899999999999999999999999999999965321 23346678999999999999999999843 2689
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC----------ceEecccCCCceEecCCCceee
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH----------SIVHGDLKPANILLDANFVSKL 668 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~----------giiHrDLkp~NILl~~~~~vKL 668 (846)
||||+++|+|.+++.. ..+++..++.++.||+.||.|||+ + +|+||||||+||||+.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 9999999999999953 348999999999999999999998 6 9999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCchH---
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITKE--- 740 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~~~ksDVwSlGviL~elltG~~pf~~~~~--- 740 (846)
+|||+++.+........ .....||+.|+|||++.+. .++.++|||||||++|+|+||++||.....
T Consensus 173 ~DFg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 246 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGD------THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246 (322)
T ss_dssp CCCTTCEEECTTSCCCC------CTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred ccCCcccccccccCccc------cccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence 99999987654332111 1235699999999999763 456688999999999999999999964211
Q ss_pred --HH---------HHHhhhhhccccCCCCCC-C-ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 741 --VQ---------YALDTGKLKNLLDPLAGD-W-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 741 --~~---------~~~~~~~~~~~ld~~~~~-~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
.. ..+..........+.... | +...+..+.+|+.+||+.+|.+||++ .++++.|+.+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~ell~~L~~l~~~~ 320 (322)
T 3soc_A 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA-GCVGERITQMQRLT 320 (322)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHC
T ss_pred cchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHHh
Confidence 00 001111111111111111 1 12345679999999999999999999 89999999887653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.46 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=204.9
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
.++|.+.+.||+|+||.||+|... +..||+|++....... ...|.+|+.++++++||||+++++++. +..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357999999999999999999875 5789999987654333 246889999999999999999999984 468899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||++||+|.+++... .++++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999543 469999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
..... .....||+.|+|||++.+..++.++||||||+++|+|+||++||............ ..........
T Consensus 164 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~~~~~~~~~~ 234 (294)
T 4eqm_A 164 TSLTQ-------TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH--IQDSVPNVTT 234 (294)
T ss_dssp ------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH--HSSCCCCHHH
T ss_pred ccccc-------cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hhccCCCcch
Confidence 32111 12345999999999999999999999999999999999999999876654432221 1111111111
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
..+...+..+.+++.+||..+|.+||+..+++.+.|+.+.
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 2233456789999999999999999966588877777654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=359.58 Aligned_cols=242 Identities=25% Similarity=0.372 Sum_probs=200.7
Q ss_pred CcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecCC
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 605 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~g 605 (846)
|....+||+|+||.||+|... +..||||++........+.+.+|+.+|+.++||||++++++| .+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 666778999999999999885 688999999877666667899999999999999999999988 4578999999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|+|.+++. ...+++..+..++.+|+.||.|||+ +||+||||||+|||++.++.+||+|||++.........
T Consensus 127 ~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-- 197 (321)
T 2c30_A 127 GALTDIVS----QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-- 197 (321)
T ss_dssp CBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred CCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--
Confidence 99999984 2469999999999999999999999 89999999999999999999999999999876543211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 765 (846)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||........... +.....+.. ..+...
T Consensus 198 ------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~-~~~~~~ 267 (321)
T 2c30_A 198 ------RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRDSPPPKL-KNSHKV 267 (321)
T ss_dssp ------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHSSCCCC-TTGGGS
T ss_pred ------cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HhcCCCCCc-CccccC
Confidence 1234699999999999999999999999999999999999999976654332111 111111111 112344
Q ss_pred HHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 766 AEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 766 ~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+..+.+|+.+||..+|.+||++ .++
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~-~el 292 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATA-QEL 292 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred CHHHHHHHHHHccCChhhCcCH-HHH
Confidence 6789999999999999999999 444
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.84 Aligned_cols=277 Identities=19% Similarity=0.230 Sum_probs=216.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVmE 601 (846)
..+|.+.+.||+|+||.||+|... +..||||++..... ...+.+|+.+|+++ +||||+++++++ ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 357999999999999999999964 68899999876532 35789999999999 999999999987 456889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc-----eeeeccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-----SKLSDFGISRF 676 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~-----vKL~DFGla~~ 676 (846)
|+ +|+|.+++... ...+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999643 3579999999999999999999999 89999999999999998887 99999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHH---Hhhhhhc
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--VQYA---LDTGKLK 751 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~--~~~~---~~~~~~~ 751 (846)
+........ ..........||+.|+|||++.+..++.++|||||||++|+|+||++||..... .... +......
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 160 YIDPETKKH-IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp SBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eecCCCCcc-ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 654322111 001112345799999999999999999999999999999999999999975321 1111 1111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCCCCCcCCCCCCCCC
Q 003121 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEP 818 (846)
Q Consensus 752 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~~~~~~~~~~~~~~ 818 (846)
........ ..+ .+.+|+..||..+|.+||++ +++.+.|+.+....+......++|.....+
T Consensus 239 ~~~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~-~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~ 299 (330)
T 2izr_A 239 TPIEVLCE----NFP-EMATYLRYVRRLDFFEKPDY-DYLRKLFTDLFDRKGYMFDYEYDWIGKQLP 299 (330)
T ss_dssp SCHHHHTT----TCH-HHHHHHHHHHHCCTTCCCCH-HHHHHHHHHHHHHTTCCCSCCCTTTTSCCC
T ss_pred CCHHHHhc----cCh-HHHHHHHHHHhCCCCCCCCH-HHHHHHHHHHHHHcCCCCCCCccCCCCCcC
Confidence 10000011 123 89999999999999999999 889999998888776666656666543333
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=365.87 Aligned_cols=265 Identities=26% Similarity=0.442 Sum_probs=212.7
Q ss_pred hhhhhcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc
Q 003121 522 EIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP 593 (846)
Q Consensus 522 ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~ 593 (846)
.+....++|...+.||+|+||.||+|.+.+ ..||||+++..... ....|.+|+.+|++++||||++++++|.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 344556789999999999999999999864 67999999764322 2356899999999999999999999984
Q ss_pred --CceEEEEEecCCCchhhhhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEe
Q 003121 594 --EVWTLVYEYLPNGSLEDRLSCKDN---------------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650 (846)
Q Consensus 594 --~~~~lVmEy~~ggsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiH 650 (846)
+..++||||+++|+|.+++..... ..++++..++.++.||+.||.|||+ ++|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 568999999999999999965321 2579999999999999999999999 89999
Q ss_pred cccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh
Q 003121 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 730 (846)
Q Consensus 651 rDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt 730 (846)
|||||+|||++.++.+||+|||+++.......... .....||+.|+|||++.+..++.++|||||||++|+|+|
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 271 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA------DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccc------cCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHh
Confidence 99999999999999999999999987654322111 123458999999999999999999999999999999999
Q ss_pred -CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 731 -GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 731 -G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
|..||............ ........+...+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 272 ~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 272 YGLQPYYGMAHEEVIYYV------RDGNILACPENCPLELYNLMRLCWSKLPADRPSF-CSIHRILQRMCERA 337 (343)
T ss_dssp TTCCTTTTSCHHHHHHHH------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHTTC--
T ss_pred cCCCcCCCCChHHHHHHH------hCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCH-HHHHHHHHHHHhhh
Confidence 99999765443221111 1111122344556789999999999999999999 88888888876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=368.81 Aligned_cols=270 Identities=24% Similarity=0.343 Sum_probs=214.2
Q ss_pred CCChhhhhhhcCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceee
Q 003121 517 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVT 587 (846)
Q Consensus 517 ~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~ 587 (846)
.+....++...++|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.+|+.+|.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3455666677889999999999999999999853 267999999764322 234689999999999 7999999
Q ss_pred EeccccC---ceEEEEEecCCCchhhhhccCCC-----------------------------------------------
Q 003121 588 LVGACPE---VWTLVYEYLPNGSLEDRLSCKDN----------------------------------------------- 617 (846)
Q Consensus 588 l~g~~~~---~~~lVmEy~~ggsL~~~L~~~~~----------------------------------------------- 617 (846)
++++|.+ ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999843 48899999999999999965432
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 618 ----------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 618 ----------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1228999999999999999999999 899999999999999999999999999998664332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... ......||+.|+|||++.+..++.++|||||||++|+|+| |++||.............. . .....
T Consensus 248 ~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--~---~~~~~ 316 (359)
T 3vhe_A 248 DYV------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--E---GTRMR 316 (359)
T ss_dssp TCE------EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH--H---TCCCC
T ss_pred cch------hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH--c---CCCCC
Confidence 111 1133458999999999999999999999999999999999 9999976443221111110 0 11122
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
.+...+..+.+|+.+||..+|.+||++ .++++.|+.+...
T Consensus 317 ~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~~~~~ 356 (359)
T 3vhe_A 317 APDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNLLQA 356 (359)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCH-HHHHHHHHHHHHH
Confidence 344456789999999999999999999 8888898887643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=378.26 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=208.4
Q ss_pred cCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc---CceEEEEEec
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYL 603 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~---~~~~lVmEy~ 603 (846)
..+|.+.+.||+|+||.||+|.+.+..||||+++... ..+.|.+|+.+|++++||||++++++|. ...++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 4468888999999999999999999999999998654 4578999999999999999999999872 2589999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp TTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 9999999996542 2457999999999999999999999 899999999999999999999999999998543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 760 (846)
....+++.|+|||++.+..++.++|||||||++|||+| |+.||....... ..+..+ ....
T Consensus 344 ---------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~--------~~~~ 406 (450)
T 1k9a_A 344 ---------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMD 406 (450)
T ss_dssp ------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT--------CCCC
T ss_pred ---------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------CCCC
Confidence 12247889999999999999999999999999999998 999997543322 112111 1223
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
.|..++..+.+|+.+||..+|.+||++ .++.+.|+.+...
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~-~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTF-LQLREQLEHIRTH 446 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHHh
Confidence 445567899999999999999999999 8888999888654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.54 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=201.1
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
...++|.+.+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||+++++++. ...++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 34568999999999999999999974 688999999765332 2346889999999999999999999984 56899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999998543 458999999999999999999999 899999999999999999999999999998654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~-~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
.... .....||+.|+|||++.+..++ .++|||||||++|+|+||++||............. . .
T Consensus 166 ~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~-----~ 229 (328)
T 3fe3_A 166 VGGK---------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--R-----G 229 (328)
T ss_dssp SSCG---------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--H-----C
T ss_pred CCCc---------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--h-----C
Confidence 3321 1234699999999999888775 79999999999999999999997765433211110 0 1
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....|...+..+.+|+.+||..+|.+||++ +++
T Consensus 230 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~-~ei 262 (328)
T 3fe3_A 230 KYRIPFYMSTDCENLLKRFLVLNPIKRGTL-EQI 262 (328)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSTTTSCCH-HHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCChhHCcCH-HHH
Confidence 112344566889999999999999999999 444
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=373.10 Aligned_cols=259 Identities=25% Similarity=0.433 Sum_probs=197.1
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-----CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
..+|.+.+.||+|+||.||+|.+. +..||||+++.... .....|.+|+.+|++++||||++++++|. ...++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457999999999999999999875 45699999976432 12356899999999999999999999984 46899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+++|+|.+++... ...+++..++.++.+|+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999533 3569999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
........ .....+|+.|+|||++.+..++.++|||||||++|||++ |++||............. .. .
T Consensus 199 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~--~~----~ 267 (373)
T 2qol_A 199 DDPEAAYT-----TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--EG----Y 267 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH--TT----E
T ss_pred cCCcccee-----ccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--cC----C
Confidence 43211111 122346789999999999999999999999999999998 999997654432211111 11 1
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+....
T Consensus 268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKF-EQIVSILDKLIRNP 311 (373)
T ss_dssp ECCCCTTCBHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHCG
T ss_pred CCCCCccccHHHHHHHHHHhCcChhhCcCH-HHHHHHHHHHHhCc
Confidence 112233456889999999999999999999 88889998886543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=362.42 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=195.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
++|.+.+.||+|+||.||+|... +..||||++...... ..+.+.+|+.+++.++||||+++++++. ...++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 47899999999999999999886 678999998755332 3467899999999999999999999984 467899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++. ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999984 33469999999999999999999999 8999999999999999999999999999986643321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. ......||+.|+|||++.+..+ +.++|||||||++|+|+||++||................... . ..
T Consensus 161 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~-~~ 230 (323)
T 3tki_A 161 ER------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---L-NP 230 (323)
T ss_dssp EC------CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT---S-TT
T ss_pred cc------ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc---C-Cc
Confidence 11 1134569999999999988775 778999999999999999999997544321111111000100 0 11
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+..+.+|+.+||..+|.+||++ .++
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~-~ei 259 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITI-PDI 259 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred cccCCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 12345789999999999999999999 444
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=363.63 Aligned_cols=264 Identities=23% Similarity=0.371 Sum_probs=196.9
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEECCe-----EEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccccC-
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLRHM-----QVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE- 594 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~-----~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~- 594 (846)
+....++|...+.||+|+||.||+|.+... .||||++...... ..+.+.+|+.++++++||||+++++++..
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 334556899999999999999999987642 7999999765322 34678999999999999999999998832
Q ss_pred -c------eEEEEEecCCCchhhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC
Q 003121 595 -V------WTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 664 (846)
Q Consensus 595 -~------~~lVmEy~~ggsL~~~L~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~ 664 (846)
. .++||||+++|+|.+++... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCC
Confidence 2 38999999999999998543 223369999999999999999999999 8999999999999999999
Q ss_pred ceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH
Q 003121 665 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY 743 (846)
Q Consensus 665 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~ 743 (846)
.+||+|||+++.......... .....+|+.|+|||.+.+..++.++|||||||++|+|+| |++||........
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 248 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQ------GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248 (323)
T ss_dssp CEEECCCCC-----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred CEEEeeccccccccccccccc------cccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence 999999999987654322111 123457889999999999999999999999999999999 9999976543221
Q ss_pred HHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 744 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 744 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
... .........+...+..+.+|+.+||..+|.+||++ .++.+.|+.+....
T Consensus 249 ~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 249 YNY------LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSF-TCLRMELENILGHL 300 (323)
T ss_dssp HHH------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHHHC-
T ss_pred HHH------HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHHh
Confidence 111 11111122344456789999999999999999999 88888888877654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=373.98 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=208.2
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
..++|...+.||+|+||.||+|.+. +..||||+++..... ....|.+|+.+|++++||||++++|+|. +..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4457889999999999999999986 678999998754221 1246889999999999999999999984 4689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999999533 2458999999999999999999999 89999999999999999999999999999865433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
...... ....+++.|+|||++.++.++.++|||||||++|||+| |.+||............. .....
T Consensus 267 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~------~~~~~ 334 (377)
T 3cbl_A 267 VYAASG------GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE------KGGRL 334 (377)
T ss_dssp EEECCS------SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH------TTCCC
T ss_pred ceeecC------CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------cCCCC
Confidence 211110 11235778999999998999999999999999999998 999997654432211110 01112
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
..|...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dP~~Rps~-~~i~~~L~~i~~ 374 (377)
T 3cbl_A 335 PCPELCPDAVFRLMEQCWAYEPGQRPSF-STIYQELQSIRK 374 (377)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHHHHHh
Confidence 2344556889999999999999999999 889999988865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=348.80 Aligned_cols=249 Identities=27% Similarity=0.469 Sum_probs=196.2
Q ss_pred cCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCC----CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ----GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~----~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
.++|...+.||+|+||.||+|.+.+..||||++...... ..+.+.+|+.+++.++||||++++++|. +..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 457899999999999999999999999999998765332 2357899999999999999999999984 4689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc---eEecccCCCceEecC--------CCceeee
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS---IVHGDLKPANILLDA--------NFVSKLS 669 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g---iiHrDLkp~NILl~~--------~~~vKL~ 669 (846)
||+++++|.+++. ...+++..++.++.|++.||.|||+ ++ |+||||||+|||++. ++.+||+
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999983 3468999999999999999999999 66 999999999999986 7789999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh
Q 003121 670 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 749 (846)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~ 749 (846)
|||++........ ....||+.|+|||++.+..++.++||||||+++|+|+||++||..............
T Consensus 159 Dfg~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 228 (271)
T 3dtc_A 159 DFGLAREWHRTTK----------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228 (271)
T ss_dssp CCCC-----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT
T ss_pred cCCcccccccccc----------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc
Confidence 9999986543221 123589999999999999999999999999999999999999976654332221111
Q ss_pred hccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 750 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 750 ~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
.......+...+..+.+|+.+||..+|.+||++ .++++.|+.|
T Consensus 229 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~e~l~~L~~l 271 (271)
T 3dtc_A 229 -----NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSF-TNILDQLTTI 271 (271)
T ss_dssp -----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHC-
T ss_pred -----CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCH-HHHHHHHhcC
Confidence 111223344556889999999999999999999 7888887653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=364.07 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=204.1
Q ss_pred CCCcccceeeeeCceEEEEEEECC--e----EEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH--M----QVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~--~----~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV 599 (846)
.+|...+.||+|+||.||+|.+.. . .||+|.+.... ......+.+|+.+++.++||||++++++|. ...++|
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 478899999999999999998753 2 38888886543 233457889999999999999999999984 568899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 9999999999998543 3468889999999999999999999 8999999999999999999999999999997754
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~ 756 (846)
...... .....||+.|+|||++.++.++.++|||||||++|+|+| |++||....... ..+..+
T Consensus 168 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------- 233 (325)
T 3kex_A 168 DDKQLL------YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-------- 233 (325)
T ss_dssp CTTCCC-----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT--------
T ss_pred cccccc------ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC--------
Confidence 332111 123458889999999999999999999999999999999 999997654322 212211
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.....+...+..+.+|+.+||..+|.+||++ .++++.|+.+..
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~el~~~l~~~~~ 276 (325)
T 3kex_A 234 ERLAQPQICTIDVYMVMVKCWMIDENIRPTF-KELANEFTRMAR 276 (325)
T ss_dssp CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCH-HHHHHHHHHHTT
T ss_pred CCCCCCCcCcHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHh
Confidence 1112233445679999999999999999999 888888887753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=349.77 Aligned_cols=255 Identities=25% Similarity=0.485 Sum_probs=210.4
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
..++|...+.||+|+||.||+|.+.+ ..||+|++..... ..+.+.+|+.++.+++||||++++++|. ...++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 34578999999999999999998875 5799999976543 3567999999999999999999999984 458899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++... ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999999543 2458999999999999999999999 8999999999999999999999999999987654322
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. .....||+.|+|||++.+..++.++||||||+++|+|+| |++||................ ....
T Consensus 160 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------~~~~ 226 (268)
T 3sxs_A 160 VS-------SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH------RLYR 226 (268)
T ss_dssp EE-------CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC------CCCC
T ss_pred hc-------ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC------CCCC
Confidence 11 123457889999999998899999999999999999999 999997665543322221111 1122
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
|...++.+.+|+.+||+.+|.+||++ .++++.|+.++.
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~-~~ll~~L~~l~~ 264 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTF-QQLLSSIEPLRE 264 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHGGGCC
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHhhh
Confidence 33346789999999999999999999 888888887753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=364.69 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=200.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcCCCceeeEecccc--Cce
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 596 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~ 596 (846)
.+.|.+.+.||+|+||.||++... +..||+|++...... ..+.+.+|+.+|++++||||++++++|. ...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 357999999999999999999986 678999999875432 2357899999999999999999999984 468
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC----ceeeeccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFG 672 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~----~vKL~DFG 672 (846)
++||||++||+|.+++. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999994 34569999999999999999999999 8999999999999998776 79999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc
Q 003121 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 752 (846)
Q Consensus 673 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~ 752 (846)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...............
T Consensus 165 ~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-- 233 (361)
T 2yab_A 165 LAHEIEDGVE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-- 233 (361)
T ss_dssp SCEECCTTCC---------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT--
T ss_pred CceEcCCCCc---------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--
Confidence 9987654321 12346999999999999889999999999999999999999999766543322111110
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
... ....++...+..+.+||.+||..+|.+||++ .++
T Consensus 234 ~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-~e~ 270 (361)
T 2yab_A 234 SYD-FDEEFFSQTSELAKDFIRKLLVKETRKRLTI-QEA 270 (361)
T ss_dssp CCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred CCC-CCchhccCCCHHHHHHHHHHCCCChhHCcCH-HHH
Confidence 000 0001112345789999999999999999999 444
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=365.26 Aligned_cols=237 Identities=23% Similarity=0.294 Sum_probs=197.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|...+.||+|+||.||++... +..||||+++.. .......+.+|+.+|+.++||||++++++|. +..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 47899999999999999999886 678999999753 2234567889999999999999999999984 5689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||++||+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999998543 468999999999999999999999 89999999999999999999999999999864322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... .....||+.|+|||++.+..++.++|||||||++|||++|++||............ ... ...
T Consensus 159 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--~~~-----~~~ 223 (337)
T 1o6l_A 159 GAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LME-----EIR 223 (337)
T ss_dssp TCC--------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHC-----CCC
T ss_pred CCc--------ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH--HcC-----CCC
Confidence 111 12345999999999999999999999999999999999999999765443211111 011 123
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCC
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
+|...+..+.+|+.+||..+|.+||
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~ 248 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhc
Confidence 4555678899999999999999999
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=351.26 Aligned_cols=252 Identities=29% Similarity=0.477 Sum_probs=204.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCc-------hhHHHHHHHHHhcCCCceeeEeccccCceE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP-------SEFQQEIDILSKIRHPNLVTLVGACPEVWT 597 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~-------~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 597 (846)
.++|...+.||+|+||.||+|.+. +..||||++........ ..+.+|+.++++++||||+++++++.+..+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 457999999999999999999985 67899999976543322 568899999999999999999999988889
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecccCCCceEecCCCc-----eeeec
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLDANFV-----SKLSD 670 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g--iiHrDLkp~NILl~~~~~-----vKL~D 670 (846)
+||||+++|+|.+.+.. ...++++..++.++.|++.||.|||+ ++ |+||||||+|||++.++. +||+|
T Consensus 98 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred EEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 99999999999988853 34579999999999999999999999 77 999999999999988776 99999
Q ss_pred cccccccccccccCCCccccccCCCCCCcccCChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003121 671 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA--SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 748 (846)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~--~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~ 748 (846)
||+++...... ....||+.|+|||++. ...++.++|||||||++|+|++|++||.............
T Consensus 173 fg~~~~~~~~~-----------~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 173 FGLSQQSVHSV-----------SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CTTCBCCSSCE-----------ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred CCccccccccc-----------cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 99987543221 2346999999999984 4567899999999999999999999997543322111111
Q ss_pred hhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 749 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
... .......+...+..+.+|+.+||..+|.+||++ +++++.|+.|
T Consensus 242 ~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~L~~l 287 (287)
T 4f0f_A 242 IRE---EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF-SYIVKELSEL 287 (287)
T ss_dssp HHH---SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTC
T ss_pred Hhc---cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCH-HHHHHHHHhC
Confidence 111 112223444566889999999999999999999 7888877653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=352.47 Aligned_cols=260 Identities=26% Similarity=0.433 Sum_probs=198.2
Q ss_pred hcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEe
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEY 602 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy 602 (846)
..++|.+.++||+|+||.||+|.+.+ .||||+++...... ...|.+|+.+|++++||||+++++++. ...++||||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~ 100 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 100 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence 45689999999999999999998766 59999997654322 356899999999999999999999874 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 101 CEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred cCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 9999999998533 4569999999999999999999999 8999999999999999999999999999986543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
... .....||+.|+|||++. +..++.++||||||+++|+|+||+.||.............. .....+...
T Consensus 176 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 248 (289)
T 3og7_A 176 SHQ------FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG-RGSLSPDLS 248 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH-HTSCCCCTT
T ss_pred ccc------ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc-ccccCcchh
Confidence 111 12345999999999996 56788999999999999999999999976443322221111 111122222
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
..+...+..+.+|+.+||..+|.+||++ .++++.|+.+.
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~-~ell~~L~~l~ 287 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSF-PRILAEIEELA 287 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHTT
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCH-HHHHHHHHHHh
Confidence 3334456889999999999999999999 88888888764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=380.49 Aligned_cols=259 Identities=29% Similarity=0.497 Sum_probs=213.2
Q ss_pred hhhhhcCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEE
Q 003121 522 EIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 599 (846)
Q Consensus 522 ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV 599 (846)
.++....+|.+.+.||+|+||.||+|.+. +..||||+++... ...+.|.+|+.+|++++||||+++++++. +..++|
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv 260 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYII 260 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEE
Confidence 34455678999999999999999999987 5789999998654 34678999999999999999999999984 568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999995332 2358889999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH--HHhhhhhccccCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDP 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~--~~~~~~~~~~ld~ 756 (846)
..... .....+|+.|+|||++..+.++.++|||||||+||||+| |++||........ .+..+
T Consensus 337 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-------- 401 (454)
T 1qcf_A 337 NEYTA-------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-------- 401 (454)
T ss_dssp HHHHT-------TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT--------
T ss_pred Cceec-------cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence 32111 122347889999999999999999999999999999999 9999976544322 11111
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
.....|...+..+.+|+.+||..+|.+||++ +++...|+.+...
T Consensus 402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 402 YRMPRPENCPEELYNIMMRCWKNRPEERPTF-EYIQSVLDDFYTA 445 (454)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTSSSS
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhHCcCH-HHHHHHHHHHHhc
Confidence 1112244556889999999999999999999 8888888876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=366.25 Aligned_cols=266 Identities=24% Similarity=0.367 Sum_probs=215.0
Q ss_pred hhcCCCcccceeeeeCceEEEEEEECC---------eEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccc
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP 593 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~---------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~ 593 (846)
...++|.+.++||+|+||.||+|.+.+ ..||||++...... ....+.+|+.+++++ +||||++++++|.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 345689999999999999999998632 56999999765322 235688999999999 9999999999984
Q ss_pred --CceEEEEEecCCCchhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCce
Q 003121 594 --EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 658 (846)
Q Consensus 594 --~~~~lVmEy~~ggsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NI 658 (846)
+..++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+ ++|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceE
Confidence 468999999999999999965431 2469999999999999999999999 8999999999999
Q ss_pred EecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003121 659 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGI 737 (846)
Q Consensus 659 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~ 737 (846)
||+.++.+||+|||+++.......... .....||+.|+|||++.+..++.++|||||||++|+|+| |..||..
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCC------CTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEcCCCcEEEcccCccccccccccccc------ccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999987654322111 133458899999999999999999999999999999999 9999976
Q ss_pred chHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCCC
Q 003121 738 TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGST 806 (846)
Q Consensus 738 ~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~~ 806 (846)
.......... ........+...+..+.+|+.+||..+|.+||++ .++++.|+.+.+......
T Consensus 297 ~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 297 VPVEELFKLL------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp CCHHHHHHHH------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHSCSCC
T ss_pred CCHHHHHHHH------HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHHHhcCC
Confidence 5443221111 1111222344556889999999999999999999 889999999887764433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=361.02 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=202.3
Q ss_pred CCCcccceeeeeCceEEEEEEEC--Ce----EEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV 599 (846)
.+|...++||+|+||.||+|.+. +. +||+|.+.... ......|.+|+.+|++++||||++++++|. ...++|
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 46899999999999999999874 22 46888886543 234567999999999999999999999984 467899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++... ...+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 95 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 95 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999999643 3569999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~ 756 (846)
...... .....||+.|+|||++.+..++.++|||||||++|+|+| |++||....... ..+..+
T Consensus 170 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-------- 235 (327)
T 3poz_A 170 EEKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-------- 235 (327)
T ss_dssp TCC-------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--------
T ss_pred Cccccc------ccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC--------
Confidence 322111 123457899999999999999999999999999999999 999997654322 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~ell~~l~~~~~ 278 (327)
T 3poz_A 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKMAR 278 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCH-HHHHHHHHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHHh
Confidence 1122344566789999999999999999999 778888887754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=347.45 Aligned_cols=262 Identities=27% Similarity=0.442 Sum_probs=213.4
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEEE
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 600 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVm 600 (846)
.+...++|...+.||+|+||.||+|...+ ..||||.+.... ...+.+.+|+.+|++++||||+++++++. +..++||
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~ 86 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT 86 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEE
Confidence 34445689999999999999999999875 579999997643 34678999999999999999999999884 4688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++.... ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999999984321 1268999999999999999999999 89999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.... .....+++.|+|||++.++.++.++||||||+++|+|+| |++||............. .....
T Consensus 163 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~------~~~~~ 229 (279)
T 1qpc_A 163 EYTA-------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE------RGYRM 229 (279)
T ss_dssp CEEC-------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH------TTCCC
T ss_pred cccc-------ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh------cccCC
Confidence 2111 123457889999999998899999999999999999999 999997654432211110 11112
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCC
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 803 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~ 803 (846)
..+...+..+.+|+.+||..+|.+||++ .++.+.|+.+.....
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTF-DYLRSVLEDFFTATE 272 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHC-
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCH-HHHHHHHHHHHHhcc
Confidence 2334456889999999999999999999 889999998877654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.01 Aligned_cols=264 Identities=26% Similarity=0.415 Sum_probs=208.1
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEecccc
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP 593 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~ 593 (846)
.+...++|...+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+++ +||||++++++|.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445678999999999999999999872 3579999997543 23456799999999999 8999999999984
Q ss_pred --CceEEEEEecCCCchhhhhccCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEec
Q 003121 594 --EVWTLVYEYLPNGSLEDRLSCKDNS--------------------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651 (846)
Q Consensus 594 --~~~~lVmEy~~ggsL~~~L~~~~~~--------------------~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHr 651 (846)
+..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+ +||+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence 5689999999999999999654321 348999999999999999999999 899999
Q ss_pred ccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-
Q 003121 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT- 730 (846)
Q Consensus 652 DLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt- 730 (846)
||||+||||+.++.+||+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|+|
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYV------VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccce------eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 999999999999999999999998765432111 1123447889999999999999999999999999999998
Q ss_pred CCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 731 GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 731 G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
|.+||............ +. .......+...+..+.+|+.+||..+|.+||++ .++++.|+.+.+.
T Consensus 271 g~~p~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 271 GVNPYPGIPVDANFYKL--IQ---NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-PNLTSFLGCQLAD 335 (344)
T ss_dssp SCCSSTTCCCSHHHHHH--HH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHC--
T ss_pred CCCCcccCCcHHHHHHH--Hh---cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHHHHHHH
Confidence 99999765332211111 00 111223344556889999999999999999999 8888888877554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=368.91 Aligned_cols=259 Identities=22% Similarity=0.335 Sum_probs=207.7
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--Cce
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 596 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~ 596 (846)
.++|.+.+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+|++++||||++++++|. ...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 457899999999999999999854 35799999875422 22346889999999999999999999984 468
Q ss_pred EEEEEecCCCchhhhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC---ceeee
Q 003121 597 TLVYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLS 669 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~---~vKL~ 669 (846)
++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996542 22468999999999999999999999 8999999999999999554 59999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhh
Q 003121 670 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTG 748 (846)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~ 748 (846)
|||+++.+......... ....||+.|+|||++.+..++.++|||||||++|||+| |.+||.............
T Consensus 227 DFG~a~~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKG------GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTC------CGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CCccccccccccccccC------CCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999866443222111 12347999999999999999999999999999999998 999997665433211111
Q ss_pred hhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 749 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
.......+...+..+.+|+.+||+.+|.+||++ .++++.|+.+...
T Consensus 301 ------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 ------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF-AIILERIEYCTQD 346 (367)
T ss_dssp ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHC
T ss_pred ------cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHhhC
Confidence 111122344456789999999999999999999 8888888887654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=353.14 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=197.1
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC-----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc-CceEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTL 598 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~l 598 (846)
..++|.+.+.||+|+||.||+|.+.. ..||+|.+...... ..+.+.+|+.+|++++||||+++++++. +..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l 92 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 92 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEE
Confidence 34579999999999999999998752 46999998754321 2356889999999999999999999984 46889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999543 3468999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH--HHhhhhhccccC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLD 755 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~--~~~~~~~~~~ld 755 (846)
...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |.+||........ .+..+
T Consensus 168 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~------- 233 (281)
T 1mp8_A 168 DSTYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG------- 233 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------
T ss_pred cccccc-------cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-------
Confidence 432111 123357889999999999999999999999999999997 9999975543221 11111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.....+...+..+.+|+.+||..+|.+||++ .++++.|+.+..
T Consensus 234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~l~~~~~ 276 (281)
T 1mp8_A 234 -ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRF-TELKAQLSTILE 276 (281)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHH
Confidence 1122344556889999999999999999999 888888887754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.82 Aligned_cols=256 Identities=25% Similarity=0.435 Sum_probs=207.6
Q ss_pred hhcCCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
...++|...+.||+|+||.||+|.+.+ ..||||++..... ..+.+.+|+.+|++++||||++++++|. ...++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 345578999999999999999999875 5799999986543 3567999999999999999999999984 46899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999999542 3469999999999999999999999 899999999999999999999999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... .....||+.|+|||++.+..++.++||||||+++|+|+| |++||.............. .....
T Consensus 175 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~------~~~~~ 241 (283)
T 3gen_A 175 YTS-------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ------GLRLY 241 (283)
T ss_dssp HHS-------TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------TCCCC
T ss_pred ccc-------ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc------ccCCC
Confidence 211 123457889999999999999999999999999999998 9999976654332221111 11122
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.+...+..+.+|+.+||+.+|.+||++ +++++.|..+..
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rps~-~~ll~~L~~~~~ 280 (283)
T 3gen_A 242 RPHLASEKVYTIMYSCWHEKADERPTF-KILLSNILDVMD 280 (283)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCChhHCcCH-HHHHHHHHHHhh
Confidence 234446789999999999999999999 788888877654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=358.61 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=200.5
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCc---hhHHHHHHHHHhcCCCceeeEeccccC------c
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACPE------V 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~---~~f~~Ei~iL~~l~HpnIv~l~g~~~~------~ 595 (846)
.++|.+.+.||+|+||.||++... +..||||++........ ..+.+|+.++++++||||+++++++.. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 457999999999999999999964 68899999987644432 368899999999999999999998742 2
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.++||||+++|+|.+++... .++++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 48999999999999999533 468999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
.+........ ......||+.|+|||++.+..++.++|||||||++|+|+||++||.............. ....
T Consensus 165 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~--~~~~ 237 (311)
T 3ork_A 165 AIADSGNSVT-----QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPI 237 (311)
T ss_dssp ----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--CCCC
T ss_pred cccccccccc-----cccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc--CCCC
Confidence 7654322111 11234689999999999999999999999999999999999999987665433222111 1000
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
+. ...+...+..+.+|+.+||..+|.+||+..+++...+..+..
T Consensus 238 ~~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 238 PP-SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CH-HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred Cc-ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 00 001112457899999999999999999997877777766544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=346.80 Aligned_cols=272 Identities=19% Similarity=0.227 Sum_probs=212.5
Q ss_pred cCCCcccceeeeeCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVmE 601 (846)
.++|.+.+.||+|+||.||+|.. .+..||||++.... ....+.+|+.+++.+ +||||+++++++ ....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45799999999999999999995 47899999987543 345789999999999 799999999988 446889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc-----eeeeccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-----SKLSDFGISRF 676 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~-----vKL~DFGla~~ 676 (846)
|+ +++|.+++... ..++++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999643 3469999999999999999999999 89999999999999987765 99999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH---HH--HHHhhhhhc
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE---VQ--YALDTGKLK 751 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~---~~--~~~~~~~~~ 751 (846)
.......... .........||+.|+|||++.+..++.++|||||||++|+|+||++||..... .. ..+......
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHI-PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp SBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccccccccc-cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7544321111 00112445799999999999999999999999999999999999999976321 11 111111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCCCCCcCCC
Q 003121 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGS 812 (846)
Q Consensus 752 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~~~~~~~~ 812 (846)
...... ....+..+.+|+.+||..+|.+||++ +++.+.|+.+....+......++|
T Consensus 240 ~~~~~~----~~~~~~~l~~li~~~l~~dp~~RP~~-~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 240 TPLREL----CAGFPEEFYKYMHYARNLAFDATPDY-DYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp SCHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCH-HHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred ccHHHH----HhhCcHHHHHHHHHHhcCCcccCCCH-HHHHHHHHHHHHhcCCCCCCcccc
Confidence 111111 11235789999999999999999999 889999999887765544433333
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=361.29 Aligned_cols=267 Identities=24% Similarity=0.365 Sum_probs=213.1
Q ss_pred CChhhhhhhcCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEe
Q 003121 518 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLV 589 (846)
Q Consensus 518 ~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~ 589 (846)
+...+++...++|...+.||+|+||.||+|.+. +..||||.+...... ....+.+|+.+|+.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444566667788999999999999999999865 467999998754321 234588999999999999999999
Q ss_pred cccc--CceEEEEEecCCCchhhhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe
Q 003121 590 GACP--EVWTLVYEYLPNGSLEDRLSCKD-------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 660 (846)
Q Consensus 590 g~~~--~~~~lVmEy~~ggsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl 660 (846)
+++. +..++||||+++|+|.+++.... ...++++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEE
Confidence 9984 46899999999999999985421 12567999999999999999999999 899999999999999
Q ss_pred cCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 003121 661 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK 739 (846)
Q Consensus 661 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~ 739 (846)
+.++.+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|+|+| |.+||....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEE------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred cCCCeEEECcCccccccccccccc------cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 999999999999998664432111 1123457899999999999999999999999999999999 899997654
Q ss_pred HHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 740 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 740 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
........ ........+...+..+.+|+.+||..+|.+||++ .++++.|+.+..
T Consensus 246 ~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~e~l~~L~~~~~ 299 (322)
T 1p4o_A 246 NEQVLRFV------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIKEEME 299 (322)
T ss_dssp HHHHHHHH------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHGGGSC
T ss_pred HHHHHHHH------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHhhc
Confidence 43221111 0111122344556889999999999999999999 788888876644
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.39 Aligned_cols=249 Identities=20% Similarity=0.359 Sum_probs=204.8
Q ss_pred CCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccc----CceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lVmE 601 (846)
++|...+.||+|+||.||+|.+++..||||++....... ...|.+|+.+|++++||||++++++|. ...++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 478889999999999999999999999999998654322 346899999999999999999999983 45789999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecccCCCceEecCCCceeeecccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g--iiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|+++|+|.+++.... ..++++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp CCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999996432 3469999999999999999999999 67 99999999999999999999999998654221
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTP---KSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~---ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
....||+.|+|||++.+..++. ++|||||||++|+|+||+.||............. ...
T Consensus 166 -------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~ 227 (271)
T 3kmu_A 166 -------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA-----LEG 227 (271)
T ss_dssp -------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH-----HSC
T ss_pred -------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH-----hcC
Confidence 1234899999999998765444 8999999999999999999997665433221111 111
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
.....+...+..+.+|+.+||+.+|.+||++ +++++.|+.+.
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~~L~~l~ 269 (271)
T 3kmu_A 228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKF-DMIVPILEKMQ 269 (271)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHhh
Confidence 2223445566889999999999999999999 88888888764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=355.76 Aligned_cols=259 Identities=28% Similarity=0.403 Sum_probs=209.7
Q ss_pred hhhcCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--
Q 003121 524 EGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-- 593 (846)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-- 593 (846)
.....+|.+.+.||+|+||.||+|... +..||||++..... .....+.+|+.+|+.++||||++++++|.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 334568999999999999999999863 26799999975432 12356889999999999999999999984
Q ss_pred CceEEEEEecCCCchhhhhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecc
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDN---------------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 652 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrD 652 (846)
...++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccc
Confidence 468999999999999999965432 2348999999999999999999999 8999999
Q ss_pred cCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-C
Q 003121 653 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-G 731 (846)
Q Consensus 653 Lkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G 731 (846)
|||+|||++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|+| |
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYV------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEE------CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred cchheEEEcCCCCEEEccccccccccccccce------eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999998764432111 1133457899999999999899999999999999999999 9
Q ss_pred CCCCCCchHHH--HHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 732 RPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 732 ~~pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.+||....... ..+..+ .....+...+..+.+|+.+||..+|.+||++ .++++.|+.+..
T Consensus 250 ~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~l~~~l~~~~~ 311 (314)
T 2ivs_A 250 GNPYPGIPPERLFNLLKTG--------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVF-ADISKDLEKMMV 311 (314)
T ss_dssp CCSSTTCCGGGHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHhhcC--------CcCCCCccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHh
Confidence 99997654322 111111 1223344556889999999999999999999 888888887754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=351.15 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=204.1
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc----CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lV 599 (846)
.++|.+.++||+|+||.||+|... +..||||++..... ...+.+.+|+.+|++++||||+++++++. ...++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 346899999999999999999987 67899999976432 33567889999999999999999999873 257899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe----cCCCceeeecccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGISR 675 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl----~~~~~vKL~DFGla~ 675 (846)
|||+++|+|.+++........+++..++.++.||+.||.|||+ ++|+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 9999999999999765555569999999999999999999999 899999999999999 788899999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCchH------H
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA--------SGELTPKSDVYSFGIILLRLLTGRPALGITKE------V 741 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~--------~~~~~~ksDVwSlGviL~elltG~~pf~~~~~------~ 741 (846)
........ ....||+.|+|||++. +..++.++|||||||++|+|+||++||..... .
T Consensus 165 ~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 165 ELEDDEQF---------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp ECCTTCCB---------CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred ecCCCCce---------eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 76543211 2345999999999986 46789999999999999999999999953211 1
Q ss_pred HHHHhhhhhccc----------------cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 742 QYALDTGKLKNL----------------LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 742 ~~~~~~~~~~~~----------------ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
...+..+..... ..+.....+...+..+.+|+.+||+.||.+||++ +++++...
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~-~ell~h~~ 305 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-DQFFAETS 305 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH-HHHHHHHH
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH-HHhhhccH
Confidence 111111110000 0012223456678899999999999999999999 55554444
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=349.27 Aligned_cols=244 Identities=26% Similarity=0.358 Sum_probs=192.7
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--------------------------CchhHHHHHHHHH
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------------------------GPSEFQQEIDILS 578 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--------------------------~~~~f~~Ei~iL~ 578 (846)
.++|.+.+.||+|+||.||+|... +..||||++...... ..+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357999999999999999999875 678999999765321 1356899999999
Q ss_pred hcCCCceeeEecccc----CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccC
Q 003121 579 KIRHPNLVTLVGACP----EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 654 (846)
Q Consensus 579 ~l~HpnIv~l~g~~~----~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLk 654 (846)
+++||||+++++++. ...++||||+++|+|.+++. ..++++..++.++.||+.||.|||+ ++|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCC
Confidence 999999999999984 35789999999999988762 3469999999999999999999999 899999999
Q ss_pred CCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCC---CCchhhHHHHHHHHHHHHhC
Q 003121 655 PANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTG 731 (846)
Q Consensus 655 p~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~~~ksDVwSlGviL~elltG 731 (846)
|+|||++.++.+||+|||+++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL--------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE--------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc--------ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 99999999999999999999876533211 12346999999999997765 47889999999999999999
Q ss_pred CCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 732 RPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 732 ~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
++||.............. .....+. +...+..+.+|+.+||..+|.+||++ .++
T Consensus 237 ~~pf~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~l~~li~~~l~~dp~~R~s~-~e~ 290 (298)
T 2zv2_A 237 QCPFMDERIMCLHSKIKS-QALEFPD----QPDIAEDLKDLITRMLDKNPESRIVV-PEI 290 (298)
T ss_dssp SCSSCCSSHHHHHHHHHH-CCCCCCS----SSCCCHHHHHHHHHHTCSCTTTSCCH-HHH
T ss_pred CCCCCCccHHHHHHHHhc-ccCCCCC----ccccCHHHHHHHHHHhhcChhhCCCH-HHH
Confidence 999976654322111110 1111111 12345789999999999999999999 444
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=369.18 Aligned_cols=246 Identities=22% Similarity=0.282 Sum_probs=196.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lV 599 (846)
.+|.+.++||+|+||+||++... +..||||+++.... .....+..|..+|.++ +||||++++++|. +..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 47899999999999999999986 57899999986532 2345688999999887 8999999999984 568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||++||+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.+|.+||+|||+++....
T Consensus 132 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999998543 469999999999999999999999 8999999999999999999999999999985322
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH--hhhhhccccCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPL 757 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~--~~~~~~~~ld~~ 757 (846)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.......... ....+...+...
T Consensus 206 ~~~--------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~ 277 (396)
T 4dc2_A 206 PGD--------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277 (396)
T ss_dssp TTC--------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred CCC--------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence 211 1134569999999999999999999999999999999999999995432110000 000000001111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
...+|...+..+.+|+.+||+.+|.+||++
T Consensus 278 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 223455567889999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=354.58 Aligned_cols=245 Identities=22% Similarity=0.334 Sum_probs=198.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcCCCceeeEecccc--CceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~ 597 (846)
+.|...+.||+|+||.||++... +..||+|++...... ..+.+.+|+.+|+.++||||++++++|. ...+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46889999999999999999986 678999999765432 2467999999999999999999999984 4689
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC----ceeeecccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGI 673 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~----~vKL~DFGl 673 (846)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999943 3569999999999999999999999 8999999999999999877 899999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.................
T Consensus 165 a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~- 234 (326)
T 2y0a_A 165 AHKIDFGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY- 234 (326)
T ss_dssp CEECCTTSC---------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC-
T ss_pred CeECCCCCc---------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC-
Confidence 987643221 1234599999999999988999999999999999999999999976554332211111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
......+...+..+.+|+.+||..+|.+||++ .++
T Consensus 235 --~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~ 269 (326)
T 2y0a_A 235 --EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI-QDS 269 (326)
T ss_dssp --CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred --CcCccccccCCHHHHHHHHHHccCChhhCCCH-HHH
Confidence 00001112335789999999999999999999 444
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=361.48 Aligned_cols=278 Identities=16% Similarity=0.236 Sum_probs=209.2
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-----------CchhHHHHHHHHHhcCCCceee
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-----------GPSEFQQEIDILSKIRHPNLVT 587 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-----------~~~~f~~Ei~iL~~l~HpnIv~ 587 (846)
..++|.+.++||+|+||.||+|.+.. ..||||++...... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35589999999999999999998853 57999998754311 0112334556667778999999
Q ss_pred EeccccC------ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec
Q 003121 588 LVGACPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 661 (846)
Q Consensus 588 l~g~~~~------~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~ 661 (846)
++++|.. ..++||||+ +|+|.+++... ...+++..++.|+.||+.||.|||+ ++|+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEe
Confidence 9998833 378999999 99999999643 3569999999999999999999999 8999999999999999
Q ss_pred --CCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 003121 662 --ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK 739 (846)
Q Consensus 662 --~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~ 739 (846)
.++.+||+|||+++.+.......... ........||+.|+|||++.+..++.++|||||||++|+|+||+.||....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYA-ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSS-CCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCeEEEEECCcceecccCCcccccc-cCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 88999999999998776543221111 111234569999999999999999999999999999999999999997432
Q ss_pred HHHHHH---h---hhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCCCCCcCCCC
Q 003121 740 EVQYAL---D---TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSE 813 (846)
Q Consensus 740 ~~~~~~---~---~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~~~~~~~~~ 813 (846)
...... . ...+..+++.... +...+..+.+|+..||..+|.+||++ .++.+.|+.+....+......+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~-~~l~~~l~~~~~~~~~~~~~~~dw~ 342 (364)
T 3op5_A 266 KDPKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLY-ENLRDILLQGLKAIGSKDDGKLDLS 342 (364)
T ss_dssp TCHHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCH-HHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred cCHHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCH-HHHHHHHHHHHHHcCCCcCCccceE
Confidence 111111 0 0111111111110 11235789999999999999999999 8899999988877766655555553
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=365.30 Aligned_cols=244 Identities=25% Similarity=0.354 Sum_probs=199.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
.++|.+.+.||+|+||.||++... +..||+|++.... ......+.+|+.+|+.++||||++++++|. +..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357899999999999999999886 4679999987532 233467889999999999999999999984 568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+.||+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999953 3569999999999999999999999 8999999999999999999999999999987643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHhhhhhcccc
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLL 754 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~~~ksDVwSlGviL~elltG~~pf~~~~~~--~~~~~~~~~~~~l 754 (846)
... .....||+.|+|||++.+ ..|+.++|||||||++|+|+||++||...... ...... +..
T Consensus 168 ~~~---------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--~~~-- 234 (384)
T 4fr4_A 168 ETQ---------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FET-- 234 (384)
T ss_dssp TCC---------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH--HHH--
T ss_pred CCc---------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH--Hhh--
Confidence 221 134569999999999974 45899999999999999999999999643321 111111 111
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 755 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+|...+..+.+|+.+||..+|.+||+..+++
T Consensus 235 --~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l 269 (384)
T 4fr4_A 235 --TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269 (384)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHH
T ss_pred --cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHH
Confidence 12234455568899999999999999999953554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=351.21 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=210.4
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccc--
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP-- 593 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~-- 593 (846)
...++|...+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+|+++ +||||++++++|.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 34568999999999999999999862 367999999865332 235689999999999 9999999999984
Q ss_pred CceEEEEEecCCCchhhhhccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCce
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDN---------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 658 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~---------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NI 658 (846)
+..++||||+++|+|.+++..... ..++++..++.++.||+.||.|||+ ++|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceE
Confidence 568999999999999999965432 2358999999999999999999999 8999999999999
Q ss_pred EecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003121 659 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGI 737 (846)
Q Consensus 659 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~ 737 (846)
|++.++.+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|+|+| |++||..
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSE------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred EEcCCCCEEEccccccccccccccce------eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999998765432111 1123447889999999999999999999999999999999 9999976
Q ss_pred chHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 738 TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 738 ~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
.......... ..... ....+...+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 251 ~~~~~~~~~~--~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~~ 309 (313)
T 1t46_A 251 MPVDSKFYKM--IKEGF---RMLSPEHAPAEMYDIMKTCWDADPLKRPTF-KQIVQLIEKQISES 309 (313)
T ss_dssp CCSSHHHHHH--HHHTC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHT
T ss_pred ccchhHHHHH--hccCC---CCCCcccCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHHHHHHHh
Confidence 5332211111 00111 111233456789999999999999999999 88888998876654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=373.40 Aligned_cols=260 Identities=31% Similarity=0.464 Sum_probs=207.7
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEEE
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 600 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVm 600 (846)
++...++|...++||+|+||.||+|.+.+ ..||||+++... ...+.|.+|+.+|++++||||++++++|. +..++||
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~ 257 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT 257 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEe
Confidence 34455678999999999999999999986 679999998654 34678999999999999999999999984 5688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++... ....+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999532 12458999999999999999999999 89999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.... .....+|+.|+|||++.++.++.++|||||||+||||+| |++||............. .....
T Consensus 334 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~------~~~~~ 400 (452)
T 1fmk_A 334 EYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------RGYRM 400 (452)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH------TTCCC
T ss_pred ceec-------ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------cCCCC
Confidence 2111 123347889999999999999999999999999999999 999997654432111110 11122
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
..|...+..+.+|+.+||..+|.+||++ +++.+.|+.+...
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~-~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTF-EYLQAFLEDYFTS 441 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTTTSC
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHhcc
Confidence 2344566889999999999999999999 8888888876543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=343.22 Aligned_cols=255 Identities=25% Similarity=0.459 Sum_probs=210.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
.++|...+.||+|+||.||+|.+. +..||+|++..... ..+.+.+|+.++++++||||++++++|. +..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357888999999999999999985 57899999986543 3567999999999999999999999984 4689999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++|+|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 999999999543 3468999999999999999999999 89999999999999999999999999999876433211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. .....||+.|+|||++.+..++.++||||||+++|+|+| |++||............. .......+
T Consensus 161 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~------~~~~~~~~ 227 (267)
T 3t9t_A 161 S-------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------TGFRLYKP 227 (267)
T ss_dssp S-------TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TTCCCCCC
T ss_pred c-------cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh------cCCcCCCC
Confidence 1 123457889999999998999999999999999999999 899997654433211111 11112223
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
...+..+.+|+.+||..+|.+||++ .++++.|+.+...
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~-~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAF-SRLLRQLAEIAES 265 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHC
T ss_pred ccCcHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHhc
Confidence 4456789999999999999999999 8888999888653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.04 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=195.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccccC----------
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE---------- 594 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~---------- 594 (846)
++|...+.||+|+||.||+|... +..||||++...... ..+.+.+|+.+|++++||||++++++|.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 36888999999999999999986 688999999764432 34679999999999999999999998621
Q ss_pred -------------------------------------------------ceEEEEEecCCCchhhhhccCCCCCCCCHHH
Q 003121 595 -------------------------------------------------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQT 625 (846)
Q Consensus 595 -------------------------------------------------~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~ 625 (846)
..++|||||++|+|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2789999999999999997666556677888
Q ss_pred HHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCCc----cccccCCCCCCccc
Q 003121 626 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT----TLCCRTDPKGTFAY 701 (846)
Q Consensus 626 ~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~----~~~~~~~~~Gt~~Y 701 (846)
++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++............ .........||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 99999999999999999 899999999999999999999999999998776542111100 00112345699999
Q ss_pred CChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCc
Q 003121 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 781 (846)
Q Consensus 702 ~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P 781 (846)
+|||++.+..++.++|||||||++|+|++|..|+............. ..+..+...+..+.+|+.+||..+|
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNL--------KFPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTT--------CCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhcc--------CCCcccccCChhHHHHHHHHccCCC
Confidence 99999999999999999999999999999987763222111111111 1111112334678999999999999
Q ss_pred CCCCChHHHH
Q 003121 782 KSRPELGKDV 791 (846)
Q Consensus 782 ~~RPt~~~~v 791 (846)
.+||++ .++
T Consensus 315 ~~Rps~-~~~ 323 (332)
T 3qd2_B 315 TERPEA-TDI 323 (332)
T ss_dssp GGSCCH-HHH
T ss_pred CcCCCH-HHH
Confidence 999999 444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=366.51 Aligned_cols=240 Identities=24% Similarity=0.286 Sum_probs=196.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhc-CCCceeeEecccc--CceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~l 598 (846)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|..+|..+ +||||+++++++. +..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 458999999999999999999886 578999999753 123345688999999998 7999999999984 56899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||++||+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999543 459999999999999999999999 899999999999999999999999999998543
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..... ....+||+.|+|||++.+..|+.++|||||||++|||+||++||............. . ..
T Consensus 176 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~-----~~ 240 (353)
T 3txo_A 176 CNGVT--------TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--N-----DE 240 (353)
T ss_dssp C-----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--H-----CC
T ss_pred cCCcc--------ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH--c-----CC
Confidence 22111 123469999999999998899999999999999999999999997765433211111 1 11
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
..+|...+..+.+|+.+||..+|.+||++
T Consensus 241 ~~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 241 VVYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 23444566889999999999999999997
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=358.99 Aligned_cols=265 Identities=24% Similarity=0.355 Sum_probs=208.6
Q ss_pred CCCcccceeeeeCceEEEEEEE------CCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc----CceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~------~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~ 597 (846)
++|.+.+.||+|+||.||++.+ .+..||||++........+.+.+|+.+|++++||||+++++++. ...+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4788999999999999999985 35789999998764444566899999999999999999999872 3478
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+++|+|.+++... ...+++..++.++.+|+.||.|||+ ++|+||||||+||||+.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999999543 2358999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHh---------hh
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD---------TG 748 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~---------~~ 748 (846)
...... ........||+.|+|||++.+..++.++||||||+++|+|+||..||........... ..
T Consensus 178 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 178 PLDKDY-----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp CTTCSE-----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred ccCCcc-----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 543211 1112345689999999999998999999999999999999999999965433211000 00
Q ss_pred hhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCC
Q 003121 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 803 (846)
Q Consensus 749 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~ 803 (846)
.............+...+..+.+|+.+||..+|.+||++ .++++.|+.+.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF-SALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHC-----
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHhhhc
Confidence 001111112233445567889999999999999999999 888888888766543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=354.66 Aligned_cols=234 Identities=25% Similarity=0.366 Sum_probs=197.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|...+.||+|+||.||++... +..||+|++... .....+.+.+|+.+|+.++||||+++++++. ...++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 47889999999999999999886 678999999754 2234567889999999999999999999984 4688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||++||+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999543 468999999999999999999999 89999999999999999999999999999865432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
. ....||+.|+|||++.+..++.++|||||||++|+|++|++||............. .. ...
T Consensus 160 ~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~-----~~~ 221 (318)
T 1fot_A 160 T-----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--NA-----ELR 221 (318)
T ss_dssp B-----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HC-----CCC
T ss_pred c-----------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hC-----CCC
Confidence 1 23469999999999999999999999999999999999999997665433211111 11 122
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCC
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
+|...+..+.+|+.+||..+|.+||
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~ 246 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRL 246 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcC
Confidence 4445568899999999999999999
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=362.77 Aligned_cols=242 Identities=24% Similarity=0.308 Sum_probs=200.0
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEecccc--CceE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWT 597 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~ 597 (846)
..++|...+.||+|+||.||+|... ++.||||+++... ......+..|..+|..+ +||||+++++++. +..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4568999999999999999999986 6789999997542 23456688999999987 9999999999984 5689
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||++||+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999543 458999999999999999999999 89999999999999999999999999999854
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||............. . .
T Consensus 169 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~-~------~ 233 (345)
T 1xjd_A 169 MLGDAK--------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-M------D 233 (345)
T ss_dssp CCTTCC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-H------C
T ss_pred ccCCCc--------ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-h------C
Confidence 322111 134569999999999999999999999999999999999999997665432211110 0 1
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
...+|...+..+.+|+.+||..+|.+||++.
T Consensus 234 ~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~ 264 (345)
T 1xjd_A 234 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVR 264 (345)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhHcCCCh
Confidence 1234455678899999999999999999983
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.62 Aligned_cols=262 Identities=24% Similarity=0.381 Sum_probs=211.0
Q ss_pred cCCCcccc-eeeeeCceEEEEEEEC----CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc-CceEEE
Q 003121 527 THNFDPSL-KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~-~LG~G~fG~Vy~g~~~----~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV 599 (846)
.++|.+.. .||+|+||.||+|.+. +..||||++..... .....+.+|+.+|++++||||+++++++. +..++|
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv 87 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 87 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEE
Confidence 34566665 8999999999999863 56799999986532 22456889999999999999999999984 468899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999853 34569999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
...... ......||+.|+|||++.+..++.++||||||+++|+|+| |++||............. ....
T Consensus 163 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~------~~~~ 231 (287)
T 1u59_A 163 DDSYYT-----ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE------QGKR 231 (287)
T ss_dssp CSCEEC-----CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH------TTCC
T ss_pred Ccceee-----ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh------cCCc
Confidence 321111 1123457899999999998899999999999999999999 999997654332211110 1112
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCC
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 805 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~ 805 (846)
...+...+..+.+|+.+||..+|.+||++ .++++.|+.+..+....
T Consensus 232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 232 MECPPECPPELYALMSDCWIYKWEDRPDF-LTVEQRMRACYYSLASK 277 (287)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHHHHHHTT
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHhcCCc
Confidence 23344566889999999999999999999 88999999887775443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=348.17 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=206.7
Q ss_pred cCCCcccceeeeeCceEEEEEEECC-----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc---cCceE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWT 597 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~---~~~~~ 597 (846)
..+|...+.||+|+||.||+|.+.. ..||+|.+...... ....+.+|+.+|++++||||++++++| ....+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4468888999999999999998642 25899998764322 235688999999999999999999986 34678
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999953 34568999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
........ .......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||.............. .
T Consensus 179 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~------~ 248 (298)
T 3f66_A 179 YDKEYYSV----HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------G 248 (298)
T ss_dssp SCGGGCBC---------CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT------T
T ss_pred cccchhcc----ccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc------C
Confidence 54332211 11234568899999999999999999999999999999999 6777765543322111111 1
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCC
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 803 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~ 803 (846)
.....+...+..+.+|+.+||..+|.+||++ .++++.|+.+.....
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFSTFI 294 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHTSC
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHhhc
Confidence 1112233445789999999999999999999 889999998876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=356.64 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=197.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC-----CCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH-----SLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 598 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~-----~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 598 (846)
+.|.+.+.||+|+||.||+|... +..||||++... .....+.+.+|+.+|+.++||||++++++| ....++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 36899999999999999999886 678999998642 122456799999999999999999999998 456899
Q ss_pred EEEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc---eeeeccccc
Q 003121 599 VYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGIS 674 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~---vKL~DFGla 674 (846)
|||||++|+|.+.+... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998887543 234568999999999999999999999 89999999999999986554 999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHhhhhhccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDTGKLKNL 753 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~-~~~~~~~~~~~ 753 (846)
+........ .....||+.|+|||++.+..++.++|||||||++|+|+||++||....... ..+..+.
T Consensus 181 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~---- 248 (351)
T 3c0i_A 181 IQLGESGLV--------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGK---- 248 (351)
T ss_dssp EECCTTSCB--------CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTC----
T ss_pred eEecCCCee--------ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCC----
Confidence 876543211 133469999999999999999999999999999999999999997754321 1111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 790 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 790 (846)
.......| ...+..+.+|+.+||..+|.+||++.+.
T Consensus 249 ~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~s~~e~ 284 (351)
T 3c0i_A 249 YKMNPRQW-SHISESAKDLVRRMLMLDPAERITVYEA 284 (351)
T ss_dssp CCCCHHHH-TTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCcccc-ccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 11000000 1235789999999999999999999433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=379.21 Aligned_cols=254 Identities=27% Similarity=0.492 Sum_probs=210.7
Q ss_pred hhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 524 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
+....+|.+.++||+|+||.||+|.+. +..||||+++... ...+.|.+|+.+|++++||||++++++|. ...++|
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 334567889999999999999999987 5789999997654 34678999999999999999999999984 468999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++.... ...+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999996432 3568999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~ 756 (846)
..... .....+++.|+|||++.+..++.++|||||||+||||+| |.+||....... ..+.. .
T Consensus 371 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------~ 435 (495)
T 1opk_A 371 DTYTA-------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------D 435 (495)
T ss_dssp CCEEC-------CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT--------T
T ss_pred Cceee-------cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--------C
Confidence 32111 123457889999999999999999999999999999999 999997654321 11111 1
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
.....|...+..+.+|+.+||+.+|.+||++ .++++.|+.+
T Consensus 436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-~el~~~L~~~ 476 (495)
T 1opk_A 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETM 476 (495)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCcChhHCcCH-HHHHHHHHHH
Confidence 1223345566889999999999999999999 7888888765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=356.07 Aligned_cols=246 Identities=20% Similarity=0.288 Sum_probs=198.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
.++|.+.+.||+|+||.||+|... +..||+|.+.... .....+.+|+.+|+.++||||++++++| .+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 457999999999999999999986 5789999987532 2345688999999999999999999998 4578999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC--CCceeeeccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA--NFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~--~~~vKL~DFGla~~~~~~ 680 (846)
++||+|.+++.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999943 23469999999999999999999999 89999999999999987 789999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... ....||+.|+|||++.+..++.++|||||||++|+|++|.+||............. ..........
T Consensus 158 ~~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~ 226 (321)
T 1tki_A 158 DNF---------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM--NAEYTFDEEA 226 (321)
T ss_dssp CEE---------EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCHHH
T ss_pred Ccc---------ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH--cCCCCCChhh
Confidence 211 12348999999999998889999999999999999999999997665433211111 1111110000
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
| ...+..+.+|+.+||..+|.+||++ .++
T Consensus 227 ~-~~~s~~~~~li~~~L~~dp~~Rpt~-~e~ 255 (321)
T 1tki_A 227 F-KEISIEAMDFVDRLLVKERKSRMTA-SEA 255 (321)
T ss_dssp H-TTSCHHHHHHHHTTSCSSGGGSCCH-HHH
T ss_pred h-ccCCHHHHHHHHHHcCCChhHCcCH-HHH
Confidence 0 1235789999999999999999999 444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=353.55 Aligned_cols=262 Identities=25% Similarity=0.341 Sum_probs=200.4
Q ss_pred hhcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc--CCCceeeEecccc------Cce
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI--RHPNLVTLVGACP------EVW 596 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l--~HpnIv~l~g~~~------~~~ 596 (846)
...++|.+.++||+|+||.||+|.+.+..||||++... ....+..|.+++..+ +||||+++++++. ...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 34458999999999999999999999999999998643 234566677777665 8999999999872 457
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEecccCCCceEecCCCceeeecc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-----KPHSIVHGDLKPANILLDANFVSKLSDF 671 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-----~~~giiHrDLkp~NILl~~~~~vKL~DF 671 (846)
++||||+++|+|.+++.. ..+++..++.++.+++.||.|||+. +..+|+||||||+||||+.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 899999999999999943 3589999999999999999999982 0129999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCch------hhHHHHHHHHHHHHhC----------CCCC
Q 003121 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK------SDVYSFGIILLRLLTG----------RPAL 735 (846)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~k------sDVwSlGviL~elltG----------~~pf 735 (846)
|+++.+........ .......||+.|+|||++.+..++.. +|||||||++|||+|| +.||
T Consensus 187 g~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 187 GLAVKFISDTNEVD----IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp TTCEECC-------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCceeecccccccc----CCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99986654322111 11123469999999999987766654 9999999999999999 6666
Q ss_pred CCchH----HHHHHhhhhhccccCCCCCCCCh-----hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 736 GITKE----VQYALDTGKLKNLLDPLAGDWPF-----VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 736 ~~~~~----~~~~~~~~~~~~~ld~~~~~~p~-----~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
..... ......... .......++. ..+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA-LRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTSCSSCCHHHHHHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHHTT
T ss_pred hhhcCCCCchhhhHHHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH-HHHHHHHHHHHhhc
Confidence 43211 111111111 1111222222 567889999999999999999999 88999999887653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.81 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=202.1
Q ss_pred hcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc---CceEEEEEe
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEY 602 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~---~~~~lVmEy 602 (846)
..++|...+.||+|+||.||+|.+.+..||||++.... ..+.+.+|+.++++++||||+++++++. ...++||||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred ChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 34578999999999999999999999999999987543 4567999999999999999999999862 358999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++.... ...+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999985432 1237889999999999999999999 899999999999999999999999999987554321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
....+++.|+|||++.+..++.++||||||+++|+|+| |++||............ ........
T Consensus 172 ----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~------~~~~~~~~ 235 (278)
T 1byg_A 172 ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV------EKGYKMDA 235 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH------TTTCCCCC
T ss_pred ----------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------hcCCCCCC
Confidence 12247889999999999999999999999999999998 99999765432211110 11112233
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
+...+..+.+|+.+||+.+|.+||++ .++++.|+.+...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSF-LQLREQLEHIKTH 274 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCH-HHHHHHHHHHHhh
Confidence 44556889999999999999999999 8888999888754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=353.43 Aligned_cols=266 Identities=25% Similarity=0.395 Sum_probs=198.6
Q ss_pred cCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHH--hcCCCceeeEeccc-----c--CceE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILS--KIRHPNLVTLVGAC-----P--EVWT 597 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~--~l~HpnIv~l~g~~-----~--~~~~ 597 (846)
.++|.+.+.||+|+||.||+|...+..||||++... ....+..|.+++. .++||||+++++.+ . ..++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 457899999999999999999999999999998743 2345555666544 58999999999754 1 2468
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC---------ceEecccCCCceEecCCCceee
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH---------SIVHGDLKPANILLDANFVSKL 668 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~---------giiHrDLkp~NILl~~~~~vKL 668 (846)
+||||+++|+|.+++... .+++..+..++.||+.||.|||+ + +|+||||||+||||+.++.+||
T Consensus 89 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence 999999999999999533 35889999999999999999999 6 9999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCchH-
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLTGRPALGITKE- 740 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-------~~~~~ksDVwSlGviL~elltG~~pf~~~~~- 740 (846)
+|||+++.+...................||+.|+|||++.+ ..++.++|||||||++|||+||..||.....
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987654332211111112234569999999999976 3566789999999999999999765522110
Q ss_pred -------------------HHHHHhhhhhccccCCCCCCC--ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 741 -------------------VQYALDTGKLKNLLDPLAGDW--PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 741 -------------------~~~~~~~~~~~~~ld~~~~~~--p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
....+...... ......| ....+..+.+|+.+||..+|.+||++ +++++.|+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~e~l~~L~~ll 317 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQR---PKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA-QXAEERMAELM 317 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCC---CCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH-HHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccC---CCCCcccccccchHHHHHHHHHHHhcCChhhCcch-HHHHHHHHHHH
Confidence 00000111001 1111111 22356789999999999999999999 89999999998
Q ss_pred hhCCCCC
Q 003121 800 ASCGGST 806 (846)
Q Consensus 800 ~~~~~~~ 806 (846)
..+....
T Consensus 318 ~~~~~~~ 324 (336)
T 3g2f_A 318 MIWERNK 324 (336)
T ss_dssp HCCCC--
T ss_pred HHHHhcc
Confidence 8775443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=353.29 Aligned_cols=239 Identities=26% Similarity=0.343 Sum_probs=188.4
Q ss_pred cCCCcccceeeeeCceEEEEEEE-----CCeEEEEEEecCCCC----CCchhHHHHHHHHHhcCCCceeeEeccc--cCc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL----QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEV 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~-----~~~~VAIK~l~~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~ 595 (846)
.++|...+.||+|+||.||++.. .+..||+|+++.... .....+.+|+.+|+.++||||++++++| .+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 34789999999999999999987 367899999986532 2345678999999999999999999998 456
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 89999999999999998543 458899999999999999999999 899999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|++||............. ..
T Consensus 170 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~--- 236 (327)
T 3a62_A 170 ESIHDGTV--------THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--KC--- 236 (327)
T ss_dssp -----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HT---
T ss_pred ccccCCcc--------ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hC---
Confidence 54332111 123469999999999999899999999999999999999999997665433211111 11
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCC
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
...+|...+..+.+|+.+||..+|.+||+
T Consensus 237 --~~~~p~~~~~~~~~li~~~L~~dp~~R~~ 265 (327)
T 3a62_A 237 --KLNLPPYLTQEARDLLKKLLKRNAASRLG 265 (327)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSCGGGSTT
T ss_pred --CCCCCCCCCHHHHHHHHHHHhcCHhhccC
Confidence 11234455688999999999999999994
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=360.79 Aligned_cols=235 Identities=21% Similarity=0.295 Sum_probs=197.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|...+.||+|+||.||++... +..||||++.... ......+.+|+.+|+.++||||+++++++. ...|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 47889999999999999999986 6789999986532 234567889999999999999999999984 4689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||++||+|.+++... ..+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999643 458999999999999999999999 89999999999999999999999999999866432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
. ....||+.|+|||++.+..++.++|||||||++|+|++|++||............. .. ...
T Consensus 195 ~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~-----~~~ 256 (350)
T 1rdq_E 195 T-----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--SG-----KVR 256 (350)
T ss_dssp B-----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HC-----CCC
T ss_pred c-----------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH--cC-----CCC
Confidence 1 22358999999999999999999999999999999999999997665433211110 01 112
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCC
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
+|...+..+.+|+.+||+.+|.+||+
T Consensus 257 ~p~~~~~~~~~li~~lL~~dp~~R~~ 282 (350)
T 1rdq_E 257 FPSHFSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhccC
Confidence 34455688999999999999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=371.16 Aligned_cols=256 Identities=23% Similarity=0.266 Sum_probs=202.6
Q ss_pred hhhhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccc--
Q 003121 521 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP-- 593 (846)
Q Consensus 521 ~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-- 593 (846)
.++....++|...++||+|+||+||+|... +..||+|++... .......+.+|+.+|..++||||++++++|.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 344455678999999999999999999987 478999999752 1222345899999999999999999999984
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
+..|+||||++||+|.+++... ...+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhh
Confidence 4689999999999999999642 3569999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 748 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~ 748 (846)
++........ ......||+.|+|||++. .+.|+.++|||||||++|||+||++||.............
T Consensus 222 a~~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 294 (437)
T 4aw2_A 222 CLKLMEDGTV-------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294 (437)
T ss_dssp CEECCTTSCE-------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred hhhcccCCCc-------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Confidence 9866443211 112356999999999997 4568999999999999999999999997765433221111
Q ss_pred hhccccCCCCCCCChhhHHHHHHHHHHHhccCcCC--CCChHHHH
Q 003121 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS--RPELGKDV 791 (846)
Q Consensus 749 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~--RPt~~~~v 791 (846)
.....+ ..+......+..+.+||.+||..+|++ ||++ +++
T Consensus 295 ~~~~~~--~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~-~ei 336 (437)
T 4aw2_A 295 NHKERF--QFPTQVTDVSENAKDLIRRLICSREHRLGQNGI-EDF 336 (437)
T ss_dssp THHHHC--CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTT-HHH
T ss_pred hccccc--cCCcccccCCHHHHHHHHHHhcccccccCCCCH-HHH
Confidence 111111 111122235678999999999888887 8998 444
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.37 Aligned_cols=254 Identities=24% Similarity=0.421 Sum_probs=204.3
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC-----eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc-CceEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTL 598 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~l 598 (846)
..++|...+.||+|+||.||+|.+.+ ..||+|.+..... ...+.+.+|+.+|+.++||||+++++++. +..++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence 34578999999999999999998653 3599999876532 23457889999999999999999999985 45789
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+++++|.+++... ...+++..++.++.+|+.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999999543 3468999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLD 755 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld 755 (846)
...... .....||+.|+|||++.+..++.++||||||+++|+|+| |++||....... ..+..+.
T Consensus 165 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~------ 231 (281)
T 3cc6_A 165 DEDYYK-------ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD------ 231 (281)
T ss_dssp ---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC------
T ss_pred cccccc-------cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC------
Confidence 432111 123457899999999998999999999999999999998 999996443321 1111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
....+...+..+.+|+.+||..+|.+||++ .++++.|+.+..
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 --RLPKPDLCPPVLYTLMTRCWDYDPSDRPRF-TELVCSLSDVYQ 273 (281)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCchhCcCH-HHHHHHHHHHHH
Confidence 112233456789999999999999999999 888888887754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=347.94 Aligned_cols=259 Identities=27% Similarity=0.465 Sum_probs=211.4
Q ss_pred hhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 524 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
+....+|...+.||+|+||.||+|.+. +..||||++.... ...+.+.+|+.++++++||||++++++|. ...++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 345568999999999999999999987 6789999997543 33567999999999999999999999984 468999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++... ....+++..++.++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 88 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999643 33569999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..... .....||+.|+|||++.+..++.++||||||+++|+|++ |.+||............. ....
T Consensus 164 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~------~~~~ 230 (288)
T 3kfa_A 164 DTYTA-------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------KDYR 230 (288)
T ss_dssp SSSEE-------ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH------TTCC
T ss_pred Ccccc-------ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh------ccCC
Confidence 32111 122347889999999999999999999999999999999 999997654322111110 1112
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
...+...+..+.+|+.+||..+|.+||++ .++++.|+.+...
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETMFQE 272 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCH-HHHHHHHHHHHHh
Confidence 22344556889999999999999999999 7888888876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=356.65 Aligned_cols=247 Identities=24% Similarity=0.348 Sum_probs=185.5
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
...++|.+.+.||+|+||.||+|... +..||||++.... ..+.+.+|+.+|++++||||++++++|. ...++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34567999999999999999999987 4679999998643 3457889999999999999999999984 4688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC---CCceeeecccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFL 677 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~---~~~vKL~DFGla~~~ 677 (846)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999843 3568999999999999999999999 89999999999999975 889999999999866
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
..... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||............. .... ...
T Consensus 202 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i-~~~~-~~~ 270 (349)
T 2w4o_A 202 EHQVL---------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI-LNCE-YYF 270 (349)
T ss_dssp --------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHH-HTTC-CCC
T ss_pred Ccccc---------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHH-HhCC-Ccc
Confidence 43221 123458999999999999899999999999999999999999996554332221111 0111 111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+....+..+.+|+.+||..+|.+||++ .++
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~ 303 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTT-FQA 303 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCH-HHH
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 122223456789999999999999999999 444
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=350.04 Aligned_cols=269 Identities=24% Similarity=0.345 Sum_probs=212.3
Q ss_pred CChhhhhhhcCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeE
Q 003121 518 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTL 588 (846)
Q Consensus 518 ~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l 588 (846)
+...++....++|.+.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344555566778999999999999999999853 367999999764322 234688999999999 79999999
Q ss_pred eccccC---ceEEEEEecCCCchhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecc
Q 003121 589 VGACPE---VWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 652 (846)
Q Consensus 589 ~g~~~~---~~~lVmEy~~ggsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrD 652 (846)
+++|.. ..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence 999843 48999999999999999965432 2238899999999999999999999 8999999
Q ss_pred cCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-C
Q 003121 653 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-G 731 (846)
Q Consensus 653 Lkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G 731 (846)
|||+|||++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|+| |
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g 247 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYV------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CccceEEECCCCCEEECCCccccccccCccce------eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCC
Confidence 99999999999999999999998664432111 1123357899999999999999999999999999999998 9
Q ss_pred CCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 732 RPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 732 ~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
++||.............. . ......+...+..+.+|+.+||..+|.+||++ .++++.|+.+...
T Consensus 248 ~~p~~~~~~~~~~~~~~~--~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~ 311 (316)
T 2xir_A 248 ASPYPGVKIDEEFCRRLK--E---GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNLLQA 311 (316)
T ss_dssp CCSSTTCCCSHHHHHHHH--H---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred CCCCcccchhHHHHHHhc--c---CccCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHhh
Confidence 999965432221111100 0 01112233456789999999999999999999 8888898887654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=346.78 Aligned_cols=259 Identities=23% Similarity=0.370 Sum_probs=205.8
Q ss_pred hcCCCcccc-eeeeeCceEEEEEEEC----CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccc-CceE
Q 003121 526 ATHNFDPSL-KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-EVWT 597 (846)
Q Consensus 526 ~~~~f~~~~-~LG~G~fG~Vy~g~~~----~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~ 597 (846)
...+|.+.. .||+|+||.||+|.+. +..||||++....... .+.+.+|+.+++.++||||+++++++. +..+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 93 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM 93 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcE
Confidence 345677777 8999999999999653 3679999998654322 356899999999999999999999984 4688
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 999999999999999543 458999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
....... .......||+.|+|||++.+..++.++||||||+++|+|+| |++||............. ..
T Consensus 168 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~~ 236 (291)
T 1xbb_A 168 RADENYY-----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE------KG 236 (291)
T ss_dssp CTTCSEE-----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH------TT
T ss_pred ccCCCcc-----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH------cC
Confidence 5432111 11123457899999999998889999999999999999999 999997655432211111 11
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
.....+...+..+.+|+.+||..+|.+||++ .++++.|+.+-...
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 237 ERMGCPAGCPREMYDLMNLCWTYDVENRPGF-AAVELRLRNYYYDV 281 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHHH
Confidence 1223344566889999999999999999999 88888998876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=365.23 Aligned_cols=251 Identities=24% Similarity=0.296 Sum_probs=200.2
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccc--Cc
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EV 595 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~ 595 (846)
+....++|...++||+|+||.||+|... +..||+|++... .......+.+|+.+|+.++||||++++++|. ..
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3344568999999999999999999986 578999998752 2233456899999999999999999999984 46
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.|+||||++||+|.+++.. ..+++..+..++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++
T Consensus 144 ~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 8999999999999999853 358999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE----LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 751 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~ 751 (846)
........ ......||+.|+|||++.+.. |+.++|||||||++|||+||++||................
T Consensus 217 ~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 289 (410)
T 3v8s_A 217 KMNKEGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289 (410)
T ss_dssp ECCTTSEE-------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred eeccCCcc-------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence 76543211 113456999999999998765 8899999999999999999999997665433221111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhccCcCC--CCChHHHH
Q 003121 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS--RPELGKDV 791 (846)
Q Consensus 752 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~--RPt~~~~v 791 (846)
..+. .+. ....+..+.+||.+||..+|.+ ||++ +++
T Consensus 290 ~~~~--~p~-~~~~s~~~~~li~~lL~~~~~rlgR~~~-~ei 327 (410)
T 3v8s_A 290 NSLT--FPD-DNDISKEAKNLICAFLTDREVRLGRNGV-EEI 327 (410)
T ss_dssp HHCC--CCT-TCCCCHHHHHHHHHHSSCGGGCTTSSCH-HHH
T ss_pred cccc--CCC-cccccHHHHHHHHHHccChhhhCCCCCH-HHH
Confidence 1111 111 1134578999999999988888 9998 554
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=359.38 Aligned_cols=241 Identities=25% Similarity=0.392 Sum_probs=198.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
.++|.+.+.||+|+||.||+|... +..||||++... .......+.+|+.+|+.++||||+++++++ ....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 457999999999999999999984 678999998653 122345789999999999999999999998 4568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+ +|+|.+++... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78998888543 459999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .+...+....
T Consensus 161 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~ 224 (336)
T 3h4j_B 161 GNF---------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-------NLFKKVNSCV 224 (336)
T ss_dssp SBT---------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-------TCBCCCCSSC
T ss_pred Ccc---------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCC
Confidence 321 123469999999999988776 78999999999999999999999654321 1111222222
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...|...+..+.+|+.+||..||.+||++ +++
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~-~ei 256 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITI-QEI 256 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCH-HHH
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCH-HHH
Confidence 33455567889999999999999999999 444
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=381.34 Aligned_cols=257 Identities=24% Similarity=0.407 Sum_probs=205.2
Q ss_pred CCCcccc-eeeeeCceEEEEEEEC----CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc-CceEEEE
Q 003121 528 HNFDPSL-KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~-~LG~G~fG~Vy~g~~~----~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVm 600 (846)
.++.... .||+|+||.||+|.+. +..||||+++.... ...+.|.+|+.+|++++|||||+++++|. +..++||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~ 414 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 414 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEE
Confidence 3444444 7999999999999874 35699999986533 34578999999999999999999999984 5689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++.. ....+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999953 34569999999999999999999999 89999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPL 757 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~~ 757 (846)
..... ......+|+.|+|||++.++.++.++|||||||+||||+| |++||....... ..+..+ .
T Consensus 490 ~~~~~-----~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~--------~ 556 (613)
T 2ozo_A 490 DSYYT-----ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------K 556 (613)
T ss_dssp -----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT--------C
T ss_pred Cceee-----eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------C
Confidence 21111 1122346789999999999999999999999999999998 999997654332 222221 1
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCC
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 803 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~ 803 (846)
....|..++..+.+|+.+||..+|.+||++ .++.+.|+.+.....
T Consensus 557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~-~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 557 RMECPPECPPELYALMSDCWIYKWEDRPDF-LTVEQRMRACYYSLA 601 (613)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSTTTSCCH-HHHHHHHHHHHHHHS
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHHHhc
Confidence 223445566899999999999999999999 888899988766543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=351.11 Aligned_cols=261 Identities=27% Similarity=0.419 Sum_probs=206.7
Q ss_pred CcccceeeeeCceEEEEEEE------CCeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc----CceEE
Q 003121 530 FDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTL 598 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~------~~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~l 598 (846)
|...++||+|+||.||++.+ .+..||||++..... .....+.+|+.+|++++||||+++++++. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48889999999999999876 357799999986532 12356899999999999999999999983 35789
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+++|+|.+++... .+++..++.++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999532 48999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH--------hhhhh
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--------DTGKL 750 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~--------~~~~~ 750 (846)
..... ........||+.|+|||++.+..++.++||||||+++|+|+||..||.......... ....+
T Consensus 186 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 186 EGHEY-----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp TTCSE-----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred ccccc-----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 43211 011234458999999999999899999999999999999999999996543221100 00001
Q ss_pred cccc-CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCC
Q 003121 751 KNLL-DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 803 (846)
Q Consensus 751 ~~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~ 803 (846)
...+ .......+...+..+.+|+.+||+.+|.+||++ .++++.|+.+.....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTF-ENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHHHhhc
Confidence 1111 112223345566889999999999999999999 888899998876653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=356.98 Aligned_cols=245 Identities=23% Similarity=0.390 Sum_probs=197.8
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
.++|.+.+.||+|+||.||+|... +..||+|++...... ....+.+|+.+|+.++||||++++++|. ...++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 347999999999999999999986 678999999865432 2356889999999999999999999984 4688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC---Cceeeecccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFL 677 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~---~~vKL~DFGla~~~ 677 (846)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++...
T Consensus 108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999998843 3568999999999999999999999 899999999999999864 46999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|++||............. .......
T Consensus 182 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~--~~~~~~~ 250 (362)
T 2bdw_A 182 NDSEA---------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK--AGAYDYP 250 (362)
T ss_dssp TTCCS---------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCC
T ss_pred cCCcc---------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hCCCCCC
Confidence 53221 123469999999999998899999999999999999999999997665432211111 1111111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
...| ...+..+.+|+.+||..+|.+||++.+
T Consensus 251 ~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e 281 (362)
T 2bdw_A 251 SPEW-DTVTPEAKSLIDSMLTVNPKKRITADQ 281 (362)
T ss_dssp TTGG-GGSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cccc-cCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 1111 234678999999999999999999943
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=352.89 Aligned_cols=254 Identities=23% Similarity=0.391 Sum_probs=201.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--Ce----EEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccc-CceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~----~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~l 598 (846)
..+|...++||+|+||.||+|.+. +. +||+|.+.... ......+.+|+.+|+.++||||++++++|. ...++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 357999999999999999999875 33 46888876543 334567999999999999999999999984 46889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||+|+.+|+|.+++... ...+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999998643 3568999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLD 755 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld 755 (846)
....... .....||+.|+|||++.+..++.++|||||||++|+|+| |++||....... ..+..+
T Consensus 169 ~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~------- 235 (327)
T 3lzb_A 169 AEEKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------- 235 (327)
T ss_dssp -----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------
T ss_pred Ccccccc------ccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-------
Confidence 4322111 123457889999999999999999999999999999999 999997654322 111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.....+...+..+.+|+.+||..+|.+||++ .++++.|+.+..
T Consensus 236 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~ 278 (327)
T 3lzb_A 236 -ERLPQPPICTIDVYMIMRKCWMIDADSRPKF-RELIIEFSKMAR 278 (327)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHT
T ss_pred -CCCCCCccCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHh
Confidence 1122344456789999999999999999999 888888888763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=357.47 Aligned_cols=240 Identities=20% Similarity=0.283 Sum_probs=198.6
Q ss_pred cCCCcccceeeeeCceEEEEEEECC--eEEEEEEecCC---CCCCchhHHHHHHHHHhc-CCCceeeEecccc--CceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPH---SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~l 598 (846)
..+|...+.||+|+||.||+|...+ ..||||++... .......+..|..+|..+ +||||+++++++. +..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4579999999999999999999874 67999999754 223456788999999988 8999999999984 56899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||++||+|.+++... ..+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999543 358999999999999999999999 899999999999999999999999999998543
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..... .....||+.|+|||++.+..++.++|||||||++|||++|++||............ .. ..
T Consensus 173 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--~~-----~~ 237 (353)
T 2i0e_A 173 WDGVT--------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--ME-----HN 237 (353)
T ss_dssp CTTCC--------BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HH-----CC
T ss_pred cCCcc--------cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH--Hh-----CC
Confidence 22111 13356999999999999999999999999999999999999999766543221111 11 11
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
..+|...+..+.+|+.+||..+|.+||+.
T Consensus 238 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 238 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 23455567889999999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=344.57 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=193.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
++|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+|+.++||||+++++++ .+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999886 67899999875432 2246788999999999999999999998 4578999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++ +|.+++... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 898888533 3568999999999999999999999 8999999999999999999999999999986543211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc---------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN--------- 752 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~--------- 752 (846)
. .....||+.|+|||++.+. .++.++|||||||++|+|+||++||.................
T Consensus 156 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 156 K--------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred c--------cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence 1 1234589999999999764 589999999999999999999999977654332221110000
Q ss_pred -----ccCCCC--------CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 -----LLDPLA--------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 -----~ld~~~--------~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..++.. ..+....+..+.+|+.+||..||.+||++ +++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~ 278 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-KQA 278 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH-HHH
Confidence 000000 01112346789999999999999999999 444
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=358.26 Aligned_cols=246 Identities=22% Similarity=0.283 Sum_probs=196.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhc-CCCceeeEecccc--CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lV 599 (846)
.+|...+.||+|+||.||++... +..||||++....... ...+.+|+.+|.++ +||||++++++|. ...|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46889999999999999999986 5789999998654333 24578899999988 8999999999984 568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||++||+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.+|.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999998543 458999999999999999999999 8999999999999999999999999999985432
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HhhhhhccccCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPL 757 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~--~~~~~~~~~ld~~ 757 (846)
... ......||+.|+|||++.+..++.++|||||||++|||++|++||......... .....+...+...
T Consensus 163 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~ 234 (345)
T 3a8x_A 163 PGD--------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234 (345)
T ss_dssp TTC--------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred CCC--------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence 211 113456999999999999999999999999999999999999999642110000 0000000000001
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
...+|...+..+.+|+.+||..+|.+||++
T Consensus 235 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 123455567889999999999999999995
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.84 Aligned_cols=272 Identities=21% Similarity=0.280 Sum_probs=211.4
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc---cCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~---~~~~~lVmE 601 (846)
.++|...+.||+|+||.||+|... +..||||++..... ...+.+|+.+++.++|++++..++.+ ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 468999999999999999999964 68899999876543 35799999999999998877776665 456789999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe---cCCCceeeeccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLS 678 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl---~~~~~vKL~DFGla~~~~ 678 (846)
|+ +++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999998533 3469999999999999999999999 899999999999999 488999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHhhhhhccc
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQYALDTGKLKNL 753 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~-----~~~~~~~~~~~~~ 753 (846)
....... ..........||+.|+|||++.+..++.++|||||||++|+|+||++||..... ....+........
T Consensus 160 ~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCB-CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccc-cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 5432111 000112345699999999999999999999999999999999999999965321 1111111111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCCCCCcCCC
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGS 812 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~~~~~~~~ 812 (846)
..... ...+..+.+|+.+||+.+|.+||++ .++.+.|+.+....+......++|
T Consensus 239 ~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 239 IEVLC----KGYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp HHHHT----TTSCHHHHHHHHHHHTSCTTCCCCH-HHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred hHHHH----hhCCHHHHHHHHHHHhcCcCcCCCH-HHHHHHHHHHHHhcCCcccccccc
Confidence 11111 2234789999999999999999999 889999999887765544433333
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=347.40 Aligned_cols=261 Identities=25% Similarity=0.416 Sum_probs=205.1
Q ss_pred CCCcccceeeeeCceEEEEEEE------CCeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc----Cce
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVW 596 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~------~~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~ 596 (846)
..|...+.||+|+||.||+|.+ .+..||||++..... .....+.+|+.+|+.++||||++++++|. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3588899999999999999985 357899999986532 33467999999999999999999999983 347
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccc
Confidence 8999999999999998543 2458999999999999999999999 8999999999999999999999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH--------h-h
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--------D-T 747 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~--------~-~ 747 (846)
....... ........||..|+|||++.+..++.++||||||+++|+|+||..|+.......... . .
T Consensus 176 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 176 IETDKEY-----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp CCTTCCE-----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred ccCCCcc-----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 6543211 111234568999999999999999999999999999999999999874332111000 0 0
Q ss_pred hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
..............+...+..+.+|+.+||..+|.+||++ .++++.|+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF-QNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHh
Confidence 0001111112223445566889999999999999999999 88888888763
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=362.27 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=197.7
Q ss_pred CCcccceeeeeCceEEEEEEEC---C--eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc---cCceEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR---H--MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLV 599 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~---~--~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~---~~~~~lV 599 (846)
.|...+.||+|+||.||+|.+. + ..||||.+..... .....|.+|+.+|++++||||++++++| ....++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677789999999999999864 2 3589999875432 2245789999999999999999999986 2467899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999953 33568899999999999999999999 8999999999999999999999999999987644
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH--HHhhhhhccccCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDP 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~--~~~~~~~~~~ld~ 756 (846)
...... .......||+.|+|||++.+..++.++|||||||++|+|+| |.+||........ .+..+
T Consensus 245 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-------- 312 (373)
T 3c1x_A 245 KEFDSV----HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-------- 312 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--------
T ss_pred cccccc----cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--------
Confidence 322111 11133457899999999999999999999999999999999 7888865433221 11111
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCC
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGG 804 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~ 804 (846)
.....|...+..+.+|+.+||..+|.+||++ .++++.|+.+.....+
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~-~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFSTFIG 359 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHTCCS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHhccc
Confidence 1112234456789999999999999999999 8899999988776543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=349.84 Aligned_cols=264 Identities=22% Similarity=0.338 Sum_probs=202.5
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEECC-----eEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccccC-
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE- 594 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~~- 594 (846)
+....++|...+.||+|+||.||+|.+.. ..||||++....... .+.+.+|+.+|++++||||++++++|.+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 34455689999999999999999997642 479999987653322 3568899999999999999999998843
Q ss_pred ------ceEEEEEecCCCchhhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc
Q 003121 595 ------VWTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 665 (846)
Q Consensus 595 ------~~~lVmEy~~ggsL~~~L~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~ 665 (846)
..++||||+++|+|.+++... .....+++..++.++.+|+.||.|||+ ++|+||||||+|||++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCc
Confidence 358999999999999998432 234679999999999999999999999 89999999999999999999
Q ss_pred eeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 003121 666 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA 744 (846)
Q Consensus 666 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~ 744 (846)
+||+|||+++.......... .....+++.|+|||.+.+..++.++||||||+++|+|+| |.+||.........
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 259 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQ------GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259 (313)
T ss_dssp EEECSCSCC----------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred EEEeecCcceecccccccCc------ccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 99999999987654321111 122347889999999999999999999999999999999 99999765432211
Q ss_pred HhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 745 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 745 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
.. .........+...+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 260 ~~------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~L~~l~~~l 310 (313)
T 3brb_A 260 DY------LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTF-SVLRLQLEKLLESL 310 (313)
T ss_dssp HH------HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHHHHC
T ss_pred HH------HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHhc
Confidence 11 11111223344456789999999999999999999 88989998887654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.68 Aligned_cols=261 Identities=25% Similarity=0.349 Sum_probs=206.1
Q ss_pred CCcccceeeeeCceEEEEEEECC-----eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--Cc-eEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EV-WTLV 599 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~-~~lV 599 (846)
.|...++||+|+||.||+|.+.+ ..||+|.+..... ...+.+.+|+.+|+.++||||++++++|. +. .++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46667899999999999998632 2699999875432 12356889999999999999999999983 33 4899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+.+|+|.+++.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999954 34568999999999999999999999 8999999999999999999999999999986654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
....... ......||+.|+|||.+.+..++.++||||||+++|+|+| |.+||.............. ...
T Consensus 177 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~------~~~ 246 (298)
T 3pls_A 177 REYYSVQ----QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ------GRR 246 (298)
T ss_dssp GGGGCSC----CSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT------TCC
T ss_pred Ccccccc----cCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc------CCC
Confidence 3321111 1134568999999999999999999999999999999999 5566654433221111110 111
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCC
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 805 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~ 805 (846)
...+...+..+.+|+.+||..+|.+||++ .++++.|+.+.....+.
T Consensus 247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTF-RVLVGEVEQIVSALLGD 292 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHCCSC
T ss_pred CCCCccchHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHHHhcc
Confidence 22234456789999999999999999999 88999999887765433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=361.43 Aligned_cols=247 Identities=21% Similarity=0.345 Sum_probs=200.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
.++|.+.+.||+|+||.||+|... +..||+|++..........+.+|+.+|+.++||||++++++|. ...++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357999999999999999999886 5789999997654334457899999999999999999999984 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC--CCceeeeccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA--NFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~--~~~vKL~DFGla~~~~~~ 680 (846)
+++|+|.+++... ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999998532 3468999999999999999999999 89999999999999974 578999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... ....||+.|+|||++.+..++.++|||||||++|+|+||++||................. .....
T Consensus 205 ~~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~ 272 (387)
T 1kob_A 205 EIV---------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW---EFDED 272 (387)
T ss_dssp SCE---------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC---CCCSS
T ss_pred cce---------eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCcc
Confidence 211 122589999999999999999999999999999999999999987654432221111111 11111
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+..+.+|+.+||..+|.+||++ .++
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~-~el 302 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTV-HDA 302 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCH-HHH
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCH-HHH
Confidence 223446789999999999999999999 444
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.88 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=200.0
Q ss_pred cCCCcccceeeeeCceEEEEEEECC---------eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--Cc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EV 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~---------~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~ 595 (846)
.++|...+.||+|+||.||+|.... ..||+|++........+.+.+|+.+|++++||||++++++|. +.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3478889999999999999998763 469999997655555677999999999999999999999984 56
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc--------ee
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--------SK 667 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~--------vK 667 (846)
.++||||+++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceee
Confidence 88999999999999999643 2348999999999999999999999 89999999999999998887 99
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhC-CCCCCCchHHHHHH
Q 003121 668 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYAL 745 (846)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG-~~pf~~~~~~~~~~ 745 (846)
|+|||++....... ...||+.|+|||++.+ ..++.++|||||||++|+|+|| .+||..........
T Consensus 162 l~Dfg~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLPKD------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229 (289)
T ss_dssp ECCCCSCTTTSCHH------------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred eccCcccccccCcc------------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH
Confidence 99999987553321 1127889999999987 6799999999999999999994 56665444322211
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
.... ....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+....
T Consensus 230 ~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 230 FYED--------RHQLPAPKAAELANLINNCMDYEPDHRPSF-RAIIRDLNSLFTPD 277 (289)
T ss_dssp HHHT--------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCH-HHHHHHHHTCC---
T ss_pred Hhhc--------cCCCCCCCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHhcCCC
Confidence 1111 111222234579999999999999999999 88888888776543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=367.01 Aligned_cols=246 Identities=20% Similarity=0.336 Sum_probs=197.6
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
.++|.+.+.||+|+||.||++... +..||+|++...... ....+.+|+.+|+.++||||++++++|. ...++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 346899999999999999999875 688999999865432 2346889999999999999999999984 4689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec---CCCceeeecccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFL 677 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~---~~~~vKL~DFGla~~~ 677 (846)
||++||+|.+.+... ..+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 90 E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999988543 469999999999999999999999 8999999999999998 4678999999999866
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
...... .....||+.|+|||++.+..|+.++|||||||++|+|++|++||............ .....+..
T Consensus 164 ~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i--~~~~~~~~ 233 (444)
T 3soa_A 164 EGEQQA--------WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFP 233 (444)
T ss_dssp CTTCCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHTCCCCC
T ss_pred cCCCce--------eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH--HhCCCCCC
Confidence 543211 12346999999999999889999999999999999999999999766543321111 11111111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
.+.|+ ..+..+.+|+.+||..||.+||++.+
T Consensus 234 ~~~~~-~~s~~~~~li~~~L~~dP~~Rpta~e 264 (444)
T 3soa_A 234 SPEWD-TVTPEAKDLINKMLTINPSKRITAAE 264 (444)
T ss_dssp TTTTT-TSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ccccc-cCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 22222 34578999999999999999999943
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.95 Aligned_cols=249 Identities=24% Similarity=0.297 Sum_probs=191.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
++|...++||+|+||+||+|... +..||||++....... ...+.+|+.+|++++||||+++++++ ....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46889999999999999999986 5789999998654332 35688999999999999999999998 456899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+.+ +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9976 55554432 23569999999999999999999999 899999999999999999999999999998764322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCC-CCchHHHHHHhhhhhc--------
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLK-------- 751 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~ksDVwSlGviL~elltG~~pf-~~~~~~~~~~~~~~~~-------- 751 (846)
.. .....||+.|+|||++.+.. ++.++|||||||++|+|+||..|| ................
T Consensus 156 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 156 RC--------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp SC--------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred cc--------ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 11 13346899999999998765 899999999999999999887775 3333221111110000
Q ss_pred ----cccC----------CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 752 ----NLLD----------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 752 ----~~ld----------~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+ ..........+..+.+|+.+||+.||.+||++ +++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~ 280 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-EEA 280 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH-HHH
Confidence 0000 00011122346789999999999999999999 444
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.71 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=192.7
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
...++|...++||+|+||.||+|... +..||+|++....... ...+.+|+.+|++++||||+++++++. ...++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 34568999999999999999999985 6789999997653322 356889999999999999999999984 468999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++ +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999975 78777753 33569999999999999999999999 8999999999999999999999999999987643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||................. .+..
T Consensus 172 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~ 241 (311)
T 3niz_A 172 PVRS--------YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG--TPNP 241 (311)
T ss_dssp CCC-----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHC--CCCT
T ss_pred Cccc--------ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHC--CCCh
Confidence 2211 123468999999999976 5689999999999999999999999965433221111100000 0000
Q ss_pred CCC-------------------------ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDW-------------------------PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~-------------------------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..| ....+..+.+|+.+||..||.+||++ +++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~el 298 (311)
T 3niz_A 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA-RDA 298 (311)
T ss_dssp TTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH-HHH
T ss_pred HHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH-HHH
Confidence 000 11234678999999999999999999 444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=353.39 Aligned_cols=262 Identities=23% Similarity=0.383 Sum_probs=209.8
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC---------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccc-
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP- 593 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~---------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~- 593 (846)
..++|.+.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|+++ +||||++++++|.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3468999999999999999999864 357999999754321 235688999999999 8999999999984
Q ss_pred -CceEEEEEecCCCchhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceE
Q 003121 594 -EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 659 (846)
Q Consensus 594 -~~~~lVmEy~~ggsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NIL 659 (846)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 468999999999999999965431 2358999999999999999999999 89999999999999
Q ss_pred ecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 003121 660 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT 738 (846)
Q Consensus 660 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~ 738 (846)
++.++.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|+|+| |.+||...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEE------CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EcCCCCEEEcccccccccccccccc------ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 9999999999999998765432111 1123457899999999998899999999999999999999 99999765
Q ss_pred hHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCC
Q 003121 739 KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 803 (846)
Q Consensus 739 ~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~ 803 (846)
.......... . ......+...+..+.+|+.+||..+|.+||++ .++++.|+.+.....
T Consensus 264 ~~~~~~~~~~--~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 264 PVEELFKLLK--E----GHRMDKPANCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRILTLTT 321 (334)
T ss_dssp CHHHHHHHHH--H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHh--c----CCCCCCCccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHhccc
Confidence 4332111110 0 11122334456789999999999999999999 888899998876543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=353.46 Aligned_cols=264 Identities=22% Similarity=0.370 Sum_probs=209.6
Q ss_pred hhhhhcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEeccc
Q 003121 522 EIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGAC 592 (846)
Q Consensus 522 ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~ 592 (846)
.++...++|...+.||+|+||.||+|...+ ..||+|.+...... ....+.+|+.+|+.+ +||||++++++|
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345556789999999999999999998753 36999999765322 235688999999999 899999999998
Q ss_pred c--CceEEEEEecCCCchhhhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceE
Q 003121 593 P--EVWTLVYEYLPNGSLEDRLSCKD-----------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 659 (846)
Q Consensus 593 ~--~~~~lVmEy~~ggsL~~~L~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NIL 659 (846)
. +..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEE
Confidence 4 56899999999999999985431 13468999999999999999999999 89999999999999
Q ss_pred ecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 003121 660 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT 738 (846)
Q Consensus 660 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~ 738 (846)
++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|+| |.+||...
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYI------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSE------ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ECCCCeEEECcccccccccccccee------ecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999998664432110 1123457889999999999999999999999999999999 99999654
Q ss_pred hHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 739 KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 739 ~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.......... ... .....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 271 ~~~~~~~~~~--~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~L~~~~~ 326 (333)
T 2i1m_A 271 LVNSKFYKLV--KDG---YQMAQPAFAPKNIYSIMQACWALEPTHRPTF-QQICSFLQEQAQ 326 (333)
T ss_dssp CSSHHHHHHH--HHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred chhHHHHHHH--hcC---CCCCCCCCCCHHHHHHHHHHhccChhhCcCH-HHHHHHHHHHHH
Confidence 3221111110 000 1112233456789999999999999999999 888888887654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=341.26 Aligned_cols=272 Identities=21% Similarity=0.280 Sum_probs=208.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc---cCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~---~~~~~lVmE 601 (846)
.++|...+.||+|+||.||+|... +..||||++..... ...+.+|+.+++.++|+|++..++.| .+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 457999999999999999999964 68899998765432 34689999999999998888777766 456789999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe---cCCCceeeeccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLS 678 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl---~~~~~vKL~DFGla~~~~ 678 (846)
|+ +|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 99999998533 3469999999999999999999999 899999999999999 788999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHhhhhhccc
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQYALDTGKLKNL 753 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~-----~~~~~~~~~~~~~ 753 (846)
........ .........||+.|+|||++.+..++.++|||||||++|+|+||++||..... ....+........
T Consensus 160 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBC-CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccC-CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 54321110 01112345799999999999999999999999999999999999999965321 1111111111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCCCCCcCCC
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGS 812 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~~~~~~~~ 812 (846)
...... ..+..+.+|+.+||+.+|.+||++ +++++.|+.+....+......++|
T Consensus 239 ~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~-~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 4hgt_A 239 IEVLCK----GYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp HHHHTT----TSCHHHHHHHHHHHTSCTTCCCCH-HHHHHHHHHHHHHHTCCTTCCCGG
T ss_pred hhhhhc----cCCHHHHHHHHHHHhcCCCCCCCH-HHHHHHHHHHHHHhCCCccCccch
Confidence 111111 224789999999999999999999 889999999887766544433433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=351.94 Aligned_cols=259 Identities=27% Similarity=0.441 Sum_probs=201.5
Q ss_pred cCCCcccceeeeeCceEEEEEEECC------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 597 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~ 597 (846)
..+|...+.||+|+||.||+|.+.. ..||||++...... ....+.+|+.++++++||||+++++++. ...+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4568888999999999999998753 35999999754321 2346889999999999999999999984 4689
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999999643 3568999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
........ ......+|+.|+|||++.+..++.++|||||||++|+|+| |+.||............ ...
T Consensus 198 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~------~~~ 266 (333)
T 1mqb_A 198 EDDPEATY-----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------NDG 266 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTT
T ss_pred cccccccc-----ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH------HCC
Confidence 54321111 1123457889999999998999999999999999999999 99999755433211111 011
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
.....+...+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 267 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKF-ADIVSILDKLIRAP 311 (333)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHHHSG
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHhcc
Confidence 1112234456789999999999999999999 88888998876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=355.53 Aligned_cols=274 Identities=18% Similarity=0.217 Sum_probs=210.5
Q ss_pred cCCCcccceeeeeCceEEEEEEEC----------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeE--------
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR----------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL-------- 588 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~----------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l-------- 588 (846)
.++|.+.+.||+|+||.||+|... +..||||++... ..+.+|+.++++++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 357999999999999999999875 467999998754 478999999999999999984
Q ss_pred -------eccc---cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCce
Q 003121 589 -------VGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 658 (846)
Q Consensus 589 -------~g~~---~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NI 658 (846)
++++ ....++||||+ +|+|.+++.... ...+++..++.|+.||+.||.|||+ ++|+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence 3443 34678999999 999999996431 3569999999999999999999999 8999999999999
Q ss_pred EecCCC--ceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003121 659 LLDANF--VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 736 (846)
Q Consensus 659 Ll~~~~--~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~ 736 (846)
|++.++ .+||+|||+++.+......... .........||+.|+|||++.+..++.++|||||||+||+|+||+.||.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAY-VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCC-CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccc-cccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999998 9999999999877644321111 1111234579999999999999899999999999999999999999997
Q ss_pred CchHHHHHHh--hhhhccccCCCCCCC--ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCCCCCcCCC
Q 003121 737 ITKEVQYALD--TGKLKNLLDPLAGDW--PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGS 812 (846)
Q Consensus 737 ~~~~~~~~~~--~~~~~~~ld~~~~~~--p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~~~~~~~~ 812 (846)
........+. ...+........... ....+..+.+|+.+||..+|.+||++ +++++.|+.+....+......+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~L~~~~~~~~~~~~~~~dw 348 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPY-AMLRNNLEALLQDLRVSPYDPIGL 348 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCH-HHHHHHHHHHHHHTTCCTTSCCCC
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCH-HHHHHHHHHHHHhcCCCcCccccC
Confidence 5431111111 111111111111111 01235789999999999999999999 899999999888776554444444
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.42 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=183.9
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
.++|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+|++++||||+++++++. +..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888999999999999999876 67899999976543 23467899999999999999999999984 46899999
Q ss_pred ecCCCchhhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 602 YLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 602 y~~ggsL~~~L~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
|++ |+|.+++... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5898888543 223468999999999999999999999 899999999999999999999999999998764
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc-----
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN----- 752 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~----- 752 (846)
..... .....||+.|+|||++.+. .++.++|||||||++|+|+||++||.................
T Consensus 160 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 160 IPVNT--------FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231 (317)
T ss_dssp SCCCC--------CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTT
T ss_pred CCccc--------CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 32111 1234689999999999764 689999999999999999999999976654322111100000
Q ss_pred -------cc--CCC-------------CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 -------LL--DPL-------------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 -------~l--d~~-------------~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.. .+. ....+...+..+.+|+.+||+.||.+||++ .++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~-~e~ 291 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA-KQA 291 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH-HHH
Confidence 00 000 000111235689999999999999999999 444
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.95 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=198.8
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
..+|.+.+.||+|+||.||+|... +..||||++....... ...+.+|+.+|++++||||++++++| .+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 347999999999999999999874 6889999998644333 34688999999999999999999998 4568899
Q ss_pred EEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 600 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
|||+++|+|.+++... .....+++..++.++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999988542 234568999999999999999999999 899999999999999999999999999998664
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........+..........+.
T Consensus 188 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 258 (310)
T 2wqm_A 188 SKTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL- 258 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC-
T ss_pred CCCcc--------ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC-
Confidence 33211 123458999999999999999999999999999999999999996543211111111001111111
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCC
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 805 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~ 805 (846)
.+...+..+.+|+.+||..+|.+||++ .++++.|+.+.+....+
T Consensus 259 --~~~~~~~~l~~li~~~l~~dp~~Rps~-~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 259 --PSDHYSEELRQLVNMCINPDPEKRPDV-TYVYDVAKRMHACTASS 302 (310)
T ss_dssp --CTTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHHC--
T ss_pred --cccccCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHHHhhhhh
Confidence 112345789999999999999999999 88999999998876544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=358.16 Aligned_cols=260 Identities=17% Similarity=0.241 Sum_probs=198.7
Q ss_pred hcCCCcccceeeee--CceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceE
Q 003121 526 ATHNFDPSLKIGEG--GYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWT 597 (846)
Q Consensus 526 ~~~~f~~~~~LG~G--~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~ 597 (846)
..++|.+.++||+| +||.||+|... +..||||++....... ...+.+|+.+|+.++||||++++++| ....+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45689999999999 99999999987 6889999997653322 35678899999999999999999998 45689
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+++|+|.+++.... ...+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999986442 3459999999999999999999999 89999999999999999999999999998765
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHh--hhhhccc
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNL 753 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~--~~~~~~~ 753 (846)
........ ..........||+.|+|||++.+ ..++.++|||||||++|+|+||++||........... .+.....
T Consensus 179 ~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 179 ISHGQRQR-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp EETTEECS-CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred cccccccc-ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 43221111 11111133469999999999987 5799999999999999999999999965433221111 0000000
Q ss_pred cC-------------------------------------CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 LD-------------------------------------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 ld-------------------------------------~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
++ .....++...+..+.+|+.+||..||.+||++ .++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-~el 331 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA-STL 331 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH-HHH
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH-HHH
Confidence 00 00111233445789999999999999999999 444
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=377.42 Aligned_cols=258 Identities=31% Similarity=0.488 Sum_probs=211.9
Q ss_pred hhhhhcCCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEE
Q 003121 522 EIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 599 (846)
Q Consensus 522 ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV 599 (846)
.++...++|.+.++||+|+||.||+|.+.+ ..||||+++... ...+.|.+|+.+|++++||||++++++|. +..+||
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv 339 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV 339 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEe
Confidence 344456678999999999999999999986 679999998654 34678999999999999999999999984 568899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+.+|+|.++|... ....+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 340 ~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999532 12458999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH--HHhhhhhccccCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDP 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~--~~~~~~~~~~ld~ 756 (846)
..... .....++..|+|||++.++.++.++|||||||+||||+| |+.||........ .+..+
T Consensus 416 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-------- 480 (535)
T 2h8h_A 416 NEYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-------- 480 (535)
T ss_dssp HHHHT-------TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT--------
T ss_pred Cceec-------ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence 32111 123347889999999999999999999999999999999 9999976543321 11111
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.....+..++..+.+|+.+||..+|.+||++ ++|.+.|+.+..
T Consensus 481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~~l~~~L~~~~~ 523 (535)
T 2h8h_A 481 YRMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQAFLEDYFT 523 (535)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTSSC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHhh
Confidence 1122344556889999999999999999999 788888886643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=339.32 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=197.0
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecC
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 604 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ 604 (846)
+|.....||+|+||.||+|... +..||||.+..........+.+|+.+++.++||||++++++|. +..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555668999999999999985 5789999998766555678999999999999999999999984 56889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-CCceeeecccccccccccccc
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-~~~vKL~DFGla~~~~~~~~~ 683 (846)
+++|.+++........+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 99999999765555567899999999999999999999 89999999999999987 899999999999876432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.....||+.|+|||++.+.. ++.++||||||+++|+|+||++||................ ......
T Consensus 180 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~ 247 (295)
T 2clq_A 180 --------TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF----KVHPEI 247 (295)
T ss_dssp ---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH----CCCCCC
T ss_pred --------ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc----cccccc
Confidence 12345899999999997653 8899999999999999999999996433222211111111 112234
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+...+..+.+|+.+||..+|.+||++ .++
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~-~~l 276 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACA-NDL 276 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCH-HHH
T ss_pred cccCCHHHHHHHHHHccCChhhCCCH-HHH
Confidence 44556889999999999999999999 444
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=362.52 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=190.7
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHH-HHhcCCCceeeEecccc--CceE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDI-LSKIRHPNLVTLVGACP--EVWT 597 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~i-L~~l~HpnIv~l~g~~~--~~~~ 597 (846)
..++|...+.||+|+||.||++... +..||||++...... ....+..|..+ ++.++||||++++++|. +..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3457999999999999999999986 467999999765322 23456677777 56789999999999984 5689
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||++||+|.+++... ..+++..+..++.+|+.||.|||+ +||+||||||+||||+.+|++||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999998543 458899999999999999999999 89999999999999999999999999999864
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
...... .....||+.|+|||++.+..|+.++|||||||++|||++|++||...+........ ...
T Consensus 190 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--~~~----- 254 (373)
T 2r5t_A 190 IEHNST--------TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNK----- 254 (373)
T ss_dssp BCCCCC--------CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH--HHS-----
T ss_pred ccCCCc--------cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--Hhc-----
Confidence 322111 12346999999999999999999999999999999999999999766543321111 111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
...++...+..+.+|+.+||..+|.+||++.
T Consensus 255 ~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 255 PLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred ccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 1123444567899999999999999999984
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=365.96 Aligned_cols=253 Identities=22% Similarity=0.242 Sum_probs=198.7
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--Cc
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EV 595 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~ 595 (846)
+....++|...+.||+|+||.||++... ++.||||+++.... .....+.+|+.+|..++||||++++++|. +.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3445568999999999999999999986 68899999975321 12346889999999999999999999984 46
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.|+||||++||+|.+++.... ..+++..+..++.+|+.||.|||+ ++|+||||||+||||+.+|++||+|||+++
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 899999999999999996432 368999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 748 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-------~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~ 748 (846)
........ ......||+.|+|||++. ...|+.++|||||||++|||+||++||.............
T Consensus 211 ~~~~~~~~-------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 211 KLRADGTV-------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp ECCTTSCE-------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred eccCCCcc-------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 76543211 112346999999999997 3568999999999999999999999997765433221111
Q ss_pred hhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCC---ChHHHH
Q 003121 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP---ELGKDV 791 (846)
Q Consensus 749 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RP---t~~~~v 791 (846)
.....+. .+.++...+..+.+||.+||. +|.+|+ ++ +++
T Consensus 284 ~~~~~~~--~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~-~ei 325 (412)
T 2vd5_A 284 HYKEHLS--LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGA-GDF 325 (412)
T ss_dssp THHHHCC--CC----CCCHHHHHHHHTTSS-CGGGCTTTTTH-HHH
T ss_pred hcccCcC--CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCH-HHH
Confidence 1111111 111223456789999999999 999984 66 444
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.44 Aligned_cols=246 Identities=25% Similarity=0.392 Sum_probs=203.2
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc------------
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------------ 593 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~------------ 593 (846)
.+|...+.||+|+||.||+|... +..||+|++... ...+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 46888999999999999999986 688999999754 257889999999999999999999873
Q ss_pred ------CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCcee
Q 003121 594 ------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 667 (846)
Q Consensus 594 ------~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vK 667 (846)
...++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEE
Confidence 23789999999999999996432 3568999999999999999999999 8999999999999999999999
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003121 668 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 747 (846)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~ 747 (846)
|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|+||..|+.........+..
T Consensus 163 l~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~ 233 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK---------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD 233 (284)
T ss_dssp ECCCTTCEESSCCSC---------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHT
T ss_pred ECcchhheecccccc---------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhc
Confidence 999999987654321 12345899999999999999999999999999999999999887433222211111
Q ss_pred hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
. ..+...+..+.+|+.+||..+|.+||++ .++++.|..+....
T Consensus 234 ~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~-~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 234 G-----------IISDIFDKKEKTLLQKLLSKKPEDRPNT-SEILRTLTVWKKSP 276 (284)
T ss_dssp T-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHTC--
T ss_pred c-----------cccccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHhhCC
Confidence 1 1223345779999999999999999999 88888888876553
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=350.17 Aligned_cols=264 Identities=24% Similarity=0.394 Sum_probs=209.4
Q ss_pred cCCCcccceeeeeCceEEEEEEE------CCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc----Cce
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVW 596 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~------~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~ 596 (846)
..+|.+.+.||+|+||.||++.+ .+..||||++..........+.+|+.+|++++||||+++++++. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34688899999999999999985 35789999998755444567999999999999999999999873 257
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+++|+|.+++... ...+++..++.++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 8999999999999999643 2468999999999999999999999 8999999999999999999999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHhh--------
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDT-------- 747 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~-~~~~~-------- 747 (846)
........ .......++..|+|||++.+..++.++||||||+++|+|+||..||....... .....
T Consensus 195 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 195 LPQDKEYY-----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp CCSSCSEE-----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccc-----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 65432110 11123457889999999998889999999999999999999999986442111 00000
Q ss_pred hhhcccc-CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 748 GKLKNLL-DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 748 ~~~~~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
..+...+ .......+...+..+.+|+.+||..+|.+||++ .++++.|+.++..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~el~~~L~~l~~~ 323 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF-RDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHH
Confidence 0000111 111122344566889999999999999999999 8899999988764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=355.40 Aligned_cols=264 Identities=20% Similarity=0.266 Sum_probs=195.6
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-----CeEEEEEEecCCCCC-----------CchhHHHHHHHHHhcCCCceeeEec
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-----------GPSEFQQEIDILSKIRHPNLVTLVG 590 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~~~-----------~~~~f~~Ei~iL~~l~HpnIv~l~g 590 (846)
.++|.+.+.||+|+||.||+|... +..||||++...... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999985 467999998765321 1234667888999999999999999
Q ss_pred ccc------CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC
Q 003121 591 ACP------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 664 (846)
Q Consensus 591 ~~~------~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~ 664 (846)
++. ...++||||+ +++|.+++... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCC
Confidence 873 3578999999 99999999543 379999999999999999999999 8999999999999999877
Q ss_pred --ceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCc--hH
Q 003121 665 --VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT--KE 740 (846)
Q Consensus 665 --~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~--~~ 740 (846)
.+||+|||+++.+........ ..........||+.|+|||++.+..++.++|||||||++|+|+||+.||... ..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQ-YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCC-CCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCcEEEEeCCCceeccccccccc-chhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 999999999987754332111 1111123457999999999999999999999999999999999999999542 11
Q ss_pred HHHHHhhhhhccccCCCCCCC--ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 741 VQYALDTGKLKNLLDPLAGDW--PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 741 ~~~~~~~~~~~~~ld~~~~~~--p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
.............+......+ +...+..+.+|+.+||..+|.+||++ +++++.|+.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~L~~~~ 327 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNY-QALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCH-HHHHHHHCTTC
T ss_pred HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCH-HHHHHHHhccC
Confidence 111111111111111000000 01345789999999999999999999 88888887653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=339.58 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=193.2
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
++|...++||+|+||.||++... +..||+|++..... ...+.+.+|+.+|++++||||++++++|. ...++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 36889999999999999999886 57899999876543 34577999999999999999999999984 468899999
Q ss_pred cCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe---cCCCceeeeccccccccc
Q 003121 603 LPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLS 678 (846)
Q Consensus 603 ~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl---~~~~~vKL~DFGla~~~~ 678 (846)
+++|+|.+++... .....+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988543 223569999999999999999999999 899999999999999 456889999999998664
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
.... .....||+.|+|||++. +.++.++||||||+++|+|++|+.||.....................
T Consensus 179 ~~~~---------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 246 (285)
T 3is5_A 179 SDEH---------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-- 246 (285)
T ss_dssp -----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--
T ss_pred Cccc---------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc--
Confidence 4321 12345899999999985 57899999999999999999999999766543322111111111111
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+..+.+|+.+||..+|.+||++ .++
T Consensus 247 --~~~~~~~~~~~li~~~L~~dP~~Rps~-~e~ 276 (285)
T 3is5_A 247 --ECRPLTPQAVDLLKQMLTKDPERRPSA-AQV 276 (285)
T ss_dssp ----CCCCHHHHHHHHHHTCSCTTTSCCH-HHH
T ss_pred --ccCcCCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 111235789999999999999999999 444
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.81 Aligned_cols=258 Identities=23% Similarity=0.285 Sum_probs=196.3
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC-----CCCCchhHHHHHHHHHhcCCCceeeEecccc--
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH-----SLQGPSEFQQEIDILSKIRHPNLVTLVGACP-- 593 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~-----~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-- 593 (846)
+....++|.+.+.||+|+||.||+|... +..||+|++... .....+.+.+|+.+|++++||||++++++|.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3444567999999999999999999886 468999998653 2233467899999999999999999999984
Q ss_pred CceEEEEEecCCCchhhhhccCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKD-------------------------------------NSPPLSWQTRIRIATELCSV 636 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~-------------------------------------~~~~l~~~~~~~i~~qia~a 636 (846)
...++||||+++|+|.+++.... ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 45889999999999999884210 01234577888999999999
Q ss_pred HHHHhhcCCCceEecccCCCceEecCCC--ceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc--CCC
Q 003121 637 LIFLHSCKPHSIVHGDLKPANILLDANF--VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GEL 712 (846)
Q Consensus 637 L~~LH~~~~~giiHrDLkp~NILl~~~~--~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~ 712 (846)
|.|||+ ++|+||||||+||||+.++ .+||+|||+++.+........ .......||+.|+|||++.+ ..+
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY----YGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCcccc----ccccccCCCccccCchhhccCCCCC
Confidence 999999 8999999999999998776 899999999987644221111 11134569999999999975 678
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 713 TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 713 ~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+.++|||||||++|+|+||++||............. ...... ........+..+.+|+.+||..+|.+||++ .++
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~~ 328 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL--NKKLCF-ENPNYNVLSPLARDLLSNLLNRNVDERFDA-MRA 328 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCT-TSGGGGGSCHHHHHHHHHHSCSCTTTSCCH-HHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH--hccccc-CCcccccCCHHHHHHHHHHcCCChhHCCCH-HHH
Confidence 999999999999999999999997665543222111 111111 111112345789999999999999999999 444
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=356.82 Aligned_cols=261 Identities=24% Similarity=0.314 Sum_probs=207.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccccC----ceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----~~~lV 599 (846)
.++|.+.++||+|+||.||+|.+. +..||||++..... ...+.+.+|+.+|++++||||+++++++.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 346899999999999999999987 67899999975432 334678899999999999999999998732 57899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe----cCCCceeeecccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGISR 675 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl----~~~~~vKL~DFGla~ 675 (846)
|||+++|+|.+++........+++..++.++.||+.||.|||+ ++|+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 9999999999999655444559999999999999999999999 899999999999999 788889999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCch------HH
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--------GELTPKSDVYSFGIILLRLLTGRPALGITK------EV 741 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~~~ksDVwSlGviL~elltG~~pf~~~~------~~ 741 (846)
........ ....||+.|+|||++.+ ..++.++|||||||++|+|+||+.||.... ..
T Consensus 165 ~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 165 ELEDDEQF---------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp ECCCGGGS---------SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred EccCCCcc---------ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 76543211 23459999999999865 467889999999999999999999995321 11
Q ss_pred HHHHhhhhhccc----------------cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 742 QYALDTGKLKNL----------------LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 742 ~~~~~~~~~~~~----------------ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
...+..+.-... ..+.....+...+..+.+|+.+||+.||.+||++ .++++.++.+..
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~-~e~l~~l~~il~ 309 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-DQFFAETSDILH 309 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH-HHHHHHHHHHHT
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccH-HHHHHHHHHHhh
Confidence 111111110000 0011223446678899999999999999999999 777777776643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=350.85 Aligned_cols=274 Identities=23% Similarity=0.301 Sum_probs=195.1
Q ss_pred CCChhhhhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccc
Q 003121 517 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP 593 (846)
Q Consensus 517 ~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~ 593 (846)
++....+.....+|.+.++||+|+||.||+|.+. +..||||++..........+.+|+.+|.++. ||||+++++++.
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 17 DFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp SSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred HhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 3334445555668999999999999999999984 6889999986654444567889999999996 999999999871
Q ss_pred ----------CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecccCCCceEec
Q 003121 594 ----------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLD 661 (846)
Q Consensus 594 ----------~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g--iiHrDLkp~NILl~ 661 (846)
..+++||||+. |+|.+++.......++++..++.++.||+.||.|||+ ++ |+||||||+||||+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~ 172 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLS 172 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEEC
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEEC
Confidence 13789999995 7999988654445679999999999999999999999 77 99999999999999
Q ss_pred CCCceeeeccccccccccccccCCC----ccccccCCCCCCcccCChhhh---ccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003121 662 ANFVSKLSDFGISRFLSQNEISSNN----TTLCCRTDPKGTFAYMDPEFL---ASGELTPKSDVYSFGIILLRLLTGRPA 734 (846)
Q Consensus 662 ~~~~vKL~DFGla~~~~~~~~~~~~----~~~~~~~~~~Gt~~Y~APE~l---~~~~~~~ksDVwSlGviL~elltG~~p 734 (846)
.++.+||+|||+++........... ..........||+.|+|||++ .+..++.++|||||||++|+|+||++|
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 252 (337)
T 3ll6_A 173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252 (337)
T ss_dssp TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 9999999999999876543221100 000011234589999999998 456789999999999999999999999
Q ss_pred CCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCC
Q 003121 735 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGG 804 (846)
Q Consensus 735 f~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~ 804 (846)
|......... .... ..+ .+...+..+.+|+.+||+.+|.+||++ .++++.|..+......
T Consensus 253 ~~~~~~~~~~--~~~~---~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~-~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 253 FEDGAKLRIV--NGKY---SIP----PHDTQYTVFHSLIRAMLQVNPEERLSI-AEVVHQLQEIAAARNV 312 (337)
T ss_dssp C--------------C---CCC----TTCCSSGGGHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHHHTTC
T ss_pred CcchhHHHhh--cCcc---cCC----cccccchHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHhccCC
Confidence 9654332211 1111 011 112233568999999999999999999 8898999988776543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=380.57 Aligned_cols=247 Identities=25% Similarity=0.421 Sum_probs=199.7
Q ss_pred ceeeeeCceEEEEEEEC----CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEecCCC
Q 003121 534 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNG 606 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~----~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy~~gg 606 (846)
++||+|+||.||+|.+. +..||||+++..... ..+.|.+|+.+|++++|||||+++++|. +..++||||+++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 47999999999999763 367999999764332 2467999999999999999999999984 4688999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+++.. ...+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.+........
T Consensus 455 ~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~- 527 (635)
T 4fl3_A 455 PLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 527 (635)
T ss_dssp EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc-
Confidence 99999953 3468999999999999999999999 8999999999999999999999999999987654322111
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH--HHhhhhhccccCCCCCCCCh
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~ 763 (846)
......||+.|+|||++.+..++.++|||||||+||||+| |+.||........ .+..+ .....|.
T Consensus 528 ----~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~--------~~~~~p~ 595 (635)
T 4fl3_A 528 ----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--------ERMGCPA 595 (635)
T ss_dssp -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------CCCCCCT
T ss_pred ----cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------CCCCCCC
Confidence 1123457899999999999999999999999999999998 9999976654321 12221 1223445
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
..+..+.+|+.+||..+|.+||++ .++.+.|+.+..
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~-~~l~~~L~~~~~ 631 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGF-AAVELRLRNYYY 631 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHHH
Confidence 567899999999999999999999 888888887654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=354.86 Aligned_cols=240 Identities=23% Similarity=0.393 Sum_probs=192.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
++|.+.+.||+|+||.||++... +..||||++..... .+.+|+++|.++ +||||+++++++. ...|+||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 46888999999999999999986 67899999976432 356799999888 7999999999984 468899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC----Cceeeeccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN----FVSKLSDFGISRFLS 678 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~----~~vKL~DFGla~~~~ 678 (846)
++||+|.+++.. ...+++..+..++.+|+.||.|||+ +||+||||||+|||+..+ +.+||+|||+++...
T Consensus 98 ~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 98 MKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999853 3469999999999999999999999 899999999999998433 359999999998764
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHhhhhhccc
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQYALDTGKLKNL 753 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~-----~~~~~~~~~~~~~ 753 (846)
..... .....||+.|+|||++.+..|+.++|||||||++|+|++|++||..... ....+..+.+
T Consensus 172 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~--- 240 (342)
T 2qr7_A 172 AENGL--------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF--- 240 (342)
T ss_dssp CTTCC--------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC---
T ss_pred CCCCc--------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc---
Confidence 43211 1234689999999999888899999999999999999999999975321 1111222211
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. ....++...+..+.+|+.+||..||.+||++ .++
T Consensus 241 -~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-~~i 275 (342)
T 2qr7_A 241 -S-LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTA-ALV 275 (342)
T ss_dssp -C-CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred -c-cCccccccCCHHHHHHHHHHCCCChhHCcCH-HHH
Confidence 1 1122223456889999999999999999999 444
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.63 Aligned_cols=257 Identities=20% Similarity=0.278 Sum_probs=196.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
.++|.+.+.||+|+||.||+|... +..||||++....... ...+.+|+.++++++||||+++++++ ....++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 457999999999999999999875 6789999997653332 25688999999999999999999998 4568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++++|.+++... .++++..++.++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999999543 468999999999999999999999 8999999999999999999999999999986654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
..... .....||+.|+|||++.+..++.++||||||+++|+|+||++||........... +.... +...
T Consensus 187 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~-~~~~ 255 (309)
T 2h34_A 187 EKLTQ-------LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH---INQAI-PRPS 255 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH---HHSCC-CCGG
T ss_pred ccccc-------ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH---hccCC-CCcc
Confidence 32111 1234589999999999988999999999999999999999999987654321111 11111 1111
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
..+...+..+.+|+.+||..+|.+||+..+++...|+.+..
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 22334457899999999999999999433888777776543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=346.27 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=203.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC--Ce--EEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HM--QVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~--~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV 599 (846)
++|...+.||+|+||.||+|... +. .||||.+.... ......+.+|+.+|+++ +||||+++++++ .+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 47888999999999999999875 44 35999887532 23456799999999999 999999999998 4568899
Q ss_pred EEecCCCchhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 600 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999996432 23479999999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHH
Q 003121 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 745 (846)
Q Consensus 667 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~ 745 (846)
||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|+|+| |++||..........
T Consensus 182 kL~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK---------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252 (327)
T ss_dssp EECCTTCEESSCEECC---------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred EEcccCcCcccccccc---------ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence 9999999875432211 122347889999999998889999999999999999998 999997665433211
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
.. ........+...+..+.+|+.+||..+|.+||++ .++++.|..+...
T Consensus 253 ~~------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~ 301 (327)
T 1fvr_A 253 KL------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQILVSLNRMLEE 301 (327)
T ss_dssp HG------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHS
T ss_pred Hh------hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHh
Confidence 11 1111223344556889999999999999999999 8888888887664
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.52 Aligned_cols=243 Identities=23% Similarity=0.302 Sum_probs=191.3
Q ss_pred ccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecCCCc
Q 003121 532 PSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS 607 (846)
Q Consensus 532 ~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ggs 607 (846)
..+.||+|+||.||+|... +..||+|++........+.+.+|+.+|++++||||++++++|. +..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3567999999999999875 6789999998765445667999999999999999999999984 46899999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe--cCCCceeeeccccccccccccccCC
Q 003121 608 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL--DANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 608 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl--~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 173 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~-- 245 (373)
T 2x4f_A 173 LFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-- 245 (373)
T ss_dssp EHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--
Confidence 99988532 3468999999999999999999999 899999999999999 56789999999999876543211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 765 (846)
....||+.|+|||++.+..++.++|||||||++|+|+||++||.............. ....... ......
T Consensus 246 -------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~--~~~~~~~-~~~~~~ 315 (373)
T 2x4f_A 246 -------KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA--CRWDLED-EEFQDI 315 (373)
T ss_dssp -------CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCSCS-GGGTTS
T ss_pred -------ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCCh-hhhccC
Confidence 223599999999999988999999999999999999999999976654332211111 1111111 111234
Q ss_pred HHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 766 AEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 766 ~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
+..+.+|+.+||..+|.+||++ .+++
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~-~e~l 341 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISA-SEAL 341 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCH-HHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCH-HHHh
Confidence 5789999999999999999999 4543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=352.47 Aligned_cols=258 Identities=25% Similarity=0.333 Sum_probs=201.4
Q ss_pred CCCChhhhhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-----CCceeeE
Q 003121 516 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----HPNLVTL 588 (846)
Q Consensus 516 ~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-----HpnIv~l 588 (846)
..|++.+.....++|.+.++||+|+||.||+|... +..||||++.... .....+..|+.+|+.+. ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 44555555666789999999999999999999984 6789999987422 22346788999999996 9999999
Q ss_pred eccc--cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC----
Q 003121 589 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---- 662 (846)
Q Consensus 589 ~g~~--~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~---- 662 (846)
++++ .+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+ +||+||||||+||||+.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence 9988 46789999999 999999986443 3459999999999999999999999 89999999999999975
Q ss_pred ---------------------CCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHH
Q 003121 663 ---------------------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 721 (846)
Q Consensus 663 ---------------------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSl 721 (846)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----------GSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----------CSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----------cCccCcccccCcHHHcCCCCCCccchHHH
Confidence 7899999999998644321 23458999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCchHHHHHHhhhhhcc-----------------cc--CCCCCCCCh-------------------
Q 003121 722 GIILLRLLTGRPALGITKEVQYALDTGKLKN-----------------LL--DPLAGDWPF------------------- 763 (846)
Q Consensus 722 GviL~elltG~~pf~~~~~~~~~~~~~~~~~-----------------~l--d~~~~~~p~------------------- 763 (846)
||++|+|+||++||................. .+ +.....||.
T Consensus 246 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 325 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325 (360)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHH
T ss_pred HHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccc
Confidence 9999999999999976554322111100000 00 000011111
Q ss_pred -hhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 764 -VQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 764 -~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+.+|+.+||+.||.+||++ .++
T Consensus 326 ~~~~~~l~~li~~~L~~dP~~Rpta-~el 353 (360)
T 3llt_A 326 IIKHELFCDFLYSILQIDPTLRPSP-AEL 353 (360)
T ss_dssp HCCCHHHHHHHHHHCCSSGGGSCCH-HHH
T ss_pred cchHHHHHHHHHHHhcCChhhCCCH-HHH
Confidence 112668899999999999999999 444
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=343.26 Aligned_cols=246 Identities=29% Similarity=0.393 Sum_probs=193.6
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-----CCchhHHHHHHHHHhcC---CCceeeEeccccC--
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-----QGPSEFQQEIDILSKIR---HPNLVTLVGACPE-- 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-----~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~-- 594 (846)
.++|.+.++||+|+||.||+|... +..||||++..... .....+.+|+.+++.++ ||||++++++|..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 468999999999999999999964 67899999875332 12346788999888775 9999999998832
Q ss_pred -----ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeee
Q 003121 595 -----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 669 (846)
Q Consensus 595 -----~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~ 669 (846)
..++||||+. |+|.+++.... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 3789999997 59999886443 2449999999999999999999999 899999999999999999999999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh
Q 003121 670 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 749 (846)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~ 749 (846)
|||+++........ ....||+.|+|||++.+..++.++|||||||++|+|+||++||..............
T Consensus 163 Dfg~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 163 DFGLARIYSYQMAL---------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp SCSCTTTSTTCCCS---------GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred eCccccccCCCccc---------CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999866432211 223589999999999999999999999999999999999999977655432221111
Q ss_pred hccccCCCCCCC----------------------ChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 750 LKNLLDPLAGDW----------------------PFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 750 ~~~~ld~~~~~~----------------------p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
... .+....| ....+..+.+|+.+||+.||.+||++.
T Consensus 234 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 292 (308)
T 3g33_A 234 LIG--LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292 (308)
T ss_dssp HHC--CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HhC--CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHH
Confidence 100 0001111 112457899999999999999999993
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=368.60 Aligned_cols=238 Identities=22% Similarity=0.267 Sum_probs=187.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|...++||+|+||.||+|... +..||||++... .......+.+|+.+|+.++||||++++++| .+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 47899999999999999999876 578999999753 223345678999999999999999999998 45689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++... ..+++..+..++.||+.||.|||+. +||+||||||+||||+.++.+||+|||+++.....
T Consensus 228 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 228 EYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred eeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999999998543 4689999999999999999999962 58999999999999999999999999999864332
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... .....||+.|+|||++.+..|+.++|||||||+||+|+||++||............. .. ...
T Consensus 303 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~-----~~~ 367 (446)
T 4ejn_A 303 GAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--ME-----EIR 367 (446)
T ss_dssp ------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HC-----CCC
T ss_pred Ccc--------cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH--hC-----CCC
Confidence 211 133569999999999999999999999999999999999999997665433211110 11 112
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCC
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
+|...+..+.+|+.+||..+|.+||
T Consensus 368 ~p~~~~~~~~~li~~~L~~dP~~R~ 392 (446)
T 4ejn_A 368 FPRTLGPEAKSLLSGLLKKDPKQRL 392 (446)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred CCccCCHHHHHHHHHHcccCHHHhC
Confidence 3445568899999999999999999
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=351.97 Aligned_cols=258 Identities=16% Similarity=0.159 Sum_probs=206.9
Q ss_pred hhhhhhcCCCcccceeeeeCceEEEEEE-------ECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC---CCceeeEec
Q 003121 521 SEIEGATHNFDPSLKIGEGGYGSIYKGL-------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR---HPNLVTLVG 590 (846)
Q Consensus 521 ~ei~~~~~~f~~~~~LG~G~fG~Vy~g~-------~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~---HpnIv~l~g 590 (846)
.++.....+|.+.++||+|+||.||+|. ..+..||||++... ....+..|+.++..++ ||||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3444556789999999999999999994 23578999999753 3567889999999997 999999999
Q ss_pred cc--cCceEEEEEecCCCchhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC----
Q 003121 591 AC--PEVWTLVYEYLPNGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---- 662 (846)
Q Consensus 591 ~~--~~~~~lVmEy~~ggsL~~~L~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~---- 662 (846)
++ .+..++||||+++|+|.+++... .....+++..++.|+.||+.||.|||+ ++|+||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccC
Confidence 87 56789999999999999999642 134579999999999999999999999 89999999999999998
Q ss_pred -------CCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003121 663 -------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 735 (846)
Q Consensus 663 -------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf 735 (846)
++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+||++||
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKG------TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTT------EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccccccccCCEEEeeCchhhhhhccCCC------ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 899999999999765422111 1123456999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 736 GITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
...... ...+....... ..++.+.+++..|++.+|.+||+..+++.+.|+.+...
T Consensus 286 ~~~~~~---------~~~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 286 VKNEGG---------ECKPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp EEEETT---------EEEECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCCCC---------ceeechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 533221 01111111122 23678999999999999999977668888888776543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=366.00 Aligned_cols=243 Identities=26% Similarity=0.400 Sum_probs=200.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
.++|.+.+.||+|+||.||+|... +..||||++.... ......+.+|+.+|+.++||||+++++++ .+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 457999999999999999999986 6889999997532 22345789999999999999999999998 4568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999953 3569999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
... .....||+.|+|||++.+..+ +.++|||||||++|+|++|++||............ ... .
T Consensus 169 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i--~~~-----~ 232 (476)
T 2y94_A 169 GEF---------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDG-----I 232 (476)
T ss_dssp TCC---------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH--HTT-----C
T ss_pred ccc---------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH--hcC-----C
Confidence 321 123469999999999988765 68999999999999999999999765432211111 001 1
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
...|...+..+.+|+.+||..+|.+||++ .+++
T Consensus 233 ~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~-~eil 265 (476)
T 2y94_A 233 FYTPQYLNPSVISLLKHMLQVDPMKRATI-KDIR 265 (476)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCH-HHHH
T ss_pred cCCCccCCHHHHHHHHHHcCCCchhCcCH-HHHH
Confidence 12234456789999999999999999999 5543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=334.08 Aligned_cols=239 Identities=25% Similarity=0.378 Sum_probs=197.7
Q ss_pred CCCcccceeeeeCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
++|.+.+.||+|+||.||+|...+ ..||+|++........+.+.+|+.+|++++||||++++++|. ...++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 468899999999999999999874 579999998766666788999999999999999999999984 4588999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe---cCCCceeeeccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl---~~~~~vKL~DFGla~~~~~~ 680 (846)
++++|.+++... ..+++..+..++.+++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++......
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 89 TGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999988543 458999999999999999999999 899999999999999 78899999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... ....||+.|+|||++.+ .++.++||||||+++|+|+||++||.............. .. ..
T Consensus 163 ~~~---------~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~-----~~ 225 (277)
T 3f3z_A 163 KMM---------RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE--GT-----FT 225 (277)
T ss_dssp SCB---------CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CC-----CC
T ss_pred cch---------hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CC-----CC
Confidence 211 23459999999999865 499999999999999999999999976654332211111 00 11
Q ss_pred CCh----hhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 761 WPF----VQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 761 ~p~----~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
++. ..+..+.+|+.+||+.+|.+||++.+
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~ 258 (277)
T 3f3z_A 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQ 258 (277)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCchhhhcCCHHHHHHHHHHccCChhhCcCHHH
Confidence 121 23578999999999999999999943
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=344.88 Aligned_cols=245 Identities=21% Similarity=0.308 Sum_probs=199.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcCCCceeeEecccc--CceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~ 597 (846)
++|.+.+.||+|+||.||+|... +..||||++...... ..+.+.+|+.+|++++||||+++++++. ...+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 46899999999999999999986 678999999865432 2456999999999999999999999984 4689
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC----ceeeecccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGI 673 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~----~vKL~DFGl 673 (846)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999953 3568999999999999999999999 8999999999999999887 799999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
+........ .....||+.|+|||++.+..++.++|||||||++|+|+||..||.................
T Consensus 166 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~- 235 (321)
T 2a2a_A 166 AHEIEDGVE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY- 235 (321)
T ss_dssp CEECCTTCC---------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-
T ss_pred ceecCcccc---------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-
Confidence 987654321 1234599999999999999999999999999999999999999976554332211111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
......+...+..+.+|+.+||..+|.+||++ .++
T Consensus 236 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~e~ 270 (321)
T 2a2a_A 236 --DFDEEFFSHTSELAKDFIRKLLVKETRKRLTI-QEA 270 (321)
T ss_dssp --CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCH-HHH
T ss_pred --ccChhhhcccCHHHHHHHHHHcCCChhhCcCH-HHH
Confidence 00101112345789999999999999999999 444
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=341.13 Aligned_cols=249 Identities=27% Similarity=0.358 Sum_probs=192.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
++|...++||+|+||.||+|... +..||||++....... ...+.+|+.++++++||||++++++| ....++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 47889999999999999999986 6789999987654322 34578999999999999999999998 456889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++++|.+++.. ...+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999998743 3568999999999999999999999 899999999999999999999999999998765332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh----------
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL---------- 750 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~---------- 750 (846)
.. .....||+.|+|||++.+ ..++.++||||||+++|+|+||++||...............
T Consensus 157 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 157 DY--------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp -----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred cc--------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 11 123458999999999976 57899999999999999999999999766543322111100
Q ss_pred --------ccccCCCCCCC------ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 --------KNLLDPLAGDW------PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 --------~~~ld~~~~~~------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+..... ....+..+.+|+.+||..+|.+||++ +++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~el 282 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC-EQL 282 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH-HHH
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH-HHH
Confidence 00000000000 01245679999999999999999999 444
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.20 Aligned_cols=243 Identities=27% Similarity=0.454 Sum_probs=197.7
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
..++|.+.+.||+|+||.||+|... +..||||++.... ......+.+|+.+++.++||||++++++|. ...++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3457899999999999999999887 4679999986532 123456889999999999999999999984 45889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+++|+|.+++... ..+++..++.++.+|+.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999998543 458999999999999999999999 899999999999999999999999999986543
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
... .....||+.|+|||++.+..++.++||||||+++|+|++|++||.............. ..
T Consensus 161 ~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~ 223 (279)
T 3fdn_A 161 SSR----------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-------VE 223 (279)
T ss_dssp -----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-------TC
T ss_pred ccc----------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-------CC
Confidence 321 1234589999999999998999999999999999999999999986654332211111 11
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
..+|...+..+.+|+.+||..+|.+||++ .+++
T Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~e~l 256 (279)
T 3fdn_A 224 FTFPDFVTEGARDLISRLLKHNPSQRPML-REVL 256 (279)
T ss_dssp CCCCTTSCHHHHHHHHHHCCSSGGGSCCH-HHHH
T ss_pred CCCCCcCCHHHHHHHHHHhccChhhCCCH-HHHh
Confidence 22344456889999999999999999999 5553
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=351.50 Aligned_cols=245 Identities=25% Similarity=0.305 Sum_probs=187.2
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
..++|...+.||+|+||.||++... +..||||++..... ....+.+|+.+++.++||||++++++| ....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3468999999999999999999986 67899999976443 346789999999999999999999998 456899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc--eeeecccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--SKLSDFGISRFLSQ 679 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~--vKL~DFGla~~~~~ 679 (846)
|+++|+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999998543 459999999999999999999999 89999999999999987765 99999999874332
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCchHH---HHHHhhhhhccccC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK-SDVYSFGIILLRLLTGRPALGITKEV---QYALDTGKLKNLLD 755 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~k-sDVwSlGviL~elltG~~pf~~~~~~---~~~~~~~~~~~~ld 755 (846)
... .....||+.|+|||++.+..++.+ +|||||||++|+|++|++||...... ...+... ....
T Consensus 171 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~~-- 238 (361)
T 3uc3_A 171 HSQ---------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI-LSVK-- 238 (361)
T ss_dssp -------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH-HTTC--
T ss_pred cCC---------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH-hcCC--
Confidence 211 123459999999999988887665 89999999999999999999754321 1111110 0000
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
... ......+..+.+|+.+||..+|.+||++ .++
T Consensus 239 ~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~-~el 272 (361)
T 3uc3_A 239 YSI-PDDIRISPECCHLISRIFVADPATRISI-PEI 272 (361)
T ss_dssp CCC-CTTSCCCHHHHHHHHHHSCSCTTTSCCH-HHH
T ss_pred CCC-CCcCCCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 000 0111245789999999999999999999 444
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=348.39 Aligned_cols=262 Identities=22% Similarity=0.321 Sum_probs=204.2
Q ss_pred hcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHh--cCCCceeeEeccccC------ceE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK--IRHPNLVTLVGACPE------VWT 597 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~--l~HpnIv~l~g~~~~------~~~ 597 (846)
..++|.+.+.||+|+||.||+|.+.+..||||++... ....+.+|++++.. ++||||+++++++.. ..+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 3457999999999999999999999999999998643 34568899999988 799999999998832 578
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCceEecccCCCceEecCCCceeee
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH--------SCKPHSIVHGDLKPANILLDANFVSKLS 669 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~giiHrDLkp~NILl~~~~~vKL~ 669 (846)
+||||+++|+|.+++.. ..+++..++.++.+|+.||.||| . ++|+||||||+||||+.++.+||+
T Consensus 117 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEEEE
Confidence 99999999999999953 35899999999999999999999 6 899999999999999999999999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCC------CCchhhHHHHHHHHHHHHhC----------CC
Q 003121 670 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE------LTPKSDVYSFGIILLRLLTG----------RP 733 (846)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~------~~~ksDVwSlGviL~elltG----------~~ 733 (846)
|||++........... .......||+.|+|||++.+.. ++.++|||||||++|+|+|| ..
T Consensus 190 Dfg~~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 190 DLGLAVRHDSATDTID----IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp CCTTCEEEETTTTEEE----ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred ECCCceeccccccccc----cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999987654321100 0113456999999999997652 33689999999999999999 67
Q ss_pred CCCCchH---HHHHHhhhhhccccCCCCC-CC-ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 734 ALGITKE---VQYALDTGKLKNLLDPLAG-DW-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 734 pf~~~~~---~~~~~~~~~~~~~ld~~~~-~~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
||..... ....+........+.+..+ .| ....+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH-HHHHHHHHHHHHTT
T ss_pred CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH-HHHHHHHHHHHHHh
Confidence 7754311 0011111111111111111 11 22456789999999999999999999 88999999887653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=346.95 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=190.9
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHHhcCCCceeeEecccc--Cc
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP--EV 595 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-----~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~ 595 (846)
...++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||++++++|. ..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34568999999999999999999886 678999999754321 1346889999999999999999999984 56
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.++||||+.+ +|.+++.. ....+++..+..++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 8999999975 88888743 33568889999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcccc
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 754 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~l 754 (846)
.+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.............. ...
T Consensus 161 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~--~~~ 230 (346)
T 1ua2_A 161 SFGSPNRA--------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE--TLG 230 (346)
T ss_dssp TTTSCCCC--------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--HHC
T ss_pred eccCCccc--------CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH--HcC
Confidence 76432211 1234689999999999764 589999999999999999999999977655332211110 000
Q ss_pred CCCCCCC------------------C-----hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 755 DPLAGDW------------------P-----FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 755 d~~~~~~------------------p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+....| + ...+..+.+|+.+||..+|.+||++ .++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~el 289 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-TQA 289 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH-HHH
T ss_pred CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH-HHH
Confidence 1111111 1 2335789999999999999999999 444
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=347.32 Aligned_cols=260 Identities=22% Similarity=0.337 Sum_probs=202.8
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--Cc
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EV 595 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~ 595 (846)
..++|.+.+.||+|+||.||+|.+. +..||||++..... .....+.+|+.++++++||||+++++++. ..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3458999999999999999999843 45799999974422 22356889999999999999999999984 46
Q ss_pred eEEEEEecCCCchhhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC---CCceee
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKL 668 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~---~~~vKL 668 (846)
.++||||+++|+|.+++..... ...+++..++.++.+|+.||.|||+ ++|+||||||+|||++. ++.+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 8999999999999999965432 2458999999999999999999999 89999999999999984 456999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhh
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDT 747 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~ 747 (846)
+|||+++........... ....||+.|+|||++.+..++.++||||||+++|+|+| |++||............
T Consensus 185 ~Dfg~~~~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKG------GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp CCCHHHHHHHC------C------CGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CccccccccccccccccC------CCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 999999865433221111 12347999999999999999999999999999999998 99999765443221111
Q ss_pred hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
. .......+...+..+.+|+.+||..+|.+||++ .++++.|..+...
T Consensus 259 ~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 259 T------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF-AIILERIEYCTQD 305 (327)
T ss_dssp H------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHC
T ss_pred h------cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCH-HHHHHHHHHHhcC
Confidence 0 111122334456789999999999999999999 8888888877653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=339.15 Aligned_cols=245 Identities=29% Similarity=0.425 Sum_probs=202.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
...|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+++.++||||++++++| ....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 346899999999999999999875 67899999976543 3356799999999999999999999988 456889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++++|.+++. ..++++..+..++.+|+.||.|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999984 2468999999999999999999999 899999999999999999999999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|++||.............. . .....
T Consensus 174 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~----~~~~~ 239 (303)
T 3a7i_A 174 IK--------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK--N----NPPTL 239 (303)
T ss_dssp CC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--S----CCCCC
T ss_pred cc--------cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc--C----CCCCC
Confidence 11 1234689999999999999999999999999999999999999976554332211111 1 11122
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 793 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~ 793 (846)
+...+..+.+|+.+||..+|.+||++ .++++
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~ 270 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTA-KELLK 270 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCH-HHHTT
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCH-HHHhh
Confidence 33445789999999999999999999 55533
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.66 Aligned_cols=239 Identities=24% Similarity=0.284 Sum_probs=187.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhc-CCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|...++||+|+||+||+|... +..||||++....... ...+..|+..+.++ +||||++++++|. ...++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 46899999999999999999986 6889999987643322 22355566666555 8999999999984 5689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+ +++|.+++... ...+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 67898888544 3469999999999999999999999 89999999999999999999999999998866433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|.+|+........ +..+.. ...
T Consensus 211 ~~---------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~-------~~~ 272 (311)
T 3p1a_A 211 GA---------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ-LRQGYL-------PPE 272 (311)
T ss_dssp -------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH-HTTTCC-------CHH
T ss_pred CC---------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-HhccCC-------Ccc
Confidence 21 123459999999999875 799999999999999999999776654433222 111111 111
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
++...+..+.+|+.+||+.+|.+||++ .++
T Consensus 273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~-~el 302 (311)
T 3p1a_A 273 FTAGLSSELRSVLVMMLEPDPKLRATA-EAL 302 (311)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCH-HHH
Confidence 222345789999999999999999999 444
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=349.83 Aligned_cols=236 Identities=23% Similarity=0.403 Sum_probs=195.5
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--------CchhHHHHHHHHHhcCCCceeeEecccc--C
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------GPSEFQQEIDILSKIRHPNLVTLVGACP--E 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--------~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~ 594 (846)
.++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|++++||||++++++|. .
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 457999999999999999999875 678999999875432 2346788999999999999999999984 4
Q ss_pred ceEEEEEecCCC-chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 595 VWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 595 ~~~lVmEy~~gg-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
..++||||+.+| +|.+++.. ...+++..+..|+.||+.||.|||. ++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 688999999777 99999853 3469999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 752 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~ 752 (846)
++........ ....||+.|+|||++.+..+ +.++|||||||++|+|++|++||...... ...
T Consensus 177 a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~ 239 (335)
T 3dls_A 177 AAYLERGKLF---------YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEA 239 (335)
T ss_dssp CEECCTTCCB---------CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTT
T ss_pred ceECCCCCce---------eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------Hhh
Confidence 9876543211 12358999999999988776 78999999999999999999999653221 111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....|...+..+.+|+.+||..+|.+||++ .++
T Consensus 240 -----~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-~el 272 (335)
T 3dls_A 240 -----AIHPPYLVSKELMSLVSGLLQPVPERRTTL-EKL 272 (335)
T ss_dssp -----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred -----ccCCCcccCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 111233356789999999999999999999 444
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=351.24 Aligned_cols=235 Identities=25% Similarity=0.342 Sum_probs=170.3
Q ss_pred ceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccc--CceEEEEEecCCCch
Q 003121 534 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYEYLPNGSL 608 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~--~~~~lVmEy~~ggsL 608 (846)
+.||+|+||.||+|... +..||||++... ....+.+|+.+|+.+. ||||++++++|. ...++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67999999999999986 678999998653 2457889999999997 999999999984 468899999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC---ceeeeccccccccccccccCC
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~---~vKL~DFGla~~~~~~~~~~~ 685 (846)
.+++... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++........
T Consensus 94 ~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 165 (325)
T 3kn6_A 94 FERIKKK---KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-- 165 (325)
T ss_dssp HHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence 9999543 569999999999999999999999 8999999999999997665 8999999999865443211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH------HHHhhhhhccccCCCCC
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ------YALDTGKLKNLLDPLAG 759 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~------~~~~~~~~~~~ld~~~~ 759 (846)
.....||+.|+|||++.+..++.++|||||||++|+|++|++||....... ..+... ..... ....
T Consensus 166 ------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~-~~~~ 237 (325)
T 3kn6_A 166 ------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDF-SFEG 237 (325)
T ss_dssp ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCC-CCCS
T ss_pred ------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCC-CCCc
Confidence 123458999999999999999999999999999999999999997543211 111100 00000 0000
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
......+..+.+|+.+||..+|.+||++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 265 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKM 265 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCH
Confidence 0012346789999999999999999999
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.00 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=179.5
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
..++|.+.+.||+|+||.||+|... +..||||++.... ......+.+|+.++++++||||+++++++. ...++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3457899999999999999999874 6889999986532 223467899999999999999999999984 46889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+++++|.+++... ..++++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999998532 3579999999999999999999999 899999999999999999999999999998764
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
...... ....||+.|+|||++.+..++.++||||||+++|+|+||++||......... . ... ...
T Consensus 164 ~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~-----~~~-~~~ 228 (278)
T 3cok_A 164 MPHEKH--------YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-N-----KVV-LAD 228 (278)
T ss_dssp ------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-SSC
T ss_pred CCCCcc--------eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-H-----HHh-hcc
Confidence 322111 1235899999999999888999999999999999999999999754432111 1 111 011
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...|...+..+.+|+.+||..+|.+||++ +++
T Consensus 229 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~~ 260 (278)
T 3cok_A 229 YEMPSFLSIEAKDLIHQLLRRNPADRLSL-SSV 260 (278)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred cCCccccCHHHHHHHHHHcccCHhhCCCH-HHH
Confidence 22344556889999999999999999999 444
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=335.64 Aligned_cols=246 Identities=22% Similarity=0.361 Sum_probs=197.9
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
.++|...+.||+|+||.||+|... +..||+|++...... ....+.+|+.++++++||||+++++++. ...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 357999999999999999999886 578999999765432 2356889999999999999999999984 4578999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc---eeeecccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGISRFL 677 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~---vKL~DFGla~~~ 677 (846)
||+++|+|.+.+... ..+++..+..++.+++.||.|||+ ++|+||||||+|||++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998888543 458999999999999999999999 89999999999999986654 999999999766
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
...... ....||+.|+|||++.+..++.++||||||+++|+|++|++||............. .......
T Consensus 159 ~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~ 227 (284)
T 3kk8_A 159 NDSEAW---------HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK--AGAYDYP 227 (284)
T ss_dssp CSSCBC---------CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCC
T ss_pred ccCccc---------cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH--hccccCC
Confidence 433211 23459999999999999999999999999999999999999997665433221111 1111111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
... ....+..+.+|+.+||+.+|.+||++ .++
T Consensus 228 ~~~-~~~~~~~~~~li~~~l~~dp~~Rps~-~~~ 259 (284)
T 3kk8_A 228 SPE-WDTVTPEAKSLIDSMLTVNPKKRITA-DQA 259 (284)
T ss_dssp TTT-TTTSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred chh-hcccCHHHHHHHHHHcccChhhCCCH-HHH
Confidence 111 12345789999999999999999999 444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=363.95 Aligned_cols=246 Identities=20% Similarity=0.256 Sum_probs=188.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccccC--------
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE-------- 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-------- 594 (846)
.++|...++||+|+||.||+|... +..||||++..... .....+.+|+.+|+.++||||++++++|..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 568999999999999999999876 67899999975421 223568899999999999999999998832
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
..|+||||+.++ |.+.+. ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 369999999764 656552 248899999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh----
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL---- 750 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~---- 750 (846)
+....... .+...||+.|+|||++.+..|+.++|||||||+||+|++|++||...+........-..
T Consensus 212 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 212 RTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282 (464)
T ss_dssp -----CCC---------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred eecCCCcc---------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 87643211 13346999999999999999999999999999999999999999876543322111000
Q ss_pred ------------ccccC--CCCCC-----------------CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 ------------KNLLD--PLAGD-----------------WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 ------------~~~ld--~~~~~-----------------~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+. +.... .....+..+.+|+.+||..||.+|||+ +++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-~e~ 353 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-DDA 353 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH-HHH
Confidence 00000 00000 001125679999999999999999999 444
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=349.61 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=191.4
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCC--CceeeEecccc--CceEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRH--PNLVTLVGACP--EVWTL 598 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~H--pnIv~l~g~~~--~~~~l 598 (846)
...+|.+.+.||+|+||.||++... +..||||++....... .+.+.+|+.+|..++| |||+++++++. ...++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 4557999999999999999999876 5779999997654322 3568899999999976 99999999984 46889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||| +.+|+|.+++... ..+++..+..|+.||+.||.|||+ ++|+||||||+||||+ ++.+||+|||+++.+.
T Consensus 87 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 4688999999643 468999999999999999999999 8999999999999997 5789999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 747 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----------~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~ 747 (846)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.........+
T Consensus 159 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-- 230 (343)
T 3dbq_A 159 PDTTSV------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-- 230 (343)
T ss_dssp -----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH--
T ss_pred cccccc------cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH--
Confidence 432211 1123469999999999865 678999999999999999999999997543221111
Q ss_pred hhhccccC-CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 748 GKLKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 748 ~~~~~~ld-~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...++ .....+|...+..+.+|+.+||..+|.+||++ .++
T Consensus 231 ---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-~e~ 271 (343)
T 3dbq_A 231 ---HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-PEL 271 (343)
T ss_dssp ---HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred ---HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCH-HHH
Confidence 11111 12234455556789999999999999999999 444
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=334.71 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=196.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy 602 (846)
++|.+.+.||+|+||.||+|... +..||||++..... ...+.+.+|+.+++.++||||+++++++. ...++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46888999999999999999886 67899999875433 23467899999999999999999999984 467899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|.+++. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999984 33568999999999999999999999 8999999999999999999999999999986643221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. ......||+.|+|||++.+..+ +.++||||||+++|+|+||+.||.................. .. ..
T Consensus 161 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~-~~ 230 (276)
T 2yex_A 161 ER------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---YL-NP 230 (276)
T ss_dssp EC------CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT---TS-TT
T ss_pred hh------cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc---cc-Cc
Confidence 11 1133468999999999987765 77899999999999999999999764432111111000000 00 11
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+..+.+|+.+||..+|.+||++ .++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~-~~i 259 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITI-PDI 259 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCH-HHH
Confidence 12345789999999999999999999 444
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.10 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=196.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
.++|.+.+.||+|+||.||+|... +..||+|++..........+.+|+.+|+.++||||+++++++ .+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 457999999999999999999987 678999999876666677899999999999999999999988 4568999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++++|.+++... ...+++..++.++.+|+.||.|||+ +|++||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999988543 3458999999999999999999999 8999999999999999999999999999764332211
Q ss_pred cCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
. .....||+.|+|||++. +..++.++||||||+++|+|+||++||............... .+.
T Consensus 173 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~ 240 (302)
T 2j7t_A 173 K--------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----DPP 240 (302)
T ss_dssp C-------------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCC
T ss_pred c--------cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc----CCc
Confidence 1 12245899999999984 567899999999999999999999999876544332221111 111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+...+..+.+|+.+||..+|.+||++ .++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l 273 (302)
T 2j7t_A 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSA-AQL 273 (302)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSCTTTSCCH-HHH
T ss_pred ccCCccccCHHHHHHHHHHcccChhhCCCH-HHH
Confidence 111233446789999999999999999999 444
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=353.56 Aligned_cols=241 Identities=22% Similarity=0.386 Sum_probs=187.0
Q ss_pred CCCccc-ceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHh-cCCCceeeEecccc------CceE
Q 003121 528 HNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSK-IRHPNLVTLVGACP------EVWT 597 (846)
Q Consensus 528 ~~f~~~-~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~-l~HpnIv~l~g~~~------~~~~ 597 (846)
++|... +.||+|+||+||++... +..||||++.. ...+.+|+.++.+ ++||||++++++|. ...|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999986 57899999863 3568899999855 58999999999873 3578
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC---CCceeeeccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGIS 674 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~---~~~vKL~DFGla 674 (846)
+|||||+||+|.+++.... ...+++..+..|+.||+.||.|||+ ++|+||||||+||||+. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999996432 3469999999999999999999999 89999999999999997 789999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHhhh
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALDTG 748 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~------~~~~~~~~ 748 (846)
+....... .....||+.|+|||++.+..|+.++|||||||++|+|+||++||..... ....+..+
T Consensus 212 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~ 282 (400)
T 1nxk_A 212 KETTSHNS---------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282 (400)
T ss_dssp EECC--------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT
T ss_pred cccCCCCc---------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC
Confidence 86543211 1234689999999999999999999999999999999999999965432 11122222
Q ss_pred hhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 749 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
.+ ......| ...+..+.+||.+||..+|.+||++ .+++
T Consensus 283 ~~----~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rpt~-~eil 320 (400)
T 1nxk_A 283 QY----EFPNPEW-SEVSEEVKMLIRNLLKTEPTQRMTI-TEFM 320 (400)
T ss_dssp CC----CCCTTTT-TTSCHHHHHHHHTTSCSSGGGSCCH-HHHH
T ss_pred cc----cCCCccc-ccCCHHHHHHHHHHCCCChhHCcCH-HHHh
Confidence 11 1111112 2345789999999999999999999 5543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=371.25 Aligned_cols=244 Identities=23% Similarity=0.314 Sum_probs=200.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|...+.||+|+||.||++... ++.||||++.... ......+.+|+.+|++++||||++++++|. ...|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 47888999999999999999985 6889999997542 233467889999999999999999999984 4689999
Q ss_pred EecCCCchhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 601 EYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
||++||+|.+++.... ....+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999986542 24579999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHhhhhhccccCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPL 757 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~--~~~~~~~~~~~~ld~~ 757 (846)
.... .....||+.|+|||++.+..|+.++|||||||++|||+||++||...... ...+...... .
T Consensus 342 ~~~~--------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-----~ 408 (543)
T 3c4z_A 342 GQTK--------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-----Q 408 (543)
T ss_dssp TCCC--------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-----C
T ss_pred CCcc--------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-----c
Confidence 3211 12346999999999999999999999999999999999999999764210 0111111111 1
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
...+|...+..+.+|+.+||..+|.+||++
T Consensus 409 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 123455567889999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=343.13 Aligned_cols=257 Identities=28% Similarity=0.397 Sum_probs=198.7
Q ss_pred CCCChhhhhhhcCCCcccceeeeeCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc
Q 003121 516 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 592 (846)
Q Consensus 516 ~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~ 592 (846)
..+.+.++....++|.+.+.||+|+||.||+|.+ .+..||||++.... .....+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 4455666777788999999999999999999998 46889999997543 3456899999999999 899999999987
Q ss_pred c--------CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC
Q 003121 593 P--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 664 (846)
Q Consensus 593 ~--------~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~ 664 (846)
. ...++||||+++|+|.+++.... ...+++..++.++.||+.||.|||. +||+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCC
Confidence 2 46889999999999999986432 3568999999999999999999999 8999999999999999999
Q ss_pred ceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 003121 665 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITK 739 (846)
Q Consensus 665 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG~~pf~~~~ 739 (846)
.+||+|||++......... .....||+.|+|||++. +..++.++|||||||++|+|+||++||....
T Consensus 167 ~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVGR--------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp CEEECCCTTTC---------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CEEEeeCcCceecCcCccc--------cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999998866432111 12345899999999997 4578999999999999999999999997665
Q ss_pred HHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 740 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 740 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.......... . +.....+...+..+.+|+.+||..+|.+||++ .++
T Consensus 239 ~~~~~~~~~~--~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l 284 (326)
T 2x7f_A 239 PMRALFLIPR--N---PAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT-EQL 284 (326)
T ss_dssp HHHHHHHHHH--S---CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCH-HHH
T ss_pred HHHHHHHhhc--C---ccccCCccccCHHHHHHHHHHhccChhhCCCH-HHH
Confidence 4432221111 0 11111122345789999999999999999999 444
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=349.33 Aligned_cols=263 Identities=23% Similarity=0.309 Sum_probs=202.3
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc------CceE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------EVWT 597 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~------~~~~ 597 (846)
..++|...+.||+|+||.||++... +..||||++..........+.+|+.+++.++||||+++++++. ...+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 4457999999999999999999974 6889999987654444567899999999999999999999873 2578
Q ss_pred EEEEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
+||||+++|+|.+++... ....++++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999988643 234679999999999999999999999 8999999999999999999999999999876
Q ss_pred cccccccCCCc-cccccCCCCCCcccCChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHHhhh
Q 003121 677 LSQNEISSNNT-TLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTGRPALGITKE----VQYALDTG 748 (846)
Q Consensus 677 ~~~~~~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~---~~~ksDVwSlGviL~elltG~~pf~~~~~----~~~~~~~~ 748 (846)
........... .........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ....+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~- 262 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN- 262 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-
Confidence 54221110000 000001224799999999987554 78999999999999999999999943211 1111111
Q ss_pred hhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 749 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
. .....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 263 ---~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~L~~~~~ 306 (317)
T 2buj_A 263 ---Q----LSIPQSPRHSSALWQLLNSMMTVDPHQRPHI-PLLLSQLEALQP 306 (317)
T ss_dssp ---C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHTCC
T ss_pred ---c----CCCCccccCCHHHHHHHHHHhhcChhhCCCH-HHHHHHhhhcCC
Confidence 1 1111123345789999999999999999999 888888887643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=373.45 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=198.8
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|+.++||||++++++|. +..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 457899999999999999999986 678999998653 2233456889999999999999999999984 568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||++||+|.+++.... ...+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999986443 3459999999999999999999999 8999999999999999999999999999987643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHhhhhhccccCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPL 757 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~--~~~~~~~~~~~~ld~~ 757 (846)
... .....||+.|+|||++.+..|+.++|||||||++|||++|++||...... ...+.. .+...
T Consensus 339 ~~~---------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~-----~i~~~ 404 (576)
T 2acx_A 339 GQT---------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-----LVKEV 404 (576)
T ss_dssp TCC---------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-----HHHHC
T ss_pred Ccc---------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-----Hhhcc
Confidence 321 12346999999999999989999999999999999999999999764320 011111 01111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCC
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
...++...+..+.+|+.+||..+|.+||+
T Consensus 405 ~~~~p~~~s~~~~dLI~~lL~~dP~~R~g 433 (576)
T 2acx_A 405 PEEYSERFSPQARSLCSQLLCKDPAERLG 433 (576)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred cccCCccCCHHHHHHHHHhccCCHHHcCC
Confidence 22345556788999999999999999994
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.67 Aligned_cols=246 Identities=26% Similarity=0.416 Sum_probs=197.7
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccc----cCceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC----PEVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~----~~~~~l 598 (846)
.++|...+.||+|+||.||++... +..||+|.+...... ..+.+.+|+.++++++||||++++++| ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357889999999999999999986 678999999765432 235688999999999999999999977 346899
Q ss_pred EEEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-----eEecccCCCceEecCCCceeeeccc
Q 003121 599 VYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-----IVHGDLKPANILLDANFVSKLSDFG 672 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g-----iiHrDLkp~NILl~~~~~vKL~DFG 672 (846)
||||+++|+|.+++... .....+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998643 234569999999999999999999999 66 9999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHhhhhh
Q 003121 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKL 750 (846)
Q Consensus 673 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~--~~~~~~~ 750 (846)
+++......... ....||+.|+|||++.+..++.++||||||+++|+|+||++||........ .+..+.
T Consensus 162 ~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~- 232 (279)
T 2w5a_A 162 LARILNHDTSFA--------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK- 232 (279)
T ss_dssp HHHHC---CHHH--------HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-
T ss_pred hheeeccccccc--------cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-
Confidence 998764321100 112489999999999988999999999999999999999999977654321 111211
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 751 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 751 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
....+...+..+.+|+.+||..+|.+||++ .+++
T Consensus 233 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~ll 266 (279)
T 2w5a_A 233 -------FRRIPYRYSDELNEIITRMLNLKDYHRPSV-EEIL 266 (279)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHH
T ss_pred -------cccCCcccCHHHHHHHHHHcCCCcccCCCH-HHHH
Confidence 112334456889999999999999999999 5553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=345.68 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=195.9
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccccC--------
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-------- 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-------- 594 (846)
.++|...++||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||++++++|..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 357999999999999999999985 678999998765332 24568899999999999999999998732
Q ss_pred --ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccc
Q 003121 595 --VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 672 (846)
Q Consensus 595 --~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFG 672 (846)
..++||||+.+ +|.+.+... ...+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 47899999975 777766432 3469999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc
Q 003121 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 751 (846)
Q Consensus 673 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~ 751 (846)
+++.+......... ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||................
T Consensus 170 ~a~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 245 (351)
T 3mi9_A 170 LARAFSLAKNSQPN----RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245 (351)
T ss_dssp TCEECCCCSSSSCC----CCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred hccccccccccccc----ccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99876533221111 1234568999999999976 458999999999999999999999998765433222211111
Q ss_pred cccCCCCCCCChh---------------------------hHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 752 NLLDPLAGDWPFV---------------------------QAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 752 ~~ld~~~~~~p~~---------------------------~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+ ..|+.. .+..+.+|+.+||..||.+||++ +++
T Consensus 246 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~ 309 (351)
T 3mi9_A 246 GSITP--EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS-DDA 309 (351)
T ss_dssp CCCCT--TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred CCCCh--hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH-HHH
Confidence 11111 111110 13568999999999999999999 444
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=348.22 Aligned_cols=240 Identities=28% Similarity=0.392 Sum_probs=193.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
..|...+.||+|+||.||+|... +..||||++....... ...+.+|+.+|++++||||++++++| .+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 35888899999999999999864 6889999997654332 24688999999999999999999988 45688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+. |+|.+++... ..++++..+..++.+++.||.|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 6787777432 3568999999999999999999999 89999999999999999999999999999865432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
....||+.|+|||++. .+.++.++|||||||++|+|+||++||.............. .. .+
T Consensus 208 ------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~-~~--~~- 271 (348)
T 1u5q_A 208 ------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NE--SP- 271 (348)
T ss_dssp ------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SC--CC-
T ss_pred ------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-cC--CC-
Confidence 2245999999999985 56789999999999999999999999976554332221111 01 11
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+...+..+.+|+.+||+.+|.+||++ +++
T Consensus 272 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~~l 303 (348)
T 1u5q_A 272 -ALQSGHWSEYFRNFVDSCLQKIPQDRPTS-EVL 303 (348)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred -CCCCCCCCHHHHHHHHHHcccChhhCcCH-HHH
Confidence 11122345789999999999999999999 444
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=345.81 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=188.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
++|...++||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||+++++++ ....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999986 678999999754322 223466899999999999999999998 4568999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
++ |+|.+++... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 5888888543 3468999999999999999999999 8999999999999999999999999999986543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
. .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||............... ...+....|
T Consensus 156 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~ 225 (324)
T 3mtl_A 156 T--------YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI--LGTPTEETW 225 (324)
T ss_dssp ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH--HCCCCTTTS
T ss_pred c--------cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH--hCCCChHhc
Confidence 1 123458999999999976 56899999999999999999999999776543322111110 001111111
Q ss_pred C-------------------------hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 P-------------------------FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p-------------------------~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+ ...+..+.+|+.+||+.||.+||++ +++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~ 279 (324)
T 3mtl_A 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA-EDA 279 (324)
T ss_dssp TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH-HHH
Confidence 1 1234678999999999999999999 444
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=360.59 Aligned_cols=244 Identities=25% Similarity=0.409 Sum_probs=187.5
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--------CCchhHHHHHHHHHhcCCCceeeEecccc-Cc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--------QGPSEFQQEIDILSKIRHPNLVTLVGACP-EV 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~ 595 (846)
.++|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+|++++||||+++++++. +.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 213 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence 347889999999999999999886 47899999875421 12235889999999999999999999984 46
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC---Cceeeeccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFG 672 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~---~~vKL~DFG 672 (846)
.++||||+++|+|.+++. ....+++..+..++.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||
T Consensus 214 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred eEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecc
Confidence 889999999999999884 33569999999999999999999999 899999999999999754 459999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHh
Q 003121 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALD 746 (846)
Q Consensus 673 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~~~ksDVwSlGviL~elltG~~pf~~~~~---~~~~~~ 746 (846)
+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||..... ....+.
T Consensus 288 ~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~ 358 (419)
T 3i6u_A 288 HSKILGETSL---------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358 (419)
T ss_dssp TTTSCC--------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH
T ss_pred cceecCCCcc---------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh
Confidence 9987654321 123459999999999863 5688999999999999999999999965432 122222
Q ss_pred hhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 747 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 747 ~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+... . .+......+..+.+|+.+||..+|.+||++ +++
T Consensus 359 ~~~~~----~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-~e~ 397 (419)
T 3i6u_A 359 SGKYN----F-IPEVWAEVSEKALDLVKKLLVVDPKARFTT-EEA 397 (419)
T ss_dssp TTCCC----C-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred cCCCC----C-CchhhcccCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 21110 0 000011235789999999999999999999 444
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=346.20 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=188.3
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
..++|...++||+|+||.||+|... +..||||++....... ...+.+|+.+|++++||||+++++++ ....++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4457999999999999999999875 6789999997653322 34678999999999999999999998 4568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe-----cCCCceeeeccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL-----DANFVSKLSDFGIS 674 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl-----~~~~~vKL~DFGla 674 (846)
|||+. |+|.+++... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99997 5999988533 458999999999999999999999 899999999999999 45566999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.................
T Consensus 185 ~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~- 255 (329)
T 3gbz_A 185 RAFGIPIRQ--------FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG- 255 (329)
T ss_dssp HHHC-------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-
T ss_pred cccCCcccc--------cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC-
Confidence 876432211 1234589999999999875 589999999999999999999999977655433222111110
Q ss_pred cCCCCCCCC-------------------------hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 LDPLAGDWP-------------------------FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 ld~~~~~~p-------------------------~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+....|+ ...+..+.+|+.+||..||.+||++ +++
T Consensus 256 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~ 316 (329)
T 3gbz_A 256 -LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA-KNA 316 (329)
T ss_dssp -CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred -CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH-HHH
Confidence 01001110 1135789999999999999999999 444
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.53 Aligned_cols=245 Identities=26% Similarity=0.383 Sum_probs=196.8
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
..+|...+.||+|+||.||+|... +..||||.+.... ....+.+|+.+|+.++||||+++++++ ....++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 457899999999999999999987 6789999997643 356799999999999999999999988 4568999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+++|+|.+++... ...+++..++.++.+|+.||.|||. +||+||||||+|||++.++.+||+|||++........
T Consensus 106 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 106 CGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999998532 3568999999999999999999999 8999999999999999999999999999987644321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. .....||+.|+|||++.+..++.++||||||+++|+|++|++||............... . +.....+
T Consensus 181 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~-~~~~~~~ 248 (314)
T 3com_A 181 K--------RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN---P-PPTFRKP 248 (314)
T ss_dssp C--------BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---C-CCCCSSG
T ss_pred c--------cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC---C-CcccCCc
Confidence 1 12346899999999999889999999999999999999999999766544322211110 0 1111123
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+..+.+|+.+||..+|.+||++ .++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~-~~l 276 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATA-TQL 276 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCH-HHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 3446789999999999999999999 444
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=334.41 Aligned_cols=239 Identities=21% Similarity=0.298 Sum_probs=194.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|...+.||+|+||.||+|... +..||||++....... ...+.+|+.++..+ +||||+++++++ .+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46889999999999999999986 6889999998653332 35688999999999 999999999998 45789999
Q ss_pred EecCCCchhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC----------------
Q 003121 601 EYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---------------- 663 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~---------------- 663 (846)
||+++|+|.+++.... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999996432 22568999999999999999999999 899999999999999844
Q ss_pred ---CceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 003121 664 ---FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITK 739 (846)
Q Consensus 664 ---~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~ 739 (846)
+.+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred CCceEEEEcccccccccCCcc------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 479999999998764321 22489999999999876 56789999999999999999998886554
Q ss_pred HHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 740 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 740 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.... +..+ .....+...+..+.+|+.+||..+|.+||++ .++
T Consensus 236 ~~~~-~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~l 277 (289)
T 1x8b_A 236 QWHE-IRQG--------RLPRIPQVLSQEFTELLKVMIHPDPERRPSA-MAL 277 (289)
T ss_dssp HHHH-HHTT--------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred HHHH-HHcC--------CCCCCCcccCHHHHHHHHHHhCCCcccCCCH-HHH
Confidence 4332 1121 1123344456889999999999999999999 444
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.89 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=189.6
Q ss_pred CCCccc-ceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEEEE
Q 003121 528 HNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~-~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lVmE 601 (846)
+.|.+. +.||+|+||.||+|... +..||||++..........+.+|+.+|.++ +||||+++++++ .+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 357664 67999999999999875 678999999876555567899999999995 799999999998 457899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc---eeeeccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGISRFLS 678 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~---vKL~DFGla~~~~ 678 (846)
|+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999543 468999999999999999999999 89999999999999988765 9999999998654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchH-------------
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKE------------- 740 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~~~ksDVwSlGviL~elltG~~pf~~~~~------------- 740 (846)
........ .........||+.|+|||++.+ ..++.++|||||||++|+|+||++||.....
T Consensus 166 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 166 LNGDCSPI-STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred cCCccccc-cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211100 0011123469999999999975 4588999999999999999999999965421
Q ss_pred ----HHHHHhhhhhccccCCCCCCCCh----hhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 741 ----VQYALDTGKLKNLLDPLAGDWPF----VQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 741 ----~~~~~~~~~~~~~ld~~~~~~p~----~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+..+. ..+|. ..+..+.+|+.+||..||.+||++ .++
T Consensus 245 ~~~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-~e~ 293 (316)
T 2ac3_A 245 CQNMLFESIQEGK---------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA-AQV 293 (316)
T ss_dssp HHHHHHHHHHHCC---------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred HHHHHHHHHhccC---------cccCchhcccCCHHHHHHHHHHhhCChhhCCCH-HHH
Confidence 111111111 11221 235789999999999999999999 444
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=335.69 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=195.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcCCCceeeEecccc--CceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~ 597 (846)
++|.+.+.||+|+||.||++... +..||+|++...... ..+.+.+|+.+|++++||||++++++|. ...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 36888999999999999999986 678999998765332 2467999999999999999999999984 4688
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC----ceeeecccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGI 673 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~----~vKL~DFGl 673 (846)
+||||+++++|.+++.. ...+++..+..++.+|+.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999853 2468999999999999999999999 8999999999999998877 899999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
+......... ....||+.|+|||++.+..++.++||||||+++|+|++|.+||.................
T Consensus 159 ~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~- 228 (283)
T 3bhy_A 159 AHKIEAGNEF---------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY- 228 (283)
T ss_dssp CEECC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-
T ss_pred ceeccCCCcc---------cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc-
Confidence 9876432211 234589999999999989999999999999999999999999976654332211111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 790 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 790 (846)
......+...+..+.+|+.+||..+|.+||++.+.
T Consensus 229 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 263 (283)
T 3bhy_A 229 --DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263 (283)
T ss_dssp --CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred --CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 00001112335789999999999999999999443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=336.23 Aligned_cols=240 Identities=24% Similarity=0.400 Sum_probs=199.2
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|.+.+.||+|+||.||+|... +..||||++.... ......+.+|+.+++.++||||+++++++. ...++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999986 5789999986532 223457899999999999999999999984 4688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+++|+|.+++... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999998543 358999999999999999999999 89999999999999999999999999998755432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
. .....||+.|+|||++.+..++.++||||||+++|+|++|++||.............. ....
T Consensus 168 ~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------~~~~ 230 (284)
T 2vgo_A 168 R----------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-------VDLK 230 (284)
T ss_dssp C----------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------TCCC
T ss_pred c----------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc-------cccC
Confidence 1 1234589999999999998999999999999999999999999976654332111110 1123
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+|...+..+.+|+.+||..+|.+||++ +++
T Consensus 231 ~~~~~~~~~~~li~~~l~~~p~~Rps~-~~l 260 (284)
T 2vgo_A 231 FPPFLSDGSKDLISKLLRYHPPQRLPL-KGV 260 (284)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred CCCcCCHHHHHHHHHHhhcCHhhCCCH-HHH
Confidence 444566889999999999999999999 554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.33 Aligned_cols=246 Identities=21% Similarity=0.283 Sum_probs=190.1
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccccC-------
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE------- 594 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~------- 594 (846)
...+|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3568999999999999999999975 678999998654322 13467899999999999999999998832
Q ss_pred -ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 595 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 595 -~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 359999999 8899999853 458999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh--
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-- 750 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~-- 750 (846)
++...... +...||+.|+|||++.+ ..++.++|||||||++|+|++|++||...............
T Consensus 175 a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 175 ARQADSEM-----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp CEECCSSC-----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccccc-----------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 98754321 23468999999999987 67999999999999999999999999776543322111000
Q ss_pred -------------------cc---ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 -------------------KN---LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 -------------------~~---~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.. ........+....+..+.+|+.+||..||.+||++ +++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~-~e~ 305 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-GEA 305 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCH-HHH
Confidence 00 00000111222346789999999999999999999 444
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=359.69 Aligned_cols=205 Identities=24% Similarity=0.328 Sum_probs=156.5
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc-------Cc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-------EV 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-------~~ 595 (846)
.++|.+.+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||++++++|. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 358999999999999999999876 578999998754322 2356889999999999999999999882 35
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.|+||||+ +|+|.+++.. ...+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccch
Confidence 79999998 5799998853 3569999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCC-------------------ccccccCCCCCCcccCChhhh-ccCCCCchhhHHHHHHHHHHHHh-----
Q 003121 676 FLSQNEISSNN-------------------TTLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLT----- 730 (846)
Q Consensus 676 ~~~~~~~~~~~-------------------~~~~~~~~~~Gt~~Y~APE~l-~~~~~~~ksDVwSlGviL~ellt----- 730 (846)
........... ......+...||+.|+|||++ ....|+.++|||||||+||||+|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 76533211000 000112445789999999986 45679999999999999999999
Q ss_pred ------CCCCCCCc
Q 003121 731 ------GRPALGIT 738 (846)
Q Consensus 731 ------G~~pf~~~ 738 (846)
|+++|.+.
T Consensus 285 ~~~~~~~~p~f~g~ 298 (458)
T 3rp9_A 285 VAYHADRGPLFPGS 298 (458)
T ss_dssp CSSGGGCCCSCC--
T ss_pred ccccccccccCCCC
Confidence 77777543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=344.34 Aligned_cols=268 Identities=20% Similarity=0.331 Sum_probs=202.1
Q ss_pred hhhhhhhcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc--Cc
Q 003121 520 FSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EV 595 (846)
Q Consensus 520 ~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~ 595 (846)
..+.....++|...+.||+|+||.||+|.+.+ .||+|++..... .....+.+|+.++++++||||+++++++. +.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 34445556789999999999999999999876 499999876432 23456889999999999999999999983 46
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 89999999999999999532 3468999999999999999999999 8999999999999998 6799999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHh
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS---------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 746 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---------~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~ 746 (846)
............ ......||+.|+|||++.. ..++.++|||||||++|+|+||+.||...........
T Consensus 178 ~~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 178 ISGVLQAGRRED---KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp ----------CC---SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred cccccccccccc---ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 654321111111 1123458999999999864 3578999999999999999999999976554332211
Q ss_pred hhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCC
Q 003121 747 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 803 (846)
Q Consensus 747 ~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~ 803 (846)
... . ..+.. .+...+..+.+|+.+||..+|.+||++ .++++.|+.+.....
T Consensus 255 ~~~--~-~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 255 MGT--G-MKPNL--SQIGMGKEISDILLFCWAFEQEERPTF-TKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHT--T-CCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCH-HHHHHHHTTC-----
T ss_pred hcc--C-CCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCH-HHHHHHHHHHHHhhc
Confidence 111 0 11111 111234679999999999999999999 889899988876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.45 Aligned_cols=242 Identities=25% Similarity=0.356 Sum_probs=195.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~ 603 (846)
++|.+.+.||+|+||.||++... +..||||++..........+.+|+.+|++++||||+++++++. ...++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 46888999999999999999986 6889999998765545567999999999999999999999884 4688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe---cCCCceeeeccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl---~~~~~vKL~DFGla~~~~~~ 680 (846)
++|+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||++......
T Consensus 89 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 89 SGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 999999988543 458999999999999999999999 899999999999999 78899999999998764332
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHhhhhhccccCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLA 758 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~--~~~~~~~~~~ld~~~ 758 (846)
. . ....||+.|+|||++.+..++.++||||||+++|+|++|++||........ .+..+. . ...
T Consensus 163 ~----~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~----~-~~~ 227 (304)
T 2jam_A 163 I----M------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY----Y-EFE 227 (304)
T ss_dssp T----T------HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC----C-CCC
T ss_pred c----c------ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC----C-CCC
Confidence 1 0 112489999999999998999999999999999999999999976544321 111111 1 111
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+...+..+.+|+.+||..+|.+||++ .++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~~ 259 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTC-EKA 259 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCH-HHH
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCH-HHH
Confidence 12223456789999999999999999999 444
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=351.48 Aligned_cols=245 Identities=25% Similarity=0.393 Sum_probs=190.6
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCC--CchhHHHHHHHHHhcC--CCceeeEeccc--cCceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR--HPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~--HpnIv~l~g~~--~~~~~lV 599 (846)
..+|.+.+.||+|+||.||++... +..||||++...... ....+.+|+.+|.+++ ||||+++++++ .+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 346999999999999999999876 578999999765432 2356899999999996 59999999987 4568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|| +.+++|.+++... ..+++..+..|+.||+.||.|||+ ++|+||||||+||||+ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 5688999999643 368899999999999999999999 8999999999999996 57999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 748 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----------~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~ 748 (846)
..... ......||+.|+|||++.+ ..++.++|||||||+||+|++|++||.........+
T Consensus 207 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~--- 277 (390)
T 2zmd_A 207 DTTSV------VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL--- 277 (390)
T ss_dssp -------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH---
T ss_pred CCccc------cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH---
Confidence 32111 1134569999999999865 368999999999999999999999997543221111
Q ss_pred hhccccCC-CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 749 KLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 749 ~~~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..++++ ....+|...+..+.+|+.+||..+|.+||++ .++
T Consensus 278 --~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-~el 318 (390)
T 2zmd_A 278 --HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-PEL 318 (390)
T ss_dssp --HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred --HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCH-HHH
Confidence 111111 1223344446789999999999999999999 444
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=358.48 Aligned_cols=240 Identities=12% Similarity=0.119 Sum_probs=184.4
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHH---HHHHhcCCCceeeEeccc----
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEI---DILSKIRHPNLVTLVGAC---- 592 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei---~iL~~l~HpnIv~l~g~~---- 592 (846)
...++|...+.||+|+||.||+|.+. +..||||++..... ...+.|.+|+ .+|++++|||||++++.|
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 34567999999999999999999864 78999999985432 2346788999 455556899999998443
Q ss_pred ---cC-------------------ceEEEEEecCCCchhhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 003121 593 ---PE-------------------VWTLVYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKPH 646 (846)
Q Consensus 593 ---~~-------------------~~~lVmEy~~ggsL~~~L~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 646 (846)
.+ ..++||||+ +|+|.+++..... ...+++..++.|+.||+.||.|||+ +
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~ 225 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---Y 225 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---C
Confidence 21 278999999 6899999964311 1234468888999999999999999 8
Q ss_pred ceEecccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC-----------CCCch
Q 003121 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----------ELTPK 715 (846)
Q Consensus 647 giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----------~~~~k 715 (846)
+|+||||||+||||+.++.+||+|||+++...... ....| +.|+|||++.+. .++.+
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV-----------VSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTCEE-----------ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCCcc-----------cCCCC-cCccChhhhcccccccccccccccCChh
Confidence 99999999999999999999999999998543211 23457 999999999887 89999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 716 SDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 716 sDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
+|||||||++|+|+||++||....... ...... ... ...+..+.+|+.+||..+|.+||++ .+++
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~------~~~~~~-~~~----~~~~~~~~~li~~~L~~dp~~Rpt~-~e~l 358 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALG------GSEWIF-RSC----KNIPQPVRALLEGFLRYPKEDRLLP-LQAM 358 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------C------CSGGGG-SSC----CCCCHHHHHHHHHHTCSSGGGCCCH-HHHH
T ss_pred hhHHHHHHHHHHHHHCCCCCccccccc------chhhhh-hhc----cCCCHHHHHHHHHHcCCCchhCCCH-HHHh
Confidence 999999999999999999996443211 111111 111 2335789999999999999999999 4443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=352.17 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=185.9
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcC-CCceeeEecccc--C--ceE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR-HPNLVTLVGACP--E--VWT 597 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~--~--~~~ 597 (846)
.++|.+.+.||+|+||.||+|... +..||||++...... ....+.+|+.+|..+. ||||++++++|. + ..|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 457999999999999999999876 678999998654222 2345789999999997 999999999983 2 579
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+. |+|..++.. ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++.+
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999997 689988853 368999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCC-------------ccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 003121 678 SQNEISSNN-------------TTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 743 (846)
Q Consensus 678 ~~~~~~~~~-------------~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~ 743 (846)
......... ......+...||+.|+|||++.+ ..|+.++|||||||++|||++|++||........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 432111000 00111244579999999999986 6799999999999999999999999977654332
Q ss_pred HHhhhhhcccc----------------------------CCCCCCC------------ChhhHHHHHHHHHHHhccCcCC
Q 003121 744 ALDTGKLKNLL----------------------------DPLAGDW------------PFVQAEQLANLAMRCCEMSRKS 783 (846)
Q Consensus 744 ~~~~~~~~~~l----------------------------d~~~~~~------------p~~~~~~l~~Li~~Cl~~~P~~ 783 (846)
........... ......+ +...+..+.+|+.+||..||.+
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 21110000000 0000000 0123567999999999999999
Q ss_pred CCChHHHH
Q 003121 784 RPELGKDV 791 (846)
Q Consensus 784 RPt~~~~v 791 (846)
|||+ +++
T Consensus 320 R~t~-~e~ 326 (388)
T 3oz6_A 320 RISA-NDA 326 (388)
T ss_dssp SCCH-HHH
T ss_pred CCCH-HHH
Confidence 9999 444
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.58 Aligned_cols=243 Identities=21% Similarity=0.287 Sum_probs=200.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccc--CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 599 (846)
.++|...+.||+|+||.||++... +..||+|++....... .+.+.+|+.+++.++||||+++++++. +..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457899999999999999999987 5789999987653322 356889999999999999999999984 458899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988533 468999999999999999999999 8999999999999999999999999999987643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.... .....||+.|+|||++.+..++.++||||||+++|+|+||+.||............... ..
T Consensus 168 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------~~ 232 (294)
T 2rku_A 168 DGER--------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------EY 232 (294)
T ss_dssp TTCC--------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------CC
T ss_pred Cccc--------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------cC
Confidence 2211 12345899999999999888999999999999999999999999776543322111110 11
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..|...+..+.+|+.+||+.+|.+||++ +++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~l 263 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTI-NEL 263 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCG-GGG
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCH-HHH
Confidence 2334456789999999999999999999 444
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=353.68 Aligned_cols=240 Identities=27% Similarity=0.366 Sum_probs=192.4
Q ss_pred CCCcccceeeeeCceEEEEEEE-----CCeEEEEEEecCCC----CCCchhHHHHHHHHHhc-CCCceeeEeccc--cCc
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHS----LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEV 595 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~VAIK~l~~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~ 595 (846)
.+|.+.+.||+|+||.||++.. .+..||||+++... ......+.+|+.+|..+ +||||+++++++ ...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999987 46889999987542 22345678899999999 699999999988 456
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 88999999999999999543 458999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHhhhhhc
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLK 751 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~~~ksDVwSlGviL~elltG~~pf~~~~~~--~~~~~~~~~~ 751 (846)
.+....... .....||+.|+|||++.++ .++.++|||||||+||+|+||+.||...... ...+.....
T Consensus 208 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~- 279 (355)
T 1vzo_A 208 EFVADETER-------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL- 279 (355)
T ss_dssp ECCGGGGGG-------GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-
T ss_pred ecccCCCCc-------ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh-
Confidence 764332111 1223599999999999863 4789999999999999999999999643211 111111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhccCcCCCC
Q 003121 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 752 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
. ....++...+..+.+|+.+||..+|.+||
T Consensus 280 ~----~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 309 (355)
T 1vzo_A 280 K----SEPPYPQEMSALAKDLIQRLLMKDPKKRL 309 (355)
T ss_dssp H----CCCCCCTTSCHHHHHHHHHHTCSSGGGST
T ss_pred c----cCCCCCcccCHHHHHHHHHHhhhCHHHhc
Confidence 1 12234455668899999999999999999
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=339.21 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=196.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC---C--eEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccc-CceE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR---H--MQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWT 597 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~---~--~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~ 597 (846)
.++|.+.+.||+|+||.||+|.+. + ..||||+++..... ..+.+.+|+.++++++||||+++++++. +..+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 357999999999999999999863 2 25999998765332 2356889999999999999999999984 4588
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+++|+|.+++... ...+++..+..++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 999999999999998643 2458999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |++||.............. ..
T Consensus 172 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~---- 241 (291)
T 1u46_A 172 PQNDDHY-----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-EG---- 241 (291)
T ss_dssp CC-CCEE-----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-SC----
T ss_pred cccccch-----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc-cC----
Confidence 5432111 11123457889999999998889999999999999999999 9999976654332211111 01
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.....+...+..+.+|+.+||..+|.+||++ .++++.|+.+..
T Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF-VALRDFLLEAQP 284 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHC-
T ss_pred CCCCCCcCcCHHHHHHHHHHccCCcccCcCH-HHHHHHHHHhCc
Confidence 1112233456889999999999999999999 788888877643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.43 Aligned_cols=241 Identities=23% Similarity=0.387 Sum_probs=191.9
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc------CceEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP------EVWTL 598 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~------~~~~l 598 (846)
.|.+...||+|+||.||+|... +..||+|.+...... ....+.+|+.+|+.++||||++++++|. ...++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4777888999999999999886 467999998754332 2356889999999999999999999873 24789
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecccCCCceEec-CCCceeeecccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLD-ANFVSKLSDFGISR 675 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g--iiHrDLkp~NILl~-~~~~vKL~DFGla~ 675 (846)
||||+++|+|.+++... ..+++..++.++.+|+.||.|||+ ++ |+||||||+|||++ .++.+||+|||++.
T Consensus 107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999543 458999999999999999999999 67 99999999999998 78999999999997
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
....... ....||+.|+|||++. +.++.++|||||||++|+|+||+.||................ ..
T Consensus 181 ~~~~~~~----------~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~ 247 (290)
T 1t4h_A 181 LKRASFA----------KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VK 247 (290)
T ss_dssp GCCTTSB----------EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CC
T ss_pred ccccccc----------ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc--CC
Confidence 5433211 1235899999999886 569999999999999999999999997644433222211110 01
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...++...+..+.+|+.+||..+|.+||++ .++
T Consensus 248 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~el 280 (290)
T 1t4h_A 248 --PASFDKVAIPEVKEIIEGCIRQNKDERYSI-KDL 280 (290)
T ss_dssp --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred --ccccCCCCCHHHHHHHHHHccCChhhCCCH-HHH
Confidence 111222334689999999999999999999 444
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=345.25 Aligned_cols=255 Identities=21% Similarity=0.256 Sum_probs=191.5
Q ss_pred hhhhhhcCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCC-----------chhHHHHHHHHHhcCCCceeeE
Q 003121 521 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG-----------PSEFQQEIDILSKIRHPNLVTL 588 (846)
Q Consensus 521 ~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~-----------~~~f~~Ei~iL~~l~HpnIv~l 588 (846)
.++....++|.+.+.||+|+||.||+|... +..||||++....... ...+.+|+.+|++++||||+++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 445566778999999999999999999875 6789999987643322 1568999999999999999999
Q ss_pred eccc-----c--CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec
Q 003121 589 VGAC-----P--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 661 (846)
Q Consensus 589 ~g~~-----~--~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~ 661 (846)
+++| . ...++||||+. |+|.+.+.. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLA 168 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEC
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEc
Confidence 9987 2 24789999997 688887753 34579999999999999999999999 8999999999999999
Q ss_pred CCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchH
Q 003121 662 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKE 740 (846)
Q Consensus 662 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~ 740 (846)
.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||.....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADAN---------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp TTCCEEECCTTC------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCCCEEEEecCcccccccccc---------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999975443221 123458999999999977 6799999999999999999999999976554
Q ss_pred HHHHHhhhh-----------------hccccCCCCCC--------CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 741 VQYALDTGK-----------------LKNLLDPLAGD--------WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 741 ~~~~~~~~~-----------------~~~~ld~~~~~--------~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
......... ....+...... .+...+..+.+|+.+||..+|.+||++ .++
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~el 314 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST-EQA 314 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH-HHH
Confidence 322111100 00000000000 112235679999999999999999999 444
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=337.80 Aligned_cols=243 Identities=20% Similarity=0.338 Sum_probs=192.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccc----CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP----EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~----~~~~lV 599 (846)
.++|.+.++||+|+||.||+|... +..||||++... ....+.+|+.+|++++ ||||+++++++. ...++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 457999999999999999999874 678999998743 3568999999999997 999999999884 347899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC-ceeeeccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLS 678 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~-~vKL~DFGla~~~~ 678 (846)
|||+.+++|.+++. .+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999883 38899999999999999999999 8999999999999999776 89999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHh------hhhh
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALD------TGKL 750 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~-~~~~~------~~~~ 750 (846)
..... ....||+.|+|||++.+ ..++.++|||||||++|+|+||+.||...... ..... ...+
T Consensus 183 ~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~ 253 (330)
T 3nsz_A 183 PGQEY---------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253 (330)
T ss_dssp TTCCC---------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred CCCcc---------ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence 43211 23458999999999987 67899999999999999999999999432211 11000 0000
Q ss_pred ccc-------c-----------------CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 KNL-------L-----------------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 ~~~-------l-----------------d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
... + .......+...+..+.+|+.+||..+|.+||++ +++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-~e~ 317 (330)
T 3nsz_A 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-REA 317 (330)
T ss_dssp HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH-HHH
T ss_pred hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH-HHH
Confidence 000 0 001111122346889999999999999999999 444
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=339.27 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=198.2
Q ss_pred hhhcCCCccc-ceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhc-CCCceeeEecccc--Cc
Q 003121 524 EGATHNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKI-RHPNLVTLVGACP--EV 595 (846)
Q Consensus 524 ~~~~~~f~~~-~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~ 595 (846)
+.-.+.|.+. +.||+|+||.||+|... +..||||++...... ....+.+|+.++..+ +||||++++++|. ..
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3334456666 78999999999999887 688999998764322 246789999999999 5699999999984 46
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC---CCceeeeccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFG 672 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~---~~~vKL~DFG 672 (846)
.++||||+++|+|.+++... ....+++..++.++.||+.||.|||. +||+||||||+||||+. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 88999999999999998533 23569999999999999999999999 89999999999999987 7899999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc
Q 003121 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 752 (846)
Q Consensus 673 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~ 752 (846)
+++........ ....||+.|+|||++.+..++.++|||||||++|+|+||++||................
T Consensus 180 ~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~- 249 (327)
T 3lm5_A 180 MSRKIGHACEL---------REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN- 249 (327)
T ss_dssp GCEEC------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-
T ss_pred cccccCCcccc---------ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc-
Confidence 99876533211 23459999999999999999999999999999999999999997765543322221111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...........+..+.+|+.+||..+|.+||++ +++
T Consensus 250 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~~l 285 (327)
T 3lm5_A 250 --VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA-EIC 285 (327)
T ss_dssp --CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred --cccCchhhcccCHHHHHHHHHHcCCChhhCcCH-HHH
Confidence 111122223456789999999999999999999 444
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=341.75 Aligned_cols=244 Identities=21% Similarity=0.287 Sum_probs=200.4
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccc--CceEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 598 (846)
...+|...+.||+|+||.||++... +..||+|++....... .+.+.+|+.+++.++||||++++++|. +..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3457999999999999999999986 4689999987653322 356889999999999999999999984 45889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+.+++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999988533 468999999999999999999999 899999999999999999999999999998764
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..... .....||+.|+|||++.+..++.++||||||+++|+|+||+.||............... .
T Consensus 193 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------~ 257 (335)
T 2owb_A 193 YDGER--------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------E 257 (335)
T ss_dssp STTCC--------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------C
T ss_pred cCccc--------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-------C
Confidence 32211 12345899999999999889999999999999999999999999766543322111110 1
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+...+..+.+|+.+||+.+|.+||++ .++
T Consensus 258 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~el 289 (335)
T 2owb_A 258 YSIPKHINPVAASLIQKMLQTDPTARPTI-NEL 289 (335)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCG-GGG
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 12233455789999999999999999999 444
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.58 Aligned_cols=243 Identities=27% Similarity=0.421 Sum_probs=191.5
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
.++|.+.+.||+|+||.||+|... +..||||++.... ......+.+|+.+++.++||||+++++++ .+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 457999999999999999999986 6889999986532 23345789999999999999999999998 4568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998543 458999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
.... ....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||............ ... .
T Consensus 164 ~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~----~ 227 (276)
T 2h6d_A 164 GEFL---------RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI---RGG----V 227 (276)
T ss_dssp ----------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHC----C
T ss_pred Ccce---------ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh---hcC----c
Confidence 3211 22358999999999987765 68999999999999999999999765432211111 111 1
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
...|...+..+.+|+.+||+.+|.+||++ .+++
T Consensus 228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~~l 260 (276)
T 2h6d_A 228 FYIPEYLNRSVATLLMHMLQVDPLKRATI-KDIR 260 (276)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHH
T ss_pred ccCchhcCHHHHHHHHHHccCChhhCCCH-HHHH
Confidence 12234456789999999999999999999 4443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=342.37 Aligned_cols=242 Identities=25% Similarity=0.407 Sum_probs=190.1
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--------CCchhHHHHHHHHHhcCCCceeeEecccc-Cce
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--------QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVW 596 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~ 596 (846)
++|.+.+.||+|+||.||+|... +..||||++..... .....+.+|+.+|++++||||+++++++. +..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 89 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence 46899999999999999999886 57899999875432 12245889999999999999999999984 458
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc---eeeecccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGI 673 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~---vKL~DFGl 673 (846)
++||||+++|+|.+++. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 99999999999999884 34569999999999999999999999 89999999999999987654 99999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHhh
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALDT 747 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~elltG~~pf~~~~~---~~~~~~~ 747 (846)
++........ ....||+.|+|||++. ...++.++|||||||++|+|++|++||..... ....+..
T Consensus 164 ~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (322)
T 2ycf_A 164 SKILGETSLM---------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234 (322)
T ss_dssp CEECCCCHHH---------HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH
T ss_pred ceeccccccc---------ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh
Confidence 9876432210 1124899999999974 45789999999999999999999999965432 1222222
Q ss_pred hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
+... ..+..+...+..+.+|+.+||..+|.+||++.+
T Consensus 235 ~~~~-----~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~ 271 (322)
T 2ycf_A 235 GKYN-----FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 271 (322)
T ss_dssp TCCC-----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred Cccc-----cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHH
Confidence 2111 000001123578999999999999999999943
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=344.28 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=191.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
++|...+.||+|+||.||+|... +..||||++....... ...+.+|+.++++++||||++++++|. ...++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 47899999999999999999987 6789999987654322 245779999999999999999999984 56899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+++++|.+++.. ...+++..+..++.+|+.||.|||+ +||+||||||+||||+.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999988642 3459999999999999999999999 899999999999999999999999999998664432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh-----------
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----------- 749 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~----------- 749 (846)
.. .....||+.|+|||++.+. .++.++|||||||++|+|+||++||..............
T Consensus 179 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 179 EV--------YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred cc--------cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence 11 1234589999999999875 789999999999999999999999977654332211100
Q ss_pred -------hccccCCC-CCCC-----ChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 750 -------LKNLLDPL-AGDW-----PFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 750 -------~~~~ld~~-~~~~-----p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
+.....+. .... ....+..+.+|+.+||..+|.+||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 302 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCA 302 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGG
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHH
Confidence 00000000 0000 112357899999999999999999993
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.14 Aligned_cols=248 Identities=23% Similarity=0.289 Sum_probs=180.9
Q ss_pred hcCCCcccceeeeeCceEEEEEEE--CCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
..++|...+.||+|+||.||+|.. .++.||||++....... ...+..+...++.++||||+++++++ ....++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 345799999999999999999998 46889999997643221 12244555567888999999999998 4568999
Q ss_pred EEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecccCCCceEecCCCceeeecccccccc
Q 003121 600 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
|||++ |+|.+++... .....+++..++.++.||+.||.|||+ + ||+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 5887776432 234679999999999999999999999 7 8999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFL----ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
...... ....||+.|+|||++ .+..++.++|||||||++|+|+||+.||.........+........
T Consensus 161 ~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (290)
T 3fme_A 161 VDDVAK---------DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC
T ss_pred cccccc---------cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC
Confidence 543211 223589999999996 4567899999999999999999999999753222211111111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+...+..+.+|+.+||..+|.+||++ .++
T Consensus 232 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~e~ 264 (290)
T 3fme_A 232 ----PQLPADKFSAEFVDFTSQCLKKNSKERPTY-PEL 264 (290)
T ss_dssp ----CCCCTTTSCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred ----CCcccccCCHHHHHHHHHHhhcChhhCcCH-HHH
Confidence 111122345789999999999999999999 444
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=374.69 Aligned_cols=240 Identities=20% Similarity=0.285 Sum_probs=200.1
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhc-CCCceeeEecccc--CceEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTL 598 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~l 598 (846)
..+|.+.+.||+|+||.||+|... +..||||++... .......+..|..+|..+ +||||+++++++. +.+||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 347899999999999999999986 467999999753 223456788999999988 7999999999984 46899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||++||+|.+++... ..+++..++.|+.||+.||.|||+ ++||||||||+||||+.+|++||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999643 459999999999999999999999 899999999999999999999999999998543
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..... .....||+.|+|||++.+..|+.++|||||||+||||+||++||...+........ .. ..
T Consensus 494 ~~~~~--------~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i--~~-----~~ 558 (674)
T 3pfq_A 494 WDGVT--------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--ME-----HN 558 (674)
T ss_dssp CTTCC--------BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HS-----SC
T ss_pred cCCcc--------cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH--Hh-----CC
Confidence 22111 13456999999999999999999999999999999999999999876543321111 11 12
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
..+|...+..+.+||.+||..+|.+||++
T Consensus 559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 23555677899999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=338.12 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=182.9
Q ss_pred hcCCCcccceeeeeCceEEEEEEE--CCeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
..++|.+.+.||+|+||.||+|.. .+..||||++..... .....+.+|+.++++++||||+++++++ .+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 356899999999999999999987 467899999875432 2346788999999999999999999988 45789999
Q ss_pred EecCCCchhhhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 601 EYLPNGSLEDRLSCK-----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~-----~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
||+++|+|.+++... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988531 124569999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh--hhhcc
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--GKLKN 752 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~--~~~~~ 752 (846)
........... .......||+.|+|||++.+ ..++.++||||||+++|+|+||++||............ .....
T Consensus 170 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 170 FLATGGDITRN---KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HCC------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred eeccCCCccch---hhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 76543211100 01123469999999999976 57899999999999999999999999765443222111 10000
Q ss_pred ccC-CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 LLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ~ld-~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
... ..........+..+.+|+.+||..+|.+||++ .++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~l 285 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA-AEL 285 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCH-HHH
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCH-HHH
Confidence 000 00111222345789999999999999999999 444
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=357.87 Aligned_cols=244 Identities=27% Similarity=0.440 Sum_probs=192.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
..|...++||+|+||.||+|... +..||||++.... ......+.+|+.+|+.++||||++++++|. ...++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 36999999999999999999986 5789999998653 233567899999999999999999999984 46889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC---CCceeeeccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLS 678 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~---~~~vKL~DFGla~~~~ 678 (846)
||++|+|.+.+... ..+++..+..|+.||+.||.|||+ +||+||||||+||||+. ++.+||+|||+++...
T Consensus 117 ~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999988543 458999999999999999999999 89999999999999976 4569999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
.... .....||+.|+|||++. +.|+.++|||||||++|+|++|++||.............. .......
T Consensus 191 ~~~~---------~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~ 258 (494)
T 3lij_A 191 NQKK---------MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK--GKYTFDS 258 (494)
T ss_dssp TTBC---------BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCS
T ss_pred CCcc---------ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCc
Confidence 4321 12346999999999986 5799999999999999999999999987655332211111 1111111
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+.| ...+..+.+|+.+||..+|.+||++ .++
T Consensus 259 ~~~-~~~s~~~~~li~~~L~~dp~~R~s~-~e~ 289 (494)
T 3lij_A 259 PEW-KNVSEGAKDLIKQMLQFDSQRRISA-QQA 289 (494)
T ss_dssp GGG-TTSCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred hhc-ccCCHHHHHHHHHHCCCChhhCccH-HHH
Confidence 112 2345789999999999999999999 444
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=358.68 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=197.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|...+.||+|+||.||++... +..||||++..... .....+.+|+.+|++++||||++++++|. ...++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46889999999999999999986 67899999976532 34567999999999999999999999984 4688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe---cCCCceeeecccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFL 677 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl---~~~~~vKL~DFGla~~~ 677 (846)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.+
T Consensus 106 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 106 EVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp CCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999998853 3569999999999999999999999 899999999999999 56789999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
...... ....||+.|+|||++.+ .|+.++|||||||++|+|++|++||.............. ......
T Consensus 180 ~~~~~~---------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~ 247 (484)
T 3nyv_A 180 EASKKM---------KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFE 247 (484)
T ss_dssp CCCCSH---------HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCC
T ss_pred cccccc---------ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCCCC
Confidence 443210 12359999999999865 799999999999999999999999987655432211111 111111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+.| ...+..+.+|+.+||..+|.+||++ .++
T Consensus 248 ~~~~-~~~s~~~~~li~~~L~~dp~~R~s~-~e~ 279 (484)
T 3nyv_A 248 LPQW-KKVSESAKDLIRKMLTYVPSMRISA-RDA 279 (484)
T ss_dssp SGGG-GGSCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred Cccc-ccCCHHHHHHHHHHCCCChhHCcCH-HHH
Confidence 1111 2346789999999999999999999 444
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=347.92 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=195.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
++|...+.||+|+||.||++... +..||+|++...... ....+.+|+.+|+.++||||++++++| ....++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 47889999999999999999987 678999999865321 235688999999999999999999988 4568999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
+++|+|.+++... ..+++..+..++.+++.||.|||+ + ||+||||||+||||+.++.+||+|||++.......
T Consensus 113 ~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999999543 358999999999999999999998 5 79999999999999999999999999987654321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh------------
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------ 749 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~------------ 749 (846)
. ....||+.|+|||++.+..++.++|||||||++|+|+||+.||..............
T Consensus 187 ~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3eqc_A 187 A----------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256 (360)
T ss_dssp --------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred c----------cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence 1 234589999999999999999999999999999999999999975443221110000
Q ss_pred ------------------------hccccCCCCCCC-ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 750 ------------------------LKNLLDPLAGDW-PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 750 ------------------------~~~~ld~~~~~~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
............ +...+..+.+|+.+||..+|.+||++ +++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~el 322 (360)
T 3eqc_A 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-KQL 322 (360)
T ss_dssp -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCH-HHH
T ss_pred cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCH-HHH
Confidence 000000001111 12245789999999999999999999 444
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=353.99 Aligned_cols=247 Identities=14% Similarity=0.113 Sum_probs=176.3
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhc--CCCceeeEecccc-----
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKI--RHPNLVTLVGACP----- 593 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l--~HpnIv~l~g~~~----- 593 (846)
...+|...+.||+|+||.||+|.+. +..||||++....... ...+.+|+.++..| +||||++++..+.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 3446889999999999999999975 6789999998765422 34577885555555 6999888653321
Q ss_pred ---------------------CceEEEEEecCCCchhhhhccCCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCC
Q 003121 594 ---------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR------IRIATELCSVLIFLHSCKPH 646 (846)
Q Consensus 594 ---------------------~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~------~~i~~qia~aL~~LH~~~~~ 646 (846)
...++||||++ |+|.+++.... ..+++..+ ..++.||+.||.|||+ +
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 33799999998 89999996532 23444555 7788999999999999 8
Q ss_pred ceEecccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHH
Q 003121 647 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGII 724 (846)
Q Consensus 647 giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~~~ksDVwSlGvi 724 (846)
+|+||||||+||||+.++.+||+|||+++....... ...||+.|+|||++.+ ..++.++|||||||+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----------ASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----------GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----------CccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 999999999999999999999999999986643211 1236799999999987 679999999999999
Q ss_pred HHHHHhCCCCCCCchHHHHH-Hhhhhhccc-cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHH
Q 003121 725 LLRLLTGRPALGITKEVQYA-LDTGKLKNL-LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 789 (846)
Q Consensus 725 L~elltG~~pf~~~~~~~~~-~~~~~~~~~-ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 789 (846)
||+|+||++||......... ......... ........+...+..+.+|+.+||+.+|.+||++.+
T Consensus 283 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 349 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHH
T ss_pred HHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 99999999999755321100 000000000 000111111245688999999999999999999943
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=354.09 Aligned_cols=246 Identities=26% Similarity=0.342 Sum_probs=189.2
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc------C--ceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------E--VWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~------~--~~~ 597 (846)
.+|...+.||+|+||.||+|.+. +..||||++.... ..+.+|+.+|+.++||||++++++|. + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36889999999999999999985 6889999986532 23457999999999999999998872 1 267
Q ss_pred EEEEecCCCchhhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC-Cceeeecccccc
Q 003121 598 LVYEYLPNGSLEDRLSC-KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISR 675 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~-~~vKL~DFGla~ 675 (846)
+||||+++ +|.+.+.. ......+++..+..++.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 56555532 1234679999999999999999999999 899999999999999955 678999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh----
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL---- 750 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~---- 750 (846)
.+...... ....||+.|+|||++.+. .|+.++|||||||+||||++|++||.............+.
T Consensus 206 ~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 206 QLVRGEPN---------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276 (420)
T ss_dssp ECCTTCCC---------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred hcccCCCc---------eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 76433211 234589999999999765 7999999999999999999999999776543322211110
Q ss_pred ------------ccccCCCCC--C----CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 ------------KNLLDPLAG--D----WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 ------------~~~ld~~~~--~----~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+... . ++...+..+.+|+.+||..+|.+||++ .++
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~-~e~ 334 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-LEA 334 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH-HHH
Confidence 000000000 0 122345789999999999999999999 444
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=343.59 Aligned_cols=246 Identities=20% Similarity=0.265 Sum_probs=186.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccccC--------
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-------- 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-------- 594 (846)
.++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||+++++++..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999875 678999999754322 23468899999999999999999998732
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
..++||||+. |+|.+.+. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 4689999997 47888773 348899999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh----
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL---- 750 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~---- 750 (846)
+....... .....||+.|+|||++.+..++.++|||||||++|+|+||++||...+...........
T Consensus 175 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 175 RTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245 (371)
T ss_dssp ------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred cccccccc---------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 86543211 12345899999999999999999999999999999999999999776543321111000
Q ss_pred -------------------------------ccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 -------------------------------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 -------------------------------~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+.....+...+..+.+|+.+||..||.+|||+ +++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-~e~ 316 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV-DEA 316 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH-HHH
Confidence 0000000000112236789999999999999999999 444
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=346.90 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=195.3
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc---------
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--------- 593 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------- 593 (846)
....+|...+.||+|+||.||+|... +..||||++.... ....+|+.+|+.++||||++++++|.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 44568999999999999999999875 6889999987542 23458999999999999999999871
Q ss_pred -------------------------------CceEEEEEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHh
Q 003121 594 -------------------------------EVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLH 641 (846)
Q Consensus 594 -------------------------------~~~~lVmEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH 641 (846)
...++||||++ |+|.+.+... .....+++..+..++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 12779999998 5777776432 23467999999999999999999999
Q ss_pred hcCCCceEecccCCCceEec-CCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHH
Q 003121 642 SCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVY 719 (846)
Q Consensus 642 ~~~~~giiHrDLkp~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVw 719 (846)
+ +||+||||||+|||++ .++.+||+|||+++.+...... ....||+.|+|||++.+. .++.++|||
T Consensus 159 ~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 159 S---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---------VAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp T---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---------CCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred H---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---------cCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9 8999999999999998 6899999999999876443211 234589999999998775 589999999
Q ss_pred HHHHHHHHHHhCCCCCCCchHHHHHHhhhhh----------------ccccCCC--CCC----CChhhHHHHHHHHHHHh
Q 003121 720 SFGIILLRLLTGRPALGITKEVQYALDTGKL----------------KNLLDPL--AGD----WPFVQAEQLANLAMRCC 777 (846)
Q Consensus 720 SlGviL~elltG~~pf~~~~~~~~~~~~~~~----------------~~~ld~~--~~~----~p~~~~~~l~~Li~~Cl 777 (846)
||||++|+|++|++||............... ....-+. ... ++...+..+.+|+.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 9999999999999999876544322211100 0000000 001 23334678999999999
Q ss_pred ccCcCCCCChHHHHH--HHHHHHHh
Q 003121 778 EMSRKSRPELGKDVW--RVLEPMRA 800 (846)
Q Consensus 778 ~~~P~~RPt~~~~v~--~~L~~l~~ 800 (846)
..+|.+||++ .+++ ..++.++.
T Consensus 307 ~~dP~~R~t~-~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 307 RYEPDLRINP-YEAMAHPFFDHLRN 330 (383)
T ss_dssp CSSGGGSCCH-HHHHTSGGGHHHHH
T ss_pred cCChhhCCCH-HHHhcCHHHHHHHh
Confidence 9999999999 4443 23344444
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=356.78 Aligned_cols=245 Identities=28% Similarity=0.445 Sum_probs=195.0
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-------------CCchhHHHHHHHHHhcCCCceeeEe
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-------------QGPSEFQQEIDILSKIRHPNLVTLV 589 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-------------~~~~~f~~Ei~iL~~l~HpnIv~l~ 589 (846)
....+|.+.++||+|+||+||+|... +..||||++..... ...+.+.+|+.+|++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34568999999999999999999986 47899999976532 2235688999999999999999999
Q ss_pred cccc--CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC---
Q 003121 590 GACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF--- 664 (846)
Q Consensus 590 g~~~--~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~--- 664 (846)
++|. ...++|||||++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCc
Confidence 9984 4688999999999999988543 459999999999999999999999 8999999999999998775
Q ss_pred ceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 003121 665 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA 744 (846)
Q Consensus 665 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~ 744 (846)
.+||+|||+++....... .....||+.|+|||++. +.++.++|||||||++|+|++|++||.........
T Consensus 187 ~~kl~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 256 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK---------LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256 (504)
T ss_dssp SEEECCCTTCEECCTTSC---------BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cEEEEECCCCEEcCCCCc---------cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 699999999987654321 12346999999999986 56999999999999999999999999876543322
Q ss_pred --HhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 745 --LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 745 --~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+..+.. ......| ...+..+.+|+.+||..+|.+||++ +++
T Consensus 257 ~~i~~~~~----~~~~~~~-~~~s~~~~~li~~~L~~dp~~R~t~-~e~ 299 (504)
T 3q5i_A 257 KKVEKGKY----YFDFNDW-KNISDEAKELIKLMLTYDYNKRCTA-EEA 299 (504)
T ss_dssp HHHHHCCC----CCCHHHH-TTSCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred HHHHcCCC----CCCcccc-CCCCHHHHHHHHHHcCCChhHCCCH-HHH
Confidence 111111 0000001 1235789999999999999999999 444
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=353.83 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=204.5
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceee-Eecc--ccCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT-LVGA--CPEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~-l~g~--~~~~~~lVmE 601 (846)
.++|.+.++||+|+||.||+|.+. +..||||++..... ...+.+|+.+++.|+|++++. +..+ ..+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 457999999999999999999975 68899999876543 346899999999998754443 3333 3567899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe---cCCCceeeeccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLS 678 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl---~~~~~vKL~DFGla~~~~ 678 (846)
|+ +++|.+++... ...+++..++.|+.||+.||.|||. ++||||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999533 3469999999999999999999999 899999999999999 688999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--H---HHHHhhhhhccc
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--V---QYALDTGKLKNL 753 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~--~---~~~~~~~~~~~~ 753 (846)
....... ..........||+.|+|||++.+..++.++|||||||+||+|++|+.||..... . ...+....+...
T Consensus 158 ~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQH-IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccc-cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 5432111 001112345799999999999999999999999999999999999999965322 1 111111112111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCC
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGG 804 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~ 804 (846)
+...... .+..+.+|+.+||..+|.+||++ .+|.+.|+.+....+.
T Consensus 237 ~~~l~~~----~p~~l~~li~~cl~~dP~~RPs~-~el~~~L~~l~~~~~~ 282 (483)
T 3sv0_A 237 IEALCRG----YPTEFASYFHYCRSLRFDDKPDY-SYLKRLFRDLFIREGF 282 (483)
T ss_dssp HHHHHTT----SCHHHHHHHHHHHTCCTTCCCCH-HHHHHHHHHHHHHTTC
T ss_pred HHHHhcC----CcHHHHHHHHHHhcCChhhCcCH-HHHHHHHHHHHHHcCC
Confidence 1111122 24789999999999999999999 8899999988665543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=348.20 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=190.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc------C--ceE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------E--VWT 597 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~------~--~~~ 597 (846)
..+|...+.||+|+||.||+|... +..||+|++..... ...+|+.+|+.++||||++++++|. + ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346999999999999999999986 45699998864322 2347999999999999999999872 1 267
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec-CCCceeeeccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRF 676 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~-~~~~vKL~DFGla~~ 676 (846)
+||||++++.+............+++..+..++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999876554443322334679999999999999999999999 8999999999999999 799999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh-----
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL----- 750 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~----- 750 (846)
....... ....||+.|+|||++.+. .|+.++|||||||++|+|++|++||...............
T Consensus 192 ~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 192 LIAGEPN---------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp CCTTCCC---------CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccCCCCC---------cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 6443211 234589999999998765 5999999999999999999999999876543322211110
Q ss_pred --------ccccC---CCCC------CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 --------KNLLD---PLAG------DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 --------~~~ld---~~~~------~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..... +... .++...+..+.+|+.+||..+|.+||++ .++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~ 319 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA-IEA 319 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH-HHH
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH-HHH
Confidence 00000 0000 1122345789999999999999999999 444
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=331.45 Aligned_cols=246 Identities=24% Similarity=0.322 Sum_probs=195.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC----CCCchhHHHHHHHHHhcCCCceeeEeccc--c--CceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS----LQGPSEFQQEIDILSKIRHPNLVTLVGAC--P--EVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~--~~~~ 597 (846)
++|.+.+.||+|+||.||++... +..||+|++.... ......+.+|+.++++++||||+++++++ . ...+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 57999999999999999999885 5789999997542 22346789999999999999999999987 2 3689
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+||||+.+| |.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 999999876 666664432 3569999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...............
T Consensus 160 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----- 228 (305)
T 2wtk_C 160 HPFAADD------TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG----- 228 (305)
T ss_dssp CTTCSSC------EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----
T ss_pred Ccccccc------ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-----
Confidence 4322111 112345999999999997654 378999999999999999999999866543321111110
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
...++...+..+.+|+.+||..+|.+||++ .+++
T Consensus 229 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll 262 (305)
T 2wtk_C 229 --SYAIPGDCGPPLSDLLKGMLEYEPAKRFSI-RQIR 262 (305)
T ss_dssp --CCCCCSSSCHHHHHHHHHHTCSSTTTSCCH-HHHH
T ss_pred --CCCCCCccCHHHHHHHHHHccCChhhCCCH-HHHh
Confidence 112334456789999999999999999999 5543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=357.21 Aligned_cols=242 Identities=29% Similarity=0.452 Sum_probs=196.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC--CCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
++|.+.++||+|+||.||+|... +..||||++... .......+.+|+.+|++++||||+++++++. ...++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 46999999999999999999986 678999998653 2234567999999999999999999999984 46889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec---CCCceeeeccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLS 678 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~---~~~~vKL~DFGla~~~~ 678 (846)
||.+|+|.+.+... ..+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 102 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 102 LYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999988543 458999999999999999999999 8999999999999995 45689999999998664
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HhhhhhccccCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDP 756 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~--~~~~~~~~~ld~ 756 (846)
.... .....||+.|+|||++.+ .|+.++|||||||++|+|++|++||......... +..+.. ..
T Consensus 176 ~~~~---------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----~~ 241 (486)
T 3mwu_A 176 QNTK---------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY----AF 241 (486)
T ss_dssp CC-------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----CS
T ss_pred CCCc---------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----CC
Confidence 3321 123469999999999865 6999999999999999999999999776543322 122111 11
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+.| ...+..+.+|+.+||..+|.+||++ .++
T Consensus 242 ~~~~~-~~~s~~~~~li~~~L~~dp~~R~t~-~~~ 274 (486)
T 3mwu_A 242 DLPQW-RTISDDAKDLIRKMLTFHPSLRITA-TQC 274 (486)
T ss_dssp CSGGG-GGSCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred CCccc-CCCCHHHHHHHHHHcCCChhhCcCH-HHH
Confidence 11111 2346789999999999999999999 444
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=340.57 Aligned_cols=255 Identities=22% Similarity=0.268 Sum_probs=185.3
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccccC------
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE------ 594 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~------ 594 (846)
.....++|.+.+.||+|+||.||+|... +..||||++.... .....+.+++..+..++||||++++++|..
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 4455678999999999999999999986 6789999986543 334567888999999999999999998721
Q ss_pred ---ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCceEecccCCCceEecC-CCceee
Q 003121 595 ---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH--SCKPHSIVHGDLKPANILLDA-NFVSKL 668 (846)
Q Consensus 595 ---~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH--~~~~~giiHrDLkp~NILl~~-~~~vKL 668 (846)
..++||||++++.+..+.........+++..+..++.+++.||.||| + +||+||||||+||||+. ++.+||
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEE
Confidence 27899999987543333222244567899999999999999999999 6 89999999999999996 899999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 747 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~ 747 (846)
+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|+|+||++||............
T Consensus 174 ~Dfg~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPN---------VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp CCCTTCBCCCTTSCC---------CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eeCCCceecCCCCCc---------ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 999999876543211 234589999999998765 4899999999999999999999999776543322111
Q ss_pred hhhc--------cccCC-----------------CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 748 GKLK--------NLLDP-----------------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 748 ~~~~--------~~ld~-----------------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.... ..+.+ .....+...+..+.+|+.+||+.+|.+||++ .++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~ 312 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP-YEA 312 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH-HHH
Confidence 1000 00000 0111222356789999999999999999999 444
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=370.31 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=207.1
Q ss_pred hhhhhcCCCcccceeeeeCceEEEEEEEC-----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc-C
Q 003121 522 EIEGATHNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-E 594 (846)
Q Consensus 522 ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~ 594 (846)
+......+|.+.+.||+|+||.||+|.+. +..||||.+...... ..+.|.+|+.+|++++||||++++|++. +
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 463 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 33444567999999999999999999875 246999998754322 2356899999999999999999999984 4
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCC
Confidence 688999999999999999643 3468999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
+......... .....||+.|+|||++.+..++.++|||||||++|||++ |.+||..............
T Consensus 539 ~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~---- 607 (656)
T 2j0j_A 539 RYMEDSTYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---- 607 (656)
T ss_dssp CSCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH----
T ss_pred eecCCCccee-------ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc----
Confidence 8765432111 123457889999999999999999999999999999997 9999976544332111110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
......|...+..+.+|+.+||..+|.+||++ .++++.|+.+..
T Consensus 608 --~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~-~el~~~L~~il~ 651 (656)
T 2j0j_A 608 --GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRF-TELKAQLSTILE 651 (656)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred --CCCCCCCccccHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHH
Confidence 11122344556889999999999999999999 888888887653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=340.57 Aligned_cols=246 Identities=28% Similarity=0.431 Sum_probs=196.1
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--------chhHHHHHHHHHhc-CCCceeeEeccc--c
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--------PSEFQQEIDILSKI-RHPNLVTLVGAC--P 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--------~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~ 593 (846)
..+|.+...||+|+||.||+|.+. +..||||++....... ...+.+|+.+++++ +||||++++++| .
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 456889999999999999999986 6899999998654221 23578999999999 799999999998 4
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
...++||||++||+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 5689999999999999998533 468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 747 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~ 747 (846)
+..+..... .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||............
T Consensus 247 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 247 SCHLEPGEK---------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp CEECCTTCC---------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccccCCCcc---------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 987654321 123469999999999864 35889999999999999999999999765543221111
Q ss_pred hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. ........+.| ...+..+.+|+.+||..+|.+||++ .++
T Consensus 318 ~--~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rps~-~el 357 (365)
T 2y7j_A 318 M--EGQYQFSSPEW-DDRSSTVKDLISRLLQVDPEARLTA-EQA 357 (365)
T ss_dssp H--HTCCCCCHHHH-SSSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred H--hCCCCCCCccc-ccCCHHHHHHHHHHcCCChhHCcCH-HHH
Confidence 0 00011000001 1234679999999999999999999 444
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=343.79 Aligned_cols=254 Identities=23% Similarity=0.279 Sum_probs=195.8
Q ss_pred hhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc-------
Q 003121 524 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP------- 593 (846)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~------- 593 (846)
.....+|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|++++||||+++++++.
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 344568999999999999999999876 578999999754322 1256889999999999999999999873
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
...++||||+. |+|.+++.. ..+++..+..|+.||+.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 24789999997 589998843 358999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh---
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK--- 749 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~--- 749 (846)
++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||..............
T Consensus 175 a~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 249 (364)
T 3qyz_A 175 ARVADPDHDHTG-----FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249 (364)
T ss_dssp CEECCGGGCBCC-----TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred eEecCCCCCccc-----cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence 987654322111 1134569999999998765 4589999999999999999999999976543221111000
Q ss_pred -----------------h-ccccCCCCCC---CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 750 -----------------L-KNLLDPLAGD---WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 750 -----------------~-~~~ld~~~~~---~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. .......... .....+..+.+|+.+||..+|.+||++ .++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e~ 311 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-EQA 311 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH-HHH
Confidence 0 0000000000 012235679999999999999999999 444
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=350.59 Aligned_cols=201 Identities=25% Similarity=0.313 Sum_probs=161.4
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc-------Cc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-------EV 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-------~~ 595 (846)
.++|.+.+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||+++++++. ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 458999999999999999999886 578999999754322 2356889999999999999999999883 34
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 699999853 3569999999999999999999999 899999999999999999999999999999
Q ss_pred ccccccccCCC--------------ccccccCCCCCCcccCChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003121 676 FLSQNEISSNN--------------TTLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPA 734 (846)
Q Consensus 676 ~~~~~~~~~~~--------------~~~~~~~~~~Gt~~Y~APE~l-~~~~~~~ksDVwSlGviL~elltG~~p 734 (846)
........... ......+...||+.|+|||++ ....|+.++|||||||++|||++|..|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 76543211000 000112456799999999986 456799999999999999999984333
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=335.73 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=188.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc-----------
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----------- 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----------- 593 (846)
.++|...+.||+|+||.||+|... +..||||++..........+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357999999999999999999987 6889999987654444567889999999999999999998762
Q ss_pred -----CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec-CCCcee
Q 003121 594 -----EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSK 667 (846)
Q Consensus 594 -----~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~-~~~~vK 667 (846)
...++||||+. |+|.+++. ..++++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEE
Confidence 35789999997 69999884 3468999999999999999999999 8999999999999997 577999
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHh
Q 003121 668 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 746 (846)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~ 746 (846)
|+|||+++........... .....||+.|+|||.+.+ ..++.++|||||||++|+|+||++||...........
T Consensus 162 l~Dfg~~~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 236 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGH-----LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236 (320)
T ss_dssp ECCCTTCBCC--------C-----CCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EccCccccccCCCcccccc-----cccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999876432211111 122347999999998876 6789999999999999999999999977654332111
Q ss_pred hhhh---------cc------------ccCCCC--CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 747 TGKL---------KN------------LLDPLA--GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 747 ~~~~---------~~------------~ld~~~--~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.... .. ...+.. ...+...+..+.+|+.+||..+|.+||++ +++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~el 303 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA-EEA 303 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH-HHH
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH-HHH
Confidence 0000 00 000000 00112345789999999999999999999 444
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.33 Aligned_cols=251 Identities=27% Similarity=0.366 Sum_probs=197.6
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC---CeEEEEEEecCCCC--CCchhHHHHHHHHHhc---CCCceeeEecccc----
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL--QGPSEFQQEIDILSKI---RHPNLVTLVGACP---- 593 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~---~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~---- 593 (846)
..++|.+.+.||+|+||.||+|... +..||||++..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4568999999999999999999873 57899999875432 2345688899988877 8999999999874
Q ss_pred ---CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeec
Q 003121 594 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 670 (846)
Q Consensus 594 ---~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~D 670 (846)
...++||||+. |+|.+++.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEec
Confidence 35789999997 69999886443 3458999999999999999999999 8999999999999999999999999
Q ss_pred cccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh
Q 003121 671 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 750 (846)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~ 750 (846)
||+++....... .....||+.|+|||++.+..++.++|||||||++|+|+||++||...............
T Consensus 164 fg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 164 FGLARIYSFQMA---------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp CCSCCCCCGGGG---------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CcccccccCCCC---------ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 999987643221 13346899999999999999999999999999999999999999776543321111000
Q ss_pred c------cc--------------cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 K------NL--------------LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 ~------~~--------------ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. .+ .......+....+..+.+|+.+||..+|.+||++ .++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~ 294 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-YSA 294 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH-HHH
Confidence 0 00 0000111223456789999999999999999999 444
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.62 Aligned_cols=246 Identities=27% Similarity=0.369 Sum_probs=196.9
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC---------chhHHHHHHHHHhcC-CCceeeEecccc-
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---------PSEFQQEIDILSKIR-HPNLVTLVGACP- 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~---------~~~f~~Ei~iL~~l~-HpnIv~l~g~~~- 593 (846)
.++|...+.||+|+||.||+|... +..||||++....... .+.+.+|+.+|+++. ||||+++++++.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 457999999999999999999985 5789999997654211 245789999999995 999999999984
Q ss_pred -CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccc
Q 003121 594 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 672 (846)
Q Consensus 594 -~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFG 672 (846)
...++||||+++|+|.+++... ..+++..+..++.+|+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence 4688999999999999999543 468999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHh
Q 003121 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 746 (846)
Q Consensus 673 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~ 746 (846)
++........ .....||+.|+|||++. ...++.++||||||+++|+|++|++||...........
T Consensus 170 ~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 240 (298)
T 1phk_A 170 FSCQLDPGEK---------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240 (298)
T ss_dssp TCEECCTTCC---------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred chhhcCCCcc---------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence 9987653321 12345899999999985 45688999999999999999999999976554332111
Q ss_pred hhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 747 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 747 ~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.. ......... .....+..+.+|+.+||..+|.+||++ .++
T Consensus 241 ~~--~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l 281 (298)
T 1phk_A 241 IM--SGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTA-EEA 281 (298)
T ss_dssp HH--HTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCH-HHH
T ss_pred Hh--cCCcccCcc-cccccCHHHHHHHHHHccCCcccCCCH-HHH
Confidence 11 111111111 112346789999999999999999999 444
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=345.69 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=177.7
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--------
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-------- 593 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-------- 593 (846)
..++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||+++++++.
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3568999999999999999999875 678999998754321 2356789999999999999999999873
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
...++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 3478999999 7899998842 469999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh--
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-- 750 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~-- 750 (846)
++...... +...||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+...........
T Consensus 179 a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 179 ARHTADEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp -----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccccccC-----------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 98654321 23458999999999987 67999999999999999999999999776543322111000
Q ss_pred ---------------ccccC--CCCCCCC-----hhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 751 ---------------KNLLD--PLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 751 ---------------~~~ld--~~~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
...+. +.....+ ...+..+.+|+.+||..||.+||++.
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~ 307 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHH
Confidence 00000 0000111 12346789999999999999999993
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.70 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=192.4
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC--------CCceeeEecccc---
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR--------HPNLVTLVGACP--- 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~--------HpnIv~l~g~~~--- 593 (846)
.++|.+.++||+|+||.||+|... +..||||++.... ...+.+.+|+.+|+.++ ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 468999999999999999999875 5789999997432 22456889999999995 788999999873
Q ss_pred ---CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecccCCCceEecCCC-----
Q 003121 594 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANF----- 664 (846)
Q Consensus 594 ---~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-giiHrDLkp~NILl~~~~----- 664 (846)
...++||||+ +++|.+.+... ....+++..++.|+.||+.||.|||+ + ||+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence 3588999999 55665555433 23569999999999999999999999 7 999999999999999775
Q ss_pred --------------------------------------------ceeeeccccccccccccccCCCccccccCCCCCCcc
Q 003121 665 --------------------------------------------VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700 (846)
Q Consensus 665 --------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~ 700 (846)
.+||+|||+++...... ....||+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----------~~~~gt~~ 258 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----------TEDIQTRQ 258 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----------CSCCSCGG
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----------ccCCCCCc
Confidence 79999999998764321 23458999
Q ss_pred cCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH------HHHH---Hh-----------hhhhc-cccC----
Q 003121 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYA---LD-----------TGKLK-NLLD---- 755 (846)
Q Consensus 701 Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~------~~~~---~~-----------~~~~~-~~ld---- 755 (846)
|+|||++.+..++.++|||||||+||+|+||++||..... .... .. .+... ....
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 9999999999999999999999999999999999964321 1100 00 00000 0000
Q ss_pred --C--------------CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 756 --P--------------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 756 --~--------------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. ....++...+..+.+|+.+||+.+|.+||++ .++
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~e~ 389 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA-AEC 389 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH-HHH
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH-HHH
Confidence 0 0113456677889999999999999999999 444
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=338.21 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=198.6
Q ss_pred hcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCc-----------------hhHHHHHHHHHhcCCCceeeE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP-----------------SEFQQEIDILSKIRHPNLVTL 588 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~-----------------~~f~~Ei~iL~~l~HpnIv~l 588 (846)
..++|.+.+.||+|+||.||+|...+..||||++........ ..+.+|+.+|++++||||+++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 346899999999999999999999889999999875422211 679999999999999999999
Q ss_pred eccc--cCceEEEEEecCCCchhhh------hccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe
Q 003121 589 VGAC--PEVWTLVYEYLPNGSLEDR------LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 660 (846)
Q Consensus 589 ~g~~--~~~~~lVmEy~~ggsL~~~------L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl 660 (846)
++++ .+..++||||+++|+|.++ +.. .....+++..++.++.||+.||.|||+. +||+||||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEE
Confidence 9998 4568999999999999998 532 1246799999999999999999999972 589999999999999
Q ss_pred cCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCc
Q 003121 661 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTP-KSDVYSFGIILLRLLTGRPALGIT 738 (846)
Q Consensus 661 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~-ksDVwSlGviL~elltG~~pf~~~ 738 (846)
+.++.+||+|||++....... .....||+.|+|||++.+. .++. ++|||||||++|+|+||++||...
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDKK----------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp CTTSCEEECCCTTCEECBTTE----------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCcEEEecccccccccccc----------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999998764331 1234589999999999877 6666 999999999999999999999765
Q ss_pred hHHHH---HHhhhhhccccC------CC----CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 739 KEVQY---ALDTGKLKNLLD------PL----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 739 ~~~~~---~~~~~~~~~~ld------~~----~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..... .+..+....... +. ....+...+..+.+|+.+||..+|.+||++ .++
T Consensus 256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-~e~ 320 (348)
T 2pml_X 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS-EDA 320 (348)
T ss_dssp SCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH-HHH
T ss_pred CcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH-HHH
Confidence 43111 111111100000 00 000013456789999999999999999999 444
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.23 Aligned_cols=247 Identities=22% Similarity=0.309 Sum_probs=194.1
Q ss_pred cCCCcccceeeeeCceEEEEEEE---CCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc------eeeEeccc--cCc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLL---RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN------LVTLVGAC--PEV 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~---~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn------Iv~l~g~~--~~~ 595 (846)
.++|.+.+.||+|+||.||+|.. .+..||||++.... ...+.+.+|+.+++.++|+| |+++++++ .+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35899999999999999999987 36789999987432 22356889999999987654 99999988 456
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-------------
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA------------- 662 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~------------- 662 (846)
.++||||+ +++|.+++.... ..++++..+..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 89999999 889999886443 3468999999999999999999999 89999999999999987
Q ss_pred ------CCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003121 663 ------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 736 (846)
Q Consensus 663 ------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~ 736 (846)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|+||++||.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCCCceEeeCcccccCcccc-----------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 6789999999998643321 23458999999999999899999999999999999999999997
Q ss_pred CchHHHHHHhhhhhccc--------------c---------------------CC--CCCCCChhhHHHHHHHHHHHhcc
Q 003121 737 ITKEVQYALDTGKLKNL--------------L---------------------DP--LAGDWPFVQAEQLANLAMRCCEM 779 (846)
Q Consensus 737 ~~~~~~~~~~~~~~~~~--------------l---------------------d~--~~~~~p~~~~~~l~~Li~~Cl~~ 779 (846)
................. . .+ .....+...+..+.+|+.+||..
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 65443221111000000 0 00 00111234567899999999999
Q ss_pred CcCCCCChHHHH
Q 003121 780 SRKSRPELGKDV 791 (846)
Q Consensus 780 ~P~~RPt~~~~v 791 (846)
||.+||++ .++
T Consensus 316 dP~~Rpt~-~el 326 (339)
T 1z57_A 316 DPAKRITL-REA 326 (339)
T ss_dssp STTTSCCH-HHH
T ss_pred CcccccCH-HHH
Confidence 99999999 444
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=345.06 Aligned_cols=198 Identities=25% Similarity=0.402 Sum_probs=150.7
Q ss_pred Ccc-cceeeeeCceEEEEEEEC----CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc----cCceEEEE
Q 003121 530 FDP-SLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC----PEVWTLVY 600 (846)
Q Consensus 530 f~~-~~~LG~G~fG~Vy~g~~~----~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~----~~~~~lVm 600 (846)
|.. .++||+|+||.||+|.+. +..||||++.... ....+.+|+.+|++++||||++++++| ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 457999999999999975 4679999997543 245789999999999999999999988 34689999
Q ss_pred EecCCCchhhhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe----cCCCceeeec
Q 003121 601 EYLPNGSLEDRLSCK------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSD 670 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl----~~~~~vKL~D 670 (846)
||+. |+|.+++... .....+++..++.|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 5777776421 123359999999999999999999999 899999999999999 6789999999
Q ss_pred cccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 003121 671 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGIT 738 (846)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~ 738 (846)
||+++.+....... .......||+.|+|||++.+. .++.++|||||||+||+|+||++||...
T Consensus 176 fg~a~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 176 MGFARLFNSPLKPL-----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TTCCC---------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCCceecCCCCccc-----ccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99998765432111 111335699999999999874 5899999999999999999999999644
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=334.84 Aligned_cols=256 Identities=22% Similarity=0.293 Sum_probs=193.7
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc-------Cce
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-------EVW 596 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-------~~~ 596 (846)
.++|.+.+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||+++++++. ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999987 688999999653221 1345789999999999999999999873 357
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
++||||+. |+|.+++.. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 89999997 689988853 358999999999999999999999 8999999999999999999999999999987
Q ss_pred cccccccCCC--ccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc-
Q 003121 677 LSQNEISSNN--TTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN- 752 (846)
Q Consensus 677 ~~~~~~~~~~--~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~- 752 (846)
.......... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.................
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 6543221110 00011233568999999998765 6789999999999999999999999977654322211100000
Q ss_pred -----------------ccC--CCCC-----CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 -----------------LLD--PLAG-----DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 -----------------~ld--~~~~-----~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+. +... ......+..+.+|+.+||..||.+||++ .++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~el 303 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA-KEA 303 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH-HHH
Confidence 000 0000 0012345789999999999999999999 444
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=334.04 Aligned_cols=244 Identities=22% Similarity=0.304 Sum_probs=191.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccccC--------
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE-------- 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-------- 594 (846)
..+|.....||+|+||.||+|... +..||||++....... ...+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 457999999999999999999876 6889999997643221 3468899999999999999999998843
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
.+++||||+. |+|.+++. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 2489999997 68888772 348999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh---
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL--- 750 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~--- 750 (846)
+...... ....||+.|+|||++.+ ..++.++|||||||++|+|+||++||...............
T Consensus 174 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 242 (353)
T 3coi_A 174 RHADAEM-----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242 (353)
T ss_dssp TC-------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCB
T ss_pred cCCCCCc-----------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 8653321 23458999999999987 67899999999999999999999999765543221111000
Q ss_pred ------------------cccc---CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 ------------------KNLL---DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 ------------------~~~l---d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.... .......+...+..+.+|+.+||..+|.+||++ .++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-~e~ 303 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA-AQA 303 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH-HHH
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH-HHH
Confidence 0000 011112223456789999999999999999999 444
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=339.42 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=190.7
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccccC--c----
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE--V---- 595 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~---- 595 (846)
..++|...+.||+|+||.||+|... +..||||++....... ...+.+|+.+|+.++||||++++++|.. .
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3568999999999999999999876 6889999997643322 3568899999999999999999999843 2
Q ss_pred --eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 596 --WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 596 --~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
+++||||+. |+|.+.+. ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 389999997 68888772 348999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh--
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-- 750 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~-- 750 (846)
++...... ....||+.|+|||++.+ ..++.++|||||||++|+|+||++||...............
T Consensus 191 a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 191 ARHADAEM-----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp C-------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccCc-----------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 98654321 23458999999999987 67999999999999999999999999776543322111100
Q ss_pred -------------------ccccCCCCCC---CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 -------------------KNLLDPLAGD---WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 -------------------~~~ld~~~~~---~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.......... .+...+..+.+|+.+||+.+|.+||++ .++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~el 321 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA-AQA 321 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH-HHH
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH-HHH
Confidence 0000000000 112235789999999999999999999 444
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=328.71 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=188.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc-------------
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC------------- 592 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~------------- 592 (846)
++|...+.||+|+||.||+|... +..||||++.... .....+.+|+.++++++||||++++++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 46888999999999999999975 6889999986422 2235688999999999999999999876
Q ss_pred --cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeec
Q 003121 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 670 (846)
Q Consensus 593 --~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~D 670 (846)
....++||||+++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 23578999999999999999643 3457889999999999999999999 8999999999999999999999999
Q ss_pred cccccccccccccCC------CccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 003121 671 FGISRFLSQNEISSN------NTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 743 (846)
Q Consensus 671 FGla~~~~~~~~~~~------~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~ 743 (846)
||++........... ...........||+.|+|||++.+. .++.++|||||||++|+|++ ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 999987643211000 0000111345689999999999764 68999999999999999998 5543222211
Q ss_pred HHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 744 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 744 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.... +..........++...+..+.+|+.+||..+|.+||++ .++
T Consensus 237 ~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~l 281 (303)
T 1zy4_A 237 ILKK--LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA-RTL 281 (303)
T ss_dssp HHHH--HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred HHHh--ccccccccCccccccchHHHHHHHHHHHhcCcccCcCH-HHH
Confidence 1111 11111122334555566789999999999999999999 444
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=347.74 Aligned_cols=199 Identities=27% Similarity=0.357 Sum_probs=168.7
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc------CCCceeeEeccc--cCc
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI------RHPNLVTLVGAC--PEV 595 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l------~HpnIv~l~g~~--~~~ 595 (846)
...+|.+.++||+|+||.||+|... +..||||++.... .....+.+|+.++..+ +||||++++++| ...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3457999999999999999999886 5789999997532 1234677899999887 577999999988 457
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc--eeeecccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--SKLSDFGI 673 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~--vKL~DFGl 673 (846)
.++||||+. ++|.+++.... ...+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 899999996 68988886443 3459999999999999999999999 89999999999999999887 99999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV 741 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~ 741 (846)
++...... ....||+.|+|||++.+..++.++|||||||+||+|+||++||......
T Consensus 249 a~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 249 SCYEHQRV-----------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp CEETTCCC-----------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ceecCCcc-----------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 97643321 2345899999999999999999999999999999999999999766543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.08 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=194.4
Q ss_pred CCCChhhhhhhcCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCC--CchhHHHHHHHHHhcC--CCceeeEec
Q 003121 516 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR--HPNLVTLVG 590 (846)
Q Consensus 516 ~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~--HpnIv~l~g 590 (846)
.++.+..+.....+|.+.+.||+|+||.||++... +..||||++...... ....+.+|+.+|.+++ ||||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 45556666667778999999999999999999876 577999999765432 2356889999999997 599999999
Q ss_pred cc--cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceee
Q 003121 591 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 668 (846)
Q Consensus 591 ~~--~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL 668 (846)
++ ....++||| +.+++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. +.+||
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEE
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEE
Confidence 88 456889999 5688999999643 468999999999999999999999 89999999999999964 89999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRPALGI 737 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----------~~~~~ksDVwSlGviL~elltG~~pf~~ 737 (846)
+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||..
T Consensus 168 ~Dfg~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 168 IDFGIANQMQPDTTSV------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp CCCSSSCC--------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eeccccccccCccccc------cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 9999998765432111 1123458999999999875 4688899999999999999999999965
Q ss_pred chHHHHHHhhhhhccccCC-CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 738 TKEVQYALDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 738 ~~~~~~~~~~~~~~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.......+. ..+++ ....++...+..+.+|+.+||..+|.+||++ .++
T Consensus 242 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~el 290 (313)
T 3cek_A 242 IINQISKLH-----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-PEL 290 (313)
T ss_dssp CCSHHHHHH-----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred HHHHHHHHH-----HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCH-HHH
Confidence 432211111 11111 1123344446789999999999999999999 444
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.03 Aligned_cols=237 Identities=27% Similarity=0.445 Sum_probs=190.8
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhc----CCCceeeEeccc
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKI----RHPNLVTLVGAC 592 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~------~~~~f~~Ei~iL~~l----~HpnIv~l~g~~ 592 (846)
...++|.+.+.||+|+||.||+|... +..||||++...... ....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34568999999999999999999874 678999999765432 233567899999999 899999999998
Q ss_pred c--CceEEEEEe-cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec-CCCceee
Q 003121 593 P--EVWTLVYEY-LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKL 668 (846)
Q Consensus 593 ~--~~~~lVmEy-~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~-~~~~vKL 668 (846)
. +..++|||| +.+++|.+++... .++++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 4 568899999 7899999999643 458999999999999999999999 8999999999999999 8899999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003121 669 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 747 (846)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~-~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~ 747 (846)
+|||++........ ....||+.|+|||++.+..+. .++||||||+++|+|++|+.||........
T Consensus 182 ~dfg~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---- 247 (312)
T 2iwi_A 182 IDFGSGALLHDEPY----------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE---- 247 (312)
T ss_dssp CCCSSCEECCSSCB----------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----
T ss_pred EEcchhhhcccCcc----------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh----
Confidence 99999987654321 234589999999999877764 589999999999999999999975543211
Q ss_pred hhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 748 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. ...++...+..+.+|+.+||..+|.+||++ .++
T Consensus 248 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~e~ 281 (312)
T 2iwi_A 248 A---------ELHFPAHVSPDCCALIRRCLAPKPSSRPSL-EEI 281 (312)
T ss_dssp T---------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred h---------ccCCcccCCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 1 112334456789999999999999999999 444
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=339.71 Aligned_cols=247 Identities=17% Similarity=0.297 Sum_probs=192.2
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-----------CCceeeEecccc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----------HPNLVTLVGACP 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-----------HpnIv~l~g~~~ 593 (846)
..+|.+.+.||+|+||.||+|... +..||||++.... .....+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 357999999999999999999974 6889999987432 22456889999999986 899999999874
Q ss_pred C------ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecccCCCceEec-----
Q 003121 594 E------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLD----- 661 (846)
Q Consensus 594 ~------~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-giiHrDLkp~NILl~----- 661 (846)
. ..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+ + ||+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 2 578999999 899999986443 3458999999999999999999999 7 999999999999994
Q ss_pred -CCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH
Q 003121 662 -ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 740 (846)
Q Consensus 662 -~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~ 740 (846)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|+||++||.....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred cCcceEEEcccccccccCCCC-----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 44589999999998764321 234589999999999999999999999999999999999999975431
Q ss_pred HH---------HHHh-----------hhhhc-ccc------C--------------CCCCCCChhhHHHHHHHHHHHhcc
Q 003121 741 VQ---------YALD-----------TGKLK-NLL------D--------------PLAGDWPFVQAEQLANLAMRCCEM 779 (846)
Q Consensus 741 ~~---------~~~~-----------~~~~~-~~l------d--------------~~~~~~p~~~~~~l~~Li~~Cl~~ 779 (846)
.. .... .+... ..+ . .....++...+..+.+|+.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence 10 0000 00000 000 0 001234566788999999999999
Q ss_pred CcCCCCChHHHH
Q 003121 780 SRKSRPELGKDV 791 (846)
Q Consensus 780 ~P~~RPt~~~~v 791 (846)
||.+||++ .++
T Consensus 321 dP~~Rpt~-~el 331 (373)
T 1q8y_A 321 DPRKRADA-GGL 331 (373)
T ss_dssp STTTCBCH-HHH
T ss_pred CccccCCH-HHH
Confidence 99999999 444
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=321.63 Aligned_cols=243 Identities=29% Similarity=0.452 Sum_probs=194.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
++|.+.+.||+|+||.||+|... +..||||++.... ......+.+|+.++++++||||+++++++. ...++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 46899999999999999999985 6789999987543 234567899999999999999999999984 46889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC---Cceeeeccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLS 678 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~---~~vKL~DFGla~~~~ 678 (846)
|+++++|.+.+... ..+++..++.++.+|+.||.|||. +||+||||||+|||++.+ +.+||+|||++....
T Consensus 102 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 102 LYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999988543 358999999999999999999999 899999999999999754 479999999998664
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HhhhhhccccCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDP 756 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~--~~~~~~~~~ld~ 756 (846)
..... ....||+.|+|||++.+ .++.++||||||+++|+|++|++||......... +..+... .
T Consensus 176 ~~~~~---------~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~ 241 (287)
T 2wei_A 176 QNTKM---------KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA----F 241 (287)
T ss_dssp CCSSC---------SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----C
T ss_pred CCCcc---------ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----C
Confidence 33211 12237999999999865 5899999999999999999999999766543321 1121111 0
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
..+.+ ...+..+.+|+.+||..+|.+||++ .+++
T Consensus 242 ~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~-~ell 275 (287)
T 2wei_A 242 DLPQW-RTISDDAKDLIRKMLTFHPSLRITA-TQCL 275 (287)
T ss_dssp CSGGG-TTSCHHHHHHHHHHTCSSGGGSCCH-HHHH
T ss_pred Cchhh-hhcCHHHHHHHHHHcccChhhCcCH-HHHh
Confidence 00111 2345789999999999999999999 5543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=331.75 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=173.5
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHH-HHHhcCCCceeeEeccc--cCceEEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~-iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
..++|...+.||+|+||.||+|... +..||||++...... ....+..|+. +++.++||||+++++++ .+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3467899999999999999999986 788999999764321 1234556666 67778999999999988 4568899
Q ss_pred EEecCCCchhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecccCCCceEecCCCceeeeccccccc
Q 003121 600 YEYLPNGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
|||+.+ +|.+++... .....+++..+..++.+++.||.|||+ + ||+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999975 777776421 224678999999999999999999999 7 899999999999999999999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFL----ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 752 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~ 752 (846)
....... ....||+.|+|||++ .+..++.++|||||||++|+|+||+.||.........+... ...
T Consensus 176 ~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~ 245 (327)
T 3aln_A 176 LVDSIAK---------TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKG 245 (327)
T ss_dssp ---------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-CCS
T ss_pred ccccccc---------ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-hcC
Confidence 6433211 223589999999998 45678999999999999999999999997654322211110 111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.............+..+.+|+.+||..+|.+||++ .++
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~el 283 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY-KEL 283 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCH-HHH
Confidence 11111111122346789999999999999999999 444
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=334.08 Aligned_cols=207 Identities=30% Similarity=0.386 Sum_probs=170.4
Q ss_pred hhhhhhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CC-----ceeeEecc
Q 003121 520 FSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HP-----NLVTLVGA 591 (846)
Q Consensus 520 ~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-Hp-----nIv~l~g~ 591 (846)
+.......++|.+.+.||+|+||.||+|... +..||||++.... .....+..|+.++..++ |+ +|++++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3344455678999999999999999999876 5789999997432 12346778999998885 55 48999988
Q ss_pred c--cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec--CCCcee
Q 003121 592 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSK 667 (846)
Q Consensus 592 ~--~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~--~~~~vK 667 (846)
| .+..++||||+. |+|.+++.... ...+++..+..++.||+.||.|||.. ..||+||||||+||||+ .++.+|
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence 7 467899999996 59999886443 24589999999999999999999952 26899999999999995 478899
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 003121 668 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV 741 (846)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~ 741 (846)
|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|+||++||......
T Consensus 202 L~DFG~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 202 IVDFGSSCQLGQRI-----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp ECCCTTCEETTCCC-----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEeccCceeccccc-----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999998764321 2345899999999999999999999999999999999999999866543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.91 Aligned_cols=238 Identities=23% Similarity=0.379 Sum_probs=195.2
Q ss_pred hhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcC--CCceeeEecccc
Q 003121 524 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIR--HPNLVTLVGACP 593 (846)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~------~~~~f~~Ei~iL~~l~--HpnIv~l~g~~~ 593 (846)
....++|.+.+.||+|+||.||+|... +..||||++...... ....+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344568999999999999999999874 688999999765432 2346788999999996 599999999984
Q ss_pred --CceEEEEEecCC-CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec-CCCceeee
Q 003121 594 --EVWTLVYEYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLS 669 (846)
Q Consensus 594 --~~~~lVmEy~~g-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~-~~~~vKL~ 669 (846)
+..++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+ .++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 568899999976 8999998543 468999999999999999999999 8999999999999999 78999999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003121 670 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 748 (846)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~ 748 (846)
|||+++....... ....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||....... ..
T Consensus 193 Dfg~~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~ 258 (320)
T 3a99_A 193 DFGSGALLKDTVY----------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RG 258 (320)
T ss_dssp CCTTCEECCSSCB----------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----HC
T ss_pred eCccccccccccc----------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh----cc
Confidence 9999987653221 23459999999999987765 688999999999999999999997554321 11
Q ss_pred hhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 749 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. ..++...+..+.+|+.+||..+|.+||++ +++
T Consensus 259 ~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~l 291 (320)
T 3a99_A 259 Q---------VFFRQRVSSECQHLIRWCLALRPSDRPTF-EEI 291 (320)
T ss_dssp C---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred c---------ccccccCCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 0 11223345789999999999999999999 444
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.54 Aligned_cols=247 Identities=25% Similarity=0.331 Sum_probs=190.9
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--C-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc------eeeEeccc--cCc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--H-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN------LVTLVGAC--PEV 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn------Iv~l~g~~--~~~ 595 (846)
.++|.+.+.||+|+||.||+|... + ..||||++.... .....+.+|+.+|+.++|+| ++.+++++ ...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 458999999999999999999875 3 679999997432 22456889999999997766 88888877 457
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe---------------
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL--------------- 660 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl--------------- 660 (846)
.++||||+ +++|.+.+... ...++++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence 89999999 56666666433 23469999999999999999999999 899999999999999
Q ss_pred ----cCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003121 661 ----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 736 (846)
Q Consensus 661 ----~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~ 736 (846)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|+||++||.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccCCCcEEEeecCccccccccc-----------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 567899999999998643321 23459999999999999999999999999999999999999997
Q ss_pred CchHHHHHHhhhhhcccc-----------------------------------CC--CCCCCChhhHHHHHHHHHHHhcc
Q 003121 737 ITKEVQYALDTGKLKNLL-----------------------------------DP--LAGDWPFVQAEQLANLAMRCCEM 779 (846)
Q Consensus 737 ~~~~~~~~~~~~~~~~~l-----------------------------------d~--~~~~~p~~~~~~l~~Li~~Cl~~ 779 (846)
.................+ .+ .........+..+.+|+.+||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 655432211111100000 00 00011123356899999999999
Q ss_pred CcCCCCChHHHH
Q 003121 780 SRKSRPELGKDV 791 (846)
Q Consensus 780 ~P~~RPt~~~~v 791 (846)
+|.+||++ .++
T Consensus 321 dP~~Rpt~-~e~ 331 (355)
T 2eu9_A 321 DPAQRITL-AEA 331 (355)
T ss_dssp STTTSCCH-HHH
T ss_pred ChhhCcCH-HHH
Confidence 99999999 444
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=342.11 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=181.3
Q ss_pred CCcccceeeeeCceEEE-EEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEEEEecC
Q 003121 529 NFDPSLKIGEGGYGSIY-KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLP 604 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy-~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lVmEy~~ 604 (846)
.|...+.||+|+||+|| .+...+..||||++... ..+.+.+|+.+|.++ +||||+++++++. ...++|||||.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34556789999999996 45566899999998653 235678999999987 8999999999884 46889999995
Q ss_pred CCchhhhhccCCCCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC-------------Ccee
Q 003121 605 NGSLEDRLSCKDNSP----PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-------------FVSK 667 (846)
Q Consensus 605 ggsL~~~L~~~~~~~----~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~-------------~~vK 667 (846)
|+|.+++....... ..++..++.++.||+.||.|||+ ++|+||||||+||||+.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996443211 11333467899999999999999 899999999999999754 4899
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 003121 668 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLT-GRPALGITK 739 (846)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-------~~~~~ksDVwSlGviL~ellt-G~~pf~~~~ 739 (846)
|+|||+++........... ......||+.|+|||++.+ ..++.++|||||||++|||+| |++||+...
T Consensus 169 L~DFG~a~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRT----NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp ECCCTTCEECCC------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EcccccceecCCCCcccee----eecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 9999999977543211110 1123469999999999975 568999999999999999999 999997654
Q ss_pred HHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 740 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 740 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.....+..+... ........+...+..+.+|+.+||+.+|.+||++ .++
T Consensus 245 ~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-~ei 293 (434)
T 2rio_A 245 SRESNIIRGIFS--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA-MKV 293 (434)
T ss_dssp THHHHHHHTCCC--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred hhHHHHhcCCCC--cccccccccccchHHHHHHHHHHhhCChhhCCCH-HHH
Confidence 333222222111 1111112234567889999999999999999999 444
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=329.76 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=168.5
Q ss_pred cCCCcccc-eeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHH-HHHhcCCCceeeEeccccC------ce
Q 003121 527 THNFDPSL-KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEID-ILSKIRHPNLVTLVGACPE------VW 596 (846)
Q Consensus 527 ~~~f~~~~-~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~-iL~~l~HpnIv~l~g~~~~------~~ 596 (846)
.++|.+.+ .||+|+||.||+|... +..||||++... ....+|+. .++.+.||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 34788855 6999999999999987 688999998642 23334444 4566799999999998732 37
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC---CCceeeecccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGI 673 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~---~~~vKL~DFGl 673 (846)
++||||+++|+|.+++.... ...+++..++.++.||+.||.|||. ++|+||||||+||||+. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 89999999999999996442 3569999999999999999999999 89999999999999976 45699999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh-hhhcc
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-GKLKN 752 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~-~~~~~ 752 (846)
++....... ....||+.|+|||++.+..++.++|||||||++|+|+||++||............ .....
T Consensus 178 ~~~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (336)
T 3fhr_A 178 AKETTQNAL----------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247 (336)
T ss_dssp CEEC--------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred ceecccccc----------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence 986543211 2345899999999998888999999999999999999999999654332110000 00000
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 753 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
.............+..+.+|+.+||..+|.+||++ .+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell 286 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI-TQFM 286 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred cccccCchhhccCCHHHHHHHHHHCCCChhHCcCH-HHHh
Confidence 00001111112346789999999999999999999 5543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=342.20 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=185.7
Q ss_pred hhcCCCcccceeeeeCceE-EEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccc--CceEEEE
Q 003121 525 GATHNFDPSLKIGEGGYGS-IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~-Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lVm 600 (846)
....+|...+.||+|+||+ ||++...++.||||++.... ...+.+|+.+|+.+ +||||+++++++. ...++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3445689999999999998 56677788999999997532 34578999999999 7999999999984 4578999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-----CCceeeecccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-----NFVSKLSDFGISR 675 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-----~~~vKL~DFGla~ 675 (846)
|||. |+|.+++.... ..+.+..++.++.||+.||.|||+ ++|+||||||+||||+. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9996 69999986443 234445677899999999999999 89999999999999953 2357799999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhc
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLK 751 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~ 751 (846)
.......... ......||+.|+|||++. ...++.++|||||||++|+|+| |.+||+..............
T Consensus 172 ~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~- 245 (432)
T 3p23_A 172 KLAVGRHSFS-----RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC- 245 (432)
T ss_dssp CC-----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC-
T ss_pred eccCCCccee-----eccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC-
Confidence 7654321111 113456999999999997 4567889999999999999999 99999765443322211111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 752 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
.......+...+..+.+|+.+||+.+|.+||++ .+++
T Consensus 246 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-~evl 282 (432)
T 3p23_A 246 ---SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSA-KHVL 282 (432)
T ss_dssp ---CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred ---CccccCccccccHHHHHHHHHHHhCCHhhCCCH-HHHH
Confidence 111111223456678999999999999999999 4443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.28 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=174.4
Q ss_pred hcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
..++|...+.||+|+||.||+|... +..||||++....... ...+..+..+++.++||||+++++++ .+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 4457889999999999999999986 6889999997653221 12344555678888999999999998 4568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecccCCCceEecCCCceeeeccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
|||+ ++.+..++... ...+++..+..++.+|+.||.|||+ + ||+||||||+|||++.++.+||+|||++....
T Consensus 103 ~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 55665555322 3568999999999999999999998 5 89999999999999999999999999997654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
..... ....||+.|+|||++. ...++.++|||||||++|+|+||+.||.........+... ....
T Consensus 177 ~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~ 246 (318)
T 2dyl_A 177 DDKAK---------DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV-LQEE 246 (318)
T ss_dssp -------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH-HHSC
T ss_pred CCccc---------cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH-hccC
Confidence 32211 2335899999999994 4568999999999999999999999997532221111111 1110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+..+. ....+..+.+|+.+||..+|.+||++ .++
T Consensus 247 -~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~-~~l 281 (318)
T 2dyl_A 247 -PPLLPG-HMGFSGDFQSFVKDCLTKDHRKRPKY-NKL 281 (318)
T ss_dssp -CCCCCS-SSCCCHHHHHHHHHHTCSCTTTSCCH-HHH
T ss_pred -CCCCCc-cCCCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 111111 11245789999999999999999999 444
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=318.92 Aligned_cols=229 Identities=17% Similarity=0.120 Sum_probs=179.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCc---hhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~---~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|.+.+.||+|+||.||+|.+. ++.||||++........ ..|.+|+.++.+++||||+++++++ .+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999987 68899999987654332 5689999999999999999999998 45689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||++|++|.+++.. . .....+..|+.||+.||.|||+ +||+||||||+||||+.+|.+||+++|
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999832 2 3555788999999999999999 899999999999999999999998543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHh-hhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-TGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~-~~~~~~~ld~~~~ 759 (846)
|++ .++.++|||||||++|+|+||+.||........... ........ +...
T Consensus 175 --------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~ 226 (286)
T 3uqc_A 175 --------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP-IEPA 226 (286)
T ss_dssp --------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCB-CCHH
T ss_pred --------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCC-CChh
Confidence 233 378899999999999999999999975443110000 00000000 0000
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
..+...+..+.+|+.+||+.||.+| ++ .++++.|+.+....
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~-~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SA-STLLNLMQQATAVA 267 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CH-HHHHHHHHHHHC--
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CH-HHHHHHHHHHhccC
Confidence 1122345789999999999999999 88 88888888877654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=349.86 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=198.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc--------Cce
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--------EVW 596 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~~~ 596 (846)
++|.+.++||+|+||.||+|... +..||||++..... .....+.+|+.+|++++||||+++++++. +..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57999999999999999999875 67899999875422 12356889999999999999999998862 357
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCc---eeeecccc
Q 003121 597 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGI 673 (846)
Q Consensus 597 ~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~---vKL~DFGl 673 (846)
++||||++||+|.+++........+++..++.|+.+++.||.|||+ +||+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 8999999999999999766555679999999999999999999999 89999999999999997664 89999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH--------
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL-------- 745 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~-------- 745 (846)
+......... ....||+.|+|||++.+..++.++|||||||++|+|+||..||..........
T Consensus 171 a~~~~~~~~~---------~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 171 AKELDQGELC---------TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp CCBTTSCCCC---------CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred cccccccccc---------ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 9876543211 23469999999999999999999999999999999999999996542211100
Q ss_pred hhhh----hccc-----cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHH----HHHHHHHHH
Q 003121 746 DTGK----LKNL-----LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD----VWRVLEPMR 799 (846)
Q Consensus 746 ~~~~----~~~~-----ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~----v~~~L~~l~ 799 (846)
.... .... ..+.....+...+..+.+|+.+||..+|.+||++.+. .+..++.+.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 0000 0000 0112223445578899999999999999999998331 344555444
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=350.74 Aligned_cols=237 Identities=25% Similarity=0.303 Sum_probs=191.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC---CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccccC--c-----
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--V----- 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~---~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~----- 595 (846)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... .....+.+|+.+|++++||||++++++|.. .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999874 57899999875422 123468899999999999999999999832 2
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.||||||++|++|.+++. ..+++..++.|+.||+.||.|||+ +|||||||||+||||+.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence 699999999999998773 269999999999999999999999 899999999999999986 89999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
..... ....||+.|+|||++.++ ++.++|||||||+||+|++|.+||.... .+
T Consensus 230 ~~~~~------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~--------------~~ 282 (681)
T 2pzi_A 230 RINSF------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRY--------------VD 282 (681)
T ss_dssp ETTCC------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEE--------------CS
T ss_pred hcccC------------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccc--------------cc
Confidence 65432 224599999999999765 4889999999999999999999985321 01
Q ss_pred CCCCCC-ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 756 PLAGDW-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 756 ~~~~~~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
...... ....+..+.+|+.+||..+|.+||+..+++...|..+.
T Consensus 283 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 283 GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 111111 11234679999999999999999988788877776543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=329.85 Aligned_cols=238 Identities=13% Similarity=0.104 Sum_probs=180.5
Q ss_pred hhhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCC-Ccee-----------
Q 003121 524 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRH-PNLV----------- 586 (846)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~f~~Ei~iL~~l~H-pnIv----------- 586 (846)
...+.+|...+.||+|+||.||+|.+. +..||||++...... ..+.|.+|+.+++.+.| +|..
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 344556888889999999999999987 789999999844332 35679999999999987 3221
Q ss_pred ----eE------eccc-------cCceEEEEEecCCCchhhhhcc----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003121 587 ----TL------VGAC-------PEVWTLVYEYLPNGSLEDRLSC----KDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645 (846)
Q Consensus 587 ----~l------~g~~-------~~~~~lVmEy~~ggsL~~~L~~----~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 645 (846)
.+ +.++ ....+++|+++ +++|.+++.. .....++++..++.|+.||+.||.|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--- 229 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--- 229 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---
Confidence 11 1111 12356677765 6899988842 1234568888999999999999999999
Q ss_pred CceEecccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhh----------ccCCCCch
Q 003121 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL----------ASGELTPK 715 (846)
Q Consensus 646 ~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l----------~~~~~~~k 715 (846)
++|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.+
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 297 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA 297 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCCc-----------cccCCC-CceeCchhhhccccccccccCcCCCch
Confidence 89999999999999999999999999998865433 123457 999999999 44568889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChH
Q 003121 716 SDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 788 (846)
Q Consensus 716 sDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 788 (846)
+|||||||++|+|+||+.||....... .....+. ... ..+..+.+|+.+||..+|.+||++.
T Consensus 298 ~DvwSlGvil~elltg~~Pf~~~~~~~------~~~~~~~-~~~----~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 298 FDTWTLGLAIYWIWCADLPNTDDAALG------GSEWIFR-SCK----NIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHHHHHHHHHHHHHHSSCCCCTTGGGS------CSGGGGS-SCC----CCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchhh------hHHHHHh-hcc----cCCHHHHHHHHHHccCChhhCcCHH
Confidence 999999999999999999997654321 1111111 111 2347899999999999999999973
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.73 Aligned_cols=233 Identities=18% Similarity=0.159 Sum_probs=177.7
Q ss_pred cCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCC--------CchhHHHHHHHHHhcC---------CCceeeEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ--------GPSEFQQEIDILSKIR---------HPNLVTLV 589 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~--------~~~~f~~Ei~iL~~l~---------HpnIv~l~ 589 (846)
.++|...++||+|+||.||+|...+..||||++...... ....+.+|+.+|+.++ ||||+++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 346889999999999999999999999999999865322 2267899999999986 55555554
Q ss_pred c-----------------cc---------------cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHH
Q 003121 590 G-----------------AC---------------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 637 (846)
Q Consensus 590 g-----------------~~---------------~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL 637 (846)
+ +| ....++||||+++|++.+.+.. ..+++..+..|+.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 4 33 3568999999999977666632 4589999999999999999
Q ss_pred HHHh-hcCCCceEecccCCCceEecCCC--------------------ceeeeccccccccccccccCCCccccccCCCC
Q 003121 638 IFLH-SCKPHSIVHGDLKPANILLDANF--------------------VSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696 (846)
Q Consensus 638 ~~LH-~~~~~giiHrDLkp~NILl~~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~ 696 (846)
.||| + ++|+||||||+||||+.++ .+||+|||+|+..... ...
T Consensus 175 ~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------------~~~ 238 (336)
T 2vuw_A 175 AVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------------IVV 238 (336)
T ss_dssp HHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------------EEE
T ss_pred HHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------------cEE
Confidence 9999 8 7999999999999999887 9999999999876432 124
Q ss_pred CCcccCChhhhccCCCCchhhHHHHHHH-HHHHHhCCCCCCCchHHHHHHhhhhhc-cccCCCCCCCChhhHHHHHHHHH
Q 003121 697 GTFAYMDPEFLASGELTPKSDVYSFGII-LLRLLTGRPALGITKEVQYALDTGKLK-NLLDPLAGDWPFVQAEQLANLAM 774 (846)
Q Consensus 697 Gt~~Y~APE~l~~~~~~~ksDVwSlGvi-L~elltG~~pf~~~~~~~~~~~~~~~~-~~ld~~~~~~p~~~~~~l~~Li~ 774 (846)
||+.|+|||++.+.. +.++||||||++ .+++++|.+||....+.........-. ..........+...+..+.+|+.
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHH
Confidence 899999999998665 889999998777 778999999995432212111110000 00011111123356789999999
Q ss_pred HHhccC
Q 003121 775 RCCEMS 780 (846)
Q Consensus 775 ~Cl~~~ 780 (846)
+||..+
T Consensus 318 ~~L~~d 323 (336)
T 2vuw_A 318 TMLNFS 323 (336)
T ss_dssp HGGGSS
T ss_pred HHhccC
Confidence 999966
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=303.89 Aligned_cols=222 Identities=21% Similarity=0.364 Sum_probs=173.8
Q ss_pred CCCccc-ceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHH-HhcCCCceeeEecccc------CceE
Q 003121 528 HNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDIL-SKIRHPNLVTLVGACP------EVWT 597 (846)
Q Consensus 528 ~~f~~~-~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL-~~l~HpnIv~l~g~~~------~~~~ 597 (846)
++|... +.||+|+||.||++... +..||||++.. ...+.+|+.++ +.++||||+++++++. ...+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 467776 67999999999999885 67899999863 35788999998 5569999999999873 3478
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC---CCceeeeccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGIS 674 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~---~~~vKL~DFGla 674 (846)
+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999996542 3469999999999999999999999 89999999999999998 789999999988
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 754 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~l 754 (846)
.... +..++.++|||||||++|+|+||++||.......... .....+
T Consensus 168 ~~~~------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~---~~~~~~ 214 (299)
T 3m2w_A 168 KETT------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRI 214 (299)
T ss_dssp EECT------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C---CSCCSS
T ss_pred cccc------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH---HHHHHH
Confidence 6432 2346789999999999999999999996554322110 011111
Q ss_pred CCCCCCCC----hhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 755 DPLAGDWP----FVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 755 d~~~~~~p----~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
......++ ...+..+.+|+.+||..+|.+||++ .+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-~e~l 255 (299)
T 3m2w_A 215 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-TEFM 255 (299)
T ss_dssp CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH-HHHH
T ss_pred hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCH-HHHh
Confidence 11111222 2346789999999999999999999 5543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-29 Score=291.93 Aligned_cols=181 Identities=20% Similarity=0.157 Sum_probs=123.6
Q ss_pred eeeeCceEEEEEE--ECCeEEEEEEecCCCCCC----------chhHHHHHHHHHhc-CCCceeeEecccc--CceEEEE
Q 003121 536 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQG----------PSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 536 LG~G~fG~Vy~g~--~~~~~VAIK~l~~~~~~~----------~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lVm 600 (846)
++.|++|.+..+. +-|..||+|++....... .+.|.+|+++|+++ .|+||+++++++. ...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555432 346789999998653221 24589999999999 7999999999985 4699999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||++||+|.++|.. ..+++.. .|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999953 3456654 588999999999999 99999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 734 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~p 734 (846)
... . +..+||+.|+|||++.+ .+..++|+||+|+++++|.+|..+
T Consensus 393 ~~~--~------~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSW--P------TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CC--S------HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Ccc--c------cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 211 1 22359999999999864 567789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-26 Score=264.68 Aligned_cols=188 Identities=16% Similarity=0.218 Sum_probs=146.2
Q ss_pred cccceeeeeCceEEEEEEECCeEEEEEEecCCCCCC--------chhHHHHHHHHHhcCCCcee--eEeccccCceEEEE
Q 003121 531 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPNLV--TLVGACPEVWTLVY 600 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~--------~~~f~~Ei~iL~~l~HpnIv--~l~g~~~~~~~lVm 600 (846)
...++||+|+||.||+|...+..+++|......... .+.|.+|+.+|++++||||+ .+++...+..+|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 446689999999999998889999999876643322 13478999999999999999 66777678889999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||++||+|.+++.. +..|+.||+.||.|||+ ++|+||||||+|||++. .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999842 56899999999999999 89999999999999998 9999999999987543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPAL 735 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~~~ksDVwSlGviL~elltG~~pf 735 (846)
....... ........||+.|+|||++.. ..|+..+|+||..+-.++.+.++.++
T Consensus 483 ~~~~~~~-~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDL-IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHH-HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccch-hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2111000 000112348999999999986 56888899999999999988887765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-22 Score=216.96 Aligned_cols=146 Identities=16% Similarity=0.104 Sum_probs=116.5
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCC------------------CchhHHHHHHHHHhcCCCce
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ------------------GPSEFQQEIDILSKIRHPNL 585 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~------------------~~~~f~~Ei~iL~~l~HpnI 585 (846)
.....|...+.||+|+||.||+|.+. +..||||+++..... ....+.+|+.+|++++|
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~--- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---
Confidence 33445667799999999999999985 688999999753221 12458899999999994
Q ss_pred eeEeccc-cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC
Q 003121 586 VTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 664 (846)
Q Consensus 586 v~l~g~~-~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~ 664 (846)
+++++++ .+..++||||++||+|.+ +.. .....++.|++.||.|||+ +||+||||||+||||+ ++
T Consensus 164 ~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 164 LAVPKVYAWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SSSCCEEEEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TT
T ss_pred CCcCeEEeccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CC
Confidence 5555544 346799999999999998 521 1345799999999999999 8999999999999999 99
Q ss_pred ceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhc
Q 003121 665 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708 (846)
Q Consensus 665 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 708 (846)
.+||+|||+|+. +..|+|||++.
T Consensus 230 ~vkl~DFG~a~~---------------------~~~~~a~e~l~ 252 (282)
T 1zar_A 230 GIWIIDFPQSVE---------------------VGEEGWREILE 252 (282)
T ss_dssp EEEECCCTTCEE---------------------TTSTTHHHHHH
T ss_pred cEEEEECCCCeE---------------------CCCCCHHHHHH
Confidence 999999999862 44578999885
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.9e-19 Score=187.82 Aligned_cols=135 Identities=16% Similarity=0.072 Sum_probs=104.6
Q ss_pred CcccceeeeeCceEEEEEEE--CCeE--EEEEEecCCCCCC------------------------chhHHHHHHHHHhcC
Q 003121 530 FDPSLKIGEGGYGSIYKGLL--RHMQ--VAIKMLHPHSLQG------------------------PSEFQQEIDILSKIR 581 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~--~~~~--VAIK~l~~~~~~~------------------------~~~f~~Ei~iL~~l~ 581 (846)
|.+...||+|+||.||+|.. .+.. ||||+++...... ...+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56678899999999999988 6888 9999976542110 025789999999998
Q ss_pred CCce--eeEeccccCceEEEEEecCC-C----chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCceEeccc
Q 003121 582 HPNL--VTLVGACPEVWTLVYEYLPN-G----SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH-SCKPHSIVHGDL 653 (846)
Q Consensus 582 HpnI--v~l~g~~~~~~~lVmEy~~g-g----sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~giiHrDL 653 (846)
|+++ ..+++. ...+|||||+.+ | +|.++... +++..+..++.|++.||.||| . .||+||||
T Consensus 129 ~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSC
T ss_pred hCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCC
Confidence 8764 333432 467899999942 4 66665421 223467889999999999999 8 89999999
Q ss_pred CCCceEecCCCceeeecccccccc
Q 003121 654 KPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 654 kp~NILl~~~~~vKL~DFGla~~~ 677 (846)
||.|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 8999999998754
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-14 Score=139.29 Aligned_cols=139 Identities=12% Similarity=0.124 Sum_probs=114.9
Q ss_pred ccCCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHH
Q 003121 42 VIEDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLD 119 (846)
Q Consensus 42 ~~~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 119 (846)
.|-++|+||||+| +.|.+||+||++.. .+..|+++||.+++...... .......+.+...+.+++.|+
T Consensus 3 ~~~~~ILv~~D~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~ 72 (146)
T 3s3t_A 3 ARYTNILVPVDSS-DAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPA---------LDPVLSELLDAEAAHAKDAMR 72 (146)
T ss_dssp CCCCEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGG---------GHHHHHHHHHHHHHHHHHHHH
T ss_pred CccceEEEEcCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccc---------cccccHHHHHHHHHHHHHHHH
Confidence 3558999999999 99999999999974 47899999999876432110 011334556677788899999
Q ss_pred HHHHHHhhcCC-eeeEEEeecCchhhHHHH-HHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 120 MCLLICRQMGV-RAEKLDTESESTEKGILE-LISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 120 ~~~~~C~~~~V-~~e~~~~e~~d~~~~I~~-~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
++...|...|+ +++..+.. |++.+.|++ +++++++|+||||+++++.+.+.+. |.++..|+..++ |-|++|
T Consensus 73 ~~~~~~~~~g~~~~~~~~~~-g~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~---Gs~~~~vl~~~~--~pVlvV 145 (146)
T 3s3t_A 73 QRQQFVATTSAPNLKTEISY-GIPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAV---GSTTSYVVDHAP--CNVIVI 145 (146)
T ss_dssp HHHHHHTTSSCCCCEEEEEE-ECHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSS---CHHHHHHHHHCS--SEEEEE
T ss_pred HHHHHHHhcCCcceEEEEec-CChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEE---cchHHHHhccCC--CCEEEe
Confidence 99999999999 88877765 689999999 9999999999999999998887765 788899999987 999987
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.59 E-value=1.6e-14 Score=141.13 Aligned_cols=146 Identities=10% Similarity=0.171 Sum_probs=113.6
Q ss_pred cCCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCC-----cccccCCCC--C-CCCCccHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPA-----QMIPVMGTK--F-PASSLEEEKVQAYREIERQ 112 (846)
Q Consensus 43 ~~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~-----~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~ 112 (846)
|-++|+||||+| +.|.+||+||++.. .+..|+++||.++. ....+.+.. + +. ..+.+..+.+...+
T Consensus 4 ~~~~ILv~vD~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 79 (162)
T 1mjh_A 4 MYKKILYPTDFS-ETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKS---VEEFENELKNKLTE 79 (162)
T ss_dssp CCCEEEEECCSC-HHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC--------------------CHHHHHHHHHHHHH
T ss_pred ccceEEEEeCCC-HHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccc---hhhhHHHHHHHHHH
Confidence 457999999999 99999999999974 47799999998764 110110000 1 11 11123455666777
Q ss_pred HHHHHHHHHHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccE
Q 003121 113 DMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCH 192 (846)
Q Consensus 113 ~~~~ll~~~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~ 192 (846)
.+++.|+++...|...|++++..+.. |+|.++|+++++++++|+||||+++++.+.|.+. |.++..|+..++ |.
T Consensus 80 ~~~~~l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~---GSv~~~vl~~~~--~p 153 (162)
T 1mjh_A 80 EAKNKMENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILL---GSVTENVIKKSN--KP 153 (162)
T ss_dssp HHHHHHHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSS---CHHHHHHHHHCC--SC
T ss_pred HHHHHHHHHHHHHHHcCCceEEEEcC-CCHHHHHHHHHHHcCCCEEEEcCCCCCCccceEe---cchHHHHHHhCC--CC
Confidence 88899999999999999999887655 7999999999999999999999999998888765 788999999975 99
Q ss_pred EEEEec
Q 003121 193 IWFICN 198 (846)
Q Consensus 193 v~~i~~ 198 (846)
|++|-.
T Consensus 154 Vlvv~~ 159 (162)
T 1mjh_A 154 VLVVKR 159 (162)
T ss_dssp EEEECC
T ss_pred EEEEeC
Confidence 999953
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.58 E-value=1.3e-14 Score=143.85 Aligned_cols=143 Identities=17% Similarity=0.254 Sum_probs=104.8
Q ss_pred CEEEEEecCCcc---------ccHHHHHHHhhcC-----CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVK---------ESKSVLLWALQNS-----GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIE 110 (846)
Q Consensus 45 ~~V~VAVD~s~~---------~S~~AL~Wal~n~-----~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 110 (846)
++|+||||+| + .|.+||.||++.. .+..|+||||.++... .+.+. ......++.+..+.+..
T Consensus 6 ~~ILv~vD~s-~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~ 81 (175)
T 2gm3_A 6 TKVMVAVNAS-TIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDED-GFDDV--DSIYASPEDFRDMRQSN 81 (175)
T ss_dssp EEEEEECCBC-SSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC-------------CCCCSHHHHHHHTTSH
T ss_pred cEEEEEECCC-cccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccc-ccccc--ccccCCHHHHHHHHHHH
Confidence 6999999999 8 9999999999964 2568999999865421 11100 01112344455555555
Q ss_pred HHHHHHHHHHHHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCc
Q 003121 111 RQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPAS 190 (846)
Q Consensus 111 ~~~~~~ll~~~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~ 190 (846)
.+.+++.|+++...|...|++++..+.. |++.++|+++++++++|+||||+++++.+.|.+. |.++..|+..++
T Consensus 82 ~~~~~~~l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~---Gsva~~vl~~a~-- 155 (175)
T 2gm3_A 82 KAKGLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFV---GTVSAFCVKHAE-- 155 (175)
T ss_dssp HHHHHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC-----------CHHHHHHHHCS--
T ss_pred HHHHHHHHHHHHHHHHHCCCceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhc---CchHHHHHhCCC--
Confidence 6677889999999999999999877655 7999999999999999999999999998888765 788899999987
Q ss_pred cEEEEEe
Q 003121 191 CHIWFIC 197 (846)
Q Consensus 191 C~v~~i~ 197 (846)
|-|++|.
T Consensus 156 ~pVlvv~ 162 (175)
T 2gm3_A 156 CPVMTIK 162 (175)
T ss_dssp SCEEEEE
T ss_pred CCEEEEc
Confidence 9999995
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2e-15 Score=168.03 Aligned_cols=137 Identities=15% Similarity=0.168 Sum_probs=97.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCC-----C---------chhHHHHHHHHHhcCCCceeeEecc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-----G---------PSEFQQEIDILSKIRHPNLVTLVGA 591 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~-----~---------~~~f~~Ei~iL~~l~HpnIv~l~g~ 591 (846)
..-|.+...||.|+||.||+|... |..||||+++..... . ......++.+.....|+|+.+++..
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 345899999999999999999875 688999998653110 0 0112233333333334444444322
Q ss_pred c--------cCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC
Q 003121 592 C--------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 663 (846)
Q Consensus 592 ~--------~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~ 663 (846)
. ....+|||||++|++|..+... .....++.||+.+|.+||. +|||||||||.||||+.+
T Consensus 174 gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 174 GFPVPEPIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREE 241 (397)
T ss_dssp TCSCCCEEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEE
T ss_pred CCCCCeeeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCC
Confidence 1 1234799999999998776421 1345788999999999999 899999999999999877
Q ss_pred C----------ceeeecccccc
Q 003121 664 F----------VSKLSDFGISR 675 (846)
Q Consensus 664 ~----------~vKL~DFGla~ 675 (846)
+ .+.|+||+-+.
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCE
T ss_pred CCcccccccccceEEEEeCCcc
Confidence 6 37899999654
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.55 E-value=4.7e-15 Score=142.18 Aligned_cols=141 Identities=14% Similarity=0.163 Sum_probs=110.3
Q ss_pred cCCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCc-ccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQ-MIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLD 119 (846)
Q Consensus 43 ~~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 119 (846)
|-++|+||||+| +.|.+||+||++.. .+..|+++||.++.. .....+ ..+.. ..+.+.+...+.+++.++
T Consensus 1 M~~~ILv~vD~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~l~ 73 (147)
T 3hgm_A 1 MFNRIMVPVDGS-KGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLS-MARPE-----QLDIPDDALKDYATEIAV 73 (147)
T ss_dssp CCSEEEEECCSB-HHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBS-SCCCG-----GGCCCTTHHHHHHHHHHH
T ss_pred CCceEEEEeCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccc-ccChh-----hhhhHHHHHHHHHHHHHH
Confidence 347999999999 99999999999973 578999999998753 211111 11111 111223445567788999
Q ss_pred HHHHHHhhcCCee---eEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 120 MCLLICRQMGVRA---EKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 120 ~~~~~C~~~~V~~---e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
++...|...|+++ +..+.. |+|.++|+++++++++|+||||+++++.+.+.+. |.++..|+..++ |-|++|
T Consensus 74 ~~~~~~~~~g~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~---Gs~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 74 QAKTRATELGVPADKVRAFVKG-GRPSRTIVRFARKRECDLVVIGAQGTNGDKSLLL---GSVAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp HHHHHHHHTTCCGGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCC---CHHHHHHHHHCS--SCEEEC
T ss_pred HHHHHHHhcCCCccceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCccccceee---ccHHHHHHhhCC--CCEEEC
Confidence 9999999999988 766644 7999999999999999999999999988887665 788899999987 998875
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.53 E-value=6.6e-14 Score=136.01 Aligned_cols=136 Identities=18% Similarity=0.230 Sum_probs=109.3
Q ss_pred cCCEEEEEec--CCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVA--KQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHL 118 (846)
Q Consensus 43 ~~~~V~VAVD--~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 118 (846)
+-++|+|||| +| +.|.+||+||++.. .+..|+++||.++.....+ .. .. ....+...+.+++.|
T Consensus 14 ~~~~ILv~vD~~~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~-----~~--~~----~~~~~~~~~~~~~~l 81 (156)
T 3fg9_A 14 VYRRILLTVDEDDN-TSSERAFRYATTLAHDYDVPLGICSVLESEDINIF-----DS--LT----PSKIQAKRKHVEDVV 81 (156)
T ss_dssp CCC-EEEECCSCCC-HHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCC-----CS--SH----HHHHHHHHHHHHHHH
T ss_pred cCceEEEEECCCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCcccc-----cc--CC----HHHHHHHHHHHHHHH
Confidence 4479999999 99 99999999999863 4789999999987643111 11 11 234556667788899
Q ss_pred HHHHHHHhhcCCe-eeEEEeecCchhhHHHHH-HHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 119 DMCLLICRQMGVR-AEKLDTESESTEKGILEL-ISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 119 ~~~~~~C~~~~V~-~e~~~~e~~d~~~~I~~~-v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
+++...+...|++ +++.+..+|+|.++|+++ ++++++|+||||+++++.+.+ + .|.++..|+..++ |-|++|
T Consensus 82 ~~~~~~~~~~g~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~-~---~Gs~~~~vl~~a~--~PVlvV 155 (156)
T 3fg9_A 82 AEYVQLAEQRGVNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSK-I---AGAIGPRLARKAP--ISVIVV 155 (156)
T ss_dssp HHHHHHHHHHTCSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSS-S---CSCHHHHHHHHCS--SEEEEE
T ss_pred HHHHHHHHHcCCCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccce-e---ecchHHHHHHhCC--CCEEEe
Confidence 9999999999994 787776658999999999 999999999999999998864 4 3678899999977 999987
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=7.3e-14 Score=137.36 Aligned_cols=138 Identities=11% Similarity=0.127 Sum_probs=104.1
Q ss_pred cCCEEEEEecCCccccHHHHHHHhhcC-CCCcEEEE--EeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVAKQVKESKSVLLWALQNS-GGKRICII--HVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLD 119 (846)
Q Consensus 43 ~~~~V~VAVD~s~~~S~~AL~Wal~n~-~~~~l~lv--HV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 119 (846)
+-++|+||||+| +.|..||+||++.. .+..|+|| ||.++.... .+...+ . ..+.+...+.+++.|+
T Consensus 16 ~~~~ILv~vD~s-~~s~~al~~A~~lA~~~a~l~ll~a~v~~~~~~~--~~~~~~-----~---~~~~~~~~~~~~~~l~ 84 (163)
T 1tq8_A 16 AYKTVVVGTDGS-DSSMRAVDRAAQIAGADAKLIIASAYLPQHEDAR--AADILK-----D---ESYKVTGTAPIYEILH 84 (163)
T ss_dssp CCCEEEEECCSS-HHHHHHHHHHHHHHTTTSEEEEEEECCC------------------------------CCTHHHHHH
T ss_pred cCCEEEEEcCCC-HHHHHHHHHHHHHhCCCCEEEEEEeeeccCcccc--cccccc-----c---HHHHHHHHHHHHHHHH
Confidence 447999999999 99999999998865 57799999 777654220 010100 0 1223334556788899
Q ss_pred HHHHHHhhcCCe-eeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEe
Q 003121 120 MCLLICRQMGVR-AEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFIC 197 (846)
Q Consensus 120 ~~~~~C~~~~V~-~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~ 197 (846)
++...|...|++ ++..+.. |+|.++|++++++.++|+||||+++++.+.|.+. +.++..|+..++ |.|++|-
T Consensus 85 ~~~~~~~~~gv~~v~~~v~~-G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~l---GSva~~vl~~a~--~PVlvV~ 157 (163)
T 1tq8_A 85 DAKERAHNAGAKNVEERPIV-GAPVDALVNLADEEKADLLVVGNVGLSTIAGRLL---GSVPANVSRRAK--VDVLIVH 157 (163)
T ss_dssp HHHHHHHTTTCCEEEEEEEC-SSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHT---BBHHHHHHHHTT--CEEEEEC
T ss_pred HHHHHHHHcCCCeEEEEEec-CCHHHHHHHHHHhcCCCEEEECCCCCCcccceee---ccHHHHHHHhCC--CCEEEEe
Confidence 999999999998 8877655 7999999999999999999999999999888775 788899999986 9999994
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.5e-13 Score=135.52 Aligned_cols=147 Identities=5% Similarity=0.031 Sum_probs=108.0
Q ss_pred cCCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccH-HHHHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEE-EKVQAYREIERQDMHNHLD 119 (846)
Q Consensus 43 ~~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ll~ 119 (846)
|-++|+||||+| +.|.+||+||++.. .+..|++|||.++... .+.+..++.....+ .....+.+...+.+++.|+
T Consensus 4 m~~~ILv~vD~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 81 (170)
T 2dum_A 4 MFRKVLFPTDFS-EGAYRAVEVFEKRNKMEVGEVILLHVIDEGTL-EELMDGYSFFYDNAEIELKDIKEKLKEEASRKLQ 81 (170)
T ss_dssp CCSEEEEECCSS-HHHHHHHHHHHHHCCSCCSEEEEEEEEETTGG-GCCC------------CCTTSHHHHHHHHHHHHH
T ss_pred ccceEEEEecCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCccc-cccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 447999999999 99999999999974 4789999999876532 11111111000000 0001223445567788899
Q ss_pred HHHHHHhhcCCeeeE--EEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEe
Q 003121 120 MCLLICRQMGVRAEK--LDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFIC 197 (846)
Q Consensus 120 ~~~~~C~~~~V~~e~--~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~ 197 (846)
++...+...|++++. .+. .|++.++|+++++++++|+||||+++++.+.|.+. +.++..|+..++ |-|++|-
T Consensus 82 ~~~~~~~~~g~~~~~~~~~~-~g~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~---Gsv~~~vl~~~~--~PVlvv~ 155 (170)
T 2dum_A 82 EKAEEVKRAFRAKNVRTIIR-FGIPWDEIVKVAEEENVSLIILPSRGKLSLSHEFL---GSTVMRVLRKTK--KPVLIIK 155 (170)
T ss_dssp HHHHHHHHHTTCSEEEEEEE-EECHHHHHHHHHHHTTCSEEEEESCCCCC--TTCC---CHHHHHHHHHCS--SCEEEEC
T ss_pred HHHHHHHHcCCceeeeeEEe-cCChHHHHHHHHHHcCCCEEEECCCCCCcccccee---chHHHHHHHhCC--CCEEEEc
Confidence 999999888999886 554 47999999999999999999999999988877765 788899999987 9999995
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.8e-13 Score=129.79 Aligned_cols=132 Identities=13% Similarity=0.145 Sum_probs=105.6
Q ss_pred CEEEEEecCCccccHHHHHHHhhcC---CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHH-HHHHHHHHH
Q 003121 45 DKIYVAVAKQVKESKSVLLWALQNS---GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIER-QDMHNHLDM 120 (846)
Q Consensus 45 ~~V~VAVD~s~~~S~~AL~Wal~n~---~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ll~~ 120 (846)
++|+||||+| +.|..||.||++.. .+..|+++||.++.......+ .....+.+... +.+++.+++
T Consensus 2 ~~ILv~~D~s-~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~ 70 (138)
T 3idf_A 2 KKLLFAIDDT-EACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAV----------LAAYDEIEMKEEEKAKLLTQK 70 (138)
T ss_dssp EEEEEECCSS-HHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHHH----------HHHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEEeCCC-HHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccccc----------cCcHHHHHHHHHHHHHHHHHH
Confidence 5899999999 99999999999976 577999999998764311100 01122344455 788899999
Q ss_pred HHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 121 CLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 121 ~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
+...|...|++++..+.. |++.++|+++++ ++|+||||+++++.+.|.+ +.++..|+..++ |-|++|
T Consensus 71 ~~~~~~~~g~~~~~~v~~-g~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~----Gs~~~~vl~~~~--~pVlvv 137 (138)
T 3idf_A 71 FSTFFTEKGINPFVVIKE-GEPVEMVLEEAK--DYNLLIIGSSENSFLNKIF----ASHQDDFIQKAP--IPVLIV 137 (138)
T ss_dssp HHHHHHTTTCCCEEEEEE-SCHHHHHHHHHT--TCSEEEEECCTTSTTSSCC----CCTTCHHHHHCS--SCEEEE
T ss_pred HHHHHHHCCCCeEEEEec-CChHHHHHHHHh--cCCEEEEeCCCcchHHHHh----CcHHHHHHhcCC--CCEEEe
Confidence 999999999999977755 689999999999 9999999999988877654 456788888877 999887
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=99.45 E-value=2.9e-13 Score=128.41 Aligned_cols=132 Identities=17% Similarity=0.207 Sum_probs=98.0
Q ss_pred CCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHH
Q 003121 44 EDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMC 121 (846)
Q Consensus 44 ~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 121 (846)
-++|+||||+| +.|.+||.||++.. .+..|+++||.+|... .. . .+ .++ .+.+...+.+++.|+++
T Consensus 2 ~~~ILv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~-~~-~-~~-----~~~---~~~~~~~~~~~~~l~~~ 69 (137)
T 2z08_A 2 FKTILLAYDGS-EHARRAAEVAKAEAEAHGARLIVVHAYEPVPD-YL-G-EP-----FFE---EALRRRLERAEGVLEEA 69 (137)
T ss_dssp CSEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEEECC-------------------------CHHHHHHHHHHHHH
T ss_pred cceEEEEeCCC-HHHHHHHHHHHHHHhhcCCEEEEEEEecCCCc-cc-c-cc-----chH---HHHHHHHHHHHHHHHHH
Confidence 37999999999 99999999999874 4789999999975421 11 1 00 111 12233445566667666
Q ss_pred HHHHhhcCC-eeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 122 LLICRQMGV-RAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 122 ~~~C~~~~V-~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
... .|+ +++..+. .|++.++|+++++++++|+||||+++++.+.|.+. |.++..|+..++ |-|++|
T Consensus 70 ~~~---~g~~~~~~~~~-~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~---Gs~~~~vl~~~~--~pVlvv 136 (137)
T 2z08_A 70 RAL---TGVPKEDALLL-EGVPAEAILQAARAEKADLIVMGTRGLGALGSLFL---GSQSQRVVAEAP--CPVLLV 136 (137)
T ss_dssp HHH---HCCCGGGEEEE-ESSHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSS---CHHHHHHHHHCS--SCEEEE
T ss_pred HHH---cCCCccEEEEE-ecCHHHHHHHHHHHcCCCEEEECCCCCchhhhhhh---ccHHHHHHhcCC--CCEEEe
Confidence 544 788 8887765 47999999999999999999999999888877664 788899999975 999887
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=3.9e-13 Score=130.99 Aligned_cols=128 Identities=19% Similarity=0.227 Sum_probs=105.4
Q ss_pred cCCEEEEEecC-CccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVAK-QVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLD 119 (846)
Q Consensus 43 ~~~~V~VAVD~-s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 119 (846)
|-++|+||||+ | +.|..||+||++.. .+..|++|||.++... . . +...+.+++.|+
T Consensus 23 m~~~ILv~vD~~s-~~s~~al~~A~~la~~~~a~l~llhV~~~~~~---------~---~--------~~~~~~~~~~l~ 81 (155)
T 3dlo_A 23 IYMPIVVAVDKKS-DRAERVLRFAAEEARLRGVPVYVVHSLPGGGR---------T---K--------DEDIIEAKETLS 81 (155)
T ss_dssp CCCCEEEECCSSS-HHHHHHHHHHHHHHHHHTCCEEEEEEECCSTT---------S---C--------HHHHHHHHHHHH
T ss_pred ccCeEEEEECCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCc---------c---c--------HHHHHHHHHHHH
Confidence 44799999999 9 99999999999974 4779999999875421 0 0 223456778899
Q ss_pred HHHHHHhhcCCeeeEEE-eecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 120 MCLLICRQMGVRAEKLD-TESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 120 ~~~~~C~~~~V~~e~~~-~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
.+...+.+.++.++..+ +..|+|.++|+++++++++|+||||+++++.+.+.+. +.++..|+..++ |-|++|
T Consensus 82 ~~~~~~~~~g~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~l---GSv~~~vl~~a~--~PVLvV 154 (155)
T 3dlo_A 82 WAVSIIRKEGAEGEEHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIF---GSVARDVILKAN--KPVICI 154 (155)
T ss_dssp HHHHHHHHTTCCEEEEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEEC---CHHHHHHHHHCS--SCEEEE
T ss_pred HHHHHHHhcCCCceEEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEe---ccHHHHHHHhCC--CCEEEe
Confidence 99999999999887643 5678999999999999999999999999888877664 788899999876 988887
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=4e-13 Score=129.33 Aligned_cols=137 Identities=18% Similarity=0.224 Sum_probs=90.8
Q ss_pred CCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccc-cCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHH
Q 003121 44 EDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIP-VMGTKFPASSLEEEKVQAYREIERQDMHNHLDM 120 (846)
Q Consensus 44 ~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 120 (846)
-++|+||||+| +.|.+||+||++.. .+..|+++||.++..... ..+...+... ..+.+...+.+++.|++
T Consensus 6 ~~~ILv~vD~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~ 78 (150)
T 3tnj_A 6 YHHILLAVDFS-SEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLDT------ETTYDAMLDVEKQKLSQ 78 (150)
T ss_dssp CSEEEEECCCS-TTHHHHHHHHHHHHHHHTCEEEEEEEEC--------CTTCCCSSS------CCCHHHHHHHHHHHHHH
T ss_pred cceEEEEeCCC-HHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccccccCcCH------HHHHHHHHHHHHHHHHH
Confidence 37999999999 99999999999974 478999999998753210 1111111110 11223334445555555
Q ss_pred HHHHHhhcCCee-eEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEe
Q 003121 121 CLLICRQMGVRA-EKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFIC 197 (846)
Q Consensus 121 ~~~~C~~~~V~~-e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~ 197 (846)
+ +.+.++.. +..+ ..|++.++|+++++++++|+||||+++++.+. .+. +.++..|+..++ |-|++|-
T Consensus 79 ~---~~~~~~~~~~~~~-~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~-~~~---Gs~~~~vl~~~~--~pVlvv~ 146 (150)
T 3tnj_A 79 I---GNTLGIDPAHRWL-VWGEPREEIIRIAEQENVDLIVVGSHGRHGLA-LLL---GSTANSVLHYAK--CDVLAVR 146 (150)
T ss_dssp H---HHHHTCCGGGEEE-EESCHHHHHHHHHHHTTCSEEEEEEC---------C---CCHHHHHHHHCS--SEEEEEE
T ss_pred H---HHHcCCCcceEEE-ecCCHHHHHHHHHHHcCCCEEEEecCCCCCcC-eEe---cchHHHHHHhCC--CCEEEEe
Confidence 4 44447774 5444 55799999999999999999999999988877 543 778899999987 9999985
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=4.8e-13 Score=127.56 Aligned_cols=134 Identities=11% Similarity=0.184 Sum_probs=95.9
Q ss_pred CEEEEEecCCccc--cHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVKE--SKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDM 120 (846)
Q Consensus 45 ~~V~VAVD~s~~~--S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 120 (846)
++|+||||+| +. |..||+||++.. .+..|+++||.++.......+.... .. .+...+..++.++.
T Consensus 2 k~ILv~vD~s-~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~------~~----~~~~~~~~~~~~~~ 70 (143)
T 3fdx_A 2 NAILVPIDIS-DKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYASLGMAYT------AE----LPGMDELREGSETQ 70 (143)
T ss_dssp CEEEEECCTT-CSSCCTTHHHHHHHHHHHHTCEEEEEEEECC--------------------------CHHHHHHHHHHH
T ss_pred CEEEEEecCC-hHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCccccccccccc------ch----hhhHHHHHHHHHHH
Confidence 6999999999 99 999999998863 5789999999987643211111110 00 11123344566677
Q ss_pred HHHHHhhcCC---eeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 121 CLLICRQMGV---RAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 121 ~~~~C~~~~V---~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
+..++.+.++ +++..+.. |++.++|+++++++++|+||||+++ +.+.+.+. |.++..|+..++ |-|++|
T Consensus 71 l~~~~~~~~~~~~~v~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~-~~~~~~~~---Gs~~~~v~~~~~--~pVlvv 142 (143)
T 3fdx_A 71 LKEIAKKFSIPEDRMHFHVAE-GSPKDKILALAKSLPADLVIIASHR-PDITTYLL---GSNAAAVVRHAE--CSVLVV 142 (143)
T ss_dssp HHHHHTTSCCCGGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEEESSC-TTCCSCSS---CHHHHHHHHHCS--SEEEEE
T ss_pred HHHHHHHcCCCCCceEEEEEe-cChHHHHHHHHHHhCCCEEEEeCCC-CCCeeeee---ccHHHHHHHhCC--CCEEEe
Confidence 7778877764 45666544 6999999999999999999999995 66666554 788899999877 999987
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.34 E-value=2.6e-12 Score=122.26 Aligned_cols=134 Identities=16% Similarity=0.196 Sum_probs=95.2
Q ss_pred CCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCC-CcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHH
Q 003121 44 EDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTP-AQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDM 120 (846)
Q Consensus 44 ~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 120 (846)
-++|+||||+| +.|.+||+||+... .+..|+++||.++ +... .+ +. . .....+.+...+.+++.|++
T Consensus 2 ~~~ILv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~--~~--~~----~-~~~~~~~~~~~~~~~~~l~~ 71 (141)
T 1jmv_A 2 YKHILVAVDLS-EESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLY--TG--LI----D-VNMSSMQDRISTETQKALLD 71 (141)
T ss_dssp CSEEEEEECCS-TTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGC--CC--CE----E-HHHHHHTTCCCCHHHHHHHH
T ss_pred CceEEEEecCc-hhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhh--cc--cc----c-cchHHHHHHHHHHHHHHHHH
Confidence 47999999999 99999999999874 4789999999854 2211 11 10 0 11112222222334455554
Q ss_pred HHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEec
Q 003121 121 CLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICN 198 (846)
Q Consensus 121 ~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~~ 198 (846)
+ +.+.|+.+....+..|+|.++|+++++++++|+||||++ ++.+.| + +.++..|+..++ |.|++|-.
T Consensus 72 ~---~~~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~-l----gs~~~~vl~~~~--~pVlvv~~ 138 (141)
T 1jmv_A 72 L---AESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHH-QDFWSK-L----MSSTRQVMNTIK--IDMLVVPL 138 (141)
T ss_dssp H---HHHSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEEC-CCCHHH-H----HHHHHHHHTTCC--SEEEEEEC
T ss_pred H---HHHcCCCceEEEEecCCHHHHHHHHHHhcCCCEEEEeCC-Cchhhh-h----cchHHHHHhcCC--CCEEEeeC
Confidence 4 445677763344456899999999999999999999999 887776 4 467889999986 99999954
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.30 E-value=5e-12 Score=119.90 Aligned_cols=129 Identities=9% Similarity=0.034 Sum_probs=92.8
Q ss_pred cCCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEee-CC-CcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVH-TP-AQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHL 118 (846)
Q Consensus 43 ~~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~-~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 118 (846)
|-++|+||||+| +.|.+||.||++.. .+..|+++||. ++ +....+....++.. . .+.+...+.+++.|
T Consensus 3 ~~~~ILv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~---~----~~~~~~~~~~~~~l 74 (138)
T 1q77_A 3 AMKVLLVLTDAY-SDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFP---P----EIKEESKKRIERRL 74 (138)
T ss_dssp CCEEEEEEESTT-CCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCC---T----HHHHHHHHHHHHHH
T ss_pred cccEEEEEccCC-HhHHHHHHHHHHHHHHcCCeEEEEEEecccccccccccccCCCCC---h----HHHHHHHHHHHHHH
Confidence 347999999999 99999999999874 47799999998 63 11100000011111 1 22334455667778
Q ss_pred HHHHHHH--hhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 119 DMCLLIC--RQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 119 ~~~~~~C--~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
+++ ..| ...| +++..+. .|++.+.|+++++++++|+||||++++ .++..|+..++ |-|++|
T Consensus 75 ~~~-~~~~~~~~~-~~~~~~~-~g~~~~~I~~~a~~~~~dliV~G~~g~------------sv~~~vl~~a~--~PVlvv 137 (138)
T 1q77_A 75 REV-WEKLTGSTE-IPGVEYR-IGPLSEEVKKFVEGKGYELVVWACYPS------------AYLCKVIDGLN--LASLIV 137 (138)
T ss_dssp HHH-HHHHHSCCC-CCCEEEE-CSCHHHHHHHHHTTSCCSEEEECSCCG------------GGTHHHHHHSS--SEEEEC
T ss_pred HHH-HHHhhccCC-cceEEEE-cCCHHHHHHHHHHhcCCCEEEEeCCCC------------chHHHHHHhCC--CceEee
Confidence 888 774 5566 7776654 579999999999999999999999753 45678888877 999886
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.25 E-value=4.6e-11 Score=129.69 Aligned_cols=143 Identities=12% Similarity=0.121 Sum_probs=113.5
Q ss_pred CCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHH
Q 003121 44 EDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMC 121 (846)
Q Consensus 44 ~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 121 (846)
-++|+||+|+| +.|..||.||+.-. .+..|+++||.++... . .. ....++....+.+...+.+++.|+++
T Consensus 7 ~k~ILv~~D~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~-~-~~-----~~~~~~~~~~~~~~~~~~~~~~l~~~ 78 (319)
T 3olq_A 7 YQNLLVVIDPN-QDDQPALRRAVYIVQRNGGRIKAFLPVYDLSY-D-MT-----TLLSPDERNAMRKGVINQKTAWIKQQ 78 (319)
T ss_dssp SCEEEEECCTT-CSCCHHHHHHHHHHHHHCCEEEEEEEECCGGG-G-CT-----TTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEECCC-cccHHHHHHHHHHHHHcCCeEEEEEEecccch-h-hc-----cccChhhHHHHHHHHHHHHHHHHHHH
Confidence 47999999999 99999999999863 4779999999865422 1 11 11233455566666677788899999
Q ss_pred HHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEecC
Q 003121 122 LLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNG 199 (846)
Q Consensus 122 ~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~~g 199 (846)
...|...|++++..+...|++.++|+++++++++|+||||+++.+.+.+.+. +..+..|+..++ |-|+++-.+
T Consensus 79 ~~~~~~~~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~---Gs~~~~vl~~~~--~PVlvv~~~ 151 (319)
T 3olq_A 79 ARYYLEAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIF---TPLDWQLLRKCP--APVWMVKDK 151 (319)
T ss_dssp HHHHHHTTCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBC---CHHHHHHHHHCS--SCEEEEESS
T ss_pred HHHHhhcCCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccc---cccHHHHHhcCC--CCEEEecCc
Confidence 9999999999998886468999999999999999999999999888877654 667788888876 999999643
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.7e-11 Score=131.82 Aligned_cols=138 Identities=14% Similarity=0.154 Sum_probs=109.7
Q ss_pred cCCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDM 120 (846)
Q Consensus 43 ~~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 120 (846)
|-++|+||||+| +.|..||+||+.-. .+..|+++||.++........ .... ..+.+..++.+++.|++
T Consensus 21 m~~~ILv~vD~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~-----~~~~----~~~~~~~~~~~~~~l~~ 90 (294)
T 3loq_A 21 QSNAMLLPTDLS-ENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSG-----GIDI----DHYIDEMSEKAEEVLPE 90 (294)
T ss_dssp TTCEEEEECCSC-TGGGGGGGGHHHHHHTTCCEEEEECCEECTTC----------CCCT----THHHHHHHHHHHHHHHH
T ss_pred hhccEEEecCCC-HHHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccc-----cccH----HHHHHHHHHHHHHHHHH
Confidence 457999999999 99999999999873 578999999998764321111 1111 23345556678889999
Q ss_pred HHHHHhhcCCeeeE-EEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEe
Q 003121 121 CLLICRQMGVRAEK-LDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFIC 197 (846)
Q Consensus 121 ~~~~C~~~~V~~e~-~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~ 197 (846)
+...|...|++++. .+.+.|++.++| ++.+.++|+||||+++.+.+.+.+. +.++..++..++ |-|++|-
T Consensus 91 ~~~~~~~~g~~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~---Gs~~~~vl~~~~--~PVlvv~ 161 (294)
T 3loq_A 91 VAQKIEAAGIKAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILL---GSVSEGVLHDSK--VPVYIFK 161 (294)
T ss_dssp HHHHHHHTTCEEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHH---CCHHHHHHHHCS--SCEEEEC
T ss_pred HHHHHHHcCCCcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceee---ccHHHHHHhcCC--CCEEEec
Confidence 99999999999998 555368999999 9999999999999999998887765 677889999987 9999994
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.1e-11 Score=128.45 Aligned_cols=140 Identities=16% Similarity=0.141 Sum_probs=109.5
Q ss_pred CCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEeccc--cCceEEEEEecC
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
..|.....++.|+++.||+....+..+++|+...........+.+|+.+|+.|. +.++.++++++ ....|+||||++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 457777778888899999998778899999987532233457999999999994 66777888776 346789999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK---------------------------------------- 644 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------------- 644 (846)
|.+|.+.+. +......++.+++.+|..||...
T Consensus 94 G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 94 GVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp SEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred CeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999987641 11234578889999999999821
Q ss_pred ----------------CCceEecccCCCceEecCCCceeeecccccc
Q 003121 645 ----------------PHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 645 ----------------~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
+..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1459999999999999876667799999764
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.6e-11 Score=128.39 Aligned_cols=143 Identities=13% Similarity=0.067 Sum_probs=106.2
Q ss_pred CEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCC-CCCCCCCccHHHHHH-HHHHHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMG-TKFPASSLEEEKVQA-YREIERQDMHNHLDM 120 (846)
Q Consensus 45 ~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~ 120 (846)
++|+||||+| +.|.+||+||++.. .+..|+++||.++... ...+ ...+.....-..++. ..+...+.+++.|++
T Consensus 1 k~ILv~vD~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 78 (268)
T 3ab8_A 1 MRILLATDGS-PQARGAEALAEWLAYKLSAPLTVLFVVDTRLA-RIPELLDFGALTVPVPVLRTELERALALRGEAVLER 78 (268)
T ss_dssp CCEEEECCSC-GGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHH-THHHHC-------CHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCC-HHHHHHHHHHHHHHHHhCCcEEEEEEeccCCc-ccccccCchHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4799999999 99999999999874 4779999999875421 0000 011100000001111 134456677889999
Q ss_pred HHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCC-hhhhhhhhcchhhHHHHhccCCCccEEEEEe
Q 003121 121 CLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADK-HYKKKMMDLKSKKAISVRQQAPASCHIWFIC 197 (846)
Q Consensus 121 ~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~-~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~ 197 (846)
+...|...|++++..+. .|++.+.|+++ ++++|+||||+++.+ .+.|.+. |.++..|+..++ |-|++|-
T Consensus 79 ~~~~~~~~g~~~~~~~~-~g~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~---Gs~~~~v~~~a~--~PVlvv~ 148 (268)
T 3ab8_A 79 VRQSALAAGVAVEAVLE-EGVPHEAILRR--ARAADLLVLGRSGEAHGDGFGGL---GSTADRVLRASP--VPVLLAP 148 (268)
T ss_dssp HHHHHHHTTCCEEEEEE-EECHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSC---CHHHHHHHHHCS--SCEEEEC
T ss_pred HHHHHHhCCCCeEEEEe-cCCHHHHHHhh--ccCCCEEEEeccCCCcccccccc---chhHHHHHHhCC--CCEEEEC
Confidence 99999999999988765 47999999999 999999999999988 7777664 778899999876 9999984
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.5e-10 Score=124.20 Aligned_cols=132 Identities=13% Similarity=0.114 Sum_probs=95.1
Q ss_pred CCEEEEEecCCccc-------cHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHH
Q 003121 44 EDKIYVAVAKQVKE-------SKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDM 114 (846)
Q Consensus 44 ~~~V~VAVD~s~~~-------S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (846)
.++|+||+|+| +. |.+||+||++-. .+..|+|+||.++..... ..+ +. .+.+...+..
T Consensus 134 ~~~Ilva~D~s-~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~----~~~------~~--~~~~~~~~~~ 200 (290)
T 3mt0_A 134 GGKILAAVDVG-NNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSS----ADP------TF--QLSETIEARY 200 (290)
T ss_dssp TCEEEEEECTT-CCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC-------------------CH--HHHHHHHHHH
T ss_pred CCeEEEEECCC-CcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCccccc----cCc------hh--HHHHHHHHHH
Confidence 37999999999 77 899999999873 578999999998753210 011 00 2223333344
Q ss_pred HHHHHHHHHHHhhcCCe-eeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEE
Q 003121 115 HNHLDMCLLICRQMGVR-AEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHI 193 (846)
Q Consensus 115 ~~ll~~~~~~C~~~~V~-~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v 193 (846)
++.+.+ ++.+.|+. ++..+ ..|+|.++|+++++++++|+||||+++++.+.+.+. |.++..|+..++ |-|
T Consensus 201 ~~~l~~---~~~~~g~~~~~~~v-~~g~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~---Gsv~~~vl~~~~--~pV 271 (290)
T 3mt0_A 201 REACRT---FQAEYGFSDEQLHI-EEGPADVLIPRTAQKLDAVVTVIGTVARTGLSGALI---GNTAEVVLDTLE--SDV 271 (290)
T ss_dssp HHHHHH---HHHHHTCCTTTEEE-EESCHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCS---CHHHHHHHTTCS--SEE
T ss_pred HHHHHH---HHHHcCCCcceEEE-eccCHHHHHHHHHHhcCCCEEEECCCCCcCCcceec---chHHHHHHhcCC--CCE
Confidence 444444 34444775 34444 557999999999999999999999999999887775 788999999976 999
Q ss_pred EEEe
Q 003121 194 WFIC 197 (846)
Q Consensus 194 ~~i~ 197 (846)
.+|-
T Consensus 272 Lvv~ 275 (290)
T 3mt0_A 272 LVLK 275 (290)
T ss_dssp EEEC
T ss_pred EEEC
Confidence 9984
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=1.8e-10 Score=124.70 Aligned_cols=137 Identities=11% Similarity=0.201 Sum_probs=105.7
Q ss_pred ccCCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHH
Q 003121 42 VIEDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLD 119 (846)
Q Consensus 42 ~~~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 119 (846)
.+-++|+||||+| +.|..||+||+... .+..|+++||.+|... ++++.. ... .+.+...+.+++.|+
T Consensus 17 ~~~~~ILv~~D~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~-~~~~~~-----~~~----~~~~~~~~~~~~~l~ 85 (309)
T 3cis_A 17 NSSLGIIVGIDDS-PAAQVAVRWAARDAELRKIPLTLVHAVSPEVA-TWLEVP-----LPP----GVLRWQQDHGRHLID 85 (309)
T ss_dssp -CTTEEEEECCSS-HHHHHHHHHHHHHHHHHTCCEEEEEECCCCCC-CTTCCC-----CCH----HHHHHHHHHHHHHHH
T ss_pred CCCCeEEEEECCC-HHHHHHHHHHHHHHHhcCCcEEEEEEecCccc-ccccCC-----CCc----hhhHHHHHHHHHHHH
Confidence 3458999999999 99999999999874 4779999999975421 111111 121 223344566778888
Q ss_pred HHHHHHhhc-----CCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEE
Q 003121 120 MCLLICRQM-----GVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIW 194 (846)
Q Consensus 120 ~~~~~C~~~-----~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~ 194 (846)
++...|... +++++..+.. |++.++|+++++ ++|+||||+++.+.+.+.+. +.++..|+..+ -|-|+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~-g~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~---Gs~~~~vl~~~--~~PVl 157 (309)
T 3cis_A 86 DALKVVEQASLRAGPPTVHSEIVP-AAAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLL---GSVSSGLLRHA--HCPVV 157 (309)
T ss_dssp HHHHHHHHHCSSSCCSCEEEEEES-SCHHHHHHHHGG--GEEEEEEESSCTTCCTTCCS---CHHHHHHHHHC--SSCEE
T ss_pred HHHHHHHHhcccCCCceEEEEEec-CCHHHHHHHHhc--CCCEEEECCCCCcccccccc---CcHHHHHHHhC--CCCEE
Confidence 888888776 8999887654 799999999996 89999999999888877664 77888999987 59999
Q ss_pred EEe
Q 003121 195 FIC 197 (846)
Q Consensus 195 ~i~ 197 (846)
+|-
T Consensus 158 vv~ 160 (309)
T 3cis_A 158 IIH 160 (309)
T ss_dssp EEC
T ss_pred EEc
Confidence 995
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.5e-10 Score=124.27 Aligned_cols=120 Identities=14% Similarity=0.135 Sum_probs=100.5
Q ss_pred cCCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDM 120 (846)
Q Consensus 43 ~~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 120 (846)
|-++|+||+|+| +.|..||.||+.-. .+..|+++||.+| +..++.|++
T Consensus 6 ~~~~ILv~~D~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~-----------------------------~~~~~~l~~ 55 (290)
T 3mt0_A 6 AIRSILVVIEPD-QLEGLALKRAQLIAGVTQSHLHLLVCEKR-----------------------------RDHSAALND 55 (290)
T ss_dssp TCCEEEEECCSS-CSCCHHHHHHHHHHHHHCCEEEEEEECSS-----------------------------SCCHHHHHH
T ss_pred hhceEEEEeCCC-ccchHHHHHHHHHHHhcCCeEEEEEeeCc-----------------------------HHHHHHHHH
Confidence 347999999999 99999999999863 4779999999863 112345666
Q ss_pred HHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEe
Q 003121 121 CLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFIC 197 (846)
Q Consensus 121 ~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~ 197 (846)
+...+...|++++..+..++++.++|++++++.++|+||||+++.+.+.+.+. +.++..++..++ |-|+++-
T Consensus 56 ~~~~~~~~~~~~~~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~---gs~~~~vl~~~~--~PVlvv~ 127 (290)
T 3mt0_A 56 LAQELREEGYSVSTNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAIL---TPDDWKLLRFAP--CPVLMTK 127 (290)
T ss_dssp HHHHHHHTTCCEEEEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSC---CHHHHHHHHHCS--SCEEEEC
T ss_pred HHHHHhhCCCeEEEEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhccc---CHHHHHHHhcCC--CCEEEec
Confidence 66677788999998887678999999999999999999999999888887765 677888888865 9999994
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.10 E-value=6.6e-10 Score=120.55 Aligned_cols=137 Identities=11% Similarity=0.128 Sum_probs=99.5
Q ss_pred CCEEEEEecCCcc-------ccHHHHHHHhhcC----CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHH
Q 003121 44 EDKIYVAVAKQVK-------ESKSVLLWALQNS----GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQ 112 (846)
Q Consensus 44 ~~~V~VAVD~s~~-------~S~~AL~Wal~n~----~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 112 (846)
.++|+||+|+| . .|.+||.||+.-. ++..|.||||.++..... +...+. .. ...+.+...+
T Consensus 156 ~~~Ilva~D~s-~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~--~~~~~~--~~---~~~~~~~~~~ 227 (319)
T 3olq_A 156 YGTIVVAANLS-NEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINI--AIELPD--FD---PNLYNNALRG 227 (319)
T ss_dssp TCEEEEECCCS-CCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSC--CTTCTT--CC---HHHHHHHHHH
T ss_pred CCeEEEEECCC-CcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhh--hccCCc--cc---HHHHHHHHHH
Confidence 37999999999 6 4699999998762 378999999998763311 111111 11 2233444445
Q ss_pred HHHHHHHHHHHHHhhcCCe-eeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCcc
Q 003121 113 DMHNHLDMCLLICRQMGVR-AEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASC 191 (846)
Q Consensus 113 ~~~~ll~~~~~~C~~~~V~-~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C 191 (846)
...+.|+.+. .+.++. ++.. +..|++.++|+++++++++|+||||+++++.+.+.+. |.++..|+..++ |
T Consensus 228 ~~~~~l~~~~---~~~~~~~~~~~-v~~g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~---Gsv~~~vl~~~~--~ 298 (319)
T 3olq_A 228 QHLIAMKELR---QKFSIPEEKTH-VKEGLPEQVIPQVCEELNAGIVVLGILGRTGLSAAFL---GNTAEQLIDHIK--C 298 (319)
T ss_dssp HHHHHHHHHH---HHTTCCGGGEE-EEESCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHH---HHHHHHHHTTCC--S
T ss_pred HHHHHHHHHH---HHhCCCcccEE-EecCCcHHHHHHHHHHhCCCEEEEeccCccCCccccc---cHHHHHHHhhCC--C
Confidence 5555555544 455654 3344 4557999999999999999999999999999988775 788999999976 9
Q ss_pred EEEEEe
Q 003121 192 HIWFIC 197 (846)
Q Consensus 192 ~v~~i~ 197 (846)
.|.+|-
T Consensus 299 pVLvv~ 304 (319)
T 3olq_A 299 DLLAIK 304 (319)
T ss_dssp EEEEEC
T ss_pred CEEEEC
Confidence 999993
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=5.6e-10 Score=123.43 Aligned_cols=140 Identities=17% Similarity=0.261 Sum_probs=107.3
Q ss_pred cceeeeeCceEEEEEEECCeEEEEEEec--CCCC-CCchhHHHHHHHHHhcC--CCceeeEeccccCc-----eEEEEEe
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLH--PHSL-QGPSEFQQEIDILSKIR--HPNLVTLVGACPEV-----WTLVYEY 602 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~VAIK~l~--~~~~-~~~~~f~~Ei~iL~~l~--HpnIv~l~g~~~~~-----~~lVmEy 602 (846)
.+.|+.|.++.||+....+..+++|+.. .... .....+.+|+.+|+.|. +.++.++++++.+. .++||||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 4568999999999998888889999876 3321 23457889999999997 45577888887543 7899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK-------------------------------------- 644 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------- 644 (846)
++|..+.+.. ...++...+..++.+++..|..||...
T Consensus 123 v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 123 VSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred cCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9998875422 234778888999999999999999731
Q ss_pred -----------------CCceEecccCCCceEecCCCc--eeeecccccccc
Q 003121 645 -----------------PHSIVHGDLKPANILLDANFV--SKLSDFGISRFL 677 (846)
Q Consensus 645 -----------------~~giiHrDLkp~NILl~~~~~--vKL~DFGla~~~ 677 (846)
+..++|+|++|.|||++.++. +.|+||+.+..-
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997653 689999988753
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.04 E-value=7.4e-10 Score=118.95 Aligned_cols=119 Identities=18% Similarity=0.204 Sum_probs=99.6
Q ss_pred CCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHH
Q 003121 44 EDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMC 121 (846)
Q Consensus 44 ~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 121 (846)
.++|+||+|+| +.|.+||.||++-. .+..|.|+||.++.. .++.++.+
T Consensus 170 ~~~Ilv~~d~s-~~s~~al~~a~~la~~~~~~l~ll~v~~~~~-----------------------------~~~~l~~~ 219 (294)
T 3loq_A 170 FDRVLVAYDFS-KWADRALEYAKFVVKKTGGELHIIHVSEDGD-----------------------------KTADLRVM 219 (294)
T ss_dssp TSEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEECSSSC-----------------------------CHHHHHHH
T ss_pred CCEEEEEECCC-HHHHHHHHHHHHHhhhcCCEEEEEEEccCch-----------------------------HHHHHHHH
Confidence 37999999999 99999999999874 477999999986532 13356666
Q ss_pred HHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEec
Q 003121 122 LLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICN 198 (846)
Q Consensus 122 ~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~~ 198 (846)
...+.+.+++++..+. .|++.++|+++++++++|+||||+++++.+.+.+. +.++..|+..++ |.|.++..
T Consensus 220 ~~~l~~~~~~~~~~~~-~g~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~---Gs~~~~vl~~~~--~pvLvv~~ 290 (294)
T 3loq_A 220 EEVIGAEGIEVHVHIE-SGTPHKAILAKREEINATTIFMGSRGAGSVMTMIL---GSTSESVIRRSP--VPVFVCKR 290 (294)
T ss_dssp HHHHHHTTCCEEEEEE-CSCHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHH---HCHHHHHHHHCS--SCEEEECS
T ss_pred HHHHHHcCCcEEEEEe-cCCHHHHHHHHHHhcCcCEEEEeCCCCCCccceee---CcHHHHHHhcCC--CCEEEECC
Confidence 7777778999887664 46999999999999999999999999999888775 778899999876 99999854
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=7.4e-10 Score=119.90 Aligned_cols=130 Identities=12% Similarity=0.158 Sum_probs=96.5
Q ss_pred CEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCL 122 (846)
Q Consensus 45 ~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~ 122 (846)
++|+||+|+| +.|.+||.||++-. .+..|++|||.++..... .+. .. +.... +..++.++++.
T Consensus 172 ~~Ilv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~-----~~~--~~---~~~~~----~~~~~~l~~~~ 236 (309)
T 3cis_A 172 APVLVGVDGS-SASELATAIAFDEASRRNVDLVALHAWSDVDVSE-----WPG--ID---WPATQ----SMAEQVLAERL 236 (309)
T ss_dssp CCEEEECCSS-HHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCTT-----CSS--CC---HHHHH----HHHHHHHHHHH
T ss_pred CeEEEEeCCC-hHHHHHHHHHHHHHHhcCCEEEEEEEeecccccC-----CCc--cc---HHHHH----HHHHHHHHHHH
Confidence 6899999999 99999999999873 578999999987643211 111 11 12222 23334444444
Q ss_pred HHHhh--cCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEe
Q 003121 123 LICRQ--MGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFIC 197 (846)
Q Consensus 123 ~~C~~--~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~ 197 (846)
..+.. .+++++..+. .|+|.++|+++++ ++|+||||+++++.+.|.+. |.++..|+..++ |-|.++-
T Consensus 237 ~~~~~~~~~~~~~~~~~-~g~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~---Gsv~~~vl~~~~--~pVlvv~ 305 (309)
T 3cis_A 237 AGWQERYPNVAITRVVV-RDQPARQLVQRSE--EAQLVVVGSRGRGGYAGMLV---GSVGETVAQLAR--TPVIVAR 305 (309)
T ss_dssp TTHHHHCTTSCEEEEEE-SSCHHHHHHHHHT--TCSEEEEESSCSSCCTTCSS---CHHHHHHHHHCS--SCEEEEC
T ss_pred HHHHhhCCCCcEEEEEE-cCCHHHHHHHhhC--CCCEEEECCCCCCCcccccc---CcHHHHHHhcCC--CCEEEeC
Confidence 44433 5788887664 5799999999998 99999999999998887775 788999999976 9999984
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=7.5e-10 Score=115.63 Aligned_cols=128 Identities=16% Similarity=0.144 Sum_probs=94.0
Q ss_pred eee-eeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc--eeeEecccc--CceEEEEEecCCCch
Q 003121 535 KIG-EGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVGACP--EVWTLVYEYLPNGSL 608 (846)
Q Consensus 535 ~LG-~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn--Iv~l~g~~~--~~~~lVmEy~~ggsL 608 (846)
.++ .|..+.||+.... +..+++|+.... ....+.+|+.+|+.+.+.+ +.++++++. +..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 4556999998765 467999997654 2357899999999996544 445777663 357899999999988
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK-------------------------------------------- 644 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------------- 644 (846)
. .. . .+ ...++.+++..|..||...
T Consensus 103 ~--~~--~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--SS--H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--TS--C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--cC--c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 4 31 1 11 2356778888888888743
Q ss_pred -----------CCceEecccCCCceEecCCCceeeeccccccc
Q 003121 645 -----------PHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 645 -----------~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
+..++|+|++|.|||++.++.+.|+|||.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999997653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=2.6e-09 Score=115.25 Aligned_cols=180 Identities=21% Similarity=0.227 Sum_probs=120.8
Q ss_pred ceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCc--eeeEecccc--C---ceEEEEEecCC
Q 003121 534 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPN--LVTLVGACP--E---VWTLVYEYLPN 605 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-Hpn--Iv~l~g~~~--~---~~~lVmEy~~g 605 (846)
..++.|.+..||+.. ..+++|+.... .....+.+|..+|+.+. +.. +.++++... + ..|+||+|++|
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458999999999753 56888986532 22457889999998883 322 334444432 1 34789999999
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK----------------------------------------- 644 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~----------------------------------------- 644 (846)
.+|.+... ..++...+..++.+++..|..||...
T Consensus 101 ~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 101 VPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp EECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred eECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 98875432 23667778888889999888888621
Q ss_pred --------------CCceEecccCCCceEecC--CCceeeeccccccccccccccCCCccccccCCCCCCccc---CChh
Q 003121 645 --------------PHSIVHGDLKPANILLDA--NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY---MDPE 705 (846)
Q Consensus 645 --------------~~giiHrDLkp~NILl~~--~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y---~APE 705 (846)
+..++|+|++|.|||++. ++.+.|+||+.+..-....... ....+ ..|+
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~------------~~~~~~~~~~~~ 243 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI------------SLMEDDEEYGME 243 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH------------TTCCTTTSCCHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH------------HHHhhccccCHH
Confidence 135899999999999998 5668899999887543211000 01111 2333
Q ss_pred hhcc-----CCCC---------chhhHHHHHHHHHHHHhCCCCC
Q 003121 706 FLAS-----GELT---------PKSDVYSFGIILLRLLTGRPAL 735 (846)
Q Consensus 706 ~l~~-----~~~~---------~ksDVwSlGviL~elltG~~pf 735 (846)
.... +..+ ...+.|++|.++|.+.+|.++|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 2211 1111 2368999999999999998776
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=4.8e-08 Score=103.04 Aligned_cols=111 Identities=15% Similarity=0.099 Sum_probs=87.2
Q ss_pred CEEEEEecCCccccHHHHHHHhhc--CCCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVKESKSVLLWALQN--SGGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCL 122 (846)
Q Consensus 45 ~~V~VAVD~s~~~S~~AL~Wal~n--~~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~ 122 (846)
++|+||+|+| +.|.+||.||.+- ..+..|.++||.++. +..+..++++.
T Consensus 155 ~~ilv~~d~s-~~~~~al~~a~~la~~~~a~l~ll~v~~~~----------------------------~~~~~~l~~~~ 205 (268)
T 3ab8_A 155 EGALLGYDAS-ESAVRALHALAPLARALGLGVRVVSVHEDP----------------------------ARAEAWALEAE 205 (268)
T ss_dssp CEEEEECCSC-HHHHHHHHHHHHHHHHHTCCEEEEEECSSH----------------------------HHHHHHHHHHH
T ss_pred CEEEEEECCC-HHHHHHHHHHHHhhhcCCCEEEEEEEcCcH----------------------------HHHHHHHHHHH
Confidence 6999999999 9999999998775 347789999998542 12334566677
Q ss_pred HHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 123 LICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 123 ~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
..+.+.|++++..+. .|++.++|+++++++ |+||||+ .+.+.+ .|.++..|+..++ |-|.++
T Consensus 206 ~~l~~~~~~~~~~~~-~g~~~~~i~~~a~~~--dliV~G~----~~~~~~---~Gs~~~~vl~~~~--~pvlvv 267 (268)
T 3ab8_A 206 AYLRDHGVEASALVL-GGDAADHLLRLQGPG--DLLALGA----PVRRLV---FGSTAERVIRNAQ--GPVLTA 267 (268)
T ss_dssp HHHHHTTCCEEEEEE-CSCHHHHHHHHCCTT--EEEEEEC----CCSCCS---SCCHHHHHHHHCS--SCEEEE
T ss_pred HHHHHcCCceEEEEe-CCChHHHHHHHHHhC--CEEEECC----cccccE---eccHHHHHHhcCC--CCEEEe
Confidence 777778999887664 579999999999999 9999998 333333 3678889998865 888876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3.4e-06 Score=91.06 Aligned_cols=134 Identities=20% Similarity=0.215 Sum_probs=91.9
Q ss_pred cceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCC---ceeeEeccc---cCceEEEEEecCCC
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP---NLVTLVGAC---PEVWTLVYEYLPNG 606 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hp---nIv~l~g~~---~~~~~lVmEy~~gg 606 (846)
...++.|....||+. +..+++|+... ......+.+|..+|..|.+. .+.+++.++ ....++||+|++|.
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 345888888899986 67788888532 11235688999999999642 244445444 23477999999998
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC------------------------------------------- 643 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~------------------------------------------- 643 (846)
+|.+... ..++......++.+++..|..||..
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8876321 1234455556666666666666642
Q ss_pred --------------CCCceEecccCCCceEecC---CCc-eeeeccccccc
Q 003121 644 --------------KPHSIVHGDLKPANILLDA---NFV-SKLSDFGISRF 676 (846)
Q Consensus 644 --------------~~~giiHrDLkp~NILl~~---~~~-vKL~DFGla~~ 676 (846)
.+..++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 344 58999997754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3.2e-06 Score=92.87 Aligned_cols=77 Identities=5% Similarity=0.027 Sum_probs=54.7
Q ss_pred cee-eeeCceEEEEEEEC--------CeEEEEEEecCCC---CCCchhHHHHHHHHHhcC-C--CceeeEeccccC----
Q 003121 534 LKI-GEGGYGSIYKGLLR--------HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIR-H--PNLVTLVGACPE---- 594 (846)
Q Consensus 534 ~~L-G~G~fG~Vy~g~~~--------~~~VAIK~l~~~~---~~~~~~f~~Ei~iL~~l~-H--pnIv~l~g~~~~---- 594 (846)
+.| +.|....+|+.... +..+++|+..... ......+.+|+.+|+.|. + ..+.++++++.+
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 77888999988765 6678999865432 112356889999999884 2 346677776643
Q ss_pred -ceEEEEEecCCCchhh
Q 003121 595 -VWTLVYEYLPNGSLED 610 (846)
Q Consensus 595 -~~~lVmEy~~ggsL~~ 610 (846)
..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 3579999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=9.1e-06 Score=90.79 Aligned_cols=74 Identities=18% Similarity=0.132 Sum_probs=52.3
Q ss_pred cceeeeeCceEEEEEEE--CCeEEEEEEecCCCC-------CCchhHHHHHHHHHhcCC--C-ceeeEeccccCceEEEE
Q 003121 533 SLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-------QGPSEFQQEIDILSKIRH--P-NLVTLVGACPEVWTLVY 600 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~--~~~~VAIK~l~~~~~-------~~~~~f~~Ei~iL~~l~H--p-nIv~l~g~~~~~~~lVm 600 (846)
...||.|.++.||++.. .+..++||...+... ...+.+..|..+|+.+.. | .+.+++.+..+..++||
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm 114 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 114 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence 45689999999999954 457899998654321 234567889999988742 3 34466666666788999
Q ss_pred EecCCC
Q 003121 601 EYLPNG 606 (846)
Q Consensus 601 Ey~~gg 606 (846)
||+++.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1.2e-05 Score=84.56 Aligned_cols=132 Identities=20% Similarity=0.179 Sum_probs=90.5
Q ss_pred eeeeeCce-EEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEeccc--cCceEEEEEecCCCch
Q 003121 535 KIGEGGYG-SIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPNGSL 608 (846)
Q Consensus 535 ~LG~G~fG-~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~lVmEy~~ggsL 608 (846)
.+..|..| .||+.... +..+.+|+-... ....+.+|..+|+.|. +--+.++++++ .+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 35556555 68886554 457889986532 2346889999999884 22345566665 4568899999999888
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK-------------------------------------------- 644 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------------- 644 (846)
.+..... ......+..+++..|..||...
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7654211 1233456666677777777532
Q ss_pred -----------CCceEecccCCCceEecCCCceeeeccccccc
Q 003121 645 -----------PHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 645 -----------~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
+..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999887777999997653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.94 E-value=2e-05 Score=85.38 Aligned_cols=138 Identities=15% Similarity=0.132 Sum_probs=81.8
Q ss_pred ceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-----CCceeeEe-c----cccCceEEEEEec
Q 003121 534 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----HPNLVTLV-G----ACPEVWTLVYEYL 603 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-----HpnIv~l~-g----~~~~~~~lVmEy~ 603 (846)
..|+.|..+.||+....+..+++|+... ....+..|..++..|. .|.++... | ...+..++||+|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3566677889999888777799999875 2345566777776663 24443311 1 1234578999999
Q ss_pred CCCchh-----------hh---hcc--CCC--C-------CCCCHHHHH-------------------------------
Q 003121 604 PNGSLE-----------DR---LSC--KDN--S-------PPLSWQTRI------------------------------- 627 (846)
Q Consensus 604 ~ggsL~-----------~~---L~~--~~~--~-------~~l~~~~~~------------------------------- 627 (846)
+|.++. .. ++. ... . ....|...+
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 01 110 000 0 011232110
Q ss_pred HHHHHHHHHHHHHhh----------cCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 628 RIATELCSVLIFLHS----------CKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 628 ~i~~qia~aL~~LH~----------~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.+...+..++.+|+. ..+..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666653 134789999999999999888889999999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.74 E-value=7.8e-05 Score=83.96 Aligned_cols=73 Identities=15% Similarity=0.104 Sum_probs=47.2
Q ss_pred cceeeeeCceEEEEEEECCeEEEEEEecCCCC-------CCchhHHHHHHHHHhc---CCCceeeEeccccCceEEEEEe
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL-------QGPSEFQQEIDILSKI---RHPNLVTLVGACPEVWTLVYEY 602 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~-------~~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~~~~~lVmEy 602 (846)
...||.|..+.||+....+..++||...+... ........|.+++..+ ....+.+++.+..+..++||||
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~~~~~~lv~e~ 118 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFDRTMALIGMRY 118 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEETTTTEEEECC
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEECCCccEEEEee
Confidence 45689899999999877677899995432111 1112333344444333 2345667777767778999999
Q ss_pred c-CC
Q 003121 603 L-PN 605 (846)
Q Consensus 603 ~-~g 605 (846)
+ +|
T Consensus 119 l~~g 122 (420)
T 2pyw_A 119 LEPP 122 (420)
T ss_dssp CCTT
T ss_pred cCCc
Confidence 9 77
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00046 Score=74.29 Aligned_cols=140 Identities=14% Similarity=0.159 Sum_probs=81.8
Q ss_pred ceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc--eeeEecc--------ccCceEEEEEec
Q 003121 534 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVGA--------CPEVWTLVYEYL 603 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn--Iv~l~g~--------~~~~~~lVmEy~ 603 (846)
+.|+.|....+|+....+..+++|+.... .....+..|+.++..|...+ +.+++.. ..+..+++|+|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 45677888899998877778999988753 23456788999888874212 2333322 134568999999
Q ss_pred CCCchhh--------------hhccC--CCCCC----C---CHHHHHH------------HHHHHHHHHHHHhhc----C
Q 003121 604 PNGSLED--------------RLSCK--DNSPP----L---SWQTRIR------------IATELCSVLIFLHSC----K 644 (846)
Q Consensus 604 ~ggsL~~--------------~L~~~--~~~~~----l---~~~~~~~------------i~~qia~aL~~LH~~----~ 644 (846)
+|..+.. .++.. .-..+ . .|...+. +...+...+.+|+.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 9865421 01110 00000 1 1222110 001134455555532 2
Q ss_pred CCceEecccCCCceEecCCCceeeecccccc
Q 003121 645 PHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 645 ~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
+.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4679999999999999987666899999765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00037 Score=74.56 Aligned_cols=71 Identities=8% Similarity=0.104 Sum_probs=48.6
Q ss_pred cceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEeccccCceEEEEEec-CCCch
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYL-PNGSL 608 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lVmEy~-~ggsL 608 (846)
.+.|+.|....+|+. ..+++|+....... .-...+|+.+++.+..-++ .++++.+.+..++|+||+ +|.+|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccC
Confidence 567888999999988 56888887653221 1234678888887742222 466777777778999999 66555
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00059 Score=73.77 Aligned_cols=73 Identities=21% Similarity=0.105 Sum_probs=56.8
Q ss_pred cceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC---CCceeeEeccc--cCceEEEEEecCCCc
Q 003121 533 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR---HPNLVTLVGAC--PEVWTLVYEYLPNGS 607 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~--~~~~~lVmEy~~ggs 607 (846)
...|+.|.+..+|+....+..+++|+.... ....|..|...|+.|. ...+.++++++ .+..++||||++|..
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 356899999999998877788999987643 2457889999998883 35566777665 356899999999876
Q ss_pred h
Q 003121 608 L 608 (846)
Q Consensus 608 L 608 (846)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00081 Score=71.38 Aligned_cols=77 Identities=16% Similarity=0.113 Sum_probs=55.9
Q ss_pred CcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCC---CceeeEeccccCceEEEEEecCC
Q 003121 530 FDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH---PNLVTLVGACPEVWTLVYEYLPN 605 (846)
Q Consensus 530 f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~H---pnIv~l~g~~~~~~~lVmEy~~g 605 (846)
......+|.|..+.||+.... |+.|.+|+...........|..|...|+.|.- -.+.+++++ +..++||||+++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~~lv~e~l~~ 94 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETTEEEEECCCC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cCceEEEEeecc
Confidence 344567999999999999876 68899998765544445678999999998842 123445544 335789999987
Q ss_pred Cch
Q 003121 606 GSL 608 (846)
Q Consensus 606 gsL 608 (846)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00047 Score=74.77 Aligned_cols=140 Identities=11% Similarity=0.054 Sum_probs=74.8
Q ss_pred eeeeeCceE-EEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCC--CceeeEeccccCceEEEEEecCCCchhh
Q 003121 535 KIGEGGYGS-IYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH--PNLVTLVGACPEVWTLVYEYLPNGSLED 610 (846)
Q Consensus 535 ~LG~G~fG~-Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~H--pnIv~l~g~~~~~~~lVmEy~~ggsL~~ 610 (846)
.|+.|+... +|+.... +..+++|...+.. ...+..|+.++..|.. -.+.+++.++.+..++|||++.+..+.+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g~ll~e~l~~~~l~~ 101 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARGLLLIEDLGDALFTE 101 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTTEEEECCCCSCBHHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCCEEEEeeCCCcchHH
Confidence 465555544 6676654 6677777654432 1355678888877742 2345566655454578999997766643
Q ss_pred hhccC---------------------C--CCCCCCHHHHH-------H-HH------------HHHHHHHHHHh---hcC
Q 003121 611 RLSCK---------------------D--NSPPLSWQTRI-------R-IA------------TELCSVLIFLH---SCK 644 (846)
Q Consensus 611 ~L~~~---------------------~--~~~~l~~~~~~-------~-i~------------~qia~aL~~LH---~~~ 644 (846)
.+... . ..+.++..... . +. ..+...+..|. ...
T Consensus 102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~ 181 (333)
T 3csv_A 102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG 181 (333)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence 33110 0 01112221110 0 00 01111222221 123
Q ss_pred CCceEecccCCCceEecCC----Cceeeecccccccc
Q 003121 645 PHSIVHGDLKPANILLDAN----FVSKLSDFGISRFL 677 (846)
Q Consensus 645 ~~giiHrDLkp~NILl~~~----~~vKL~DFGla~~~ 677 (846)
+..++|||+.+.|||++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4689999999999999874 67899999987653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0014 Score=74.71 Aligned_cols=73 Identities=14% Similarity=0.069 Sum_probs=49.8
Q ss_pred cceeeeeCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEeccccCceEEEEEecCCCch
Q 003121 533 SLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGSL 608 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~--~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lVmEy~~ggsL 608 (846)
...|+.|-...+|+....+ ..+++|+....... .-...+|..+|..|...++ .++++.+.+ .+||||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC--eEEEEeeCCccC
Confidence 3468888889999998876 78999987543211 1123689999999965444 467777754 359999998655
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00062 Score=76.93 Aligned_cols=71 Identities=20% Similarity=0.254 Sum_probs=50.3
Q ss_pred ceeeeeCceEEEEEEEC---------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEeccccCceEEEEEec
Q 003121 534 LKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYL 603 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~---------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lVmEy~ 603 (846)
..|+.|....||+.... +..+++|+.... .....+..|..++..|...++ .++++.+.+. +||||+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~g--~v~e~l 154 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSGG--RLEEYI 154 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETTE--EEECCC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCCC--EEEEEe
Confidence 46888888999998865 367999988432 112566789999998853333 5677776643 899999
Q ss_pred CCCch
Q 003121 604 PNGSL 608 (846)
Q Consensus 604 ~ggsL 608 (846)
+|.+|
T Consensus 155 ~G~~l 159 (429)
T 1nw1_A 155 PSRPL 159 (429)
T ss_dssp CEEEC
T ss_pred CCccc
Confidence 87554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0014 Score=72.78 Aligned_cols=140 Identities=21% Similarity=0.261 Sum_probs=83.8
Q ss_pred ceeeeeCceEEEEEEEC---------CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEeccccCceEEEEEec
Q 003121 534 LKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYL 603 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~---------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~lVmEy~ 603 (846)
+.|..|-...+|+.... +..+++|+... .......+.+|..+++.|. +.-..++++.|.+. +||||+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g--~v~e~i 132 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG--RLEQYI 132 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE--EEEECC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc--cEEEEe
Confidence 35666778889988764 36789988633 2234556779999998884 32235667777663 999999
Q ss_pred CCCchhhh--------------h---ccCC--CCCCC--CHHHHHHHHHHHHH-------------------HHHHHh--
Q 003121 604 PNGSLEDR--------------L---SCKD--NSPPL--SWQTRIRIATELCS-------------------VLIFLH-- 641 (846)
Q Consensus 604 ~ggsL~~~--------------L---~~~~--~~~~l--~~~~~~~i~~qia~-------------------aL~~LH-- 641 (846)
+|.+|... | +... ...+. -+.++.++..++.. .+..|.
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 98665421 0 1111 01112 24455555543321 223332
Q ss_pred --h-cCCCceEecccCCCceEecCC----Cceeeeccccccc
Q 003121 642 --S-CKPHSIVHGDLKPANILLDAN----FVSKLSDFGISRF 676 (846)
Q Consensus 642 --~-~~~~giiHrDLkp~NILl~~~----~~vKL~DFGla~~ 676 (846)
. ..+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 123579999999999999876 7899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0027 Score=69.84 Aligned_cols=72 Identities=14% Similarity=0.135 Sum_probs=44.5
Q ss_pred ceeeeeCceEEEEEEECC----------eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc-eeeEeccccCceEEEEEe
Q 003121 534 LKIGEGGYGSIYKGLLRH----------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGACPEVWTLVYEY 602 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~----------~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~lVmEy 602 (846)
..|+.|....+|+....+ ..+++|+...... .......|..++..|...+ +.++++.+. .++||+|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~--~~~v~e~ 115 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN--GGRIEEW 115 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET--TEEEEEC
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC--CcEEEEE
Confidence 457778888999987764 6788888654321 1113468999998884333 335665543 4689999
Q ss_pred cCCCch
Q 003121 603 LPNGSL 608 (846)
Q Consensus 603 ~~ggsL 608 (846)
++|.++
T Consensus 116 i~G~~l 121 (369)
T 3c5i_A 116 LYGDPL 121 (369)
T ss_dssp CCSEEC
T ss_pred ecCCcC
Confidence 998654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.011 Score=63.46 Aligned_cols=139 Identities=12% Similarity=0.138 Sum_probs=81.3
Q ss_pred ceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCC--ceeeEecc-------ccCceEEEEEec
Q 003121 534 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGA-------CPEVWTLVYEYL 603 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~l~g~-------~~~~~~lVmEy~ 603 (846)
..|+ |....||+.... +..+++|+..+.. .....+..|..++..|... .+.+++.. ..+..++||+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4576 888899987664 4579999987442 2456788899998887421 23444433 123457899999
Q ss_pred CCCchhh-----------h---hcc----CC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHhh--
Q 003121 604 PNGSLED-----------R---LSC----KD--NSPPLSWQTR----IRI---------------ATELCSVLIFLHS-- 642 (846)
Q Consensus 604 ~ggsL~~-----------~---L~~----~~--~~~~l~~~~~----~~i---------------~~qia~aL~~LH~-- 642 (846)
+|..+.. . ++. .. ....+++... ..+ ...+...+..|..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865421 0 110 00 0112222211 001 1111122333322
Q ss_pred --cCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 643 --CKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 643 --~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1346799999999999999 4 889999997653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0072 Score=65.83 Aligned_cols=33 Identities=15% Similarity=0.255 Sum_probs=28.6
Q ss_pred CCceEecccCCCceEecCCCceeeecccccccc
Q 003121 645 PHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 645 ~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+..++|+|+.+.|||++.++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 357999999999999998888999999877643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.16 E-value=0.024 Score=57.45 Aligned_cols=123 Identities=16% Similarity=0.123 Sum_probs=76.8
Q ss_pred CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCC
Q 003121 606 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 685 (846)
Q Consensus 606 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 685 (846)
-+|.++|... ..|+++.++|.++.|.+.+|.-+-... ++ ..+=+.|..|+|..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 3788988655 468999999999999999987762111 11 1233457899999999887653 1110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCChh
Q 003121 686 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764 (846)
Q Consensus 686 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 764 (846)
.....+.+||.+. ...+.+.=|||||+++|.-+- |-++ +-+..
T Consensus 98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-------------------------~eE~e 141 (229)
T 2yle_A 98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-------------------------NEERE 141 (229)
T ss_dssp -------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-------------------------TEEEC
T ss_pred ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-------------------------ccchh
Confidence 0233466888763 344678899999999998875 2111 12234
Q ss_pred hHHHHHHHHHHHhcc
Q 003121 765 QAEQLANLAMRCCEM 779 (846)
Q Consensus 765 ~~~~l~~Li~~Cl~~ 779 (846)
.++.|-.||..|+..
T Consensus 142 LS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 142 LSPPLEQLIDHMANT 156 (229)
T ss_dssp CCHHHHHHHHHHTTC
T ss_pred hCHHHHHHHHHHHhc
Confidence 456788888888765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.44 E-value=0.083 Score=59.30 Aligned_cols=139 Identities=14% Similarity=0.182 Sum_probs=84.5
Q ss_pred ceeeeeCceEEEEEEEC---------CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEeccccCceEEEEEec
Q 003121 534 LKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYL 603 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~---------~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~lVmEy~ 603 (846)
+.|..|-...+|+.... +..+++++...... ..-...+|..+++.|. +.-..++++.+. .++||+|+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~~~I~efI 152 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP--EGRIEEFI 152 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET--TEEEEECC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC--CCEEEEEe
Confidence 45766778889998876 57799998654321 1223468999998884 222345555444 36899999
Q ss_pred CCCchhhh--------------h---ccC-------C---CCCCCCHHHHHHHHHHH-------------------HHHH
Q 003121 604 PNGSLEDR--------------L---SCK-------D---NSPPLSWQTRIRIATEL-------------------CSVL 637 (846)
Q Consensus 604 ~ggsL~~~--------------L---~~~-------~---~~~~l~~~~~~~i~~qi-------------------a~aL 637 (846)
+|.+|... | +.. . ...+.-+.++..+..++ ...+
T Consensus 153 ~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e~ 232 (424)
T 3mes_A 153 DGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEEI 232 (424)
T ss_dssp CSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHHH
T ss_pred CCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHHH
Confidence 98764210 0 000 0 11222344444443322 1222
Q ss_pred HHHhh---------------------cCCCceEecccCCCceEecCCCceeeeccccccc
Q 003121 638 IFLHS---------------------CKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 638 ~~LH~---------------------~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
..|.. ..+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 233 ~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 233 DQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 33321 12356899999999999 7788999999998764
|
| >2fxo_A Myosin heavy chain, cardiac muscle beta isoform; coiled coil (dimeric, parallel), familial hypertrophic cardiomyopathy, FHC-associated mutant E924K; 2.50A {Homo sapiens} SCOP: h.1.26.1 PDB: 2fxm_A | Back alignment and structure |
|---|
Probab=93.78 E-value=4.1 Score=37.54 Aligned_cols=99 Identities=20% Similarity=0.245 Sum_probs=49.1
Q ss_pred HHHHHhhHHHHHHHHHHHHHHHHHhhchHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHhHHHHHHHHHHHHHHHHHH
Q 003121 395 RRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 474 (846)
Q Consensus 395 ~k~~~~e~~~~eE~k~rke~e~~La~~k~ele~~~~~~~e~~eel~~~~~q~~~l~~q~~e~~~~~~ele~~~~~~~e~l 474 (846)
...+.++..+..+...|++++.....-..+...+..+++.-.+-+..+.+....+..+..+......+++.+ +
T Consensus 20 eel~~lke~l~k~e~~r~ele~~~~~l~~Ek~~L~~qL~~E~~~l~e~EE~~~~L~~~k~eLe~~l~el~~r-------l 92 (129)
T 2fxo_A 20 EEFTRLKEALEKSEARRKELEEKMVSLLQEKNDLQLQVQAEQDNLADAEERCDQLIKNKIQLEAKVKEMNKR-------L 92 (129)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-------H
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHH-------H
Confidence 345556666777778888888777666666666655554433333333333333333333333333333333 3
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 475 QNYKKEQDELQMERDKAVKEAEELRK 500 (846)
Q Consensus 475 ~~~k~e~~e~~~~~~~~~~e~e~~r~ 500 (846)
.........+...+.+...+...++.
T Consensus 93 eeeee~~~~L~~~kkkle~e~~~Lk~ 118 (129)
T 2fxo_A 93 EDEEEMNAELTAKKRKLEDECSELKR 118 (129)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 33333333444444444444444443
|
| >3vkg_A Dynein heavy chain, cytoplasmic; AAA+ protein, molecular motor, microtubles, motor protein; HET: ADP SPM; 2.81A {Dictyostelium discoideum} PDB: 3vkh_A* | Back alignment and structure |
|---|
Probab=93.52 E-value=2.2 Score=58.77 Aligned_cols=14 Identities=14% Similarity=0.173 Sum_probs=9.2
Q ss_pred cCCCEEEEccCCCC
Q 003121 153 YGIRKLVMGAAADK 166 (846)
Q Consensus 153 ~~i~~LVmGs~~~~ 166 (846)
-+-+.|.+|-.|.|
T Consensus 1645 p~GhaLLVGvgGSG 1658 (3245)
T 3vkg_A 1645 PQGHALLIGVSGGG 1658 (3245)
T ss_dssp TTCCEEEEESTTSS
T ss_pred CCCCeEEecCCCCc
Confidence 34577888876655
|
| >3vkg_A Dynein heavy chain, cytoplasmic; AAA+ protein, molecular motor, microtubles, motor protein; HET: ADP SPM; 2.81A {Dictyostelium discoideum} PDB: 3vkh_A* | Back alignment and structure |
|---|
Probab=92.57 E-value=2.6 Score=57.92 Aligned_cols=10 Identities=20% Similarity=0.404 Sum_probs=5.6
Q ss_pred HHH-HHHHHhc
Q 003121 769 LAN-LAMRCCE 778 (846)
Q Consensus 769 l~~-Li~~Cl~ 778 (846)
|.+ |+.+|++
T Consensus 2595 fqkLlllr~lR 2605 (3245)
T 3vkg_A 2595 FRKILLMKAFH 2605 (3245)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHHHhC
Confidence 434 3667774
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=92.46 E-value=1.3 Score=51.53 Aligned_cols=34 Identities=26% Similarity=0.319 Sum_probs=13.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 465 QKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 498 (846)
Q Consensus 465 ~~~~~~~e~l~~~k~e~~e~~~~~~~~~~e~e~~ 498 (846)
++.......++..+++..+++.+......+..++
T Consensus 544 ~~~~~le~~~~~~~~~~~~l~~e~~~~~~~~~~l 577 (597)
T 3oja_B 544 QENIALEKQLDNKRAKQAELRQETSLKRQKVKQL 577 (597)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhhhhHHHHHHHHHHHHHHHHHHH
Confidence 3333333333344444444444443333333333
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.40 E-value=0.62 Score=51.60 Aligned_cols=30 Identities=33% Similarity=0.444 Sum_probs=25.2
Q ss_pred ceEecccCCCceEe------cCCCceeeeccccccc
Q 003121 647 SIVHGDLKPANILL------DANFVSKLSDFGISRF 676 (846)
Q Consensus 647 giiHrDLkp~NILl------~~~~~vKL~DFGla~~ 676 (846)
.++|+|+.+.|||+ +.+..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998764
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A | Back alignment and structure |
|---|
Probab=91.16 E-value=0.65 Score=58.90 Aligned_cols=31 Identities=3% Similarity=0.093 Sum_probs=19.2
Q ss_pred HHHHHHHHHHHHHHHHHH-----HHHhhcCCeeeEE
Q 003121 105 AYREIERQDMHNHLDMCL-----LICRQMGVRAEKL 135 (846)
Q Consensus 105 ~~~~~~~~~~~~ll~~~~-----~~C~~~~V~~e~~ 135 (846)
.+.+..+++.+.++.... ..+.+-||....+
T Consensus 479 lciNy~nEkLq~~f~~~~f~~eq~ey~~Egi~~~~i 514 (1184)
T 1i84_S 479 LCINYTNEKLQQLFNHTMFILEQEEYQREGIEWNFI 514 (1184)
T ss_dssp HHHHHHHHHHHHHHHHHHTHHHHHHHHHHTCSCCCC
T ss_pred HHHHHHHHHHHHHHHHhhhHHHHHHHHhcCCCcccc
Confidence 455666666666665543 4556778877644
|
| >3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori} | Back alignment and structure |
|---|
Probab=90.97 E-value=16 Score=37.63 Aligned_cols=7 Identities=0% Similarity=-0.130 Sum_probs=3.5
Q ss_pred eCceEEE
Q 003121 539 GGYGSIY 545 (846)
Q Consensus 539 G~fG~Vy 545 (846)
||-|.|.
T Consensus 189 ~g~avv~ 195 (256)
T 3na7_A 189 KNTSIVT 195 (256)
T ss_dssp GGGSEEE
T ss_pred CCceEEE
Confidence 4555553
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=89.91 E-value=7.5 Score=48.56 Aligned_cols=30 Identities=3% Similarity=0.017 Sum_probs=15.6
Q ss_pred HHHHHHHHHHHHHHHH-----HHHHhhcCCeeeEE
Q 003121 106 YREIERQDMHNHLDMC-----LLICRQMGVRAEKL 135 (846)
Q Consensus 106 ~~~~~~~~~~~ll~~~-----~~~C~~~~V~~e~~ 135 (846)
..+..+++.+.++... ...+.+-||....+
T Consensus 453 cINy~NEkLQq~F~~~~f~~EqeeY~~EgI~w~~i 487 (1080)
T 2dfs_A 453 CINYANEKLQQQFNMHVFKLEQEEYMKEQIPWTLI 487 (1080)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHTCCTTCC
T ss_pred HHHhhhHHHHHHHHHHhhHHHHHHHhhcCCccccc
Confidence 4455555555544443 24445567766544
|
| >3qwe_A GMIP, GEM-interacting protein; structural genomics consortium, SGC, protein binding; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.56 E-value=9.4 Score=39.84 Aligned_cols=57 Identities=28% Similarity=0.420 Sum_probs=48.4
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHH
Q 003121 357 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE 413 (846)
Q Consensus 357 ~~~~~l~~~~~~~e~~~~~a~~e~~r~~~a~~~~~~~~~k~~~~e~~~~eE~k~rke 413 (846)
.+++.|.....++++.|+++-++..|.+|.-.++..+++|||.-=....+|..+-+.
T Consensus 98 ~~~~~L~~~~~e~ek~RK~~Ke~w~r~eKk~~dae~~l~KAK~~Y~~r~ee~ekak~ 154 (279)
T 3qwe_A 98 DYYQPLAAKRTEIEKWRKEFKEQWMKEQKRMNEAVQALRRAQLQYVQRSEDLRARSQ 154 (279)
T ss_dssp HTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 467888889999999999999999999999999999999999877777777665444
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A | Back alignment and structure |
|---|
Probab=88.27 E-value=1.8 Score=54.88 Aligned_cols=7 Identities=29% Similarity=0.833 Sum_probs=4.2
Q ss_pred HHHHhhc
Q 003121 62 LLWALQN 68 (846)
Q Consensus 62 L~Wal~n 68 (846)
|.|-++.
T Consensus 438 F~wlv~~ 444 (1184)
T 1i84_S 438 FRWILTR 444 (1184)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 4576664
|
| >2b9c_A Striated-muscle alpha tropomyosin; alpha-helix, coiled coil, alanine, axial stagger, radius, SIDE-chain packing, crystal packing; 2.30A {Rattus norvegicus} SCOP: h.1.5.1 | Back alignment and structure |
|---|
Probab=87.02 E-value=16 Score=34.37 Aligned_cols=91 Identities=26% Similarity=0.221 Sum_probs=51.1
Q ss_pred HHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhhchHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHhHHHHHHHHH
Q 003121 386 AEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQ 465 (846)
Q Consensus 386 a~~~~~~~~~k~~~~e~~~~eE~k~rke~e~~La~~k~ele~~~~~~~e~~eel~~~~~q~~~l~~q~~e~~~~~~ele~ 465 (846)
|++.+=++-|..|.+|+--...-.+-..+|..|...+...+...+..+++...|..+.......+.+.........+|+.
T Consensus 29 aek~adE~eR~~k~lE~r~~~deEr~~~lE~qLkeak~~aeeadrKyeE~~RKl~~~E~dLeraeeRae~aE~k~~eLEe 108 (147)
T 2b9c_A 29 AEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEE 108 (147)
T ss_dssp HHHHHHHHTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhhhcccHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 44555455555555555544444455556666666666666666666666666666555555555555555555666666
Q ss_pred HHHHHHHHHHH
Q 003121 466 KIISAVELLQN 476 (846)
Q Consensus 466 ~~~~~~e~l~~ 476 (846)
++......++.
T Consensus 109 eL~~~~~nlKs 119 (147)
T 2b9c_A 109 ELKTVTNNLKS 119 (147)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 55544444433
|
| >2ocy_A RAB guanine nucleotide exchange factor SEC2; RAB, GEF, guanine exchange factor, coiled-coil, endocytosis/exocytosis complex; 3.30A {Saccharomyces cerevisiae} SCOP: h.1.33.1 | Back alignment and structure |
|---|
Probab=86.54 E-value=22 Score=33.58 Aligned_cols=38 Identities=21% Similarity=0.123 Sum_probs=26.7
Q ss_pred HHHHHhhHHHHHHHHHHHHHHHHHhhchHHHHHHHHHH
Q 003121 395 RRAKASESLYAEELKRRKEFEEALANGKLELERMKKQH 432 (846)
Q Consensus 395 ~k~~~~e~~~~eE~k~rke~e~~La~~k~ele~~~~~~ 432 (846)
.+.+.+...+.+|..+|.+.|.+...-..|++++--.+
T Consensus 58 ~e~~~L~~~l~~E~~~R~~aE~~~~~ie~ElEeLTasL 95 (154)
T 2ocy_A 58 DEVKRLREDIAKENELRTKAEEEADKLNKEVEDLTASL 95 (154)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34555666777888888888877777777777776444
|
| >3tnu_B Keratin, type II cytoskeletal 5; coiled-coil, structural support, cytosolic protein; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.42 E-value=14 Score=33.79 Aligned_cols=63 Identities=22% Similarity=0.328 Sum_probs=30.5
Q ss_pred HHHHhhHHHHHHHHHHHH----HHHHHhhchHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHhHH
Q 003121 396 RAKASESLYAEELKRRKE----FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQ 458 (846)
Q Consensus 396 k~~~~e~~~~eE~k~rke----~e~~La~~k~ele~~~~~~~e~~eel~~~~~q~~~l~~q~~e~~~ 458 (846)
...+.|.||..-+..-+. -.+.+...|.++.++++..+.+--+++-++.++..|+..+.+...
T Consensus 5 nr~eaE~~y~~K~eel~~~~~~~~~~l~~~k~Ei~elrr~iq~L~~el~~l~~~~~~LE~~l~e~e~ 71 (129)
T 3tnu_B 5 SRTEAESWYQTKYEELQQTAGRHGDDLRNTKHEISEMNRMIQRLRAEIDNVKKQCANLQNAIADAEQ 71 (129)
T ss_dssp -----------------------------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHH
Confidence 345667777654332111 134677788999999998888888888777778888777766543
|
| >3bas_A Myosin heavy chain, striated muscle/general control protein GCN4 chimera; alpha-helical coiled coil, disorder, salt links; 2.30A {Argopecten irradians} SCOP: h.1.26.1 PDB: 1nkn_A 3bat_A | Back alignment and structure |
|---|
Probab=84.17 E-value=8.5 Score=32.97 Aligned_cols=33 Identities=15% Similarity=0.080 Sum_probs=18.4
Q ss_pred HHHHhhHHHHHHHHHHHHHHHHHhhchHHHHHH
Q 003121 396 RAKASESLYAEELKRRKEFEEALANGKLELERM 428 (846)
Q Consensus 396 k~~~~e~~~~eE~k~rke~e~~La~~k~ele~~ 428 (846)
..+.....+..+...|++++.....--.+...+
T Consensus 22 el~~lke~l~k~e~~rkele~~~~~l~~ek~~L 54 (89)
T 3bas_A 22 QMDKMKEDLAKTERIKKELEEQNVTLLEQKNDL 54 (89)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 344455556666677777776655433333333
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=84.04 E-value=20 Score=44.79 Aligned_cols=11 Identities=9% Similarity=0.138 Sum_probs=5.3
Q ss_pred CcEEEEEeeCC
Q 003121 72 KRICIIHVHTP 82 (846)
Q Consensus 72 ~~l~lvHV~~p 82 (846)
.....|+..-|
T Consensus 654 t~phfVRCIkP 664 (1080)
T 2dfs_A 654 TTPHYVRCIKP 664 (1080)
T ss_dssp SEEEEEEEECC
T ss_pred cCCeeEEEecC
Confidence 34455555444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.69 E-value=4.2 Score=40.87 Aligned_cols=114 Identities=7% Similarity=0.189 Sum_probs=74.8
Q ss_pred cCCCceeeE-eccccCceEEEEEecCCC-chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCc
Q 003121 580 IRHPNLVTL-VGACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 657 (846)
Q Consensus 580 l~HpnIv~l-~g~~~~~~~lVmEy~~gg-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~N 657 (846)
..||+.+.. +..-.+.+.+.++.-..+ ++.. + ..++...+++++..|+....+++. -+|--|.|+|
T Consensus 42 ~~~~~Fl~~~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 42 QHSPYFIDAELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp SCCTTBCCEEEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred ccCCcccceEEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 367887744 222244444444443322 3333 2 236778999999999998766654 5888999999
Q ss_pred eEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003121 658 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 735 (846)
Q Consensus 658 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf 735 (846)
|+++.++.+++.-.|+-..+. |. .++...=+-.+=|++..+++++..|
T Consensus 110 L~f~~~~~p~i~~RGik~~l~-------------------------P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVD-------------------------PL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp EEECTTSCEEESCCEETTTBS-------------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEEcCCCCEEEEEccCccCCC-------------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999999888643221 11 1122222345778899999998887
|
| >2efr_A General control protein GCN4 and tropomyosin 1 Al; destabilizing cluster, hydrophobic core, contractIle protein; 1.80A {Saccharomyces cerevisiae} PDB: 2efs_A 2d3e_A | Back alignment and structure |
|---|
Probab=80.39 E-value=40 Score=31.88 Aligned_cols=58 Identities=16% Similarity=0.173 Sum_probs=27.7
Q ss_pred HHHHHHhHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 439 LQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAE 496 (846)
Q Consensus 439 l~~~~~q~~~l~~q~~e~~~~~~ele~~~~~~~e~l~~~k~e~~e~~~~~~~~~~e~e 496 (846)
+..+..+....+.+..........|+..+...-..+...+.....++...+....++.
T Consensus 79 Ik~L~~kLKEAE~RAE~AERsv~kLEk~id~lEd~L~~~Kek~~~i~~eLd~tl~el~ 136 (155)
T 2efr_A 79 IKVLSDKLKEAETRAEFAERSVTKLEKSIDDLEDELYAQKLKYKAISEEMKQLEDKVE 136 (155)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3333344444444444444555555555555544455445444445444444444433
|
| >2i1j_A Moesin; FERM, coiled-coil, C-ermad, ERM, radixin, ezrin, MER actin binding, masking, regulation, SELF-inhibition, cell A membrane protein; 2.10A {Spodoptera frugiperda} PDB: 2i1k_A 1e5w_A | Back alignment and structure |
|---|
Probab=80.18 E-value=2.3 Score=49.33 Aligned_cols=23 Identities=9% Similarity=0.186 Sum_probs=15.6
Q ss_pred CEEEEEecCCccccHHHHHHHhhc
Q 003121 45 DKIYVAVAKQVKESKSVLLWALQN 68 (846)
Q Consensus 45 ~~V~VAVD~s~~~S~~AL~Wal~n 68 (846)
+.+-|.||.+ ..+...|.=..++
T Consensus 14 gt~e~~vd~~-tt~~ell~~V~~~ 36 (575)
T 2i1j_A 14 AELEFAIQQT-TTGKQLFDQVVKT 36 (575)
T ss_dssp CEEEEEEETT-CBHHHHHHHHHHH
T ss_pred CeEEEEECCC-CCHHHHHHHHHHH
Confidence 3555778877 6777777666665
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 846 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-18 | |
| d1f5na1 | 300 | a.114.1.1 (A:284-583) Interferon-induced guanylate | 8e-06 | |
| d1eq1a_ | 166 | a.63.1.1 (A:) Apolipophorin-III {Manduca sexta [Ta | 5e-05 | |
| d2es4d1 | 280 | a.137.15.1 (D:53-332) Lipase chaperone LifO (LipB) | 4e-04 | |
| d2es4d1 | 280 | a.137.15.1 (D:53-332) Lipase chaperone LifO (LipB) | 8e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-64
Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 26/276 (9%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC 592
+IG G +G++YKG VA+KML+ + Q F+ E+ +L K RH N++ +G
Sbjct: 15 RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 593 PEVWT-LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
+V ++ SL L I IA + + +LH SI+H
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL---A 708
DLK NI L + K+ DFG++ S+ S L G+ +M PE +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSILWMAPEVIRMQD 182
Query: 709 SGELTPKSDVYSFGIILLRLLTGRP---ALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765
+ +SDVY+FGI+L L+TG+ + ++ + + G L L + + P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP--- 239
Query: 766 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801
+ + L C + R RP + +E + S
Sbjct: 240 -KAMKRLMAECLKKKRDERPLF-PQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 8e-57
Identities = 73/270 (27%), Positives = 120/270 (44%), Gaps = 22/270 (8%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 592
++G G +G ++ G H +VA+K L S P F E +++ +++H LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 593 PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 652
E ++ EY+ NGSL D L + L+ + +A ++ + F+ + +H D
Sbjct: 79 QEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 653 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 712
L+ ANIL+ K++DFG++R + NE R K + PE + G
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNE-------YTAREGAKFPIKWTAPEAINYGTF 187
Query: 713 TPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLAN 771
T KSDV+SFGI+L ++T GR + ++NL P E+L
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCPEELYQ 241
Query: 772 LAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801
L C + + RP + VLE +
Sbjct: 242 LMRLCWKERPEDRPTF-DYLRSVLEDFFTA 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-54
Identities = 65/269 (24%), Positives = 114/269 (42%), Gaps = 28/269 (10%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 592
IG+G +G + G R +VA+K + + F E +++++RH NLV L+G
Sbjct: 14 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 593 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
+V EY+ GSL D L + S L ++ + ++C + +L ++ VH
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NNFVHR 127
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL N+L+ + V+K+SDFG+++ S + K + PE L +
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASST-----------QDTGKLPVKWTAPEALREKK 176
Query: 712 LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 770
+ KSDV+SFGI+L + + GR + + D P +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCPPAVY 230
Query: 771 NLAMRCCEMSRKSRPELGKDVWRVLEPMR 799
+ C + RP + LE ++
Sbjct: 231 EVMKNCWHLDAAMRPSF-LQLREQLEHIK 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-54
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 523 IEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSK 579
+E +F+ ++G G G ++K + + +A K++H ++ +E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 580 IRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 637
P +V GA ++ E++ GSL+ L + + Q +++ + L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 638 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
+L H I+H D+KP+NIL+++ KL DFG+S L + G
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----------ANSFVG 165
Query: 698 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
T +YM PE L + +SD++S G+ L+ + GR
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 3e-54
Identities = 72/304 (23%), Positives = 129/304 (42%), Gaps = 35/304 (11%)
Query: 514 FFSDFSFSEIEGATHNFDPSL---------KIGEGGYGSIYKGLLR-----HMQVAIKML 559
F F+F + A F + IG G +G + G L+ + VAIK L
Sbjct: 3 FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62
Query: 560 HP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKD 616
++ + +F E I+ + HPN++ L G ++ E++ NGSL+ +
Sbjct: 63 KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF--LRQ 120
Query: 617 NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 676
N + + + + + + +L + VH DL NIL+++N V K+SDFG+SRF
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPA 734
L + +++ T K + PE + + T SDV+S+GI++ +++ RP
Sbjct: 178 LEDD---TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234
Query: 735 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 794
+T + + + P L L + C + R RP+ +
Sbjct: 235 WDMTNQDV-------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF-GQIVNT 286
Query: 795 LEPM 798
L+ M
Sbjct: 287 LDKM 290
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 5e-54
Identities = 78/269 (28%), Positives = 119/269 (44%), Gaps = 20/269 (7%)
Query: 535 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 592
K+G+G +G ++ G +VAIK L P + P F QE ++ K+RH LV L
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 82
Query: 593 PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 652
E +V EY+ GSL + L + +A ++ S + ++ + VH D
Sbjct: 83 EEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 138
Query: 653 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 712
L+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 139 LRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRF 191
Query: 713 TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANL 772
T KSDV+SFGI+L L T + LD + P + P E L +L
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECP----ESLHDL 246
Query: 773 AMRCCEMSRKSRPELGKDVWRVLEPMRAS 801
+C + RP + + LE S
Sbjct: 247 MCQCWRKEPEERPTF-EYLQAFLEDYFTS 274
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 7e-54
Identities = 60/270 (22%), Positives = 119/270 (44%), Gaps = 22/270 (8%)
Query: 535 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 592
+IG G +G ++ G + VAIK + + +F +E +++ K+ HP LV L G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 593 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 651
LV+E++ +G L D + + +T + + ++C + + ++H
Sbjct: 71 EQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEGM---AYLEEACVIHR 125
Query: 652 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 711
DL N L+ N V K+SDFG++RF+ ++ +S+ T K + PE +
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWASPEVFSFSR 178
Query: 712 LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLAN 771
+ KSDV+SFG+++ + + + ++++ P + + +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKPRLASTHVYQ 233
Query: 772 LAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801
+ C + + RP + R L + S
Sbjct: 234 IMNHCWKERPEDRPAF-SRLLRQLAEIAES 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-53
Identities = 65/297 (21%), Positives = 114/297 (38%), Gaps = 42/297 (14%)
Query: 535 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 592
IG+G +G +++G R +VA+K+ + + EI +RH N++ + A
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNK 68
Query: 593 ----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS-----C 643
LV +Y +GSL D L N ++ + I++A S L LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
+I H DLK NIL+ N ++D G++ S+ +T GT YM
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD----SATDTIDIAPNHRVGTKRYMA 180
Query: 704 PEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-------------A 744
PE L E ++D+Y+ G++ + GI ++ Q
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 745 LDTGKLKNLLDP-LAGDWPFVQA-EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799
+ + L P + W +A +A + C + +R + + L +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLS 296
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 5e-53
Identities = 56/262 (21%), Positives = 105/262 (40%), Gaps = 30/262 (11%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 590
+IG G + ++YKGL ++VA L L F++E ++L ++HPN+V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 591 AC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
+ + LV E + +G+L+ L + + ++ L FLH+
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 645 PHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
P I+H DLK NI + K+ D G++ +S + GT +M
Sbjct: 133 PP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVI------GTPEFMA 181
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763
PE + + DVY+FG+ +L + T + ++ + + P +
Sbjct: 182 PE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR--RVTSGVKPA--SFDK 236
Query: 764 VQAEQLANLAMRCCEMSRKSRP 785
V ++ + C ++ R
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERY 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 184 bits (467), Expect = 5e-53
Identities = 72/288 (25%), Positives = 140/288 (48%), Gaps = 24/288 (8%)
Query: 516 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQE 573
S ++ + E + K+G G YG +Y+G+ + + VA+K L +++ EF +E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 574 IDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 631
++ +I+HPNLV L+G C + ++ E++ G+L D L + N +S + +AT
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMAT 122
Query: 632 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 691
++ S + +L + +H DL N L+ N + K++DFG+SR ++ + +++
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA--- 176
Query: 692 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 751
K + PE LA + + KSDV++FG++L + T + +D ++
Sbjct: 177 ----KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP------YPGIDLSQVY 226
Query: 752 NLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
LL+ + P E++ L C + + RP ++ + E M
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETM 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 6e-53
Identities = 57/270 (21%), Positives = 110/270 (40%), Gaps = 24/270 (8%)
Query: 534 LKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 588
+++G G +GS+ +G+ R + VAIK+L + + E +E I+ ++ +P +V L
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 589 VGACPEV-WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+G C LV E G L L + + ++ + +L +
Sbjct: 75 IGVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLE---EKN 129
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
VH DL N+LL +K+SDFG+S+ L ++ + + PE +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK-----WPLKWYAPECI 184
Query: 708 ASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 766
+ + +SDV+S+G+ + L+ G+ K + + + + P
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGKRMECPPECP 238
Query: 767 EQLANLAMRCCEMSRKSRPELGKDVWRVLE 796
+L L C + RP+ V + +
Sbjct: 239 PELYALMSDCWIYKWEDRPDF-LTVEQRMR 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-52
Identities = 61/272 (22%), Positives = 115/272 (42%), Gaps = 23/272 (8%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 587
+ ++G G +G + G R VAIKM+ S EF +E ++ + H LV
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 588 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
L G C ++ EY+ NG L + L + Q + + ++C + +L
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+H DL N L++ V K+SDFG+SR++ +E +S K + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-------SVGSKFPVRWSPPE 171
Query: 706 FLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764
L + + KSD+++FG+++ + + G+ + +++ L P +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQGLRLYRPHL 225
Query: 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796
+E++ + C RP + +L+
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-52
Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 535 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 588
++G G +G++ KG + VA+K+L + E E +++ ++ +P +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 589 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+G C E W LV E G L L + + + I + ++ + +L +
Sbjct: 74 IGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
VH DL N+LL +K+SDFG+S+ L ++ +T K + PE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALR-----ADENYYKAQTHGKWPVKWYAPECI 182
Query: 708 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 764
+ + KSDV+SFG+++ + +P G+ EV L+ G+ P
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----RMGCPAGCP-- 236
Query: 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
++ +L C ++RP V L
Sbjct: 237 --REMYDLMNLCWTYDVENRPGF-AAVELRLRNY 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 6e-52
Identities = 63/268 (23%), Positives = 106/268 (39%), Gaps = 25/268 (9%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPN 584
+++ IG G YG K + + K L S+ E+++L +++HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 585 LVTLVGAC----PEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 639
+V +V EY G L ++ L + +R+ T+L L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 640 LH--SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 697
H S H+++H DLKPAN+ LD KL DFG++R L+ + +S
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVG------ 176
Query: 698 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757
T YM PE + KSD++S G +L L P + + + +
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREGK 230
Query: 758 AGDWPFVQAEQLANLAMRCCEMSRKSRP 785
P+ +++L + R + RP
Sbjct: 231 FRRIPYRYSDELNEIITRMLNLKDYHRP 258
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 61/260 (23%), Positives = 108/260 (41%), Gaps = 26/260 (10%)
Query: 535 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
++G+G +G +YK + A K++ S + ++ EIDIL+ HPN+V L+ A
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
++ E+ G+++ + + PL+ + + L +LH + I+H
Sbjct: 79 YYENNLWILIEFCAGGAVDAVM--LELERPLTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS- 709
DLK NIL + KL+DFG+S ++ T+ R GT +M PE +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTR--------TIQRRDSFIGTPYWMAPEVVMCE 185
Query: 710 ----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765
K+DV+S GI L+ + P ++ L K + W
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS--- 242
Query: 766 AEQLANLAMRCCEMSRKSRP 785
+ +C E + +R
Sbjct: 243 -SNFKDFLKKCLEKNVDARW 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-51
Identities = 71/274 (25%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNL 585
++D +GEG YG + + R VA+K++ ++ P ++EI I + H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 586 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
V G + L EY G L DR+ + R +L + +++LH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG- 121
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
I H D+KP N+LLD K+SDFG++ N +C GT Y+
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVA 173
Query: 704 PEFLASGEL-TPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDW 761
PE L E DV+S GI+L +L G + Q D + K L+P W
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP----W 229
Query: 762 PFVQAEQLANLAMRCCEMSRKSRP---ELGKDVW 792
+ + L + + +R ++ KD W
Sbjct: 230 KKIDSA-PLALLHKILVENPSARITIPDIKKDRW 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-50
Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 26/277 (9%)
Query: 535 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 588
IG G +G +Y G L + A+K L+ + G S+F E I+ HPN+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 589 VGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
+G C +V Y+ +G L + ++ + + + I ++ +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
VH DL N +LD F K++DFG++R + E ++ +T K +M E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF----DSVHNKTGAKLPVKWMALE 204
Query: 706 FLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764
L + + T KSDV+SFG++L L+T G P + + + LL P P
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--EYCP-- 260
Query: 765 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801
+ L + ++C + RP ++ + + ++
Sbjct: 261 --DPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFST 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 65/260 (25%), Positives = 107/260 (41%), Gaps = 23/260 (8%)
Query: 535 KIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLV 586
K+G+G +G + +G + + VA+K L P L + +F +E++ + + H NL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 587 TLVGACPEVWT-LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
L G +V E P GSL DR + + T R A ++ + +L S
Sbjct: 75 RLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLGTLSRYAVQVAEGMGYLES--- 129
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
+H DL N+LL + K+ DFG+ R L QN+ FA+ PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK-----VPFAWCAPE 184
Query: 706 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765
L + + SD + FG+ L + T I L + P D P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP--- 241
Query: 766 AEQLANLAMRCCEMSRKSRP 785
+ + N+ ++C + RP
Sbjct: 242 -QDIYNVMVQCWAHKPEDRP 260
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 27/290 (9%)
Query: 521 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQG-PSEFQQE 573
+EI IG G +G +YKG+L+ + VAIK L + +F E
Sbjct: 2 TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59
Query: 574 IDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 631
I+ + H N++ L G + ++ EY+ NG+L+ ++ S + +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF--LREKDGEFSVLQLVGMLR 117
Query: 632 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 691
+ + + +L + VH DL NIL+++N V K+SDFG+SR L + ++ T+
Sbjct: 118 GIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 692 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 751
+ PE ++ + T SDV+SFGI++ ++T +K
Sbjct: 175 -----IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MK 224
Query: 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801
+ D P + L M+C + R RP+ D+ +L+ + +
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKF-ADIVSILDKLIRA 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 6e-50
Identities = 65/261 (24%), Positives = 100/261 (38%), Gaps = 33/261 (12%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLV 589
+IG G +G++Y VAIK + Q + +E+ L K+RHPN +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 590 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
G LV EY + + + + PL + L +LHS H+
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDL---LEVHKKPLQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
++H D+K NILL + KL DFG + ++ GT +M PE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------------NSFVGTPYWMAPEVI 183
Query: 708 AS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764
+ G+ K DV+S GI + L +P L + AL +G W
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPALQSGHWS-- 240
Query: 765 QAEQLANLAMRCCEMSRKSRP 785
E N C + + RP
Sbjct: 241 --EYFRNFVDSCLQKIPQDRP 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 7e-50
Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 30/264 (11%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHP 583
+F+ +G+G +G++Y + +A+K+L L+ + ++E++I S +RHP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 584 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
N++ L G L+ EY P G++ L Q TEL + L + H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH 123
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
S ++H D+KP N+LL + K++DFG S SS TTLC GT Y
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC------GTLDY 170
Query: 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761
+ PE + K D++S G++ L G+P A + + + +
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFTF 223
Query: 762 PFVQAEQLANLAMRCCEMSRKSRP 785
P E +L R + + RP
Sbjct: 224 PDFVTEGARDLISRLLKHNPSQRP 247
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (444), Expect = 1e-49
Identities = 72/315 (22%), Positives = 129/315 (40%), Gaps = 50/315 (15%)
Query: 517 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQG-PS 568
+ +E +N + IGEG +G +++ + VA+KML + +
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 569 EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------- 612
+FQ+E ++++ +PN+V L+G C + L++EY+ G L + L
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 613 -------SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 665
PPLS ++ IA ++ + + +L K VH DL N L+ N V
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMV 178
Query: 666 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 725
K++DFG+SR + + + +M PE + T +SDV+++G++L
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDA------IPIRWMPPESIFYNRYTTESDVWAYGVVL 232
Query: 726 LRLLTGR--PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS 783
+ + P G+ E + + D P +L NL C
Sbjct: 233 WEIFSYGLQPYYGMAHEEV-------IYYVRDGNILACPENCPLELYNLMRLCWSKLPAD 285
Query: 784 RPELGKDVWRVLEPM 798
RP + R+L+ M
Sbjct: 286 RPSF-CSIHRILQRM 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-48
Identities = 66/284 (23%), Positives = 113/284 (39%), Gaps = 48/284 (16%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKI-RHPNL 585
+G G +G + +QVA+KML + E+ +++++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 586 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK--------------------DNSPPLSW 623
V L+GAC L++EY G L + L K ++ L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 624 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683
+ + A ++ + FL S VH DL N+L+ V K+ DFG++R + +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGITKEV 741
+M PE L G T KSDV+S+GI+L + + P GI +
Sbjct: 221 VVRGNAR------LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 742 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
+ K + + D PF E++ + C + RP
Sbjct: 275 NF------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 6e-48
Identities = 60/255 (23%), Positives = 108/255 (42%), Gaps = 23/255 (9%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
KIG+G G++Y + +VAI+ ++ EI ++ + ++PN+V + +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
+ +V EYL GSL D ++ + + E L FLHS + ++H
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 710
D+K NILL + KL+DFG ++ + R+ GT +M PE +
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--------SKRSTMVGTPYWMAPEVVTRK 191
Query: 711 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 770
PK D++S GI+ + ++ G P ++ + P + + A
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIATNGTPELQNPEKLSAI-FR 247
Query: 771 NLAMRCCEMSRKSRP 785
+ RC +M + R
Sbjct: 248 DFLNRCLDMDVEKRG 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-47
Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 31/278 (11%)
Query: 535 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL 588
IGEG +G +++G+ + VAIK + E F QE + + HP++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 589 VGACPEVWT-LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 647
+G E ++ E G L + L + I A +L + L +L S +
Sbjct: 74 IGVITENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAYLESKR--- 128
Query: 648 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 707
VH D+ N+L+ +N KL DFG+SR++ + + K +M PE +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-------SKGKLPIKWMAPESI 181
Query: 708 ASGELTPKSDVYSFGIILLRLLTG--RPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765
T SDV+ FG+ + +L +P G+ P+ + P
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCP--- 235
Query: 766 AEQLANLAMRCCEMSRKSRP---ELGKDVWRVLEPMRA 800
L +L +C RP EL + +LE +A
Sbjct: 236 -PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-46
Identities = 74/308 (24%), Positives = 125/308 (40%), Gaps = 55/308 (17%)
Query: 515 FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR----HMQVAIKMLHPH-SLQGPSE 569
++D F + IGEG +G + K ++ M AIK + + S +
Sbjct: 9 WNDIKFQD------------VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 570 FQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------S 613
F E+++L K+ HPN++ L+GAC L EY P+G+L D L
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 614 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673
+ LS Q + A ++ + +L +H DL NIL+ N+V+K++DFG+
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR- 732
SR +T + +M E L T SDV+S+G++L +++
Sbjct: 174 SRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 733 -PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791
P G+T Y + L + P +++ +L +C RP +
Sbjct: 225 TPYCGMTCAELY-------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQI 276
Query: 792 WRVLEPMR 799
L M
Sbjct: 277 LVSLNRML 284
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-46
Identities = 64/290 (22%), Positives = 117/290 (40%), Gaps = 40/290 (13%)
Query: 535 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKI-RHPNL 585
+G G +G + + M VA+KML P + E+ +LS + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 586 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK---------------DNSPPLSWQTRIR 628
V L+GAC ++ EY G L + L K D+ L + +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 629 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688
+ ++ + FL S + +H DL NILL ++K+ DFG++R + N++
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI------KNDSN 200
Query: 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 748
+ + + +M PE + + T +SDV+S+GI L L + + V
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--- 257
Query: 749 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
K + + P ++ ++ C + RP K + +++E
Sbjct: 258 -YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-KQIVQLIEKQ 305
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (416), Expect = 4e-46
Identities = 65/276 (23%), Positives = 118/276 (42%), Gaps = 25/276 (9%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLV 589
+G GG ++ H VA+K+L + PS F++E + + HP +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 590 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
+ +V EY+ +L D + + P++ + I + + C L F H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ- 129
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
+ I+H D+KPANI++ A K+ DFGI+R ++ + S T GT Y+
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-----GTAQYLS 182
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763
PE + +SDVYS G +L +LTG P V A ++ P +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ--HVREDPIPPSARHEG 240
Query: 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799
+ + L + ++ + ++R + ++ L +
Sbjct: 241 L-SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (422), Expect = 4e-46
Identities = 54/258 (20%), Positives = 98/258 (37%), Gaps = 25/258 (9%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
++G G +G +++ R A K + ++EI +S +RHP LV L A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
++YE++ G L ++++ + N +S + ++C L +H ++ VH
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 651 GDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
DLKP NI+ + KL DFG++ L GT + PE
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---------QSVKVTTGTAEFAAPEVAE 198
Query: 709 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 767
+ +D++S G++ LL+G G + N+ D E
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS----E 254
Query: 768 QLANLAMRCCEMSRKSRP 785
+ + +R
Sbjct: 255 DGKDFIRKLLLADPNTRM 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-45
Identities = 58/278 (20%), Positives = 111/278 (39%), Gaps = 27/278 (9%)
Query: 530 FDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRH 582
F +G G +G++YKGL + VAIK L S + E E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 583 PNLVTLVGACPE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
P++ L+G C L+ + +P G L D +++ + Q + ++ + +L
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDY--VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
+VH DL N+L+ K++DFG+++ L E K +
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE------KEYHAEGGKVPIKW 179
Query: 702 MDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 760
M E + T +SDV+S+G+ + L+T G + L
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLP 233
Query: 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
P + + + ++C + SRP+ +++ M
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKM 270
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 164 bits (415), Expect = 4e-45
Identities = 54/257 (21%), Positives = 104/257 (40%), Gaps = 23/257 (8%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
++G G +G +++ + + K ++ + EI I++++ HP L+ L A
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
L+ E+L G L DR+ +S I + C L +H HSIVH
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 651 GDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
D+KP NI+ + S K+ DFG++ L+ +EI T T + PE +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---------ATAEFAAPEIVD 201
Query: 709 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 768
+ +D+++ G++ LL+G +++ + + + + V E
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--KRCDWEFDEDAFSSVSPE- 258
Query: 769 LANLAMRCCEMSRKSRP 785
+ + + R
Sbjct: 259 AKDFIKNLLQKEPRKRL 275
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 8e-45
Identities = 67/305 (21%), Positives = 129/305 (42%), Gaps = 35/305 (11%)
Query: 512 PQFFSDFSF---SEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHP 561
P++FS E E A S ++G+G +G +Y+G+ + + +VAIK ++
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 562 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNS 618
S++ EF E ++ + ++V L+G + ++ E + G L+ L +
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 619 -------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671
P S I++A E+ + +L++ + VH DL N ++ +F K+ DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 731
G++R + + + +M PE L G T SDV+SFG++L + T
Sbjct: 178 GMTRDIYETDYYRKGGKGL------LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231
Query: 732 RPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791
+ L+ +++ D P + L L C + + K RP ++
Sbjct: 232 AEQPYQGLSNEQV-----LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-LEI 285
Query: 792 WRVLE 796
++
Sbjct: 286 ISSIK 290
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-44
Identities = 60/264 (22%), Positives = 100/264 (37%), Gaps = 26/264 (9%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHP 583
+F +GEG + ++ + AIK+L + + +E D++S++ HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 584 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
V L E Y NG L + E+ S L +LH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLH 125
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
I+H DLKP NILL+ + +++DFG ++ LS + + GT Y
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV------GTAQY 176
Query: 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761
+ PE L SD+++ G I+ +L+ G P E KL+ D+
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-------YDF 229
Query: 762 PFVQAEQLANLAMRCCEMSRKSRP 785
P + +L + + R
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRL 253
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-44
Identities = 51/258 (19%), Positives = 101/258 (39%), Gaps = 26/258 (10%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
+G G +G +++ + K + ++EI IL+ RH N++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 593 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
E +++E++ + +R+ ++ L+ + + ++C L FLHS H+I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 651 GDLKPANILLDA--NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
D++P NI+ + K+ +FG +R L + Y PE
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---------NFRLLFTAPEYYAPEVHQ 176
Query: 709 SGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 767
++ +D++S G ++ LL+G P L T + + +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS----I 232
Query: 768 QLANLAMRCCEMSRKSRP 785
+ + R RKSR
Sbjct: 233 EAMDFVDRLLVKERKSRM 250
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 4e-43
Identities = 63/260 (24%), Positives = 100/260 (38%), Gaps = 28/260 (10%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGA 591
+G G + + + VAIK + +L+G + EI +L KI+HPN+V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 592 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
L+ + + G L DR+ K + + R+ ++ + +LH IV
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IV 129
Query: 650 HGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
H DLKP N+L D + +SDFG+S+ + +T C GT Y+ PE
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STAC------GTPGYVAPEV 180
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765
LA + D +S G+I LL G P + P D
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS--- 237
Query: 766 AEQLANLAMRCCEMSRKSRP 785
+ + E + R
Sbjct: 238 -DSAKDFIRHLMEKDPEKRF 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (394), Expect = 4e-43
Identities = 67/278 (24%), Positives = 111/278 (39%), Gaps = 40/278 (14%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---------FQQEIDIL 577
N++P +G G + + + + + A+K++ S +E+DIL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 578 SKIR-HPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 634
K+ HPN++ L LV++ + G L D L+ LS + +I L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALL 120
Query: 635 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 694
V+ LH +IVH DLKP NILLD + KL+DFG S L E +
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---------KLRE 168
Query: 695 PKGTFAYMDPEFLASGEL------TPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDT 747
GT +Y+ PE + + D++S G+I+ LL G P + + +
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228
Query: 748 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
P D+ + + +L R + + R
Sbjct: 229 SGNYQFGSPEWDDYS----DTVKDLVSRFLVVQPQKRY 262
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 1e-41
Identities = 49/261 (18%), Positives = 92/261 (35%), Gaps = 20/261 (7%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
KIG G +G IY G +VAIK+ + + E I ++ + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 593 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
+ +V E L + S S +T + +A ++ S + ++HS + +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFI 125
Query: 650 HGDLKPANIL---LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 706
H D+KP N L + + DFG+++ + + + GT Y
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR-THQHIPYRENKNLTGTARYASINT 184
Query: 707 LASGELTPKSDVYSFGIILLRLLTGRPAL--GITKEVQYALDTGKLKNLLDPLAGDWPFV 764
E + + D+ S G +L+ G + + K + P+
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 765 QAEQLANLAMRCCEMSRKSRP 785
+E A C + +P
Sbjct: 245 PSE-FATYLNFCRSLRFDDKP 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-40
Identities = 62/265 (23%), Positives = 102/265 (38%), Gaps = 29/265 (10%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSK-IRH 582
+F +G+G +G ++ + AIK L + + E +LS H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 583 PNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
P L + E V EYL G L + + A E+ L FL
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL 119
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
HS IV+ DLK NILLD + K++DFG+ + + + T C GT
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFC------GTPD 168
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760
Y+ PE L + D +SFG++L +L G+ + D +L + +
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-------HGQDEEELFHSIRMDNPF 221
Query: 761 WPFVQAEQLANLAMRCCEMSRKSRP 785
+P ++ +L ++ + R
Sbjct: 222 YPRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 67/294 (22%), Positives = 120/294 (40%), Gaps = 45/294 (15%)
Query: 535 KIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHP 583
+GEG +G + +VA+KML + + S+ E++++ I +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 584 NLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIR 628
N++ L+GAC + ++ EY G+L + L + + LS + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 629 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 688
A ++ + +L S +H DL N+L+ + V K++DFG++R + + T
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 689 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGITKEVQYALD 746
+M PE L T +SDV+SFG++L + T P G+ E +
Sbjct: 197 GR------LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF--- 247
Query: 747 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800
K L + D P +L + C RP K + L+ + A
Sbjct: 248 ----KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRIVA 296
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (373), Expect = 3e-40
Identities = 49/266 (18%), Positives = 92/266 (34%), Gaps = 28/266 (10%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
+IGEG +G I++G LL + QVAIK S + + E + + V
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 593 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
LV + L + S +T A ++ + + +H S+V
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDL---LDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123
Query: 650 HGDLKPANILLDANFVS-----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 704
+ D+KP N L+ + DFG+ +F + ++ + + + GT YM
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR-DPVTKQHIPYREKKNLSGTARYMSI 182
Query: 705 EFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP-----LAG 759
E + + D+ + G + + L G K ++ L
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 760 DWPFVQAEQLANLAMRCCEMSRKSRP 785
+P E+ ++ + P
Sbjct: 243 GFP----EEFYKYMHYARNLAFDATP 264
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (374), Expect = 4e-40
Identities = 62/264 (23%), Positives = 104/264 (39%), Gaps = 31/264 (11%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHP 583
+F +G G +G ++ RH A+K+L + + E +LS + HP
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 584 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
++ + G + ++ +Y+ G L L P A E+C L +LH
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYLH 121
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
S I++ DLKP NILLD N K++DFG ++++ GT Y
Sbjct: 122 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----------TYTLCGTPDY 167
Query: 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761
+ PE +++ D +SFGI++ +L G Y +T K + +
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-------YDSNTMKTYEKILNAELRF 220
Query: 762 PFVQAEQLANLAMRCCEMSRKSRP 785
P E + +L R R
Sbjct: 221 PPFFNEDVKDLLSRLITRDLSQRL 244
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-39
Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 16/263 (6%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGA 591
IGEG YG + ++VAIK + P Q +EI IL + RH N++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 592 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
P + + YL + L + LS ++ L ++HS +++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 709
H DLKP+N+LL+ K+ DFG++R ++ T+ T Y PE + +
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARV-----ADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 710 GEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 768
+ T D++S G IL +L+ RP + L L P D + +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQEDLNCIINLK 244
Query: 769 LANLAMRCCEMSRKSRPELGKDV 791
N + ++ L +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNA 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 60/289 (20%), Positives = 107/289 (37%), Gaps = 39/289 (13%)
Query: 535 KIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQGP-SEFQQEIDILSKIRH-PNL 585
+G G +G + + + VA+KML + E+ IL I H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 586 VTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSP-------------PLSWQTRIRI 629
V L+GAC + ++ E+ G+L L K N L+ + I
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 630 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 689
+ ++ + FL S +H DL NILL V K+ DFG++R + ++
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 690 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 749
+M PE + T +SDV+SFG++L + + + ++
Sbjct: 197 R------LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---- 246
Query: 750 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
+ L + P ++ + C RP ++ L +
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNL 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 55/264 (20%), Positives = 105/264 (39%), Gaps = 33/264 (12%)
Query: 536 IGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 592
+G G G + + + + A+KML + ++E+++ + + P++V +V
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVY 74
Query: 593 PEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 646
++ +V E L G L R+ + + I + + +LHS
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 647 SIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
+I H D+KP N+L + N + KL+DFG ++ + + T P T Y+
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYTPYYVA 181
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLTGRPAL--GITKEVQYALDTGKLKNLLDPLAGDW 761
PE L + D++S G+I+ LL G P + + T + +W
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 762 PFVQAEQLANLAMRCCEMSRKSRP 785
V +E++ L + R
Sbjct: 242 SEV-SEEVKMLIRNLLKTEPTQRM 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (363), Expect = 3e-38
Identities = 64/269 (23%), Positives = 106/269 (39%), Gaps = 33/269 (12%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQE---IDILSKI 580
+F IG GG+G +Y A+K L + QG + E + ++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 581 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 638
P +V + A P+ + + + + G L LS S A E+ L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLE 121
Query: 639 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 698
+H+ +V+ DLKPANILLD + ++SD G++ S+ + GT
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----------PHASVGT 168
Query: 699 FAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDP 756
YM PE L G +D +S G +L +LL G P + ++ +D L +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-- 226
Query: 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRP 785
+ P + +L +L + R
Sbjct: 227 ---ELPDSFSPELRSLLEGLLQRDVNRRL 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-38
Identities = 60/266 (22%), Positives = 104/266 (39%), Gaps = 34/266 (12%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGP------SEFQQEIDILSKIRHPNLV 586
++G G + + K + +Q A K + + + ++E+ IL +I+HPN++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 587 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 644
TL L+ E + G L D L+ + ++ + + +LHS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFD---FLAEKESLTEEEATEFLKQILNGVYYLHS-- 131
Query: 645 PHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
I H DLKP NI+L V K+ DFG++ + + GT
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---------EFKNIFGTPE 181
Query: 701 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 759
++ PE + L ++D++S G+I LL+G P LG TK+ A + D
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 760 DWPFVQAEQLANLAMRCCEMSRKSRP 785
+ + R K R
Sbjct: 242 NTS----ALAKDFIRRLLVKDPKKRM 263
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 57/239 (23%), Positives = 91/239 (38%), Gaps = 36/239 (15%)
Query: 506 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS 563
++ P + S+++ + IG G +G +Y+ L VAIK +
Sbjct: 8 ATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKV---- 53
Query: 564 LQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCK 615
LQ +E+ I+ K+ H N+V L LV +Y+P
Sbjct: 54 LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 616 DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGIS 674
L +L L ++HS I H D+KP N+LLD + V KL DFG +
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
+ L + E + + + + T DV+S G +L LL G+P
Sbjct: 171 KQLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 8e-37
Identities = 68/274 (24%), Positives = 115/274 (41%), Gaps = 29/274 (10%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVG 590
KIG+G +G ++K R +VA+K + + + P +EI IL ++H N+V L+
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 591 ACPEVWT----------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 640
C + LV+++ + + + R+ L + L ++
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGL---LSNVLVKFTLSEIKRVMQMLLNGLYYI 133
Query: 641 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 700
H K I+H D+K AN+L+ + V KL+DFG++R S + N+ T+ T
Sbjct: 134 HRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK----NSQPNRYTNRVVTLW 186
Query: 701 YMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLA 758
Y PE L + P D++ G I+ + T P + G T++ Q AL +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI---SQLCGSITP 243
Query: 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792
WP V +L RK + L V
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-36
Identities = 71/289 (24%), Positives = 111/289 (38%), Gaps = 33/289 (11%)
Query: 526 ATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI 580
A ++ +IGEG YG ++K VA+K + + + P +E+ +L +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 581 ---RHPNLVTLVGACPEVWT-------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 630
HPN+V L C T LV+E++ K P + +T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMM 122
Query: 631 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 690
+L L FLHS H +VH DLKP NIL+ ++ KL+DFG++R S
Sbjct: 123 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---------M 170
Query: 691 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGK 749
T T Y PE L D++S G I + +P G + Q
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---I 227
Query: 750 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798
L + P DWP A + + K ++ + +L
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-35
Identities = 54/265 (20%), Positives = 97/265 (36%), Gaps = 42/265 (15%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE------FQQEIDILSKIR--HPN 584
+G GG+GS+Y G+ ++ VAIK + + E E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 585 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
++ L+ P+ + L+ E + L + ++ + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN 128
Query: 643 CKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
++H D+K NIL+D N KL DFG L TD GT Y
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------VYTDFDGTRVY 175
Query: 702 MDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760
PE++ + V+S GI+L ++ G +E+ G++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RGQV---------F 222
Query: 761 WPFVQAEQLANLAMRCCEMSRKSRP 785
+ + + +L C + RP
Sbjct: 223 FRQRVSSECQHLIRWCLALRPSDRP 247
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-35
Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 24/209 (11%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE-----FQQEIDILSKIRHPNLVT 587
+GEG + ++YK ++ VAIK + + +EI +L ++ HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 588 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 645
L+ A +LV++++ KDNS L+ L +LH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVI---IKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--- 118
Query: 646 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 705
H I+H DLKP N+LLD N V KL+DFG+++ T T Y PE
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--------RAYTHQVVTRWYRAPE 170
Query: 706 FLASGEL-TPKSDVYSFGIILLRLLTGRP 733
L + D+++ G IL LL P
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVP 199
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-34
Identities = 62/269 (23%), Positives = 104/269 (38%), Gaps = 28/269 (10%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHP 583
+FD +G+G +G + + A+K+L + E E +L RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 584 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 641
L L A + V EY G L LS + + E+ S L +LH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLH 122
Query: 642 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 701
S +V+ D+K N++LD + K++DFG+ + E S+ T+ GT Y
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFC---GTPEY 171
Query: 702 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761
+ PE L + D + G+++ ++ GR Y D +L L+ +
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-------YNQDHERLFELILMEEIRF 224
Query: 762 PFVQAEQLANLAMRCCEMSRKSRPELGKD 790
P + + +L + K R G
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPS 253
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 8e-34
Identities = 58/212 (27%), Positives = 87/212 (41%), Gaps = 20/212 (9%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPN 584
NF KIGEG YG +YK + VA+K + + PS +EI +L ++ HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 585 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
+V L+ LV+E+L + + +L L F HS
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
H ++H DLKP N+L++ KL+DFG++R T Y
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTL------WYR 169
Query: 703 DPEFLA-SGELTPKSDVYSFGIILLRLLTGRP 733
PE L + D++S G I ++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 129 bits (324), Expect = 8e-34
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 24/238 (10%)
Query: 535 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGA 591
KIGEG YG +YK + + A+K + PS +EI IL +++H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 592 CPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649
LV+E+L + C+ L T +L + + + H ++
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA- 708
H DLKP N+L++ K++DFG++R + + Y P+ L
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--------LWYRAPDVLMG 174
Query: 709 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQ 765
S + + D++S G I ++ G P G+++ Q + L P + +WP V
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNVT 229
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 2e-33
Identities = 55/315 (17%), Positives = 111/315 (35%), Gaps = 47/315 (14%)
Query: 478 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 537
KK ++ ++ A + + L+K + +++ + QF + +G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQF-------DRIK---------TLG 50
Query: 538 EGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVGAC 592
G +G + + A+K+L + + E IL + P LV L +
Sbjct: 51 TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110
Query: 593 PEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 650
+ L V EY+ G + L S A ++ +LHS +++
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIY 164
Query: 651 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 710
DLKP N+L+D +++DFG ++ GT + PE + S
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKR-----------VKGRTWTLCGTPEALAPEIILSK 213
Query: 711 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 770
D ++ G+++ + G P +A ++ + +P + L
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF-------FADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 771 NLAMRCCEMSRKSRP 785
+L ++ R
Sbjct: 267 DLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 8e-32
Identities = 53/270 (19%), Positives = 102/270 (37%), Gaps = 34/270 (12%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 590
+G G YG++ + +VAIK L+ +E+ +L +RH N++ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 591 ACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
T LV ++ G+ +L L + ++ L ++H+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLM---KHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
H DLKP N+ ++ + K+ DFG++R T T Y
Sbjct: 140 AGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE-----------MTGYVVTRWYR 185
Query: 703 DPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761
PE + + T D++S G I+ ++TG+ + + +K P A
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEFV 243
Query: 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791
+Q+++ N E+ +K + +
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNA 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 122 bits (307), Expect = 4e-31
Identities = 50/246 (20%), Positives = 105/246 (42%), Gaps = 31/246 (12%)
Query: 500 KSRKEASSSSHMPQFFSDFSFSEIE-GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAI 556
++R ++H P+ + D+ +E G ++ K+G G Y +++ + + +V +
Sbjct: 6 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65
Query: 557 KMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE----VWTLVYEYLPNGSLEDR 611
K+L P + + ++EI IL +R PN++TL + LV+E++ N +
Sbjct: 66 KILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122
Query: 612 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSD 670
L+ E+ L + HS I+H D+KP N+++D + +L D
Sbjct: 123 YQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLID 173
Query: 671 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLL 729
+G++ F + + + PE L ++ D++S G +L ++
Sbjct: 174 WGLAEFYHPGQE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224
Query: 730 TGRPAL 735
+
Sbjct: 225 FRKEPF 230
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 20/236 (8%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 590
KIGEG YG+++K R H VA+K + PS +EI +L +++H N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 591 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 648
TLV+E+ + SC + + +L L F H ++
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 649 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 708
+H DLKP N+L++ N KL++FG++R + T +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGI---PVRCYSAEVVT----LWYRPPDVLFG 175
Query: 709 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 764
+ + D++S G I L L +V L + L P WP +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEEQWPSM 230
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 5e-29
Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 30/276 (10%)
Query: 529 NFDPSLKIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSL----QGPSEFQQEIDILSK 579
NF+ +G G YG ++ A+K+L ++ + + E +L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 580 IRH-PNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 636
IR P LVTL A L+ +Y+ G L LS ++ Q + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG------EI 138
Query: 637 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
++ L I++ D+K NILLD+N L+DFG+S+ +E D
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-------RAYDFC 191
Query: 697 GTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 754
GT YM P+ + G+ D +S G+++ LLTG + E + +
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
Query: 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 790
+P +P + +L R K R G
Sbjct: 252 EP---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 284
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-28
Identities = 54/269 (20%), Positives = 101/269 (37%), Gaps = 32/269 (11%)
Query: 535 KIGEGGYGSIYKGLLRH--MQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVG 590
+G G YGS+ ++VA+K L S+ +E+ +L ++H N++ L+
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 591 ACPEVWTL-------VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
+L + +L L + + C+ L+ + ++ L ++HS
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS- 139
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 703
I+H DLKP+N+ ++ + K+ DFG++R +
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----------EMTGYVATRWYRAP 187
Query: 704 PEFLASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWP 762
L D++S G I+ LLTGR G Q L L+ + P A
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELLK 244
Query: 763 FVQAEQLANLAMRCCEMSRKSRPELGKDV 791
+ +E N +M + + +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGA 273
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 6e-27
Identities = 42/211 (19%), Positives = 76/211 (36%), Gaps = 30/211 (14%)
Query: 535 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 590
IG G G + VAIK L +E+ ++ + H N+++L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 591 ACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 642
T LV E + + D + + ++ + LHS
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137
Query: 643 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 702
+H DLKP+NI++ ++ K+ DFG++R + T T Y
Sbjct: 138 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---------MMTPYVVTRYYR 185
Query: 703 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
PE + D++S G I+ ++ +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (264), Expect = 2e-25
Identities = 37/217 (17%), Positives = 77/217 (35%), Gaps = 27/217 (12%)
Query: 535 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 592
K+G G + +++ ++ + VA+K++ + + EI +L ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 593 ---------------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 637
P +V + G L K + +I+ +L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 638 IFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 696
++ + I+H D+KP N+L++ L I+ + + T
Sbjct: 139 DYM--HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI------ 190
Query: 697 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 733
T Y PE L +D++S ++ L+TG
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.2 bits (197), Expect = 8e-18
Identities = 24/158 (15%), Positives = 46/158 (29%), Gaps = 19/158 (12%)
Query: 535 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL----------QGPSEFQQEIDILSKIRHP 583
+GEG +++ + +K G F ++
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 584 NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 643
L L G Y + N L + L + + + + + +
Sbjct: 67 ALQKLQGLAVPKV---YAWEGNAVLME-LIDAKELYRVRVENPDEVLDMILEEVAKFYH- 121
Query: 644 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681
IVHGDL N+L+ + + DF S + +
Sbjct: 122 --RGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156
|
| >d1f5na1 a.114.1.1 (A:284-583) Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 300 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain superfamily: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain family: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain domain: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (109), Expect = 8e-06
Identities = 22/141 (15%), Positives = 62/141 (43%)
Query: 360 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 419
L + E +A E K+++ ++I + + + +E++ + E+
Sbjct: 158 QDLKKKYYEEPRKGIQAEEILQTYLKSKESMTDAILQTDQTLTEKEKEIEVERVKAESAQ 217
Query: 420 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 479
L M+++++++ME+ + + + ++ E+D+ EQ+ A++L + +
Sbjct: 218 ASAKMLHEMQRKNEQMMEQKERSYQEHLKQLTEKMENDRVQLLKEQERTLALKLQEQEQL 277
Query: 480 EQDELQMERDKAVKEAEELRK 500
++ Q E E ++L+
Sbjct: 278 LKEGFQKESRIMKNEIQDLQT 298
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 846 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.78 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.7 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.61 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.54 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.48 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.48 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.64 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.48 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.72 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.2 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.18 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 87.01 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=429.99 Aligned_cols=263 Identities=26% Similarity=0.410 Sum_probs=209.3
Q ss_pred hcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEe
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEY 602 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy 602 (846)
..++|.+.++||+|+||+||+|.+++ .||||+++..... ..+.|.+|+.+|++++|||||+++|++. +..++||||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey 84 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 84 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEec
Confidence 45689999999999999999998765 5999999765332 3467899999999999999999999984 468999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
|++|+|.+++... ..++++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.......
T Consensus 85 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999533 3469999999999999999999999 8999999999999999999999999999987654322
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.. ......||+.|+|||++.+ +.|+.++|||||||+||||+||+.||............ .......+...
T Consensus 160 ~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~-~~~~~~~p~~~ 232 (276)
T d1uwha_ 160 SH------QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VGRGYLSPDLS 232 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH-HHHTSCCCCGG
T ss_pred cc------cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH-HhcCCCCCcch
Confidence 11 1134569999999999964 35899999999999999999999999765433221111 11112223233
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
..+...++.+.+|+.+||..+|.+|||+ +++++.|+.+..+.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~-~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLF-PQILASIELLARSL 274 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHTC
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHHHcC
Confidence 3444556889999999999999999999 88999999988753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=415.35 Aligned_cols=254 Identities=25% Similarity=0.467 Sum_probs=201.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEecC
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 604 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~~ 604 (846)
++|...++||+|+||+||+|.+. +..||||+++... ...+.|.+|+.+|++++|||||+++|+| .+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 47888999999999999999986 4679999997643 3467899999999999999999999998 457899999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+|+|.+++.. ....+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999998853 34568999999999999999999999 899999999999999999999999999998765433211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.....||+.|+|||++.+..|+.++|||||||++|||+| |++||.............. ......|.
T Consensus 159 -------~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~------~~~~~~p~ 225 (263)
T d1sm2a_ 159 -------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST------GFRLYKPR 225 (263)
T ss_dssp -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH------TCCCCCCT
T ss_pred -------ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh------cCCCCCcc
Confidence 123468999999999999999999999999999999999 5677765443322111111 11223345
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
..++.+.+|+.+||+.+|.+||++ +++++.|+.+..+
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~-~~il~~L~~i~es 262 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAF-SRLLRQLAEIAES 262 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCH-HHHHHHHHHHHhC
Confidence 567889999999999999999999 8888999988754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=417.26 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=210.1
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEec
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYL 603 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy~ 603 (846)
..++|.+.++||+|+||+||+|.+++ ..||||+++... ...+.|.+|+.+|++++|||||+++|+|. +..++||||+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~ 89 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYM 89 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeC
Confidence 34578899999999999999999975 679999997543 44678999999999999999999999884 5688999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++|+|.+++.... ..++++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.+......
T Consensus 90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999874332 2358999999999999999999999 89999999999999999999999999999977543221
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCchHHHHHHhhhhhccccCCCCCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNLLDPLAGDWP 762 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG-~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 762 (846)
. .....||+.|+|||++.++.++.++|||||||+||||+|| .+||........ +.. + ........|
T Consensus 166 ~-------~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~-~~~--i---~~~~~~~~p 232 (272)
T d1qpca_ 166 A-------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-IQN--L---ERGYRMVRP 232 (272)
T ss_dssp C-------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHH--H---HTTCCCCCC
T ss_pred c-------ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH-HHH--H---HhcCCCCCc
Confidence 1 2345699999999999999999999999999999999995 566654443221 111 1 111222334
Q ss_pred hhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 763 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 763 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
...++.+.+|+.+||+.+|.+|||+ ++|.+.|+++-.
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~-~ei~~~L~~~ft 269 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTF-DYLRSVLEDFFT 269 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCH-HHHHHHhhhhhh
Confidence 4566889999999999999999999 889899988654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=414.61 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=197.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
++|++.++||+|+||+||+|.+. +..||||++..... ...+.+.+|+.+|++++|||||++++++ .+..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46889999999999999999986 67899999976533 2346799999999999999999999998 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
|++|+|.+++. ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999994 33579999999999999999999999 8999999999999999999999999999997754322
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. ..+..+||+.|+|||++.+..+ +.++|||||||+||+|+||++||.................. ....
T Consensus 159 ~~------~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~----~~~~ 228 (271)
T d1nvra_ 159 ER------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----YLNP 228 (271)
T ss_dssp EC------CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT----TSTT
T ss_pred cc------cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----CCCc
Confidence 11 1234579999999999988876 57899999999999999999999655432211111111111 1111
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+..+.+|+.+||+.+|.+|||+ +++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~-~ei 257 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITI-PDI 257 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCH-HHH
Confidence 22346789999999999999999999 444
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=415.69 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=204.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
.+|...++||+|+||+||+|... +..||||++........+.+.+|+.+|++++|||||+++++| .+..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46899999999999999999876 788999999876666667899999999999999999999998 45789999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
+||+|.+++.. .++++..+..|+.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.+......
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999998743 359999999999999999999999 89999999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.....||+.|+|||++.++.|+.++|||||||++|+|+||++||............... . ......+.
T Consensus 173 --------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-~---~~~~~~~~ 240 (293)
T d1yhwa1 173 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-G---TPELQNPE 240 (293)
T ss_dssp --------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-C---SCCCSSGG
T ss_pred --------ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC-C---CCCCCCcc
Confidence 13456999999999999999999999999999999999999999766544322221111 0 11112344
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+..+.+|+.+||..+|.+||++ +++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~-~ei 267 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSA-KEL 267 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 567889999999999999999999 444
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-48 Score=419.18 Aligned_cols=258 Identities=25% Similarity=0.411 Sum_probs=198.0
Q ss_pred CCCcccceeeeeCceEEEEEEECC-----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--cCceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 599 (846)
.+|.+.++||+|+||+||+|.+.. ..||||.+...... ..+.|.+|+.+|++++|||||+++|+| .+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 457778899999999999998852 25899988754332 235699999999999999999999998 4578999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
||||++|+|.+++.. ....+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998853 34569999999999999999999999 8999999999999999999999999999997765
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
....... .......||+.|+|||++.++.|+.++|||||||+||||+| |++||............ .....
T Consensus 181 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i------~~~~~ 251 (299)
T d1jpaa_ 181 DTSDPTY---TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI------EQDYR 251 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTTCC
T ss_pred CCCccee---eecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH------HcCCC
Confidence 4322111 11223468999999999999999999999999999999998 89999765543221111 11112
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
...|...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 252 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~-~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 LPPPMDCPSALHQLMLDCWQKDRNHRPKF-GQIVNTLDKMIR 292 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHhc
Confidence 23345567889999999999999999999 788889987754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=414.76 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=208.1
Q ss_pred CCCcccc-eeeeeCceEEEEEEEC----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc-CceEEEE
Q 003121 528 HNFDPSL-KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~-~LG~G~fG~Vy~g~~~----~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVm 600 (846)
++|.... +||+|+||+||+|.++ +..||||+++..... ..+.|.+|+.+|++++|||||+++|+|. +..++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 3455555 4999999999999875 346999999765322 2457999999999999999999999984 5789999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
|||++|+|.+++.. ....+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 88 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 88 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp ECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999998742 33579999999999999999999999 89999999999999999999999999999977543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPL 757 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~~ 757 (846)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |++||....... ..+..+ .
T Consensus 163 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~--------~ 229 (285)
T d1u59a_ 163 DSYY-----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------K 229 (285)
T ss_dssp SCEE-----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--------C
T ss_pred cccc-----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------C
Confidence 2211 11234568999999999999999999999999999999998 999997654332 222221 2
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
....|...++.+.+|+.+||..+|.+||++ .++.+.|+.+...
T Consensus 230 ~~~~p~~~~~~l~~li~~cl~~~p~~RPs~-~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 230 RMECPPECPPELYALMSDCWIYKWEDRPDF-LTVEQRMRACYYS 272 (285)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHHHH
Confidence 234455667899999999999999999999 7788888765543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-48 Score=416.38 Aligned_cols=256 Identities=27% Similarity=0.473 Sum_probs=209.1
Q ss_pred hhcCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 525 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 525 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
...++|.+.++||+|+||+||+|.+. +..||||+++... ...+.|.+|+.+|++++|||||+++|+|. +..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34567899999999999999999986 6789999987543 34678999999999999999999999984 5689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
|||++|+|.+++.... ...+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 93 E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999986443 3579999999999999999999999 89999999999999999999999999999976543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC-CCCchHHHHHHhhhhhccccCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA-LGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~p-f~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.... .+...||+.|+|||++.++.|+.++|||||||++|||+||..| |....... .... +. .....
T Consensus 169 ~~~~-------~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~--i~---~~~~~ 235 (287)
T d1opja_ 169 TYTA-------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYEL--LE---KDYRM 235 (287)
T ss_dssp SSEE-------ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHH--HH---TTCCC
T ss_pred Ccee-------eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHH--Hh---cCCCC
Confidence 2211 1233589999999999999999999999999999999996655 44333222 1111 00 11223
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
..|...++.+.+|+.+||+.+|.+|||+ +++.+.|+.+.
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~-~ei~~~L~~~~ 274 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETMF 274 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHTT
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHH
Confidence 3455567889999999999999999999 77888887653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=412.99 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=192.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccc----CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lV 599 (846)
++|++.+.||+|+||+||+|... +..||||++....... .+.|.+|+.+|++++|||||+++++|. ..+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 47999999999999999999886 6789999998764432 345889999999999999999999873 347899
Q ss_pred EEecCCCchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecccCCCceEecCCCceeeeccccccc
Q 003121 600 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCK--PHSIVHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~giiHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
||||++|+|.+++... .....+++..++.++.||+.||.|||+.. .++||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998543 23467999999999999999999999832 13599999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--Hhhhhhcccc
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLL 754 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~--~~~~~~~~~l 754 (846)
+...... .....||+.|+|||++.+..|+.++|||||||++|||+||++||...+..... +..+.
T Consensus 164 ~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~----- 230 (269)
T d2java1 164 LNHDTSF--------AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK----- 230 (269)
T ss_dssp C-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----
T ss_pred cccCCCc--------cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-----
Confidence 7543211 12346999999999999999999999999999999999999999766543321 11211
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 755 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 755 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....|...++.+.+|+.+||+.||.+||++ +++
T Consensus 231 ---~~~~~~~~s~~l~~li~~~L~~dp~~Rps~-~el 263 (269)
T d2java1 231 ---FRRIPYRYSDELNEIITRMLNLKDYHRPSV-EEI 263 (269)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred ---CCCCCcccCHHHHHHHHHHcCCChhHCcCH-HHH
Confidence 122344556889999999999999999999 444
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=410.71 Aligned_cols=245 Identities=25% Similarity=0.428 Sum_probs=198.5
Q ss_pred ceeeeeCceEEEEEEECC----eEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEecCCC
Q 003121 534 LKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNG 606 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~----~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy~~gg 606 (846)
++||+|+||+||+|.+++ +.||||+++...... .+.|.+|+.+|++++|||||+++|+|. +..+||||||++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 469999999999998753 569999997643322 356999999999999999999999994 4688999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccCCC
Q 003121 607 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 686 (846)
Q Consensus 607 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 686 (846)
+|.+++.. ..++++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.+.......
T Consensus 93 ~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~-- 164 (277)
T d1xbba_ 93 PLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-- 164 (277)
T ss_dssp EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE--
T ss_pred cHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc--
Confidence 99999853 3569999999999999999999999 899999999999999999999999999998765432211
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHhhhhhccccCCCCCCCCh
Q 003121 687 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 687 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.......||+.|+|||++.++.++.++|||||||++|||+| |++||....... ..+..+ .....|.
T Consensus 165 ---~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--------~~~~~p~ 233 (277)
T d1xbba_ 165 ---KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--------ERMGCPA 233 (277)
T ss_dssp ---EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------CCCCCCT
T ss_pred ---ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--------CCCCCCc
Confidence 11234569999999999999999999999999999999998 899997654432 112221 2233455
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
..+..+.+|+.+||+.+|.+||++ .+|...|+..
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~-~~i~~~L~~~ 267 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGF-AAVELRLRNY 267 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCH-HHHHHHhhCH
Confidence 567899999999999999999999 7777777654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=410.17 Aligned_cols=240 Identities=26% Similarity=0.443 Sum_probs=201.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|.+.+.||+|+||+||+|... ++.||||++... .......+.+|+.+|++++|||||++++++. +..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 36899999999999999999986 578999998643 2234567899999999999999999999984 4688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
|||++|+|.+++... .++++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999533 469999999999999999999999 89999999999999999999999999999865432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
.. ....||+.|+|||++.+..|+.++|||||||+||+|+||++||.............+ ....
T Consensus 160 ~~----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-------~~~~ 222 (263)
T d2j4za1 160 RR----------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-------VEFT 222 (263)
T ss_dssp CC----------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------TCCC
T ss_pred cc----------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc-------CCCC
Confidence 11 224599999999999999999999999999999999999999976654332211111 1123
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+|...++.+.+|+.+||+.||.+|||+ +++
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~-~ei 252 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPML-REV 252 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCH-HHH
Confidence 455567889999999999999999999 554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=412.79 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=202.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
+.|++.+.||+|+||+||+|.+. +..||||++........+.|.+|+++|++++|||||+++++| .+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999986 578999999876666667899999999999999999999998 45789999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++|+|.+++... ..++++..+..|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence 999999987533 3469999999999999999999999 8999999999999999999999999999986543321
Q ss_pred CCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
......||+.|+|||++. ...|+.++|||||||+||+|+||++||............... .+..
T Consensus 166 -------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~----~~~~ 234 (288)
T d2jfla1 166 -------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS----EPPT 234 (288)
T ss_dssp -------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS----CCCC
T ss_pred -------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC----CCCC
Confidence 113456999999999984 456899999999999999999999999765543322211111 1111
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+...+..+.+|+.+||+.||.+|||+ +++
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~-~el 266 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTT-SQL 266 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred CCccccCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 22344567889999999999999999999 444
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=401.04 Aligned_cols=250 Identities=25% Similarity=0.449 Sum_probs=208.8
Q ss_pred CCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEEecC
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 604 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmEy~~ 604 (846)
++|...++||+|+||+||+|.+++ ..||||+++.... ..+.|.+|+.++++++|||||+++|+|. ...++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 578899999999999999999974 5899999986543 4678999999999999999999999984 56899999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+|+|.+++... ...+++..+++|+.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++.+.......
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999987533 3568899999999999999999999 899999999999999999999999999998765432211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||............ ........|.
T Consensus 158 -------~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i------~~~~~~~~p~ 224 (258)
T d1k2pa_ 158 -------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI------AQGLRLYRPH 224 (258)
T ss_dssp -------CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH------HTTCCCCCCT
T ss_pred -------ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH------HhCCCCCCcc
Confidence 134569999999999999999999999999999999998 89999876543321111 1122233455
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHH
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 797 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~ 797 (846)
..++.+.+|+.+||+.+|.+|||+ ++++..|.+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~-~eil~~L~d 257 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTF-KILLSNILD 257 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHC
T ss_pred cccHHHHHHHHHHccCCHhHCcCH-HHHHHHhhC
Confidence 667899999999999999999999 777766643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=408.08 Aligned_cols=258 Identities=26% Similarity=0.446 Sum_probs=200.9
Q ss_pred cCCCcccceeeeeCceEEEEEEECC------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 597 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~ 597 (846)
.+.|...++||+|+||.||+|.+++ ..||||+++..... ....|.+|+.+|++++|||||+++|+|. +..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 3468888999999999999998764 36999999754332 2346889999999999999999999984 5789
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+|||||.+|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+
T Consensus 86 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999887533 3569999999999999999999999 89999999999999999999999999999976
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCchHHHHHHhhhhhccccCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNLLDP 756 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG-~~pf~~~~~~~~~~~~~~~~~~ld~ 756 (846)
........ ......||+.|+|||++.++.++.++|||||||+||||+|| .+|+........ +. .+.+.
T Consensus 161 ~~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~-~~-----~i~~~ 229 (283)
T d1mqba_ 161 EDDPEATY-----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-MK-----AINDG 229 (283)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HH-----HHHTT
T ss_pred cCCCccce-----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH-HH-----HHhcc
Confidence 54322111 11334689999999999999999999999999999999995 455544333221 11 11122
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
.....|...+..+.+|+.+||+.+|.+||++ .+|++.|+.+...
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKF-ADIVSILDKLIRA 273 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHHHS
T ss_pred CCCCCchhhHHHHHHHHHHHCcCCHhHCcCH-HHHHHHHHHHhhC
Confidence 2334455567889999999999999999999 7888899887653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=415.76 Aligned_cols=256 Identities=26% Similarity=0.433 Sum_probs=204.6
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEeccc--cC
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PE 594 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~ 594 (846)
..++|.+.++||+|+||+||+|.+.+ ..||+|.+.... ......|.+|+.+|.++ +|||||+++|+| .+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34678999999999999999998753 259999987543 23456799999999998 899999999998 45
Q ss_pred ceEEEEEecCCCchhhhhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccC
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDN--------------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 654 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLk 654 (846)
..++|||||++|+|.++|..... ...+++..++.|+.||+.||.|||+ ++|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence 68999999999999999965421 2468999999999999999999999 899999999
Q ss_pred CCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCC
Q 003121 655 PANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRP 733 (846)
Q Consensus 655 p~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~ 733 (846)
|+|||++.++.+||+|||+|+......... ..+...||+.|+|||++.++.|+.++|||||||+||||+| |++
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYV------VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred hhccccccCCeEEEeeccccccccCCCcee------eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence 999999999999999999998765432211 1133458999999999999999999999999999999998 899
Q ss_pred CCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHH
Q 003121 734 ALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 796 (846)
Q Consensus 734 pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~ 796 (846)
||............ +. .....+.|...++.+.+|+.+||+.+|.+|||+ ++|++.|.
T Consensus 266 Pf~~~~~~~~~~~~--~~---~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~-~ei~~~L~ 322 (325)
T d1rjba_ 266 PYPGIPVDANFYKL--IQ---NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-PNLTSFLG 322 (325)
T ss_dssp SSTTCCCSHHHHHH--HH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHH
T ss_pred CCCCCCHHHHHHHH--Hh---cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHh
Confidence 99754332211111 00 112234455667899999999999999999999 77777774
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=410.74 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=200.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|++.+.||+|+||+||+|... +..||||++... .....+.+.+|+.+|++++|||||+++++|. +..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46999999999999999999986 678999998753 2233467999999999999999999999984 4689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
|||+||+|.+++... ..+++..+..++.|++.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988543 469999999999999999999999 89999999999999999999999999999977543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
..... .....||+.|+|||++.+..|+.++|||||||+||+|+||++||...+......... . ....
T Consensus 162 ~~~~~------~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~-----~~~~ 228 (288)
T d1uu3a_ 162 SKQAR------ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--K-----LEYD 228 (288)
T ss_dssp --------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--T-----TCCC
T ss_pred Ccccc------cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--c-----CCCC
Confidence 22111 133569999999999999999999999999999999999999998765433221111 1 1123
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+|...++.+.+||.+||+.||.+|||+ +++
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~-~e~ 258 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGC-EEM 258 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTS-GGG
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCH-HHH
Confidence 455567889999999999999999998 444
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-46 Score=407.17 Aligned_cols=263 Identities=26% Similarity=0.439 Sum_probs=212.5
Q ss_pred hhhhhhcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEeccc
Q 003121 521 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGAC 592 (846)
Q Consensus 521 ~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~ 592 (846)
.+++-..++|++.+.||+|+||+||+|.+.+ +.||||+++...... ...|.+|+.+|++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3445556789999999999999999998754 579999987644322 35699999999999999999999998
Q ss_pred c--CceEEEEEecCCCchhhhhccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceE
Q 003121 593 P--EVWTLVYEYLPNGSLEDRLSCKD---------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 649 (846)
Q Consensus 593 ~--~~~~lVmEy~~ggsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gii 649 (846)
. +..++||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+ ++||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeE
Confidence 4 57899999999999999985432 13458999999999999999999999 8999
Q ss_pred ecccCCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHH
Q 003121 650 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 729 (846)
Q Consensus 650 HrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ell 729 (846)
||||||+||||+.++.+||+|||+|+.......... .+...||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell 236 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA------DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccc------cCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHH
Confidence 999999999999999999999999987654332211 13356899999999999999999999999999999999
Q ss_pred hCC-CCCCCchHHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 730 TGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 730 tG~-~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
+|. +||........... +.+......|...+..+.+|+.+||+.+|.+|||+ .+|.+.|+.|.
T Consensus 237 ~~~~~p~~~~~~~e~~~~------v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~-~ev~~~L~~i~ 300 (301)
T d1lufa_ 237 SYGLQPYYGMAHEEVIYY------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSF-CSIHRILQRMC 300 (301)
T ss_dssp TTTCCTTTTSCHHHHHHH------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHTT
T ss_pred ccCCCCCCCCCHHHHHHH------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHhc
Confidence 985 78876654432111 11122233455666889999999999999999999 88888888763
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=403.32 Aligned_cols=255 Identities=31% Similarity=0.472 Sum_probs=202.6
Q ss_pred cCCCcccceeeeeCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEEEEecC
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLP 604 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lVmEy~~ 604 (846)
.++|.+.+.||+|+||+||+|.+++ ..||||+++... ...+.|.+|+.+|++++|||||+++|+|. +..++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecC
Confidence 4579999999999999999999975 579999997543 45678999999999999999999999984 46889999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+|+|..++.... ...+++..++.|+.+|+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+.......
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999998885432 2469999999999999999999999 899999999999999999999999999998765433211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~-~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
.....||+.|+|||++.++.++.++|||||||+||||+||. +|+....... .+..-. .....+.+.
T Consensus 171 -------~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~i~-----~~~~~~~~~ 237 (285)
T d1fmka3 171 -------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVE-----RGYRMPCPP 237 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHH-----TTCCCCCCT
T ss_pred -------eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-HHHHHH-----hcCCCCCCc
Confidence 13346999999999999999999999999999999999954 5554443322 111110 111223445
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
..++.+.+|+.+||+.+|.+||++ ++|.+.|+++-.
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~-~~i~~~L~~~~~ 273 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTF-EYLQAFLEDYFT 273 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTTTS
T ss_pred ccCHHHHHHHHHHcccCHhHCcCH-HHHHHHHhhhhc
Confidence 567889999999999999999999 788888886543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=400.54 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=202.9
Q ss_pred CCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc---CceEEEEEecC
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYLP 604 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~---~~~~lVmEy~~ 604 (846)
++|.+.++||+|+||.||+|.++++.||||+++... ..+.|.+|+.+|++++|||||+++|+|. +.+++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 467888999999999999999999999999997543 4578999999999999999999999883 34799999999
Q ss_pred CCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccccC
Q 003121 605 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 684 (846)
Q Consensus 605 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 684 (846)
+|+|.++|.... ..++++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 999999995432 2358999999999999999999999 899999999999999999999999999998654321
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 685 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 685 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
....+|+.|+|||++.++.++.++|||||||++|||+| |++||........... +......+.|.
T Consensus 158 --------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~------i~~~~~~~~~~ 223 (262)
T d1byga_ 158 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------VEKGYKMDAPD 223 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH------HTTTCCCCCCT
T ss_pred --------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH------HHcCCCCCCCc
Confidence 12348999999999999999999999999999999998 7888876543221111 11122334455
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
..+..+.+|+.+||..||.+||++ .++.+.|+.++..
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~-~~l~~~L~~i~~~ 260 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSF-LQLREQLEHIKTH 260 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcccCHhHCcCH-HHHHHHHHHHHhC
Confidence 566889999999999999999999 7899999988753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=398.21 Aligned_cols=239 Identities=23% Similarity=0.399 Sum_probs=191.0
Q ss_pred cccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc------CceEEEE
Q 003121 531 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP------EVWTLVY 600 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~------~~~~lVm 600 (846)
....+||+|+||+||+|.+. +..||+|++...... ..+.|.+|+++|++++|||||+++++|. ..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55668999999999999987 468999998765332 2356899999999999999999999873 2478999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecccCCCceEec-CCCceeeecccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLD-ANFVSKLSDFGISRFL 677 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g--iiHrDLkp~NILl~-~~~~vKL~DFGla~~~ 677 (846)
|||++|+|.+++... ..+++..++.|+.||+.||.|||+ ++ |+||||||+||||+ .++.+||+|||+|+..
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999543 469999999999999999999999 66 99999999999996 5789999999999864
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
..... ....||+.|+|||++.+ +|+.++|||||||+||||+||++||............ +.....
T Consensus 166 ~~~~~----------~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~--i~~~~~-- 230 (270)
T d1t4ha_ 166 RASFA----------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVK-- 230 (270)
T ss_dssp CTTSB----------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--HTTTCC--
T ss_pred cCCcc----------CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH--HHcCCC--
Confidence 33211 23469999999999864 6999999999999999999999999754433322211 111111
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...++...++.+.+|+.+||+.+|++|||+ +++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~-~el 263 (270)
T d1t4ha_ 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSI-KDL 263 (270)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred CcccCccCCHHHHHHHHHHccCCHhHCcCH-HHH
Confidence 112233345679999999999999999999 554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=414.10 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=197.8
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
.++|++.++||+|+||+||+|... +..||+|+++...... ...+.+|+.+|++++|||||+++++| .+..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457999999999999999999986 6789999998653322 45789999999999999999999998 456899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
||+||+|.+++... ..+++..+..++.||+.||.|||+. +||+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 99999999999643 4599999999999999999999972 379999999999999999999999999998764422
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh-----hh-------
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-----GK------- 749 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~-----~~------- 749 (846)
. ...+||+.|+|||++.+..|+.++|||||||++|||+||+.||...+........ +.
T Consensus 160 ~----------~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 160 A----------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp C-------------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred c----------ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 1 2346999999999999999999999999999999999999999654321110000 00
Q ss_pred ------------------------hccccCCCCCCCC-hhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 750 ------------------------LKNLLDPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 750 ------------------------~~~~ld~~~~~~p-~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
.........+..+ ...+..+.+|+.+||..||.+|||+ ++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta-~e~L 296 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-KQLM 296 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCH-HHHH
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCH-HHHh
Confidence 0000000000111 1235679999999999999999999 5553
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=401.28 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=197.6
Q ss_pred cCCCcccceeeeeCceEEEEEEECC-----eEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccc-CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV 599 (846)
.++|++.+.||+|+||.||+|.+.. ..||||.++...... .+.|.+|+.+|++++|||||+++|+|. +..++|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEE
Confidence 4579999999999999999998753 458999886543222 356899999999999999999999984 568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+++|+|.+++... ..++++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 86 ~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 9999999999987533 3568999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH--HHhhhhhccccCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDP 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~--~~~~~~~~~~ld~ 756 (846)
..... .+...||+.|+|||++.++.|+.++|||||||++|||+| |.+||........ .+..+
T Consensus 161 ~~~~~-------~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~-------- 225 (273)
T d1mp8a_ 161 STYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-------- 225 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--------
T ss_pred Cccee-------ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------
Confidence 32211 123458999999999999999999999999999999998 8999976544322 11211
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
.....|...++.+.+|+.+||..+|.+|||+ ++|.+.|+.+.
T Consensus 226 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-~ei~~~L~~i~ 267 (273)
T d1mp8a_ 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRF-TELKAQLSTIL 267 (273)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHH
Confidence 1223445567889999999999999999999 78888887764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-46 Score=407.02 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=186.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccc--CceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVmE 601 (846)
.+.|++.+.||+|+||+||+|... +..||||++...... ....+.+|+.+|++++|||||++++++. +..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356999999999999999999986 678999999765432 2356889999999999999999999984 46899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec---CCCceeeeccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLS 678 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~---~~~~vKL~DFGla~~~~ 678 (846)
||+||+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||+. .++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999953 3569999999999999999999999 8999999999999995 57899999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
..... ....||+.|+|||++.+..|+.++|||||||+||+|+||++||............. .... ...
T Consensus 162 ~~~~~---------~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~-~~~ 229 (307)
T d1a06a_ 162 PGSVL---------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL--KAEY-EFD 229 (307)
T ss_dssp --------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--TTCC-CCC
T ss_pred CCCee---------eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh--ccCC-CCC
Confidence 43211 23469999999999999999999999999999999999999997665433221111 1111 111
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...+...++.+.+|+.+||..+|.+|||+ +++
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~-~ei 261 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTC-EQA 261 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCH-HHH
Confidence 12233456789999999999999999999 554
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=406.06 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=205.4
Q ss_pred CCCcccceeeeeCceEEEEEEECC------eEEEEEEecCC-CCCCchhHHHHHHHHHhcCCCceeeEecccc-CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~------~~VAIK~l~~~-~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV 599 (846)
.+|+..++||+|+||+||+|.+.. ..||+|.++.. .....+.|.+|+.+|++++|||||+++|+|. +..+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 369999999999999999998753 25999998754 3334567999999999999999999999984 567899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
|||+.+|+|.+.+... ...+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.+..
T Consensus 89 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 9999999999887543 4579999999999999999999999 8999999999999999999999999999998754
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHhhhhhccccCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDP 756 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~--~~~~~~~~~~~~ld~ 756 (846)
...... .....||+.|+|||++.++.|+.++|||||||+||||+| |.+||...... ...+..+
T Consensus 164 ~~~~~~------~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-------- 229 (317)
T d1xkka_ 164 EEKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-------- 229 (317)
T ss_dssp TCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT--------
T ss_pred cccccc------ccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------
Confidence 332111 123458999999999999999999999999999999999 89999765432 2222221
Q ss_pred CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 757 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 757 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.....|...+..+.+|+.+||..+|.+||++ .+++..|..+..
T Consensus 230 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKMAR 272 (317)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHhCCCChhhCcCH-HHHHHHHHHHHh
Confidence 1223455667889999999999999999999 677777777653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-46 Score=405.10 Aligned_cols=239 Identities=26% Similarity=0.351 Sum_probs=195.9
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCc---hhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~---~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
.|+..++||+|+||+||+|... +..||||++........ +.+.+|+.+|++++|||||+++++| .+..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888999999999999999876 57899999986554332 4588999999999999999999998 457899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
||.+|+|..++.. ..++++..++.|+.||+.||.|||+ +|||||||||+||||+.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999999876642 3569999999999999999999999 89999999999999999999999999999865432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 758 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~ 758 (846)
....||+.|+|||++.+ +.|+.++|||||||++|||++|++||.............. ......
T Consensus 169 -----------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~-~~~~~~-- 234 (309)
T d1u5ra_ 169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPAL-- 234 (309)
T ss_dssp -----------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCC--
T ss_pred -----------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-CCCCCC--
Confidence 23459999999999864 4689999999999999999999999976554432221111 111111
Q ss_pred CCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 759 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 759 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+...++.+.+|+.+||+.||.+|||+ +++
T Consensus 235 --~~~~~s~~~~~li~~~L~~dP~~Rpt~-~el 264 (309)
T d1u5ra_ 235 --QSGHWSEYFRNFVDSCLQKIPQDRPTS-EVL 264 (309)
T ss_dssp --SCTTSCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred --CCCCCCHHHHHHHHHHCcCChhHCcCH-HHH
Confidence 122345789999999999999999999 554
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.2e-46 Score=409.94 Aligned_cols=246 Identities=21% Similarity=0.334 Sum_probs=201.9
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
++|.+.+.||+|+||.||+|... |..||||++........+.+.+|+.+|++++|||||+++++| .+..|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47999999999999999999986 688999999866544556789999999999999999999998 45789999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec--CCCceeeecccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~--~~~~vKL~DFGla~~~~~~~ 681 (846)
+||+|.+++.. ...++++..+..|+.||+.||.|||+ +|||||||||+||||+ .++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999843 23569999999999999999999999 8999999999999996 46889999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. ....||+.|+|||++.+..|+.++|||||||++|+|+||++||...+.............. .....
T Consensus 181 ~~---------~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~ 248 (350)
T d1koaa2 181 SV---------KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN---MDDSA 248 (350)
T ss_dssp CE---------EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---SCCGG
T ss_pred cc---------ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCccc
Confidence 11 1235999999999999999999999999999999999999999766543322111111100 11111
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....++.+.+||.+||..||.+|||+ +++
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~-~ei 277 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTI-HQA 277 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCH-HHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 23456789999999999999999999 554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.3e-46 Score=408.86 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=202.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
++|++.+.||+|+||+||+|... +..||||++..........+.+|+.+|++|+|||||+++++| .+.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46999999999999999999985 688999999865544456788999999999999999999998 45689999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec--CCCceeeecccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~--~~~~vKL~DFGla~~~~~~~ 681 (846)
+||+|.+++.. ...++++..++.|+.||+.||.|||+ +|||||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999988743 34569999999999999999999999 8999999999999998 57899999999999875432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCC
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 761 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 761 (846)
.. ....||+.|+|||++.+..|+.++|||||||+||+|+||++||................ . ......
T Consensus 184 ~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~-~~~~~~ 251 (352)
T d1koba_ 184 IV---------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--W-EFDEDA 251 (352)
T ss_dssp CE---------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC--C-CCCSST
T ss_pred ce---------eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C-CCCccc
Confidence 11 12358999999999999999999999999999999999999997765543222111111 1 111222
Q ss_pred ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 762 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 762 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
+...+..+.+||.+||..||.+|||+ +++
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~-~ei 280 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTV-HDA 280 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCH-HHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 33456789999999999999999999 554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=398.17 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=201.1
Q ss_pred ChhhhhhhcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEe
Q 003121 519 SFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLV 589 (846)
Q Consensus 519 ~~~ei~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~ 589 (846)
...+++...++|.+.++||+|+||.||+|.+.+ +.||||+++..... ....+.+|..++.++ +||||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 344555555689999999999999999998742 57999998754332 234577888888887 689999999
Q ss_pred cccc---CceEEEEEecCCCchhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccc
Q 003121 590 GACP---EVWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 653 (846)
Q Consensus 590 g~~~---~~~~lVmEy~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDL 653 (846)
+++. ...++|||||++|+|.++|.... ....+++..++.|+.||+.||.|||+ ++||||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcC
Confidence 9873 35889999999999999986432 13468999999999999999999999 89999999
Q ss_pred CCCceEecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhC-C
Q 003121 654 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-R 732 (846)
Q Consensus 654 kp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG-~ 732 (846)
||+||||+.++.+||+|||+|+......... ..+...||+.|+|||++.++.++.++|||||||++|||+|| .
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~ 234 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYV------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSC------CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccceeECCCCcEEEccCcchhhcccccccc------ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCC
Confidence 9999999999999999999998765432211 12345699999999999999999999999999999999996 5
Q ss_pred CCCCCchHHH---HHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 733 PALGITKEVQ---YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 733 ~pf~~~~~~~---~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
+||....... ..+..+ .....|...++.+.+|+.+||+.+|.+|||+ +++++.|+.+.
T Consensus 235 ~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-~eil~~L~~il 295 (299)
T d1ywna1 235 SPYPGVKIDEEFCRRLKEG--------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNLL 295 (299)
T ss_dssp CSSTTCCCSHHHHHHHHHT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhcC--------CCCCCCccCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHH
Confidence 6786543322 222221 1223344566889999999999999999999 88888998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=396.38 Aligned_cols=245 Identities=23% Similarity=0.338 Sum_probs=199.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcCCCceeeEecccc--CceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~ 597 (846)
+.|++.+.||+|+||+||+|... +..||||++...... ..+.|.+|+.+|++++|||||+++++|. +..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46999999999999999999986 678999999765332 2357899999999999999999999984 4688
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC----ceeeecccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGI 673 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~----~vKL~DFGl 673 (846)
+|||||+||+|.+++... .++++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999543 469999999999999999999999 8999999999999998776 599999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 753 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ 753 (846)
++........ ....||+.|+|||++.+..++.++|||||||+||+|+||++||.................
T Consensus 164 a~~~~~~~~~---------~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~- 233 (293)
T d1jksa_ 164 AHKIDFGNEF---------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY- 233 (293)
T ss_dssp CEECTTSCBC---------SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-
T ss_pred hhhcCCCccc---------cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-
Confidence 9876543211 234699999999999999999999999999999999999999976654432211111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
......+...+..+.+||.+||..||.+||++ +++
T Consensus 234 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-~ei 268 (293)
T d1jksa_ 234 --EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI-QDS 268 (293)
T ss_dssp --CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCH-HHH
T ss_pred --CCCchhcCCCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 00111112345789999999999999999999 544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-45 Score=391.68 Aligned_cols=259 Identities=24% Similarity=0.399 Sum_probs=201.7
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCc---hhHHHHHHHHHhcCCCceeeEeccccC------c
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACPE------V 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~---~~f~~Ei~iL~~l~HpnIv~l~g~~~~------~ 595 (846)
.++|.+.+.||+|+||+||+|... ++.||||+++.....+. ..|.+|+.+|+.++|||||++++++.. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 357999999999999999999976 78899999987654443 458899999999999999999998732 3
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.|+|||||+||+|.+++... .++++..++.|+.||+.||.|||+ +||+||||||+||||+.++.++|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999988543 469999999999999999999999 899999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccC
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 755 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld 755 (846)
.......... ......||+.|+|||++.+..|+.++|||||||++|+|+||++||................. ..
T Consensus 160 ~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~-~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVT-----QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-IP 233 (277)
T ss_dssp ECC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-CC
T ss_pred hhcccccccc-----ccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC-CC
Confidence 6544322111 12345699999999999999999999999999999999999999987665443222211111 11
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHH
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 799 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~ 799 (846)
+ ...+...++.+.+|+.+||..||.+||+..+++...|..++
T Consensus 234 ~--~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 P--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp G--GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C--chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1 11122345789999999999999999954488877777664
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-46 Score=395.75 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=196.8
Q ss_pred CCCcccceeeeeCceEEEEEEECC-----eEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccc-CceEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTL 598 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~l 598 (846)
++|++.+.||+|+||.||+|.+.+ ..||||++....... .+.|.+|+.+|++++|||||+++|+|. +..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 468899999999999999998753 369999987654332 356899999999999999999999995 45789
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 678 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~ 678 (846)
||||+++|+|.+.+... ..++++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999887543 3469999999999999999999999 899999999999999999999999999999775
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHhhhhhccccCCC
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 757 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~~~~~~~~~~~~~~~ld~~ 757 (846)
...... .......||+.|+|||++.+..++.++|||||||++|||+| |++||...+.........+. ..
T Consensus 163 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~-----~~ 232 (273)
T d1u46a_ 163 QNDDHY-----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-----GE 232 (273)
T ss_dssp C-CCEE-----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS-----CC
T ss_pred cCCCcc-----eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC-----CC
Confidence 443211 11133458899999999999999999999999999999998 89999766554422111111 11
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
..+.+...+..+.+|+.+||..+|++|||+ .+|.+.|++.
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTF-VALRDFLLEA 272 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCCChhHCcCH-HHHHHHHHhc
Confidence 223344456789999999999999999999 7788887754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=403.93 Aligned_cols=238 Identities=23% Similarity=0.292 Sum_probs=200.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|++.+.||+|+||.||+|... +..||||++.+. .......+.+|+.+|++++||||++++++|. +.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 47999999999999999999976 678999999754 2234567899999999999999999999984 4689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
|||+||+|.+++... ..+++..++.++.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999998543 468999999999999999999999 89999999999999999999999999999865432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... ....+||+.|+|||++.+..|+.++|||||||++|||+||++||...+........ ... ...
T Consensus 159 ~~~--------~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i--~~~-----~~~ 223 (337)
T d1o6la_ 159 GAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LME-----EIR 223 (337)
T ss_dssp TCC--------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHC-----CCC
T ss_pred Ccc--------cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH--hcC-----CCC
Confidence 211 12346999999999999999999999999999999999999999776653321111 111 123
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCC
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPE 786 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt 786 (846)
+|...+..+.+||.+||+.||.+||+
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred CCccCCHHHHHHHHhhccCCchhhcc
Confidence 45566788999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-45 Score=399.51 Aligned_cols=234 Identities=25% Similarity=0.367 Sum_probs=197.6
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVm 600 (846)
++|++.+.||+|+||+||+|... +..||||+++.. .....+.+.+|+.+|+.++|||||++++++ .+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 36899999999999999999976 688999998753 233456799999999999999999999998 45689999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
|||+||+|..++... ..+++..+..++.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999988533 458889999999999999999999 89999999999999999999999999999876532
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
. ....||+.|+|||++.+..|+.++|||||||+||+|+||++||...+.......... . ...
T Consensus 158 ~-----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~-----~~~ 219 (316)
T d1fota_ 158 T-----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--A-----ELR 219 (316)
T ss_dssp B-----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--C-----CCC
T ss_pred c-----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--C-----CCC
Confidence 2 234699999999999999999999999999999999999999977655432211111 1 123
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCC
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
+|...+..+.+|+.+||..+|.+||
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~ 244 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRL 244 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhcc
Confidence 4455668899999999999999996
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=392.40 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=202.4
Q ss_pred cceeeeeCceEEEEEEECC-----eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccc---CceEEEEEec
Q 003121 533 SLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYL 603 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~~-----~~VAIK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~---~~~~lVmEy~ 603 (846)
.++||+|+||+||+|.+.. ..||||+++.... ...+.|.+|+++|++++|||||+++|+|. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4679999999999998753 2589999975322 22457999999999999999999999872 3578999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999988533 4567888999999999999999999 89999999999999999999999999999977654322
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCCCCh
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 763 (846)
... ......||+.|+|||.+.++.++.++||||||+++|||+||..||........... .+........|.
T Consensus 187 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~-----~i~~g~~~~~p~ 257 (311)
T d1r0pa_ 187 SVH----NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-----YLLQGRRLLQPE 257 (311)
T ss_dssp CTT----CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH-----HHHTTCCCCCCT
T ss_pred cce----ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH-----HHHcCCCCCCcc
Confidence 211 12345699999999999999999999999999999999997777654322111100 011111223344
Q ss_pred hhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 764 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 764 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
..++.+.+|+.+||..+|.+||++ .+|++.|+.+....
T Consensus 258 ~~~~~l~~li~~cl~~dP~~RPs~-~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 258 YCPDPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFSTF 295 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHTC
T ss_pred cCcHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHHHhh
Confidence 566889999999999999999999 88889999887653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=394.53 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=205.4
Q ss_pred CCCcccceeeeeCceEEEEEEECC--e--EEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEeccc--cCceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLRH--M--QVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~~--~--~VAIK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV 599 (846)
++|.+.++||+|+||+||+|.+++ . .||||.+.... ....+.|.+|+.+|+++ +|||||+++|+| .+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 467888899999999999998863 2 58889886543 33456799999999999 799999999998 4568999
Q ss_pred EEecCCCchhhhhccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 600 YEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
|||+++|+|.++|... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999998643 234679999999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCchHHHHHH
Q 003121 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYAL 745 (846)
Q Consensus 667 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~-~pf~~~~~~~~~~ 745 (846)
||+|||+++........ ....||..|+|||.+.++.|+.++|||||||++|||+||. +||...+......
T Consensus 167 kl~DfG~a~~~~~~~~~---------~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp EECCTTCEESSCEECCC-------------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred EEccccccccccccccc---------cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999865443211 1235899999999999999999999999999999999965 6776554433211
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
.. ........|...++.+.+||.+||+.+|++||++ +++++.|+.+...
T Consensus 238 ~i------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-~eil~~L~~i~~~ 286 (309)
T d1fvra_ 238 KL------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQILVSLNRMLEE 286 (309)
T ss_dssp HG------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHS
T ss_pred HH------HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHhc
Confidence 11 1112234455667899999999999999999999 8888889887653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=391.68 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=207.2
Q ss_pred cCCCcccceeeeeCceEEEEEEECC---------eEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccc--
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP-- 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~~---------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~-- 593 (846)
.++|.+.+.||+|+||.||+|...+ ..||||+++..... ....+.+|+..+.++ +|||||+++|+|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4578899999999999999998643 36999999765432 235688899999888 8999999999984
Q ss_pred CceEEEEEecCCCchhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEe
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 660 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl 660 (846)
+..++|||||++|+|.++|.... ....+++..++.++.||+.||.|||+ ++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 46899999999999999996442 13468999999999999999999999 899999999999999
Q ss_pred cCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 003121 661 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK 739 (846)
Q Consensus 661 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~~ 739 (846)
+.++.+||+|||+++.......... .....||+.|+|||.+.++.|+.++|||||||++|||+| |.+||....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCC------CTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCCCeEeccchhhccccccccccc------cccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999999997765432221 133568999999999999999999999999999999998 789997555
Q ss_pred HHHHHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 740 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 740 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
.... ... +........|...++.+.+|+.+||+.+|.+|||+ .+|++.|+.+.+.
T Consensus 243 ~~~~-~~~-----i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~-~eil~~L~~i~a~ 297 (299)
T d1fgka_ 243 VEEL-FKL-----LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRIVAL 297 (299)
T ss_dssp HHHH-HHH-----HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred HHHH-HHH-----HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCH-HHHHHHHHHHhhc
Confidence 4321 111 11222334455567889999999999999999999 8899999988764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=392.19 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=208.7
Q ss_pred hhhcCCCcccceeeeeCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--c
Q 003121 524 EGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--P 593 (846)
Q Consensus 524 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~ 593 (846)
+...++|...++||+|+||+||+|.+. ++.||||+++..... ....|.+|+.+|++++|||||+++|+| .
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 334568889999999999999999875 357999999754322 224589999999999999999999998 4
Q ss_pred CceEEEEEecCCCchhhhhccC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCce
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCK-------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 666 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~-------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~v 666 (846)
+..++||||+++|+|.+++... .....+++..+..++.+++.||.|||. ++|+||||||+||||+.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceE
Confidence 5789999999999999987532 233468999999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCchHHHHHH
Q 003121 667 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYAL 745 (846)
Q Consensus 667 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG-~~pf~~~~~~~~~~ 745 (846)
||+|||+++.+...... .......||+.|+|||.+.++.++.++|||||||+||||+|| .+||..........
T Consensus 173 Kl~DFGla~~~~~~~~~------~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~ 246 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYY------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246 (308)
T ss_dssp EECCTTCCCGGGGGGCE------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred EEeecccceeccCCcce------eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999876554321 112334589999999999999999999999999999999998 57886654433211
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHH
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 798 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l 798 (846)
. +.+....+.|...+..+.+|+.+||+.+|.+||++ ++|++.|+..
T Consensus 247 ~------i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-~~il~~L~~~ 292 (308)
T d1p4oa_ 247 F------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIKEE 292 (308)
T ss_dssp H------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHGGG
T ss_pred H------HHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHh
Confidence 1 11122233345566889999999999999999999 7777777654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-44 Score=399.64 Aligned_cols=234 Identities=21% Similarity=0.298 Sum_probs=197.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccc--CceEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 600 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lVm 600 (846)
++|++.+.||+|+||.||+|.+. +..||||++... .....+.+.+|+.+|+.++|||||++++++. ...++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 37899999999999999999986 688999998643 2233467899999999999999999999984 4688999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 680 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~ 680 (846)
||+.+|+|..++... ..+++..+..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998543 469999999999999999999999 89999999999999999999999999999876432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
. ....||+.|+|||++.+..|+.++|||||||+||+|+||++||...+.......... . ...
T Consensus 195 ~-----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~-----~~~ 256 (350)
T d1rdqe_ 195 T-----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--G-----KVR 256 (350)
T ss_dssp B-----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--C-----CCC
T ss_pred c-----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc--C-----CCC
Confidence 1 234599999999999999999999999999999999999999987654432211111 1 112
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCC
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRP 785 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RP 785 (846)
+|...+..+.+|+.+||..||.+|+
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCT
T ss_pred CCccCCHHHHHHHHHHhhhCHHhcc
Confidence 3445568899999999999999995
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=393.20 Aligned_cols=243 Identities=25% Similarity=0.329 Sum_probs=200.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHH-hcCCCceeeEecccc--CceEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILS-KIRHPNLVTLVGACP--EVWTLV 599 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~---~~~~~~~f~~Ei~iL~-~l~HpnIv~l~g~~~--~~~~lV 599 (846)
++|.+.+.||+|+||+||+|... ++.||||++++. .....+.+..|+.++. .++|||||++++++. +..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 47899999999999999999985 688999999753 2234456777888775 689999999999984 568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~ 679 (846)
||||++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999543 458999999999999999999999 8999999999999999999999999999986543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 759 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~ 759 (846)
.... .+...||+.|+|||++.+..|+.++|||||||++|+|+||++||............ ... ..
T Consensus 156 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-~~~------~~ 220 (320)
T d1xjda_ 156 GDAK--------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RMD------NP 220 (320)
T ss_dssp TTCC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHC------CC
T ss_pred cccc--------ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-HcC------CC
Confidence 2211 13456999999999999999999999999999999999999999766543321111 111 12
Q ss_pred CCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 760 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 760 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.+|...+..+.+|+.+||..+|.+||++..++
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred CCCccCCHHHHHHHHHhcccCCCCCcCHHHHH
Confidence 34555678899999999999999999984334
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.8e-44 Score=397.81 Aligned_cols=239 Identities=26% Similarity=0.358 Sum_probs=192.8
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHH---HHHHHhcCCCceeeEeccc--cCceE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQE---IDILSKIRHPNLVTLVGAC--PEVWT 597 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~f~~E---i~iL~~l~HpnIv~l~g~~--~~~~~ 597 (846)
++|++.++||+|+||.||+|... +..||||++..... .....+.+| +.+++.++|||||+++++| .+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999986 67899999864321 222334444 6677778899999999998 45689
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
+|||||+||+|.++|... ..+++..+..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999543 468899999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHhhhhhccccC
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDTGKLKNLLD 755 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~-~~~~~~~~~~~ld 755 (846)
..... ....||+.|+|||++.. ..|+.++|||||||+||||+||++||....... ..+.. ...
T Consensus 158 ~~~~~----------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-----~~~ 222 (364)
T d1omwa3 158 SKKKP----------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-----MTL 222 (364)
T ss_dssp SSSCC----------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-----HSS
T ss_pred CCCcc----------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hcc
Confidence 54321 23469999999999975 468999999999999999999999997543211 11111 111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 756 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 756 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
.....+|...++.+.+||.+||..||.+||+.
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 223 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence 22233444567889999999999999999994
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.7e-44 Score=379.96 Aligned_cols=243 Identities=27% Similarity=0.404 Sum_probs=199.0
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCc---------hhHHHHHHHHHhcC-CCceeeEecccc--
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---------SEFQQEIDILSKIR-HPNLVTLVGACP-- 593 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~---------~~f~~Ei~iL~~l~-HpnIv~l~g~~~-- 593 (846)
++|++.+.||+|+||+||+|+.. ++.||||++........ +.+.+|+.+|++++ |||||+++++|.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 47899999999999999999884 68899999987543321 24789999999997 999999999984
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccc
Q 003121 594 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 673 (846)
Q Consensus 594 ~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGl 673 (846)
+.+|||||||++|+|.++|.. ..++++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchh
Confidence 568999999999999999953 3469999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--H
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--L 745 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~--~ 745 (846)
++.+...... ....||+.|+|||++.+ ..++.++||||+||+||+|+||++||......... +
T Consensus 157 a~~~~~~~~~---------~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i 227 (277)
T d1phka_ 157 SCQLDPGEKL---------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227 (277)
T ss_dssp CEECCTTCCB---------CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eeEccCCCce---------eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH
Confidence 9877543211 23469999999999863 34788999999999999999999999876543321 1
Q ss_pred hhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 746 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 746 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..+.. .+ ........++.+.+|+.+||+.+|.+||++ +++
T Consensus 228 ~~~~~----~~-~~~~~~~~s~~~~~li~~~L~~~p~~R~s~-~ei 267 (277)
T d1phka_ 228 MSGNY----QF-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTA-EEA 267 (277)
T ss_dssp HHTCC----CC-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCH-HHH
T ss_pred HhCCC----CC-CCcccccCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 11111 11 111223456889999999999999999998 444
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=381.68 Aligned_cols=244 Identities=26% Similarity=0.290 Sum_probs=189.0
Q ss_pred cceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC-----chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEec
Q 003121 533 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-----PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 603 (846)
Q Consensus 533 ~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~-----~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy~ 603 (846)
+++||+|+||+||+|... ++.||||+++...... ...+.+|+.+|++++|||||+++++| .+..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 568999999999999875 5789999987643221 34688999999999999999999998 45789999999
Q ss_pred CCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccccc
Q 003121 604 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 683 (846)
Q Consensus 604 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~~ 683 (846)
.++++..++ .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 998887766 334568889999999999999999999 89999999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc------ccC-
Q 003121 684 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN------LLD- 755 (846)
Q Consensus 684 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~------~ld- 755 (846)
. ....||+.|+|||++... .|+.++|||||||++|||+||.+||................. ..+
T Consensus 157 ~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 157 Y--------THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp C--------CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred c--------cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence 1 234699999999998754 589999999999999999999999977655443221111000 000
Q ss_pred ---------CCCCCCC-----hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 756 ---------PLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 756 ---------~~~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
......+ ...++.+.+|+.+||+.||.+|||+ +++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa-~e~ 277 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-TQA 277 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH-HHH
T ss_pred hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCH-HHH
Confidence 0000111 1235689999999999999999999 444
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=390.81 Aligned_cols=261 Identities=22% Similarity=0.322 Sum_probs=197.3
Q ss_pred CCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHH--HHHhcCCCceeeEeccccC------ceEEEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID--ILSKIRHPNLVTLVGACPE------VWTLVY 600 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~--iL~~l~HpnIv~l~g~~~~------~~~lVm 600 (846)
+|.+.+.||+|+||.||+|++++..||||+++... ...+.+|.+ .+.+++|||||+++|+|.+ ..++||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 56677889999999999999999999999986432 334444544 4567899999999999832 478999
Q ss_pred EecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEecccCCCceEecCCCceeeecccccc
Q 003121 601 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-----KPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 601 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-----~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
|||++|+|.++|.. .+++|..++.++.+++.||.|||.. +.+|||||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999953 3589999999999999999999973 23699999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCC------CCchhhHHHHHHHHHHHHhCCCCCCCchHH--------
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE------LTPKSDVYSFGIILLRLLTGRPALGITKEV-------- 741 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~------~~~ksDVwSlGviL~elltG~~pf~~~~~~-------- 741 (846)
......... ........||+.|+|||++.+.. ++.++|||||||+||||+||.+||+.....
T Consensus 157 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 157 RHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp EEETTTTEE----CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred cccCCCcce----eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 775432111 11123467999999999987542 677899999999999999999887432110
Q ss_pred -----HHHHhhhhhccccCCCCC-CC-ChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhh
Q 003121 742 -----QYALDTGKLKNLLDPLAG-DW-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 801 (846)
Q Consensus 742 -----~~~~~~~~~~~~ld~~~~-~~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~ 801 (846)
...+........+.|..+ .+ +......+.+|+.+||..+|.+||++ .+|.+.|+.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH-HHHHHHHHHHHHh
Confidence 000111111111111111 11 12245679999999999999999999 8898999988754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=385.32 Aligned_cols=257 Identities=24% Similarity=0.397 Sum_probs=207.6
Q ss_pred hcCCCcccceeeeeCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccc--C
Q 003121 526 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--E 594 (846)
Q Consensus 526 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~ 594 (846)
..++|.+.++||+|+||.||+|.+.+ +.||||+++..... ....|.+|+.+++++ +|||||+++|+|. +
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 34578889999999999999998642 57999999865432 234688999999999 7999999999994 4
Q ss_pred ceEEEEEecCCCchhhhhccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceE
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKD---------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 659 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~---------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NIL 659 (846)
..++|||||++|+|.+++.... ....+++..+..|+.||+.||.|||+ +++|||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccc
Confidence 6899999999999999986542 23468999999999999999999999 89999999999999
Q ss_pred ecCCCceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 003121 660 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT 738 (846)
Q Consensus 660 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~ellt-G~~pf~~~ 738 (846)
++.++.+||+|||+++......... ..+...||+.|+|||++.++.++.++|||||||++|||+| |.+||...
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSE------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccCcccccccchheeccCCCcce------EeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999765432211 1234568999999999999999999999999999999999 67777554
Q ss_pred hHHH---HHHhhhhhccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHh
Q 003121 739 KEVQ---YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 800 (846)
Q Consensus 739 ~~~~---~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~ 800 (846)
.... ..+..+ .....|...+..+.+||.+||+.+|.+||++ .+++++|+.+..
T Consensus 252 ~~~~~~~~~i~~~--------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~-~~il~~L~~~i~ 307 (311)
T d1t46a_ 252 PVDSKFYKMIKEG--------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-KQIVQLIEKQIS 307 (311)
T ss_dssp CSSHHHHHHHHHT--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcC--------CCCCCcccccHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHhhc
Confidence 3322 222221 1222334456889999999999999999999 788888886544
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=388.53 Aligned_cols=248 Identities=20% Similarity=0.280 Sum_probs=198.9
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
.++|.+.+.||+|+||+||+|... +..||||+++... .+...+.+|+.+|+.++|||||++++++ .+.+|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 357999999999999999999986 6789999997643 2244688999999999999999999998 4578999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC--Cceeeeccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN--FVSKLSDFGISRFLSQN 680 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~--~~vKL~DFGla~~~~~~ 680 (846)
|+||+|.+++... ..++++..+..|+.||+.||.|||+ +||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999532 3469999999999999999999999 899999999999999854 58999999999876433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccccCCCCCC
Q 003121 681 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 760 (846)
Q Consensus 681 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~ld~~~~~ 760 (846)
... ....||+.|+|||.+.+..|+.++|||||||++|+|+||++||.............. ..... ...
T Consensus 158 ~~~---------~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~-~~~ 225 (321)
T d1tkia_ 158 DNF---------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN--AEYTF-DEE 225 (321)
T ss_dssp CEE---------EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCC-CHH
T ss_pred Ccc---------cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCC-Chh
Confidence 211 123489999999999999999999999999999999999999977655332211111 00000 000
Q ss_pred CChhhHHHHHHHHHHHhccCcCCCCChHHHHHH
Q 003121 761 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 793 (846)
Q Consensus 761 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~ 793 (846)
.+...++.+.+|+.+||..||.+||++ +++++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~-~eil~ 257 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTA-SEALQ 257 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCH-HHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCH-HHHhc
Confidence 011245779999999999999999999 55543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-44 Score=390.51 Aligned_cols=243 Identities=22% Similarity=0.367 Sum_probs=192.5
Q ss_pred CCCcccc-eeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccc------CceE
Q 003121 528 HNFDPSL-KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP------EVWT 597 (846)
Q Consensus 528 ~~f~~~~-~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~------~~~~ 597 (846)
++|.+.. .||+|+||.||+|... ++.||||+++. ...+.+|+.++.++ +|||||+++++|. ..+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4788765 5999999999999975 57899999863 35788999997665 8999999999873 3479
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC---CCceeeeccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGIS 674 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~---~~~vKL~DFGla 674 (846)
+|||||+||+|.++|.... ..++++..+..|+.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 9999999999999996432 3569999999999999999999999 89999999999999985 567999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcccc
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 754 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~l 754 (846)
+........ ....||+.|+|||++.+..|+.++|||||||+||+|+||++||........... +...+
T Consensus 162 ~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i 229 (335)
T d2ozaa1 162 KETTSHNSL---------TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRI 229 (335)
T ss_dssp EECCCCCCC---------CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CC
T ss_pred eeccCCCcc---------ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHH
Confidence 876543211 234699999999999999999999999999999999999999965432211000 00011
Q ss_pred CCCCCCCC----hhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 755 DPLAGDWP----FVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 755 d~~~~~~p----~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
......+| ...++.+.+|+.+||..+|.+||++ .+++
T Consensus 230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-~eil 270 (335)
T d2ozaa1 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-TEFM 270 (335)
T ss_dssp CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCH-HHHH
T ss_pred hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCH-HHHH
Confidence 11111122 2346789999999999999999999 5543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=377.44 Aligned_cols=234 Identities=23% Similarity=0.379 Sum_probs=192.2
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC------chhHHHHHHHHHhcC--CCceeeEecccc--Cc
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG------PSEFQQEIDILSKIR--HPNLVTLVGACP--EV 595 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~------~~~f~~Ei~iL~~l~--HpnIv~l~g~~~--~~ 595 (846)
++|.+.+.||+|+||+||+|... +..||||++....... ...+.+|+.+|++++ |||||++++++. +.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999986 6789999997643322 234779999999996 899999999984 56
Q ss_pred eEEEEEecCC-CchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-CCceeeecccc
Q 003121 596 WTLVYEYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGI 673 (846)
Q Consensus 596 ~~lVmEy~~g-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-~~~vKL~DFGl 673 (846)
.++||||+.+ +++.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccc
Confidence 8999999976 5777777433 469999999999999999999999 89999999999999985 47999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc
Q 003121 674 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 752 (846)
Q Consensus 674 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~ 752 (846)
|+...... .+...||+.|+|||++.+..+ +.++|||||||+||+|+||++||....... .+
T Consensus 158 a~~~~~~~----------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~----~~---- 219 (273)
T d1xwsa_ 158 GALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RG---- 219 (273)
T ss_dssp CEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----HC----
T ss_pred ceeccccc----------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh----hc----
Confidence 98654321 134569999999999988765 567899999999999999999997654321 11
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
...++...+..+.+|+.+||..||.+|||+ +++
T Consensus 220 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~-~ei 252 (273)
T d1xwsa_ 220 -----QVFFRQRVSSECQHLIRWCLALRPSDRPTF-EEI 252 (273)
T ss_dssp -----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred -----ccCCCCCCCHHHHHHHHHHccCCHhHCcCH-HHH
Confidence 112333456889999999999999999999 444
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=376.44 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=192.4
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
++|...++||+|+||+||+|.+. ++.||||+++.... .....+.+|+.+|++++|||||+++++| .+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 47999999999999999999986 67899999976532 2356799999999999999999999998 457899999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+.++.+. ++.. .....+++..+..++.||+.||.|||+ +|||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99765444 4432 234569999999999999999999999 899999999999999999999999999998764432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhcc--------
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN-------- 752 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~-------- 752 (846)
.. .....||+.|+|||.+.... ++.++|||||||++|+|++|++||...+.............
T Consensus 157 ~~--------~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 157 RT--------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp BC--------TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cc--------ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence 11 12345999999999987765 57899999999999999999999976654332211100000
Q ss_pred ---ccCCCCCCC-----------ChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 ---LLDPLAGDW-----------PFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 ---~ld~~~~~~-----------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
........+ ....+..+.+|+.+||..||.+|||+ +++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~-~el 280 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-KAA 280 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 000000000 01224678999999999999999999 554
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=375.66 Aligned_cols=250 Identities=26% Similarity=0.343 Sum_probs=195.9
Q ss_pred cCCCcccceeeeeCceEEEEEEEC---CeEEEEEEecCCCC--CCchhHHHHHHHHHhc---CCCceeeEecccc-----
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL--QGPSEFQQEIDILSKI---RHPNLVTLVGACP----- 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~---~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~----- 593 (846)
.++|++.++||+|+||+||+|.+. ++.||||+++.... .....+.+|+.+|+.| +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 458999999999999999999874 45699999875432 2344678899888776 7999999999872
Q ss_pred --CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecc
Q 003121 594 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671 (846)
Q Consensus 594 --~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DF 671 (846)
...+++|||+.+|++..... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecch
Confidence 25789999999887765443 334568999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh-
Q 003121 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL- 750 (846)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~- 750 (846)
|+++....... .....||+.|+|||++.+..|+.++|||||||++|||+||++||............-..
T Consensus 161 g~~~~~~~~~~---------~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 161 GLARIYSFQMA---------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp CSCCCCCGGGG---------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred hhhhhhccccc---------CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 99886543321 13456999999999999999999999999999999999999999766543321111000
Q ss_pred -------------------ccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 -------------------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 -------------------~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
..........++...++.+.+|+.+||+.||.+|||+ +++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa-~e~ 290 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-YSA 290 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH-HHH
Confidence 0000001112233446789999999999999999999 444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-42 Score=370.42 Aligned_cols=249 Identities=23% Similarity=0.300 Sum_probs=194.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC-CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmEy 602 (846)
++|...++||+|+||+||+|.+. ++.||||++..... .....+.+|+.+|++++|||||+++++| .+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 47899999999999999999887 57899999976532 2246799999999999999999999998 4578999999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 682 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~~ 682 (846)
+.++++..+.. ....+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98877777663 34679999999999999999999999 8999999999999999999999999999987654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh-----------
Q 003121 683 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL----------- 750 (846)
Q Consensus 683 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~----------- 750 (846)
. .....|++.|+|||.+.+. .++.++|||||||++|||++|++||...+...........
T Consensus 156 ~--------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 156 K--------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred c--------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 1 1233589999999999764 5799999999999999999999999765543321111000
Q ss_pred ----ccc---cCC----CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 751 ----KNL---LDP----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 751 ----~~~---ld~----~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
... ... ....++...+..+.+|+.+||+.||++|||+ +++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~-~el 278 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-KQA 278 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH-HHH
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 000 000 0011122345789999999999999999999 554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=366.83 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=192.3
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccc---------
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------- 593 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------- 593 (846)
.++|.+.++||+|+||+||+|.+. ++.||||++..... .....+.+|+.+|++++||||++++++|.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 358999999999999999999986 67899999876533 23467899999999999999999998872
Q ss_pred -CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccc
Q 003121 594 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 672 (846)
Q Consensus 594 -~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFG 672 (846)
...++||||+.++++.... .....+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecc
Confidence 3478999999888776554 334568999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc
Q 003121 673 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 751 (846)
Q Consensus 673 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~ 751 (846)
+++.+.......... .....||+.|+|||++.+. .|+.++|||||||++|||+||++||................
T Consensus 163 ~~~~~~~~~~~~~~~----~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~ 238 (318)
T d3blha1 163 LARAFSLAKNSQPNR----YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238 (318)
T ss_dssp TCEECCC-----CCC----CCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eeeeccccccccccc----ccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 998765443221111 1335699999999999765 68999999999999999999999997655433322111111
Q ss_pred cccCC-----------------CCC-CCC-------hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 752 NLLDP-----------------LAG-DWP-------FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 752 ~~ld~-----------------~~~-~~p-------~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+ ... ..+ ......+.+|+.+||+.||++|||+ +++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa-~el 302 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS-DDA 302 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH-HHH
Confidence 10000 000 000 0113467899999999999999999 444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-41 Score=367.72 Aligned_cols=264 Identities=20% Similarity=0.258 Sum_probs=198.5
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc---cCceEEEEEe
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEY 602 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~---~~~~~lVmEy 602 (846)
++|.+.+.||+|+||+||+|.+. ++.||||++..... ...+..|+++++.++|+|++.+++.| .+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46999999999999999999976 67899999876532 34689999999999888777665554 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEec---CCCceeeecccccccccc
Q 003121 603 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLSQ 679 (846)
Q Consensus 603 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~---~~~~vKL~DFGla~~~~~ 679 (846)
+. |+|.+.+.. ....+++..++.++.|++.||.|||+ ++||||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 94 566665532 23569999999999999999999999 8999999999999985 456799999999998765
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHh--hhhhccccCCC
Q 003121 680 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNLLDPL 757 (846)
Q Consensus 680 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~--~~~~~~~ld~~ 757 (846)
....... .........||+.|+|||++.+..++.++|||||||++|||+||++||........... .........+
T Consensus 159 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~- 236 (299)
T d1ckia_ 159 ARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 236 (299)
T ss_dssp TTTCCBC-CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-
T ss_pred cccccce-eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-
Confidence 4322111 11122456799999999999999999999999999999999999999965433221111 0000000001
Q ss_pred CCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhC
Q 003121 758 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 802 (846)
Q Consensus 758 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~ 802 (846)
....+...++.+.+|+.+||..+|.+||++ +.+.+.|+.+....
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~-~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCH-HHHHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCH-HHHHHHHHHHHHHc
Confidence 001112334789999999999999999999 77888888765443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=372.47 Aligned_cols=247 Identities=26% Similarity=0.324 Sum_probs=190.9
Q ss_pred CCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccc--------CceEE
Q 003121 529 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--------EVWTL 598 (846)
Q Consensus 529 ~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~~~~l 598 (846)
+|...++||+|+||+||+|++. ++.||||++..... .+.+|+.+|++++||||++++++|. ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888889999999999999986 67899999976432 3458999999999999999999872 13689
Q ss_pred EEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC-ceeeecccccccc
Q 003121 599 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFL 677 (846)
Q Consensus 599 VmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~-~vKL~DFGla~~~ 677 (846)
|||||++|.+..+.........+++..+..|+.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999877555544333445679999999999999999999999 8999999999999999765 8999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhh-------
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------- 749 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~------- 749 (846)
...... ....||+.|+|||.+.+ ..|+.++|||||||++|||++|++||............-+
T Consensus 174 ~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 174 VRGEPN---------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CTTSCC---------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCCccc---------ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 543211 23469999999998875 4789999999999999999999999976654332211100
Q ss_pred ---------hccccCC------CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 750 ---------LKNLLDP------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 750 ---------~~~~ld~------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
.....-+ .........++.+.+|+.+||..||.+|||+ .+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-~e~L 301 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-LEAC 301 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH-HHHH
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH-HHHh
Confidence 0000000 0011122346789999999999999999999 5553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-40 Score=358.40 Aligned_cols=265 Identities=20% Similarity=0.249 Sum_probs=205.4
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCC-CceeeEeccc--cCceEEEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH-PNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~H-pnIv~l~g~~--~~~~~lVmE 601 (846)
.++|.+.++||+|+||+||+|++. ++.||||++.... ....+.+|+++++.|.| +|++.+++++ ....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 357999999999999999999976 6889999986543 34568899999999975 8999988877 456889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecC-----CCceeeeccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-----NFVSKLSDFGISRF 676 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~-----~~~vKL~DFGla~~ 676 (846)
|+ +|+|.+++... ...+++..+..++.|++.||.|||+ +|||||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 78999888543 3468999999999999999999999 89999999999999974 57899999999998
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchH---HHH--HHhhhhhc
Q 003121 677 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE---VQY--ALDTGKLK 751 (846)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~---~~~--~~~~~~~~ 751 (846)
+........ ..........||+.|+|||++.+..++.++|||||||++|||+||+.||..... ... .+...+..
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQH-IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccc-eeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 754432211 111122456799999999999999999999999999999999999999964322 111 11111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHHHHHHHHHhhCCCC
Q 003121 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 805 (846)
Q Consensus 752 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L~~l~~~~~~~ 805 (846)
........ ..++.+.+++..|+..+|.+||++ +.+.+.|+.+....+..
T Consensus 235 ~~~~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y-~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 235 TPLRELCA----GFPEEFYKYMHYARNLAFDATPDY-DYLQGLFSKVLERLNTT 283 (293)
T ss_dssp SCHHHHTT----TSCHHHHHHHHHHHHCCTTCCCCH-HHHHHHHHHHHHHTTCC
T ss_pred CChHHhcC----CCCHHHHHHHHHHhcCCcccCcCH-HHHHHHHHHHHHHcCCC
Confidence 11111112 234789999999999999999998 77888888776554433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=370.95 Aligned_cols=252 Identities=24% Similarity=0.296 Sum_probs=191.6
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccccC------ceE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE------VWT 597 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~------~~~ 597 (846)
+.+|...++||+|+||+||+|... ++.||||++...... ..+.+.+|+.+|++++||||+++++++.. ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 357999999999999999999876 688999999764322 23468899999999999999999998732 235
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccc
Q 003121 598 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 677 (846)
Q Consensus 598 lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~ 677 (846)
++++|+.+|+|.+++.. ..+++..++.++.||+.||.|||+ +|||||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 56677789999999853 358999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhc-----
Q 003121 678 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK----- 751 (846)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~----- 751 (846)
......... .....||+.|+|||++.. ..++.++||||+||++|+|+||++||................
T Consensus 160 ~~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 160 DPDHDHTGF-----LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234 (345)
T ss_dssp CGGGCBCCT-----TCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred cCCCcccee-----eccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCCh
Confidence 554322211 234579999999999854 567899999999999999999999997654322211110000
Q ss_pred --------------cccCCCCCCCC-----hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 752 --------------NLLDPLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 752 --------------~~ld~~~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
....+.....+ ...+..+.+|+.+||..||.+||++ +++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta-~e~ 292 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-EQA 292 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 00001111111 1224578999999999999999999 555
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-41 Score=368.75 Aligned_cols=246 Identities=20% Similarity=0.279 Sum_probs=188.6
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccccC--------
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE-------- 594 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-------- 594 (846)
.++|...++||+|+||+||+|... ++.||||+++...... .+.+.+|+.+|+.++|||||+++++|..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999986 6889999997643321 3468899999999999999999998832
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeeccccc
Q 003121 595 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 674 (846)
Q Consensus 595 ~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla 674 (846)
.+|+||||| +++|..++. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccce
Confidence 468999999 667777663 2459999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhh---
Q 003121 675 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL--- 750 (846)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~--- 750 (846)
+...... +...||+.|+|||++.+. .++.++|||||||++|+|++|++||...+...........
T Consensus 169 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 169 RQADSEM-----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237 (346)
T ss_dssp EECCSSC-----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eccCCcc-----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence 8764322 234699999999998764 5789999999999999999999999766543321111000
Q ss_pred -----------------ccccC----CCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHHH
Q 003121 751 -----------------KNLLD----PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 792 (846)
Q Consensus 751 -----------------~~~ld----~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 792 (846)
...+. ..........+..+.+|+.+||..||.+|||+ ++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-~eiL 299 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-GEAL 299 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH-HHHH
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH-HHHh
Confidence 00000 00011122345778999999999999999999 5553
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.7e-40 Score=357.80 Aligned_cols=243 Identities=19% Similarity=0.330 Sum_probs=191.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccc----CceEEE
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP----EVWTLV 599 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~----~~~~lV 599 (846)
.++|.+.++||+|+||+||+|+.. ++.||||+++.. ....+.+|+.+|+++. ||||++++++|. ...++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 457999999999999999999986 688999998753 3567899999999995 999999999873 358899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCC-Cceeeeccccccccc
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLS 678 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~-~~vKL~DFGla~~~~ 678 (846)
||||.+|+|..+. ..+++..+..++.||+.||.|||+ +||+||||||+||||+.+ +.+||+|||+|+...
T Consensus 111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999998764 358999999999999999999999 899999999999999865 469999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHhh---------
Q 003121 679 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDT--------- 747 (846)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~-~~~~~--------- 747 (846)
..... ....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||....... .....
T Consensus 182 ~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 182 PGQEY---------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp TTCCC---------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred CCCcc---------cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 43211 234589999999998765 57999999999999999999999996433211 00000
Q ss_pred ------h------hhccccCC---------CCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 748 ------G------KLKNLLDP---------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 748 ------~------~~~~~ld~---------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
. .+...... .........++.+.+|+.+||..||.+|||+ +++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-~e~ 316 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-REA 316 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 0 00000000 0011112345789999999999999999999 444
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-40 Score=351.31 Aligned_cols=249 Identities=24% Similarity=0.262 Sum_probs=194.7
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--cCceEEEEE
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 601 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lVmE 601 (846)
++|+..++||+|+||+||+|++. +..||||+++...... ...+.+|+.+|+.++||||++++++| .+..++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47899999999999999999986 5779999997654322 45789999999999999999999998 456889999
Q ss_pred ecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccccccccc
Q 003121 602 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 681 (846)
Q Consensus 602 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~~~~~~~ 681 (846)
|+.+++|..++. ....+++..++.++.|++.||.|||. ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988874 33568899999999999999999999 899999999999999999999999999998765433
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCc-hHHHHHHhhhhhcc-------
Q 003121 682 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGIT-KEVQYALDTGKLKN------- 752 (846)
Q Consensus 682 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~ksDVwSlGviL~elltG~~pf~~~-~~~~~~~~~~~~~~------- 752 (846)
... ....+++.|+|||.+.... ++.++|||||||++|||++|+.||... +.............
T Consensus 156 ~~~--------~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 156 RCY--------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp SCC--------CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred ccc--------eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence 211 2234789999999987665 689999999999999999999886333 22211111000000
Q ss_pred -----cc----------CCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 753 -----LL----------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 753 -----~l----------d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.. .......+...+..+.+|+.+||+.||.+|||+ +++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa-~e~ 280 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-EEA 280 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 00 001111223345689999999999999999999 444
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-41 Score=364.82 Aligned_cols=242 Identities=28% Similarity=0.374 Sum_probs=193.5
Q ss_pred CCCcccceeeeeCceEEEEEEE-----CCeEEEEEEecCCC----CCCchhHHHHHHHHHhcCC-CceeeEeccc--cCc
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHS----LQGPSEFQQEIDILSKIRH-PNLVTLVGAC--PEV 595 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~VAIK~l~~~~----~~~~~~f~~Ei~iL~~l~H-pnIv~l~g~~--~~~ 595 (846)
++|++.++||+|+||+||+|.. .++.||||+++... ....+.+.+|+.+|++++| |||+++++++ ...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4699999999999999999986 25789999987542 2234678899999999976 8999999988 456
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.+|.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchh
Confidence 88999999999999998544 347788999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHhhhhhc
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLK 751 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~~~ksDVwSlGviL~elltG~~pf~~~~~~--~~~~~~~~~~ 751 (846)
.+........ ....|++.|++||.+.+. .++.++|||||||+||+|+||++||...... ...+......
T Consensus 178 ~~~~~~~~~~-------~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 178 EFVADETERA-------YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp ECCGGGGGGG-------CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred hhcccccccc-------cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence 7654332211 223589999999999764 4788999999999999999999999654321 1111111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCCh
Q 003121 752 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 787 (846)
Q Consensus 752 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 787 (846)
. ...+|...+..+.+|+.+||..+|.+||++
T Consensus 251 ~-----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 251 S-----EPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp C-----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred C-----CCCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence 1 123445567899999999999999999963
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=360.43 Aligned_cols=245 Identities=20% Similarity=0.252 Sum_probs=184.2
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc--------Cc
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--------EV 595 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~~ 595 (846)
++|.+.++||+|+||+||+|.+. +..||||++...... ....+.+|+.+|++++|||||+++++|. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999986 688999999865432 1245889999999999999999999883 35
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.|+|||||.++.+..+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhh
Confidence 78999999776555432 358999999999999999999999 899999999999999999999999999988
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhh--------
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-------- 747 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~-------- 747 (846)
....... .+...||+.|+|||++.+..+++++||||+||++|+|++|++||...+........
T Consensus 168 ~~~~~~~---------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~ 238 (355)
T d2b1pa1 168 TAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_dssp ----------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccc---------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence 6654321 12345899999999999999999999999999999999999999765433211100
Q ss_pred ----------------hh-----------hccccCCCCCCCChhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 748 ----------------GK-----------LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 748 ----------------~~-----------~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.. +.....+.....+...+..+.+|+.+||..||.+|||+ +++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta-~el 308 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-DDA 308 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH-HHH
T ss_pred HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH-HHH
Confidence 00 00000011111122346789999999999999999999 554
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=358.35 Aligned_cols=246 Identities=20% Similarity=0.281 Sum_probs=190.0
Q ss_pred cCCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccc-------Cc
Q 003121 527 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-------EV 595 (846)
Q Consensus 527 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-------~~ 595 (846)
.++|.+.++||+|+||+||+|... ++.||||++...... ....+.+|+.+|+.++|||||++++++. ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999875 688999999865432 2346889999999999999999999873 23
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 596 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 596 ~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.+++|+|+.+|+|.+++. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhc
Confidence 467788889999999984 2459999999999999999999999 899999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHhhhhhccc-
Q 003121 676 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL- 753 (846)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~ksDVwSlGviL~elltG~~pf~~~~~~~~~~~~~~~~~~- 753 (846)
...... ....||+.|+|||.+.+. .++.++|||||||++|+|++|++||...+..............
T Consensus 170 ~~~~~~-----------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 170 HTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238 (348)
T ss_dssp CCTGGG-----------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccCccc-----------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 654322 234589999999987765 4689999999999999999999999766543322111000000
Q ss_pred ----------------cC--CCCCCCC-----hhhHHHHHHHHHHHhccCcCCCCChHHHH
Q 003121 754 ----------------LD--PLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGKDV 791 (846)
Q Consensus 754 ----------------ld--~~~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 791 (846)
.. +.....+ ...+..+.+||.+||..||.+|||+ +++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-~el 298 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-AQA 298 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH-HHH
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH-HHH
Confidence 00 0000000 1235678999999999999999999 554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-35 Score=328.10 Aligned_cols=249 Identities=18% Similarity=0.254 Sum_probs=186.3
Q ss_pred CCCcccceeeeeCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-----------CCceeeEecccc-
Q 003121 528 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----------HPNLVTLVGACP- 593 (846)
Q Consensus 528 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-----------HpnIv~l~g~~~- 593 (846)
++|.+.++||+|+||+||+|+.. ++.||||+++.... ..+.+.+|+.+|+.++ ||||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999875 68899999975432 2356788999998885 578888988873
Q ss_pred ---CceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCC------
Q 003121 594 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF------ 664 (846)
Q Consensus 594 ---~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~------ 664 (846)
...+++|+++..+..............+++..+..++.||+.||.|||+. .||+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccc
Confidence 34667787776665544444445567789999999999999999999973 6799999999999998654
Q ss_pred ceeeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--
Q 003121 665 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-- 742 (846)
Q Consensus 665 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ksDVwSlGviL~elltG~~pf~~~~~~~-- 742 (846)
.+||+|||.+....... ....||+.|+|||++....|+.++||||+||++++|++|++||.......
T Consensus 170 ~~kl~dfg~s~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp EEEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred eeeEeeccccccccccc-----------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 48999999988654321 23459999999999999999999999999999999999999996432210
Q ss_pred ----HH--------------Hhhhhh-cc---------ccCC-----------CCCCCChhhHHHHHHHHHHHhccCcCC
Q 003121 743 ----YA--------------LDTGKL-KN---------LLDP-----------LAGDWPFVQAEQLANLAMRCCEMSRKS 783 (846)
Q Consensus 743 ----~~--------------~~~~~~-~~---------~ld~-----------~~~~~p~~~~~~l~~Li~~Cl~~~P~~ 783 (846)
.. ...... .. .+.. ....++...+..+.+|+.+||..||.+
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence 00 000000 00 0000 012233456788999999999999999
Q ss_pred CCChHHHH
Q 003121 784 RPELGKDV 791 (846)
Q Consensus 784 RPt~~~~v 791 (846)
|||+ +++
T Consensus 319 Rpta-~e~ 325 (362)
T d1q8ya_ 319 RADA-GGL 325 (362)
T ss_dssp CBCH-HHH
T ss_pred CcCH-HHH
Confidence 9999 554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=5.1e-22 Score=198.64 Aligned_cols=162 Identities=14% Similarity=0.122 Sum_probs=119.2
Q ss_pred cccceeeeeCceEEEEEEEC-CeEEEEEEecCCCCC-----C-------------chhHHHHHHHHHhcCCCceeeEecc
Q 003121 531 DPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-----G-------------PSEFQQEIDILSKIRHPNLVTLVGA 591 (846)
Q Consensus 531 ~~~~~LG~G~fG~Vy~g~~~-~~~VAIK~l~~~~~~-----~-------------~~~f~~Ei~iL~~l~HpnIv~l~g~ 591 (846)
.+.++||+|+||+||+|... +..||||+++..... . ...+.+|...|.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45678999999999999865 688999998653211 0 0124568899999999999988876
Q ss_pred ccCceEEEEEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccCCCceEecCCCceeeecc
Q 003121 592 CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 671 (846)
Q Consensus 592 ~~~~~~lVmEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDLkp~NILl~~~~~vKL~DF 671 (846)
.. .++||||++++.+..+ +......++.|++.+|.|||. +||+||||||+|||++++ .++|+||
T Consensus 83 ~~--~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EG--NAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ET--TEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred cC--CEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEEC
Confidence 43 4799999988766442 223456889999999999999 899999999999999976 4889999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCC------hhhhccCCCCchhhHHHHHHHH
Q 003121 672 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMD------PEFLASGELTPKSDVYSFGIIL 725 (846)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~A------PE~l~~~~~~~ksDVwSlGviL 725 (846)
|+|....... ...|.. .+.+ ...|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~----------------~~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEG----------------WREILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTT----------------HHHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCC----------------cHHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9987553221 111211 1222 35688899999976544
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.78 E-value=6.1e-19 Score=172.84 Aligned_cols=144 Identities=17% Similarity=0.251 Sum_probs=110.5
Q ss_pred CEEEEEecCCcc---------ccHHHHHHHhhcC--CCC---cEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVK---------ESKSVLLWALQNS--GGK---RICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIE 110 (846)
Q Consensus 45 ~~V~VAVD~s~~---------~S~~AL~Wal~n~--~~~---~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 110 (846)
.||+||||+| . .|++||+||++|+ .++ .|+++||.++.... ...........+.....++..
T Consensus 2 ~ki~vavd~s-~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 77 (171)
T d2gm3a1 2 TKVMVAVNAS-TIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDG---FDDVDSIYASPEDFRDMRQSN 77 (171)
T ss_dssp EEEEEECCBC-SSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC-------------CCCCSHHHHHHHTTSH
T ss_pred CEEEEEEcCC-cccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccc---cccccccccCHHHHHHHHHHH
Confidence 5899999998 5 7999999999996 344 59999999875321 111222334567777888888
Q ss_pred HHHHHHHHHHHHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCc
Q 003121 111 RQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPAS 190 (846)
Q Consensus 111 ~~~~~~ll~~~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~ 190 (846)
.+.++++|+++...|...++++++.+.+ |++.++||++|+++++|+||||+++.+.+.|.+. |.++..|++.++
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~l---GSv~~~vi~~~~-- 151 (171)
T d2gm3a1 78 KAKGLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFV---GTVSAFCVKHAE-- 151 (171)
T ss_dssp HHHHHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC-----------CHHHHHHHHCS--
T ss_pred HHHHHHHHHHHHHHHHhcCCceEEEEEe-CChHHHHHHHHhhcCCcEEEeccCCccccccCcc---CcHHHHHHhCCC--
Confidence 8899999999999999999999987655 7999999999999999999999999999998775 789999999987
Q ss_pred cEEEEEec
Q 003121 191 CHIWFICN 198 (846)
Q Consensus 191 C~v~~i~~ 198 (846)
|.|++|-.
T Consensus 152 cpVlvV~~ 159 (171)
T d2gm3a1 152 CPVMTIKR 159 (171)
T ss_dssp SCEEEEEC
T ss_pred CCEEEEeC
Confidence 99999953
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.70 E-value=7.7e-17 Score=155.46 Aligned_cols=149 Identities=10% Similarity=0.117 Sum_probs=119.1
Q ss_pred cCCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCC-----CCCCCCccHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGT-----KFPASSLEEEKVQAYREIERQDMH 115 (846)
Q Consensus 43 ~~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 115 (846)
|=++|+||||+| +.|.+||+||++.. .+.+|+|+||.++......... ........++....+++...+.++
T Consensus 2 m~~~ILvavD~s-~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (160)
T d1mjha_ 2 MYKKILYPTDFS-ETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAK 80 (160)
T ss_dssp CCCEEEEECCSC-HHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHH
T ss_pred CcCeEEEEECCC-HHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHH
Confidence 558999999999 99999999999974 5779999999877533221110 111112234455567777788899
Q ss_pred HHHHHHHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEE
Q 003121 116 NHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWF 195 (846)
Q Consensus 116 ~ll~~~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~ 195 (846)
+.++++...|...||++++.+.. |+|.++|+++++++++|+||||+|+.+.+++.+. |.++..|+.+++ |.|++
T Consensus 81 ~~l~~~~~~~~~~gv~~~~~~~~-G~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~---GS~a~~vl~~s~--~pVlv 154 (160)
T d1mjha_ 81 NKMENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILL---GSVTENVIKKSN--KPVLV 154 (160)
T ss_dssp HHHHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSS---CHHHHHHHHHCC--SCEEE
T ss_pred HHHHHHHHHHHhcCCeEEEEEEe-ccHHHHHhhhhhccccceEEeccCCCCccccccc---CcHHHHHHhcCC--CCEEE
Confidence 99999999999999999988765 6999999999999999999999999999998876 788999999986 99999
Q ss_pred Eec
Q 003121 196 ICN 198 (846)
Q Consensus 196 i~~ 198 (846)
|-+
T Consensus 155 V~~ 157 (160)
T d1mjha_ 155 VKR 157 (160)
T ss_dssp ECC
T ss_pred EcC
Confidence 954
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.61 E-value=1.4e-15 Score=142.11 Aligned_cols=132 Identities=15% Similarity=0.184 Sum_probs=102.8
Q ss_pred CEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCL 122 (846)
Q Consensus 45 ~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~ 122 (846)
++|+||||+| +.|.+|++||++.. .+.+|+|+||.++.... . .. .......+...+.+++.++++.
T Consensus 2 k~Ilv~~D~s-~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~------~-~~----~~~~~~~~~~~~~~~~~l~~~~ 69 (135)
T d2z3va1 2 KTILLAYDGS-EHARRAAEVAKAEAEAHGARLIVVHAYEPVPDY------L-GE----PFFEEALRRRLERAEGVLEEAR 69 (135)
T ss_dssp CEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTT------C-CT----THHHHHHHHHHHHHHHHHHHHH
T ss_pred CEEEEEECCC-HHHHHHHHHHHHHHHHcCCEEEEEEEecCCccc------c-cc----chhHHHHHHHHHHHHHHHHHHH
Confidence 6899999999 99999999999973 57899999999865321 1 11 1223333444556666666655
Q ss_pred HHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 123 LICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 123 ~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
. ..++...+.++..|+|.++||++|+++++|+||||+|+++.+.|.+. |.++..+++.++ |.|.+|
T Consensus 70 ~---~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~---Gs~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 70 A---LTGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFL---GSQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp H---HHCCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSC---BHHHHHHHHHCS--SCEEEE
T ss_pred H---hcCCCeEEEEEEcCChHHHHHHHhhhhheeeEEeccCCCCccccccc---CcHHHHHHHhCC--CCEEeC
Confidence 4 45666666666779999999999999999999999999998887775 788999999987 999886
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.54 E-value=1.7e-14 Score=136.37 Aligned_cols=139 Identities=12% Similarity=0.107 Sum_probs=102.4
Q ss_pred CEEEEEecCCccccHHHHHHHhhcC-CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVKESKSVLLWALQNS-GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLL 123 (846)
Q Consensus 45 ~~V~VAVD~s~~~S~~AL~Wal~n~-~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~ 123 (846)
++|+||||+| +.|.+||+||++.. ..+.++++|+..+.......... .......+...+.++++++.+..
T Consensus 6 k~ILv~vD~s-~~s~~al~~A~~la~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~~~ 76 (147)
T d1tq8a_ 6 KTVVVGTDGS-DSSMRAVDRAAQIAGADAKLIIASAYLPQHEDARAADI--------LKDESYKVTGTAPIYEILHDAKE 76 (147)
T ss_dssp CEEEEECCSS-HHHHHHHHHHHHHHTTTSEEEEEEECCC----------------------------CCTHHHHHHHHHH
T ss_pred CEEEEEECCC-HHHHHHHHHHHHHHhcCCCEEEEEEEeccccccccccc--------chhhhHHHHHHHHHHHHHHHHHH
Confidence 7999999999 99999999999873 44555556655443221111000 11133455566778899999999
Q ss_pred HHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEEe
Q 003121 124 ICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFIC 197 (846)
Q Consensus 124 ~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i~ 197 (846)
.|.+.++......+..|++.+.|+++++++++|+||||+++.+.+.|.+. |.++..+++.++ |.|++|.
T Consensus 77 ~~~~~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~---Gs~~~~ll~~~~--~pVlvV~ 145 (147)
T d1tq8a_ 77 RAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLL---GSVPANVSRRAK--VDVLIVH 145 (147)
T ss_dssp HHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHT---BBHHHHHHHHTT--CEEEEEC
T ss_pred HHHHcCCCcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCccccccc---ccHHHHHHHhCC--CCEEEEe
Confidence 99999987655666778999999999999999999999999999888775 778899999986 9999984
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.48 E-value=1.1e-14 Score=135.90 Aligned_cols=122 Identities=10% Similarity=0.055 Sum_probs=91.5
Q ss_pred CEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHHHH
Q 003121 45 DKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCL 122 (846)
Q Consensus 45 ~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~ 122 (846)
++|+||+|.| +.|.+||+||.+.. .+..|+|+||.++.............. .. ....+..++.+++.++.+.
T Consensus 5 k~ILv~~D~S-~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~~~~~~~-~~----~~~~e~~~~~~~~~l~~~~ 78 (138)
T d1q77a_ 5 KVLLVLTDAY-SDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLP-FP----PEIKEESKKRIERRLREVW 78 (138)
T ss_dssp EEEEEEESTT-CCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCC-CC----THHHHHHHHHHHHHHHHHH
T ss_pred CEEEEEEeCC-HHHHHHHHHHHHhhhhccceEEEEEEccCcccccccccccccc-hh----hhhhhhhhhhccccchhhc
Confidence 7999999999 99999999999984 478999999997642211111111111 11 2344555667777788888
Q ss_pred HHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhh
Q 003121 123 LICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMM 173 (846)
Q Consensus 123 ~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~ 173 (846)
..+...+++++..+.. |+|.+.|+++|+++++|+||||+||.+.++|-+.
T Consensus 79 ~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l~ 128 (138)
T d1q77a_ 79 EKLTGSTEIPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPSAYLCKVID 128 (138)
T ss_dssp HHHHSCCCCCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHH
T ss_pred ccccccceeEEEeeec-chhHHHHHHhhhhccCCEEEEecCCCcHHHHHhc
Confidence 8888888888877644 7999999999999999999999998777666554
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.48 E-value=5.1e-14 Score=131.95 Aligned_cols=134 Identities=16% Similarity=0.148 Sum_probs=99.1
Q ss_pred cCCEEEEEecCCccccHHHHHHHhhcC--CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHHH
Q 003121 43 IEDKIYVAVAKQVKESKSVLLWALQNS--GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLDM 120 (846)
Q Consensus 43 ~~~~V~VAVD~s~~~S~~AL~Wal~n~--~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 120 (846)
|-++|+||||+| +.|..||.||.... .+..|+++||.+++.... +.. .+......++... +.+...
T Consensus 1 myk~ILv~vD~s-~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~--~~~------~~~~~~~~~~~~~---~~~~~~ 68 (140)
T d1jmva_ 1 MYKHILVAVDLS-EESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLY--TGL------IDVNMSSMQDRIS---TETQKA 68 (140)
T ss_dssp CCSEEEEEECCS-TTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGC--CCC------EEHHHHHHTTCCC---CHHHHH
T ss_pred CCCeEEEEECCC-HHHHHHHHHHHHHHHHcCCeEEEEEEeeeccccc--ccc------cccchHHHHHHHH---HHHHHH
Confidence 458999999999 99999999999885 578999999988764311 111 1122222222222 334455
Q ss_pred HHHHHhhcCCeeeEEEeecCchhhHHHHHHHHcCCCEEEEccCCCChhhhhhhhcchhhHHHHhccCCCccEEEEE
Q 003121 121 CLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 196 (846)
Q Consensus 121 ~~~~C~~~~V~~e~~~~e~~d~~~~I~~~v~~~~i~~LVmGs~~~~~~~R~~~~~~~~~a~~v~~sa~~~C~v~~i 196 (846)
....+.+.+....+.++..+++.++|+++++++++|+||||+|+++... + +..+..+++.++ |.|++|
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~--l----gs~~~~li~~~~--~pVliV 136 (140)
T d1jmva_ 69 LLDLAESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSK--L----MSSTRQVMNTIK--IDMLVV 136 (140)
T ss_dssp HHHHHHHSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHH--H----HHHHHHHHTTCC--SEEEEE
T ss_pred HHHHHHhcCCceEEEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCCC--c----ccHHHHHHhccC--CCEEEE
Confidence 5556666677767677788999999999999999999999999877653 3 456789999986 999998
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=3e-07 Score=93.86 Aligned_cols=145 Identities=15% Similarity=0.143 Sum_probs=97.4
Q ss_pred hhhhcCCCcccceeeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEeccc--cCceEEE
Q 003121 523 IEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLV 599 (846)
Q Consensus 523 i~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~lV 599 (846)
++.....|...+..+.+..+.||+....+..+.+|+...........+.+|...|..|. +--+.+++.++ .+..++|
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 33334455544444444457899988788889999887665555567889999988774 32244555554 4567899
Q ss_pred EEecCCCchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 003121 600 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK----------------------------------- 644 (846)
Q Consensus 600 mEy~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~----------------------------------- 644 (846)
|++++|.++.+..... .....++.+++..|..||+..
T Consensus 89 ~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999998886654211 112334555566666666421
Q ss_pred ---------------------CCceEecccCCCceEecCCCceeeecccccc
Q 003121 645 ---------------------PHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 645 ---------------------~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
+..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987667799999765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.64 E-value=7.1e-05 Score=75.16 Aligned_cols=127 Identities=17% Similarity=0.138 Sum_probs=80.7
Q ss_pred eeeeeCc-eEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCC--ceeeEeccc--cCceEEEEEecCCCch
Q 003121 535 KIGEGGY-GSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGAC--PEVWTLVYEYLPNGSL 608 (846)
Q Consensus 535 ~LG~G~f-G~Vy~g~~~~-~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~l~g~~--~~~~~lVmEy~~ggsL 608 (846)
.+..|.. +.||+....+ ..+.+|...... ...+..|...|+.|... .+.++++++ ....++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 6789887765 457888766543 34678899999887432 245566554 4567899999998776
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------------------------------------------
Q 003121 609 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC--------------------------------------------- 643 (846)
Q Consensus 609 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~--------------------------------------------- 643 (846)
.+.. +.. ..++.++...|.-||..
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4421 110 11122333333333321
Q ss_pred ----------CCCceEecccCCCceEecCCCceeeecccccc
Q 003121 644 ----------KPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 644 ----------~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
.+..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11247999999999999987777899999754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.48 E-value=0.00014 Score=78.67 Aligned_cols=75 Identities=17% Similarity=0.113 Sum_probs=52.7
Q ss_pred ceeeeeCceEEEEEEEC--CeEEEEEEecCC-------CCCCchhHHHHHHHHHhcC-C--CceeeEeccccCceEEEEE
Q 003121 534 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPH-------SLQGPSEFQQEIDILSKIR-H--PNLVTLVGACPEVWTLVYE 601 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~--~~~VAIK~l~~~-------~~~~~~~f~~Ei~iL~~l~-H--pnIv~l~g~~~~~~~lVmE 601 (846)
+.||.|....||+.... +..|+||.-.+. .....+....|...|..+. + ..+.+++++.++..++|||
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvmE 111 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVME 111 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEEC
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEEe
Confidence 45899999999998754 457899965431 1123456778999988773 2 3466778888888899999
Q ss_pred ecCCCch
Q 003121 602 YLPNGSL 608 (846)
Q Consensus 602 y~~ggsL 608 (846)
|+.+..+
T Consensus 112 ~L~~~~~ 118 (392)
T d2pula1 112 DLSHLKI 118 (392)
T ss_dssp CCTTSEE
T ss_pred ccCCccc
Confidence 9987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.72 E-value=0.0049 Score=63.45 Aligned_cols=153 Identities=14% Similarity=0.097 Sum_probs=81.3
Q ss_pred hhhhhhcCCCcccce-----eeeeCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce--eeEecc--
Q 003121 521 SEIEGATHNFDPSLK-----IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL--VTLVGA-- 591 (846)
Q Consensus 521 ~ei~~~~~~f~~~~~-----LG~G~fG~Vy~g~~~~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI--v~l~g~-- 591 (846)
.++.....+|.+... |..|---+.|+....+..+++|++... .+.+.+..|+.+|..|...++ ...+-.
T Consensus 6 ~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~ 83 (316)
T d2ppqa1 6 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKD 83 (316)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred HHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceecC
Confidence 444444455655433 334555678998888888999998653 234567778888888743222 111111
Q ss_pred ------ccCceEEEEEecCCCchhhh--------------hc----cCCC--CCCCCHH------------------HHH
Q 003121 592 ------CPEVWTLVYEYLPNGSLEDR--------------LS----CKDN--SPPLSWQ------------------TRI 627 (846)
Q Consensus 592 ------~~~~~~lVmEy~~ggsL~~~--------------L~----~~~~--~~~l~~~------------------~~~ 627 (846)
.......++.++.+...... +. .... ....... ...
T Consensus 84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (316)
T d2ppqa1 84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 163 (316)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence 13345567777766433210 00 0000 0000000 011
Q ss_pred HHHHHHHHHHHHHhh-cCCCceEecccCCCceEecCCCceeeecccccc
Q 003121 628 RIATELCSVLIFLHS-CKPHSIVHGDLKPANILLDANFVSKLSDFGISR 675 (846)
Q Consensus 628 ~i~~qia~aL~~LH~-~~~~giiHrDLkp~NILl~~~~~vKL~DFGla~ 675 (846)
..+..+...+...+. .-+.|+||+|+.++|||++.+...-|.||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 112222222222221 235789999999999999988777899999765
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.20 E-value=0.013 Score=60.70 Aligned_cols=132 Identities=12% Similarity=0.151 Sum_probs=75.6
Q ss_pred eEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce--eeEecc-------ccCceEEEEEecCCCchhh-
Q 003121 542 GSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL--VTLVGA-------CPEVWTLVYEYLPNGSLED- 610 (846)
Q Consensus 542 G~Vy~g~~~-~~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI--v~l~g~-------~~~~~~lVmEy~~ggsL~~- 610 (846)
-.||+.... |..|++|+.++.. .+.+.+..|...|..|...+| +..+.. .....+.+++|++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 479998775 6779999987643 345678899999988842222 222211 1345678999998754321
Q ss_pred -----------------hhccC--CCCCCCCHHH-------------------HHHHHHHHHHHHHHHh----hcCCCce
Q 003121 611 -----------------RLSCK--DNSPPLSWQT-------------------RIRIATELCSVLIFLH----SCKPHSI 648 (846)
Q Consensus 611 -----------------~L~~~--~~~~~l~~~~-------------------~~~i~~qia~aL~~LH----~~~~~gi 648 (846)
..... .....++... ...+...+...+..+. ...+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00000 0111222211 1112222222333332 2235689
Q ss_pred EecccCCCceEecCCCceeeeccccccc
Q 003121 649 VHGDLKPANILLDANFVSKLSDFGISRF 676 (846)
Q Consensus 649 iHrDLkp~NILl~~~~~vKL~DFGla~~ 676 (846)
||+|+.|.|||++.+ ..++||+-|..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 35899997763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.18 E-value=0.0069 Score=64.69 Aligned_cols=72 Identities=19% Similarity=0.276 Sum_probs=48.6
Q ss_pred ceeeeeCceEEEEEEECC---------eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEeccccCceEEEEEec
Q 003121 534 LKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYL 603 (846)
Q Consensus 534 ~~LG~G~fG~Vy~g~~~~---------~~VAIK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lVmEy~ 603 (846)
+.|+.|-.=.+|+..... ..|.+++... . ...-...+|..+++.+.-.++ .+++++|++ .+||||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--ceEEEEe
Confidence 457777788999987642 3577776652 2 223356689999998853344 467887765 6799999
Q ss_pred CCCchh
Q 003121 604 PNGSLE 609 (846)
Q Consensus 604 ~ggsL~ 609 (846)
+|.+|.
T Consensus 124 ~g~~l~ 129 (395)
T d1nw1a_ 124 PSRPLS 129 (395)
T ss_dssp CEEECC
T ss_pred ccccCC
Confidence 876543
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=87.01 E-value=1.2 Score=42.48 Aligned_cols=93 Identities=13% Similarity=0.150 Sum_probs=60.2
Q ss_pred CCEEEEEecCCccccHHHHHHHhhcC----CCCcEEEEEeeCCCcccccCCCCCCCCCccHHHHHHHHHHHHHHHHHHHH
Q 003121 44 EDKIYVAVAKQVKESKSVLLWALQNS----GGKRICIIHVHTPAQMIPVMGTKFPASSLEEEKVQAYREIERQDMHNHLD 119 (846)
Q Consensus 44 ~~~V~VAVD~s~~~S~~AL~Wal~n~----~~~~l~lvHV~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 119 (846)
+++|+|||-|. ..|+- |.|.|..+ ....|+++||..-... . +..-..
T Consensus 24 ~~kv~Va~SGG-~DS~~-Ll~lL~~~~~~~~~~~i~~~~vdh~~r~---------~------------------s~~~~~ 74 (216)
T d1wy5a1 24 ERRVLIAFSGG-VDSVV-LTDVLLKLKNYFSLKEVALAHFNHMLRE---------S------------------AERDEE 74 (216)
T ss_dssp CCEEEEECCSS-HHHHH-HHHHHHHSTTTTTCSEEEEEEEECCSST---------H------------------HHHHHH
T ss_pred CCeEEEEeCCc-HHHHH-HHHHHHHHHHhcCCCcEEEEEeeccccc---------c------------------hhhhhh
Confidence 46999999999 78884 44555442 3447999999642110 0 011123
Q ss_pred HHHHHHhhcCCeeeEEEeecC--------ch--------hhHHHHHHHHcCCCEEEEccCCC
Q 003121 120 MCLLICRQMGVRAEKLDTESE--------ST--------EKGILELISHYGIRKLVMGAAAD 165 (846)
Q Consensus 120 ~~~~~C~~~~V~~e~~~~e~~--------d~--------~~~I~~~v~~~~i~~LVmGs~~~ 165 (846)
..+.+|...||.+....+... .. ...+.+++++++++.|++|-|.+
T Consensus 75 ~~~~~~~~l~i~~~i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~d 136 (216)
T d1wy5a1 75 FCKEFAKERNMKIFVGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (216)
T ss_dssp HHHHHHHHHTCCEEEEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred HHHHHHHhhhhhhhhhccchhhhccCCccchHHHHHHHHHHHhhhhccccccceeEeeeecc
Confidence 457889999998775543211 00 24678899999999999997653
|